PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nakkazi, E				Nakkazi, Esther			A dose of reality about fakes	NATURE MEDICINE			English	News Item																			0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					358	358		10.1038/nm0410-358b	http://dx.doi.org/10.1038/nm0410-358b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376020	Bronze			2022-12-25	WOS:000276446800013
J	Eldakak, A; Rancati, G; Rubinstein, B; Paul, P; Conaway, V; Li, R				Eldakak, Amr; Rancati, Giulia; Rubinstein, Boris; Paul, Parama; Conaway, Veronica; Li, Rong			Asymmetrically inherited multidrug resistance transporters are recessive determinants in cellular replicative ageing	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; YEAST; LOCALIZATION; SPERMIDINE; AUTOPHAGY; POLARITY; SEPTINS; SIR2	Cellular ageing is known to correlate with the accumulation of many harmful agents', but it is unclear whether ageing can also result from the deterioration of components that are beneficial to the cell, but have a low rate of renewal. Here, we report a group of plasma membrane-associated transporters in yeast, belonging to the multidrug resistance (MDR) protein families, that may represent the latter type of ageing determinants. During the division of a yeast cell, newly synthesized transporter proteins are deposited mostly into the growing bud, whereas previously synthesized MDR proteins remain tightly associated with the mother cortex. Thus, the new and old pools of membrane-bound MDR proteins are spatially segregated during yeast asymmetric cell division, with the older pool stably inherited by the ageing mother. A model based on the observed dynamics of MDR protein inheritance and turnover predicted a decline in MDR activity as the mother cell advances in replicative age. As MDR proteins have crucial roles in cellular metabolism, detoxification and stress response, their collective decline may lead to fitness loss at an advanced age. Supporting this hypothesis, mutants lacking certain MDR genes exhibited a reduced replicative lifespan (RLS), whereas introduction of only one extra copy of these MDR genes extended RLS.	[Eldakak, Amr; Rancati, Giulia; Rubinstein, Boris; Paul, Parama; Conaway, Veronica; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org		Rancati, Giulia/0000-0003-0835-0139	National Institutes of Health [R01GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Zhou for assistance on RLS experiments; C. Seidel and B. Fleharty for help on RNA purification and quantitative RT-PCR; R. Zhu, K. Wagner and J. Haug for assistamce with cell-sorting experiments and B. Slaughter, N. Pavelka and S. Xia for technical advice and critical comments. This research is supported by the National Institutes of Health, grant R01GM057063 to R.L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burke D., 2000, METHODS YEAST GENETI; BURKE DJ, 1991, MOL CELL BIOL, V11, P3691, DOI 10.1128/MCB.11.7.3691; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; EGILMEZ NK, 1990, J GERONTOL, V45, pB9, DOI 10.1093/geronj/45.1.B9; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Henderson KA, 2008, CURR OPIN CELL BIOL, V20, P723, DOI 10.1016/j.ceb.2008.09.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Kirchman PA, 2007, MECH AGEING DEV, V128, P187, DOI 10.1016/j.mad.2006.10.003; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200	30	37	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					799	U55		10.1038/ncb2085	http://dx.doi.org/10.1038/ncb2085			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20657593	Green Accepted			2022-12-25	WOS:000280561600012
J	Gretarsdottir, S; Baas, AF; Thorleifsson, G; Holm, H; den Heijer, M; de Vries, JPPM; Kranendonk, SE; Zeebregts, CJAM; van Sterkenburg, SM; Geelkerken, RH; van Rij, AM; Williams, MJA; Boll, APM; Kostic, JP; Jonasdottir, A; Jonasdottir, A; Walters, GB; Masson, G; Sulem, P; Saemundsdottir, J; Mouy, M; Magnusson, KP; Tromp, G; Elmore, JR; Sakalihasan, N; Limet, R; Defraigne, JO; Ferrell, RE; Ronkainen, A; Ruigrok, YM; Wijmenga, C; Grobbee, DE; Shah, SH; Granger, CB; Quyyumi, AA; Vaccarino, V; Patel, RS; Zafari, AM; Levey, AI; Austin, H; Girelli, D; Pignatti, PF; Olivieri, O; Martinelli, N; Malerba, G; Trabetti, E; Becker, LC; Becker, DM; Reilly, MP; Rader, DJ; Mueller, T; Dieplinger, B; Haltmayer, M; Urbonavicius, S; Lindblad, B; Gottsater, A; Gaetani, E; Pola, R; Wells, P; Rodger, M; Forgie, M; Langlois, N; Corral, J; Vicente, V; Fontcuberta, J; Espana, F; Grarup, N; Jorgensen, T; Witte, DR; Hansen, T; Pedersen, O; Aben, KK; de Graaf, J; Holewijn, S; Folkersen, L; Franco-Cereceda, A; Eriksson, P; Collier, DA; Stefansson, H; Steinthorsdottir, V; Rafnar, T; Valdimarsson, EM; Magnadottir, HB; Sveinbjornsdottir, S; Olafsson, I; Magnusson, MK; Palmason, R; Haraldsdottir, V; Andersen, K; Onundarson, PT; Thorgeirsson, G; Kiemeney, LA; Powell, JT; Carey, DJ; Kuivaniemi, H; Lindholt, JS; Jones, GT; Kong, A; Blankensteijn, JD; Matthiasson, SE; Thorsteinsdottir, U; Stefansson, K				Gretarsdottir, Solveig; Baas, Annette F.; Thorleifsson, Gudmar; Holm, Hilma; den Heijer, Martin; de Vries, Jean-Paul P. M.; Kranendonk, Steef E.; Zeebregts, Clark J. A. M.; van Sterkenburg, Steven M.; Geelkerken, Robert H.; van Rij, Andre M.; Williams, Michael J. A.; Boll, Albert P. M.; Kostic, Jelena P.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Walters, G. Bragi; Masson, Gisli; Sulem, Patrick; Saemundsdottir, Jona; Mouy, Magali; Magnusson, Kristinn P.; Tromp, Gerard; Elmore, James R.; Sakalihasan, Natzi; Limet, Raymond; Defraigne, Jean-Olivier; Ferrell, Robert E.; Ronkainen, Antti; Ruigrok, Ynte M.; Wijmenga, Cisca; Grobbee, Diederick E.; Shah, Svati H.; Granger, Christopher B.; Quyyumi, Arshed A.; Vaccarino, Viola; Patel, Riyaz S.; Zafari, A. Maziar; Levey, Allan I.; Austin, Harland; Girelli, Domenico; Pignatti, Pier Franco; Olivieri, Oliviero; Martinelli, Nicola; Malerba, Giovanni; Trabetti, Elisabetta; Becker, Lewis C.; Becker, Diane M.; Reilly, Muredach P.; Rader, Daniel J.; Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard; Urbonavicius, Sigitas; Lindblad, Bengt; Gottsater, Anders; Gaetani, Eleonora; Pola, Roberto; Wells, Philip; Rodger, Marc; Forgie, Melissa; Langlois, Nicole; Corral, Javier; Vicente, Vicente; Fontcuberta, Jordi; Espana, Francisco; Grarup, Niels; Jorgensen, Torben; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf; Aben, Katja K.; de Graaf, Jacqueline; Holewijn, Suzanne; Folkersen, Lasse; Franco-Cereceda, Anders; Eriksson, Per; Collier, David A.; Stefansson, Hreinn; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Valdimarsson, Einar M.; Magnadottir, Hulda B.; Sveinbjornsdottir, Sigurlaug; Olafsson, Isleifur; Magnusson, Magnus Karl; Palmason, Robert; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur; Kiemeney, Lambertus A.; Powell, Janet T.; Carey, David J.; Kuivaniemi, Helena; Lindholt, Jes S.; Jones, Gregory T.; Kong, Augustine; Blankensteijn, Jan D.; Matthiasson, Stefan E.; Thorsteinsdottir, Unnur; Stefansson, Kari			Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm	NATURE GENETICS			English	Article							VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; FAMILY-HISTORY; LOCUS; RISK; HOMEOSTASIS; ARTERIAL; DISEASE; LINKAGE; 9P21	We performed a genome-wide association study on 1,292 individuals with abdominal aortic aneurysms (AAAs) and 30,503 controls from Iceland and The Netherlands, with a follow-up of top markers in up to 3,267 individuals with AAAs and 7,451 controls. The A allele of rs7025486 on 9q33 was found to associate with AAA, with an odds ratio (OR) of 1.21 and P = 4.6 x 10(-10). In tests for association with other vascular diseases, we found that rs7025486[A] is associated with early onset myocardial infarction (OR = 1.18, P = 3.1 x 10(-5)), peripheral arterial disease (OR = 1.14, P = 3.9 x 10(-5)) and pulmonary embolism (OR = 1.20, P = 0.00030), but not with intracranial aneurysm or ischemic stroke. No association was observed between rs7025486[A] and common risk factors for arterial and venous diseases-that is, smoking, lipid levels, obesity, type 2 diabetes and hypertension. Rs7025486 is located within DAB2IP, which encodes an inhibitor of cell growth and survival.	[Gretarsdottir, Solveig; Thorleifsson, Gudmar; Holm, Hilma; Kostic, Jelena P.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Walters, G. Bragi; Masson, Gisli; Sulem, Patrick; Saemundsdottir, Jona; Mouy, Magali; Stefansson, Hreinn; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Populat Genom, Reykjavik, Iceland; [Baas, Annette F.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Baas, Annette F.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [den Heijer, Martin; Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Kranendonk, Steef E.] TweeSteden Hosp Tilburg, Dept Surg, Tilburg, Netherlands; [Zeebregts, Clark J. A. M.] Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [van Sterkenburg, Steven M.] Locat Rijnstate, Alysis Zorggroep, Div Vasc Surg, Dept Surg, Arnhem, Netherlands; [Geelkerken, Robert H.] Med Spectrum Twente, Dept Surg, Enschede, Netherlands; [van Rij, Andre M.; Jones, Gregory T.] Univ Otago, Dunedin Sch Med, Dept Surg, Dunedin, New Zealand; [Williams, Michael J. A.] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Boll, Albert P. M.] Canisius Wilhelmina Hosp Nijmegen, Dept Surg, Nijmegen, Netherlands; [Magnusson, Kristinn P.] Univ Akureyri, Borgir Vid Nordurslod, Akureyri, Iceland; [Tromp, Gerard; Carey, David J.; Kuivaniemi, Helena] Weis Ctr Res, Geisinger Clin, Weis Ctr Res, Danville, PA 17822 USA; [Elmore, James R.] Weis Ctr Res, Geisinger Clin, Dept Vasc Surg, Danville, PA 17822 USA; [Sakalihasan, Natzi; Limet, Raymond; Defraigne, Jean-Olivier] Univ Liege, Liege, Belgium; [Ferrell, Robert E.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Ronkainen, Antti] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Shah, Svati H.; Granger, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shah, Svati H.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Granger, Christopher B.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA; [Quyyumi, Arshed A.; Vaccarino, Viola; Patel, Riyaz S.; Zafari, A. Maziar; Levey, Allan I.] Emory Univ, Sch Med, Atlanta, GA USA; [Patel, Riyaz S.] Cardiff Univ, Cardiff, S Glam, Wales; [Zafari, A. Maziar] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Austin, Harland] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Pignatti, Pier Franco; Malerba, Giovanni; Trabetti, Elisabetta] Univ Verona, Dept Life & Reprod Sci, Sect Biol & Genet, I-37100 Verona, Italy; [Becker, Lewis C.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Johns Hopkins GeneSTAR Res Program, Baltimore, MD USA; [Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard] Konventhosp Barmherzige Brueder, Dept Lab Med, Linz, Austria; [Urbonavicius, Sigitas; Lindholt, Jes S.] Viborg Hosp, Vasc Res Unit, Viborg, Denmark; [Lindblad, Bengt; Gottsater, Anders] Skaane Univ Hosp, Vasc Ctr, Malmo, Sweden; [Gaetani, Eleonora; Pola, Roberto] Catholic Univ, Lab Vasc Biol & Genet, A Gemelli Univ Hosp, Sch Med,Dept Med, Rome, Italy; [Pola, Roberto] Tufts Univ, Sch Med, Dept Med, Div Cardiovasc Res,Caritas St Elizabeths Med Ctr, Boston, MA 02111 USA; [Wells, Philip] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [Rodger, Marc] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada; [Forgie, Melissa] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Langlois, Nicole] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Corral, Javier; Vicente, Vicente] Univ Murcia, Dept Med, Ctr Reg Hemodonac, Murcia, Spain; [Fontcuberta, Jordi] Santa Creu & St Pau Hosp, Hemostasia & Thrombosis Unit, Barcelona, Spain; [Espana, Francisco] Hosp La Fe, Res Ctr, E-46009 Valencia, Spain; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Jorgensen, Torben] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-1168 Copenhagen, Denmark; [Aben, Katja K.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Aben, Katja K.] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Folkersen, Lasse; Eriksson, Per] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Franco-Cereceda, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Collier, David A.] Kings Coll London, Div Psychol Med & Social Genet, London WC2R 2LS, England; [Collier, David A.] Kings Coll London, Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Valdimarsson, Einar M.; Sveinbjornsdottir, Sigurlaug; Olafsson, Isleifur; Magnusson, Magnus Karl; Palmason, Robert; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur] Landspitali Univ Hosp, Reykjavik, Iceland; [Magnadottir, Hulda B.] Upper Valley Neurol Neurosurg, Lebanon, NH USA; [Magnusson, Magnus Karl; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur; Matthiasson, Stefan E.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Powell, Janet T.] Imperial Coll Charing Cross, London, England; [Blankensteijn, Jan D.] VU Med Ctr Amsterdam, Div Surg, Amsterdam, Netherlands; [Blankensteijn, Jan D.] Radboud Univ Nijmegen, Med Ctr, Dept Vasc Surg, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; St. Antonius Hospital Utrecht; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; Rijnstate Hospital; Medical Spectrum Twente; University of Otago; University of Otago; Radboud University Nijmegen; University of Akureyri; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kuopio University Hospital; University of Eastern Finland; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Duke University; Duke University; Duke University; Emory University; Cardiff University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Verona; University of Verona; Johns Hopkins University; University of Pennsylvania; Konventhospital Der Barmherzigen Bruder; Aarhus University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; St. Elizabeth's Medical Center; Tufts University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Murcia; Hospital Universitari i Politecnic La Fe; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; University of Copenhagen; Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London; University of London; King's College London; Landspitali National University Hospital; University of Iceland; Radboud University Nijmegen; Imperial College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Stefansson, K (corresponding author), DeCODE Genet, Populat Genom, Reykjavik, Iceland.	solveig.gretarsdottir@decode.is; kstefans@decode.is	Walters, G. Bragi/L-4215-2013; Urbonavicius, Sigitas/U-4209-2019; Witte, Daniel/AAF-9535-2019; Magnusson, Kristinn P Pétur/X-4907-2019; Martinelli, Nicola/J-5622-2016; Kiemeney, Lambertus A./D-3357-2009; Witte, Daniel R/C-1722-2008; Wijmenga, Cisca/D-2173-2009; España, Francisco/A-7286-2008; Aben, Katja KH/G-9686-2016; Stefansson, Kari/AAE-7187-2019; Wijmenga, Cisca/AAE-7719-2019; , Viola/AAW-5600-2020; Grarup, Niels/K-2807-2015; Onundarson, Pall T./AAJ-1037-2020; Magnusson, Kristinn/A-6479-2011; Michael, Williams J A/C-1759-2008; Powell, Janet/AAW-8669-2021; Zafari, Abarmard/GRF-6849-2022; Collier, David A/D-1649-2011; Geelkerken, R. H./AAF-7404-2019; Vicente, Vicente/L-6185-2019; Xie, Huangming/B-2260-2012; Olivieri, Oliviero/A-9126-2008; Blankensteijn, Jan D/Q-9291-2016; Malerba, Giovanni/T-3278-2019; Pedersen, Oluf/AAG-8015-2020; Kuivaniemi, Helena/Q-8178-2019; Pedersen, Oluf/Z-1731-2019; Granger, Christopher B/D-3458-2014; Jørgensen, Torben/Z-1335-2018; Girelli, Domenico/B-1183-2008; de Graaf, J./H-8038-2014; Tromp, Gerard/B-2677-2017; Urbonavicius, Sigitas/D-7997-2015; Levey, Allan/F-2104-2011; Grobbee, Diederick/C-7651-2014; Lindholt, Jes/J-2907-2014; den Heijer, Martin/J-8036-2015	Walters, G. Bragi/0000-0002-5415-6487; Witte, Daniel/0000-0002-0769-2922; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Martinelli, Nicola/0000-0001-6465-5119; Kiemeney, Lambertus A./0000-0002-2368-1326; Witte, Daniel R/0000-0002-0769-2922; Aben, Katja KH/0000-0002-0214-2147; Wijmenga, Cisca/0000-0002-5635-1614; Grarup, Niels/0000-0001-5526-1070; Magnusson, Kristinn/0000-0003-4528-6826; Michael, Williams J A/0000-0003-4822-4962; Powell, Janet/0000-0002-3905-1468; Collier, David A/0000-0003-4087-1559; Vicente, Vicente/0000-0002-4278-3264; Olivieri, Oliviero/0000-0001-8209-9056; Blankensteijn, Jan D/0000-0002-2062-8749; Kuivaniemi, Helena/0000-0001-5753-8766; Pedersen, Oluf/0000-0002-3321-3972; Granger, Christopher B/0000-0002-0045-3291; Girelli, Domenico/0000-0001-9684-1899; Tromp, Gerard/0000-0002-7761-0806; Urbonavicius, Sigitas/0000-0002-1838-2065; Levey, Allan/0000-0002-3153-502X; Grobbee, Diederick/0000-0003-4472-4468; Lindholt, Jes/0000-0001-9536-4488; den Heijer, Martin/0000-0003-3620-5617; Magnusson, Magnus Karl/0000-0001-8593-4934; Rodger, Marc/0000-0001-8166-3487; Stefansson, Hreinn/0000-0002-9331-6666; Reilly, Muredach/0000-0002-3035-9386; Folkersen, Lasse/0000-0003-0708-9530; Gaetani, Eleonora/0000-0002-7808-1491; Pola, Roberto/0000-0001-5224-2931; Corral, Javier/0000-0003-0288-1107; Kong, Augustine/0000-0001-8193-5438; Malerba, Giovanni/0000-0001-8705-8560; Jorgensen, Torben/0000-0001-9453-2830; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Jones, Gregory T/0000-0002-6950-4210; Hansen, Torben/0000-0001-8748-3831; Espana, Francisco/0000-0001-7829-2021; Langlois, Nicole/0000-0002-4953-6549; Eriksson, Per/0000-0002-5635-2692	US National Heart, Lung, and Blood Institute (NHLBI) [HL064310, HL044682, HL087698, HL58625]; National Institutes of Health [R01HL089650-02]; European Community [FP7/2007-2013, HEALTH-F2-2008-200647, HEALTH-F4-2007-201413]; Swedish Research Council [12660]; F. Lundberg; US National Institute of Neurological Disorders and Stroke [NS034395]; American Heart Association; University of Kuopio; Netherlands Heart Foundation [2009T001, 2005T014]; Health Research Council of New Zealand; UK Medical Research Council; British Heart Foundation; Instituto Carlos III, Spain [RECAVA RD06/0014/0004, RD06/0014/0039, 06/0014/0016]; Novartis Foundation for Cardiovascular Excellence; Danish Research Council; Danish Diabetes Association; Danish Centre for Health Technology Assessment; Novo Nordisk; Research Foundation of Copenhagen County; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Velux foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058625] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087698, R01HL064310, R18HL058625, R01HL089650, R01HL058625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034395] Funding Source: NIH RePORTER; Medical Research Council [G9817803B, G0501184] Funding Source: researchfish; MRC [G0501184] Funding Source: UKRI	US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); F. Lundberg; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); University of Kuopio; Netherlands Heart Foundation(Netherlands Heart Foundation); Health Research Council of New Zealand(Health Research Council of New Zealand); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Instituto Carlos III, Spain(Instituto de Salud Carlos III); Novartis Foundation for Cardiovascular Excellence; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Diabetes Association; Danish Centre for Health Technology Assessment; Novo Nordisk(Novo Nordisk); Research Foundation of Copenhagen County; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Velux foundation(Velux Fonden); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the individuals who participated in the study and whose contribution made this work possible. This study was funded in part through grants from the US National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (R01HL089650-02), and from two projects in the European Community's Seventh Framework Programme (FP7/2007-2013): the Fighting Aneurysmal Disease project grant agreement HEALTH-F2-2008-200647, and ENGAGE project grant agreement HEALTH-F4-2007-201413. The gene expression study in aorta and mammary artery was funded by the Swedish Research Council (12660) and a donation by F. Lundberg. The recruitment of AAA sample sets and controls from Belgium, Canada and Pittsburgh was funded in part by grants from the NHLBI (HL064310 to H. K. and HL044682 to R. E. F.). The Finnish IA sample collection was funded in part by the US National Institute of Neurological Disorders and Stroke (NS034395 to G. Tromp), the American Heart Association, Michigan Affiliate (to G. Tromp) and the University of Kuopio (to A. R.). A. F. B. and Y.M.R. were supported by grants from the Dr. E. Dekker program of the Netherlands Heart Foundation (2009T001 and 2005T014 respectively). New Zealand samples were recruited and genotyped through the Vascular Research Consortium of New Zealand with funding via a program grant from the Health Research Council of New Zealand. Sample collection in Danville, Pennsylvania, was funded by a grant from the American Heart Association (to D.J.C.). UK sample collection was funded partially by grants from the UK Medical Research Council and the British Heart Foundation (to J.T.P.). The recruitment of VTE patients and controls from Spain was funded in part by grants from the Instituto Carlos III (RECAVA RD06/0014/0004, RD06/0014/0039 and 06/0014/0016). DNA isolation of Dutch AAA samples was funded from a grant from the Novartis Foundation for Cardiovascular Excellence. The GeneSTAR Research Program was funded in part by the NHLBI (HL087698 to L. C. B. and HL58625 to D. M. B.). The Danish Study of control subjects was funded by research grants from the Danish Research Council, the Danish Diabetes Association, the Danish Centre for Health Technology Assessment, Novo Nordisk, the Research Foundation of Copenhagen County, the Danish Ministry of Internal Affairs and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation and the Velux foundation. The Inter99 was initiated by T.J. (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T. F. Thomsen. The steering committee comprises the former two and C. Pisinger.	Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Assar AN, 2009, POSTGRAD MED J, V85, P268, DOI 10.1136/pgmj.2008.074666; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Braekkan SK, 2008, J THROMB HAEMOST, V6, P1851, DOI 10.1111/j.1538-7836.2008.03102.x; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Crawford CM, 2003, J MANIP PHYSIOL THER, V26, P184, DOI 10.1016/S0161-4754(02)54111-7; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Elmore JR, 2009, J VASC SURG, V49, P1525, DOI 10.1016/j.jvs.2009.01.041; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Grootenboer N, 2009, EUR J VASC ENDOVASC, V38, P278, DOI 10.1016/j.ejvs.2009.05.004; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Iwashita S, 2008, MOL BIOSYST, V4, P213, DOI 10.1039/b716357f; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ogata T, 2005, J VASC SURG, V42, P891, DOI 10.1016/j.jvs.2005.08.002; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Qiu GH, 2007, J HEPATOL, V46, P655, DOI 10.1016/j.jhep.2006.11.012; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rice JA., 1995, MATH STAT DATA ANAL, V1, P308; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sandford RM, 2007, EUR J VASC ENDOVASC, V33, P381, DOI 10.1016/j.ejvs.2006.10.025; Shibamura H, 2004, CIRCULATION, V109, P2103, DOI 10.1161/01.CIR.0000127857.77161.A1; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Thompson AR, 2009, EUR J HUM GENET, V17, P391, DOI 10.1038/ejhg.2008.196; van Vlijmen-van Keulen CJ, 2005, EUR J VASC ENDOVASC, V30, P29, DOI 10.1016/j.ejvs.2004.12.029; Wahlgren CM, 2010, J VASC SURG, V51, P3, DOI 10.1016/j.jvs.2009.08.036; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	37	141	148	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					692	U71		10.1038/ng.622	http://dx.doi.org/10.1038/ng.622			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622881	Green Accepted			2022-12-25	WOS:000280524000014
J	Forsman, U; Sjoberg, M; Turunen, M; Sindelar, PJ				Forsman, Ulrika; Sjoberg, Mats; Turunen, Mikael; Sindelar, Pavel J.			4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE ELECTRON-TRANSPORT; LIVER PLASMA-MEMBRANE; PURIFICATION; DEFICIENCY; DISEASES; TISSUES; RAT; AGE	Coenzyme Q (Q) is an electron transporter in the respiratory chain and a lipid-soluble antioxidant that decreases in humans with age. Here we show that 4-nitrobenzoate inhibited 4-hydroxybenzoate: polyprenyl transferase (Coq2) in a competitive manner and dose-dependently decreased Q in mammalian cells without accumulation of Q intermediates. As 4-nitrobenzoate neither interfered with mitochondrial respiration nor induced oxidative stress, it should prove a valuable tool for studies on both Q deficiency and Q supplementation.	[Forsman, Ulrika; Sjoberg, Mats; Turunen, Mikael; Sindelar, Pavel J.] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sindelar, Pavel J.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Forsman, U (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	pavel.j.sindelar@gmail.com			Loo and Hans Osterman Foundation for Geriatric Research; Ollie and Elof Ericsson Foundation; O.E. and Edla Johansson Foundation; Helge Ax:son Johnson foundation; Carl Trygger Foundation	Loo and Hans Osterman Foundation for Geriatric Research; Ollie and Elof Ericsson Foundation(Ericsson); O.E. and Edla Johansson Foundation; Helge Ax:son Johnson foundation; Carl Trygger Foundation	We thank T. Chojnacki (Institute of Biochemistry and Biophysics, Polish Academy of Sciences) for kindly providing the various radioactive and non-radioactive isoprenoids. We are also indebted to J.W. DePierre and B. D. Nelson (Department of Biochemistry and Biophysics, Stockholm Univ.) for valuable discussions during preparation of the manuscript. This work was supported by the Loo and Hans Osterman Foundation for Geriatric Research, the Ollie and Elof Ericsson Foundation, the O.E. and Edla Johansson Foundation, the Helge Ax:son Johnson foundation and the Carl Trygger Foundation.	ALAM SS, 1975, ARCH BIOCHEM BIOPHYS, V171, P183, DOI 10.1016/0003-9861(75)90022-3; Clarke CF, 2000, PROTOPLASMA, V213, P134, DOI 10.1007/BF01282151; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Galpern WR, 2007, MITOCHONDRION, V7, pS146, DOI 10.1016/j.mito.2007.01.004; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007; Lenaz G, 2007, MITOCHONDRION, V7, pS8, DOI 10.1016/j.mito.2007.03.009; Martin SF, 2001, J BIOENERG BIOMEMBR, V33, P143, DOI 10.1023/A:1010704715979; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; NAMBUDIRI AMD, 1977, BIOCHEM BIOPH RES CO, V76, P282, DOI 10.1016/0006-291X(77)90723-9; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Rotig A, 2007, MITOCHONDRION, V7, pS112, DOI 10.1016/j.mito.2007.02.008; Singh U, 2007, NUTR REV, V65, P286, DOI [10.1301/nr.2007.jun.286-293, 10.1111/j.1753-4887.2007.tb00306.x]; Sohal RS, 2004, METHOD ENZYMOL, V378, P146; SUN IL, 1992, P NATL ACAD SCI USA, V89, P11126, DOI 10.1073/pnas.89.23.11126; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887	22	29	29	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					515	517		10.1038/NCHEMBIO.372	http://dx.doi.org/10.1038/NCHEMBIO.372			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20526342				2022-12-25	WOS:000278878700011
J	Padmanabhan, S; Amin, T; Sampat, B; Cook-Deegan, R; Chandrasekharan, S				Padmanabhan, Swathi; Amin, Tahir; Sampat, Bhaven; Cook-Deegan, Robert; Chandrasekharan, Subhashini			Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India	NATURE BIOTECHNOLOGY			English	Editorial Material							CERVICAL-CANCER PREVENTION; DEVELOPING-COUNTRIES; ACCESS; CHALLENGES; HEALTH; IMPACT		[Padmanabhan, Swathi; Cook-Deegan, Robert; Chandrasekharan, Subhashini] Duke Univ, Inst Genome Sci & Policy, Ctr Genome Eth Law & Policy, Durham, NC 27706 USA; [Amin, Tahir] Initiat Med Access & Knowledge, New York, NY USA; [Sampat, Bhaven] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Duke University; Columbia University	Padmanabhan, S (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Genome Eth Law & Policy, Durham, NC 27706 USA.	shubha.c@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	Duke University; Asian and Pacific Studies Institute at Duke University; Dannenberg Awards; Focus Program; Public Policy Studies Department at Duke University; National Human Genome Research Institute; Department of Energy (CEER, Duke University, Center of Excellence for ELSI Research) [P50 HG003391]; Charles M. Josiah Trent Foundation; Echoing Green Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	Duke University; Asian and Pacific Studies Institute at Duke University; Dannenberg Awards; Focus Program; Public Policy Studies Department at Duke University; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy (CEER, Duke University, Center of Excellence for ELSI Research)(United States Department of Energy (DOE)); Charles M. Josiah Trent Foundation; Echoing Green Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all the interviewees for their voluntary participation in this study, and J.T. Schiller and M. Angrist for helpful discussion and comments. S. P. was supported by travel awards from the Alice M. Baldwin Scholars program at Duke University, the Janet B. Chiang grant from the Asian and Pacific Studies Institute at Duke University, the Dannenberg Awards, the Stay In Focus grant from the Focus Program and the Public Policy Studies Department at Duke University. S. C. and R.C.-D. gratefully acknowledge the support of the National Human Genome Research Institute and the Department of Energy (CEER grant P50 HG003391, Duke University, Center of Excellence for ELSI Research). S. C. and R.C.-D. also received a grant from the Charles M. Josiah Trent Foundation that supported travel for S. C. T. A. gratefully acknowledges the support of the Echoing Green Fellowship.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; [Anonymous], CDC VACC PRIC LIST; Batson A, 2008, HEALTH AFFAIR, V27, P140, DOI 10.1377/hlthaff.27.1.140; Batson A, 2006, VACCINE, V24, P219, DOI 10.1016/j.vaccine.2006.05.042; Chaifetz S, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-1; Chokshi DA, 2007, JAMA-J AM MED ASSOC, V298, P1934, DOI 10.1001/jama.298.16.1934; Diaz M, 2008, BRIT J CANCER, V99, P230, DOI 10.1038/sj.bjc.6604462; FERLAY J, 2004, 5 IARC; Fraillery D, 2007, CLIN VACCINE IMMUNOL, V14, P1285, DOI 10.1128/CVI.00164-07; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; GHANDI G, 2008, UPDATE GAVI ALLIANCE; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Inglis S, 2006, VACCINE, V24, P99, DOI 10.1016/j.vaccine.2006.05.119; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; JAY CH, 2008, J PHARM SCI, V10, P1; Jodar L, 2005, BIRK ADV INFECT DIS, P55; KAISER J, 2009, SCIENCE, V320, P860; Kane MA, 2006, VACCINE, V24, P132, DOI 10.1016/j.vaccine.2006.05.128; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Lydon P, 2008, VACCINE, V26, P6706, DOI 10.1016/j.vaccine.2008.10.015; Mahoney RT, 2004, VACCINE, V22, P786, DOI 10.1016/j.vaccine.2003.04.001; Maybarduk P, 2009, AM J LAW MED, V35, P323, DOI 10.1177/009885880903500205; *MIHR PIPRA, IP HDB BEST PRACT RO; Milstien JB, 2007, VACCINE, V25, P7610, DOI 10.1016/j.vaccine.2007.09.007; Milstlen JB, 2006, HEALTH AFFAIR, V25, P1061, DOI 10.1377/hlthaff.25.4.1061; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Salicrup LA, 2006, BIOTECHNOL ADV, V24, P69, DOI 10.1016/j.biotechadv.2005.06.004; Salicrup LA, 2007, NAT BIOTECHNOL, V25, P976, DOI 10.1038/nbt0907-976; Sankaranarayanan R, 2008, VACCINE, V26, pM43, DOI 10.1016/j.vaccine.2008.05.005; Schiller JT, 2006, VACCINE, V24, P147, DOI 10.1016/j.vaccine.2006.05.123; Sinha GP, 2007, EC TIMES        1016; 2007, GAVI ALLIANCE PROGR; 2010, DONATING MORE ONE MI; 2006, GSK ROTAVIRUS VACCIN; 2008, MAKING CERVICAL CANC; 2009, DONATING MORE ONE MI; 2009, ALL GIRLS DESERVE PR; 2003, MMWR WEEKLY     0912; 2008, HPV VACCINE ADOPTION; 2008, THAINDIAN NEWS  1020; GARDASIL ACCESS PROG	41	33	34	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					671	679		10.1038/nbt0710-671	http://dx.doi.org/10.1038/nbt0710-671			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	623FL	20622834	Green Accepted, hybrid			2022-12-25	WOS:000279723900019
J	Castoreno, AB; Smurnyy, Y; Torres, AD; Vokes, MS; Jones, TR; Carpenter, AE; Eggert, US				Castoreno, Adam B.; Smurnyy, Yegor; Torres, Angelica D.; Vokes, Martha S.; Jones, Thouis R.; Carpenter, Anne E.; Eggert, Ulrike S.			Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis	NATURE CHEMICAL BIOLOGY			English	Article							CONTRACTILE RING; MYOSIN-II; GTPASES; ANILLIN; MICROTUBULES; PROTEIN; INHIBITOR; SPINDLE; KINASE; ACTIN	We report the discovery of small molecules that target the Rho pathway, which is a central regulator of cytokinesis-the final step in cell division. We have developed a way of targeting a small molecule screen toward a specific pathway, which should be widely applicable to the investigation of any signaling pathway. In a chemical genetic variant of a classical modifier screen, we used RNA interference (RNAi) to sensitize cells and identified small molecules that suppressed or enhanced the RNAi phenotype. We discovered promising candidate molecules, which we named Rhodblock 1-8, and we identified the target of Rhodblock 6 as Rho kinase. Several Rhodblocks inhibited one function of the Rho pathway in cells: the correct localization of phosphorylated myosin light chain during cytokinesis. Rhodblocks differentially perturb Rho pathway proteins in cells and can be used to dissect the mechanism of the Rho pathway during cytokinesis.	[Castoreno, Adam B.; Smurnyy, Yegor; Torres, Angelica D.; Eggert, Ulrike S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Castoreno, Adam B.; Smurnyy, Yegor; Torres, Angelica D.; Eggert, Ulrike S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Vokes, Martha S.; Jones, Thouis R.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Castoreno, AB (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	ulrike_eggert@dfci.harvard.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Eggert, Ulrike/0000-0003-0932-5525; Jones, Thouis/0000-0001-6584-9660	Life Sciences Research Foundation (Novartis); L'Oreal for Women in Science; Society for Biomolecular Screening; US National Institutes of Health (NIH) [5 RL1 CA133834-03]; NIH [R01 GM082834]; Claudia Adams Barr Program; Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082834] Funding Source: NIH RePORTER	Life Sciences Research Foundation (Novartis); L'Oreal for Women in Science; Society for Biomolecular Screening; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr Program; Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at ICCB-Longwood, the Nikon Imaging Center at Harvard Medical School and the Broad Institute's Imaging Platform for their assistance and F. Roth for helpful discussions. We thank C. Field (Harvard Medical School), R. Saint (Australian National University) and E. Griffis (University of California, San Francisco) for reagents. Funding for M.S.V., T.R.J. and A.E.C. was from the Life Sciences Research Foundation (Novartis), L'Oreal for Women in Science, the Society for Biomolecular Screening and the US National Institutes of Health (NIH) 5 RL1 CA133834-03. A.B.C., Y.S., A.D.T. and U.S.E. were supported by NIH grant R01 GM082834, the Claudia Adams Barr Program and the Dana-Farber Cancer Institute.	Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; D'Avino PP, 2009, J CELL SCI, V122, P1071, DOI 10.1242/jcs.034785; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2006, MOL BIOSYST, V2, P93, DOI 10.1039/b515335b; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hickson GRX, 2008, BIOCHEM SOC T, V36, P439, DOI 10.1042/BST0360439; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Maddox AS, 2003, MOL CELL, V11, P846, DOI 10.1016/S1097-2765(03)00151-5; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mishima M, 2003, CURR BIOL, V13, pR589, DOI 10.1016/S0960-9822(03)00521-9; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Perrimon N, 2007, DRUG DISCOV TODAY, V12, P28, DOI 10.1016/j.drudis.2006.10.006; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Vale RD, 2009, J CELL BIOL, V186, P727, DOI 10.1083/jcb.200902083; Walker K, 2005, CURR OPIN GENET DEV, V15, P62, DOI 10.1016/j.gde.2004.11.001; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652	50	45	46	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					457	463		10.1038/nchembio.363	http://dx.doi.org/10.1038/nchembio.363			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20436488	Green Accepted			2022-12-25	WOS:000277748100016
J	Charles, N; Hardwick, D; Daugas, E; Illei, GG; Rivera, J				Charles, Nicolas; Hardwick, Donna; Daugas, Eric; Illei, Gabor G.; Rivera, Juan			Basophils and the T helper 2 environment can promote the development of lupus nephritis	NATURE MEDICINE			English	Article							LYN-DEFICIENT MICE; T-CELLS; REVISED CRITERIA; INTERFERON-GAMMA; IMMUNOGLOBULIN-E; DISEASE; CLASSIFICATION; ERYTHEMATOSUS; RESPONSES; AUTOREACTIVITY	In systemic lupus erythematosus (SLE), self-reactive antibodies can target the kidney (lupus nephritis), leading to functional failure and possible mortality. We report that activation of basophils by autoreactive IgE causes their homing to lymph nodes, promoting T helper type 2 (T(H)2) cell differentiation and enhancing the production of self-reactive antibodies that cause lupus-like nephritis in mice lacking the Src family protein tyrosine kinase Lyn (Lyn(-/-) mice). Individuals with SLE also have elevated serum IgE, self-reactive IgEs and activated basophils that express CD62 ligand (CD62L) and the major histocompatibility complex (MHC) class II molecule human leukocyte antigen-DR (HLA-DR), parameters that are associated with increased disease activity and active lupus nephritis. Basophils were also present in the lymph nodes and spleen of subjects with SLE. Thus, in Lyn(-/-) mice, basophils and IgE autoantibodies amplify autoantibody production that leads to lupus nephritis, and in individuals with SLE IgE autoantibodies and activated basophils are factors associated with disease activity and nephritis.	[Charles, Nicolas; Rivera, Juan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Hardwick, Donna] NIAMS, Off Clin Director, NIH, Bethesda, MD USA; [Daugas, Eric] Univ Paris Diderot, Inst Natl Sante & Rech Med U699, Dept Nephrol, Assistance Publ Hop Paris,Hop Bichat, Paris, France; [Illei, Gabor G.] Natl Inst Dent & Craniofacial Res, Sjogrens Syndrome Clin, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Rivera, J (corresponding author), NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA.	juan_rivera@nih.gov	CHARLES, Nicolas/S-2214-2019; CHARLES, Nicolas/P-5430-2014	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; DAUGAS, Eric/0000-0001-7256-7979	Laboratory Animal Care and Use Section; Flow Cytometry Section of the Office of Science and Technology, NIAMS; National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041156, ZIDAR041180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000704] Funding Source: NIH RePORTER	Laboratory Animal Care and Use Section; Flow Cytometry Section of the Office of Science and Technology, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Daruwalla and G. Souto-Adeva (Office of the Clinical Director, NIAMS) for human samples, data input and analysis and H. C. Oettgen (Harvard University) for providing the Igh-7<SUP>-/-</SUP> mice. We also thank M. Hourseau for human sample preparation and L. B. Schwartz (Virginia Commonwealth University) and A. F. Walls (University of Southampton) for the gift of human basophil-specific monoclonal antibodies. We acknowledge the support of the Laboratory Animal Care and Use Section and the Flow Cytometry Section of the Office of Science and Technology, NIAMS. This research was supported by the intramural programs of NIAMS and National Institute of Dental and Craniofacial Research, NIH.	Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497, DOI 10.1590/S0100-879X2004001000008; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; DECARLI M, 1994, AUTOIMMUNITY, V18, P301; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Getz EB, 2009, J CLIN PHARMACOL, V49, P1025, DOI 10.1177/0091270009341183; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Heine G, 2002, NEPHROL DIAL TRANSPL, V17, P1790, DOI 10.1093/ndt/17.10.1790; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLMDAHL R, 1991, AUTOIMMUNITY, V8, P271, DOI 10.3109/08916939109007634; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KEPLEY CL, 1995, J IMMUNOL, V154, P6548; Kono DH, 2000, J IMMUNOL, V164, P38, DOI 10.4049/jimmunol.164.1.38; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kyttaris Vasileios C, 2005, Curr Rheumatol Rep, V7, P469, DOI 10.1007/s11926-005-0054-3; Lee HY, 2008, RHEUMATOLOGY, V47, P789, DOI 10.1093/rheumatology/ken108; Levesque MC, 2009, CLIN EXP IMMUNOL, V157, P198, DOI 10.1111/j.1365-2249.2009.03979.x; Liang MH, 2004, ARTHRITIS RHEUM-US, V50, P3418, DOI 10.1002/art.20628; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Liossis SNC, 2001, J INVEST MED, V49, P157, DOI 10.2310/6650.2001.34042; LIU FT, 1980, J IMMUNOL, V124, P2728; Lu R, 2009, GENES IMMUN, V10, P397, DOI 10.1038/gene.2009.19; Masutani K, 2001, ARTHRITIS RHEUM, V44, P2097, DOI 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6; McEuen AR, 1999, LAB INVEST, V79, P27; Miyajima H, 1996, INT ARCH ALLERGY IMM, V111, P152, DOI 10.1159/000237360; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Schroeder JT, 1997, J ALLERGY CLIN IMMUN, V99, P429, DOI 10.1016/S0091-6749(97)70065-4; Seshan SV, 2009, ARCH PATHOL LAB MED, V133, P233, DOI 10.1043/1543-2165-133.2.233; Shimizu S, 2005, J IMMUNOL, V175, P7185, DOI 10.4049/jimmunol.175.11.7185; Singh RR, 1995, J CLIN INVEST, V96, P2990, DOI 10.1172/JCI118371; Sinico RA, 2009, ANN NY ACAD SCI, V1173, P47, DOI 10.1111/j.1749-6632.2009.04746.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; TORAN EJ, 1995, J NATL MED ASSOC, V87, P693; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zeng DF, 2003, J CLIN INVEST, V112, P1211, DOI 10.1172/JCI200317165; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3	57	243	254	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					701	U107		10.1038/nm.2159	http://dx.doi.org/10.1038/nm.2159			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20512127	Green Accepted			2022-12-25	WOS:000278394200037
J	Dekker, FJ; Rocks, O; Vartak, N; Menninger, S; Hedberg, C; Balamurugan, R; Wetzel, S; Renner, S; Gerauer, M; Scholermann, B; Rusch, M; Kramer, JW; Rauh, D; Coates, GW; Brunsveld, L; Bastiaens, PIH; Waldmann, H				Dekker, Frank J.; Rocks, Oliver; Vartak, Nachiket; Menninger, Sascha; Hedberg, Christian; Balamurugan, Rengarajan; Wetzel, Stefan; Renner, Steffen; Gerauer, Marc; Schoelermann, Beate; Rusch, Marion; Kramer, John W.; Rauh, Daniel; Coates, Geoffrey W.; Brunsveld, Luc; Bastiaens, Philippe I. H.; Waldmann, Herbert			Small-molecule inhibition of APT1 affects Ras localization and signaling	NATURE CHEMICAL BIOLOGY			English	Article							ACYL-PROTEIN THIOESTERASE; CRYSTAL-STRUCTURE; 2-BROMOPALMITATE; PALMITOYLATION; LIPASE; INVASION; COMPLEX	Cycles of depalmitoylation and repalmitoylation critically control the steady-state localization and function of various peripheral membrane proteins, such as Ras proto-oncogene products. Interference with acylation using small molecules is a strategy to modulate cellular localization-and thereby unregulated signaling-caused by palmitoylated Ras proteins. We present the knowledge-based development and characterization of a potent inhibitor of acyl protein thioesterase 1 (APT1), a bona fide depalmitoylating enzyme that is, so far, poorly characterized in cells. The inhibitor, palmostatin B, perturbs the cellular acylation cycle at the level of depalmitoylation and thereby causes a loss of the precise steady-state localization of palmitoylated Ras. As a consequence, palmostatin B induces partial phenotypic reversion in oncogenic HRasG12V-transformed fibroblasts. We identify APT1 as one of the thioesterases in the acylation cycle and show that this protein is a cellular target of the inhibitor.	[Dekker, Frank J.; Menninger, Sascha; Hedberg, Christian; Balamurugan, Rengarajan; Wetzel, Stefan; Renner, Steffen; Gerauer, Marc; Rusch, Marion; Brunsveld, Luc; Bastiaens, Philippe I. H.; Waldmann, Herbert] Univ Dortmund, Fachbereich Chem, D-4600 Dortmund, Germany; [Dekker, Frank J.; Menninger, Sascha; Hedberg, Christian; Balamurugan, Rengarajan; Wetzel, Stefan; Renner, Steffen; Gerauer, Marc; Schoelermann, Beate; Rusch, Marion; Brunsveld, Luc; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Rocks, Oliver; Vartak, Nachiket; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany; [Kramer, John W.; Coates, Geoffrey W.] Baker Lab, Dept Chem & Biol Chem, Ithaca, NY USA; [Rauh, Daniel] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany	Dortmund University of Technology; Max Planck Society; Max Planck Society; Max Planck Society	Dekker, FJ (corresponding author), Univ Groningen, Univ Ctr Pharm, Groningen, Netherlands.	philippe.bastiaens@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Vartak, Nachiket/A-2979-2009; Waldmann, Herbert/B-7406-2017; Rocks, Oliver/AFI-7418-2022; Rauh, Daniel/G-1595-2013; Dekker, Frank J./H-2544-2014; Renner, Steffen/C-3400-2009; Balamurugan, Rengarajan/X-9584-2018; Rocks, Oliver/ABG-3341-2020	Vartak, Nachiket/0000-0002-2966-4631; Waldmann, Herbert/0000-0002-9606-7247; Dekker, Frank J./0000-0001-7217-9300; Renner, Steffen/0000-0002-0720-5629; Balamurugan, Rengarajan/0000-0002-8373-5736; Rocks, Oliver/0000-0001-6349-9193; Vartak, Nachiket/0000-0001-8813-4799; Brunsveld, Luc/0000-0001-5675-511X; Rauh, Daniel/0000-0002-1970-7642	Max-Planck Gesellschaft; Deutsche Forschungsgemeinschaft; Netherlands Organization for Scientific Research (NWO); European Union	Max-Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	We are grateful to H. Schutz for technical assistance with the western blots and immunofluorescence experiments. This work was financially supported by the Max-Planck Gesellschaft, the Deutsche Forschungsgemeinschaft, the Netherlands Organization for Scientific Research (NWO) (TALENT-stipendium for F.J.D.) and the European Union (Marie Curie fellowship for F.J.D.). N.V. is grateful to the International Max Planck Research School-Chemical Biology for providing a doctoral fellowship. C.H. and R.B. are grateful to the Alexander von Humboldt Foundation for postdoctoral fellowships. We thank the US National Institutes of Health for a Chemical/Biology Interface (CBI) Training Grant (to J.W.K.).	Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Biel M, 2006, CHEM-EUR J, V12, P4121, DOI 10.1002/chem.200501128; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Crimmins MT, 2001, J ORG CHEM, V66, P894, DOI 10.1021/jo001387r; Deck P, 2005, ANGEW CHEM INT EDIT, V44, P4975, DOI 10.1002/anie.200462625; Dekker FJ, 2005, CURR OPIN CHEM BIOL, V9, P232, DOI 10.1016/j.cbpa.2005.03.003; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; GRECCO HE, NAT METHODS IN PRESS; HADVARY P, 1991, J BIOL CHEM, V266, P2021; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Inoue T, 2002, J ORG CHEM, V67, P5250, DOI 10.1021/jo0257896; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Karaguni IM, 2002, CANCER RES, V62, P1718; Koch MA, 2004, P NATL ACAD SCI USA, V101, P16721, DOI 10.1073/pnas.0404719101; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Muller O, 2004, ANGEW CHEM INT EDIT, V43, P450, DOI 10.1002/anie.200352587; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Silvius JR, 2002, CURR TOP MEMBR, V52, P371; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Wang Z, 2008, NAT CHEM BIOL, V4, P557, DOI 10.1038/nchembio.104; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEIBEL EK, 1987, J ANTIBIOT, V40, P1081, DOI 10.7164/antibiotics.40.1081; WETZEL S, 2009, THESIS DORTMUND U; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148	40	271	277	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					449	456		10.1038/nchembio.362	http://dx.doi.org/10.1038/nchembio.362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20418879				2022-12-25	WOS:000277748100015
J	Fraley, SI; Feng, YF; Krishnamurthy, R; Kim, DH; Celedon, A; Longmore, GD; Wirtz, D				Fraley, Stephanie I.; Feng, Yunfeng; Krishnamurthy, Ranjini; Kim, Dong-Hwee; Celedon, Alfredo; Longmore, Gregory D.; Wirtz, Denis			A distinctive role for focal adhesion proteins in three-dimensional cell motility	NATURE CELL BIOLOGY			English	Article							FIBRONECTIN FIBRILLOGENESIS; PERICELLULAR PROTEOLYSIS; 3D MATRIX; CANCER; MIGRATION; MECHANISM; SUBSTRATE; KINASE; MECHANOSENSORS; CYTOSKELETAL	Focal adhesions are large multi-protein assemblies that form at the basal surface of cells on planar dishes, and that mediate cell signalling, force transduction and adhesion to the substratum. Although much is known about focal adhesion components in two-dimensional (2D) systems, their role in migrating cells in a more physiological three-dimensional (3D) matrix is largely unknown. Live-cell microscopy shows that for cells fully embedded in a 3D matrix, focal adhesion proteins, including vinculin, paxillin, talin, alpha-actinin, zyxin, VASP, FAK and p130Cas, do not form aggregates but are diffusely distributed throughout the cytoplasm. Despite the absence of detectable focal adhesions, focal adhesion proteins still modulate cell motility, but in a manner distinct from cells on planar substrates. Rather, focal adhesion proteins in matrix-embedded cells regulate cell speed and persistence by affecting protrusion activity and matrix deformation, two processes that have no direct role in controlling 2D cell speed. This study shows that membrane protrusions constitute a critical motility/matrix-traction module that drives cell motility in a 3D matrix.	[Fraley, Stephanie I.; Krishnamurthy, Ranjini; Kim, Dong-Hwee; Celedon, Alfredo; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Fraley, Stephanie I.; Feng, Yunfeng; Kim, Dong-Hwee; Longmore, Gregory D.; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Feng, Yunfeng; Longmore, Gregory D.] Washington Univ, Sch Med, Washington Univ BRIGHT Inst, St Louis, MO 63110 USA; [Celedon, Alfredo] Pontificia Univ Catolica Chile, Dept Mech Engn, Santiago 6904411, Chile	Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pontificia Universidad Catolica de Chile	Wirtz, D (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	glongmor@dom.wustl.edu; wirtz@jhu.edu	Wirtz, Denis/A-3257-2010; Fraley, Stephanie I./S-6162-2019; Kim, Dong-Hwee/AAU-4058-2021; Fraley, Stephanie/GSN-9847-2022	Kim, Dong-Hwee/0000-0003-0625-0660; Celedon, Alfredo/0000-0002-3224-8831; Feng, Yunfeng/0000-0001-9150-7795; Fraley, Stephanie/0000-0003-1548-4442	NIH [CA143868, GM084204, GM080673, CA85839]; ARCS; NSF-GRFP; NATIONAL CANCER INSTITUTE [R01CA085839, U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204, R01GM080673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from NIH (CA143868, GM084204, GM080673, and CA85839). S.I.F. was supported by ARCS and NSF-GRFP. We thank Michael McCaffery and Ned Perkins for help with confocal microscopy, members of the Wirtz and Longmore groups for helpful discussions, and John Isaacs of JHMI and his group for generously providing E006AA prostate cancer cells.	Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Hanada M, 2005, CLIN EXP METASTAS, V22, P485, DOI 10.1007/s10585-005-3733-6; Kole TP, 2005, MOL BIOL CELL, V16, P328, DOI 10.1091/mbc.e04-06-0485; Lee JSH, 2006, J CELL SCI, V119, P1760, DOI 10.1242/jcs.02899; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mao Y, 2006, CELL COMMUN ADHES, V13, P267, DOI 10.1080/15419060601072215; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Munevar S, 2001, MOL BIOL CELL, V12, P3947, DOI 10.1091/mbc.12.12.3947; Panorchan P, 2006, BIOPHYS J, V91, P3499, DOI 10.1529/biophysj.106.084988; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Ren XD, 2000, J CELL SCI, V113, P3673; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Salgia R, 1999, ONCOGENE, V18, P67, DOI 10.1038/sj.onc.1202273; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	31	429	437	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					598	U169		10.1038/ncb2062	http://dx.doi.org/10.1038/ncb2062			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473295	Green Accepted			2022-12-25	WOS:000278213400012
J	Jiao, YQ; Wang, YH; Xue, DW; Wang, J; Yan, MX; Liu, GF; Dong, GJ; Zeng, DL; Lu, ZF; Zhu, XD; Qian, Q; Li, JY				Jiao, Yongqing; Wang, Yonghong; Xue, Dawei; Wang, Jing; Yan, Meixian; Liu, Guifu; Dong, Guojun; Zeng, Dali; Lu, Zefu; Zhu, Xudong; Qian, Qian; Li, Jiayang			Regulation of OsSPL14 by OsmiR156 defines ideal plant architecture in rice	NATURE GENETICS			English	Article							SBP-BOX GENE; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTORS; ARABIDOPSIS; MIR156; SPL8	Increasing crop yield is a major challenge for modern agriculture. The development of new plant types, which is known as ideal plant architecture (IPA), has been proposed as a means to enhance rice yield potential over that of existing high-yield varieties(1,2). Here, we report the cloning and characterization of a semidominant quantitative trait locus, IPA1 (Ideal Plant Architecture 1), which profoundly changes rice plant architecture and substantially enhances rice grain yield. The IPA1 quantitative trait locus encodes OsSPL14 (SOUAMOSA PROMOTER BINDING PROTEIN-LIKE 14) and is regulated by microRNA (miRNA) OsmiR156 in vivo. We demonstrate that a point mutation in OsSPL14 perturbs OsmiR156-directed regulation of OsSPL14, generating an 'ideal' rice plant with a reduced tiller number, increased lodging resistance and enhanced grain yield. Our study suggests that OsSPL14 may help improve rice grain yield by facilitating the breeding of new elite rice varieties.	[Jiao, Yongqing; Wang, Yonghong; Wang, Jing; Liu, Guifu; Lu, Zefu; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Jiao, Yongqing; Wang, Yonghong; Wang, Jing; Liu, Guifu; Lu, Zefu; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Xue, Dawei; Yan, Meixian; Dong, Guojun; Zeng, Dali; Zhu, Xudong; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.	qianqian188@hotmail.com; jyli@genetics.ac.cn	Xue, Dawei/H-2324-2018; XUE, Dawei/B-3262-2010; qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020; yan, mei/AAA-1379-2022	Xue, Dawei/0000-0001-9904-7615; XUE, Dawei/0000-0001-9904-7615; Lu, Zefu/0000-0001-9322-8351	Ministry of Agriculture of the People's Republic of China [2008ZX08009]; Ministry of Science and Technology [2005CB1208]; National Natural Science Foundation of China [30710103903]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank K. Chong (Institute of Botany, Chinese Academy of Sciences) for providing the pTCK303 vector. This work was supported by grants from Ministry of Agriculture of the People's Republic of China (2008ZX08009), Ministry of Science and Technology (2005CB1208) and National Natural Science Foundation of China (30710103903).	Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; FUKUTA Y, 2004, PLANT ANIMAL GENOME, V12, P167; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khush G. S., 1995, Geojournal, V35, P329, DOI 10.1007/BF00989140; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Miyamoto N, 2004, THEOR APPL GENET, V109, P700, DOI 10.1007/s00122-004-1690-0; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Virk PS, 2004, I RICE RES NOTES, V29, pS1; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6	26	864	1022	48	544	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					541	U36		10.1038/ng.591	http://dx.doi.org/10.1038/ng.591			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20495565				2022-12-25	WOS:000278081500022
J	Simon, BM; Murdoch, CE; Scott, CT				Simon, Brenda M.; Murdoch, Charles E.; Scott, Christopher T.			Pluripotent patents make prime time: an analysis of the emerging landscape	NATURE BIOTECHNOLOGY			English	Editorial Material							STEM-CELLS		[Simon, Brenda M.; Murdoch, Charles E.; Scott, Christopher T.] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA; [Simon, Brenda M.; Murdoch, Charles E.; Scott, Christopher T.] Stanford Univ, Program Stem Cells Soc, Stanford, CA 94305 USA	Stanford University; Stanford University	Simon, BM (corresponding author), Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA.	bmsimon@stanford.edu; cscott@stanford.edu	Simon, Brenda/GVU-3293-2022					[Anonymous], 2010, US Patent Application Patent, Patent No. [12/703,015, 12703015]; [Anonymous], 2008, Japan Patent, Patent No. [2008-131577, 2008131577]; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; JAENISCH R, 2010, Patent No. 12703061; JAENISCH R, Patent No. 7682828; NORMILE D, 2010, SCI INSIDER     0208; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Sakurada K, 2010, Patent No. [2450603, GB2450603]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; *USPTO, 2008, MAN PAT EX PROC; USPTO BOARD PATENT A, 2010, Patent No. 7029913; Vrtovec KT, 2008, NAT BIOTECHNOL, V26, P393, DOI 10.1038/nbt0408-393; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; 2006, Patent No. 10997146	16	10	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					557	559		10.1038/nbt0610-557	http://dx.doi.org/10.1038/nbt0610-557			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20531331				2022-12-25	WOS:000278820200014
J	Yang, S; Kim, J; Ryu, JH; Oh, H; Chun, CH; Kim, BJ; Min, BH; Chun, JS				Yang, Siyoung; Kim, Jonghwan; Ryu, Je-Hwang; Oh, Hwanhee; Chun, Churl-Hong; Kim, Byoung Ju; Min, Byoung Hyun; Chun, Jang-Soo			Hypoxia-inducible factor-2 alpha is a catabolic regulator of osteoarthritic cartilage destruction	NATURE MEDICINE			English	Article							ENDOTHELIAL PAS DOMAIN; II COLLAGEN EXPRESSION; RENAL-CELL CARCINOMA; GROWTH-FACTOR-I; ARTICULAR CHONDROCYTES; FACTOR (HIF)-1-ALPHA; GENE-EXPRESSION; MURINE MODEL; HIF-2-ALPHA; HIF-1-ALPHA	Osteoarthritic cartilage destruction is caused by an imbalance between anabolic and catabolic factors. Here, we show that hypoxia-inducible factor-2 alpha (HIF-2 alpha, encoded by EPAS1) is a catabolic transcription factor in the osteoarthritic process. HIF-2 alpha directly induces the expression in chondrocytes of genes encoding catabolic factors, including matrix metalloproteinases (MMP1, MMP3, MMP9, MMP12 and MMP13), aggrecanase-1 (ADAMTS4), nitric oxide synthase-2 (NOS2) and prostaglandin-endoperoxide synthase-2 (PTGS2). HIF-2 alpha expression was markedly increased in human and mouse osteoarthritic cartilage, and its ectopic expression triggered articular cartilage destruction in mice and rabbits. Moreover, mice transgenic for Epas1 only in chondrocytes showed spontaneous cartilage destruction, whereas heterozygous genetic deletion of Epas1 in mice suppressed cartilage destruction caused by destabilization of the medial meniscus (DMM) or collagenase injection, with concomitant modulation of catabolic factors. Our results collectively demonstrate that HIF-2 alpha causes cartilage destruction by regulating crucial catabolic genes.	[Yang, Siyoung; Kim, Jonghwan; Ryu, Je-Hwang; Oh, Hwanhee; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Sch Life Sci, Kwangju, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Dept Orthoped Surg, Sch Med, Iksan, South Korea; [Kim, Byoung Ju; Min, Byoung Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Kim, Byoung Ju; Min, Byoung Hyun] Ajou Univ, Dept Orthoped Surg, Suwon 441749, South Korea	Gwangju Institute of Science & Technology (GIST); Wonkwang University; Ajou University; Ajou University	Chun, JS (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Sch Life Sci, Kwangju, South Korea.	jschun@gist.ac.kr		Yang, Siyoung/0000-0002-6374-0140	National Research Foundation of Korea [2009-00631480, 2009-0092210]; Korea Healthcare Technology [A084062]; Korea Research Foundation [KRF-2006-312-C00611]; Bioimaging Research Center (Gwangju Institute of Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology; Korea Research Foundation(National Research Foundation of Korea); Bioimaging Research Center (Gwangju Institute of Science and Technology)	This work was supported by grants from the National Research Foundation of Korea (Cell Dynamics Research Center 2009-00631480 and 2009-0092210), the Korea Healthcare Technology research and development project (A084062), the Korea Research Foundation (KRF-2006-312-C00611) and the Bioimaging Research Center (Gwangju Institute of Science and Technology).	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hofer T, 2001, FASEB J, V15, P2715, DOI 10.1096/fj.01-0546fje; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; KIVIRANTA I, 1984, HISTOCHEMISTRY, V80, P569; Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008; Kumar S, 2001, OSTEOARTHR CARTILAGE, V9, P641, DOI 10.1053/joca.2001.0421; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Martin G, 2004, ARTHRITIS RHEUM-US, V50, P3549, DOI 10.1002/art.20596; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Pan MR, 2002, J BIOL CHEM, V277, P32775, DOI 10.1074/jbc.M202334200; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2007, CURR OPIN RHEUMATOL, V19, P457, DOI 10.1097/BOR.0b013e3282ba5693; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schipani E, 2001, GENE DEV, V15, P2865; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Sowter HM, 2003, CANCER RES, V63, P6130; Tanaka T, 2002, J MOL CELL CARDIOL, V34, P739, DOI 10.1006/jmcc.2002.2012; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200	47	365	382	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					687	U91		10.1038/nm.2153	http://dx.doi.org/10.1038/nm.2153			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495569				2022-12-25	WOS:000278394200035
J	Koteva, K; Hong, HJ; Wang, XD; Nazi, I; Hughes, D; Naldrett, MJ; Buttner, MJ; Wright, GD				Koteva, Kalinka; Hong, Hee-Jeon; Wang, Xiao Dong; Nazi, Ishac; Hughes, Donald; Naldrett, Mike J.; Buttner, Mark J.; Wright, Gerard D.			A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor	NATURE CHEMICAL BIOLOGY			English	Article							ENTEROCOCCUS-FAECIUM; GLYCOPEPTIDE ANTIBIOTICS; STREPTOMYCES-COELICOLOR; INDUCTION SIGNALS; RESISTANCE GENES; SYSTEM; VANA; INHIBITORS; FAECALIS	Inducible resistance to the glycopeptide antibiotic vancomycin requires expression of vanH, vanA and vanX, controlled by a two-component regulatory system consisting of a receptor histidine kinase, VanS, and a response regulator, VanR. The identity of the VanS receptor ligand has been debated. Using a synthesized vancomycin photoaffinity probe, we show that vancomycin directly binds Streptomyces coelicolor VanS (VanSsc) and this binding is correlated with resistance and required for vanH, vanA and vanX gene expression.	[Koteva, Kalinka; Wang, Xiao Dong; Nazi, Ishac; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Koteva, Kalinka; Wang, Xiao Dong; Nazi, Ishac; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Hong, Hee-Jeon; Naldrett, Mike J.; Buttner, Mark J.] John Innes Ctr, Norwich, Norfolk, England; [Hong, Hee-Jeon] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Hughes, Donald] McMaster Univ, Dept Chem, Hamilton, ON, Canada	McMaster University; McMaster University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; McMaster University	Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Koteva, Kalinka/0000-0002-6446-9567; Buttner, Mark/0000-0002-3505-2981; Wright, Gerard/0000-0002-9129-7131	Canadian Institutes of Health Research [MT-14981]; Canada Research Chair in Biochemistry; Biotechnology and Biological Sciences Research Council of the UK (BBSRC) [208/P20040]; Royal Society; Medical Research Council (UK); MRC [G0700141] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [P20040, BBS/E/J/00000015] Funding Source: researchfish; Medical Research Council [G0700141] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemistry(Canada Research Chairs); Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Epand for technical assistance with isothermal titration calorimetry and G. Saalbach (John Innes Centre Proteomics Facility) for the Orbitrap analysis. D. Kahne and C. Walsh provided helpful analysis of preliminary data. This research is funded in part by a Canadian Institutes of Health Research grant (MT-14981), a Canada Research Chair in Biochemistry (to G. D. W.), Biotechnology and Biological Sciences Research Council of the UK (BBSRC) grant 208/P20040 (to H.-J.H. and M.J.B.) and a grant-in-aid to the John Innes Centre from the BBSRC. H.-J.H. acknowledges support from the Royal Society and the Medical Research Council (UK).	ALLEN NE, 1995, FEMS MICROBIOL LETT, V132, P107, DOI 10.1016/0378-1097(95)00296-H; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Arthur M, 1999, MICROBIOL-UK, V145, P1849, DOI 10.1099/13500872-145-8-1849; Baptista M, 1996, ANTIMICROB AGENTS CH, V40, P2291, DOI 10.1128/AAC.40.10.2291; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; GrissomArnold J, 1997, MICROB DRUG RESIST, V3, P53, DOI 10.1089/mdr.1997.3.53; HANDWERGER S, 1990, FEMS MICROBIOL LETT, V70, P167, DOI 10.1016/S0378-1097(05)80033-3; Hong HJ, 2008, ADV EXP MED BIOL, V631, P200; Hong HJ, 2004, MOL MICROBIOL, V52, P1107, DOI 10.1111/j.1365-2958.2004.04032.x; Hutchings MI, 2006, MOL MICROBIOL, V59, P923, DOI 10.1111/j.1365-2958.2005.04953.x; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Lai MH, 1996, ANTIMICROB AGENTS CH, V40, P1645, DOI 10.1128/AAC.40.7.1645; Mani N, 1998, J ANTIBIOT, V51, P471, DOI 10.7164/antibiotics.51.471; Marshall CG, 1997, P NATL ACAD SCI USA, V94, P6480, DOI 10.1073/pnas.94.12.6480; Neu JM, 2001, FEMS MICROBIOL LETT, V199, P15, DOI 10.1111/j.1574-6968.2001.tb10644.x; Pootoolal J, 2002, ANNU REV PHARMACOL, V42, P381, DOI 10.1146/annurev.pharmtox.42.091601.142813; Prestwich GD, 1997, PHOTOCHEM PHOTOBIOL, V65, P222, DOI 10.1111/j.1751-1097.1997.tb08548.x; Roy RS, 2001, CHEM BIOL, V8, P1095, DOI 10.1016/S1074-5521(01)00075-8; Schwalbe RS, 1996, ANTIMICROB AGENTS CH, V40, P2416, DOI 10.1128/AAC.40.10.2416; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; Van Bambeke F, 2004, DRUGS, V64, P913, DOI 10.2165/00003495-200464090-00001; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	22	95	98	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					327	329		10.1038/nchembio.350	http://dx.doi.org/10.1038/nchembio.350			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20383152				2022-12-25	WOS:000276823200010
J	Subramanian, D; Laketa, V; Muller, R; Tischer, C; Zarbakhsh, S; Pepperkok, R; Schultz, C				Subramanian, Devaraj; Laketa, Vibor; Mueller, Rainer; Tischer, Christian; Zarbakhsh, Sirus; Pepperkok, Rainer; Schultz, Carsten			Activation of membrane-permeant caged PtdIns(3)P induces endosomal fusion in cells	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; RAB5; PHOSPHOINOSITIDES; 3-PHOSPHATE; PHOTOLYSIS; EFFECTORS; ESTERS; YEAST	Phosphatidylinositol 3-phosphate (PtdIns(3)P) is a phospholipid residing on early endosomes, where it is proposed to be involved in endosomal fusion. We synthesized membrane-permeant derivatives of PtdIns(3)P, including a caged version that is to our knowledge the first photoactivatable phosphoinositide derivative developed so far. In living cells, photoactivation of caged PtdIns(3)P induced rapid endosomal fusion in an EEA1-dependent fashion, thus providing in vivo evidence that PtdIns(3)P is a sufficient signal for driving this process.	[Subramanian, Devaraj; Laketa, Vibor; Mueller, Rainer; Tischer, Christian; Zarbakhsh, Sirus; Pepperkok, Rainer; Schultz, Carsten] European Mol Biol Inst, Cell Biol & Biophys Unit, Heidelberg, Germany		Schultz, C (corresponding author), European Mol Biol Inst, Cell Biol & Biophys Unit, Heidelberg, Germany.	schultz@embl.de		Mueller, Rainer/0000-0003-3464-494X; Schultz, Carsten/0000-0002-5824-2171; Laketa, Vibor/0000-0002-9472-2738; Pepperkok, Rainer/0000-0002-9762-3583	Volkswagen Foundation [I81/597, I81/797]; Helmholtz-Initiative on Systems Biology	Volkswagen Foundation(Volkswagen); Helmholtz-Initiative on Systems Biology	We thank the Advanced Light Microscopy Facility of the European Molecular Biology Laboratory (EMBL), and we also thank C. Funaya and C. Antony of the EMBL Electron Microscopy Core Facility for EM sample preparation. Funding was provided by the Volkswagen Foundation (I81/597 and I81/797) and the Helmholtz-Initiative on Systems Biology (SBCancer) to C. S.	Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Dinkel C, 2003, TETRAHEDRON LETT, V44, P1157, DOI 10.1016/S0040-4039(02)02834-4; Dinkel C, 2001, ANGEW CHEM INT EDIT, V40, P3004, DOI 10.1002/1521-3773(20010817)40:16<3004::AID-ANIE3004>3.0.CO;2-O; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Kantevari S, 2006, CHEMBIOCHEM, V7, P174, DOI 10.1002/cbic.200500345; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; WALKER JW, 1987, NATURE, V327, P249, DOI 10.1038/327249a0; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	24	58	59	3	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					324	326		10.1038/nchembio.348	http://dx.doi.org/10.1038/nchembio.348			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20364126				2022-12-25	WOS:000276823200009
J	Di Bella, D; Lazzaro, F; Brusco, A; Plumari, M; Battaglia, G; Pastore, A; Finardi, A; Cagnoli, C; Tempia, F; Frontali, M; Veneziano, L; Sacco, T; Boda, E; Brussino, A; Bonn, F; Castellotti, B; Baratta, S; Mariotti, C; Gellera, C; Fracasso, V; Magri, S; Langer, T; Plevani, P; Di Donato, S; Muzi-Falconi, M; Taroni, F				Di Bella, Daniela; Lazzaro, Federico; Brusco, Alfredo; Plumari, Massimo; Battaglia, Giorgio; Pastore, Annalisa; Finardi, Adele; Cagnoli, Claudia; Tempia, Filippo; Frontali, Marina; Veneziano, Liana; Sacco, Tiziana; Boda, Enrica; Brussino, Alessandro; Bonn, Florian; Castellotti, Barbara; Baratta, Silvia; Mariotti, Caterina; Gellera, Cinzia; Fracasso, Valentina; Magri, Stefania; Langer, Thomas; Plevani, Paolo; Di Donato, Stefano; Muzi-Falconi, Marco; Taroni, Franco			Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28	NATURE GENETICS			English	Article							M-AAA PROTEASE; RESPIRATORY-CHAIN COMPLEXES; SPINOCEREBELLAR ATAXIA; SPASTIC PARAPLEGIA; CEREBELLAR ATAXIAS; SUBSTRATE RECOGNITION; SUBUNIT COMPOSITION; CLINICAL-FEATURES; ATP HYDROLYSIS; FTSH	Autosomal dominant spinocerebellar ataxias (SCAs) are genetically heterogeneous neurological disorders characterized by cerebellar dysfunction mostly due to Purkinje cell degeneration. Here we show that AFG3L2 mutations cause SCA type 28. Along with paraplegin, which causes recessive spastic paraplegia, AFG3L2 is a component of the conserved m-AAA metalloprotease complex involved in the maintenance of the mitochondrial proteome. We identified heterozygous missense mutations in five unrelated SCA families and found that AFG3L2 is highly and selectively expressed in human cerebellar Purkinje cells. m-AAA-deficient yeast cells expressing human mutated AFG3L2 homocomplex show respiratory deficiency, proteolytic impairment and deficiency of respiratory chain complex IV. Structure homology modeling indicates that the mutations may affect AFG3L2 substrate handling. This work identifies AFG3L2 as a novel cause of dominant neurodegenerative disease and indicates a previously unknown role for this component of the mitochondrial protein quality control machinery in protecting the human cerebellum against neurodegeneration.	[Di Bella, Daniela; Plumari, Massimo; Castellotti, Barbara; Baratta, Silvia; Mariotti, Caterina; Gellera, Cinzia; Fracasso, Valentina; Magri, Stefania; Di Donato, Stefano; Taroni, Franco] Fdn IRCCS, Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Lazzaro, Federico; Plevani, Paolo; Muzi-Falconi, Marco] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Brusco, Alfredo; Cagnoli, Claudia; Brussino, Alessandro] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Brusco, Alfredo; Cagnoli, Claudia; Brussino, Alessandro] San Giovanni Battista Hosp, Unit Med Genet, Turin, Italy; [Battaglia, Giorgio; Finardi, Adele] Fdn IRCCS, Ist Neurol Carlo Besta, Unit Mol Neuroanat, Milan, Italy; [Pastore, Annalisa] Natl Inst Med Res, London NW7 1AA, England; [Tempia, Filippo; Sacco, Tiziana; Boda, Enrica] Univ Turin, Physiol Sect, Dept Neurosci, Turin, Italy; [Tempia, Filippo; Sacco, Tiziana; Boda, Enrica] Natl Inst Neurosci, Rita Levi Montalcini Ctr Brain Repair, Turin, Italy; [Frontali, Marina; Veneziano, Liana] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Bonn, Florian; Langer, Thomas] Univ Cologne, Inst Genet, D-5000 Cologne 41, Germany; [Bonn, Florian; Langer, Thomas] Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne 41, Germany	IRCCS Istituto Neurologico Besta; University of Milan; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Istituto Neurologico Besta; MRC National Institute for Medical Research; University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Cologne; University of Cologne	Taroni, F (corresponding author), Fdn IRCCS, Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy.	ftaroni@istituto-besta.it	Brusco, Alfredo/A-1811-2013; Gellera, Cinzia/J-7887-2016; Mariotti, Caterina/AAP-9425-2021; Di Donato, Stefano/B-9717-2012; Taroni, Franco/N-3879-2013; Di Bella, Daniela/K-2270-2016; Magri, Stefania/Q-8785-2019; Baratta, Silvia/AAL-3579-2021; Magri, Stefania/J-9900-2018; Finardi, Adele/K-3970-2016; Muzi-Falconi, Marco/A-6035-2012; Di Bella, Daniela/AAI-4492-2021; Boda, Enrica/AFM-7909-2022; Lazzaro, Federico/J-3585-2013; Tempia, Filippo/A-5883-2012; Veneziano, Liana/F-7858-2018; CASTELLOTTI, BARBARA/J-4939-2016	Brusco, Alfredo/0000-0002-8318-7231; Gellera, Cinzia/0000-0002-3582-665X; Mariotti, Caterina/0000-0003-2405-3564; Taroni, Franco/0000-0002-2420-5233; Di Bella, Daniela/0000-0003-0912-5136; Magri, Stefania/0000-0002-9610-7544; Baratta, Silvia/0000-0003-3886-7729; Magri, Stefania/0000-0002-9610-7544; Finardi, Adele/0000-0001-6156-975X; Muzi-Falconi, Marco/0000-0001-7046-6090; Di Bella, Daniela/0000-0003-0912-5136; Lazzaro, Federico/0000-0001-6415-2925; Tempia, Filippo/0000-0003-2778-0943; Veneziano, Liana/0000-0002-9921-8450; CASTELLOTTI, BARBARA/0000-0002-9098-3041; PLEVANI, PAOLO/0000-0003-1869-2626; BODA, Enrica/0000-0002-1006-2577; Langer, Thomas/0000-0003-1250-1462	Italian Ministry of Health [56/2005/1]; European Commission; Telethon-UILDM [GUP04009]; Fondazione Telethon-Italia [GGP07110, GGP030406, GGP09301]; Regione Piemonte Ricerca Sanitaria Finalizzata; National Organization for Rare Disorders; Regione Piemonte [A183]; Compagnia di San Paolo; Fondazione Cariplo; MRC [MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256] Funding Source: researchfish	Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Telethon-UILDM(Fondazione Telethon); Fondazione Telethon-Italia(Fondazione Telethon); Regione Piemonte Ricerca Sanitaria Finalizzata(Regione Piemonte); National Organization for Rare Disorders; Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Cariplo(Fondazione Cariplo); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the affected individuals and their families for participating in this study, our colleagues A. Salmaggi and C. P. Trevisan for referring to us the index patients from families MI-A0762 and MI-A0650, respectively, M. Rimoldi for his help in respiratory chain analysis and V. Seveso for her help with blue native electrophoresis. This work was supported by grants from the Italian Ministry of Health (RF2006 ex art. 56/2005/1 "Malattie Neurodegenerative" to F. Taroni), European Commission FP6 Integrated Project EUROSCA (to F. Taroni and S. D. D.), Telethon-UILDM (GUP04009 to F. Taroni), Fondazione Telethon-Italia (GGP07110 to A. Brusco, GGP030406 to M.M.-F. and GGP09301 to F. Taroni and M.M.-F.), Regione Piemonte Ricerca Sanitaria Finalizzata (to A. Brusco), National Organization for Rare Disorders (to A. Brusco), Regione Piemonte (CIPE 2004, project A183 to F. Tempia), Compagnia di San Paolo (to F. Tempia) and Fondazione Cariplo (to P. P.).	Adams A, 1997, METHODS YEAST GENETI; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Banfi S, 1999, GENOMICS, V59, P51, DOI 10.1006/geno.1999.5818; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Darby IA, 2006, SITU HYBRIDIZATION P; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dunn CD, 2008, MOL BIOL CELL, V19, P5387, DOI 10.1091/mbc.E08-01-0103; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Finardi A, 2006, J NEUROPATH EXP NEUR, V65, P883, DOI 10.1097/01.jnen.0000235117.67558.6d; Fracasso V., 2010, NAT PROTOC, DOI [10. 1038/nprot. 2010. 26, DOI 10.1038/NPROT.2010.26]; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Graef M, 2006, J STRUCT BIOL, V156, P101, DOI 10.1016/j.jsb.2006.01.009; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Koppen M, 2009, MOL BIOL CELL, V20, P4216, DOI 10.1091/mbc.E09-03-0218; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Magri S., 2010, NAT PROTOC, P1, DOI [10.1038/nprot.2010.25, DOI 10.1038/NPROT.2010.25]; Maltecca F, 2008, J NEUROSCI, V28, P2827, DOI 10.1523/JNEUROSCI.4677-07.2008; Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; MATILLADUENAS A, 2009, CELLULAR MOL PATHWAY, DOI DOI 10.1007/S12311-009-0144-2; Nasir J, 2006, MOVEMENT DISORD, V21, P859, DOI 10.1002/mds.20846; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; RECOGNITION, 2002, FEBS LETT, V529, P6; Sacco T, 2006, MOL CELL NEUROSCI, V33, P170, DOI 10.1016/j.mcn.2006.07.006; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soong BW, 2007, CURR OPIN NEUROL, V20, P438, DOI 10.1097/WCO.0b013e3281fbd3dd; Stevanin G, 2008, CURR NEUROL NEUROSCI, V8, P198, DOI 10.1007/s11910-008-0032-z; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	52	218	222	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					313	U66		10.1038/ng.544	http://dx.doi.org/10.1038/ng.544			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20208537				2022-12-25	WOS:000276150500010
J	Berger, AH; Niki, M; Morotti, A; Taylor, BS; Socci, ND; Viale, A; Brennan, C; Szoke, J; Motoi, N; Rothman, PB; Teruya-Feldstein, J; Gerald, WL; Ladanyi, M; Pandolfi, PP				Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Taylor, Barry S.; Socci, Nicholas D.; Viale, Agnes; Brennan, Cameron; Szoke, Janos; Motoi, Noriko; Rothman, Paul B.; Teruya-Feldstein, Julie; Gerald, William L.; Ladanyi, Marc; Pandolfi, Pier Paolo			Identification of DOK genes as lung tumor suppressors	NATURE GENETICS			English	Article							BRONCHIOALVEOLAR STEM-CELLS; ACTIVATED PROTEIN-KINASE; NEGATIVE REGULATORS; DOCKING PROTEIN; MAP KINASE; CANCER; CARCINOMA; LEUKEMIA; RECEPTOR; FAMILY	Genome-wide analyses of human lung adenocarcinoma have identified regions of consistent copy-number gain or loss, but in many cases the oncogenes and tumor suppressors presumed to reside in these loci remain to be determined. Here we identify the downstream of tyrosine kinase (Dok) family members Dok1, Dok2 and Dok3 as lung tumor suppressors. Single, double or triple compound loss of these genes in mice results in lung cancer, with penetrance and latency dependent on the number of lost Dok alleles. Cancer development is preceded by an aberrant expansion and signaling profile of alveolar type II cells and bronchioalveolar stem cells. In human lung adenocarcinoma, we identify DOK2 as a target of copy-number loss and mRNA downregulation and find that DOK2 suppresses lung cancer cell proliferation in vitro and in vivo. Given the genomic localization of DOK2, we propose it as an 8p21.3 haploinsufficient human lung tumor suppressor.	[Berger, Alice H.; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Berger, Alice H.; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Pandolfi, Pier Paolo] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA; [Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Szoke, Janos; Motoi, Noriko; Teruya-Feldstein, Julie; Gerald, William L.; Ladanyi, Marc; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; [Berger, Alice H.; Pandolfi, Pier Paolo] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Niki, Masaru; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Lab, New York, NY USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Brennan, Cameron; Gerald, William L.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of Iowa; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Morotti, Alessandro/J-7590-2018; Ladanyi, Marc/AAG-8585-2019; Motoi, Noriko/A-9718-2009; Motoi, Noriko/AAO-5642-2020; Brennan, Cameron/R-7082-2019	Morotti, Alessandro/0000-0002-8407-2903; Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Brennan, Cameron/0000-0003-4064-8891	National Cancer Institute [CA-129243, CA-64593]; Society of MSKCC; Thomas G. Labrecque Foundation; NATIONAL CANCER INSTITUTE [R01CA142787, P01CA129243, R01CA132591, P01CA064593] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society of MSKCC; Thomas G. Labrecque Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Politi, H. E. Varmus, L. F. Cai, C. F. Kim, T. Motoi, R. Hobbs, J. Clohessy, T. Yung, A. Carracedo, K. Ito, Pandolfi lab members, members of the Memorial Sloan-Kettering Cancer Center (MSKCC) Lung Cancer Oncogenome Group and members of the Dana-Farber/Harvard Cancer Center Lung Cancer Research Program for advice and discussion; B. Clarkson (MSKCC) for reagents and discussion; M. Asher, T. Matos and A. Egia for histology services and immunohistochemistry; and the MSKCC, University of Iowa, and Dana-Farber Cancer Institute flow cytometry core facilities for technical assistance. This work was funded by National Cancer Institute grants and CA-129243 (to M. L.) CA-64593 (to P. P. P.) and by the Steps for Breath Fund from the Society of MSKCC and the Thomas G. Labrecque Foundation (to M. N.).	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Cong F, 1999, MOL CELL BIOL, V19, P8314; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; EMI M, 1992, CANCER RES, V52, P5368; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Inoue A, 2007, J BIOCHEM, V142, P257, DOI 10.1093/jb/mvm127; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kashiwada M, 2006, J IMMUNOL, V176, P3958, DOI 10.4049/jimmunol.176.7.3958; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lau SK, 2002, APPL IMMUNOHISTO M M, V10, P97, DOI 10.1097/00022744-200206000-00001; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MACOSKA JA, 1995, CANCER RES, V55, P5390; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; OHATA H, 1993, GENE CHROMOSOME CANC, V7, P85, DOI 10.1002/gcc.2870070204; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Scholnick SB, 1996, J NATL CANCER I, V88, P1676, DOI 10.1093/jnci/88.22.1676; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wistuba II, 1999, CANCER RES, V59, P1973; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	41	94	96	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					216	U27		10.1038/ng.527	http://dx.doi.org/10.1038/ng.527			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139980	Green Accepted			2022-12-25	WOS:000274912400009
J	Boulenguez, P; Liabeuf, S; Bos, R; Bras, H; Jean-Xavier, C; Brocard, C; Stil, A; Darbon, P; Cattaert, D; Delpire, E; Marsala, M; Vinay, L				Boulenguez, Pascale; Liabeuf, Sylvie; Bos, Remi; Bras, Helene; Jean-Xavier, Celine; Brocard, Cecile; Stil, Aurelie; Darbon, Pascal; Cattaert, Daniel; Delpire, Eric; Marsala, Martin; Vinay, Laurent			Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury	NATURE MEDICINE			English	Article							K-CL COTRANSPORTER; POST-ACTIVATION DEPRESSION; RECIPROCAL INHIBITION; NEUROPATHIC PAIN; ANION GRADIENT; ADULT-RATS; IN-VITRO; EXPRESSION; MOTONEURONS; MECHANISM	Hyperexcitability of spinal reflexes and reduced synaptic inhibition are commonly associated with spasticity after spinal cord injury (SCI). In adults, the activation of gamma-aminobutyric acid(A) (GABA(A)) and glycine receptors inhibits neurons as a result of low intracellular chloride (Cl-) concentration, which is maintained by the potassium-chloride cotransporter KCC2 (encoded by Slc12a5). We show that KCC2 is downregulated after SCI in rats, particularly in motoneuron membranes, thereby depolarizing the Cl-equilibrium potential and reducing the strength of postsynaptic inhibition. Blocking KCC2 in intact rats reduces the rate-dependent depression (RDD) of the Hoffmann reflex, as is observed in spasticity. RDD is also decreased in KCC2-deficient mice and in intact rats after intrathecal brain-derived neurotrophic factor (BDNF) injection, which downregulates KCC2. The early decrease in KCC2 after SCI is prevented by sequestering BDNF at the time of SCI. Conversely, after SCI, BDNF upregulates KCC2 and restores RDD. Our results open new perspectives for the development of therapeutic strategies to alleviate spasticity.	[Boulenguez, Pascale; Liabeuf, Sylvie; Bos, Remi; Bras, Helene; Jean-Xavier, Celine; Brocard, Cecile; Stil, Aurelie; Darbon, Pascal; Vinay, Laurent] CNRS, Lab Plast & Physiopathol Motricite UMR6196, Marseille, France; [Boulenguez, Pascale; Liabeuf, Sylvie; Bos, Remi; Bras, Helene; Jean-Xavier, Celine; Brocard, Cecile; Stil, Aurelie; Darbon, Pascal; Vinay, Laurent] Aix Marseille Univ, Marseille, France; [Cattaert, Daniel] CNRS, Ctr Neurosci Integrat & Cognit, Talence, France; [Cattaert, Daniel] Univ Bordeaux, Talence, France; [Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Anesthesiol Res Lab, La Jolla, CA 92093 USA; [Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University; University of California System; University of California San Diego; Slovak Academy of Sciences	Vinay, L (corresponding author), CNRS, Lab Plast & Physiopathol Motricite UMR6196, Marseille, France.	vinay@dpm.cnrs-mrs.fr	Cattaert, Daniel/D-8630-2014; Bras, Helene/L-8915-2018; Darbon, Pascal/A-4903-2012	Darbon, Pascal/0000-0002-7772-9604; Bos, Remi/0000-0003-2639-3271; Jean-Xavier, Celine/0000-0003-0500-1099	Christopher and Dana Reeve Foundation [VB1-0502-2, VB2-0801-2]; French Agence Nationale pour la Recherche; French Institut pour la Recherche sur la Moelle epiniere et l'Encephale; US National Institutes of Health [GM074771, NS051644]; Slovak Research and Development Agency [APVV-0314-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051644] Funding Source: NIH RePORTER	Christopher and Dana Reeve Foundation; French Agence Nationale pour la Recherche(French National Research Agency (ANR)); French Institut pour la Recherche sur la Moelle epiniere et l'Encephale; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovak Research and Development Agency(Slovak Research and Development Agency); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Christopher and Dana Reeve Foundation (VB1-0502-2 and VB2-0801-2 to L. V.), the French Agence Nationale pour la Recherche (to L. V.), the French Institut pour la Recherche sur la Moelle epiniere et l'Encephale (to L. V.), the US National Institutes of Health (GM074771 to E. D. and NS051644 to M. M.) and the Slovak Research and Development Agency (APVV-0314-06 to M. M.). We thank the company Pharmaxon for their help and expertise concerning SCI in rats. We also thank all team members, particularly F. Brocard, P. Coulon, K. Sadlaoud and S. Tazerart, for their assistance throughout the experiments, and F. Clarac for his support.	Alvarez FJ, 1997, J COMP NEUROL, V379, P150; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boorman GI, 1996, ELECTROMYOGR MOTOR C, V101, P84, DOI 10.1016/0924-980X(95)00262-J; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Boyce VS, 2007, J NEUROPHYSIOL, V98, P1988, DOI 10.1152/jn.00391.2007; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crone C, 2007, EXP BRAIN RES, V181, P193, DOI 10.1007/s00221-007-0993-1; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Edgerton V R, 1997, Adv Neurol, V72, P233; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Edgley SA, 2006, EXP BRAIN RES, V171, P541, DOI 10.1007/s00221-005-0302-9; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Jean-Xavier C, 2007, P NATL ACAD SCI USA, V104, P11477, DOI 10.1073/pnas.0704832104; Jean-Xavier C, 2006, J NEUROPHYSIOL, V96, P2274, DOI 10.1152/jn.00328.2006; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Katz R, 1999, J PHYSIOLOGY-PARIS, V93, P379, DOI 10.1016/S0928-4257(00)80065-0; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mazzocchio R, 1997, BRAIN, V120, P991, DOI 10.1093/brain/120.6.991; Miletic G, 2008, PAIN, V137, P532, DOI 10.1016/j.pain.2007.10.016; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Norton JA, 2008, BRAIN, V131, P1478, DOI 10.1093/brain/awn050; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Remy-Neris O, 1999, EXP BRAIN RES, V129, P433, DOI 10.1007/s002210050910; Riekki R, 2008, J NEUROPHYSIOL, V99, P3075, DOI 10.1152/jn.00606.2007; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Stil A, 2009, NEUROSCIENCE, V164, P809, DOI 10.1016/j.neuroscience.2009.08.035; SYKOVA E, 1992, CAN J PHYSIOL PHARM, V70, pS301, DOI 10.1139/y92-276; THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473, DOI 10.1152/jn.1992.68.5.1473; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; WALLIS DI, 1992, GEN PHARMACOL-VASC S, V23, P1035, DOI 10.1016/0306-3623(92)90283-P; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Yates C, 2008, SPINAL CORD, V46, P798, DOI 10.1038/sc.2008.49; Ziskind-Conhaim L, 1998, PERSPECT DEV NEUROBI, V5, P279	49	376	394	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					302	U97		10.1038/nm.2107	http://dx.doi.org/10.1038/nm.2107			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20190766	Green Published			2022-12-25	WOS:000275289500035
J	Gaulton, KJ; Nammo, T; Pasquali, L; Simon, JM; Giresi, PG; Fogarty, MP; Panhuis, TM; Mieczkowski, P; Secchi, A; Bosco, D; Berney, T; Montanya, E; Mohlke, KL; Lieb, JD; Ferrer, J				Gaulton, Kyle J.; Nammo, Takao; Pasquali, Lorenzo; Simon, Jeremy M.; Giresi, Paul G.; Fogarty, Marie P.; Panhuis, Tami M.; Mieczkowski, Piotr; Secchi, Antonio; Bosco, Domenico; Berney, Thierry; Montanya, Eduard; Mohlke, Karen L.; Lieb, Jason D.; Ferrer, Jorge			A map of open chromatin in human pancreatic islets	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BETA-CELLS; VARIANTS; RISK; SUSCEPTIBILITY; REVEALS; ORGANIZATION; INSIGHTS	Tissue-specific transcriptional regulation is central to human disease(1). To identify regulatory DNA active in human pancreatic islets, we profiled chromatin by formaldehyde-assisted isolation of regulatory elements(2-4) coupled with high-throughput sequencing (FAIRE-seq). We identified similar to 80,000 open chromatin sites. Comparison of FAIRE-seq data from islets to that from five non-islet cell lines revealed similar to 3,300 physically linked clusters of islet-selective open chromatin sites, which typically encompassed single genes that have islet-specific expression. We mapped sequence variants to open chromatin sites and found that rs7903146, a TCF7L2 intronic variant strongly associated with type 2 diabetes(5), is located in islet-selective open chromatin. We found that human islet samples heterozygous for rs7903146 showed allelic imbalance in islet FAIRE signals and that the variant alters enhancer activity, indicating that genetic variation at this locus acts in cis with local chromatin and regulatory changes. These findings illuminate the tissue-specific organization of cis-regulatory elements and show that FAIRE-seq can guide the identification of regulatory variants underlying disease susceptibility.	[Nammo, Takao; Pasquali, Lorenzo; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Gaulton, Kyle J.; Simon, Jeremy M.; Fogarty, Marie P.; Panhuis, Tami M.; Mieczkowski, Piotr; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Nammo, Takao; Pasquali, Lorenzo; Montanya, Eduard; Ferrer, Jorge] CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Barcelona, Spain; [Simon, Jeremy M.; Giresi, Paul G.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Secchi, Antonio] Ist Sci San Raffaele, Clin Transplant Unit, I-20132 Milan, Italy; [Bosco, Domenico; Berney, Thierry] Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Montanya, Eduard] Univ Barcelona, Lab Diabet & Expt Endocrinol, Inst Invest Biomed Bellvitge IDIBELL, Hosp Univ Bellvitge,Endocrine Unit, E-08007 Barcelona, Spain; [Mohlke, Karen L.; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Mohlke, Karen L.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ferrer, Jorge] Hosp Clin Barcelona, Dept Endocrinol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of North Carolina; University of North Carolina Chapel Hill; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of North Carolina; University of North Carolina Chapel Hill; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Barcelona; Hospital Clinic de Barcelona	Ferrer, J (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	mohlke@med.unc.edu; jlieb@bio.unc.edu; jferrer@clinic.ub.es	Berney, Thierry/ABE-9450-2021; Pasquali, Lorenzo/B-6239-2008; Ferrer, Jorge/A-3176-2012	Berney, Thierry/0000-0002-4230-9378; Pasquali, Lorenzo/0000-0003-2423-1826; Ferrer, Jorge/0000-0002-5959-5729; Gaulton, Kyle/0000-0003-1318-7161; Bosco, Domenico/0000-0003-3453-9613; Mieczkowski, Piotr/0000-0003-2418-0096; Montanya, Eduard/0000-0003-2518-9076; Lieb, Jason/0000-0001-7601-8061	European Union [SAF2008-03116]; Juvenile Diabetes Research Foundation [26-2008-633, 31-2008-416, 6-2005-1178]; US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE) [U54 HG004563]; US National Institutes of Health [R01 DK072193]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193] Funding Source: NIH RePORTER	European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank X. Garcia for experimental support in rs7903146 functional studies, I. Moran for insights and help in the analysis of COREs, P. Maechler (Univ. Geneva Medical Center) for generously providing insulin release data, L. Piemonti and R. Nano (San Raffaele Scientific Institute), and M. Nacher (IDIBELL) for human islets. This work was supported by the European Union VI Framework Programme project Eurodia to J. F., Ministerio de Ciencia e Innovacion (SAF2008-03116) to J. F., Juvenile Diabetes Research Foundation (26-2008-633 to J. F., 31-2008-416 to T. B., 6-2005-1178 and 31-2008-416 to A. S.), the US National Human Genome Research Institute Encyclopedia Of DNA Elements (NHGRI ENCODE) project (U54 HG004563 subcontract to J. D. L.) and R01 DK072193 (US National Institutes of Health) to K. L. M. K. L. M. is a Pew Scholar in the Biomedical Sciences.	Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luco RF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000079; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; McCarthy MI, 2007, TRENDS PHARMACOL SCI, V28, P598, DOI 10.1016/j.tips.2007.10.008; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mohlke KL, 2008, HUM MOL GENET, V17, pR102, DOI 10.1093/hmg/ddn275; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sander M, 2000, DEVELOPMENT, V127, P5533; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	57	400	405	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					255	U41		10.1038/ng.530	http://dx.doi.org/10.1038/ng.530			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20118932	Green Accepted, Green Submitted			2022-12-25	WOS:000274912400016
J	Gohil, VM; Sheth, SA; Nilsson, R; Wojtovich, AP; Lee, JH; Perocchi, F; Chen, W; Clish, CB; Ayata, C; Brookes, PS; Mootha, VK				Gohil, Vishal M.; Sheth, Sunil A.; Nilsson, Roland; Wojtovich, Andrew P.; Lee, Jeong Hyun; Perocchi, Fabiana; Chen, William; Clish, Clary B.; Ayata, Cenk; Brookes, Paul S.; Mootha, Vamsi K.			Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis	NATURE BIOTECHNOLOGY			English	Article							HYPOXIA-INDUCIBLE FACTOR; CHEMICAL INHIBITION; ISCHEMIC TOLERANCE; CANCER-CELLS; FACTOR-I; APOPTOSIS; ADAPTATION; GLUTAMINE; PATIENT; DISEASE	Most cells have the inherent capacity to shift their reliance on glycolysis relative to oxidative metabolism, and studies in model systems have shown that targeting such shifts may be useful in treating or preventing a variety of diseases ranging from cancer to ischemic injury. However, we currently have a limited number of mechanistically distinct classes of drugs that alter the relative activities of these two pathways. We screen for such compounds by scoring the ability of >3,500 small molecules to selectively impair growth and viability of human fibroblasts in media containing either galactose or glucose as the sole sugar source. We identify several clinically used drugs never linked to energy metabolism, including the antiemetic meclizine, which attenuates mitochondrial respiration through a mechanism distinct from that of canonical inhibitors. We further show that meclizine pretreatment confers cardioprotection and neuroprotection against ischemia-reperfusion injury in murine models. Nutrient-sensitized screening may provide a useful framework for understanding gene function and drug action within the context of energy metabolism.	[Gohil, Vishal M.; Sheth, Sunil A.; Nilsson, Roland; Perocchi, Fabiana; Chen, William; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Gohil, Vishal M.; Sheth, Sunil A.; Nilsson, Roland; Perocchi, Fabiana; Chen, William; Clish, Clary B.; Mootha, Vamsi K.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Gohil, Vishal M.; Sheth, Sunil A.; Nilsson, Roland; Perocchi, Fabiana; Chen, William; Clish, Clary B.; Mootha, Vamsi K.] Harvard Univ, Cambridge, MA 02138 USA; [Gohil, Vishal M.; Sheth, Sunil A.; Nilsson, Roland; Perocchi, Fabiana; Chen, William; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wojtovich, Andrew P.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Wojtovich, Andrew P.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Lee, Jeong Hyun; Ayata, Cenk] Massachusetts Gen Hosp, Dept Radiol, Stroke & Neurovasc Regulat Lab, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Nilsson, Roland/AAJ-3519-2021; Clish, Clary/AAB-7124-2019; Ahmadi, Ayat/G-4602-2011; Lee, Jeong Hyun/G-1676-2013; Clish, Clary B/ABB-9374-2021	Ahmadi, Ayat/0000-0002-8018-9784; Lee, Jeong Hyun/0000-0003-0504-0119; Clish, Clary B/0000-0001-8259-9245; Wojtovich, Andrew/0000-0002-7725-5349; Gohil, Vishal/0000-0002-9920-2563; Brookes, Paul/0000-0002-8639-8413; perocchi, fabiana/0000-0002-1102-6500; Nilsson, Roland/0000-0002-6020-7498	United Mitochondrial Disease Foundation; Howard Hughes Medical Institute; National Institutes of Health [RO1 HL-071158]; Deane Institute for Integrative Research in Stroke and Atrial Fibrillation; American Heart Association [0815770D]; Burroughs Wellcome Fund; Center for Integration of Medical and Innovative Technology; American Diabetes Association/Smith Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081457] Funding Source: NIH RePORTER	United Mitochondrial Disease Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deane Institute for Integrative Research in Stroke and Atrial Fibrillation; American Heart Association(American Heart Association); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Center for Integration of Medical and Innovative Technology; American Diabetes Association/Smith Family Foundation(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Shoubridge for the MCH58 cell line; M. MacDonald for immortalized striatal cells; R. Xavier for the HRE luciferase construct; S. Norton, B. Wagner and the Broad Chemical Screening Platform for assistance in compound arraying; J. Evans of the Whitehead Institute/MIT BioImaging Center for assistance with high-throughput microscopy; C. Belcher-Timme for technical assistance; T. Kitami for assistance with mitochondrial imaging; M. Mehta for assistance reviewing drug toxicity data; S. Calvo, A. Chess, R. Gould, E. Lander, A. Ting, S. Vafai and members of Mootha lab for valuable discussions and comments. This work was supported by fellowships or grants from the United Mitochondrial Disease Foundation (V. M. G.); Howard Hughes Medical Institute (S. A. S. and V. K. M.); National Institutes of Health (RO1 HL-071158 to P. S. B.); Deane Institute for Integrative Research in Stroke and Atrial Fibrillation (C. A.); American Heart Association (#0815770D to A. P. W.); the Burroughs Wellcome Fund (V. K. M.); the Center for Integration of Medical and Innovative Technology (V. K. M.); and the American Diabetes Association/Smith Family Foundation (V. K. M.).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Blumenthal, 2006, GOODMAN GILMANS PHAR; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; GIURGEA M, 1966, MED PHARMACOL EXP, V15, P375; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Hoesch RE, 2007, NEUROLOGIST, V13, P331, DOI 10.1097/NRL.0b013e318154bb79; Huber R, 2004, J NEUROSCI RES, V75, P441, DOI 10.1002/jnr.10868; Hunter AJ, 2007, INT J RADIAT BIOL, V83, P105, DOI 10.1080/09553000601121157; Jeong DW, 2004, BIOCHEM BIOPH RES CO, V313, P984, DOI 10.1016/j.bbrc.2003.12.033; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Lione A, 1996, REPROD TOXICOL, V10, P247, DOI 10.1016/0890-6238(96)00053-6; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MIYAZAKI S, 1995, LIFE SCI, V57, P2137, DOI 10.1016/0024-3205(95)02206-X; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Philipp S, 2006, EUR J HEART FAIL, V8, P347, DOI 10.1016/j.ejheart.2005.10.009; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Riepe MW, 1997, J CEREBR BLOOD F MET, V17, P257, DOI 10.1097/00004647-199703000-00002; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Sugino T, 1999, NEUROSCI LETT, V259, P9, DOI 10.1016/S0304-3940(98)00875-1; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025; Wojtovich AP, 2009, BASIC RES CARDIOL, V104, P121, DOI 10.1007/s00395-009-0001-y; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; 1987, FED REG, V52, P15866	48	220	232	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					249	U100		10.1038/nbt.1606	http://dx.doi.org/10.1038/nbt.1606			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20160716	Green Accepted			2022-12-25	WOS:000275288300023
J	Mast, FD; Fagarasanu, A; Rachubinski, R				Mast, Fred D.; Fagarasanu, Andrei; Rachubinski, Richard			The peroxisomal protein importomer: a bunch of transients with expanding waistlines	NATURE CELL BIOLOGY			English	Editorial Material							MEMBRANES	Peroxisomes can import large multimeric protein complexes and even 9-nm gold particles decorated with peroxisome-targeting signals. They achieve these feats of protein passage using a distinctive translocon whose highly dynamic aqueous pore can expand to accommodate the increasing girths of different peroxisome receptor-cargo complexes.	[Mast, Fred D.; Fagarasanu, Andrei; Rachubinski, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Mast, FD (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	rick.rachubinski@ualberta.ca	Mast, Fred/A-6507-2011; Mast, Fred/AAM-2426-2021	Mast, Fred/0000-0002-2177-6647; Mast, Fred/0000-0002-2177-6647				Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; LABARCA P, 1986, J MEMBRANE BIOL, V94, P285, DOI 10.1007/BF01869724; McNew JA, 1996, TRENDS BIOCHEM SCI, V21, P54, DOI 10.1016/S0968-0004(96)80181-2; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Tabak HF, 2008, CURR OPIN CELL BIOL, V20, P393, DOI 10.1016/j.ceb.2008.05.008; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675	12	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					203	205		10.1038/ncb0310-203	http://dx.doi.org/10.1038/ncb0310-203			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20190827				2022-12-25	WOS:000275054200003
J	Min, J; Zaslavsky, A; Fedele, G; McLaughlin, SK; Reczek, EE; De Raedt, T; Guney, I; Strochlic, DE; MacConaill, LE; Beroukhim, R; Bronson, RT; Ryeom, S; Hahn, WC; Loda, M; Cichowski, K				Min, Junxia; Zaslavsky, Alexander; Fedele, Giuseppe; McLaughlin, Sara K.; Reczek, Elizabeth E.; De Raedt, Thomas; Guney, Isil; Strochlic, David E.; MacConaill, Laura E.; Beroukhim, Rameen; Bronson, Roderick T.; Ryeom, Sandra; Hahn, William C.; Loda, Massimo; Cichowski, Karen			An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappa B	NATURE MEDICINE			English	Article							ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; EZH2; MUTATIONS; INACTIVATION; SIGNATURE; REVEALS; BRAF	Metastasis is responsible for the majority of prostate cancer-related deaths; however, little is known about the molecular mechanisms that underlie this process. Here we identify an oncogene-tumor suppressor cascade that promotes prostate cancer growth and metastasis by coordinately activating the small GTPase Ras and nuclear factor-kappa B (NF-kappa B). Specifically, we show that loss of the Ras GTPase-activating protein (RasGAP) gene DAB2IP induces metastatic prostate cancer in an orthotopic mouse tumor model. Notably, DAB2IP functions as a signaling scaffold that coordinately regulates Ras and NF-kappa B through distinct domains to promote tumor growth and metastasis, respectively. DAB2IP is suppressed in human prostate cancer, where its expression inversely correlates with tumor grade and predicts prognosis. Moreover, we report that epigenetic silencing of DAB2IP is a key mechanism by which the polycomb-group protein histone-lysine N-methyltransferase EZH2 activates Ras and NF-kappa B and triggers metastasis. These studies define the mechanism by which two major pathways can be simultaneously activated in metastatic prostate cancer and establish EZH2 as a driver of metastasis.	[Min, Junxia; McLaughlin, Sara K.; Reczek, Elizabeth E.; De Raedt, Thomas; Cichowski, Karen] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Min, Junxia; Fedele, Giuseppe; McLaughlin, Sara K.; Reczek, Elizabeth E.; De Raedt, Thomas; Guney, Isil; Strochlic, David E.; Beroukhim, Rameen; Bronson, Roderick T.; Hahn, William C.; Loda, Massimo; Cichowski, Karen] Harvard Univ, Sch Med, Boston, MA USA; [Zaslavsky, Alexander; Ryeom, Sandra] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Fedele, Giuseppe; Guney, Isil; Strochlic, David E.; Beroukhim, Rameen; Hahn, William C.; Loda, Massimo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [MacConaill, Laura E.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen; Hahn, William C.; Loda, Massimo] Broad Inst Harvard, Cambridge, MA USA; [Beroukhim, Rameen; Hahn, William C.] MIT, Cambridge, MA 02139 USA; [Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Cichowski, Karen] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Cichowski, K (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	kcichowski@rics.bwh.harvard.edu	De Raedt, Thomas/AAC-3172-2021; Min, Junxia/E-7622-2016	Min, Junxia/0000-0001-8099-6327	US Department of Defense [PC074048]; Ludwig Center at Dana-Farber/Harvard Cancer Center; NATIONAL CANCER INSTITUTE [K08CA122833] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); Ludwig Center at Dana-Farber/Harvard Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The PMMP-luc-neo retroviral luciferase construct was generously provided by A. L. Kung and M. Chheda (Dana-Farber Cancer Institute (DFCI)). pRL-TK was a gift from J. Boehm (Broad Institute). We thank D. Barbie (DFCI), J. Boehm for NF-kappa B target primers and R. Chen (DFCI) for I kappa B alpha SR and G. Evan for helpful discussions. This grant was supported by in part by the US Department of Defense (PC074048) and the Ludwig Center at Dana-Farber/Harvard Cancer Center.	Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Arai Y, 1996, Int J Urol, V3, P373, DOI 10.1111/j.1442-2042.1996.tb00556.x; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2007, GROWTH FACTORS, V25, P355, DOI 10.1080/08977190701830375; CARTER BS, 1990, CANCER RES, V50, P6830; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen H, 2003, J BIOL CHEM, V278, P3121, DOI 10.1074/jbc.M208230200; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; Daskivich TJ, 2006, CURR OPIN UROL, V16, P173, DOI 10.1097/01.mou.0000193392.77469.e2; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Dote H, 2005, BRIT J CANCER, V92, P1117, DOI 10.1038/sj.bjc.6602458; Gioeli D, 1999, CANCER RES, V59, P279; GUMERLOCK PH, 1991, CANCER RES, V51, P1632; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, pCH3; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Sellers WR, 2002, CANCER CELL, V2, P349, DOI 10.1016/S1535-6108(02)00187-3; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; von Bergh ARM, 2004, GENE CHROMOSOME CANC, V39, P324, DOI 10.1002/gcc.20004; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weinberg RA, 2007, BIOL CANC; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	50	293	336	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					286	U82		10.1038/nm.2100	http://dx.doi.org/10.1038/nm.2100			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20154697	Green Accepted			2022-12-25	WOS:000275289500033
J	Verdeguer, F; Le Corre, S; Fischer, E; Callens, C; Garbay, S; Doyen, A; Igarashi, P; Terzi, F; Pontoglio, M				Verdeguer, Francisco; Le Corre, Stephanie; Fischer, Evelyne; Callens, Celine; Garbay, Serge; Doyen, Antonia; Igarashi, Peter; Terzi, Fabiola; Pontoglio, Marco			A mitotic transcriptional switch in polycystic kidney disease	NATURE MEDICINE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-BETA; PLANAR CELL POLARITY; CYST FORMATION; RENAL INJURY; SLOW-ONSET; ADULT MICE; GENE; INACTIVATION; PKD1; DYSFUNCTION	Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a transcription factor required for the expression of several renal cystic genes and whose prenatal deletion leads to polycystic kidney disease (PKD)(1). We show here that inactivation of Hnf1b from postnatal day 10 onward does not elicit cystic dilations in tubules after their proliferative morphogenetic elongation is over. Cystogenic resistance is intrinsically linked to the quiescent state of cells. In fact, when Hnf1b deficient quiescent cells are forced to proliferate by an ischemia-reperfusion injury, they give rise to cysts, owing to loss of oriented cell division. Remarkably, in quiescent cells, the transcription of crucial cystogenic target genes is maintained even in the absence of HNF-1 beta. However, their expression is lost as soon as cells proliferate and the chromatin of target genes acquires heterochromatin marks. These results unveil a previously undescribed aspect of gene regulation. It is well established that transcription is shut off during the mitotic condensation of chromatin(2,3). We propose that transcription factors such as HNF-1 beta might be involved in reprogramming gene expression after transcriptional silencing is induced by mitotic chromatin condensation. Notably, HNF-1 beta remains associated with the mitotically condensed chromosomal barrels. This association suggests that HNF-1 beta is a bookmarking factor that is necessary for reopening the chromatin of target genes after mitotic silencing. (C) 2010 Nature America, Inc. All rights reserved.	[Le Corre, Stephanie; Terzi, Fabiola] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Ctr Rech Croissance & Signalisat,U845, Paris, France; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Pediat, Dallas, TX 75390 USA; [Verdeguer, Francisco; Fischer, Evelyne; Callens, Celine; Garbay, Serge; Doyen, Antonia; Pontoglio, Marco] Inst Pasteur, Gene Express Dev & Dis Lab, Dept Dev Biol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pontoglio, M (corresponding author), Univ Paris 05, CNRS, INSERM, Inst Cochin,Team 26,U567,UMR 8104, Paris, France.	marco.pontoglio@inserm.fr	fischer, evelyne/GLT-9457-2022; Verdeguer, Francisco/O-5486-2016; Terzi, Fabiola/N-5482-2018	Verdeguer, Francisco/0000-0002-5798-1503; Igarashi, Peter/0000-0001-8698-1185; fischer, evelyne/0000-0001-5054-1444	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Paris Descartes; Polycystic Kidney Disease Foundation; Societe de Nephrologie; Agence Nationale Recherche; Fondation de la Recherche Medicale; Fundacion La Caixa; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042921, R01DK042921] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Descartes; Polycystic Kidney Disease Foundation; Societe de Nephrologie; Agence Nationale Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Fundacion La Caixa(La Caixa Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to S. Bettiol, J. B. Weitzman and M. Yaniv for critical advice. We are grateful to R. Sandford (Cambridge Institute of Medical Research) for Pkd2-specific antibodies and to B. Viollet, (Institut Cochin, Paris) for the GFP-HNF-4 alpha fusion construct. MxCre mice were kindly provided by K. Rajewsky (Harvard Medical School, Boston), and the ROSA26R strain was provided by P. Soriano (Fred Hutchinson Cancer Research Center, Seattle). We thank E. Perret and P. Roux from the "Plate-Forme d'Imagerie Dynamique," Institut Pasteur, Paris) for assistance and advice. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Universite Paris Descartes, Polycystic Kidney Disease Foundation, Societe de Nephrologie, Agence Nationale Recherche, Fondation de la Recherche Medicale. F. V. was a recipient of a fellowship from Societe de Nephrologie and from Fundacion La Caixa.	Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Fischer E, 2004, NEPHROL DIAL TRANSPL, V19, P2700, DOI 10.1093/ndt/gfh533; Gong YM, 2009, J AM SOC NEPHROL, V20, P41, DOI 10.1681/ASN.2008020238; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Komura JI, 2007, P NATL ACAD SCI USA, V104, P15741, DOI 10.1073/pnas.0702363104; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lantinga-van Leeuwen IS, 2007, HUM MOL GENET, V16, P3188, DOI 10.1093/hmg/ddm299; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Marquez MG, 2002, ANAT EMBRYOL, V205, P431, DOI 10.1007/s00429-002-0262-9; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1997, MOL CELL BIOL, V17, P4948, DOI 10.1128/MCB.17.9.4948; Runembert I, 2004, AM J PHYSIOL-RENAL, V287, pF960, DOI 10.1152/ajprenal.00064.2004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147; Takakura A, 2008, J AM SOC NEPHROL, V19, P2351, DOI 10.1681/ASN.2007101139; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040	32	107	110	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2010	16	1					106	U143		10.1038/nm.2068	http://dx.doi.org/10.1038/nm.2068			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	19966811	Green Accepted			2022-12-25	WOS:000273395500043
J	Werner, AK; Romeis, T; Witte, CP				Werner, Andrea K.; Romeis, Tina; Witte, Claus-Peter			Ureide catabolism in Arabidopsis thaliana and Escherichia coli	NATURE CHEMICAL BIOLOGY			English	Article							ALLANTOATE AMIDOHYDROLASE; SUBCELLULAR-LOCALIZATION; CHROMOSOMAL REGION; DEGRADATION; METABOLISM; NITROGEN; PATHWAY; PURIFICATION; PREDICTION; COMPLEX	The availability of whole genome sequences boosts the identification of biochemical pathways conserved across species using tools of comparative genomics. A cross-organism protein association analysis allowed us to identify two enzymes, ureidoglycine aminohydrolase and ureidoglycolate amidohydrolase, that catalyze the final reactions of purine degradation in the model plant Arabidopsis thaliana. A similar pathway was found in Escherichia coli, while an alternative metabolic route via ureidoglycine transaminase can be predicted for other organisms.	[Werner, Andrea K.; Romeis, Tina; Witte, Claus-Peter] Free Univ Berlin, Inst Biol, Abt Biochem Pflanzen, D-1000 Berlin, Germany	Free University of Berlin	Witte, CP (corresponding author), Free Univ Berlin, Inst Biol, Abt Biochem Pflanzen, D-1000 Berlin, Germany.	cpwitte@zedat.fu-berlin.de	Witte, Claus-Peter/L-1676-2017	Witte, Claus-Peter/0000-0002-3617-7807	Deutsche Forschungsgemeinschaft [WI 3411/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank F.-Q. Cao for technical support and A. Schafer from the Institute for Chemistry of the Freie Universitat Berlin for NMR measurements. This work was financially supported by the Deutsche Forschungsgemeinschaft (WI 3411/1-1).	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; DRIFT CVD, 1970, ARCH BIOCHEM BIOPHYS, V136, P273, DOI 10.1016/0003-9861(70)90351-6; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Munoz A, 2001, PLANT PHYSIOL, V125, P828, DOI 10.1104/pp.125.2.828; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; SGRAVENMADE EJ, 1970, BIOCHIM BIOPHYS ACTA, V198, P569, DOI 10.1016/0005-2744(70)90134-8; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; VANDERDRIFT C, 1971, ARCH BIOCHEM BIOPHYS, V145, P465, DOI 10.1016/S0003-9861(71)80006-1; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Werner AK, 2008, PLANT PHYSIOL, V146, P418, DOI 10.1104/pp.107.110809; WINKLER RG, 1988, PLANT PHYSIOL, V86, P1084, DOI 10.1104/pp.86.4.1084	18	62	72	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					19	21		10.1038/NCHEMBIO.265	http://dx.doi.org/10.1038/NCHEMBIO.265			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19935661				2022-12-25	WOS:000272802500006
J	Bartlett, GJ; Choudhary, A; Raines, RT; Woolfson, DN				Bartlett, Gail J.; Choudhary, Amit; Raines, Ronald T.; Woolfson, Derek N.			n ->pi* interactions in proteins	NATURE CHEMICAL BIOLOGY			English	Article							ALPHA-HELIX; SECONDARY STRUCTURE; CONFORMATION; RESOLUTION; STABILITY; MECHANISM; PROLINE; THERMODYNAMICS; ENERGIES; MOLECULE	Hydrogen bonds between backbone amides are common in folded proteins. Here, we show that an intimate interaction between backbone amides also arises from the delocalization of a lone pair of electrons (n) from an oxygen atom to the antibonding orbital (pi*) of the subsequent carbonyl group. Natural bond orbital analysis predicted significant n ->pi* interactions in certain regions of the Ramachandran plot. These predictions were validated by a statistical analysis of a large, non-redundant subset of protein structures determined to high resolution. The correlation between these two independent studies is striking. Moreover, the n ->pi* interactions are abundant and especially prevalent in common secondary structures such as alpha-, 3(10)- and polyproline II helices and twisted beta-sheets. In addition to their evident effects on protein structure and stability, n ->pi* interactions could have important roles in protein folding and function, and merit inclusion in computational force fields.	[Bartlett, Gail J.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Choudhary, Amit] Univ Wisconsin, Grad Program Biophys, Madison, WI USA; [Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Woolfson, Derek N.] Univ Bristol, Dept Biochem, Bristol, Avon, England	University of Bristol; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Bristol, Avon, England.	rtraines@wisc.edu; d.n.woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Raines, Ronald T./A-5009-2013; Bartlett, Gail/F-3064-2015	Raines, Ronald T./0000-0001-7164-1719; Woolfson, Derek/0000-0002-0394-3202	University of Bristol; Biotechnology and Biological Sciences Research Council of the United Kingdom [D003016]; US National Institutes of Health [R01 AR044276]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044276] Funding Source: NIH RePORTER	University of Bristol; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Spencer, J. Harvey, A. Mulholland, B. Bromley, M.D. Shoulders, B.R. Caes, C.N. Bradford, M.J. Palte and E. Moutevelis for helpful discussions. Financial support was provided by the University of Bristol and the Biotechnology and Biological Sciences Research Council of the United Kingdom (grant D003016) to D.N.W. and the US National Institutes of Health grant R01 AR044276 to R.T.R.	ALTMANN KH, 1990, BIOPOLYMERS, V30, P107, DOI 10.1002/bip.360300112; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Dai N, 2009, J AM CHEM SOC, V131, P13728, DOI 10.1021/ja904177k; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Esposito L, 2000, PROTEIN SCI, V9, P2038; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Frisch M., 2016, GAUSSIAN 16 REVISION; Gao JM, 2008, PROTEIN SCI, V17, P1096, DOI 10.1110/ps.083439708; Gorske BC, 2009, J AM CHEM SOC, V131, P16555, DOI 10.1021/ja907184g; Gray H.B., 1965, ELECT CHEM BONDING; Gray HB, 2009, CHEM PHYS LETT, V483, P1, DOI 10.1016/j.cplett.2009.10.051; Hinderaker MP, 2003, PROTEIN SCI, V12, P1188, DOI 10.1110/ps.0241903; Hodges JA, 2006, ORG LETT, V8, P4695, DOI 10.1021/ol061569t; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Isaacs ED, 1999, PHYS REV LETT, V82, P600, DOI 10.1103/PhysRevLett.82.600; Jakobsche CE, 2010, J AM CHEM SOC, V132, P6651, DOI 10.1021/ja100931y; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khaliullin RZ, 2007, J PHYS CHEM A, V111, P8753, DOI 10.1021/jp073685z; LAING M, 1987, J CHEM EDUC, V64, P124, DOI 10.1021/ed064p124; Landis C. R., 2005, VALENCY BONDING NATU; Lario PI, 2003, J AM CHEM SOC, V125, P12787, DOI 10.1021/ja0289954; LEWIS PN, 1971, P NATL ACAD SCI USA, V68, P2293, DOI 10.1073/pnas.68.9.2293; Mahan SD, 2004, PROTEIN ENG DES SEL, V17, P625, DOI 10.1093/protein/gzh074; Makhatadze GI, 2005, ADV PROTEIN CHEM, V72, P199, DOI 10.1016/S0065-3233(05)72008-8; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Monticelli L, 2005, J PHYS CHEM B, V109, P20064, DOI 10.1021/jp054729b; Novotny M, 2005, J MOL BIOL, V347, P231, DOI 10.1016/j.jmb.2005.01.037; Pal TK, 2010, J PHYS CHEM B, V114, P1038, DOI 10.1021/jp909339r; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; RABER DJ, 1984, INORG CHEM, V23, P4076, DOI 10.1021/ic00192a047; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; SHEINERMAN FB, 1995, J AM CHEM SOC, V117, P10098, DOI 10.1021/ja00145a022; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stapley BJ, 1999, PROTEIN SCI, V8, P587; TANAKA S, 1976, MACROMOLECULES, V9, P159, DOI 10.1021/ma60049a027; TOBIAS DJ, 1991, BIOCHEMISTRY-US, V30, P6059, DOI 10.1021/bi00238a033; TONIOLO C, 1981, MAKROMOL CHEM, V182, P2007; VENKATACHALAPATHI YV, 1979, NATURE, V281, P83, DOI 10.1038/281083a0; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Weinhold F, 2005, ADV PROTEIN CHEM, V72, P121, DOI 10.1016/S0065-3233(05)72005-2; WEINHOLD F, 1998, ENCY COMPUTATIONAL C, V3, P792; YANG AS, 1995, J MOL BIOL, V252, P351, DOI 10.1006/jmbi.1995.0502; YUN RH, 1991, PROTEINS, V10, P219, DOI 10.1002/prot.340100306; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZIMMERMAN SS, 1977, P NATL ACAD SCI USA, V74, P4126, DOI 10.1073/pnas.74.10.4126	50	271	271	3	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					615	620		10.1038/NCHEMBIO.406	http://dx.doi.org/10.1038/NCHEMBIO.406			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20622857	Green Accepted			2022-12-25	WOS:000280096600013
J	Ghaderi, D; Taylor, RE; Padler-Karavani, V; Diaz, S; Varki, A				Ghaderi, Darius; Taylor, Rachel E.; Padler-Karavani, Vered; Diaz, Sandra; Varki, Ajit			Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins	NATURE BIOTECHNOLOGY			English	Article							ACETYLNEURAMINIC ACID; MONOCLONAL-ANTIBODY; MECHANISM; CETUXIMAB; GLYCOSYLATION; SPECIFICITY; COMBINATION; DIVERSITY	Recombinant glycoprotein therapeutics produced in nonhuman mammalian cell lines and/or with animal serum are often modified with the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc; refs. 1,2). This documented contamination has generally been ignored in drug development because healthy individuals were not thought to react to Neu5Gc (ref. 2). However, recent findings indicate that all humans have Neu5Gc-specific antibodies, sometimes at high levels(3,4). Working with two monoclonal antibodies in clinical use, we demonstrate the presence of covalently bound Neu5Gc in cetuximab (Erbitux) but not panitumumab (Vectibix). Anti-Neu5Gc antibodies from healthy humans interact with cetuximab in a Neu5Gc-specific manner and generate immune complexes in vitro. Mice with a human-like defect in Neu5Gc synthesis generate antibodies to Neu5Gc after injection with cetuximab, and circulating anti-Neu5Gc antibodies can promote drug clearance. Finally, we show that the Neu5Gc content of cultured human and nonhuman cell lines and their secreted glycoproteins can be reduced by adding a human sialic acid to the culture medium. Our findings may be relevant to improving the half-life, efficacy and immunogenicity of glycoprotein therapeutics.	[Ghaderi, Darius; Taylor, Rachel E.; Padler-Karavani, Vered; Diaz, Sandra; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Ghaderi, Darius; Taylor, Rachel E.; Padler-Karavani, Vered; Diaz, Sandra; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ghaderi, Darius; Taylor, Rachel E.; Padler-Karavani, Vered; Diaz, Sandra; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Varki, A (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	PADLER-KARAVANI, VERED/AAC-6055-2022	PADLER-KARAVANI, VERED/0000-0002-4761-3571	US National Institutes of Health [R01-GM32373, R01-CA38701]; International Sephardic Education Foundation; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Sephardic Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01-GM32373 and R01-CA38701 to A. V. and The International Sephardic Education Foundation for V.P.-K. Haemophilus influenzae strain 2019 was a generous gift from M. Apicella, Department of Microbiology, University of Iowa.	Abdel-Motal UM, 2009, VACCINE, V27, P3072, DOI 10.1016/j.vaccine.2009.03.019; Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Benatuil L, 2005, EUR J IMMUNOL, V35, P2638, DOI 10.1002/eji.200526146; Borys MC, 2010, BIOTECHNOL BIOENG, V105, P1048, DOI 10.1002/bit.22644; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; DEBEIRE P, 1985, EUR J BIOCHEM, V151, P607, DOI 10.1111/j.1432-1033.1985.tb09147.x; Delbaldo C, 2005, EUR J CANCER, V41, P1739, DOI 10.1016/j.ejca.2005.04.029; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Gagneux P, 2001, AM J PHYS ANTHROPOL, V115, P99, DOI 10.1002/ajpa.1061; Galili U, 2004, TRANSPLANTATION, V78, P1093, DOI 10.1097/01.TP.0000142673.32394.95; Galili U, 1996, VACCINE, V14, P321, DOI 10.1016/0264-410X(95)00189-8; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Higgins E, 2010, GLYCOCONJUGATE J, V27, P211, DOI 10.1007/s10719-009-9261-x; HOKKE CH, 1990, FEBS LETT, V275, P9, DOI 10.1016/0014-5793(90)81427-P; Jahn EM, 2009, NEW BIOTECHNOL, V25, P280, DOI 10.1016/j.nbt.2009.03.012; Koren E, 2008, J IMMUNOL METHODS, V333, P1, DOI 10.1016/j.jim.2008.01.001; Martin MJ, 2006, NAT MED, V12, P1115, DOI 10.1038/nm1006-1115; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216; Noguchi A, 1996, NEPHRON, V72, P599, DOI 10.1159/000188946; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Saadeh CE, 2007, ANN PHARMACOTHER, V41, P606, DOI 10.1345/aph.1H492; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Tahara H, 2010, J IMMUNOL, V184, P3269, DOI 10.4049/jimmunol.0902857; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Van Hoeyveld E, 2000, CLIN CHEM, V46, P283; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935	38	257	304	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					863	U145		10.1038/nbt.1651	http://dx.doi.org/10.1038/nbt.1651			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20657583	Green Accepted			2022-12-25	WOS:000280757500027
J	Frutos, S; Goger, M; Giovani, B; Cowburn, D; Muir, TW				Frutos, Silvia; Goger, Michael; Giovani, Baldissera; Cowburn, David; Muir, Tom W.			Branched intermediate formation stimulates peptide bond cleavage in protein splicing	NATURE CHEMICAL BIOLOGY			English	Article							SYNECHOCYSTIS SP PCC6803; YEAST VMA1 PROTOZYME; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; DNAE INTEIN; MECHANISM; CATALYSIS; PRECURSOR; AUTOPROTEOLYSIS; IDENTIFICATION	Protein splicing is a post-translational modification in which an intein domain excises itself out of a host protein. Here, we investigate how the steps in the splicing process are coordinated so as to maximize the production of the final splice products and minimize the generation of undesired cleavage products. Our approach has been to prepare a branched intermediate (and analogs thereof) of the Mycobacterium xenopi DNA gyrase A (Mxe GyrA) intein using protein semisynthesis. Kinetic analysis of these molecules indicates that the high fidelity of this protein-splicing reaction results from the penultimate step in the process (intein-succinimide formation) being rate-limiting. NMR experiments indicate that formation of the branched intermediate affects the local structure around the amide bond that is cleaved during succinimide formation. We propose that this structural change reflects a reorganization of the catalytic apparatus to accelerate succinimide formation at the C-terminal splice junction. (C) 2010 Nature America, Inc. All rights reserved.	[Frutos, Silvia; Giovani, Baldissera; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; [Goger, Michael; Cowburn, David] New York Struct Biol Ctr, New York, NY USA	Rockefeller University	Frutos, S (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@mail.rockefeller.edu	Cowburn, David/A-8448-2008; Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Cowburn, David/0000-0001-6770-7172	US National Institutes of Health [GM086868, GM55843]; Generalitat de Catalunya (Spain); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354, R01GM086868, R29GM055843, R01GM055843, R37GM086868] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.W. Lockless for helpful discussions. This work is supported by US National Institutes of Health grants GM086868 and GM55843 (to T.W.M.) and by the Generalitat de Catalunya (Spain) for the postdoctoral fellowships Beatriu de Pinos (S.F).	Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DELAGLIO F, 1991, Journal of Biomolecular NMR, V1, P439, DOI 10.1007/BF02192865; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Johansson DGA, 2009, J AM CHEM SOC, V131, P9475, DOI 10.1021/ja9010817; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Lopez X, 2003, J PHYS CHEM A, V107, P2304, DOI 10.1021/jp022014s; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mills KV, 2005, J BIOL CHEM, V280, P2714, DOI 10.1074/jbc.M412313200; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nogami S, 1997, GENETICS, V147, P73; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Southworth MW, 1999, BIOTECHNIQUES, V27, P110, DOI 10.2144/99271st04; STREITWIESER A, 1973, J AM CHEM SOC, V95, P6273, DOI 10.1021/ja00800a020; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Telenti A, 1997, J BACTERIOL, V179, P6378, DOI 10.1128/jb.179.20.6378-6382.1997; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	37	54	57	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					527	533		10.1038/NCHEMBIO.371	http://dx.doi.org/10.1038/NCHEMBIO.371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20495572	Green Accepted			2022-12-25	WOS:000278878700013
J	Hoischen, A; van Bon, BWM; Gilissen, C; Arts, P; van Lier, B; Steehouwer, M; de Vries, P; de Reuver, R; Wieskamp, N; Mortier, G; Devriendt, K; Amorim, MZ; Revencu, N; Kidd, A; Barbosa, M; Turner, A; Smith, J; Oley, C; Henderson, A; Hayes, IM; Thompson, EM; Brunner, HG; de Vries, BBA; Veltman, JA				Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Mortier, Geert; Devriendt, Koen; Amorim, Marta Z.; Revencu, Nicole; Kidd, Alexa; Barbosa, Mafalda; Turner, Anne; Smith, Janine; Oley, Christina; Henderson, Alex; Hayes, Ian M.; Thompson, Elizabeth M.; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.			De novo mutations of SETBP1 cause Schinzel-Giedion syndrome	NATURE GENETICS			English	Article							PROTEIN; GENE; DELINEATION; LEUKEMIA; FUSION	Schinzel-Giedion syndrome is characterized by severe mental retardation, distinctive facial features and multiple congenital malformations; most affected individuals die before the age of ten. We sequenced the exomes of four affected individuals (cases) and found heterozygous de novo variants in SETBP1 in all four. We also identified SETBP1 mutations in eight additional cases using Sanger sequencing. All mutations clustered to a highly conserved 11-bp exonic region, suggesting a dominant-negative or gain-of-function effect.	[Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Mortier, Geert] Univ Antwerp Hosp, Ctr Med Genet, Antwerp, Belgium; [Devriendt, Koen] Leuven Univ Hosp, Ctr Human Genet, Katholieke Univ Leuven, Louvain, Belgium; [Amorim, Marta Z.] Hosp Pediat Coimbra, Serv Genet Coimbra, Coimbra, Portugal; [Revencu, Nicole] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Kidd, Alexa] Christchurch Hosp, Canterbury Hlth Labs, Christchurch, New Zealand; [Barbosa, Mafalda] Inst Nacl Saude Doutor Ricardo, Ctr Genet Med Doutor Jacinto Magalhaes, Porto, Portugal; [Turner, Anne] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Smith, Janine] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Oley, Christina] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Henderson, Alex] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hayes, Ian M.] No Reg Genet Serv, Auckland, New Zealand; [Thompson, Elizabeth M.] Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia	Radboud University Nijmegen; University of Antwerp; KU Leuven; University Hospital Leuven; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Canterbury Health Laboratories; Christchurch Hospital New Zealand; University of Sydney; University of Sydney; Birmingham Women's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Womens & Childrens Hospital Australia	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	Gilissen, Christian/E-5246-2012; Brunner, Han/C-9928-2013; Mortier, Geert/D-2542-2012; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/D-1282-2013; Hoischen, Alexander/AGF-7293-2022; van Bon, Bregje/Q-2445-2015; van Bon, Bregje/D-3720-2013; Arts, Peer/Q-4139-2019	Gilissen, Christian/0000-0003-1693-9699; Mortier, Geert/0000-0001-9871-4578; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; van Bon, Bregje/0000-0003-2234-0105; Arts, Peer/0000-0002-6742-6239	Netherlands Organization for Health Research and Development [917-66-36, 911-08-025, 917-86-319]; EU [Health-F5-2009-223143, LSHG-CT-2006-37627]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); EU(European Commission)	We thank the subjects and their parents for participation in this study. We thank S. Keijzers-Vloet, J. de Ligt, N. Leijsten and personnel from the Sequencing Facility Nijmegen for technical assistance and I. Saleem for referring patient 3 to us. This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J. A. V. and to B.B.A.d.V.), the EU-funded TECHGENE project (Health-F5-2009-223143 to P.A. and J.A.V.) and the AnEUploidy project (LSHG-CT-2006-37627 to A.Hoischen, B.W.M.v.B., H.G.B., B.B.A.d.V. and J.A.V.).	Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; KRUEGER RC, 1990, J BIOL CHEM, V265, P12075; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Minn D, 2002, AM J MED GENET, V109, P211, DOI 10.1002/ajmg.10348; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; NIEDUSZYNSKI IA, 1990, BIOCHEM J, V271, P243, DOI 10.1042/bj2710243; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VAREZVENEGAS R, 2002, GENE, V285, P25; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407	15	333	344	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					483	485		10.1038/ng.581	http://dx.doi.org/10.1038/ng.581			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436468				2022-12-25	WOS:000278081500009
J	Kim, DU; Hayles, J; Kim, D; Wood, V; Park, HO; Won, M; Yoo, HS; Duhig, T; Nam, M; Palmer, G; Han, S; Jeffery, L; Baek, ST; Lee, H; Shim, YS; Lee, M; Kim, L; Heo, KS; Noh, EJ; Lee, AR; Jang, YJ; Chung, KS; Choi, SJ; Park, JY; Park, Y; Kim, HM; Park, SK; Park, HJ; Kang, EJ; Kim, HB; Kang, HS; Park, HM; Kim, K; Song, K; Bin Song, K; Nurse, P; Hoe, KL				Kim, Dong-Uk; Hayles, Jacqueline; Kim, Dongsup; Wood, Valerie; Park, Han-Oh; Won, Misun; Yoo, Hyang-Sook; Duhig, Trevor; Nam, Miyoung; Palmer, Georgia; Han, Sangjo; Jeffery, Linda; Baek, Seung-Tae; Lee, Hyemi; Shim, Young Sam; Lee, Minho; Kim, Lila; Heo, Kyung-Sun; Noh, Eun Joo; Lee, Ah-Reum; Jang, Young-Joo; Chung, Kyung-Sook; Choi, Shin-Jung; Park, Jo-Young; Park, Youngwoo; Kim, Hwan Mook; Park, Song-Kyu; Park, Hae-Joon; Kang, Eun-Jung; Kim, Hyong Bai; Kang, Hyun-Sam; Park, Hee-Moon; Kim, Kyunghoon; Song, Kiwon; Bin Song, Kyung; Nurse, Paul; Hoe, Kwang-Lae			Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe	NATURE BIOTECHNOLOGY			English	Article							PROTEIN LOCALIZATION; GLOBAL ANALYSIS; SACCHAROMYCES; SCREEN; CONSERVATION; MECHANISMS; MUTATIONS; EFFICIENT; NETWORKS; MODULES	We report the construction and analysis of 4,836 heterozygous diploid deletion mutants covering 98.4% of the fission yeast genome providing a tool for studying eukaryotic biology. Comprehensive gene dispensability comparisons with budding yeast-the only other eukaryote for which a comprehensive knockout library exists-revealed that 83% of single-copy orthologs in the two yeasts had conserved dispensability. Gene dispensability differed for certain pathways between the two yeasts, including mitochondrial translation and cell cycle checkpoint control. We show that fission yeast has more essential genes than budding yeast and that essential genes are more likely than nonessential genes to be present in a single copy, to be broadly conserved and to contain introns. Growth fitness analyses determined sets of haploinsufficient and haploproficient genes for fission yeast, and comparisons with budding yeast identified specific ribosomal proteins and RNA polymerase subunits, which may act more generally to regulate eukaryotic cell growth.	[Kim, Dong-Uk; Won, Misun; Yoo, Hyang-Sook; Nam, Miyoung; Baek, Seung-Tae; Lee, Hyemi; Shim, Young Sam; Kim, Lila; Heo, Kyung-Sun; Noh, Eun Joo; Lee, Ah-Reum; Jang, Young-Joo; Chung, Kyung-Sook; Choi, Shin-Jung; Park, Jo-Young; Park, Youngwoo; Hoe, Kwang-Lae] Korea Res Inst Biosci & Biotechnol, Integrat Om Res Ctr, Taejon, South Korea; [Hayles, Jacqueline; Wood, Valerie; Duhig, Trevor; Palmer, Georgia; Jeffery, Linda; Nurse, Paul] Cancer Res UK, London Res Inst, London, England; [Kim, Dongsup; Han, Sangjo; Lee, Minho] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Wood, Valerie] Wellcome Trust Sanger Inst, Cambridge, England; [Park, Han-Oh; Park, Hae-Joon; Kang, Eun-Jung] Bioneer Corp, Taejon, South Korea; [Kim, Hwan Mook; Park, Song-Kyu; Hoe, Kwang-Lae] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Ochang, Chungcheongbuk, South Korea; [Kim, Hyong Bai] Korea Univ, Dept Bioinformat & Biotechnol, Jochiwon, Chungnam, South Korea; [Kang, Hyun-Sam] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Park, Hee-Moon] Chungnam Natl Univ, Dept Microbiol, Taejon, South Korea; [Kim, Kyunghoon] Kangwon Natl Univ, Div Life Sci, Chunchon, Kangwon Do, South Korea; [Song, Kiwon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Bin Song, Kyung] Chungnam Natl Univ, Dept Food & Nutr, Taejon, South Korea; [Nurse, Paul] Rockefeller Univ, New York, NY 10021 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cancer Research UK; Korea Advanced Institute of Science & Technology (KAIST); Wellcome Trust Sanger Institute; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University; Seoul National University (SNU); Chungnam National University; Kangwon National University; Yonsei University; Chungnam National University; Rockefeller University	Hoe, KL (corresponding author), Korea Res Inst Biosci & Biotechnol, Integrat Om Res Ctr, Taejon, South Korea.	kwanghoe@kribb.re.kr	Kim, Dongsup/C-1612-2011; Heemoon, Park/F-5783-2013; Wood, Valerie/Y-7759-2018; Lee, Minho/ABG-5008-2020	Heemoon, Park/0000-0001-6780-9283; Wood, Valerie/0000-0001-6330-7526; Lee, Minho/0000-0002-0168-9546; Heo, Kyung-Sun/0000-0003-3800-7665; Baek, Seung Tae/0000-0003-0040-1501; Hoe, Kwang Lae/0000-0002-3943-4549	Ministry of Education, Science and Technology (MOEST) of Korea; Bioneer Corp.; Wellcome Trust; Cancer Research UK; Breast Cancer Research Foundation (BCRF); Rockefeller University	Ministry of Education, Science and Technology (MOEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Bioneer Corp.; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation (BCRF); Rockefeller University	We thank members of our laboratories for their participation in the construction and analysis of the deletion mutants, particularly H.-R. Hwang, H.-S. Ahn, Y.-D. Kim, S. Park, H.-J. Lee, J.-H. Ahn, Y.-S. Kil, S.-Y. Park, J.-H. Lim, J.-H. Song, Y.-K. Ryoo, J.-Y. Kim, M.-J. Oh, S. Kong, J. Ahn, N. Sun, N. Peat, R. Mandeville and J.-J. Li. We also thank J.-H. Roe and W.-K. Huh for reading this manuscript and for their insightful comments and O. Nielsen for his patience with the many requests for pON177. This work was supported by the intramural research program of KRIBB (Mission 2007), the Chemical Genomics Research Program and the 21st Century Frontier Research Program from the Ministry of Education, Science and Technology (MOEST) of Korea. This work was also supported by Bioneer Corp., The Wellcome Trust, Cancer Research UK, The Breast Cancer Research Foundation (BCRF) and The Rockefeller University.	AYSCOUGH K, 1993, J CELL SCI, V106, P1227; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Chiron S, 2005, GENETICS, V169, P1891, DOI 10.1534/genetics.104.037473; Choi DH, 2008, J MICROBIOL, V46, P75, DOI 10.1007/s12275-008-0013-6; Decottignies A, 2003, GENOME RES, V13, P399, DOI 10.1101/gr.636103; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Entian KD, 2007, METHOD MICROBIOL, V36, P629, DOI 10.1016/S0580-9517(06)36025-4; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gregan J, 2005, CURR BIOL, V15, P1663, DOI 10.1016/j.cub.2005.07.059; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Jorgensen P, 2002, GENETICS, V162, P1091; Jozwiak J, 2008, LANCET ONCOL, V9, P73, DOI 10.1016/S1470-2045(07)70411-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2006, TOP CURR GENET, V15, P233, DOI 10.1007/4735_97	44	488	5308	1	246	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					617	U111		10.1038/nbt.1628	http://dx.doi.org/10.1038/nbt.1628			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20473289	Green Accepted			2022-12-25	WOS:000278820200027
J	Krieger, U; Lippman, ZB; Zamir, D				Krieger, Uri; Lippman, Zachary B.; Zamir, Dani			The flowering gene SINGLE FLOWER TRUSS drives heterosis for yield in tomato	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GROWTH; MAIZE; OVERDOMINANT; LYCOPERSICON; POPULATION; DROSOPHILA; MUTATIONS; ORTHOLOG; SIGNALS	Intercrossing different varieties of plants frequently produces hybrid offspring with superior vigor and increased yields, in a poorly understood phenomenon known as heterosis(1,2). One classical unproven model for heterosis is overdominance, which posits in its simplest form that improved vigor can result from a single heterozygous gene(3-8). Here we report that heterozygosity for tomato loss-of-function alleles of SINGLE FLOWER TRUSS (SFT), which is the genetic originator of the flowering hormone florigen, increases yield by up to 60%. Yield overdominance from SFT heterozygosity is robust, occurring in distinct genetic backgrounds and environments. We show that several traits integrate pleiotropically to drive heterosis in a multiplicative manner(9), and these effects derive from a suppression of growth termination mediated by SELF PRUNING (SP), an antagonist of SFT. Our findings provide the first example of a single overdominant gene for yield and suggest that single heterozygous mutations may improve productivity in other agricultural organisms.	[Krieger, Uri; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel; [Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Hebrew University of Jerusalem; Cold Spring Harbor Laboratory	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel.	lippman@cshl.edu; zamir@agri.huji.ac.il		Lippman, Zachary/0000-0001-7668-9025	European Commission; Israel Science Foundation (ISF); United States National Science Foundation [DBI-0922442]	European Commission(European CommissionEuropean Commission Joint Research Centre); Israel Science Foundation (ISF)(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF))	We thank D. Jackson, R. Martienssen, Y. Semel, Y. Eshed and members of the Lippman laboratory for comments and discussion. We also thank the researchers and field crew at the Western Galilee experimental station in Akko, Israel, Kibbutz Kfar Masaryk, Israel and Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York. This research was supported by individual grants from the European Commission EU-SOL Project and The Israel Science Foundation (ISF) to D.Z. and from a Heterosis Challenge Grant DBI-0922442 from the United States National Science Foundation Plant Genome Research Program to Z. B. L.	Belo A, 2010, THEOR APPL GENET, V120, P355, DOI 10.1007/s00122-009-1128-9; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Crow J. F., 1952, Heterosis., P282; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; Darwin CR, 1876, EFFECTS CROSS SELF F; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; MULLER HJ, 1961, GENETICS, V46, P727; MULLER HJ, 1961, GENETICS, V46, P737; Pnueli L, 1998, DEVELOPMENT, V125, P1979; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; SCHWARTZ D, 1973, THEOR APPL GENET, V43, P117, DOI 10.1007/BF00306560; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; WALLACE B, 1957, P NATL ACAD SCI USA, V43, P404, DOI 10.1073/pnas.43.5.404; WALLACE B, 1959, 10 P INT C GEN MONTR, V1, P408; Whaley WG, 1939, AM J BOT, V26, P609, DOI 10.2307/2436798; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	36	319	355	14	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					459	U138		10.1038/ng.550	http://dx.doi.org/10.1038/ng.550			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348958				2022-12-25	WOS:000277179500020
J	Lamprecht, B; Walter, K; Kreher, S; Kumar, R; Hummel, M; Lenze, D; Kochert, K; Bouhlel, MA; Richter, J; Soler, E; Stadhouders, R; Johrens, K; Wurster, KD; Callen, DF; Harte, MF; Giefing, M; Barlow, R; Stein, H; Anagnostopoulos, I; Janz, M; Cockerill, PN; Siebert, R; Dorken, B; Bonifer, C; Mathas, S				Lamprecht, Bjoern; Walter, Korden; Kreher, Stephan; Kumar, Raman; Hummel, Michael; Lenze, Dido; Koechert, Karl; Bouhlel, Mohamed Amine; Richter, Julia; Soler, Eric; Stadhouders, Ralph; Joehrens, Korinna; Wurster, Kathrin D.; Callen, David F.; Harte, Michael F.; Giefing, Maciej; Barlow, Rachael; Stein, Harald; Anagnostopoulos, Ioannis; Janz, Martin; Cockerill, Peter N.; Siebert, Reiner; Doerken, Bernd; Bonifer, Constanze; Mathas, Stephan			Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma	NATURE MEDICINE			English	Article							REED-STERNBERG CELLS; STIMULATING FACTOR-I; HODGKIN LYMPHOMA; DIFFERENTIAL TRANSCRIPTION; DNA HYPOMETHYLATION; BREAST-CANCER; B-CELLS; KAPPA-B; GENE; RECEPTOR	Mammalian genomes contain many repetitive elements, including long terminal repeats (LTRs), which have long been suspected to have a role in tumorigenesis. Here we present evidence that aberrant LTR activation contributes to lineage-inappropriate gene expression in transformed human cells and that such gene expression is central for tumor cell survival. We show that B cell-derived Hodgkin's lymphoma cells depend on the activity of the non-B, myeloid-specific proto-oncogene colony-stimulating factor 1 receptor (CSF1R). In these cells, CSF1R transcription initiates at an aberrantly activated endogenous LTR of the MaLR family (THE1B). Derepression of the THE1 subfamily of MaLR LTRs is widespread in the genome of Hodgkin's lymphoma cells and is associated with impaired epigenetic control due to loss of expression of the corepressor CBFA2T3. Furthermore, we detect LTR-driven CSF1R transcripts in anaplastic large cell lymphoma, in which CSF1R is known to be expressed aberrantly. We conclude that LTR derepression is involved in the pathogenesis of human lymphomas, a finding that might have diagnostic, prognostic and therapeutic implications.	[Lamprecht, Bjoern; Kreher, Stephan; Koechert, Karl; Wurster, Kathrin D.; Janz, Martin; Doerken, Bernd; Mathas, Stephan] Max Delbruck Ctr Mol Med, Berlin, Germany; [Lamprecht, Bjoern; Kreher, Stephan; Koechert, Karl; Wurster, Kathrin D.; Janz, Martin; Doerken, Bernd; Mathas, Stephan] Charite, CVK, D-13353 Berlin, Germany; [Walter, Korden; Bouhlel, Mohamed Amine; Barlow, Rachael; Cockerill, Peter N.; Bonifer, Constanze] Univ Leeds, St Jamess Univ Hosp, Sect Expt Haematol, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Kumar, Raman; Callen, David F.] Univ Adelaide, Breast Canc Genet Grp, Discipline Med, Adelaide, SA 5005, Australia; [Hummel, Michael; Lenze, Dido; Joehrens, Korinna; Stein, Harald; Anagnostopoulos, Ioannis] Charite, Inst Pathol, CBF, D-13353 Berlin, Germany; [Richter, Julia; Giefing, Maciej; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Richter, Julia; Giefing, Maciej; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Soler, Eric; Stadhouders, Ralph] Erasmus MC, Univ Med Ctr, Dept Cell Biol, Rotterdam, Netherlands; [Harte, Michael F.] Cytopia Res Pty Ltd, Richmond, Vic, Australia; [Giefing, Maciej] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint James's University Hospital; University of Leeds; University of Adelaide; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Erasmus University Rotterdam; Erasmus MC; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Mathas, S (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	c.bonifer@leeds.ac.uk; stephan.mathas@charite.de	Soler, Eric/ABE-9723-2021; Kumar, Raman/AHE-0538-2022; Mathas, Stephan/I-5589-2015; Stadhouders, Ralph/J-8663-2015	Soler, Eric/0000-0003-0521-7463; Kumar, Raman/0000-0001-7976-8386; Bonifer, Constanze/0000-0002-4267-0825; Callen, David/0000-0002-6189-9991; Stadhouders, Ralph/0000-0002-1060-5607; Kochert, Karl/0000-0002-5548-2022; Cockerill, Peter/0000-0002-4410-8174; Janz, Martin/0000-0002-1127-0044; Hummel, Michael/0000-0001-6717-605X; Giefing, Maciej/0000-0002-4760-8246	Federation of European Biochemical Societies; Deutsche Forschungsgemeinschaft [SFB/TRR54]; Wilhelm Sander-Stiftung; Deutsche Krebshilfe; KinderKrebsInitiative Buchholz/Holm-Seppensen; Susan G. Komen for the Cure; Leukaemia and Lymphoma Research; Cancer Research UK; Yorkshire Cancer Research	Federation of European Biochemical Societies; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); KinderKrebsInitiative Buchholz/Holm-Seppensen; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research	We thank F. Hummel, S. Kressmann, S. Meier, C. Cieluch, B. Wollert-Wulf and R. Zuhlke-Jenisch for outstanding technical assistance, H. Tagoh for help with experiments, P. Rahn for cell sorting and K. Rajewsky for helpful discussion and critical reading of the manuscript. M. G. is funded by the Federation of European Biochemical Societies. This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR54), the Wilhelm Sander-Stiftung, the Deutsche Krebshilfe, the KinderKrebsInitiative Buchholz/Holm-Seppensen, Susan G. Komen for the Cure, Leukaemia and Lymphoma Research, Cancer Research UK and Yorkshire Cancer Research. We also thank V. Diehl (University Cologne) for cell lines L1236 and L591, A. Engert (University Cologne) for L540Cy cells, P. Krammer (German Cancer Research Center Heidelberg) for BJAB cells, L. Staudt (US National Cancer Institute) for OCI-Ly3 and OCI-Ly10 cells, M. Falk (Helmholtz Zentrum Munchen) for BL-60 cells and S. Rosen (Northwestern University) for MM1.S cells.	Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700; Borowitz MJ., 2008, WHO CLASSIFICATION T, P149; Burns CJ, 2009, BIOORG MED CHEM LETT, V19, P1206, DOI 10.1016/j.bmcl.2008.12.073; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fan T, 2008, EPIGENETICS-US, V3, P134, DOI 10.4161/epi.3.3.6252; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Gamou T, 1998, BLOOD, V91, P4028, DOI 10.1182/blood.V91.11.4028.411a45_4028_4037; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; Janz M, 2006, CELL CYCLE, V5, P1057, DOI 10.4161/cc.5.10.2737; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; KACINSKI BM, 1995, ANN MED, V27, P79, DOI 10.3109/07853899509031941; Kluger HM, 2004, CLIN CANCER RES, V10, P173, DOI 10.1158/1078-0432.CCR-0699-3; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; MOREAU A, 1992, LEUKEMIA, V6, P126; Ohshima K, 2001, INT J CANCER, V92, P678, DOI 10.1002/1097-0215(20010601)92:5<678::AID-IJC1259>3.0.CO;2-R; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786	39	232	237	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					571	579		10.1038/nm.2129	http://dx.doi.org/10.1038/nm.2129			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436485				2022-12-25	WOS:000277394700036
J	Kroiss, J; Kaltenpoth, M; Schneider, B; Schwinger, MG; Hertweck, C; Maddula, RK; Strohm, E; Svatos, A				Kroiss, Johannes; Kaltenpoth, Martin; Schneider, Bernd; Schwinger, Maria-Gabriele; Hertweck, Christian; Maddula, Ravi Kumar; Strohm, Erhard; Svatos, Ales			Symbiotic streptomycetes provide antibiotic combination prophylaxis for wasp offspring	NATURE CHEMICAL BIOLOGY			English	Article							PHYSIOLOGICAL ACTIVITIES; PIERICIDIN; BACTERIA; PROTECT; GARDEN; ANTS	Beewolf digger wasps cultivate specific symbiotic bacteria (Streptomyces spp.) that are incorporated into the larval cocoon for protection against pathogens. We identified the molecular basis of this protective symbiosis in the natural context and demonstrate that the bacteria produce a 'cocktail' of nine antibiotic substances. The complementary action of all symbiont-produced antibiotics confers a potent antimicrobial defense for the wasp larvae that parallels the 'combination prophylaxis' known from human medicine.	[Kroiss, Johannes; Maddula, Ravi Kumar; Svatos, Ales] Max Planck Inst Chem Ecol, Res Grp Mass Spectrometry, Jena, Germany; [Kaltenpoth, Martin; Strohm, Erhard] Univ Regensburg, Dept Zool, Regensburg, Germany; [Schneider, Bernd] Max Planck Inst Chem Ecol, Res Grp Biosynth NMR, Jena, Germany; [Schwinger, Maria-Gabriele; Hertweck, Christian] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany	Max Planck Society; University of Regensburg; Max Planck Society; Hans Knoll Institute (HKI)	Kroiss, J (corresponding author), Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany.	mkaltenpoth@ice.mpg.de; svatos@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014; Hertweck, Christian/AAZ-8452-2021; Hertweck, Christian/G-1896-2014; Svatos, Ales/A-3305-2014; Schneider, Bernd/A-3287-2014	Kaltenpoth, Martin/0000-0001-9450-0345; Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Svatos, Ales/0000-0003-1032-7288; Schneider, Bernd/0000-0003-4788-1565	Max Planck Society; German Research Foundation Deutsche Forschungsgemeinschaft; Volkswagen Foundation; International Leibniz Research School for Microbial and Biomolecular Interactions; Jena School for Microbial Communication	Max Planck Society(Max Planck Society); German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); International Leibniz Research School for Microbial and Biomolecular Interactions; Jena School for Microbial Communication	We acknowledge financial support from the Max Planck Society (J.K., B. S., R. K. M. and A. S.), the German Research Foundation Deutsche Forschungsgemeinschaft ( J.K., M. K. and E. S.), the Volkswagen Foundation ( M. K.), the International Leibniz Research School for Microbial and Biomolecular Interactions (M.-G. S. and C. H.) and the Jena School for Microbial Communication (M.-G. S. and C. H.). We thank K. Roeser-Mueller, T. Engl and K. Angermeier ( all at the University of Regensburg) for providing beewolf cocoons; J. Doubsky ( Max Planck Institute for Chemical Ecology) for the camalexin standard; and J. Seger for valuable comments on the manuscript.	Behal V, 2000, ADV APPL MICROBIOL, V47, P113; Bourtzis K, 2006, INSECT SYMBIOSIS; Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Goettler W, 2007, ARTHROPOD STRUCT DEV, V36, P1, DOI 10.1016/j.asd.2006.08.003; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Herzner G, 2007, CURR BIOL, V17, pR46, DOI 10.1016/j.cub.2006.11.060; Holscher D, 2009, PLANT J, V60, P907, DOI 10.1111/j.1365-313X.2009.04012.x; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; MATSUMOTO M, 1987, J ANTIBIOT, V40, P149, DOI 10.7164/antibiotics.40.149; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Shin HJ, 2007, J MICROBIOL BIOTECHN, V17, P1403; Strohm E, 2001, ECOL ENTOMOL, V26, P198, DOI 10.1046/j.1365-2311.2001.00300.x; Strohm E, 1995, ZOOLOGY, V98, P137; TAKAHASHI N, 1968, AGR BIOL CHEM TOKYO, V32, P1115, DOI 10.1080/00021369.1968.10859204; TAMURA S, 1963, AGR BIOL CHEM TOKYO, V27, P576, DOI 10.1080/00021369.1963.10858144; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; WINSTON LG, 2005, HOSP MED, P623; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	25	269	277	3	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					261	263		10.1038/NCHEMBIO.331	http://dx.doi.org/10.1038/NCHEMBIO.331			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20190763				2022-12-25	WOS:000275734000008
J	Lam, TKT				Lam, Tony K. T.			Neuronal regulation of homeostasis by nutrient sensing	NATURE MEDICINE			English	Article							HEPATIC GLUCOSE-PRODUCTION; CENTRAL INSULIN ACTION; CHAIN FATTY-ACIDS; FOOD-INTAKE; PROTEIN-KINASE; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; LIPID-METABOLISM; SKELETAL-MUSCLE; GASTRIC BYPASS	In type 2 diabetes and obesity, the homeostatic control of glucose and energy balance is impaired, leading to hyperglycemia and hyperphagia. Recent studies indicate that nutrient-sensing mechanisms in the body activate negative-feedback systems to regulate energy and glucose homeostasis through a neuronal network. Direct metabolic signaling within the intestine activates gut-brain and gut-brain-liver axes to regulate energy and glucose homeostasis, respectively. In parallel, direct metabolism of nutrients within the hypothalamus regulates food intake and blood glucose levels. These findings highlight the importance of the central nervous system in mediating the ability of nutrient sensing to maintain homeostasis. Futhermore, they provide a physiological and neuronal framework by which enhancing or restoring nutrient sensing in the intestine and the brain could normalize energy and glucose homeostasis in diabetes and obesity.	[Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca			Canadian Institutes of Health Research [MOP-82701, 86554] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Asilmaz E, 2004, J CLIN INVEST, V113, P414, DOI 10.1172/JCI200419511; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Cha SH, 2009, BIOCHEM BIOPH RES CO, V386, P212, DOI 10.1016/j.bbrc.2009.06.017; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2007, GASTROENTEROLOGY, V132, P2158, DOI 10.1053/j.gastro.2007.03.049; Cummings DE, 2009, INT J OBESITY, V33, pS33, DOI 10.1038/ijo.2009.15; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Edgerton DS, 2006, J CLIN INVEST, V116, P521, DOI 10.1172/JCI27073; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Knauf C, 2008, DIABETES, V57, P2603, DOI 10.2337/db07-1788; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Lam CKL, 2008, AM J PHYSIOL-ENDOC M, V295, pE491, DOI 10.1152/ajpendo.90481.2008; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Reed JA, 2008, AM J PHYSIOL-ENDOC M, V294, pE752, DOI 10.1152/ajpendo.00463.2007; Ross R, 2008, DIABETES, V57, P2061, DOI 10.2337/db08-0206; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sindelar DK, 1996, DIABETES, V45, P1594, DOI 10.2337/diabetes.45.11.1594; Stafford JM, 2008, DIABETES, V57, P1482, DOI 10.2337/db07-1702; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937	71	95	96	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					392	395		10.1038/nm0410-392	http://dx.doi.org/10.1038/nm0410-392			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376051				2022-12-25	WOS:000276446800040
J	Matsuzaki, M; Hayama, T; Kasai, H; Ellis-Davies, GCR				Matsuzaki, Masanori; Hayama, Tatsuya; Kasai, Haruo; Ellis-Davies, Graham C. R.			Two-photon uncaging of gamma-aminobutyric acid in intact brain tissue	NATURE CHEMICAL BIOLOGY			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; DENDRITIC SPINES; SYNAPTIC CONNECTIONS; CAGED GLUTAMATE; GABA; RAT; SYNAPSES; NEURONS; PHOTOLYSIS; RECEPTORS	We have synthesized a photosensitive ( or caged) 4-carboxymethoxy-5,7-dinitroindolinyl (CDNI) derivative of gamma-aminobutyric acid (GABA). Two-photon excitation of CDNI-GABA produced rapid activation of GABAergic currents in neurons in brain slices with an axial resolution of approximately 2 mu m and enabled high-resolution functional mapping of GABA-A receptors. Two-photon uncaging of GABA, the main inhibitory neurotransmitter, should allow detailed studies of receptor function and synaptic integration with subcellular precision.	[Matsuzaki, Masanori; Hayama, Tatsuya; Kasai, Haruo] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Tokyo, Japan; [Matsuzaki, Masanori; Hayama, Tatsuya; Kasai, Haruo] Univ Tokyo, Ctr NanoBio Integrat, Tokyo, Japan; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19104 USA	University of Tokyo; University of Tokyo; Drexel University	Matsuzaki, M (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol, Tokyo, Japan.	mzakim@m.u-tokyo.ac.jp		Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	US National Institutes of Health [GM53395]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20021008, 19680020]; Precursory Research for Embryonic Science and Technology (PRESTO); Japan Science and Technology Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology (PRESTO); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grant GM53395 ( to G.C.R.E.-D.), a Grant-in-Aid for Scientific Research on Priority Areas (Elucidation of neural network function in the brain, number 20021008, to M. M.), a Grant-in-Aid for Young Scientists ( A) ( number 19680020, to M. M.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and funding from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency ( to M. M.).	Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Curten B, 2005, PHOTOCHEM PHOTOBIOL, V81, P641, DOI 10.1562/2004-07-08-RA-226.1; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Eder M, 2004, REV NEUROSCIENCE, V15, P167, DOI 10.1515/REVNEURO.2004.15.3.167; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; ELLISDAVIES GCR, 2008, NEW ENCY NEUROSCIENC, pE876; GEE KR, 1994, J AM CHEM SOC, V116, P8366, DOI 10.1021/ja00097a054; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2008, J NEUROPHYSIOL, V99, P1535, DOI 10.1152/jn.01127.2007; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Molnar P, 2000, EUR J PHARMACOL, V391, P255, DOI 10.1016/S0014-2999(00)00106-0; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Papageorgiou G, 2007, TETRAHEDRON, V63, P9668, DOI 10.1016/j.tet.2007.07.030; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Zayat L, 2007, CHEMBIOCHEM, V8, P2035, DOI 10.1002/cbic.200700354	25	77	82	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					255	257		10.1038/NCHEMBIO.321	http://dx.doi.org/10.1038/NCHEMBIO.321			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20173751	Green Accepted			2022-12-25	WOS:000275734000006
J	Ramessar, K; Capell, T; Twyman, RM; Christou, P				Ramessar, Koreen; Capell, Teresa; Twyman, Richard M.; Christou, Paul			Going to ridiculous lengths-European coexistence regulations for GM crops	NATURE BIOTECHNOLOGY			English	Article									[Ramessar, Koreen; Capell, Teresa; Christou, Paul] Univ Lleida, Dept Prod Vegetal Ciencia Forestal 1, Lleida, Spain; [Twyman, Richard M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Christou, Paul] Passeig Lluis Co, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Universitat de Lleida; University of Warwick; ICREA	Ramessar, K (corresponding author), Univ Lleida, Dept Prod Vegetal Ciencia Forestal 1, Lleida, Spain.	christou@pvcf.udl.es	Capell, Teresa/AAD-8609-2022; Twyman, Richard M/M-5016-2018; Capell, Teresa/B-2757-2011; Christou, Paul/C-8645-2011	Twyman, Richard M/0000-0002-8764-3003; Capell, Teresa/0000-0002-6436-4538; Christou, Paul/0000-0001-6358-7396	ICREA Funding Source: Custom	ICREA(ICREA)		Abbott A, 2007, NATURE, V450, P928, DOI 10.1038/450928a; *APROSE, 2007, GUIA 2007 BUEN PRACT; Aylor DE, 2004, AGR FOREST METEOROL, V123, P125, DOI 10.1016/j.agrformet.2003.12.007; Beckmann V, 2006, AM J AGR ECON, V88, P1193, DOI 10.1111/j.1467-8276.2006.00932.x; Binimelis R, 2008, J AGR ENVIRON ETHIC, V21, P437, DOI 10.1007/s10806-008-9099-4; Brookes G., 2004, COEXISTENCE GM NONGM; BROOKES G, 2004, GM MAIZE POLLEN MOVE; CORTIVARELA J, 2007, P 2 ANN CAMBR C REG; DECARVALHO PC, 2009, COEXISTENCIA ENTRE C; Devos Y, 2009, AGRON SUSTAIN DEV, V29, P11, DOI 10.1051/agro:2008051; Devos Yann, 2005, Environmental Biosafety Research, V4, P71, DOI 10.1051/ebr:2005013; *EUROPABIO, 2007, EU COURT REJ AUSTR B; European Commission, 2003, OFFICIAL J EUROPEA L, VL189, P36; European Commission, 2003, OFF J EUR UNION L, VL268, P24; KALAITZANDONAKE.N, 2005, P 2 INT C COEX GM NO, P29; Luna S, 2001, CROP SCI, V41, P1551, DOI 10.2135/cropsci2001.4151551x; Messean A., 2006, TECHNICAL REPORT SER; PATERNIA.E, 1974, EUPHYTICA, V23, P129, DOI 10.1007/BF00032751; Ramessar K, 2008, NAT BIOTECHNOL, V26, P975, DOI 10.1038/nbt0908-975; Ramessar K, 2009, MOL BREEDING, V23, P99, DOI 10.1007/s11032-008-9217-z; Sanvido O, 2008, TRANSGENIC RES, V17, P317, DOI 10.1007/s11248-007-9103-1; *SCP, 2001, OP SCI COMM PLANTS A; [No title captured]	23	42	42	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					133	136		10.1038/nbt0210-133	http://dx.doi.org/10.1038/nbt0210-133			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20139947				2022-12-25	WOS:000274317200017
J	Reveille, JD; Sims, AM; Danoy, P; Evans, DM; Leo, P; Pointon, JJ; Jin, R; Zhou, XD; Bradbury, LA; Appleton, LH; Davis, JC; Diekman, L; Doan, T; Dowling, A; Duan, R; Duncan, EL; Farrar, C; Hadler, J; Harvey, D; Karaderi, T; Mogg, R; Pomeroy, E; Pryce, K; Taylor, J; Savage, L; Deloukas, P; Kumanduri, V; Peltonen, L; Ring, SM; Whittaker, P; Glazov, E; Thomas, GP; Maksymowych, WP; Inman, RD; Ward, MM; Stone, MA; Weisman, MH; Wordsworth, BP; Brown, MA				Reveille, John D.; Sims, Anne-Marie; Danoy, Patrick; Evans, David M.; Leo, Paul; Pointon, Jennifer J.; Jin, Rui; Zhou, Xiaodong; Bradbury, Linda A.; Appleton, Louise H.; Davis, John C.; Diekman, Laura; Doan, Tracey; Dowling, Alison; Duan, Ran; Duncan, Emma L.; Farrar, Claire; Hadler, Johanna; Harvey, David; Karaderi, Tugce; Mogg, Rebecca; Pomeroy, Emma; Pryce, Karena; Taylor, Jacqueline; Savage, Laurie; Deloukas, Panos; Kumanduri, Vasudev; Peltonen, Leena; Ring, Sue M.; Whittaker, Pamela; Glazov, Evgeny; Thomas, Gethin P.; Maksymowych, Walter P.; Inman, Robert D.; Ward, Michael M.; Stone, Millicent A.; Weisman, Michael H.; Wordsworth, B. Paul; Brown, Matthew A.		Australo-Anglo-Amer Spondyloarthri	Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci	NATURE GENETICS			English	Article							GENETIC-SUSCEPTIBILITY; VARIANTS; DISEASE; RISK; TNF	To identify susceptibility loci for ankylosing spondylitis, we undertook a genome-wide association study in 2,053 unrelated ankylosing spondylitis cases among people of European descent and 5,140 ethnically matched controls, with replication in an independent cohort of 898 ankylosing spondylitis cases and 1,518 controls. Cases were genotyped with Illumina HumHap370 genotyping chips. In addition to strong association with the major histocompatibility complex (MHC; P < 10(-800)), we found association with SNPs in two gene deserts at 2p15 (rs10865331; combined P = 1.9 x 10(-19)) and 21q22 (rs2242944; P = 8.3 x 10(-20)), as well as in the genes ANTXR2 (rs4333130; P = 9.3 x 10(-8)) and IL1R2 (rs2310173; P = 4.8 x 10(-7)). We also replicated previously reported associations at IL23R (rs11209026; P = 9.1 x 10(-14)) and ERAP1 (rs27434; P = 5.3 x 10(-12)). This study reports four genetic loci associated with ankylosing spondylitis risk and identifies a major role for the interleukin (IL)-23 and IL-1 cytokine pathways in disease susceptibility.	[Reveille, John D.; Jin, Rui; Zhou, Xiaodong; Diekman, Laura] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Evans, David M.; Ring, Sue M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Pointon, Jennifer J.; Appleton, Louise H.; Farrar, Claire; Harvey, David; Karaderi, Tugce; Wordsworth, B. Paul; Brown, Matthew A.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Davis, John C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mogg, Rebecca; Pomeroy, Emma; Stone, Millicent A.] Royal Natl Hosp Rheumat Dis, Natl Hlth Serv Fdn Trust, Bath BA1 1RL, Avon, England; [Mogg, Rebecca; Pomeroy, Emma; Stone, Millicent A.] Univ Bath, Bath BA2 7AY, Avon, England; [Savage, Laurie] Spondylitis Assoc Amer, Sherman Oaks, CA USA; [Deloukas, Panos; Kumanduri, Vasudev; Peltonen, Leena; Whittaker, Pamela] Wellcome Trust Sanger Inst, Cambridge, England; [Maksymowych, Walter P.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Inman, Robert D.; Stone, Millicent A.] Univ Toronto, Toronto, ON, Canada; [Ward, Michael M.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Weisman, Michael H.] Cedars Sinai Med Ctr, Dept Med Rheumatol, Los Angeles, CA 90048 USA; [Sims, Anne-Marie; Danoy, Patrick; Leo, Paul; Bradbury, Linda A.; Doan, Tracey; Dowling, Alison; Duan, Ran; Duncan, Emma L.; Hadler, Johanna; Pryce, Karena; Taylor, Jacqueline; Glazov, Evgeny; Thomas, Gethin P.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia	University of Texas System; University of Texas Health Science Center Houston; University of Bristol; University of Oxford; University of California System; University of California San Francisco; Royal National Hospital for Rheumatic Diseases (RNHRD); University of Bath; Wellcome Trust Sanger Institute; University of Alberta; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Cedars Sinai Medical Center; University of Queensland	Brown, MA (corresponding author), Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia.	john.d.reveille@uth.tmc.edu; matt.brown@uq.edu.au	Duncan, Emma L/L-1224-2013; Glazov, Evgeny A/F-9951-2010; Brown, Matthew A/E-5749-2010; Dowling, Alison/AAW-3631-2021; Deloukas, Panos/B-2922-2013; Leo, Paul/R-4464-2019; Leo, Paul J/B-3470-2011; Karaderi, Tugce/W-8729-2019; Thomas, Gethin P/A-3624-2011; Evans, David M/H-6325-2013	Duncan, Emma L/0000-0002-8143-4403; Brown, Matthew A/0000-0003-0538-8211; Deloukas, Panos/0000-0001-9251-070X; Leo, Paul J/0000-0001-8325-4134; Karaderi, Tugce/0000-0001-9763-8139; Evans, David M/0000-0003-0663-4621; Thomas, Gethin/0000-0001-9081-3686; Maksymowych, Walter/0000-0002-1291-1755; Pomeroy, Emma/0000-0001-6251-2165; Inman, Robert/0000-0002-4750-1422	National Ankylosing Spondylitis Society (UK); Spondyloarthritis Association of America; US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [P01-052915, R01-AR046208]; University of Texas [UL1RR024188]; Cedars-Sinai General Clinical Research Center [MO1-RR00425]; NIAMS/National Institutes of Health; Arthritis Research Campaign (UK); Wellcome Trust [076113]; Oxford Radcliffe Hospital Biomedical Research Centre [A91202]; National Health and Medical Research Council (Australia); UK Medical Research Council; University of Bristol; MRC [G0600705, G0800582] Funding Source: UKRI; Medical Research Council [G9815508, G0600705, G0800582] Funding Source: researchfish; Versus Arthritis [19356] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046208, P01AR052915, ZIAAR041153] Funding Source: NIH RePORTER	National Ankylosing Spondylitis Society (UK); Spondyloarthritis Association of America; US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Texas; Cedars-Sinai General Clinical Research Center; NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Research Campaign (UK)(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Radcliffe Hospital Biomedical Research Centre; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank all participants, with and without ankylosing spondylitis, who provided the case and control DNA and clinical information necessary for this study. We are also very grateful for the invaluable support received from the National Ankylosing Spondylitis Society (UK) and Spondyloarthritis Association of America in subject recruitment. We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them and the whole Avon Longitudinal Study of Parents And Children (ALSPAC) team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. This study was funded by US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants P01-052915 and R01-AR046208. Funding was also received from the University of Texas at Houston Clinical and Translational Science Award grant UL1RR024188, Cedars-Sinai General Clinical Research Center grant MO1-RR00425, Intramural Research Program of NIAMS/National Institutes of Health, and Rebecca Cooper Foundation (Australia). This study was funded in part by the Arthritis Research Campaign (UK), by the Wellcome Trust (grant number 076113) and by the Oxford Radcliffe Hospital Biomedical Research Centre ankylosing spondylitis chronic disease cohort (theme code A91202). M.A.B. is funded by the National Health and Medical Research Council (Australia). The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for ALSPAC.	Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CALIN A, 1983, ARTHRITIS RHEUM, V26, P1460, DOI 10.1002/art.1780261207; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Goto Y, 2008, BIOCHEM J, V416, P109, DOI 10.1042/BJ20080965; Kiiveri HT, 2003, INST MATH S, V40, P127; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Laval SH, 2001, AM J HUM GENET, V68, P918, DOI 10.1086/319509; LUSA L, 2008, GENEMETA METAANALYSI; MIELANTS H, 1995, J RHEUMATOL, V22, P2273; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	24	476	499	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					123	U47		10.1038/ng.513	http://dx.doi.org/10.1038/ng.513			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062062	Green Accepted			2022-12-25	WOS:000274084400007
J	Doi, M; Takahashi, Y; Komatsu, R; Yamazaki, F; Yamada, H; Haraguchi, S; Emoto, N; Okuno, Y; Tsujimoto, G; Kanematsu, A; Ogawa, O; Todo, T; Tsutsui, K; van der Horst, GTJ; Okamura, H				Doi, Masao; Takahashi, Yukari; Komatsu, Rie; Yamazaki, Fumiyoshi; Yamada, Hiroyuki; Haraguchi, Shogo; Emoto, Noriaki; Okuno, Yasushi; Tsujimoto, Gozoh; Kanematsu, Akihiro; Ogawa, Osamu; Todo, Takeshi; Tsutsui, Kazuyoshi; van der Horst, Gijsbertus T. J.; Okamura, Hitoshi			Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6	NATURE MEDICINE			English	Article							PRIMARY ALDOSTERONISM; EXPRESSION; GENE; TRILOSTANE; MOUSE; RAT; 11-BETA-HYDROXYLASE; MUTATIONS; PRESSURE; WEB	Malfunction of the circadian clock has been linked to the pathogenesis of a variety of diseases. We show that mice lacking the core clock components Cryptochrome-1 (Cry1) and Cryptochrome-2 (Cry2) (Cry-null mice) show salt-sensitive hypertension due to abnormally high synthesis of the mineralocorticoid aldosterone by the adrenal gland. An extensive search for the underlying cause led us to identify type VI 3 beta-hydroxyl-steroid dehydrogenase (Hsd3b6) as a new hypertension risk factor in mice. Hsd3b6 is expressed exclusively in aldosterone-producing cells and is under transcriptional control of the circadian clock. In Cry-null mice, Hsd3b6 messenger RNA and protein levels are constitutively high, leading to a marked increase in 3 beta-hydroxysteroid dehydrogenase-isomerase (3 beta-HSD) enzymatic activity and, as a consequence, enhanced aldosterone production. These data place Hsd3b6 in a pivotal position through which circadian clock malfunction is coupled to the development of hypertension. Translation of these findings to humans will require clinical examination of human HSD3B1 gene, which we found to be functionally similar to mouse Hsd3b6.	[Doi, Masao; Takahashi, Yukari; Komatsu, Rie; Yamazaki, Fumiyoshi; Yamada, Hiroyuki; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto, Japan; [Haraguchi, Shogo; Tsutsui, Kazuyoshi] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Biol, Lab Integrat Brain Sci,Shinjuku Ku, Tokyo, Japan; [Emoto, Noriaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med,Chuo Ku, Kobe, Hyogo 657, Japan; [Okuno, Yasushi] Kyoto Univ, Dept Syst Biosci Drug Discovery, Sakyo Ku, Kyoto, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Dept Genom Drug Discovery Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan; [Kanematsu, Akihiro; Ogawa, Osamu] Kyoto Univ, Dept Urol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Suita, Osaka, Japan; [van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands	Kyoto University; Waseda University; Kobe University; Kyoto University; Kyoto University; Kyoto University; Osaka University; Erasmus University Rotterdam; Erasmus MC	Okamura, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto, Japan.	okamurah@pharm.kyoto-u.ac.jp	van der Horst, Gijsbertus TJ/E-3661-2015; Doi, Masao/J-9267-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Doi, Masao/0000-0001-6264-9217; Haraguchi, Shogo/0000-0002-8731-3311; Okamura, Hitoshi/0000-0002-3013-4881; Emoto, Noriaki/0000-0001-6673-2616	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nakatomi Foundation, SRF; Senri Life Science Foundation; Takeda Science Foundation; Netherlands Organization of Scientific research [ZonMW Vici 918.36.619]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation, SRF; Senri Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Netherlands Organization of Scientific research(Netherlands Organization for Scientific Research (NWO))	We thank T. Ono, A. Hirasawa, T. Koshimizu, K. Terasawa, H. Nishinaga, M. Sato, Y. Yamaguchi, M. Matsuo, J. M. Fustin, K. Toida, H. Sei and K. Ishimura for technical support and valuable discussion. We also thank T. Michel for critical reading of the manuscript. This work was supported in part by the Specially Promoted Research (to H. O.) and Grant-in-Aid for Young Scientists (to M. D.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from Nakatomi Foundation, SRF (to H. O.), Senri Life Science Foundation, Takeda Science Foundation (to M. D.) and the Netherlands Organization of Scientific research, ZonMW Vici 918.36.619 (to G.T.J.v.d.H.). Trilostane was a generous gift from Mochida Pharmaceutical. Eplerenone was a generous gift from Pfizer.	Abbaszade IG, 1997, ENDOCRINOLOGY, V138, P1392, DOI 10.1210/en.138.4.1392; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Brown NJ, 2003, CIRCULATION, V107, P2512, DOI 10.1161/01.CIR.0000071081.35693.9A; Brown R, 2003, NAT REV DRUG DISCOV, V2, P177, DOI 10.1038/nrd1039; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Furlan R, 2000, CIRCULATION, V102, P1912, DOI 10.1161/01.CIR.102.16.1912; GIROUD CJP, 1956, P SOC EXP BIOL MED, V92, P154; GOMEZSANCHEZ C, 1976, ENDOCRINOLOGY, V99, P567, DOI 10.1210/endo-99-2-567; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JUNGMANN E, 1982, RES EXP MED, V180, P193, DOI 10.1007/BF01851059; Kaplan N.M., 2006, KAPLANS CLIN HYPERTE, P410; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Mason JI, 1997, STEROIDS, V62, P164, DOI 10.1016/S0039-128X(96)00176-6; Matsunaga M, 2004, P NATL ACAD SCI USA, V101, P17282, DOI 10.1073/pnas.0407176101; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Moisan AM, 1999, J CLIN ENDOCR METAB, V84, P4410, DOI 10.1210/jc.84.12.4410; NAKADA T, 1985, UROLOGY, V25, P207, DOI 10.1016/0090-4295(85)90548-5; OGISHIMA T, 1992, ENDOCRINOLOGY, V130, P2971, DOI 10.1210/en.130.5.2971; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Peng LH, 2002, MOL CELL ENDOCRINOL, V187, P213, DOI 10.1016/S0303-7207(01)00689-X; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Rainey WE, 1999, MOL CELL ENDOCRINOL, V151, P151, DOI 10.1016/S0303-7207(99)00051-9; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; RHEAUME E, 1992, NAT GENET, V1, P239, DOI 10.1038/ng0792-239; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; WINTERBERG B, 1985, CARDIOLOGY, V72, P117, DOI 10.1159/000173956; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x	47	298	309	1	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					67	U102		10.1038/nm.2061	http://dx.doi.org/10.1038/nm.2061			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20023637	Green Submitted			2022-12-25	WOS:000273395500038
J	Echtler, K; Stark, K; Lorenz, M; Kerstan, S; Walch, A; Jennen, L; Rudelius, M; Seidl, S; Kremmer, E; Emambokus, NR; von Bruehl, ML; Frampton, J; Isermann, B; Genzel-Boroviczeny, O; Schreiber, C; Mehilli, J; Kastrati, A; Schwaiger, M; Shivdasani, RA; Massberg, S				Echtler, Katrin; Stark, Konstantin; Lorenz, Michael; Kerstan, Sandra; Walch, Axel; Jennen, Luise; Rudelius, Martina; Seidl, Stefan; Kremmer, Elisabeth; Emambokus, Nikla R.; von Bruehl, Marie-Luise; Frampton, Jon; Isermann, Berend; Genzel-Boroviczeny, Orsolya; Schreiber, Christian; Mehilli, Julinda; Kastrati, Adnan; Schwaiger, Markus; Shivdasani, Ramesh A.; Massberg, Steffen			Platelets contribute to postnatal occlusion of the ductus arteriosus	NATURE MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERMANENT ANATOMIC CLOSURE; TRANSCRIPTION FACTOR NF-E2; IN-VIVO; NITRIC-OXIDE; PREMATURE-INFANTS; GLYCOPROTEIN IIB; ADHESION; PROSTAGLANDIN; ACTIVATION	The ductus arteriosus (DA) is a fetal shunt vessel between the pulmonary artery and the aorta that closes promptly after birth. Failure of postnatal DA closure is a major cause of morbidity and mortality particularly in preterm neonates. The events leading to DA closure are incompletely understood. Here we show that platelets have an essential role in DA closure. Using intravital microscopy of neonatal mice, we observed that platelets are recruited to the luminal aspect of the DA during closure. DA closure is impaired in neonates with malfunctioning platelet adhesion or aggregation or with defective platelet biogenesis. Defective DA closure resulted in a left-to-right shunt with increased pulmonary perfusion, pulmonary vascular remodeling and right ventricular hypertrophy. Our findings indicate that platelets are crucial for DA closure by promoting thrombotic sealing of the constricted DA and by supporting luminal remodeling. A retrospective clinical study revealed that thrombocytopenia is an independent predictor for failure of DA closure in preterm human newborns, indicating that platelets are likely to contribute to DA closure in humans.	[Echtler, Katrin; Stark, Konstantin; Lorenz, Michael; Kerstan, Sandra; von Bruehl, Marie-Luise; Mehilli, Julinda; Kastrati, Adnan; Massberg, Steffen] Tech Univ Munich, Klin Herz & Kreislauferkrankungen, Deutsch Herzzentrum, Munich, Germany; [Walch, Axel; Jennen, Luise] Gesell Strahlen & Umweltforsch MbH, Inst Pathol, Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Umwelt & Gesundheit, D-8042 Neuherberg, Germany; [Rudelius, Martina; Seidl, Stefan] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany; [Kremmer, Elisabeth] Inst Mol Immunol, Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Munich, Germany; [Emambokus, Nikla R.] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Frampton, Jon] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England; [Isermann, Berend] Univ Klinikum Heidelberg, Med Klin, Heidelberg, Germany; [Genzel-Boroviczeny, Orsolya] Univ Munich, Perinatalzentrum, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Munich, Germany; [Schreiber, Christian] Tech Univ Munich, Klin Herz & Gefasschirurg, Deutsch Herzzentrum, Munich, Germany; [Schwaiger, Markus] Tech Univ Munich, Nukl Med Klin Klinikums Rechts Isar, Munich, Germany; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol & Canc Biol, Boston, MA 02115 USA; [Massberg, Steffen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Massberg, Steffen] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Birmingham; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Massberg, S (corresponding author), Tech Univ Munich, Klin Herz & Kreislauferkrankungen, Deutsch Herzzentrum, Munich, Germany.	massberg@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; Massberg, Steffen/AAN-6054-2021; , Kastrati/Y-2389-2019; Stark, Konstantin/AAJ-2815-2020; Walch, Axel/B-4554-2012	Stark, Konstantin/0000-0002-5369-8399; Walch, Axel/0000-0001-5578-4023; schwaiger, markus/0000-0002-2305-7144	Deutsche Forschungsgemeinschaft; Ernst und Berta-Grimmke Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst und Berta-Grimmke Foundation	We thank M. Shakibaei, S. Reder and J. Schwarz for their support. This work was supported by the Deutsche Forschungsgemeinschaft and the Ernst und Berta-Grimmke Foundation.	Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bancalari E, 2005, BIOL NEONATE, V88, P192, DOI 10.1159/000087582; Boo N. Y., 2006, SMJ Singapore Medical Journal, V47, P763; Clyman RI, 1999, PEDIATR RES, V45, P19, DOI 10.1203/00006450-199901000-00005; Clyman RI, 2002, AM J PHYSIOL-REG I, V282, pR199, DOI 10.1152/ajpregu.00298.2001; CLYMAN RI, 1980, J PEDIATR-US, V97, P455, DOI 10.1016/S0022-3476(80)80205-8; Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Fabre JE, 2001, J CLIN INVEST, V107, P603, DOI 10.1172/JCI10881; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fischer LM, 2005, PHARMACOTHERAPY, V25, P503, DOI 10.1592/phco.25.4.503.61021; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gordon PV, 2007, J PEDIATR GASTR NUTR, V45, P509, DOI 10.1097/MPG.0b013e3181558591; Hammerman C, 2001, DRUG SAFETY, V24, P537, DOI 10.2165/00002018-200124070-00005; Hermes-DeSantis ER, 2006, J PERINATOL, V26, pS14, DOI 10.1038/sj.jp.7211465; HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004; Higgs EA, 1997, BRIT J PHARMACOL, V120, P439, DOI 10.1111/j.1476-5381.1997.tb06831.x; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; KAAPA P, 1993, J PEDIATR-US, V123, P115, DOI 10.1016/S0022-3476(05)81553-7; Kajino H, 2000, AM J PHYSIOL-REG I, V279, pR278, DOI 10.1152/ajpregu.2000.279.1.R278; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; LLOYD TR, 1994, AM HEART J, V127, P1664, DOI 10.1016/0002-8703(94)90415-4; MACINTYRE DE, 1975, NATURE, V258, P337, DOI 10.1038/258337a0; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; MEYERS KM, 1979, NATURE, V282, P331, DOI 10.1038/282331a0; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Noori S, 2009, PEDIATRICS, V123, pE138, DOI 10.1542/peds.2008-2418; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Olley P M, 1978, Adv Prostaglandin Thromboxane Res, V4, P345; RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251; RELLER MD, 1991, AM J DIS CHILD, V145, P1017, DOI 10.1001/archpedi.1991.02160090069025; Roberts I, 2008, BLOOD REV, V22, P173, DOI 10.1016/j.blre.2008.03.004; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Seidner SR, 2001, PEDIATR RES, V50, P365, DOI 10.1203/00006450-200109000-00012; Sheffield MJ, 2009, J PERINATOL, V29, P39, DOI 10.1038/jp.2008.122; SHIMADA S, 1989, PEDIATR RES, V26, P565, DOI 10.1203/00006450-198912000-00010; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SILVER MM, 1981, HUM PATHOL, V12, P1123, DOI 10.1016/S0046-8177(81)80333-4; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Smith GCS, 1998, PHARMACOL REV, V50, P35; Struthmann L, 2009, J THROMB HAEMOST, V7, P1727, DOI 10.1111/j.1538-7836.2009.03582.x; TADA T, 1990, ACTA ANAT, V139, P326; Theilmeier G, 2002, BLOOD, V99, P4486, DOI 10.1182/blood.V99.12.4486; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Van Overmeire B, 2004, LANCET, V364, P1945, DOI 10.1016/S0140-6736(04)17477-1; Waleh N, 2005, PEDIATR RES, V57, P254, DOI 10.1203/01.PDR.0000148278.64777.EF; Wu DM, 2002, BLOOD, V99, P3623, DOI 10.1182/blood.V99.10.3623	60	110	119	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					75	U111		10.1038/nm.2060	http://dx.doi.org/10.1038/nm.2060			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	19966813				2022-12-25	WOS:000273395500039
J	Ewers, H; Romer, W; Smith, AE; Bacia, K; Dmitrieff, S; Chai, WG; Mancini, R; Kartenbeck, J; Chambon, V; Berland, L; Oppenheim, A; Schwarzmann, G; Feizi, T; Schwille, P; Sens, P; Helenius, A; Johannes, L				Ewers, Helge; Roemer, Winfried; Smith, Alicia E.; Bacia, Kirsten; Dmitrieff, Serge; Chai, Wengang; Mancini, Roberta; Kartenbeck, Juergen; Chambon, Valerie; Berland, Ludwig; Oppenheim, Ariella; Schwarzmann, Guenter; Feizi, Ten; Schwille, Petra; Sens, Pierre; Helenius, Ari; Johannes, Ludger			GM1 structure determines SV40-induced membrane invagination and infection	NATURE CELL BIOLOGY			English	Article							SV40 CAPSID PROTEINS; MURINE POLYOMA-VIRUS; CHOLERA-TOXIN; LIPID RAFTS; SHIGA TOXIN; INDEPENDENT ENDOCYTOSIS; GANGLIOSIDE GM1; SIMIAN VIRUS-40; INSECT CELLS; SIMIAN-VIRUS-40	Incoming simian virus 40 (SV40) particles enter tight-fitting plasma membrane invaginations after binding to the carbohydrate moiety of GM1 gangliosides in the host cell plasma membrane through pentameric VP1 capsid proteins. This is followed by activation of cellular signalling pathways, endocytic internalization and transport of the virus via the endoplasmic reticulum to the nucleus. Here we show that the association of SV40 (as well as isolated pentameric VP1) with GM1 is itself sufficient to induce dramatic membrane curvature that leads to the formation of deep invaginations and tubules not only in the plasma membrane of cells, but also in giant unilamellar vesicles (GUVs). Unlike native GM1 molecules with long acyl chains, GM1 molecular species with short hydrocarbon chains failed to support such invagination, and endocytosis and infection did not occur. To conceptualize the experimental data, a physical model was derived based on energetic considerations. Taken together, our analysis indicates that SV40, other polyoma viruses and some bacterial toxins (Shiga and cholera) use glycosphingolipids and a common pentameric protein scaffold to induce plasma membrane curvature, thus directly promoting their endocytic uptake into cells.	[Ewers, Helge; Smith, Alicia E.; Mancini, Roberta; Kartenbeck, Juergen; Helenius, Ari] ETH, Inst Biochem, HPM E, CH-8093 Zurich, Switzerland; [Roemer, Winfried; Chambon, Valerie; Johannes, Ludger] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Roemer, Winfried; Chambon, Valerie; Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Bacia, Kirsten; Schwille, Petra] Tech Univ Dresden, Inst Biophys, BIOTEC, D-01307 Dresden, Germany; [Dmitrieff, Serge; Sens, Pierre] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR Gulliver 7083, F-75231 Paris 05, France; [Chai, Wengang; Feizi, Ten] Imperial Coll London, Glycosci Lab, Harrow HA1 3UJ, Middx, England; [Kartenbeck, Juergen] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Berland, Ludwig] Inst Curie, Ctr Rech, Lab Physicochim, F-75248 Paris 05, France; [Berland, Ludwig] Univ Paris 06, CNRS, UMR168, F-75252 Paris 05, France; [Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91120 Jerusalem, Israel; [Schwarzmann, Guenter] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, Membrane Biol & Lipid Biochem Unit, D-53123 Bonn, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Hebrew University of Jerusalem; University of Bonn	Helenius, A (corresponding author), ETH, Inst Biochem, HPM E, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	sens, pierre/C-3537-2011; Johannes, Ludger/M-9778-2017; Ewers, Helge/I-3455-2012; Ewers, Helge/ABF-3629-2021; Schwille, Petra/A-4983-2010; Johannes, Ludger/W-8593-2019	sens, pierre/0000-0003-4523-3791; Johannes, Ludger/0000-0002-2168-0004; Ewers, Helge/0000-0003-3948-4332; Johannes, Ludger/0000-0002-2168-0004; Feizi, Ten/0000-0001-6495-0329; Dmitrieff, Serge/0000-0002-1362-5670	Swiss SystemsX.ch [LipidX-2008/011]; Human Frontier Science Program; FEBS; CNRS; Israel Science Foundation [604/07]; Delegation Generale pour l'Armement; Wellcome Trust; Deutsche Forschungsgemeinschaft; European Regional Development Fund [4212/04-01]	Swiss SystemsX.ch; Human Frontier Science Program(Human Frontier Science Program); FEBS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Israel Science Foundation(Israel Science Foundation); Delegation Generale pour l'Armement; Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Regional Development Fund(European Commission)	This work was funded by the Swiss SystemsX.ch initiative, grant LipidX-2008/011 (to A.H.), the Human Frontier Science Program (to A.E.S., L.J. and P.S.), a FEBS fellowship (to H.E.), a CNRS fellowship (to W.R.), the Israel Science Foundation (Grant # 604/07 to A.O.), the Delegation Generale pour l'Armement (to L.B.), the Wellcome Trust (to W.C. and T.F.), Deutsche Forschungsgemeinschaft (to G.S.) and the European Regional Development Fund grant # 4212/04-01 (to K.B. and P.S.). H. E. thanks D. Choquet for his patience and support. The authors thank M. Abd-El-Latif for the preparation of VLPs and pentamers.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Campanero-Rhodes MA, 2007, J VIROL, V81, P12846, DOI 10.1128/JVI.01311-07; Chai W, 2006, ANAL CHEM, V78, P1581, DOI 10.1021/ac051606e; Chai WG, 2003, METHOD ENZYMOL, V362, P160; COLE CN, 2001, POLYOMAVIRIDAE VIRUS, P2141; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dangoria NS, 1996, J GEN VIROL, V77, P2173, DOI 10.1099/0022-1317-77-9-2173; Deserno M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031903; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ewers H, 2007, NANO LETT, V7, P2263, DOI 10.1021/nl070766y; FACCI L, 1984, J NEUROCHEM, V42, P299, DOI 10.1111/j.1471-4159.1984.tb02678.x; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Foret L, 2008, P NATL ACAD SCI USA, V105, P14763, DOI 10.1073/pnas.0801173105; Gilbert J, 2005, J VIROL, V79, P615, DOI 10.1128/JVI.79.1.615-618.2005; Gilbert JM, 2000, J VIROL, V74, P8582, DOI 10.1128/JVI.74.18.8582-8588.2000; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HUMMELER K, 1970, J VIROL, V6, P87, DOI 10.1128/JVI.6.1.87-93.1970; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kosukegawa A, 1996, BBA-GEN SUBJECTS, V1290, P37; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LIPOWSKY R, 1992, J PHYS 2, V2; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roitman-Shemer V, 2007, BIOCHEM BIOPH RES CO, V353, P424, DOI 10.1016/j.bbrc.2006.12.038; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SCHWARZMANN G, 1983, BIOCHEMISTRY-US, V22, P5041, DOI 10.1021/bi00290a025; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Turner MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118103; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yan YW, 1996, STRUCTURE, V4, P157, DOI 10.1016/S0969-2126(96)00019-6; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	56	297	303	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					11	U36		10.1038/ncb1999	http://dx.doi.org/10.1038/ncb1999			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20023649				2022-12-25	WOS:000272973800007
J	Hancock, DB; Eijgelsheim, M; Wilk, JB; Gharib, SA; Loehr, LR; Marciante, KD; Franceschini, N; van Durme, YMTA; Chen, TH; Barr, RG; Schabath, MB; Couper, DJ; Brusselle, GG; Psaty, BM; van Duijn, CM; Rotter, JI; Uitterlinden, AG; Hofman, A; Punjabi, NM; Rivadeneira, F; Morrison, AC; Enright, PL; North, KE; Heckbert, SR; Lumley, T; Stricker, BHC; O'Connor, GT; London, SJ				Hancock, Dana B.; Eijgelsheim, Mark; Wilk, Jemma B.; Gharib, Sina A.; Loehr, Laura R.; Marciante, Kristin D.; Franceschini, Nora; van Durme, Yannick M. T. A.; Chen, Ting-hsu; Barr, R. Graham; Schabath, Matthew B.; Couper, David J.; Brusselle, Guy G.; Psaty, Bruce M.; van Duijn, Cornelia M.; Rotter, Jerome I.; Uitterlinden, Andre G.; Hofman, Albert; Punjabi, Naresh M.; Rivadeneira, Fernando; Morrison, Alanna C.; Enright, Paul L.; North, Kari E.; Heckbert, Susan R.; Lumley, Thomas; Stricker, Bruno H. C.; O'Connor, George T.; London, Stephanie J.			Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function	NATURE GENETICS			English	Article							LUNG-FUNCTION DECLINE; SEROTONINERGIC RECEPTORS; REFERENCE VALUES; ADAM33 GENE; IDENTIFICATION; HEART; POPULATION; HEDGEHOG; DESIGN; RAGE	Spirometric measures of lung function are heritable traits that reflect respiratory health and predict morbidity and mortality. We meta-analyzed genome-wide association studies for two clinically important lung-function measures: forced expiratory volume in the first second (FEV1) and its ratio to forced vital capacity (FEV1/FVC), an indicator of airflow obstruction. This meta-analysis included 20,890 participants of European ancestry from four CHARGE Consortium studies: Atherosclerosis Risk in Communities, Cardiovascular Health Study, Framingham Heart Study and Rotterdam Study. We identified eight loci associated with FEV1/FVC (HHIP, GPR126, ADAM19, AGER-PPT2, FAM13A, PTCH1, PID1 and HTR4) and one locus associated with FEV1 (INTS12-GSTCD-NPNT) at or near genome-wide significance (P < 5 x 10(-8)) in the CHARGE Consortium dataset. Our findings may offer insights into pulmonary function and pathogenesis of chronic lung disease.	[Hancock, Dana B.; Loehr, Laura R.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Eijgelsheim, Mark; Brusselle, Guy G.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Hofman, Albert; Rivadeneira, Fernando; Stricker, Bruno H. C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Wilk, Jemma B.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Gharib, Sina A.; Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Gharib, Sina A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Loehr, Laura R.; Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Marciante, Kristin D.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [van Durme, Yannick M. T. A.; Brusselle, Guy G.] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium; [van Durme, Yannick M. T. A.; Brusselle, Guy G.] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Chen, Ting-hsu; O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Chen, Ting-hsu; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY USA; [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Couper, David J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rivadeneira, Fernando; Stricker, Bruno H. C.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Punjabi, Naresh M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol & Dis Control, Ctr Human Genet, Houston, TX USA; [Enright, Paul L.] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Stricker, Bruno H. C.] Netherlands Genom Initiat, Rotterdam, Netherlands; [Stricker, Bruno H. C.] Inspectorate Hlth Care, The Hague, Netherlands; [London, Stephanie J.] NIEHS, Lab Resp Biol, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Erasmus University Rotterdam; Erasmus MC; Boston University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Ghent University; Ghent University; Ghent University Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; Columbia University; Columbia University; H Lee Moffitt Cancer Center & Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	London, SJ (corresponding author), NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	Punjabi, Naresh/EMH-1007-2022; Schabath, Matthew B./J-3763-2016; Hancock, Dana/D-8577-2012; Rivadeneira, Fernando/O-5385-2015; Rotter, Jerome/AAY-6598-2021; London, Stephanie/C-3734-2019	Schabath, Matthew B./0000-0003-3241-3216; Rivadeneira, Fernando/0000-0001-9435-9441; London, Stephanie/0000-0003-4911-5290; Morrison, Alanna/0000-0001-6381-4296; Couper, David/0000-0002-4313-9235; Hancock, Dana/0000-0003-2240-3604; GHARIB, SINA A./0000-0002-2480-4367; Van Duijn, Cornelia/0000-0002-2374-9204; Loehr, Laura/0000-0002-9054-1825; O'Connor, George/0000-0002-6476-3926	Intramural NIH HHS [ZIA ES043012-11, Z01 ES043012] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; NCRR NIH HHS [M01-RR00425, M01 RR000425] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402, U01HG004402] Funding Source: Medline; NHLBI NIH HHS [N01HC55020, R01HL086694, N01-HC-55015, R01HL087641, R01 HL086694, R01 HL077612, N01-HC-55016, N01HC85086, N01HC55015, N01 HC-55222, N01-HC-55021, N01HC55222, N01-HC-55019, N01-HC-75150, N01-HC-55020, N01HC55016, N01HC55019, N01HC75150, N01HC25195, N02-HL-6-4278, N01-HC-25195, N01-HC-55022, R01 HL059367, U01 HL080295, R01HL59367, RC1 HL100543, R01 HL087641, N01HC55018, N01HC55021, N01HC55022, R01 HL087652, N01-HC-85079 THROUGH N01-HC-85086, N01HC85079, N01-HC-55018] Funding Source: Medline; NIDDK NIH HHS [DK063491, P30 DK063491] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC055016, N01HC085079, N01HC055019, N01HC035129, N01HC055015, N01HC045133, N01HC055022, N01HC055018, N01HC015103, N01HC075150, N01HC025195, N01HC055020, N01HC095159, N01HC055021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, U01HL080295, RC1HL100543, R01HL059367, R01HL086694, R42HL055018, R01HL087641, R01HL077612, R01HL064278, R01HL087652, R41HL055019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012, Z01ES043012] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2001, GENET EPIDEMIOL, V21, pS341, DOI 10.1002/gepi.2001.21.s1.s341; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; CARDOSO WV, 1995, AM J PHYSIOL-LUNG C, V269, pL429, DOI 10.1152/ajplung.1995.269.4.L429; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen MH, 2007, CELL, V130, P386, DOI 10.1016/j.cell.2007.07.017; CRAPO RO, 1994, NEW ENGL J MED, V331, P25, DOI 10.1056/NEJM199407073310107; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; DeMeo DL, 2003, SEMIN RESP CRIT CARE, V24, P151, DOI 10.1055/s-2003-39014; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Dupont LJ, 1999, EUR RESPIR J, V14, P642, DOI 10.1034/j.1399-3003.1999.14c26.x; Eisner MD, 2007, ANN EPIDEMIOL, V17, P364, DOI 10.1016/j.annepidem.2006.10.008; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; ENRIGHT PL, 1993, AM REV RESPIR DIS, V147, P125, DOI 10.1164/ajrccm/147.1.125; ENRIGHT PL, 1994, CHEST, V106, P827, DOI 10.1378/chest.106.3.827; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Givelber RJ, 1998, AM J RESP CRIT CARE, V157, P1445, DOI 10.1164/ajrccm.157.5.9704021; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hole DJ, 1996, BRIT MED J, V313, P711; Huang JTJ, 2005, INT J MOL MED, V15, P719; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Jongepier H, 2004, CLIN EXP ALLERGY, V34, P757, DOI 10.1111/j.1365-2222.2004.1938.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; *NAT HEART BLOOD I, 1989, QUAL ASS QUAL CONTR; PAUWELS RA, 2001, AM J RESP CRIT CARE, V163, P1276; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; TEAM RDC, 2007, LANGUAGE ENV STAT CO; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WEY E, 1994, EUR J BIOCHEM, V220, P753, DOI 10.1111/j.1432-1033.1994.tb18676.x; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	76	451	465	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					45	U61		10.1038/ng.500	http://dx.doi.org/10.1038/ng.500			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20010835	Green Accepted			2022-12-25	WOS:000273055100015
J	Hsiao, TL; Revelles, O; Chen, LF; Sauer, U; Vitkup, D				Hsiao, Tzu-Lin; Revelles, Olga; Chen, Lifeng; Sauer, Uwe; Vitkup, Dennis			Automatic policing of biochemical annotations using genomic correlations	NATURE CHEMICAL BIOLOGY			English	Article							DATABASE; GENES; EXPRESSION; PATHWAY; ERRORS; IDENTIFICATION; CONSERVATION; CANNIBALISM	With the increasing role of computational tools in the analysis of sequenced genomes, there is an urgent need to maintain high accuracy of functional annotations. Misannotations can be easily generated and propagated through databases by functional transfer based on sequence homology. We developed and optimized an automatic policing method to detect biochemical misannotations using context genomic correlations. The method works by finding genes with unusually weak genomic correlations in their assigned network positions. We demonstrate the accuracy of the method using a cross-validated approach. In addition, we show that the method identifies a significant number of potential misannotations in Bacillus subtilis, including metabolic assignments already shown to be incorrect experimentally. The experimental analysis of the mispredicted genes forming the leucine degradation pathway in B. subtilis demonstrates that computational policing tools can generate important biological hypotheses.	[Hsiao, Tzu-Lin; Chen, Lifeng; Vitkup, Dennis] Columbia Univ, Irving Canc Res Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Hsiao, Tzu-Lin; Chen, Lifeng; Vitkup, Dennis] Columbia Univ, Irving Canc Res Ctr, Dept Biomed Informat, New York, NY USA; [Revelles, Olga; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland	Columbia University; Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vitkup, D (corresponding author), Columbia Univ, Irving Canc Res Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	dv2121@columbia.edu	Sauer, Uwe/Y-3556-2019; Califano, Andrea/F-7239-2012		US National Institutes of Health [GM079759]; National Centers for Biomedical Computing (MAGNet) [U54CA121852]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing (MAGNet); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Feldman, A. Rzhetsky, M. de Hoon, S. Gilman and C. Weinreb for comments on the manuscript and valuable discussions. This work was supported in part by US National Institutes of Health grant GM079759 to D. V. and National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University.	Andrade MA, 1999, BIOINFORMATICS, V15, P391, DOI 10.1093/bioinformatics/15.5.391; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Borenstein E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl792; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Green ML, 2005, NUCLEIC ACIDS RES, V33, P4035, DOI 10.1093/nar/gki711; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jerga A, 2007, J BIOL CHEM, V282, P21738, DOI 10.1074/jbc.M703536200; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100023; Kharchenko P, 2004, BIOINFORMATICS, V20, P178, DOI 10.1093/bioinformatics/bth930; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Linial M, 2003, TRENDS BIOTECHNOL, V21, P298, DOI 10.1016/S0167-7799(03)00139-2; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Middendorf M, 2004, BIOINFORMATICS, V20, P232, DOI 10.1093/bioinformatics/bth923; Minami H, 2004, J BACTERIOL, V186, P1213, DOI 10.1128/JB.186.4.1213-1214.2004; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sauer U, 1996, APPL ENVIRON MICROB, V62, P3687, DOI 10.1128/AEM.62.10.3687-3696.1996; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Sonenshein A.L., 2001, BACILLUS SUBTILIS IT; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Wieser D, 2004, BIOINFORMATICS, V20, P342, DOI 10.1093/bioinformatics/bth938; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298	49	26	26	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					34	40		10.1038/NCHEMBIO.266	http://dx.doi.org/10.1038/NCHEMBIO.266			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19935659	Green Accepted, Green Submitted			2022-12-25	WOS:000272802500009
J	Hu, HH; Boisson-Dernier, A; Israelsson-Nordstrom, M; Bohmer, M; Xue, SW; Ries, A; Godoski, J; Kuhn, JM; Schroeder, JI				Hu, Honghong; Boisson-Dernier, Aurelien; Israelsson-Nordstroem, Maria; Boehmer, Maik; Xue, Shaowu; Ries, Amber; Godoski, Jan; Kuhn, Josef M.; Schroeder, Julian I.			Carbonic anhydrases are upstream regulators of CO2-controlled stomatal movements in guard cells	NATURE CELL BIOLOGY			English	Article							ABSCISIC-ACID; PHOSPHOENOLPYRUVATE CARBOXYLASE; ANION CHANNELS; BLUE-LIGHT; CO2; CONDUCTANCE; MODULATION; RESPONSES; SIGNALS; TOBACCO	The continuing rise in atmospheric CO2 causes stomatal pores in leaves to close and thus globally affects CO2 influx into plants, water use efficiency and leaf heat stress(1-4). However, the CO2-binding proteins that control this response remain unknown. Moreover, which cell type responds to CO2, mesophyll or guard cells, and whether photosynthesis mediates this response are matters of debate(5-8). We demonstrate that Arabidopsis thaliana double-mutant plants in the beta-carbonic anhydrases beta CA1 and beta CA4 show impaired CO2-regulation of stomatal movements and increased stomatal density, but retain functional abscisic-acid and blue-light responses. beta CA-mediated CO2-triggered stomatal movements are not, in first-order, linked to whole leaf photosynthesis and can function in guard cells. Furthermore, guard cell beta CA-overexpressing plants exhibit instantaneous enhanced water use efficiency. Guard cell expression of mammalian alpha CAII complements the reduced sensitivity of ca1 ca4 plants, showing that carbonic anhydrase-mediated catalysis is an important mechanism for beta CA-mediated CO2 induced stomatal closure and patch clamp analyses indicate that CO2/HCO3-transfers the signal to anion channel regulation. These findings, together with ht1-2 (ref.9) epistasis analysis demonstrate that carbonic anhydrases function early in the CO2 signalling pathway, which controls gas-exchange between plants and the atmosphere.	[Hu, Honghong; Boisson-Dernier, Aurelien; Israelsson-Nordstroem, Maria; Boehmer, Maik; Xue, Shaowu; Ries, Amber; Godoski, Jan; Kuhn, Josef M.; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Xue, Shaowu] Shanxi Univ, Inst Mol Sci, Taiyuan 030006, Peoples R China	University of California System; University of California San Diego; Shanxi University	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Xue, Shaowu/D-5400-2011; Xue, Shaowu/O-8678-2019; Böhmer, Maik/ABE-1146-2021; Nordström, Maria/B-4561-2013; Bohmer, Maik/E-3533-2010	Xue, Shaowu/0000-0002-8838-3362; Xue, Shaowu/0000-0002-8838-3362; Bohmer, Maik/0000-0001-6675-273X; Boisson-Dernier, Aurelien/0000-0002-9790-3710; Schroeder, Julian/0000-0002-3283-5972	NSF [MCB0918220]; NIH [GM060396]; DOE [DE-FG02-03ER15449]; Swedish Research Council Formas; Deutsche Forschungsgemeinschaft; EMBO; King Abdullah University of Science and Technology (KAUST) [KUS-F1-021-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Maktabi, J. Young and C. Engineer for preliminary analyses of aca mutants, R. Xu for assistance, S. Zeeman for suggestions and K. Iba (Kyushu University, Japan) for providing ht1-2 seeds. This research was supported by NSF (MCB0918220), NIH (GM060396) and in part by DOE (DE-FG02-03ER15449) grants (to J. I. S.) and by fellowships from the Swedish Research Council Formas (to M. I. -N.), the Deutsche Forschungsgemeinschaft (to M. B.), EMBO (to J. M. K.) and in part from the King Abdullah University of Science and Technology (KAUST; No. KUS-F1-021-31 to H. H.).	Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; [Anonymous], 2008, NATURE, V452, P269, DOI 10.1038/452269a; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Boisson-Dernier A, 2008, CURR BIOL, V18, P63, DOI 10.1016/j.cub.2007.11.067; Brearley J, 1997, PLANTA, V203, P145, DOI 10.1007/s004250050176; Cousins AB, 2007, PLANT PHYSIOL, V145, P1006, DOI 10.1104/pp.107.103390; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Gehlen J, 1996, PLANT MOL BIOL, V32, P831, DOI 10.1007/BF00020481; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holden C, 2009, SCIENCE, V323, P193, DOI 10.1126/science.323.5911.193; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Leymarie J, 1998, PLANT PHYSIOL BIOCH, V36, P539, DOI 10.1016/S0981-9428(98)80180-0; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; Marten H, 2008, PLANT J, V55, P698, DOI 10.1111/j.1365-313X.2008.03542.x; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; NATELSON S, 1978, CLIN CHEM, V24, P1082; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; PIGOTT JD, 1989, ANAL CHEM, V61, P638, DOI 10.1021/ac00181a031; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; RADIN JW, 1994, P NATL ACAD SCI USA, V91, P7217, DOI 10.1073/pnas.91.15.7217; Raschke K, 2003, PLANTA, V217, P639, DOI 10.1007/s00425-003-1033-4; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roelfsema MRG, 2006, PLANT CELL ENVIRON, V29, P1595, DOI 10.1111/j.1365-3040.2006.01536.x; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; von Caemmerer S, 2004, J EXP BOT, V55, P1157, DOI 10.1093/jxb/erh128; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; WILBUR KM, 1948, J BIOL CHEM, V11; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	55	293	322	10	141	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					87	U234		10.1038/ncb2009	http://dx.doi.org/10.1038/ncb2009			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010812	Green Accepted			2022-12-25	WOS:000272973800017
J	Kardash, E; Reichman-Fried, M; Maitre, JL; Boldajipour, B; Papusheva, E; Messerschmidt, EM; Heisenberg, CP; Raz, E				Kardash, Elena; Reichman-Fried, Michal; Maitre, Jean-Leon; Boldajipour, Bijan; Papusheva, Ekaterina; Messerschmidt, Esther-Maria; Heisenberg, Carl-Philipp; Raz, Erez			A role for Rho GTPases and cell-cell adhesion in single-cell motility in vivo	NATURE CELL BIOLOGY			English	Article							E-CADHERIN; SPATIOTEMPORAL DYNAMICS; MIGRATION; ZEBRAFISH; MEMBRANE; BEHAVIOR; ACTIVATION; CATENIN; PROBES; ACTIN	Cell migration is central to embryonic development, homeostasis and disease(1), processes in which cells move as part of a group or individually. Whereas the mechanisms controlling single-cell migration in vitro are relatively well understood(2-4), less is known about the mechanisms promoting the motility of individual cells in vivo. In particular, it is not clear how cells that form blebs in their migration use those protrusions to bring about movement in the context of the three-dimensional cellular environment(5,6). Here we show that the motility of chemokine-guided germ cells within the zebrafish embryo requires the function of the small Rho GTPases Rac1 and RhoA, as well as E-cadherin-mediated cell-cell adhesion. Using fluorescence resonance energy transfer we demonstrate that Rac1 and RhoA are activated in the cell front. At this location, Rac1 is responsible for the formation of actin-rich structures, and RhoA promotes retrograde actin flow. We propose that these actin-rich structures undergoing retrograde flow are essential for the generation of E-cadherin-mediated traction forces between the germ cells and the surrounding tissue and are therefore crucial for cell motility in vivo.	[Kardash, Elena; Reichman-Fried, Michal; Boldajipour, Bijan; Messerschmidt, Esther-Maria; Raz, Erez] Ctr Mol Biol Inflammat, Inst Cell Biol, D-48149 Munster, Germany; [Maitre, Jean-Leon; Papusheva, Ekaterina; Heisenberg, Carl-Philipp] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Raz, E (corresponding author), Ctr Mol Biol Inflammat, Inst Cell Biol, Von Esmarch Str 56, D-48149 Munster, Germany.	erez.raz@uni-muenster.de	Maître, Jean-Léon/C-4372-2017	Maître, Jean-Léon/0000-0002-3688-1474; Boldajipour, Bijan/0000-0003-2065-555X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Kardash, Elena/0000-0002-7425-9862	Deutsche Forschungsgemeinschaft (DFG); Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The FRET biosensors for Rac and RhoA were a gift from M. Matsuda. The yellow variant of GFP, YPet, was generously provided by P. Daugherty. Lifeact fusions were a gift from R. Wedlich-Soldner, and the GFP-CLIP-170 was provided by Franck Perez. We thank Donna Arndt-Jovin and Tom Jovin for their help with the FRET experiments. This work is supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Max Planck Society. E.K. and B.B. are students at the International Max Planck Research School, Gottingen.	Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Koprunner M, 2001, GENE DEV, V15, P2877; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Mich JK, 2009, DEV BIOL, V328, P342, DOI 10.1016/j.ydbio.2009.01.036; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; OYAMA T, 1994, CANCER RES, V54, P6282; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	41	193	199	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					47	U112		10.1038/ncb2003	http://dx.doi.org/10.1038/ncb2003			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010816				2022-12-25	WOS:000272973800011
J	Cope, DW; Di Giovanni, G; Fyson, SJ; Orban, G; Errington, AC; Lorincz, ML; Gould, TM; Carter, DA; Crunelli, V				Cope, David W.; Di Giovanni, Giuseppe; Fyson, Sarah J.; Orban, Gergely; Errington, Adam C.; Lorincz, Magor L.; Gould, Timothy M.; Carter, David A.; Crunelli, Vincenzo			Enhanced tonic GABA(A) inhibition in typical absence epilepsy	NATURE MEDICINE			English	Article							GAMMA-HYDROXYBUTYRIC ACID; RAT-BRAIN; SYNAPTIC-TRANSMISSION; MOUSE MODEL; RECEPTORS; MECHANISMS; SPIKE; WAVE; THALAMUS; SEIZURES	The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired gamma-aminobutyric acid (GABA)-ergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABA(A) receptor-dependent 'tonic' inhibition is increased in thalamocortical neurons from diverse genetic and pharmacological models of absence seizures. Increased tonic inhibition is due to compromised GABA uptake by the GABA transporter GAT-1 in the genetic models tested, and GAT-1 is crucial in governing seizure genesis. Extrasynaptic GABA(A) receptors are a requirement for seizures in two of the best characterized models of absence epilepsy, and the selective activation of thalamic extrasynaptic GABA(A) receptors is sufficient to elicit both electrographic and behavioral correlates of seizures in normal rats. These results identify an apparently common cellular pathology in typical absence seizures that may have epileptogenic importance and highlight potential therapeutic targets for the treatment of absence epilepsy.	[Cope, David W.; Di Giovanni, Giuseppe; Fyson, Sarah J.; Orban, Gergely; Errington, Adam C.; Lorincz, Magor L.; Gould, Timothy M.; Carter, David A.; Crunelli, Vincenzo] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Cope, DW (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	copedw@cf.ac.uk; crunelli@cf.ac.uk	Carter, David/A-4479-2010; Orban, Gergely/J-8561-2016; Errington, Adam/D-1678-2011; Lőrincz, Magor L/C-7746-2012; Di Giovanni, Giuseppe/N-3047-2013; Crunelli, Vincenzo/A-7258-2010	Carter, David/0000-0002-8419-3975; Orban, Gergely/0000-0003-4222-9391; Errington, Adam/0000-0002-2171-389X; Lőrincz, Magor L/0000-0001-5240-1904; Di Giovanni, Giuseppe/0000-0003-2006-563X; Crunelli, Vincenzo/0000-0001-7154-9752	Epilepsy Research UK [P0802]; Italian Ministry for University and Scientific Research; Wellcome Trust [71436]; European Union [HEALTH F2-2007-202167]	Epilepsy Research UK; Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	We thank P. Blanning for his help in genotyping mice, D. Belelli who kindly provided the genotyping protocol for the delta subunit-knockout mice and K. Thomas for initial discussions on the antisense oligodeoxynucleotide experiments. H. Parri, S. Hughes and N. Leresche commented on a previous version of the manuscript. D. W. C. is a research Fellow of Epilepsy Research UK (grant P0802), and G.O. was supported by a Fellowship of the Italian Ministry for University and Scientific Research. This work was also supported by the Wellcome Trust (grant 71436) and the European Union (grant HEALTH F2-2007-202167).	Aizawa M, 1997, NEUROSCI RES, V29, P17, DOI 10.1016/S0168-0102(97)00066-7; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANERJEE PK, 1993, NEUROSCIENCE, V56, P11, DOI 10.1016/0306-4522(93)90557-V; Beckman ML, 1999, J NEUROSCI, V19; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Bessaih T, 2006, J NEUROPHYSIOL, V96, P3074, DOI 10.1152/jn.00682.2006; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Bragina L, 2008, J NEUROCHEM, V105, P1781, DOI 10.1111/j.1471-4159.2008.05273.x; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; De Biasi S, 1998, NEUROSCIENCE, V83, P815, DOI 10.1016/S0306-4522(97)00414-4; Ettinger AB, 1999, EPILEPSIA, V40, P1159, DOI 10.1111/j.1528-1157.1999.tb00835.x; FARIELLO RG, 1987, NEUROPHARMACOLOGY, V26, P161, DOI 10.1016/0028-3908(87)90204-8; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fletcher CF, 1999, HUM MOL GENET, V8, P1907, DOI 10.1093/hmg/8.10.1907; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Herd MB, 2009, EUR J NEUROSCI, V29, P1177, DOI 10.1111/j.1460-9568.2009.06680.x; Hosford DA, 1997, EPILEPSIA, V38, P408, DOI 10.1111/j.1528-1157.1997.tb01729.x; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; Hu J, 2008, NEUROPHARMACOLOGY, V54, P309, DOI 10.1016/j.neuropharm.2007.09.013; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; JUHASZ G, 1990, NEUROSCI LETT, V114, P333, DOI 10.1016/0304-3940(90)90586-X; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LeFeuvre Y, 1997, J PHYSIOL-LONDON, V502, P91, DOI 10.1111/j.1469-7793.1997.091bl.x; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Pow DV, 2005, CELL TISSUE RES, V320, P379, DOI 10.1007/s00441-004-0928-0; Quick MW, 1997, J NEUROSCI, V17, P2967; RICHARDS DA, 1995, J NEUROCHEM, V65, P1674; SNEAD OC, 1991, NEUROPHARMACOLOGY, V30, P161, DOI 10.1016/0028-3908(91)90199-L; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sutch RJ, 1999, NEUROCHEM INT, V34, P415, DOI 10.1016/S0197-0186(99)00046-7; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang D, 2003, MOL PHARMACOL, V64, P905, DOI 10.1124/mol.64.4.905; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021	48	304	312	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1392	U6		10.1038/nm.2058	http://dx.doi.org/10.1038/nm.2058			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966779	Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000272407800019
J	Gutierrez, GJ; Tsuji, T; Chen, MF; Jiang, W; Ronai, ZA				Gutierrez, Gustavo J.; Tsuji, Toshiya; Chen, Meifan; Jiang, Wei; Ronai, Ze'ev A.			Interplay between Cdh1 and JNK activity during the cell cycle	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE CHECKPOINT; TERMINAL KINASE JNK; PHOSPHATASE CDC14; UBIQUITIN LIGASE; S-PHASE; DEGRADATION; PHOSPHORYLATION; CDC20; MITOSIS	The ubiquitin ligase APC/C(Cdh1) coordinates degradation of key cell cycle regulators. We report here that a nuclear-localized portion of the stress-activated kinase JNK is degraded by the APC/C(Cdh1) during exit from mitosis and the G1 phase of the cell cycle. Expression of a non-degradable JNK induces prometaphase-like arrest and aberrant mitotic spindle dynamics. Moreover, JNK phosphorylates Cdh1 directly, during G2 and early mitosis, changing its subcellular localization and attenuating its ability to activate the APC/C during G2/M. This regulatory mechanism between JNK and Cdh1 reveals an important function for JNK during the cell cycle.	[Gutierrez, Gustavo J.; Tsuji, Toshiya; Chen, Meifan; Jiang, Wei; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@sanfordburnham.org	Gutierrez, Gustavo/B-6771-2013; Gutierrez, Gustavo/AAO-9957-2021; Holt, Janet E/B-2415-2013	Gutierrez, Gustavo/0000-0003-4133-5002; Gutierrez, Gustavo/0000-0001-8652-972X; Chen, Meifan/0000-0002-4190-4001; Jiang, Wei/0000-0002-2309-9571; RONAI, ZEEV/0000-0002-3859-0400	NCI [CA78419]; Sass foundation; NATIONAL CANCER INSTITUTE [R01CA138143, R01CA078419] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sass foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to R. Agami, M. Brandeis, J. Lukas, J. Bartek, J. Kyriakis, T. Hunter, H. Piwnica-Worms, S. Tsai, J. Hsieh, T. Lorca and O. Coux for essential reagents used in this work. Supports by NCI grant (CA78419) to Z.A.R. and the Sass foundation to G.J.G. are gratefully acknowledged.	ALEXAKI VI, 2008, PIGMENT CELL MELANOM; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	39	44	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					686	U130		10.1038/ncb2071	http://dx.doi.org/10.1038/ncb2071			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20581839	Green Accepted			2022-12-25	WOS:000279374400012
J	Palanisamy, N; Ateeq, B; Kalyana-Sundaram, S; Pflueger, D; Ramnarayanan, K; Shankar, S; Han, B; Cao, Q; Cao, XH; Suleman, K; Kumar-Sinha, C; Dhanasekaran, SM; Chen, YB; Esgueva, R; Banerjee, S; LaFargue, CJ; Siddiqui, J; Demichelis, F; Moeller, P; Bismar, TA; Kuefer, R; Fullen, DR; Johnson, TM; Greenson, JK; Giordano, TJ; Tan, P; Tomlins, SA; Varambally, S; Rubin, MA; Maher, CA; Chinnaiyan, AM				Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Pflueger, Dorothee; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Cao, Xuhong; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Chen, Ying-bei; Esgueva, Raquel; Banerjee, Samprit; LaFargue, Christopher J.; Siddiqui, Javed; Demichelis, Francesca; Moeller, Peter; Bismar, Tarek A.; Kuefer, Rainer; Fullen, Douglas R.; Johnson, Timothy M.; Greenson, Joel K.; Giordano, Thomas J.; Tan, Patrick; Tomlins, Scott A.; Varambally, Sooryanarayana; Rubin, Mark A.; Maher, Christopher A.; Chinnaiyan, Arul M.			Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma	NATURE MEDICINE			English	Article							ETS TRANSCRIPTION FACTOR; EML4-ALK FUSION GENE; BRAF ACTIVATION; THYROID-CANCER; BREAST-CANCER; LUNG-CANCER; TRANSFORMATION; MUTATIONS; ADENOCARCINOMA; IDENTIFICATION	Although recurrent gene fusions involving erythroblastosis virus E26 transformation-specific (ETS) family transcription factors are common in prostate cancer, their products are considered 'undruggable' by conventional approaches. Recently, rare targetable gene fusions involving the anaplastic lymphoma receptor tyrosine kinase (ALK) gene, have been identified in 1-5% of lung cancers(1), suggesting that similar rare gene fusions may occur in other common epithelial cancers, including prostate cancer. Here we used paired-end transcriptome sequencing to screen ETS rearrangement-negative prostate cancers for targetable gene fusions and identified the SLC45A3-BRAF (solute carrier family 45, member 3-v-raf murine sarcoma viral oncogene homolog B1) and ESRP1-RAF1 (epithelial splicing regulatory protein-1-v-raf-1 murine leukemia viral oncogene homolog-1) gene fusions. Expression of SLC45A3-BRAF or ESRP1-RAF1 in prostate cells induced a neoplastic phenotype that was sensitive to RAF and mitogen-activated protein kinase kinase (MAP2K1) inhibitors. Screening a large cohort of patients, we found that, although rare, recurrent rearrangements in the RAF pathway tend to occur in advanced prostate cancers, gastric cancers and melanoma. Taken together, our results emphasize the key role of RAF family gene rearrangements in cancer, suggest that RAF and MEK inhibitors may be useful in a subset of gene fusion-harboring solid tumors and demonstrate that sequencing of tumor transcriptomes and genomes may lead to the identification of rare targetable fusions across cancer types.	[Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Cao, Xuhong; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Siddiqui, Javed; Tomlins, Scott A.; Varambally, Sooryanarayana; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker; Ramnarayanan, Kalpana; Shankar, Sunita; Han, Bo; Cao, Qi; Suleman, Khalid; Kumar-Sinha, Chandan; Dhanasekaran, Saravana M.; Siddiqui, Javed; Fullen, Douglas R.; Greenson, Joel K.; Giordano, Thomas J.; Tomlins, Scott A.; Varambally, Sooryanarayana; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Palanisamy, Nallasivam; Kalyana-Sundaram, Shanker; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Pflueger, Dorothee; Chen, Ying-bei; Esgueva, Raquel; LaFargue, Christopher J.; Demichelis, Francesca; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Pflueger, Dorothee; Kuefer, Rainer] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Cao, Xuhong; Chinnaiyan, Arul M.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Banerjee, Samprit] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Siddiqui, Javed; Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Moeller, Peter] Univ Hosp Ulm, Dept Pathol, Ulm, Germany; [Bismar, Tarek A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Bismar, Tarek A.] Calgary Lab Serv, Calgary, AB, Canada; [Fullen, Douglas R.; Johnson, Timothy M.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Maher, Christopher A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Ulm University; Howard Hughes Medical Institute; Cornell University; Cornell University; University of Michigan System; University of Michigan; Ulm University; University of Calgary; University of Calgary; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National University of Singapore	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020; chen, ying/HHS-8254-2022; Demichelis, Francesca/J-9829-2016; Cao, Qi/A-5517-2010; Bismar, Tarek/ABH-6129-2020; Kalyana-Sundaram, Shanker/F-6860-2012	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Demichelis, Francesca/0000-0002-8266-8631; Cao, Qi/0000-0002-5140-3681; Rubin, Mark/0000-0002-8321-9950; Tomlins, Scott/0000-0001-8661-9821; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Varambally, Sooryanarayana/0000-0002-2277-1127; Kumar, Chandan/0000-0002-8696-3400; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Giordano, Thomas/0000-0003-0641-8873; LaFargue, Christopher/0000-0001-6473-8061	US National Institutes of Health [R01CA132874]; Early Detection Research Network [UO1 CA111275]; Prostate SPORE [P50CA69568]; National Center for Integrative Bioinformatics [U54 DA21519-01A1]; Department of Defense [R01 CA125612-01]; Prostate Cancer Foundation; Doris Duke Charitable Foundation; Burroughs Welcome Foundation; Melanoma Research Alliance; American Association of Cancer Research Amgen; Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection; Genentech Foundation; Expedition Inspiration; Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE [R01CA125612, P50CA069568, R01CA132874, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; Prostate SPORE; National Center for Integrative Bioinformatics; Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Welcome Foundation(Burroughs Wellcome Fund); Melanoma Research Alliance; American Association of Cancer Research Amgen; Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection; Genentech Foundation(Roche HoldingGenentech); Expedition Inspiration; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. B. Jenkins (Mayo Clinic) for providing prostate cancer tissues with BRAF overexpression for FISH evaluation, R. Morey for assistance in paired-end sequencing and Illumina for technical support. We thank T. Barrette, R. Lonigro, M. Quist, C. Quist and S. Begley for hardware support, sample database maintenance, data curation and maintenance of paired-end sequence data and useful discussions; D. Sanders and M. Vinco for their assistance in procuring gastric cancer samples; and D. Kim, R. Mehra and R. Varambally for providing prostate and melanoma tissue microarray and clinical information from the University of Michigan cohort. We thank D. F. Fries, X. Jiang, L. Wang, R. Jagirdar, N. Kitabayashi and X. Jing for technical assistance, K. Giles for critical reading of the manuscript and A. K. Tewari, Biobank, Weill Cornell Medical College, for providing prostate cancer samples for mutation analysis. This work was supported in part by the US National Institutes of Health (R01CA132874), Early Detection Research Network grant UO1 CA111275, Prostate SPORE grant P50CA69568, the National Center for Integrative Bioinformatics (U54 DA21519-01A1), the National Center for Functional Genomics supported by the Department of Defense (A. M. C.) and R01 CA125612-01 (M. A. R. and F. D.). S. A. T. is supported by a Young Investigator Award from the Prostate Cancer Foundation. A. M. C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award, a Burroughs Welcome Foundation Award in Clinical Translational Research and the Prostate Cancer Foundation. A. M. C. is an American Cancer Society Research Professor. N. P. is supported by the development award from the Melanoma Research Alliance. C. A. M. currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship, and a Prostate Cancer Foundation Young Investigator Award. B. A. is supported by a Genentech Foundation Postdoctoral Fellowship and Young Investigator Award from Expedition Inspiration. T. A. B. is supported by funding from the Prostate Cancer Foundation, a Young Investigator Award and the Canadian Institute of Health Research.	Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dessars B, 2007, J INVEST DERMATOL, V127, P1468, DOI 10.1038/sj.jid.5700725; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; GARTE SJ, 1987, CANCER RES, V47, P3159; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang L, 2003, CANCER RES, V63, P5209; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978	32	363	392	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					793	U94		10.1038/nm.2166	http://dx.doi.org/10.1038/nm.2166			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20526349	Green Accepted			2022-12-25	WOS:000279631900029
J	Carter, CC; Onafuwa-Nuga, A; McNamara, LA; Riddell, J; Bixby, D; Savona, MR; Collins, KL				Carter, Christoph C.; Onafuwa-Nuga, Adewunmi; McNamara, Lucy A.; Riddell, James; Bixby, Dale; Savona, Michael R.; Collins, Kathleen L.			HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HEMATOPOIETIC STEM-CELLS	HIV causes a chronic infection characterized by depletion of CD4(+) T lymphocytes and the development of opportunistic infections. Despite drugs that inhibit viral spread, HIV infection has been difficult to cure because of uncharacterized reservoirs of infected cells that are resistant to highly active antiretroviral therapy (HAART) and the immune response. Here we used CD34(+) cells from infected people as well as in vitro studies of wild-type HIV to show infection and killing of CD34(+) multipotent hematopoietic progenitor cells (HPCs). In some HPCs, we detected latent infection that stably persisted in cell culture until viral gene expression was activated by differentiation factors. A unique reporter HIV that directly detects latently infected cells in vitro confirmed the presence of distinct populations of active and latently infected HPCs. These findings have major implications for understanding HIV bone marrow pathology and the mechanisms by which HIV causes persistent infection.	[Carter, Christoph C.; Collins, Kathleen L.] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Carter, Christoph C.; Collins, Kathleen L.] Univ Michigan, Med Sci Testing Program, Ann Arbor, MI 48109 USA; [Onafuwa-Nuga, Adewunmi; Riddell, James; Bixby, Dale; Savona, Michael R.; Collins, Kathleen L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [McNamara, Lucy A.; Collins, Kathleen L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [McNamara, Lucy A.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, KL (corresponding author), Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA.	klcollin@umich.edu		McNamara, Lucy/0000-0001-8240-7493	US National Institutes of Health [RO1 AI051192, MO1-RR000042]; Burroughs Wellcome Foundation; University of Michigan; Rackham Predoctoral Fellowship; US National Science Foundation; Bernard Maas Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051192] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); University of Michigan(University of Michigan System); Rackham Predoctoral Fellowship; US National Science Foundation(National Science Foundation (NSF)); Bernard Maas Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by US National Institutes of Health grant RO1 AI051192, MO1-RR000042, the Burroughs Wellcome Foundation, the University of Michigan Molecular Mechanisms in Microbial Pathogenesis Training Grant (C. C. C.), the Rackham Predoctoral Fellowship (C. C. C.), a US National Science Foundation predoctoral fellowship (L. A. M.) and a Bernard Maas Fellowship (L. A. M.). We thank C. van de Ven (University of Michigan) for umbilical cord blood and C. McIntyre-Ramm for assistance with human studies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health: p89.6 from R. G. Collman (University of Pennsylvania), pNL4-3 from M. Martin (Viral Pathogenesis and Vaccine Section at the US National Institute of Allergy and Infectious Diseases), p94UG-114.1 and pYU-2 from B. Hahn (University of Alabama at Birmingham) and pMJ4 from T. Ndung'u (Nelson Mandela School of Medicine), B. Renjifo (Harvard School of Public Health) and M. Essex (Harvard School of Public Health). pCMV-G was from N. Hopkins, (Massachusetts Institute of Technology), pCMV-HIV-1 and pHIV-7/SF-GFP were from S.-J.-K. Yee (City of Hope National Medical Center) and pEGFP-N2-LAMP1 was from N. Andrews (Yale University).	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Davis TA, 1998, J IMMUNOL, V160, P3689; Gasmi M, 1999, J VIROL, V73, P1828, DOI 10.1128/JVI.73.3.1828-1834.1999; Kohno T, 2002, J VIROL METHODS, V106, P167, DOI 10.1016/S0166-0934(02)00162-3; Kuroda H, 2009, J VIROL METHODS, V157, P113, DOI 10.1016/j.jviromet.2008.11.021; Majka M, 1999, J CLIN INVEST, V104, P1739, DOI 10.1172/JCI7779; NEAL TF, 1995, BLOOD, V86, P1749, DOI 10.1182/blood.V86.5.1749.bloodjournal8651749; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Weichold FF, 1998, BLOOD, V91, P907, DOI 10.1182/blood.V91.3.907.907_907_915; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	20	231	238	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					446	U127		10.1038/nm.2109	http://dx.doi.org/10.1038/nm.2109			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20208541	Green Accepted			2022-12-25	WOS:000276446800049
J	Chen, JJ; Ai, YX; Wang, JL; Haracska, L; Zhuang, ZH				Chen, Junjun; Ai, Yongxing; Wang, Jialiang; Haracska, Lajos; Zhuang, Zhihao			Chemically ubiquitylated PCNA as a probe for eukaryotic translesion DNA synthesis	NATURE CHEMICAL BIOLOGY			English	Article							CELL NUCLEAR ANTIGEN; POLYMERASE-ETA; UBIQUITIN-BINDING; SLIDING-CLAMP; POL-ETA; REPAIR; DAMAGE; SUMO; MONOUBIQUITINATION; PROTEINS	The rapid growth in ubiquitin biology requires facile chemical approaches for protein ubiquitylation that can overcome the common problem of low yield faced by the enzymatic reaction catalyzed by ubiquitin ligases. We report a chemical approach for monoubiquitylation and SUMOylation of PCNA through disulfide exchange and intein chemistry. We used the chemically ubiquitylated and SUMOylated PCNAs in studying translesion DNA synthesis and revealed a surprising degree of flexibility of the ubiquitin modification.	[Chen, Junjun; Ai, Yongxing; Wang, Jialiang; Zhuang, Zhihao] Univ Delaware, Dept Chem & Biochem, Newark, DC USA; [Haracska, Lajos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Temesvari, Hungary	University of Delaware; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Chen, JJ (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DC USA.	zzhuang@udel.edu			University of Delaware Research Foundation [UDRF08000654]; Hungarian Science Foundation (OTKA) [77495-TAMOP-4.2.2/08/1]	University of Delaware Research Foundation; Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank S. Prakash (University of Texas Medical Branch) for the generous gift of yeast Pold. We also thank C. Thorpe for helpful discussions. This work was supported in part by a grant from the University of Delaware Research Foundation to Z. Z. (UDRF08000654).L. H. acknowledges funding from the Hungarian Science Foundation (OTKA 77495-TAMOP-4.2.2/08/1).	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gamblin DP, 2008, MOL BIOSYST, V4, P558, DOI 10.1039/b802199f; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	25	108	112	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					270	272		10.1038/NCHEMBIO.316	http://dx.doi.org/10.1038/NCHEMBIO.316			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20208521				2022-12-25	WOS:000275734000011
J	McMillin, DW; Delmore, J; Weisberg, E; Negri, JM; Geer, DC; Klippel, S; Mitsiades, N; Schlossman, RL; Munshi, NC; Kung, AL; Griffin, JD; Richardson, PG; Anderson, KC; Mitsiades, CS				McMillin, Douglas W.; Delmore, Jake; Weisberg, Ellen; Negri, Joseph M.; Geer, D. Corey; Klippel, Steffen; Mitsiades, Nicholas; Schlossman, Robert L.; Munshi, Nikhil C.; Kung, Andrew L.; Griffin, James D.; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.			Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity	NATURE MEDICINE			English	Article							MULTIPLE-MYELOMA CELLS; LENALIDOMIDE PLUS DEXAMETHASONE; HISTONE DEACETYLASE INHIBITION; BONE-MARROW STROMA; GENE-EXPRESSION; CLINICAL-IMPLICATIONS; MOLECULAR SEQUELAE; RESISTANCE; BORTEZOMIB; IDENTIFICATION	Conventional anticancer drug screening is typically performed in the absence of accessory cells of the tumor microenvironment, which can profoundly alter antitumor drug activity. To address this limitation, we developed the tumor cell-specific in vitro bioluminescence imaging (CS-BLI) assay. Tumor cells (for example, myeloma, leukemia and solid tumors) stably expressing luciferase are cultured with nonmalignant accessory cells (for example, stromal cells) for selective quantification of tumor cell viability, in presence versus absence of stromal cells or drug treatment. CS-BLI is high-throughput scalable and identifies stroma-induced chemoresistance in diverse malignancies, including imatinib resistance in leukemic cells. A stroma-induced signature in tumor cells correlates with adverse clinical prognosis and includes signatures for activated Akt, Ras, NF-kappa B, HIF-1 alpha, myc, hTERT and IRF4; for biological aggressiveness; and for self-renewal. Unlike conventional screening, CS-BLI can also identify agents with increased activity against tumor cells interacting with stroma. One such compound, reversine, shows more potent activity in an orthotopic model of diffuse myeloma bone lesions than in conventional subcutaneous xenografts. Use of CS-BLI, therefore, enables refined screening of candidate anticancer agents to enrich preclinical pipelines with potential therapeutics that overcome stroma-mediated drug resistance and can act in a synthetic lethal manner in the context of tumor-stroma interactions.	[McMillin, Douglas W.; Delmore, Jake; Negri, Joseph M.; Geer, D. Corey; Klippel, Steffen; Mitsiades, Nicholas; Schlossman, Robert L.; Munshi, Nikhil C.; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA; [McMillin, Douglas W.; Delmore, Jake; Weisberg, Ellen; Negri, Joseph M.; Geer, D. Corey; Klippel, Steffen; Mitsiades, Nicholas; Schlossman, Robert L.; Munshi, Nikhil C.; Griffin, James D.; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA USA; [McMillin, Douglas W.; Delmore, Jake; Weisberg, Ellen; Negri, Joseph M.; Geer, D. Corey; Klippel, Steffen; Schlossman, Robert L.; Munshi, Nikhil C.; Griffin, James D.; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Munshi, Nikhil C.] Boston VA Healthcare Syst, Boston, MA USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Dana-Farber Cancer Institute	Mitsiades, CS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA.	constantine_mitsiades@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022; Munshi, Nikhil/ABE-2338-2021	Kung, Andrew L/0000-0002-9091-488X; 	Dunkin Donuts Rising Stars program at the Dana-Farber Cancer Institute; Chambers Medical Foundation; Steven Cobb Foundation; US National Institutes of Health [R01CA050947]; NATIONAL CANCER INSTITUTE [R01CA124929, R01CA050947, P50CA100707, P01CA155258, P01CA078378] Funding Source: NIH RePORTER	Dunkin Donuts Rising Stars program at the Dana-Farber Cancer Institute; Chambers Medical Foundation; Steven Cobb Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Dunkin Donuts Rising Stars program at the Dana-Farber Cancer Institute (C. S. M.), the Chambers Medical Foundation (C. S. M. and P. G. R.), the Steven Cobb Foundation (D. W. M., C. S. M.) and US National Institutes of Health grant R01CA050947 (C. S. M. and K. C. A.). We wish to thank T. Libermann and M. Joseph-Bruno (Harvard Institutes of Medicine Genomics Core) for generation of gene expression data and L. Buon for help with bioinformatic analyses.	Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Grigorieva I, 1998, EXP HEMATOL, V26, P597; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lindvall C, 2003, CANCER RES, V63, P1743; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mitsiades CS, 2003, CANCER RES, V63, P6689; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mitsiades N, 2003, BLOOD, V101, P4055, DOI 10.1182/blood-2002-11-3514; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Richardson PG, 2006, BLOOD, V108, P3458, DOI 10.1182/blood-2006-04-015909; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Roodman GD, 2002, J BONE MINER RES, V17, P1921, DOI 10.1359/jbmr.2002.17.11.1921; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	38	240	251	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					483	U171		10.1038/nm.2112	http://dx.doi.org/10.1038/nm.2112			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20228816	Green Accepted			2022-12-25	WOS:000276446800055
J	Mooney, P				Mooney, Paul			In search of little blue pills	NATURE MEDICINE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					360	360		10.1038/nm0410-360b	http://dx.doi.org/10.1038/nm0410-360b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376024	Bronze			2022-12-25	WOS:000276446800017
J	Myers, MG; Kahn, CR; Accili, D				Myers, Martin G., Jr.; Kahn, C. Ronald; Accili, Domenico			Leptin therapy for type 1 diabetes gains traction	NATURE MEDICINE			English	Editorial Material									[Myers, Martin G., Jr.] Univ Michigan Med Sch, Dept Med, Ann Arbor, MI USA; [Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA USA; [Kahn, C. Ronald] Harvard Med Sch, Boston, MA USA; [Accili, Domenico] Columbia Univ, Dept Med, New York, NY USA	University of Michigan System; University of Michigan; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Columbia University	Myers, MG (corresponding author), Univ Michigan Med Sch, Dept Med, Ann Arbor, MI USA.		Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NIDDK NIH HHS [R01 DK082659] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107	1	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					380	380		10.1038/nm0410-380	http://dx.doi.org/10.1038/nm0410-380			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376045	Bronze			2022-12-25	WOS:000276446800056
J	Kamatani, Y; Matsuda, K; Okada, Y; Kubo, M; Hosono, N; Daigo, Y; Nakamura, Y; Kamatani, N				Kamatani, Yoichiro; Matsuda, Koichi; Okada, Yukinori; Kubo, Michiaki; Hosono, Naoya; Daigo, Yataro; Nakamura, Yusuke; Kamatani, Naoyuki			Genome-wide association study of hematological and biochemical traits in a Japanese population	NATURE GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; PLATELET GLYCOPROTEIN-IB; HEMOGLOBIN LEVELS; LOCI; MUTATION; VARIANTS; GENE; ERYTHROCYTE; PROTEIN; HUMANS	We report genome-wide association studies for hematological and biochemical traits from similar to 14,700 Japanese individuals. We identified 60 associations for 8 hematological traits and 29 associations for 12 biochemical traits at genome-wide significance levels (P < 5 x 10(-8)). Of these, 46 associations were new to this study and 43 replicated previous reports. We compared these associated loci with those reported in similar GWAS in European populations. When the minor allele frequency was >10% in the Japanese population, 32 (94.1%) and 31 (91.2%) of the 34 hematological loci previously reported to be associated in a European population were replicated with P-values less than 0.05 and 0.01, respectively, and 31 (73.8%) and 27 (64.3%) of the 42 European biochemical loci were replicated.	[Kamatani, Yoichiro; Matsuda, Koichi; Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Kamatani, Yoichiro; Daigo, Yataro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Okada, Yukinori; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Kanagawa, Japan; [Kubo, Michiaki; Hosono, Naoya] RIKEN, Lab Genotyping Dev, Kanagawa, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Kanagawa, Japan	University of Tokyo; University of Tokyo; RIKEN; RIKEN; RIKEN	Kamatani, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	kamatani@msb.biglobe.ne.jp	Kubo, Michiaki/N-7947-2015; Kamatani, Yoichiro/N-5513-2015; Matsuda, Koichi/D-4597-2011	Daigo, Yataro/0000-0002-0915-3025; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the technical staff of the Laboratory for Genotyping Development at RIKEN for SNP genotyping and K. Kamatani for useful advice about statistical analyses. We also thank all the participants and the staff of the BioBank Japan project. This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bagnasco SM, 2001, AM J PHYSIOL-RENAL, V281, pF400, DOI 10.1152/ajprenal.2001.281.3.F400; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Garner C, 2006, EUR J HUM GENET, V14, P101, DOI 10.1038/sj.ejhg.5201499; HARMON JT, 1986, J BIOL CHEM, V261, P3224; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichida K, 2008, CLIN GENET, V74, P243, DOI 10.1111/j.1399-0004.2008.01021.x; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Maguire JM, 2008, STROKE, V39, P1710, DOI 10.1161/STROKEAHA.107.507228; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; MILLER JL, 1991, P NATL ACAD SCI USA, V88, P4761, DOI 10.1073/pnas.88.11.4761; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nose J, 2008, J HUM GENET, V53, P425, DOI 10.1007/s10038-008-0266-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; Whitehead A., 2002, METAANALYSIS CONTROL; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	40	378	389	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					210	U25		10.1038/ng.531	http://dx.doi.org/10.1038/ng.531			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139978				2022-12-25	WOS:000274912400008
J	Chi-Ham, CL; Clark, KL; Bennett, AB				Chi-Ham, Cecilia L.; Clark, Kerri L.; Bennett, Alan B.			The intellectual property landscape for gene suppression technologies in plants	NATURE BIOTECHNOLOGY			English	Editorial Material							CHALCONE SYNTHASE GENE; DOUBLE-STRANDED-RNA; ANTISENSE RNA; TRANSGENIC PLANTS; CAENORHABDITIS-ELEGANS; POLYGALACTURONASE GENE; FLOWER PIGMENTATION; EXPRESSION; INHIBITION; TOBACCO		[Chi-Ham, Cecilia L.; Clark, Kerri L.; Bennett, Alan B.] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Chi-Ham, CL (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	abbennett@ucdavis.edu	Bennett, Alan B/D-8980-2011	Bennett, Alan B/0000-0002-3684-4307				BENITEC LTD, 2003, Patent No. 6573099; Brummell DA, 2003, PLANT J, V33, P793, DOI 10.1046/j.1365-313X.2003.01659.x; DELAUNEY AJ, 1988, P NATL ACAD SCI USA, V85, P4300, DOI 10.1073/pnas.85.12.4300; ECKER JR, 1986, P NATL ACAD SCI USA, V83, P5372, DOI 10.1073/pnas.83.15.5372; Fenton GM, 2007, INTELLECTUAL PROPERT; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fire A., 2003, U. S. Patent, Patent No. [No. 6,506,559, 6506559]; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Howard K, 2003, NAT BIOTECHNOL, V21, P1441, DOI 10.1038/nbt1203-1441; JORGENSEN RA, 1994, Patent No. 5283184; JORGENSEN RA, 1993, Patent No. 5231020; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; LINDBO JA, 1992, VIROLOGY, V189, P725, DOI 10.1016/0042-6822(92)90595-G; Metzlaff M, 1997, CELL, V88, P845, DOI 10.1016/S0092-8674(00)81930-3; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; PANG SZ, 1993, BIO-TECHNOL, V11, P819, DOI 10.1038/nbt0793-819; RODERMEL SR, 1988, CELL, V55, P673, DOI 10.1016/0092-8674(88)90226-7; ROTHSTEIN SJ, 1987, P NATL ACAD SCI USA, V84, P8439, DOI 10.1073/pnas.84.23.8439; Sanders RA, 2005, NAT BIOTECHNOL, V23, P287, DOI 10.1038/nbt0305-287b; Schmidt C, 2007, NAT BIOTECHNOL, V25, P273, DOI 10.1038/nbt0307-273; SHEEHY RE, 1988, P NATL ACAD SCI USA, V85, P8805, DOI 10.1073/pnas.85.23.8805; SHEWMAKER CK, 1992, Patent No. 5107065; SHEWMAKER CK, 1998, Patent No. 5759829; SIMONS RW, 1988, GENE, V72, P35, DOI 10.1016/0378-1119(88)90125-4; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stam M, 1998, MOL CELL BIOL, V18, P6165, DOI 10.1128/MCB.18.11.6165; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VANDERKROL AR, 1990, PLANT MOL BIOL, V14, P457, DOI 10.1007/BF00027492; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959	32	11	15	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					32	37		10.1038/nbt0110-32	http://dx.doi.org/10.1038/nbt0110-32			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20062036				2022-12-25	WOS:000273430400015
J	Johnson, PL; Truitt, W; Fitz, SD; Minick, PE; Dietrich, A; Sanghani, S; Traskman-Bendz, L; Goddard, AW; Brundin, L; Shekhar, A				Johnson, Philip L.; Truitt, William; Fitz, Stephanie D.; Minick, Pamela E.; Dietrich, Amy; Sanghani, Sonal; Traskman-Bendz, Lil; Goddard, Andrew W.; Brundin, Lena; Shekhar, Anantha			A key role for orexin in panic anxiety	NATURE MEDICINE			English	Article							CEREBROSPINAL-FLUID; GABA DYSFUNCTION; DISORDER; RATS; HYPOTHALAMUS; INHIBITION; ALPRAZOLAM; HYPOCRETIN; SYSTEM; SLEEP	Panic disorder is a severe anxiety disorder with recurrent, debilitating panic attacks. In individuals with panic disorder there is evidence of decreased central gamma-aminobutyric acid (GABA) activity as well as marked increases in autonomic and respiratory responses after intravenous infusions of hypertonic sodium lactate(1-3). In a rat model of panic disorder, chronic inhibition of GABA synthesis in the dorsomedial-perifornical hypothalamus of rats produces anxiety-like states and a similar vulnerability to sodium lactate-induced cardioexcitatory responses(4-9). The dorsomedial-perifornical hypothalamus is enriched in neurons containing orexin (ORX, also known as hypocretin)(10), which have a crucial role in arousal(10,11), vigilance(10) and central autonomic mobilization(12), all of which are key components of panic. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state in the rat panic model, and either silencing of the hypothalamic gene encoding ORX (Hcrt) with RNAi or systemic ORX-1 receptor antagonists blocks the panic responses. Moreover, we show that human subjects with panic anxiety have elevated levels of ORX in the cerebrospinal fluid compared to subjects without panic anxiety. Taken together, our results suggest that the ORX system may be involved in the pathophysiology of panic anxiety and that ORX antagonists constitute a potential new treatment strategy for panic disorder. (C) 2010 Nature America, Inc. All rights reserved.	[Johnson, Philip L.; Truitt, William; Fitz, Stephanie D.; Minick, Pamela E.; Dietrich, Amy; Goddard, Andrew W.; Shekhar, Anantha] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Truitt, William] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Sanghani, Sonal] Indiana Univ, Sch Med, Dept Biochem, Indianapolis, IN 46202 USA; [Traskman-Bendz, Lil; Brundin, Lena] Univ Lund Hosp, Dept Clin Sci, Sect Psychiat, S-22185 Lund, Sweden; [Shekhar, Anantha] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Lund University; Skane University Hospital	Shekhar, A (corresponding author), Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA.	ashekhar@iupui.edu	Johnson, Philip/K-8574-2019	Johnson, Philip/0000-0002-5398-8214; Brundin, Lena/0000-0002-8327-6242	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065702, R01MH052619] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001108] Funding Source: Medline; NCRR NIH HHS [UL1 RR025761-015988, UL1RR025761, UL1 RR025761] Funding Source: Medline; NIMH NIH HHS [R01 MH065702, R01 MH052619, R01 MH065702-06, R01 MH52619, R01 MH052619-11] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AM PSYCH ASS, 2005, DIAGN STAT MAN MENT, P429; Andreatini R, 2001, BRAZ J MED BIOL RES, V34, P145, DOI 10.1590/S0100-879X2001000200001; Boshuisen ML, 2002, BIOL PSYCHIAT, V52, P126, DOI 10.1016/S0006-3223(02)01355-0; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Brundin L, 2007, EUR NEUROPSYCHOPHARM, V17, P573, DOI 10.1016/j.euroneuro.2007.01.005; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; COWLEY DS, 1991, BIOL PSYCHIAT, V30, P49, DOI 10.1016/0006-3223(91)90069-X; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Ferguson AV, 2003, FRONT NEUROENDOCRIN, V24, P141, DOI 10.1016/S0091-3022(03)00028-1; Goddard AW, 2004, AM J PSYCHIAT, V161, P2186, DOI 10.1176/appi.ajp.161.12.2186; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; GORMAN JM, 1994, AM J PSYCHIAT, V151, P547; GRILLON C, 1994, BIOL PSYCHIAT, V35, P431, DOI 10.1016/0006-3223(94)90040-X; Ishii Y, 2005, BEHAV BRAIN RES, V157, P331, DOI 10.1016/j.bbr.2004.07.012; Johnson PL, 2008, NEUROPSYCHOPHARMACOL, V33, P2093, DOI 10.1038/sj.npp.1301621; Johnson PL, 2006, J NEUROSCI, V26, P7093, DOI 10.1523/JNEUROSCI.0408-06.2006; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; LIEBOWITZ MR, 1986, J CLIN PSYCHOPHARM, V6, P13; LIEBOWITZ MR, 1986, AM J PSYCHIAT, V143, P495; Ludewig S, 2002, DEPRESS ANXIETY, V15, P55, DOI 10.1002/da.10026; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Samuels BC, 2004, AM J PHYSIOL-REG I, V287, pR472, DOI 10.1152/ajpregu.00667.2003; Shekhar A, 2003, ANN NY ACAD SCI, V985, P308; Shekhar A, 1997, J NEUROSCI, V17, P9726; Shekhar A, 1996, PHARMACOL BIOCHEM BE, V55, P249, DOI 10.1016/S0091-3057(96)00077-9; Shekhar A, 2000, NEUROPHARMACOLOGY, V39, P1139, DOI 10.1016/S0028-3908(99)00215-4; Shekhar A, 2006, J NEUROSCI, V26, P9205, DOI 10.1523/JNEUROSCI.2491-06.2006	31	262	283	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					111	U149		10.1038/nm.2075	http://dx.doi.org/10.1038/nm.2075			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20037593	Green Accepted, Green Submitted			2022-12-25	WOS:000273395500044
J	Smutny, M; Cox, HL; Leerberg, JM; Kovacs, EM; Conti, MA; Ferguson, C; Hamilton, NA; Parton, RG; Adelstein, RS; Yap, AS				Smutny, Michael; Cox, Hayley L.; Leerberg, Joanne M.; Kovacs, Eva M.; Conti, Mary Anne; Ferguson, Charles; Hamilton, Nicholas A.; Parton, Robert G.; Adelstein, Robert S.; Yap, Alpha S.			Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens	NATURE CELL BIOLOGY			English	Article							CELL-CELL CONTACTS; CADHERIN-ADHESIVE CONTACTS; PHOSPHATIDYLINOSITOL 3-KINASE; ACTIN; JUNCTIONS; MORPHOGENESIS; ORGANIZATION; ORCHESTRATE; MATURATION; MUTATIONS	Classic cadherin receptors cooperate with regulators of the actin cytoskeleton to control tissue organization in health and disease. At the apical junctions of epithelial cells, the cadherin ring of the zonula adherens (ZA) couples with a contiguous ring of actin filaments(1-3) to support morphogenetic processes such as tissue integration and cellular morphology(4,5). However, the molecular mechanisms that coordinate adhesion and cytoskeleton at these junctions are poorly understood. Previously we identified nonmuscle myosin II as a target of Rho signalling that supports cadherin junctions in mammalian epithelial cells(6). Myosin II has various cellular functions, which are increasingly attributable to the specific biophysical properties and regulation of its different isoforms(7). Here we report that myosin II isoforms have distinct and necessary roles at cadherin junctions. Although two of the three mammalian myosin II isoforms are found at the ZA, their localization is regulated by different upstream signalling pathways. Junctional localization of myosin IIA required E-cadherin adhesion, Rho/ROCK and myosin light-chain kinase, whereas junctional myosin IIB depended on Rap1. Further, these myosin II isoforms support E-cadherin junction integrity by different mechanisms. Myosin IIA RNA-mediated interference (RNAi) selectively perturbed the accumulation of E-cadherin in the apical ZA, decreased cadherin homophilic adhesion and disrupted cadherin clustering. In contrast, myosin IIB RNAi decreased filament content, altered dynamics, and increased the lateral movement of the perijunctional actin ring. Myosin IIA and IIB therefore identify two distinct functional modules, with different upstream signals that control junctional localization, and distinct functional effects. We propose that these two isoform-based modules cooperate to coordinate adhesion receptor and F-actin organization to form apical cadherin junctions.	[Smutny, Michael; Cox, Hayley L.; Leerberg, Joanne M.; Kovacs, Eva M.; Ferguson, Charles; Hamilton, Nicholas A.; Parton, Robert G.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia; [Conti, Mary Anne; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	University of Queensland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Yap, Alpha S./J-1554-2014; Hamilton, Nicholas A/A-6033-2010; Parton, Robert G/C-5673-2009; Kovacs, Eva/U-3526-2019	Yap, Alpha S./0000-0002-1038-8956; Hamilton, Nicholas A/0000-0003-0331-3427; Parton, Robert G/0000-0002-7494-5248; Kovacs, Eva/0000-0002-7228-4028; Adelstein, Robert/0000-0002-8683-2144; Smutny, Michael/0000-0002-5920-9090	National Health and Medical Research Council (NHMRC) of Australia; National Institutes of Health (NIH); ACRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004218] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank our colleagues who provided reagents, especially Jim Bear for the pLL5.0 lentiviral construct, Rachel Murphy and Nigel McMillan for training us in lentiviral work, Regine Hartmann for her assistance with cloning, Suzie Verma and Carmen Buttery for assistance with tissue culture, and our colleagues in the laboratory for their untiring support and encouragement. The work in Australia was funded by the National Health and Medical Research Council (NHMRC) of Australia; that in the USA was supported by the National Institutes of Health (NIH). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF) Cancer Biology Imaging Centre at the Institute for Molecular Bioscience, established with the generous support of the ACRF. We gratefully acknowledge the help and advice of Guanghui Wang and the NIH National Heart, Lung and Blood	Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dube N, 2008, CELL SIGNAL, V20, P1608, DOI 10.1016/j.cellsig.2008.05.006; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kolega J, 1998, J CELL SCI, V111, P2085; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; YONEMURA S, 1995, J CELL SCI, V108, P127	37	226	230	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					696	U147		10.1038/ncb2072	http://dx.doi.org/10.1038/ncb2072			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20543839	Green Accepted			2022-12-25	WOS:000279374400013
J	Chan, J; Lewis, AR; Gilbert, M; Karwaski, MF; Bennet, AJ				Chan, Jefferson; Lewis, Andrew R.; Gilbert, Michel; Karwaski, Marie-France; Bennet, Andrew J.			A direct NMR method for the measurement of competitive kinetic isotope effects	NATURE CHEMICAL BIOLOGY			English	Article							TRANSITION-STATE; SALMONELLA-TYPHIMURIUM; NATURAL-ABUNDANCE; HYDROLYSIS; SIALIDASE; MECHANISMS; CATALYSIS; ENZYMES; ACID	We present a technique that uses (13)C NMR spectroscopy to measure kinetic isotope effects on the second-order rate constant (k(cat)/K(m)) for enzyme-catalyzed reactions. Using only milligram quantities of isotopically labeled substrates, precise competitive KIEs can be determined while following the ongoing reaction directly in a NMR spectrometer. Our results for the Vibrio cholerae sialidase-catalyzed hydrolysis of natural substrate analogs support a concerted enzymatic transition state for these reactions.	[Chan, Jefferson; Lewis, Andrew R.; Bennet, Andrew J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Gilbert, Michel; Karwaski, Marie-France] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Simon Fraser University; National Research Council Canada	Chan, J (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bennet@sfu.ca		Chan, Jefferson/0000-0003-4139-4379; Gilbert, Michel/0000-0002-0204-4408	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors thank W. Wakarchuk and M. Schur (Institute for Biological Sciences, National Research Council Canada, Ottawa) for providing the labeled 2,3-sialosides. This work was financially supported by the Natural Sciences and Engineering Research Council of Canada.	Berger S., 2004, 200 MORE NMR EXPT PR, P128; Berti PJ, 1997, J AM CHEM SOC, V119, P12079, DOI 10.1021/ja971317a; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; FRIEBOLIN H, 1980, ANGEW CHEM INT EDIT, V19, P208, DOI 10.1002/anie.198002081; GUO XM, 1993, BIOCHEM J, V294, P653, DOI 10.1042/bj2940653; GUO XM, 1994, J AM CHEM SOC, V116, P5572, DOI 10.1021/ja00092a007; Huang XC, 1997, J AM CHEM SOC, V119, P11147, DOI 10.1021/ja963733l; Indurugalla D, 2001, J AM CHEM SOC, V123, P10889, DOI 10.1021/ja011232g; KIM MJ, 1988, J AM CHEM SOC, V110, P6481, DOI 10.1021/ja00227a031; Kohen A., 2006, ISOTOPE EFFECTS CHEM; Lee JK, 2004, J AM CHEM SOC, V126, P3769, DOI 10.1021/ja0394028; Melander L., 1980, REACTION RATES ISOTO; SCHIMERLIK MI, 1975, BIOCHEMISTRY-US, V14, P5347, DOI 10.1021/bi00695a020; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; SINGLETON DA, 1995, J AM CHEM SOC, V117, P9357, DOI 10.1021/ja00141a030; TANAKA Y, 1994, J BIOL CHEM, V269, P32306; Taylor EA, 2007, J AM CHEM SOC, V129, P6984, DOI 10.1021/ja071087s; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; WILSON JC, 1995, J AM CHEM SOC, V117, P4214, DOI 10.1021/ja00120a002; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	24	53	53	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					405	407		10.1038/nchembio.352	http://dx.doi.org/10.1038/nchembio.352			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20418878				2022-12-25	WOS:000277748100008
J	Koketsu, K; Watanabe, K; Suda, H; Oguri, H; Oikawa, H				Koketsu, Kento; Watanabe, Kenji; Suda, Haruna; Oguri, Hiroki; Oikawa, Hideaki			Reconstruction of the saframycin core scaffold defines dual Pictet-Spengler mechanisms	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; BIOSYNTHETIC-PATHWAY; RATIONAL DESIGN; GENE-CLUSTER; POLYKETIDE; ANTIBIOTICS; SYSTEM; ENZYME; MX1	Saframycin A is a potent antitumor antibiotic with a unique pentacyclic tetrahydroisoquinoline scaffold. We found that the nonribosomal peptide synthetase SfmC catalyzes a seven-step transformation of readily synthesized dipeptidyl substrates with long acyl chains into a complex saframycin scaffold. Based on a series of enzymatic reactions, we propose a detailed mechanism involving the reduction of various peptidyl thioesters by a single R domain followed by iterative C domain-mediated Pictet-Spengler reactions.	[Koketsu, Kento; Suda, Haruna; Oguri, Hiroki; Oikawa, Hideaki] Hokkaido Univ, Div Chem, Grad Sch Sci, Sapporo, Hokkaido, Japan; [Watanabe, Kenji] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Hokkaido University; University of Shizuoka	Koketsu, K (corresponding author), Hokkaido Univ, Div Chem, Grad Sch Sci, Sapporo, Hokkaido, Japan.	hoik@sci.hokudai.ac.jp	Watanabe, Kenji/N-2012-2015; Oguri, Hiroki/F-9541-2015; Oguri, Hiroki/AAV-2045-2020; Oikawa, Hideaki/F-9128-2012; Oguri, Hiroki/B-7366-2014	Watanabe, Kenji/0000-0002-0463-4831; Oguri, Hiroki/0000-0001-8007-1631; Oguri, Hiroki/0000-0001-8007-1631; Oikawa, Hideaki/0000-0002-6947-3397; 	Japan Society for the Promotion of Science (JSPS) [20310126]; Japan Science and Technology (JST); JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) ((B) 20310126 to H. Oikawa) and in part by a grant from Japan Science and Technology (JST) (Research for Promoting Technological Seeds 01-073 to H. Oikawa). A fellowship to K. K. from the JSPS is gratefully acknowledged. We thank Y. Kumaki and S. Oka (both of Hokkaido University) for obtaining NMR and mass data.	ARAI T, 1977, J ANTIBIOT, V30, P1015; Baltz RH, 2005, NAT PROD REP, V22, P717, DOI 10.1039/b416648p; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Cuevas C, 2000, ORG LETT, V2, P2545, DOI 10.1021/ol0062502; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Duerfahrt T, 2004, CHEM BIOL, V11, P261, DOI 10.1016/j.chembiol.2004.01.013; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fu CY, 2009, J MICROBIOL BIOTECHN, V19, P439, DOI 10.4014/jmb.0808.484; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Li L, 2008, J BACTERIOL, V190, P251, DOI 10.1128/JB.00826-07; MIKAMI Y, 1985, J BIOL CHEM, V260, P344; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Myers AG, 1999, J AM CHEM SOC, V121, P10828, DOI 10.1021/ja993079k; Pospiech A, 1996, MICROBIOL-UK, V142, P741, DOI 10.1099/00221287-142-4-741; Schmidt EW, 2004, TETRAHEDRON LETT, V45, P3921, DOI 10.1016/j.tetlet.2004.03.112; Scott JD, 2002, CHEM REV, V102, P1669, DOI 10.1021/cr010212u; Velasco A, 2005, MOL MICROBIOL, V56, P144, DOI 10.1111/j.1365-2958.2004.04433.x; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Watanabe K, 2009, CHEMBIOCHEM, V10, P1965, DOI 10.1002/cbic.200900260; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Xue YQ, 2000, NATURE, V403, P571, DOI 10.1038/35000624	23	85	91	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					408	410		10.1038/nchembio.365	http://dx.doi.org/10.1038/nchembio.365			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20453862	Green Submitted			2022-12-25	WOS:000277748100009
J	[Anonymous]				[Anonymous]			Cancer vaccine approval could open floodgates	NATURE MEDICINE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					615	615						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526296	Bronze			2022-12-25	WOS:000278394200008
J	Katsnelson, A				Katsnelson, Alla			Substandard drugs overshadowed by focus on fakes	NATURE MEDICINE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					364	364		10.1038/nm0410-364b	http://dx.doi.org/10.1038/nm0410-364b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376033	Bronze			2022-12-25	WOS:000276446800026
J	Meinecke, M; Cizmowski, C; Schliebs, W; Kruger, V; Beck, S; Wagner, R; Erdmann, R				Meinecke, Michael; Cizmowski, Christian; Schliebs, Wolfgang; Krueger, Vivien; Beck, Sabrina; Wagner, Richard; Erdmann, Ralf			The peroxisomal importomer constitutes a large and highly dynamic pore	NATURE CELL BIOLOGY			English	Article							MITOCHONDRIAL INNER MEMBRANE; RECEPTOR PEX5P; PROTEIN IMPORT; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; CHANNEL; COMPLEX; TRANSLOCATION; PREPROTEINS; INSERTION	The peroxisomal protein import machinery differs fundamentally from known translocons (endoplasmic reticulum, mitochondria, chloroplasts, bacteria) as it allows membrane passage of folded, even oligomerized proteins(1). However, the mechanistic principles of protein translocation across the peroxisomal membrane remain unknown. There are various models that consider membrane invagination events, vesicle fusion or the existence of large import pores. Current data show that a proteinaceous peroxisomal importomer enables docking of the cytosolic cargo-loaded receptors, cargo translocation and receptor recycling(2). Remarkably, the cycling import receptor Pex5p changes its topology from a soluble cytosolic form to an integral membrane-bound form. According to the transient pore hypothesis, the membrane-bound receptor is proposed to form the core component of the peroxisomal import pore(3). Here, we demonstrate that the membrane-associated import receptor Pex5p together with its docking partner Pex14p forms a gated ion-conducting channel which can be opened to a diameter of about 9 nm by the cytosolic receptor-cargo complex. The newly identified pore shows striking dynamics, as expected for an import machinery translocating proteins of variable sizes.	[Cizmowski, Christian; Schliebs, Wolfgang; Beck, Sabrina; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Bochum, Germany; [Meinecke, Michael; Krueger, Vivien; Wagner, Richard] Univ Osnabruck, FB Biol Chem, D-4500 Osnabruck, Germany	Ruhr University Bochum; University Osnabruck	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Bochum, Germany.	ralf.erdmann@rub.de	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [SFB431, SFB642, DFGSchl 584/1-2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB431 (M. M. and R. W.), SFB642 (R. E.), DFGSchl 584/1-2 (WS) and the Fonds der Chemischen Industrie. We thank Wolf Kunau for helpful comments and discussion.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; ELGERSMA Y, 1996, J BIOL CHEM, V9, P185; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; LABARCA P, 1986, J MEMBRANE BIOL, V94, P285, DOI 10.1007/BF01869724; LEMMENS M, 1989, BIOCHIM BIOPHYS ACTA, V984, P351, DOI 10.1016/0005-2736(89)90302-7; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Titorenko VI, 2002, J CELL BIOL, V156, P481, DOI 10.1083/jcb.200111075; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1	32	198	200	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					273	U68		10.1038/ncb2027	http://dx.doi.org/10.1038/ncb2027			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154681				2022-12-25	WOS:000275054200013
J	James, D; Nam, HS; Seandel, M; Nolan, D; Janovitz, T; Tomishima, M; Studer, L; Lee, G; Lyden, D; Benezra, R; Zaninovic, N; Rosenwaks, Z; Rabbany, SY; Rafii, S				James, Daylon; Nam, Hyung-Song; Seandel, Marco; Nolan, Daniel; Janovitz, Tyler; Tomishima, Mark; Studer, Lorenz; Lee, Gabsang; Lyden, David; Benezra, Robert; Zaninovic, Nikica; Rosenwaks, Zev; Rabbany, Sina Y.; Rafii, Shahin			Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF beta inhibition is Id1 dependent	NATURE BIOTECHNOLOGY			English	Article							COMMITMENT; DIFFERENTIATION; EXPRESSION; GROWTH	Previous efforts to differentiate human embryonic stem cells (hESCs) into endothelial cells have not achieved sustained expansion and stability of vascular cells. To define vasculogenic developmental pathways and enhance differentiation, we used an endothelial cell-specific VE-cadherin promoter driving green fluorescent protein (GFP) (hVPr-GFP) to screen for factors that promote vascular commitment. In phase 1 of our method, inhibition of transforming growth factor (TGF)beta at day 7 of differentiation increases hVPr-GFP(+) cells by tenfold. In phase 2, TGF beta inhibition maintains the proliferation and vascular identity of purified endothelial cells, resulting in a net 36-fold expansion of endothelial cells in homogenous monolayers, which exhibited a transcriptional profile of Id1(high)VEGFR2(high)VE-cadherin(+) ephrinB2(+). Using an Id1-YFP hESC reporter line, we showed that TGF beta inhibition sustains Id1 expression in hESC-derived endothelial cells and that Id1 is required for increased proliferation and preservation of endothelial cell commitment. Our approach provides a serum-free method for differentiation and long-term maintenance of hESC-derived endothelial cells at a scale relevant to clinical application.	[James, Daylon; Seandel, Marco; Nolan, Daniel; Janovitz, Tyler; Lyden, David; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY USA; [Nam, Hyung-Song; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Seandel, Marco] Mem Sloan Kettering Canc Ctr, Dept Med, Div Med Oncol, New York, NY 10021 USA; [Tomishima, Mark; Studer, Lorenz; Lee, Gabsang] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Zaninovic, Nikica; Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, New York, NY USA	Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY USA.	srafii@med.cornell.edu	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; , namhyeongsong/0000-0002-0429-5446	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952, RC2HL101846, R01HL058707, P01HL059312, R01HL097797, R21HL083222, P50HL084936, R01HL119872, R01HL075234, P01HL067839, R01HL061849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [U01 HL066952-050002, U01 HL066952-010002, P01 HL067839-040004, R21 HL083222, R21 HL083222-01, R01 HL075234, U01 HL066952-040002, R01 HL075234-04, U01 HL066952, P01 HL067839-020004, P50 HL084936, R01 HL058707-04, U01 HL066952-030002, P50 HL084936-010003, R21 HL083222-02, P50 HL084936-030003, P01 HL067839, R01 HL075234-03, U01 HL066952-020002, R01 HL061849-02, R01 HL075234-01, R01 HL119872, P01 HL059312-080006, RC2 HL101846, R01 HL058707-03, P01 HL059312-060006, R01 HL097797-02, R01 HL061849-03S1, R01 HL097797, R01 HL097797-01, P50 HL084936-020003, P01 HL059312, R01 HL061849-03, R01 HL061849, P01 HL059312-100006, R01 HL097797-03, R01 HL075234-02, R01 HL061849-05, P01 HL067839-050004, R01 HL061849-04, P01 HL067839-030004, P01 HL059312-070006, P01 HL059312-090006, P50 HL084936-040003, P01 HL067839-010004] Funding Source: Medline; NIAID NIH HHS [RC1 AI080309, RC1 AI080309-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK095039] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAI H, 2009, J CELL BIOCH    1130, DOI DOI 10.1002/JCB.22410; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gehling UM, 2000, BLOOD, V95, P3106; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nourse MB, 2010, ARTERIOSCL THROM VAS, V30, P80, DOI 10.1161/ATVBAHA.109.194233; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Rafii S, 2008, SCIENCE, V319, P163, DOI 10.1126/science.1153615; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	25	223	250	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					161	U15		10.1038/nbt.1605	http://dx.doi.org/10.1038/nbt.1605			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20081865	Green Accepted			2022-12-25	WOS:000274317200025
J	McCarroll, SA; Bradner, JE; Turpeinen, H; Volin, L; Martin, PJ; Chilewski, SD; Antin, JH; Lee, SJ; Ruutu, T; Storer, B; Warren, EH; Zhang, B; Zhao, LP; Ginsburg, D; Soiffer, RJ; Partanen, J; Hansen, JA; Ritz, J; Palotie, A; Altshuler, D				McCarroll, Steven A.; Bradner, James E.; Turpeinen, Hannu; Volin, Liisa; Martin, Paul J.; Chilewski, Shannon D.; Antin, Joseph H.; Lee, Stephanie J.; Ruutu, Tapani; Storer, Barry; Warren, Edus H.; Zhang, Bo; Zhao, Lue Ping; Ginsburg, David; Soiffer, Robert J.; Partanen, Jukka; Hansen, John A.; Ritz, Jerome; Palotie, Aarno; Altshuler, David			Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease	NATURE GENETICS			English	Article							MINOR HISTOCOMPATIBILITY ANTIGEN; H-Y; RISK-FACTOR; CELL; UGT2B17; TRANSPLANTATION; IDENTIFICATION	Transplantation and pregnancy, in which two diploid genomes reside in one body, can each lead to diseases in which immune cells from one individual target antigens encoded in the other's genome. One such disease, graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT, or bone marrow transplant), is common even after transplants between HLA-identical siblings, indicating that cryptic histocompatibility loci exist outside the HLA locus. The immune system of an individual whose genome is homozygous for a gene deletion could recognize epitopes encoded by that gene as alloantigens. Analyzing common gene deletions in three HSCT cohorts (1,345 HLA-identical sibling donor-recipient pairs), we found that risk of acute GVHD was greater (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.4-4.6) when donor and recipient were mismatched for homozygous deletion of UGT2B17, a gene expressed in GVHD-affected tissues and giving rise to multiple histocompatibility antigens. Human genome structural variation merits investigation as a potential mechanism in diseases of alloimmunity.	[McCarroll, Steven A.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [McCarroll, Steven A.; Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [McCarroll, Steven A.; Bradner, James E.; Chilewski, Shannon D.; Palotie, Aarno; Altshuler, David] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Bradner, James E.; Antin, Joseph H.; Lee, Stephanie J.; Soiffer, Robert J.; Ritz, Jerome] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Bradner, James E.; Antin, Joseph H.; Lee, Stephanie J.; Soiffer, Robert J.; Ritz, Jerome] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Turpeinen, Hannu; Partanen, Jukka] Finnish Red Cross Blood Serv, Dept Res & Dev, Helsinki, Finland; [Volin, Liisa; Ruutu, Tapani] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Martin, Paul J.; Lee, Stephanie J.; Storer, Barry; Warren, Edus H.; Zhang, Bo; Zhao, Lue Ping; Hansen, John A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Martin, Paul J.; Warren, Edus H.; Hansen, John A.] Univ Washington, Dept Med, Seattle, WA USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Palotie, Aarno] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Helsinki; Helsinki University Central Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Helsinki; Wellcome Trust Sanger Institute	McCarroll, SA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	mccarroll@genetics.med.harvard.edu	Pillay, Nischalan/F-9536-2012; Altshuler, David M/A-4476-2009; Partanen, Jukka/B-7207-2014	Altshuler, David M/0000-0002-7250-4107; Partanen, Jukka/0000-0001-6681-4734; McCarroll, Steven/0000-0002-6954-8184; Palotie, Aarno/0000-0002-2527-5874; Volin, Liisa/0000-0002-9731-8335; Warren, Edus/0000-0002-9570-2755	Broad Institute of MIT and Harvard; Academy of Finland; Helsinki University Central Hospital Research Fund; Fred Hutchinson Cancer Research Center; Lilly Life Sciences Research fellowship; S. Juselius Foundation; Center of Excellence Program of the Finnish Academy; National Institutes of Health [HA070149, AI29530, AI33484, CA18029, HL087690]; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087690, P01HL070149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484, P01AI029530, U19AI029530] Funding Source: NIH RePORTER	Broad Institute of MIT and Harvard; Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Fund; Fred Hutchinson Cancer Research Center; Lilly Life Sciences Research fellowship; S. Juselius Foundation; Center of Excellence Program of the Finnish Academy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank the patients, donors and clinical care teams at Helsinki University Central Hospital, the Dana-Farber Cancer Institute and the Fred Hutchinson Cancer Research Center. We also wish to thank D. Sese and colleagues at the Brigham and Women's Hospital Tissue Typing Laboratory; the Ted and Eileen Pasquarello Tissue Bank; Q. Yang and colleagues at the Quality Assurance Office for Clinical Trials at Dana-Farber Cancer Institute; E. Lander, Y. Ofran, J. Chien and M. Daly for helpful conversations on the project and data; and B. Blazar, C. KeeverTaylor and D. Senitzer for providing patient samples for the Nichols et al. cohort further studied here. This work was supported by the Broad Institute of MIT and Harvard (D. A., S. A. M.), the Academy of Finland (L. V., H. T., J. P.), the Helsinki University Central Hospital Research Fund (L. V.), the Fred Hutchinson Cancer Research Center, a Lilly Life Sciences Research fellowship (S. A. M.), the S. Juselius Foundation (J. P.), the Center of Excellence Program of the Finnish Academy (A. P.) and the National Institutes of Health (HA070149 to J. H. A.; AI29530 to J. R.; AI33484, CA18029 and HL087690 to J. A. H.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; COLIN Y, 1991, BLOOD, V78, P2747; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutler C, 2006, BLOOD, V108, P756, DOI 10.1182/blood-2006-01-0233; GALE RP, 1984, LANCET, V2, P28, DOI 10.1016/S0140-6736(84)92009-9; GALE RP, 1994, ANN INTERN MED, V120, P646, DOI 10.7326/0003-4819-120-8-199404150-00004; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivanov R, 2005, CLIN CANCER RES, V11, P1694, DOI 10.1158/1078-0432.CCR-04-1772; Kamei M, 2009, BLOOD, V113, P5041, DOI 10.1182/blood-2008-07-171678; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P320, DOI 10.1016/j.bbmt.2003.12.304; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Miklos DB, 2004, BLOOD, V103, P353, DOI 10.1182/blood-2003-03-0984; Murata M, 2003, J EXP MED, V197, P1279, DOI 10.1084/jem.20030044; Nichols WC, 1996, BLOOD, V88, P4429, DOI 10.1182/blood.V88.12.4429.bloodjournal88124429; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Schulze JJ, 2008, J CLIN ENDOCR METAB, V93, P2500, DOI 10.1210/jc.2008-0218; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Terakura S, 2005, BRIT J HAEMATOL, V129, P221, DOI 10.1111/j.1365-2141.2005.05427.x; Terakura S, 2007, TRANSPLANTATION, V83, P1242, DOI 10.1097/01.tp.0000259931.72622.d1; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Warren EH, 2000, J IMMUNOL, V164, P2807, DOI 10.4049/jimmunol.164.5.2807; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zorn E, 2004, J EXP MED, V199, P1133, DOI 10.1084/jem.20031560	32	72	74	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1341	U112		10.1038/ng.490	http://dx.doi.org/10.1038/ng.490			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19935662	Green Accepted			2022-12-25	WOS:000272144900018
J	von Kriegsheim, A; Baiocchi, D; Birtwistle, M; Sumpton, D; Bienvenut, W; Morrice, N; Yamada, K; Lamond, A; Kalna, G; Orton, R; Gilbert, D; Kolch, W				von Kriegsheim, Alex; Baiocchi, Daniela; Birtwistle, Marc; Sumpton, David; Bienvenut, Willy; Morrice, Nicholas; Yamada, Kayo; Lamond, Angus; Kalna, Gabriella; Orton, Richard; Gilbert, David; Kolch, Walter			Cell fate decisions are specified by the dynamic ERK interactome	NATURE CELL BIOLOGY			English	Article							SIGNAL-REGULATED KINASE; FACIO-CUTANEOUS SYNDROME; NERVE GROWTH-FACTOR; MAP KINASE; PROTEIN-KINASE; ACTIVATION; TRANSCRIPTION; MUTATIONS; PEA-15; TRPS1	Extracellular signal-regulated kinase (ERK) controls fundamental cellular functions, including cell fate decisions(1,2). In PC12, cells shifting ERK activation from transient to sustained induces neuronal differentiation(3). As ERK associates with both regulators and effectors(4), we hypothesized that the mechanisms underlying the switch could be revealed by assessing the dynamic changes in ERK-interacting proteins that specifically occur under differentiation conditions. Using quantitative proteomics, we identified 284 ERK-interacting proteins. Upon induction of differentiation, 60 proteins changed their binding to ERK, including many proteins that were not known to participate in differentiation. We functionally characterized a subset, showing that they regulate the pathway at several levels and by different mechanisms, including signal duration, ERK localization, feedback, crosstalk with the Akt pathway and differential interaction and phosphorylation of transcription factors. Integrating these data with a mathematical model confirmed that ERK dynamics and differentiation are regulated by distributed control mechanisms rather than by a single master switch.	[von Kriegsheim, Alex; Baiocchi, Daniela; Birtwistle, Marc; Sumpton, David; Bienvenut, Willy; Kalna, Gabriella; Kolch, Walter] Beatson Inst Canc Res, Signalling & Prote Lab, Glasgow G61 1BD, Lanark, Scotland; [Morrice, Nicholas] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Yamada, Kayo; Lamond, Angus] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Gilbert, David] Univ Glasgow, Dept Comp Sci, Bioinformat Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Orton, Richard; Kolch, Walter] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	Beatson Institute; University of Dundee; University of Dundee; University of Glasgow; University of Glasgow	Kolch, W (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	walter.kolch@ucd.ie	von Kriegsheim, Alex/C-2371-2016; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Gilbert, David/G-1432-2011; RASOR, Scotland/A-3274-2011	von Kriegsheim, Alex/0000-0002-4952-8573; Lamond, Angus/0000-0001-6204-6045; Sumpton, David/0000-0002-9004-4079; Birtwistle, Marc/0000-0003-0415-6523; Birtwistle, Marc/0000-0002-0341-0705; Kolch, Walter/0000-0001-5777-5016; Bienvenut, Willy/0000-0003-4192-3920	European Union [LSHG-CT-2003-505520]; RASOR; BBSRC; EPSRC; Cancer Research UK; MRC [G0301131, G0801738] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C511613/1, BB/C511572/1] Funding Source: researchfish; Medical Research Council [G0301131, G0801738] Funding Source: researchfish	European Union(European Commission); RASOR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Mortensen for help with MSQuant, A. Pitt and C. Ward for help with MS, O. Rath for the design of primers and G. Cesareni and A. Chatraryamontri for help with submission of the interaction data to the IMEx consortium through MINT. The work was supported by the European Union Interaction Proteome project (LSHG-CT-2003-505520), the RASOR project (BBSRC and EPSRC) and Cancer Research UK.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Brewer Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000093; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; George AJT, 2005, TRENDS IMMUNOL, V26, P653, DOI 10.1016/j.it.2005.09.011; Harrisingh MC, 2004, CELL CYCLE, V3, P1255, DOI 10.4161/cc.3.10.1182; Kaiser FJ, 2004, EUR J HUM GENET, V12, P121, DOI 10.1038/sj.ejhg.5201094; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kobayashi H, 2002, AM J MED GENET, V107, P26, DOI 10.1002/ajmg.10081; Krueger J, 2005, MOL BIOL CELL, V16, P3552, DOI 10.1091/mbc.E04-11-1007; Le Gallic L, 2004, MOL CELL BIOL, V24, P1206, DOI 10.1128/MCB.24.3.1206-1218.2004; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Volmat V, 2001, J CELL SCI, V114, P3433; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	32	212	214	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1458	U172		10.1038/ncb1994	http://dx.doi.org/10.1038/ncb1994			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935650	Green Accepted			2022-12-25	WOS:000272251300013
J	Ernst, T; Chase, AJ; Score, J; Hidalgo-Curtis, CE; Bryant, C; Jones, AV; Waghorn, K; Zoi, K; Ross, FM; Reiter, A; Hochhaus, A; Drexler, HG; Duncombe, A; Cervantes, F; Oscier, D; Boultwood, J; Grand, FH; Cross, NCP				Ernst, Thomas; Chase, Andrew J.; Score, Joannah; Hidalgo-Curtis, Claire E.; Bryant, Catherine; Jones, Amy V.; Waghorn, Katherine; Zoi, Katerina; Ross, Fiona M.; Reiter, Andreas; Hochhaus, Andreas; Drexler, Hans G.; Duncombe, Andrew; Cervantes, Francisco; Oscier, David; Boultwood, Jacqueline; Grand, Francis H.; Cross, Nicholas C. P.			Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders	NATURE GENETICS			English	Article							ACQUIRED UNIPARENTAL DISOMY; SOMATIC MUTATIONS; METHYLATION; CHROMATIN; CANCER; PROTEINS; ENHANCER; TET2; MDS; PCR	Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disorders revealed 49 monoallelic or biallelic EZH2 mutations in 42 individuals; the mutations were found most commonly in those with myelodysplastic/myeloproliferative neoplasms (27 out of 219 individuals, or 12%) and in those with myelofibrosis (4 out of 30 individuals, or 13%). EZH2 encodes the catalytic subunit of the polycomb repressive complex 2 (PRC2), a highly conserved histone H3 lysine 27 (H3K27) methyltransferase that influences stem cell renewal by epigenetic repression of genes involved in cell fate decisions. EZH2 has oncogenic activity, and its overexpression has previously been causally linked to differentiation blocks in epithelial tumors. Notably, the mutations we identified resulted in premature chain termination or direct abrogation of histone methyltransferase activity, suggesting that EZH2 acts as a tumor suppressor for myeloid malignancies.	[Ernst, Thomas; Chase, Andrew J.; Score, Joannah; Hidalgo-Curtis, Claire E.; Bryant, Catherine; Jones, Amy V.; Waghorn, Katherine; Ross, Fiona M.; Grand, Francis H.; Cross, Nicholas C. P.] Univ Southampton, Sch Med, Div Human Genet, Southampton SO9 5NH, Hants, England; [Ernst, Thomas; Chase, Andrew J.; Score, Joannah; Hidalgo-Curtis, Claire E.; Bryant, Catherine; Jones, Amy V.; Waghorn, Katherine; Ross, Fiona M.; Grand, Francis H.; Cross, Nicholas C. P.] Wessex Reg Genet Lab, Salisbury, Wilts, England; [Ernst, Thomas; Duncombe, Andrew] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany; [Zoi, Katerina] Acad Athens, Biomed Res Fdn, Haematol Res Lab, Athens, Greece; [Reiter, Andreas] Heidelberg Univ, Med Fak Klin Med Mannheim, Med Univ Klin 3, D-6800 Mannheim, Germany; [Drexler, Hans G.] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany; [Duncombe, Andrew] Southampton Gen Hosp, Dept Haematol, Southampton SO9 4XY, Hants, England; [Cervantes, Francisco] Univ Barcelona, Dept Hematol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Oscier, David] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Boultwood, Jacqueline] John Radcliffe Hosp, Leukaemia & Lymphoma Res Mol Haematol Unit, Oxford OX3 9DU, England	University of Southampton; Friedrich Schiller University of Jena; Academy of Athens; Ruprecht Karls University Heidelberg; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Southampton; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford	Cross, NCP (corresponding author), Univ Southampton, Sch Med, Div Human Genet, Southampton SO9 5NH, Hants, England.	ncpc@soton.ac.uk	Cross, Nicholas/B-4817-2009	Cross, Nicholas/0000-0001-5481-2555; Chase, Andrew/0000-0001-6617-9953; Boultwood, Jacqueline/0000-0002-4330-2928; Jones, Amy Victoria/0000-0003-3467-6765; Hochhaus, Andreas/0000-0003-0626-0834	Leukemia Research specialist programme [0282]; Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe e.V., Germany); German Jose Carreras Foundation [H 03/01]	Leukemia Research specialist programme; Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe e.V., Germany)(Deutsche Krebshilfe); German Jose Carreras Foundation	This work was supported by a Leukemia Research specialist programme grant number 0282. T. E. was supported by the Dr. Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe e.V., Germany). A. H. was supported by the German Jose Carreras Foundation (H 03/01). We thank D. Reinberg and S. Orkin for providing reagents for the histone methyltransferase assays.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CROSS NCP, 1994, LEUKEMIA, V8, P186; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; Heinrichs S, 2009, LEUKEMIA, V23, P1605, DOI 10.1038/leu.2009.82; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mitelman F, 2009, CANC CYTOGENETICS; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; MOUTHON MA, 1994, BLOOD, V84, P1085; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; NAKAGAWA T, 1995, LEUKEMIA LYMPHOMA, V17, P335, DOI 10.3109/10428199509056841; Raghavan M, 2010, ADV ENZYME REGUL, V50, P96, DOI 10.1016/j.advenzreg.2009.10.030; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; White HE, 2007, CLIN CHEM, V53, P1960, DOI 10.1373/clinchem.2007.093351; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	39	863	909	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					722	U109		10.1038/ng.621	http://dx.doi.org/10.1038/ng.621			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601953				2022-12-25	WOS:000280524000020
J	Ptacin, JL; Lee, SF; Garner, EC; Toro, E; Eckart, M; Comolli, LR; Moerner, W; Shapiro, L				Ptacin, Jerod L.; Lee, Steven F.; Garner, Ethan C.; Toro, Esteban; Eckart, Michael; Comolli, Luis R.; Moerner, We.; Shapiro, Lucy			A spindle-like apparatus guides bacterial chromosome segregation	NATURE CELL BIOLOGY			English	Article							DNA SEGREGATION; CAULOBACTER-CRESCENTUS; BACILLUS-SUBTILIS; PARTITIONING PROTEIN; PLASMID SEGREGATION; F-PLASMID; BINDING; CELL; SOPA; PARB	Until recently, a dedicated mitotic apparatus that segregates newly replicated chromosomes into daughter cells was believed to be unique to eukaryotic cells. Here we demonstrate that the bacterium Caulobacter crescentus segregates its chromosome using a partitioning (Par) apparatus that has surprising similarities to eukaryotic spindles. We show that the C. crescentus ATPase ParA forms linear polymers in vitro and assembles into a narrow linear structure in vivo. The centromere-binding protein ParB binds to and destabilizes ParA structures in vitro. We propose that this ParB-stimulated ParA depolymerization activity moves the centromere to the opposite cell pole through a burnt bridge Brownian ratchet mechanism. Finally, we identify the pole-specific TipN protein(1,2) as a new component of the Par system that is required to maintain the directionality of DNA transfer towards the new cell pole. Our results elucidate a bacterial chromosome segregation mechanism that features basic operating principles similar to eukaryotic mitotic machines, including a multivalent protein complex at the centromere that stimulates the dynamic disassembly of polymers to move chromosomes into daughter compartments.	[Ptacin, Jerod L.; Toro, Esteban; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Lee, Steven F.; Moerner, We.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Garner, Ethan C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Eckart, Michael] Stanford Univ, Stanford Prot & Nucle Acid Facil, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Comolli, Luis R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Garner, Ethan/J-4025-2014; Moerner, William E/C-3260-2008; Comolli, Luis Raul/C-5907-2017	Garner, Ethan/0000-0003-0141-3555; Moerner, William E/0000-0002-2830-209X; Comolli, Luis Raul/0000-0002-9313-6550	National Institutes of Health [R01 GM51426 R24, GM073011-04d]; NIH/NIGMS [F32GM088966-1, R01GM086196-2]; Smith Stanford Graduate Fellowship; Helen Hay Whitney postdoctoral fellowship; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM073011, F32GM088966, R01GM051426, R01GM086196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Smith Stanford Graduate Fellowship; Helen Hay Whitney postdoctoral fellowship; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jimmy Blair for assistance with modelling of ParA mutants, and critical reading of the manuscript; and Grant Bowman, Erin Goley and Julie Biteen for technical advice. We thank Jian Zhu and Thomas Earnest for providing purified 6His-ParB. This work is supported by National Institutes of Health grants R01 GM51426 R24 and GM073011-04d to L.S., NIH/NIGMS fellowship F32GM088966-1 to LP., NIH/NIGMS award R01GM086196-2 to W.E.M., the Smith Stanford Graduate Fellowship to E.T., and a Helen Hay Whitney postdoctoral fellowship to E.G. This work was also supported by the Director, Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Batt SM, 2009, J MOL BIOL, V385, P1361, DOI 10.1016/j.jmb.2008.12.016; BITEEN JS, 2008, NATURE METHODS; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; BOWMAN GR, MOL MICROBIOL, V76, P173; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; Ebersbach G, 2004, MOL MICROBIOL, V52, P385, DOI 10.1111/j.1365-2958.2004.04002.x; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Fiebig A, 2006, MOL MICROBIOL, V60, P1164, DOI 10.1111/j.1365-2958.2006.05175.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101	41	249	253	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					791	U46		10.1038/ncb2083	http://dx.doi.org/10.1038/ncb2083			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20657594	Green Accepted			2022-12-25	WOS:000280561600011
J	Xu, GQ; Paige, JS; Jaffrey, SR				Xu, Guoqiang; Paige, Jeremy S.; Jaffrey, Samie R.			Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling	NATURE BIOTECHNOLOGY			English	Article							CELL NUCLEAR ANTIGEN; MASS-SPECTROMETRY; PROTEIN; ACETYLATION; PHOSPHORYLATION; PREDICTION; IDENTIFICATION; PURIFICATION; SITES; RECOGNITION	Protein ubiquitination is a post-translational modification (PTM) that regulates various aspects of protein function by different mechanisms. Characterization of ubiquitination has lagged behind that of smaller PTMs, such as phosphorylation, largely because of the difficulty of isolating and identifying peptides derived from the ubiquitinated portion of proteins. To address this issue, we generated a monoclonal antibody that enriches for peptides containing lysine residues modified by diglycine, an adduct left at sites of ubiquitination after trypsin digestion. We use mass spectrometry to identify 374 diglycine-modified lysines on 236 ubiquitinated proteins from HEK293 cells, including 80 proteins containing multiple sites of ubiquitination. Seventy-two percent of these proteins and 92% of the ubiquitination sites do not appear to have been reported previously. Ubiquitin remnant profiling of the multi-ubiquitinated proteins proliferating cell nuclear antigen (PCNA) and tubulin alpha-1A reveals differential regulation of ubiquitination at specific sites by microtubule inhibitors, demonstrating the effectiveness of our method to characterize the dynamics of lysine ubiquitination.	[Xu, Guoqiang; Paige, Jeremy S.; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA	Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA.	srj2003@med.cornell.edu		Xu, Guoqiang/0000-0002-4753-4769; Jaffrey, Samie/0000-0003-3615-6958	US National Institutes of Health (NIH) [RR19355, RR22615]; Weill Cornell, NIH [MH086128]; National Cancer Institute [T32CA062948]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022615, S10RR019355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086128] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Neubert and G. Zhang (New York University) for useful suggestions, P. Zhou (Weill Cornell Medical College, WCMC) for the His<INF>6</INF>-ubiquitin plasmid, U. Hengst, A. Deglincerti, R. Almeida and B. Derakhshan for the assistance during initial cell culturing, S. Gross and Y. Ma (WCMC Mass Spectrometry Core Facility) for helpful discussion in MS/MS analysis, F. Campagne, L. Skrabanek, J. Sun (WCMC Institute for Computational Biomedicine) for instructions and assistance in bioinformatic analysis. The mass spectrometry work was performed at the WCMC Mass Spectrometry Core Facility using instrumentation supported by US National Institutes of Health (NIH) RR19355 and RR22615. This work was supported by grants from Weill Cornell, NIH (MH086128) (S. R. J.), and a pharmacology cancer training grant from the National Cancer Institute (T32CA062948) (G. X. and J.S.P.).	Ahmad S, 2002, BIOINFORMATICS, V18, P819, DOI 10.1093/bioinformatics/18.6.819; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; BEERS EP, 1993, J BIOL CHEM, V268, P21645; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DERRIEN D, 1989, GLYCOCONJUGATE J, V6, P241, DOI 10.1007/BF01050652; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ERICSSON C, 1986, EXP CELL RES, V167, P127, DOI 10.1016/0014-4827(86)90210-7; ETLINGER JD, 1993, ENZYME PROTEIN, V47, P325, DOI 10.1159/000468690; Galluzzi L, 2001, FEBS LETT, V489, P254, DOI 10.1016/S0014-5793(00)02333-4; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Prosperi E, 1997, Prog Cell Cycle Res, V3, P193; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; ROSNER J, 1979, TEST AUDITORY ANAL T; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Srikumar T, 2010, PROTEOMICS, V10, P337, DOI 10.1002/pmic.200900627; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tomlinson E, 2007, PROTEOMICS, V7, P1016, DOI 10.1002/pmic.200601008; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Wisniewski JR, 2008, PROTEINS, V73, P710, DOI 10.1002/prot.22104; Xu GQ, 2009, P NATL ACAD SCI USA, V106, P19310, DOI 10.1073/pnas.0908958106; Xu P, 2006, BBA-PROTEINS PROTEOM, V1764, P1940, DOI 10.1016/j.bbapap.2006.09.004; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	49	376	380	9	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					868	U154		10.1038/nbt.1654	http://dx.doi.org/10.1038/nbt.1654			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20639865	Green Accepted			2022-12-25	WOS:000280757500028
J	Aghajan, M; Jonai, N; Flick, K; Fu, F; Luo, ML; Cai, XL; Ouni, I; Pierce, N; Tang, XB; Lomenick, B; Damoiseaux, R; Hao, R; del Moral, PM; Verma, R; Li, Y; Li, C; Houk, KN; Jung, ME; Zheng, N; Huang, L; Deshaies, RJ; Kaiser, P; Huang, J				Aghajan, Mariam; Jonai, Nao; Flick, Karin; Fu, Fei; Luo, Manlin; Cai, Xiaolu; Ouni, Ikram; Pierce, Nathan; Tang, Xiaobo; Lomenick, Brett; Damoiseaux, Robert; Hao, Rui; del Moral, Pierre M.; Verma, Rati; Li, Ying; Li, Cheng; Houk, Kendall N.; Jung, Michael E.; Zheng, Ning; Huang, Lan; Deshaies, Raymond J.; Kaiser, Peter; Huang, Jing			Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase	NATURE BIOTECHNOLOGY			English	Article							QUANTITATIVE-ANALYSIS; SIGNALING NETWORK; MTOR; TARGET; METHIONINE; SCFMET30; COMPLEX; ARREST; GROWTH; CELLS	The target of rapamycin (TOR) plays a central role in eukaryotic cell growth control(1). With prevalent hyperactivation of the mammalian TOR (mTOR) pathway in human cancers(2), strategies to enhance TOR pathway inhibition are needed. We used a yeast-based screen to identify small-molecule enhancers of rapamycin (SMERs) and discovered an inhibitor (SMER3) of the Skp1-Cullin-F-box (SCF)(Met30) ubiquitin ligase, a member of the SCF E3-ligase family, which regulates diverse cellular processes including transcription, cell-cycle control and immune response(3). We show here that SMER3 inhibits SCFMet30 in vivo and in vitro, but not the closely related SCFCdc4. Furthermore, we demonstrate that SMER3 diminishes binding of the F-box subunit Met30 to the SCF core complex in vivo and show evidence for SMER3 directly binding to Met30. Our results show that there is no fundamental barrier to obtaining specific inhibitors to modulate function of individual SCF complexes.	[Aghajan, Mariam; Jonai, Nao; Fu, Fei; Lomenick, Brett; Hao, Rui; Huang, Jing] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Aghajan, Mariam; Jonai, Nao; Fu, Fei; Lomenick, Brett; Hao, Rui; Huang, Jing] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Flick, Karin; Ouni, Ikram; Kaiser, Peter] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92717 USA; [Luo, Manlin] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Cai, Xiaolu; Li, Ying; Houk, Kendall N.; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Pierce, Nathan; Verma, Rati; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; [Tang, Xiaobo; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [del Moral, Pierre M.] Roche Diagnost Corp, Roche Appl Sci, Indianapolis, IN USA; [Li, Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Huang, Lan] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; California Institute of Technology; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Irvine; University of California System; University of California Irvine	Huang, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	pkaiser@uci.edu; jinghuang@mednet.ucla.edu	Lomenick, Brett/AAR-3294-2020; Damoiseaux, Robert/F-1086-2011; luo, man/HGC-7868-2022; Luo, Man/GWQ-4789-2022; Damoiseaux, Robert/S-6712-2019; Deshaies, Raymond/B-8354-2014; Hao, Rui/I-5162-2013; Huang, Lan/C-3618-2011; hao, rui/E-4965-2011; Lomenick, Brett/E-7291-2010	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; Deshaies, Raymond/0000-0002-3671-9354; Lomenick, Brett/0000-0002-5023-9998	American Cancer Society; U.S. National Institutes of Health; NIH UCLA Chemistry-Biology Interface Predoctoral Training Program; Roche Diagnostics Corporation; NATIONAL CANCER INSTITUTE [R01CA124974, T32CA113265, R01CA107134, R21CA149774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997, R01GM066164, R01GM074830] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH UCLA Chemistry-Biology Interface Predoctoral Training Program; Roche Diagnostics Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for grant support from the American Cancer Society and the U.S. National Institutes of Health and for traineeship support of M. A. and B. L. by the NIH UCLA Chemistry-Biology Interface Predoctoral Training Program. N.Z. and R.J.D. are investigators of the Howard Hughes Medical Institute. We thank D. Skowyra (Saint Louis University) and M. Tyers (University of Edinburgh, UK) for their generous gifts of bacculo virus constructs and anti-Met4 antibody, respectively. We also thank J. Salcedo (Roche Diagnostics Corporation) for support toward differential scanning fluorimetry experiments.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Booher Keith R., 2008, Biotechnology Journal, V3, P524, DOI 10.1002/biot.200800012; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Duncan MC, 2007, P NATL ACAD SCI USA, V104, P6235, DOI 10.1073/pnas.0607773104; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUO HY, 1993, CANCER RES, V53, P5676; HALPERN BC, 1974, P NATL ACAD SCI USA, V71, P1133, DOI 10.1073/pnas.71.4.1133; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sawyers CL, 2002, J CLIN ONCOL, V20, P3568, DOI 10.1200/JCO.2002.20.17.3568; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	40	107	113	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					738	U1750		10.1038/nbt.1645	http://dx.doi.org/10.1038/nbt.1645			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20581845	Green Accepted, Green Submitted			2022-12-25	WOS:000279723900032
J	Bei, JX; Li, Y; Jia, WH; Feng, BJ; Zhou, GQ; Chen, LZ; Feng, QS; Low, HQ; Zhang, HX; He, FC; Tai, ES; Kang, TB; Liu, ET; Liu, JJ; Zeng, YX				Bei, Jin-Xin; Li, Yi; Jia, Wei-Hua; Feng, Bing-Jian; Zhou, Gangqiao; Chen, Li-Zhen; Feng, Qi-Sheng; Low, Hui-Qi; Zhang, Hongxing; He, Fuchu; Tai, E. Shyong; Kang, Tiebang; Liu, Edison T.; Liu, Jianjun; Zeng, Yi-Xin			A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; 2ND PRIMARY CANCERS; N-TERMINAL KINASE; HAN CHINESE; LINKAGE; HLA; MEMBER; VARIANTS; SCAN; RISK	To identify genetic susceptibility loci for nasopharyngeal carcinoma (NPC), a genome-wide association study was performed using 464,328 autosomal SNPs in 1,583 NPC affected individuals (cases) and 1,894 controls of southern Chinese descent. The top 49 SNPs from the genome-wide association study were genotyped in 3,507 cases and 3,063 controls of southern Chinese descent from Guangdong and Guangxi. The seven supportive SNPs were further confirmed by transmission disequilibrium test analysis in 279 trios from Guangdong. We identified three new susceptibility loci, TNFRSF19 on 13q12 (rs9510787, P-combined = 1.53 x 10(-9), odds ratio (OR) = 1.20), MDS1-EVI1 on 3q26 (rs6774494, P-combined = 1.34 x 10(-8), OR = 0.84) and the CDKN2A-CDKN2B gene cluster on 9p21 (rs1412829, P-combined = 4.84 x 10(-7), OR = 0.78). Furthermore, we confirmed the role of HLA by revealing independent associations at rs2860580 (P-combined = 4.88 x 10(-67), OR = 0.58), rs2894207 (P-combined = 3.42 x 10(-33), OR = 0.61) and rs28421666 (P-combined = 2.49 x 10(-18), OR = 0.67). Our findings provide new insights into the pathogenesis of NPC by highlighting the involvement of pathways related to TNFRSF19 and MDS1-EVI1 in addition to HLA molecules.	[Bei, Jin-Xin; Jia, Wei-Hua; Feng, Bing-Jian; Chen, Li-Zhen; Feng, Qi-Sheng; Kang, Tiebang; Liu, Jianjun; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-Hua; Feng, Bing-Jian; Chen, Li-Zhen; Feng, Qi-Sheng; Kang, Tiebang; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yi; Low, Hui-Qi; Liu, Edison T.; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Feng, Bing-Jian] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Zhou, Gangqiao; Zhang, Hongxing; He, Fuchu] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore	Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Utah System of Higher Education; University of Utah; Academy of Military Medical Sciences - China; National University of Singapore; National University of Singapore	Zeng, YX (corresponding author), State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China.	liuj3@gis.a-star.edu.sg; zengyx@sysucc.org.cn	Bei, Jin-Xin/AAO-1259-2020; Liu, Edison/C-4141-2008; Tai, E Shyong/J-9831-2013; Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019; He, Fuchu/0000-0002-8571-2351; Zhou, Gangqiao/0000-0002-4895-5063; Tai, E Shyong/0000-0003-2929-8966				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hu LF, 2008, EUR J HUM GENET, V16, P343, DOI 10.1038/sj.ejhg.5201951; Hu SM, 1999, GENOMICS, V62, P103, DOI 10.1006/geno.1999.5979; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu CC, 2005, INT J CANCER, V115, P742, DOI 10.1002/ijc.20946; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; Mensah FK, 2007, GENET EPIDEMIOL, V31, P348, DOI 10.1002/gepi.20215; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Morikawa Y, 2008, ANN NY ACAD SCI, V1126, pA1, DOI 10.1196/annals.1366.036; Ng CC, 2009, J HUM GENET, V54, P392, DOI 10.1038/jhg.2009.49; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Scelo G, 2007, CANCER CAUSE CONTROL, V18, P269, DOI 10.1007/s10552-006-0101-z; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Xu J, 1999, INT J CANCER, V84, P396, DOI 10.1002/(SICI)1097-0215(19990820)84:4&lt;396::AID-IJC11&gt;3.0.CO;2-#; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	44	293	313	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					599	U173		10.1038/ng.601	http://dx.doi.org/10.1038/ng.601			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20512145				2022-12-25	WOS:000279242400012
J	Connelly, JT; Gautrot, JE; Trappmann, B; Tan, DWM; Donati, G; Huck, WTS; Watt, FM				Connelly, John T.; Gautrot, Julien E.; Trappmann, Britta; Tan, David Wei-Min; Donati, Giacomo; Huck, Wilhelm T. S.; Watt, Fiona M.			Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions	NATURE CELL BIOLOGY			English	Article							TRANSIT-AMPLIFYING CELLS; TERMINAL DIFFERENTIATION; POLYMER BRUSHES; SKIN-DISEASE; EXPRESSION; DYNAMICS; FOS; SRF; KERATINOCYTES; TRANSCRIPTION	Epidermal homeostasis depends on a balance between stem cell renewal and differentiation and is regulated by extrinsic signals from the extracellular matrix (ECM)(1,2). A powerful approach to analysing the pathways involved is to engineer single-cell microenvironments in which individual variables are precisely and quantitatively controlled(3-5). Here, we employ micropatterned surfaces to identify the signalling pathways by which restricted ECM contact triggers human epidermal stem cells to initiate terminal differentiation. On small (20 mu m diameter) circular islands, keratinocytes remained rounded, and differentiated at higher frequency than cells that could spread on large (50 mu m diameter) islands. Differentiation did not depend on ECM composition or density. Rather, the actin cytoskeleton mediated shape-induced differentiation by regulating serum response factor (SRF) transcriptional activity. Knockdown of SRF or its co-factor MAL inhibited differentiation, whereas overexpression of MAL stimulated SRF activity and involucrin expression. SRF target genes FOS and JUNB were also required for differentiation: c-Fos mediated serum responsiveness, whereas JunB was regulated by actin and MAL. Our findings demonstrate how biophysical cues are transduced into transcriptional responses that determine epidermal cell fate.	[Connelly, John T.; Tan, David Wei-Min; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Gautrot, Julien E.; Trappmann, Britta; Huck, Wilhelm T. S.] Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Cambridge CB2 1EW, England; [Donati, Giacomo; Watt, Fiona M.] CRUK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Huck, Wilhelm T. S.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	University of Cambridge; University of Cambridge; CRUK Cambridge Institute; Radboud University Nijmegen	Watt, FM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	Fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022; Huck, Wilhelm T.S./B-1471-2012; Trappmann, Britta/AAQ-8712-2020; Gautrot, Julien/S-7920-2016	Watt, Fiona/0000-0001-9151-5154; Gautrot, Julien/0000-0002-1614-2578; Trappmann, Britta/0000-0002-6260-4075; DONATI, Giacomo/0000-0002-0370-8288; Connelly, John/0000-0002-5955-8848	Wellcome Trust; Medical Research Council (MRC); Cancer research UK (CRUK); TUMIC European Union FP7 network; NIH (National Institutes of Health)	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer research UK (CRUK)(Cancer Research UK); TUMIC European Union FP7 network; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Wellcome Trust, the Medical Research Council (MRC), Cancer research UK (CRUK) and the TUMIC European Union FP7 network. J.T.C. is the recipient of an NIH (National Institutes of Health) postdoctoral fellowship. We thank R. Treisman and G. Posern for providing reagents and the core facilities of the Wellcome Trust Centre for Stem Cell Research for technical assistance.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; DOVER R, 1987, J INVEST DERMATOL, V89, P349, DOI 10.1111/1523-1747.ep12471751; GANDARILLAS A, 1995, ONCOGENE, V11, P1403; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Honma M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/mbc.E05-12-1173; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Masutani H, 1997, ONCOGENE, V15, P1661, DOI 10.1038/sj.onc.1201328; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Watt FM, 2010, PHILOS T R SOC B, V365, P155, DOI 10.1098/rstb.2009.0149; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhou F, 2006, J AM CHEM SOC, V128, P16253, DOI 10.1021/ja0654377; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	39	335	342	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					711	U177		10.1038/ncb2074	http://dx.doi.org/10.1038/ncb2074			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20581838	Green Published, Green Submitted			2022-12-25	WOS:000279374400015
J	Jun, JI; Lau, LF				Jun, Joon-Il; Lau, Lester F.			The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing	NATURE CELL BIOLOGY			English	Article							HUMAN SKIN FIBROBLASTS; BENIGN PROSTATIC HYPERPLASIA; ONCOGENE-INDUCED SENESCENCE; IMMEDIATE-EARLY GENE; CELLULAR SENESCENCE; IN-VIVO; INTEGRIN ALPHA(6)BETA(1); REGULATES SENESCENCE; MOLECULAR-MECHANISMS; GROWTH ARREST	Cellular senescence is a recognized mechanism of tumour suppression; however, its contribution to other pathologies is not well understood. We show that the matricellular protein CCN1 (also known as CYR61; cysteine-rich protein 61), which is dynamically expressed at sites of wound repair, can induce fibroblast senescence by binding to integrin a(6)beta(1) and the heparan sulphate proteoglycans (receptors involved in cell adhesion). CCN1 induces DNA damage response pathways and activates p53 and the RAC1-NOX1 complex, which generates reactive oxygen species (ROS). This results in the ROS-dependent activation of the p16(INK4a)/pRb pathway, leading to senescence and concomitant expression of antifibrotic genes. Senescent fibroblasts accumulate in granulation tissues of healing cutaneous wounds and express antifibrotic genes in wild-type mice. These processes are lost in knockin mice that express a senescence-defective Ccn1 mutant, resulting in exacerbated fibrosis. Topical application of CCN1 protein to wounds reverses these defects. Thus, fibroblast senescence is a CCN1-dependent wound healing response in cutaneous injury that functions to curb fibrosis during tissue repair.	[Jun, Joon-Il; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA.	LFLau@uic.edu		Lau, Lester/0000-0002-4364-2914	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. DiPietro for advice, J. Campisi and S. Lowe for reagents, S. W. Shin for assistance, and members of the laboratory for discussion. This work was supported by grants from the National Institutes of Health to L.F.L.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chiarugi Paola, 2003, Ital J Biochem, V52, P28; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mori A, 2007, CANCER INVEST, V25, P738, DOI 10.1080/02770900701512597; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Schomber T, 2004, BLOOD, V103, P4511, DOI 10.1182/blood-2003-07-2397; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wilson L, 2002, BIOTECHNIQUES, V32, P548, DOI 10.2144/02323st07; Wu WS, 2003, ONCOGENE, V22, P955, DOI 10.1038/sj.onc.1206237; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	69	579	599	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					676	U106		10.1038/ncb2070	http://dx.doi.org/10.1038/ncb2070			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526329	Green Accepted			2022-12-25	WOS:000279374400011
J	Schultz, C				Schultz, Carsten			Challenges in studying phospholipid signaling	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN DOMAINS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; ORPHAN RECEPTORS; LIVING CELLS; MEMBRANE; LIGANDS; PHOSPHOINOSITIDES; 4,5-BISPHOSPHATE; ACTIVATION; ESTERS		European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Schultz, C (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	schultz@embl.de		Schultz, Carsten/0000-0002-5824-2171				Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balla T, 2005, TRENDS ENDOCRIN MET, V16, P289, DOI 10.1016/j.tem.2005.07.006; Brown HA, 2009, NAT CHEM BIOL, V5, P602, DOI 10.1038/nchembio0909-602; Dinkel C, 2001, ANGEW CHEM INT EDIT, V40, P3004, DOI 10.1002/1521-3773(20010817)40:16<3004::AID-ANIE3004>3.0.CO;2-O; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Neef AB, 2009, ANGEW CHEM INT EDIT, V48, P1498, DOI 10.1002/anie.200805507; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Schultz C, 2003, BIOORGAN MED CHEM, V11, P885, DOI 10.1016/S0968-0896(02)00552-7; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019	26	19	19	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					473	475		10.1038/nchembio.389	http://dx.doi.org/10.1038/nchembio.389			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20559309				2022-12-25	WOS:000278878700002
J	Murray, KC; Nakae, A; Stephens, MJ; Rank, M; D'Amico, J; Harvey, PJ; Li, XL; Harris, RLW; Ballou, EW; Anelli, R; Heckman, CJ; Mashimo, T; Vavrek, R; Sanelli, L; Gorassini, MA; Bennett, DJ; Fouad, K				Murray, Katherine C.; Nakae, Aya; Stephens, Marilee J.; Rank, Michelle; D'Amico, Jessica; Harvey, Philip J.; Li, Xiaole; Harris, R. Luke W.; Ballou, Edward W.; Anelli, Roberta; Heckman, Charles J.; Mashimo, Takashi; Vavrek, Romana; Sanelli, Leo; Gorassini, Monica A.; Bennett, David J.; Fouad, Karim			Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors	NATURE MEDICINE			English	Article							PERSISTENT INWARD CURRENTS; PLATEAU POTENTIALS; POSTSYNAPTIC POTENTIALS; SIGNAL-TRANSDUCTION; CALCIUM CURRENTS; MUSCLE SPASMS; RATS; 5-HYDROXYTRYPTAMINE; SPASTICITY; TURTLE	Muscle paralysis after spinal cord injury is partly caused by a loss of brainstem-derived serotonin (5-HT), which normally maintains motoneuron excitability by regulating crucial persistent calcium currents. Here we examine how over time motoneurons compensate for lost 5-HT to regain excitability. We find that, months after a spinal transection in rats, changes in post-transcriptional editing of 5-HT2C receptor mRNA lead to increased expression of 5-HT2C receptor isoforms that are spontaneously active (constitutively active) without 5-HT. Such constitutive receptor activity restores large persistent calcium currents in motoneurons in the absence of 5-HT. We show that this helps motoneurons recover their ability to produce sustained muscle contractions and ultimately enables recovery of motor functions such as locomotion. However, without regulation from the brain, these sustained contractions can also cause debilitating muscle spasms. Accordingly, blocking constitutively active 5-HT2C receptors with SB206553 or cyproheptadine, in both rats and humans, largely eliminates these calcium currents and muscle spasms, providing a new rationale for antispastic drug therapy.	[Murray, Katherine C.; Stephens, Marilee J.; Rank, Michelle; Harvey, Philip J.; Li, Xiaole; Harris, R. Luke W.; Vavrek, Romana; Sanelli, Leo; Bennett, David J.; Fouad, Karim] Univ Alberta, Ctr Neurosci, Fac Rehabil Med, Edmonton, AB, Canada; [Nakae, Aya; Mashimo, Takashi] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Osaka, Japan; [D'Amico, Jessica; Anelli, Roberta; Gorassini, Monica A.] Univ Alberta, Fac Med, Ctr Neurosci, Edmonton, AB, Canada; [Heckman, Charles J.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA	University of Alberta; Osaka University; University of Alberta; Northwestern University	Bennett, DJ (corresponding author), Univ Alberta, Ctr Neurosci, Fac Rehabil Med, Edmonton, AB, Canada.	bennettd@ualberta.ca	Rank, Michelle/AAQ-2281-2020; RANK, MICHELLE/G-8293-2013	Rank, Michelle/0000-0002-8547-0321; D'Amico, Jessica/0000-0002-3487-0712; Bennett, David/0000-0001-7838-7573; Heckman, CJ/0000-0002-1324-7278; Fouad, Karim/0000-0003-3654-7852	Alberta Heritage Foundation; Canadian Institutes of Health Research; US National Institutes of Health [NS47567, NS48170]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048170, R01NS047567] Funding Source: NIH RePORTER	Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to F. Geddes, T. Tanaka, K. Miyake, G. Van Patten, J. Nevett-Duchcherer, G. Funk, M. Finlay and L. Hahn for assistance. This research was supported by the Alberta Heritage Foundation, Canadian Institutes of Health Research and the US National Institutes of Health (NS47567 and NS48170).	Ashby P, 1987, HDB SPINAL CORD, P119; BAKER LL, 1987, BRAIN RES, V420, P340, DOI 10.1016/0006-8993(87)91255-8; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; BARBEAU H, 1982, J NEUROL NEUROSUR PS, V45, P923, DOI 10.1136/jnnp.45.10.923; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Berg KA, 2008, J PHARMACOL EXP THER, V324, P1084, DOI 10.1124/jpet.107.131524; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; BROWNSTONE RM, 1994, EXP BRAIN RES, V102, P34; Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; CARLSSON A, 1963, EXPERIENTIA, V19, P359, DOI 10.1007/BF02152316; Chanrion B, 2008, MOL PHARMACOL, V73, P748, DOI 10.1124/mol.107.041574; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Gorassini MA, 2009, J NEUROPHYSIOL, V101, P969, DOI 10.1152/jn.91131.2008; Gurevich I, 2002, J NEUROSCI, V22, P10529; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1141, DOI 10.1152/jn.00335.2005; Hayashi Y, 2010, EXP NEUROL, V221, P68, DOI 10.1016/j.expneurol.2009.10.003; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Holohean AM, 2004, BRIT J PHARMACOL, V143, P351, DOI 10.1038/sj.bjp.0705935; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hultborn H, 2003, J PHYSIOL-LONDON, V552, P945, DOI 10.1113/jphysiol.2003.050971; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P609, DOI 10.1016/S0028-3908(97)00038-5; Kennett GA, 1996, BRIT J PHARMACOL, V117, P427, DOI 10.1111/j.1476-5381.1996.tb15208.x; Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4; KUHN RA, 1948, B J HOPKINS HOSP, V84, P43; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; McGrew L, 2004, MOL PHARMACOL, V65, P252, DOI 10.1124/mol.65.1.252; Mejia-Gervacio S, 2004, NEUROSCIENCE, V123, P123, DOI 10.1016/j.neuroscience.2003.08.049; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; NEWTON BW, 1988, BRAIN RES BULL, V20, P349, DOI 10.1016/0361-9230(88)90064-0; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Norton JA, 2008, BRAIN, V131, P1478, DOI 10.1093/brain/awn050; Perrier JF, 2000, J PHYSIOL-LONDON, V528, P107, DOI 10.1111/j.1469-7793.2000.t01-1-00107.x; Perrier JF, 2005, J NEUROSCI, V25, P7993, DOI 10.1523/JNEUROSCI.1957-05.2005; Perrier JF, 2003, J NEUROPHYSIOL, V89, P954, DOI 10.1152/jn.00753.2002; Rank MM, 2007, J NEUROPHYSIOL, V97, P3166, DOI 10.1152/jn.01168.2006; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V53, P1345, DOI 10.1152/jn.1985.53.6.1345; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Ung RV, 2008, EUR J NEUROSCI, V28, P2231, DOI 10.1111/j.1460-9568.2008.06508.x; WAINBERG M, 1990, J NEUROL NEUROSUR PS, V53, P754, DOI 10.1136/jnnp.53.9.754; WALLIS DI, 1993, NEUROPHARMACOLOGY, V32, P73, DOI 10.1016/0028-3908(93)90132-M; WESTPHAL RS, 1994, MOL PHARMACOL, V46, P937	60	264	273	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					694	U99		10.1038/nm.2160	http://dx.doi.org/10.1038/nm.2160			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20512126	Green Accepted			2022-12-25	WOS:000278394200036
J	Villa-Diaz, LG; Nandivada, H; Ding, J; Nogueira-De-Souza, NC; Krebsbach, PH; O'Shea, KS; Lahann, J; Smith, GD				Villa-Diaz, Luis G.; Nandivada, Himabindu; Ding, Jun; Nogueira-de-Souza, Naiara C.; Krebsbach, Paul H.; O'Shea, K. Sue; Lahann, Joerg; Smith, Gary D.			Synthetic polymer coatings for long-term growth of human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							SELF-RENEWAL; BIOMATERIALS; MATRICES; CULTURE	We report a fully defined synthetic polymer coating, poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH), which sustains long-term human embryonic stem (hES) cell growth in several different culture media, including commercially available defined media. The development of a standardized, controllable and sustainable culture matrix for hES cells is an essential step in elucidating mechanisms that control hES cell behavior and in optimizing conditions for biomedical applications of hES cells.	[Nandivada, Himabindu; Lahann, Joerg] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Villa-Diaz, Luis G.; Ding, Jun; Nogueira-de-Souza, Naiara C.; Smith, Gary D.] Univ Michigan, Dept Obstet & Ginecol, Ann Arbor, MI 48109 USA; [Villa-Diaz, Luis G.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Nogueira-de-Souza, Naiara C.] Barrelos Canc Hosp, Human Biol Res Lab, Sao Paulo, Brazil; [Krebsbach, Paul H.; Lahann, Joerg] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [O'Shea, K. Sue] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Lahann, Joerg] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Lahann, Joerg] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Smith, Gary D.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrated Physiol, Ann Arbor, MI 48109 USA; [Smith, Gary D.] Univ Michigan, Reprod Sci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hospital de Cancer de Barretos; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lahann, J (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	lahann@umich.edu; smithgd@umich.edu	Nandivada, Himabindu/J-2607-2012; Krebsbach, Paul H./AAC-4765-2021; Diaz, Luis Villa/Q-3463-2017; Lahann, Joerg/J-7663-2013	Diaz, Luis Villa/0000-0001-5709-9054; Souza, Naiara/0000-0002-4486-181X	University of Michigan; National Science Foundation (NSF); US National Institutes of Health [P20 GM-069985, R01 DE016530]; National Institute of Dental and Craniofacial Research [T32]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016530, T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.N. acknowledges funding from the University of Michigan Rackham Predoctoral Fellowship. J.L. gratefully acknowledges support from the National Science Foundation (NSF) in the form of a CAREER grant and funding from the NSF under the MRI program. We would like to thank J.H. Elisseeff and N. Hwang for their insightful comments throughout this study. We further thank J. Garcia-Perez, M. Morell, L. S. D. Emmett, M. Dzaman, M. Bormann, C. Pacut, N. Leff and J. MacDonald for their valuable assistance. We would also like to thank C. Smith, M. Yoshida and S. Brown for their invaluable comments on the manuscript. This research was supported by US National Institutes of Health grants P20 GM-069985, R01 DE016530 and the National Institute of Dental and Craniofacial Research T32 Tissue Engineering and Regeneration Training Program DE 07057.	Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Hakala H, 2009, TISSUE ENG PT A, V15, P1775, DOI 10.1089/ten.tea.2008.0316; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Prowse ABJ, 2009, STEM CELLS DEV, V18, P1135, DOI 10.1089/scd.2009.0080; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	12	270	287	5	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					581	583		10.1038/nbt.1631	http://dx.doi.org/10.1038/nbt.1631			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20512122	Green Accepted			2022-12-25	WOS:000278820200021
J	Yanes, O; Clark, J; Wong, DM; Patti, GJ; Sanchez-Ruiz, A; Benton, HP; Trauger, SA; Desponts, C; Ding, S; Siuzdak, G				Yanes, Oscar; Clark, Julie; Wong, Diana M.; Patti, Gary J.; Sanchez-Ruiz, Antonio; Benton, H. Paul; Trauger, Sunia A.; Desponts, Caroline; Ding, Sheng; Siuzdak, Gary			Metabolic oxidation regulates embryonic stem cell differentiation	NATURE CHEMICAL BIOLOGY			English	Article							SELF-RENEWAL; NADPH OXIDASE; INFLAMMATION; IDENTIFICATION; PROLIFERATION; SPECIFICATION; SPECTROMETRY; GLUTATHIONE; RESOLUTION; PROTEINS	Metabolites offer an important unexplored complementary approach to understanding the pluripotency of stem cells. Using MS-based metabolomics, we show that embryonic stem cells are characterized by abundant metabolites with highly unsaturated structures whose levels decrease upon differentiation. By monitoring the reduced and oxidized glutathione ratio as well as ascorbic acid levels, we demonstrate that the stem cell redox status is regulated during differentiation. On the basis of the oxidative biochemistry of the unsaturated metabolites, we experimentally manipulated specific pathways in embryonic stem cells while monitoring the effects on differentiation. Inhibition of the eicosanoid signaling pathway promoted pluripotency and maintained levels of unsaturated fatty acids. In contrast, downstream oxidized metabolites (for example, neuroprotectin D1) and substrates of pro-oxidative reactions (for example, acyl-carnitines), promoted neuronal and cardiac differentiation. We postulate that the highly unsaturated metabolome sustained by stem cells allows them to differentiate in response to in vivo oxidative processes such as inflammation.	[Yanes, Oscar; Wong, Diana M.; Patti, Gary J.; Benton, H. Paul; Trauger, Sunia A.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yanes, Oscar; Wong, Diana M.; Patti, Gary J.; Benton, H. Paul; Trauger, Sunia A.; Siuzdak, Gary] Scripps Res Inst, Scripps Ctr Mass Spectrometry, La Jolla, CA 92037 USA; [Clark, Julie; Sanchez-Ruiz, Antonio; Desponts, Caroline; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Clark, Julie; Sanchez-Ruiz, Antonio; Desponts, Caroline; Ding, Sheng] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Yanes, O (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sding@scripps.edu; siuzdak@scripps.edu	Yanes, Oscar/N-3630-2016; Benton, Paul/C-5394-2008; Sanchez-Ruiz, Antonio/AAO-3882-2021	Yanes, Oscar/0000-0003-3695-7157; Sanchez-Ruiz, Antonio/0000-0002-3656-7442; Trauger, Sunia/0000-0002-1678-8715; Siuzdak, Gary/0000-0002-4749-0014	California Institute for Regenerative Medicine; US Department of Energy; US National Science Foundation; US National Cancer Institute; US National Institutes of Health; NATIONAL EYE INSTITUTE [R24EY017540] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank G. G. Haraldsson and C.D. Magnusson (University of Iceland) for providing us with selachyl alcohol; C.T. McMurray and J.W. Trauger for helpful comments; and S. Hilcove, S. Ku and D. Watry for technical assistance. We gratefully acknowledge financial support from the California Institute for Regenerative Medicine, US Department of Energy, US National Science Foundation, US National Cancer Institute and US National Institutes of Health. A.S.-R. thanks Fundacion Ramon Areces for his postdoctoral fellowship.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BROHULT A, 1958, NATURE, V181, P1484, DOI 10.1038/1811484b0; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; CORDEAULOSSOUARN L, 1991, BIOL CELL, V71, P57, DOI 10.1016/0248-4900(91)90051-N; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; IDELLWENGER JA, 1982, J MOL CELL CARDIOL, V14, P413, DOI 10.1016/0022-2828(82)90172-9; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200; MARTENSSON J, 1992, P NATL ACAD SCI USA, V89, P11566, DOI 10.1073/pnas.89.23.11566; Oz M, 2005, ARCH BIOCHEM BIOPHYS, V434, P344, DOI 10.1016/j.abb.2004.11.010; PRUSS TP, 1998, Patent No. 5731354; Rellan-Alvarez R, 2006, ANAL BIOCHEM, V356, P254, DOI 10.1016/j.ab.2006.05.032; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Tsuneto M, 2005, BIOCHEM BIOPH RES CO, V335, P1239, DOI 10.1016/j.bbrc.2005.08.016; Wada K, 2006, FASEB J, V20, P1785, DOI 10.1096/fj.06-5809com; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	39	374	387	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					411	417		10.1038/nchembio.364	http://dx.doi.org/10.1038/nchembio.364			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20436487	Green Accepted			2022-12-25	WOS:000277748100010
J	Aikawa, Y; Katsumoto, T; Zhang, P; Shima, H; Shino, M; Terui, K; Ito, E; Ohno, H; Stanley, ER; Singh, H; Tenen, DG; Kitabayashi, I				Aikawa, Yukiko; Katsumoto, Takuo; Zhang, Pu; Shima, Haruko; Shino, Mika; Terui, Kiminori; Ito, Etsuro; Ohno, Hiroaki; Stanley, E. Richard; Singh, Harinder; Tenen, Daniel G.; Kitabayashi, Issay			PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; ZINC-FINGER PROTEIN; BONE-MARROW-CELLS; C-FMS; FACTOR-RECEPTOR; BINDING-PROTEIN; EXPRESSION; GENE	Leukemias and other cancers possess self-renewing stem cells that help to maintain the cancer(1,2). Cancer stem cell eradication is thought to be crucial for successful anticancer therapy. Using an acute myeloid leukemia (AML) model induced by the leukemia-associated monocytic leukemia zinc finger (MOZ)-TIF2 fusion protein, we show here that AML can be cured by the ablation of leukemia stem cells. The MOZ fusion proteins MOZ-TIF2 and MOZ-CBP interacted with the transcription factor PU.1 to stimulate the expression of macrophage colony-stimulating factor receptor (CSF1R, also known as M-CSFR, c-FMS or CD115). Studies using PU.1-deficient mice showed that PU.1 is essential for the ability of MOZ-TIF2 to establish and maintain AML stem cells. Cells expressing high amounts of CSF1R (CSF1R(high) cells), but not those expressing low amounts of CSF1R (CSF1R(low) cells), showed potent leukemia-initiating activity. Using transgenic mice expressing a drug-inducible suicide gene controlled by the CSF1R promoter, we cured AML by ablation of CSF1R(high) cells. Moreover, induction of AML was suppressed in CSF1R-deficient mice and CSF1R inhibitors slowed the progression of MOZ-TIF2-induced leukemia. Thus, in this subtype of AML, leukemia stem cells are contained within the CSF1R(high) cell population, and we suggest that targeting of PU.1-mediated upregulation of CSF1R expression might be a useful therapeutic approach.	[Aikawa, Yukiko; Katsumoto, Takuo; Shima, Haruko; Shino, Mika; Kitabayashi, Issay] Natl Canc Ctr, Div Mol Oncol, Res Inst, Chuo Ku, Tokyo, Japan; [Zhang, Pu; Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA USA; [Terui, Kiminori; Ito, Etsuro] Hirosaki Univ, Sch Med, Dept Pediat, Hirosaki, Aomori 036, Japan; [Ohno, Hiroaki] Kyowa Hakko Kirin, Pharmacol Res Labs, Div Res, Gunma, Japan; [Stanley, E. Richard] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	National Cancer Center - Japan; Harvard University; Hirosaki University; Kyowa Kirin Ltd; Yeshiva University; Albert Einstein College of Medicine; University of Chicago; National University of Singapore	Kitabayashi, I (corresponding author), Natl Canc Ctr, Div Mol Oncol, Res Inst, Chuo Ku, Tokyo, Japan.	ikitabay@ncc.go.jp	Stanley, Evan R/J-9154-2013; Kitabayashi, Issay/G-2204-2017	Stanley, Evan R/0000-0002-2910-2065; Tenen, Daniel/0000-0002-6423-3888; Ito, Etsuro/0000-0002-0168-2475; Kitabayashi, Issay/0000-0002-8409-0407	Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation of Japan; US National Institutes of Health [R01-CA41456, CA32551, 5P30-CA13330]; NATIONAL CANCER INSTITUTE [R01CA041456, R01CA032551, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719] Funding Source: NIH RePORTER	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank D. E. Zhang for the CSF1R promoter mutant lacking PU.1-binding sites, Y. Kamei and A. Iwama for MOZ-TIF2 cDNA, H. Ichikawa for N-MYC cDNA, T. Taya for SaOS2 cells (National Cancer Center Research Institute) and A. Kuchiba for help with statistical analyses. This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare and from the Japanese Ministry of Education, Culture, Sports, Science and Technology (I. K.), by the Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan (I. K.), and by US National Institutes of Health grants R01-CA41456 (D. G. T.), CA32551 and 5P30-CA13330 (E. R. S.).	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Dewar AL, 2005, CELL CYCLE, V4, P851, DOI 10.4161/cc.4.7.1788; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; PREISLER HD, 1987, CANCER RES, V47, P874; RAMBALDI A, 1988, J CLIN INVEST, V81, P1030, DOI 10.1172/JCI113413; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Taylor JR, 2006, ONCOGENE, V25, P147, DOI 10.1038/sj.onc.1209007; Terui K, 2008, HAEMATOL-HEMATOL J, V93, P1591, DOI 10.3324/haematol.13020; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; WANG C, 1988, J CELL PHYSIOL, V135, P133, DOI 10.1002/jcp.1041350119; Yoshida H, 2007, MOL CELL BIOL, V27, P5819, DOI 10.1128/MCB.02422-06; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	33	69	83	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					580	U115		10.1038/nm.2122	http://dx.doi.org/10.1038/nm.2122			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418886	Green Accepted			2022-12-25	WOS:000277394700037
J	Bendle, GM; Linnemann, C; Hooijkaas, AI; Bies, L; de Witte, MA; Jorritsma, A; Kaiser, ADM; Pouw, N; Debets, R; Kieback, E; Uckert, W; Song, JY; Haanen, JBAG; Schumacher, TNM				Bendle, Gavin M.; Linnemann, Carsten; Hooijkaas, Anna I.; Bies, Laura; de Witte, Moniek A.; Jorritsma, Annelies; Kaiser, Andrew D. M.; Pouw, Nadine; Debets, Reno; Kieback, Elisa; Uckert, Wolfgang; Song, Ji-Ying; Haanen, John B. A. G.; Schumacher, Ton N. M.			Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy	NATURE MEDICINE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; BONE-MARROW FAILURE; CANCER REGRESSION; TUMOR-REGRESSION; TCR-ALPHA; LYMPHOCYTES; IMMUNOTHERAPY; BETA; MELANOMA; ANTIGEN	The transfer of T cell receptor (TCR) genes can be used to induce immune reactivity toward defined antigens to which endogenous T cells are insufficiently reactive. This approach, which is called TCR gene therapy, is being developed to target tumors and pathogens, and its clinical testing has commenced in patients with cancer. In this study we show that lethal cytokine-driven autoimmune pathology can occur in mouse models of TCR gene therapy under conditions that closely mimic the clinical setting. We show that the pairing of introduced and endogenous TCR chains in TCR gene-modified T cells leads to the formation of self-reactive TCRs that are responsible for the observed autoimmunity. Furthermore, we demonstrate that adjustments in the design of gene therapy vectors and target T cell populations can be used to reduce the risk of TCR gene therapy-induced autoimmune pathology.	[Bendle, Gavin M.; Linnemann, Carsten; Hooijkaas, Anna I.; Bies, Laura; de Witte, Moniek A.; Jorritsma, Annelies; Kaiser, Andrew D. M.; Haanen, John B. A. G.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Pouw, Nadine; Debets, Reno] Erasmus MC Daniel den Hoed Canc Ctr, Lab Expt Tumor Immunol, Dept Med Oncol, Rotterdam, Netherlands; [Kieback, Elisa; Uckert, Wolfgang] Max Delbruck Ctr Mol Med, Berlin, Germany; [Song, Ji-Ying] Netherlands Canc Inst, Div Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands; [Haanen, John B. A. G.] Netherlands Canc Inst, Div Med Oncol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Netherlands Cancer Institute; Netherlands Cancer Institute	Bendle, GM (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	g.bendle@nki.nl; t.schumacher@nki.nl	Haanen, John/AAD-8578-2022; Kaiser, Andrew D/C-2617-2012; Haanen, John/AAD-8534-2022; Schumacher, Ton/Y-2432-2019	Haanen, John/0000-0001-5884-7704; Schumacher, Ton/0000-0003-0517-8804; Pouw, Nadine/0000-0002-6470-3720	Leukaemia and Lymphoma Research Travel Fellowship [06037]; Netherlands Organization for Scientific Research [431-00-005]; Dutch Cancer Society [NKI 2009-4282, 2003-2860]	Leukaemia and Lymphoma Research Travel Fellowship; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	We thank the Experimental Animal Department for animal husbandry, H. van Tinteren for advice on statistical analysis and R. Gomez for experimental assistance. We are grateful to A. Pfauth and F. van Diepen for assistance with flow cytometry. G. M. B. is supported by a Leukaemia and Lymphoma Research Travel Fellowship (06037). C. L. is a fellow in the PhD Fellowship Program of Boehringer Ingelheim Fonds-Foundation for Basic Research in Biomedicine. T.N.M.S. and J.B.A.G.H. are supported by grants from The Netherlands Organization for Scientific Research (431-00-005), the Dutch Cancer Society (NKI 2009-4282 and 2003-2860), The Landsteiner Foundation for Blood Transfusion Research (04-08) and FP6 Integrated Project Adoptive T cell Targeting to Activate Cancer Killing (ATTACK). Cytotoxic T lymphocyte clone LP9 was kindly provided by G. Adema (Radboud University).	Agbaht K, 2007, TRANSFUSION, V47, P1405, DOI 10.1111/j.1537-2995.2007.01282.x; Bendle GM, 2009, CURR OPIN IMMUNOL, V21, P209, DOI 10.1016/j.coi.2009.02.007; Bloom ML, 2004, EXP HEMATOL, V32, P1163, DOI 10.1016/j.exphem.2004.08.006; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; de Witte MA, 2008, J IMMUNOL, V181, P5128, DOI 10.4049/jimmunol.181.7.5128; de Witte MA, 2008, J IMMUNOL, V181, P2563, DOI 10.4049/jimmunol.181.4.2563; de Witte MA, 2006, BLOOD, V108, P870, DOI 10.1182/blood-2005-08-009357; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; GREENBAUM BH, 1991, J CLIN ONCOL, V9, P1889, DOI 10.1200/JCO.1991.9.10.1889; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kessels HWHG, 2006, J IMMUNOL, V177, P976, DOI 10.4049/jimmunol.177.2.976; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Kolen S, 2002, J IMMUNOTHER, V25, P385, DOI 10.1097/00002371-200209000-00002; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morris EC, 2005, P NATL ACAD SCI USA, V102, P7934, DOI 10.1073/pnas.0500357102; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Romieu R, 1998, J IMMUNOL, V161, P5133; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Schreurs MWJ, 2000, CANCER RES, V60, P6995; Schroeder ML, 2002, BRIT J HAEMATOL, V117, P275, DOI 10.1046/j.1365-2141.2002.03450.x; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Sebestyen Z, 2008, J IMMUNOL, V180, P7736, DOI 10.4049/jimmunol.180.11.7736; Shrikant P, 2002, J IMMUNOL, V169, P1753, DOI 10.4049/jimmunol.169.4.1753; Tang Y, 2010, BLOOD, V115, P541, DOI 10.1182/blood-2009-03-211383; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; Uckert W, 2009, CANCER IMMUNOL IMMUN, V58, P809, DOI 10.1007/s00262-008-0649-4; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Voss RH, 2008, J IMMUNOL, V180, P391, DOI 10.4049/jimmunol.180.1.391; Weinhold M, 2007, J IMMUNOL, V179, P5534, DOI 10.4049/jimmunol.179.8.5534; Willemsen RA, 2000, GENE THER, V7, P1369, DOI 10.1038/sj.gt.3301253; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046	41	300	316	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					565	U98		10.1038/nm.2128	http://dx.doi.org/10.1038/nm.2128			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20400962				2022-12-25	WOS:000277394700035
J	Lammers, M; Neumann, H; Chin, JW; James, LC				Lammers, Michael; Neumann, Heinz; Chin, Jason W.; James, Leo C.			Acetylation regulates Cyclophilin A catalysis, immunosuppression and HIV isomerization	NATURE CHEMICAL BIOLOGY			English	Article							C VIRUS-REPLICATION; H4-K16 ACETYLATION; CYCLOSPORINE-A; ACTIVE-SITE; CALCINEURIN; INHIBITION; EXPRESSION; CELLS; INFECTIVITY; SENSITIVITY	Cyclophilin A (CypA) is a ubiquitous cis-trans prolyl isomerase with key roles in immunity and viral infection. CypA suppresses T-cell activation through cyclosporine complexation and is required for effective HIV-1 replication in host cells. We show that CypA is acetylated in diverse human cell lines and use a synthetically evolved acetyllysyl-tRNA synthetase/tRNA(CUA) pair to produce recombinant acetylated CypA in Escherichia coli. We determined atomic-resolution structures of acetylated CypA and its complexes with cyclosporine and HIV-1 capsid. Acetylation markedly inhibited CypA catalysis of cis to trans isomerization and stabilized cis rather than trans forms of the HIV-1 capsid. Furthermore, CypA acetylation antagonized the immunosuppressive effects of cyclosporine by inhibiting the sequential steps of cyclosporine binding and calcineurin inhibition. Our results reveal that acetylation regulates key functions of CypA in immunity and viral infection and provide a general set of mechanisms by which acetylation modulates interactions to regulate cell function.	[Lammers, Michael; Neumann, Heinz; Chin, Jason W.; James, Leo C.] MRC, Mol Biol Lab, Prot & Nucle Acid Chem Div, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Prot & Nucle Acid Chem Div, Hills Rd, Cambridge CB2 2QH, England.	chin@mrc-lmb.cam.ac.uk; lcj@mrc-lmb.cam.ac.uk	Neumann, Heinz/ABC-7323-2021; Lammers, Michael/AAX-1164-2020; Neumann, Heinz/F-7875-2014	Neumann, Heinz/0000-0001-9657-1913; Lammers, Michael/0000-0003-4168-4640	UK Medical Research Council; MRC [MC_U105181009, MC_U105181010, MC_UP_A024_1008] Funding Source: UKRI; Medical Research Council [MC_U105181009, MC_UP_A024_1008, MC_U105181010] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council.	Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 1996, J VIROL, V70, P4220, DOI 10.1128/JVI.70.7.4220-4227.1996; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Decker ED, 2003, PROTEOMICS, V3, P2019, DOI 10.1002/pmic.200300473; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; ENZ A, 1994, ANAL BIOCHEM, V216, P147, DOI 10.1006/abio.1994.1018; ETZKORN FA, 1994, BIOCHEMISTRY-US, V33, P2380, DOI 10.1021/bi00175a005; Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; HELEKAR SA, 1994, NEURON, V12, P179, DOI 10.1016/0896-6273(94)90162-7; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; KE HM, 1992, J MOL BIOL, V228, P539, DOI 10.1016/0022-2836(92)90841-7; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kung L, 2001, AM J TRANSPLANT, V1, P325, DOI 10.1034/j.1600-6143.2001.10407.x; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Min L, 2005, FRONT BIOSCI-LANDMRK, V10, P385, DOI 10.2741/1536; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nahreini P, 2001, CELL MOL NEUROBIOL, V21, P65, DOI 10.1023/A:1007173329237; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ow WB, 2001, PROTEIN SCI, V10, P2346, DOI 10.1110/ps.23301; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Watashi K, 2007, REV MED VIROL, V17, P245, DOI 10.1002/rmv.534; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08	38	81	83	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					331	337		10.1038/nchembio.342	http://dx.doi.org/10.1038/nchembio.342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20364129	Green Published, Bronze, Green Accepted			2022-12-25	WOS:000276823200011
J	Shmelkov, SV; Hormigo, A; Jing, DQ; Proenca, CC; Bath, KG; Milde, T; Shmelkov, E; Kushner, JS; Baljevic, M; Dincheva, I; Murphy, AJ; Valenzuela, DM; Gale, NW; Yancopoulos, GD; Ninan, I; Lee, FS; Rafii, S				Shmelkov, Sergey V.; Hormigo, Adilia; Jing, Deqiang; Proenca, Catia C.; Bath, Kevin G.; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Dincheva, Iva; Murphy, Andrew J.; Valenzuela, David M.; Gale, Nicholas W.; Yancopoulos, George D.; Ninan, Ipe; Lee, Francis S.; Rafii, Shahin			Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice	NATURE MEDICINE			English	Article							CAUDATE-NUCLEUS; SHORT-TERM; LONG-TERM; DISORDER; FAMILY; MODELS; BRAIN; EPIDEMIOLOGY; PLASTICITY; VARIANTS	Obsessive-compulsive disorder (OCD) is a common psychiatric disorder defined by the presence of obsessive thoughts and repetitive compulsive actions, and it often encompasses anxiety and depressive symptoms(1,2). Recently, the corticostriatal circuitry has been implicated in the pathogenesis of OCD3,4. However, the etiology, pathophysiology and molecular basis of OCD remain unknown. Several studies indicate that the pathogenesis of OCD has a genetic component(5-8). Here we demonstrate that loss of a neuron-specific transmembrane protein, SLIT and NTRK-like protein-5 (Slitrk5), leads to OCD-like behaviors in mice, which manifests as excessive self-grooming and increased anxiety-like behaviors, and is alleviated by the selective serotonin reuptake inhibitor fluoxetine. Slitrk5(-/-) mice show selective overactivation of the orbitofrontal cortex, abnormalities in striatal anatomy and cell morphology and alterations in glutamate receptor composition, which contribute to deficient corticostriatal neurotransmission. Thus, our studies identify Slitrk5 as an essential molecule at corticostriatal synapses and provide a new mouse model of OCD-like behaviors.	[Jing, Deqiang; Proenca, Catia C.; Bath, Kevin G.; Dincheva, Iva; Lee, Francis S.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Shmelkov, Sergey V.; Hormigo, Adilia; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, New York, NY USA; [Shmelkov, Sergey V.; Hormigo, Adilia; Milde, Till; Shmelkov, Evgeny; Kushner, Jared S.; Baljevic, Muhamed; Rafii, Shahin] Weill Cornell Med Coll, Dept Geriatr Med, New York, NY USA; [Hormigo, Adilia] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Hormigo, Adilia] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Proenca, Catia C.] Inst Gulbenkian Ciencias, Gulbenkian PhD Programe Biomed, Oeiras, Portugal; [Dincheva, Iva; Lee, Francis S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Murphy, Andrew J.; Valenzuela, David M.; Gale, Nicholas W.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Ninan, Ipe] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Instituto Gulbenkian de Ciencia; Cornell University; Regeneron; New York University; NYU Langone Medical Center	Lee, FS (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY USA.	fslee@med.cornell.edu; srafii@med.cornell.edu	Milde, Till/AAR-4528-2021; Baljevic, Muhamed/GOE-3611-2022; Milde, Till/L-7755-2015	Milde, Till/0000-0002-7267-1052; Murphy, Andrew/0000-0003-4152-4081; Ninan, Ipe/0000-0001-9774-6455; Kushner, Jared S./0000-0003-4821-0990	US National Institutes of Health [MH079513, NS052819, HL66592, HL097797, AI080309]; Burroughs Wellcome Foundation; International Mental Health Research Organization; Sackler Institute; New York Community Trust; Pritzker Consortium; National Alliance for Research on Schizophrenia and Depression; Mildred-Scheel-Stiftung, Deutsche Krebshilfe; Gulbenkian PhD Programe in Biomedicine; Fundacao para Ciencia e Tecnologia; Howard Hughes Medical Institute; Ansary Stem Cell Institute; Anbinder and Newmans Own Foundations; Qatar National Priorities Research Program; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, U01HL066952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079513, RC1MH088814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052819] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); International Mental Health Research Organization; Sackler Institute; New York Community Trust; Pritzker Consortium; National Alliance for Research on Schizophrenia and Depression(NARSAD); Mildred-Scheel-Stiftung, Deutsche Krebshilfe(Deutsche Krebshilfe); Gulbenkian PhD Programe in Biomedicine; Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Anbinder and Newmans Own Foundations; Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Empire State Stem Cell Board; New York State Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Flint Beal for providing expertise on behavioral experiments. We thank G. Thurston for critical comments and suggestions. PSD95-cherry was a kind gift from R. H. Edwards (University of California-San Francisco). We acknowledge support from US National Institutes of Health grants MH079513 (F. S. L.) and NS052819 (F. S. L.), HL66592 (S. R.), HL097797 (S. R.) and AI080309 (S. R.), Burroughs Wellcome Foundation (F. S. L.), International Mental Health Research Organization (F. S. L.), the Sackler Institute (K. G. B., F. S. L.), DeWitt-Wallace Fund of the New York Community Trust (F. S. L.), Pritzker Consortium (F. S. L.), National Alliance for Research on Schizophrenia and Depression (S. V. S.), Mildred-Scheel-Stiftung, Deutsche Krebshilfe (T. M.), Gulbenkian PhD Programe in Biomedicine (C. C. P.), Fundacao para Ciencia e Tecnologia (C. C. P.), Howard Hughes Medical Institute (S. R.), Ansary Stem Cell Institute (S. R.), Anbinder and Newmans Own Foundations (S. R.), Qatar National Priorities Research Program (S. R.), Empire State Stem Cell Board (S. R.) and the New York State Department of Health grant NYS C024180 (S. R.).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Aylward EH, 1996, ARCH GEN PSYCHIAT, V53, P577; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CLIFFORD CA, 1984, PSYCHOL MED, V14, P791, DOI 10.1017/S0033291700019760; Deng H, 2006, ACTA NEUROL SCAND, V114, P400, DOI 10.1111/j.1600-0404.2006.00706.x; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Hollander E, 2007, CNS SPECTRUMS, V12, P5, DOI 10.1017/S1092852900002467; Joel D, 2006, PROG NEURO-PSYCHOPH, V30, P374, DOI 10.1016/j.pnpbp.2005.11.006; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Milde T, 2007, LEUKEMIA, V21, P824, DOI 10.1038/sj.leu.2404525; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; RASMUSSEN SA, 1984, J CLIN PSYCHIAT, V45, P450; Rauch SL, 2007, BIOL PSYCHIAT, V61, P330, DOI 10.1016/j.biopsych.2005.12.012; Rauch SL, 2003, NEUROSURG CLIN N AM, V14, P213, DOI 10.1016/S1042-3680(02)00114-6; ROBINSON D, 1995, ARCH GEN PSYCHIAT, V52, P393; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Shmelkov SV, 2001, ANAL BIOCHEM, V290, P26, DOI 10.1006/abio.2001.4969; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Szeszko PR, 2004, AM J PSYCHIAT, V161, P1049, DOI 10.1176/appi.ajp.161.6.1049; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang L, 2009, BEHAV PHARMACOL, V20, P119, DOI 10.1097/FBP.0b013e32832a80ad; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001	38	217	220	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					598	U135		10.1038/nm.2125	http://dx.doi.org/10.1038/nm.2125			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418887	Green Accepted			2022-12-25	WOS:000277394700040
J	Srikanth, S; Jung, HJ; Kim, KD; Souda, P; Whitelegge, J; Gwack, Y				Srikanth, Sonal; Jung, Hea-Jin; Kim, Kyun-Do; Souda, Puneet; Whitelegge, Julian; Gwack, Yousang			A novel EF-hand protein, CRACR2A, is a cytosolic Ca2+ sensor that stabilizes CRAC channels in T cells	NATURE CELL BIOLOGY			English	Article							STORE; STIM1; ORAI1; MEMBRANE; ACTIVATION; ENTRY; BINDING; DOMAIN; OLIGOMERIZATION; TRANSCRIPTION	Orai1 and STIM1 are critical components of Ca2+ release-activated Ca2+ (CRAC) channels that mediate store-operated Ca2+ entry (SOCE) in immune cells. Although it is known that Orai1 and STIM1 co-cluster and physically interact to mediate SOCE, the cytoplasmic machinery modulating these functions remains poorly understood. We sought to find modulators of Orai1 and STIM1 using affinity protein purification and identified a novel EF-hand protein, CRACR2A (also called CRAC regulator 2A, EFCAB4B or FLJ33805). We show that CRACR2A interacts directly with Orai1 and STIM1, forming a ternary complex that dissociates at elevated Ca2+ concentrations. Studies using knockdown mediated by small interfering RNA (siRNA) and mutagenesis show that CRACR2A is important for clustering of Orai1 and STIM1 upon store depletion. Expression of an EF-hand mutant of CRACR2A enhanced STIM1 clustering, elevated cytoplasmic Ca2+ and induced cell death, suggesting its active interaction with CRAC channels. These observations implicate CRACR2A, a novel Ca2+ binding protein that is highly expressed in T cells and conserved in vertebrates, as a key regulator of CRAC channel-mediated SOCE.	[Srikanth, Sonal; Jung, Hea-Jin; Kim, Kyun-Do; Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Souda, Puneet; Whitelegge, Julian] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gwack, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	ygwack@mednet.ucla.edu			National Institute of Health [AI-083432]; Stein Oppenheimer Endowment Award; Cancer Research Coordinating Committee; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083432] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stein Oppenheimer Endowment Award; Cancer Research Coordinating Committee; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Kenneth Philipson for critical reading of this manuscript and kind suggestions on Ca<SUP>2+</SUP> overlay experiments. We thank Bernard Ribalet for help with patch clamp experiments, Baljit Khakh for sharing equipments and Earl Homsher for helpful discussions. This work was supported by National Institute of Health grant AI-083432, Stein Oppenheimer Endowment Award, Cancer Research Coordinating Committee Award (Y.G.) and a fellowship from the American Heart Association (S.S.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bauer MC, 2008, BIOCHEMISTRY-US, V47, P6089, DOI 10.1021/bi800496a; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	48	177	184	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					436	U63		10.1038/ncb2045	http://dx.doi.org/10.1038/ncb2045			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418871	Green Accepted			2022-12-25	WOS:000277283700009
J	Stolz, A; Ertych, N; Kienitz, A; Vogel, C; Schneider, V; Fritz, B; Jacob, R; Dittmar, G; Weichert, W; Petersen, I; Bastians, H				Stolz, Ailine; Ertych, Norman; Kienitz, Anne; Vogel, Celia; Schneider, Verena; Fritz, Barbara; Jacob, Ralf; Dittmar, Gunnar; Weichert, Wilko; Petersen, Iver; Bastians, Holger			The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells	NATURE CELL BIOLOGY			English	Article							CHK2 PROTEIN-KINASE; HUMAN CANCER-CELLS; LUNG-CANCER; INSTABILITY; ANEUPLOIDY; PHOSPHORYLATION; CHECKPOINT; P53; SUSCEPTIBILITY; TUMORIGENESIS	Chromosomal instability (CIN) is a major hallmark of human cancer and might contribute to tumorigenesis(1). Genes required for the normal progression of mitosis represent potential CIN genes and, as such, are important tumour suppressors. The Chk2 kinase and its downstream targets p53 and Brca1 are tumour suppressors that have been functionally linked to the DNA damage response pathway(2). Here, we report a function of Chk2, independent of p53 and DNA damage, that is required for proper progression of mitosis, and for the maintenance of chromosomal stability in human somatic cells. Depletion of Chk2 or abrogation of its kinase activity causes abnormal mitotic spindle assembly associated with a delay in mitosis, which promotes the generation of lagging chromosomes, chromosome missegregation and CIN, while still allowing survival and growth. Furthermore, we have identified Brca1 as a mitotic target of the Chk2 kinase in the absence of DNA damage. Accordingly, loss of BRCA1 or its Chk2-mediated phosphorylation leads to spindle formation defects and CIN. Thus, the CHK2-BRCA1 tumour suppressor pathway is required for chromosomal stability, which might contribute to their tumour suppressor function.	[Stolz, Ailine; Ertych, Norman; Kienitz, Anne; Vogel, Celia; Schneider, Verena; Bastians, Holger] Univ Marburg, Inst Mol Biol & Tumour Res IMT, D-35037 Marburg, Germany; [Fritz, Barbara] Univ Marburg, Inst Human Genet, D-35033 Marburg, Germany; [Jacob, Ralf] Univ Marburg, Inst Cell Biol & Cell Pathol, D-35032 Marburg, Germany; [Dittmar, Gunnar] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Weichert, Wilko] Charite, Inst Pathol, D-10117 Berlin, Germany; [Petersen, Iver] Univ Jena, Inst Pathol, D-07740 Jena, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Bastians, H (corresponding author), Univ Marburg, Inst Mol Biol & Tumour Res IMT, Emil Mannkopf Str 2, D-35037 Marburg, Germany.	bastians@imt.uni-marburg.de	Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019; Jacob, Ralf/B-8163-2011	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; 	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Robert Benezra, Loren Michel, Prasad Jallepalli, Bert Vogelstein, Jiri Lukas, Stephen Taylor, Reuven Agami, Fen Xia, Junjie Chen, Sylvie Mazoyer, Jay Chung, Michael Brandeis, Linda Wordeman and Duane Compton for providing cell lines, antibodies and plasmids. We thank Robert J. Schultz (Developmental Therapeutics Program of the National Cancer Institute, USA) for the gift of UCN-01, and Rolf Muller and Alexandra Elli for support. We are grateful to Heike Krebber and Matthias Dobbelstein for comments on the manuscript. This work was supported by a grant and a Heisenberg fellowship to H. B. from the Deutsche Forschungsgemeinschaft.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bunz F, 2002, CANCER RES, V62, P1129; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Fritz B, 1998, HUM GENET, V103, P441, DOI 10.1007/s004390050848; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KISHIMOTO Y, 1992, CANCER RES, V52, P4799; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stolz A, 2009, CANCER RES, V69, P3874, DOI 10.1158/0008-5472.CAN-08-3597; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	36	108	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					492	U179		10.1038/ncb2051	http://dx.doi.org/10.1038/ncb2051			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20364141				2022-12-25	WOS:000277283700015
J	Xiang, H; Zhu, JD; Chen, Q; Dai, FY; Li, X; Li, MW; Zhang, HY; Zhang, GJ; Li, D; Dong, Y; Zhao, L; Lin, Y; Cheng, DJ; Yu, J; Sun, JF; Zhou, XY; Ma, KL; He, YH; Zhao, YX; Guo, SC; Ye, MZ; Guo, GW; Li, YR; Li, RQ; Zhang, XQ; Ma, LJ; Kristiansen, K; Guo, QH; Jiang, JH; Beck, S; Xia, QY; Wang, W; Wang, J				Xiang, Hui; Zhu, Jingde; Chen, Quan; Dai, Fangyin; Li, Xin; Li, Muwang; Zhang, Hongyu; Zhang, Guojie; Li, Dong; Dong, Yang; Zhao, Li; Lin, Ying; Cheng, Daojun; Yu, Jian; Sun, Jinfeng; Zhou, Xiaoyu; Ma, Kelong; He, Yinghua; Zhao, Yangxing; Guo, Shicheng; Ye, Mingzhi; Guo, Guangwu; Li, Yingrui; Li, Ruiqiang; Zhang, Xiuqing; Ma, Lijia; Kristiansen, Karsten; Guo, Qiuhong; Jiang, Jianhao; Beck, Stephan; Xia, Qingyou; Wang, Wen; Wang, Jun			Single base-resolution methylome of the silkworm reveals a sparse epigenomic map	NATURE BIOTECHNOLOGY			English	Article							DNA METHYLATION; CPG METHYLATION; BOMBYX-MORI; GENOME; EXPRESSION; ARABIDOPSIS; GENES; TRANSCRIPTION; EVOLUTION; ALIGNMENT	Epigenetic regulation in insects may have effects on diverse biological processes. Here we survey the methylome of a model insect, the silkworm Bombyx mori, at single-base resolution using Illumina high-throughput bisulfite sequencing (MethylC-Seq). We conservatively estimate that 0.11% of genomic cytosines are methylcytosines, all of which probably occur in CG dinucleotides. CG methylation is substantially enriched in gene bodies and is positively correlated with gene expression levels, suggesting it has a positive role in gene transcription. We find that transposable elements, promoters and ribosomal DNAs are hypomethylated, but in contrast, genomic loci matching small RNAs in gene bodies are densely methylated. This work contributes to our understanding of epigenetics in insects, and in contrast to previous studies of the highly methylated genomes of Arabidopsis(1) and human(2), demonstrates a strategy for sequencing the epigenomes of organisms such as insects that have low levels of methylation.	[Xiang, Hui; Chen, Quan; Zhang, Guojie; Ye, Mingzhi; Guo, Guangwu; Li, Yingrui; Li, Ruiqiang; Zhang, Xiuqing; Ma, Lijia; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Xiang, Hui; Li, Xin; Dong, Yang; Zhao, Li; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp, Kunming, Peoples R China; [Zhu, Jingde; Zhang, Hongyu; Yu, Jian; Sun, Jinfeng; Zhou, Xiaoyu; Ma, Kelong; He, Yinghua; Zhao, Yangxing; Guo, Shicheng] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Canc Epigenet & Gene Therapy Program, Shanghai 200030, Peoples R China; [Zhu, Jingde] Fudan Univ, Obstet & Gynecol Hosp, Canc Epigenet Lab, Shanghai 200433, Peoples R China; [Dai, Fangyin; Li, Dong; Lin, Ying; Cheng, Daojun; Xia, Qingyou] Southwest Univ, Inst Sericulture & Syst Biol, Coll Biotechnol, Key Sericultural Lab,Agr Minist, Chongqing, Peoples R China; [Li, Muwang] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Guo, Qiuhong; Jiang, Jianhao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Beck, Stephan] UCL, UCL Canc Inst, London, England	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Kunming Institute of Zoology; Shanghai Jiao Tong University; Fudan University; Southwest University - China; Chinese Academy of Agricultural Sciences; University of Copenhagen; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of London; University College London	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	xiaqy@swu.edu.cn; wwang@mail.kiz.ac.cn; wangj@genomics.org.cn	Li, Xin/A-4137-2011; Li, Yingrui/K-1064-2015; Zhao, Li/E-8117-2015; Zhang, Guojie/J-7273-2019; Kristiansen, Karsten/J-5148-2014; Zhang, Guojie/B-6188-2014; Wang, Wen/AAP-9873-2020; SUN, JIN/GPX-9641-2022; Guo, Shicheng/A-1204-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Li, Xin/0000-0001-8328-4894; Zhang, Guojie/0000-0001-6860-1521; Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Guojie/0000-0001-6860-1521; Guo, Shicheng/0000-0002-7047-9972; Xia, Qingyou/0000-0002-9263-2886; Wang, Wen/0000-0002-7801-2066; Wang, Jun/0000-0002-8540-8931; Dai, Fangyin/0000-0002-0215-2177; Wang, Jun/0000-0002-2113-5874; Zhao, Li/0000-0001-6776-1996	National Natural Science Foundation of China [90919056, 2007CB815700, 30870296, 30725008, 2005CB121000, 2009CB825606, 2009CB825607]; Chinese Academy of Sciences; Department of Sciences and Technology of Yunnan Province [2008CC017, 2008GA002]; China Postdoctoral Science Foundation; Chinese 863 Program [2006AA10A121]; Danish Platform for Integrative Biology; Danish Natural Science Research Council; Solexa [272-07-0196]; Shanghai Science Foundation [07DJ14074]; National Science Foundation [90919024, 30872963]; European 6th program [LSHB-CT-2005-019067]; Chinese Academy of Sciences-Max Planck Society	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Sciences and Technology of Yunnan Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese 863 Program(National High Technology Research and Development Program of China); Danish Platform for Integrative Biology; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa; Shanghai Science Foundation; National Science Foundation(National Science Foundation (NSF)); European 6th program(European Commission); Chinese Academy of Sciences-Max Planck Society(Max Planck SocietyChinese Academy of Sciences)	We thank J. Ridley for English editing on the manuscript. This work was supported by a 973 Program grant (no. 2007CB815700), a key project of the National Natural Science Foundation of China (no. 90919056), the 100 Talents Program of Chinese Academy of Sciences, two Provincial Key Grants of the Department of Sciences and Technology of Yunnan Province (no. 2008CC017 and no. 2008GA002) and a Chinese Academy of Sciences-Max Planck Society Fellowship to W. W.; a National Natural Science Foundation of China grant (no. 30870296) and a China Postdoctoral Science Foundation grant to H. X.; the National Natural Science Foundation of China (no. 30725008), a Chinese 863 Program grant (no. 2006AA10A121), the Danish Platform for Integrative Biology, the Ole Romer grant from the Danish Natural Science Research Council, and a Solexa Project grant (no. 272-07-0196) to J.W.; a 973 Program grant (no. 2005CB121000) to Q.X.; a Shanghai Science Foundation grant (no. 07DJ14074), two National Science Foundation grants (no. 90919024 and no. 30872963), two 973 Program grants (no. 2009CB825606 and no. 2009CB825607) and a European 6th program grant (no. LSHB-CT-2005-019067) to J.Z.	Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Farcas R, 2009, MOL BIOL EVOL, V26, P1379, DOI 10.1093/molbev/msp046; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Lawrence RJ, 2004, CELL CYCLE, V3, P880; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mandrioli M, 2006, CELL MOL LIFE SCI, V63, P1933, DOI 10.1007/s00018-006-6039-1; Mandrioli M, 2007, CHROMOSOME RES, V15, P1015, DOI 10.1007/s10577-007-1176-4; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Schaefer M, 2007, BIOESSAYS, V29, P208, DOI 10.1002/bies.20548; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Uno T, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.8; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; XIANG ZH, 1995, GENETICS BREEDING SI; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	30	231	257	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					516	U181		10.1038/nbt.1626	http://dx.doi.org/10.1038/nbt.1626			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20436463				2022-12-25	WOS:000277452700033
J	Dolgin, E				Dolgin, Elie			Anticounterfeit campaigners go back to school	NATURE MEDICINE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					362	362		10.1038/nm0410-362c	http://dx.doi.org/10.1038/nm0410-362c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376028	Bronze			2022-12-25	WOS:000276446800021
J	Gupta, R; Lavollay, M; Mainardi, JL; Arthur, M; Bishai, WR; Lamichhane, G				Gupta, Radhika; Lavollay, Marie; Mainardi, Jean-Luc; Arthur, Michel; Bishai, William R.; Lamichhane, Gyanu			The Mycobacterium tuberculosis protein Ldt(Mt2) is a nonclassical transpeptidase required for virulence and resistance to amoxicillin	NATURE MEDICINE			English	Article							CLAVULANIC ACID; PEPTIDOGLYCAN; PERSISTENCE; INHIBITION; MECHANISM; PHASE	The peptidoglycan layer is a vital component of the bacterial cell wall. The existing paradigm describes the peptidoglycan network as a static structure that is cross-linked predominantly by 4 -> 3 transpeptide linkages. However, the nonclassical 3 -> 3 linkages predominate the transpeptide networking of the peptidoglycan layer of nonreplicating Mycobacterium tuberculosis(1,2). The molecular basis of these linkages and their role in the physiology of the peptidoglycan layer, virulence and susceptibility of M. tuberculosis to drugs remain undefined. Here we identify MT2594 as an L,D-transpeptidase that generates 3 -> 3 linkages in M. tuberculosis. We show that the loss of this protein leads to altered colony morphology, loss of virulence and increased susceptibility to amoxicillin-clavulanate during the chronic phase of infection. This suggests that 3 -> 3 cross-linking is vital to the physiology of the peptidoglycan layer. Although a functional homolog exists, expression of ldt(Mt2) is dominant throughout the growth phases of M. tuberculosis. 4 -> 3 transpeptide linkages are targeted by one of the most widely used classes of antibacterial drugs in human clinical use today, beta-lactams. Recently, meropenem-clavulanate was shown to be effective against drug-resistant M. tuberculosis(3). Our study suggests that a combination of L,D-transpeptidase and beta-lactamase inhibitors could effectively target persisting bacilli during the chronic phase of tuberculosis.	[Gupta, Radhika; Bishai, William R.; Lamichhane, Gyanu] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Lavollay, Marie; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 06, Ctr Rech Cordeliers, Lab Rech Mol Antibiot, Paris, France; [Lavollay, Marie; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 05, Paris, France; [Lavollay, Marie; Mainardi, Jean-Luc; Arthur, Michel] INSERM, Paris, France; [Mainardi, Jean-Luc] Hop Europeen Georges Pompidou, Paris, France	Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Lamichhane, G (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	lamichhane@jhu.edu	Arthur, Michel/G-3680-2013; LAVOLLAY, Marie/G-6824-2015; MAINARDI, Jean-Luc/E-2714-2014	Arthur, Michel/0000-0003-1007-636X; LAVOLLAY, Marie/0000-0003-1464-6913; MAINARDI, Jean-Luc/0000-0002-4159-0129; Gupta, Radhika/0000-0002-0445-0194; Lamichhane, Gyanu/0000-0002-2214-0114	US National Institutes of Health [AI30036]; Foundation pour la Recherche Medicale [200661107918]; Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030036] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge the support of US National Institutes of Health award AI30036. This work was also supported by the Foundation pour la Recherche Medicale (Equipe FRM 2006 (Dequation 200661107918)). M. Lavollay is the recipient of an Institut National de la Sante et de la Recherche Medicale PhD fellowship (Poste d'Accueil pour Pharmacien, Medecin, et Veterinaire).	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Auger G, 2003, FEMS MICROBIOL LETT, V219, P115, DOI 10.1016/S0378-1097(02)01203-X; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Crick DC, 2008, MYCOBACTERIAL CELL ENVELOPE, P25; Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954; Fauci AS, 2008, J INFECT DIS, V197, P1493, DOI 10.1086/587904; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goren M. B., 1979, TUBERCULOSIS, P63; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; LAVOLLAY M, 2009, MOL MICROBI IN PRESS; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Matsuhashi M, 1966, Tanpakushitsu Kakusan Koso, V11, P875; NADLER JP, 1991, CHEST, V99, P1025, DOI 10.1378/chest.99.4.1025; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WIETZERBIN J, 1974, BIOCHEMISTRY-US, V13, P3471, DOI 10.1021/bi00714a008	29	198	205	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					466	U22		10.1038/nm.2120	http://dx.doi.org/10.1038/nm.2120			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20305661	Green Accepted			2022-12-25	WOS:000276446800052
J	Sagona, AP; Nezis, IP; Pedersen, NM; Liestol, K; Poulton, J; Rusten, TE; Skotheim, RI; Raiborg, C; Stenmark, H				Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Liestol, Knut; Poulton, John; Rusten, Tor Erik; Skotheim, Rolf I.; Raiborg, Camilla; Stenmark, Harald			PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody	NATURE CELL BIOLOGY			English	Article							ESCRT-III; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PROTEIN INTERACTIONS; MEDIATED ABSCISSION; STRUCTURAL BASIS; EARLY ENDOSOMES; COILED-COIL; AUTOPHAGY; MEMBRANE; TUMORIGENESIS	Several subunits of the class III phosphatidylinositol-3-OH kinase (PI(3)K-III) complex are known as tumour suppressors. Here we uncover a function for this complex and its catalytic product phosphatidylinositol-3-phosphate (PtdIns( 3) P) in cytokinesis. We show that PtdIns(3) P localizes to the midbody during cytokinesis and recruits a centrosomal protein, FYVE-CENT (ZFYVE26), and its binding partner TTC19, which in turn interacts with CHMP4B, an endosomal sorting complex required for transport (ESCRT)-III subunit implicated in the abscission step of cytokinesis. Translocation of FYVE-CENT and TTC19 from the centrosome to the midbody requires another FYVE-CENT-interacting protein, the microtubule motor KIF13A. Depletion of the VPS34 or Beclin 1 subunits of PI(3)K-III causes cytokinesis arrest and an increased number of binucleate and multinucleate cells, in a similar manner to the depletion of FYVE-CENT, KIF13A or TTC19. These results provide a mechanism for the translocation and docking of a cytokinesis regulatory machinery at the midbody.	[Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Liestol, Knut; Poulton, John; Rusten, Tor Erik; Skotheim, Rolf I.; Raiborg, Camilla; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway; [Sagona, Antonia P.; Nezis, Ioannis P.; Pedersen, Nina Marie; Poulton, John; Rusten, Tor Erik; Raiborg, Camilla; Stenmark, Harald] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; [Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0310 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Stenmark, H (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway.	stenmark@ulrik.uio.no	Nezis, Ioannis/AAE-8625-2020; Stenmark, Harald/B-8868-2008; Nezis, Ioannis P/I-4910-2014; Skotheim, Rolf I./H-6192-2017; Nezis, Ioannis/Q-6124-2019	Nezis, Ioannis P/0000-0003-0233-7574; Skotheim, Rolf I./0000-0002-5609-4048; Nezis, Ioannis/0000-0003-0233-7574; Rusten, Tor Erik/0000-0002-9150-2676	Research Council of Norway; South-Eastern Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	We thank Nobutaka Hirokawa for providing the expression construct for Myc-KIF13A, Aviva Tolkovsky for the gift of HeLa GFP-LC3 cells, Wes Sundquist for providing CHMP4A constructs, and Thomas P. Neufeld for the vps34 mutant flies. A.P.S. is a PhD student of the ENDOCYTE Research Training Network of the European Union. I.P.N. is a postdoctoral fellow of the Stem Cell Research Programme of the Research Council of Norway. N.M.P. is a postdoctoral fellow of the South-Eastern Norway Regional Health Authority. C.R. is a postdoctoral fellow, and T.E.R. and R.I.S. are senior research fellows, of the Norwegian Cancer Society.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Montagnac G, 2008, BIOCHEM SOC T, V36, P442, DOI 10.1042/BST0360442; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Raiborg C, 2001, J CELL SCI, V114, P2255; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stenmark H, 2001, SEMIN CELL DEV BIOL, V12, P193, DOI 10.1006/scdb.2000.0236; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	42	162	177	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					362	U140		10.1038/ncb2036	http://dx.doi.org/10.1038/ncb2036			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20208530	Green Published			2022-12-25	WOS:000276194600009
J	Said, EA; Dupuy, FP; Trautmann, L; Zhang, YW; Shi, Y; El-Far, M; Hill, BJ; Noto, A; Ancuta, P; Peretz, Y; Fonseca, SG; Van Grevenynghe, J; Boulassel, MR; Bruneau, J; Shoukry, NH; Routy, JP; Douek, DC; Haddad, EK; Sekaly, RP				Said, Elias A.; Dupuy, Franck P.; Trautmann, Lydie; Zhang, Yuwei; Shi, Yu; El-Far, Mohamed; Hill, Brenna J.; Noto, Alessandra; Ancuta, Petronela; Peretz, Yoav; Fonseca, Simone G.; Van Grevenynghe, Julien; Boulassel, Mohamed R.; Bruneau, Julie; Shoukry, Naglaa H.; Routy, Jean-Pierre; Douek, Daniel C.; Haddad, Elias K.; Sekaly, Rafick-Pierre			Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC VIRAL-INFECTION; SERUM IL-10 LEVELS; DISEASE PROGRESSION; PD-1 EXPRESSION; DENDRITIC CELLS; ANTIRETROVIRAL THERAPY; CYTOKINE SIGNALING-3; IMMUNE ACTIVATION; HUMAN MACROPHAGES	Viral replication and microbial translocation from the gut to the blood during HIV infection lead to hyperimmune activation, which contributes to the decline in CD4(+) T cell numbers during HIV infection. Programmed death-1 (PD-1) and interleukin-10 (IL-10) are both upregulated during HIV infection. Blocking interactions between PD-1 and programmed death ligand-1 (PD-L1) and between IL-10 and IL-10 receptor (IL-10R) results in viral clearance and improves T cell function in animal models of chronic viral infections. Here we show that high amounts of microbial products and inflammatory cytokines in the plasma of HIV-infected subjects lead to upregulation of PD-1 expression on monocytes that correlates with high plasma concentrations of IL-10. Triggering of PD-1 expressed on monocytes by PD-L1 expressed on various cell types induced IL-10 production and led to reversible CD4(+) T cell dysfunction. We describe a new function for PD-1 whereby microbial products inhibit T cell expansion and function by upregulating PD-1 levels and IL-10 production by monocytes after binding of PD-1 by PD-L1.	[Said, Elias A.; Dupuy, Franck P.; Trautmann, Lydie; Zhang, Yuwei; Shi, Yu; El-Far, Mohamed; Noto, Alessandra; Ancuta, Petronela; Peretz, Yoav; Fonseca, Simone G.; Van Grevenynghe, Julien; Bruneau, Julie; Shoukry, Naglaa H.; Haddad, Elias K.; Sekaly, Rafick-Pierre] CRCHUM, Hop St Luc, Montreal, PQ, Canada; [Said, Elias A.; Dupuy, Franck P.; Trautmann, Lydie; Zhang, Yuwei; Shi, Yu; El-Far, Mohamed; Noto, Alessandra; Ancuta, Petronela; Peretz, Yoav; Fonseca, Simone G.; Van Grevenynghe, Julien; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3C 3J7, Canada; [Said, Elias A.; Dupuy, Franck P.; Trautmann, Lydie; Zhang, Yuwei; Shi, Yu; El-Far, Mohamed; Noto, Alessandra; Ancuta, Petronela; Peretz, Yoav; Fonseca, Simone G.; Van Grevenynghe, Julien; Routy, Jean-Pierre; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, CRCHUM, Inst Nat Sante & Rech Med, U743, Montreal, PQ H3C 3J7, Canada; [Trautmann, Lydie; Sekaly, Rafick-Pierre] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Hill, Brenna J.; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Boulassel, Mohamed R.; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Immunodeficiency Serv & Div Hematol, Montreal, PQ, Canada; [Bruneau, Julie] Univ Montreal, Dept Med Familiale, Montreal, PQ, Canada; [Shoukry, Naglaa H.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Haddad, Elias K.; Sekaly, Rafick-Pierre] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Vaccine & Gene Therapy Institute of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McGill University; Royal Victoria Hospital; Universite de Montreal; Universite de Montreal; McGill University	Sekaly, RP (corresponding author), CRCHUM, Hop St Luc, Montreal, PQ, Canada.	Rafick-pierre.sekaly@umontreal.ca	Said, Elias/AAY-5557-2020; FONSECA, SIMONE GONÇALVES/U-9278-2019; Zhang, Yuwei/H-3287-2018	Ancuta, Petronela/0000-0003-1922-5640; El-Far, Mohamed/0000-0002-6458-4207; Trautmann, Lydie/0000-0002-3012-0009; Said, Elias/0000-0003-4224-6351	Canadian Institutes of Health Research (CIHR); Canadian Foundation for Infectious Diseases; Fonds de la recherche en sante du Quebec; US National Institutes of Health; Canadian Foundation for AIDS Research; Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076174, ZIAAI005066, ZIAAI005033, ZIAAI005034, ZIAAI005031] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Infectious Diseases; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for AIDS Research; Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the subjects for their participation in this study. We also thank M. Legault and C. Grignon for their clinical assistance with the recruitment of study subjects. We are grateful to V. A. Evans and J. D. Schatzle for help in manuscript revision. E. A. S., L. T., M. E.-F. and J. V. G. are funded by the Canadian Institutes of Health Research (CIHR). N. H. S. holds a joint New Investigator Award from the Canadian Foundation for Infectious Diseases and CIHR. J. B. and J.-P. R. are clinician-scientists supported by Fonds de la recherche en sante du Quebec. R.-P. S. is the Canada Research Chair in Human Immunology. This study was supported by funds from the US National Institutes of Health, the CIHR, the Canadian Foundation for AIDS Research, the Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI) and the Canadian Network for Vaccines and Immunotherapeutics. This study was funded in part by the Intramural Program of the US National Institutes of Health. Vectors were generously provided by E. Cohen at the Institut de Recherches Cliniques de Montreal. The lentiviral vector pWPI (empty vector), packaging plasmid psPAX2 and envelope plasmid pMD2G were generously provided by D. Trono (University of Geneva).	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Boasso A, 2008, CLIN IMMUNOL, V129, P132, DOI 10.1016/j.clim.2008.05.009; BREEN EC, 1990, J IMMUNOL, V144, P480; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bright JJ, 1998, J IMMUNOL, V161, P1772; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; CHOLLETMARTIN S, 1994, AIDS, V8, P879, DOI 10.1097/00002030-199407000-00003; Clerici M, 1996, BLOOD, V88, P574, DOI 10.1182/blood.V88.2.574.bloodjournal882574; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; El-Far Mohamed, 2008, Curr HIV/AIDS Rep, V5, P13, DOI 10.1007/s11904-008-0003-7; Frankenberger M, 1996, BLOOD, V87, P373; Geng L, 2006, J VIRAL HEPATITIS, V13, P725, DOI 10.1111/j.1365-2893.2006.00746.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Groschel S, 2008, J MOL MED, V86, P443, DOI 10.1007/s00109-008-0310-x; Hagiwara E, 1996, AIDS RES HUM RETROV, V12, P127, DOI 10.1089/aid.1996.12.127; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KETLINSKY SA, 1992, VESTN ROS AKAD MED+, P36; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kumar A, 1998, CLIN EXP IMMUNOL, V114, P78; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; MALEFYT RD, 1991, J EXP MED, V174, P915; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; SalazarGonzalez JF, 1997, CLIN IMMUNOL IMMUNOP, V84, P36, DOI 10.1006/clin.1997.4364; Shrestha S, 2007, CANCER EPIDEM BIOMAR, V16, P1626, DOI 10.1158/1055-9965.EPI-06-0881; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Swaminathan S, 2003, SEMIN HEMATOL, V40, P107, DOI 10.1016/S0037-1963(03)70002-X; Than S, 1997, J INFECT DIS, V175, P47, DOI 10.1093/infdis/175.1.47; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	50	320	350	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					452	U136		10.1038/nm.2106	http://dx.doi.org/10.1038/nm.2106			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20208540	Green Accepted			2022-12-25	WOS:000276446800050
J	Eden, ER; White, IJ; Tsapara, A; Futter, CE				Eden, Emily R.; White, Ian J.; Tsapara, Anna; Futter, Clare E.			Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction	NATURE CELL BIOLOGY			English	Article							TYROSINE-PHOSPHATASE 1B; ENDOPLASMIC-RETICULUM; MULTIVESICULAR ENDOSOMES; INWARD VESICULATION; VESICLE FORMATION; PROTEIN; HRS; CELLS; PTP1B; VAP	The epidermal growth factor receptor (EGFR) is a critical determinator of cell fate. Signalling from this receptor tyrosine kinase is spatially regulated by progression through the endocytic pathway, governing receptor half-life and accessibility to signalling proteins and phosphatases. Endocytosis of EGFR is required for interaction with the protein tyrosine phosphatase PTP1B (ref. 1), which localizes to the cytoplasmic face of the endoplasmic reticulum (ER)(2), raising the question of how PTP1B comes into contact with endosomal EGFR. We show that EGFR-PTP1B interaction occurs by means of direct membrane contacts between the perimeter membrane of multivesicular bodies (MVBs) and the ER. The population of EGFR interacting with PTP1B is the same population that undergo ESCRT (endosomal sorting complex required for transport)-mediated sorting within MVBs, and PTP1B activity promotes the sequestration of EGFR on to MVB internal vesicles. Membrane contacts between endosomes and the ER form in both the presence and absence of stimulation by EGF. Thus membrane contacts between endosomes and the ER may represent a global mechanism for direct interaction between proteins on these two organelles.	[Eden, Emily R.; White, Ian J.; Tsapara, Anna; Futter, Clare E.] UCL, Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London	Futter, CE (corresponding author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	c.futter@ucl.ac.uk	TSAPARA, ANNA/AAT-8478-2020	Eden, Emily/0000-0001-9352-5532; Futter, Clare/0000-0001-5559-9389	Wellcome Trust [078304]; Cancer Research UK [C20675]; MRC [G0801878] Funding Source: UKRI; Medical Research Council [G0801878] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Lorna Bailey, Tim Levine, Steve Moss, Minoo Razi and the Futter laboratory and Institute of Ophthalmology EM unit members for technical help and advice. This work was funded by the Wellcome Trust (078304) and Cancer Research UK (C20675).	Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966	35	234	237	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					267	U64		10.1038/ncb2026	http://dx.doi.org/10.1038/ncb2026			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118922				2022-12-25	WOS:000275054200012
J	Dupuis, J; Langenberg, C; Prokopenko, I; Saxena, R; Soranzo, N; Jackson, AU; Wheeler, E; Glazer, NL; Bouatia-Naji, N; Gloyn, AL; Lindgren, CM; Magi, R; Morris, AP; Randall, J; Johnson, T; Elliott, P; Rybin, D; Thorleifsson, G; Steinthorsdottir, V; Henneman, P; Grallert, H; Dehghan, A; Hottenga, JJ; Franklin, CS; Navarro, P; Song, K; Goel, A; Perry, JRB; Egan, JM; Lajunen, T; Grarup, N; Sparso, T; Doney, A; Voight, BF; Stringham, HM; Li, M; Kanoni, S; Shrader, P; Cavalcanti-Proenca, C; Kumari, M; Qi, L; Timpson, NJ; Gieger, C; Zabena, C; Rocheleau, G; Ingelsson, E; An, P; O'Connell, J; Luan, J; Elliott, A; McCarroll, SA; Payne, F; Roccasecca, RM; Pattou, F; Sethupathy, P; Ardlie, K; Ariyurek, Y; Balkau, B; Barter, P; Beilby, JP; Ben-Shlomo, Y; Benediktsson, R; Bennett, AJ; Bergmann, S; Bochud, M; Boerwinkle, E; Bonnefond, A; Bonnycastle, LL; Borch-Johnsen, K; Bottcher, Y; Brunner, E; Bumpstead, SJ; Charpentier, G; Chen, YDI; Chines, P; Clarke, R; Coin, LJM; Cooper, MN; Cornelis, M; Crawford, G; Crisponi, L; Day, INM; de Geus, EJC; Delplanque, J; Dina, C; Erdos, MR; Fedson, AC; Fischer-Rosinsky, A; Forouhi, NG; Fox, CS; Frants, R; Franzosi, MG; Galan, P; Goodarzi, MO; Graessler, J; Groves, CJ; Grundy, S; Gwilliam, R; Gyllensten, U; Hadjadj, S; Hallmans, G; Hammond, N; Han, XJ; Hartikainen, AL; Hassanali, N; Hayward, C; Heath, SC; Hercberg, S; Herder, C; Hicks, AA; Hillman, DR; Hingorani, AD; Hofman, A; Hui, J; Hung, J; Isomaa, B; Johnson, PRV; Jorgensen, T; Jula, A; Kaakinen, M; Kaprio, J; Kesaniemi, YA; Kivimaki, M; Knight, B; Koskinen, S; Kovacs, P; Kyvik, KO; Lathrop, GM; Lawlor, DA; Le Bacquer, O; Lecoeur, C; Li, Y; Lyssenko, V; Mahley, R; Mangino, M; Manning, AK; Martinez-Larrad, MT; McAteer, JB; McCulloch, LJ; McPherson, R; Meisinger, C; Melzer, D; Meyre, D; Mitchell, BD; Morken, MA; Mukherjee, S; Naitza, S; Narisu, N; Neville, MJ; Oostra, BA; Orru, M; Pakyz, R; Palmer, CNA; Paolisso, G; Pattaro, C; Pearson, D; Peden, JF; Pedersen, NL; Perola, M; Pfeiffer, AFH; Pichler, I; Polasek, O; Posthuma, D; Potter, SC; Pouta, A; Province, MA; Psaty, BM; Rathmann, W; Rayner, NW; Rice, K; Ripatti, S; Rivadeneira, F; Roden, M; Rolandsson, O; Sandbaek, A; Sandhu, M; Sanna, S; Sayer, AA; Scheet, P; Scott, LJ; Seedorf, U; Sharp, SJ; Shields, B; Sigurosson, G; Sijbrands, EJG; Silveira, A; Simpson, L; Singleton, A; Smith, NL; Sovio, U; Swift, A; Syddall, H; Syvanen, AC; Tanaka, T; Thorand, B; Tichet, J; Tonjes, A; Tuomi, T; Uitterlinden, AG; van Dijk, KW; van Hoek, M; Varma, D; Visvikis-Siest, S; Vitart, V; Vogelzangs, N; Waeber, G; Wagner, PJ; Walley, A; Walters, GB; Ward, KL; Watkins, H; Weedon, MN; Wild, SH; Willemsen, G; Witteman, JCM; Yarnell, JWG; Zeggini, E; Zelenika, D; Zethelius, B; Zhai, GJ; Zhao, JH; Zillikens, MC; Borecki, IB; Loos, RJF; Meneton, P; Magnusson, PKE; Nathan, DM; Williams, GH; Hattersley, AT; Silander, K; Salomaa, V; Smith, GD; Bornstein, SR; Schwarz, P; Spranger, J; Karpe, F; Shuldiner, AR; Cooper, C; Dedoussis, GV; Serrano-Rios, M; Morris, AD; Lind, L; Palmer, LJ; Hu, FB; Franks, PW; Ebrahim, S; Marmot, M; Kao, WHL; Pankow, JS; Sampson, MJ; Kuusisto, J; Laakso, M; Hansen, T; Pedersen, O; Pramstaller, PP; Wichmann, HE; Illig, T; Rudan, I; Wright, AF; Stumvoll, M; Campbell, H; Wilson, JF; Bergman, RN; Buchanan, TA; Collins, FS; Mohlke, KL; Tuomilehto, J; Valle, TT; Altshuler, D; Rotter, JI; Siscovick, DS; Penninx, BWJH; Boomsma, DI; Deloukas, P; Spector, TD; Frayling, TM; Ferrucci, L; Kong, A; Thorsteinsdottir, U; Stefansson, K; van Duijn, CM; Aulchenko, YS; Cao, A; Scuteri, A; Schlessinger, D; Uda, M; Ruokonen, A; Jarvelin, MR; Waterworth, DM; Vollenweider, P; Peltonen, L; Mooser, V; Abecasis, GR; Wareham, NJ; Sladek, R; Froguel, P; Watanabe, RM; Meigs, JB; Groop, L; Boehnke, M; McCarthy, MI; Florez, JC; Barroso, I				Dupuis, Josee; Langenberg, Claudia; Prokopenko, Inga; Saxena, Richa; Soranzo, Nicole; Jackson, Anne U.; Wheeler, Eleanor; Glazer, Nicole L.; Bouatia-Naji, Nabila; Gloyn, Anna L.; Lindgren, Cecilia M.; Magi, Reedik; Morris, Andrew P.; Randall, Joshua; Johnson, Toby; Elliott, Paul; Rybin, Denis; Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Henneman, Peter; Grallert, Harald; Dehghan, Abbas; Hottenga, Jouke Jan; Franklin, Christopher S.; Navarro, Pau; Song, Kijoung; Goel, Anuj; Perry, John R. B.; Egan, Josephine M.; Lajunen, Taina; Grarup, Niels; Sparso, Thomas; Doney, Alex; Voight, Benjamin F.; Stringham, Heather M.; Li, Man; Kanoni, Stavroula; Shrader, Peter; Cavalcanti-Proenca, Christine; Kumari, Meena; Qi, Lu; Timpson, Nicholas J.; Gieger, Christian; Zabena, Carina; Rocheleau, Ghislain; Ingelsson, Erik; An, Ping; O'Connell, Jeffrey; Luan, Jian'an; Elliott, Amanda; McCarroll, Steven A.; Payne, Felicity; Roccasecca, Rosa Maria; Pattou, Francois; Sethupathy, Praveen; Ardlie, Kristin; Ariyurek, Yavuz; Balkau, Beverley; Barter, Philip; Beilby, John P.; Ben-Shlomo, Yoav; Benediktsson, Rafn; Bennett, Amanda J.; Bergmann, Sven; Bochud, Murielle; Boerwinkle, Eric; Bonnefond, Amelie; Bonnycastle, Lori L.; Borch-Johnsen, Knut; Boettcher, Yvonne; Brunner, Eric; Bumpstead, Suzannah J.; Charpentier, Guillaume; Chen, Yii-Der Ida; Chines, Peter; Clarke, Robert; Coin, Lachlan J. M.; Cooper, Matthew N.; Cornelis, Marilyn; Crawford, Gabe; Crisponi, Laura; Day, Ian N. M.; de Geus, Eco J. C.; Delplanque, Jerome; Dina, Christian; Erdos, Michael R.; Fedson, Annette C.; Fischer-Rosinsky, Antje; Forouhi, Nita G.; Fox, Caroline S.; Frants, Rune; Franzosi, Maria Grazia; Galan, Pilar; Goodarzi, Mark O.; Graessler, Juergen; Groves, Christopher J.; Grundy, Scott; Gwilliam, Rhian; Gyllensten, Ulf; Hadjadj, Samy; Hallmans, Goeran; Hammond, Naomi; Han, Xijing; Hartikainen, Anna-Liisa; Hassanali, Neelam; Hayward, Caroline; Heath, Simon C.; Hercberg, Serge; Herder, Christian; Hicks, Andrew A.; Hillman, David R.; Hingorani, Aroon D.; Hofman, Albert; Hui, Jennie; Hung, Joe; Isomaa, Bo; Johnson, Paul R. V.; Jorgensen, Torben; Jula, Antti; Kaakinen, Marika; Kaprio, Jaakko; Kesaniemi, Y. Antero; Kivimaki, Mika; Knight, Beatrice; Koskinen, Seppo; Kovacs, Peter; Kyvik, Kirsten Ohm; Lathrop, G. Mark; Lawlor, Debbie A.; Le Bacquer, Olivier; Lecoeur, Cecile; Li, Yun; Lyssenko, Valeriya; Mahley, Robert; Mangino, Massimo; Manning, Alisa K.; Teresa Martinez-Larrad, Maria; McAteer, Jarred B.; McCulloch, Laura J.; McPherson, Ruth; Meisinger, Christa; Melzer, David; Meyre, David; Mitchell, Braxton D.; Morken, Mario A.; Mukherjee, Sutapa; Naitza, Silvia; Narisu, Narisu; Neville, Matthew J.; Oostra, Ben A.; Orru, Marco; Pakyz, Ruth; Palmer, Colin N. A.; Paolisso, Giuseppe; Pattaro, Cristian; Pearson, Daniel; Peden, John F.; Pedersen, Nancy L.; Perola, Markus; Pfeiffer, Andreas F. H.; Pichler, Irene; Polasek, Ozren; Posthuma, Danielle; Potter, Simon C.; Pouta, Anneli; Province, Michael A.; Psaty, Bruce M.; Rathmann, Wolfgang; Rayner, Nigel W.; Rice, Kenneth; Ripatti, Samuli; Rivadeneira, Fernando; Roden, Michael; Rolandsson, Olov; Sandbaek, Annelli; Sandhu, Manjinder; Sanna, Serena; Sayer, Avan Aihie; Scheet, Paul; Scott, Laura J.; Seedorf, Udo; Sharp, Stephen J.; Shields, Beverley; Sigurosson, Gunnar; Sijbrands, Eric J. G.; Silveira, Angela; Simpson, Laila; Singleton, Andrew; Smith, Nicholas L.; Sovio, Ulla; Swift, Amy; Syddall, Holly; Syvanen, Ann-Christine; Tanaka, Toshiko; Thorand, Barbara; Tichet, Jean; Tonjes, Anke; Tuomi, Tiinamaija; Uitterlinden, Andre G.; van Dijk, Ko Willems; van Hoek, Mandy; Varma, Dhiraj; Visvikis-Siest, Sophie; Vitart, Veronique; Vogelzangs, Nicole; Waeber, Gerard; Wagner, Peter J.; Walley, Andrew; Walters, G. Bragi; Ward, Kim L.; Watkins, Hugh; Weedon, Michael N.; Wild, Sarah H.; Willemsen, Gonneke; Witteman, Jaqueline C. M.; Yarnell, John W. G.; Zeggini, Eleftheria; Zelenika, Diana; Zethelius, Bjorn; Zhai, Guangju; Zhao, Jing Hua; Zillikens, M. Carola; Borecki, Ingrid B.; Loos, Ruth J. F.; Meneton, Pierre; Magnusson, Patrik K. E.; Nathan, David M.; Williams, Gordon H.; Hattersley, Andrew T.; Silander, Kaisa; Salomaa, Veikko; Smith, George Davey; Bornstein, Stefan R.; Schwarz, Peter; Spranger, Joachim; Karpe, Fredrik; Shuldiner, Alan R.; Cooper, Cyrus; Dedoussis, George V.; Serrano-Rios, Manuel; Morris, Andrew D.; Lind, Lars; Palmer, Lyle J.; Hu, Frank B.; Franks, Paul W.; Ebrahim, Shah; Marmot, Michael; Kao, W. H. Linda; Pankow, James S.; Sampson, Michael J.; Kuusisto, Johanna; Laakso, Markku; Hansen, Torben; Pedersen, Oluf; Pramstaller, Peter Paul; Wichmann, H. Erich; Illig, Thomas; Rudan, Igor; Wright, Alan F.; Stumvoll, Michael; Campbell, Harry; Wilson, James F.; Bergman, Richard N.; Buchanan, Thomas A.; Collins, Francis S.; Mohlke, Karen L.; Tuomilehto, Jaakko; Valle, Timo T.; Altshuler, David; Rotter, Jerome I.; Siscovick, David S.; Penninx, Brenda W. J. H.; Boomsma, Dorret I.; Deloukas, Panos; Spector, Timothy D.; Frayling, Timothy M.; Ferrucci, Luigi; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari; van Duijn, Cornelia M.; Aulchenko, Yurii S.; Cao, Antonio; Scuteri, Angelo; Schlessinger, David; Uda, Manuela; Ruokonen, Aimo; Jarvelin, Marjo-Riitta; Waterworth, Dawn M.; Vollenweider, Peter; Peltonen, Leena; Mooser, Vincent; Abecasis, Goncalo R.; Wareham, Nicholas J.; Sladek, Robert; Froguel, Philippe; Watanabe, Richard M.; Meigs, James B.; Groop, Leif; Boehnke, Michael; McCarthy, Mark I.; Florez, Jose C.; Barroso, Ines		DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten Procardis Consortiu; MAGIC Investigators	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL DYSFUNCTION; PLASMA-GLUCOSE; INSULIN-RESISTANCE; ESSENTIAL COMPONENTS; TRIGLYCERIDE LEVELS; MODEL ASSESSMENT; CIRCADIAN CLOCK; DISEASE RISK; FOLLOW-UP	Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes.	[Jackson, Anne U.; Stringham, Heather M.; Han, Xijing; Li, Yun; Lyssenko, Valeriya; Scott, Laura J.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Dupuis, Josee; Manning, Alisa K.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dupuis, Josee; Fox, Caroline S.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Langenberg, Claudia; Luan, Jian'an; Forouhi, Nita G.; Sandhu, Manjinder; Sharp, Stephen J.; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Prokopenko, Inga; Gloyn, Anna L.; Lindgren, Cecilia M.; Magi, Reedik; Bennett, Amanda J.; Groves, Christopher J.; Hassanali, Neelam; Johnson, Paul R. V.; McCulloch, Laura J.; Neville, Matthew J.; Rayner, Nigel W.; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Prokopenko, Inga; Lindgren, Cecilia M.; Magi, Reedik; Morris, Andrew P.; Randall, Joshua; Goel, Anuj; Peden, John F.; Rayner, Nigel W.; Watkins, Hugh; Zeggini, Eleftheria; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Saxena, Richa; Voight, Benjamin F.; Elliott, Amanda; McCarroll, Steven A.; Crawford, Gabe; McAteer, Jarred B.; Altshuler, David; Florez, Jose C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Saxena, Richa; Voight, Benjamin F.; Elliott, Amanda; McCarroll, Steven A.; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Soranzo, Nicole; Bumpstead, Suzannah J.; Gwilliam, Rhian; Hammond, Naomi; Potter, Simon C.; Varma, Dhiraj; Zeggini, Eleftheria; Deloukas, Panos; Spector, Timothy D.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Soranzo, Nicole; Mangino, Massimo; Zhai, Guangju; Spector, Timothy D.] Kings Coll London, Twin Res & Genet Epidemiol Dept, London WC2R 2LS, England; [Wheeler, Eleanor; Payne, Felicity; Roccasecca, Rosa Maria; Barroso, Ines] Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge, England; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Psaty, Bruce M.; Ferrucci, Luigi] Univ Washington, Dept Med, Seattle, WA USA; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Bonnefond, Amelie; Delplanque, Jerome; Dina, Christian; Le Bacquer, Olivier; Lecoeur, Cecile; Meyre, David; Froguel, Philippe] Univ Lille 2, Inst Pasteur, CNRS, Unite Mixte Rech 8090, Lille, France; [Johnson, Toby; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Johnson, Toby; Bochud, Murielle] CHU Vaudois, Univ Inst Social & Preventat Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Elliott, Paul; Coin, Lachlan J. M.; Sovio, Ulla; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London, England; [Rybin, Denis] Boston Univ, Data Coordinating Ctr, Boston, MA 02215 USA; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Walters, G. Bragi; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Henneman, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Grallert, Harald; Gieger, Christian; Meisinger, Christa; Thorand, Barbara; Wichmann, H. Erich; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany; [Dehghan, Abbas; Hofman, Albert; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Witteman, Jaqueline C. M.; van Duijn, Cornelia M.; Aulchenko, Yurii S.] Erasmus Med Coll, Dept Epidemiol, Rotterdam, Netherlands; [Hottenga, Jouke Jan; de Geus, Eco J. C.; Posthuma, Danielle; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Franklin, Christopher S.; Wild, Sarah H.; Rudan, Igor; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Navarro, Pau; Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Song, Kijoung; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline, Div Genet Res & Dev, King Of Prussia, PA USA; [Goel, Anuj; Peden, John F.; Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Perry, John R. B.; Knight, Beatrice; Melzer, David; Shields, Beverley; Weedon, Michael N.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Inst Biomed & Clin Sci, Exeter, Devon, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Lajunen, Taina] Univ Oulu, Bioctr, Natl Inst Hlth & Welf, Unit Child & Adolescent Hlth & Welf, Oulu, Finland; [Grarup, Niels; Sparso, Thomas; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Doney, Alex] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med & Therapeut, Level 7, Dundee DD1 9SY, Scotland; [Li, Man] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kanoni, Stavroula; Dedoussis, George V.] Harokopio Univ, Dept Nutr Dietet, Athens, Greece; [Shrader, Peter; Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Kumari, Meena; Brunner, Eric; Hingorani, Aroon D.; Kivimaki, Mika; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London, England; [Qi, Lu; Cornelis, Marilyn; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Cornelis, Marilyn; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Timpson, Nicholas J.; Day, Ian N. M.; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Zabena, Carina; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Hosp Clin San Carlos, Fdn Invest Biomed, Madrid, Spain; [Rocheleau, Ghislain; Sladek, Robert] McGill Univ, Dept Med, Montreal, PQ, Canada; [Rocheleau, Ghislain; Sladek, Robert] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Rocheleau, Ghislain; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Ingelsson, Erik; Pedersen, Nancy L.; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ingelsson, Erik; Zethelius, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [An, Ping; Province, Michael A.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [O'Connell, Jeffrey; Mitchell, Braxton D.; Pakyz, Ruth; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Pattou, Francois] Univ Lille Nord France, INSERM, U859, Lille, France; [Sethupathy, Praveen; Bonnycastle, Lori L.; Chines, Peter; Erdos, Michael R.; Morken, Mario A.; Narisu, Narisu; Pearson, Daniel; Swift, Amy; Collins, Francis S.; Schlessinger, David] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Ariyurek, Yavuz] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; [Balkau, Beverley] Univ Paris 11, INSERM, U780, Villejuif, France; [Barter, Philip] Heart Res Inst, Sydney, NSW, Australia; [Beilby, John P.; Hui, Jennie] QEII Med Ctr, Dept Mol Genet, PathW Lab Western Australia, Nedlands, WA, Australia; [Beilby, John P.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Benediktsson, Rafn; Sigurosson, Gunnar] Landspitali Univ Hosp, Reykjavik, Iceland; [Benediktsson, Rafn; Sigurosson, Gunnar] Iceland Heart Assoc, Kopavogur, Iceland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Borch-Johnsen, Knut] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Boettcher, Yvonne; Tonjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Essonnes, France; [Chen, Yii-Der Ida; Goodarzi, Mark O.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Cooper, Matthew N.; Fedson, Annette C.; Simpson, Laila; Ward, Kim L.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [Crisponi, Laura; Naitza, Silvia; Orru, Marco; Sanna, Serena; Cao, Antonio; Scuteri, Angelo; Uda, Manuela] Cittadella Univ Monserrato, CNR, INN, Cagliari, Italy; [Fedson, Annette C.; Hillman, David R.; Mukherjee, Sutapa; Simpson, Laila; Ward, Kim L.; Palmer, Lyle J.] Queen Elizabeth II Med Ctr, Western Australian Sleep Disorders Res Inst, Perth, WA, Australia; [Fischer-Rosinsky, Antje; Pfeiffer, Andreas F. H.; Spranger, Joachim] Charite, Dept Endocrinol Diabetol & Nutr, D-13353 Berlin, Germany; [Fischer-Rosinsky, Antje; Pfeiffer, Andreas F. H.; Spranger, Joachim] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [Fox, Caroline S.; Williams, Gordon H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Frants, Rune; van Dijk, Ko Willems] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Franzosi, Maria Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Galan, Pilar] Univ Paris 13, INRA, INSERM, Bobigny, France; [Graessler, Juergen; Bornstein, Stefan R.; Schwarz, Peter] Univ Dresden, Dept Med 3, Div Prevent & Care Diabet, Dresden, Germany; [Grundy, Scott] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hadjadj, Samy] Univ Poitiers, Unite Format & Rech, Ctr Hosp Univ Poitiers, INSERM,U927,CIC 0802, Poitiers, France; [Hallmans, Goeran] Umea Univ, Sect Nutr Res, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Heath, Simon C.; Lathrop, G. Mark; Zelenika, Diana] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Hercberg, Serge; Meneton, Pierre] Fac Med Paris Descartes, INSERM, U872, Paris, France; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Hicks, Andrew A.; Pattaro, Cristian; Pichler, Irene; Pramstaller, Peter Paul] European Acad Bozen Bolzano, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pattaro, Cristian; Pichler, Irene; Pramstaller, Peter Paul] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Hillman, David R.; Mukherjee, Sutapa] Sir Charles Gairdner Hosp, Dept Pulm Physiol, Perth, WA, Australia; [Hui, Jennie; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Perth, WA, Australia; [Hung, Joe] Sir Charles Gairdner Hosp, Heart Inst Western Australia, Nedlands, WA 6009, Australia; [Hung, Joe] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Malmska Municipal Hlth Care Ctr & Hosp, Pietarsaari, Finland; [Johnson, Paul R. V.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, Copenhagen, Denmark; [Jula, Antti] Natl Inst Hlth & Welf, Unit Populat Studies, Turku, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaprio, Jaakko; Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Fac Med, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Unit Child & Adolescent Mental Hlth, Helsinki, Finland; [Kaprio, Jaakko; Perola, Markus; Ripatti, Samuli; Wagner, Peter J.; Silander, Kaisa; Peltonen, Leena] Univ Helsinki, Inst tute Mol Med Finland FIMM, Helsinki, Finland; [Kesaniemi, Y. Antero] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; [Koskinen, Seppo] Natl Inst Hlth & Welf, Unit Living Condit Hlth & Wellbeing, Helsinki, Finland; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Lyssenko, Valeriya; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Mahley, Robert] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [McAteer, Jarred B.; Nathan, David M.; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [McAteer, Jarred B.; Nathan, David M.; Williams, Gordon H.; Altshuler, David; Meigs, James B.; Florez, Jose C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Neville, Matthew J.; Karpe, Fredrik; McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England; [Oostra, Ben A.] Erasmus Med Coll, Dept Clin Genet, Rotterdam, Netherlands; [Palmer, Colin N. A.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy; [Perola, Markus; Ripatti, Samuli; Wagner, Peter J.; Silander, Kaisa; Peltonen, Leena] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki, Finland; [Perola, Markus; Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Polasek, Ozren] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Dept Med Stat Epidemiol & Med Informat, Zagreb 41000, Croatia; [Posthuma, Danielle] VU Univ & Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Pouta, Anneli] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Psaty, Bruce M.; Smith, Nicholas L.; Ferrucci, Luigi] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; van Hoek, Mandy; Zillikens, M. Carola] Erasmus Med Coll, Dept Internal Med, Rotterdam, Netherlands; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Rolandsson, Olov] Umea Univ, Sect Family Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Sandbaek, Annelli] Univ Aarhus, Dept Gen Practice, Sch Publ Hlth, Aarhus, Denmark; [Sandhu, Manjinder] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England; [Sayer, Avan Aihie; Syddall, Holly; Cooper, Cyrus] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Silveira, Angela; Anders Hamsten Procardis Consortiu] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Dept Vet Affairs, Off Res & Dev, Seattle, WA USA; [Syvanen, Ann-Christine; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Tanaka, Toshiko] MedStar Res Inst, Baltimore, MD USA; [Tichet, Jean] Inst Interreg Sante IRSA, La Riche, France; [Tonjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Tuomi, Tiinamaija] Univ Helsinki, Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands; [Visvikis-Siest, Sophie] Nancy Univ Henri Poincare, Res Unit, Nancy, France; [Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Walley, Andrew; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Yarnell, John W. G.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Zethelius, Bjorn] Med Prod Agcy, Uppsala, Sweden; [Salomaa, Veikko] Natl Inst Hlth & Welf, Unit Chron Dis Epidemiol & Prevent, Helsinki, Finland; [Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Franks, Paul W.] Umea Univ Hosp, Med Sect, Dept Publ Hlth & Clin Med, Genet Epidemiol & Clin Res Grp, S-90185 Umea, Sweden; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Kao, W. H. Linda] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kao, W. H. Linda] Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sampson, Michael J.] Norfolk & Norwich Univ Hosp Natl Hlth Serv Trust, Dept Endocrinol & Diabet, Norwich, Norfolk, England; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pramstaller, Peter Paul] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter Paul] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Rudan, Igor] Univ Split, Sch Med, Split, Croatia; [Rudan, Igor] Gen Info Ltd, Zagreb, Croatia; [Bergman, Richard N.; Buchanan, Thomas A.; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Dept Med, Los Angeles, CA 90033 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Tuomilehto, Jaakko; Valle, Timo T.] Natl Inst Hlth & Welf, Unit Diabet Prevent, Helsinki, Finland; [Siscovick, David S.] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Scuteri, Angelo] Univ Iceland, Fac Med, Reykjavik, Iceland; [Ruokonen, Aimo] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Dept Clin Sci Clin Chem, Oulu, Finland; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, Hlth Protect Agcy Ctr Environm & Hlth, London, England	University of Michigan System; University of Michigan; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; University of London; King's College London; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Imperial College London; Boston University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; University of Edinburgh; University of Edinburgh; GlaxoSmithKline; University of Oxford; University of Exeter; University of Plymouth; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Finland National Institute for Health & Welfare; University of Oulu; Novo Nordisk; Hagedorn Research Institute; University of Dundee; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harokopio University Athens; Harvard University; Massachusetts General Hospital; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; Hospital Clinico San Carlos; McGill University; McGill University; Karolinska Institutet; Uppsala University; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; Heart Research Institute; University of Western Australia; University of Western Australia; University of Bristol; Landspitali National University Hospital; Icelandic Heart Association; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Steno Diabetes Center; Aarhus University; Leipzig University; Centre Hospitalier Sud Francilien; Cedars Sinai Medical Center; University of Oxford; University of Oxford; University of Western Australia; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; University of Western Australia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Technische Universitat Dresden; University of Texas System; University of Texas Southwestern Medical Center Dallas; Uppsala University; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Umea University; University of Oulu; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; European Academy of Bozen-Bolzano; University of Lubeck; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Folkhalsan Research Center; University of Oxford; University of Copenhagen; University of Copenhagen; Finland National Institute for Health & Welfare; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; Finland National Institute for Health & Welfare; Leipzig University; University of Southern Denmark; Lund University; Skane University Hospital; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Ottawa; University of Ottawa Heart Institute; University of Oxford; Erasmus University Rotterdam; Erasmus MC; University of Dundee; Universita della Campania Vanvitelli; Finland National Institute for Health & Welfare; University of Helsinki; University of Zagreb; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oulu; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Heinrich Heine University Dusseldorf; Umea University; Aarhus University; University of Cambridge; University of Southampton; University of Texas System; UTMD Anderson Cancer Center; University of Munster; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Leipzig University; University of Helsinki; Helsinki University Central Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Lorraine; Vrije Universiteit Amsterdam; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; Queens University Belfast; Medical Products Agency; Finland National Institute for Health & Welfare; Harvard University; Brigham & Women's Hospital; Umea University; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Southern Denmark; Krankenhaus Bozen; University of Lubeck; University of Munich; University of Munich; University of Split; University of Southern California; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; Finland National Institute for Health & Welfare; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oulu; University of Southern California; Imperial College London	Boehnke, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	boehnke@umich.edu; mark.mccarthy@drl.ox.ac.uk; jcflorez@partners.org; ib1@sanger.ac.uk	Hicks, Andrew Anthony/E-9518-2017; Polasek, Ozren/B-6002-2011; Pramstaller, Peter P/C-2357-2008; Franks, Paul/AAA-3300-2020; Schwarz, Peter/AAF-1558-2020; Loos, Ruth J F/Q-2862-2016; Abecasis, Goncalo R/B-7840-2010; Pfeiffer, Andreas F.H./AAJ-2311-2020; Walters, G. Bragi/L-4215-2013; Kyvik, Kirsten O/K-5680-2016; Wilson, James F/A-5704-2009; Elliott, Amanda/G-5120-2012; Payne, Felicity/GKF-2573-2022; Manning, Alisa Knodle/ABC-7711-2021; Rotter, Jerome/AAY-6598-2021; Mangino, Massimo/F-5134-2011; Visvikis-Siest, Sophie/H-2324-2014; Marmot, M G/Y-3920-2019; Ward, Kim/X-9856-2019; Stefansson, Kari/AAE-7187-2019; Jørgensen, Torben/Z-1335-2018; Palmer, Lyle John/N-1948-2019; Voight, Benjamin/F-1775-2011; Saxena, Richa/AAG-7279-2020; Rivadeneira, Fernando/O-5385-2015; BOUATIA-NAJI, NABILA/D-5863-2013; van Hoek, Mandy/B-9325-2014; Study, GoDARTS/K-9448-2016; Coin, Lachlan JM/A-9001-2014; Palmer, Lyle John/K-3196-2014; Prokopenko, Inga/AAU-9895-2020; Sayer, Avan Aihie/A-4359-2012; Rudan, Igor/I-1467-2012; Pedersen, Oluf/Z-1731-2019; Altshuler, David M/A-4476-2009; Wichmann, Heinz Erich/AAA-5695-2022; Langenberg, Claudia/ABG-9067-2021; Attrill, Lauren/V-1688-2018; Mukherjee, Sutapa/U-7262-2017; Singleton, Andrew B/C-3010-2009; FROGUEL, Philippe/O-6799-2017; Sijbrands, Eric/A-1065-2009; Boehm, Bernhard Otto/F-8750-2015; Lajunen, Taina K/J-7337-2013; Cooper, Matthew N/J-4420-2014; Dedoussis, George/AAN-7252-2021; Grarup, Niels/K-2807-2015; Palmer, Colin NA/C-7053-2008; HERCBERG, Serge/B-4429-2008; Navarro, Pau/AAJ-8091-2021; Uda, Manuela/AAC-2645-2019; Deloukas, Panos/B-2922-2013; Kivimaki, Mika/B-3607-2012; van Dijk, Ko Willems/A-1798-2008; Meisinger, Christine/B-5358-2014; Ripatti, Samuli/H-9446-2014; Mitchell, Braxton/CAF-0876-2022; Prokopenko, Inga/H-3241-2014; Li, Man/AAX-3400-2020; Narisu, Narisu/T-6908-2019; SIMPSON, LAILA/O-7281-2014; Spector, Tim D/F-6533-2012; Boomsma, Dorret I/AAX-4470-2020; Meyre, David/D-7315-2011; Timpson, Nicholas John/O-7548-2015; Pilar, Galan/F-2908-2017; paolisso, giuseppe/AAP-8516-2020; Pedersen, Oluf/AAG-8015-2020; Penninx, Brenda WJH/S-7627-2017; NAITZA, SILVIA/AAB-8775-2022; Campbell, Harry/E-2959-2010; Magnusson, Patrik KE/C-4458-2017; Serrano Ríos, Manuel/E-4625-2019; Fox, Laura J/C-6249-2016; Coin, Lachlan/O-4976-2019; Roden, Michael/AAD-3843-2019; Bouatia-Naji, Nabila/AGF-1400-2022; Heath, Simon C/J-4138-2012; Kanoni, Stavroula/AAN-7161-2021; Thorand, Barbara/B-5349-2014; sanna, serena/H-3009-2019; Serge, Hercberg/F-3038-2017; Mägi, Reedik/AAJ-9679-2021; Meigs, James/P-3927-2019; Sladek, Robert/R-2391-2019; Doney, Alexander SF/P-7437-2017; Sovio, Ulla/H-8532-2019; Walley, Andrew J/D-2573-2009; Grallert, Harald/B-3424-2013; van Dijk, Ko Willems/AAT-4681-2021; Stumvoll, Michael/ABE-1121-2021; Hayward, Caroline/M-8818-2016; Crisponi, Laura/AAC-2642-2019; Meneton, Pierre/T-1216-2019; Pattou, Francois/O-6151-2017; Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Ben-Shlomo, Yoav/ABD-2004-2021; Goodarzi, Mark/AAH-7106-2021; Naitza, Silvia/D-5620-2017; Loos, Ruth/GON-5877-2022; Rice, Kenneth M/A-4150-2013; Kaprio, Jaakko/A-1820-2008; Bonnefond, Amélie/O-2784-2017; Brunner, Eric/H-2114-2011; Benediktsson, Rafn/R-2457-2018; Davey Smith, George/A-7407-2013; Aulchenko, Yurii/M-8270-2013; Dina, Christian R/D-3535-2015; Hui, Jennie/A-9543-2013; Dehghan, Abbas/ABE-7377-2020; de Geus, Eco J.C./M-9318-2015; Dehghan, Abbas/B-9896-2008; McCarthy, Mark/M-3763-2015	Hicks, Andrew Anthony/0000-0001-6320-0411; Polasek, Ozren/0000-0002-5765-1862; Loos, Ruth J F/0000-0002-8532-5087; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Walters, G. Bragi/0000-0002-5415-6487; Kyvik, Kirsten O/0000-0003-2981-0245; Wilson, James F/0000-0001-5751-9178; Payne, Felicity/0000-0003-4228-581X; Mangino, Massimo/0000-0002-2167-7470; Visvikis-Siest, Sophie/0000-0001-8104-8425; Marmot, M G/0000-0002-2431-6419; Palmer, Lyle John/0000-0002-1628-3055; Rivadeneira, Fernando/0000-0001-9435-9441; Coin, Lachlan JM/0000-0002-4300-455X; Palmer, Lyle John/0000-0002-1628-3055; Rudan, Igor/0000-0001-6993-6884; Pedersen, Oluf/0000-0002-3321-3972; Altshuler, David M/0000-0002-7250-4107; Langenberg, Claudia/0000-0002-5017-7344; Mukherjee, Sutapa/0000-0001-5021-1648; FROGUEL, Philippe/0000-0003-2972-0784; Sijbrands, Eric/0000-0001-8857-7389; Lajunen, Taina K/0000-0001-8012-457X; Cooper, Matthew N/0000-0003-1139-3682; Dedoussis, George/0000-0002-7798-6221; Grarup, Niels/0000-0001-5526-1070; Palmer, Colin NA/0000-0002-6415-6560; HERCBERG, Serge/0000-0002-3168-1350; Navarro, Pau/0000-0001-5576-8584; Uda, Manuela/0000-0002-4890-6456; Deloukas, Panos/0000-0001-9251-070X; Kivimaki, Mika/0000-0002-4699-5627; van Dijk, Ko Willems/0000-0002-2172-7394; Ripatti, Samuli/0000-0002-0504-1202; Prokopenko, Inga/0000-0003-1624-7457; Li, Man/0000-0002-3839-0281; SIMPSON, LAILA/0000-0001-7189-4791; Meyre, David/0000-0003-4850-7444; Timpson, Nicholas John/0000-0002-7141-9189; Pilar, Galan/0000-0003-1706-3107; paolisso, giuseppe/0000-0002-2137-455X; Penninx, Brenda WJH/0000-0001-7779-9672; NAITZA, SILVIA/0000-0002-0108-757X; Campbell, Harry/0000-0002-6169-6262; Magnusson, Patrik KE/0000-0002-7315-7899; Serrano Ríos, Manuel/0000-0002-3214-1444; Coin, Lachlan/0000-0002-4300-455X; Bouatia-Naji, Nabila/0000-0001-5424-2134; Heath, Simon C/0000-0002-9550-0897; Kanoni, Stavroula/0000-0002-1691-9615; Thorand, Barbara/0000-0002-8416-6440; sanna, serena/0000-0002-3768-1749; Serge, Hercberg/0000-0002-3168-1350; Meigs, James/0000-0002-2439-2657; Sladek, Robert/0000-0002-2730-1204; Doney, Alexander SF/0000-0002-6210-5620; Sovio, Ulla/0000-0002-0799-1105; Walley, Andrew J/0000-0001-7707-7549; van Dijk, Ko Willems/0000-0002-2172-7394; Stumvoll, Michael/0000-0001-6225-8240; Hayward, Caroline/0000-0002-9405-9550; Crisponi, Laura/0000-0001-9128-8537; Pattou, Francois/0000-0001-8388-3766; Bochud, Murielle/0000-0002-5727-0218; Ben-Shlomo, Yoav/0000-0001-6648-3007; Goodarzi, Mark/0000-0001-6364-5103; Rice, Kenneth M/0000-0001-5779-4495; Kaprio, Jaakko/0000-0002-3716-2455; Bonnefond, Amélie/0000-0001-9976-3005; Brunner, Eric/0000-0002-0595-4474; Benediktsson, Rafn/0000-0002-2954-9801; Davey Smith, George/0000-0002-1407-8314; Aulchenko, Yurii/0000-0002-7899-1575; Dina, Christian R/0000-0002-7722-7348; Hui, Jennie/0000-0002-1653-2496; de Geus, Eco J.C./0000-0001-6022-2666; Beilby, John/0000-0002-4915-2254; Glazer, Nicole/0000-0002-6397-609X; Hansen, Torben/0000-0001-8748-3831; Watkins, Hugh/0000-0002-5287-9016; Meisinger, Christa/0000-0002-9026-6544; Magi, Reedik/0000-0002-2964-6011; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Goel, Anuj/0000-0003-2307-4021; Dehghan, Abbas/0000-0001-6403-016X; Bergmann, Sven/0000-0002-6785-9034; Kumari, Meena/0000-0001-9716-1035; Hattersley, Andrew/0000-0001-5620-473X; Forouhi, Nita/0000-0002-5041-248X; Karpe, Fredrik/0000-0002-2751-1770; Rybin, Denis/0000-0002-3657-4829; Posthuma, Danielle/0000-0001-7582-2365; Aihie Sayer, Avan/0000-0003-1283-6457; Soranzo, Nicole/0000-0003-1095-3852; McCarthy, Mark/0000-0002-4393-0510; Barroso, Ines/0000-0001-5800-4520; Weedon, Michael/0000-0002-6174-6135; SCUTERI, ANGELO/0000-0003-4784-5441; Saxena, Richa/0000-0003-2233-1065; Lawlor, Debbie A/0000-0002-6793-2262; Dupuis, Josee/0000-0003-2871-3603; Hillman, David/0000-0001-9987-539X; Pankow, James/0000-0001-7076-483X; Johnson, Toby/0000-0002-5998-3270; bennett, amanda/0000-0003-2140-8710; Graessler, Juergen/0000-0003-3619-8517; Randall, Joshua/0000-0003-1540-203X; s, hema/0000-0002-3440-9475; Voight, Benjamin/0000-0002-6205-9994; Silveira, Angela/0000-0003-2063-4935; Mitchell, Braxton/0000-0003-4920-4744; Cooper, Cyrus/0000-0003-3510-0709; Tuomi, Tiinamaija/0000-0002-8306-6202; Jorgensen, Torben/0000-0001-9453-2830; Shuldiner, Alan/0000-0001-9921-4305; Bergman, Richard/0000-0003-1539-4471; Seedorf, Udo/0000-0003-4652-5358; Zeggini, Eleftheria/0000-0003-4238-659X; Wheeler, Eleanor/0000-0002-8616-6444; Hingorani, Aroon/0000-0001-8365-0081; Elliott, Paul/0000-0002-7511-5684; Kaakinen, Marika/0000-0002-9228-0462; Kovacs, Peter/0000-0002-0290-5423; Van Duijn, Cornelia/0000-0002-2374-9204; Pichler, Irene/0000-0001-8251-0757; Melzer, David/0000-0002-0170-3838; Willemsen, Gonneke/0000-0003-3755-0236; Gloyn, Anna/0000-0003-1205-1844; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Gieger, Christian/0000-0001-6986-9554; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Waeber, Gerard/0000-0003-4193-788X; Lindgren, Cecilia/0000-0002-4903-9374; Abecasis, Goncalo/0000-0003-1509-1825	ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600331, MC_UP_A620_1015, G0902037, G0701863, G0601261, G0801056, MC_U137686857, MC_U127561128, G0700222, MC_U127592696, G0600705, MC_U106188470] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [U1475000002, G0801056B, U1475000001, G0600717B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0600705, MC_U127561128, G0701863, G0902037, G0700222(81696), G0600331, G0601261, MC_UP_A620_1014, G0100222, MC_U137686857, G0700222, MC_U127592696, MC_UP_A620_1015, G8802774, G19/35, MC_U106188470, G0801056, MC_U106179471] Funding Source: Medline; NIDDK NIH HHS [R01 DK078616-01A1, P30 DK040561, R01 DK078616, R01 DK029867, P30 DK040561-14, K24 DK080140, R01 DK072193] Funding Source: Medline; The Dunhill Medical Trust [R69/0208] Funding Source: Medline; Wellcome Trust [077016, 081682, 089061, 090532, 091746, 064890, 088885, 077011] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140, R01DK072193, R01DK029867, R01DK078616, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050, ZIAAG000965, ZIAAG000015, ZIAAG000675] Funding Source: NIH RePORTER	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); The Dunhill Medical Trust(Dunhill Medical Trust); Wellcome Trust(Wellcome Trust); Chief Scientist Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bergman RN, 2003, DIABETES, V52, P2168, DOI 10.2337/diabetes.52.8.2168; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Clemmons DR, 2004, HORM RES, V62, P77, DOI 10.1159/000080763; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Genuth S, 2003, DIABETES CARE, V26, P3160; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keane D, 2008, BIOCHEM SOC T, V36, P955, DOI 10.1042/BST0360955; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Petitti D. B., 2000, METAANALYSIS DECISIO, P94; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; R Development Core Team, 2007, R LANG ENV STAT COMP; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Warton K, 2004, GENE, V342, P85, DOI 10.1016/j.gene.2004.07.027; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	74	1567	1609	7	297	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					105	U32		10.1038/ng.520	http://dx.doi.org/10.1038/ng.520			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081858	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000274084400005
J	Liu, LZ; Zhong, Q; Tian, T; Dubin, K; Athale, SK; Kupper, TS				Liu, Luzheng; Zhong, Qiong; Tian, Tian; Dubin, Krista; Athale, Shruti K.; Kupper, Thomas S.			Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity	NATURE MEDICINE			English	Article							VACCINIA ANKARA MVA; SMALLPOX VACCINATION; SKIN; COMPLICATIONS; EFFICACY; ANTIGEN	Variola major (smallpox) infection claimed hundreds of millions lives before it was eradicated by a simple vaccination strategy: epicutaneous application of the related orthopoxvirus vaccinia virus (VACV) to superficially injured skin (skin scarification, s.s.)(1). However, the remarkable success of this strategy was attributed to the immunogenicity of VACV rather than to the unique mode of vaccine delivery. We now show that VACV immunization via s.s., but not conventional injection routes, is essential for the generation of superior T cell-mediated immune responses that provide complete protection against subsequent challenges, independent of neutralizing antibodies. Skin-resident effector memory T cells (T-EM cells) provide complete protection against cutaneous challenge, whereas protection against lethal respiratory challenge requires both respiratory mucosal TEM cells and central memory T cells (T-CM cells). Vaccination with recombinant VACV (rVACV) expressing a tumor antigen was protective against tumor challenge only if delivered via the s.s. route; it was ineffective if delivered by hypodermic injection. The clinically safer nonreplicative modified vaccinia Ankara virus (MVA) also generated far superior protective immunity when delivered via the s.s. route compared to intramuscular (i.m.) injection as used in MVA clinical trials. Thus, delivery of rVACV-based vaccines, including MVA vaccines, through physically disrupted epidermis has clear-cut advantages over conventional vaccination via hypodermic injection.	[Liu, Luzheng; Zhong, Qiong; Tian, Tian; Dubin, Krista; Athale, Shruti K.; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Skin Dis Res Ctr,Dept Dermatol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kupper, TS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Skin Dis Res Ctr,Dept Dermatol, Boston, MA 02115 USA.	lzliu@rics.bwh.harvard.edu; tkupper@partners.org	Kupper, Thomas/O-4962-2019		NIH-US National Institute of Allergy and Infectious Diseases [R01 AI042124, R37 AI025082, U19AI57330, AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025082, U19AI057330, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065807] Funding Source: NIH RePORTER	NIH-US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. Moss ( US National Institute of Health (NIH)) for providing rVACV expressing EGFP and OT-IT cell epitope OVA<INF>257-264</INF>, as well as WR-VACV. We thank K. Rock ( University of Massachusetts Medical School) for providing the MO5 cell line and M. Seaman ( Beth Israel Hospital) for providing the MVA stocks. FTY720 was provided by V. Brinkmann at Novartis Pharmaceuticals. This work was supported by NIH-US National Institute of Allergy and Infectious Diseases grants R01 AI042124 and R37 AI025082 to T. S. K. and NIH grant U19AI57330 subcontracted to T. S. K., a Dermatology Foundation Research Career Development Award to L. L. and a Career Development Award and a New Opportunities Grant to L. L. from US National Institute of Allergy and Infectious Diseases-New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease (AI057159).	Bray M, 2003, ANTIVIR RES, V58, P101, DOI 10.1016/S0166-3542(03)00008-1; Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; EARL PL, 1998, CURRENT PROTOCOLS MO, V2, pCH16; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; KUPPER TS, 1995, J INVEST DERMATOL, V105, P62; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; NEFF JM, 1967, PEDIATRICS, V39, P916; NEFF JM, 1970, J AMER MED ASSOC, V213, P123, DOI 10.1001/jama.213.1.123; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Partidos CD, 2005, CELL MOL LIFE SCI, V62, P1418, DOI 10.1007/s00018-005-4529-1; Phelps AL, 2007, VACCINE, V25, P34, DOI 10.1016/j.vaccine.2006.07.022; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Stewart AJ, 2006, J INFECTION, V52, P329, DOI 10.1016/j.jinf.2005.07.021; Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496	26	177	180	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					224	U132		10.1038/nm.2078	http://dx.doi.org/10.1038/nm.2078			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20081864	Green Accepted			2022-12-25	WOS:000274297000045
J	Noon, AT; Shibata, A; Rief, N; Lobrich, M; Stewart, GS; Jeggo, PA; Goodarzi, AA				Noon, Angela T.; Shibata, Atsushi; Rief, Nicole; Loebrich, Markus; Stewart, Grant S.; Jeggo, Penelope A.; Goodarzi, Aaron A.			53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair	NATURE CELL BIOLOGY			English	Article							ZINC-FINGER PROTEINS; ATAXIA-TELANGIECTASIA; MRN COMPLEX; CHROMATIN; DAMAGE; ATM; 53BP1; MDC1; ACTIVATION; PATHWAY	DNA double-strand breaks (DSBs) trigger ATM (ataxia telangiectasia mutated) signalling and elicit genomic rearrangements and chromosomal fragmentation if misrepaired or unrepaired. Although most DSB repair is ATM-independent, similar to 15% of ionizing radiation (IR)-induced breaks persist in the absence of ATM-signalling(1). 53BP1 (p53-binding protein 1) facilitates ATM-dependent DSB repair but is largely dispensable for ATM activation or checkpoint arrest. ATM promotes DSB repair within heterochromatin by phosphorylating KAP-1 (KRAB-associated protein 1, also known as TIF1 beta, TRIM28 or KRIP-1; ref. 2). Here, we show that the ATM signalling mediator proteins MDC1, RNF8, RNF168 and 53BP1 are also required for heterochromatic DSB repair. Although KAP-1 phosphorylation is critical for 53BP1-mediated repair, overall phosphorylated KAP-1 (pKAP-1) levels are only modestly affected by 53BP1 loss. pKAP-1 is transiently pan-nuclear but also forms foci overlapping with gamma H2AX in heterochromatin. Cells that do not form 53BP1 foci, including human RIDDLE (radiosensitivity, immunodeficiency, dysmorphic features and learning difficulties) syndrome cells, fail to form pKAP-1 foci. 53BP1 amplifies Mre11-NBS1 accumulation at late-repairing DSBs, concentrating active ATM and leading to robust, localized pKAP-1. We propose that ionizing-radiation induced foci (IRIF) spatially concentrate ATM activity to promote localized alterations in regions of chromatin otherwise inhibitory to repair.	[Noon, Angela T.; Shibata, Atsushi; Jeggo, Penelope A.; Goodarzi, Aaron A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Stewart, Grant S.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Rief, Nicole; Loebrich, Markus] Tech Univ Darmstadt, Radiat Biol & DNA Repair, D-64287 Darmstadt, Germany	University of Sussex; Cancer Research UK; University of Birmingham; Technical University of Darmstadt	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; a.goodarzi@sussex.ac.uk	Shibata, Atsushi/AAX-1283-2021	Shibata, Atsushi/0000-0001-8912-6977; Stewart, Grant/0000-0002-0960-3241	Alberta Heritage Foundation for Medical Research; Association for International Cancer Research (AICR); MRC; AICR; Wellcome Research Fund; Department of Health (UK); EU [LSHG-CT-2005-512113, FI6R-CT-2003-508842]; Medical Research Council [G0500897, G0801130B] Funding Source: researchfish; MRC [G0500897] Funding Source: UKRI	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Association for International Cancer Research (AICR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; Wellcome Research Fund; Department of Health (UK); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Paull for discussions of unpublished data, A. Vindigni for mass spectrometry analysis, K. Iwabuchi for 53BP1 expression constructs and Y. Shiloh and Y. Ziv for providing KAP-1 expression constructs. A. A. G. was supported by grants from the Alberta Heritage Foundation for Medical Research and the Association for International Cancer Research (AICR). The P. A. J. laboratory is funded by the MRC, AICR, the Wellcome Research Fund, the Department of Health (UK) and the EU integrated projects on DNA-Repair (LSHG-CT-2005-512113) and Risc-Rad (FI6R-CT-2003-508842).	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; YUAN J, 2009, J BIOL CHEM; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	40	254	259	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					177	U191		10.1038/ncb2017	http://dx.doi.org/10.1038/ncb2017			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081839				2022-12-25	WOS:000274139400012
J	Griffin, NM; Yu, JY; Long, F; Oh, P; Shore, S; Li, Y; Koziol, JA; Schnitzer, JE				Griffin, Noelle M.; Yu, Jingyi; Long, Fred; Oh, Phil; Shore, Sabrina; Li, Yan; Koziol, Jim A.; Schnitzer, Jan E.			Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; SHOTGUN PROTEOMICS; IN-VIVO; PROTEIN; SERUM; LUNG; STANDARDS; PEPTIDES; CAVEOLAE; DISEASE	Replicate mass spectrometry (MS) measurements and the use of multiple analytical methods can greatly expand the comprehensiveness of shotgun proteomic profiling of biological samples(1-5). However, the inherent biases and variations in such data create computational and statistical challenges for quantitative comparative analysis(6). We developed and tested a normalized, label-free quantitative method termed the normalized spectral index (SIN), which combines three MS abundance features: peptide count, spectral count and fragment-ion (tandem MS or MS/MS) intensity. SIN largely eliminated variances between replicate MS measurements, permitting quantitative reproducibility and highly significant quantification of thousands of proteins detected in replicate MS measurements of the same and distinct samples. It accurately predicts protein abundance more often than the five other methods we tested. Comparative immunoblotting and densitometry further validate our method. Comparative quantification of complex data sets from multiple shotgun proteomics measurements is relevant for systems biology and biomarker discovery.	[Griffin, Noelle M.; Yu, Jingyi; Long, Fred; Oh, Phil; Shore, Sabrina; Li, Yan; Schnitzer, Jan E.] Proteogenom Res Inst Syst Med, San Diego, CA USA; [Griffin, Noelle M.; Yu, Jingyi; Long, Fred; Oh, Phil; Shore, Sabrina; Li, Yan; Schnitzer, Jan E.] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Koziol, Jim A.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Schnitzer, JE (corresponding author), Proteogenom Res Inst Syst Med, San Diego, CA USA.	jschnitzer@prism-sd.org			National Institute of Health [RO1HL074063, R33CA118602, P01CA104898]; NATIONAL CANCER INSTITUTE [R33CA118602, P01CA104898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074063] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health grants (to J. E. S): RO1HL074063, R33CA118602 and P01CA104898.	Anderle M, 2004, BIOINFORMATICS, V20, P3575, DOI 10.1093/bioinformatics/bth446; Baggerly KA, 2003, PROTEOMICS, V3, P1667, DOI 10.1002/pmic.200300522; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Cheng Y, 2000, ISMB; Chiang MC, 2007, MOL CELL PROTEOMICS, V6, P781, DOI 10.1074/mcp.M600356-MCP200; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KENDALL MG, 1980, MULTIVARIATE ANAL; Kislinger T, 2005, J AM SOC MASS SPECTR, V16, P1207, DOI 10.1016/j.jasms.2005.02.015; Klimek J, 2008, J PROTEOME RES, V7, P96, DOI 10.1021/pr070244j; Kolodziej EP, 2003, ENVIRON TOXICOL CHEM, V22, P2622, DOI 10.1897/03-42; Koziol JA, 2006, ANAL CHEM, V78, P3203, DOI 10.1021/ac051248f; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Li Y, 2009, MOL CELL PROTEOMICS, V8, P1219, DOI 10.1074/mcp.M800215-MCP200; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Mirkin B., 1996, MATH CLASSIFICATION; Oh P, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P34; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Service RF, 2008, SCIENCE, V321, P1758, DOI [10.1126/science.321.5897.1758, 10.1126/science.321.5897.1760]; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Slebos RJC, 2008, J PROTEOME RES, V7, P5286, DOI 10.1021/pr8004666; TUKEY JW, 1953, T NEW YORK ACAD SCI, V16, P88, DOI 10.1111/j.2164-0947.1953.tb01326.x; Wagner M, 2003, PROTEOMICS, V3, P1692, DOI 10.1002/pmic.200300519; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wong JWH, 2008, BRIEF BIOINFORM, V9, P156, DOI 10.1093/bib/bbm046; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	40	308	327	4	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					83	U116		10.1038/nbt.1592	http://dx.doi.org/10.1038/nbt.1592			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20010810	Green Accepted			2022-12-25	WOS:000273430400025
J	Ashida, H; Kim, M; Schmidt-Supprian, M; Ma, A; Ogawa, M; Sasakawa, C				Ashida, Hiroshi; Kim, Minsoo; Schmidt-Supprian, Marc; Ma, Averil; Ogawa, Michinaga; Sasakawa, Chihiro			A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKK gamma to dampen the host NF-kappa B-mediated inflammatory response	NATURE CELL BIOLOGY			English	Article							DEPENDENT GENE-EXPRESSION; IMMUNE-RESPONSES; POLYUBIQUITIN CHAINS; PROTEIN; ACTIVATION; SYSTEM; BINDS; DISCRIMINATION; RECOGNITION; EFFECTORS	NF-kappa B (nuclear factor kappa B) has a pivotal role in many cellular processes, including the inflammatory and immune responses and, therefore, its activation is tightly regulated by the IKK (I kappa B kinase) complex and by I kappa B alpha degradation. When Shigella bacteria multiply within epithelial cells they release peptidoglycans, which are recognized by Nod1 and stimulate the NF-kappa B pathway, thus leading to a severe inflammatory response. Here, we show that IpaH9.8, a Shigella effector possessing E3 ligase activity, dampens the NF-kappa B-mediated inflammatory response to the bacterial infection in a unique way. IpaH9.8 interacts with NEMO/IKK gamma and ABIN-1, a ubiquitin-binding adaptor protein, promoting ABIN-1-dependent polyubiquitylation of NEMO. Consequently, polyubiquitylated NEMO undergoes proteasome-dependent degradation, which perturbs NF-kappa B activation. As NEMO is essential for NF-kappa B activation, we propose that the polyubiquitylation and degradation of NEMO during Shigella infection is a new bacterial strategy to modulate host inflammatory responses.	[Ashida, Hiroshi; Ogawa, Michinaga; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, Tokyo 1088639, Japan; [Ashida, Hiroshi; Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Tokyo; University of Tokyo; Max Planck Society; University of California System; University of California San Francisco	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Kim, Minsoo/0000-0001-8536-8653	The Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST);  [20229006];  [20659067];  [18073003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	The Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Sasakawa laboratory for their advice. This work was supported by Grand-in-Aid for Scientific Research (S) (20229006); a Grand-in-Aid for Exploratory Research (20659067); a Grant-in-Aid for Scientific Research on Priority Areas (18073003); the Strategic Cooperation to Control Emerging and Reemerging Infections Funded by The Special Coordination Funds for Promoting Science and Technology; and a Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; WAGNER S, 2008, ONCOGENE, V21, P1; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	34	192	201	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					66	U164		10.1038/ncb2006	http://dx.doi.org/10.1038/ncb2006			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010814	Green Accepted			2022-12-25	WOS:000272973800014
J	Gerlach, H; Laumann, V; Martens, S; Becker, CFW; Goody, RS; Geyer, M				Gerlach, Holger; Laumann, Vanessa; Martens, Sascha; Becker, Christian F. W.; Goody, Roger S.; Geyer, Matthias			HIV-1 Nef membrane association depends on charge, curvature, composition and sequence	NATURE CHEMICAL BIOLOGY			English	Article							VIRUS TYPE-1 NEF; PROTEIN-KINASE-C; PLASMA-MEMBRANE; BAR DOMAINS; CELL; MYRISTOYLATION; PHOSPHOLIPIDS; LOCALIZATION; ORGANIZATION; TRAFFICKING	Nef-mediated internalization of T-cell receptor molecules from the surface of an infected cell is required for the pathogenicity of HIV and disease progression to AIDS. This function depends on the N-terminal myristoylation of Nef, a lipid modification that targets the protein to membranes. We have analyzed how specific membrane properties and sequence motifs within Nef determine this interaction. Using time-resolved techniques we find that the association with membranes is a biphasic process with a fast rate for an electrostatic-driven protein-liposome interaction and a slow rate for the formation of an amphipathic helix. The rate of myristate insertion into liposomes depends on membrane curvature, while changes in the lipid composition with respect to phosphoinositides, cholesterol or sphingomyelin did not significantly alter the interaction. Moreover, Nef binding to membranes requires negatively charged liposomes, and mutations of basic and hydrophobic residues strongly diminished the association and changed the binding kinetics differently.	[Gerlach, Holger; Laumann, Vanessa; Becker, Christian F. W.; Goody, Roger S.; Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; [Martens, Sascha] Univ Vienna, Max F Perutz Labs, Vienna, Austria	Max Planck Society; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Phys Biochem Abt, Rheinlanddamm 201, D-44139 Dortmund, Germany.	matthias.geyer@mpi-dortmund.mpg.de	Martens, Sascha/C-3693-2011; Goody, Roger S/J-8845-2014; Becker, Christian F/A-4891-2010; Becker, Christian/E-3588-2010	Goody, Roger S/0000-0002-0772-0444; Becker, Christian F/0000-0002-8890-7082; Martens, Sascha/0000-0003-3786-8199; Geyer, Matthias/0000-0002-7718-5002				Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Arbuzova A, 1997, J BIOL CHEM, V272, P27167, DOI 10.1074/jbc.272.43.27167; Barnham KJ, 1997, BIOCHEMISTRY-US, V36, P5970, DOI 10.1021/bi9629945; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dries DR, 2008, J BIOL CHEM, V283, P7885, DOI 10.1074/jbc.M709943200; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mui B, 2003, METHOD ENZYMOL, V367, P3; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	48	74	76	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					46	53		10.1038/NCHEMBIO.268	http://dx.doi.org/10.1038/NCHEMBIO.268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19935658				2022-12-25	WOS:000272802500011
J	Kienast, Y; von Baumgarten, L; Fuhrmann, M; Klinkert, WEF; Goldbrunner, R; Herms, J; Winkler, F				Kienast, Yvonne; von Baumgarten, Louisa; Fuhrmann, Martin; Klinkert, Wolfgang E. F.; Goldbrunner, Roland; Herms, Jochen; Winkler, Frank			Real-time imaging reveals the single steps of brain metastasis formation	NATURE MEDICINE			English	Article							MELANOMA METASTASES; MDA-MB-435 CELLS; BREAST-CANCER; TUMOR-CELL; GROWTH; ANGIOGENESIS; EXPRESSION; DORMANCY; VEGF; MICROMETASTASES	Brain metastasis frequently occurs in individuals with cancer and is often fatal. We used multiphoton laser scanning microscopy to image the single steps of metastasis formation in real time. Thus, it was possible to track the fate of individual metastasizing cancer cells in vivo in relation to blood vessels deep in the mouse brain over minutes to months. The essential steps in this model were arrest at vascular branch points, early extravasation, persistent close contacts to microvessels and perivascular growth by vessel cooption (melanoma) or early angiogenesis (lung cancer). Inefficient steps differed between the tumor types. Long-term dormancy was only observed for single perivascular cancer cells, some of which moved continuously. Vascular endothelial growth factor-A (VEGF-A) inhibition induced long-term dormancy of lung cancer micrometastases by preventing angiogenic growth to macrometastases. The ability to image the establishment of brain metastases in vivo provides new insights into their evolution and response to therapies.	[Kienast, Yvonne; von Baumgarten, Louisa; Winkler, Frank] Univ Munich, Dept Neurol, D-8000 Munich, Germany; [Kienast, Yvonne; Fuhrmann, Martin; Herms, Jochen] Univ Munich, Dept Neuropathol, D-8000 Munich, Germany; [Goldbrunner, Roland] Univ Munich, Dept Neurosurg, D-8000 Munich, Germany; [Klinkert, Wolfgang E. F.] Max Planck Inst Neurobiol, Martinsried, Germany	University of Munich; University of Munich; University of Munich; Max Planck Society	Winkler, F (corresponding author), Univ Munich, Dept Neurol, D-8000 Munich, Germany.	frank.winkler@med.uni-muenchen.de	Herms, Jochen/D-3518-2011; Fuhrmann, Martin/E-4565-2011; Fuhrmann, Martin/J-2707-2018; von Baumgarten, Louisa/A-4636-2016	Fuhrmann, Martin/0000-0001-7672-2913; Winkler, Frank/0000-0003-4892-6104	German Cancer Foundation (Deutsche Kebshilfe); German Research Foundation (Deutsche Forschungsgemeinschaft) [WI1930/4-1]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung); German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie) [16IN0675, 13N10171, 13N9268]; Hypatia Foundation	German Cancer Foundation (Deutsche Kebshilfe); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie)(Federal Ministry for Economic Affairs and Energy (BMWi)); Hypatia Foundation	W. and J.H. received funding for this work from the German Cancer Foundation (Deutsche Kebshilfe), and F. W. received a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft; WI1930/4-1). J.H. received additional funding from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) and German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie) (16IN0675; 13N10171; 13N9268). Y.K. received a research grant from the Hypatia Foundation. We wish to thank C. Eggert for her excellent technical assistance, A. Ullrich, W. Hiddemann, R. Jain and U. Koedel for helpful discussions, K. Ogston for editing the manuscript and G. Mitteregger for her supervision of the animal facility. The PC14-PE6 human lung cancer cell line was kindly provided by I.J. Fidler, MD Anderson Cancer Center.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chambers AF, 2000, ADV CANCER RES, V79, P91, DOI 10.1016/S0065-230X(00)79003-8; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dome B, 2003, J NEUROPATH EXP NEUR, V62, P655; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; FIDLER IJ, 1986, CANCER RES, V46, P5167; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoffman RM, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1992485; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Ito S, 2001, INT J CANCER, V93, P212, DOI 10.1002/ijc.1318; KAWAGUCHI T, 1982, Invasion and Metastasis, V2, P40; KAYE AH, 2001, BRAIN TUMORS ENCY AP, P999; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; KOOP S, 1995, CANCER RES, V55, P2520; Kusters B, 2007, ONCOGENE, V26, P5808, DOI 10.1038/sj.onc.1210360; Kusters B, 2002, CANCER RES, V62, P341; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; SCHACKERT G, 1989, INT J CANCER, V44, P892, DOI 10.1002/ijc.2910440524; Scherbarth S, 1997, CANCER RES, V57, P4105; Seitz G, 2008, CELL PROLIFERAT, V41, P365, DOI 10.1111/j.1365-2184.2008.00520.x; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; WOOD S, 1958, ARCH PATHOL, V66, P550; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yano S, 2000, CANCER RES, V60, P4959	37	712	723	1	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					116	U157		10.1038/nm.2072	http://dx.doi.org/10.1038/nm.2072			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20023634				2022-12-25	WOS:000273395500045
J	Monier, B; Pelissier-Monier, A; Brand, AH; Sanson, B				Monier, Bruno; Pelissier-Monier, Anne; Brand, Andrea H.; Sanson, Benedicte			An actomyosin-based barrier inhibits cell mixing at compartmental boundaries in Drosophila embryos	NATURE CELL BIOLOGY			English	Article							ASSISTED LASER INACTIVATION; LINEAGE RESTRICTION BOUNDARY; NONMUSCLE MYOSIN-II; CRANIOFRONTONASAL SYNDROME; GENE-EXPRESSION; DORSAL CLOSURE; EPH RECEPTORS; GROWTH CONE; HEDGEHOG; ADHESION	Partitioning tissues into compartments that do not intermix is essential for the correct morphogenesis of animal embryos and organs(1-3). Several hypotheses have been proposed to explain compartmental cell sorting, mainly differential adhesion(1-9), but also regulation of the cytoskeleton(10,11) or of cell proliferation(10,12). Nevertheless, the molecular and cellular mechanisms that keep cells apart at boundaries remain unclear. Here we demonstrate, in early Drosophila melanogaster embryos, that actomyosin-based barriers stop cells from invading neighbouring compartments. Our analysis shows that cells can transiently invade neighbouring compartments, especially when they divide, but are then pushed back into their compartment of origin. Actomyosin cytoskeletal components are enriched at compartmental boundaries, forming cable-like structures when the epidermis is mitotically active. When MyoII (non-muscle myosin II) function is inhibited, including locally at the cable by chromophore-assisted laser inactivation (CALI)(13,14), in live embryos, dividing cells are no longer pushed back, leading to compartmental cell mixing. We propose that local regulation of actomyosin contractibility, rather than differential adhesion, is the primary mechanism sorting cells at compartmental boundaries.	[Monier, Bruno; Pelissier-Monier, Anne; Brand, Andrea H.; Sanson, Benedicte] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Pelissier-Monier, Anne; Brand, Andrea H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Monier, B (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	bm343@cam.ac.uk; bs251@cam.ac.uk	Brand, Andrea H/F-8220-2014	Brand, Andrea H/0000-0002-2089-6954; Sanson, Benedicte/0000-0002-2782-4195; Monier, Bruno/0000-0002-3553-6396	HFSP; Wellcome Trust; EMBO; ARC (Association pour la Recherche contre le Cancer); Herchel Smith; Medical Research Council [G0300072] Funding Source: researchfish; MRC [G0300072] Funding Source: UKRI	HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Herchel Smith; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Lawrence for the initial observation of the segmental pattern of MyoII cables and for Supplementary Information, Movie 1; B. Bordbar for help in screening chromosomal deficiencies; D. Kiehart, R. Karess, G. Davis, J. Pradel, R. Holmgren, the UK Protein Trap Insertion Consortium, the Bloomington Stock Centre and the Developmental Studies Hybridoma Bank for reagents and B. Harris, R. Keynes, L. Perrin, M. Semeriva and D. St Johnston for critical reading of the manuscript. This work was funded by HFSP and Wellcome Trust grants to B. S; a Wellcome Trust Program Grant to A. H. B; an EMBO fellowship to A. P-M and ARC (Association pour la Recherche contre le Cancer) and Herchel Smith fellowships to B. M.	BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blair SS, 1997, DEVELOPMENT, V124, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P287; Chandraratna D, 2007, J CELL SCI, V120, P2594, DOI 10.1242/jcs.03472; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Clyne PJ, 2003, GENETICS, V165, P1433; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Horstkotte E, 2005, PHOTOCHEM PHOTOBIOL, V81, P358, DOI 10.1562/2004-07-22-RA-240.1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Inoue T, 2001, DEVELOPMENT, V128, P561; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; JAY DG, 1988, P NATL ACAD SCI USA, V85, P5454, DOI 10.1073/pnas.85.15.5454; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Laplante C, 2006, DEVELOPMENT, V133, P3255, DOI 10.1242/dev.02492; Larsen C, 2008, DEV BIOL, V321, P310, DOI 10.1016/j.ydbio.2008.04.026; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; MARTINEZARIAS A, DEV DROSPHILLA MELAN; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Vegh M, 2003, GENETICS, V163, P1427; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yan P, 2006, BIOCHEMISTRY-US, V45, P4736, DOI 10.1021/bi052395a; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	60	174	175	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					60	U147		10.1038/ncb2005	http://dx.doi.org/10.1038/ncb2005			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966783	Green Accepted			2022-12-25	WOS:000272973800013
J	Repapi, E; Sayers, I; Wain, LV; Burton, PR; Johnson, T; Obeidat, M; Zhao, JH; Ramasamy, A; Zhai, GJ; Vitart, V; Huffman, JE; Igl, W; Albrecht, E; Deloukas, P; Henderson, J; Granell, R; McArdle, WL; Rudnicka, AR; Barroso, I; Loos, RJF; Wareham, NJ; Mustelin, L; Rantanen, T; Surakka, I; Imboden, M; Wichmann, HE; Grkovic, I; Jankovic, S; Zgaga, L; Hartikainen, AL; Peltonen, L; Gyllensten, U; Johansson, A; Zaboli, G; Campbell, H; Wild, SH; Wilson, JF; Glaser, S; Homuth, G; Volzke, H; Mangino, M; Soranzo, N; Spector, TD; Polasek, O; Rudan, I; Wright, AF; Heliovaara, M; Ripatti, S; Pouta, A; Naluai, AT; Olin, AC; Toren, K; Cooper, MN; James, AL; Palmer, LJ; Hingorani, AD; Wannamethee, SG; Whincup, PH; Smith, GD; Ebrahim, S; McKeever, TM; Pavord, ID; MacLeod, AK; Morris, AD; Porteous, DJ; Cooper, C; Dennison, E; Shaheen, S; Karrasch, S; Schnabel, E; Schulz, H; Grallert, H; Bouatia-Naji, N; Delplanque, J; Froguel, P; Blakey, JD; Britton, JR; Morris, RW; Holloway, JW; Lawlor, DA; Hui, J; Nyberg, F; Jarvelin, MR; Jackson, C; Kahonen, M; Kaprio, J; Probst-Hensch, NM; Koch, B; Hayward, C; Evans, DM; Elliott, P; Strachan, DP; Hall, IP; Tobin, MD				Repapi, Emmanouela; Sayers, Ian; Wain, Louise V.; Burton, Paul R.; Johnson, Toby; Obeidat, Ma'en; Zhao, Jing Hua; Ramasamy, Adaikalavan; Zhai, Guangju; Vitart, Veronique; Huffman, Jennifer E.; Igl, Wilmar; Albrecht, Eva; Deloukas, Panos; Henderson, John; Granell, Raquel; McArdle, Wendy L.; Rudnicka, Alicja R.; Barroso, Ines; Loos, Ruth J. F.; Wareham, Nicholas J.; Mustelin, Linda; Rantanen, Taina; Surakka, Ida; Imboden, Medea; Wichmann, H. Erich; Grkovic, Ivica; Jankovic, Stipan; Zgaga, Lina; Hartikainen, Anna-Liisa; Peltonen, Leena; Gyllensten, Ulf; Johansson, Asa; Zaboli, Ghazal; Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Glaeser, Sven; Homuth, Georg; Voelzke, Henry; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.; Polasek, Ozren; Rudan, Igor; Wright, Alan F.; Heliovaara, Markku; Ripatti, Samuli; Pouta, Anneli; Naluai, Asa Torinsson; Olin, Anna-Carin; Toren, Kjell; Cooper, Matthew N.; James, Alan L.; Palmer, Lyle J.; Hingorani, Aroon D.; Wannamethee, S. Goya; Whincup, Peter H.; Smith, George Davey; Ebrahim, Shah; McKeever, Tricia M.; Pavord, Ian D.; MacLeod, Andrew K.; Morris, Andrew D.; Porteous, David J.; Cooper, Cyrus; Dennison, Elaine; Shaheen, Seif; Karrasch, Stefan; Schnabel, Eva; Schulz, Holger; Grallert, Harald; Bouatia-Naji, Nabila; Delplanque, Jerome; Froguel, Philippe; Blakey, John D.; Britton, John R.; Morris, Richard W.; Holloway, John W.; Lawlor, Debbie A.; Hui, Jennie; Nyberg, Fredrik; Jarvelin, Marjo-Riitta; Jackson, Cathy; Kahonen, Mika; Kaprio, Jaakko; Probst-Hensch, Nicole M.; Koch, Beate; Hayward, Caroline; Evans, David M.; Elliott, Paul; Strachan, David P.; Hall, Ian P.; Tobin, Martin D.		Wellcome Trust Case Control Consor; NSHD Resp Study Team	Genome-wide association study identifies five loci associated with lung function	NATURE GENETICS			English	Article							ADVANCED GLYCATION ENDPRODUCTS; IDIOPATHIC PULMONARY-FIBROSIS; IN-VITRO; RECEPTOR; HEIGHT; HEALTH; POPULATION; MORTALITY; VARIANTS; CANCER	Pulmonary function measures are heritable traits that predict morbidity and mortality and define chronic obstructive pulmonary disease (COPD). We tested genome-wide association with forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) in the SpiroMeta consortium (n = 20,288 individuals of European ancestry). We conducted a meta-analysis of top signals with data from direct genotyping (n <= 32,184 additional individuals) and in silico summary association data from the CHARGE Consortium (n = 21,209) and the Health 2000 survey (n < 883). We confirmed the reported locus at 4q31 and identified associations with FEV1 or FEV1/FVC and common variants at five additional loci: 2q35 in TNS1 (P = 1.11 x 10(-12)), 4q24 in GSTCD (2.18 x 10(-23)), 5q33 in HTR4 (P = 4.29 x 10(-9)), 6p21 in AGER (P = 3.07 x 10(-15)) and 15q23 in THSD4 (P = 7.24 x 10(-15)). mRNA analyses showed expression of TNS1, GSTCD, AGER, HTR4 and THSD4 in human lung tissue. These associations offer mechanistic insight into pulmonary function regulation and indicate potential targets for interventions to alleviate respiratory disease.	[Repapi, Emmanouela; Wain, Louise V.; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Repapi, Emmanouela; Wain, Louise V.; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Sayers, Ian; Obeidat, Ma'en; Blakey, John D.; Hall, Ian P.] Univ Nottingham Hosp, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Ramasamy, Adaikalavan; Shaheen, Seif] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Zhai, Guangju; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Vitart, Veronique; Huffman, Jennifer E.; Wright, Alan F.; Hayward, Caroline] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Igl, Wilmar; Gyllensten, Ulf; Johansson, Asa; Zaboli, Ghazal] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Albrecht, Eva; Wichmann, H. Erich; Schnabel, Eva; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Deloukas, Panos; Barroso, Ines; Peltonen, Leena; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Henderson, John] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [McArdle, Wendy L.] Univ Bristol, Avon Longitudinal Study Parents & Children Lab, Dept Social Med, Bristol, Avon, England; [Rudnicka, Alicja R.; Whincup, Peter H.; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England; [Mustelin, Linda; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Rantanen, Taina] Univ Jyvaskyla, Finnish Ctr Interdisciplinary Gerontol, Jyvaskyla, Finland; [Surakka, Ida; Peltonen, Leena; Ripatti, Samuli; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida; Peltonen, Leena; Heliovaara, Markku; Ripatti, Samuli] Natl Inst Hlth & Welf, Helsinki, Finland; [Imboden, Medea; Probst-Hensch, Nicole M.] Univ Zurich, Inst Social & Prevent Med, Dept Chron Dis Epidemiol NICER, CH-8006 Zurich, Switzerland; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Grkovic, Ivica; Jankovic, Stipan; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Zgaga, Lina; Polasek, Ozren] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Rudan, Igor] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Glaeser, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, SHIP Clin Edidemiol Res, Greifswald, Germany; [Polasek, Ozren; Rudan, Igor] Gen Info, Zagreb, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Naluai, Asa Torinsson] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Cooper, Matthew N.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol, W Australian Sleep Disorders Res Inst, Perth, WA, Australia; [Olin, Anna-Carin; Toren, Kjell; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [James, Alan L.; Palmer, Lyle J.; Hui, Jennie] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Perth, WA, Australia; [Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Wannamethee, S. Goya; Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London, England; [Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Noncommunicable Dis Epidemiol Unit, London WC1, England; [McKeever, Tricia M.] Univ Nottingham, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [McKeever, Tricia M.] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Pavord, Ian D.] Univ Hosp Leicester Natl Hlth Serv Trust, Glenfield Hosp, Inst Lung Hlth, Leicester, Leics, England; [MacLeod, Andrew K.; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Morris, Andrew D.] Univ Dundee, Biomed Res Inst, Ninewells Hosp, Dundee, Scotland; [Cooper, Cyrus; Dennison, Elaine] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR, Musculoskeletal Biomed Res Unit, Oxford, England; [Karrasch, Stefan; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Bouatia-Naji, Nabila; Delplanque, Jerome; Froguel, Philippe] Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England; [NSHD Resp Study Team] MRC Natl Survey Hlth & Dev, MRC Unit Lifelong Hlth & Ageing, London, England; [Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Sch Med, Infect Inflammat & Immun Div, Southampton, Hants, England; [Holloway, John W.] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Human Genet, Southampton, Hants, England; [Hui, Jennie] PathW lab Med WA, Nedlands, WA, Australia; [Nyberg, Fredrik] AstraZeneca Res & Dev, Molndal, Sweden; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jackson, Cathy] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Probst-Hensch, Nicole M.] Univ Basel, Inst Social & Prevent Med, Swiss Trop Inst, Basel, Switzerland; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC, HPA, Ctr Environm & Hlth, London, England	University of Leicester; University of Leicester; University of Nottingham; University of London; Queen Mary University London; University of Cambridge; Imperial College London; Imperial College London; University of London; King's College London; University of Edinburgh; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wellcome Trust Sanger Institute; University of Bristol; University of Bristol; St Georges University London; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Finland National Institute for Health & Welfare; University of Zurich; University of Munich; University of Munich; University of Split; University of Zagreb; University of Oulu; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Finland National Institute for Health & Welfare; University of Gothenburg; University of Western Australia; University of Western Australia; University of Gothenburg; University of Western Australia; University of London; University College London; University of London; University College London; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Edinburgh; University of Dundee; University of Southampton; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London; University of Southampton; University of Southampton; University of Western Australia; AstraZeneca; University of Oulu; University of Oulu; University of St Andrews; Tampere University; Tampere University; Tampere University Hospital; University of Basel; Swiss Tropical & Public Health Institute; Health Protection Agency; Imperial College London	Tobin, MD (corresponding author), Univ Leicester, Dept Hlth Sci, Adrian Bldg, Leicester, Leics, England.	ian.hall@nottingham.ac.uk; mt47@leicester.ac.uk	Holloway, John W/B-5424-2009; Cooper, Matthew N/J-4420-2014; Grković, Ivica/D-8728-2017; BOUATIA-NAJI, NABILA/D-5863-2013; Palmer, Lyle John/N-1948-2019; Granell, Raquel/AAB-5256-2022; Rantanen, Taina/O-6579-2016; Grallert, Harald/B-3424-2013; Loos, Ruth J F/Q-2862-2016; Burton, Paul R/H-7527-2016; Janković, Stipan/E-3315-2017; Wilson, James F/A-5704-2009; Olin, Anna-Carin/ABH-2627-2021; Kaprio, Jaakko/A-1820-2008; Zgaga, Lina/Q-9415-2018; Naluai, Åsa Torinsson/AAB-2166-2021; Ramasamy, Adaikalavan/G-2632-2010; Spector, Tim D/F-6533-2012; Pinheiro, Maísa/E-7424-2012; Loos, Ruth/GON-5877-2022; Deloukas, Panos/B-2922-2013; Schulz, Holger/J-5643-2015; Hayward, Caroline/M-8818-2016; Polasek, Ozren/B-6002-2011; Ripatti, Samuli/H-9446-2014; Naluai, Åsa Torinsson/P-3269-2015; Karrasch, Stefan/GQI-2691-2022; Mangino, Massimo/F-5134-2011; Porteous, David J/C-7289-2013; Bouatia-Naji, Nabila/AGF-1400-2022; Hui, Jennie/A-9543-2013; jackson, cathy/H-4869-2013; Evans, David M/H-6325-2013; Johansson, Åsa/AAG-6799-2021; FROGUEL, Philippe/O-6799-2017; Granell, Raquel/AAY-4846-2020; Palmer, Lyle John/K-3196-2014; Rudan, Igor/I-1467-2012; Johansson, Åsa/G-5270-2011; Porteous, David/AAA-3446-2021; Wichmann, Heinz Erich/AAA-5695-2022; Davey Smith, George/A-7407-2013; Campbell, Harry/E-2959-2010; MacLeod, Andrew/Q-8655-2016	Holloway, John W/0000-0001-9998-0464; Cooper, Matthew N/0000-0003-1139-3682; Grković, Ivica/0000-0001-9010-2091; Palmer, Lyle John/0000-0002-1628-3055; Granell, Raquel/0000-0002-4890-4012; Rantanen, Taina/0000-0002-1604-1945; Loos, Ruth J F/0000-0002-8532-5087; Wilson, James F/0000-0001-5751-9178; Kaprio, Jaakko/0000-0002-3716-2455; Zgaga, Lina/0000-0003-4089-9703; Naluai, Åsa Torinsson/0000-0002-0504-6492; Ramasamy, Adaikalavan/0000-0002-7598-2892; Deloukas, Panos/0000-0001-9251-070X; Schulz, Holger/0000-0002-1157-200X; Hayward, Caroline/0000-0002-9405-9550; Polasek, Ozren/0000-0002-5765-1862; Ripatti, Samuli/0000-0002-0504-1202; Naluai, Åsa Torinsson/0000-0002-0504-6492; Mangino, Massimo/0000-0002-2167-7470; Porteous, David J/0000-0003-1249-6106; Bouatia-Naji, Nabila/0000-0001-5424-2134; Hui, Jennie/0000-0002-1653-2496; Evans, David M/0000-0003-0663-4621; Johansson, Åsa/0000-0002-2915-4498; FROGUEL, Philippe/0000-0003-2972-0784; Palmer, Lyle John/0000-0002-1628-3055; Rudan, Igor/0000-0001-6993-6884; Johansson, Åsa/0000-0002-2915-4498; Porteous, David/0000-0003-1249-6106; Davey Smith, George/0000-0002-1407-8314; Campbell, Harry/0000-0002-6169-6262; Whincup, Peter/0000-0002-5589-4107; Tobin, Martin/0000-0002-3596-7874; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Morris, Richard/0000-0001-7240-4563; Lawlor, Debbie A/0000-0002-6793-2262; Rudnicka, Alicja R/0000-0003-0369-8574; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; MacLeod, Andrew/0000-0003-3298-5193; Johnson, Toby/0000-0002-5998-3270; s, hema/0000-0002-3440-9475; Surakka, Ida/0000-0002-6669-5541; Sayers, Ian/0000-0001-5601-5410; Hingorani, Aroon/0000-0001-8365-0081; Wain, Louise/0000-0003-4951-1867; Wannamethee, Sasiwarang/0000-0001-9484-9977; Hall, Ian/0000-0001-9933-3216; Pavord, Ian/0000-0002-4288-5973; Cooper, Cyrus/0000-0003-3510-0709; McKeever, Tricia/0000-0003-0914-0416; /0000-0001-8085-0731; Kahonen, Mika/0000-0002-4510-7341; Nyberg, Fredrik/0000-0003-0892-5668; Dennison, Elaine/0000-0002-3048-4961; Barroso, Ines/0000-0001-5800-4520; Soranzo, Nicole/0000-0003-1095-3852; Elliott, Paul/0000-0002-7511-5684	Academy of Finland [104781, 120315, 1114194]; Center of Excellence in Complex Disease Genetics; Arthritis Research Campaign; Asthma UK; AstraZeneca; Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council; British Heart Foundation [PG/06/154/22043, PG/97012, FS05/125]; British Lung Foundation; Cancer Research United Kingdom; Chief Scientists Office, part of the Scottish Government Health Directorate [CZD/16/6]; Department of Health Air Pollution PRP [0020029]; ENGAGE [HEALTH-F4-2007-201413]; European Commission [FP-5/QLG1-CT-2000-01643, FP-7/2007-2013, FP-6 LSHB-CT-2006-018996, FP-6 LSHG-CT-2006-01947, HEALTH-F2-2008-201865-GEFOS, QLG2-CT-2002-01254]; Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701, 01GI0883]; German Asthma and COPD Network (COSYCONET) [01GI0883]; German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network; Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International; Leicester Biomedical Research Unit in Cardiovascular Science (NIHR); Medical Research Council UK [G0500539, G0501942, G0000943, G990146]; Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit; Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute; National Institute for Health Research comprehensive Biomedical Research Centre; St. Thomas' NHS Foundation Trust; National Institute for Health; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1014, G0501942, G0600717B, G9815508, G0000934, G0800582, G9900991B, G0600331, G0902125, MC_U106179471, MC_U106188470, G0401540, MC_U123092721, G0801056B, G0600705, MC_U123092720, G0801056, U1475000001, MC_U127561128] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/2, CZB/4/710] Funding Source: researchfish; MRC [G0600705, G0000934, MC_U127561128, G0600331, G0902125, G0801056, G0501942, MC_U123092720, MC_U106188470, G0401540, MC_U123092721, G0800582] Funding Source: UKRI	Academy of Finland(Academy of Finland); Center of Excellence in Complex Disease Genetics(Academy of Finland); Arthritis Research Campaign(Versus Arthritis); Asthma UK; AstraZeneca(AstraZeneca); Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); British Lung Foundation; Cancer Research United Kingdom(Cancer Research UK); Chief Scientists Office, part of the Scottish Government Health Directorate; Department of Health Air Pollution PRP; ENGAGE; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Asthma and COPD Network (COSYCONET); German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network; Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Leicester Biomedical Research Unit in Cardiovascular Science (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas' NHS Foundation Trust; National Institute for Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the many colleagues who contributed to collection and phenotypic characterization of the clinical sampling, genotyping and analysis of the GWAS data. We especially thank those who kindly agreed to participate in the studies. Major funding for this work is from the following sources (in alphabetical order): Academy of Finland (including project grants 104781, 120315 and 1114194) and Center of Excellence in Complex Disease Genetics; Arthritis Research Campaign; Asthma UK; AstraZeneca; Biocenter Oulu, University of Oulu; Biocentrum Helsinki; Biotechnology and Biological Sciences Research Council project grant; British Heart Foundation (including project grants PG/06/154/22043 and PG/97012 and Senior Research Fellowship FS05/125); British Lung Foundation; Cancer Research United Kingdom; Chief Scientists Office, part of the Scottish Government Health Directorate (including grant CZD/16/6); Department of Health Air Pollution PRP (ref. no. 0020029); ENGAGE project (HEALTH-F4-2007-201413); European Commission (EURO-BLCS, FP-5/QLG1-CT-2000-01643, FP-7/2007-2013, FP-6 LSHB-CT-2006-018996 (GABRIEL), FP-6 LSHG-CT-2006-01947 (EUROSPAN), HEALTH-F2-2008-201865-GEFOS and FP-5 GenomEUtwin project QLG2-CT-2002-01254); Finnish Ministry of Education; German Federal Ministry of Education and Research (BMBF, including grants 01ZZ96030, 01ZZ0701 and 01GI0883 and German Asthma and COPD Network (COSYCONET) grant 01GI0883); German Ministry for Education, Research and Cultural Affairs; German National Genome Research Network (NGFN-2 and NGFN-plus); Healthway, Western Australia; HEFCE Science Research Investment Fund; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; International Osteoporosis Foundation; Juvenile Diabetes Research Foundation International; Leicester Biomedical Research Unit in Cardiovascular Science (NIHR); Medical Research Council UK (including grants G0500539, G0501942, G0000943 and G990146); Medical Research Fund of the Tampere University Hospital; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; MRC Human Genetics Unit; Munich Center of Health Sciences, as part of LMUinnovativ; National Human Genome Research Institute; National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute (grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01)); Oulu University Hospital; PHOEBE (FP6, LSHG-CT-2006-518418); Public Population Project in Genomics (Genome Canada and Genome Quebec), Republic of Croatia Ministry of Science, Education and Sports (research grant 108-1080315-0302); Royal Society; Siemens Health Care Sector; Swedish Heart and Lung Foundation (grant 20050561); Swedish Medical Research Council (project no.K2007-66X-20270-01-3); Swedish Research Council for Working Life and Social Research (FAS, grants 2001-0263 and 2003-0139); the Great Wine Estates of the Margaret River region of Western Australia; UBS Wealth Foundation (grant BA29s8Q7-DZZ); UK Department of Health Policy Research Programme; University of Nottingham; University of Bristol; US National Institutes of Health (U01 DK062418); US National Institutes of Health-National Institute of Mntal Health (5R01MH63706: 02);; Wellcome Trust including grants 068545/Z/02, 076113/B/04/Z, 079895, 077016/Z/05/Z, 075883 and 086160/Z/08/A); and Zentren fur Innovationskompetenz (BMBF grant 03ZIK012).	Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupont LJ, 1999, EUR RESPIR J, V14, P642, DOI 10.1034/j.1399-3003.1999.14c26.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; LEWITTER FI, 1984, AM J EPIDEMIOL, V120, P518, DOI 10.1093/oxfordjournals.aje.a113912; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Sayers I, 2006, EUR J PHARMACOL, V531, P9, DOI 10.1016/j.ejphar.2005.11.026; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Wadsworth SJ, 2006, J CLIN IMMUNOL, V26, P376, DOI 10.1007/s10875-006-9029-z; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WEIGT C, 1992, J MOL BIOL, V227, P593, DOI 10.1016/0022-2836(92)90915-7; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	42	427	437	0	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					36	U51		10.1038/ng.501	http://dx.doi.org/10.1038/ng.501			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20010834	Bronze, Green Accepted			2022-12-25	WOS:000273055100014
J	Villablanca, EJ; Raccosta, L; Zhou, D; Fontana, R; Maggioni, D; Negro, A; Sanvito, F; Ponzoni, M; Valentinis, B; Bregni, M; Prinetti, A; Steffensen, KR; Sonnino, S; Gustafsson, JA; Doglioni, C; Bordignon, C; Traversari, C; Russo, V				Villablanca, Eduardo J.; Raccosta, Laura; Zhou, Dan; Fontana, Raffaella; Maggioni, Daniela; Negro, Aurora; Sanvito, Francesca; Ponzoni, Maurilio; Valentinis, Barbara; Bregni, Marco; Prinetti, Alessandro; Steffensen, Knut R.; Sonnino, Sandro; Gustafsson, Jan-Ake; Doglioni, Claudio; Bordignon, Claudio; Traversari, Catia; Russo, Vincenzo			Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses	NATURE MEDICINE			English	Article							NUCLEAR RECEPTORS; T-CELLS; MIGRATION; METABOLISM; CHOLESTEROL; IMMUNOGENICITY; INFLAMMATION; OXYSTEROLS; DEPLETION; THERAPY	Sterol metabolism has recently been linked to innate and adaptive immune responses through liver X receptor (LXR) signaling. Whether products of sterol metabolism interfere with antitumor responses is currently unknown. Dendritic cells (DCs) initiate immune responses, including antitumor activity after their CC chemokine receptor-7 (CCR7)-dependent migration to lymphoid organs. Here we report that human and mouse tumors produce LXR ligands that inhibit CCR7 expression on maturing DCs and, therefore, their migration to lymphoid organs. In agreement with this observation, we detected CD83(+)CCR7(-) DCs within human tumors. Mice injected with tumors expressing the LXR ligand-inactivating enzyme sulfotransferase 2B1b (SULT2B1b) successfully controlled tumor growth by regaining DC migration to tumor-draining lymph nodes and by developing overt inflammation within tumors. The control of tumor growth was also observed in chimeric mice transplanted with bone marrow from mice lacking the gene encoding LXR-alpha (Nr1h3(-/-) mice) Thus, we show a new mechanism of tumor immunoescape involving products of cholesterol metabolism. The manipulation of this pathway could restore antitumor immunity in individuals with cancer.	[Villablanca, Eduardo J.; Raccosta, Laura; Fontana, Raffaella; Maggioni, Daniela; Negro, Aurora; Bordignon, Claudio; Russo, Vincenzo] Ist Sci San Raffaele, Div Mol Oncol, Program Immunol & Bio Immuno Gene Therapy Canc, Canc Gene Therapy Unit, I-20132 Milan, Italy; [Villablanca, Eduardo J.] Univ Vita Salute San Raffaele, Milan, Italy; [Zhou, Dan; Valentinis, Barbara; Bordignon, Claudio; Traversari, Catia] MolMed SpA, Milan, Italy; [Sanvito, Francesca; Ponzoni, Maurilio; Doglioni, Claudio] Ist Sci San Raffaele, Dept Pathol, I-20132 Milan, Italy; [Bregni, Marco] Ist Sci San Raffaele, Strateg Program Oncol, I-20132 Milan, Italy; [Prinetti, Alessandro; Sonnino, Sandro] Univ Milan, Dept Med Chem Biochem & Biotechnol, Ctr Excellence Neurodegenerat Dis, Segrate, Italy; [Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Novum, Dept Biosci & Nutr, Huddinge, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Karolinska Institutet; University of Houston System; University of Houston	Russo, V (corresponding author), Ist Sci San Raffaele, Div Mol Oncol, Program Immunol & Bio Immuno Gene Therapy Canc, Canc Gene Therapy Unit, I-20132 Milan, Italy.	catia.traversari@molmed.com; v.russo@hsr.it	Villablanca, Eduardo/E-1380-2016; raccosta, laura/K-3101-2016; Sonnino, Sandro/R-4154-2017; Russo, Vincenzo/K-5650-2016; Prinetti, Alessandro/R-4206-2017; Daniela, Maggioni/AAN-6553-2020	Villablanca, Eduardo/0000-0001-9522-9729; raccosta, laura/0000-0002-1625-9573; Sonnino, Sandro/0000-0001-8180-5908; Russo, Vincenzo/0000-0003-1592-5041; Prinetti, Alessandro/0000-0003-0252-2593; Daniela, Maggioni/0000-0001-9894-6387; bregni, marco/0000-0002-3789-1199; DOGLIONI, Claudio/0000-0002-4969-5216; Steffensen, Knut/0000-0001-6093-2801	Fondazione Cariplo, Italian Association for Cancer Research, European Community [LSHC-CT-2006-518334]; Italian Ministry of Health	Fondazione Cariplo, Italian Association for Cancer Research, European Community(European CommissionFondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy)	We thank M. E. Bianchi and G. Parmiani for helpful discussions and for the critical review of this manuscript. Additionally, we thank D. Mangelsdorf, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, for providing us with GAL4-LXRs plasmids; M. Liden, Ludwig Institute for Cancer Research, Stockholm, for GAL4-RXR and TK-MHC100-luc plasmids; F. Nystrom, Linkoping University, for GAL4-PPAR-gamma plasmid; C. Strott, National Institutes of Health, for the mouse SULT2B1b-encoding plasmid; L. Naldini, Scientific Institute S. Raffaele, for the lentiviral vector hPGK.GFP.wPRE.mhCMV.Delta NGFr.SV40PA; and M. Rocchi and C. Lanterna for technical help. This work was supported by Fondazione Cariplo, Italian Association for Cancer Research, European Community Project 'Cancer Immunotherapy' LSHC-CT-2006-518334 and the Italian Ministry of Health.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Degl'Innocenti E, 2008, CANCER RES, V68, P292, DOI 10.1158/0008-5472.CAN-07-2429; Fuda H, 2007, J LIPID RES, V48, P1343, DOI 10.1194/jlr.M700018-JLR200; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; He DN, 2006, DRUG METAB DISPOS, V34, P1749, DOI 10.1124/dmd.106.011114; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; LE NF, 2001, J BIOL CHEM, V276, P17920; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; MAVILIO F, 1994, BLOOD, V83, P1988; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Shimizu C, 2003, ENDOCRINOLOGY, V144, P1186, DOI 10.1210/en.2002-221011; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Villablanca EJ, 2008, J LEUKOCYTE BIOL, V84, P871, DOI 10.1189/jlb.0108047; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058	35	211	219	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					98	U137		10.1038/nm.2074	http://dx.doi.org/10.1038/nm.2074			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20037595				2022-12-25	WOS:000273395500042
J	Conde, L; Halperin, E; Akers, NK; Brown, KM; Smedby, KE; Rothman, N; Nieters, A; Slager, SL; Brooks-Wilson, A; Agana, L; Riby, J; Liu, JJ; Adami, HO; Darabi, H; Hjalgrim, H; Low, HQ; Humphreys, K; Melbye, M; Chang, ET; Glimelius, B; Cozen, W; Davis, S; Hartge, P; Morton, LM; Schenk, M; Wang, SS; Armstrong, B; Kricker, A; Milliken, S; Purdue, MP; Vajdic, CM; Boyle, P; Lan, Q; Zahm, SH; Zhang, YW; Zheng, TZ; Becker, N; Benavente, Y; Boffetta, P; Brennan, P; Butterbach, K; Cocco, P; Foretova, L; Maynadie, M; de Sanjose, S; Staines, A; Spinelli, JJ; Achenbach, SJ; Call, TG; Camp, NJ; Glenn, M; Caporaso, NE; Cerhan, JR; Cunningham, JM; Goldin, LR; Hanson, CA; Kay, NE; Lanasa, MC; Leis, JF; Marti, GE; Rabe, KG; Rassenti, LZ; Spector, LG; Strom, SS; Vachon, CM; Weinberg, JB; Holly, EA; Chanock, S; Smith, MT; Bracci, PM; Skibola, CF				Conde, Lucia; Halperin, Eran; Akers, Nicholas K.; Brown, Kevin M.; Smedby, Karin E.; Rothman, Nathaniel; Nieters, Alexandra; Slager, Susan L.; Brooks-Wilson, Angela; Agana, Luz; Riby, Jacques; Liu, Jianjun; Adami, Hans-Olov; Darabi, Hatef; Hjalgrim, Henrik; Low, Hui-Qi; Humphreys, Keith; Melbye, Mads; Chang, Ellen T.; Glimelius, Bengt; Cozen, Wendy; Davis, Scott; Hartge, Patricia; Morton, Lindsay M.; Schenk, Maryjean; Wang, Sophia S.; Armstrong, Bruce; Kricker, Anne; Milliken, Sam; Purdue, Mark P.; Vajdic, Claire M.; Boyle, Peter; Lan, Qing; Zahm, Shelia H.; Zhang, Yawei; Zheng, Tongzhang; Becker, Nikolaus; Benavente, Yolanda; Boffetta, Paolo; Brennan, Paul; Butterbach, Katja; Cocco, Pierluigi; Foretova, Lenka; Maynadie, Marc; de Sanjose, Silvia; Staines, Anthony; Spinelli, John J.; Achenbach, Sara J.; Call, Timothy G.; Camp, Nicola J.; Glenn, Martha; Caporaso, Neil E.; Cerhan, James R.; Cunningham, Julie M.; Goldin, Lynn R.; Hanson, Curtis A.; Kay, Neil E.; Lanasa, Mark C.; Leis, Jose F.; Marti, Gerald E.; Rabe, Kari G.; Rassenti, Laura Z.; Spector, Logan G.; Strom, Sara S.; Vachon, Celine M.; Weinberg, J. Brice; Holly, Elizabeth A.; Chanock, Stephen; Smith, Martyn T.; Bracci, Paige M.; Skibola, Christine F.			Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32	NATURE GENETICS			English	Article							NECROSIS-FACTOR TNF; HIGH-RESOLUTION; HLA; SUSCEPTIBILITY; HAPLOTYPE; POLYMORPHISMS	To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome-wide association study. We identified two variants associated with follicular lymphoma at 6p21.32 (rs10484561, combined P = 1.12 x 10(-29) and rs7755224, combined P = 2.00 x 10(-19); r(2) = 1.0), supporting the idea that major histocompatibility complex genetic variation influences follicular lymphoma susceptibility. We also found confirmatory evidence of a previously reported association between chronic lymphocytic leukemia/small lymphocytic lymphoma and rs735665 (combined P = 4.24 x 10(-9)).	[Conde, Lucia; Akers, Nicholas K.; Agana, Luz; Riby, Jacques; Smith, Martyn T.; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Halperin, Eran] Tel Aviv Univ, Mol Microbiol & Biotechnol Dept, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Brown, Kevin M.] Translat Genom Res Inst TGen, Integrat Canc Genom Div, Phoenix, AZ USA; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Rothman, Nathaniel; Hartge, Patricia; Morton, Lindsay M.; Wang, Sophia S.; Purdue, Mark P.; Lan, Qing; Zahm, Shelia H.; Caporaso, Neil E.; Goldin, Lynn R.; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Nieters, Alexandra; Becker, Nikolaus; Butterbach, Katja] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Nieters, Alexandra] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, D-7800 Freiburg, Germany; [Slager, Susan L.; Achenbach, Sara J.; Call, Timothy G.; Cerhan, James R.; Cunningham, Julie M.; Hanson, Curtis A.; Kay, Neil E.; Leis, Jose F.; Rabe, Kari G.; Vachon, Celine M.] Mayo Clin, Coll Med, Rochester, MN USA; [Brooks-Wilson, Angela; Spinelli, John J.] British Columbia Canc Agcy, British Columbia Canc Res Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Liu, Jianjun; Low, Hui-Qi] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Adami, Hans-Olov; Darabi, Hatef; Humphreys, Keith] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hjalgrim, Henrik; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Chang, Ellen T.] Canc Prevent Inst Calif, Fremont, CA USA; [Chang, Ellen T.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Glimelius, Bengt] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [Glimelius, Bengt] Uppsala Univ, Akademiska Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Davis, Scott] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Schenk, Maryjean] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Etiol, Duarte, CA 91010 USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Armstrong, Bruce; Kricker, Anne] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Milliken, Sam] St Vincents Hosp, Dept Haematol, Sydney, NSW 2010, Australia; [Vajdic, Claire M.] Univ New S Wales, Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia; [Boyle, Peter; Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Zhang, Yawei; Zheng, Tongzhang] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Benavente, Yolanda; de Sanjose, Silvia] Catalan Inst Oncol, Unit Infect & Canc UNIC, Canc Epidemiol Res Programme, Barcelona, Spain; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Cocco, Pierluigi] Univ Cagliari, Dept Publ Hlth, Occupat Hlth Sect, Cagliari, Italy; [Foretova, Lenka] Masaryk Mem Canc Inst, Brno, Czech Republic; [Maynadie, Marc] Univ Burgundy, Univ Hosp Dijon, Registry Hematol Malignancies, EA4184, Dijon, France; [Staines, Anthony] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Camp, Nicola J.; Glenn, Martha] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Lanasa, Mark C.; Weinberg, J. Brice] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Marti, Gerald E.] US Natl Inst Hlth, Div Cell & Gene Therapies, Off Cellular Tissues & Gene Therapies, US FDA, Bethesda, MD USA; [Rassenti, Laura Z.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Spector, Logan G.] Univ Minnesota, Prevent & Etiol Res Program, Masonic Canc Ctr, Minneapolis, MN USA; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Holly, Elizabeth A.; Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Tel Aviv University; Translational Genomics Research Institute; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Mayo Clinic; British Columbia Cancer Agency; Simon Fraser University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Statens Serum Institut; Cancer Prevention Institute of California; Stanford University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital; University of Southern California; Fred Hutchinson Cancer Center; Wayne State University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Yale University; Catalan Institute of Oncology; Icahn School of Medicine at Mount Sinai; World Health Organization; International Agency for Research on Cancer (IARC); University of Cagliari; Masaryk Memorial Cancer Institute; CHU Dijon Bourgogne; Universite de Bourgogne; University College Dublin; University of British Columbia; Utah System of Higher Education; University of Utah; Duke University; National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco	Skibola, CF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Brooks-Wilson, Angela/E-9399-2012; Spinelli, John J./B-6210-2013; Boffetta, Paolo/AAI-7767-2021; Conde, Lucia/D-9295-2011; Boyle, Peter/A-4380-2014; de Sanjosé Llongueras, Silvia/H-6339-2014; Hjalgrim, Henrik/AAG-4973-2021; Morton, Lindsay M/B-5234-2015; Staines, Anthony/AFQ-7565-2022; Vajdic, Claire/AAP-5940-2020; Chang, Ellen/G-5700-2010; Benavente, Yolanda/H-9810-2014; Purdue, Mark P/C-9228-2016; Cocco, Pierluigi/AAM-7474-2021; Armstrong, Bruce K/K-9464-2015; Morton, Lindsay/AAE-7495-2022	Brooks-Wilson, Angela/0000-0003-1009-6408; Spinelli, John J./0000-0002-9119-3287; Boffetta, Paolo/0000-0002-3811-2791; Boyle, Peter/0000-0001-6251-0610; Morton, Lindsay M/0000-0001-9767-2310; Staines, Anthony/0000-0001-9161-1357; Purdue, Mark P/0000-0003-1177-3108; Armstrong, Bruce K/0000-0001-8940-7525; Morton, Lindsay/0000-0001-9767-2310; Liu, Jianjun/0000-0002-3255-3019; Foretova, Lenka/0000-0003-0494-2620; Vajdic, Claire/0000-0002-3612-8298; Conde, Lucia/0000-0001-5180-543X; Cerhan, James/0000-0002-7482-178X; Spector, Logan/0000-0003-2516-0222; melbye, mads/0000-0001-8264-6785; WANG, SOPHIA/0000-0003-2597-9393	National Cancer Institute (NCI), US National Institutes of Health (NIH) [CA122663, CA104682, CA45614, CA89745]; American Cancer Society [IRG-07-06401]; Agency for Science and Technology and Research of Singapore (A*STAR); NCI [R01 CA91253, R01 CA118444, CA62006]; Swedish Cancer Society; Swedish Research Council; Danish Medical Research Council; Information Management Services, Inc.; NIH (NCI); US Public Health Service (PHS) [N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, N02-PC-71105]; National Health and Medical Research Council of Australia; Cancer Council NSW; University of Sydney Medical Foundation; Canadian Cancer Society; Canadian Institutes of Health Research; German Jose Carreras Leukemia Foundation [DJCLS_R04/08, R07/26f]; EC [QLK4-CT-2000-00422]; Federal Office for Radiation Protection (Germany) [StSch4261, StSch4420]; Spanish Ministry of Health [06/02/0073]; FIS [08-1555]; Marato TV3 (Spain) [051210]; La Fondation de France [1999 0084 71]; Compagnia di San Paolo di Torino; Health Research Board, Ireland; Ministry of Health of the Czech Republic [MZ0 MOU 2005]; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC065064, N01PC067010, N01PC067008] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R03CA089745, R01CA045614, R01CA087014, U01CA118444, R01CA092153, R01CA104682, R01CA062006, R01CA122663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	National Cancer Institute (NCI), US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Agency for Science and Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Information Management Services, Inc.; NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); University of Sydney Medical Foundation(University of Sydney); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Jose Carreras Leukemia Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Federal Office for Radiation Protection (Germany); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); FIS(Instituto de Salud Carlos III); Marato TV3 (Spain); La Fondation de France(Fondation de France); Compagnia di San Paolo di Torino(Compagnia di San Paolo); Health Research Board, Ireland; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants CA122663 and CA104682 from the National Cancer Institute (NCI), US National Institutes of Health (NIH) (C. F. S.); grants CA45614 and CA89745 from the NCI, NIH (E. A. H.); the American Cancer Society (IRG-07-06401) and a charitable donation by S. Chase (K. B.). E. H. is a faculty fellow of the Edmond J. Safra Bioinformatics program at Tel-Aviv University. SCALE study: We thank X.Y. Chen, H. B. Toh, K. K. Heng and W.Y. Meah from Genome Institute of Singapore for their support in genotyping analyses. We are also grateful to L. Klareskog, Center for Molecular Medicine, and L. Alfredsson, Institute of Environmental Medicine at the Karolinska Institute, Stockholm, Sweden, for sharing DNA from their EIRA study control population and to E. Rehnberg for help with imputing genotypes in the SCALE study. The following agencies contributed funding to SCALE that facilitated the present project: Agency for Science and Technology and Research of Singapore (A*STAR), NCI, the Swedish Cancer Society, the Swedish Research Council and the Danish Medical Research Council. GEC-Mayo Study: This study is supported by grants R01 CA91253 and R01 CA118444 from the NCI. NCI-SEER study: We thank P. Hui of the Information Management Services, Inc. for programming support, and we acknowledge the contributions of the staff and scientists at the SEER centers of Iowa, Los Angeles, Detroit and Seattle for conducting the study's field effort. We especially acknowledge the contributions of study site principal investigator L. Bernstein (Los Angeles). The NCI-SEER study was supported by the Intramural Research Program of the NIH (NCI) and by US Public Health Service (PHS) contracts N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010 and N02-PC-71105. Yale study: This study is supported by grant CA62006 from the NCI and the Intramural Research Program of the NIH (NCI). NSW study: The NSW study was supported by a National Health and Medical Research Council of Australia project grant, Cancer Council NSW, a University of Sydney Medical Foundation Program Grant and the Intramural Research Program of the NIH (NCI). BC study: Funding for the British Columbia study was from the Canadian Cancer Society and the Canadian Institutes of Health Research. A.B.-W. is a Senior Scholar of the Michael Smith Foundation for Health Research. EpiLymph study: Funding was available from the German Jose Carreras Leukemia Foundation (DJCLS_R04/08 and R07/26f) (A.N.), the EC 5<SUP>th</SUP> Framework Program Quality of Life grant No. QLK4-CT-2000-00422 (P. Boffetta, P. Brennan), the Federal Office for Radiation Protection grants No. StSch4261 and StSch4420 (Germany), the Spanish Ministry of Health grants Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP) (06/02/0073), FIS 08-1555 and Marato TV3 (051210) (Spain), La Fondation de France, no. 1999 0084 71 (M. Maynadie), Compagnia di San Paolo di Torino, Programma Oncologia 2001 (P. C.), the Health Research Board, Ireland, and the Ministry of Health of the Czech Republic, MZ0 MOU 2005 (L. F.).	Abdou AM, 2010, LEUKEMIA, V24, P1055, DOI 10.1038/leu.2010.17; Al-Tonbary Y, 2004, Hematology, V9, P139, DOI 10.1080/1024533042000205487; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Choi HB, 2008, INT J HEMATOL, V87, P203, DOI 10.1007/s12185-008-0040-4; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; Nathalang O, 1999, EUR J IMMUNOGENET, V26, P389, DOI 10.1046/j.1365-2370.1999.00177.x; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022	13	120	122	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					661	664		10.1038/ng.626	http://dx.doi.org/10.1038/ng.626			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639881	Green Accepted, Green Submitted			2022-12-25	WOS:000280524000008
J	Berkel, S; Marshall, CR; Weiss, B; Howe, J; Roeth, R; Moog, U; Endris, V; Roberts, W; Szatmari, P; Pinto, D; Bonin, M; Riess, A; Engels, H; Sprengel, R; Scherer, SW; Rappold, GA				Berkel, Simone; Marshall, Christian R.; Weiss, Birgit; Howe, Jennifer; Roeth, Ralph; Moog, Ute; Endris, Volker; Roberts, Wendy; Szatmari, Peter; Pinto, Dalila; Bonin, Michael; Riess, Angelika; Engels, Hartmut; Sprengel, Rolf; Scherer, Stephen W.; Rappold, Gudrun A.			Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation	NATURE GENETICS			English	Article							POSTSYNAPTIC DENSITY; PROTEINS	Using microarrays, we identified de novo copy number variations in the SHANK2 synaptic scaffolding gene in two unrelated individuals with autism-spectrum disorder (ASD) and mental retardation. DNA sequencing of SHANK2 in 396 individuals with ASD, 184 individuals with mental retardation and 659 unaffected individuals (controls) revealed additional variants that were specific to ASD and mental retardation cases, including a de novo nonsense mutation and seven rare inherited changes. Our findings further link common genes between ASD and intellectual disability.	[Berkel, Simone; Weiss, Birgit; Roeth, Ralph; Endris, Volker; Rappold, Gudrun A.] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [Marshall, Christian R.; Howe, Jennifer; Pinto, Dalila; Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5S 1A1, Canada; [Moog, Ute] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany; [Roberts, Wendy] Univ Toronto, Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Offord Ctr Child Studies, Hamilton, ON, Canada; [Bonin, Michael; Riess, Angelika] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany; [Engels, Hartmut] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Sprengel, Rolf] Univ Heidelberg, Max Planck Inst Med Res MPI, Heidelberg, Germany; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Eberhard Karls University of Tubingen; University of Bonn; Max Planck Society; Ruprecht Karls University Heidelberg; University of Toronto	Rappold, GA (corresponding author), Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de	Pinto, Dalila/C-4218-2016; Scherer, Stephen W./B-3785-2013	Pinto, Dalila/0000-0002-8769-0846; Scherer, Stephen W./0000-0002-8326-1999	international Autism Genome Project; Autism Speaks; German Mental Retardation Network (MRNET); Federal Ministry of Education and Research, Germany; Deutsche Forschungsgesellschaft (DFG) [SFB488]; Medical Faculty of Heidelberg; CellNetworks-Cluster of Excellence [EXC81]; Centre for Applied Genomics, Genome Canada; Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR); Canadian Institute for Advanced Research (CIFAR); McLaughlin Centre; Canada Foundation for Innovation; Ontario Ministry of Research and Innovation; Hospital for Sick Children Foundation	international Autism Genome Project; Autism Speaks; German Mental Retardation Network (MRNET); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Medical Faculty of Heidelberg; CellNetworks-Cluster of Excellence; Centre for Applied Genomics, Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); McLaughlin Centre; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Hospital for Sick Children Foundation	We gratefully thank E. Fenner, M. Fritsche and S. Peykov for sequencing and technical support, and we thank all the affected individuals' families for their cooperation. We thank A. Fiebig, A. Franke and S. Schreiber at POPGEN (University of Kiel, Kiel, Germany) and A. Stewart, R. McPherson and R. Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada) for generously providing population control microarray data. The international Autism Genome Project and Autism Speaks is also gratefully acknowledged for support. Funding was provided by the German Mental Retardation Network (MRNET), supported by the Federal Ministry of Education and Research, Germany, by the Deutsche Forschungsgesellschaft (DFG; SFB488) and the Medical Faculty of Heidelberg. S. B. was funded by a fellowship of CellNetworks-Cluster of Excellence (EXC81) and is a member of Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS). S. W. S. is supported by The Centre for Applied Genomics, Genome Canada and Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research (CIFAR), the McLaughlin Centre, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation and the Hospital for Sick Children Foundation. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children. G.A.R. is a member of CellNetworks-Cluster of Excellence (EXC81). Dedicated to Mrs. Elisabeth Berkel.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Sheng M, 2000, J CELL SCI, V113, P1851; Szatmari P, 2008, AM J MED GENET B, V147B, P3, DOI 10.1002/ajmg.b.30561; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	15	380	402	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					489	491		10.1038/ng.589	http://dx.doi.org/10.1038/ng.589			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20473310				2022-12-25	WOS:000278081500011
J	Kwiatkowski, N; Jelluma, N; Filippakopoulos, P; Soundararajan, M; Manak, MS; Kwon, M; Choi, HG; Sim, T; Deveraux, QL; Rottmann, S; Pellman, D; Shah, JV; Kops, GJPL; Knapp, S; Gray, NS				Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.			Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function	NATURE CHEMICAL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; POLE BODY DUPLICATION; RECEPTOR TYROSINE KINASE; GROWTH IN-VIVO; MITOTIC CHECKPOINT; CENTROSOME DUPLICATION; KINETOCHORE LOCALIZATION; CHROMOSOMAL INSTABILITY; EXTRA CENTROSOMES; PROTEIN-KINASE	Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability. As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-molecule inhibitor of Mps1 should facilitate dissection of Mps1-related biology. We describe the cellular effects and Mps1 cocrystal structures of new, selective small-molecule inhibitors of Mps1. Consistent with RNAi studies, chemical inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects. However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses. Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.	[Kwiatkowski, Nicholas; Choi, Hwan Geun; Sim, Taebo; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Choi, Hwan Geun; Sim, Taebo; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jelluma, Nannette; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands; [Jelluma, Nannette; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Canc Genom Ctr, Utrecht, Netherlands; [Filippakopoulos, Panagis; Soundararajan, Meera; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford, England; [Filippakopoulos, Panagis; Soundararajan, Meera; Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Manak, Michael S.; Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Harvard Inst Med, Boston, MA 02115 USA; [Kwon, Mijung; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Deveraux, Quinn L.; Rottmann, Sabine] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Novartis	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Kops, Geert/0000-0003-3555-5295; Filippakopoulos, Panagis/0000-0002-1515-1317; Soundararajan, Meera/0000-0003-4687-0151	Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575, R01GM077238] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.(Ministry of Research and Innovation, OntarioMerck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. King ( Harvard Medical School), B. Vogelstein ( Howard Hughes Medical Institute and Johns Hopkins Medical Institutions) and E. Nigg ( Max Planck Institute of Biochemistry, Munich) for reagents and R. King, T. Mitchison, A. Abrieu, U. Eggert, C. Walsh, F. Sigoillot and E. Chung for helpful discussions. We also thank Ambit Biosciences and Invitrogen Corporation for technical support in the initial compound screening and enzymatic activity assays, respectively, as well as the Nikon Imaging Facility ( Harvard Medical School) and the Dana-Farber Flow Cytometry Lab for technical help and instrument use. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schmidt M, 2007, DRUG RESIST UPDATE, V10, P162, DOI 10.1016/j.drup.2007.06.003; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; SOULE HD, 1990, CANCER RES, V50, P6075; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	50	176	186	4	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					359	368		10.1038/nchembio.345	http://dx.doi.org/10.1038/nchembio.345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20383151	Green Accepted			2022-12-25	WOS:000276823200015
J	Sistare, FD; Dieterle, F; Troth, S; Holder, DJ; Gerhold, D; Andrews-Cleavenger, D; Baer, W; Betton, G; Bounous, D; Carl, K; Collins, N; Goering, P; Goodsaid, F; Gu, YZ; Guilpin, V; Harpur, E; Hassan, A; Jacobson-Kram, D; Kasper, P; Laurie, D; Lima, BS; Maciulaitis, R; Mattes, W; Maurer, G; Obert, LA; Ozer, J; Papaluca-Amati, M; Phillips, JA; Pinches, M; Schipper, MJ; Thompson, KL; Vamvakas, S; Vidal, JM; Vonderscher, J; Walker, E; Webb, C; Yu, Y				Sistare, Frank D.; Dieterle, Frank; Troth, Sean; Holder, Daniel J.; Gerhold, David; Andrews-Cleavenger, Dina; Baer, William; Betton, Graham; Bounous, Denise; Carl, Kevin; Collins, Nathaniel; Goering, Peter; Goodsaid, Federico; Gu, Yi-Zhong; Guilpin, Valerie; Harpur, Ernie; Hassan, Alita; Jacobson-Kram, David; Kasper, Peter; Laurie, David; Lima, Beatriz Silva; Maciulaitis, Romaldas; Mattes, William; Maurer, Gerard; Obert, Leslie Ann; Ozer, Josef; Papaluca-Amati, Marisa; Phillips, Jonathan A.; Pinches, Mark; Schipper, Matthew J.; Thompson, Karol L.; Vamvakas, Spiros; Vidal, Jean-Marc; Vonderscher, Jacky; Walker, Elizabeth; Webb, Craig; Yu, Yan			Towards consensus practices to qualify safety biomarkers for use in early drug development	NATURE BIOTECHNOLOGY			English	Article							KIDNEY INJURY; MOLECULE-1	Application of any new biomarker to support safety-related decisions during regulated phases of drug development requires provision of a substantial data set that critically assesses analytical and biological performance of that biomarker. Such an approach enables stakeholders from industry and regulatory bodies to objectively evaluate whether superior standards of performance have been met and whether specific claims of fit-for-purpose use are supported. It is therefore important during the biomarker evaluation process that stakeholders seek agreement on which critical experiments are needed to test that a biomarker meets specific performance claims, how new biomarker and traditional comparators will be measured and how the resulting data will be merged, analyzed and interpreted.	[Sistare, Frank D.; Troth, Sean; Holder, Daniel J.; Gerhold, David; Yu, Yan] Merck Res Labs, West Point, PA USA; [Andrews-Cleavenger, Dina] Amgen Inc, Thousand Oaks, CA 91320 USA; [Dieterle, Frank; Carl, Kevin; Laurie, David; Maurer, Gerard] Nova Pharma AG, Basel, Switzerland; [Baer, William; Hassan, Alita; Schipper, Matthew J.; Webb, Craig] ClinXus, Grand Rapids, MI USA; [Baer, William; Hassan, Alita; Schipper, Matthew J.; Webb, Craig] Van Andel Res Inst, Grand Rapids, MI USA; [Bounous, Denise] Bristol Myers Squibb Co, Princeton, NJ USA; [Collins, Nathaniel; Gu, Yi-Zhong] Schering Plough Res Inst, Summit, NJ USA; [Goering, Peter; Goodsaid, Federico; Jacobson-Kram, David; Thompson, Karol L.] US FDA, Silver Spring, MD USA; [Guilpin, Valerie; Harpur, Ernie] Sanofi Aventis, Malvern, PA USA; [Kasper, Peter; Maciulaitis, Romaldas; Papaluca-Amati, Marisa; Vamvakas, Spiros; Vidal, Jean-Marc] European Med Agcy, London, England; [Lima, Beatriz Silva] Univ Lisbon, IMED UL, P-1699 Lisbon, Portugal; [Mattes, William; Walker, Elizabeth] Crit Path Inst, Tucson, AZ USA; [Obert, Leslie Ann; Ozer, Josef] Pfizer Inc, Groton, CT 06340 USA; [Phillips, Jonathan A.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Vonderscher, Jacky] Hoffmann La Roche AG, Basel, Switzerland	Merck & Company; Amgen; Novartis; Van Andel Institute; Bristol-Myers Squibb; Merck & Company; Schering-Plough Research Institute; US Food & Drug Administration (FDA); Sanofi-Aventis; Universidade de Lisboa; Pfizer; Boehringer Ingelheim; Roche Holding	Sistare, FD (corresponding author), Merck Res Labs, West Point, PA USA.	frank_sistare@merck.com	Troth, Sean P./R-6885-2019; Lima, Beatriz Silva/A-4284-2014; Webb, Craig/I-8123-2012	Troth, Sean P./0000-0002-4696-5129; Lima, Beatriz Silva/0000-0003-0910-7245; Mattes, William/0000-0001-8653-4289; Maurer, Gerald/0000-0002-9043-7657; Phillips, Jonathan/0000-0001-7290-754X; Maciulaitis, Romaldas/0000-0003-0106-4033; Gerhold, David/0000-0001-5739-730X				Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Altar CA, 2008, CLIN PHARMACOL THER, V83, P368, DOI 10.1038/sj.clpt.6100451; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Crissman JW, 2004, TOXICOL PATHOL, V32, P126, DOI 10.1080/01926230490268756; CUMMINS B, 1987, AM HEART J, V113, P1333, DOI 10.1016/0002-8703(87)90645-4; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; European Medicines Agency, 2007, EV MED HUM US INN DR; Food and Drug Administration, 2004, INN STAGN CHALL OPP; Harrell FE, 2001, REGRESSION MODELING; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; INGLESE J, 2008, E LILLY CO NIH CHEM; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Mattes WB, 2010, NAT BIOTECHNOL, V28, P432, DOI 10.1038/nbt0510-432; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Sistare FD, 2007, CLIN PHARMACOL THER, V82, P210, DOI 10.1038/sj.clpt.6100243; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Wagner JA, 2007, CLIN PHARMACOL THER, V81, P104, DOI 10.1038/sj.clpt.6100017; Wagner JA, 2008, ANNU REV PHARMACOL, V48, P631, DOI 10.1146/annurev.pharmtox.48.113006.094611; Wilson C, 2007, CLIN PHARMACOL THER, V81, P153, DOI 10.1038/sj.clpt.6100088; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624	24	93	98	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					446	454		10.1038/nbt.1634	http://dx.doi.org/10.1038/nbt.1634			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458314				2022-12-25	WOS:000277452700024
J	Thorgeirsson, TE; Gudbjartsson, DF; Surakka, I; Vink, JM; Amin, N; Geller, F; Sulem, P; Rafnar, T; Esko, T; Walter, S; Gieger, C; Rawal, R; Mangino, M; Prokopenko, I; Magi, R; Keskitalo, K; Gudjonsdottir, IH; Gretarsdottir, S; Stefansson, H; Thompson, JR; Aulchenko, YS; Nelis, M; Aben, KK; den Heijer, M; Dirksen, A; Ashraf, H; Soranzo, N; Valdes, AM; Steves, C; Uitterlinden, AG; Hofman, A; Tonjes, A; Kovacs, P; Hottenga, JJ; Willemsen, G; Vogelzangs, N; Doring, A; Dahmen, N; Nitz, B; Pergadia, ML; Saez, B; De Diego, V; Lezcano, V; Garcia-Prats, MD; Ripatti, S; Perola, M; Kettunen, J; Hartikainen, AL; Pouta, A; Laitinen, J; Isohanni, M; Huei-Yi, S; Allen, M; Krestyaninova, M; Hall, AS; Jones, GT; van Rij, AM; Mueller, T; Dieplinger, B; Haltmayer, M; Jonsson, S; Matthiasson, SE; Oskarsson, H; Tyrfingsson, T; Kiemeney, LA; Mayordomo, JI; Lindholt, JS; Pedersen, JH; Franklin, WA; Wolf, H; Montgomery, GW; Heath, AC; Martin, NG; Madden, PAF; Giegling, I; Rujescu, D; Jarvelin, MR; Salomaa, V; Stumvoll, M; Spector, TD; Wichmann, HE; Metspalu, A; Samani, NJ; Penninx, BW; Oostra, BA; Boomsma, DI; Tiemeier, H; van Duijn, CM; Kaprio, J; Gulcher, JR; McCarthy, MI; Peltonen, L; Thorsteinsdottir, U; Stefansson, K				Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel F.; Surakka, Ida; Vink, Jacqueline M.; Amin, Najaf; Geller, Frank; Sulem, Patrick; Rafnar, Thorunn; Esko, Tonu; Walter, Stefan; Gieger, Christian; Rawal, Rajesh; Mangino, Massimo; Prokopenko, Inga; Magi, Reedik; Keskitalo, Kaisu; Gudjonsdottir, Iris H.; Gretarsdottir, Solveig; Stefansson, Hreinn; Thompson, John R.; Aulchenko, Yurii S.; Nelis, Mari; Aben, Katja K.; den Heijer, Martin; Dirksen, Asger; Ashraf, Haseem; Soranzo, Nicole; Valdes, Ana M.; Steves, Claire; Uitterlinden, Andre G.; Hofman, Albert; Tonjes, Anke; Kovacs, Peter; Hottenga, Jouke Jan; Willemsen, Gonneke; Vogelzangs, Nicole; Doering, Angela; Dahmen, Norbert; Nitz, Barbara; Pergadia, Michele L.; Saez, Berta; De Diego, Veronica; Lezcano, Victoria; Garcia-Prats, Maria D.; Ripatti, Samuli; Perola, Markus; Kettunen, Johannes; Hartikainen, Anna-Liisa; Pouta, Anneli; Laitinen, Jaana; Isohanni, Matti; Huei-Yi, Shen; Allen, Maxine; Krestyaninova, Maria; Hall, Alistair S.; Jones, Gregory T.; van Rij, Andre M.; Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard; Jonsson, Steinn; Matthiasson, Stefan E.; Oskarsson, Hogni; Tyrfingsson, Thorarinn; Kiemeney, Lambertus A.; Mayordomo, Jose I.; Lindholt, Jes S.; Pedersen, Jesper Holst; Franklin, Wilbur A.; Wolf, Holly; Montgomery, Grant W.; Heath, Andrew C.; Martin, Nicholas G.; Madden, Pamela A. F.; Giegling, Ina; Rujescu, Dan; Jaervelin, Marjo-Riitta; Salomaa, Veikko; Stumvoll, Michael; Spector, Tim D.; Wichmann, H-Erich; Metspalu, Andres; Samani, Nilesh J.; Penninx, Brenda W.; Oostra, Ben A.; Boomsma, Dorret I.; Tiemeier, Henning; van Duijn, Cornelia M.; Kaprio, Jaakko; Gulcher, Jeffrey R.; McCarthy, Mark I.; Peltonen, Leena; Thorsteinsdottir, Unnur; Stefansson, Kari		ENGAGE Consortium	Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; MOLECULAR-GENETICS; GENES; METAANALYSIS; IMPUTATION; QUANTITY; 15Q25	Smoking is a common risk factor for many diseases(1). We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P < 5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence2-4. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).	[Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel F.; Geller, Frank; Sulem, Patrick; Rafnar, Thorunn; Gudjonsdottir, Iris H.; Gretarsdottir, Solveig; Stefansson, Hreinn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Thorgeirsson, Thorgeir E.] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Surakka, Ida; Ripatti, Samuli; Huei-Yi, Shen; Kaprio, Jaakko; Peltonen, Leena] Univ Helsinki, Inst Mol Med FIMM, FIN-00014 Helsinki, Finland; [Surakka, Ida; Ripatti, Samuli; Perola, Markus; Huei-Yi, Shen; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Vink, Jacqueline M.; Hottenga, Jouke Jan; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ VU Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Amin, Najaf; Walter, Stefan; Uitterlinden, Andre G.; Hofman, Albert; Tiemeier, Henning; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Project, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Gieger, Christian; Rawal, Rajesh; Doering, Angela; Nitz, Barbara; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Mangino, Massimo; Soranzo, Nicole; Valdes, Ana M.; Steves, Claire; Spector, Tim D.] Kings Coll London, St Thomas Hosp Campus, Dept Twin Res & Genet Epidemiol, London, England; [Prokopenko, Inga; Magi, Reedik; Allen, Maxine; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Prokopenko, Inga; Magi, Reedik; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Keskitalo, Kaisu; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester, Leics, England; [Aben, Katja K.; den Heijer, Martin; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Aulchenko, Yurii S.; Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Nelis, Mari; den Heijer, Martin] Radboud Univ Nijmegen, Dept Endocrinol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Dirksen, Asger; Ashraf, Haseem] Gentofte Univ Hosp, Dept Pulm Med, Hellerup, Denmark; [Soranzo, Nicole; Kettunen, Johannes; Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, England; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Tonjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Tonjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Vogelzangs, Nicole; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Pergadia, Michele L.; Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Saez, Berta] Inst Nanotecnol Aragon, Zaragoza, Spain; [De Diego, Veronica; Lezcano, Victoria; Hartikainen, Anna-Liisa] Hosp San Pedro, Div Dermatol, Logrono, Spain; [Garcia-Prats, Maria D.] San Jorge Hosp, Div Pathol, Huesca, Spain; [Isohanni, Matti] Univ Oulu, Inst Clin Med, Oulu, Finland; [Pouta, Anneli; Jaervelin, Marjo-Riitta] Natl Inst Hlth & Welf, Lifecourse & Serv Dept, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Krestyaninova, Maria] Wellcome Trust Genome Campus, European Bioinformat Inst, Cambridge, England; [Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds, W Yorkshire, England; [Jones, Gregory T.; van Rij, Andre M.] Univ Otago Sch Med, Vasc Res Grp, Dunedin, New Zealand; [Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard] Konventhosp Barmherzige Brueder Linz, Dept Lab Med, Linz, Austria; [Jonsson, Steinn] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Matthiasson, Stefan E.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Oskarsson, Hogni] Therapeia, Reykjavik, Iceland; [Tyrfingsson, Thorarinn] Vogur Hosp, Natl Ctr Addict Med, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Mayordomo, Jose I.] Univ Zaragoza, Zaragoza, Spain; [Lindholt, Jes S.] Viborg Hosp, Vasc Res Unit, Viborg, Denmark; [Pedersen, Jesper Holst] Univ Copenhagen, Rigshosp, Dept Cardiothorac Surg, DK-2100 Copenhagen, Denmark; [Franklin, Wilbur A.] Univ Colorado Denver, Dept Pathol, Aurora, CO USA; [Wolf, Holly] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA; [Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Giegling, Ina; Rujescu, Dan] Univ Munich LMU, Dept Psychiat, Munich, Germany; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Fac Med, London, England; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Samani, Nilesh J.] Univ Leicester, Clin Sci Wing, Glenfield Hosp, Dept Cardiovas Sci, Leicester, Leics, England; [Oostra, Ben A.] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Alcohol Abuse Serv, Helsinki, Finland	University of California System; University of California Santa Cruz; University of Helsinki; Finland National Institute for Health & Welfare; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Tartu; Estonian Biocentre; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; King's College London; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; University of Leicester; Radboud University Nijmegen; Radboud University Nijmegen; University of Copenhagen; Herlev & Gentofte Hospital; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; Leipzig University; Leipzig University; Leipzig University; Vrije Universiteit Amsterdam; Johannes Gutenberg University of Mainz; Washington University (WUSTL); Hospital Universidad San Jorge; University of Oulu; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Leeds; University of Otago; Konventhospital Der Barmherzigen Bruder; Landspitali National University Hospital; University of Iceland; Radboud University Nijmegen; University of Zaragoza; Aarhus University; Rigshospitalet; University of Copenhagen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; QIMR Berghofer Medical Research Institute; University of Munich; Imperial College London; University of Oulu; University of Oulu; University of Munich; University of Munich; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kstefans@decode.is	Aben, Katja KH/G-9686-2016; Wichmann, Heinz Erich/AAA-5695-2022; Amin, Najaf N/D-1859-2012; Boomsma, Dorret I/AAX-4470-2020; Montgomery, Grant W/B-7148-2008; Prokopenko, Inga/AAU-9895-2020; Prokopenko, Inga/H-3241-2014; Hall, Alistair/K-1953-2019; Tuluc, Petronel/C-2527-2011; Vink, Jacqueline/A-7648-2012; Rujescu, Dan/GRS-3875-2022; Mayordomo, Jose/K-3453-2013; Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019; Spector, Tim D/F-6533-2012; Giegling, Ina/ABA-3677-2021; Mangino, Massimo/F-5134-2011; Nelis, Mari/ABG-7775-2020; Stumvoll, Michael/ABE-1121-2021; Penninx, Brenda WJH/S-7627-2017; Aulchenko, Yurii/M-8270-2013; Mägi, Reedik/AAJ-9679-2021; Walter, Stefan/I-6940-2012; Ripatti, Samuli/H-9446-2014; Tiemeier, Henning/H-6534-2019; Kaprio, Jaakko/A-1820-2008; Uhlen, Mathias/B-3262-2016; McCarthy, Mark/M-3763-2015; Lindholt, Jes/J-2907-2014; den Heijer, Martin/J-8036-2015; Estivill, Xavier/A-3125-2013	Aben, Katja KH/0000-0002-0214-2147; Montgomery, Grant W/0000-0002-4140-8139; Prokopenko, Inga/0000-0003-1624-7457; Kiemeney, Lambertus A./0000-0002-2368-1326; Mangino, Massimo/0000-0002-2167-7470; Nelis, Mari/0000-0001-9748-1020; Stumvoll, Michael/0000-0001-6225-8240; Penninx, Brenda WJH/0000-0001-7779-9672; Aulchenko, Yurii/0000-0002-7899-1575; Ripatti, Samuli/0000-0002-0504-1202; Tiemeier, Henning/0000-0002-4395-1397; Kaprio, Jaakko/0000-0002-3716-2455; Gudbjartsson, Daniel/0000-0002-5222-9857; Rawal, Rajesh/0000-0002-0151-9344; Uhlen, Mathias/0000-0002-4858-8056; Whitfield, John/0000-0002-1103-0876; Jones, Gregory T/0000-0002-6950-4210; Kovacs, Peter/0000-0002-0290-5423; Gudjonsdottir, Iris Hronn/0000-0001-6013-9520; Amin, Najaf/0000-0002-8944-1771; Van Duijn, Cornelia/0000-0002-2374-9204; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Valdes, Ana M./0000-0003-1141-4471; Gieger, Christian/0000-0001-6986-9554; Nitz, Barbara/0000-0001-6289-7237; Shen, Huei-yi/0000-0003-2798-6140; Willemsen, Gonneke/0000-0003-3755-0236; McCarthy, Mark/0000-0002-4393-0510; Surakka, Ida/0000-0002-6669-5541; Magi, Reedik/0000-0002-2964-6011; Martin, Nicholas/0000-0003-4069-8020; Esko, Tonu/0000-0003-1982-6569; Stefansson, Hreinn/0000-0002-9331-6666; Geller, Frank/0000-0002-9238-3269; Lindholt, Jes/0000-0001-9536-4488; den Heijer, Martin/0000-0003-3620-5617; Estivill, Xavier/0000-0002-0723-2256; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Steves, Claire/0000-0002-4910-0489; Hall, Alistair/0000-0003-0306-7887; Walter, Stefan/0000-0002-6010-7550; Soranzo, Nicole/0000-0003-1095-3852; Krestyaninova, Maria/0000-0002-8705-8111	US National Institutes of Health [R01DA017932]; European Commission [LSHM-CT-2004-005166, HEALTH-F42007-201413]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all the participants in the genetic studies whose contributions made this work possible. This work was supported in part by the US National Institutes of Health (R01DA017932) and the European Commission's Sixth Framework Program, Integrated Project GENADDICT (LSHM-CT-2004-005166). The ENGAGE smoking consortium was formed through a component of the Integrated Project ENGAGE, supported by the European Commission's Seventh Framework Program, grant agreement HEALTH-F42007-201413. ENGAGE projects have benefited from the SIMBioMS platform<SUP>28</SUP>, which has greatly facilitated data exchange and annotation. Further acknowledgments are listed in the Supplementary Note online.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Chanock SJ, 2008, NATURE, V452, P537, DOI 10.1038/452537a; Collins Allan C, 2009, Handb Exp Pharmacol, P85, DOI 10.1007/978-3-540-69248-5_4; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Krestyaninova M, 2009, BIOINFORMATICS, V25, P2768, DOI 10.1093/bioinformatics/btp420; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9; Mineur YS, 2008, BIOCHEM PHARMACOL, V75, P323, DOI 10.1016/j.bcp.2007.06.010; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Ray R, 2009, J NEUROGENET, V23, P252, DOI 10.1080/01677060802572887; RICE JA, 1995, MATH STAT DATA ANAL, P299; Rose RJ, 2010, HANDBOOK OF BEHAVIOR GENETICS, P411, DOI 10.1007/978-0-387-76727-7_28; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, INT J EPIDEMIOL, V39, P577, DOI 10.1093/ije/dyp385; Thorgeirsson TE, 2008, BIOL PSYCHIAT, V64, P919, DOI 10.1016/j.biopsych.2008.09.010; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; World Health Organization, 2008, WAIST CIRCUMFERENCE	36	519	526	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					448	U135		10.1038/ng.573	http://dx.doi.org/10.1038/ng.573			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20418888	Green Accepted			2022-12-25	WOS:000277179500018
J	Saito, Y; Uchida, N; Tanaka, S; Suzuki, N; Tomizawa-Murasawa, M; Sone, A; Najima, Y; Takagi, S; Aoki, Y; Wake, A; Taniguchi, S; Shultz, LD; Ishikawa, F				Saito, Yoriko; Uchida, Naoyuki; Tanaka, Satoshi; Suzuki, Nahoko; Tomizawa-Murasawa, Mariko; Sone, Akiko; Najima, Yuho; Takagi, Shinsuke; Aoki, Yuki; Wake, Atsushi; Taniguchi, Shuichi; Shultz, Leonard D.; Ishikawa, Fumihiko			Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML	NATURE BIOTECHNOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; COLONY-STIMULATING FACTOR; BONE-MARROW; SELF-RENEWAL; IN-VITRO; G-CSF; CHEMOTHERAPY; BLOOD; TRANSPLANTATION; MOBILIZATION	Cancer stem cells have been proposed to be important for initiation, maintenance and recurrence of various malignancies, including acute myeloid leukemia (AML)(1-3). We have previously reported(4) that CD34+CD38-human primary AML stem cells residing in the endosteal region of the bone marrow are relatively chemotherapy resistant. Using a NOD/SCID/IL2r gamma(null) mouse model of human AML, we now show that the AML stem cells in the endosteal region are cell cycle quiescent and that these stem cells can be induced to enter the cell cycle by treatment with granulocyte colony-stimulating factor (G-CSF). In combination with cell cycle-dependent chemotherapy, G-CSF treatment significantly enhances induction of apoptosis and elimination of human primary AML stem cells in vivo. The combination therapy leads to significantly increased survival of secondary recipients after transplantation of leukemia cells compared with chemotherapy alone.	[Saito, Yoriko; Suzuki, Nahoko; Tomizawa-Murasawa, Mariko; Sone, Akiko; Najima, Yuho; Takagi, Shinsuke; Aoki, Yuki; Ishikawa, Fumihiko] RIKEN, Res Ctr Allergy & Immunol, Res Unit Human Dis Models, Yokohama, Kanagawa, Japan; [Uchida, Naoyuki; Takagi, Shinsuke; Wake, Atsushi; Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Tanaka, Satoshi] Nippon Becton Dickinson Co, Tokyo, Japan; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME 04609 USA	RIKEN; Toranomon Hospital; Becton Dickinson; Jackson Laboratory	Ishikawa, F (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Res Unit Human Dis Models, Yokohama, Kanagawa, Japan.	f_ishika@rcai.riken.jp	石川, 文彦/L-4488-2014; Najima, Yuho/W-3858-2019	Najima, Yuho/0000-0001-8910-0021	NIH/NINDS [R21NS064328]; NINDS [R01NS038650, P30-NS045758, RC2 NS069476-01, P01NS057228]; Miracles for Madison Fund; NATIONAL CANCER INSTITUTE [R01CA020408] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miracles for Madison Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NINDS R21NS064328 to B. K. K., NINDS R01NS038650 to A. H. M. B., NINDS core P30-NS045758, RC2 NS069476-01 and Miracles for Madison Fund to B. K. K. and A. H. M. B. and NINDS P01NS057228 to M. M. R. We thank R. Levine and E. Nurre for expert technical assistance and J. Ward for pathology services.	Amadori S, 2005, BLOOD, V106, P27, DOI 10.1182/blood-2004-09-3728; BOEKHORST PAWT, 1993, LEUKEMIA, V7, P1191; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buchner T, 2004, NEW ENGL J MED, V350, P2215, DOI 10.1056/NEJM200405203502124; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Estey EH, 1999, BLOOD, V93, P2478, DOI 10.1182/blood.V93.8.2478.408k04_2478_2484; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fukuda S, 2007, BLOOD, V110, P860, DOI 10.1182/blood-2006-06-031401; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Milligan DW, 2006, BLOOD, V107, P4614, DOI 10.1182/blood-2005-10-4202; Mori T, 2008, BIOL BLOOD MARROW TR, V14, P651, DOI 10.1016/j.bbmt.2008.03.006; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; OHNO R, 1994, BLOOD, V83, P2086; Ooi J, 2004, BLOOD, V103, P489, DOI 10.1182/blood-2003-07-2420; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sipkins DA, 2009, NEW ENGL J MED, V361, P1307, DOI 10.1056/NEJMcibr0904291; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	37	291	304	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					275	U133		10.1038/nbt.1607	http://dx.doi.org/10.1038/nbt.1607			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20160717	Green Accepted			2022-12-25	WOS:000275288300027
J	Lee, I; Ambaru, B; Thakkar, P; Marcotte, EM; Rhee, SY				Lee, Insuk; Ambaru, Bindu; Thakkar, Pranjali; Marcotte, Edward M.; Rhee, Seung Y.			Rational association of genes with traits using a genome-scale gene network for Arabidopsis thaliana	NATURE BIOTECHNOLOGY			English	Article							PROTEIN COMPLEXES; COP9 SIGNALOSOME; INSERTIONAL MUTAGENESIS; WIDE PREDICTION; INTERACTION MAP; EXPRESSION; INTERACTOME; AUXIN; YEAST	We introduce a rational approach for associating genes with plant traits by combined use of a genome-scale functional network and targeted reverse genetic screening. We present a probabilistic network (AraNet) of functional associations among 19,647 (73%) genes of the reference flowering plant Arabidopsis thaliana. AraNet associations are predictive for diverse biological pathways, and outperform predictions derived only from literature-based protein interactions, achieving 21% precision for 55% of genes. AraNet prioritizes genes for limited-scale functional screening, resulting in a hit-rate tenfold greater than screens of random insertional mutants, when applied to early seedling development as a test case. By interrogating network neighborhoods, we identify AT1G80710 (now DROUGHT SENSITIVE 1; DRS1) and AT3G05090 (now LATERAL ROOT STIMULATOR 1; LRS1) as regulators of drought sensitivity and lateral root development, respectively. AraNet (http://www.functionalnet.org/aranet/) provides a resource for plant gene function identification and genetic dissection of plant traits.	[Lee, Insuk] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Lee, Insuk; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ambaru, Bindu; Thakkar, Pranjali; Rhee, Seung Y.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	Yonsei University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Carnegie Institution for Science	Lee, I (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	insuklee@yonsei.ac.kr; marcotte@icmb.utexas.edu; rhee@acoma.stanford.edu	Lee, Insuk/F-7722-2010	Marcotte, Edward/0000-0001-8808-180X; Ambaru (Ph.D), Purna Sudha Bindu/0000-0003-0131-0353	Carnegie Institution for Science; National Science Foundation [MCB-0520140]; Korean government [2009-0063342, 20090070968]; Yonsei University [2008-7-0284, 2008-1-0018]; National Science Foundation, National Institutes of Health; Welch Foundation [F1515]; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088624, R01GM076536, R01GM067779] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820823] Funding Source: National Science Foundation	Carnegie Institution for Science; National Science Foundation(National Science Foundation (NSF)); Korean government(Korean Government); Yonsei University; National Science Foundation, National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to M. Ahn, A. Noorani and V. Bakshi for technical assistance, J. Shin for assistance on AraNet web design, T. Nakagawa (Shimane University, Japan) for providing pGWB2, K. Barton for providing lab space and D. Meinke, M. Running, W. Briggs, Z. Wang and K. Dreher for helpful discussions. This work was supported by Carnegie Institution for Science (B. A., S.Y.R.), a grant from the National Science Foundation (MCB-0520140) to S.Y.R. and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (no. 2009-0063342, 20090070968) and Yonsei University (no. 2008-7-0284, 2008-1-0018) to I. L. and from the National Science Foundation, National Institutes of Health, and Welch (F1515) and Packard Foundations to E. M. M.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Catala R, 2007, PLANT CELL, V19, P2952, DOI 10.1105/tpc.106.049981; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cui J, 2008, NUCLEIC ACIDS RES, V36, pD999, DOI 10.1093/nar/gkm844; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Goodger JQD, 2005, J EXP BOT, V56, P2389, DOI 10.1093/jxb/eri231; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McElver J, 2001, GENETICS, V159, P1751; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; MUNNS R, 1988, PLANT PHYSIOL, V88, P703, DOI 10.1104/pp.88.3.703; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peng ZH, 2001, PLANT CELL, V13, P2393, DOI 10.1105/tpc.13.11.2393; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	50	262	270	3	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					149	U14		10.1038/nbt.1603	http://dx.doi.org/10.1038/nbt.1603			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20118918	Green Accepted			2022-12-25	WOS:000274317200023
J	Feldman, MB; Terry, DS; Altman, RB; Blanchard, SC				Feldman, Michael B.; Terry, Daniel S.; Altman, Roger B.; Blanchard, Scott C.			Aminoglycoside activity observed on single pre-translocation ribosome complexes	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDYL-TRANSFER-RNA; MESSENGER-RNA; HYBRID STATE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ANTIBIOTICS; TRANSLATION; INHIBITION; SUBUNIT	Aminoglycoside-class antibiotics bind directly to ribosomal RNA, imparting pleiotropic effects on ribosome function. Despite in-depth structural investigations of aminoglycoside-RNA oligonucleotide and aminoglycoside-ribosome interactions, mechanisms explaining the unique ribosome inhibition profiles of chemically similar aminoglycosides remain elusive. Here, using single-molecule fluorescence resonance energy transfer (smFRET) methods, we show that high-affinity aminoglycoside binding to the conserved decoding site region of the functional pre-translocation ribosome complex specifically remodels the nature of intrinsic dynamic processes within the particle. The extents of these effects, which are distinct for each member of the aminoglycoside class, strongly correlate with their inhibition of EF-G-catalyzed translocation. Neomycin, a 4,5-linked aminoglycoside, binds with lower affinity to one or more secondary binding sites, mediating distinct structural and dynamic perturbations that further enhance translocation inhibition. These new insights help explain why closely related aminoglycosides elicit pleiotropic translation activities and demonstrate the potential utility of smFRET as a tool for dissecting the mechanisms of antibiotic action.	[Feldman, Michael B.; Terry, Daniel S.; Altman, Roger B.; Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Feldman, Michael B.] Rockefeller Univ, Sloan Kettering Triinst MD PhD Program, New York, NY 10021 USA; [Terry, Daniel S.] Triinst Training Program Computat Biol & Med, New York, NY USA	Cornell University; Rockefeller University	Blanchard, SC (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	scb2005@med.cornell.edu	Terry, Daniel/B-3521-2008; Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Feldman, Michael/0000-0001-7364-5211; Terry, Daniel/0000-0001-9021-0084	US National Institute of General Medical Sciences [5R01GM079238-03]; New York State Foundation for Science, Technology and Innovation; US National Science Foundation; US National Institutes of Health [GM07739]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM079238] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New York State Foundation for Science, Technology and Innovation; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Munro for comments and suggestions during the preparation of this manuscript and for the generation of ribosome structural diagrams. We thank all members of the laboratory for their constructive comments during preparation of this manuscript, as well as R. Green (Johns Hopkins School of Medicine, Howard Hughes Medical Institute) for providing MS2-tagged rRNA constructs. This work was supported by the US National Institute of General Medical Sciences (5R01GM079238-03), New York State Foundation for Science, Technology and Innovation, and a US National Science Foundation CAREER award. M.B.F. is a trainee in the Weill Cornell/Rockefeller University/Sloan-Kettering Tri-Institutional MD-PhD Program supported by US National Institutes of Health Medical Scientist Training Program grant GM07739. D.S.T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; CAMPUZANO S, 1979, BIOCHEMISTRY-US, V18, P1570, DOI 10.1021/bi00575a029; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; DAVIES J, 1968, J BIOL CHEM, V243, P3312; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; FAST R, 1987, BIOCHIMIE, V69, P131, DOI 10.1016/0300-9084(87)90245-8; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; Jerinic O, 2000, J MOL BIOL, V304, P707, DOI 10.1006/jmbi.2000.4269; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; Kaul M, 2002, BIOCHEMISTRY-US, V41, P7695, DOI 10.1021/bi020130f; Kim HD, 2007, BIOPHYS J, V93, P3575, DOI 10.1529/biophysj.107.109884; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; MISUMI M, 1978, BIOCHEM BIOPH RES CO, V84, P358, DOI 10.1016/0006-291X(78)90178-X; Munro JB, 2008, BIOPOLYMERS, V89, P565, DOI 10.1002/bip.20961; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; Prammananan T, 1998, J INFECT DIS, V177, P1573, DOI 10.1086/515328; Puglisi JD, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P419; Qin Feng, 2007, V403, P253, DOI 10.1007/978-1-59745-529-9_17; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Ryu DH, 2002, BIOCHEMISTRY-US, V41, P10499, DOI 10.1021/bi026086l; Sander P, 1996, MOL MICROBIOL, V22, P841, DOI 10.1046/j.1365-2958.1996.01532.x; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SEMENKOV Y, 1992, FEBS LETT, V296, P207, DOI 10.1016/0014-5793(92)80380-Y; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Sucheck SJ, 2000, J AM CHEM SOC, V122, P5230, DOI 10.1021/ja000575w; Vaiana AC, 2009, J MOL BIOL, V386, P648, DOI 10.1016/j.jmb.2008.12.035; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; YAMADA T, 1980, NUCLEIC ACIDS RES, V8, P5767, DOI 10.1093/nar/8.23.5767; Youngman EM, 2005, METHODS, V36, P305, DOI 10.1016/j.ymeth.2005.04.007; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	52	64	68	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					54	62		10.1038/NCHEMBIO.274	http://dx.doi.org/10.1038/NCHEMBIO.274			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19946275	Green Accepted			2022-12-25	WOS:000272802500012
J	Saito, H; Kobayashi, T; Hara, T; Fujita, Y; Hayashi, K; Furushima, R; Inoue, T				Saito, Hirohide; Kobayashi, Tetsuhiro; Hara, Tomoaki; Fujita, Yoshihiko; Hayashi, Karin; Furushima, Rie; Inoue, Tan			Synthetic translational regulation by an L7Ae-kink-turn RNP switch	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN INTERACTIONS; GENE-EXPRESSION; MESSENGER-RNA; L7AE PROTEIN; IN-VIVO; BIOLOGY; MOTIF; RIBOSWITCHES; BINDING; C/D	The regulation of cell signaling pathways and the reconstruction of genetic circuits are important aspects of bioengineering research. Both of these goals require molecular devices to transmit information from an input biomacromolecule to the desired outputs. Here, we show that an RNA-protein (RNP)-containing L7Ae-kink-turn interaction can be used to construct translational regulators under control of an input protein that regulates the expression of desired output proteins. We built a system in which L7Ae, an archaeal ribosomal protein, regulates the translation of a designed mRNA in vitro and in human cells. The translational regulator composed of the RNP might provide new therapeutic strategies based on the detection, repair or rewiring of intrinsic cellular defects, and it may also serve as an invaluable tool for the dissection of the behavior of complex, higher-order circuits in the cell.	[Saito, Hirohide; Kobayashi, Tetsuhiro; Hara, Tomoaki; Inoue, Tan] Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Sakyo Ku, Kyoto, Japan; [Saito, Hirohide; Fujita, Yoshihiko; Hayashi, Karin; Furushima, Rie; Inoue, Tan] Japan Sci & Technol Agcy, ICORP, Chiyoda Ku, Tokyo, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Saito, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Sakyo Ku, Oiwake Cho, Kyoto, Japan.	h-saito@kuchem.kyoto-u.ac.jp; tan@kuchem.kyoto-u.ac.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	The authors thank Y. Shimizu (University of Tokyo) for providing us with the PURE - system solutions, A. Huttenhofer (Innsbruck Medical University, Biocenter) and T. S. Rozhdestvensky (University of Muenster) for providing us with the L7Ae plasmids, and S. Kashida (Kyoto University) for providing us with the p481 and pSk 7 plasmids. The authors also thank A. Kitamura (JST) for RNP structural modeling. This work was supported by a Grant-in-Aid for Young Scientists (A) (H.S.) and the International Cooperative Research Project, Japan Science and Technology Agency (H.S. and T.I.).	Atsumi S, 2001, EMBO J, V20, P5453, DOI 10.1093/emboj/20.19.5453; Babitzke P, 2009, ANNU REV MICROBIOL, V63, P27, DOI 10.1146/annurev.micro.091208.073514; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gallivan JP, 2007, CURR OPIN CHEM BIOL, V11, P612, DOI 10.1016/j.cbpa.2007.10.004; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Hamma T, 2004, STRUCTURE, V12, P893, DOI 10.1016/S0969-2126(04)00096-6; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; KAERN M, 2006, SYSTEM MODELING CELL, pCH13; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Matsumura S, 2003, NUCLEIC ACIDS RES, V31, P5544, DOI 10.1093/nar/gkg760; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Ogawa A, 2008, CHEMBIOCHEM, V9, P206, DOI 10.1002/cbic.200700478; Paraskeva E, 1998, P NATL ACAD SCI USA, V95, P951, DOI 10.1073/pnas.95.3.951; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Saito H, 2007, J BIOTECHNOL, V132, P1, DOI 10.1016/j.jbiotec.2007.07.952; Saito H, 2009, CHEMBIOCHEM, V10, P1640, DOI 10.1002/cbic.200900205; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Sharma V, 2008, J AM CHEM SOC, V130, P16310, DOI 10.1021/ja805203w; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STRIPECKE R, 1992, NUCLEIC ACIDS RES, V20, P5555, DOI 10.1093/nar/20.21.5555; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Topp S, 2008, RNA, V14, P2498, DOI 10.1261/rna.1269008; Turner B, 2005, RNA, V11, P1192, DOI 10.1261/rna.2680605; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Winkler WC, 2005, CURR OPIN CHEM BIOL, V9, P594, DOI 10.1016/j.cbpa.2005.09.016; Yamauchi T, 2008, CHEMBIOCHEM, V9, P1040, DOI 10.1002/cbic.200700782	47	104	109	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					71	78		10.1038/NCHEMBIO.273	http://dx.doi.org/10.1038/NCHEMBIO.273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	20016495				2022-12-25	WOS:000272802500014
J	Barretina, J; Taylor, BS; Banerji, S; Ramos, AH; Lagos-Quintana, M; DeCarolis, PL; Shah, K; Socci, ND; Weir, BA; Ho, A; Chiang, DY; Reva, B; Mermel, CH; Getz, G; Antipin, Y; Beroukhim, R; Major, JE; Hatton, C; Nicoletti, R; Hanna, M; Sharpe, T; Fennell, TJ; Cibulskis, K; Onofrio, RC; Saito, T; Shukla, N; Lau, C; Nelander, S; Silver, SJ; Sougnez, C; Viale, A; Winckler, W; Maki, RG; Garraway, LA; Lash, A; Greulich, H; Root, DE; Sellers, WR; Schwartz, GK; Antonescu, CR; Lander, ES; Varmus, HE; Ladanyi, M; Sander, C; Meyerson, M; Singer, S				Barretina, Jordi; Taylor, Barry S.; Banerji, Shantanu; Ramos, Alexis H.; Lagos-Quintana, Mariana; DeCarolis, Penelope L.; Shah, Kinjal; Socci, Nicholas D.; Weir, Barbara A.; Ho, Alan; Chiang, Derek Y.; Reva, Boris; Mermel, Craig H.; Getz, Gad; Antipin, Yevgenyi; Beroukhim, Rameen; Major, John E.; Hatton, Charles; Nicoletti, Richard; Hanna, Megan; Sharpe, Ted; Fennell, Tim J.; Cibulskis, Kristian; Onofrio, Robert C.; Saito, Tsuyoshi; Shukla, Neerav; Lau, Christopher; Nelander, Sven; Silver, Serena J.; Sougnez, Carrie; Viale, Agnes; Winckler, Wendy; Maki, Robert G.; Garraway, Levi A.; Lash, Alex; Greulich, Heidi; Root, David E.; Sellers, William R.; Schwartz, Gary K.; Antonescu, Cristina R.; Lander, Eric S.; Varmus, Harold E.; Ladanyi, Marc; Sander, Chris; Meyerson, Matthew; Singer, Samuel			Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy	NATURE GENETICS			English	Article							GASTROINTESTINAL STROMAL TUMORS; HUMAN CANCER GENES; DEDIFFERENTIATED LIPOSARCOMA; ANTAGONIST NUTLIN-3A; PIK3CA GENE; MUTATIONS; CELLS; PATHWAY; P53; CENSUS	Soft-tissue sarcomas, which result in approximately 10,700 diagnoses and 3,800 deaths per year in the United States(1), show remarkable histologic diversity, with more than 50 recognized subtypes(2). However, knowledge of their genomic alterations is limited. We describe an integrative analysis of DNA sequence, copy number and mRNA expression in 207 samples encompassing seven major subtypes. Frequently mutated genes included TP53 (17% of pleomorphic liposarcomas), NF1 (10.5% of myxofibrosarcomas and 8% of pleomorphic liposarcomas) and PIK3CA (18% of myxoid/round-cell liposarcomas, or MRCs). PIK3CA mutations in MRCs were associated with Akt activation and poor clinical outcomes. In myxofibrosarcomas and pleomorphic liposarcomas, we found both point mutations and genomic deletions affecting the tumor suppressor NF1. Finally, we found that short hairpin RNA (shRNA)-based knockdown of several genes amplified in dedifferentiated liposarcoma, including CDK4 and YEATS4, decreased cell proliferation. Our study yields a detailed map of molecular alterations across diverse sarcoma subtypes and suggests potential subtype-specific targets for therapy.	[Taylor, Barry S.; Socci, Nicholas D.; Reva, Boris; Antipin, Yevgenyi; Major, John E.; Nelander, Sven; Lash, Alex; Greulich, Heidi; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Barretina, Jordi; Banerji, Shantanu; Ramos, Alexis H.; Shah, Kinjal; Weir, Barbara A.; Chiang, Derek Y.; Mermel, Craig H.; Beroukhim, Rameen; Hatton, Charles; Nicoletti, Richard; Hanna, Megan; Winckler, Wendy; Garraway, Levi A.; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Banerji, Shantanu; Ramos, Alexis H.; Weir, Barbara A.; Chiang, Derek Y.; Mermel, Craig H.; Beroukhim, Rameen; Hatton, Charles; Nicoletti, Richard; Hanna, Megan; Garraway, Levi A.; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Barretina, Jordi; Banerji, Shantanu; Ramos, Alexis H.; Shah, Kinjal; Weir, Barbara A.; Chiang, Derek Y.; Mermel, Craig H.; Getz, Gad; Beroukhim, Rameen; Sharpe, Ted; Fennell, Tim J.; Cibulskis, Kristian; Onofrio, Robert C.; Silver, Serena J.; Sougnez, Carrie; Winckler, Wendy; Garraway, Levi A.; Root, David E.; Lander, Eric S.; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA USA; [Taylor, Barry S.] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA; [Lagos-Quintana, Mariana; DeCarolis, Penelope L.; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, Sarcoma Biol Lab, Sarcoma Dis Management Program, New York, NY 10021 USA; [Ho, Alan; Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, Lab New Drug Dev, Dept Med, New York, NY 10021 USA; [Saito, Tsuyoshi; Shukla, Neerav; Lau, Christopher; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Saito, Tsuyoshi; Shukla, Neerav; Lau, Christopher; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Lab, New York, NY USA; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA USA; [Varmus, Harold E.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Novartis; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Sander, C (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	sanderc@mskcc.org; matthew_meyerson@dfci.harvard.edu; singers@mskcc.org	Mermel, Craig/AAZ-7322-2020; Sander, Chris/H-1452-2011; Meyerson, Matthew L/E-7123-2012; Reva, Boris/AAB-8932-2022; Ladanyi, Marc/AAG-8585-2019; Cibulskis, Kristian/AAC-7380-2019; Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019; Chiang, Derek/L-6452-2019; Reva, Boris A./B-6436-2014; Barretina, Jordi/A-7192-2013	Mermel, Craig/0000-0002-0816-3395; Sander, Chris/0000-0001-6059-6270; Maki, Robert G/0000-0002-9853-2528; Reva, Boris A./0000-0002-8805-389X; Meyerson, Matthew/0000-0002-9133-8108; Lash, Alex/0000-0003-3787-1590; Cibulskis, Kristian/0000-0003-1343-1582; Barretina, Jordi/0000-0002-3478-4080; Singer, Samuel/0000-0001-9713-8230; Hatton, Charlie/0000-0001-9903-4291; Nelander, Sven/0000-0003-1758-1262	Anbinder Fund; Soft Tissue Sarcoma [P01 CA047179]; Kristen Ann Carr Fund; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE [P50CA140146, K08CA122833, P01CA047179] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Anbinder Fund; Soft Tissue Sarcoma; Kristen Ann Carr Fund; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For advice and discussion, we thank W. M. Lin, J.S. Boehm, C. M. Johannessen, A.J. Bass, M. Garber, S. Finn, J.A. Fletcher, W. C. Hahn, T. Golub and all the members of the Spanish Group for Research on Sarcomas (GEIS). We are grateful for the technical assistance and support of B. S. Blumenstail, L. Ziaugra and S. B. Gabriel of the Broad Genetic Analysis Platform; J. Baldwin of the Broad Sequencing Platform; J. Franklin, S. Mahan and K. Ardlie of the Broad Biological Samples Platform; and H. Le, P. Lizotte, B. Wong, A. Allen, A. Derr, C. Nguyen and J. K. Grenier of the Broad RNAi Platform. We thank L. Borsu for assistance with Sequenom assays at Memorial Sloan-Kettering Cancer Center (MSKCC). The MSKCC Sequenom facility is supported by the Anbinder Fund. We also thank the members of the MSKCC Genomics Core Laboratory and N.H. Moraco for clinical data support. J. A. Fletcher (Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA) and J. Nishio (Fukuoka University, Fukuoka, Japan) provided the LPS141 and FU-DDLS-1 cell lines, respectively. J. B. is a Beatriu de Pinos fellow of the Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya. B. S. T. is a fellow of the Geoffrey Beene Cancer Research Center at MSKCC. This work was supported in part by the Soft Tissue Sarcoma Program Project (P01 CA047179, S. J. S., M. L. and C. Sander), the Kristen Ann Carr Fund and the Starr Foundation Cancer Consortium and by a generous donation from M. B. Zuckerman.	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Ambrosini G, 2008, MOL CANCER THER, V7, P890, DOI 10.1158/1535-7163.MCT-07-0518; Antonescu CR, 2001, CLIN CANCER RES, V7, P3977; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; FLETCHER C, 2002, PATHOLOGY GENETICS T, V427; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Idbaih A, 2005, LAB INVEST, V85, P176, DOI 10.1038/labinvest.3700202; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maertens O, 2006, HUM MOL GENET, V15, P1015, DOI 10.1093/hmg/ddl016; Maertens O, 2006, HUM MUTAT, V27, P1030, DOI 10.1002/humu.20389; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nishio J, 2003, INT J ONCOL, V22, P535; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Singer S, 2007, CANCER RES, V67, P6626, DOI 10.1158/0008-5472.CAN-07-0584; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Upadhyaya M, 2004, HUM MUTAT, V23, P134, DOI 10.1002/humu.10305; van de Rijn M, 2006, ANNU REV PATHOL-MECH, V1, P435, DOI 10.1146/annurev.pathol.1.110304.100052; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	54	501	518	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					715	U103		10.1038/ng.619	http://dx.doi.org/10.1038/ng.619			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601955	Green Accepted, Green Submitted			2022-12-25	WOS:000280524000019
J	Johnson, AD; Yanek, LR; Chen, MH; Faraday, N; Larson, MG; Tofler, G; Lin, SJ; Kraja, AT; Province, MA; Yang, QO; Becker, DM; O'Donnell, CJ; Becker, LC				Johnson, Andrew D.; Yanek, Lisa R.; Chen, Ming-Huei; Faraday, Nauder; Larson, Martin G.; Tofler, Geoffrey; Lin, Shiow J.; Kraja, Aldi T.; Province, Michael A.; Yang, Qiong; Becker, Diane M.; O'Donnell, Christopher J.; Becker, Lewis C.			Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists	NATURE GENETICS			English	Article							GLYCOPROTEIN-VI; RECEPTOR; PROTEIN; GENE; EXPRESSION; MOLECULE; VARIANT; RESPONSIVENESS; POLYMORPHISMS; HEMOSTASIS		[Johnson, Andrew D.; Chen, Ming-Huei; Larson, Martin G.; Yang, Qiong; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Johnson, Andrew D.; O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Yanek, Lisa R.; Becker, Diane M.; Becker, Lewis C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesia & Crit Care Med, Baltimore, MD USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Tofler, Geoffrey] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Lin, Shiow J.; Kraja, Aldi T.; Province, Michael A.] Washington Univ Med, Div Stat Genom, St Louis, MO USA; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Boston University; Johns Hopkins University; Boston University; Royal North Shore Hospital; University of Sydney; Washington University (WUSTL); Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Johnson, AD (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	johnsonad2@nhlbi.nih.gov	Yang, Qiong/G-5438-2014; Johnson, Andrew D/G-6520-2013	Johnson, Andrew D/0000-0001-6369-5178; Larson, Martin/0000-0002-9631-1254; Chen, Ming-Huei/0000-0003-3551-8726	US National Heart, Lung, and Blood Institute [N01-HC-25195, N02-HL-6-4278, U01 HL72518, R01 HL087698-01, R01-HL-48157]; National Center for Research Resources [M01-RR000052]; Washington University DSG; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, M01RR005280] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072518, R01HL064278, R01HL048157, R01HL087698, ZIAHL006002] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Washington University DSG; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the US National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc. for genotyping services (Contract No. N02-HL-6-4278). This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research used the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. This work was supported by the National Heart, Lung, and Blood Institute through the PROGENI (U01 HL72518) and STAMPEED (R01 HL087698-01) consortia, and through R01-HL-48157. This research was conducted in part using the resources of the Johns Hopkins General Clinical Research Center, funded through the National Center for Research Resources, M01-RR000052 and the Washington University DSG cluster. We thank G. Ehret and S. Ganesh for providing R code that was modified to generate plots displayed in Figures 1 and 2 and Supplementary Figure 2.	Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Croft SA, 2001, CIRCULATION, V104, P1459, DOI 10.1161/hc3801.096397; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Faraday N, 2007, PHARMACOGENOMICS, V8, P1413, DOI 10.2217/14622416.8.10.1413; FREEMAN K, 1995, AM J HYPERTENS, V8, P863, DOI 10.1016/0895-7061(95)00155-I; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Guidetti GF, 2008, J BIOL CHEM, V283, P28795, DOI 10.1074/jbc.M801588200; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Holada K, 2006, HAEMATOLOGICA, V91, P1126; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Jones M, 2009, TRANSFUSION, V49, P376, DOI 10.1111/j.1537-2995.2008.01954.x; Joutsi-Korhonen L, 2003, BLOOD, V101, P4372, DOI 10.1182/blood-2002-08-2591; Kambayashi JI, 1996, THROMB RES, V81, P85, DOI 10.1016/0049-3848(95)00216-2; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Mukamal KJ, 2005, ALCOHOL CLIN EXP RES, V29, P1906, DOI 10.1097/01.alc.0000183011.86768.61; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn M J, 2001, Pharmacogenomics, V2, P341, DOI 10.1517/14622416.2.4.341; Salles II, 2008, BLOOD REV, V22, P155, DOI 10.1016/j.blre.2007.11.002; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shaughnessy JD, 1999, ONCOGENE, V18, P2069; Small KM, 2006, P NATL ACAD SCI USA, V103, P5472, DOI 10.1073/pnas.0601345103; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Trifiro E, 2009, BLOOD, V114, P1893, DOI 10.1182/blood-2009-03-209510; Wang Z, 2009, J THROMB HAEMOST, V7, P693, DOI 10.1111/j.1538-7836.2009.03289.x; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; Yabe M, 2006, BIOCHEM BIOPH RES CO, V347, P1001, DOI 10.1016/j.bbrc.2006.06.180; Yang Q, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S12; Yowe D, 2001, BIOCHEM J, V359, P109, DOI 10.1042/0264-6021:3590109	49	198	202	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					608	U186		10.1038/ng.604	http://dx.doi.org/10.1038/ng.604			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20526338	Green Accepted			2022-12-25	WOS:000279242400014
J	Kunarso, G; Chia, NY; Jeyakani, J; Hwang, C; Lu, XY; Chan, YS; Ng, HH; Bourque, G				Kunarso, Galih; Chia, Na-Yu; Jeyakani, Justin; Hwang, Catalina; Lu, Xinyi; Chan, Yun-Shen; Ng, Huck-Hui; Bourque, Guillaume			Transposable elements have rewired the core regulatory network of human embryonic stem cells	NATURE GENETICS			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; TRANSCRIPTIONAL NETWORK; GENE-EXPRESSION; PROTEIN CTCF; EVOLUTION; VERTEBRATE; MOUSE; LINES	Detection of new genomic control elements is critical in understanding transcriptional regulatory networks in their entirety. We studied the genome-wide binding locations of three key regulatory proteins (POU5F1, also known as OCT4; NANOG; and CTCF) in human and mouse embryonic stem cells. In contrast to CTCF, we found that the binding profiles of OCT4 and NANOG are markedly different, with only similar to 5% of the regions being homologously occupied. We show that transposable elements contributed up to 25% of the bound sites in humans and mice and have wired new genes into the core regulatory network of embryonic stem cells. These data indicate that species-specific transposable elements have substantially altered the transcriptional circuitry of pluripotent stem cells.	[Chia, Na-Yu; Lu, Xinyi; Chan, Yun-Shen; Ng, Huck-Hui; Bourque, Guillaume] Genome Inst Singapore, Gene Regulat Lab, Singapore, Singapore; [Kunarso, Galih] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Chia, Na-Yu; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Hwang, Catalina] Princeton Univ, Princeton, NJ 08544 USA; [Lu, Xinyi; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chan, Yun-Shen; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Princeton University; National University of Singapore; National University of Singapore; National University of Singapore	Bourque, G (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore, Singapore.	bourque@gis.a-star.edu.sg	Chan, Yun-Shen/GWC-4616-2022; Ng, Huck Hui/A-1135-2009; Bourque, Guillaume/AFR-2927-2022	Bourque, Guillaume/0000-0002-3933-9656; LU, Xinyi/0000-0002-3885-3960; CHIA, NA YU/0000-0003-1092-4699	Agency for Science, Technology and Research (A*STAR) of Singapore	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR) of Singapore.	Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	29	509	525	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					631	U111		10.1038/ng.600	http://dx.doi.org/10.1038/ng.600			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20526341				2022-12-25	WOS:000279242400018
J	Yang, JA; Benyamin, B; McEvoy, BP; Gordon, S; Henders, AK; Nyholt, DR; Madden, PA; Heath, AC; Martin, NG; Montgomery, GW; Goddard, ME; Visscher, PM				Yang, Jian; Benyamin, Beben; McEvoy, Brian P.; Gordon, Scott; Henders, Anjali K.; Nyholt, Dale R.; Madden, Pamela A.; Heath, Andrew C.; Martin, Nicholas G.; Montgomery, Grant W.; Goddard, Michael E.; Visscher, Peter M.			Common SNPs explain a large proportion of the heritability for human height	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; ARTIFICIAL SELECTION; COMPLEX DISEASES; TRAITS; LOCI; POPULATIONS; PREDICTION	SNPs discovered by genome-wide association studies (GWASs) account for only a small fraction of the genetic variation of complex traits in human populations. Where is the remaining heritability? We estimated the proportion of variance for human height explained by 294,831 SNPs genotyped on 3,925 unrelated individuals using a linear model analysis, and validated the estimation method with simulations based on the observed genotype data. We show that 45% of variance can be explained by considering all SNPs simultaneously. Thus, most of the heritability is not missing but has not previously been detected because the individual effects are too small to pass stringent significance tests. We provide evidence that the remaining heritability is due to incomplete linkage disequilibrium between causal variants and genotyped SNPs, exacerbated by causal variants having lower minor allele frequency than the SNPs explored to date.	[Yang, Jian; Benyamin, Beben; McEvoy, Brian P.; Gordon, Scott; Henders, Anjali K.; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Madden, Pamela A.; Heath, Andrew C.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Goddard, Michael E.] Univ Melbourne, Dept Food & Agr Syst, Parkville, Vic 3052, Australia	QIMR Berghofer Medical Research Institute; Washington University (WUSTL); University of Melbourne	Visscher, PM (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	peter.visscher@qimr.edu.au	Nyholt, Dale Robert/J-3174-2017; Yang, Jian/A-5852-2010; Girelli, Domenico/B-1183-2008; Visscher, Peter/ABB-6151-2020; Benyamin, Beben/D-9195-2012; Montgomery, Grant W/B-7148-2008; Henders, Anjali/E-3126-2017	Nyholt, Dale Robert/0000-0001-7159-3040; Yang, Jian/0000-0003-2001-2474; Girelli, Domenico/0000-0001-9684-1899; Visscher, Peter/0000-0002-2143-8760; Benyamin, Beben/0000-0001-5608-2293; Montgomery, Grant W/0000-0002-4140-8139; Goddard, Michael/0000-0001-9917-7946; Martin, Nicholas/0000-0003-4069-8020; Henders, Anjali/0000-0003-3672-1451	Australian National Health and Medical Research Council [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485]; US National Institutes of Health [AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854]; Australian Research Council [DP0770096]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013321, R01AA010249, R01AA013320, R01AA007535, R01AA013326, R01AA014041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to the twins and their families for their generous participation in these studies. We would like to thank staff at the Queensland Institute of Medical Research: D. Statham, A. Eldridge and M. Grace for sample collection, M. Campbell, L. Bowdler, S. Crooks and staff of the Molecular Epidemiology Laboratory for sample processing and preparation, B. Cornes for height data preparation, D. Smyth and H. Beeby for IT support and A. McRae and H. Lee for discussions. We thank N. Wray for helpful comments on the manuscript. We acknowledge funding from the Australian National Health and Medical Research Council (grants 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688 and 552485), the US National Institutes of Health (grants AA07535, AA10248, AA014041, AA13320, AA13321, AA13326 and DA12854) and the Australian Research Council (grant DP0770096).	DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DIXON WJ, 1960, ANN MATH STAT, V31, P385, DOI 10.1214/aoms/1177705900; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GALTON F, 1886, NATURE, V33, P295; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HASEMAN JK, 1972, BEHAV GENET, V2, P2; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zhang XS, 2005, GENETICS, V169, P411, DOI 10.1534/genetics.104.032573	32	2658	2702	19	420	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					565	U131		10.1038/ng.608	http://dx.doi.org/10.1038/ng.608			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20562875	Green Accepted			2022-12-25	WOS:000279242400007
J	Wang, XB; He, L; Wu, YI; Hahn, KM; Montell, DJ				Wang, Xiaobo; He, Li; Wu, Yi I.; Hahn, Klaus M.; Montell, Denise J.			Light-mediated activation reveals a key role for Rac in collective guidance of cell movement in vivo	NATURE CELL BIOLOGY			English	Article							BORDER CELLS; MIGRATION; GTPASES; MORPHOGENESIS; BEHAVIOR	The small GTPase Rac induces actin polymerization, membrane ruffling and focal contact formation in cultured single cells(1) but can either repress or stimulate motility in epithelial cells depending on the conditions(2, 3). The role of Rac in collective epithelial cell movements in vivo, which are important for both morphogenesis and metastasis(4-7), is therefore difficult to predict. Recently, photoactivatable analogues of Rac (PA-Rac) have been developed, allowing rapid and reversible activation or inactivation of Rac using light(8). In cultured single cells, light-activated Rac leads to focal membrane ruffling, protrusion and migration. Here we show that focal activation of Rac is also sufficient to polarize an entire group of cells in vivo, specifically the border cells of the Drosophila ovary. Moreover, activation or inactivation of Rac in one cell of the cluster caused a dramatic response in the other cells, suggesting that the cells sense direction as a group according to relative levels of Rac activity. Communication between cells of the cluster required Jun amino-terminal kinase (JNK) but not guidance receptor signalling. These studies further show that photoactivatable proteins are effective tools in vivo.	[Wang, Xiaobo; He, Li; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Wu, Yi I.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Johns Hopkins University; Johns Hopkins Medicine; University of North Carolina; University of North Carolina Chapel Hill	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, 855 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu	Wang, Xiaobo/A-8604-2011	Wang, Xiaobo/0000-0002-3311-1378; Hahn, Klaus/0000-0002-1970-7562; HE, LI/0000-0003-2155-606X	Cell Migration Consortium;  [GM046425];  [GM057464]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R29GM046425, R01GM057464, R01GM046425, R55GM057464] Funding Source: NIH RePORTER	Cell Migration Consortium; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM046425 to D.J.M. and GM057464 to K.M.H. and by the Cell Migration Consortium.	Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Llense F, 2008, CURR BIOL, V18, P538, DOI 10.1016/j.cub.2008.03.029; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; McDonald Jocelyn A., 2004, V294, P175; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sander EE, 1999, EUR J CANCER, V35, P1302, DOI 10.1016/S0959-8049(99)00145-8; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Wang XJ, 2007, DEV BIOL, V301, P532, DOI 10.1016/j.ydbio.2006.08.031; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241	31	229	231	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					591	U154		10.1038/ncb2061	http://dx.doi.org/10.1038/ncb2061			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473296	Green Submitted, Green Accepted			2022-12-25	WOS:000278213400011
J	Westly, E				Westly, Erica			When powerhouses fail	NATURE MEDICINE			English	News Item							MITOCHONDRIAL-DNA; DISEASE											Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schiff M, 2009, J INHERIT METAB DIS, V32, P684, DOI 10.1007/s10545-009-1263-0; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	6	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					625	627		10.1038/nm0610-625	http://dx.doi.org/10.1038/nm0610-625			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526309				2022-12-25	WOS:000278394200020
J	Dieterle, F; Perentes, E; Cordier, A; Roth, DR; Verdes, P; Grenet, O; Pantano, S; Moulin, P; Wahl, D; Mahl, A; End, P; Staedtler, F; Legay, F; Carl, K; Laurie, D; Chibout, SD; Vonderscher, J; Maurer, G				Dieterle, Frank; Perentes, Elias; Cordier, Andre; Roth, Daniel R.; Verdes, Pablo; Grenet, Olivier; Pantano, Serafino; Moulin, Pierre; Wahl, Daniel; Mahl, Andreas; End, Peter; Staedtler, Frank; Legay, Francois; Carl, Kevin; Laurie, David; Chibout, Salah-Dine; Vonderscher, Jacky; Maurer, Gerard			Urinary clusterin, cystatin C, beta 2-microglobulin and total protein as markers to detect drug-induced kidney injury	NATURE BIOTECHNOLOGY			English	Article							GLOMERULAR-FILTRATION-RATE; ALANINE AMINOPEPTIDASE; GENE-EXPRESSION; RAT; BIOMARKERS; NEPHROTOXICITY; GENTAMICIN; DYSFUNCTION; IMPAIRMENT; EXCRETION	Earlier and more reliable detection of drug-induced kidney injury would improve clinical care and help to streamline drug-development. As the current standards to monitor renal function, such as blood urea nitrogen (BUN) or serum creatinine (SCr), are late indicators of kidney injury, we conducted ten nonclinical studies to rigorously assess the potential of four previously described nephrotoxicity markers to detect drug-induced kidney and liver injury. Whereas urinary clusterin outperformed BUN and SCr for detecting proximal tubular injury, urinary total protein, cystatin C and beta 2-microglobulin showed a better diagnostic performance than BUN and SCr for detecting glomerular injury. Gene and protein expression analysis, in-situ hybridization and immunohistochemistry provide mechanistic evidence to support the use of these four markers for detecting kidney injury to guide regulatory decision making in drug development. The recognition of the qualification of these biomarkers by the EMEA and FDA will significantly enhance renal safety monitoring.	[Dieterle, Frank; Perentes, Elias; Cordier, Andre; Roth, Daniel R.; Verdes, Pablo; Grenet, Olivier; Pantano, Serafino; Moulin, Pierre; Wahl, Daniel; Mahl, Andreas; End, Peter; Staedtler, Frank; Legay, Francois; Carl, Kevin; Laurie, David; Chibout, Salah-Dine; Vonderscher, Jacky; Maurer, Gerard] Novartis Inst BioMed Res, Basel, Switzerland	Novartis	Dieterle, F (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	frank.dieterle@novartis.com						BERNARD A, 1986, TOXICOL APPL PHARM, V84, P431, DOI 10.1016/0041-008X(86)90248-6; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; COLLE A, 1990, J IMMUNOASSAY, V11, P199, DOI 10.1080/01971529008053269; Conti M, 2006, CLIN CHEM LAB MED, V44, P288, DOI 10.1515/CCLM.2006.050; Correa-Rotter R, 1998, J AM SOC NEPHROL, V9, P33; CORREAROTTER R, 1992, KIDNEY INT, V41, P938, DOI 10.1038/ki.1992.144; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; *EMEA, BIOM WEBS; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Ghiggeri GM, 2002, KIDNEY INT, V62, P2184, DOI 10.1046/j.1523-1755.2002.00664.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL F, 2001, EREGRESSION MODELING; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Herget-Rosenthal S, 2007, CLIN BIOCHEM, V40, P946, DOI 10.1016/j.clinbiochem.2007.04.013; Hidaka S, 2002, CELL TISSUE RES, V310, P289, DOI 10.1007/s00441-002-0629-5; Ishii A, 2007, TOXICOL PATHOL, V35, P376, DOI 10.1080/01926230701230320; KAYE WA, 1981, ANN CLIN LAB SCI, V11, P530; Kharasch ED, 2006, TOXICOL SCI, V90, P419, DOI 10.1093/toxsci/kfj088; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; Mattes WB, 2009, CLIN PHARMACOL THER, V85, P327, DOI 10.1038/clpt.2008.270; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; ROSENBERG ME, 1995, EXP NEPHROL, V3, P9; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; RYBAK MJ, 1987, ANTIMICROB AGENTS CH, V31, P1461, DOI 10.1128/AAC.31.10.1461; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sistare FD, 2010, NAT BIOTECHNOL, V28, P446, DOI 10.1038/nbt.1634; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; THIELEMANS N, 1994, NEPHRON, V66, P453, DOI 10.1159/000187863; TROLLFORS B, 1984, INFECTION, V12, P20, DOI 10.1007/BF01641019; Tsuchiya Y, 2005, ARCH TOXICOL, V79, P500, DOI 10.1007/s00204-005-0666-4; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Yoshida T, 2002, KIDNEY INT, V61, P1646, DOI 10.1046/j.1523-1755.2002.00341.x; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624	43	251	269	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					463	U114		10.1038/nbt.1622	http://dx.doi.org/10.1038/nbt.1622			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458316				2022-12-25	WOS:000277452700026
J	Vermeulen, L; Melo, FDSE; van der Heijden, M; Cameron, K; de Jong, JH; Borovski, T; Tuynman, JB; Todaro, M; Merz, C; Rodermond, H; Sprick, MR; Kemper, K; Richel, DJ; Stassi, G; Medema, JP				Vermeulen, Louis; Melo, Felipe De Sousa E.; van der Heijden, Maartje; Cameron, Kate; de Jong, Joan H.; Borovski, Tijana; Tuynman, Jurriaan B.; Todaro, Matilde; Merz, Christian; Rodermond, Hans; Sprick, Martin R.; Kemper, Kristel; Richel, Dick J.; Stassi, Giorgio; Medema, Jan Paul			Wnt activity defines colon cancer stem cells and is regulated by the microenvironment	NATURE CELL BIOLOGY			English	Article							HEPATOCYTE GROWTH-FACTOR; COLORECTAL-CANCER; BETA-CATENIN; TUMOR PROGRESSION; SMALL-INTESTINE; MET ONCOGENE; EXPRESSION; RECEPTOR; NICHE; GENE	Despite the presence of mutations in APC or beta-catenin, which are believed to activate the Wnt signalling cascade constitutively, most colorectal cancers show cellular heterogeneity when beta-catenin localization is analysed, indicating a more complex regulation of Wnt signalling. We explored this heterogeneity with a Wnt reporter construct and observed that high Wnt activity functionally designates the colon cancer stem cell (CSC) population. In adenocarcinomas, high activity of the Wnt pathway is observed preferentially in tumour cells located close to stromal myofibroblasts, indicating that Wnt activity and cancer stemness may be regulated by extrinsic cues. In agreement with this notion, myofibroblast-secreted factors, specifically hepatocyte growth factor, activate beta-catenin-dependent transcription and subsequently CSC clonogenicity. More significantly, myofibroblast-secreted factors also restore the CSC phenotype in more differentiated tumour cells both in vitro and in vivo. We therefore propose that stemness of colon cancer cells is in part orchestrated by the microenvironment and is a much more dynamic quality than previously expected that can be defined by high Wnt activity.	[Vermeulen, Louis; Melo, Felipe De Sousa E.; van der Heijden, Maartje; Cameron, Kate; de Jong, Joan H.; Borovski, Tijana; Tuynman, Jurriaan B.; Rodermond, Hans; Sprick, Martin R.; Kemper, Kristel; Richel, Dick J.; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, CEMM, LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Cellular & Mol Pathophysiol Lab, Dept Surg & Oncol Sci, I-90127 Palermo, Italy; [Merz, Christian] APOGENIX GmbH, D-69120 Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Palermo	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, CEMM, LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	J.P.Medema@amc.uva.nl	todaro, matilde/AAC-1003-2022; Pillay, Nischalan/F-9536-2012; Stassi, Giorgio/AAC-1175-2022; De Sousa E Melo, Felipe/F-9498-2010; Tuynman, JB/AAS-7745-2020; Tuynman, J/X-2465-2019; Sprick, Martin R./A-8611-2008; Vermeulen, Louis/B-7488-2008; Sprick, Martin R./I-7995-2019	todaro, matilde/0000-0001-8686-8043; Tuynman, JB/0000-0001-5952-8000; Sprick, Martin R./0000-0001-9691-7574; Vermeulen, Louis/0000-0002-6066-789X; Sprick, Martin R./0000-0001-9691-7574; Medema, Jan Paul/0000-0003-3045-2924	Netherlands Organisation for Scientific Research; Dutch Cancer Society (KWF Kankerbestrijding) [2009-4416]; Academisch Medisch Centrum (AMC); AMC Graduate School; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding); Academisch Medisch Centrum (AMC); AMC Graduate School; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The authors are indebted to the work performed by Willem Bemelman and Thomas van Gulik, surgeons at the AMC without whom the studies described here would not have been possible. In addition, we thank Riccardo Fodde for constructive discussions on CSCs and Wnt, and the animal care takers for their work for this project. Finally, we thank Berend Hooibrink and Toni van Capel for assistance with fluorescence-activated cell sorting experiments. This work was supported by a VICI grant from the Netherlands Organisation for Scientific Research and a Dutch Cancer Society (KWF Kankerbestrijding) grant (2009-4416) (to J.P.M.), an Academisch Medisch Centrum (AMC) fellowship (to L. V. and F.d.S.M.), the AMC Graduate School (to K. K.) and by the Associazione Italiana per la Ricerca sul Cancro (AIRC) (to G. S. and M. T.).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boon EMJ, 2002, CANCER RES, V62, P5126; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; GRODEN J, 1995, CANCER RES, V55, P1531; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; STOKER M, 1985, J CELL SCI, V77, P209; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	48	1314	1375	2	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					468	U121		10.1038/ncb2048	http://dx.doi.org/10.1038/ncb2048			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418870				2022-12-25	WOS:000277283700012
J	Gouagna, LC; Bancone, G; Yao, F; Yameogo, B; Dabire, KR; Costantini, C; Simpore, J; Ouedraogo, JB; Modiano, D				Gouagna, Louis Clement; Bancone, Germana; Yao, Frank; Yameogo, Bienvenue; Dabire, Kounbobr Roch; Costantini, Carlo; Simpore, Jacques; Ouedraogo, Jean Bosco; Modiano, David			Genetic variation in human HBB is associated with Plasmodium falciparum transmission	NATURE GENETICS			English	Article							ENHANCED GAMETOCYTE FORMATION; SICKLE-CELL TRAIT; HEMOGLOBIN-C; ERYTHROCYTES; PROTECTION; MALARIA; MECHANISM; INFECTIVITY; ANTIGENS; CARRIERS	Genetic factors are known to have a role in determining susceptibility to infectious diseases(1,2), although it is unclear whether they may also influence host efficiency in transmitting pathogens. We examine variants in HBB that have been shown to be protective against malaria(3) and test whether these are associated with the transmission of the parasite from the human host to the Anopheles vector. We conducted cross-sectional malariological surveys on 3,739 human subjects and transmission experiments involving 60 children and 6,446 mosquitoes in Burkina Faso, West Africa. Protective hemoglobins C (HbC, beta 6Glu -> Lys)(4,5) and S (beta 6Glu -> Val)(6-8) are associated with a twofold in vivo (odds ratio 2.17, 95% CI 1.57-3.01, P = 1.0 x 10(-6)) and a fourfold ex vivo (odds ratio 4.12, 95% CI 1.90-9.29, P = 7.0 x 10(-5)) increase of parasite transmission from the human host to the Anopheles vector. This provides an example of how host genetic variation may influence the transmission dynamics of an infectious disease.	[Bancone, Germana; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, Rome, Italy; [Gouagna, Louis Clement] IRD, Unite Rech 16, Bobo Dioulasso, Burkina Faso; [Yao, Frank; Yameogo, Bienvenue; Dabire, Kounbobr Roch; Ouedraogo, Jean Bosco] IRSS, Direct Reg Bobo Dioulasso, Bobo Dioulasso, Burkina Faso; [Costantini, Carlo] Org Coordinat Lutte Endemies Afrique Cent, Unite Rech 016, IRD, Yaounde, Cameroon; [Simpore, Jacques] Ctr Med St Camille, Ouagadougou, Burkina Faso; [Modiano, David] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Fondazione Cenci Bolognetti; Sapienza University Rome	Modiano, D (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth Sci, Rome, Italy.	david.modiano@uniroma1.it	SIMPORE, Jacques/ABA-4873-2020; Dabire, Roch Kounbobr/ABF-3525-2020; Costantini, Carlo/F-3470-2012	SIMPORE, Jacques/0000-0002-0415-9161; Costantini, Carlo/0000-0003-1016-129X; Bancone, Germana/0000-0003-4550-0431; Gouagna, Louis Clement/0000-0003-0957-4484; Ouedraogo, Jean Bosco/0000-0003-0412-8733	EU [LSHP-CT-2004-503578]; Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome 'La Sapienza'	EU(European Commission); Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome 'La Sapienza'(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	We are grateful to the study participants for their understanding and cooperation and to the laboratory and field staff of the IRSS/Centre Muraz of Bobo Dioulasso and of the Centre Medical Saint Camille of Ouagadougou, Burkina Faso, for skilled work, logistics and collaboration. We are indebted to the staff of the IRD Antenne de Bobo Dioulasso for logistic support. We thank G. Modiano, V. Petrarca, B. Arca and M. Coluzzi for continuous advice and L. Ranford-Cartwright and E. Ferraro for statistical support. This work was funded by grants from the EU, Sixth Framework Programme, BioMalPar Network of Excellence, LSHP-CT-2004-503578 and from the Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome 'La Sapienza'.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Robert V, 1996, AM J TROP MED HYG, V54, P111, DOI 10.4269/ajtmh.1996.54.111; TCHUINKAM T, 1993, TROP MED PARASITOL, V44, P271; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; Trager W, 1999, EXP PARASITOL, V91, P115, DOI 10.1006/expr.1998.4347; TRAGER W, 1992, J PROTOZOOL, V39, P429, DOI 10.1111/j.1550-7408.1992.tb01476.x; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Verra F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000978; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Williams TN, 2006, MOL BIOCHEM PARASIT, V149, P121, DOI 10.1016/j.molbiopara.2006.05.007; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Wilson K, 1997, PARASITOL TODAY, V13, P33, DOI 10.1016/S0169-4758(96)40009-6; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	33	58	59	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					328	U80		10.1038/ng.554	http://dx.doi.org/10.1038/ng.554			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20305663				2022-12-25	WOS:000276150500012
J	Jayaraman, K				Jayaraman, Killugudi			Failure of Indian whistleblower scheme points to deeper woes	NATURE MEDICINE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					364	364		10.1038/nm0410-364a	http://dx.doi.org/10.1038/nm0410-364a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376034	Bronze			2022-12-25	WOS:000276446800025
J	Lebrin, F; Srun, S; Raymond, K; Martin, S; van den Brink, S; Freitas, C; Breant, C; Mathivet, T; Larrivee, B; Thomas, JL; Arthur, HM; Westermann, CJJ; Disch, F; Mager, JJ; Snijder, RJ; Eichmann, A; Mummery, CL				Lebrin, Franck; Srun, Samly; Raymond, Karine; Martin, Sabrina; van den Brink, Stieneke; Freitas, Catarina; Breant, Christiane; Mathivet, Thomas; Larrivee, Bruno; Thomas, Jean-Leon; Arthur, Helen M.; Westermann, Cornelis J. J.; Disch, Frans; Mager, Johannes J.; Snijder, Repke J.; Eichmann, Anne; Mummery, Christine L.			Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; TGF-BETA RECEPTOR; PDGF-B; VASCULAR DEVELOPMENT; ANGIOGENESIS; PERICYTES; ENDOGLIN; GROWTH; MOUSE; MICE	Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder characterized by vascular malformations. Many affected individuals develop recurrent nosebleeds, which can severely affect their quality of life and are clinically difficult to treat. We report here that treatment with thalidomide reduced the severity and frequency of nosebleeds (epistaxis) in the majority of a small group of subjects with HHT tested. The blood hemoglobin levels of the treated individuals rose as a result of reduced hemorrhage and enhanced blood vessel stabilization. In mice heterozygous for a null mutation in the Eng gene (encoding endoglin), an experimental model of HHT, thalidomide treatment stimulated mural cell coverage and thus rescued vessel wall defects. Thalidomide treatment increased platelet-derived growth factor-B (PDGF-B) expression in endothelial cells and stimulated mural cell activation. The effects of thalidomide treatment were partially reversed by pharmacological or genetic interference with PDGF signaling from endothelial cells to pericytes. Biopsies of nasal epithelium from individuals with HHT treated or not with thalidomide showed that similar mechanisms may explain the effects of thalidomide treatment in humans. Our findings demonstrate the ability of thalidomide to induce vessel maturation, which may be useful as a therapeutic strategy for the treatment of vascular malformations.	[Lebrin, Franck; Srun, Samly; Martin, Sabrina; Freitas, Catarina; Breant, Christiane; Mathivet, Thomas; Larrivee, Bruno; Eichmann, Anne] Coll France, Inst Nat Sante & Rech Med, U833, F-75231 Paris, France; [Raymond, Karine] Inst Curie, CNRS, Ctr Rech, UMR144, F-75231 Paris, France; [van den Brink, Stieneke] Hubrecht Inst, Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Thomas, Jean-Leon] Inst Nat Sante & Rech Med, U711, Paris, France; [Westermann, Cornelis J. J.; Disch, Frans; Mager, Johannes J.; Snijder, Repke J.] St Antonius Hosp, Nieuwegein, Netherlands; [Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Arthur, Helen M.] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); St. Antonius Hospital Utrecht; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK	Lebrin, F (corresponding author), Coll France, Inst Nat Sante & Rech Med, U833, F-75231 Paris, France.	franck.lebrin@college-de-france.fr; c.l.mummery@lumc.nl	Thomas, Jean-Leon/F-1151-2016; Mathivet, Thomas/L-2663-2016; Freitas, Catarina M/A-2555-2017; Raymond, Karine/E-2693-2017; Arthur, Helen/C-7808-2009	Freitas, Catarina M/0000-0002-3393-5326; Raymond, Karine/0000-0001-5892-8117; Mummery, Christine/0000-0002-4549-6535; Larrivee, Bruno/0000-0003-1388-3108; Arthur, Helen/0000-0001-6522-1363; lebrin, franck/0000-0002-1650-6757; Mathivet, Thomas/0000-0001-7761-1684	Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche (Agence Nationale de la Recherche blanc, Neuroscience); Fondation pour la Recherche Medicale; Fondation Bettencourt; Association pour la Recherche sur le Cancer [3980]; Netherlands Heart Foundation [2008B106]; British Heart Foundation; EU [QLG1-CT-2001-01032]; Stichting Wetenschappelijk Onderzoek Rendu Osler; Besluit subsidies investeringen kennisinfrastructuur; HHT Foundation International	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (Agence Nationale de la Recherche blanc, Neuroscience)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Bettencourt; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Netherlands Heart Foundation(Netherlands Heart Foundation); British Heart Foundation(British Heart Foundation); EU(European Commission); Stichting Wetenschappelijk Onderzoek Rendu Osler; Besluit subsidies investeringen kennisinfrastructuur; HHT Foundation International	We thank A. Nishiyama (University of Connecticut Stem Cell Institute) for providing NG2DsRedBAC mice. This work was supported by grants from Institut National de la Sante et de la Recherche Medicale, Agence Nationale de la Recherche (Agence Nationale de la Recherche blanc, Neuroscience), Fondation pour la Recherche Medicale, Fondation Bettencourt, Association pour la Recherche sur le Cancer (3980), the Netherlands Heart Foundation (2008B106), the British Heart Foundation, the EU (QLG1-CT-2001-01032), Stichting Wetenschappelijk Onderzoek Rendu Osler and the Besluit subsidies investeringen kennisinfrastructuur program 'Dutch Platform for Tissue Engineering' and HHT Foundation International.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Bauditz J, 2004, GUT, V53, P609, DOI 10.1136/gut.2003.029710; Bauditz J, 2007, WORLD J GASTROENTERO, V13, P5979, DOI 10.3748/wjg.13.5979; Bose P, 2009, NEW ENGL J MED, V360, P2143, DOI 10.1056/NEJMc0901421; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Cirulli A, 2003, ACTA HAEMATOL-BASEL, V110, P29, DOI 10.1159/000072411; Dabak V, 2008, DIGEST DIS SCI, V53, P1632, DOI 10.1007/s10620-007-0067-z; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dudley A, 2003, BIOCHEM BIOPH RES CO, V310, P135, DOI 10.1016/j.bbrc.2003.08.129; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hasumi Y, 2007, INT J CANCER, V121, P2606, DOI 10.1002/ijc.22999; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; JOHNSON WE, 1996, CARNIVORE BEHAV ECOL, V2, P189; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kamalaporn P, 2009, EUR J GASTROEN HEPAT, V21, P1347, DOI 10.1097/MEG.0b013e32832c9346; Kurstin R, 2002, ONCOLOGY-NY, V16, P21; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2008, TRENDS CARDIOVAS MED, V18, P25, DOI 10.1016/j.tcm.2007.11.003; Letarte M, 2005, CARDIOVASC RES, V68, P155, DOI 10.1016/j.cardiores.2005.04.028; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; PREZENCINAS M, 2002, HAEMATOLOGICA, V87, pELT34; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Torsney E, 2003, CIRCULATION, V107, P1653, DOI 10.1161/01.CIR.0000058170.92267.00; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Vollmar B, 2000, AM J PHYSIOL-HEART C, V279, pH1591, DOI 10.1152/ajpheart.2000.279.4.H1591; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	42	235	250	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					420	U101		10.1038/nm.2131	http://dx.doi.org/10.1038/nm.2131			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20364125				2022-12-25	WOS:000276446800046
J	Rothenberg, ME; Spergel, JM; Sherrill, JD; Annaiah, K; Martin, LJ; Cianferoni, A; Gober, L; Kim, C; Glessner, J; Frackelton, E; Thomas, K; Blanchard, C; Liacouras, C; Verma, R; Aceves, S; Collins, MH; Brown-Whitehorn, T; Putnam, PE; Franciosi, JP; Chiavacci, RM; Grant, SFA; Abonia, JP; Sleiman, PMA; Hakonarson, H				Rothenberg, Marc E.; Spergel, Jonathan M.; Sherrill, Joseph D.; Annaiah, Kiran; Martin, Lisa J.; Cianferoni, Antonella; Gober, Laura; Kim, Cecilia; Glessner, Joseph; Frackelton, Edward; Thomas, Kelly; Blanchard, Carine; Liacouras, Chris; Verma, Ritu; Aceves, Seema; Collins, Margaret H.; Brown-Whitehorn, Terri; Putnam, Phil E.; Franciosi, James P.; Chiavacci, Rosetta M.; Grant, Struan F. A.; Abonia, J. Pablo; Sleiman, Patrick M. A.; Hakonarson, Hakon			Common variants at 5q22 associate with pediatric eosinophilic esophagitis	NATURE GENETICS			English	Article							EOTAXIN-3; CHILDREN	Eosinophilic esophagitis (EoE) is an allergic disorder characterized by the accumulation of eosinophils in the esophagus. We report association of EoE with variants at chromosome 5q22 encompassing TSLP and WDR36 (rs3806932, combined P = 3.19 x 10(-9)). TSLP is overexpressed in esophageal biopsies from individuals with EoE compared with unaffected individuals, whereas WDR36 expression is unaltered between the two groups. These data implicate the 5q22 locus in the pathogenesis of EoE and identify TSLP as the most likely candidate gene in the region.	[Spergel, Jonathan M.; Cianferoni, Antonella; Liacouras, Chris; Verma, Ritu; Brown-Whitehorn, Terri; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Rothenberg, Marc E.; Sherrill, Joseph D.; Blanchard, Carine; Abonia, J. Pablo] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Allergy & Immunol,Med Ctr, Cincinnati, OH 45221 USA; [Spergel, Jonathan M.; Cianferoni, Antonella; Gober, Laura; Brown-Whitehorn, Terri] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Annaiah, Kiran; Kim, Cecilia; Glessner, Joseph; Frackelton, Edward; Thomas, Kelly; Chiavacci, Rosetta M.; Grant, Struan F. A.; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Martin, Lisa J.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Human Genet,Med Ctr, Cincinnati, OH 45221 USA; [Liacouras, Chris; Verma, Ritu] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Aceves, Seema] Univ Calif San Diego, Div Allergy & Immunol, Riley Hosp Children, San Diego, CA 92103 USA; [Collins, Margaret H.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Pathol,Med Ctr, Cincinnati, OH 45221 USA; [Putnam, Phil E.; Franciosi, James P.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Gastroenterol Hepatol & Nutr,Med Ctr, Cincinnati, OH 45221 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hakonarson, H (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Martin, Lisa/E-2425-2016; Sherrill, Joseph/B-6662-2014	Martin, Lisa/0000-0001-8702-9946; Glessner, Joseph/0000-0001-5131-2811; Grant, Struan/0000-0003-2025-5302; Abonia, Juan/0000-0003-3788-6485; Spergel, Jonathan/0000-0002-4658-5353	US National Institutes of Health (NIH) [U19 AI070235, NIH R01 DK076893]; Food Allergy Project; Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation; American Partnership for Eosinophilic Disorders (APFED); Children's Hospital of Philadelphia; Buckeye Foundation; Coltswold Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235, R01AI083450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Project; Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation; American Partnership for Eosinophilic Disorders (APFED); Children's Hospital of Philadelphia; Buckeye Foundation; Coltswold Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all of the participating families and subjects. We thank B. Buckmeier, A. Ahrens, S. Jameson, M. Palazzolo, H. Foote, M. Mingler, M. Shuker and E. Stucke for assistance with patient enrollment, DNA preparation and/or database management. This work was supported in part by US National Institutes of Health (NIH) U19 AI070235, NIH R01 DK076893, Food Allergy Project, Campaign Urging Research for Eosinophilic Disorders (CURED) Foundation, American Partnership for Eosinophilic Disorders (APFED), The Children's Hospital of Philadelphia Chair's Institutive, the Buckeye Foundation and the Coltswold Foundation. All genome-wide genotyping was funded by an Institute Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia.	Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Challa Pratap, 2008, Int Ophthalmol Clin, V48, P73, DOI 10.1097/IIO.0b013e318187e71a; Collins MH, 2008, CLIN GASTROENTEROL H, V6, P621, DOI 10.1016/j.cgh.2008.01.004; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Konikoff MR, 2006, CLIN GASTROENTEROL H, V4, P1328, DOI 10.1016/j.cgh.2006.08.013; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Malerba G, 2000, AM J RESP CRIT CARE, V162, P1587, DOI 10.1164/ajrccm.162.4.9909031; Noel RJ, 2004, NEW ENGL J MED, V351, P940, DOI 10.1056/NEJM200408263510924; Oyoshi MK, 2009, ADV IMMUNOL, V102, P135, DOI 10.1016/S0065-2776(09)01203-6; Spergel JM, 2007, J ALLERGY CLIN IMMUN, V119, P509, DOI 10.1016/j.jaci.2006.11.016; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941	14	298	309	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					289	291		10.1038/ng.547	http://dx.doi.org/10.1038/ng.547			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20208534	Green Accepted			2022-12-25	WOS:000276150500006
J	Mack, GS; Marshall, A				Mack, George S.; Marshall, Andrew			Lost in migration	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNAS; BREAST-CANCER; TUMOR-CELLS; METASTASIS; EXPRESSION; PROGRESSION; INHIBITION; MELANOMA; MOTILITY; RECEPTOR											Chen EX, 2004, JAMA-J AM MED ASSOC, V292, P2150, DOI 10.1001/jama.292.17.2150; Chishima T, 1997, P NATL ACAD SCI USA, V94, P11573, DOI 10.1073/pnas.94.21.11573; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fernandez CA, 2009, J UROLOGY, V182, P2188, DOI 10.1016/j.juro.2009.07.032; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; Hoffman A, 2008, J MED CHEM, V51, P1406, DOI 10.1021/jm701087n; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Katz MH, 2004, CANCER RES, V64, P1828, DOI 10.1158/0008-5472.CAN-03-3350; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; KORC M, 2007, J CLIN INVEST, V118, P89; LODISH H, 2003, MOL CELL BIOL; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rudland PS, 2000, CANCER RES, V60, P1595; Talukder AH, 2002, CLIN CANCER RES, V8, P3285; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	30	54	56	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					214	229		10.1038/nbt0310-214	http://dx.doi.org/10.1038/nbt0310-214			16	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20212481				2022-12-25	WOS:000275288300015
J	Orth, JD; Thiele, I; Palsson, BO				Orth, Jeffrey D.; Thiele, Ines; Palsson, Bernhard O.			What is flux balance analysis?	NATURE BIOTECHNOLOGY			English	Article							SCALE METABOLIC RECONSTRUCTIONS; ESCHERICHIA-COLI; IN-SILICO; MODELS; NETWORKS; OPTIMIZATION; CAPABILITIES; INFORMATION		[Orth, Jeffrey D.; Palsson, Bernhard O.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Thiele, Ines] Univ Iceland, Reykjavik, Iceland	University of California System; University of California San Diego; University of Iceland	Orth, JD (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	palsson@ucsd.edu	damiani, chiara/R-4256-2016; Thiele, Ines/A-7629-2014	Thiele, Ines/0000-0002-8071-7110; Palsson, Bernhard/0000-0003-2357-6785	National Institutes of Health [R01 GM057089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant no. R01 GM057089.	[Anonymous], ECOSAL ESCHERICHIA C; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jung TS, 2009, BIOINFORMATICS, V25, P2850, DOI 10.1093/bioinformatics/btp496; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308; Lee DY, 2003, BIOINFORMATICS, V19, P2144, DOI 10.1093/bioinformatics/btg271; Lee S, 2000, COMPUT CHEM ENG, V24, P711, DOI 10.1016/S0098-1354(00)00323-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VARMA A, 1995, BIOTECHNOL BIOENG, V45, P69, DOI 10.1002/bit.260450110; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202	30	2036	2077	25	414	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					245	248		10.1038/nbt.1614	http://dx.doi.org/10.1038/nbt.1614			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20212490	Green Accepted			2022-12-25	WOS:000275288300022
J	Holm, H; Gudbjartsson, DF; Arnar, DO; Thorleifsson, G; Thorgeirsson, G; Stefansdottir, H; Gudjonsson, SA; Jonasdottir, A; Mathiesen, EB; Njolstad, I; Nyrnes, A; Wilsgaard, T; Hald, EM; Hveem, K; Stoltenberg, C; Lochen, ML; Kong, A; Thorsteinsdottir, U; Stefansson, K				Holm, Hilma; Gudbjartsson, Daniel F.; Arnar, David O.; Thorleifsson, Gudmar; Thorgeirsson, Gudmundur; Stefansdottir, Hrafnhildur; Gudjonsson, Sigurjon A.; Jonasdottir, Aslaug; Mathiesen, Ellisiv B.; Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Hald, Erin M.; Hveem, Kristian; Stoltenberg, Camilla; Lochen, Maja-Lisa; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Several common variants modulate heart rate, PR interval and QRS duration	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAIN; GENOME-WIDE ASSOCIATION; HOLT-ORAM-SYNDROME; SODIUM-CHANNEL; ALPHA-MYOSIN; ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; GENETIC-FACTORS; EXPRESSION; DISEASE	Electrocardiographic measures are indicative of the function of the cardiac conduction system. To search for sequence variants that modulate heart rate, PR interval and QRS duration in individuals of European descent, we performed a genome-wide association study in similar to 10,000 individuals and followed up the top signals in an additional similar to 10,000 individuals. We identified several genome-wide significant associations (with P < 1.6 x 10(-7)). We identified one locus for heart rate (MYH6), four for PR interval (TBX5, SCN10A, CAV1 and ARHGAP24) and four for QRS duration (TBX5, SCN10A, 6p21 and 10q21). We tested for association between these loci and subjects with selected arrhythmias in Icelandic and Norwegian case-control sample sets. We observed correlations between TBX5 and CAV1 and atrial fibrillation (P = 4.0 x 10(-5) and P = 0.00032, respectively), between TBX5 and advanced atrioventricular block (P = 0.0067), and between SCN10A and pacemaker implantation (P = 0.0029). We also replicated previously described associations with the QT interval.	[Holm, Hilma; Gudbjartsson, Daniel F.; Thorleifsson, Gudmar; Gudjonsson, Sigurjon A.; Jonasdottir, Aslaug; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Arnar, David O.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp N Norway, Dept Neurol, Tromso, Norway; [Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Lochen, Maja-Lisa] Univ Tromso, Inst Community Med, Tromso, Norway; [Nyrnes, Audhild] Univ Hosp N Norway, Dept Geriatr, Tromso, Norway; [Hald, Erin M.; Lochen, Maja-Lisa] Univ Hosp N Norway, Dept Cardiol, Tromso, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Oslo, Norway	Landspitali National University Hospital; University of Iceland; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH)	Holm, H (corresponding author), deCODE genet, Reykjavik, Iceland.	hilma.holm@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Hveem, Kristian/AFV-4683-2022; Stoltenberg, Camilla/G-5090-2017; Njolstad, Inger/X-3784-2019	Lochen, Maja-Lisa/0000-0002-8532-6573; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Gudbjartsson, Daniel/0000-0002-5222-9857				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411c; BJORNSSON S, 1993, LAEKNABLADID, V79, P21; BRODSKY M, 1977, ARCH INTERN MED, V137, P165, DOI 10.1001/archinte.137.2.165; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Hesse B, 2001, AM J MED, V110, P253, DOI 10.1016/S0002-9343(00)00713-0; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Katoh M, 2004, INT J MOL MED, V14, P333; KURABAYASHI M, 1988, J CLIN INVEST, V82, P524, DOI 10.1172/JCI113627; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li JP, 2009, ANN NONINVAS ELECTRO, V14, P147, DOI 10.1111/j.1542-474X.2009.00289.x; Li QY, 1997, NAT GENET, V15, P21; Lindauer James, 2005, Journal of Electrocardiology, V38, P90, DOI 10.1016/j.jelectrocard.2005.06.062; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; LOWN B, 1952, CIRCULATION, V5, P693, DOI 10.1161/01.CIR.5.5.693; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Mutikainen S, 2009, ANN NONINVAS ELECTRO, V14, P57, DOI 10.1111/j.1542-474X.2008.00273.x; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; SAKSENA S, 2004, ELECTROPHYSIOLOGICAL; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; ZAKUT R, 1995, ONCOGENE, V11, P393; Zhou SH, 2009, ANN NONINVAS ELECTRO, V14, pS3, DOI 10.1111/j.1542-474X.2008.00258.x	56	279	284	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					117	U40		10.1038/ng.511	http://dx.doi.org/10.1038/ng.511			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062063				2022-12-25	WOS:000274084400006
J	Janes, MR; Limon, JJ; So, LM; Chen, J; Lim, RJ; Chavez, MA; Vu, C; Lilly, MB; Mallya, S; Ong, ST; Konopleva, M; Martin, MB; Ren, PD; Liu, Y; Rommel, C; Fruman, DA				Janes, Matthew R.; Limon, Jose J.; So, Lomon; Chen, Jing; Lim, Raymond J.; Chavez, Melissa A.; Vu, Collin; Lilly, Michael B.; Mallya, Sharmila; Ong, S. Tiong; Konopleva, Marina; Martin, Michael B.; Ren, Pingda; Liu, Yi; Rommel, Christian; Fruman, David A.			Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor	NATURE MEDICINE			English	Article							MAMMALIAN TARGET; PHILADELPHIA-CHROMOSOME; RAPAMYCIN; MTOR; ACTIVATION; TYROSINE; 3-KINASE; PATHWAY; COMPLEX; PI3K	Targeting the mammalian target of rapamycin (mTOR) protein is a promising strategy for cancer therapy. The mTOR kinase functions in two complexes, TORC1 (target of rapamycin complex-1) and TORC2 (target of rapamycin complex-2); however, neither of these complexes is fully inhibited by the allosteric inhibitor rapamycin or its analogs. We compared rapamycin with PP242, an inhibitor of the active site of mTOR in both TORC1 and TORC2 (hereafter referred to as TORC1/2), in models of acute leukemia harboring the Philadelphia chromosome (Ph) translocation. We demonstrate that PP242, but not rapamycin, causes death of mouse and human leukemia cells. In vivo, PP242 delays leukemia onset and augments the effects of the current front-line tyrosine kinase inhibitors more effectively than does rapamycin. Unexpectedly, PP242 has much weaker effects than rapamycin on the proliferation and function of normal lymphocytes. PI-103, a less selective TORC1/2 inhibitor that also targets phosphoinositide 3-kinase (PI3K), is more immunosuppressive than PP242. These findings establish that Ph+ transformed cells are more sensitive than normal lymphocytes to selective TORC1/2 inhibitors and support the development of such inhibitors for leukemia therapy.	[Janes, Matthew R.; Limon, Jose J.; So, Lomon; Chen, Jing; Lim, Raymond J.; Chavez, Melissa A.; Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA; [Janes, Matthew R.; Limon, Jose J.; So, Lomon; Chen, Jing; Lim, Raymond J.; Chavez, Melissa A.; Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Vu, Collin; Lilly, Michael B.; Mallya, Sharmila] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA; [Ong, S. Tiong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Cellular Therapy, Houston, TX 77030 USA; [Martin, Michael B.; Ren, Pingda; Liu, Yi; Rommel, Christian] Intellikine Inc, La Jolla, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National University of Singapore; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fruman, DA (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA.	dfruman@uci.edu		Ong, S. Tiong/0000-0001-9460-3483	University of California Irvine [CA-62203, GM-076516]; US National Institutes of Health [T32-CA009054, T34GM069337]; University of California Industry-University Cooperative Research Program; Chao Family Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055246, P50GM076516, T34GM069337] Funding Source: NIH RePORTER	University of California Irvine(University of California System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Industry-University Cooperative Research Program(University of California System); Chao Family Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Shokat, T. Wilson, and M. Kharas for support and helpful discussions and R. Nguyen for constructing BCR-ABL mutants. For access to the LSM710 Zeiss confocal microscope we thank E. Gratton's laboratory in the Department of Biomedical Engineering, University of California-Irvine. The SUP-B15 cells stably expressing firefly luciferase (SUP-B15<SUP>ffLuc</SUP>) were a kind gift from M. Jensen ( City of Hope). Technical assistance was provided through the Optical Biology Core facility of the Developmental Biology Center, a shared resource supported in part by the Cancer Center Support Grant (CA-62203) and the Center for Complex Biological Systems Support Grant (GM-076516) at the University of California Irvine. The Lumina IVIS bioluminescent imager was supported by a grant to the University of California-Irvine from the California Institute of Regenerative Medicine. This work was supported by US National Institutes of Health training grant T32-CA009054 ( to M.R.J.), National Institutes of Health Minority Access to Research Careers grant T34GM069337 ( to M. A. C.), a Research Scholar Grant from the American Cancer Society ( to D. A. F.), a Discovery Grant from the University of California Industry-University Cooperative Research Program ( to D. A. F.), a sponsored research agreement from Intellikine, Inc. ( to D. A. F.) and a Bridge award from the Chao Family Comprehensive Cancer Center. M.R.J. is an awardee of the Jackie Murphy and Carol Malouf Scholar Achievement Rewards for College Scientists.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Abraham Robert T, 2009, F1000 Biol Rep, V1, P8, DOI 10.3410/B1-8; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Burgess MR, 2006, THESCIENTIFICWORLDJO, V6, P918, DOI 10.1100/tsw.2006.184; Chiarini F, 2009, CANCER RES, V69, P3520, DOI 10.1158/0008-5472.CAN-08-4884; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Durand CA, 2009, J IMMUNOL, V183, P5673, DOI 10.4049/jimmunol.0900432; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foa R, 2008, BLOOD, V112, P119; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gruber F, 2009, BRIT J HAEMATOL, V145, P581, DOI 10.1111/j.1365-2141.2009.07666.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Janes MR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe25; Kennedy JA, 2008, LEUKEMIA, V22, P2029, DOI 10.1038/leu.2008.206; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kojima K, 2008, LEUKEMIA, V22, P1728, DOI 10.1038/leu.2008.158; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; LOPEZFAUQUED M, INT J CANCER, DOI DOI 10.1002/IJC.24926; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2005, HISTOL HISTOPATHOL, V20, P239, DOI 10.14670/HH-20.239; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Prabhu S, 2007, ONCOGENE, V26, P1188, DOI 10.1038/sj.onc.1209901; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sankhala K, 2009, TARGET ONCOL, V4, P135, DOI 10.1007/s11523-009-0107-z; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Shor B, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-28; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08	49	289	344	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					205	U115		10.1038/nm.2091	http://dx.doi.org/10.1038/nm.2091			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20072130	Green Accepted			2022-12-25	WOS:000274297000042
J	Li, RQ; Li, YR; Zheng, HC; Luo, RB; Zhu, HM; Li, QB; Qian, WB; Ren, YY; Tian, G; Li, JX; Zhou, GY; Zhu, X; Wu, HL; Qin, JJ; Jin, X; Li, DF; Cao, HZ; Hu, XD; Blanche, H; Cann, H; Zhang, XQ; Li, SG; Bolund, L; Kristiansen, K; Yang, HM; Wang, J; Wang, J				Li, Ruiqiang; Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Zhu, Hongmei; Li, Qibin; Qian, Wubin; Ren, Yuanyuan; Tian, Geng; Li, Jinxiang; Zhou, Guangyu; Zhu, Xuan; Wu, Honglong; Qin, Junjie; Jin, Xin; Li, Dongfang; Cao, Hongzhi; Hu, Xueda; Blanche, Helene; Cann, Howard; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; Yang, Huanming; Wang, Jun; Wang, Jian			Building the sequence map of the human pan-genome	NATURE BIOTECHNOLOGY			English	Article							MULTILOCUS GENOTYPE DATA; COPY-NUMBER VARIATION; POPULATION-STRUCTURE; GENETIC-STRUCTURE; DNA; CLASSIFICATION; INFERENCE; PATTERNS	Here we integrate the de novo assembly of an Asian and an African genome with the NCBI reference human genome, as a step toward constructing the human pan-genome. We identified similar to 5 Mb of novel sequences not present in the reference genome in each of these assemblies. Most novel sequences are individual or population specific, as revealed by their comparison to all available human DNA sequence and by PCR validation using the human genome diversity cell line panel. We found novel sequences present in patterns consistent with known human migration paths. Cross-species conservation analysis of predicted genes indicated that the novel sequences contain potentially functional coding regions. We estimate that a complete human pan-genome would contain similar to 19-40 Mb of novel sequence not present in the extant reference genome. The extensive amount of novel sequence contributing to the genetic variation of the pan-genome indicates the importance of using complete genome sequencing and de novo assembly.	[Li, Ruiqiang; Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Zhu, Hongmei; Li, Qibin; Qian, Wubin; Ren, Yuanyuan; Tian, Geng; Li, Jinxiang; Zhou, Guangyu; Zhu, Xuan; Wu, Honglong; Qin, Junjie; Jin, Xin; Li, Dongfang; Cao, Hongzhi; Hu, Xueda; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Zheng, Hancheng; Luo, Ruibang; Jin, Xin] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Blanche, Helene; Cann, Howard] CEPH, Fdn Jean Dausset, Paris, France; [Bolund, Lars] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Wu, Honglong; Li, Dongfang; Cao, Hongzhi] Shenzhen Univ, Sch Med, Genome Res Inst, Shenzhen, Peoples R China	Beijing Genomics Institute (BGI); University of Copenhagen; South China University of Technology; Foundation Jean Dausset-CEPH; Aarhus University; Shenzhen University	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; wangjian@genomics.org.cn	Kristiansen, Karsten/J-5148-2014; Jin, Xin/ABF-1329-2020; Li, Yingrui/K-1064-2015; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kristiansen, Karsten/0000-0002-6024-0917; Jin, Xin/0000-0001-7554-4975; Wang, Jun/0000-0002-2113-5874; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-8540-8931	Chinese Academy of Science [GJHZ0701-6]; National Natural Science Foundation of China [30725008, 30890032]; Danish Natural Science Research Council	Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish Natural Science Research Council(Danish Natural Science Research Council)	This project is supported by the Chinese Academy of Science (GJHZ0701-6), the National Natural Science Foundation of China (30725008; 30890032), Shenzhen local government, the Danish Platform for Integrative Biology, the Ole Romer grant from the Danish Natural Science Research Council. L. Goodman edited the manuscript. J. Sun, M. Zhao, Y. Liu, Y. Zheng and H. Wang helped on designing the primers. W. Jin helped on experimental validation. San A, J. Wang, Y. Huang, M. Jian, M. Chen, Y. Huang, Xiaoli Ren, H. Liang, H. Zheng, S. Lin helped on the data production.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Cann HM, 2002, SCIENCE, V296, P261; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LI R, GENOME RES IN PRESS; Li YR, 2009, NAT BIOTECHNOL, V27, P820, DOI 10.1038/nbt0909-820; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005	37	162	172	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					57	U83		10.1038/nbt.1596	http://dx.doi.org/10.1038/nbt.1596			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	19997067				2022-12-25	WOS:000273430400021
J	Ostrowski, M; Carmo, NB; Krumeich, S; Fanget, I; Raposo, G; Savina, A; Moita, CF; Schauer, K; Hume, AN; Freitas, RP; Goud, B; Benaroch, P; Hacohen, N; Fukuda, M; Desnos, C; Seabra, MC; Darchen, F; Amigorena, S; Moita, LF; Thery, C				Ostrowski, Matias; Carmo, Nuno B.; Krumeich, Sophie; Fanget, Isabelle; Raposo, Graca; Savina, Ariel; Moita, Catarina F.; Schauer, Kristine; Hume, Alistair N.; Freitas, Rui P.; Goud, Bruno; Benaroch, Philippe; Hacohen, Nir; Fukuda, Mitsunori; Desnos, Claire; Seabra, Miguel C.; Darchen, Francois; Amigorena, Sebastian; Moita, Luis F.; Thery, Clotilde			Rab27a and Rab27b control different steps of the exosome secretion pathway	NATURE CELL BIOLOGY			English	Article							CELL-DERIVED EXOSOMES; MULTIVESICULAR ENDOSOMES; PLASMA-MEMBRANE; B-LYMPHOCYTES; VESICLES; PROTEINS; GRANULES; RELEASE; GTPASES; ASSOCIATION	Exosomes are secreted membrane vesicles that share structural and biochemical characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes could be involved in intercellular communication and in the pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome biogenesis and secretion are, however, poorly understood. Using an RNA interference (RNAi) screen, we identified five Rab GTPases that promote exosome secretion in HeLa cells. Among these, Rab27a and Rab27b were found to function in MVE docking at the plasma membrane. The size of MVEs was strongly increased by Rab27a silencing, whereas MVEs were redistributed towards the perinuclear region upon Rab27b silencing. Thus, the two Rab27 isoforms have different roles in the exosomal pathway. In addition, silencing two known Rab27 effectors, Slp4 (also known as SYTL4, synaptotagmin-like 4) and Slac2b (also known as EXPH5, exophilin 5), inhibited exosome secretion and phenocopied silencing of Rab27a and Rab27b, respectively. Our results therefore strengthen the link between MVEs and exosomes, and introduce ways of manipulating exosome secretion in vivo.	[Carmo, Nuno B.; Moita, Catarina F.; Freitas, Rui P.; Moita, Luis F.] Inst Mol Med, Cell Biol Immune Syst Unit, P-1649028 Lisbon, Portugal; [Ostrowski, Matias; Krumeich, Sophie; Savina, Ariel; Benaroch, Philippe; Amigorena, Sebastian; Thery, Clotilde] INSERM, U932, F-75005 Paris, France; [Ostrowski, Matias; Krumeich, Sophie; Raposo, Graca; Savina, Ariel; Schauer, Kristine; Goud, Bruno; Benaroch, Philippe; Amigorena, Sebastian; Thery, Clotilde] Inst Curie, F-75005 Paris, France; [Raposo, Graca; Schauer, Kristine; Goud, Bruno] CNRS, UMR144, F-75005 Paris, France; [Hume, Alistair N.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Seabra, Miguel C.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1169056 Lisbon, Portugal; [Seabra, Miguel C.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02142 USA; [Hacohen, Nir] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Fanget, Isabelle; Desnos, Claire; Darchen, Francois] CNRS, Inst Biol Physicochim, FRE 3146, F-75005 Paris, France; [Fukuda, Mitsunori] Tohoku Univ, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9809578, Japan	Universidade de Lisboa; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Imperial College London; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); Tohoku University	Moita, LF (corresponding author), Inst Mol Med, Cell Biol Immune Syst Unit, Sala P3-B-40,Edificio Egas Moniz,Ave Prof Egas Mo, P-1649028 Lisbon, Portugal.	lmoita@fm.ul.pt; clotilde.thery@curie.fr	Moita, Luis/HCI-2793-2022; Fukuda, MItsunori/I-1511-2015; Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; thery, clotilde/F-6373-2013; Goud, Bruno/GWC-4807-2022; Carmo, Nuno/AAP-7327-2021; Carmo, Nuno/L-9869-2017; Moita, Luis F./L-1296-2013	Moita, Luis/0000-0003-0707-315X; Fukuda, MItsunori/0000-0002-8620-5853; Seabra, Miguel C/0000-0002-6404-4892; thery, clotilde/0000-0001-8294-6884; Carmo, Nuno/0000-0001-6570-7400; Moita, Luis F./0000-0003-0707-315X; Schauer, Kristine/0000-0002-6102-8790; Amigorena, Sebastian/0000-0001-8583-8416; Benaroch, Philippe/0000-0002-2655-0129; Ferreira Moita, Catarina/0000-0002-9910-2343; Hume, Alistair/0000-0001-9443-1087; Raposo, graca/0000-0001-9590-1298; Ostrowski, Matias/0000-0002-3982-1338	Institut National du Cancer; Institut Curie; Association pour la Recherche sur le Cancer and Fondation de France; Agence Nationale de la Recherche [ANR-06-BLAN-0211-02]; Fundacao Luso-Americana para o Desenvolvimento; Funda ao para a Ciencia e a Tecnologia [PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Institut National du Cancer(Institut National du Cancer (INCA) France); Institut Curie; Association pour la Recherche sur le Cancer and Fondation de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao Luso-Americana para o Desenvolvimento; Funda ao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by post-doctoral salaries from Institut National du Cancer and Institut Curie to M. O., grants from Association pour la Recherche sur le Cancer and Fondation de France to C. T., and from the Agence Nationale de la Recherche to F. D. (ANR-06-BLAN-0211-02). L. F. M. is a Young Investigator from the Human Frontier Science Program and receives support from Fundacao Luso-Americana para o Desenvolvimento and Funda ao para a Ciencia e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). We thank PICT IbiSA Imaging Facility at Curie Institute, V. Racine and J.-B. Sibarita for providing a copy of their multidimensional image analysis program, I. Hurbain for help in electron microscopy quantification, P. Simoes and M. H. Raquel for some of the lentiviral preparations, T. Tolmachova for bones of Rab27-knockout mice, J. Mordoh for providing an anti-CD63 FC-5.01 antibody and R. Allan for critical reading of the manuscript.	Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Beraud-Dufour S, 2002, J CELL SCI, V115, P1779; Blott EJ, 2001, J CELL SCI, V114, P2405; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fukuda M, 2002, J BIOL CHEM, V277, P39673, DOI 10.1074/jbc.M205349200; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ramalho JS, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-2; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Savina A, 2002, J CELL SCI, V115, P2505; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	49	1548	1611	15	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					19	U61		10.1038/ncb2000	http://dx.doi.org/10.1038/ncb2000			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966785	Green Submitted			2022-12-25	WOS:000272973800008
J	Henkel, J; Maurer, SM				Henkel, Joachim; Maurer, Stephen M.			Parts, property and sharing	NATURE BIOTECHNOLOGY			English	Article							PATENTS; INNOVATION; MODELS; ACCESS		[Henkel, Joachim] Tech Univ Munich, Munich, Germany; [Maurer, Stephen M.] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA; [Maurer, Stephen M.] Univ Calif Berkeley, Boalt Law Sch, Berkeley, CA 94720 USA	Technical University of Munich; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Henkel, J (corresponding author), Tech Univ Munich, Munich, Germany.	smaurer@law.berkeley.edu		Henkel, Joachim/0000-0002-6065-0983				Berthels N, 2009, CAM INTELLECT PROP, P194, DOI 10.1017/CBO9780511581182.015; BESSEN J, 2008, PATENT FAILURE; *BIOBRICKS FDN, 2009, BIOBR PUBL AGR; Goldstein JA, 2009, CAM INTELLECT PROP, P50, DOI 10.1017/CBO9780511581182.006; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HENKEL J, AM EC REV P IN PRESS; HENKEL J, DEFENSIVE PUBLISHING; Henkel J, 2008, HARVARD BUS REV, V86, P129; Henkel J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100161; Henkel J, 2006, RES POLICY, V35, P953, DOI 10.1016/j.respol.2006.04.010; Hope J, 2009, CAM INTELLECT PROP, P171, DOI 10.1017/CBO9780511581182.014; Horn LA, 2009, CAM INTELLECT PROP, P33, DOI 10.1017/CBO9780511581182.004; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jefferson R., 2006, Innovations: Technology / Governance / Globalisation, V1, P13, DOI 10.1162/itgg.2006.1.4.13; Lawrence S, 2008, NAT BIOTECHNOL, V26, P1326, DOI 10.1038/nbt1208-1326; Lemley MA, 2007, TEX LAW REV, V85, P1991; MAURER S, 2006, HDB EC INFORM SYSTEM, P285; Maurer SM, 2009, EMBO REP, V10, P806, DOI 10.1038/embor.2009.165; Maurer Stephen M., 2007, UMKC LAW REV, V76, P405; Merges RP, 2004, U CHICAGO LAW REV, V71, P183; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Rai AK, 2009, CAM INTELLECT PROP, P213, DOI 10.1017/CBO9780511581182.017; Rutz B, 2009, EMBO REP, V10, pS14, DOI 10.1038/embor.2009.131; SHAPIRO C, 2001, INNOVATION POLICY EC, V1, P1; Spence M, 2009, CAM INTELLECT PROP, P161, DOI 10.1017/CBO9780511581182.013; STERN S, 2006, BIOL RESOURCE CTR KN; Ullrich H, 2009, CAM INTELLECT PROP, P339, DOI 10.1017/CBO9780511581182.024; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; van Zimmeren E, 2006, B WORLD HEALTH ORGAN, V84, P352, DOI 10.2471/BLT.06.030445; van Zimmeren E, 2009, CAM INTELLECT PROP, P63, DOI 10.1017/CBO9780511581182.007; Verbeure B, 2006, TRENDS BIOTECHNOL, V24, P115, DOI 10.1016/j.tibtech.2006.01.002; Verbeure B, 2009, CAM INTELLECT PROP, P3, DOI 10.1017/CBO9780511581182.003	32	27	27	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1095	1098		10.1038/nbt1209-1095	http://dx.doi.org/10.1038/nbt1209-1095			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010583				2022-12-25	WOS:000272708300019
J	Rexach, JE; Rogers, CJ; Yu, SH; Tao, JF; Sun, YE; Hsieh-Wilson, LC				Rexach, Jessica E.; Rogers, Claude J.; Yu, Seok-Ho; Tao, Jifang; Sun, Yi E.; Hsieh-Wilson, Linda C.			Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags	NATURE CHEMICAL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; GLCNAC-MODIFIED PROTEINS; PHOSPHORYLATION; TRANSCRIPTION; COMPLEX; MECP2; IDENTIFICATION; GLYCOPROTEINS; TRANSFERASE; CREB	Mechanistic studies of O-GlcNAc glycosylation have been limited by an inability to monitor the glycosylation stoichiometries of proteins obtained from cells. Here we describe a powerful method to visualize the O-GlcNAc-modified protein subpopulation using resolvable polyethylene glycol mass tags. This approach enables rapid quantification of in vivo glycosylation levels on endogenous proteins without the need for protein purification, advanced instrumentation or expensive radiolabels. In addition, it establishes the glycosylation state (for example, mono-, di-, tri-) of proteins, providing information regarding overall O-GlcNAc site occupancy that cannot be obtained using mass spectrometry. Finally, we apply this strategy to rapidly assess the complex interplay between glycosylation and phosphorylation and discover an unexpected reverse 'yin-yang' relationship on the transcriptional repressor MeCP2 that was undetectable by traditional methods. We anticipate that this mass-tagging strategy will advance our understanding of O-GlcNAc glycosylation, as well as other post-translational modifications and poorly understood glycosylation motifs.	[Rexach, Jessica E.; Rogers, Claude J.; Yu, Seok-Ho; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rexach, Jessica E.; Rogers, Claude J.; Yu, Seok-Ho; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Tao, Jifang; Sun, Yi E.] Univ Calif Los Angeles, Med Retardat Res Ctr, Inst Neuropsychiat, Los Angeles, CA USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Rexach, JE (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	lhw@caltech.edu		Yu, Seok-Ho/0000-0002-8372-1094	US National Institutes of Health [R01 GM084724, F31 NS056525-02]; Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056525] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following people for their generous gifts: G. Hart (The Johns Hopkins University School of Medicine) for the OGT antibody, S. Whiteheart (University of Kentucky College of Medicine) for the OGA antibody, W. Wang and K. Hu (US National Institute of Aging) for the MeCP2 antibodies, P. Greengard and A. Nairn (The Rockefeller University) for the synapsin antibody and P. Qasba (US National Cancer Institute) for the Y289L GalT construct. We thank P. Clark and T. Wilson for a critical reading of the manuscript. We also thank P. Clark (California Institute of Technology) for preparing the Y289L GalT used in these studies and for contributing to the aminooxy-linker synthesis. This work was supported by grants from the US National Institutes of Health (R01 GM084724 to L.C.H.-W. and F31 NS056525-02 to J.E.R.) and the Rett Syndrome Research Foundation (Y.E.S.).	Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Hanover J. A., 2009, BIOCHIM BIOPHYS ACTA, V1800, P80; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HOLT GD, 1986, J BIOL CHEM, V261, P8049; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; LUTHI T, 1991, J NEUROCHEM, V56, P1493; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; ROQUEMORE EP, 1992, J BIOL CHEM, V267, P555; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	122	129	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					645	651		10.1038/NCHEMBIO.412	http://dx.doi.org/10.1038/NCHEMBIO.412			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20657584	Green Accepted			2022-12-25	WOS:000281084900007
J	Itoh, H; Nonoue, Y; Yano, M; Izawa, T				Itoh, Hironori; Nonoue, Yasunori; Yano, Masahiro; Izawa, Takeshi			A pair of floral regulators sets critical day length for Hd3a florigen expression in rice	NATURE GENETICS			English	Article							PHOTOPERIODIC CONTROL; FLOWERING TIME; LONG-DISTANCE; ARABIDOPSIS; GENE; PROTEIN; PLANTS; INDUCTION; SIGNAL; LOCUS	The critical day length triggering photoperiodic flowering is set as an acute, accurate threshold in many short-day plants, including rice(1,2). Here, we show that, unlike the Arabidopsis florigen gene FT3, the rice florigen gene Hd3a (Heading date 3a) is toggled by only a 30-min day-length reduction. Hd3a expression is induced by Ehd1 (Early heading date 1) expression when blue light coincides with the morning phase set by OsGIGANTEA(OsGI)-dependent circadian clocks. Ehd1 expression is repressed by both night breaks under short-day conditions and morning light signals under long-day conditions. Ghd7 (Grain number, plant height and heading date 7) was acutely induced when phytochrome signals coincided with a photosensitive phase set differently by distinct photoperiods and this induction repressed Ehd1 the next morning. Thus, two distinct gating mechanisms-of the floral promoter Ehd1 and the floral repressor Ghd7-could enable manipulation of slight differences in day length to control Hd3a transcription with a critical day-length threshold.	[Itoh, Hironori; Izawa, Takeshi] Natl Inst Agrobiol Sci, Photosynth & Photobiol Res Unit, Tsukuba, Ibaraki, Japan; [Nonoue, Yasunori] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki, Japan; [Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Izawa, T (corresponding author), Natl Inst Agrobiol Sci, Photosynth & Photobiol Res Unit, Tsukuba, Ibaraki, Japan.	tizawa@nias.affrc.go.jp	Yano, Masahiro/AAC-5441-2019; Ding, Cheng-Qiang/B-6287-2011	Yano, Masahiro/0000-0003-1510-4622; Izawa, Takeshi/0000-0001-5109-0024	Ministry of Agriculture, Forestry and Fisheries of Japan [GPN0001]; Ministry of Education, Culture, Sports, Science and Technology [20770040]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank N. Tanabe and K. Toyoshima for their assistance in plasmid construction and plant transformation. This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, GPN0001) to T.I. and from the Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid For Young Scientists (B) (20770040) to H.I.	Andres F, 2009, PLANT PHYSIOL, V151, P681, DOI 10.1104/pp.109.139097; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Guan JC, 2004, PLANT MOL BIOL, V56, P795, DOI 10.1007/s11103-004-5182-z; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; IKEDA K, 1985, JARQ-JPN AGR RES Q, V18, P164; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nishida H, 2002, CROP SCI, V42, P348, DOI 10.2135/cropsci2002.0348; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; TAKIMOTO A, 1961, PLANT CELL PHYSIOL, V2, P213, DOI 10.1093/oxfordjournals.pcp.a077680; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thomas B., 1997, PHOTOPERIODISM PLANT; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	29	196	216	3	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					635	U115		10.1038/ng.606	http://dx.doi.org/10.1038/ng.606			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20543848				2022-12-25	WOS:000279242400019
J	Tang, T; Li, L; Tang, J; Li, Y; Lin, WY; Martin, F; Grant, D; Solloway, M; Parker, L; Ye, WL; Forrest, W; Ghilardi, N; Oravecz, T; Platt, KA; Rice, DS; Hansen, GM; Abuin, A; Eberhart, DE; Godowski, P; Holt, KH; Peterson, A; Zambrowicz, BP; de Sauvage, FJ				Tang, Tracy; Li, Li; Tang, Jerry; Li, Yun; Lin, Wei Yu; Martin, Flavius; Grant, Deanna; Solloway, Mark; Parker, Leon; Ye, Weilan; Forrest, William; Ghilardi, Nico; Oravecz, Tamas; Platt, Kenneth A.; Rice, Dennis S.; Hansen, Gwenn M.; Abuin, Alejandro; Eberhart, Derek E.; Godowski, Paul; Holt, Kathleen H.; Peterson, Andrew; Zambrowicz, Brian P.; de Sauvage, Frederic J.			A mouse knockout library for secreted and transmembrane proteins	NATURE BIOTECHNOLOGY			English	Article							MUTAGENESIS; MICE; IDENTIFY; GENES; MODEL	Large collections of knockout organisms facilitate the elucidation of gene functions. Here we used retroviral insertion or homologous recombination to disrupt 472 genes encoding secreted and membrane proteins in mice, providing a resource for studying a large fraction of this important class of drug target. The knockout mice were subjected to a systematic phenotypic screen designed to uncover alterations in embryonic development, metabolism, the immune system, the nervous system and the cardiovascular system. The majority of knockout lines exhibited altered phenotypes in at least one of these therapeutic areas. To our knowledge, a comprehensive phenotypic assessment of a large number of mouse mutants generated by a gene-specific approach has not been described previously.	[Tang, Tracy; Grant, Deanna; Solloway, Mark; Ghilardi, Nico; Peterson, Andrew; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Li, Li; Tang, Jerry; Li, Yun] Genentech Inc, Bioinformat, San Francisco, CA 94080 USA; [Lin, Wei Yu; Martin, Flavius; Godowski, Paul] Genentech Inc, Immunol, San Francisco, CA 94080 USA; [Parker, Leon; Ye, Weilan] Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Forrest, William] Genentech Inc, Nonclin Biostat, San Francisco, CA 94080 USA; [Oravecz, Tamas; Platt, Kenneth A.; Rice, Dennis S.; Hansen, Gwenn M.; Abuin, Alejandro; Eberhart, Derek E.; Holt, Kathleen H.; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Lexicon Pharmaceuticals	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sauvage@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Ghilardi, Nico/0000-0003-4945-3097; Ye, Weilan/0000-0002-6219-3982				ABUIN A, 2007, CONDITIONAL MUTAGENE, P129; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Brommage R, 2008, OBESITY, V16, P2362, DOI 10.1038/oby.2008.361; Brown SDM, 2005, NAT GENET, V37, P1155, DOI 10.1038/ng1105-1155; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Fitzgerald, 2003, MODEL ORGANISMS DRUG, P251; Friddle CJ, 2003, COLD SPRING HARB SYM, V68, P311, DOI 10.1101/sqb.2003.68.311; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Morgan H, 2010, NUCLEIC ACIDS RES, V38, pD577, DOI 10.1093/nar/gkp1007; POGORELOV VM, 2008, EXPT ANIMAL MODELS N, P17; Savelieva KV, 2008, NEUROSCI LETT, V438, P205, DOI 10.1016/j.neulet.2008.04.013; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wilson L, 2005, GENOME RES, V15, P1095, DOI 10.1101/gr.3826505; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zambrowicz Brian P., 2007, P3, DOI 10.1016/B978-012369393-8/50002-X	37	252	276	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					749	U149		10.1038/nbt.1644	http://dx.doi.org/10.1038/nbt.1644			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20562862				2022-12-25	WOS:000279723900034
J	Miura, K; Ikeda, M; Matsubara, A; Song, XJ; Ito, M; Asano, K; Matsuoka, M; Kitano, H; Ashikari, M				Miura, Kotaro; Ikeda, Mayuko; Matsubara, Atsushi; Song, Xian-Jun; Ito, Midori; Asano, Kenji; Matsuoka, Makoto; Kitano, Hidemi; Ashikari, Motoyuki			OsSPL14 promotes panicle branching and higher grain productivity in rice	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; DNA METHYLATION; TRANSCRIPTION FACTORS; PROTEIN; PLANTS; GENES; ACCUMULATION; EXPRESSION; MERISTEM; ENCODES	Identification of alleles that improve crop production and lead to higher-yielding varieties are needed for food security. Here we show that the quantitative trait locus WFP (WEALTHY FARMER'S PANICLE) encodes OsSPL14 (SQUAMOSA PROMOTER BINDING PROTEIN-LIKE 14, also known as IPA1). Higher expression of OsSPL14 in the reproductive stage promotes panicle branching and higher grain yield in rice. OsSPL14 controls shoot branching in the vegetative stage and is affected by microRNA excision. We also demonstrate the feasibility of using the OsSLP14(WFP) allele to increase rice crop yield. Introduction of the high-yielding OsSPL14(WFP) allele into the standard rice variety Nipponbare resulted in increased rice production.	[Miura, Kotaro; Ikeda, Mayuko; Matsubara, Atsushi; Song, Xian-Jun; Ito, Midori; Asano, Kenji; Matsuoka, Makoto; Kitano, Hidemi; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Ashikari, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	ashi@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [QTL-1001]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	We thank K. Imamura for providing the detailed protocol for in situ hybridization, S. Mizuno for maintenance of the paddy field and E. Kouketsu and K. Sakata for helping to produce transgenic plants. This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Integrated Research Project for Plants, Insects and Animals using Genome Technology, QTL-1001).	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; KOUCHI H, 1993, MOL GEN GENET, V238, P106, DOI 10.1007/BF00279537; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Miura K, 2009, P NATL ACAD SCI USA, V106, P11218, DOI 10.1073/pnas.0901942106; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Sasaki T, 2008, RICE, V1, P1, DOI 10.1007/s12284-008-9010-y; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	32	662	749	20	265	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					545	U102		10.1038/ng.592	http://dx.doi.org/10.1038/ng.592			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20495564				2022-12-25	WOS:000278081500023
J	Siekhaus, D; Haesemeyer, M; Moffitt, O; Lehmann, R				Siekhaus, Daria; Haesemeyer, Martin; Moffitt, Olivia; Lehmann, Ruth			RhoL controls invasion and Rap1 localization during immune cell transmigration in Drosophila	NATURE CELL BIOLOGY			English	Article							SMALL GTPASES; BLOOD-CELLS; MIGRATION; ADHESION; MECHANISMS; INTEGRIN; MELANOGASTER; LEUKOCYTE; RECEPTOR; TISSUE	Human immune cells have to penetrate an endothelial barrier during their beneficial pursuit of infection and their destructive infiltration of tissues in autoimmune diseases. This transmigration requires Rap1 GTPase to activate integrin affinity(1). We define a new model system for this process by demonstrating, with live imaging and genetics, that during embryonic development Drosophila melanogaster immune cells penetrate an epithelial, Drosophila E-cadherin (DE-cadherin)-based tissue barrier. A mutant in RhoL, a GTPase homologue that is specifically expressed in haemocytes, blocks this invasive step but not other aspects of guided migration. RhoL mediates integrin adhesion caused by Drosophila Rap1 overexpression and moves Rap1 away from a concentration in the cytoplasm to the leading edge during invasive migration. These findings indicate that a programmed migratory step during Drosophila development bears striking molecular similarities to vertebrate immune cell transmigration during inflammation, and identify RhoL as a new regulator of invasion, adhesion and Rap1 localization. Our work establishes the utility of Drosophila for identifying novel components of immune cell transmigration and for understanding the in vivo interplay of immune cells with the barriers they penetrate.	[Lehmann, Ruth] NYU, Sch Med, HHMI, New York, NY 10016 USA; NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	Lehmann, R (corresponding author), NYU, Sch Med, HHMI, New York, NY 10016 USA.	Ruth.Lehmann@med.nyu.edu	Haesemeyer, Martin/Q-2123-2017; Siekhaus, Daria/AAN-1779-2020	Haesemeyer, Martin/0000-0003-2704-3601; Siekhaus, Daria/0000-0001-8323-8353; Moffitt, Olivia/0000-0001-5107-1413; Lehmann, Ruth/0000-0002-8454-5651	NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Jukam, P. Kunwar, A-M. Sudarov, and S. Wang for help during the GAL4 enhancer screen, and D. Demy for input. We thank all the people who shared their reagents: U. Heberlein, K. Brueckner, N. Perrimon, D. Montell, R. Reuter and A. Page-McCaw for stocks and T. Uemura, D. Branton, R, Dubreuil, H. Bellen, N. Lowe, D. Ryoo and J. Treisman for antibodies. We thank the Developmental Studies Hybridoma Bank developed with NICHD support and maintained by the University of Iowa for antibodies and the Bloomington Stock Center for flies. We are grateful for conversations with P. Rangan, P. Kunwar and many other members of the laboratory. We thank M. Dustin, S. Schwab and laboratory members for comments on the manuscript. We thank NICHD for supporting part of this work. R.L. is an investigator of the HHMI.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi EY, 2009, FRONT BIOSCI-LANDMRK, V14, P1596, DOI 10.2741/3327; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; de Velasco B, 2006, DEV GENES EVOL, V216, P39, DOI 10.1007/s00427-005-0029-4; Etzioni A, 1999, BLOOD, V94, P3281, DOI 10.1182/blood.V94.10.3281.422k37_3281_3288; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Menasche G, 2007, IMMUNOL REV, V218, P82, DOI 10.1111/j.1600-065X.2007.00543.x; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	35	49	50	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					605	U181		10.1038/ncb2063	http://dx.doi.org/10.1038/ncb2063			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20495554	Green Accepted			2022-12-25	WOS:000278213400013
J	Kohout, SC; Bell, SC; Liu, LJ; Xu, Q; Minor, DL; Isacoff, EY				Kohout, Susy C.; Bell, Sarah C.; Liu, Lijun; Xu, Qiang; Minor, Daniel L., Jr.; Isacoff, Ehud Y.			Electrochemical coupling in the voltage-dependent phosphatase Ci-VSP	NATURE CHEMICAL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PTEN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SENSING PHOSPHATASE; BINDING MOTIF; CHANNELS; PHOSPHOINOSITIDES; ACTIVATION; MECHANISM; MEMBRANE; SENSORS	In the voltage-sensing phosphatase Ci-VSP, a voltage-sensing domain (VSD) controls a lipid phosphatase domain (PD). The mechanism by which the domains are allosterically coupled is not well understood. Using an in vivo assay, we found that the interdomain linker that connects the VSD to the PD is essential for coupling the full-length protein. Biochemical assays showed that the linker is also needed for activity in the isolated PD. We also identified a late step of VSD motion in the full-length protein that depends on the linker. Notably, we found that this VSD motion requires PI(4,5)P(2), a substrate of Ci-VSP. These results suggest that the voltage-driven motion of the VSD turns the enzyme on by rearranging the linker into an activated conformation, and that this activated conformation is stabilized by PI(4,5)P(2). We propose that Ci-VSP activity is self-limited because its decrease of PI(4,5)P(2) levels decouples the VSD from the enzyme.	[Kohout, Susy C.; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bell, Sarah C.; Isacoff, Ehud Y.] Univ Calif Berkeley, Chem Biol Grad Program, Berkeley, CA 94720 USA; [Liu, Lijun; Xu, Qiang; Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.; Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359; Kohout, Susy/0000-0002-8159-8934	US National Institutes of Health [R01NS035549, U24NS57631, R01DC007664]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631, R01NS035549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants R01NS035549 (E.Y.I.), U24NS57631 (E.Y.I.) and R01DC007664 (D. L. M.) from the US National Institutes of Health and by an American Heart Association Established Investigator Award ( D. L. M.). We thank Y. Okamura ( Japanese National Institute for Physiological Sciences) for kindly providing the Ci-VSP cDNA, T. Meyer ( Stanford University) for kindly providing the LDR and CFInp cDNA, E. Reuveny ( Weizmann Institute of Science) for providing the IRK1 construct, S. Nakanishi ( Osaka Bioscience Institute) for providing the mGluR1 alpha receptor, J. Groves and P. Nair ( University of California, Berkeley) for access to and instructions on use of the lipid - extruder, and H. Janovjak, K. Nakajo, E. Peled and F. Tombola for helpful discussions.	Borah HN, 1998, J CHEM RES-S, P272, DOI 10.1039/a707961c; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gronbaek K, 1998, BLOOD, V91, P4388; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Worby CA, 2005, MOL INTERV, V5, P274, DOI 10.1124/mi.5.5.5; Xiao Y, 2007, CELL SIGNAL, V19, P1434, DOI 10.1016/j.cellsig.2007.01.021	32	54	55	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					369	375		10.1038/nchembio.349	http://dx.doi.org/10.1038/nchembio.349			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20364128	Green Accepted			2022-12-25	WOS:000276823200016
J	Novoa, I; Gallego, J; Ferreira, PG; Mendez, R				Novoa, Isabel; Gallego, Javier; Ferreira, Pedro G.; Mendez, Raul			Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC POLYADENYLATION; MESSENGER-RNA; POLY(A) TAIL; DEADENYLATION; EXPRESSION; GENES; PHOSPHORYLATION; FRACTIONATION; DEGRADATION; SPECIFICITY	Meiotic and early-embryonic cell divisions in vertebrates take place in the absence of transcription and rely on the translational regulation of stored maternal messenger RNAs. Most of these mRNAs are regulated by the cytoplasmic-polyadenylation-element-binding protein (CPEB), which mediates translational activation and repression through cytoplasmic changes in their poly(A) tail length. It was unknown whether translational regulation by cytoplasmic polyadenylation and CPEB can also regulate mRNAs at specific points of mitotic cell-cycle divisions. Here we show that CPEB-mediated post-transcriptional regulation by phase-specific changes in poly(A) tail length is required for cell proliferation and specifically for entry into M phase in mitotically dividing cells. This translational control is mediated by two members of the CPEB family of proteins, CPEB1 and CPEB4. We conclude that regulation of poly(A) tail length is not only required to compensate for the lack of transcription in specialized cell divisions but also acts as a general mechanism to control mitosis.	[Novoa, Isabel; Gallego, Javier; Ferreira, Pedro G.; Mendez, Raul] Ctr Genom Regulat, Gene Regulat Program, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendez, R (corresponding author), Ctr Genom Regulat, Gene Regulat Program, C Dr Aiguader 88, Barcelona 08003, Spain.	inovoa@ir.vhebron.net; raul.mendez@crg.es	Ferreira, Pedro G/J-6379-2013; Ferreira, Pedro/HDO-1346-2022; Gallego, Javier/GQI-2928-2022	Ferreira, Pedro G/0000-0003-3838-8664; Gallego, Javier/0000-0001-5635-5001; Mendez, Raul/0000-0002-1952-6905; Novoa, Isabel/0000-0003-1821-1685	Spanish Ministry of Science and Innovation; Fundacio 'Marato de TV3'; FIS and Marie Curie Reintegration grants; MEC	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio 'Marato de TV3'; FIS and Marie Curie Reintegration grants; MEC(European Commission)	Anti-MS2 antibodies were provided by Mike Kiledjian (Rutgers University), anti-CPSF100 antibodies by James Manley (Columbia University), and anti-CPEB1 antibodies by Dominique Weil (Institut Andre Lwoff). We thank Oscar Fornas (Flow Cytometry Facility at UPF) and Lauro Sumoy (Microarray Facility) for technical advice, and members of the Mendez and Fatima Gebauer laboratory, Mercedes Fernandez, Juan Valcarcel, Josep Vilardell, Roderic Guigo and other colleagues from the Gene Expression Program, for helpful advice and critically reading the manuscript. This work was supported by grants from the Spanish Ministry of Science and Innovation, Fundacio 'Marato de TV3' to R. M., and FIS and Marie Curie Reintegration grants to I.N. R.M. is a recipient of a contract from the I3 contract (MEC), and I.N. from the 'Programa Ramon y Cajal' (MEC).	Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Cao QP, 2006, NAT STRUCT MOL BIOL, V13, P1128, DOI 10.1038/nsmb1169; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Pique Maria, 2006, V322, P183; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Walker J, 1998, METH MOL B, V77, P365; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	44	119	124	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					447	U82		10.1038/ncb2046	http://dx.doi.org/10.1038/ncb2046			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20364142				2022-12-25	WOS:000277283700010
J	McGovern, DPB; Gardet, A; Torkvist, L; Goyette, P; Essers, J; Taylor, KD; Neale, BM; Ong, RTH; Lagace, C; Li, C; Green, T; Stevens, CR; Beauchamp, C; Fleshner, PR; Carlson, M; D'Amato, M; Halfvarson, J; Hibberd, ML; Lordal, M; Padyukov, L; Andriulli, A; Colombo, E; Latiano, A; Palmieri, O; Bernard, EJ; Deslandres, C; Hommes, DW; de Jong, DJ; Stokkers, PC; Weersma, RK; Sharma, Y; Silverberg, MS; Cho, JH; Wu, J; Roeder, K; Brant, SR; Schumm, LP; Duerr, RH; Dubinsky, MC; Glazer, NL; Haritunians, T; Ippoliti, A; Melmed, GY; Siscovick, DS; Vasiliauskas, EA; Targan, SR; Annese, V; Wijmenga, C; Pettersson, S; Rotter, JI; Xavier, RJ; Daly, MJ; Rioux, JD; Seielstad, M				McGovern, Dermot P. B.; Gardet, Agnes; Torkvist, Leif; Goyette, Philippe; Essers, Jonah; Taylor, Kent D.; Neale, Benjamin M.; Ong, Rick T. H.; Lagace, Caroline; Li, Chun; Green, Todd; Stevens, Christine R.; Beauchamp, Claudine; Fleshner, Phillip R.; Carlson, Marie; D'Amato, Mauro; Halfvarson, Jonas; Hibberd, Martin L.; Lordal, Mikael; Padyukov, Leonid; Andriulli, Angelo; Colombo, Elisabetta; Latiano, Anna; Palmieri, Orazio; Bernard, Edmond-Jean; Deslandres, Colette; Hommes, Daan W.; de Jong, Dirk J.; Stokkers, Pieter C.; Weersma, Rinse K.; Sharma, Yashoda; Silverberg, Mark S.; Cho, Judy H.; Wu, Jing; Roeder, Kathryn; Brant, Steven R.; Schumm, L. Phillip; Duerr, Richard H.; Dubinsky, Marla C.; Glazer, Nicole L.; Haritunians, Talin; Ippoliti, Andy; Melmed, Gil Y.; Siscovick, David S.; Vasiliauskas, Eric A.; Targan, Stephan R.; Annese, Vito; Wijmenga, Cisca; Pettersson, Sven; Rotter, Jerome I.; Xavier, Ramnik J.; Daly, Mark J.; Rioux, John D.; Seielstad, Mark		NIDDK IBD Genetics Consortium	Genome-wide association identifies multiple ulcerative colitis susceptibility loci	NATURE GENETICS			English	Article							GENETIC-VARIANTS; CROHNS-DISEASE; RISK; CONTRIBUTE; IMMUNITY	Ulcerative colitis is a chronic, relapsing inflammatory condition of the gastrointestinal tract with a complex genetic and environmental etiology. In an effort to identify genetic variation underlying ulcerative colitis risk, we present two distinct genome-wide association studies of ulcerative colitis and their joint analysis with a previously published scan(1), comprising, in aggregate, 2,693 individuals with ulcerative colitis and 6,791 control subjects. Fifty-nine SNPs from 14 independent loci attained an association significance of P < 10(-5). Seven of these loci exceeded genome-wide significance (P < 5 x 10(-8)). After testing an independent cohort of 2,009 cases of ulcerative colitis and 1,580 controls, we identified 13 loci that were significantly associated with ulcerative colitis (P < 5 x 10(-8)), including the immunoglobulin receptor gene FCGR2A, 5p15, 2p16 and ORMDL3 (orosomucoid1-like 3). We confirmed association with 14 previously identified ulcerative colitis susceptibility loci, and an analysis of acknowledged Crohn's disease loci showed that roughly half of the known Crohn's disease associations are shared with ulcerative colitis. These data implicate approximately 30 loci in ulcerative colitis, thereby providing insight into disease pathogenesis.	[McGovern, Dermot P. B.; Fleshner, Phillip R.; Dubinsky, Marla C.; Ippoliti, Andy; Melmed, Gil Y.; Vasiliauskas, Eric A.; Targan, Stephan R.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Gardet, Agnes; Li, Chun; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Gardet, Agnes; Li, Chun; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastroenterol Unit, Boston, MA USA; [Torkvist, Leif] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Torkvist, Leif; Lordal, Mikael] Karolinska Univ Hosp, IBD Clin Res Grp, Stockholm, Sweden; [Goyette, Philippe; Lagace, Caroline; Beauchamp, Claudine; Rioux, John D.] Univ Montreal, Montreal, PQ, Canada; [Goyette, Philippe; Lagace, Caroline; Beauchamp, Claudine; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Essers, Jonah; Neale, Benjamin M.; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Taylor, Kent D.; Haritunians, Talin; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ong, Rick T. H.; Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Green, Todd; Stevens, Christine R.; Xavier, Ramnik J.; Daly, Mark J.] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Carlson, Marie] Univ Uppsala Hosp, Dept Med Sci, Gastroenterol Res Grp, Uppsala, Sweden; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Halfvarson, Jonas] Orebro Univ Hosp, Dept Internal Med, Div Gastroenterol, Orebro, Sweden; [Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Lordal, Mikael] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Padyukov, Leonid] Karolinska Univ Hosp Solna, Rheumatol Unit, Dept Med, Karolinska Inst, Stockholm, Sweden; [Andriulli, Angelo; Colombo, Elisabetta; Latiano, Anna; Palmieri, Orazio; Annese, Vito] Osped Casa Sollievo Sofferenza, Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo, Italy; [Bernard, Edmond-Jean] Univ Montreal, Ctr Hosp Univ, Montreal, PQ, Canada; [Deslandres, Colette] Hop St Justine, Dept Gastroenterol, Montreal, PQ H3T 1C5, Canada; [Hommes, Daan W.] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands; [de Jong, Dirk J.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Stokkers, Pieter C.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [NIDDK IBD Genetics Consortium] Yale Univ, NIDDK, New Haven, CT USA; [Sharma, Yashoda; Cho, Judy H.] Yale Univ, Dept Med, Sect Digest Dis, New Haven, CT 06520 USA; [Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Cho, Judy H.] Yale Univ, Dept Genet, New Haven, CT USA; [Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Roeder, Kathryn; Brant, Steven R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Roeder, Kathryn; Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Schumm, L. Phillip] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Dept Gen Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Pettersson, Sven] Singapore Gen Hosp, Lab Inflammat Biol, Singapore 0316, Singapore; [Seielstad, Mark] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universite de Montreal; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cedars Sinai Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Orebro University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; IRCCS Casa Sollievo Della Sofferenza; Universite de Montreal; Universite de Montreal; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University; Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Yale University; Carnegie Mellon University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Groningen; Karolinska Institutet; Singapore General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	McGovern, DPB (corresponding author), Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	mcgovernd@cshs.org; john.david.rioux@umontreal.ca; mark.seielstad@ucsf.edu	Rotter, Jerome/AAY-6598-2021; Hibberd, Martin L/D-5050-2009; Palmieri, Orazio/J-7697-2012; Wijmenga, Cisca/AAE-7719-2019; Weersma, Rinse/ABE-3807-2021; Andriulli, Angelo/B-5027-2017; Rioux, John D/A-9599-2015; D'Amato, Mauro/F-2450-2010; Annese, Vito/AGW-4200-2022; D'Amato, Mauro/B-5050-2019; Seielstad, Mark/T-7841-2019; Daly, Mark J/B-2453-2017; de Jong, D.J./L-4417-2015; Silverberg, Mark/B-4183-2008; Duerr, Richard H/B-4188-2009; Halfvarson, Jonas/AAU-4687-2020; Deslandres, Colette/AAO-5814-2021; Latiano, Anna/R-1965-2016; Wijmenga, Cisca/D-2173-2009; Padyukov, Leonid/A-4890-2009	Palmieri, Orazio/0000-0002-0019-7929; Wijmenga, Cisca/0000-0002-5635-1614; Andriulli, Angelo/0000-0001-8862-7083; Rioux, John D/0000-0001-7560-8326; D'Amato, Mauro/0000-0003-2743-5197; Annese, Vito/0000-0002-0082-892X; D'Amato, Mauro/0000-0003-2743-5197; Daly, Mark J/0000-0002-0949-8752; Duerr, Richard H/0000-0001-6586-3905; Latiano, Anna/0000-0003-3719-2061; Hibberd, Martin/0000-0001-8587-1849; Seielstad, Mark/0000-0001-5783-1401; Glazer, Nicole/0000-0002-6397-609X; Roeder, Kathryn/0000-0002-8869-6254; Padyukov, Leonid/0000-0003-2950-5670; Halfvarson, Jonas/0000-0003-0122-7234; Melmed, Gil/0000-0002-2591-5165; Stevens, Christine/0000-0002-2621-2234; Schumm, Phil/0000-0002-3050-2429	US National Center for Research Resources (NCRR) [M01-RR00425]; US National Institutes of Health/NIDDK [P01-DK046763, DK83756, DK086502, DK043351, DK062431, DK062422, DK062420, DK062432, DK062423, DK062413, DK062429]; Diabetes Endocrinology Research Center [DK063491]; Cedars-Sinai Medical Center; US National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL087652]; US National Institute of Neurological Disorders and Stroke; Crohn's and Colitis Foundation of America; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation; US National Institute of Allergy and Infectious Diseases [AI065687, AI067152]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK064869]; Swedish Society of Medicine; Bengt Ihre Foundation; Karolinska Institutet; Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council; Soderbergh Foundation; Swedish Cancer Foundation;  [DK76984];  [DK084554]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085080, N01HC035129, N01HC085086, N01HC085085, N01HC085083, N01HC085084, N01HC085082, N01HC045133, N01HC085079, N01HC085081, N01HC075150, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152, P01AI065687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062429, U01DK062420, P30DK043351, R01DK060049, U01DK062423, U01DK062413, R03DK076984, RC1DK086502, P30DK063491, R21DK084554, P30DK040561, U01DK062431, P01DK046763, U01DK062432, R01DK064869, U01DK062422, R01DK083756] Funding Source: NIH RePORTER	US National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Endocrinology Research Center; Cedars-Sinai Medical Center; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Crohn's and Colitis Foundation of America; Bohmfalk Funds for Medical Research; Burroughs Wellcome Medical Foundation(Burroughs Wellcome Fund); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Society of Medicine; Bengt Ihre Foundation; Karolinska Institutet(Karolinska Institutet); Swedish National Program for IBD Genetics; Swedish Organization for IBD; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Soderbergh Foundation; Swedish Cancer Foundation; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by US National Center for Research Resources (NCRR) grant M01-RR00425 to the Cedars-Sinai General Research Center Genotyping core; US National Institutes of Health/NIDDK grant P01-DK046763; Diabetes Endocrinology Research Center grant DK063491; Cedars-Sinai Medical Center Inflammatory Bowel Disease Research Funds. Additional funding was provided by grants DK76984 (M. C. D.) and DK084554 (M. C. D. and D. P. B. M.). Cardiovascular Health Study research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150 and N01-HC-45133; grant numbers U01 HL080295 and R01 HL087652 from the US National Heart, Lung, and Blood Institute; and additional contribution from the US National Institute of Neurological Disorders and Stroke. A full list of principal Cardiovascular Health Study investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. A. G. is supported by the Crohn's and Colitis Foundation of America. R.J.X. and M.J.D. are supported by grants DK83756, DK086502 and DK043351 (NIDDK).; The NIDDK IBD Genetics Consortium is funded by the following grants: DK062431 (S. R. B.), DK062422 (J.H.C.), DK062420 (R. H. D.), DK062432 (J.D.R.), DK062423 (M. S. S.), DK062413 (D. P. B. M.) and DK062429 (J.H.C.). J.H.C. is also funded by Bohmfalk Funds for Medical Research, Burroughs Wellcome Medical Foundation and the Crohn's and Colitis Foundation of America. J.D.R. is also funded by grants from the US National Institute of Allergy and Infectious Diseases (AI065687; AI067152) and from the US National Institute of Diabetes and Digestive and Kidney Diseases (DK064869).; Activities in Sweden were supported by the Swedish Society of Medicine, the Bengt Ihre Foundation, the Karolinska Institutet, the Swedish National Program for IBD Genetics, the Swedish Organization for IBD, the Swedish Medical Research Council, the Soderbergh Foundation and the Swedish Cancer Foundation. Support for genotyping and genetic data analysis was provided by the Singapore National Cancer Centre, Singapore General Hospital and the Singapore Millennium Foundation (to S. P.) and the Agency for Science Technology and Research (A*STAR), Singapore (to M. L. H. and M. S.). Genotyping and DNA handling at the Genome Institute of Singapore were performed by W.Y. Meah, K. K. Heng, H. B. Toh, X. Lin, S. Rajaram, D. Tan and C. H. Wong. We are grateful to the funders and investigators of the Epidemiological Investigation of Rheumatoid Arthritis for providing genotype data from healthy Swedish individuals.	Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wang Y, 2000, J BIOL CHEM, V275, P27013; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	27	470	491	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					332	U88		10.1038/ng.549	http://dx.doi.org/10.1038/ng.549			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20228799	Green Accepted			2022-12-25	WOS:000276150500013
J	Shapiro, MG; Westmeyer, GG; Romero, PA; Szablowski, JO; Kuster, B; Shah, A; Otey, CR; Langer, R; Arnold, FH; Jasanoff, A				Shapiro, Mikhail G.; Westmeyer, Gil G.; Romero, Philip A.; Szablowski, Jerzy O.; Kuester, Benedict; Shah, Ameer; Otey, Christopher R.; Langer, Robert; Arnold, Frances H.; Jasanoff, Alan			Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine	NATURE BIOTECHNOLOGY			English	Article							BLOOD OXYGENATION; NUCLEUS-ACCUMBENS; BRAIN; INVIVO; P450BM-3; RELEASE; ACID; RAT; STIMULATION; MECHANISMS	The development of molecular probes that allow in vivo imaging of neural signaling processes with high temporal and spatial resolution remains challenging. Here we applied directed evolution techniques to create magnetic resonance imaging (MRI) contrast agents sensitive to the neurotransmitter dopamine. The sensors were derived from the heme domain of the bacterial cytochrome P450-BM3 (BM3h). Ligand binding to a site near BM3h's paramagnetic heme iron led to a drop in MRI signal enhancement and a shift in optical absorbance. Using an absorbance-based screen, we evolved the specificity of BM3h away from its natural ligand and toward dopamine, producing sensors with dissociation constants for dopamine of 3.3-8.9 mu M. These molecules were used to image depolarization-triggered neurotransmitter release from PC12 cells and in the brains of live animals. Our results demonstrate the feasibility of molecular-level functional MRI using neural activity-dependent sensors, and our protein engineering approach can be generalized to create probes for other targets.	[Shapiro, Mikhail G.; Szablowski, Jerzy O.; Shah, Ameer; Langer, Robert; Jasanoff, Alan] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Westmeyer, Gil G.; Kuester, Benedict; Jasanoff, Alan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Romero, Philip A.; Otey, Christopher R.; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Jasanoff, Alan] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California Institute of Technology; Massachusetts Institute of Technology (MIT)	Jasanoff, A (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jasanoff@mit.edu		Szablowski, Jerzy/0000-0001-7851-5408; Arnold, Frances H./0000-0002-4027-364X; Shapiro, Mikhail/0000-0002-0291-4215; Westmeyer, Gil Gregor/0000-0001-7224-8919	Dana Foundation; Raymond & Beverley Sackler Fellowship; US National Institutes of Health (NIH) [R01-DA28299, DP2-OD2441, R01-GM068664, R01-DE013023]; Caltech Jacobs Institute for Molecular Medicine; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028299] Funding Source: NIH RePORTER	Dana Foundation; Raymond & Beverley Sackler Fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Jacobs Institute for Molecular Medicine; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Lelyveld for helpful discussions and assistance with in vitro measurements, N. Shah for help with MRI procedures and W. Schulze for help with automated analysis methods. We are grateful to C. Jennings and D. Cory for comments and suggestions about the manuscript, and to D. Vaughan for consultation regarding histology. We thank P. Caravan and again D. Cory for access to low-field relaxometers. M. G. S. thanks the Fannie and John Hertz Foundation and the Paul and Daisy Soros Fellowship for generous support. This work was funded by a Dana Foundation Brain & Immuno-Imaging grant, a Raymond & Beverley Sackler Fellowship and US National Institutes of Health (NIH) grants R01-DA28299 and DP2-OD2441 ( New Innovator Award) to A.J., NIH grant R01-GM068664 and a grant from the Caltech Jacobs Institute for Molecular Medicine to F. H. A. and NIH grant R01-DE013023 to R. L.	BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; BUXTON RB, 2001, INTRO FUNCTIONAL MAG; Chen ZJ, 2004, J NEUROSURG, V101, P314, DOI 10.3171/jns.2004.101.2.0314; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Duong TQ, 2000, MAGN RESON MED, V44, P231, DOI 10.1002/1522-2594(200008)44:2<231::AID-MRM10>3.0.CO;2-T; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; EWING AG, 1982, BRAIN RES, V249, P361, DOI 10.1016/0006-8993(82)90070-1; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; GARRIS PA, 1994, J NEUROSCI, V14, P442; GERHARDT GA, 1986, J NEUROCHEM, V46, P842, DOI 10.1111/j.1471-4159.1986.tb13048.x; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jasanoff A, 2007, CURR OPIN NEUROBIOL, V17, P593, DOI 10.1016/j.conb.2007.11.002; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lewis D. F. V., 2001, GUIDE CYTOCHROME P45; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Li QS, 2000, CHEM-EUR J, V6, P1531, DOI 10.1002/(SICI)1521-3765(20000502)6:9<1531::AID-CHEM1531>3.3.CO;2-4; Lindsey KP, 2006, NEUROIMAG CLIN N AM, V16, P553, DOI 10.1016/j.nic.2006.06.003; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Macdonald IDG, 1998, BIOPHYS J, V74, P3241, DOI 10.1016/S0006-3495(98)78030-0; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; MICHAEL AC, 1987, NEUROSCI LETT, V76, P81, DOI 10.1016/0304-3940(87)90196-0; MODI S, 1995, BIOCHEMISTRY-US, V34, P8982, DOI 10.1021/bi00028a006; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohnuma K, 2006, J NEUROSCI METH, V151, P250, DOI 10.1016/j.jneumeth.2005.08.004; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otey CR, 2006, BIOTECHNOL BIOENG, V93, P494, DOI 10.1002/bit.20744; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; YOUNG AMJ, 1992, NEUROSCIENCE, V48, P871, DOI 10.1016/0306-4522(92)90275-7	36	120	128	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					264	U120		10.1038/nbt.1609	http://dx.doi.org/10.1038/nbt.1609			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20190737	Green Accepted, Green Published			2022-12-25	WOS:000275288300025
J	Chamberlain, JR; Chamberlain, JS				Chamberlain, Joel R.; Chamberlain, Jeffrey S.			Muscling in Gene therapies for muscular dystrophy target RNA	NATURE MEDICINE			English	Editorial Material							SYSTEMIC DELIVERY; EXPANSIONS; SEQUENCE		[Chamberlain, Joel R.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JR (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	jrcham@uw.edu; jsc5@uw.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	NIAMS NIH HHS [R37 AR040864] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040864] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Arnett ALH, 2009, CURR OPIN GENET DEV, V19, P290, DOI 10.1016/j.gde.2009.03.005; Goyenvalle A, 2009, MOL THER, V17, P1234, DOI 10.1038/mt.2009.113; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	14	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					170	171		10.1038/nm0210-170	http://dx.doi.org/10.1038/nm0210-170			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20134472				2022-12-25	WOS:000274297000036
J	Jones, CT; Catanese, MT; Law, LMJ; Khetani, SR; Syder, AJ; Ploss, A; Oh, TS; Schoggins, JW; MacDonald, MR; Bhatia, SN; Rice, CM				Jones, Christopher T.; Catanese, Maria Teresa; Law, Lok Man J.; Khetani, Salman R.; Syder, Andrew J.; Ploss, Alexander; Oh, Thomas S.; Schoggins, John W.; MacDonald, Margaret R.; Bhatia, Sangeeta N.; Rice, Charles M.			Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system	NATURE BIOTECHNOLOGY			English	Article							ANTIVIRAL SIGNALING PROTEIN; MOLECULAR CLONES; ADAPTER PROTEIN; RNA REPLICATION; HEPATOMA-CELLS; CULTURE; TRANSMISSION; GRANULES; STRESS; ENTRY	Hepatitis C virus (HCV), which infects 2-3% of the world population, is a causative agent of chronic hepatitis and the leading indication for liver transplantation(1). The ability to propagate HCV in cell culture (HCVcc) is a relatively recent breakthrough and a key tool in the quest for specific antiviral therapeutics. Monitoring HCV infection in culture generally involves bulk population assays, use of genetically modified viruses and/or terminal processing of potentially precious samples. Here we develop a cell-based fluorescent reporter system that allows sensitive distinction of individual HCV-infected cells in live or fixed samples. We demonstrate use of this technology for several previously intractable applications, including live-cell imaging of viral propagation and host response, as well as visualizing infection of primary hepatocyte cultures. Integration of this reporter with modern image-based analysis methods could open new doors for HCV research.	[Jones, Christopher T.; Catanese, Maria Teresa; Law, Lok Man J.; Syder, Andrew J.; Ploss, Alexander; Oh, Thomas S.; Schoggins, John W.; MacDonald, Margaret R.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA; [Khetani, Salman R.; Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA	Rockefeller University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@rockefeller.edu	Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252	The Rockefeller University Bioimaging Core Facility; Empire State Stem Cell Fund through NY State Department of Health (NYSDOH) [C023046]; Public Health Service [R01 AI075099, R01 DK56966]; National Institutes of Health (NIH) through the NIH Roadmap for Medical Research [1 R01 DK085713-01]; Greenberg Medical Research Institute; Starr Foundation; National Research Service Award [DK081193]; Women & Science Fellowship; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056966, F32DK081193, R01DK085713] Funding Source: NIH RePORTER	The Rockefeller University Bioimaging Core Facility; Empire State Stem Cell Fund through NY State Department of Health (NYSDOH); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health (NIH) through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Women & Science Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the expert support of The Rockefeller University Bioimaging Core Facility, with special thanks to A. North, S. Galdeen and S. Bhuvanendran. We thank The Rockefeller University Flow Cytometry Resource Center, supported by the Empire State Stem Cell Fund through NY State Department of Health (NYSDOH) contract no. C023046; opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH, or the State of NY. We are grateful to C. Stoyanov ( The Rockefeller University) for YF17D(5'C25Venus2AUbi), J. Tazi for G3BP (Institut de Genetique Moleculaire de Montpellier) and I. Frolov (UTMB) for Venezuelan equine encephalitis virus-EGFP. We thank M. Holz, A. Forest, M. Panis and A. Webson for laboratory support and C. Murray for critical reading of the manuscript. This work was supported by Public Health Service grants R01 AI075099 ( C. M. R.) and R01 DK56966 (S.N.B.). This work was also funded by the Office of the Director/National Institutes of Health (NIH) through the NIH Roadmap for Medical Research, Grant 1 R01 DK085713-01 ( C. M. R. and S.N.B.). Information on this Roadmap Transformative R01 Program can be found at http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-08-029.html. Additional funding was provided by the Greenberg Medical Research Institute and the Starr Foundation ( C. M. R.). S.N.B. is an Howard Hughes Medical Investigator investigator. C. T. J. was supported by National Research Service Award DK081193; M. T. C. was supported by a Women & Science Fellowship; L. M. J. L. is supported by a Natural Sciences and Engineering Research Council of Canada fellowship. A. P. is a recipient of a Kimberly Lawrence-Netter cancer research discovery fund award.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bartenschlager R, 2006, CURR OPIN MICROBIOL, V9, P416, DOI 10.1016/j.mib.2006.06.012; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; PLOSS A, P NATL ACAD IN PRESS; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schutz S, 2007, CELL HOST MICROBE, V2, P284, DOI 10.1016/j.chom.2007.10.009; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Wollman R, 2007, J CELL SCI, V120, P3715, DOI 10.1242/jcs.013623; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	34	196	203	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					167	U16		10.1038/nbt.1604	http://dx.doi.org/10.1038/nbt.1604			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20118917	Green Submitted, Green Accepted			2022-12-25	WOS:000274317200026
J	Morgan, CT; Lee, MH; Kimble, J				Morgan, Clinton T.; Lee, Myon-Hee; Kimble, Judith			Chemical reprogramming of Caenorhabditis elegans germ cell fate	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHATASE LIP-1; MEK INHIBITORS; DIFFERENTIATION; ACTIVATION; RAS	Small molecules can control cell fate in vivo and may allow directed induction of desired cell types, providing an attractive alternative to transplant-based approaches in regenerative medicine. We have chemically induced functional oocytes in Caenorhabditis elegans adults that otherwise produced only sperm. These findings suggest that chemical approaches to therapeutic cell reprogramming may be feasible and provide a powerful platform for analyzing molecular mechanisms of in vivo cell reprogramming.	[Morgan, Clinton T.; Kimble, Judith] Univ Wisconsin, Med Scientist Training Program, Madison, WI 53706 USA; [Morgan, Clinton T.; Kimble, Judith] Univ Wisconsin, Integrated Program Biochem, Madison, WI USA; [Lee, Myon-Hee; Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Med Scientist Training Program, Madison, WI 53706 USA.	jekimble@wisc.edu	Morgan, Clinton/AAM-7410-2021	Lee, Myon Hee/0000-0001-9020-2391	US National Institutes of Health [RO1 GM069454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454, T32GM008692] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ward (University of Arizona) and B. Grant (Rutgers University) for providing reagents. We are grateful to L. Vanderploeg, A. Steinberg and A. HelsleyMarchbanks for help preparing the figures and manuscript. We thank the Kimble lab members for helpful discussions. This work was supported by US National Institutes of Health grant RO1 GM069454. J. K. is an investigator with the Howard Hughes Medical Institute.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bachorik JL, 2005, P NATL ACAD SCI USA, V102, P10893, DOI 10.1073/pnas.0504593102; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; BARTON MK, 1987, GENETICS, V115, P107; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; CASTAIGNE S, 1990, BLOOD, V76, P1704; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Ellis R, 2006, WORMBOOK, DOI [10.1895/wormbook.1.82.1, DOI 10.1895/WORMBOOK.1.82.1]; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hajnal A, 2002, EMBO J, V21, P4317, DOI 10.1093/emboj/cdf430; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Riddle D. L, 1997, C ELEGANS, P47; Subramaniam K, 2003, CURR BIOL, V13, P134, DOI 10.1016/S0960-9822(03)00005-8; Sundaram Meera V, 2006, WormBook, P1; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	29	35	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					102	104		10.1038/NCHEMBIO.282	http://dx.doi.org/10.1038/NCHEMBIO.282			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081824	Green Accepted			2022-12-25	WOS:000273651700008
J	Asokan, A; Conway, JC; Phillips, JL; Li, CW; Hegge, J; Sinnott, R; Yadav, S; DiPrimio, N; Nam, HJ; Agbandje-McKenna, M; McPhee, S; Wolff, J; Samulski, RJ				Asokan, Aravind; Conway, Julia C.; Phillips, Jana L.; Li, Chengwen; Hegge, Julia; Sinnott, Rebecca; Yadav, Swati; DiPrimio, Nina; Nam, Hyun-Joo; Agbandje-McKenna, Mavis; McPhee, Scott; Wolff, Jon; Samulski, R. Jude			Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle	NATURE BIOTECHNOLOGY			English	Article							VIRAL VECTORS; AAV VECTORS; HEPARIN-BINDING; EXPRESSION; SEROTYPES; IDENTIFICATION; THERAPY; TROPISM; TISSUE; TYPE-2	Reengineering the receptor footprints of adeno-associated virus (AAV) isolates may yield variants with improved properties for clinical applications. We generated a panel of synthetic AAV2 vectors by replacing a hexapeptide sequence in a previously identified heparan sulfate receptor footprint with corresponding residues from other AAV strains. This approach yielded several chimeric capsids displaying systemic tropism after intravenous administration in mice. Of particular interest, an AAV2/AAV8 chimera designated AAV2i8 displayed an altered antigenic profile, readily traversed the blood vasculature, and selectively transduced cardiac and whole-body skeletal muscle tissues with high efficiency. Unlike other AAV serotypes, which are preferentially sequestered in the liver, AAV2i8 showed markedly reduced hepatic tropism. These features of AAV2i8 suggest that it is well suited to translational studies in gene therapy of musculoskeletal disorders.	[Asokan, Aravind; Conway, Julia C.; Phillips, Jana L.; Li, Chengwen; Sinnott, Rebecca; Yadav, Swati; DiPrimio, Nina; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA; [Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Nam, Hyun-Joo; Agbandje-McKenna, Mavis] Univ Florida, Macromol Struct Grp, Gainesville, FL USA; [Hegge, Julia; Wolff, Jon] Mirus Bio Corp, Madison, WI USA; [McPhee, Scott] Asklepios Biopharmaceut Inc, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA.	aravind_asokan@med.unc.edu		(Sinnott) DeVaux, Rebecca/0000-0002-8793-1099	American Heart Association [0735637N]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR055712]; National Institute of Allergy and Infectious Diseases [R01AI072176]; National Heart, Lung, and Blood Institute [R01HL089221]; Senator Paul Wellstone Center for Muscular Dystrophy [U54AR056953]; National Institute of General Medical Sciences [R01GM082946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR056953, R21AR055712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Senator Paul Wellstone Center for Muscular Dystrophy; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the American Heart Association (A. A.; no. 0735637N); National Institute of Arthritis and Musculoskeletal and Skin Diseases (A. A. & R.J.S.; R21AR055712); National Institute of Allergy and Infectious Diseases (R.J.S. and A. A.; R01AI072176); National Heart, Lung, and Blood Institute (A. A.; R01HL089221); Senator Paul Wellstone Center for Muscular Dystrophy (R.J.S.; U54AR056953); National Institute of General Medical Sciences (M. A.-M.; R01GM082946); and Asklepios Biopharmaceutical for research support. We would also like to MirusBio Corp. for assistance with isolated limb perfusion studies.	Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Levy HC, 2009, J STRUCT BIOL, V165, P146, DOI 10.1016/j.jsb.2008.12.002; Muller OJ, 2006, CARDIOVASC RES, V70, P70, DOI 10.1016/j.cardiores.2005.12.017; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Raake PW, 2008, GENE THER, V15, P12, DOI 10.1038/sj.gt.3303035; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	21	171	192	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					79	U107		10.1038/nbt.1599	http://dx.doi.org/10.1038/nbt.1599			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20037580	Green Published, Green Accepted			2022-12-25	WOS:000273430400024
J	Kwakkenbos, MJ; Diehl, SA; Yasuda, E; Bakker, AQ; van Geelen, CMM; Lukens, MV; van Bleek, GM; Widjojoatmodjo, MN; Bogers, WMJM; Mei, H; Radbruch, A; Scheeren, FA; Spits, H; Beaumont, T				Kwakkenbos, Mark J.; Diehl, Sean A.; Yasuda, Etsuko; Bakker, Arjen Q.; van Geelen, Caroline M. M.; Lukens, Michael V.; van Bleek, Grada M.; Widjojoatmodjo, Myra N.; Bogers, Willy M. J. M.; Mei, Henrik; Radbruch, Andreas; Scheeren, Ferenc A.; Spits, Hergen; Beaumont, Tim			Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming	NATURE MEDICINE			English	Article							CLASS-SWITCH RECOMBINATION; SYNCYTIAL VIRUS-INFECTION; GERMINAL CENTER FORMATION; SECRETING PLASMA-CELLS; EPSTEIN-BARR-VIRUS; SOMATIC HYPERMUTATION; EXPRESSION; DIFFERENTIATION; BCL6; IL-21	The B cell lymphoma-6 (Bcl-6) and Bcl-xL proteins are expressed in germinal center B cells and enable them to endure the proliferative and mutagenic environment of the germinal center. By introducing these genes into peripheral blood memory B cells and culturing these cells with two factors produced by follicular helper T cells, CD40 ligand (CD40L) and interleukin-21 (IL-21), we convert them to highly proliferating, cell surface B cell receptor (BCR)-positive, immunoglobulin-secreting B cells with features of germinal center B cells, including expression of activation-induced cytidine deaminase (AID). We generated cloned lines of B cells specific for respiratory syncytial virus and used these cells as a source of antibodies that effectively neutralized this virus in vivo. This method provides a new tool to study B cell biology and signal transduction through antigen-specific B cell receptors and for the rapid generation of high-affinity human monoclonal antibodies. (C) 2010 Nature America, Inc. All rights reserved.	[Kwakkenbos, Mark J.; Yasuda, Etsuko; Bakker, Arjen Q.; van Geelen, Caroline M. M.; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Kwakkenbos, Mark J.; Diehl, Sean A.; Yasuda, Etsuko; Bakker, Arjen Q.; van Geelen, Caroline M. M.; Scheeren, Ferenc A.; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Lukens, Michael V.; van Bleek, Grada M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Widjojoatmodjo, Myra N.] Netherlands Vaccine Inst, Bilthoven, Netherlands; [Bogers, Willy M. J. M.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Mei, Henrik; Radbruch, Andreas] German Rheumatism Res Ctr, Berlin, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Deutsches Rheuma-Forschungszentrum (DRFZ)	Beaumont, T (corresponding author), Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	tbeaumont@aimmtherapeutics.com	Spits, Hergen/N-2581-2019; Diehl, Sean/C-7166-2008; Diehl, Sean/AAE-2779-2020	Spits, Hergen/0000-0003-3269-8338; Diehl, Sean/0000-0001-9700-235X; Diehl, Sean/0000-0001-9700-235X; Radbruch, Andreas/0000-0001-5753-0000; Kwakkenbos, Mark/0000-0003-0340-5655; Scheeren, Ferenc/0000-0002-8304-9023	US National Institutes of Health-National Institute of Allergy and Infectious Diseases [F32AI063846]; Wilhelmina Research Fund [OZF-02-004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063846] Funding Source: NIH RePORTER	US National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wilhelmina Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Hooijbrink for his excellent help with FACS sorting and maintenance of the flow cytometry facility, J. Boes for her excellent work on virus titrations at the Netherlands Vaccine Institute and R. Molenkamp and D. Pajkrt of the Department of Clinical Virology of the Academic Medical Center for helpful discussions. Human cDNA encoding Bcl-xL was kindly provided by S. Korsmeyer (Howard Hughes Medical Institute, Harvard Medical School). Id-3 was a gift from C. Murre (University of California, San Diego). CD40L-L cells were from J. Banchereau (Baylor University). S. A. D. is supported by US National Institutes of Health-National Institute of Allergy and Infectious Diseases grant F32AI063846. M. V. L. is supported by grant OZF-02-004 from the Wilhelmina Research Fund.	BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; DEINHARDT F, 1974, CANCER RES, V34, P1241; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Heemskerk MHM, 1999, CELL IMMUNOL, V195, P10, DOI 10.1006/cimm.1999.1520; Jaleco AC, 1999, BLOOD, V94, P2637, DOI 10.1182/blood.V94.8.2637.420k22_2637_2646; Johnson S, 1999, J INFECT DIS, V180, P35, DOI 10.1086/314846; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Prince GA, 1999, LAB INVEST, V79, P1385; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sidwell RW, 2006, ANTIVIR RES, V71, P379, DOI 10.1016/j.antiviral.2006.05.014; Smit LA, 2003, CANCER RES, V63, P3894; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Zwick MB, 2008, NAT BIOTECHNOL, V26, P886, DOI 10.1038/nbt0808-886	34	205	251	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					123	U164		10.1038/nm.2071	http://dx.doi.org/10.1038/nm.2071			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20023635	Green Accepted			2022-12-25	WOS:000273395500046
J	Gao, C; Cao, WP; Bao, L; Zuo, W; Xie, GM; Cai, TT; Fu, W; Zhang, J; Wu, W; Zhang, X; Chen, YG				Gao, Chan; Cao, Weipeng; Bao, Lan; Zuo, Wei; Xie, Guoming; Cai, Tiantian; Fu, Wei; Zhang, Jian; Wu, Wei; Zhang, Xu; Chen, Ye-Guang			Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PROTEIN; REQUIRES DIRECT BINDING; CATENIN PATHWAY; BETA-CATENIN; UBIQUITINATION; GENE; TUMORIGENESIS; LIGASE; INHIBITION; ACTIVATION	In eukaryotic cells, autophagy is a highly conserved self-digestion process to promote cell survival in response to nutrient starvation and other metabolic stresses. Autophagy is regulated by cell signalling such as the mTOR (mammalian target of rapamycin) pathway. However, the significance of autophagy in modulation of signal transduction is unclear. Here we show that autophagy negatively regulates Wnt signalling by promoting Dishevelled (Dvl) degradation. Von Hippel-Lindau protein-mediated ubiquitylation is critical for the binding of Dvl2 to p62, which in turn facilitates the aggregation and the LC3-mediated autophagosome recruitment of Dvl2 under starvation; the ubiquitylated Dvl2 aggregates are ultimately degraded through the autophagy-lysosome pathway. Moreover, a reverse correlation between Dvl expression and autophagy is observed in late stages of colon cancer development, indicating that autophagy may contribute to the aberrant activation of Wnt signalling in tumour formation.	[Gao, Chan; Cao, Weipeng; Zuo, Wei; Xie, Guoming; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Gao, Chan; Cao, Weipeng; Zuo, Wei; Xie, Guoming; Cai, Tiantian; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Bao, Lan; Zhang, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Wei] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100191, Peoples R China; [Zhang, Jian] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	高, 雨莉/HGU-8187-2022; Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401, 2010CB833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	We thank Terje Johansen for p62 constructs, Long Yu for human LC3 construct, Noboru Mizushima for Atg5<SUP>-/-</SUP> MEFs, Masaaki Komatsu for Atg7<SUP>-/-</SUP> MEFs, and Li Yu, Rod Nusse, Daniel J. Klionsky, Juan Liang and Zhao Chen for suggestions. This work was supported by grants from the National Natural Science Foundation of China (30930050 and 30921004) and the 973 Program (2006CB943401 and 2010CB833706) to Y.-G.C.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	57	292	305	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					781	+		10.1038/ncb2082	http://dx.doi.org/10.1038/ncb2082			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639871				2022-12-25	WOS:000280561600010
J	Noble, SM; French, S; Kohn, LA; Chen, V; Johnson, AD				Noble, Suzanne M.; French, Sarah; Kohn, Lisa A.; Chen, Victoria; Johnson, Alexander D.			Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity	NATURE GENETICS			English	Article							SIGNATURE-TAGGED MUTAGENESIS; SELECTABLE MARKER URA3; LARGE-SCALE; GENE IDENTIFICATION; FILAMENTOUS GROWTH; HYPHAL FORMATION; UNITED-STATES; VIRULENCE; MUTANTS; STRAINS	Candida albicans is the most common cause of serious fungal disease in humans. Creation of isogenic null mutants of this diploid organism, which requires sequential gene targeting, allows dissection of virulence mechanisms. Published analyses of such mutants show a near-perfect correlation between C. albicans pathogenicity and the ability to undergo a yeast-to-hypha morphological switch in vitro. However, most studies have used mutants constructed with a marker that is itself a virulence determinant and therefore complicates their interpretation. Using alternative markers, we created similar to 3,000 homozygous deletion strains affecting 674 genes, or roughly 11% of the C. albicans genome. Screening for infectivity in a mouse model and for morphological switching and cell proliferation in vitro, we identified 115 infectivity-attenuated mutants, of which nearly half demonstrated normal morphological switching and proliferation. Analysis of such mutants revealed that virulence requires the glycolipid glucosylceramide. To our knowledge, this is the first C. albicans small molecule that has been found to be required specifically for virulence.	[Noble, Suzanne M.; Kohn, Lisa A.; Chen, Victoria; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Noble, Suzanne M.; French, Sarah] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Noble, SM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	suzanne.noble@ucsf.edu		Noble, Suzanne/0000-0001-9855-8448	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI062800] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K08 AI062800-02, K08 AI062800-01, K08 AI062800-03, K08 AI062800] Funding Source: Medline; PHS HHS [R01 A149187] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; Arguelles JC, 1999, RES MICROBIOL, V150, P521, DOI 10.1016/S0923-2508(99)00105-9; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Badrane H, 2008, MICROBIOL-SGM, V154, P3296, DOI 10.1099/mic.0.2008/018002-0; Bastidas RJ, 2009, P NATL ACAD SCI USA, V106, P351, DOI 10.1073/pnas.0811994106; Bouchonville K, 2009, EUKARYOT CELL, V8, P1554, DOI 10.1128/EC.00209-09; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Elson SL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000664; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Huh WK, 2001, INFECT IMMUN, V69, P3939, DOI 10.1128/IAI.69.6.3939-3946.2001; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Mecsas J, 2002, CURR OPIN MICROBIOL, V5, P33, DOI 10.1016/S1369-5274(02)00282-5; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Sharkey LL, 2005, MICROBIOL-SGM, V151, P1061, DOI 10.1099/mic.0.27487-0; Shea JE, 2000, CURR OPIN MICROBIOL, V3, P451, DOI 10.1016/S1369-5274(00)00120-X; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wu W, 2007, MOL MICROBIOL, V64, P1587, DOI 10.1111/j.1365-2958.2007.05759.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998	51	472	488	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2010	42	7					590	U166		10.1038/ng.605	http://dx.doi.org/10.1038/ng.605			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20543849	Green Accepted			2022-12-25	WOS:000279242400011
J	Fan, ZG; Spencer, JA; Lu, Y; Pitsillides, CM; Singh, G; Kim, P; Yun, SH; Toxavidis, V; Strom, TB; Lin, CP; Koulmanda, M				Fan, Zhigang; Spencer, Joel A.; Lu, Yan; Pitsillides, Costas M.; Singh, Gurbakhshish; Kim, Pilhan; Yun, Seok H.; Toxavidis, Vasilis; Strom, Terry B.; Lin, Charles P.; Koulmanda, Maria			In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response	NATURE MEDICINE			English	Article							TRANSPLANTATION TOLERANCE; INDUCTION; REJECTION; GENERATION; AUTOIMMUNE; APOPTOSIS; BALANCE; FOXP3	Here we present methods to longitudinally track islet allograft-infiltrating T cells in live mice by endoscopic confocal microscopy and to analyze circulating T cells by in vivo flow cytometry. We developed a new reporter mouse whose T cell subsets express distinct, 'color-coded' proteins enabling in vivo detection and identification of effector T cells (T(eff) cells) and discrimination between natural and induced regulatory T cells (nT(reg) and iT(reg) cells). Using these tools, we observed marked differences in the T cell response in recipients receiving tolerance-inducing therapy (CD154-specific monoclonal antibody plus rapamycin) compared to untreated controls. These results establish real-time cell tracking as a powerful means to probe the dynamic cellular interplay mediating immunologic rejection or transplant tolerance.	[Fan, Zhigang; Lu, Yan; Singh, Gurbakhshish; Toxavidis, Vasilis; Strom, Terry B.; Koulmanda, Maria] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med, Boston, MA 02215 USA; [Spencer, Joel A.; Pitsillides, Costas M.; Lin, Charles P.] Harvard Univ, Sch Med, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02215 USA; [Spencer, Joel A.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA; [Pitsillides, Costas M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Kim, Pilhan; Yun, Seok H.] Harvard Univ, Sch Med,Adv Microscopy Program, Massachusetts Gen Hosp, Wellman Ctr Photomed,Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Strom, TB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med, Boston, MA 02215 USA.	tstrom@bidmc.harvard.edu; lin@helix.mgh.harvard.edu	Spencer, Joel/A-4590-2013; Strom, Terry B./E-9268-2010; Kim, Pilhan/C-1836-2011; Spencer, Joel/GLT-9687-2022	Strom, Terry B./0000-0002-7570-0736; Kim, Pilhan/0000-0001-8388-1840; Spencer, Joel/0000-0002-4013-8763	US National Institutes of Health [R21 AI081010, R01 EY14106, P01-AI041521, P01-AI041521-S1]; Juvenile Diabetes Research Foundation (JDRF) [7-2005-1329]; NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, R21AI081010] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the US National Institutes of Health (R21 AI081010 to S.H.Y. and R01 EY14106 to C.P.L. and P01-AI041521 and P01-AI041521-S1 to T.B.S.) and the Juvenile Diabetes Research Foundation (JDRF 7-2005-1329 to T.B.S. and M.K.).	Betti M, 2006, ANN ONCOL, V17, P235; Edinger M, 2003, METHODS, V31, P172, DOI 10.1016/S1046-2023(03)00127-0; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Medarova Z, 2008, MAGN RESON MED, V59, P712, DOI 10.1002/mrm.21494; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Strom TB, 2004, J CLIN INVEST, V113, P1681, DOI 10.1172/JCI200422153; Strom TB, 1996, CURR OPIN IMMUNOL, V8, P688, DOI 10.1016/S0952-7915(96)80087-2; Toso C, 2006, TRANSPL P, V38, P3033, DOI 10.1016/j.transproceed.2006.08.135; Tran HM, 1997, J IMMUNOL, V159, P2232; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zheng XX, 2003, IMMUNOL REV, V196, P75, DOI 10.1046/j.1600-065X.2003.00089.x; Zhong XM, 2007, EUR J IMMUNOL, V37, P2400, DOI 10.1002/eji.200737296	29	119	124	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					718	U125		10.1038/nm.2155	http://dx.doi.org/10.1038/nm.2155			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495571	Green Accepted			2022-12-25	WOS:000278394200040
J	Balestrini, A; Cosentino, C; Errico, A; Garner, E; Costanzo, V				Balestrini, Alessia; Cosentino, Claudia; Errico, Alessia; Garner, Elizabeth; Costanzo, Vincenzo			GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication	NATURE CELL BIOLOGY			English	Article							POLYMERASE-ALPHA; XENOPUS; INITIATION; CHROMATIN; PHOSPHORYLATION; ORIGINS; GEMININ; BINDING; CDC45; SLD3	Many of the factors required for chromosomal DNA replication have been identified in unicellular eukaryotes. However, DNA replication is poorly understood in multicellular organisms. Here, we report the identification of GEMC1 (geminin coiled-coil containing protein 1), a novel vertebrate protein required for chromosomal DNA replication. GEMC1 is highly conserved in vertebrates and is preferentially expressed in proliferating cells. Using Xenopus laevis egg extract we show that Xenopus GEMC1 (xGEMC1) binds to the checkpoint and replication factor TopBP1, which promotes binding of xGEMC1 to chromatin during pre-replication complex (pre-RC) formation. We demonstrate that xGEMC1 interacts directly with replication factors such as Cdc45 and the kinase Cdk2-CyclinE, through which it is heavily phosphorylated. Phosphorylated xGEMC1 stimulates initiation of DNA replication, whereas depletion of xGEMC1 prevents the onset of DNA replication owing to the impairment of Cdc45 loading onto chromatin. Similarly, downregulation of GEMC1 expression prevents DNA replication in embryonic and somatic vertebrate cells. These data suggest that GEMC1 promotes initiation of chromosomal DNA replication in multicellular organisms by mediating TopBP1- and Cdk2-dependent recruitment of Cdc45 onto replication origins.	[Errico, Alessia; Costanzo, Vincenzo] London Res Inst, Cell Cycle Labs, S Mimms EN6 3LD, Herts, England		Costanzo, V (corresponding author), London Res Inst, Cell Cycle Labs, S Mimms EN6 3LD, Herts, England.	vincenzo.costanzo@cancer.org.uk	Cosentino, Claudia/AAF-1100-2019	Costanzo, Vincenzo/0000-0002-2920-9508	Cancer Research UK; Lister Institute of Preventive Medicine; European Research Council (ERC) [N. 206281]; EMBO	Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO))	We thank T. Hunt, members of Clare Hall Laboratories and members of the Genome Stability Unit for their comments, H. Mahbubani and J. Kirk for technical support with X. laevis, J. Gannon for technical assistance in antibody production and M. Wu for embryo injection. This work was supported by grants from Cancer Research UK. V. C. is also supported by the Lister Institute of Preventive Medicine, the European Research Council (ERC) start-up grant (N. 206281) and the EMBO Young Investigator Program (YIP).	BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Costanzo V, 2004, METH MOL B, V241, P255; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; KUBOTA Y, 1993, J CELL BIOL, V123, P1321, DOI 10.1083/jcb.123.6.1321; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SLACK J, 1984, NATURE, V311, P107, DOI 10.1038/311107a0; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	36	78	80	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					484	U156		10.1038/ncb2050	http://dx.doi.org/10.1038/ncb2050			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383140	Green Accepted			2022-12-25	WOS:000277283700014
J	Marlow, MS; Dogan, J; Frederick, KK; Valentine, KG; Wand, AJ				Marlow, Michael S.; Dogan, Jakob; Frederick, Kendra K.; Valentine, Kathleen G.; Wand, A. Joshua			The role of conformational entropy in molecular recognition by calmodulin	NATURE CHEMICAL BIOLOGY			English	Article							SIDE-CHAIN DYNAMICS; TARGET RECOGNITION; INTERNAL DYNAMICS; STRUCTURAL BASIS; SPIN RELAXATION; NMR RELAXATION; BINDING; PROTEINS; COMPLEX; MODEL	The physical basis for high-affinity interactions involving proteins is complex and potentially involves a range of energetic contributions. Among these are changes in protein conformational entropy, which cannot yet be reliably computed from molecular structures. We have recently used changes in conformational dynamics as a proxy for changes in conformational entropy of calmodulin upon association with domains from regulated proteins. The apparent change in conformational entropy was linearly related to the overall binding entropy. This view warrants a more quantitative foundation. Here we calibrate an 'entropy meter' using an experimental dynamical proxy based on NMR relaxation and show that changes in the conformational entropy of calmodulin are a significant component of the energetics of binding. Furthermore, the distribution of motion at the interface between the target domain and calmodulin is surprisingly noncomplementary. These observations promote modification of our understanding of the energetics of protein-ligand interactions.	[Marlow, Michael S.; Dogan, Jakob; Frederick, Kendra K.; Valentine, Kathleen G.; Wand, A. Joshua] Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Marlow, Michael S.; Dogan, Jakob; Frederick, Kendra K.; Valentine, Kathleen G.; Wand, A. Joshua] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu		Frederick, Kendra/0000-0002-1656-5167	US National Institutes of Health [DK 39806, GM 08275]; Wenner-Gren Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Bedard, A. Seitz and J. K. Kranz of the University of Pennsylvania for preparation of isotopically labeled smMLCK(p) peptide. We thank K. Sharp for helpful discussion. Financial support was provided by the US National Institutes of Health (DK 39806). K. K. F. acknowledges financial support from the US National Institutes of Health (GM 08275). J. D. acknowledges financial support from the Wenner-Gren Foundations.	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balog E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028103; BROMBERG S, 1994, PROTEIN SCI, V3, P997, DOI 10.1002/pro.5560030702; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chatfield DC, 1998, J AM CHEM SOC, V120, P5301, DOI 10.1021/ja972215n; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DAquino JA, 1996, PROTEINS, V25, P143, DOI 10.1002/prot.1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELLWO MJ, 1989, J AM CHEM SOC, V111, P4571, DOI 10.1021/ja00195a007; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EHRHARDT MR, 1995, BIOCHEMISTRY-US, V34, P2731, DOI 10.1021/bi00009a001; Frederick KK, 2008, J PHYS CHEM B, V112, P12095, DOI 10.1021/jp8038576; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Homans SW, 2007, DRUG DISCOV TODAY, V12, P534, DOI 10.1016/j.drudis.2007.05.004; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Igumenova TI, 2005, BIOCHEMISTRY-US, V44, P12627, DOI 10.1021/bi050832f; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Frederick KK, 2006, BIOCHEMISTRY-US, V45, P9841, DOI 10.1021/bi060865a; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lee AL, 2002, BIOCHEMISTRY-US, V41, P13814, DOI 10.1021/bi026380d; Li DW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118108; Li DW, 2009, J AM CHEM SOC, V131, P7226, DOI 10.1021/ja902477s; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Marcus Y, 2006, BIOPHYS CHEM, V124, P200, DOI 10.1016/j.bpc.2006.04.013; Marlow MS, 2006, BIOCHEMISTRY-US, V45, P8732, DOI 10.1021/bi060420m; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Prabhu NV, 2003, BIOCHEMISTRY-US, V42, P562, DOI 10.1021/bi026544q; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Skrynnikov NR, 2001, J AM CHEM SOC, V123, P4556, DOI 10.1021/ja004179p; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a	50	210	210	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					352	358		10.1038/nchembio.347	http://dx.doi.org/10.1038/nchembio.347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20383153	Green Accepted			2022-12-25	WOS:000276823200014
J	Radstake, TRDJ; Gorlova, O; Rueda, B; Martin, JE; Alizadeh, BZ; Palomino-Morales, R; Coenen, MJ; Vonk, MC; Voskuyl, AE; Schuerwegh, AJ; Broen, JC; van Riel, PLCM; van't Slot, R; Italiaander, A; Ophoff, RA; Riemekasten, G; Hunzelmann, N; Simeon, CP; Ortego-Centeno, N; Gonzalez-Gay, MA; Gonzalez-Escribano, MF; Airo, P; van Laar, J; Herrick, A; Worthington, J; Hesselstrand, R; Smith, V; de Keyser, F; Houssiau, F; Chee, MM; Madhok, R; Shiels, P; Westhovens, R; Kreuter, A; Kiener, H; de Baere, E; Witte, T; Padykov, L; Klareskog, L; Beretta, L; Scorza, R; Lie, BA; Hoffmann-Vold, AM; Carreira, P; Varga, J; Hinchcliff, M; Gregersen, PK; Lee, AT; Ying, J; Han, Y; Weng, SF; Amos, CI; Wigley, FM; Hummers, L; Nelson, JL; Agarwal, SK; Assassi, S; Gourh, P; Tan, FK; Koeleman, BPC; Arnett, FC; Martin, J; Mayes, MD				Radstake, Timothy R. D. J.; Gorlova, Olga; Rueda, Blanca; Martin, Jose-Ezequiel; Alizadeh, Behrooz Z.; Palomino-Morales, Rogelio; Coenen, Marieke J.; Vonk, Madelon C.; Voskuyl, Alexandre E.; Schuerwegh, Annemie J.; Broen, Jasper C.; van Riel, Piet L. C. M.; van't Slot, Ruben; Italiaander, Annet; Ophoff, Roel A.; Riemekasten, Gabriela; Hunzelmann, Nico; Simeon, Carmen P.; Ortego-Centeno, Norberto; Gonzalez-Gay, Miguel A.; Gonzalez-Escribano, Maria F.; Airo, Paolo; van Laar, Jaap; Herrick, Ariane; Worthington, Jane; Hesselstrand, Roger; Smith, Vanessa; de Keyser, Filip; Houssiau, Fredric; Chee, Meng May; Madhok, Rajan; Shiels, Paul; Westhovens, Rene; Kreuter, Alexander; Kiener, Hans; de Baere, Elfride; Witte, Torsten; Padykov, Leonid; Klareskog, Lars; Beretta, Lorenzo; Scorza, Rafaella; Lie, Benedicte A.; Hoffmann-Vold, Anna-Maria; Carreira, Patricia; Varga, John; Hinchcliff, Monique; Gregersen, Peter K.; Lee, Annette T.; Ying, Jun; Han, Younghun; Weng, Shih-Feng; Amos, Christopher I.; Wigley, Fredrick M.; Hummers, Laura; Nelson, J. Lee; Agarwal, Sandeep K.; Assassi, Shervin; Gourh, Pravitt; Tan, Filemon K.; Koeleman, Bobby P. C.; Arnett, Frank C.; Martin, Javier; Mayes, Maureen D.		Spanish Scleroderma Grp	Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus	NATURE GENETICS			English	Article							CD4 T-CELLS; LUPUS-ERYTHEMATOSUS; FUNCTIONAL POLYMORPHISM; JAPANESE POPULATION; CD3-ZETA EXPRESSION; COMPLEX; RISK; SCLERODERMA; MECHANISMS; PHENOTYPE	Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs that leads to profound disability and premature death. To identify new SSc susceptibility loci, we conducted the first genome-wide association study in a population of European ancestry including a total of 2,296 individuals with SSc and 5,171 controls. Analysis of 279,621 autosomal SNPs followed by replication testing in an independent case-control set of European ancestry (2,753 individuals with SSc (cases) and 4,569 controls) identified a new susceptibility locus for systemic sclerosis at CD247 (1q22-23, rs2056626, P = 2.09 x 10(-7) in the discovery samples, P = 3.39 x 10(-9) in the combined analysis). Additionally, we confirm and firmly establish the role of the MHC (P = 2.31 x 10(-18)), IRF5 (P = 1.86 x 10(-13)) and STAT4 (P = 3.37 x 10(-9)) gene regions as SSc genetic risk factors.	[Radstake, Timothy R. D. J.; Vonk, Madelon C.; Broen, Jasper C.; van Riel, Piet L. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Gorlova, Olga; Ying, Jun; Han, Younghun; Weng, Shih-Feng; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Rueda, Blanca; Martin, Jose-Ezequiel; Palomino-Morales, Rogelio; Arnett, Frank C.; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Alizadeh, Behrooz Z.; van't Slot, Ruben; Italiaander, Annet; Ophoff, Roel A.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Coenen, Marieke J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Voskuyl, Alexandre E.] Vrije Univ VU Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; [Schuerwegh, Annemie J.] Leiden Univ, Dept Rheumatol, Nijmegen, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Riemekasten, Gabriela] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Hunzelmann, Nico] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany; [Simeon, Carmen P.] Hosp Valle de Hebron, Med Interna Serv, Barcelona, Spain; [Ortego-Centeno, Norberto] Hosp Clin Univ, Med Interna Serv, Granada, Spain; [Gonzalez-Gay, Miguel A.; Carreira, Patricia] Hosp Marques de Valdecilla, Serv Reumatol, Santander, Spain; [Gonzalez-Escribano, Maria F.] Hosp Virgen del Rocio, Serv Inmunol, Seville, Spain; [Airo, Paolo] Univ Brescia, Brescia, Italy; [van Laar, Jaap] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Herrick, Ariane; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Dept Rheumatol & Epidemiol, Manchester, Lancs, England; [Hesselstrand, Roger] Lund Univ, Lund, Sweden; [Houssiau, Fredric] Katholieke Univ Leuven, Leuven, Belgium; [Chee, Meng May; Madhok, Rajan; Shiels, Paul] Univ Glasgow, Glasgow, Lanark, Scotland; [Westhovens, Rene] Univ Antwerp, B-2020 Antwerp, Belgium; [Kreuter, Alexander] Ruhr Univ Bochum, Bochum, Germany; [Kiener, Hans] Univ Vienna, Vienna, Austria; [de Baere, Elfride] Univ Ghent, Dept Genet, B-9000 Ghent, Belgium; [Witte, Torsten] Leibniz Univ Hannover, Hannover, Germany; [Padykov, Leonid; Klareskog, Lars] Karolinska Inst, Stockholm, Sweden; [Beretta, Lorenzo; Scorza, Rafaella] Univ Milan, Milan, Italy; [Lie, Benedicte A.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway; [Hoffmann-Vold, Anna-Maria] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Carreira, Patricia] Hosp 12 Octubre, E-28041 Madrid, Spain; [Varga, John; Hinchcliff, Monique] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Gregersen, Peter K.; Lee, Annette T.] Feinstein Inst Med Res, Manhasset, NY USA; [Hummers, Laura] Johns Hopkins Univ, Med Ctr, Baltimore, MD 21218 USA; [Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Agarwal, Sandeep K.; Assassi, Shervin; Gourh, Pravitt; Tan, Filemon K.; Mayes, Maureen D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA	Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); Virgen del Rocio University Hospital; University of Brescia; Newcastle University - UK; University of Manchester; Lund University; KU Leuven; University of Glasgow; University of Antwerp; Ruhr University Bochum; University of Vienna; Ghent University; Leibniz University Hannover; Karolinska Institutet; University of Milan; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Hospital Universitario 12 de Octubre; Northwestern University; Feinberg School of Medicine; Northwell Health; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	tradstake73@gmail.com; maureen.d.mayes@uth.tmc.edu	Worthington, Jane/M-9770-2014; van Riel, P.L.C.M./H-8082-2014; Riemekasten, Gabriela/B-5019-2017; Witte, Torsten/B-5783-2016; De Baere, Elfride/E-7405-2017; Palomino-Morales, Rogelio J/L-5720-2014; Carreira, Patricia E/D-4429-2018; Martin, Javier/B-8141-2008; González-Escribano, María Francisca/X-5554-2019; Martín, Javier/AAV-5209-2021; Rueda-Medina, Blanca/F-3156-2019; Martín, María/HDL-9512-2022; Varga, John/AAK-6472-2021; Vonk, M.C./L-4726-2015; Centeno, Norberto Ortego/C-4793-2019; González-Gay, Miguel A./B-2306-2008; Martin, Jose-Ezequiel/A-6136-2011; Coenen, Marieke/A-2159-2010; Beretta, Lorenzo/AAB-8605-2019; Alizadeh, Behrooz Z Ziad/J-2921-2017; Padyukov, Leonid/A-4890-2009; Gourh, Pravitt/L-9478-2017; Martin, Jose Ezequiel/F-4869-2012	Worthington, Jane/0000-0003-0544-042X; De Baere, Elfride/0000-0002-5609-6895; Palomino-Morales, Rogelio J/0000-0003-3507-343X; Carreira, Patricia E/0000-0001-8279-3806; Martin, Javier/0000-0002-2202-0622; Rueda-Medina, Blanca/0000-0002-0263-7000; Vonk, M.C./0000-0002-2266-9907; Centeno, Norberto Ortego/0000-0003-2325-0937; González-Gay, Miguel A./0000-0002-7924-7406; Coenen, Marieke/0000-0001-8796-2031; Beretta, Lorenzo/0000-0002-6529-6258; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Kreuter, Alexander/0000-0003-2275-499X; Padyukov, Leonid/0000-0003-2950-5670; Weng, Shih-Feng/0000-0001-8684-3487; Herrick, Ariane/0000-0003-4941-7926; Hinchcliff, Monique/0000-0002-8652-9890; Shiels, Paul/0000-0002-7577-9843; Gourh, Pravitt/0000-0002-6488-1850; Hummers, Laura/0000-0002-4864-4011; Klareskog, Lars/0000-0001-9601-6186; Voskuyl, Alexandre/0000-0002-9699-1827; Martin, Jose Ezequiel/0000-0002-0051-8868	Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); Spanish Society of Rheumatology; Spanish Ministry of Science [SAF2009-11110]; Junta de Andaluc a, Spain [CTS-4977]; Instituto de Salud Carlos III (ISCIII) [RD08/0075]; Netherlands Organization for Health Research and Development [016.096.121]; Dutch Diabetes Research Foundation [2008.40.001]; Dutch Arthritis Foundation [NR 09-1-408]; US National Insitutes of Mental Health [R01 MH078075]; German Research Foundation; US National Institutes of Health; National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS) [R01 AR055258,]; Two-Stage Genome Wide Association Study in Systemic Sclerosis; NIH-NIAMS Center of Research Translation (CORT) [SSc (P50AR054144)]; NIH-NIAMS SSc Family Registry; DNA Repository [N01-AR-0-2251]; University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences [3UL1RR024148]; NIH-NIAMS K08 [K08AR054404]; SSc Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR002251, K08AR054404, P50AR054144, R01AR055258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER	Dutch Association of Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Arthritis Foundation (National Reumafonds); Spanish Society of Rheumatology; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andaluc a, Spain(Junta de Andalucia); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Diabetes Research Foundation; Dutch Arthritis Foundation; US National Insitutes of Mental Health; German Research Foundation(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Two-Stage Genome Wide Association Study in Systemic Sclerosis; NIH-NIAMS Center of Research Translation (CORT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIAMS SSc Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DNA Repository; University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences; NIH-NIAMS K08(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); SSc Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the following grants: T.R.D.J.R. was funded by the VIDI laureate from the Dutch Association of Research (NWO) and Dutch Arthritis Foundation (National Reumafonds). J.M. was funded by GEN-FER from the Spanish Society of Rheumatology, SAF2009-11110 from the Spanish Ministry of Science, CTS-4977 from Junta de Andaluc a, Spain and in part by Redes Tematicas de Investigacion Cooperativa Sanitaria Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), Spain (J.M.). R. B. is supported by the I3P Consejo Superior de Investigaciones Cientificas program funded by the 'Fondo Social Europeo'. B.Z.A. is supported by the Netherlands Organization for Health Research and Development (ZonMW grant 016.096.121). B. K. is supported by the Dutch Diabetes Research Foundation (grant 2008.40.001) and the Dutch Arthritis Foundation (Reumafonds, grant NR 09-1-408). Genotyping of the Dutch control samples was sponsored by US National Insitutes of Mental Health funding, R01 MH078075 (R.O.A.). The German controls were from the PopGen biobank (to B. K.). The PopGen project received infrastructure support through the German Research Foundation excellence cluster 'Inflammation at Interfaces'. The US analyses were supported by the US National Institutes of Health and National Institute of Arthritis and Musculoskeletal Diseases (NIH-NIAMS) R01 AR055258, Two-Stage Genome Wide Association Study in Systemic Sclerosis, (M. D. M.) and by the NIH-NIAMS Center of Research Translation (CORT) in SSc (P50AR054144) (F. C. A.), the NIH-NIAMS SSc Family Registry and DNA Repository (N01-AR-0-2251) (M. D. M.), University of Texas Health Science Center-Houston Center for Clinical and Translational Sciences (Houston Clinical and Translational Science Awards Program) (NIH-National Center for Research Resources 3UL1RR024148) (F. C. A.), NIH-NIAMS K08 Award (K08AR054404) (S. K. A.), SSc Foundation New Investigator Award (S. K. A.).	Agarwal SK, 2008, RHEUM DIS CLIN N AM, V34, P17, DOI 10.1016/j.rdc.2007.10.001; ARNETT FC, ANN RHEUM DIS; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gorman CL, 2008, J IMMUNOL, V180, P1060, DOI 10.4049/jimmunol.180.2.1060; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P1845, DOI 10.1002/art.24600; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Krishnan S, 2001, BLOOD, V97, P3851, DOI 10.1182/blood.V97.12.3851; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Tsuchiya N, 2009, ANN RHEUM DIS, V68, P1375, DOI 10.1136/ard.2009.111310; Warchol T, 2009, TISSUE ANTIGENS, V74, P68, DOI 10.1111/j.1399-0039.2009.01264.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	24	290	293	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2010	42	5					426	U71		10.1038/ng.565	http://dx.doi.org/10.1038/ng.565			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20383147	Green Accepted			2022-12-25	WOS:000277179500014
J	Ghosn, Z				Ghosn, Zeinab			Crackdown on pharmacies in Lebanon spurs blame game	NATURE MEDICINE			English	News Item																			0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					359	359		10.1038/nm0410-359a	http://dx.doi.org/10.1038/nm0410-359a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376022				2022-12-25	WOS:000276446800014
J	Ma, L; Reinhardt, F; Pan, E; Soutschek, J; Bhat, B; Marcusson, EG; Teruya-Feldstein, J; Bell, GW; Weinberg, RA				Ma, Li; Reinhardt, Ferenc; Pan, Elizabeth; Soutschek, Juergen; Bhat, Balkrishen; Marcusson, Eric G.; Teruya-Feldstein, Julie; Bell, George W.; Weinberg, Robert A.			Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model	NATURE BIOTECHNOLOGY			English	Article							CANCER METASTASIS; IN-VIVO; ADJUVANT CHEMOTHERAPY; MICRORNA; INVASION; TRASTUZUMAB; BEVACIZUMAB; SELECTION; GENES	MicroRNAs (miRNAs) are increasingly implicated in the regulation of metastasis. Despite their potential as targets for anti-metastatic therapy, miRNAs have only been silenced in normal tissues of rodents and nonhuman primates. Therefore, the development of effective approaches for sequence-specific inhibition of miRNAs in tumors remains a scientific and clinical challenge. Here we show that systemic treatment of tumor-bearing mice with miR-10b antagomirs-a class of chemically modified anti-miRNA oligonucleotide-suppresses breast cancer metastasis. Both in vitro and in vivo, silencing of miR-10b with antagomirs significantly decreases miR-10b levels and increases the levels of a functionally important miR-10b target, Hoxd10. Administration of miR-10b antagomirs to mice bearing highly metastatic cells does not reduce primary mammary tumor growth but markedly suppresses formation of lung metastases in a sequence-specific manner. The miR-10b antagomir, which is well tolerated by normal animals, appears to be a promising candidate for the development of new anti-metastasis agents.	[Ma, Li; Reinhardt, Ferenc; Pan, Elizabeth; Bell, George W.; Weinberg, Robert A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Ma, Li; Reinhardt, Ferenc; Pan, Elizabeth; Bell, George W.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA USA; [Ma, Li; Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA USA; [Soutschek, Juergen; Bhat, Balkrishen; Marcusson, Eric G.] Regulus Therapeut, Carlsbad, CA USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Isis Pharmaceuticals Inc; Memorial Sloan Kettering Cancer Center	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	weinberg@wi.mit.edu	Xie, Huangming/B-2260-2012; Ma, Li/GQR-1313-2022	Ma, Li/0000-0001-9965-989X; Marcusson, Eric/0000-0002-0504-8674	Life Sciences Research Foundation Fellowship; Margaret and Herman Sokol Award; National Institutes of Health (NIH) [K99/R00]; NATIONAL CANCER INSTITUTE [K99CA138572] Funding Source: NIH RePORTER	Life Sciences Research Foundation Fellowship; Margaret and Herman Sokol Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. L. Daige at Regulus for technical assistance, M. Ebert, P. Sharp and S. Valastyan for advice on miRNA sponge design, the Histology Core Labs at Massachusetts Institute of Technology (MIT) and Memorial Sloan-Kettering Cancer Center for assistance with histology, B. Bierie and other members of the Weinberg Lab for useful discussions. L. M. is a recipient of a Life Sciences Research Foundation Fellowship, a Margaret and Herman Sokol Award and a National Institutes of Health (NIH) Pathway to Independence Award (K99/R00). R. A. W. is an American Cancer Society Research Professor and a D. K. Ludwig Cancer Research Professor. This research is supported by an NIH grant to R. A. W. and the Ludwig Center for Molecular Oncology at MIT.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Huse JT, 2009, CELL CYCLE, V8, P3611, DOI 10.4161/cc.8.22.9893; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Talmadge JE, 2007, CANCER RES, V67, P11471, DOI 10.1158/0008-5472.CAN-07-2496; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	46	582	619	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					341	U67		10.1038/nbt.1618	http://dx.doi.org/10.1038/nbt.1618			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20351690	Green Accepted, Green Published			2022-12-25	WOS:000276462400021
J	Mills, AE; Tereskerz, PM				Mills, Ann E.; Tereskerz, Patti M.			Empirical analysis of major stem cell patent cases: the role of universities	NATURE BIOTECHNOLOGY			English	Editorial Material									[Mills, Ann E.; Tereskerz, Patti M.] Univ Virginia, Ctr Biomed Ethics & Humanities, Program Eth & Policy Hlth Syst, Charlottesville, VA 22903 USA	University of Virginia	Mills, AE (corresponding author), Univ Virginia, Ctr Biomed Ethics & Humanities, Program Eth & Policy Hlth Syst, Charlottesville, VA 22903 USA.	amh2r@virginia.edu						Allison JR, 2004, GEORGETOWN LAW J, V92, P435; [Anonymous], U.S. Patent, Patent No. [5,352,605, 5352605]; Azher AI, 2004, U PA J INT ECON LAW, V25, P383; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Federal Trade Commission, 2003, PROM INN PROP BAL CO; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Merrill S. A., 2004, PATENT SYSTEM 21 CEN; Merrill Stephen A., 2006, REAP BEN GEN PROT RE; Obama Barack, 2009, REMOVING BARRIERS RE; Parchomovsky G, 2005, U PENN LAW REV, V154, P1, DOI 10.2307/25047582; WALSH JP, 2003, PATENTS KNOWLEDGE BA, P285, DOI DOI 10.1017/CBO9780511493232.010; 4940835	12	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					325	329		10.1038/nbt0410-325	http://dx.doi.org/10.1038/nbt0410-325			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	580PW	20379173	Bronze			2022-12-25	WOS:000276462400016
J	Barouch, DH; O'Brien, KL; Simmons, NL; King, SL; Abbink, P; Maxfield, LF; Sun, YH; La Porte, A; Riggs, AM; Lynch, DM; Clark, SL; Backus, K; Perry, JR; Seaman, MS; Carville, A; Mansfield, KG; Szinger, JJ; Fischer, W; Muldoon, M; Korber, B				Barouch, Dan H.; O'Brien, Kara L.; Simmons, Nathaniel L.; King, Sharon L.; Abbink, Peter; Maxfield, Lori F.; Sun, Ying-Hua; La Porte, Annalena; Riggs, Ambryice M.; Lynch, Diana M.; Clark, Sarah L.; Backus, Katherine; Perry, James R.; Seaman, Michael S.; Carville, Angela; Mansfield, Keith G.; Szinger, James J.; Fischer, Will; Muldoon, Mark; Korber, Bette			Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOGENICITY; REPLICATION; VARIANTS; VECTORS; STEP	The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine development(1,2). Antigens derived from natural HIV-1 sequences have elicited only a limited breadth of cellular immune responses in nonhuman primate studies and clinical trials to date. Polyvalent 'mosaic' antigens, in contrast, are designed to optimize cellular immunologic coverage of global HIV-1 sequence diversity(3). Here we show that mosaic HIV-1 Gag, Pol and Env antigens expressed by recombinant, replication-incompetent adenovirus serotype 26 vectors markedly augmented both the breadth and depth without compromising the magnitude of antigen-specific T lymphocyte responses as compared with consensus or natural sequence HIV-1 antigens in rhesus monkeys. Polyvalent mosaic antigens therefore represent a promising strategy to expand cellular immunologic vaccine coverage for genetically diverse pathogens such as HIV-1.	[Barouch, Dan H.; O'Brien, Kara L.; Simmons, Nathaniel L.; King, Sharon L.; Abbink, Peter; Maxfield, Lori F.; Sun, Ying-Hua; La Porte, Annalena; Riggs, Ambryice M.; Lynch, Diana M.; Clark, Sarah L.; Backus, Katherine; Perry, James R.; Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Barouch, Dan H.] Harvard Univ, Boston, MA 02115 USA; [Carville, Angela; Mansfield, Keith G.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Szinger, James J.; Fischer, Will; Korber, Bette] Los Alamos Natl Lab, Los Alamos, NM USA; [Muldoon, Mark] Univ Manchester, Sch Math, Manchester, Lancs, England; [Muldoon, Mark; Korber, Bette] Santa Fe Inst, Santa Fe, NM 87501 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Manchester; The Santa Fe Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Div Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Muldoon, Mark/T-9192-2019; Muldoon, Mark R/C-7505-2009; Fischer, Will/B-1323-2013; Fischer, Will/AAD-2807-2019; Barouch, Dan/Y-3918-2019	Fischer, Will/0000-0003-4579-4062; Fischer, Will/0000-0003-4579-4062; Korber, Bette/0000-0002-2026-5757; Szinger, James/0000-0002-6605-9940; Simmons, Nathaniel/0000-0001-6080-2783; Muldoon, Mark/0000-0002-5004-7195; Maxfield, Lori/0000-0002-7595-6205	US National Institutes of Health (NIH) AIDS Research and Reference Reagent Program; NIH [AI058727, AI066305, AI066924, AI078526, AI084794, RR000168, AI067854, AI061734]; Los Alamos National Laboratory; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, R01AI058727, R01AI066924, U01AI067854, U19AI066305, U19AI078526, U19AI067854, P30AI060354, P01AI061734] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) AIDS Research and Reference Reagent Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Haynes, N. Letvin, P. Swanson, F. Stephens, B. Hahn, J. McElrath, J. Goudsmit, M. Pau, N. Michael, M. Marovich and M. Pensiero for generous advice and assistance. We obtained peptides from the US National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from NIH grants AI058727 (D. H. B.), AI066305 (D. H. B.), AI066924 (D. H. B.), AI078526 (D. H. B.), AI084794 (D. H. B.), RR000168, AI067854 (B. K.), AI061734 (B. K.) and directed research funding from Los Alamos National Laboratory (B. K.).	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2005, NAT IMMUNOL, V6, P247, DOI 10.1038/ni1167; Barry AP, 2007, J IMMUNOL, V178, P8002, DOI 10.4049/jimmunol.178.12.8002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MONTEFIORI D, 2004, CURR PROTOC IMMUNOL, V64; Pinheiro J, 2001, MIXED EFFECTS MODELS; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251	20	291	333	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					319	U116		10.1038/nm.2089	http://dx.doi.org/10.1038/nm.2089			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20173752	Green Accepted, Bronze			2022-12-25	WOS:000275289500038
J	Canettieri, G; Di Marcotullio, L; Greco, A; Coni, S; Antonucci, L; Infante, P; Pietrosanti, L; De Smaele, E; Ferretti, E; Miele, E; Pelloni, M; De Simone, G; Pedone, EM; Gallinari, P; Giorgi, A; Steinkuhler, C; Vitagliano, L; Pedone, C; Schinina, ME; Screpanti, I; Gulino, A				Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; De Simone, Giuseppina; Pedone, Emilia Maria; Gallinari, Paola; Giorgi, Alessandra; Steinkuehler, Christian; Vitagliano, Luigi; Pedone, Carlo; Schinina, M. Eugenia; Screpanti, Isabella; Gulino, Alberto			Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; MEDULLOBLASTOMA; PROLIFERATION; ACTIVATION; TRANSCRIPTION; SUPPRESSOR; NEUROGENESIS; DEGRADATION; RENKCTD11; NEURONS	Hedgehog signalling is crucial for development and is deregulated in several tumours, including medulloblastoma. Regulation of the transcriptional activity of Gli (glioma-associated oncogene) proteins, effectors of the Hedgehog pathway, is poorly understood. We show here that Gli1 and Gli2 are acetylated proteins and that their HDAC-mediated deacetylation promotes transcriptional activation and sustains a positive autoregulatory loop through Hedgehog-induced upregulation of HDAC1. This mechanism is turned off by HDAC1 degradation through an E3 ubiquitin ligase complex formed by Cullin3 and REN, a Gli antagonist lost in human medulloblastoma. Whereas high HDAC1 and low REN expression in neural progenitors and medulloblastomas correlates with active Hedgehog signalling, loss of HDAC activity suppresses Hedgehog-dependent growth of neural progenitors and tumour cells. Consistent with this, abrogation of Gli1 acetylation enhances cellular proliferation and transformation. These data identify an integrated HDAC-and ubiquitin-mediated circuitry, where acetylation of Gli proteins functions as an unexpected key transcriptional checkpoint of Hedgehog signalling.	[Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; Screpanti, Isabella; Gulino, Alberto] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Giorgi, Alessandra; Schinina, M. Eugenia] Univ Roma La Sapienza, Dept Biochem Sci, I-00161 Rome, Italy; [Gallinari, Paola; Steinkuehler, Christian] IRBM, Merck Res Labs Rome, I-00040 Pomezia, Italy; [Gulino, Alberto] Neuromed Inst, I-86077 Pozzilli, Italy; [De Simone, Giuseppina; Pedone, Emilia Maria; Vitagliano, Luigi; Pedone, Carlo] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy	Sapienza University Rome; Sapienza University Rome; Merck & Company; IRCCS Neuromed; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, 324 Viale Regina Elena, I-00161 Rome, Italy.	alberto.gulino@uniroma1.it	De Simone, Giuseppina/AAJ-4964-2021; Pedone, Emilia/HDN-2342-2022; Gallinari, Paola/ABE-8238-2021; Miele, Evelina/M-4611-2013; Infante, Paola/G-9094-2018; De Smaele, Enrico/C-1124-2013; Pedone, Emilia Maria/K-2229-2015; Miele, Evelina/AAK-1963-2021; Miele, Evelina/ABB-7545-2021; Ferretti, Elisabetta/G-5413-2013	Pedone, Emilia/0000-0003-0203-8611; Miele, Evelina/0000-0002-4747-1032; De Smaele, Enrico/0000-0003-4524-4423; Pedone, Emilia Maria/0000-0003-0203-8611; Miele, Evelina/0000-0002-4747-1032; Antonucci, Laura/0000-0001-8965-2432; De Simone, Giuseppina/0000-0001-9783-5431; Infante, Paola/0000-0003-0682-3916; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; CANETTIERI, Gianluca/0000-0001-6694-2613; Ferretti, Elisabetta/0000-0001-7265-6429	Associazione Italiana per la Ricerca sul Cancro, Telethon [GGP07118]; Ministry of University and Research (FIRB and PRIN); Ministry of Health; Fondazione Roma Foundation; Mariani Foundation; Cenci-Bolognetti Foundation; Rome Oncogenomic Center	Associazione Italiana per la Ricerca sul Cancro, Telethon(Fondazione AIRC per la ricerca sul cancroFondazione Telethon); Ministry of University and Research (FIRB and PRIN)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministry of Health; Fondazione Roma Foundation(Fondazione Roma); Mariani Foundation; Cenci-Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Rome Oncogenomic Center	We thank M. P. Scott for the gift of Ptch1<SUP>-/-</SUP> cells, G. Giannini and M. Levrero, for helpful suggestions, L. Di Magno, M. Della Guardia, C. Fragomeli and D. Mazza for experimental support. This work was supported by the Associazione Italiana per la Ricerca sul Cancro, Telethon Grant GGP07118, the Ministry of University and Research (FIRB and PRIN), the Ministry of Health, the Fondazione Roma Foundation, the Mariani Foundation, the Cenci-Bolognetti Foundation and the Rome Oncogenomic Center.	ALTABA ARI, 2006, HEDGEHOG GLI SIGNALI, P48349; Argenti B, 2005, J NEUROSCI, V25, P8338, DOI 10.1523/JNEUROSCI.2438-05.2005; Bar EE, 2007, AM J PATHOL, V170, P347, DOI 10.2353/ajpath.2007.060066; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shaked M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002668; Spiller SE, 2006, J NEURO-ONCOL, V79, P259, DOI 10.1007/s11060-006-9142-0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	42	256	269	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					132	U91		10.1038/ncb2013	http://dx.doi.org/10.1038/ncb2013			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081843				2022-12-25	WOS:000274139400007
J	Houghton, AM; Rzymkiewicz, DM; Ji, HB; Gregory, AD; Egea, EE; Metz, HE; Stolz, DB; Land, SR; Marconcini, LA; Kliment, CR; Jenkins, KM; Beaulieu, KA; Mouded, M; Frank, SJ; Wong, KK; Shapiro, SD				Houghton, A. McGarry; Rzymkiewicz, Danuta M.; Ji, Hongbin; Gregory, Alyssa D.; Egea, Eduardo E.; Metz, Heather E.; Stolz, Donna B.; Land, Stephanie R.; Marconcini, Luiz A.; Kliment, Corrine R.; Jenkins, Kimberly M.; Beaulieu, Keith A.; Mouded, Majd; Frank, Stuart J.; Wong, Kwok K.; Shapiro, Steven D.			Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth	NATURE MEDICINE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; LEUKOCYTE ELASTASE; G972R VARIANT; K-RAS; CANCER; INTERLEUKIN-8; ASSOCIATION; EXPRESSION; PHOSPHORYLATION; INFLAMMATION	Lung cancer is the leading cause of cancer death worldwide(1). Recent data suggest that tumor-associated inflammatory cells may modify lung tumor growth and invasiveness(2,3). To determine the role of neutrophil elastase (encoded by Elane) on tumor progression, we used the loxP-Stop-loxP K-ras(G12D) (LSL-K-ras) model of mouse lung adenocarcinoma(4) to generate LSL-K-ras-Elane(-/-) mice. Tumor burden was markedly reduced in LSL-K-ras-Elane(-/-) mice at all time points after induction of mutant K-ras expression. Kaplan-Meier survival analysis showed that whereas all LSL-K-ras-Elane(+/+) mice died, none of the mice lacking neutrophil elastase died. Neutrophil elastase directly induced tumor cell proliferation in both human and mouse lung adenocarcinomas by gaining access to an endosomal compartment within tumor cells, where it degraded insulin receptor substrate-1 (IRS-1). Immunoprecipitation studies showed that, as neutrophil elastase degraded IRS-1, there was increased interaction between phosphatidylinositol 3-kinase (PI3K) and the potent mitogen platelet-derived growth factor receptor (PDGFR), thereby skewing the PI3K axis toward tumor cell proliferation. The inverse relationship identified between neutrophil elastase and IRS-1 in LSL-K-ras mice was also identified in human lung adenocarcinomas, thus translating these findings to human disease. This study identifies IRS-1 as a key regulator of PI3K within malignant cells. Additionally, to our knowledge, this is the first description of a secreted proteinase gaining access to the inside of a cell and altering intracellular signaling.	[Houghton, A. McGarry; Gregory, Alyssa D.; Egea, Eduardo E.; Metz, Heather E.; Kliment, Corrine R.; Jenkins, Kimberly M.; Beaulieu, Keith A.; Mouded, Majd; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Houghton, A. McGarry; Gregory, Alyssa D.; Egea, Eduardo E.; Metz, Heather E.; Jenkins, Kimberly M.; Beaulieu, Keith A.; Mouded, Majd; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Houghton, A. McGarry; Stolz, Donna B.; Land, Stephanie R.; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Rzymkiewicz, Danuta M.; Marconcini, Luiz A.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Ji, Hongbin] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Ji, Hongbin] Chinese Acad Sci, Shanghai, Peoples R China; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Land, Stephanie R.] Univ Pittsburgh, Sch Med, Dept Biostat, Pittsburgh, PA USA; [Frank, Stuart J.] Univ Alabama, Div Endocrinol Diabet & Metab, Birmingham, AL USA; [Wong, Kwok K.] Dana Farber Canc Inst, Dept Med, Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Wong, Kwok K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wong, Kwok K.] Harvard Univ, Sch Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Houghton, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	houghtonm@dom.pitt.edu	Kliment, Corrine/HGE-0877-2022		US National Institutes of Health National Heart, Lung, and Blood Institute [K08HL085286, RO1HL054853, RO1DK058259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054853, K08HL085286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058259] Funding Source: NIH RePORTER	US National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants K08HL085286 and RO1HL054853 from the US National Institutes of Health National Heart, Lung, and Blood Institute ( A. M. H. and S. D. S.) and by grant RO1DK058259 from the US National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (S.J.F.). ONO Pharmaceutical provided the ONO-5046. LSL-K-ras mice were provided by T. Jacks ( Massachusetts Institute of Technology). AdenoCre was obtained from the University of Iowa Gene Transfer Vector Core. We would like to recognize members of the Shapiro lab for their assistance and comments regarding the preparation of this manuscript.	ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P3942, DOI 10.1073/pnas.89.9.3942; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bellocq A, 1998, AM J PATHOL, V152, P83; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Foekens JA, 2003, CANCER RES, V63, P337; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Han CH, 2006, ONCOL REP, V16, P1205; Haqqani AS, 2000, NEOPLASIA, V2, P561, DOI 10.1038/sj.neo.7900110; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Liou TG, 1996, J IMMUNOL, V157, P2624; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Neuhausen SL, 2005, PROSTATE, V64, P168, DOI 10.1002/pros.20216; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Sentinelli F, 2006, J ENDOCRINOL, V188, P271, DOI 10.1677/joe.1.06290; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tu YZ, 2001, BIOCHEM J, V354, P315, DOI 10.1042/0264-6021:3540315; Wada Y, 2007, ONCOL REP, V17, P161; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719	32	463	490	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2010	16	2					219	U127		10.1038/nm.2084	http://dx.doi.org/10.1038/nm.2084			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20081861	Green Accepted			2022-12-25	WOS:000274297000044
J	Zhu, YP; Suits, MDL; Thompson, AJ; Chavan, S; Dinev, Z; Dumon, C; Smith, N; Moremen, KW; Xiang, Y; Siriwardena, A; Williams, SJ; Gilbert, HJ; Davies, GJ				Zhu, Yanping; Suits, Michael D. L.; Thompson, Andrew J.; Chavan, Sambhaji; Dinev, Zoran; Dumon, Claire; Smith, Nicola; Moremen, Kelley W.; Xiang, Yong; Siriwardena, Aloysius; Williams, Spencer J.; Gilbert, Harry J.; Davies, Gideon J.			Mechanistic insights into a Ca2+-dependent family of alpha-mannosidases in a human gut symbiont	NATURE CHEMICAL BIOLOGY			English	Article							BACTEROIDES-THETAIOTAOMICRON; PSEUDOMONAS-CELLULOSA; STRUCTURAL BASIS; MOLECULAR-BASIS; INHIBITION; MANNANASE; MICROBIOME; CATALYSIS; RESIDUES	Colonic bacteria, exemplified by Bacteroides thetaiotaomicron, play a key role in maintaining human health by harnessing large families of glycoside hydrolases (GHs) to exploit dietary polysaccharides and host glycans as nutrients. Such GH family expansion is exemplified by the 23 family GH92 glycosidases encoded by the B. thetaiotaomicron genome. Here we show that these are alpha-mannosidases that act via a single displacement mechanism to utilize host N-glycans. The three-dimensional structure of two GH92 mannosidases defines a family of two-domain proteins in which the catalytic center is located at the domain interface, providing acid (glutamate) and base (aspartate) assistance to hydrolysis in a Ca2+-dependent manner. The three-dimensional structures of the GH92s in complex with inhibitors provide insight into the specificity, mechanism and conformational itinerary of catalysis. Ca2+ plays a key catalytic role in helping distort the mannoside away from its ground-state C-4(1) chair conformation toward the transition state.	[Zhu, Yanping; Dumon, Claire; Smith, Nicola; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Zhu, Yanping; Moremen, Kelley W.; Xiang, Yong; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Suits, Michael D. L.; Thompson, Andrew J.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Chavan, Sambhaji; Siriwardena, Aloysius] Univ Picardie Jules Vernes, Fac Sci, Lab Glucides, CNRS,UMR 6219, Amiens, France; [Dinev, Zoran; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Dinev, Zoran; Williams, Spencer J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3052, Australia	Newcastle University - UK; University System of Georgia; University of Georgia; University of York - UK; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Melbourne; University of Melbourne	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	davies@ysbl.york.ac.uk; hgilbert@ccrc.uga.edu	Williams, Spencer/C-3545-2009; Davies, Gideon J/A-9042-2011; Claire, Dumon/AAI-2553-2021; Moremen, Kelley/AAD-4661-2019; Thompson, Andrew James/ABH-4904-2020	Williams, Spencer/0000-0001-6341-4364; Davies, Gideon J/0000-0002-7343-776X; Claire, Dumon/0000-0003-4925-7336; Thompson, Andrew James/0000-0001-7865-1856	The Biotechnology and Biological Sciences Research Council of the UK; European Molecular Biology Laboratory; Marie Curie European Reintegration, European Community; Department for Innovation, Universities and Skills (DIUS), UK, Newcastle University; Chinese Scholarship Council; US National Institutes of Health [GM047533, RR005351, DK075322]; Agence Nationale de Recherche sur le Sida et les Hepatities Virales (ANRS); Centre National de la Recherche Scientifique; Biotechnology and Biological Sciences Research Council [BB/G016127/1, BB/E000568/1] Funding Source: researchfish; BBSRC [BB/G016127/1, BB/E000568/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533, P41GM103390] Funding Source: NIH RePORTER	The Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; Marie Curie European Reintegration, European Community(European Commission); Department for Innovation, Universities and Skills (DIUS), UK, Newcastle University; Chinese Scholarship Council(China Scholarship Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche sur le Sida et les Hepatities Virales (ANRS)(ANRS); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Withers (University of British Columbia) for compound 9. The Biotechnology and Biological Sciences Research Council of the UK is thanked for funding. M. D. L. S. is a European Molecular Biology Laboratory long-term fellowship holder, and G. J. D. is a Royal Society/Wolfson Research Merit Award recipient. C. D. was supported by a Marie Curie European Reintegration grant within the 7th European Community Framework Programme. Y. Z. is supported by the Department for Innovation, Universities and Skills (DIUS), UK, Newcastle University and the Chinese Scholarship Council. S. J. W. thanks the Australian Research Council for funding support. K. W. M. acknowledges the support of US National Institutes of Health grants GM047533, RR005351 and DK075322. S. C. is supported by a postdoctoral fellowship from the Agence Nationale de Recherche sur le Sida et les Hepatities Virales (ANRS). A. S. is supported by Centre National de la Recherche Scientifique.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Crich D, 2004, ANGEW CHEM INT EDIT, V43, P5386, DOI 10.1002/anie.200453688; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grant Barbara., 2002, INT J ACAD DEV, V5, P6, DOI [DOI 10.1080/136014400410060, 10.1080/136014400410060]; Gridley JJ, 2000, J CHEM SOC PERK T 1, P1471, DOI 10.1039/a909165c; Heikinheimo P, 2003, J MOL BIOL, V327, P631, DOI 10.1016/S0022-2836(03)00172-4; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; ITO Y, 1994, ANGEW CHEM INT EDIT, V33, P1765, DOI 10.1002/anie.199417651; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; KAYAKIRI H, 1989, J ORG CHEM, V54, P4015, DOI 10.1021/jo00278a003; Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuntz DA, 2009, CHEMBIOCHEM, V10, P268, DOI 10.1002/cbic.200800538; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; MARUYAMA Y, 1994, CARBOHYD RES, V251, P89, DOI 10.1016/0008-6215(94)84278-7; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Offen WA, 2009, CHEM COMMUN, P2484, DOI 10.1039/b902240f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Terinek M, 2005, TETRAHEDRON-ASYMMETR, V16, P449, DOI 10.1016/j.tetasy.2004.11.068; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whitfield DM, 2007, CARBOHYD RES, V342, P1726, DOI 10.1016/j.carres.2007.05.012; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	42	90	98	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					125	132		10.1038/NCHEMBIO.278	http://dx.doi.org/10.1038/NCHEMBIO.278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081828	Green Accepted			2022-12-25	WOS:000273651700012
J	Liu, XD; Invernizzi, P; Lu, Y; Kosoy, R; Lu, Y; Bianchi, I; Podda, M; Xu, C; Xie, G; Macciardi, F; Selmi, C; Lupoli, S; Shigeta, R; Ransom, M; Lleo, A; Lee, AT; Mason, AL; Myers, RP; Peltekian, KM; Ghent, CN; Bernuzzi, F; Zuin, M; Rosina, F; Borghesio, E; Floreani, A; Lazzari, R; Niro, G; Andriulli, A; Muratori, L; Muratori, P; Almasio, PL; Andreone, P; Margotti, M; Brunetto, M; Coco, B; Alvaro, D; Bragazzi, MC; Marra, F; Pisano, A; Rigamonti, C; Colombo, M; Marzioni, M; Benedetti, A; Fabris, L; Strazzabosco, M; Portincasa, P; Palmieri, VO; Tiribelli, C; Croce, L; Bruno, S; Rossi, S; Vinci, M; Prisco, C; Mattalia, A; Toniutto, P; Picciotto, A; Galli, A; Ferrari, C; Colombo, S; Casella, G; Morini, L; Caporaso, N; Colli, A; Spinzi, G; Montanari, R; Gregersen, PK; Heathcote, EJ; Hirschfield, GM; Siminovitch, KA; Amos, CI; Gershwin, ME; Seldin, MF				Liu, Xiangdong; Invernizzi, Pietro; Lu, Yue; Kosoy, Roman; Lu, Yan; Bianchi, Ilaria; Podda, Mauro; Xu, Chun; Xie, Gang; Macciardi, Fabio; Selmi, Carlo; Lupoli, Sara; Shigeta, Russell; Ransom, Michael; Lleo, Ana; Lee, Annette T.; Mason, Andrew L.; Myers, Robert P.; Peltekian, Kevork M.; Ghent, Cameron N.; Bernuzzi, Francesca; Zuin, Massimo; Rosina, Floriano; Borghesio, Elisabetta; Floreani, Annarosa; Lazzari, Roberta; Niro, Grazia; Andriulli, Angelo; Muratori, Luigi; Muratori, Paolo; Almasio, Piero L.; Andreone, Pietro; Margotti, Marzia; Brunetto, Maurizia; Coco, Barbara; Alvaro, Domenico; Bragazzi, Maria C.; Marra, Fabio; Pisano, Alessandro; Rigamonti, Cristina; Colombo, Massimo; Marzioni, Marco; Benedetti, Antonio; Fabris, Luca; Strazzabosco, Mario; Portincasa, Piero; Palmieri, Vincenzo O.; Tiribelli, Claudio; Croce, Lory; Bruno, Savino; Rossi, Sonia; Vinci, Maria; Prisco, Cleofe; Mattalia, Alberto; Toniutto, Pierluigi; Picciotto, Antonio; Galli, Andrea; Ferrari, Carlo; Colombo, Silvia; Casella, Giovanni; Morini, Lorenzo; Caporaso, Nicola; Colli, Agostino; Spinzi, Giancarlo; Montanari, Renzo; Gregersen, Peter K.; Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.; Amos, Christopher I.; Gershwin, M. Eric; Seldin, Michael F.			Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SPI-B; CELL; VARIANTS; RISK; TRANSCRIPTION; EXPRESSION; ASTHMA	A genome-wide association screen for primary biliary cirrhosis risk alleles was performed in an Italian cohort. The results from the Italian cohort replicated IL12A and IL12RB associations, and a combined meta-analysis using a Canadian dataset identified newly associated loci at SPIB (P = 7.9 x 10(-11), odds ratio (OR) = 1.46), IRF5-TNPO3 (P = 2.8 x 10(-10), OR = 1.63) and 17q12-21 (P = 1.7 x 10(-10), OR = 1.38).	[Invernizzi, Pietro; Kosoy, Roman; Selmi, Carlo; Shigeta, Russell; Ransom, Michael; Lleo, Ana; Gershwin, M. Eric; Seldin, Michael F.] Univ Calif Davis, Davis, CA 95616 USA; [Liu, Xiangdong; Lu, Yan; Xu, Chun; Xie, Gang; Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Hlth Network, Toronto, ON, Canada; [Invernizzi, Pietro; Bianchi, Ilaria; Podda, Mauro; Selmi, Carlo; Lleo, Ana; Bernuzzi, Francesca] IRCCS, Ist Clin Humanitas, Rozzano, Italy; [Lu, Yue; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Bianchi, Ilaria; Podda, Mauro; Macciardi, Fabio; Selmi, Carlo; Lleo, Ana; Bernuzzi, Francesca; Zuin, Massimo; Rigamonti, Cristina; Colombo, Massimo] Univ Milan, Milan, Italy; [Macciardi, Fabio] Univ Calif Irvine, Irvine, CA USA; [Lupoli, Sara] Ist Sci San Raffaele, I-20132 Milan, Italy; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Mason, Andrew L.] Univ Alberta, Edmonton, AB, Canada; [Liu, Xiangdong; Myers, Robert P.] Univ Calgary, Calgary, AB, Canada; [Peltekian, Kevork M.] Dalhousie Univ, Halifax, NS, Canada; [Ghent, Cameron N.] London Hlth Sci Ctr, London, ON, Canada; [Rosina, Floriano; Borghesio, Elisabetta] Gradenigo Hosp, Turin, Italy; [Floreani, Annarosa; Lazzari, Roberta; Fabris, Luca] Univ Padua, Padua, Italy; [Niro, Grazia; Andriulli, Angelo] Casa Sollievo della Sofferenza Hosp, San Giovanni Rotondo, Italy; [Muratori, Luigi; Muratori, Paolo; Andreone, Pietro; Margotti, Marzia] Univ Bologna, Bologna, Italy; [Almasio, Piero L.] Univ Palermo, Palermo, Italy; [Brunetto, Maurizia; Coco, Barbara] Azienda Osped Univ Pisana, Pisa, Italy; [Alvaro, Domenico; Bragazzi, Maria C.] Univ Sapienza Rome, Rome, Italy; [Marra, Fabio; Pisano, Alessandro; Galli, Andrea] Univ Florence, Florence, Italy; [Marzioni, Marco; Benedetti, Antonio] Univ Politecn Marche, Ancona, Italy; [Strazzabosco, Mario] Yale Univ, New Haven, CT USA; [Strazzabosco, Mario] Univ Milano Bicocca, Monza, Italy; [Portincasa, Piero; Palmieri, Vincenzo O.] Univ Bari, Bari, Italy; [Tiribelli, Claudio; Croce, Lory] Univ Trieste, Trieste, Italy; [Bruno, Savino; Rossi, Sonia] Osped Fatebene Fratelli & Oftalm, Milan, Italy; [Vinci, Maria; Prisco, Cleofe] Osped Maggiore Niguarda, Milan, Italy; [Mattalia, Alberto] Santa Croce Carle Hosp, Cuneo, Italy; [Toniutto, Pierluigi] Univ Udine, I-33100 Udine, Italy; [Picciotto, Antonio] Univ Genoa, Genoa, Italy; [Ferrari, Carlo] Univ Parma, Azienda Osped, I-43100 Parma, Italy; [Colombo, Silvia] Treviglio Hosp, Treviglio, Italy; [Casella, Giovanni] Desio Hosp, Desio, Italy; [Morini, Lorenzo] Magenta Hosp, Magenta, Italy; [Caporaso, Nicola] Univ Naples Federico 2, Naples, Italy; [Colli, Agostino] AO Lecco, Dept Internal Med, Lecce, Italy; [Spinzi, Giancarlo] AO Valduce, Corno, Italy; [Montanari, Renzo] Osped Negrar, Verona, Italy; [Heathcote, E. Jenny; Hirschfield, Gideon M.; Siminovitch, Katherine A.] Univ Toronto, Toronto, ON, Canada; [Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; IRCCS Humanitas Research Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Milan; University of California System; University of California Irvine; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwell Health; University of Alberta; University of Calgary; Dalhousie University; London Health Sciences Centre; Humanitas Hospital Gradenigo; University of Padua; IRCCS Casa Sollievo Della Sofferenza; University of Bologna; University of Palermo; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sapienza University Rome; University of Florence; Marche Polytechnic University; Yale University; University of Milano-Bicocca; Universita degli Studi di Bari Aldo Moro; University of Trieste; University of Udine; University of Genoa; University of Parma; University Hospital of Parma; University of Naples Federico II; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Seldin, MF (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	mfseldin@ucdavis.edu	Mason, Andrew/D-2938-2013; Siminovitch, Katherine/K-1475-2013; Muratori, Luigi/I-3181-2012; Peltekian, Kevork M/D-1083-2010; Niro, Grazia G/Q-9087-2016; Andriulli, Angelo/B-5027-2017; Fabris, Luca/J-7565-2018; Andreone, Pietro/K-8050-2016; Marzioni, Marco/A-8153-2011; Ferrari, Carlo/D-5663-2017; ALVARO, Domenico/J-8600-2018; Selmi, Carlo/ABG-4899-2021; Galli, Andrea/AAC-1623-2019; Hirschfield, Gideon M/M-2143-2015; Marra, Fabio/K-7263-2016; Invernizzi, Pietro/AAB-8367-2022; Lleo, Ana/AAA-5759-2019; Macciardi, Fabio/N-3768-2014; croce', lory saveria l/E-2565-2011; Brunetto, Maurizia/AAU-2906-2020; bernuzzi, francesca/AAQ-7073-2020; Benedetti, Antonio/A-8189-2011; Tiribelli, Claudio/A-4716-2014; Bossa, Fabrizio/B-3078-2017	Mason, Andrew/0000-0002-0470-9522; Muratori, Luigi/0000-0002-8748-8031; Peltekian, Kevork M/0000-0002-9560-5576; Niro, Grazia G/0000-0002-6169-9586; Andriulli, Angelo/0000-0001-8862-7083; Fabris, Luca/0000-0001-8538-6317; Andreone, Pietro/0000-0002-4794-9809; Marzioni, Marco/0000-0001-6014-6165; Ferrari, Carlo/0000-0002-5461-6842; ALVARO, Domenico/0000-0003-3771-9644; Selmi, Carlo/0000-0002-0323-0376; Hirschfield, Gideon M/0000-0002-6736-2255; Marra, Fabio/0000-0001-8629-0878; Invernizzi, Pietro/0000-0003-3262-1998; Lleo, Ana/0000-0002-0561-7902; Macciardi, Fabio/0000-0003-0537-4266; croce', lory saveria l/0000-0001-9890-7011; Brunetto, Maurizia/0000-0001-8364-9152; Zuin, Massimo/0000-0003-3906-4362; Bernuzzi, Francesca/0000-0002-5008-7525; Benedetti, Antonio/0000-0003-0280-4574; Bruno, Savino/0000-0002-3887-864X; portincasa, piero/0000-0001-5359-1471; Ferrari, Carlo/0000-0002-7843-4963; Galli, Andrea/0000-0001-5416-6290; Toniutto, Pierluigi/0000-0002-2566-3041; Cadamuro, Massimiliano/0000-0002-0899-7613; palmieri, vincenzo ostilio/0000-0002-7649-6028; Tiribelli, Claudio/0000-0001-6596-7595; Bossa, Fabrizio/0000-0002-4518-9949	US National Institutes of Health [R01 DK056839, R01 DK80670, K23 DK68290, RO3 DK78527]; Canadian Institutes for Health Research [MOP 74621]; Ontario Research Fund [RE01-061]; Canadian Primary Biliary Cirrhosis Society; American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068290, R03DK078527, R01DK080670, R01DK056839, R01DK091823] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Primary Biliary Cirrhosis Society; American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the subjects and physicians who contributed DNA samples and clinical data for this study. This work was supported in part by the US National Institutes of Health (R01 DK056839, R01 DK80670, K23 DK68290 and RO3 DK78527), the Canadian Institutes for Health Research (MOP 74621), the Ontario Research Fund (RE01-061), the Canadian Primary Biliary Cirrhosis Society, the American Gastroenterological Association and the A.J. and Sigismunda Palumbo Charitable Trust.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Romero F, 1999, EMBO J, V18, P3419, DOI 10.1093/emboj/18.12.3419; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8	15	302	311	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					658	660		10.1038/ng.627	http://dx.doi.org/10.1038/ng.627			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639880	Green Accepted, Green Published			2022-12-25	WOS:000280524000007
J	Schatz, MC; Langmead, B; Salzberg, SL				Schatz, Michael C.; Langmead, Ben; Salzberg, Steven L.			Cloud computing and the DNA data race	NATURE BIOTECHNOLOGY			English	Article							GENOME; STANDARD		[Schatz, Michael C.; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Langmead, Ben] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schatz, MC (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	mschatz@umiacs.umd.edu	Langmead, Ben/F-4218-2012; Schatz, Michael/L-2690-2019; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Langmead, Ben/0000-0003-2437-1976; Schatz, Michael/0000-0002-4118-4446; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432	NIGMS NIH HHS [R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845-10, R01 LM006845-09, R01 LM006845, R01-LM006845] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		*AM COM, NETFL SEL AM WEB SER; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chu CT., 2007, P 19 INT C NEURAL IN, P281, DOI DOI 10.1234/12345678; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Dongarra JJ, 1996, COMMUN ACM, V39, P84, DOI 10.1145/233977.234000; FOLEY J, 2009, PLUG CLOUD      0114; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; *HARV MED SCH, AWS CASE STUD; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; LIN J, 2010, SYNTHESIS LECTURES H, V1, P177; Litzkow M. J., 1988, 8th International Conference on Distributed Computing Systems (Cat. No.88CH2541-1), P104, DOI 10.1109/DCS.1988.12507; MALEWICZ G, 2009, PODC 09 P 28 ACM S P; MARKOFF J, 2006, NY TIMES        0614; MATSUNAGA A, 2008, P IEEE 4 INT C ESCIE; Matthews SJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S15; Moore GE, 1965, ELECTRONICS, V38, P114; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Wall DP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-259; Yu Y, 2008, S OP SYST DES IMPL O	23	164	194	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					691	693		10.1038/nbt0710-691	http://dx.doi.org/10.1038/nbt0710-691			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20622843	Green Accepted, Green Published			2022-12-25	WOS:000279723900026
J	Wang, XC; Li, WD; Zhao, DF; Liu, B; Shi, Y; Chen, BH; Yang, HW; Guo, PF; Geng, X; Shang, ZH; Peden, E; Kage-Nakadai, E; Mitani, S; Xue, D				Wang, Xiaochen; Li, Weida; Zhao, Dongfeng; Liu, Bin; Shi, Yong; Chen, Baohui; Yang, Hengwen; Guo, Pengfei; Geng, Xin; Shang, Zhihong; Peden, Erin; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			Caenorhabditis elegans transthyretin-like protein TTR-52 mediates recognition of apoptotic cells by the CED-1 phagocyte receptor	NATURE CELL BIOLOGY			English	Article							CORPSE ENGULFMENT; CRKII/DOCK180/RAC PATHWAY; PHOSPHATIDYLSERINE; DEATH; CLEARANCE; MIGRATION; SURFACE; DRAPER; GENE; CALRETICULIN	During apoptosis, dying cells are swiftly removed by phagocytes. It is not fully understood how apoptotic cells are recognized by phagocytes. Here we report the identification and characterization of the Caenorhabditis elegans ttr-52 gene, which encodes a transthyretin-like protein and is required for efficient cell corpse engulfment. The TTR-52 protein is expressed in, and secreted from, C. elegans endoderm and clusters around apoptotic cells. Genetic analysis indicates that TTR-52 acts in the cell corpse engulfment pathway mediated by CED-1, CED-6 and CED-7 and affects clustering of the phagocyte receptor CED-1 around apoptotic cells. TTR-52 recognizes surface-exposed phosphatidylserine (PtdSer) in vivo and binds to both PtdSer and the extracellular domain of CED-1 in vitro. TTR-52 is therefore the first bridging molecule identified in C. elegans that mediates recognition of apoptotic cells by crosslinking the PtdSer 'eat me' signal with the phagocyte receptor CED-1.	[Wang, Xiaochen; Shi, Yong; Yang, Hengwen; Geng, Xin; Shang, Zhihong; Peden, Erin; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Xiaochen; Li, Weida; Zhao, Dongfeng; Liu, Bin; Chen, Baohui; Guo, Pengfei] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] JST, CREST, Shinjuku Ku, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; National Institute of Biological Sciences, Beijing; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	wangxiaochen@nibs.ac.cn; ding.xue@colorado.edu	Yang, Hengwen/G-8091-2012; Guo, Peng/GWC-0572-2022; Li, Weida/M-4700-2013; guo, peng/AAG-4052-2019; Geng, Xin/C-7634-2012; liu, Bin/V-3391-2019; yang, hengwen/GQH-7922-2022	liu, Bin/0000-0001-7489-9125; XUE, DING/0000-0002-8429-8136; Chen, Baohui/0000-0002-8999-6531; Li, Weida/0000-0001-6578-6321; Guo, Pengfei/0000-0002-4618-6803; yang, hengwen/0000-0002-6418-1985	NIGMS NIH HHS [R01 GM79097, R01 GM59083, T32 GM142607, R01 GM079097-04, R01 GM079097, R01 GM088241, T32 GM008759, R01 GM059083-11, R01 GM059083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088241, R01GM059083, R01GM079097, T32GM008759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; BRENNER S, 1974, GENETICS, V77, P71; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Eneqvist T, 2003, EUR J BIOCHEM, V270, P518, DOI 10.1046/j.1432-1033.2003.03408.x; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geng X, 2008, NAT STRUCT MOL BIOL, V15, P1094, DOI 10.1038/nsmb.1488; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lee Y, 2006, MOL CELLS, V22, P141; Lundberg E, 2006, J STRUCT BIOL, V155, P445, DOI 10.1016/j.jsb.2006.04.002; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Riddle DL, 1997, C ELEGANS; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Saverwyns H, 2008, INT J PARASITOL, V38, P1545, DOI 10.1016/j.ijpara.2008.04.004; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Schreiber G, 2002, J ENDOCRINOL, V175, P61, DOI 10.1677/joe.0.1750061; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Sonnhammer ELL, 1997, GENOMICS, V46, P200, DOI 10.1006/geno.1997.4989; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	54	85	94	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					655	U69		10.1038/ncb2068	http://dx.doi.org/10.1038/ncb2068			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526330	Green Accepted			2022-12-25	WOS:000279374400009
J	Kao, RY; Yang, D; Lau, LS; Tsui, WHW; Hu, LH; Dai, J; Chan, MP; Chan, CM; Wang, P; Zheng, BJ; Sun, JA; Huang, JD; Madar, J; Chen, GH; Chen, HL; Guan, Y; Yuen, KY				Kao, Richard Y.; Yang, Dan; Lau, Lai-Shan; Tsui, Wayne H. W.; Hu, Lihong; Dai, Jun; Chan, Mei-Po; Chan, Che-Man; Wang, Pui; Zheng, Bo-Jian; Sun, Jian; Huang, Jian-Dong; Madar, Jason; Chen, Guanhua; Chen, Honglin; Guan, Yi; Yuen, Kwok-Yung			Identification of influenza A nucleoprotein as an antiviral target	NATURE BIOTECHNOLOGY			English	Article							OSELTAMIVIR-RESISTANT INFLUENZA; SMALL-MOLECULE INHIBITORS; VIRUS NUCLEOPROTEIN; NUCLEAR-LOCALIZATION; RIBONUCLEOPROTEIN COMPLEXES; VIRAL NUCLEOPROTEIN; CHEMICAL GENETICS; RNA-BINDING; REPLICATION; INFECTIONS	Influenza A remains a significant public health challenge because of the emergence of antigenically shifted or highly virulent strains(1-5). Antiviral resistance to available drugs such as adamantanes or neuraminidase inhibitors has appeared rapidly(6-9), creating a need for new antiviral targets and new drugs for influenza virus infections. Using forward chemical genetics, we have identified influenza A nucleoprotein (NP) as a druggable target and found a small-molecule compound, nucleozin, that triggers the aggregation of NP and inhibits its nuclear accumulation. Nucleozin impeded influenza A virus replication in vitro with a nanomolar median effective concentration (EC(50)) and protected mice challenged with lethal doses of avian influenza A H5N1. Our results demonstrate that viral NP is a valid target for the development of small-molecule therapies.	[Kao, Richard Y.; Lau, Lai-Shan; Tsui, Wayne H. W.; Dai, Jun; Chan, Mei-Po; Chan, Che-Man; Wang, Pui; Zheng, Bo-Jian; Chen, Honglin; Guan, Yi; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Dai, Jun] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Kao, Richard Y.; Zheng, Bo-Jian; Chen, Honglin; Guan, Yi; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Yang, Dan; Hu, Lihong; Sun, Jian; Chen, Guanhua] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Huang, Jian-Dong] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Kao, RY (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	rytkao@hkucc.hku.hk; kyyuen@hkucc.hku.hk	YANG, Dan/HHD-2733-2022; Chen, Honglin/C-4224-2009; Chen, GuanHua/G-6630-2014; Chan, Mei/AAA-3224-2020; SUN, Jian/B-2687-2010; /C-4277-2009; /D-3151-2009	Chen, Honglin/0000-0001-5108-8338; /0000-0001-7531-2816; /0000-0002-1726-9335; Guan, Yi/0000-0001-6057-9243; Kao, Richard Y/0000-0001-8703-4980; Yuen, Kwok-yung/0000-0002-2083-1552	University of Hong Kong; Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grant Council [AoE/M-12/06]; Hong Kong Sanatorium Hospital Doctors' Donation Fund	University of Hong Kong(University of Hong Kong); Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grant Council; Hong Kong Sanatorium Hospital Doctors' Donation Fund	This study was supported in part by the Carol Yu Center for Infection Seed Fund for Basic Research from the University of Hong Kong, the Research Fund for the Control of Infectious Diseases and the Area of Excellence Scheme of the University Grant Council (Grant AoE/M-12/06). The Beckman Coulter Core system is a generous gift from the Hong Kong Sanatorium Hospital Doctors' Donation Fund by Y.-C. Tsao, C.-M. Chan, G. Lo, K.-M. Lai, R. K. Y. Lo, M. Tsao, B. S. S. Tse, T.-F. Tse, S. W. C. Wu, D. Y. C. Yu, R. Y. H. Yu and Y.-K. Tsao. We are grateful to R. Webster for gifts of the pHW2000 plasmids and E. Hoffmann for luciferase reporter system. We thank V. Poon, C. Chan and Q. Zhang for mice studies and K. H. Chan for virus strains. The use of Confocal Systems Core Facility provided by the LKS Faculty of Medicine, HKU, is acknowledged.	Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; DAVEY J, 1985, CELL, V40, P667, DOI 10.1016/0092-8674(85)90215-6; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Strausberg RL, 2003, SCIENCE, V300, P294, DOI 10.1126/science.1083395; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	23	188	211	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					600	U88		10.1038/nbt.1638	http://dx.doi.org/10.1038/nbt.1638			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20512121	Green Published			2022-12-25	WOS:000278820200024
J	Rodin, S; Domogatskaya, A; Strom, S; Hansson, EM; Chien, KR; Inzunza, J; Hovatta, O; Tryggvason, K				Rodin, Sergey; Domogatskaya, Anna; Strom, Susanne; Hansson, Emil M.; Chien, Kenneth R.; Inzunza, Jose; Hovatta, Outi; Tryggvason, Karl			Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION; DERIVATION; PURIFICATION; FIBROBLASTS; CULTURE; SYSTEM; GROWTH; CHAIN; LINES	We describe a system for culturing human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells on a recombinant form of human laminin-511, a component of the natural hES cell niche. The system is devoid of animal products and feeder cells and contains only one undefined component, human albumin. The hES cells self-renewed with normal karyotype for at least 4 months (20 passages), after which the cells could produce teratomas containing cell lineages of all three germ layers. When plated on laminin-511 in small clumps, hES cells spread out in a monolayer, maintaining cellular homogeneity with approximately 97% OCT4-positive cells. Adhesion of hES cells was dependent on alpha 6 beta 1 integrin. The use of homogeneous monolayer hES or iPS cell cultures provides more controllable conditions for the design of differentiation methods. This xeno-free and feeder-free system may be useful for the development of cell lineages for therapeutic purposes.	[Rodin, Sergey; Domogatskaya, Anna; Tryggvason, Karl] Karolinska Inst, Div Matrix Biol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Strom, Susanne; Hovatta, Outi] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Strom, Susanne; Hovatta, Outi] Karolinska Univ Hosp, Stockholm, Sweden; [Hansson, Emil M.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Chien, Kenneth R.] Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Inzunza, Jose] Karolinska Inst, Novum, Dept Biosci & Nutr, Huddinge, Sweden; [Inzunza, Jose] Karolinska Hosp, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Tryggvason, K (corresponding author), Karolinska Inst, Div Matrix Biol, Dept Med Biochem & Biophys, Stockholm, Sweden.	karl.tryggvason@ki.se	Domogatskaya, Anna/F-5794-2012	Domogatskaya, Anna/0000-0002-6468-1963; Inzunza, Jose/0000-0003-0876-6767; Rodin, Sergey/0000-0002-6954-1986	Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Soderberg's Foundation; Swedish Research Council; Swedish Cancer Foundation; Harvard Stem Cell Institute; Leducq Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Soderberg's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Harvard Stem Cell Institute; Leducq Foundation(Leducq Foundation)	We thank A.-S. Nilsson and A.-M. Stromberg for excellent technical assistance, C. Cowan for collaboration in procuring the iPS cell lines, F. Holm and R. Bergstrom for their help with the cell cultures and D. Baker for carrying out karyotyping of hES cells. This work was supported in part by grants from the Knut and Alice Wallenberg Foundation (K. T.), the Novo Nordisk Foundation (K. T.), the Soderberg's Foundation (K. T.), the Swedish Research Council (K. T., O.H.), the Swedish Cancer Foundation (K. T.), the Harvard Stem Cell Institute (K. R. C.) and the Leducq Foundation (K. R. C.). E. M. H. is a Wenner-Gren Foundation fellow. EU: ESTOOLS (O.H.) has not been used for the derivation of new hES cell lines.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; COOPER AR, 1983, DEV BIOL, V96, P467, DOI 10.1016/0012-1606(83)90183-5; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Domogatskaya A, 2008, STEM CELLS, V26, P2800, DOI 10.1634/stemcells.2007-0389; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Iivanainen A, 1997, J BIOL CHEM, V272, P27862, DOI 10.1074/jbc.272.44.27862; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Wondimu Z, 2006, MATRIX BIOL, V25, P89, DOI 10.1016/j.matbio.2005.10.001; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189	32	380	410	0	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					611	U102		10.1038/nbt.1620	http://dx.doi.org/10.1038/nbt.1620			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20512123				2022-12-25	WOS:000278820200026
J	Rosenwaks, Z; Simon, C; Wallace, DC				Rosenwaks, Zev; Simon, Carlos; Wallace, Douglas C.			A mother's gift, minus mitochondria	NATURE MEDICINE			English	Editorial Material							HUMAN EMBRYOS		[Rosenwaks, Zev] New York Presbyterian Hosp, Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Simon, Carlos] Univ Valencia, Dept Obstet & Gynecology, Valencia, Spain; [Simon, Carlos] Inst Valenciano Infertilidad, Valencia, Spain; [Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genetics, Irvine, CA USA	Cornell University; NewYork-Presbyterian Hospital; University of Valencia; University of Valencia; University of California System; University of California Irvine	Rosenwaks, Z (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.		Simon, Carlos/G-2186-2014	Simon, Carlos/0000-0003-0902-9531				Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Escriba MJ, 2006, FERTIL STERIL, V86, P1601, DOI 10.1016/j.fertnstert.2006.04.047; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368	3	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					645	645		10.1038/nm0610-645	http://dx.doi.org/10.1038/nm0610-645			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526317	Bronze			2022-12-25	WOS:000278394200041
J	Bonventre, JV; Vaidya, VS; Schmouder, R; Feig, P; Dieterle, F				Bonventre, Joseph V.; Vaidya, Vishal S.; Schmouder, Robert; Feig, Peter; Dieterle, Frank			Next-generation biomarkers for detecting kidney toxicity	NATURE BIOTECHNOLOGY			English	Article							INJURY; QUALIFICATION		[Bonventre, Joseph V.; Vaidya, Vishal S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA; [Schmouder, Robert] Novartis Inst BioMed Res, E Hanover, NJ USA; [Feig, Peter] Merck Res Labs, Rahway, NJ USA; [Dieterle, Frank] Novartis Inst BioMed Res, Basel, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Merck & Company; Novartis	Bonventre, JV (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016723] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK072381] Funding Source: Medline; NIEHS NIH HHS [R00 ES016723-03S1, R00 ES016723-04, R00 ES016723] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blowey Douglas L, 2005, Adolesc Med Clin, V16, P31, DOI 10.1016/j.admecli.2004.10.001; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Kellum John A, 2002, Curr Opin Crit Care, V8, P509, DOI 10.1097/00075198-200212000-00005; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Mutlib AE, 2000, TOXICOL APPL PHARM, V169, P102, DOI 10.1006/taap.2000.9055; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wingard JR, 1999, CLIN INFECT DIS, V29, P1402, DOI 10.1086/313498	13	374	400	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					436	440		10.1038/nbt0510-436	http://dx.doi.org/10.1038/nbt0510-436			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458311	Green Accepted			2022-12-25	WOS:000277452700021
J	Drost, J; Mantovani, F; Tocco, F; Elkon, R; Comel, A; Holstege, H; Kerkhoven, R; Jonkers, J; Voorhoeve, PM; Agami, R; Del Sal, G				Drost, Jarno; Mantovani, Fiamma; Tocco, Francesca; Elkon, Ran; Comel, Anna; Holstege, Henne; Kerkhoven, Ron; Jonkers, Jos; Voorhoeve, P. Mathijs; Agami, Reuven; Del Sal, Giannino			BRD7 is a candidate tumour suppressor gene required for p53 function	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; TRANSCRIPTIONAL REGULATION; EXPRESSION SIGNATURE; S-PHASE; ACETYLATION; BREAST; SENESCENCE; CELLS; BROMODOMAIN; HISTONE	Oncogene-induced senescence is a p53-dependent defence mechanism against uncontrolled proliferation. Consequently, many human tumours harbour p53 mutations and others show a dysfunctional p53 pathway, frequently by unknown mechanisms. Here we identify BRD7 (bromodomain-containing 7) as a protein whose inhibition allows full neoplastic transformation in the presence of wild-type p53. In human breast tumours harbouring wild-type, but not mutant, p53 the BRD7 gene locus was frequently deleted and low BRD7 expression was found in a subgroup of tumours. Functionally, BRD7 is required for efficient p53-mediated transcription of a subset of target genes. BRD7 interacts with p53 and p300 and is recruited to target gene promoters, affecting histone acetylation, p53 acetylation and promoter activity. Thus, BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence.	[Drost, Jarno; Elkon, Ran; Voorhoeve, P. Mathijs; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Mantovani, Fiamma; Tocco, Francesca; Comel, Anna; Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk, I-34012 Trieste, Italy; [Mantovani, Fiamma; Tocco, Francesca; Comel, Anna; Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34100 Trieste, Italy; [Holstege, Henne; Jonkers, Jos] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Kerkhoven, Ron] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; University of Trieste; Netherlands Cancer Institute; Netherlands Cancer Institute	Voorhoeve, PM (corresponding author), Duke NUS Grad Med Sch, Div Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	mathijs.voorhoeve@duke-nus.edu.sg; r.agami@nki.nl; delsal@lncib.it	Drost, Jarno/J-9758-2012; Jonkers, Jos/AAG-3246-2019; agami, reuven/GOG-8289-2022; Drost, Jarno/M-6964-2017	Drost, Jarno/0000-0002-2941-6179; Jonkers, Jos/0000-0002-9264-9792; Drost, Jarno/0000-0002-2941-6179; Holstege, Henne/0000-0002-7688-3087; DEL SAL, GIANNINO/0000-0003-2185-6003; Agami, Reuven/0000-0002-2848-2473	Dutch Cancer Society; European Young Investigator (EURYI); Centre for Biomedical Genetics (CBG); European Research Council (ERC); Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca; EC [503576, 502963]	Dutch Cancer Society(KWF Kankerbestrijding); European Young Investigator (EURYI)(European Science Foundation (ESF)); Centre for Biomedical Genetics (CBG); European Research Council (ERC)(European Research Council (ERC)European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank Licio Collavin for discussion; Mauro Giacca, Marina Lusic and Lucia Pattarini for access to ICGEB facilities; Thomas Dobner for providing BRD7 expression constructs; Bruno Amati for p300 expression plasmid; Roderick Bijersbergen for assistance in the RNA-mediated interference array experiment; and Joachim Oude-Vrielink and Mariette Schrier for technical assistance. This work was supported by grants from the Dutch Cancer Society (KWF) to J.D., P. M. V and R. A., a European Young Investigator (EURYI) award to R.A. and by the Centre for Biomedical Genetics (CBG) (R.A.), the European Research Council (ERC) (R.A.), the Associazione Italiana per la Ricerca sul Cancro, Ministero dell'Universita e della Ricerca (G.D.S.) and by EC FP6 (contracts 503576 and 502963).	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Argos M, 2008, CANCER GENET CYTOGEN, V182, P69, DOI 10.1016/j.cancergencyto.2008.01.001; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; GEVRY N, GENES DEV, V21, P1869; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kzhyshkowska J, 2003, BIOCHEM J, V371, P385, DOI 10.1042/BJ20021281; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; ROEPMAN P, CLIN CANC RES, V15, P7003; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; SPRUCK CH, 1992, CANCER RES, V52, P4787; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yu Y, 2000, ACTA BIOCH BIOPH SIN, V32, P327; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013	49	148	155	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					380	U189		10.1038/ncb2038	http://dx.doi.org/10.1038/ncb2038			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228809				2022-12-25	WOS:000276194600011
J	Franke, A; Balschun, T; Sina, C; Ellinghaus, D; Hasler, R; Mayr, G; Albrecht, M; Wittig, M; Buchert, E; Nikolaus, S; Gieger, C; Wichmann, HE; Sventoraityte, J; Kupcinskas, L; Onnie, CM; Gazouli, M; Anagnou, NP; Strachan, D; McArdle, WL; Mathew, CG; Rutgeerts, P; Vermeire, S; Vatn, MH; Krawczak, M; Rosenstiel, P; Karlsen, TH; Schreiber, S				Franke, Andre; Balschun, Tobias; Sina, Christian; Ellinghaus, David; Haesler, Robert; Mayr, Gabriele; Albrecht, Mario; Wittig, Michael; Buchert, Eva; Nikolaus, Susanna; Gieger, Christian; Wichmann, H. Erich; Sventoraityte, Jurgita; Kupcinskas, Limas; Onnie, Clive M.; Gazouli, Maria; Anagnou, Nicholas P.; Strachan, David; McArdle, Wendy L.; Mathew, Christopher G.; Rutgeerts, Paul; Vermeire, Severine; Vatn, Morten H.; Krawczak, Michael; Rosenstiel, Philip; Karlsen, Tom H.; Schreiber, Stefan		IBSEN Study Grp	Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY; BTNL2	We performed a genome-wide association analysis of 1,897,764 SNPs in 1,043 German ulcerative colitis (UC) cases and 1,703 controls. We discovered new associations at chromosome 7q22 (rs7809799) and at chromosome 22q13 in IL17REL (rs5771069) and confirmed these associations in six replication panels (2,539 UC cases and 5,428 controls) from different regions of Europe (overall study sample P(rs7809799) = 8.81 x 10(-11) and P(rs5771069) = 4.21 x 10(-8), respectively).	[Franke, Andre; Balschun, Tobias; Ellinghaus, David; Haesler, Robert; Wittig, Michael; Buchert, Eva; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Kiel, Germany; [Sina, Christian; Nikolaus, Susanna] Univ Kiel, PopGen Biobank, Univ Hosp Schleswig Holstein, Kiel, Germany; [Sina, Christian; Nikolaus, Susanna; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Univ Hosp Schleswig Holstein, Kiel, Germany; [Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Saarbrucken, Germany; [Gieger, Christian; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Sventoraityte, Jurgita; Kupcinskas, Limas] Kaunas Univ Med, Dept Gastroenterol, Kaunas, Lithuania; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Gazouli, Maria; Anagnou, Nicholas P.] Univ Athens, Sch Med, Dept Biol, GR-11527 Athens, Greece; [Strachan, David] St Georges Univ, Div Community Hlth Sci, London, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; [Rutgeerts, Paul; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Vatn, Morten H.] Akershus Univ Hosp, Fac Med, Oslo, Norway; [Vatn, Morten H.; Karlsen, Tom H.] Univ Hosp, Rikshosp, Dept Med, Oslo, Norway; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Lithuanian University of Health Sciences; University of London; King's College London; Athens Medical School; National & Kapodistrian University of Athens; St Georges University London; University of Bristol; KU Leuven; University Hospital Leuven; University of Oslo; University of Oslo; National Hospital Norway; University of Kiel	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Kiel, Germany.	a.franke@mucosa.de	Ellinghaus, David/ABC-3610-2020; Albrecht, Mario/B-6694-2008; Balschun, Tobias/B-2356-2010; Wichmann, Heinz Erich/AAA-5695-2022; Ellinghaus, David/G-4467-2012; Gazouli, Maria/W-6245-2019; Mathew, Christopher G/G-3434-2015; Krawczak, Michael/A-8964-2010; Ellinghaus, Eva/E-6490-2012; Franke, Andre/B-2151-2010; Sina, Christian/D-5348-2014; Anagnou, Nicholas/GLR-3609-2022; Gazouli, Maria/I-2572-2018; Rosenstiel, Philip/A-5137-2009; Häsler, Robert/A-4908-2009	Ellinghaus, David/0000-0002-4332-6110; Albrecht, Mario/0000-0002-3103-9624; Gazouli, Maria/0000-0002-3295-6811; Mathew, Christopher G/0000-0003-4178-1838; Krawczak, Michael/0000-0003-2603-1502; Ellinghaus, Eva/0000-0003-2914-3382; Franke, Andre/0000-0003-1530-5811; Gazouli, Maria/0000-0002-3295-6811; Rosenstiel, Philip/0000-0002-9692-8828; Häsler, Robert/0000-0003-4174-8229; Gieger, Christian/0000-0001-6986-9554; Vermeire, Severine/0000-0001-9942-3019	BMBF through the National Genome Research Network (NGFN); PopGen Biobank; Cooperative Research in the Region of Augsburg (KORA); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Sciences (MC Health); UK Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934, MC_qA137934] Funding Source: UKRI; Medical Research Council [MC_qA137934, G0000934] Funding Source: researchfish	BMBF through the National Genome Research Network (NGFN); PopGen Biobank; Cooperative Research in the Region of Augsburg (KORA); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Sciences (MC Health); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all individuals with UC and CD studied here, their families and physicians for their cooperation. We acknowledge the cooperation of the German Crohn and Colitis Foundation (Deutsche Morbus Crohn und Colitis Vereingung e. V.), the German Ministry of Education and Research (BMBF) competence network "IBD" and the contributing gastroenterologists. We thank E. Melum and K. Holm for discussion and support; T. Wesse, T. Henke, C. Furstenau, S. Ehlers and R. Vogler for expert technical help; T. Wienker and M. Steffens (Institut fur Medizinische Biometrie, Informatik und Epidemiologie, University of Bonn) for performing the quality control of the GWAS datasets; B. A. Lie and the Norwegian Bone Marrow Donor Registry at Rikshospitalet University Hospital, Oslo, for contributing the healthy Norwegian control population; and the following individuals for their invaluable participation in the collection of the Baltic (Lithuanian and Latvian) patient panel: G. Kiudelis, L. Jonaitis, A. Zvirbliene, G. Denapiene, A. Irnius, J. Valantinas, V. Svalbonas, D. Krukas, G. Simulionis, Z. Sukys, M. Leja and A. Derovs. This study was supported by the BMBF through the National Genome Research Network (NGFN), the PopGen Biobank and the Cooperative Research in the Region of Augsburg (KORA) research platform. KORA was initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and the Munich Center of Health Sciences (MC Health) as part of the LMUinnovativ initiative. The project received infrastructure support through the Deutsche Forschungsgemeinschaft clusters of excellence Multimodal Computing and Interaction, Future Ocean, and Inflammation and Interfaces. We acknowledge use of DNA from the 1958 British Birth Cohort collection (courtesy of R. Jones, S. Ring, W. McArdle and M. Pembrey), funded by the UK Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02). C. G. M. and C.M.O. were supported by The Wellcome Trust and Core (UK).	Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hommes DW, 1996, CLIN EXP IMMUNOL, V106, P529, DOI 10.1046/j.1365-2249.1996.d01-863.x; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Pathan S, 2009, TISSUE ANTIGENS, V74, P322, DOI 10.1111/j.1399-0039.2009.01314.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406	15	147	150	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2010	42	4					292	294		10.1038/ng.553	http://dx.doi.org/10.1038/ng.553			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20228798				2022-12-25	WOS:000276150500007
J	Ikeuchi, Y; Kimura, S; Numata, T; Nakamura, D; Yokogawa, T; Ogata, T; Wada, T; Suzuki, T; Suzuki, T				Ikeuchi, Yoshiho; Kimura, Satoshi; Numata, Tomoyuki; Nakamura, Daigo; Yokogawa, Takashi; Ogata, Toshihiko; Wada, Takeshi; Suzuki, Takeo; Suzuki, Tsutomu			Agmatine-conjugated cytidine in a tRNA anticodon is essential for AUA decoding in archaea	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID SPECIFICITIES; CODON; IDENTIFICATION; POLYAMINES; BIOSYNTHESIS; NUCLEOSIDE; INSIGHTS	A modified base at the first (wobble) position of some tRNA anticodons is critical for deciphering the genetic code. In eukaryotes and eubacteria, AUA codons are decoded by tRNAs(Ile) with modified bases pseudouridine (and/or inosine) and lysidine, respectively. The mechanism by which archaeal species translate AUA codons is unclear. We describe a polyamine-conjugated modified base, 2-agmatinylcytidine (agm(2)C or agmatidine), at the wobble position of archaeal tRNA(Ile) that decodes AUA codons specifically. We demonstrate that archaeal cells use agmatine to synthesize agm(2)C of tRNA(Ile). We also identified a new enzyme, tRNA(Ile)-agm(2)C synthetase (TiaS), that catalyzes agm(2)C formation in the presence of agmatine and ATP. Although agm2C is chemically similar to lysidine, TiaS constitutes a distinct class of enzyme from tRNA(Ile)-lysidine synthetase (TilS), suggesting that the decoding systems evolved convergently across domains.	[Ikeuchi, Yoshiho; Kimura, Satoshi; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Numata, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Japan; [Numata, Tomoyuki] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Nakamura, Daigo; Yokogawa, Takashi] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 50111, Japan; [Ogata, Toshihiko; Wada, Takeshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Gifu University; University of Tokyo	Ikeuchi, Y (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	ikeuchi, yoshiho/C-1713-2014; Numata, Tomoyuki/L-6952-2018; Ikeuchi, Yoshiho/N-1057-2019; Suzuki, Tsutomu/J-1776-2015	ikeuchi, yoshiho/0000-0002-2829-3840; Numata, Tomoyuki/0000-0002-4244-8829; Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Ministry of Education, Science, Sports, and Culture of Japan; Japan Society for the Promotion of Science Fellowship; Japan Science and Technology; New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	We are grateful to Y. Sakaguchi, T. Saigo, K. Nishikawa, S. Ohno and Y. Nomura for technical support and many fruitful discussions. Special thanks are due to Thermo Fischer Scientific for FT-MS analysis. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan ( to Tsutomu Suzuki, T. Y. and T. W.); by a Japan Society for the Promotion of Science Fellowship for Japanese Junior Scientists ( to Y. I.); by a PRESTO program grant from Japan Science and Technology ( to T.N.) and by a grant from the New Energy and Industrial Technology Development Organization (NEDO) ( to Tsutomu Suzuki).	Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Grosjean H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-470; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kohrer C, 2008, RNA, V14, P117, DOI 10.1261/rna.795508; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Nakanishi K, 2009, NATURE, V461, P1144, DOI 10.1038/nature08474; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Randau L, 2005, FEBS LETT, V579, P2945, DOI 10.1016/j.febslet.2005.04.051; Salowe SP, 2009, J BIOL CHEM, V284, P9656, DOI 10.1074/jbc.M809013200; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki T, 2010, FEBS LETT, V584, P272, DOI 10.1016/j.febslet.2009.11.085; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Yokoyama Shigeyuki, 1995, P207	30	94	97	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					277	282		10.1038/NCHEMBIO.323	http://dx.doi.org/10.1038/NCHEMBIO.323			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20139989				2022-12-25	WOS:000275734000013
J	Marshall, A				Marshall, Andrew			2nd-generation GM traits progress	NATURE BIOTECHNOLOGY			English	News Item																			0	6	7	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					306	306		10.1038/nbt0410-306	http://dx.doi.org/10.1038/nbt0410-306			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20379167				2022-12-25	WOS:000276462400009
J	Van Vlierberghe, P; Palomero, T; Khiabanian, H; Van der Meulen, J; Castillo, M; Van Roy, N; De Moerloose, B; Philippe, J; Gonzalez-Garcia, S; Toribio, ML; Taghon, T; Zuurbier, L; Cauwelier, B; Harrison, CJ; Schwab, C; Pisecker, M; Strehl, S; Langerak, AW; Gecz, J; Sonneveld, E; Pieters, R; Paietta, E; Rowe, JM; Wiernik, PH; Benoit, Y; Soulier, J; Poppe, B; Yao, XP; Cordon-Cardo, C; Meijerink, J; Rabadan, R; Speleman, F; Ferrando, A				Van Vlierberghe, Pieter; Palomero, Teresa; Khiabanian, Hossein; Van der Meulen, Joni; Castillo, Mireia; Van Roy, Nadine; De Moerloose, Barbara; Philippe, Jan; Gonzalez-Garcia, Sara; Toribio, Maria L.; Taghon, Tom; Zuurbier, Linda; Cauwelier, Barbara; Harrison, Christine J.; Schwab, Claire; Pisecker, Markus; Strehl, Sabine; Langerak, Anton W.; Gecz, Jozef; Sonneveld, Edwin; Pieters, Rob; Paietta, Elisabeth; Rowe, Jacob M.; Wiernik, Peter H.; Benoit, Yves; Soulier, Jean; Poppe, Bruce; Yao, Xiaopan; Cordon-Cardo, Carlos; Meijerink, Jules; Rabadan, Raul; Speleman, Frank; Ferrando, Adolfo			PHF6 mutations in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							FORSSMAN-LEHMANN-SYNDROME; X-INACTIVATION PROFILE; GENE-EXPRESSION; LINKED GENE; CHROMOSOME; PROTEIN	Tumor suppressor genes on the X chromosome may skew the gender distribution of specific types of cancer(1,2). T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with an increased incidence in males(3). In this study, we report the identification of inactivating mutations and deletions in the X-linked plant homeodomain finger 6 (PHF6) gene in 16% of pediatric and 38% of adult primary T-ALL samples. Notably, PHF6 mutations are almost exclusively found in T-ALL samples from male subjects. Mutational loss of PHF6 is importantly associated with leukemias driven by aberrant expression of the homeobox transcription factor oncogenes TLX1 and TLX3. Overall, these results identify PHF6 as a new X-linked tumor suppressor in T-ALL and point to a strong genetic interaction between PHF6 loss and aberrant expression of TLX transcription factors in the pathogenesis of this disease.	[Van Vlierberghe, Pieter; Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10027 USA; [Van Vlierberghe, Pieter; Van der Meulen, Joni; Van Roy, Nadine; Poppe, Bruce; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Van Vlierberghe, Pieter; Zuurbier, Linda; Pieters, Rob; Meijerink, Jules] Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Palomero, Teresa; Castillo, Mireia; Cordon-Cardo, Carlos; Ferrando, Adolfo] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Khiabanian, Hossein; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [De Moerloose, Barbara; Benoit, Yves] Ghent Univ Hosp, Dept Pediat Hemato Oncol, B-9000 Ghent, Belgium; [Philippe, Jan; Taghon, Tom] Ghent Univ Hosp, Dept Clin Chem Immunol & Microbiol, B-9000 Ghent, Belgium; [Gonzalez-Garcia, Sara; Toribio, Maria L.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Cauwelier, Barbara] Hosp St Jan, Dept Hematol, Brugge, Belgium; [Harrison, Christine J.; Schwab, Claire] Newcastle Univ, Leukaemia Res Cytogenet Grp, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pisecker, Markus; Strehl, Sabine] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Langerak, Anton W.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Gecz, Jozef] Univ Adelaide, Dept Genet & Mol Pathol, Adelaide, SA, Australia; [Gecz, Jozef] Univ Adelaide, Dept Pediat, Adelaide, SA, Australia; [Sonneveld, Edwin; Pieters, Rob] DCOG, The Hague, Netherlands; [Paietta, Elisabeth; Wiernik, Peter H.] Montefiore Med Ctr N, Bronx, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Rowe, Jacob M.] Technion Israel Inst Technol, Haifa, Israel; [Soulier, Jean] Hop St Louis, APHP, INSERM, Hematol Lab,U944, Paris, France; [Yao, Xiaopan] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Columbia University; Columbia University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Newcastle University - UK; Saint Anna Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Adelaide; University of Adelaide; Dutch Childhood Oncology Group; Montefiore Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Columbia University	Ferrando, A (corresponding author), Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10027 USA.	af2196@columbia.edu	Ferrando, Adolfo A/Q-7026-2016; González-García, Sara/Y-9913-2019; Taghon, Tom/M-9111-2018; Gecz, Jozef/X-3469-2019; Van Vlierberghe, Pieter/G-8894-2013; Khiabanian, Hossein/N-7207-2019; speleman, frank/AAR-5184-2020; Rabadan, Raul/AAZ-7367-2020; Van der Meulen, Joni/AFS-1616-2022; Castillo-Martin, Mireia/H-6152-2013; Philippé, Jan/A-1027-2008; philippé, jan/AAG-8964-2019; De+Moerloose, Barbara/AAN-3298-2020; Meijerink, Jules P/D-4393-2017; Toribio, Maria L/C-2039-2017	González-García, Sara/0000-0002-0315-2136; Gecz, Jozef/0000-0002-7884-6861; Van Vlierberghe, Pieter/0000-0001-9063-7205; Khiabanian, Hossein/0000-0003-1446-4394; speleman, frank/0000-0002-6628-8559; Van der Meulen, Joni/0000-0002-1916-2769; Philippé, Jan/0000-0003-4857-5746; philippé, jan/0000-0003-4857-5746; Meijerink, Jules P/0000-0002-6860-798X; De Moerloose, Barbara/0000-0002-2449-539X; Zuurbier, Linda/0000-0002-8473-1147; van der Meulen, Jan/0000-0002-9451-2335; Strehl, Sabine/0000-0002-0179-0628; Rabadan, Raul/0000-0001-7946-9255; Harrison, Christine/0000-0002-0526-6794; Taghon, Tom/0000-0002-5781-0288; Toribio, Maria L/0000-0002-8637-0373	Fund for Scientific Research (FWO) Flanders [G.0198.08, G.0869.10N]; GOA-UGent [12051203]; IWT-Vlaanderen [060848]; Children Cancer Fund Ghent; Leukemia Research UK; Stichting Kinderen Kankervrij [KiKa 2007-012]; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation against Cancer; Austrian Ministry of Science and Research [GZ 200.136/1-VI/1/2005]; US National Library of Medicine [1R01LM010140-01]; ECOG tumor bank; DCOG tumor bank; Spain's Plan Nacional [BFU 2007-60990, PlanE2009-0110]; Comunidad de Madrid [S-SAL0304-2006]; Fundacion MM [RECAVA RD06/0014/1012]; Fundacion Ramon Areces; Alex's Lemonade Stand Foundation; US Northeast Biodefense Center [U54-AI057158]; US National Institutes of Health [R01CA120196, R01CA129382]; Rally across America Foundation; Swim across America Foundation; Golfers against Cancer Foundation; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [U24CA114737, R01CA120196, R01CA129382, R01CA155743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	Fund for Scientific Research (FWO) Flanders(FWO); GOA-UGent; IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Children Cancer Fund Ghent; Leukemia Research UK; Stichting Kinderen Kankervrij; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation against Cancer; Austrian Ministry of Science and Research; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); ECOG tumor bank; DCOG tumor bank; Spain's Plan Nacional; Comunidad de Madrid(Comunidad de Madrid); Fundacion MM; Fundacion Ramon Areces; Alex's Lemonade Stand Foundation; US Northeast Biodefense Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rally across America Foundation; Swim across America Foundation; Golfers against Cancer Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by the Fund for Scientific Research (FWO) Flanders (postdoctoral grants to P. V. V. and T. T., PhD grant to J.V.d.M., senior clinical investigator award to B. P. and project grants G.0198.08 and G.0869.10N to F. S.); the GOA-UGent (grant no. 12051203); the IWT-Vlaanderen (SBO grant no. 060848); the Children Cancer Fund Ghent (F. S.); Leukemia Research UK (C.J.H.); the Stichting Kinderen Kankervrij (KiKa; grant no. KiKa 2007-012 to L.Z.); the Belgian Program of Interuniversity Poles of Attraction; the Belgian Foundation against Cancer; the Austrian Ministry of Science and Research (GEN-AU Child, GZ 200.136/1-VI/1/2005 to S. S.), the US National Library of Medicine (1R01LM010140-01 to R. R. and H. K.); the ECOG and DCOG tumor banks; grants from Spain's Plan Nacional (BFU 2007-60990 and PlanE2009-0110 to M. L. T.), Comunidad de Madrid (S-SAL0304-2006 to M. L. T.), Fundacion MM (M. L. T.), Instituto de Salud Carlos III (RECAVA RD06/0014/1012 to M. L. T.), an Institutional Grant from the Fundacion Ramon Areces (M. L. T.), the Alex's Lemonade Stand Foundation Young Investigator Award (T. P.); a US Northeast Biodefense Center ARRA award (U54-AI057158 to R. R.); the US National Institutes of Health (R01CA120196 and R01CA129382 to A. F.); the Rally across America Foundation (A. F); the Swim across America Foundation (A. F.); the Golfers against Cancer Foundation (A. F.); and a Leukemia and Lymphoma Society Scholar Award (A. F.). We thank the Pediatric Cardiosurgery Units from Centro Especial Ramon y Cajal and Ciudad Sanitaria La Paz (Madrid, Spain) for thymus samples.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Erdogan F, 2006, CYTOGENET GENOME RES, V115, P247, DOI 10.1159/000095921; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; KHIABANIAN H, 2010, NATURE PRECEDINGS; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; van Grotel M, 2006, HAEMATOLOGICA, V91, P1212; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007	28	214	215	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					338	U95		10.1038/ng.542	http://dx.doi.org/10.1038/ng.542			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20228800	Green Accepted			2022-12-25	WOS:000276150500014
J	Campioni, S; Mannini, B; Zampagni, M; Pensalfini, A; Parrini, C; Evangelisti, E; Relini, A; Stefani, M; Dobson, CM; Cecchi, C; Chiti, F				Campioni, Silvia; Mannini, Benedetta; Zampagni, Mariagioia; Pensalfini, Anna; Parrini, Claudia; Evangelisti, Elisa; Relini, Annalisa; Stefani, Massimo; Dobson, Christopher M.; Cecchi, Cristina; Chiti, Fabrizio			A causative link between the structure of aberrant protein oligomers and their toxicity	NATURE CHEMICAL BIOLOGY			English	Article							SOLUBLE AMYLOID OLIGOMERS; MOLTEN GLOBULE INTERMEDIATE; HYPF-N; NEUROBLASTOMA-CELLS; MEMBRANE DISRUPTION; MISFOLDING DISEASES; COMMON MECHANISM; ALPHA-SYNUCLEIN; AGGREGATION; CYTOTOXICITY	The aberrant assembly of peptides and proteins into fibrillar aggregates proceeds through oligomeric intermediates that are thought to be the primary pathogenic species in many protein deposition diseases. We describe two types of oligomers formed by the HypF-N protein that are morphologically and tinctorially similar, as detected with atomic force microscopy and thioflavin T assays, though one is benign when added to cell cultures whereas the other is toxic. Structural investigation at a residue-specific level using site-directed labeling with pyrene indicated differences in the packing of the hydrophobic interactions between adjacent protein molecules in the oligomers. The lower degree of hydrophobic packing was found to correlate with a higher ability to penetrate the cell membrane and cause an influx of Ca2+ ions. Our findings suggest that structural flexibility and hydrophobic exposure are primary determinants of the ability of oligomeric assemblies to cause cellular dysfunction and its consequences, such as neurodegeneration.	[Campioni, Silvia; Mannini, Benedetta; Zampagni, Mariagioia; Pensalfini, Anna; Evangelisti, Elisa; Stefani, Massimo; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Dept Biochem Sci, Florence, Italy; [Parrini, Claudia; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy; [Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Florence; University of Genoa; University of Cambridge	Chiti, F (corresponding author), Univ Florence, Dept Biochem Sci, Florence, Italy.	fabrizio.chiti@unifi.it	Pensalfini, Anna/X-5563-2019; Mannini, Benedetta/GLV-6007-2022; Mannini, Benedetta/ABC-4854-2020; Relini, Annalisa/AHC-3105-2022	Mannini, Benedetta/0000-0001-6812-7348; Cecchi, Cristina/0000-0001-8387-7737; RELINI, ANNALISA/0000-0002-4040-9279; STEFANI, MASSIMO/0000-0002-4490-1922	European Union; Italian Ministero dell'Istruzione, Universita e Ricerca [FIRB RBNE03PX83, PRIN 2006058958, PRIN 2007XY59Z]; Fondazione Cariplo, Ente Cassa di Risparmio di Firenze; European Molecular Biology Organization Young Investigator Programme	European Union(European Commission); Italian Ministero dell'Istruzione, Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo, Ente Cassa di Risparmio di Firenze(Fondazione Cariplo); European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO))	This work was supported by the European Union (Project EURAMY), by the Italian Ministero dell'Istruzione, Universita e Ricerca (FIRB RBNE03PX83, PRIN 2006058958 and PRIN 2007XY59Z), Fondazione Cariplo, Ente Cassa di Risparmio di Firenze (project "Lipid rafts" 2008) and the European Molecular Biology Organization Young Investigator Programme. We are grateful to S. Torrassa and D. Nichino for assistance with AFM measurements and to I. Shalova for assistance in the purification and labeling of some of the variants used in this work.	Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; BIRKS JB, 1967, NATURE, V214, P1187, DOI 10.1038/2141187a0; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2008, J MOL BIOL, V379, P554, DOI 10.1016/j.jmb.2008.04.002; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; Cecchi C, 2008, J MOL MED, V86, P197, DOI 10.1007/s00109-007-0265-3; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christensen PA, 2008, FEBS LETT, V582, P1341, DOI 10.1016/j.febslet.2008.03.017; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; DOWNS TR, 1983, ANAL BIOCHEM, V131, P538, DOI 10.1016/0003-2697(83)90212-9; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Haugland R. P., 2002, HDB FLUORESCENT PROB, P95; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Inaba S, 2005, J PEPT RES, V65, P485, DOI 10.1111/j.1399-3011.2005.00250.X; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kheterpal I, 2006, ACCOUNTS CHEM RES, V39, P584, DOI 10.1021/ar050057w; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; Marcon G, 2005, J MOL BIOL, V347, P323, DOI 10.1016/j.jmb.2005.01.034; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Oma Y, 2005, BBA-PROTEINS PROTEOM, V1748, P174, DOI 10.1016/j.bbapap.2004.12.017; Oma Y, 2004, J BIOL CHEM, V279, P21217, DOI 10.1074/jbc.M309887200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Rosano C, 2002, J MOL BIOL, V321, P785, DOI 10.1016/S0022-2836(02)00713-1; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	44	430	435	3	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					140	147		10.1038/NCHEMBIO.283	http://dx.doi.org/10.1038/NCHEMBIO.283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081829	Green Published			2022-12-25	WOS:000273651700014
J	Pais-Correia, AM; Sachse, M; Guadagnini, S; Robbiati, V; Lasserre, R; Gessain, A; Gout, O; Alcover, A; Thoulouze, MI				Pais-Correia, Ana-Monica; Sachse, Martin; Guadagnini, Stephanie; Robbiati, Valentina; Lasserre, Remi; Gessain, Antoine; Gout, Olivier; Alcover, Andres; Thoulouze, Maria-Isabel			Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPARAN-SULFATE PROTEOGLYCANS; LYMPHOTROPIC-VIRUS; LEUKEMIA-VIRUS; IMMUNOLOGICAL SYNAPSE; HELICOBACTER-PYLORI; ANTIGEN-EXPRESSION; PERIPHERAL-BLOOD; LECTIN-BINDING; I TAX	Human T cell leukemia virus type 1 (HTLV-1) is a lymphotropic retrovirus whose cell-to-cell transmission requires cell contacts. HTLV-1-infected T lymphocytes form 'virological synapses', but the mechanism of HTLV-1 transmission remains poorly understood. We show here that HTLV-1-infected T lymphocytes transiently store viral particles as carbohydrate-rich extracellular assemblies that are held together and attached to the cell surface by virally-induced extracellular matrix components, including collagen and agrin, and cellular linker proteins, such as tetherin and galectin-3. Extracellular viral assemblies rapidly adhere to other cells upon cell contact, allowing virus spread and infection of target cells. Their removal strongly reduces the ability of HTLV-1-producing cells to infect target cells. Our findings unveil a novel virus transmission mechanism based on the generation of extracellular viral particle assemblies whose structure, composition and function resemble those of bacterial biofilms. HTLV-1 biofilm-like structures represent a major route for virus transmission from cell to cell.	[Pais-Correia, Ana-Monica; Robbiati, Valentina; Lasserre, Remi; Alcover, Andres; Thoulouze, Maria-Isabel] Inst Pasteur, CNRS, Unite Biol Cellulaire Lymphocytes, Unite Rech Associee 1961, Paris, France; [Gessain, Antoine] Inst Pasteur, CNRS, Unite Epidemiol & Physiopathol Virus Oncogenes, URA 1930, Paris, France; [Gout, Olivier] Fdn A Rothschild, Serv Neurol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Alcover, A (corresponding author), Inst Pasteur, CNRS, Unite Biol Cellulaire Lymphocytes, Unite Rech Associee 1961, Paris, France.	andres.alcover@pasteur.fr; marie-isabelle.thoulouze@pasteur.fr	Sachse, Martin/W-7403-2019; Thoulouze, Maria-Isabel/AAK-6761-2021; Lasserre, Rémi/N-5646-2016	Thoulouze, Maria-Isabel/0000-0002-1780-0421; Lasserre, Rémi/0000-0002-6996-0179; Sachse, Martin/0000-0001-5981-9166; Alcover, Andres/0000-0002-9507-3450	La Ligue Contre le Cancer, l'Association pour la Recherche Contre le Cancer; l'Agence National de Recherche, l'Institut Pasteur [PTR-214]; CNRS; Fundacao para a Ciencia e a Tecnologia, Portugal; European Union	La Ligue Contre le Cancer, l'Association pour la Recherche Contre le Cancer; l'Agence National de Recherche, l'Institut Pasteur; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Union(European Commission)	This work has been funded by La Ligue Contre le Cancer, l'Association pour la Recherche Contre le Cancer, l'Agence National de Recherche, l'Institut Pasteur PTR-214, and the CNRS. A.-M. P.-C. is supported by Fundacao para a Ciencia e a Tecnologia, Portugal, V. R. by the European Union Marie Curie Actions Early Stage Training Program Intrapath and R. L. by a Bourse Roux, Institut Pasteur and l'Agence National de Recherche. We thank the US National Institutes of Health AIDS Research and Reference Reagent Program for providing MT2 cells and Env-specific 0.5 alpha antibodies. We thank M. Ruegg (University of Basel) for agrin-specific antibodies, C. Pique (Institut Cochin, Institut National de la Sante et de la Recherche Medicale (INSERM)) for Env gp46-specific antibody and S. Charrin and E. Rubinstein (Institut A. Lwoff, INSERM) for tetraspanin-specific antibodies. We thank S. Ozden and P.-E. Ceccaldi for the C91/PL cell line and expertise, F. Delebecque (Novartis) for the gift of pCS-HTLV-1, and A. Cartaud, J. Cartaud and U. Hazan for sharing expertise. We thank C. Cuche for technical assistance and S. Bassot for technical help with human samples. We thank ICAReB (plateforme d'investigation clinique et d'acces aux ressources biologiques) and the Centre d'Immunologie Humaine, Institut Pasteur for support in biomedical research. We thank, E. Perret, P. Roux, C. Machu A. Danckaert and M. C. Prevost for sharing expertise in microscopy, J. M. Ghigo and S. Wain-Hobson for helpful discussions and R. Mahieux (Ecole Normale Superieure de Lyon, INSERM) for pLTR-Luc plasmid and for suggestions and critical reading of the manuscript.	Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Barnard AL, 2005, BLOOD, V106, P988, DOI 10.1182/blood-2004-07-2850; Bonifait L, 2008, APPL ENVIRON MICROB, V74, P4969, DOI 10.1128/AEM.00558-08; COFFIN JM, 1997, RETROVIRUSES, P27; Dityatev A, 2006, CELL TISSUE RES, V326, P647, DOI 10.1007/s00441-006-0217-1; DONEGAN E, 1994, TRANSFUSION, V34, P478, DOI 10.1046/j.1537-2995.1994.34694295061.x; ELNABOUT R, 1989, MATRIX, V9, P411, DOI 10.1016/S0934-8832(89)80047-2; Fowler M, 2006, CELL MICROBIOL, V8, P44, DOI 10.1111/j.1462-5822.2005.00599.x; Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105; GESSAIN A, 1990, J GEN VIROL, V71, P333, DOI 10.1099/0022-1317-71-2-333; Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05; Grange MP, 1998, INT J CANCER, V75, P804, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;804::AID-IJC22&gt;3.0.CO;2-4; Gupta SK, 1997, INFECT IMMUN, V65, P2747, DOI 10.1128/IAI.65.7.2747-2753.1997; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Hsu DK, 1996, AM J PATHOL, V148, P1661; Humbert M, 2006, AIDS REV, V8, P51; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kambara C, 2002, J NEUROIMMUNOL, V125, P179, DOI 10.1016/S0165-5728(02)00042-5; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Le Blanc I, 2001, VIRUS RES, V78, P5, DOI 10.1016/S0168-1702(01)00278-7; Mahieux R, 2005, J GEN VIROL, V86, P2489, DOI 10.1099/vir.0.80973-0; Majorovits E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002251; Mazurov D, 2006, VIROLOGY, V346, P194, DOI 10.1016/j.virol.2005.10.033; McClure SF, 1997, GLYCOCONJUGATE J, V14, P365, DOI 10.1023/A:1018526813159; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; MUNOZ E, 1995, J CLIN INVEST, V96, P2413, DOI 10.1172/JCI118298; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Neu TR, 1999, METHOD ENZYMOL, V310, P145; OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Yi T, 2000, BIOCHEM BIOPH RES CO, V276, P579, DOI 10.1006/bbrc.2000.3517; ZACHAROPOULOS VR, 1992, J VIROL, V66, P4601, DOI 10.1128/JVI.66.7.4601-4605.1992; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com	51	211	218	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					83	U119		10.1038/nm.2065	http://dx.doi.org/10.1038/nm.2065			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20023636				2022-12-25	WOS:000273395500040
J	Schoenfelder, S; Sexton, T; Chakalova, L; Cope, NF; Horton, A; Andrews, S; Kurukuti, S; Mitchell, JA; Umlauf, D; Dimitrova, DS; Eskiw, CH; Luo, YQ; Wei, CL; Ruan, YJ; Bieker, JJ; Fraser, P				Schoenfelder, Stefan; Sexton, Tom; Chakalova, Lyubomira; Cope, Nathan F.; Horton, Alice; Andrews, Simon; Kurukuti, Sreenivasulu; Mitchell, Jennifer A.; Umlauf, David; Dimitrova, Daniela S.; Eskiw, Christopher H.; Luo, Yanquan; Wei, Chia-Lin; Ruan, Yijun; Bieker, James J.; Fraser, Peter			Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; RNA-POLYMERASE-II; CONTROL REGION; INTERCHROMOSOMAL ASSOCIATIONS; NUCLEAR-ORGANIZATION; SPATIAL-ORGANIZATION; EKLF; EXPRESSION; SITES; FACTORIES	The discovery of interchromosomal interactions in higher eukaryotes points to a functional interplay between genome architecture and gene expression, challenging the view of transcription as a one-dimensional process. However, the extent of interchromosomal interactions and the underlying mechanisms are unknown. Here we present the first genome-wide analysis of transcriptional interactions using the mouse globin genes in erythroid tissues. Our results show that the active globin genes associate with hundreds of other transcribed genes, revealing extensive and preferential intra- and interchromosomal transcription interactomes. We show that the transcription factor Klf1 mediates preferential co-associations of Klf1-regulated genes at a limited number of specialized transcription factories. Our results establish a new gene expression paradigm, implying that active co-regulated genes and their regulatory factors cooperate to create specialized nuclear hot spots optimized for efficient and coordinated transcriptional control.	[Schoenfelder, Stefan; Sexton, Tom; Chakalova, Lyubomira; Cope, Nathan F.; Horton, Alice; Kurukuti, Sreenivasulu; Mitchell, Jennifer A.; Umlauf, David; Dimitrova, Daniela S.; Eskiw, Christopher H.; Fraser, Peter] Lab Chromatin & Gene Express, Cambridge, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Luo, Yanquan; Wei, Chia-Lin; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Bieker, James J.] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Icahn School of Medicine at Mount Sinai	Fraser, P (corresponding author), Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge, England.	peter.fraser@bbsrc.ac.uk	Fraser, Peter/B-7549-2009; Chakalova, Lyubomira/C-6810-2012; kurukuti, sreenivasulu/AAI-5663-2020	Sexton, Thomas/0000-0002-7824-1846; Mitchell, Jennifer/0000-0002-7147-4604; Fraser, Peter/0000-0002-0041-1227	Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M723, BB/E017460/1, BBS/E/B/0000C151] Funding Source: researchfish; Medical Research Council [G0800036] Funding Source: researchfish; BBSRC [BBS/E/B/0000M723, BBS/E/B/0000C151, BB/E017460/1] Funding Source: UKRI; MRC [G0800036] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Laboratory of Chromatin and Gene Expression for their help and advice, and also thank C. Osborne and P. Schoenfelder for critical reading of the manuscript, A. Segonds-Pichon for help with the statistical analyses, and L. Mercer and M. Anderton for handling mouse strains. We are indebted to J. Cunningham, T. Abramova and V. Jansen for providing tissue from Klf1<SUP>-/-</SUP> mice. D. U. is recipient of an European Molecular Biology Organisation long-term fellowship. P. F. is a Senior Fellow of the Medical Research Council. This work was supported by the Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; COPE NF, 2009, CSH PROTOC, DOI DOI 10.1101/PDB.PROT5137; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Iborra FJ, 1996, J CELL SCI, V109, P1427; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Shyu YC, 2006, CELL RES, V16, P347, DOI 10.1038/sj.cr.7310045; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Volpi EV, 2000, J CELL SCI, V113, P1565; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	56	507	528	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					53	U71		10.1038/ng.496	http://dx.doi.org/10.1038/ng.496			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20010836	Green Accepted, Bronze			2022-12-25	WOS:000273055100016
J	Alders, M; Hogan, BM; Gjini, E; Salehi, F; Al-Gazali, L; Hennekam, EA; Holmberg, EE; Mannens, MMAM; Mulder, MF; Offerhaus, GJA; Prescott, TE; Schroor, EJ; Verheij, JBGM; Witte, M; Zwijnenburg, PJ; Vikkula, M; Schulte-Merker, S; Hennekam, RC				Alders, Marielle; Hogan, Benjamin M.; Gjini, Evisa; Salehi, Faranak; Al-Gazali, Lihadh; Hennekam, Eric A.; Holmberg, Eva E.; Mannens, Marcel M. A. M.; Mulder, Margot F.; Offerhaus, G. Johan A.; Prescott, Trine E.; Schroor, Eelco J.; Verheij, Joke B. G. M.; Witte, Merlijn; Zwijnenburg, Petra J.; Vikkula, Mikka; Schulte-Merker, Stefan; Hennekam, Raoul C.			Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans	NATURE GENETICS			English	Article							HEREDITARY LYMPHEDEMA; TRANSCRIPTION FACTOR; HENNEKAM-SYNDROME; SYSTEM; LYMPHANGIECTASIA	Lymphedema, lymphangiectasias, mental retardation and unusual facial characteristics define the autosomal recessive Hennekam syndrome. Homozygosity mapping identified a critical chromosomal region containing CCBE1, the human ortholog of a gene essential for lymphangiogenesis in zebrafish. Homozygous and compound heterozygous mutations in seven subjects paired with functional analysis in a zebrafish model identify CCBE1 as one of few genes causing primary generalized lymph-vessel dysplasia in humans.	[Hennekam, Raoul C.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Alders, Marielle; Salehi, Faranak; Mannens, Marcel M. A. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Hogan, Benjamin M.; Gjini, Evisa; Witte, Merlijn; Schulte-Merker, Stefan] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands; [Hennekam, Eric A.] Univ Med Ctr Utrecht, Dept Clin Genet, Utrecht, Netherlands; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat & Pathol, Al Ain, U Arab Emirates; [Holmberg, Eva E.; Prescott, Trine E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Med Genet, N-0027 Oslo, Norway; [Mulder, Margot F.] Free Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Offerhaus, G. Johan A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Offerhaus, G. Johan A.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schroor, Eelco J.] Isala Clin, Dept Pediat Amalia, Zwolle, Netherlands; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Genet, NL-9713 AV Groningen, Netherlands; [Zwijnenburg, Petra J.] Free Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Vikkula, Mikka] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium; [Zwijnenburg, Petra J.; Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; United Arab Emirates University; University of Oslo; National Hospital Norway; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Isala Clinics; University of Groningen; Vrije Universiteit Amsterdam; Universite Catholique Louvain; University of Amsterdam; Academic Medical Center Amsterdam	Hennekam, RC (corresponding author), UCL, Great Ormond St Hosp Children, Inst Child Hlth, Clin & Mol Genet Unit, London, England.	r.c.hennekam@amc.uva.nl	Hogan, Benjamin/AAD-7410-2022; Hogan, Benjamin M/J-1807-2014; Vikkula, Miikka/Q-1038-2018	Hogan, Benjamin/0000-0002-0651-7065; Hogan, Benjamin M/0000-0002-0651-7065; Vikkula, Miikka/0000-0002-6236-338X	Koninklijke Nederlandse Akademie van Wetenschappen; Australian National Health and Medical Research Council CJ Martin Fellowship	Koninklijke Nederlandse Akademie van Wetenschappen; Australian National Health and Medical Research Council CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	S. S. -M. and E. G. were supported by the Koninklijke Nederlandse Akademie van Wetenschappen, B. M. H. by an Australian National Health and Medical Research Council CJ Martin Fellowship. M. J. Van De Vijver (Academic Medical Centre Amsterdam) provided gut biopsies of controls and H. Begthel (Hubrecht Institute, Utrecht) performed histology. T. Nilsson (McGill University) generously provided the GalNAcT2<SUP>GFP</SUP> cell line and A. Akhmanova (Erasmus Medical Center, Rotterdam) the NPY: mVenus cell line. We are grateful to the subjects and their families for their cooperation.	Al-Gazali LI, 2003, CLIN DYSMORPHOL, V12, P227, DOI 10.1097/00019605-200310000-00003; Bellini C, 2003, AM J MED GENET A, V120A, P92, DOI 10.1002/ajmg.a.20180; Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; HENNEKAM RCM, 1989, AM J MED GENET, V34, P593, DOI 10.1002/ajmg.1320340429; HILLIARD RI, 1990, PEDIATRICS, V86, P988; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; Van Balkom IDC, 2002, AM J MED GENET, V112, P412, DOI 10.1002/ajmg.10707; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	15	200	209	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1272	1274		10.1038/ng.484	http://dx.doi.org/10.1038/ng.484			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19935664				2022-12-25	WOS:000272144900006
J	Remmers, EF; Cosan, F; Kirino, Y; Ombrello, MJ; Abaci, N; Satorius, C; Le, JM; Yang, B; Korman, BD; Cakiris, A; Aglar, O; Emrence, Z; Azakli, H; Ustek, D; Tugal-Tutkun, I; Akman-Demir, G; Chen, W; Amos, CI; Dizon, MB; Kose, AA; Azizlerli, G; Erer, B; Brand, OJ; Kaklamani, VG; Kaklamanis, P; Ben-Chetrit, E; Stanford, M; Fortune, F; Ghabra, M; Ollier, WER; Cho, YH; Bang, D; O'Shea, J; Wallace, GR; Gadina, M; Kastner, DL; Gul, A				Remmers, Elaine F.; Cosan, Fulya; Kirino, Yohei; Ombrello, Michael J.; Abaci, Neslihan; Satorius, Colleen; Le, Julie M.; Yang, Barbara; Korman, Benjamin D.; Cakiris, Aris; Aglar, Oznur; Emrence, Zeliha; Azakli, Hulya; Ustek, Duran; Tugal-Tutkun, Ilknur; Akman-Demir, Gulsen; Chen, Wei; Amos, Christopher I.; Dizon, Michael B.; Kose, Afet Akdag; Azizlerli, Gulsevim; Erer, Burak; Brand, Oliver J.; Kaklamani, Virginia G.; Kaklamanis, Phaedon; Ben-Chetrit, Eldad; Stanford, Miles; Fortune, Farida; Ghabra, Marwen; Ollier, William E. R.; Cho, Young-Hun; Bang, Dongsik; O'Shea, John; Wallace, Graham R.; Gadina, Massimo; Kastner, Daniel L.; Gul, Ahmet			Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERLEUKIN-10 RECEPTOR; LOCI; RISK; GENE; SUSCEPTIBILITY; TRANSCRIPTION; POLYMORPHISM; PROMOTER; COLITIS	Behcet's disease is a genetically complex disease of unknown etiology characterized by recurrent inflammatory attacks affecting the orogenital mucosa, eyes and skin. We performed a genome-wide association study with 311,459 SNPs in 1,215 individuals with Behcet's disease (cases) and 1,278 healthy controls from Turkey. We confirmed the known association of Behcet's disease with HLA-B*51 and identified a second, independent association within the MHC Class I region. We also identified an association at IL10 (rs1518111, P = 1.88 x 10(-8)). Using a meta-analysis with an additional five cohorts from Turkey, the Middle East, Europe and Asia, comprising a total of 2,430 cases and 2,660 controls, we identified associations at IL10 (rs1518111, P = 3.54 x 10(-18), odds ratio = 1.45, 95% CI 1.34-1.58) and the IL23R-IL12RB2 locus (rs924080, P = 6.69 x 10(-9), OR = 1.28, 95% CI 1.18-1.39). The disease-associated IL10 variant (the rs1518111 A allele) was associated with diminished mRNA expression and low protein production.	[Remmers, Elaine F.; Kirino, Yohei; Ombrello, Michael J.; Satorius, Colleen; Le, Julie M.; Korman, Benjamin D.; Kastner, Daniel L.] NIAMSD, Clin Invest Lab, Bethesda, MD 20892 USA; [Cosan, Fulya; Erer, Burak; Gul, Ahmet] Istanbul Univ, Dept Internal Med, Istanbul Fac Med, Div Rheumatol, Istanbul, Turkey; [Abaci, Neslihan; Cakiris, Aris; Aglar, Oznur; Emrence, Zeliha; Azakli, Hulya; Ustek, Duran; Gul, Ahmet] Istanbul Univ, Dept Genet, Inst Expt Med, Istanbul, Turkey; [Yang, Barbara; Dizon, Michael B.; Gadina, Massimo] NIAMSD, Translat Immunol Sect, Off Sci & Technol, Bethesda, MD 20892 USA; [Tugal-Tutkun, Ilknur] Istanbul Univ, Istanbul Fac Med, Dept Ophthalmol, Istanbul, Turkey; [Akman-Demir, Gulsen] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Chen, Wei; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kose, Afet Akdag; Azizlerli, Gulsevim] Istanbul Univ, Dept Dermatol, Istanbul Fac Med, Istanbul, Turkey; [Brand, Oliver J.] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kaklamani, Virginia G.] Northwestern Univ, Translat Breast Canc Res Div Hematol & Oncol, Chicago, IL 60611 USA; [Kaklamanis, Phaedon] Athens Med Ctr, Dept Rheumatol, Athens, Greece; [Ben-Chetrit, Eldad] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel; [Stanford, Miles] Kings Coll London, London WC2R 2LS, England; [Fortune, Farida] Queen Marys Coll, London, England; [Ghabra, Marwen] Univ Hosp, Damascus, Syria; [Ollier, William E. R.] Univ Manchester, Ctr Integrated Genom Med Res, Sch Immun & Infect, Manchester, Lancs, England; [Cho, Young-Hun] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Bang, Dongsik] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [O'Shea, John] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Wallace, Graham R.] Univ Birmingham, Acad Unit Ophthalmol, Birmingham, W Midlands, England	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Istanbul University; Istanbul University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Istanbul University; Istanbul University; University of Texas System; UTMD Anderson Cancer Center; Istanbul University; University of Birmingham; Northwestern University; Hebrew University of Jerusalem; Hadassah University Medical Center; University of London; King's College London; University of London; Queen Mary University London; University of Manchester; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Birmingham	Remmers, EF (corresponding author), NIAMSD, Clin Invest Lab, Bethesda, MD 20892 USA.	remmerse@mail.nih.gov	abacı, neslihan/AAD-5036-2020; Kirino, Yohei/B-3701-2009; Ustek, Duran/C-3484-2009; Köse, Afet Akdağ/AAY-4638-2020; Gul, Ahmet/AAT-7787-2020; Emrence, Zeliha/AAB-8563-2020; erer, burak/AAR-5866-2021; Gadina, Massimo/R-4195-2019; Cakiris, Aris/AAE-2249-2020	Kirino, Yohei/0000-0002-9488-661X; Ustek, Duran/0000-0002-0060-2859; Gul, Ahmet/0000-0001-8219-3720; Remmers, Elaine F/0000-0002-9522-1249; Yang, Barbara/0000-0001-5018-095X; Azakli, Hulya/0000-0001-6073-0724; Ombrello, Michael/0000-0003-3322-4089; Korman, Benjamin/0000-0002-4873-2628; Bang, Dongsik/0000-0002-6476-4259; Wallace, Graham/0000-0003-2054-0509	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health; Istanbul University; UK Behcet's Syndrome Society; US NIH [AR44422, PC30CA016772]; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041083, ZIAAR041139, R01AR044422, ZIAAR041162, ZIAAR041106, ZICAR041181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Istanbul University(Istanbul University); UK Behcet's Syndrome Society; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the US National Institutes of Health, by the Istanbul University Research Fund and by the UK Behcet's Syndrome Society. This work was also supported in the part by US NIH grants to C. I. A. (AR44422 and PC30CA016772). We thank all of our subjects for their enthusiastic support of our studies aiming to understand and find better treatments for Behcet's disease, and we thank O. Aksakalli and H. Ustek for their help in blood collection.	Barrett JC, 2009, COLD SPRING HARB PRO; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gul A, 2000, ANN RHEUM DIS, V59, P622, DOI 10.1136/ard.59.8.622; Gul A, 2001, ARTHRITIS RHEUM, V44, P239, DOI 10.1002/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X; International Study Group for Behcet's Disease, 1990, LANCET, V335, P1078; Kaklamani VG, 2008, J RHEUMATOL, V35, P2376, DOI 10.3899/jrheum.080676; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Temple SEL, 2003, IMMUNOGENETICS, V55, P629, DOI 10.1007/s00251-003-0621-6; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Wallace GR, 2007, HUM IMMUNOL, V68, P122, DOI 10.1016/j.humimm.2006.11.010	24	476	500	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2010	42	8					698	U78		10.1038/ng.625	http://dx.doi.org/10.1038/ng.625			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622878	Green Submitted, Green Accepted			2022-12-25	WOS:000280524000015
J	Singer, JB; Lewitzky, S; Leroy, E; Yang, F; Zhao, XJ; Klickstein, L; Wright, TM; Meyer, J; Paulding, CA				Singer, Jonathan B.; Lewitzky, Steve; Leroy, Elisabeth; Yang, Fan; Zhao, Xiaojun; Klickstein, Lloyd; Wright, Timothy M.; Meyer, Joanne; Paulding, Charles A.			A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury	NATURE GENETICS			English	Article							THERAPEUTIC ARTHRITIS RESEARCH; RANDOMIZED CONTROLLED-TRIAL; HYPERSENSITIVITY; HEPATOTOXICITY; ABACAVIR; EVENT; HLA-B-ASTERISK-5701; OSTEOARTHRITIS; PATHOGENESIS; IBUPROFEN	Lumiracoxib is a selective cyclooxygenase-2 inhibitor developed for the symptomatic treatment of osteoarthritis and acute pain(1). Concerns over hepatotoxicity have contributed to the withdrawal or non-approval of lumiracoxib in most major drug markets worldwide. We performed a case-control genome-wide association study on 41 lumiracoxib-treated patients with liver injury (cases) and 176 matched lumiracoxib-treated patients without liver injury (controls). Several SNPs from the MHC class II region showed strong evidence of association (the top SNP was rs9270986 with P = 2.8 x 10(-10)). These findings were replicated in an independent set of 98 lumiracoxib-treated cases and 405 matched lumiracoxib-treated controls (top SNP rs3129900, P = 4.4 x 10(-12)). Fine mapping identified a strong association to a common HLA haplotype (HLA-DRB1*1501-HLA-DQB1*0602-HLADRB5*0101-HLA-DQA1*0102, most significant allele P = 6.8 x 10(-25), allelic odds ratio = 5.0, 95% CI 3.6-7.0). These results offer the potential to improve the safety profile of lumiracoxib by identifying individuals at elevated risk for liver injury and excluding them from lumiracoxib treatment.	[Singer, Jonathan B.; Lewitzky, Steve; Leroy, Elisabeth; Yang, Fan; Zhao, Xiaojun; Klickstein, Lloyd; Wright, Timothy M.; Meyer, Joanne; Paulding, Charles A.] Novartis Inst BioMed Res, Cambridge, MA USA	Novartis	Paulding, CA (corresponding author), Novartis Inst BioMed Res, Cambridge, MA USA.	charles.paulding@novartis.com						Bannwarth B, 2007, EXPERT OPIN PHARMACO, V8, P1551, DOI 10.1517/14656566.8.10.1551; Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER) and the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA) Guidance for industry, 2009, PATIENT REPORTED OUT; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Matchaba P, 2005, CLIN THER, V27, P1196, DOI 10.1016/j.clinthera.2005.07.019; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; O'Donohue J, 2000, GUT, V47, P717, DOI 10.1136/gut.47.5.717; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Senior John R, 2007, Clin Liver Dis, V11, P507, DOI 10.1016/j.cld.2007.06.002; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Uetrecht J, 2007, ANNU REV PHARMACOL, V47, P513, DOI 10.1146/annurev.pharmtox.47.120505.105150	21	286	303	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					711	U94		10.1038/ng.632	http://dx.doi.org/10.1038/ng.632			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639878				2022-12-25	WOS:000280524000018
J	Yount, JS; Moltedo, B; Yang, YY; Charron, G; Moran, TM; Lopez, CB; Hang, HC				Yount, Jacob S.; Moltedo, Bruno; Yang, Yu-Ying; Charron, Guillaume; Moran, Thomas M.; Lopez, Carolina B.; Hang, Howard C.			Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3	NATURE CHEMICAL BIOLOGY			English	Article							DEFECTIVE INTERFERING PARTICLES; VESICULAR STOMATITIS-VIRUS; DENDRITIC CELLS; PROTEIN PALMITOYLATION; CHEMICAL REPORTERS; BACTERIAL; EVASION; MICE	Identification of immune effectors and the post-translational modifications that control their activity is essential for dissecting mechanisms of immunity. Here we demonstrate that the antiviral activity of interferon-induced transmembrane protein 3 (IFITM3) is post-translationally regulated by S-palmitoylation. Large-scale profiling of palmitoylated proteins in a dendritic cell line using a chemical reporter strategy revealed over 150 lipid-modified proteins with diverse cellular functions, including innate immunity. We discovered that S-palmitoylation of IFITM3 on membrane-proximal cysteines controls its clustering in membrane compartments and its antiviral activity against influenza virus. The sites of S-palmitoylation are highly conserved among the IFITM family of proteins in vertebrates, which suggests that S-palmitoylation of these immune effectors may be an ancient post-translational modification that is crucial for host resistance to viral infections. The S-palmitoylation and clustering of IFITM3 will be important for elucidating its mechanism of action and for the design of antiviral therapeutics.	[Yount, Jacob S.; Yang, Yu-Ying; Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10021 USA; [Moltedo, Bruno; Moran, Thomas M.; Lopez, Carolina B.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Hang, HC (corresponding author), Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.	hhang@rockefeller.edu	Yount, Jacob/F-9905-2014; Lopez, Carolina/A-8887-2008	Lopez, Carolina/0000-0002-7669-6572; Yount, Jacob/0000-0002-6128-4575	Cancer Research Institute; Anderson Cancer Center; US National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [AI041111, AI083284-01]; Rockefeller University; Ellison Medical Foundation; Irma T. Hirschl and Monique Weill-Caulier Trust; Lerner Trust; US National Institute of Drug Abuse of the US National Institutes of Health [1R21DA025751-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041111, R01AI083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025751] Funding Source: NIH RePORTER	Cancer Research Institute; Anderson Cancer Center; US National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rockefeller University; Ellison Medical Foundation(Lawrence Ellison Foundation); Irma T. Hirschl and Monique Weill-Caulier Trust; Lerner Trust; US National Institute of Drug Abuse of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	J.S.Y. is a postdoctoral fellow of the Irving Institute Fellowship Program of the Cancer Research Institute. Y.-Y.Y. was supported in part by the Anderson Cancer Center postdoctoral fellowship. G.C. acknowledges the Weill-Cornell/Rockefeller/Sloan-Kettering Tri-institutional Program in Chemical Biology. The authors would like to thank A. Li for technical support. T.M.M. is supported by grant AI041111 and C.B.L. is supported by grant AI083284-01, both from the US National Institute of Allergy and Infectious Diseases of the US National Institutes of Health. H.C.H. acknowledges support from The Rockefeller University, Ellison Medical Foundation, Irma T. Hirschl and Monique Weill-Caulier Trust, Lerner Trust and the US National Institute of Drug Abuse of the US National Institutes of Health (1R21DA025751-01).	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Alber D, 1996, J INTERF CYTOK RES, V16, P375, DOI 10.1089/jir.1996.16.375; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Shen ZH, 1997, J IMMUNOL, V158, P2723; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; VEIT M, 1989, VIROLOGY, V168, P173, DOI 10.1016/0042-6822(89)90417-0; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yang YY, 2010, J AM CHEM SOC, V132, P3640, DOI 10.1021/ja908871t; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	32	264	277	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					610	614		10.1038/NCHEMBIO.405	http://dx.doi.org/10.1038/NCHEMBIO.405			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20601941	Green Accepted			2022-12-25	WOS:000280096600012
J	Weber, C				Weber, Christian			Far from the Heart: Receptor cross-talk in remote conditioning	NATURE MEDICINE			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; INJURY; TRIAL; KAPPA; DELTA; CCR5; MU		[Weber, Christian] Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, D-5100 Aachen, Germany; [Weber, Christian] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	RWTH Aachen University; Maastricht University	Weber, C (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res, D-5100 Aachen, Germany.	cweber@ukaachen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714				Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Liehn EA, 2008, J CELL MOL MED, V12, P496, DOI 10.1111/j.1582-4934.2007.00194.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Peart JN, 2004, BASIC RES CARDIOL, V99, P29, DOI 10.1007/s00395-003-0430-y; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rentoukas I, 2010, JACC-CARDIOVASC INTE, V3, P49, DOI 10.1016/j.jcin.2009.10.015; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Weinbrenner C, 2004, CARDIOVASC RES, V61, P591, DOI 10.1016/j.cardiores.2003.10.008	16	30	32	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					760	762		10.1038/nm0710-760	http://dx.doi.org/10.1038/nm0710-760			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613755				2022-12-25	WOS:000279631900024
J	Singh, M; Lima, A; Molina, R; Hamilton, P; Clermont, AC; Devasthali, V; Thompson, JD; Cheng, JH; Reslan, HB; Ho, CCK; Cao, TC; Lee, CV; Nannini, MA; Fuh, G; Carano, RAD; Koeppen, H; Yu, RX; Forrest, WF; Plowman, GD; Johnson, L				Singh, Mallika; Lima, Anthony; Molina, Rafael; Hamilton, Patricia; Clermont, Anne C.; Devasthali, Vidusha; Thompson, Jennifer D.; Cheng, Jason H.; Reslan, Hani Bou; Ho, Calvin C. K.; Cao, Timothy C.; Lee, Chingwei V.; Nannini, Michelle A.; Fuh, Germaine; Carano, Richard A. D.; Koeppen, Hartmut; Yu, Ron X.; Forrest, William F.; Plowman, Gregory D.; Johnson, Leisa			Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; TYROSINE KINASE INHIBITORS; ADVANCED PANCREATIC-CANCER; HUMAN TUMOR XENOGRAFTS; PLUS GEMCITABINE; LUNG; EGFR; CHEMOTHERAPY; BEVACIZUMAB	The low rate of approval of novel anti-cancer agents underscores the need for better preclinical models of therapeutic response as neither xenografts nor early-generation genetically engineered mouse models (GEMMs) reliably predict human clinical outcomes. Whereas recent, sporadic GEMMs emulate many aspects of their human disease counterpart more closely, their ability to predict clinical therapeutic responses has never been tested systematically. We evaluated the utility of two state-of-the-art, mutant Kras-driven GEMMs-one of non-small-cell lung carcinoma and another of pancreatic adenocarcinoma-by assessing responses to existing standard-of-care chemotherapeutics, and subsequently in combination with EGFR and VEGF inhibitors. Standard clinical endpoints were modeled to evaluate efficacy, including overall survival and progression-free survival using noninvasive imaging modalities. Comparisons with corresponding clinical trials indicate that these GEMMs model human responses well, and lay the foundation for the use of validated GEMMs in predicting outcome and interrogating mechanisms of therapeutic response and resistance. (C) 2010 Nature America, Inc. All rights reserved.	[Singh, Mallika; Lima, Anthony; Molina, Rafael; Hamilton, Patricia; Clermont, Anne C.; Devasthali, Vidusha; Thompson, Jennifer D.; Cheng, Jason H.; Johnson, Leisa] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Reslan, Hani Bou; Ho, Calvin C. K.; Cao, Timothy C.; Carano, Richard A. D.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Lee, Chingwei V.; Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Nannini, Michelle A.] Genentech Inc, Dept Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Yu, Ron X.; Forrest, William F.] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Plowman, Gregory D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Singh, M (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	msingh@gene.com; leisaj@gene.com	PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X				Abate-Shen C, 2006, CLIN CANCER RES, V12, P5274, DOI 10.1158/1078-0432.CCR-06-0500; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alley MC, 2004, CANC DRUG DISC DEV, P125; Baselga J, 2008, J CLIN ONCOL, V26, P1582, DOI 10.1200/JCO.2007.15.3700; Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Brugger W, 2009, J CLIN ONCOL, V27; Cappuzzo F, 2009, J CLIN ONCOL, V27; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Collett D, 1994, MODELLING SURVIVAL D; Cook N, 2008, METHOD ENZYMOL, V439, P73, DOI 10.1016/S0076-6879(07)00406-5; Davies AM, 2006, CLIN LUNG CANCER, V7, P385, DOI 10.3816/CLC.2006.n.021; De Clerck NM, 2004, NEOPLASIA, V6, P374, DOI 10.1593/neo.03481; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Graham KC, 2005, CANCER RES, V65, P5231, DOI 10.1158/0008-5472.CAN-05-0440; HAINSWORTH J, 2008, J THORAC ONCOL, V3, pS302; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; HERBST RS, 2009, 100 ANN M AM ASS CAN; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hsu J, 1996, MULTIPLE COMP; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kindler HL, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.12.0949; Kindler HL, 2005, J CLIN ONCOL, V23, P8033, DOI 10.1200/JCO.2005.01.9661; Ko AH, 2008, INVEST NEW DRUG, V26, P463, DOI 10.1007/s10637-008-9127-2; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laurent-Puig P, 2008, CURR OPIN ONCOL, V20, P454, DOI 10.1097/CCO.0b013e32830218d6; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lim EH, 2009, J THORAC ONCOL, V4, P12, DOI 10.1097/JTO.0b013e3181913e28; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Miller VA, 2009, J CLIN ONCOL, V27; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Pazdur R, 2008, ONCOLOGIST, V13, P19, DOI 10.1634/theoncologist.13-S2-19; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; *RDEVELOPMENTCORET, 2008, LANG ENV STAT COMP; Rozenblum E, 1997, CANCER RES, V57, P1731; Ruiz MIG, 2009, BRIT J CANCER, V100, P145, DOI 10.1038/sj.bjc.6604781; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Singh M, 2006, CLIN CANCER RES, V12, P5312, DOI 10.1158/1078-0432.CCR-06-0437; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Therneau T, 2008, SURVIVAL SURVIVAL AN; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tortora G, 2008, NAT CLIN PRACT ONCOL, V5, P521, DOI 10.1038/ncponc1161; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Varmus H, 2005, COLD SH Q B, V70, P1, DOI 10.1101/sqb.2005.70.039; Wirtzfeld LA, 2005, CANCER RES, V65, P6337, DOI 10.1158/0008-5472.CAN-05-0414; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Yang Y, 2008, MOL CANCER THER, V7, P952, DOI 10.1158/1535-7163.MCT-07-2045; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	67	188	194	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					585	U74		10.1038/nbt.1640	http://dx.doi.org/10.1038/nbt.1640			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20495549				2022-12-25	WOS:000278820200022
J	Dieterle, F; Sistare, F; Goodsaid, F; Papaluca, M; Ozer, JS; Webb, CP; Baer, W; Senagore, A; Schipper, MJ; Vonderscher, J; Sultana, S; Gerhold, DL; Phillips, JA; Maurer, G; Carl, K; Laurie, D; Harpur, E; Sonee, M; Ennulat, D; Holder, D; Andrews-Cleavenger, D; Gu, YZ; Thompson, KL; Goering, PL; Vidal, JM; Abadie, E; Maciulaitis, R; Jacobson-Kram, D; Defelice, AF; Hausner, EA; Blank, M; Thompson, A; Harlow, P; Throckmorton, D; Xiao, S; Xu, N; Taylor, W; Vamvakas, S; Flamion, B; Lima, BS; Kasper, P; Pasanen, M; Prasad, K; Troth, S; Bounous, D; Robinson-Gravatt, D; Betton, G; Davis, MA; Akunda, J; McDuffie, JE; Suter, L; Obert, L; Guffroy, M; Pinches, M; Jayadev, S; Blomme, EA; Beushausen, SA; Barlow, VG; Collins, N; Waring, J; Honor, D; Snook, S; Lee, JH; Rossi, P; Walker, E; Mattes, W				Dieterle, Frank; Sistare, Frank; Goodsaid, Federico; Papaluca, Marisa; Ozer, Josef S.; Webb, Craig P.; Baer, William; Senagore, Anthony; Schipper, Matthew J.; Vonderscher, Jacky; Sultana, Stefan; Gerhold, David L.; Phillips, Jonathan A.; Maurer, Gerard; Carl, Kevin; Laurie, David; Harpur, Ernie; Sonee, Manisha; Ennulat, Daniela; Holder, Dan; Andrews-Cleavenger, Dina; Gu, Yi-Zhong; Thompson, Karol L.; Goering, Peter L.; Vidal, Jean-Marc; Abadie, Eric; Maciulaitis, Romaldas; Jacobson-Kram, David; Defelice, Albert F.; Hausner, Elizabeth A.; Blank, Melanie; Thompson, Aliza; Harlow, Patricia; Throckmorton, Douglas; Xiao, Shen; Xu, Nancy; Taylor, William; Vamvakas, Spiros; Flamion, Bruno; Lima, Beatriz Silva; Kasper, Peter; Pasanen, Markku; Prasad, Krishna; Troth, Sean; Bounous, Denise; Robinson-Gravatt, Denise; Betton, Graham; Davis, Myrtle A.; Akunda, Jackie; McDuffie, James Eric; Suter, Laura; Obert, Leslie; Guffroy, Magalie; Pinches, Mark; Jayadev, Supriya; Blomme, Eric A.; Beushausen, Sven A.; Barlow, Valerie G.; Collins, Nathaniel; Waring, Jeff; Honor, David; Snook, Sandra; Lee, Jinhe; Rossi, Phil; Walker, Elizabeth; Mattes, William			Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium	NATURE BIOTECHNOLOGY			English	Article							INJURY	The first formal qualification of safety biomarkers for regulatory decision making marks a milestone in the application of biomarkers to drug development. Following submission of drug toxicity studies and analyses of biomarker performance to the Food and Drug Administration (FDA) and European Medicines Agency (EMEA) by the Predictive Safety Testing Consortium's (PSTC) Nephrotoxicity Working Group, seven renal safety biomarkers have been qualified for limited use in nonclinical and clinical drug development to help guide safety assessments. This was a pilot process, and the experience gained will both facilitate better understanding of how the qualification process will probably evolve and clarify the minimal requirements necessary to evaluate the performance of biomarkers of organ injury within specific contexts.	[Dieterle, Frank; Maurer, Gerard; Carl, Kevin; Laurie, David] Novartis Pharma AG, Basel, Switzerland; [Sistare, Frank; Ozer, Josef S.; Gerhold, David L.] Merck Res Labs, Dept Invest Lab Sci, West Point, PA USA; [Goodsaid, Federico; Thompson, Karol L.; Goering, Peter L.; Jacobson-Kram, David; Defelice, Albert F.; Hausner, Elizabeth A.; Blank, Melanie; Thompson, Aliza; Harlow, Patricia; Throckmorton, Douglas; Xiao, Shen; Xu, Nancy; Taylor, William] US FDA, Silver Spring, MD USA; [Papaluca, Marisa; Vidal, Jean-Marc; Abadie, Eric; Maciulaitis, Romaldas; Vamvakas, Spiros; Flamion, Bruno; Lima, Beatriz Silva; Kasper, Peter; Pasanen, Markku; Prasad, Krishna] European Med Agcy, London, England; [Webb, Craig P.; Baer, William; Senagore, Anthony; Schipper, Matthew J.; Sultana, Stefan] ClinXus, Grand Rapids, MI USA; [Webb, Craig P.] Van Andel Res Inst, Grand Rapids, MI USA; [Baer, William] Grand Valley Med Specialists, Grand Rapids, MI USA; [Senagore, Anthony] Spectrum Hlth, Grand Rapids, MI USA; [Schipper, Matthew J.] Innovat Analyt Inc, Kalamazoo, MI USA; [Vonderscher, Jacky; Suter, Laura] Hoffmann La Roche AG, Basel, Switzerland; [Phillips, Jonathan A.; Jayadev, Supriya] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Harpur, Ernie; Guffroy, Magalie; Barlow, Valerie G.] Sanofi Aventis, Malvern, PA USA; [Sonee, Manisha; McDuffie, James Eric; Snook, Sandra] Johnson & Johnson, San Diego, CA USA; [Ennulat, Daniela] GlaxoSmith, King Of Prussia, PA USA; [Holder, Dan] Merck Res Labs, Dept Biometr, West Point, PA USA; [Andrews-Cleavenger, Dina] Amgen Inc, Thousand Oaks, CA 91320 USA; [Gu, Yi-Zhong; Collins, Nathaniel] Schering Plough Res Inst, Summit, NJ USA; [Maciulaitis, Romaldas] Kaunas Med Univ, Dept Basic & Clin Pharmacol, Nephrol Clin Kaunas Med Univ Clin, Kaunas, Lithuania; [Maciulaitis, Romaldas] State Med Control Agcy, Kaunas, Lithuania; [Pasanen, Markku] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland; [Troth, Sean] Merck Res Labs, Dept Pathol, West Point, PA USA; [Bounous, Denise] Bristol Myers Squibb Co, Princeton, NJ USA; [Robinson-Gravatt, Denise; Obert, Leslie; Beushausen, Sven A.] Pfizer Inc, Groton, CT 06340 USA; [Betton, Graham; Pinches, Mark] AstraZeneca, Macclesfield, Cheshire, England; [Davis, Myrtle A.] NCI, Natl Inst Hlth, Bethesda, MD 20892 USA; [Akunda, Jackie] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Blomme, Eric A.; Waring, Jeff; Honor, David; Lee, Jinhe] Abbott Labs, Abbott Pk, IL 60064 USA; [Rossi, Phil; Walker, Elizabeth; Mattes, William] Crit Path Inst, Tucson, AZ USA	Novartis; Merck & Company; US Food & Drug Administration (FDA); Van Andel Institute; Grand Valley State University; Michigan State University; Michigan State University College of Human Medicine; Roche Holding; Boehringer Ingelheim; Sanofi-Aventis; Johnson & Johnson; Johnson & Johnson USA; GlaxoSmithKline; Merck & Company; Amgen; Merck & Company; Schering-Plough Research Institute; Lithuanian University of Health Sciences; University of Eastern Finland; Merck & Company; Bristol-Myers Squibb; Pfizer; AstraZeneca; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Eli Lilly; Abbott Laboratories	Dieterle, F (corresponding author), Novartis Pharma AG, Basel, Switzerland.	frank.dieterle@novartis.com	Webb, Craig/I-8123-2012; Papaluca, Marisa/GWZ-2025-2022; Blomme, Eric/GQZ-8372-2022; Troth, Sean P./R-6885-2019; Lima, Beatriz Silva/A-4284-2014; Suter-Dick, Laura/A-9093-2019	Troth, Sean P./0000-0002-4696-5129; Lima, Beatriz Silva/0000-0003-0910-7245; Suter-Dick, Laura/0000-0002-1449-3913; Gerhold, David/0000-0001-5739-730X; Maurer, Gerald/0000-0002-9043-7657; Phillips, Jonathan/0000-0001-7290-754X; Maciulaitis, Romaldas/0000-0003-0106-4033; Mattes, William/0000-0001-8653-4289				Altar CA, 2008, CLIN PHARMACOL THER, V83, P368, DOI 10.1038/sj.clpt.6100451; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Goodsaid F, 2010, NAT BIOTECHNOL, V28, P441, DOI 10.1038/nbt0510-441; Harrell FE, 2001, REGRESSION MODELING; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Ozer JS, 2010, NAT BIOTECHNOL, V28, P486, DOI 10.1038/nbt.1627; Sistare FD, 2010, NAT BIOTECHNOL, V28, P446, DOI 10.1038/nbt.1634; Trof RJ, 2006, SHOCK, V26, P245, DOI 10.1097/01.shk.0000225415.5969694.ce; Varghese SA, 2007, J AM SOC NEPHROL, V18, P913, DOI 10.1681/ASN.2006070767	12	298	320	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					455	462		10.1038/nbt.1625	http://dx.doi.org/10.1038/nbt.1625			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458315				2022-12-25	WOS:000277452700025
J	Lagos, D; Pollara, G; Henderson, S; Gratrix, F; Fabani, M; Milne, RSB; Gotch, F; Boshoff, C				Lagos, Dimitrios; Pollara, Gabriel; Henderson, Stephen; Gratrix, Fiona; Fabani, Martin; Milne, Richard S. B.; Gotch, Frances; Boshoff, Chris			miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; KAPOSI-SARCOMA; TARGET RECOGNITION; INDUCED MICRORNA; HERPESVIRUS; CREB; CELLS; PHOSPHORYLATION; ACTIVATION; RESPONSES	MicroRNAs are small, non-coding RNAs that negatively regulate gene expression(1). It has been proposed that microRNAs could function in the regulation of innate immunity(2,3), but this has not been demonstrated for viral infection. Here we test this hypothesis using the human pathogenic virus Kaposi's sarcoma-associated herpesvirus (KSHV) and one of its putative natural cellular targets, primary lymphatic endothelial cells(4) (LECs). We show that an early antiviral microRNA response (6 h post-infection) includes expression of microRNAs that enhance viral gene expression. In particular, the CREB-induced miR-132 microRNA is highly upregulated after infection and has a negative effect on the expression of interferon-stimulated genes, facilitating viral replication. We show a similar function for miR-132 during infection of monocytes with herpes simplex virus-1 (HSV-1) and human cytomegalovirus (HCMV). miR-132 regulates innate antiviral immunity by inhibiting expression of the p300 transcriptional co-activator. p300 is downregulated early after KSHV infection, and inhibition of miR-132 induction restores p300 expression. Furthermore, p300 regulates miR-132 levels, revealing a dynamic equilibrium between miR-132 and p300. By targeting p300, rather than a transcription factor or signalling protein, miR-132 has a broad role in the regulation of antiviral immunity.	[Lagos, Dimitrios; Pollara, Gabriel; Henderson, Stephen; Gratrix, Fiona; Boshoff, Chris] UCL, UCL Canc Inst, Canc Res UK Viral Oncol Grp, London WC1E 6BT, England; [Fabani, Martin] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Milne, Richard S. B.] UCL, Royal Free Hosp, UCL Ctr Virol, London NW3 2PF, England; [Gotch, Frances] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England	Cancer Research UK; University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London	Lagos, D (corresponding author), UCL, UCL Canc Inst, Canc Res UK Viral Oncol Grp, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.	d.lagos@ucl.ac.uk; c.boshoff@ucl.ac.uk		Henderson, Stephen/0000-0002-9032-3828; Lagos, Dimitris/0000-0003-0637-281X	U.K. Medical Research Council; Cancer Research U.K; Medical Research Council [MC_U105178803, G0501957, G0800168] Funding Source: researchfish; MRC [G0501957, MC_U105178803, G0800168] Funding Source: UKRI	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research U.K(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the U.K. Medical Research Council and Cancer Research U.K. We thank G. Wilkinson and R. Stanton for providing HCMV and C. Atkinson for help with HCMV qPCR. We are grateful to members of the Cancer Research UK Viral Oncology Group, in particular J. Funes and V. Emuss for advice and discussions.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fabani MM, 2008, RNA, V14, P336, DOI 10.1261/rna.844108; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li M, 2000, MOL CELL BIOL, V20, P8254, DOI 10.1128/MCB.20.21.8254-8263.2000; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin RT, 2001, ONCOGENE, V20, P800, DOI 10.1038/sj.onc.1204163; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	40	260	280	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					513	U232		10.1038/ncb2054	http://dx.doi.org/10.1038/ncb2054			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418869				2022-12-25	WOS:000277283700018
J	Rivero, FD; Saura, A; Prucca, CG; Carranza, PG; Torri, A; Lujan, HD				Rivero, Fernando D.; Saura, Alicia; Prucca, Cesar G.; Carranza, Pedro G.; Torri, Alessandro; Lujan, Hugo D.			Disruption of antigenic variation is crucial for effective parasite vaccine	NATURE MEDICINE			English	Article							GIARDIA-LAMBLIA TROPHOZOITES; EXPERIMENTAL HUMAN INFECTIONS; MURIS TROPHOZOITES; MONGOLIAN GERBILS; SURFACE-PROTEINS; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSE; MICE; SUSCEPTIBILITY; DUODENALIS	Giardia lamblia is a human intestinal pathogen. Like many protozoan microorganisms, Giardia undergoes antigenic variation, a mechanism assumed to allow parasites to evade the host's immune response, producing chronic and/or recurrent infections. Recently, we found that the mechanism controlling variant-specific surface protein (VSP) switching in Giardia involves components of the RNA interference machinery and that disruption of this pathway generates trophozoites simultaneously expressing many VSPs. Here we use these altered trophozoites to determine the role of antigenic variation in a gerbil model of giardiasis. Our results show that either primary infection with trophozoites simultaneously expressing many VSPs or immunization with purified VSPs from the transgenic cells protects gerbils from subsequent Giardia infections. These results constitute, to our knowledge, the first experimental evidence that antigenic variation is essential for parasite survival within hosts and that artificial disruption of this mechanism might be useful in generating vaccines against major pathogens that show similar behavior.	[Rivero, Fernando D.; Saura, Alicia; Prucca, Cesar G.; Carranza, Pedro G.; Torri, Alessandro; Lujan, Hugo D.] Catholic Univ Cordoba, Lab Biochem & Mol Biol, Sch Med, Cordoba, Argentina	Catholic University of Cordoba	Lujan, HD (corresponding author), Catholic Univ Cordoba, Lab Biochem & Mol Biol, Sch Med, Cordoba, Argentina.	hlujan@ucc.edu.ar	Prucca, César Germán/AAC-4630-2021; Prucca, César/AAQ-4401-2020; RIVERO, Fernando/AFV-5689-2022	Prucca, César Germán/0000-0003-4165-4660; Torri, Alessandro/0000-0001-6340-5572	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Catholic University of Cordoba; Howard Hughes Medical Institute; EU	Agencia Nacional para la Promocion de la Ciencia y la Tecnologia; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Catholic University of Cordoba; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EU(European Commission)	We thank T. E. Nash (National Institute of Allergy and Infectious Diseases, US National Institutes of Health) for providing VSP-specific mAbs and Giardia strains and M. E. Rivarola and the Pathology Service of the School of Medicine, Catholic University of Cordoba, for technical assistance. This work was supported by grants from the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Catholic University of Cordoba, the Howard Hughes Medical Institute and the EU CONTENT Project. H. D. L. is a Howard Hughes Medical Institute International Research Scholar and a Member of the Scientific Investigator's Career of the Consejo Nacional de Investigaciones Cientificas y Tecnicas.	ADAM RD, 1988, J EXP MED, V167, P109, DOI 10.1084/jem.167.1.109; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AGGARWAL A, 1988, INFECT IMMUN, V56, P1420, DOI 10.1128/IAI.56.6.1420-1423.1988; AGGARWAL A, 1987, AM J TROP MED HYG, V36, P325, DOI 10.4269/ajtmh.1987.36.325; ANDERS RF, 1982, PARASITE IMMUNOL, V4, P47, DOI 10.1111/j.1365-3024.1982.tb00419.x; Anderson KA, 2004, CAN VET J, V45, P924; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; BELOSEVIC M, 1987, PARASITE IMMUNOL, V9, P11, DOI 10.1111/j.1365-3024.1987.tb00484.x; Bouza M, 2000, EXP PARASITOL, V96, P43, DOI 10.1006/expr.2000.4540; BURET A, 1992, GASTROENTEROLOGY, V103, P506, DOI 10.1016/0016-5085(92)90840-U; Buret AG, 2008, PARASITE, V15, P261, DOI 10.1051/parasite/2008153261; BUTSCHER WG, 1988, IMMUNOLOGY, V64, P175; BYRD LG, 1994, INFECT IMMUN, V62, P3583, DOI 10.1128/IAI.62.8.3583-3585.1994; Carranza PG, 2002, INFECT IMMUN, V70, P5265, DOI 10.1128/IAI.70.9.5265-5268.2002; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; DENG MY, 1992, APPL ENVIRON MICROB, V58, P2368, DOI 10.1128/AEM.58.8.2368-2374.1992; Deselliers LP, 1997, DIGEST DIS SCI, V42, P2411, DOI 10.1023/A:1018879621272; Dunn LA, 2001, INFECT IMMUN, V69, P6503, DOI 10.1128/IAI.69.10.6503-6510.2001; Eckmann L, 2003, PARASITE IMMUNOL, V25, P259, DOI 10.1046/j.1365-3024.2003.00634.x; Faubert G, 2000, CLIN MICROBIOL REV, V13, P35, DOI 10.1128/CMR.13.1.35-54.2000; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; GOTTSTEIN B, 1993, PARASITOL RES, V79, P644, DOI 10.1007/BF00932506; GOTTSTEIN B, 1991, PARASITE IMMUNOL, V13, P649, DOI 10.1111/j.1365-3024.1991.tb00560.x; Hemphill A, 1996, PARASITOL RES, V82, P206, DOI 10.1007/s004360050096; HEYWORTH MF, 1992, J PARASITOL, V78, P73, DOI 10.2307/3283690; HILL DR, 1984, J IMMUNOL, V132, P2046; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; LUJAN HD, 1995, J BIOL CHEM, V270, P13807, DOI 10.1074/jbc.270.23.13807; Mann JFS, 2009, EXPERT REV VACCINES, V8, P103, DOI 10.1586/14760584.8.1.103; Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOSS DM, 1990, J CLIN MICROBIOL, V28, P254, DOI 10.1128/JCM.28.2.254-257.1990; MOWATT MR, 1991, MOL BIOCHEM PARASIT, V49, P215, DOI 10.1016/0166-6851(91)90065-E; Muller N, 2005, INT J PARASITOL, V35, P1339, DOI 10.1016/j.ijpara.2005.07.008; NASH T, 1992, PARASITOL TODAY, V8, P229, DOI 10.1016/0169-4758(92)90119-M; NASH TE, 1990, J IMMUNOL, V144, P4362; NASH TE, 1987, J INFECT DIS, V156, P974, DOI 10.1093/infdis/156.6.974; Nash TE, 2002, MOL MICROBIOL, V45, P585, DOI 10.1046/j.1365-2958.2002.03029.x; NASH TE, 1991, INFECT IMMUN, V59, P1334, DOI 10.1128/IAI.59.4.1334-1340.1991; Nash TE, 1997, PHILOS T R SOC B, V352, P1369, DOI 10.1098/rstb.1997.0122; NASH TE, 1986, J IMMUNOL, V136, P2628; Olson ME, 2000, PARASITOL TODAY, V16, P213, DOI 10.1016/S0169-4758(99)01623-3; Olson ME, 1997, CAN VET J, V38, P777; PIMENTA PFP, 1991, INFECT IMMUN, V59, P3989, DOI 10.1128/IAI.59.11.3989-3996.1991; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Ropolo AS, 2005, INFECT IMMUN, V73, P5208, DOI 10.1128/IAI.73.8.5208-5211.2005; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Stager S, 1998, INFECT IMMUN, V66, P1287; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; Uehlinger FD, 2007, VET PARASITOL, V146, P182, DOI 10.1016/j.vetpar.2007.01.013; UPCROFT JA, 1990, INT J PARASITOL, V20, P489, DOI 10.1016/0020-7519(90)90196-T; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Zarnbrano-Villa S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4	58	51	56	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					551	U83		10.1038/nm.2141	http://dx.doi.org/10.1038/nm.2141			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418884				2022-12-25	WOS:000277394700033
J	Zhang, WK; Wang, D; Duan, YY; Loy, MMT; Chan, HC; Huang, PB				Zhang, Wei Kevin; Wang, Dong; Duan, Yuanyuan; Loy, Michael M. T.; Chan, Hsiao Chang; Huang, Pingbo			Mechanosensitive gating of CFTR	NATURE CELL BIOLOGY			English	Article							REGULATORY VOLUME DECREASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; POTASSIUM CHANNELS; PRIMARY CULTURES; APICAL MEMBRANE; CATION CHANNEL; MOUSE NEPHRON; MODEL	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion and intracellular ligand-gated channel associated with cystic fibrosis, a lethal genetic disorder common among Caucasians(1). Here we show that CFTR is robustly activated by membrane stretch induced by negative pressures as small as 5 mmHg at the single-channel, cellular and tissue levels. Stretch increased the product of the number of channels present and probability of being open (NPo), and also increased the unitary conductance of CFTR in cell-attached membrane patches. CFTR stretch-mediated activation appears to be an intrinsic property independent of cytosolic factors and kinase signalling. CFTR stretch-mediated activation resulted in chloride transport in Calu-3 human airway epithelial cells and mouse intestinal tissues. Our study has revealed an unexpected function of CFTR in mechanosensing, in addition to its roles as a ligand-gated anion channel(1) and a regulator of other membrane transporters(2), demonstrating for the first time a mechanosensitive anion channel with a clearly defined molecular identity. Given that CFTR is often found in mechanically dynamic environments, its mechanosensitivity has important physiological implications in epithelial ion transport and cell volume regulation in vivo.	[Zhang, Wei Kevin; Loy, Michael M. T.; Huang, Pingbo] Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Wei Kevin; Wang, Dong; Duan, Yuanyuan; Huang, Pingbo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Loy, Michael M. T.] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med, Minist Educ China,Sch Biomed Sci,Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong; Ministry of Education, China	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Hong Kong, Hong Kong, Peoples R China.	bohuangp@ust.hk	Huang, Pingbo/I-1127-2019; Zhang, Wei/M-4241-2019; Chan, Hsiao Chang/E-1507-2016	Huang, Pingbo/0000-0002-4560-8760; Zhang, Wei/0000-0003-4960-6137; 	Hong Kong Research Grants Council [GRF661009]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	We thank R. Madhavan for stimulating discussion, J.M. Stutts for critical reading of the manuscript and Changyan Xie for assistance in manuscript preparation. This work was supported by the Hong Kong Research Grants Council grant GRF661009 (to P.H.).	Azizi F, 1997, EXP LUNG RES, V23, P257, DOI 10.3109/01902149709087371; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Barriere H, 2003, AM J PHYSIOL-RENAL, V284, pF796, DOI 10.1152/ajprenal.00237.2002; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; CHANG WH, 1992, J EXP BIOL, V169, P87; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1996, AM J PHYSIOL, V270, P259; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fischer H, 1998, PFLUG ARCH EUR J PHY, V436, P175, DOI 10.1007/s004240050620; FISCHER H, 1994, J GEN PHYSIOL, V104, P541, DOI 10.1085/jgp.104.3.541; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; HALE T, 2004, EXERCISE PHYSL THEMA; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; HAWS C, 1992, AM J PHYSIOL, V263, P692; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; KONDO M, 1992, AM J PHYSIOL, V262, P176; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; Muhm JM, 2007, NEW ENGL J MED, V357, P18, DOI 10.1056/NEJMoa062770; Sardini A, 2003, BBA-BIOMEMBRANES, V1618, P153, DOI 10.1016/j.bbamem.2003.10.008; Schultz B. D., 1999, Physiological Reviews, V79, pS109; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; Valverde MA, 2000, CELL PHYSIOL BIOCHEM, V10, P321, DOI 10.1159/000016365; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Yao XQ, 2001, BBA-BIOMEMBRANES, V1511, P381, DOI 10.1016/S0005-2736(01)00300-5	40	57	59	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					507	U214		10.1038/ncb2053	http://dx.doi.org/10.1038/ncb2053			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20400957				2022-12-25	WOS:000277283700017
J	Chatterjee, C; McGinty, RK; Fierz, B; Muir, TW				Chatterjee, Champak; McGinty, Robert K.; Fierz, Beat; Muir, Tom W.			Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; RING DOMAIN; H2B; METHYLATION; UBIQUITIN; CHROMATIN	We have developed a readily accessible disulfide-directed methodology for the site-specific modification of histones by ubiquitin and ubiquitin-like proteins. The disulfide-linked analog of mono-ubiquitylated H2B stimulated the H3K79 methyltransferase activity of hDot1L to a similar extent as the native isopeptide linkage. This permitted structure-activity studies of ubiquitylated mononucleosomes that revealed plasticity in the mechanism of hDot1L stimulation and identified surfaces of ubiquitin important for activation.	[Chatterjee, Champak; McGinty, Robert K.; Fierz, Beat; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA	Rockefeller University	Chatterjee, C (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Chatterjee, Champak/R-7214-2017; Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044	US National Institutes of Health [RC2CA148354]; Starr Cancer Consortium; Novartis; Swiss National Science Foundations; US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Novartis(Novartis); Swiss National Science Foundations(Swiss National Science Foundation (SNSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge J. Fernandez, L. Miller and R. Angeletti for assistance with ESI-MS analysis. We thank J. Kim and R. Subramanian for help in preparing hDot1 and M. Pratt for stimulating discussions. This work was funded by the US National Institutes of Health (grant number RC2CA148354) and the Starr Cancer Consortium. B. F. was supported by the Novartis and Swiss National Science Foundations. R. K. M. was supported by a US National Institutes of Health Medical Scientist Training Program grant.	Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Rabanal F, 1996, TETRAHEDRON LETT, V37, P1347, DOI 10.1016/0040-4039(96)00019-6; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	23	195	200	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					267	269		10.1038/NCHEMBIO.315	http://dx.doi.org/10.1038/NCHEMBIO.315			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20208522				2022-12-25	WOS:000275734000010
J	Hotamisligil, GS				Hotamisligil, Goekhan S.			Endoplasmic reticulum stress and atherosclerosis	NATURE MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; ER STRESS; DEFICIENT MICE; APOLIPOPROTEIN-E; ADIPOSE-TISSUE; T-CELLS; OBESITY; APOPTOSIS; INFLAMMATION	Atherosclerosis and related cardiovascular diseases represent one of the greatest threats to human health worldwide. Despite important progress in prevention and treatment, these conditions still account for one third of all deaths annually. Often presented together with obesity, insulin resistance and type 2 diabetes, these chronic diseases are strongly influenced by pathways that lie at the interface of chronic inflammation and nutrient metabolism. Here I discuss recent advances in the study of endoplasmic reticulum stress as one mechanism that links immune response with nutrient sensing in the pathogenesis of atherosclerosis and its complications.	[Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Complex Dis, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Broad Inst, Massachusetts Inst Technol & Harvard, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK052539, R01DK064360] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052539-11, R01 DK064360, R01 DK064360-07, R01 DK052539] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AQEL NM, 1984, ATHEROSCLEROSIS, V53, P265, DOI 10.1016/0021-9150(84)90127-8; Baumgartl J, 2006, CELL METAB, V3, P247, DOI 10.1016/j.cmet.2006.02.010; Bowes AJ, 2009, AM J PATHOL, V174, P330, DOI 10.2353/ajpath.2009.080385; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Libby P, 2009, J LIPID RES, V50, pS352, DOI 10.1194/jlr.R800099-JLR200; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI [10.1089/ars.2009.2469, 10.1089/ARS.2009.2469]; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu K, 2009, ATHEROSCLEROSIS, V207, P123, DOI 10.1016/j.atherosclerosis.2009.04.019; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou J, 2009, BIOFACTORS, V35, P120, DOI 10.1002/biof.17	50	219	232	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					396	399		10.1038/nm0410-396	http://dx.doi.org/10.1038/nm0410-396			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376052	Green Accepted			2022-12-25	WOS:000276446800041
J	Newgard, CB; Attie, AD				Newgard, Christopher B.; Attie, Alan D.			Getting biological about the genetics of diabetes	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; COMMON VARIANTS; OBESE; SUSCEPTIBILITY; GENES; EXPRESSION; CONTRIBUTE; LOCI; RETINOL-BINDING-PROTEIN-4; IDENTIFICATION	New technology has provided methods for collecting large amounts of data reflecting gene expression, metabolite and protein abundance, and post-translational modification of proteins. Integration of these various data sets enable the genetic mapping of many new phenotypes and facilitates the creation of network models that link genetic variation with intermediate traits leading to human disease. The first round of genome-wide association studies has not accounted for common human diseases to the extent that was expected. New phenotyping approaches and methods of data integration should bring these studies closer to their promised goals.	[Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Attie, Alan D.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA.	newga002@mc.duke.edu; adattie@wisc.edu						Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	42	27	27	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					388	391		10.1038/nm0410-388	http://dx.doi.org/10.1038/nm0410-388			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376050				2022-12-25	WOS:000276446800039
J	Lloyd, CM; Saglani, S				Lloyd, Clare M.; Saglani, Sejal			BEDSIDE TO BENCH The emerging epithelium	NATURE MEDICINE			English	Editorial Material							ASTHMA; MEPOLIZUMAB; CELLS		[Lloyd, Clare M.; Saglani, Sejal] Univ London Imperial Coll Sci Technol & Med, UK Med Res Council, Leukocyte Biol Sect, London, England; [Lloyd, Clare M.; Saglani, Sejal] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Asthma UK Ctr Allerg Mech Asthma, London, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; University of London; King's College London	Lloyd, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, UK Med Res Council, Leukocyte Biol Sect, London, England.	c.lloyd@imperial.ac.uk	Saglani, Sejal/AAE-5072-2019	Lloyd, Clare/0000-0001-8977-6726; Saglani, Sejal/0000-0001-5192-6418	Wellcome Trust [087618, 057704] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Siddiqui S, 2009, AM J RESP CRIT CARE, V180, P383, DOI 10.1164/rccm.200905-0788ED; Willis-Owen SAG, 2009, CURR ALLERGY ASTHM R, V9, P3, DOI 10.1007/s11882-009-0001-x; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	11	32	32	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					273	274		10.1038/nm0310-273	http://dx.doi.org/10.1038/nm0310-273			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20208514	Green Accepted			2022-12-25	WOS:000275289500030
J	Carnes, EC; Lopez, DM; Donegan, NP; Cheung, A; Gresham, H; Timmins, GS; Brinker, CJ				Carnes, Eric C.; Lopez, DeAnna M.; Donegan, Niles P.; Cheung, Ambrose; Gresham, Hattie; Timmins, Graham S.; Brinker, C. Jeffrey			Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria	NATURE CHEMICAL BIOLOGY			English	Article							TO-CELL COMMUNICATION; VIRULENCE; EXPRESSION; DIFFUSION; IDENTIFICATION; INFECTION; ENDOSOME; ESCAPE	It is postulated that in addition to cell density, other factors such as the dimensions and diffusional characteristics of the environment could influence quorum sensing (QS) and induction of genetic reprogramming. Modeling studies predict that QS may operate at the level of a single cell, but, owing to experimental challenges, the potential benefits of QS by individual cells remain virtually unexplored. Here we report a physical system that mimics isolation of a bacterium, such as within an endosome or phagosome during infection, and maintains cell viability under conditions of complete chemical and physical isolation. For Staphylococcus aureus, we show that quorum sensing and genetic reprogramming can occur in a single isolated organism. Quorum sensing allows S. aureus to sense confinement and to activate virulence and metabolic pathways needed for survival. To demonstrate the benefit of confinement-induced quorum sensing to individuals, we showed that quorum-sensing bacteria have significantly greater viability over non-QS bacteria.	[Carnes, Eric C.; Lopez, DeAnna M.; Brinker, C. Jeffrey] Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; [Donegan, Niles P.; Cheung, Ambrose] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol, Hanover, NH 03756 USA; [Gresham, Hattie] New Mexico Vet Adm Hlth Care Syst, Albuquerque, NM USA; [Timmins, Graham S.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Brinker, C. Jeffrey] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Brinker, C. Jeffrey] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; Dartmouth College; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories; University of New Mexico	Brinker, CJ (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA.	cjbrink@sandia.gov		timmins, graham/0000-0002-4971-718X; Donegan, Niles/0000-0002-8328-2044	US Air Force Office of Scientific Research (AFOSR) [FA 9550-07-1-0054]; US National Science Foundation [DGE-0504276]; Defense Threat Reduction Agency [B0844671]; US National Institutes of Health (NIH) [AI-037142, AI-047441]; NIH [R01 AI-064926]; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering; Sandia National Laboratories; NIH/Roadmap for Medical Research [PHS 2 PN2 EY016570B]; US Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]; NATIONAL EYE INSTITUTE [PN2EY016570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081090, R01AI064926, R01AI047441, R01AI037142] Funding Source: NIH RePORTER	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Sandia National Laboratories(United States Department of Energy (DOE)); NIH/Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.C.C. was supported by US Air Force Office of Scientific Research (AFOSR) grant FA 9550-07-1-0054 and US National Science Foundation Integrative Graduate Education and Research Traineeship Fellowship grant DGE-0504276. D.M.L. was supported by AFOSR grant FA 9550-07-1-0054 and Defense Threat Reduction Agency grant B0844671. N.P.D., A.C. and G.S.T. were supported by US National Institutes of Health (NIH) grants AI-037142 and AI-047441. H.G. was supported by NIH grant R01 AI-064926. C.J.B. was supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering and Sandia National Laboratories' Laboratory Directed Research and Development program. Further support was provided by the NIH/Roadmap for Medical Research grant PHS 2 PN2 EY016570B. The authors also acknowledge L. Kenney and M. Federle for useful comments. Some images in this paper were generated in the University of New Mexico Cancer Center Fluorescence Microscopy Facility, supported as detailed at http://hsc.unm.edu/crtc/microscopy/Facility.html. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the US Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	Alberghini S, 2009, FEMS MICROBIOL LETT, V292, P149, DOI 10.1111/j.1574-6968.2008.01478.x; Baca HK, 2007, ACCOUNTS CHEM RES, V40, P836, DOI 10.1021/ar600027u; Baca HK, 2006, SCIENCE, V313, P337, DOI 10.1126/science.1126590; Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doshi DA, 2000, SCIENCE, V290, P107, DOI 10.1126/science.290.5489.107; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; James S, 2000, J MOL BIOL, V296, P1127, DOI 10.1006/jmbi.1999.3484; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Kupferwasser LI, 2003, J CLIN INVEST, V112, P222, DOI 10.1172/JCI200316876; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Rothfork JM, 2003, J IMMUNOL, V171, P5389, DOI 10.4049/jimmunol.171.10.5389; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Shompole S, 2003, MOL MICROBIOL, V49, P919, DOI 10.1046/j.1365-2958.2003.03618.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	29	157	158	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					41	45		10.1038/NCHEMBIO.264	http://dx.doi.org/10.1038/NCHEMBIO.264			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19935660	Green Accepted			2022-12-25	WOS:000272802500010
J	Smolke, CD				Smolke, Christina D.			Building outside of the box: iGEM and the BioBricks Foundation	NATURE BIOTECHNOLOGY			English	Article									Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	csmolke@stanford.edu						Baumgardner Jordan, 2009, J Biol Eng, V3, P11, DOI 10.1186/1754-1611-3-11; Haynes Karmella A, 2008, J Biol Eng, V2, P8, DOI 10.1186/1754-1611-2-8; Knight T., 2007, DRAFT STANDARD BIOBR; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; [No title captured]	6	120	136	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1099	1102		10.1038/nbt1209-1099	http://dx.doi.org/10.1038/nbt1209-1099			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010584				2022-12-25	WOS:000272708300020
J	Noguchi, A; Kitamura, T; Onaka, H; Horinouchi, S; Ohnishi, Y				Noguchi, Akio; Kitamura, Takeshi; Onaka, Hiroyasu; Horinouchi, Sueharu; Ohnishi, Yasuo			A copper-containing oxidase catalyzes C-nitrosation in nitrosobenzamide biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-GLAUCESCENS TYROSINASE; IDENTIFICATION; LIGANDS	Although C-nitroso aromatic compounds have several bioactivities of medicinal interest, the biosynthetic enzymes involved in C-nitrosation have remained unknown until now. Here, we report the entire biosynthesis pathway of 4-hydroxy-3-nitrosobenzamide in Streptomyces murayamaensis, in which a tyrosinase-like copper-containing monooxygenase is responsible for the C-nitrosation. This finding indicates diverse catalytic functions of tyrosinase-like copper-containing monooxygenases in nature.	[Noguchi, Akio; Kitamura, Takeshi; Horinouchi, Sueharu; Ohnishi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan; [Onaka, Hiroyasu] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama, Japan	University of Tokyo; Toyama Prefectural University	Noguchi, A (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp		Ohnishi, Yasuo/0000-0001-7633-9236; Onaka, Hiroyasu/0000-0003-4536-1881				BLINOV NO, 1989, IZV AN SSSR BIOL+, V1, P70; Blinova I. N., 1975, CHEM NAT COMPD, V11, P506; CANDELORO S, 1969, NATURE, V224, P589, DOI 10.1038/224589a0; CHAIN E. B., 1955, NATURE, V176, P645, DOI 10.1038/176645a0; CONE MC, 1995, TETRAHEDRON, V51, P3095, DOI 10.1016/0040-4020(95)00071-F; CRONHEIM G, 1947, J ORG CHEM, V12, P20, DOI 10.1021/jo01165a003; Gould SJ, 1996, J AM CHEM SOC, V118, P9228, DOI 10.1021/ja9524356; Gowenlock BG, 2004, CHEM REV, V104, P3315, DOI 10.1021/cr030450k; HUBER M, 1988, BIOCHEMISTRY-US, V27, P5610, DOI 10.1021/bi00415a032; JACKMAN MP, 1991, BIOCHEM J, V274, P707, DOI 10.1042/bj2740707; Kohashi PY, 2004, PROTEIN EXPRES PURIF, V34, P202, DOI 10.1016/j.pep.2003.11.015; KUROBANE I, 1987, J ANTIBIOT, V40, P1131, DOI 10.7164/antibiotics.40.1131; Nakamura M, 2000, BIOCHEM J, V350, P537, DOI 10.1042/0264-6021:3500537; Omura S, 1999, J ANTIBIOT, V52, P61, DOI 10.7164/antibiotics.52.61; RICE WG, 1993, NATURE, V361, P473, DOI 10.1038/361473a0; Suzuki H, 2006, J BIOL CHEM, V281, P824, DOI 10.1074/jbc.M505806200; Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200; Tomoda H, 1999, J ANTIBIOT, V52, P1101, DOI 10.7164/antibiotics.52.1101; YANG CC, 1981, ANTIMICROB AGENTS CH, V20, P558, DOI 10.1128/AAC.20.4.558	19	33	35	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					641	643		10.1038/NCHEMBIO.418	http://dx.doi.org/10.1038/NCHEMBIO.418			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20676084				2022-12-25	WOS:000281084900006
J	Warner, JR; Reeder, PJ; Karimpour-Fard, A; Woodruff, LBA; Gill, RT				Warner, Joseph R.; Reeder, Philippa J.; Karimpour-Fard, Anis; Woodruff, Lauren B. A.; Gill, Ryan T.			Rapid profiling of a microbial genome using mixtures of barcoded oligonucleotides	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; ESCHERICHIA-COLI; GENE-DELETION; PARALLEL ANALYSIS; RESISTANCE GENE; NEXT-GENERATION; ACID; ARRAYS; RECOMBINATION; EXPRESSION	A fundamental goal in biotechnology and biology is the development of approaches to better understand the genetic basis of traits. Here we report a versatile method, trackable multiplex recombineering (TRMR), whereby thousands of specific genetic modifications are created and evaluated simultaneously. To demonstrate TRMR, in a single day we modified the expression of >95% of the genes in Escherichia coli by inserting synthetic DNA cassettes and molecular barcodes upstream of each gene. Barcode sequences and microarrays were then used to quantify population dynamics. Within a week we mapped thousands of genes that affect E. coli growth in various media (rich, minimal and cellulosic hydrolysate) and in the presence of several growth inhibitors (beta-glucoside, D-fucose, valine and methylglyoxal). This approach can be applied to a broad range of traits to identify targets for future genome-engineering endeavors.	[Warner, Joseph R.; Reeder, Philippa J.; Woodruff, Lauren B. A.; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Karimpour-Fard, Anis] Univ Colorado, Hlth Sci Ctr, Sch Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	rtg@colorado.edu		Andrews, Lauren/0000-0003-1627-1430	Colorado Center for Biorefining and Biofuels; Colorado Energy Initiative; Shell	Colorado Center for Biorefining and Biofuels; Colorado Energy Initiative; Shell(Royal Dutch Shell)	We thank D. Court (Center for Cancer Research, National Cancer Institute at Frederick, Maryland) for sharing plasmid pSIM5, C. Nislow and G. Giaever (University of Toronto, Ontario) for help with microarray analysis, A. Mohagheghi and M. Zhang (US National Renewable Energy Laboratories) for hydrolysate samples, M. O'Donnell for help in preparation of selective agar plates, Agilent for access to the Oligonucleotide Library Synthesis product, and H. Marshall and the University of Colorado Microarray Facility for molecular barcode genotyping. The authors appreciate financial support provided by Shell, the Colorado Center for Biorefining and Biofuels (http://www.C2B2web.org) and the Colorado Energy Initiative (http://rasei.colorado.edu).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Blanchard AP, 1996, BIOSENS BIOELECTRON, V11, P687, DOI 10.1016/0956-5663(96)83302-1; Chen SF, 2006, J CHROMATOGR A, V1104, P54, DOI 10.1016/j.chroma.2005.11.136; Cho RJ, 1998, P NATL ACAD SCI USA, V95, P3752, DOI 10.1073/pnas.95.7.3752; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DEFEZ R, 1981, GENETICS, V97, P11; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FERRANTE AA, 1995, P NATL ACAD SCI USA, V92, P7617, DOI 10.1073/pnas.92.17.7617; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Meijnen JP, 2008, APPL ENVIRON MICROB, V74, P5031, DOI 10.1128/AEM.00924-08; Mohagheghi A, 2010, BIOTECHNOL BIOENG, V105, P992, DOI 10.1002/bit.22625; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Perni S, 2005, FOOD MICROBIOL, V22, P491, DOI 10.1016/j.fm.2004.11.014; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Pierce SE, 2006, NAT METHODS, V3, P601, DOI 10.1038/NMETH905; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SUTTON A, 1981, J BACTERIOL, V148, P998, DOI 10.1128/JB.148.3.998-1001.1981; Sycheva EV, 2007, MICROBIOLOGY+, V76, P712, DOI 10.1134/S0026261707060094; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEINSTOCK O, 1992, J BACTERIOL, V174, P5560, DOI 10.1128/JB.174.17.5560-5566.1992; WESSLER SR, 1981, J MOL BIOL, V149, P579, DOI 10.1016/0022-2836(81)90348-X; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhu MM, 2001, METAB ENG, V3, P218, DOI 10.1006/mben.2001.0186	50	207	233	3	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					856	U138		10.1038/nbt.1653	http://dx.doi.org/10.1038/nbt.1653			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20639866				2022-12-25	WOS:000280757500026
J	Cramer, LP				Cramer, Louise P.			Forming the cell rear first: breaking cell symmetry to trigger directed cell migration	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENT BUNDLES; FIBROBLAST POLARIZATION; MYOSIN IIB; RHO-KINASE; POLARITY; DYNAMICS; MOTILITY; PROTRUSION; LOCOMOTION; MECHANISM	Directed cell migration requires the breaking of cell symmetry to generate a cell front and a cell rear along an axis approximately aligned with the direction of locomotion. In most cell types, regulated actin polymerization promotes initial cell front formation and its subsequent persistent protrusion, whereas myosin II-based forces are required to initially create and then maintain the cell rear. Molecular models for cell migration have focused extensively on cell protrusion, and the breaking of cell symmetry is almost universally portrayed with the cell front forming first. Although data supports this model for cells moving towards chemo-attractants, in the absence of any guidance cue, cell symmetry is broken by the cells constitutively forming the cell rear first. This allows an alternative model for triggering cell migration starting with retraction at the back of the cell. In this model, actomyosin II activity within the cell body and prospective cell rear occurs before a spatial bias in actin polymerization at the cell front. Creating the cell rear first may be a useful tool employed by a wide-range of migrating cell types, particularly when moving away from repellent cues.	[Cramer, Louise P.] UCL, MRC Lab, London WC1E 6BT, England; [Cramer, Louise P.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Cramer, LP (corresponding author), UCL, MRC Lab, Gower St, London WC1E 6BT, England.	l.cramer@ucl.ac.uk			Biotechnology and Biological Sciences Research Council [C18722] Funding Source: Medline; Medical Research Council [MC_CF12266] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		ALLEN RD, 1975, MOL CELL MOVEMENT, P239; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; CHEN WT, 1981, J CELL SCI, V49, P1; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DUNN GA, 1995, J CELL SCI, V108, P1239; Dunn GA, 1980, CELL ADHESION MOTILI, P409; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Koehl G, 2002, CELL BIOL INT, V26, P287, DOI 10.1006/cbir.2001.0855; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Mast SO, 1926, J MORPHOL PHYSIOL, V41, P347, DOI 10.1002/jmor.1050410205; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mseka T, 2007, J CELL SCI, V120, P4332, DOI 10.1242/jcs.017640; Mseka T, 2009, CELL MOTIL CYTOSKEL, V66, P743, DOI 10.1002/cm.20403; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Peckham M, 2001, J CELL SCI, V114, P1367; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shutova MS, 2008, CELL MOTIL CYTOSKEL, V65, P734, DOI 10.1002/cm.20295; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Swailes NT, 2004, J ANAT, V205, P381, DOI 10.1111/j.0021-8782.2004.00341.x; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026; ZIGMOND SH, 1979, J CELL BIOL, V82, P517, DOI 10.1083/jcb.82.2.517	40	79	80	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					628	632		10.1038/ncb0710-628	http://dx.doi.org/10.1038/ncb0710-628			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20596043				2022-12-25	WOS:000279374400002
J	Kochi, Y; Okada, Y; Suzuki, A; Ikari, K; Terao, C; Takahashi, A; Yamazaki, K; Hosono, N; Myouzen, K; Tsunoda, T; Kamatani, N; Furuichi, T; Ikegawa, S; Ohmura, K; Mimori, T; Matsuda, F; Iwamoto, T; Momohara, S; Yamanaka, H; Yamada, R; Kubo, M; Nakamura, Y; Yamamoto, K				Kochi, Yuta; Okada, Yukinori; Suzuki, Akari; Ikari, Katsunori; Terao, Chikashi; Takahashi, Atsushi; Yamazaki, Keiko; Hosono, Naoya; Myouzen, Keiko; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Furuichi, Tatsuya; Ikegawa, Shiro; Ohmura, Koichiro; Mimori, Tsuneyo; Matsuda, Fumihiko; Iwamoto, Takuji; Momohara, Shigeki; Yamanaka, Hisashi; Yamada, Ryo; Kubo, Michiaki; Nakamura, Yusuke; Yamamoto, Kazuhiko			A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; EFFECTOR T-CELLS; JAPANESE POPULATION; TH17 CELLS; CROHNS-DISEASE; RISK LOCUS; POLYMORPHISM; RECRUITMENT; TRAF1-C5	Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here, through a genome-wide association study of rheumatoid arthritis, we identified a polymorphism in CCR6, the gene encoding chemokine (C-C motif) receptor 6 (a surface marker for Th17 cells) at 6q27, that was associated with rheumatoid arthritis susceptibility and was validated in two independent replication cohorts from Japan (rs3093024, a total of 7,069 individuals with rheumatoid arthritis (cases) and 20,727 controls, overall odds ratio = 1.19, P = 7.7 x 10(-19)). We identified a triallelic dinucleotide polymorphism of CCR6 (CCR6DNP) in strong linkage disequilibrium with rs3093024 that showed effects on gene transcription. The CCR6DNP genotype was correlated with the expression level of CCR6 and was associated with the presence of interleukin-17 (IL-17) in the sera of subjects with rheumatoid arthritis. Moreover, CCR6DNP was associated with susceptibility to Graves' and Crohn's diseases. These results suggest that CCR6 is critically involved in IL-17-driven autoimmunity in human diseases.	[Kochi, Yuta; Suzuki, Akari; Myouzen, Keiko; Yamada, Ryo; Yamamoto, Kazuhiko] RIKEN, CGM, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Okada, Yukinori; Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, CGM, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Okada, Yukinori; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Ikari, Katsunori; Iwamoto, Takuji; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Terao, Chikashi; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Yamazaki, Keiko; Hosono, Naoya; Kubo, Michiaki] RIKEN, CGM, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Tsunoda, Tatsuhiko] RIKEN, CGM, Lab Med Informat, Yokohama, Kanagawa, Japan; [Furuichi, Tatsuya; Ikegawa, Shiro] RIKEN, CGM, Lab Bone & Joint Dis, Yokohama, Kanagawa, Japan; [Matsuda, Fumihiko; Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Nakamura, Yusuke] RIKEN, CGM, Lab Int Alliance, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; RIKEN; University of Tokyo; Tokyo Women's Medical University; Kyoto University; RIKEN; RIKEN; RIKEN; Kyoto University; RIKEN; University of Tokyo	Kochi, Y (corresponding author), RIKEN, CGM, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan.	ykochi@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Iwamoto, Takuji/L-3075-2013; Ikegawa, Shiro/N-6895-2015; Kubo, Michiaki/N-7947-2015; Yamamoto, Kazuhiko/N-5096-2015; Matsuda, Fumihiko/B-9893-2009	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ikegawa, Shiro/0000-0003-0316-2147; Yamada, Ryo/0000-0002-1587-630X	Rotary Club of Osaka-Midosuji District 2660 Rotary International; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Genetics and Allied research in Rheumatoid Arthritis Networking (GARNET) consortium	Rotary Club of Osaka-Midosuji District 2660 Rotary International; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genetics and Allied research in Rheumatoid Arthritis Networking (GARNET) consortium	We thank K. Shimada, Y. Hayashi, K. Kobayashi, M. Kitazato and other members of the Laboratory for Autoimmune Diseases, RIKEN and Y. Katagiri at Tokyo Women's Medical University, for their technical assistance. We also thank the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The replication study of rheumatoid arthritis was performed under the support of Genetics and Allied research in Rheumatoid Arthritis Networking (GARNET) consortium.	Aikawa Y, 2002, INFLAMM RES, V51, P188, DOI 10.1007/PL00000291; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Lee HS, 2007, MOL MED, V13, P455, DOI 10.2119/2007-00072.Lee; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nishimoto K, 2010, ANN RHEUM DIS, V69, P368, DOI 10.1136/ard.2008.104315; Okada Y, 2008, J RHEUMATOL, V35, P1723; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	42	211	239	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2010	42	6					515	U63		10.1038/ng.583	http://dx.doi.org/10.1038/ng.583			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20453841				2022-12-25	WOS:000278081500017
J	Mor, A; Suliman, S; Ben-Yishay, R; Yunger, S; Brody, Y; Shav-Tal, Y				Mor, Amir; Suliman, Shimrit; Ben-Yishay, Rakefet; Yunger, Sharon; Brody, Yehuda; Shav-Tal, Yaron			Dynamics of single mRNP nucleocytoplasmic transport and export through the nuclear pore in living cells	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA TRANSPORT; KINETIC-ANALYSIS; MAMMALIAN-CELLS; COMPLEX; TRANSLOCATION; PROTEIN; PARTICLE; TRANSCRIPTION; LOCALIZATION; DYSTROPHIN	The flow of genetic information in eukaryotic cells occurs through the nucleocytoplasmic translocation of mRNAs. Knowledge of in vivo messenger RNA export kinetics remains poor in comparison with that of protein transport. We have established a mammalian system that allowed the real-time visualization and quantification of large single mRNA-protein complexes (mRNPs) during export. The in vivo dynamics of bulk mRNP transport and export, from transcription to the nuclear pore complex (NPC), occurred within a 5-40 minute time frame, with no NPC pile-up. mRNP export was rapid (about 0.5 s) and kinetically faster than nucleoplasmic diffusion. Export inhibition demonstrated that mRNA-NPC interactions were independent of ongoing export. Nucleoplasmic transport dynamics of intron-containing and intronless mRNAs were similar, yet an intron did increase export efficiency. Here we provide visualization and analysis at the single mRNP level of the various steps in nuclear gene expression and the inter-chromatin tracks through which mRNPs diffuse, and demonstrate the kinetics of mRNP-NPC interactions and translocation.	[Shav-Tal, Yaron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Inst Nanotechnol, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Shav-Tal, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	shavtaly@mail.biu.ac.il		Shav-Tal, Yaron/0000-0002-8017-948X	Israel Science Foundation [250/06]; Israel Ministries of Health and Science	Israel Science Foundation(Israel Science Foundation); Israel Ministries of Health and Science	We thank J. Tremblay (Laval University, Canada) for GFP-Dys and GFP-mini-Dys, J. Ellenberg (EMBL Heidelberg, Germany) for the POM121-mCherry plasmid, and R. Drummer (Bar-Ilan University (BIU), Israel) for statistical analysis. This work was supported by grants to Y.S.T. from the Israel Science Foundation (grant 250/06) and the Israel Ministries of Health and Science. Y.S.T. thanks the Israel Science Foundation for the fluorescence live-cell imaging microscope. Y.B. is an Azrielli fellow. Y.S.T. is the Jane Stern Lebell Family Fellow in Life Sciences at BIU.	Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; BASTOS RN, 1977, CELL, V11, P641, DOI 10.1016/0092-8674(77)90081-2; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Braga J, 2004, PROG MOL SUBCELL BIO, V35, P119; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chapdelaine P, 2000, PROTEIN ENG, V13, P611, DOI 10.1093/protein/13.9.611; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; DARGEMONT C, 1992, J CELL BIOL, V118, P1, DOI 10.1083/jcb.118.1.1; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fakan S, 2004, HISTOCHEM CELL BIOL, V122, P83, DOI 10.1007/s00418-004-0681-1; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FRANKE WW, 1974, CELL NUCLEUS, V1, P219; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Iborra FJ, 2000, J CELL SCI, V113, P291; Iborra FJ, 1998, J CELL SCI, V111, P2269; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; JELINEK W, 1973, J MOL BIOL, V75, P515, DOI 10.1016/0022-2836(73)90458-0; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MARIMAN E, 1982, NUCLEIC ACIDS RES, V10, P6131, DOI 10.1093/nar/10.19.6131; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; MICHAEL WM, 1995, CELL, V83, P415; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Pante N, 1997, RNA, V3, P498; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RIEDEL N, 1987, P NATL ACAD SCI USA, V84, P3540, DOI 10.1073/pnas.84.11.3540; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHRODER HC, 1988, BIOCHEM J, V252, P777, DOI 10.1042/bj2520777; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; Siebrasse JP, 2002, EMBO REP, V3, P887, DOI 10.1093/embo-reports/kvf171; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Visser AE, 2000, J CELL SCI, V113, P2585; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	57	189	190	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					543	U61		10.1038/ncb2056	http://dx.doi.org/10.1038/ncb2056			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453848				2022-12-25	WOS:000278213400006
J	Pesnot, T; Jorgensen, R; Palcic, MM; Wagner, GK				Pesnot, Thomas; Jorgensen, Rene; Palcic, Monica M.; Wagner, Gerd K.			Structural and mechanistic basis for a new mode of glycosyltransferase inhibition	NATURE CHEMICAL BIOLOGY			English	Article							RATIONAL DESIGN; GLYCOSYLATION; SUBSTRATE	Glycosyltransferases are carbohydrate-active enzymes with essential roles in numerous important biological processes. We have developed a new donor analog for galactosyltransferases that locks a representative target enzyme in a catalytically inactive conformation, thus almost completely abolishing sugar transfer. Results with other galactosyltransferases suggest that this unique mode of glycosyltransferase inhibition may also be generally applicable to other members of this important enzyme family.	[Pesnot, Thomas; Wagner, Gerd K.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Jorgensen, Rene; Palcic, Monica M.] Carlsberg Lab, Copenhagen, Denmark	University of East Anglia	Wagner, GK (corresponding author), Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England.	g.wagner@uea.ac.uk	Jørgensen, René/P-5619-2014; Wagner, Gerd/D-4759-2013	Jørgensen, René/0000-0003-0672-466X; Wagner, Gerd/0000-0003-1086-2301	UK Engineering and Physical Sciences Research Council [EP/D059186/1]; UK Medical Research Council [G0701861]; Leverhulme Trust [RF/4/RFG/2008/0544]; Danish Agency for Science, Technology and Innovation [272-08-0449]; Engineering and Physical Sciences Research Council [EP/D059186/1] Funding Source: researchfish; Medical Research Council [G0701861] Funding Source: researchfish; EPSRC [EP/D059186/1] Funding Source: UKRI; MRC [G0701861] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); Danish Agency for Science, Technology and Innovation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. D. Djurhuus, D. Adlercreutz and M. H. Bien for excellent technical assistance during this research. The plasmid for the Neisseria meningitidis alpha-1,4-GalT was a generous gift from W. W. Wakarchuk (National Research Council of Canada). AA(Gly) B was cloned by H. J. Lee (University of Alberta) and N. O. L. Seto (National Research Council of Canada). We also thank A. Henriksen (Carlsberg Laboratory) for supplying equipment and tools for protein crystallography and for helpful discussions. We are grateful for the help with X-ray data collection provided by the beamline staff at I-911 at MAX-lab (Lund, Sweden) and at X12 at Deutsches Elektronen- Synchrotron (European Molecular Biology Laboratory, Hamburg, Germany). This work was supported by the UK Engineering and Physical Sciences Research Council (First Grant EP/D059186/1 to G. K. W.), the UK Medical Research Council (Discipline Hopping Award G0701861 to G. K. W.), the Leverhulme Trust (Research Fellowship RF/4/RFG/2008/0544 to G. K. W.) and the Danish Agency for Science, Technology and Innovation (grant 272-08-0449 to M. M. P.). We thank the Engineering and Physical Sciences Research Council National Mass Spectrometry Service Centre, Swansea, for the recording of mass spectra.	Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Collier A, 2008, CHEM COMMUN, P178, DOI 10.1039/b714379f; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Greco NJ, 2007, NAT PROTOC, V2, P305, DOI 10.1038/nprot.2006.464; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Pesnot T, 2008, ORG BIOMOL CHEM, V6, P2884, DOI 10.1039/b805216f; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qian X., 2000, CARBOHYDRATES CHEM B, P293; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Schuman B, 2007, TOP CURR CHEM, V272, P217, DOI 10.1007/128_2006_089; Takaya K, 2005, J MED CHEM, V48, P6054, DOI 10.1021/jm0504297; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Weadge J.T., 2009, WILEY ENCY CHEM BIOL, V2, P198	19	62	66	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					321	323		10.1038/nchembio.343	http://dx.doi.org/10.1038/nchembio.343			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20364127	Green Accepted			2022-12-25	WOS:000276823200008
J	[Anonymous]				[Anonymous]			Blame your genes, but not your copy numbers	NATURE MEDICINE			English	Editorial Material																		Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					526	526		10.1038/nm0510-526	http://dx.doi.org/10.1038/nm0510-526			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448576				2022-12-25	WOS:000277394700028
J	De Palma, M; Naldini, L				De Palma, Michele; Naldini, Luigi			Antagonizing metastasis	NATURE BIOTECHNOLOGY			English	Editorial Material							MICRORNAS		[De Palma, Michele; Naldini, Luigi] San Raffaele Univ, San Raffaele Telethon Inst Gene Therapy & Vita Sa, Milan, Italy	Vita-Salute San Raffaele University	De Palma, M (corresponding author), San Raffaele Univ, San Raffaele Telethon Inst Gene Therapy & Vita Sa, Milan, Italy.	naldini.luigi@hsr.it	De Palma, Michele/L-5350-2016; Naldini, Luigi/E-9083-2012	De Palma, Michele/0000-0001-9128-5459; NALDINI, Luigi/0000-0002-7835-527X	Telethon [TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	13	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					331	332		10.1038/nbt0410-331	http://dx.doi.org/10.1038/nbt0410-331			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20379176				2022-12-25	WOS:000276462400018
J	Hettmer, S; Wagers, AJ				Hettmer, Simone; Wagers, Amy J.			Muscling in Uncovering the origins of rhabdomyosarcoma	NATURE MEDICINE			English	Editorial Material							ALVEOLAR RHABDOMYOSARCOMA; STEM-CELLS; MOUSE; GENE		[Hettmer, Simone; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hettmer, Simone; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA; [Hettmer, Simone] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hettmer, Simone] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Hettmer, S (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	amy.wagers@joslin.harvard.edu		Hettmer, Simone/0000-0003-1709-4448	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Keller C, 2005, CANCER RES, V65, P7530, DOI 10.1158/0008-5472.CAN-05-0477; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Linardic CM, 2005, CANCER RES, V65, P4490, DOI 10.1158/0008-5472.CAN-04-3194; Linardic CM, 2007, CANCER RES, V67, P6691, DOI 10.1158/0008-5472.CAN-06-3210; Lisboa S, 2008, PEDIATR BLOOD CANCER, V51, P554, DOI 10.1002/pbc.21646; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; Oberlin O, 2008, J CLIN ONCOL, V26, P2384, DOI 10.1200/JCO.2007.14.7207; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; Shinkoda Y, 2009, PEDIATR BLOOD CANCER, V52, P286, DOI 10.1002/pbc.21783; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	14	83	86	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2010	16	2					171	173		10.1038/nm0210-171	http://dx.doi.org/10.1038/nm0210-171			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20134473				2022-12-25	WOS:000274297000037
J	Louie, CM; Caridi, G; Lopes, VS; Brancati, F; Kispert, A; Lancaster, MA; Schlossman, AM; Otto, EA; Leitges, M; Grone, HJ; Lopez, I; Gudiseva, HV; O'Toole, JF; Vallespin, E; Ayyagari, R; Ayuso, C; Cremers, FPM; den Hollander, AI; Koenekoop, RK; Dallapiccola, B; Ghiggeri, GM; Hildebrandt, F; Valente, EM; Williams, DS; Gleeson, JG				Louie, Carrie M.; Caridi, Gianluca; Lopes, Vanda S.; Brancati, Francesco; Kispert, Andreas; Lancaster, Madeline A.; Schlossman, Andrew M.; Otto, Edgar A.; Leitges, Michael; Groene, Hermann-Josef; Lopez, Irma; Gudiseva, Harini V.; O'Toole, John F.; Vallespin, Elena; Ayyagari, Radha; Ayuso, Carmen; Cremers, Frans P. M.; den Hollander, Anneke I.; Koenekoop, Robert K.; Dallapiccola, Bruno; Ghiggeri, Gian Marco; Hildebrandt, Friedhelm; Valente, Enza Maria; Williams, David S.; Gleeson, Joseph G.			AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis	NATURE GENETICS			English	Article							RHODOPSIN KNOCKOUT MICE; JOUBERT-SYNDROME; IN-VIVO; INTRAFLAGELLAR TRANSPORT; CONNECTING CILIA; MUTATIONS CAUSE; GENE; MOUSE; PROTEIN; DISEASE	Degeneration of photoreceptors is a common feature of ciliopathies, owing to the importance of the specialized ciliary structure of these cells. Mutations in AHI1, which encodes a cilium-localized protein, have been shown to cause a form of Joubert syndrome that is highly penetrant for retinal degeneration(1,2). We show that Ahi1-null mice fail to form retinal outer segments and have abnormal distribution of opsin throughout their photoreceptors. Apoptotic cell death of photoreceptors occurs rapidly between 2 and 4 weeks of age in these mice and is significantly (P = 0.00175 and 0.00613) delayed by a reduced dosage of opsin. This phenotype also shows dosage-sensitive genetic interactions with Nphp1, another ciliopathy-related gene. Although it is not a primary cause of retinal blindness in humans, we show that an allele of AHI1 is associated with a more than sevenfold increase in relative risk of retinal degeneration within a cohort of individuals with the hereditary kidney disease nephronophthisis. Our data support context-specific roles for AHI1 as a contributor to retinopathy and show that AHI1 may explain a proportion of the variability in retinal phenotypes observed in nephronophthisis.	[Louie, Carrie M.; Lancaster, Madeline A.; Schlossman, Andrew M.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat, La Jolla, CA 92093 USA; [Caridi, Gianluca; Ghiggeri, Gian Marco] IRCCS, Ist Giannina Gaslini, Lab Fisiopatol Uremia, Genoa, Italy; [Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90024 USA; [Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Lopes, Vanda S.; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brancati, Francesco; Valente, Enza Maria] Casa Sollievo Sofferenza Hosp, Casa Sollievo Sofferenza Mendel Inst, Rome, Italy; [Brancati, Francesco] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Otto, Edgar A.; O'Toole, John F.; Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Dept Pediat, Ann Arbor, MI 48109 USA; [Otto, Edgar A.; O'Toole, John F.; Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Dept Human Genet, Ann Arbor, MI 48109 USA; [Leitges, Michael] Univ Oslo, Ctr Biotechnol, Oslo, Norway; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-6900 Heidelberg, Germany; [Lopez, Irma; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; [Gudiseva, Harini V.; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Vallespin, Elena; Ayuso, Carmen] CIBERER, Fdn Jimenez Diaz, Dept Med Genet, Madrid, Spain; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Dept Ophthalmol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Pediat Sci, Messina, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; G d'Annunzio University of Chieti-Pescara; Hannover Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Oslo; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of California System; University of California San Diego; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Radboud University Nijmegen; Radboud University Nijmegen; IRCCS Bambino Gesu; University of Messina	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Cremers, Frans/A-5625-2014; Brancati, Francesco/AAC-3778-2022; Leitges, Michael/AAN-1953-2021; Caridi, Gianluca/F-7052-2010; Hollander, Anneke den/N-4911-2014; Koenekoop, Robert/AAT-6676-2021; Valente, Enza Maria/G-2942-2017; Ghiggeri, Gian Marco/N-4712-2015; Vallespin, Elena/E-5277-2018; Dallapiccola, Bruno/K-8692-2016	Cremers, Frans/0000-0002-4954-5592; Brancati, Francesco/0000-0003-3624-2354; Caridi, Gianluca/0000-0001-6700-3001; Valente, Enza Maria/0000-0002-0600-6820; Ghiggeri, Gian Marco/0000-0003-3659-9062; Vallespin, Elena/0000-0002-8080-8629; Lancaster, Madeline/0000-0003-2324-8853; Ayuso, Carmen/0000-0002-9242-7065; Leitges, Michael/0000-0003-4203-6995; Otto, Edgar/0000-0002-2387-9973; Dallapiccola, Bruno/0000-0002-5031-1013	University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility [NINDS P30NS047101]; US National Institutes of Health [R01NS048453, R01DK068306, P30NS047101, F31NS059281, R01EY007042]; National Institute for General Medical Sciences [T32 GM008666]; Telethon-Italy [GP08145]; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY007042, R01EY013408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, F31NS059281] Funding Source: NIH RePORTER	University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon-Italy(Fondazione Telethon); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Siever and K. Teofilo for assistance with histology; G. Silva, L. Cheng and M. Davidson for assistance with ERG testing; A. Avila for assistance with clinical data and selecting controls; J. Lem, G. Lemke, T. Burstyn-Cohen and A. Wynshaw-Boris for sharing mice and for feedback and suggestions; K. Zhang, L. Goldstein and B. Zheng for feedback and suggestions; T. Li and E. Pierce for sharing antibodies; C.-H. Sung for sharing rhodopsin plasmid; J. Kim and V. Cantagrel for technical advice; and J. Meerloo with the University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility (NINDS P30NS047101) for microscopy services and support. This work was supported by the US National Institutes of Health R01NS048453 (J.G.G.), R01DK068306 (F.H.), P30NS047101 (J.G.G.), F31NS059281 (C.M.L.), R01EY007042 (D.S.W.), UCSD Genetics Training Program institutional training grant T32 GM008666 from the National Institute for General Medical Sciences (C.M.L. and M.A.L), GP08145 grant from Telethon-Italy (E.M.V.) and the Burroughs Wellcome Fund (J.G.G.). D.S.W. is a Jules and Doris Stein RPB Professor. J.G.G. and F.H. are investigators of the Howard Hughes Medical Institute.	Bhowmick R, 2009, TRAFFIC, V10, P648, DOI 10.1111/j.1600-0854.2009.00896.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; El Bradey M, 2004, J OCUL PHARMACOL TH, V20, P217, DOI 10.1089/1080768041223657; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fleiss JL, 2013, STAT METHODS RATES P; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; Kroes HY, 2008, EUR J MED GENET, V51, P24, DOI 10.1016/j.ejmg.2007.10.001; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	46	144	146	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					175	U117		10.1038/ng.519	http://dx.doi.org/10.1038/ng.519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081859	Green Accepted, Green Submitted			2022-12-25	WOS:000274084400017
J	Mi, J; Liu, YM; Rabbani, ZN; Yang, ZG; Urban, JH; Sullenger, BA; Clary, BM				Mi, Jing; Liu, Yingmiao; Rabbani, Zahid N.; Yang, Zhongguang; Urban, Johannes H.; Sullenger, Bruce A.; Clary, Bryan M.			In vivo selection of tumor-targeting RNA motifs	NATURE CHEMICAL BIOLOGY			English	Article							CELL-PROLIFERATION; APTAMERS; P68; HELICASE; PROTEIN; CANCER; ENRICHMENT; LIGANDS	In an effort to target the in vivo context of tumor-specific moieties, we screened a large library of nuclease-resistant RNA oligonucleotides in tumor-bearing mice to identify candidate molecules with the ability to localize to hepatic colon cancer metastases. One of the selected molecules is an RNA aptamer that binds to p68, an RNA helicase that has been shown to be upregulated in colorectal cancer.	[Mi, Jing; Liu, Yingmiao; Urban, Johannes H.; Sullenger, Bruce A.; Clary, Bryan M.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Rabbani, Zahid N.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Yang, Zhongguang] Moses Cone Mem Hosp, Dept Internal Med, Greensboro, NC USA	Duke University; Duke University; Moses Cone Memorial Hospital	Clary, BM (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	bruce.sullenger@duke.edu; bryan.clary@duke.edu		Rabbani, zahid/0000-0002-4101-7947	Elsa U. Pardee Foundation; American Cancer Society; US National Institutes of Health [NIH-5U19-AI-067798-04, NIH-R01-CA129190]; NATIONAL CANCER INSTITUTE [R01CA129190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	Elsa U. Pardee Foundation; American Cancer Society(American Cancer Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Z.R. Liu for kindly providing the p68-expressing plasmid pHM6 (Georgia State University) and Y. Wang for his insightful suggestions. We thank Y. Zhao, Z. Vujaskovic, H. Guo, Z. Mi and D. Wang for their technical assistance. We also are grateful to C. Kontos and X. Zhang for their critical reading of this manuscript. This work was supported by the Elsa U. Pardee Foundation (J.M.), an American Cancer Society pilot award (J.M.) and US National Institutes of Health grants NIH-5U19-AI-067798-04 (Z.N.R.) and NIH-R01-CA129190 (B.A.S.).	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Berezovski MV, 2008, J AM CHEM SOC, V130, P9137, DOI 10.1021/ja801951p; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; Raddatz MSL, 2008, ANGEW CHEM INT EDIT, V47, P5190, DOI 10.1002/anie.200800216; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Shi H, 2007, P NATL ACAD SCI USA, V104, P3742, DOI 10.1073/pnas.0607805104; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; SULLENGER BA, 1993, SCIENCE, V262, P1566, DOI 10.1126/science.8248806; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022	18	187	197	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					22	24		10.1038/NCHEMBIO.277	http://dx.doi.org/10.1038/NCHEMBIO.277			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19946274	Green Accepted			2022-12-25	WOS:000272802500007
J	Veeriah, S; Taylor, BS; Meng, S; Fang, F; Yilmaz, E; Vivanco, I; Janakiraman, M; Schultz, N; Hanrahan, AJ; Pao, W; Ladanyi, M; Sander, C; Heguy, A; Holland, EC; Paty, PB; Mischel, PS; Liau, L; Cloughesy, TF; Mellinghoff, IK; Solit, DB; Chan, TA				Veeriah, Selvaraju; Taylor, Barry S.; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Schultz, Nikolaus; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Sander, Chris; Heguy, Adriana; Holland, Eric C.; Paty, Philip B.; Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.			Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies	NATURE GENETICS			English	Article							UBIQUITIN-PROTEIN LIGASE; TUMOR-SUPPRESSOR GENE; RECESSIVE JUVENILE PARKINSONISM; CYCLIN-E; FHIT GENE; CANCER; CARCINOMA; EXPRESSION; OVARIAN; SUBUNIT	Mutation of the gene PARK2, which encodes an E3 ubiquitin ligase, is the most common cause of early-onset Parkinson's disease(1-3). In a search for multisite tumor suppressors, we identified PARK2 as a frequently targeted gene on chromosome 6q25.2-q27 in cancer. Here we describe inactivating somatic mutations and frequent intragenic deletions of PARK2 in human malignancies. The PARK2 mutations in cancer occur in the same domains, and sometimes at the same residues, as the germline mutations causing familial Parkinson's disease. Cancer-specific mutations abrogate the growth-suppressive effects of the PARK2 protein. PARK2 mutations in cancer decrease PARK2's E3 ligase activity, compromising its ability to ubiquitinate cyclin E and resulting in mitotic instability. These data strongly point to PARK2 as a tumor suppressor on 6q25.2-q27. Thus, PARK2, a gene that causes neuronal dysfunction when mutated in the germline, may instead contribute to oncogenesis when altered in non-neuronal somatic cells.	[Veeriah, Selvaraju; Meng, Shasha; Fang Fang; Yilmaz, Emrullah; Vivanco, Igor; Janakiraman, Manickam; Hanrahan, Aphrothiti J.; Pao, William; Ladanyi, Marc; Heguy, Adriana; Mellinghoff, Ingo K.; Solit, David B.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Taylor, Barry S.; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Pao, William; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Mischel, Paul S.; Liau, Linda; Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org; chant@mskcc.org	Heguy, Adriana/GPP-3907-2022; Cloughesy, Timothy Francis/AGV-1013-2022; Yilmaz, Emrullah/AAR-6228-2021; Chan, Timothy A/ABD-5850-2021; Ladanyi, Marc/AAG-8585-2019; Sander, Chris/H-1452-2011; Schultz, Nikolaus/ABE-6347-2020; Meng, Shasha/AAR-3936-2020; Vivanco, Igor/AAN-8578-2021; Solit, David B./AAC-5309-2019	Sander, Chris/0000-0001-6059-6270; Liau, Linda/0000-0002-4053-0052; Yilmaz, Emrullah/0000-0003-2308-713X; Janakiraman, Manickam/0000-0003-4423-6237; Schultz, Nikolaus/0000-0002-0131-4904; Vivanco, Igor/0000-0001-6347-9416	Brain Tumors Funders' Collaborative Fund; Cancer Genome Atlas Project; Flight Attendants Medical Research Institute; Louis Gerstner Foundation; Memorial Sloan-Kettering Society; Elsa U. Pardee Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA121210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086875] Funding Source: NIH RePORTER	Brain Tumors Funders' Collaborative Fund; Cancer Genome Atlas Project; Flight Attendants Medical Research Institute; Louis Gerstner Foundation; Memorial Sloan-Kettering Society; Elsa U. Pardee Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Wongvipat, K. Huberman, I. Dolgalev and S. Thomas for exceptional technical expertise. We thank R. Levine for helpful discussions and comments. B. S. T. is the David H. Koch Fellow in cancer genomics. This work was supported in part by The Brain Tumors Funders' Collaborative Fund (I. K. M.), The Cancer Genome Atlas Project (N. S, C. S.), the Flight Attendants Medical Research Institute (T. A. C.), the Louis Gerstner Foundation (T. A. C.), the Memorial Sloan-Kettering Society (T. A. C.), the Elsa U. Pardee Foundation (T. A. C.) and the Doris Duke Charitable Foundation (T. A.C.)	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corti O, 2005, CR BIOL, V328, P131, DOI 10.1016/j.crvi.2004.10.009; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Courjal F, 1996, INT J CANCER, V69, P247; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Ekholm-Reed Susanna, 2004, Cancer Research, V64, P2939; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2000, MAMM GENOME, V11, P417, DOI 10.1007/s003350010080; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Ledesma MD, 2002, J NEUROCHEM, V83, P1431, DOI 10.1046/j.1471-4159.2002.01253.x; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Martinez-Noel G, 2001, EUR J BIOCHEM, V268, P5912, DOI 10.1046/j.0014-2956.2001.02541.x; Mhawech-Fauceglia P, 2008, INT J GYNECOL PATHOL, V27, P539, DOI 10.1097/PGP.0b013e31816bcda4; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rankin CA, 2001, J BIOMED SCI, V8, P421; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Schlossmacher Michael G., 2005, V301, P351; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	62	283	291	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					77	U98		10.1038/ng.491	http://dx.doi.org/10.1038/ng.491			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19946270	Bronze, Green Accepted			2022-12-25	WOS:000273055100020
J	Erbay, E; Babaev, VR; Mayers, JR; Makowski, L; Charles, KN; Snitow, ME; Fazio, S; Wiest, MM; Watkins, SM; Linton, MF; Hotamisligil, GS				Erbay, Ebru; Babaev, Vladimir R.; Mayers, Jared R.; Makowski, Liza; Charles, Khanichi N.; Snitow, Melinda E.; Fazio, Sergio; Wiest, Michelle M.; Watkins, Steven M.; Linton, MacRae F.; Hotamisligil, Goekhan S.			Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis	NATURE MEDICINE			English	Article							ACID-BINDING PROTEIN; ER STRESS; INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLIC DISEASES; COA DESATURASE; MICE LACKING; AP2; CHOLESTEROL; APOPTOSIS	Macrophages show endoplasmic reticulum (ER) stress when exposed to lipotoxic signals associated with atherosclerosis, although the pathophysiological importance and the underlying mechanisms of this phenomenon remain unknown. Here we show that mitigation of ER stress with a chemical chaperone results in marked protection against lipotoxic death in macrophages and prevents macrophage fatty acid-binding protein-4 (aP2) expression. Using genetic and chemical models, we show that aP2 is the predominant regulator of lipid-induced macrophage ER stress. The absence of lipid chaperones incites an increase in the production of phospholipids rich in monounsaturated fatty acids and bioactive lipids that render macrophages resistant to lipid-induced ER stress. Furthermore, the impact of aP2 on macrophage lipid metabolism and the ER stress response is mediated by upregulation of key lipogenic enzymes by the liver X receptor. Our results demonstrate the central role for lipid chaperones in regulating ER homeostasis in macrophages in atherosclerosis and show that ER responses can be modified, genetically or chemically, to protect the organism against the deleterious effects of hyperlipidemia.	[Erbay, Ebru; Mayers, Jared R.; Charles, Khanichi N.; Snitow, Melinda E.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Makowski, Liza] Duke Univ, Med Ctr, Sarah W Stedman Nutr Ctr, Chapel Hill, NC USA; [Wiest, Michelle M.; Watkins, Steven M.] Lip Technol, W Sacramento, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; Duke University	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu		Erbay, Ebru/0000-0001-9584-1803; Makowski, Liza/0000-0002-5337-8037; Mayers, Jared/0000-0002-8607-1787	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL090258, R01HL065405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, U24DK059637, R01DK052539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065405-09, F32 HL090258, R01 HL065405, HL65405] Funding Source: Medline; NIDDK NIH HHS [DK DK52539, P30 DK040561-14, U24 DK059637, R01 DK052539, DK59637, P30 DK040561] Funding Source: Medline; NIEHS NIH HHS [T32 ES016645] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AQEL NM, 1984, ATHEROSCLEROSIS, V53, P265, DOI 10.1016/0021-9150(84)90127-8; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Erbay Ebru, 2007, Curr Atheroscler Rep, V9, P222, DOI 10.1007/s11883-007-0023-6; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; KUEHL RO, 2000, DESIGN EXPT STAT PRI, P56; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pan W, 2003, BIOINFORMATICS, V19, P1333, DOI 10.1093/bioinformatics/btg167; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SHA RS, 1993, J BIOL CHEM, V268, P7885; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700	50	379	399	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1383	U5		10.1038/nm.2067	http://dx.doi.org/10.1038/nm.2067			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966778	Green Accepted			2022-12-25	WOS:000272407800018
J	Kharas, MG; Lengner, CJ; Al-Shahrour, F; Bullinger, L; Ball, B; Zaidi, S; Morgan, K; Tam, W; Paktinat, M; Okabe, R; Gozo, M; Einhorn, W; Lane, SW; Scholl, C; Frohling, S; Fleming, M; Ebert, BL; Gilliland, DG; Jaenisch, R; Daley, GQ				Kharas, Michael G.; Lengner, Christopher J.; Al-Shahrour, Fatima; Bullinger, Lars; Ball, Brian; Zaidi, Samir; Morgan, Kelly; Tam, Winnie; Paktinat, Mahnaz; Okabe, Rachel; Gozo, Maricel; Einhorn, William; Lane, Steven W.; Scholl, Claudia; Froehling, Stefan; Fleming, Mark; Ebert, Benjamin L.; Gilliland, D. Gary; Jaenisch, Rudolf; Daley, George Q.			Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia	NATURE MEDICINE			English	Article							RNA-BINDING PROTEIN; ONCOGENIC PATHWAY SIGNATURES; GENE-EXPRESSION; STEM-CELLS; THERAPEUTIC-EFFICACY; HUMAN CANCER; PROGENITOR; TRANSFORMATION; DIFFERENTIATION; PROGRESSION	RNA-binding proteins of the Musashi (Msi) family are expressed in stem cell compartments and in aggressive tumors, but they have not yet been widely explored in the blood. Here we demonstrate that Msi2 is the predominant form expressed in hematopoietic stem cells (HSCs), and its knockdown leads to reduced engraftment and depletion of HSCs in vivo. Overexpression of human MSI2 in a mouse model increases HSC cell cycle progression and cooperates with the chronic myeloid leukemia-associated BCR-ABL1 oncoprotein to induce an aggressive leukemia. MSI2 is overexpressed in human myeloid leukemia cell lines, and its depletion leads to decreased proliferation and increased apoptosis. Expression levels in human myeloid leukemia directly correlate with decreased survival in patients with the disease, thereby defining MSI2 expression as a new prognostic marker and as a new target for therapy in acute myeloid leukemia (AML).	[Kharas, Michael G.; Al-Shahrour, Fatima; Ball, Brian; Morgan, Kelly; Tam, Winnie; Paktinat, Mahnaz; Okabe, Rachel; Gozo, Maricel; Einhorn, William; Ebert, Benjamin L.; Gilliland, D. Gary; Daley, George Q.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lengner, Christopher J.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Al-Shahrour, Fatima] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Bullinger, Lars; Scholl, Claudia; Froehling, Stefan] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Zaidi, Samir; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA; [Einhorn, William; Lane, Steven W.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Fleming, Mark] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gilliland, D. Gary] Merck Res Labs, N Wales, PA USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ulm University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Merck & Company; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital	Kharas, MG (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	mkharas@partners.org; george.daley@childrens.harvard.edu	Lane, Steven/C-3215-2012; Bullinger, Lars/AAL-7965-2020	Lane, Steven/0000-0002-8050-6209; Bullinger, Lars/0000-0002-5890-5510; Lengner, Christopher/0000-0002-0574-5189; Ball, Brian/0000-0001-8625-7023; Fleming, Mark/0000-0003-0948-4024	US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases; NIH; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084261] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S. Armstrong (Children's Hospital Boston) for valuable reagents. We would like to acknowledge T. Zhang, D. Kalaitzidis, K. Gritsman, P. Stern and S. Sykes for their critical suggestions and J.-A. Kwon for assistance with microarray processing. We would like to thank M. Wernig for his assistance with the project. M.G.K. was supported by the US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award. This work was supported by grants from the NIH (D.G.G., R.J. and G.Q.D.), the Leukemia and Lymphoma Society (D.G.G. and G.Q.D.) and the Howard Hughes Medical Institute (D.G.G. and G.Q.D.). C.J.L. was supported by a Ruth L. Kirschstein Fellowship from the NIH.	Barbouti A, 2003, CANCER RES, V63, P1202; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kanai R, 2006, J GENE MED, V8, P1329, DOI 10.1002/jgm.965; Kanal R, 2007, HUM GENE THER, V18, P63, DOI 10.1089/hum.2006.107; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	33	250	270	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					903	U101		10.1038/nm.2187	http://dx.doi.org/10.1038/nm.2187			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20616797	Green Published, Green Accepted			2022-12-25	WOS:000280649200030
J	Nikoloski, G; Langemeijer, SMC; Kuiper, RP; Knops, R; Massop, M; Tonnissen, ERLTM; van der Heijden, A; Scheele, TN; Vandenberghe, P; de Witte, T; van der Reijden, BA; Jansen, JH				Nikoloski, Gorica; Langemeijer, Saskia M. C.; Kuiper, Roland P.; Knops, Ruth; Massop, Marion; Tonnissen, Evelyn R. L. T. M.; van der Heijden, Adrian; Scheele, Theresia N.; Vandenberghe, Peter; de Witte, Theo; van der Reijden, Bert A.; Jansen, Joop H.			Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR ACTIVITY; ENHANCER; COMPLEX; TET2	In myelodysplastic syndromes (MDS), deletions of chromosome 7 or 7q are common and correlate with a poor prognosis. The relevant genes on chromosome 7 are unknown. We report here that EZH2, located at 7q36.1, is frequently targeted in MDS. Analysis of EZH2 deletions, missense and frameshift mutations strongly suggests that EZH2 is a tumor suppressor. As EZH2 functions as a histone methyltransferase, abnormal histone modification may contribute to epigenetic deregulation in MDS.	[Nikoloski, Gorica; Langemeijer, Saskia M. C.; Knops, Ruth; Massop, Marion; Tonnissen, Evelyn R. L. T. M.; van der Heijden, Adrian; Scheele, Theresia N.; van der Reijden, Bert A.; Jansen, Joop H.] Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Nikoloski, Gorica; Langemeijer, Saskia M. C.; Kuiper, Roland P.; Knops, Ruth; Massop, Marion; Tonnissen, Evelyn R. L. T. M.; van der Heijden, Adrian; Scheele, Theresia N.; de Witte, Theo; van der Reijden, Bert A.; Jansen, Joop H.] Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Kuiper, Roland P.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vandenberghe, Peter] Katholieke Univ Leuven Hosp, Lab Genet Malignant Disorders, Ctr Human Genet, Louvain, Belgium; [de Witte, Theo] Radboud Univ Nijmegen, Dept Tumorimmunol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Radboud University Nijmegen	Jansen, JH (corresponding author), Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	j.jansen@labgk.umcn.nl	van der Reijden, Bert A/A-3543-2014; van der Heijden, Adrian/G-4691-2016; de Witte, T.J.M./L-4762-2015; Koorenhof-Scheele, Thessa/D-9688-2016; Tonnissen, Evelyn/G-4724-2016; Knops, Ruth G.H.J.N./F-5280-2016; Nikoloski, Gorica/E-3989-2016; Kuiper, Roland/A-9646-2014; Jansen, J.H./H-8054-2014	Jansen, J.H./0000-0001-9459-568X; Vandenberghe, Peter/0000-0003-4719-1935	Dutch Organization for Scientific Research (NWO) [92003420]; Stichting Vanderes [07-183]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Stichting Vanderes	We thank R. Woestenenk and E. Kamping for technical assistance. This work was supported by grants from the Dutch Organization for Scientific Research (NWO, 92003420) and the Stichting Vanderes (07-183). P. V. is a clinical investigator of Fonds Wetenschappelijk Onderzoek Vlaanderen.	Brunning RD, 2008, WHO CLASSIFICATION T, P87; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116	14	574	595	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					665	667		10.1038/ng.620	http://dx.doi.org/10.1038/ng.620			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601954				2022-12-25	WOS:000280524000009
J	Clementi, N; Chirkova, A; Puffer, B; Micura, R; Polacek, N				Clementi, Nina; Chirkova, Anna; Puffer, Barbara; Micura, Ronald; Polacek, Norbert			Atomic mutagenesis reveals A2660 of 23S ribosomal RNA as key to EF-G GTPase activation	NATURE CHEMICAL BIOLOGY			English	Article							ELONGATION-FACTOR-G; AMINOACYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; CONFORMATIONAL-CHANGE; EUKARYOTIC RIBOSOMES; SARCIN/RICIN DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ALPHA-SARCIN; FACTOR TU	Following ribosomal peptide bond formation, the reaction products, peptidyl-tRNA and deacylated tRNA, need to be translocated from the A- and P-sites to the P- and E-sites, respectively. This process is facilitated by the GTPase elongation factor G (EF-G). The mechanism describing how the ribosome activates GTP hydrolysis is poorly understood in molecular terms. By using an 'atomic mutagenesis' approach, which allows the manipulation of specific functional groups on 23S rRNA nucleotides in the context of the entire ribosome, we disclose the adenine exocyclic N6 amino group at A2660 of the sarcin- ricin loop as a key determinant for triggering GTP hydrolysis on EF-G. We show that the purine pi system-expanding characteristics of the exocyclic functional group at the C6 position of A2660 are essential. We propose that stacking interactions of A2660 with EF-G may act as a molecular trigger to induce repositioning of suspected functional amino acids in EF-G that in turn promote GTP hydrolysis.	[Clementi, Nina; Chirkova, Anna; Polacek, Norbert] Med Univ Innsbruck, Innsbruck Bioctr, Div Genom & RN, Innsbruck, Austria; [Puffer, Barbara; Micura, Ronald] Univ Innsbruck, Inst Organ Chem, Ctr Mol Biosci, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Innsbruck	Polacek, N (corresponding author), Med Univ Innsbruck, Innsbruck Bioctr, Div Genom & RN, Innsbruck, Austria.	norbert.polacek@i-med.ac.at	Polacek, Norbert/AAV-7346-2020	Polacek, Norbert/0000-0001-5317-3990; Clementi, Nina/0000-0002-3668-3435	Austrian Science Foundation [I317, P21641, Y315]; Austrian Ministry of Science and Research [P0726-012-012, D-110420-012-012]; Austrian Science Fund (FWF) [Y 315] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Y.-L. Chan, S. Connell, M. Erlacher, M. Pech, P. Sergiev, T. Tenson, O. Vesper, D. Wilson and M. Zywicki for valuable comments and suggestions. A. Huttenhofer is acknowledged for his support at the Division of Genomics and RNomics. We thank A. Mankin (University of Illinois at Chicago) and N. Shankaran (University of Illinois at Chicago) for the GAC deletion mutant, M. Sprinzl (University of Bayreuth) for the parental EF-G clone, T. Tenson (University of Tartu) for the LepA clone and W. Piendl and G. Brosch for help with the EF- G and LepA purifications, respectively. We acknowledge F. Handle for experimental help during a lab rotation. This work was funded by the Austrian Science Foundation (FWF) (I317 and P21641 to R. M. and Y315 to N. P.) and the Austrian Ministry of Science and Research (GenAU project consortium 'non-coding RNAs' P0726-012-012 to R. M. and D-110420-012-012 to N. P.).	Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; BENSON S, 1975, EUR J BIOCHEM, V59, P573, DOI 10.1111/j.1432-1033.1975.tb02484.x; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Chan YL, 2006, J MOL BIOL, V355, P1014, DOI 10.1016/j.jmb.2005.11.037; Chan YL, 2004, J MOL BIOL, V337, P263, DOI 10.1016/j.jmb.2004.01.020; Chirkova A, 2010, CURR ORG CHEM, V14, P148, DOI 10.2174/138527210790069848; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ENDO Y, 1982, J BIOL CHEM, V257, P9054; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Erlacher MD, 2008, RNA BIOL, V5, P5, DOI 10.4161/rna.5.1.5922; Erlacher MD, 2006, J AM CHEM SOC, V128, P4453, DOI 10.1021/ja0588454; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; Lancaster L, 2008, RNA, V14, P1999, DOI 10.1261/rna.1202108; Lang K, 2008, CHEM BIOL, V15, P485, DOI 10.1016/j.chembiol.2008.03.014; Leonov AA, 2003, J BIOL CHEM, V278, P25664, DOI 10.1074/jbc.M302873200; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Macbeth MR, 1999, J MOL BIOL, V285, P965, DOI 10.1006/jmbi.1998.2388; MARCHANT A, 1994, EUR J BIOCHEM, V226, P141, DOI 10.1111/j.1432-1033.1994.tb20035.x; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; Munishkin A, 1997, P NATL ACAD SCI USA, V94, P12280, DOI 10.1073/pnas.94.23.12280; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Seo HS, 2006, BIOCHEMISTRY-US, V45, P2504, DOI 10.1021/bi0516677; SPERTI S, 1975, BIOCHEM J, V148, P447, DOI 10.1042/bj1480447; Sprinzl M, 2000, BIOL CHEM, V381, P367, DOI 10.1515/BC.2000.049; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; TAPPRICH WE, 1990, EMBO J, V9, P2649, DOI 10.1002/j.1460-2075.1990.tb07447.x; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013; Yu HJ, 2009, J MOL BIOL, V386, P802, DOI 10.1016/j.jmb.2008.12.071; Zavialov A. V., 2005, J BIOL-LONDON, V4, P9	48	45	46	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					344	351		10.1038/nchembio.341	http://dx.doi.org/10.1038/nchembio.341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20348921				2022-12-25	WOS:000276823200013
J	Teo, CF; Ingale, S; Wolfert, MA; Elsayed, GA; Not, LG; Chatham, JC; Wells, L; Boons, GJ				Teo, Chin Fen; Ingale, Sampat; Wolfert, Margreet A.; Elsayed, Galal A.; Noet, Laszlo G.; Chatham, John C.; Wells, Lance; Boons, Geert-Jan			Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc	NATURE CHEMICAL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; CREB COACTIVATOR CRTC2; INSULIN-RESISTANCE; NUCLEOCYTOPLASMIC PROTEINS; GLYCOSYLATION; STRESS; GLCNACYLATION; NUCLEAR; GLUCOSE; TRANSFERASE	Studies of post-translational modification by beta-N-acetyl-D-glucosamine (O-GlcNAc) are hampered by a lack of efficient tools such as O-GlcNAc-specific antibodies that can be used for detection, isolation and site localization. We have obtained a large panel of O-GlcNAc-specific IgG monoclonal antibodies having a broad spectrum of binding partners by combining three-component immunogen methodology with hybridoma technology. Immunoprecipitation followed by large-scale shotgun proteomics led to the identification of more than 200 mammalian O-GlcNAc-modified proteins, including a large number of new glycoproteins. A substantial number of the glycoproteins were enriched by only one of the antibodies. This observation, combined with the results of inhibition ELISAs, suggests that the antibodies, in addition to their O-GlcNAc dependence, also appear to have different but overlapping local peptide determinants. The monoclonal antibodies made it possible to delineate differentially modified proteins of liver in response to trauma-hemorrhage and resuscitation in a rat model.	[Teo, Chin Fen; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Teo, Chin Fen; Ingale, Sampat; Wolfert, Margreet A.; Elsayed, Galal A.; Wells, Lance; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ingale, Sampat; Wells, Lance; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Elsayed, Galal A.] Ain Shams Univ, Fac Sci, Dept Chem, Cairo, Egypt; [Noet, Laszlo G.; Chatham, John C.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Chatham, John C.] Univ Alabama, Dept Med, Div Cardiovasc Med, Birmingham, AL 35294 USA; [Chatham, John C.] Univ Alabama, Ctr Cardiovasc Biol, Birmingham, AL 35294 USA; [Chatham, John C.] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wells, L (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	lwells@ccrc.uga.edu; gjboons@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Wells, Lance/H-3118-2013; Wolfert, Margreet A/J-1726-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Wolfert, Margreet A/0000-0003-4864-0026; Wells, Lance/0000-0003-4956-5363; Elsayed, galal/0000-0002-5542-667X	US National Institute of Diabetes and Digestive and Kidney [NIH RO1 DK075069]; Research Resource for Integrated Glycotechnology [NIH/NCRR P41R005351]; National Cancer Institute of the US National Institutes of Health [NIH/NCI R01CA088986, NIH HL067464, HL079364]; American Heart Association (Southeast Affiliation); NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067464, R01HL079364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Research Resource for Integrated Glycotechnology; National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association (Southeast Affiliation)(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Davis (University of Georgia) for monoclonal antibody production, J.-M. Lim and L. Zhao for expert assistance with mass spectrometry, E. G. El-Karim for assistance with molecular biology and T. Buskas for assistance with glycopeptide synthesis and protein conjugation. We also thank BioInquire, Inc. for access to the beta version of ProteoIQ that was used in the evaluation of the mass spectrometry data. We thank G. W. Hart (Johns Hopkins School of Medicine) for CTD110.6 and AL28 (anti-OGT antibodies) and S. W. Whiteheart (University of Kentucky) for the anti- OGA antibody. This research was supported by a grant from the US National Institute of Diabetes and Digestive and Kidney disorders (NIH RO1 DK075069 to L. W.), the Research Resource for Integrated Glycotechnology (NIH/NCRR P41R005351 to G.-J.B.) and the National Cancer Institute of the US National Institutes of Health (NIH/NCI R01CA088986 to G.-J.B.). C. F. T. was supported by a predoctoral fellowship from the American Heart Association (Southeast Affiliation). This work was further supported by grants NIH HL067464 and HL079364 (to J.C.C.).	Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Golks A, 2008, EMBO REP, V9, P748, DOI 10.1038/embor.2008.129; Guinez C, 2007, BIOCHEM BIOPH RES CO, V361, P414, DOI 10.1016/j.bbrc.2007.07.020; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Not LG, 2007, SHOCK, V28, P345, DOI 10.1097/shk.0b013e3180487ebb; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Viner RI, 2009, J PROTEOMICS, V72, P874, DOI 10.1016/j.jprot.2009.02.005; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wang Z., 2008, CLIN PROTEOM, V4, P5, DOI [10.1007/s12014-008-9008-x, DOI 10.1007/S12014-008-9008-X]; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	36	130	135	4	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					338	343		10.1038/nchembio.338	http://dx.doi.org/10.1038/nchembio.338			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20305658	Green Accepted			2022-12-25	WOS:000276823200012
J	Yasuno, K; Bilguvar, K; Bijlenga, P; Low, SK; Krischek, B; Auburger, G; Simon, M; Krex, D; Arlier, Z; Nayak, N; Ruigrok, YM; Niemelaa, M; Tajima, A; Fraunberg, MVZ; Doczi, T; Wirjatijasa, F; Hata, A; Blasco, J; Oszvald, A; Kasuya, H; Zilani, G; Schoch, B; Singh, P; Stuer, C; Risselada, R; Beck, J; Sola, T; Ricciardi, F; Aromaa, A; Illig, T; Schreiber, S; van Duijn, CM; van den Berg, LH; Perret, C; Proust, C; Roder, C; Ozturk, AK; Gaal, E; Berg, D; Geisen, C; Friedrich, CM; Summers, P; Frangi, AF; State, MW; Wichmann, HE; Breteler, MMB; Wijmenga, C; Mane, S; Peltonen, L; Elio, V; Sturkenboom, MCJM; Lawford, P; Byrne, J; Macho, J; Sandalcioglu, EI; Meyer, B; Raabe, A; Steinmetz, H; Rufenacht, D; Jaaskelainen, JE; Hernesniemi, J; Rinkel, GJE; Zembutsu, H; Inoue, I; Palotie, A; Cambien, F; Nakamura, Y; Lifton, RP; Gunel, M				Yasuno, Katsuhito; Bilguvar, Kaya; Bijlenga, Philippe; Low, Siew-Kee; Krischek, Boris; Auburger, Georg; Simon, Matthias; Krex, Dietmar; Arlier, Zulfikar; Nayak, Nikhil; Ruigrok, Ynte M.; Niemelaa, Mika; Tajima, Atsushi; Fraunberg, Mikael von Und Zu; Doczi, Tamas; Wirjatijasa, Florentina; Hata, Akira; Blasco, Jordi; Oszvald, Agi; Kasuya, Hidetoshi; Zilani, Gulam; Schoch, Beate; Singh, Pankaj; Stueer, Carsten; Risselada, Roelof; Beck, Juergen; Sola, Teresa; Ricciardi, Filomena; Aromaa, Arpo; Illig, Thomas; Schreiber, Stefan; van Duijn, Cornelia M.; van den Berg, Leonard H.; Perret, Claire; Proust, Carole; Roder, Constantin; Ozturk, Ali K.; Gaal, Emilia; Berg, Daniela; Geisen, Christof; Friedrich, Christoph M.; Summers, Paul; Frangi, Alejandro F.; State, Matthew W.; Wichmann, H. Erich; Breteler, Monique M. B.; Wijmenga, Cisca; Mane, Shrikant; Peltonen, Leena; Elio, Vivas; Sturkenboom, Miriam C. J. M.; Lawford, Patricia; Byrne, James; Macho, Juan; Sandalcioglu, Erol I.; Meyer, Bernhard; Raabe, Andreas; Steinmetz, Helmuth; Ruefenacht, Daniel; Jaaskelainen, Juha E.; Hernesniemi, Juha; Rinkel, Gabriel J. E.; Zembutsu, Hitoshi; Inoue, Ituro; Palotie, Aarno; Cambien, Francois; Nakamura, Yusuke; Lifton, Richard P.; Gunel, Murat			Genome-wide association study of intracranial aneurysm identifies three new risk loci	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; IMPUTATION; EPIDEMIOLOGY; PROBABILITY; PREVALENCE; DESIGNS; FALSE; BIAS	Saccular intracranial aneurysms are balloon-like dilations of the intracranial arterial wall; their hemorrhage commonly results in severe neurologic impairment and death. We report a second genome-wide association study with discovery and replication cohorts from Europe and Japan comprising 5,891 cases and 14,181 controls with similar to 832,000 genotyped and imputed SNPs across discovery cohorts. We identified three new loci showing strong evidence for association with intracranial aneurysms in the combined dataset, including intervals near RBBP8 on 18q11.2 (odds ratio (OR) = 1.22, P = 1.1 x 10(-12)), STARD13-KL on 13q13.1 (OR = 1.20, P = 2.5 x 10(-9)) and a gene-rich region on 10q24.32 (OR = 1.29, P = 1.2 x 10(-9)). We also confirmed prior associations near SOX17 (8q11.23-q12.1; OR = 1.28, P = 1.3 x 10(-12)) and CDKN2A-CDKN2B (9p21.3; OR = 1.31, P = 1.5 x 10(-22)). It is noteworthy that several putative risk genes play a role in cell-cycle progression, potentially affecting the proliferation and senescence of progenitor-cell populations that are responsible for vascular formation and repair.	[Yasuno, Katsuhito; Bilguvar, Kaya; Arlier, Zulfikar; Nayak, Nikhil; Ozturk, Ali K.; Gaal, Emilia; State, Matthew W.; Lifton, Richard P.; Gunel, Murat] Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet,Yale Ctr Human Genet & Ge, New Haven, CT 06510 USA; [Yasuno, Katsuhito; Bilguvar, Kaya; Arlier, Zulfikar; Nayak, Nikhil; Ozturk, Ali K.; Gaal, Emilia; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Yasuno, Katsuhito; Bilguvar, Kaya; Arlier, Zulfikar; Nayak, Nikhil; Ozturk, Ali K.; Gaal, Emilia; Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Bijlenga, Philippe; Ruefenacht, Daniel] Univ Hosp Geneva, Serv Neurochirurg, Dept Clin Neurosci, Geneva, Switzerland; [Low, Siew-Kee; Zembutsu, Hitoshi; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Krischek, Boris; Roder, Constantin] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Auburger, Georg; Wirjatijasa, Florentina; Ricciardi, Filomena; Steinmetz, Helmuth] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Simon, Matthias] Univ Bonn, Dept Neurosurg, D-5300 Bonn, Germany; [Krex, Dietmar] Tech Univ Dresden, Carl Gustav Carus Univ Hosp Dresden, Dept Neurosurg, D-8027 Dresden, Germany; [Ruigrok, Ynte M.; van den Berg, Leonard H.; Rinkel, Gabriel J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Niemelaa, Mika; Gaal, Emilia; Hernesniemi, Juha] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; [Tajima, Atsushi; Inoue, Ituro] Tokai Univ, Sch Med, Div Mol Life Sci, Kanagawa 2591100, Japan; [Fraunberg, Mikael von Und Zu; Jaaskelainen, Juha E.] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Doczi, Tamas] Univ Pecs, Sch Med, Pecs, Hungary; [Hata, Akira] Chiba Univ, Sch Med, Dept Publ Hlth, Chiba 280, Japan; [Blasco, Jordi; Macho, Juan] Hosp Clin Barcelona, Dept Vasc Radiol, Barcelona, Spain; [Oszvald, Agi; Beck, Juergen; Raabe, Andreas] Goethe Univ Frankfurt, Dept Neurosurg, Frankfurt, Germany; [Kasuya, Hidetoshi] Tokyo Womens Univ, Med Ctr E, Dept Neurosurg, Tokyo, Japan; [Zilani, Gulam; Summers, Paul; Byrne, James] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Schoch, Beate; Sandalcioglu, Erol I.] Univ Hosp, Dept Neurosurg, Essen, Germany; [Singh, Pankaj; Lawford, Patricia] Univ Sheffield, Med Phys Grp, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Singh, Pankaj] Royal Hallamshire Hosp, Dept Neurosurg, Sheffield S10 2JF, S Yorkshire, England; [Stueer, Carsten; Meyer, Bernhard] Tech Univ Munich, Dept Neurosurg, Munich, Germany; [Risselada, Roelof; Sturkenboom, Miriam C. J. M.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Sola, Teresa; Elio, Vivas] Hosp Gen Cataluna, San Cugat Del Valles, Spain; [Aromaa, Arpo] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Helsinki, Finland; [Illig, Thomas; Wichmann, H. Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Netherlands Consortium Hlth Aging, Rotterdam, Netherlands; [Perret, Claire; Proust, Carole; Cambien, Francois] Univ Paris 06, INSERM, UMR S937, Paris, France; [Berg, Daniela] Univ Tubingen, Dept Neurodegenerat, Ctr Neurol, Tubingen, Germany; [Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Geisen, Christof] Deutsch Rotes Kreuz Blood Donor Serv Baden Wuertt, Dept Mol Haemostasis, Inst Transfus Med & Immunohaematol, Frankfurt, Germany; [Friedrich, Christoph M.] Fraunhofer Inst Algorithms & Sci Comp, St Augustin, Germany; [Frangi, Alejandro F.] Univ Pompeu Fabra, Barcelona, Spain; [Frangi, Alejandro F.] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Frangi, Alejandro F.] ICREA, Barcelona, Spain; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Mane, Shrikant] Yale Univ, Keck Fdn Biotechnol Resource Lab, New Haven, CT USA; [Peltonen, Leena; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Peltonen, Leena; Palotie, Aarno] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Ruefenacht, Daniel] Clin Hirslanden, Swiss Neuro Inst, Dept Neuroradiol, Zurich, Switzerland; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; University of Geneva; University of Tokyo; Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of Bonn; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Utrecht University; Utrecht University Medical Center; University of Helsinki; Helsinki University Central Hospital; Tokai University; Kuopio University Hospital; University of Eastern Finland; University of Pecs; Chiba University; University of Barcelona; Hospital Clinic de Barcelona; Goethe University Frankfurt; Tokyo Women's Medical University; University of Oxford; University of Duisburg Essen; University of Sheffield; University of Sheffield; Technical University of Munich; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Fraunhofer Gesellschaft; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; ICREA; Yale University; Yale University; University of Groningen; University of Groningen; Yale University; Wellcome Trust Sanger Institute; University of Helsinki; Howard Hughes Medical Institute; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet,Yale Ctr Human Genet & Ge, New Haven, CT 06510 USA.	richard.lifton@yale.edu; murat.gunel@yale.edu	State, Matthew/W-2256-2019; Meyer, Bernhard/Q-9413-2016; Friedrich, Christoph M./N-8674-2017; Güresir, Ági/AIE-6274-2022; Krex, Dietmar/E-6833-2014; Cambien, Francois/AAP-9751-2020; Summers, Paul E/D-5211-2016; Simon, Matthias/F-3046-2014; Meyer, Bernhard/AAH-3329-2019; Niemelä, Mika R/F-2539-2015; Tajima, Atsushi/C-1053-2008; Berg, Daniela/A-8728-2019; Yasuno, Katsuhito/E-1960-2012; Breteler, Monique M.B./J-5058-2014; Doczi, Tamas/C-5750-2009; Bijlenga, Philippe/S-1049-2016; Frangi, Alejandro F/C-6500-2008; Wichmann, Heinz Erich/AAA-5695-2022; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Friedrich, Christoph M./0000-0001-7906-0038; Güresir, Ági/0000-0003-1492-5461; Summers, Paul E/0000-0002-5085-1095; Meyer, Bernhard/0000-0001-6486-7955; Niemelä, Mika R/0000-0003-1526-0684; Tajima, Atsushi/0000-0001-6808-5491; Berg, Daniela/0000-0001-5796-5442; Yasuno, Katsuhito/0000-0002-3606-532X; Breteler, Monique M.B./0000-0002-0626-9305; Bijlenga, Philippe/0000-0002-3586-2757; Frangi, Alejandro F/0000-0002-2675-528X; Wijmenga, Cisca/0000-0002-5635-1614; Low, Siew-Kee/0000-0003-2386-0698; Van Duijn, Cornelia/0000-0002-2374-9204; Palotie, Aarno/0000-0002-2527-5874; von und zu Fraunberg, Mikael/0000-0002-8457-4639; Macho Fernandez, Juan Miguel/0000-0002-8417-7094; State, Matthew/0000-0003-1624-8302	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health (NIH) [R01NS057756, U24 NS051869]; Howard Hughes Medical Institute; European Commission [FP6-IST-2004-027703]; Bundesministerium fur Bildung und Forschung [01GI9907]; Utrecht Control cohort by the Prinses Beatrix Fonds; Adessium foundation; Clinical and Translational Science Award [UL1 RR024139]; National Center for Research Resources, NIH; Yale University Biomedical High Performance Computing Center (NIH) [RR19895]; ICREA Funding Source: Custom; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, R01NS057756] Funding Source: NIH RePORTER	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Utrecht Control cohort by the Prinses Beatrix Fonds; Adessium foundation; Clinical and Translational Science Award; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Yale University Biomedical High Performance Computing Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICREA(ICREA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the participants who made this study possible. We thank A. Chamberlain, B. Meseck-Selchow and members of the Keck Foundation Biotechnology Resource Laboratory for their technical help. This study was supported by the Yale Center for Human Genetics and Genomics and the Yale Program on Neurogenetics, the US National Institutes of Health (NIH) grants R01NS057756 (M. G.) and U24 NS051869 (S. M.) and the Howard Hughes Medical Institute (R. P. L.). This study is partially funded by the European Commission under the 6th Framework Programme through the @neurIST (www.aneurist.org) project under contract no. FP6-IST-2004-027703. The Frankfurt case cohort collection was supported by Bundesministerium fur Bildung und Forschung (01GI9907), Utrecht Control cohort by the Prinses Beatrix Fonds and the Adessium foundation (L.H.v.d.B.). S. M. was supported in part by the Clinical and Translational Science Award UL1 RR024139, National Center for Research Resources, NIH. We would also like to acknowledge the use of Yale University Biomedical High Performance Computing Center (NIH grant: RR19895).	Albright LAC, 2003, J NEUROSURG, V99, P637, DOI 10.3171/jns.2003.99.4.0637; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Breslow NE, 1980, IARC SCI PUBL, P5; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; ROSENBAUM PR, 1991, J ROY STAT SOC B MET, V53, P597; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	39	218	229	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					420	U69		10.1038/ng.563	http://dx.doi.org/10.1038/ng.563			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20364137	Green Accepted			2022-12-25	WOS:000277179500013
J	Dubois, PCA; Trynka, G; Franke, L; Hunt, KA; Romanos, J; Curtotti, A; Zhernakova, A; Heap, GAR; Adany, R; Aromaa, A; Bardella, MT; van den Berg, LH; Bockett, NA; de la Concha, EG; Dema, B; Fehrmann, RSN; Fernandez-Arquero, M; Fiatal, S; Grandone, E; Green, PM; Groen, HJM; Gwilliam, R; Houwen, RHJ; Hunt, SE; Kaukinen, K; Kelleher, D; Korponay-Szabo, I; Kurppa, K; MacMathuna, P; Maki, M; Mazzilli, MC; McCann, OT; Mearin, ML; Mein, CA; Mirza, MM; Mistry, V; Mora, B; Morley, KI; Mulder, CJ; Murray, JA; Nunez, C; Oosterom, E; Ophoff, RA; Polanco, I; Peltonen, L; Platteel, M; Rybak, A; Salomaa, V; Schweizer, JJ; Sperandeo, MP; Tack, GJ; Turner, G; Veldink, JH; Verbeek, WHM; Weersma, RK; Wolters, VM; Urcelay, E; Cukrowska, B; Greco, L; Neuhausen, SL; McManus, R; Barisani, D; Deloukas, P; Barrett, JC; Saavalainen, P; Wijmenga, C; van Heel, DA				Dubois, Patrick C. A.; Trynka, Gosia; Franke, Lude; Hunt, Karen A.; Romanos, Jihane; Curtotti, Alessandra; Zhernakova, Alexandra; Heap, Graham A. R.; Adany, Roza; Aromaa, Arpo; Bardella, Maria Teresa; van den Berg, Leonard H.; Bockett, Nicholas A.; de la Concha, Emilio G.; Dema, Barbara; Fehrmann, Rudolf S. N.; Fernandez-Arquero, Miguel; Fiatal, Szilvia; Grandone, Elvira; Green, Peter M.; Groen, Harry J. M.; Gwilliam, Rhian; Houwen, Roderick H. J.; Hunt, Sarah E.; Kaukinen, Katri; Kelleher, Dermot; Korponay-Szabo, Ilma; Kurppa, Kalle; MacMathuna, Padraic; Maki, Markku; Mazzilli, Maria Cristina; McCann, Owen T.; Mearin, M. Luisa; Mein, Charles A.; Mirza, Muddassar M.; Mistry, Vanisha; Mora, Barbara; Morley, Katherine I.; Mulder, Chris J.; Murray, Joseph A.; Nunez, Concepcion; Oosterom, Elvira; Ophoff, Roel A.; Polanco, Isabel; Peltonen, Leena; Platteel, Mathieu; Rybak, Anna; Salomaa, Veikko; Schweizer, Joachim J.; Sperandeo, Maria Pia; Tack, Greetje J.; Turner, Graham; Veldink, Jan H.; Verbeek, Wieke H. M.; Weersma, Rinse K.; Wolters, Victorien M.; Urcelay, Elena; Cukrowska, Bozena; Greco, Luigi; Neuhausen, Susan L.; McManus, Ross; Barisani, Donatella; Deloukas, Panos; Barrett, Jeffrey C.; Saavalainen, Paivi; Wijmenga, Cisca; van Heel, David A.			Multiple common variants for celiac disease influencing immune gene expression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; RISK VARIANTS; ALLELES; IMPUTATION; SELECTION; DELETION; THYMUS; CELLS	We performed a second-generation genome-wide association study of 4,533 individuals with celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with P-GWAS < 10(-4) and 18 SNPs from 14 known loci in a further 4,918 cases and 5,684 controls. Variants from 13 new regions reached genome-wide significance (P-combined < 5 x 10(-8)); most contain genes with immune functions (BACH2, CCR4, CD80, CIITA-SOCS1-CLEC16A, ICOSLG and ZMIZ1), with ETS1, RUNX3, THEMIS and TNFRSF14 having key roles in thymic T-cell selection. There was evidence to suggest associations for a further 13 regions. In an expression quantitative trait meta-analysis of 1,469 whole blood samples, 20 of 38 (52.6%) tested loci had celiac risk variants correlated (P < 0.0028, FDR 5%) with cis gene expression.	[Dubois, Patrick C. A.; Franke, Lude; Hunt, Karen A.; Heap, Graham A. R.; Bockett, Nicholas A.; Mistry, Vanisha; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England; [Trynka, Gosia; Franke, Lude; Romanos, Jihane; Fehrmann, Rudolf S. N.; Oosterom, Elvira; Platteel, Mathieu; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Curtotti, Alessandra; Mein, Charles A.] Queen Mary Univ London, Genome Ctr, Barts & London Sch Med & Dent, London, England; [Zhernakova, Alexandra] Univ Med Ctr Utrecht, Div Biomed Genet, Utrecht, Netherlands; [Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Dept Prevent Med, H-4012 Debrecen, Hungary; [Aromaa, Arpo; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Bardella, Maria Teresa] Osped Maggiore Policlin Mangiagalli & Regina Elen, Fdn IRCCS, Milan, Italy; [Bardella, Maria Teresa] Univ Milan, Dept Med Sci, Milan, Italy; [van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de la Concha, Emilio G.; Dema, Barbara; Fernandez-Arquero, Miguel; Nunez, Concepcion; Urcelay, Elena] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [Fiatal, Szilvia] Univ Debrecen, Publ Hlth Res Grp, Hungarian Acad Sci, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Green, Peter M.; Mirza, Muddassar M.] Kings Coll London, Guys Hosp, NIHR GSTFT KCL Comprehens Biomed Res Ctr, Sch Med, London WC2R 2LS, England; [Groen, Harry J. M.] Univ Med Ctr Groningen, Dept Pulmonol, NL-9713 AV Groningen, Netherlands; [Gwilliam, Rhian; Hunt, Sarah E.; McCann, Owen T.; Morley, Katherine I.; Peltonen, Leena; Deloukas, Panos; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge, England; [Houwen, Roderick H. J.; Wolters, Victorien M.] Univ Med Ctr Utrecht, Dept Paediat Gastroenterol, Utrecht, Netherlands; [Kaukinen, Katri; Kurppa, Kalle; Maki, Markku] Univ Tampere, Paediat Res Ctr, Sch Med, FIN-33101 Tampere, Finland; [Kaukinen, Katri; Kurppa, Kalle; Maki, Markku] Tampere Univ Hosp, Tampere, Finland; [Kelleher, Dermot; Turner, Graham; McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Korponay-Szabo, Ilma] Heim Pal Childrens Hosp, Budapest, Hungary; [Korponay-Szabo, Ilma] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pediat, H-4012 Debrecen, Hungary; [MacMathuna, Padraic] Mater Misericordiae Univ Hosp, Gastrointestinal Unit, Dublin, Ireland; [Mazzilli, Maria Cristina; Mora, Barbara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Mearin, M. Luisa; Schweizer, Joachim J.] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands; [Mulder, Chris J.; Tack, Greetje J.; Verbeek, Wieke H. M.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Murray, Joseph A.] Mayo Clin, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Polanco, Isabel] Hosp La Paz, Dept Pediat Gastroenterol, Madrid, Spain; [Peltonen, Leena] FIMM, Helsinki, Finland; [Rybak, Anna] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Sperandeo, Maria Pia; Greco, Luigi] Univ Naples Federico II, European Lab Food Induced Dis, Naples, Italy; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Cukrowska, Bozena] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Barisani, Donatella] Univ Milano Bicocca, Fac Med, Dept Expt Med, Monza, Italy; [Saavalainen, Paivi] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Saavalainen, Paivi] Univ Helsinki, Res Program Mol Med, Helsinki, Finland	University of London; Queen Mary University London; University of Groningen; University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; University of Debrecen; Finland National Institute for Health & Welfare; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Utrecht University; Utrecht University Medical Center; Hospital Clinico San Carlos; Hungarian Academy of Sciences; University of Debrecen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Groningen; Wellcome Trust Sanger Institute; Utrecht University; Utrecht University Medical Center; Tampere University; Tampere University; Tampere University Hospital; Trinity College Dublin; University of Debrecen; Mater Misericordiae University Hospital; University College Dublin; Sapienza University Rome; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Mayo Clinic; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; Hospital Universitario La Paz; Children's Memorial Health Institute; University of Naples Federico II; University of Groningen; Children's Memorial Health Institute; City of Hope; Beckman Research Institute of City of Hope; University of Milano-Bicocca; University of Helsinki; University of Helsinki	van Heel, DA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England.	lude@cleverfranke.com; d.vanheel@qmul.ac.uk	Dr Fiatal, Szilvia/GQH-2653-2022; Zhernakova, Alexandra/ABA-9372-2020; Weersma, Rinse/ABE-3807-2021; Rybak, Anna/HGB-1849-2022; McManus, Ross/AAE-9236-2020; Korponay-Szabó, Ilma/AAF-9048-2022; Korponay-Szabó, Ilma/AFK-1690-2022; Romanos, Jihane/F-7372-2012; Deloukas, Panos/B-2922-2013; Núñez, Concepción/H-8517-2017; Groen, Harry/AAP-2242-2021; Dema, Barbara/AAM-2354-2020; Saavalainen, Päivi M/E-8621-2011; Fehrmann, Rudolf/E-2551-2011; Morley, Katherine I/A-2986-2011; Franke, Lude/P-7036-2016; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Grandone, Elvira/M-1127-2019	Deloukas, Panos/0000-0001-9251-070X; Fehrmann, Rudolf/0000-0002-7516-315X; Morley, Katherine I/0000-0002-2725-5535; Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Grandone, Elvira/0000-0002-8980-9783; Bockett, Nicholas/0000-0002-7630-7637; Trynka, Gosia/0000-0002-6955-9529; Mein, Charles/0000-0003-0811-9658; murray, joseph/0000-0003-1941-9090; McManus, Ross/0000-0002-0529-9617; Cukrowska, Bozena/0000-0001-6887-0094; Barrett, Jeffrey/0000-0002-1152-370X; Zhernakova, Alexandra/0000-0002-4574-0841; Kurppa, Kalle/0000-0003-4757-2164; van Heel, David/0000-0002-0637-2265; Urcelay, Elena/0000-0001-8470-8396; Hunt, Sarah/0000-0002-8350-1235; Nunez, Concepcion/0000-0002-9489-1603; MacMathuna, Padraic/0000-0003-4116-7563; Veldink, Jan/0000-0001-5572-9657; Groen, Harry J.M./0000-0002-2978-5265; Heap, Graham/0000-0003-4131-6792	Wellcome Trust [084743, 085475]; Coeliac Disease Consortium; Dutch Government [BSIK03009]; Netherlands Organisation for Scientific Research (NWO) [918.66.620]; Italian Ministry of Healthy [RC2009]; Prinses Beatrix Fonds; Adessium foundation; Amyotrophic Lateral Sclerosis Association; Netherlands Genomics Initiative [93519031]; NWO (ZonMW) [916.10.135]; MRC [G0700545]; Royal Netherlands Academy of Arts and Sciences; COPACETIC (EU) [201379]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF); Department of Health via the National Institute for Health Research (NIHR); NIH [DK050678, DK081645, NS058980, DK57892, DK071003]; EU Commission [MEXT-CT-2005-025270]; Academy of Finland [OTKA 61868]; University of Helsinki Funds; Tampere University Hospital; Foundation of Pediatric Research; Sigrid Juselius Foundation; Hungarian Academy of Sciences [2006TKI247]; UMC Cooperation [6/06/2006/NDON]; Science Foundation Ireland [CP08/0213]; Irish Health Research Board;  [U01 DK062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003, R01DK050678, R56DK071003, U01DK062418, R01DK081645, R01DK057892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058980] Funding Source: NIH RePORTER; Medical Research Council [G0700545] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Coeliac Disease Consortium; Dutch Government; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Italian Ministry of Healthy(Ministry of Health, Italy); Prinses Beatrix Fonds; Adessium foundation; Amyotrophic Lateral Sclerosis Association; Netherlands Genomics Initiative; NWO (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Netherlands Academy of Arts and Sciences; COPACETIC (EU)(European Commission); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); University of Helsinki Funds; Tampere University Hospital; Foundation of Pediatric Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Hungarian Academy of Sciences(Hungarian Academy of Sciences); UMC Cooperation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Coeliac UK for assistance with direct recruitment of individuals with celiac disease, and UK clinicians (L. C. Dinesen, G. K. T. Holmes, P. D. Howdle, J.R.F. Walters, D. S. Sanders, J. Swift, R. Crimmins, P. Kumar, D. P. Jewell, S. P. L. Travis and K. Moriarty) who recruited the celiac disease blood samples described in our previous studies<SUP>1,22</SUP>. We thank the genotyping facility of the UMCG (J. Smolonska and P. van der Vlies) for generating part of the GWAS and replication data and the gene expression data; R. Booij and M. Weenstra for preparation of Italian samples; H. Ahola, A. Heimonen, L. Koskinen, E. Einarsdottir and K. Loytynoja for their work on Finnish sample collection, preparation and data handling; and E. Szathmari, J.B. Kovacs, M. Lorincz and A. Nagy for their work with the Hungarian families. The Health2000 organization, Finrisk consortium, K. Mustalahti, M. Perola, K. Kristiansson and J. Koskinen are thanked for providing the Finnish control genotypes. We thank D. G. Clayton and N. Walker for providing T1DGC data in the required format. We thank the Irish Transfusion Service and Trinity College Dublin Biobank for control samples and V. Trimble, E. Close, G. Lawlor, A. Ryan, M. Abuzakouk, C. O'Morain and G. Horgan for celiac disease sample collection and preparation We acknowledge DNA provided by Mayo Clinic Rochester and thank M. Bonamico and M. Barbato (Department of Paediatrics, Sapienza University of Rome, Italy) for recruiting individuals. We thank Polish clinicians for recruitment of individuals with celiac disease (Z. Domagala, A. Szaflarska-Poplawska, B. Oralewska, W. Cichy, B. Korczowski, K. Fryderek, E. Hapyn, K. Karczewska, A. Zalewska, I. Sakowska-Maliszewska, R. Mozrzymas, A. Zabka, M. Kolasa and B. Iwanczak). We thank M. Szperl for isolating DNA from blood samples provided by the Children's Memorial Health Institute (Warsaw, Poland). Dutch and UK genotyping for the second celiac disease GWAS was funded by the Wellcome Trust (084743 to D. A. v. H.). Italian genotyping for the second celiac disease GWAS was funded by the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009 to C. W.) and by the Netherlands Organisation for Scientific Research (NWO, VICI grant 918.66.620 to C. W.). E. G. is funded by the Italian Ministry of Healthy (grant RC2009). L.H.v.d.B. acknowledges funding from the Prinses Beatrix Fonds, the Adessium foundation and the Amyotrophic Lateral Sclerosis Association. L. F. received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). P. C. A. D. is an MRC Clinical Training Fellow (G0700545). G. T. received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). The gene expression study was funded in part by COPACETIC (EU grant 201379). This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2 (WTCCC2). A full list of the WTCCC2 investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the WTCCC2 project was provided by the Wellcome Trust under award 085475.; This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Istitute of Child Health and Human Development (NICHD) and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. We acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We acknowledge funding from the NIH: DK050678 and DK081645 (to S. L. N.), NS058980 (to R.A.O.); and DK57892 and DK071003 (to J. A. M.). The collection of Finnish and Hungarian subjects with celiac disease was funded by the EU Commission (MEXT-CT-2005-025270), the Academy of Finland, Hungarian Scientific Research Fund (contract OTKA 61868), the University of Helsinki Funds, the Competitive Research Funding of the Tampere University Hospital, the Foundation of Pediatric Research, the Sigrid Juselius Foundation and the Hungarian Academy of Sciences (2006TKI247 to R. A.). Funding for the collection and genotyping of the Polish samples was provided by UMC Cooperation Project (6/06/2006/NDON). R. M. is funded by Science Foundation Ireland. C. Nunez has a FIS contract (CP08/0213). The Dublin Centre for Clinical Research contributed to collection of samples from affected individuals and is funded by the Irish Health Research Board and the Wellcome Trust. Finally, we thank all individuals with celiac disease and control individuals for participating in this study.	Allen PM, 2009, NAT IMMUNOL, V10, P805, DOI 10.1038/ni0809-805; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Franke L, 2008, AM J HUM GENET, V82, P1316, DOI 10.1016/j.ajhg.2008.05.008; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wang J, 2003, J IMMUNOL, V170, P3986, DOI 10.4049/jimmunol.170.8.3986; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	46	677	689	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					295	U42		10.1038/ng.543	http://dx.doi.org/10.1038/ng.543			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20190752	Green Submitted, Green Accepted			2022-12-25	WOS:000276150500008
J	Pereg, Y; Liu, BY; O'Rourke, KM; Sagolla, M; Dey, A; Komuves, L; French, DM; Dixit, VM				Pereg, Yaron; Liu, Bob Y.; O'Rourke, Karen M.; Sagolla, Meredith; Dey, Anwesha; Komuves, Laszlo; French, Dorothy M.; Dixit, Vishva M.			Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; PHOSPHATASES; CHECKPOINT; CANCER; PHOSPHORYLATION; TUMORIGENESIS; DISRUPTION; SYSTEM; GUARDS; CELLS	The dual specificity (Tyr/Thr) phosphatase Cdc25A activates cyclin-dependent kinases (Cdks) to promote cell-cycle progression and has significant oncogenic potential(1). Cdc25A protein levels are regulated tightly in normal tissues, but many human cancers overexpress Cdc25A. The underlying mechanism for overexpression has been enigmatic(2). Here we show that Cdc25A is stabilized by the ubiquitin hydrolase Dub3. Upon binding Cdc25A, Dub3 removes the polyubiquitin modifications that mark Cdc25A for proteasomal degradation. Dub3 knockdown in cells increased Cdc25A ubiquitylation and degradation, resulting in reduced Cdk/Cyclin activity and arrest at G1/S and G2/M phases of the cell cycle. In contrast, acute Dub3 overexpression produced a signature response to oncogene induction: cells accumulated in S and G2 because of replication stress, and activated a DNA damage response. Dub3 also transformed NIH-3T3 cells and cooperated with activated H-Ras to promote growth in soft agar. Importantly, we show that Dub3 overexpression is responsible for an abnormally high level of Cdc25A in a subset of human breast cancers. Moreover, Dub3 knockdown significantly retarded the growth of breast tumour xenografts in nude mice. As a major regulator of Cdc25A, Dub3 is an example of a transforming ubiquitin hydrolase that a key component of the cell cycle machinery.	[Pereg, Yaron; O'Rourke, Karen M.; Dey, Anwesha; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Liu, Bob Y.] Genentech Inc, Dept Canc Pathways & Targets, San Francisco, CA 94080 USA; [Sagolla, Meredith; Komuves, Laszlo; French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wallace RW, 1997, DRUG DISCOV TODAY, V2, P83, DOI 10.1016/S1359-6446(97)01004-0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	22	98	106	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					400	U226		10.1038/ncb2041	http://dx.doi.org/10.1038/ncb2041			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228808				2022-12-25	WOS:000276194600013
J	Santra, S; Liao, HX; Zhang, RJ; Muldoon, M; Watson, S; Fischer, W; Theiler, J; Szinger, J; Balachandran, H; Buzby, A; Quinn, D; Parks, RJ; Tsao, CY; Carville, A; Mansfield, KG; Pavlakis, GN; Felber, BK; Haynes, BF; Korber, BT; Letvin, NL				Santra, Sampa; Liao, Hua-Xin; Zhang, Ruijin; Muldoon, Mark; Watson, Sydeaka; Fischer, Will; Theiler, James; Szinger, James; Balachandran, Harikrishnan; Buzby, Adam; Quinn, David; Parks, Robert J.; Tsao, Chun-Yen; Carville, Angela; Mansfield, Keith G.; Pavlakis, George N.; Felber, Barbara K.; Haynes, Barton F.; Korber, Bette T.; Letvin, Norman L.			Mosaic vaccines elicit CD8(+) T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL RESPONSES; RHESUS-MONKEYS; AIDS	An effective HIV vaccine must elicit immune responses that recognize genetically diverse viruses(1,2). It must generate CD8(+) T lymphocytes that control HIV replication and CD4(+) T lymphocytes that provide help for the generation and maintenance of both cellular and humoral immune responses against the virus(3-5). Creating immunogens that can elicit cellular immune responses against the genetically varied circulating isolates of HIV presents a key challenge for creating an HIV vaccine(6,7). Polyvalent mosaic immunogens derived by in silico recombination of natural strains of HIV are designed to induce cellular immune responses that recognize genetically diverse circulating virus isolates(8). Here we immunized rhesus monkeys by plasmid DNA prime and recombinant vaccinia virus boost with vaccine constructs expressing either consensus or polyvalent mosaic proteins. As compared to consensus immunogens, the mosaic immunogens elicited CD8(+) T lymphocyte responses to more epitopes of each viral protein than did the consensus immunogens and to more variant sequences of CD8(+) T lymphocyte epitopes. This increased breadth and depth of epitope recognition may contribute both to protection against infection by genetically diverse viruses and to the control of variant viruses that emerge as they mutate away from recognition by cytotoxic T lymphocytes.	[Santra, Sampa; Balachandran, Harikrishnan; Buzby, Adam; Quinn, David; Letvin, Norman L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Liao, Hua-Xin; Zhang, Ruijin; Parks, Robert J.; Tsao, Chun-Yen; Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC USA; [Muldoon, Mark] Univ Manchester, Sch Math, Manchester, Lancs, England; [Watson, Sydeaka; Fischer, Will; Theiler, James; Szinger, James; Korber, Bette T.] Los Alamos Natl Lab, Los Alamos, NM USA; [Watson, Sydeaka] Baylor Univ, Dept Stat Sci, Waco, TX 76798 USA; [Carville, Angela; Mansfield, Keith G.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Pavlakis, George N.; Felber, Barbara K.] NCI, NIH, Frederick, MD 21701 USA; [Korber, Bette T.] Santa Fe Inst, Santa Fe, NM 87501 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Duke University; University of Manchester; United States Department of Energy (DOE); Los Alamos National Laboratory; Baylor University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Santa Fe Institute	Letvin, NL (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	nletvin@bidmc.harvard.edu	Quinn, David/N-3730-2019; Fischer, Will/B-1323-2013; Muldoon, Mark/T-9192-2019; Fischer, Will/AAD-2807-2019; Muldoon, Mark R/C-7505-2009	Quinn, David/0000-0002-1411-0417; Fischer, Will/0000-0003-4579-4062; Fischer, Will/0000-0003-4579-4062; Muldoon, Mark/0000-0002-5004-7195; Quinn, David/0000-0002-5335-8968; Szinger, James/0000-0002-6605-9940; Korber, Bette/0000-0002-2026-5757; Balachandran, Harikrishnan/0000-0001-9336-0555	US National Institutes of Health [AI-0678501]; HIV Research and Design (HIVRAD) [P01 AI-61734]; National Institute of Allergy and Infectious Diseases [N01 AI-50010]; Los Alamos National Laboratory; NATIONAL CANCER INSTITUTE [ZIABC010350, ZIABC010749] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Research and Design (HIVRAD); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Tomaras for generous advice and assistance with reagents and antibody data. We also thank C. Lord for assistance with reagents. This work was supported by US National Institutes of Health grant AI-0678501 (Center for HIV AIDS Vaccine Immunology), HIV Research and Design (HIVRAD) P01 AI-61734, National Institute of Allergy and Infectious Diseases contract N01 AI-50010 and a Los Alamos National Laboratory-directed research grant to B. T. K., W. F. and S. W.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040015; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; HEENEY JL, 2004, EXPERT REV VACCINES, V3, pE53; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Santra S, 2004, P NATL ACAD SCI USA, V101, P11088, DOI 10.1073/pnas.0401954101; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; SETTE A, 1989, J IMMUNOL, V143, P1265	18	183	215	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					324	U122		10.1038/nm.2108	http://dx.doi.org/10.1038/nm.2108			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20173754	Green Accepted, Bronze			2022-12-25	WOS:000275289500039
J	Ahmed, S; Brickner, DG; Light, WH; Cajigas, I; McDonough, M; Froyshteter, AB; Volpe, T; Brickner, JH				Ahmed, Sara; Brickner, Donna G.; Light, William H.; Cajigas, Ivelisse; McDonough, Michele; Froyshteter, Alexander B.; Volpe, Tom; Brickner, Jason H.			DNA zip codes control an ancient mechanism for gene targeting to the nuclear periphery	NATURE CELL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; REVERSE RECRUITMENT; ACTIVE GENES; PORE; EXPRESSION; TRANSCRIPTION; LOCALIZATION; ORGANIZATION; ASSOCIATION	Many genes in Saccharomyces cerevisiae are recruited to the nuclear periphery after transcriptional activation. We have identified two gene recruitment sequences (GRS I and II) from the promoter of the INO1 gene that target the gene to the nuclear periphery. These GRSs function as DNA zip codes and are sufficient to target a nucleoplasmic locus to the nuclear periphery. Targeting requires components of the nuclear pore complex (NPC) and a GRS is sufficient to confer a physical interaction with the NPC. GRS I elements are enriched in promoters of genes that interact with the NPC, and genes that are induced by protein folding stress. Full transcriptional activation of INO1 and another GRS-containing gene requires GRS-mediated targeting of the promoter to the nuclear periphery. Finally, GRS I also functions as a DNA zip code in Schizosaccharomyces pombe, suggesting that this mechanism of targeting to the nuclear periphery has been conserved over approximately one billion years of evolution.	[Ahmed, Sara; Brickner, Donna G.; Light, William H.; Cajigas, Ivelisse; Froyshteter, Alexander B.; Brickner, Jason H.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [McDonough, Michele; Volpe, Tom] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Brickner, JH (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-brickner@northwestern.edu		Brickner, Jason/0000-0001-8019-3743; McDonough, Michele/0000-0002-3718-6465	Searle Leadership Fund at Northwestern University; The Searle Funds at The Chicago Community Trust; American Cancer Society; National Institutes of Health [GM080484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080484] Funding Source: NIH RePORTER	Searle Leadership Fund at Northwestern University; The Searle Funds at The Chicago Community Trust; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Robert Lamb for generously sharing his confocal microscope. Also, we thank Audrey Gasch, Richard Carthew, Rick Gaber, Sandy Westerheide, Jonathan Widom, Susan Wente, Michael Rout and members of the Brickner lab for helpful discussions. This work was supported by the Searle Leadership Fund at Northwestern University, a gift of The Searle Funds at The Chicago Community Trust (J. H. B.), an Institutional Research Grant from the American Cancer Society (J. H. B.) and National Institutes of Health grant GM080484 (J. H. B.).	Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner Jason H, 2004, PLoS Biol, V2, pe342; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chekanova JA, 2008, RNA, V14, P66, DOI 10.1261/rna.764108; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leber JH, 2004, PLOS BIOL, V2, P1197, DOI 10.1371/journal.pbio.0020235; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sarma NJ, 2007, GENETICS, V175, P1127, DOI 10.1534/genetics.106.068932; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; SIKORSKI RS, 1989, GENETICS, V122, P19; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SWIFT S, 1995, NUCLEIC ACIDS RES, V23, P1426, DOI 10.1093/nar/23.8.1426; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0	39	140	142	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					111	U43		10.1038/ncb2011	http://dx.doi.org/10.1038/ncb2011			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098417	Green Accepted			2022-12-25	WOS:000274139400005
J	Chambers, JC; Zhao, J; Terracciano, CMN; Bezzina, CR; Zhang, WH; Kaba, R; Navaratnarajah, M; Lotlikar, A; Sehmi, JS; Kooner, MK; Deng, GH; Siedlecka, U; Parasramka, S; El-Hamamsy, I; Wass, MN; Dekker, LRC; de Jong, JSSG; Sternberg, MJE; McKenna, W; Severs, NJ; de Silva, R; Wilde, AAM; Anand, P; Yacoub, M; Scott, J; Elliott, P; Wood, JN; Kooner, JS				Chambers, John C.; Zhao, Jing; Terracciano, Cesare M. N.; Bezzina, Connie R.; Zhang, Weihua; Kaba, Riyaz; Navaratnarajah, Manoraj; Lotlikar, Amol; Sehmi, Joban S.; Kooner, Manraj K.; Deng, Guohong; Siedlecka, Urszula; Parasramka, Saurabh; El-Hamamsy, Ismail; Wass, Mark N.; Dekker, Lukas R. C.; de Jong, Jonas S. S. G.; Sternberg, Michael J. E.; McKenna, William; Severs, Nicholas J.; de Silva, Ranil; Wilde, Arthur A. M.; Anand, Praveen; Yacoub, Magdi; Scott, James; Elliott, Paul; Wood, John N.; Kooner, Jaspal S.			Genetic variation in SCN10A influences cardiac conduction	NATURE GENETICS			English	Article							SODIUM-CHANNEL NA(V)1.8; QT INTERVAL DURATION; COMMON VARIANTS; SUDDEN-DEATH; DRG NEURONS; MORTALITY; HEART; DISEASE; BURDEN; PAIN	To identify genetic factors influencing cardiac conduction, we carried out a genome-wide association study of electrocardiographic time intervals in 6,543 Indian Asians. We identified association of a nonsynonymous SNP, rs6795970, in SCN10A (P = 2.8 x 10(-15)) with PR interval, a marker of cardiac atrioventricular conduction. Replication testing among 6,243 Indian Asians and 5,370 Europeans confirmed that rs6795970 (G>A) is associated with prolonged cardiac conduction (longer P-wave duration, PR interval and QRS duration, P = 10(-5) to 10(-20)). SCN10A encodes Na(V)1.8, a sodium channel. We show that SCN10A is expressed in mouse and human heart tissue and that PR interval is shorter in Scn10a(-/-) mice than in wild-type mice. We also find that rs6795970 is associated with a higher risk of heart block (P < 0.05) and a lower risk of ventricular fibrillation (P = 0.01). Our findings provide new insight into the pathogenesis of cardiac conduction, heart block and ventricular fibrillation.	[Chambers, John C.; Zhang, Weihua; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Chambers, John C.; Zhang, Weihua; Sehmi, Joban S.; Kooner, Manraj K.; Deng, Guohong; Parasramka, Saurabh; de Silva, Ranil; Kooner, Jaspal S.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Zhao, Jing; Lotlikar, Amol; Wood, John N.] UCL, Wolfson Inst Biomed Res, London, England; [Terracciano, Cesare M. N.; Kaba, Riyaz; Navaratnarajah, Manoraj; Sehmi, Joban S.; Kooner, Manraj K.; Siedlecka, Urszula; El-Hamamsy, Ismail; Severs, Nicholas J.; de Silva, Ranil; Yacoub, Magdi; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bezzina, Connie R.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Bezzina, Connie R.; Dekker, Lukas R. C.; de Jong, Jonas S. S. G.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Deng, Guohong] Univ London Imperial Coll Sci Technol & Med, Dept Gastroenterol & Hepatol, London, England; [Wass, Mark N.; Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; [McKenna, William] UCL, Inst Cardiovasc Sci, London, England; [Anand, Praveen] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London, England	Imperial College London; University of London; University College London; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London; University of London; University College London; Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England.	john.chambers@ic.ac.uk; j.kooner@ic.ac.uk	zhang, weihua/GXV-1334-2022; Wass, Mark N/F-5540-2010; McKenna, William J/C-3243-2008; Wass, Mark/H-3398-2019	McKenna, William J/0000-0001-7994-2460; Wass, Mark/0000-0001-5428-6479; Elliott, Paul/0000-0002-7511-5684; Sternberg, Michael/0000-0002-1884-5445; Zhao, Jing/0000-0003-2587-1198; Bezzina, Connie/0000-0002-0633-3514	British Heart Foundation [SP/04/002, F/99089]; Wellcome Trust [084723/Z/08/Z]; Netherlands Heart Foundation [2007B202]; Leducq Foundation [05-CVD]; BBSRC LOLA [BB/F000227/1]; Biotechnology and Biological Sciences Research Council [BB/F020481/1]; National Institute for Health Research Biomedical Research Centres; Wellcome Trust; BBSRC [BB/F000227/1, BB/F020481/1] Funding Source: UKRI; MRC [G9717869, G0601966, G0901905, G0700931, G0801056] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0601966, G0801056, G0700931, G9717869, G0901905, G0801056B] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Leducq Foundation(Leducq Foundation); BBSRC LOLA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research Biomedical Research Centres; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participants involved in the research. The LOLIPOP study was supported by the British Heart Foundation (SP/04/002) and by the Wellcome Trust (084723/Z/08/Z). Studies in the AGNES population were supported by the Netherlands Heart Foundation (Grant 2007B202) and the Leducq Foundation (Grant 05-CVD). J. Z. was supported by a BBSRC LOLA award (BB/F000227/1). R. K. was supported by the British Heart Foundation (Grant F/99089). M. N. W. is supported by the Biotechnology and Biological Sciences Research Council grant BB/F020481/1. W. M. is funded by the National Institute for Health Research Biomedical Research Centres scheme. J.N.W. is a member of the Wellcome Trust-funded London Pain Consortium. We thank G. Turner and M. Minett for maintaining the Scn10a-null mutant mouse colony, M.W. Tanck and R. Pazoki for help in statistical analyses and S. Rothery for technical assistance.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Harty TP, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-12; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kerr NCH, 2004, J BIOL CHEM, V279, P24826, DOI 10.1074/jbc.M401281200; Knollmann BC, 2008, NATURE, V451, P929, DOI 10.1038/nature06799; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Malik-Hall M, 2003, MOL BRAIN RES, V110, P298, DOI 10.1016/S0169-328X(02)00661-7; Matsumoto S, 2007, NEUROPHARMACOLOGY, V52, P904, DOI 10.1016/j.neuropharm.2006.10.008; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Souslova VA, 1997, GENOMICS, V41, P201, DOI 10.1006/geno.1997.4669; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Vrtovec B, 2003, CIRCULATION, V107, P1764, DOI 10.1161/01.CIR.0000057980.84624.95; Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	33	197	202	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					149	U80		10.1038/ng.516	http://dx.doi.org/10.1038/ng.516			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062061				2022-12-25	WOS:000274084400012
J	Pfeufer, A; van Noord, C; Marciante, KD; Arking, DE; Larson, MG; Smith, AV; Tarasov, KV; Muller, M; Sotoodehnia, N; Sinner, MF; Verwoert, GC; Li, M; Kao, WHL; Kottgen, A; Coresh, J; Bis, JC; Psaty, BM; Rice, K; Rotter, JI; Rivadeneira, F; Hofman, A; Kors, JA; Stricker, BHC; Uitterlinden, AG; van Duijn, CM; Beckmann, BM; Sauter, W; Gieger, C; Lubitz, SA; Newton-Cheh, C; Wang, TJ; Magnani, JW; Schnabel, RB; Chung, MK; Barnard, J; Smith, JD; Van Wagoner, DR; Vasan, RS; Aspelund, T; Eiriksdottir, G; Harris, TB; Launer, LJ; Najjar, SS; Lakatta, E; Schlessinger, D; Uda, M; Abecasis, GR; Muller-Myhsok, B; Ehret, GB; Boerwinkle, E; Chakravarti, A; Soliman, EZ; Lunetta, KL; Perz, S; Wichmann, HE; Meitinger, T; Levy, D; Gudnason, V; Ellinor, PT; Sanna, S; Kaab, S; Witteman, JCM; Alonso, A; Benjamin, EJ; Heckbert, SR				Pfeufer, Arne; van Noord, Charlotte; Marciante, Kristin D.; Arking, Dan E.; Larson, Martin G.; Smith, Albert Vernon; Tarasov, Kirill V.; Mueller, Martina; Sotoodehnia, Nona; Sinner, Moritz F.; Verwoert, Germaine C.; Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef; Bis, Joshua C.; Psaty, Bruce M.; Rice, Kenneth; Rotter, Jerome I.; Rivadeneira, Fernando; Hofman, Albert; Kors, Jan A.; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Beckmann, Britt M.; Sauter, Wiebke; Gieger, Christian; Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Magnani, Jared W.; Schnabel, Renate B.; Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.; Vasan, Ramachandran S.; Aspelund, Thor; Eiriksdottir, Gudny; Harris, Tamara B.; Launer, Lenore J.; Najjar, Samer S.; Lakatta, Edward; Schlessinger, David; Uda, Manuela; Abecasis, Goncalo R.; Mueller-Myhsok, Bertram; Ehret, Georg B.; Boerwinkle, Eric; Chakravarti, Aravinda; Soliman, Elsayed Z.; Lunetta, Kathryn L.; Perz, Siegfried; Wichmann, H-Erich; Meitinger, Thomas; Levy, Daniel; Gudnason, Vilmundur; Ellinor, Patrick T.; Sanna, Serena; Kaeaeb, Stefan; Witteman, Jacqueline C. M.; Alonso, Alvaro; Benjamin, Emelia J.; Heckbert, Susan R.			Genome-wide association study of PR interval	NATURE GENETICS			English	Article							ATRIAL-FIBRILLATION; COMMON VARIANTS; SODIUM-CHANNEL; HEART-RATE; ATHEROSCLEROSIS RISK; NATIONAL HEART; SYSTEM; DESIGN; INDIVIDUALS; VARIABILITY	The electrocardiographic PR interval (or PQ interval) reflects atrial and atrioventricular nodal conduction, disturbances of which increase risk of atrial fibrillation. We report a meta-nalysis of genome-wide association studies for PR interval from seven population-based European studies in the CHARGE Consortium: AGES, ARIC, CHS, FHS, KORA, Rotterdam Study, and SardiNIA (N = 28,517). We identified nine loci associated with PR interval at P < 5 x 10(-8). At the 3p22.2 locus, we observed two independent associations in voltage-gated sodium channel genes, SCN10A and SCN5A. Six of the loci were near cardiac developmental genes, including CAV1-CAV2, NKX25 (CSX1), SOX5, WNT11, MEIS1, and TBX5-TBX3, providing pathophysiologically interesting candidate genes. Five of the loci, SCN5A, SCN10A, NKX2-5, CAV1-CAV2, and SOX5, were also associated with atrial fibrillation (N = 5,741 cases, P < 0.0056). This suggests a role for common variation in ion channel and developmental genes in atrial and atrioventricular conduction as well as in susceptibility to atrial fibrillation.	[Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [van Noord, Charlotte; Verwoert, Germaine C.; Rivadeneira, Fernando; Hofman, Albert; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging Leiden, Leiden, Netherlands; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.; Wang, Thomas J.; Schnabel, Renate B.; Vasan, Ramachandran S.; Levy, Daniel; Benjamin, Emelia J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Heart Prevent Clin & Res Inst, Iceland Heart Assoc, Kopavogur, Iceland; [Tarasov, Kirill V.; Najjar, Samer S.; Lakatta, Edward] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Tarasov, Kirill V.; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Mueller, Martina; Sauter, Wiebke; Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Mueller, Martina; Sinner, Moritz F.; Beckmann, Britt M.; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-80804 Munich, Germany; [Verwoert, Germaine C.; Rivadeneira, Fernando; Stricker, Bruno H. C.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Res Inst, Seattle, WA USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Dept Common Dis Genet Program, Inst Med Genet, W Hollywood, CA USA; [Kors, Jan A.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Stricker, Bruno H. C.] Inspectorate Hlth Care, The Hague, Netherlands; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Med Clin Cardiol 2, Mainz, Germany; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Heart & Vasc Res Inst, Cleveland, OH 44106 USA; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Heart Prevent Clin & Res Inst, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Uda, Manuela; Sanna, Serena] CNR, Ist Neurogenet Neurofarmacol, Cagliari, Italy; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Chakravarti, Aravinda] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Univ, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE,Med Ctr, Winston Salem, NC 27109 USA; [Perz, Siegfried] Helmholtz Ctr, Inst Biol & Med Imaging, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Cardiol & Prevent Med Div,Evans Dept Med, Boston, MA 02118 USA	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Johns Hopkins University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Johannes Gutenberg University of Mainz; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); University of Michigan System; University of Michigan; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Wake Forest University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; Boston University; Boston University	Pfeufer, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany.	arne.pfeufer@web.de; heckbert@u.washington.edu	Van Wagoner, David R/C-6783-2008; Rice, Kenneth M/A-4150-2013; Kottgen, Anna/D-2920-2012; Soliman, Elsayed Z/AAD-7135-2020; Aspelund, Thor/C-5983-2008; Schnabel, Renate B/F-6527-2014; Müller-Nurasyid, Martina/I-8735-2018; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Wichmann, Heinz Erich/AAA-5695-2022; Gudnason, Vilmundur/K-6885-2015; Levy, Daniel/ABF-6873-2021; Launer, Lenore J/A-8218-2010; Abecasis, Goncalo R/B-7840-2010; Li, Man/AAX-3400-2020; Pfeufer, Arne/B-6634-2013; Müller-Myhsok, Bertram/A-3289-2013; EHRET, Georg B/A-9532-2009; Kaab, Stefan/H-3915-2012; Schnabel, Renate B/ABE-6668-2021; Smith, Albert Vernon/K-5150-2015; Ramachandran, Vasan/Y-2527-2019; Sinner, Moritz/AAW-5043-2020; Aspelund, Thor/K-7022-2019; Rivadeneira, Fernando/O-5385-2015; Alonso, Alvaro/A-4917-2010; Meitinger, Thomas/O-1318-2015; Levy, Daniel/ABB-2752-2021; Lakatta, Edward G/AAL-1447-2020; sanna, serena/H-3009-2019; Uda, Manuela/AAC-2645-2019; Soliman, Elsayed/D-8124-2011; Aspelund, Thor/F-4826-2011; Smith, Jonathan D./H-9723-2013; Benjamin, Emelia/E-7103-2011	Van Wagoner, David R/0000-0001-8250-9828; Rice, Kenneth M/0000-0001-5779-4495; Soliman, Elsayed Z/0000-0001-5632-8150; Aspelund, Thor/0000-0002-7998-5433; Müller-Nurasyid, Martina/0000-0003-3793-5910; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Levy, Daniel/0000-0003-1843-8724; Li, Man/0000-0002-3839-0281; EHRET, Georg B/0000-0002-5730-0675; Schnabel, Renate B/0000-0001-7170-9509; Smith, Albert Vernon/0000-0003-1942-5845; Ramachandran, Vasan/0000-0001-7357-5970; Aspelund, Thor/0000-0002-7998-5433; Rivadeneira, Fernando/0000-0001-9435-9441; Alonso, Alvaro/0000-0002-2225-8323; sanna, serena/0000-0002-3768-1749; Uda, Manuela/0000-0002-4890-6456; Soliman, Elsayed/0000-0001-5632-8150; Van Duijn, Cornelia/0000-0002-2374-9204; Smith, Jonathan D./0000-0002-0415-386X; Gieger, Christian/0000-0001-6986-9554; Tarasov, Kirill/0000-0001-7799-4670; Lakatta, Edward/0000-0002-4772-0035; Meitinger, Thomas/0000-0002-8838-8403; Ballantyne, Christie/0000-0002-6432-1730; Lunetta, Kathryn/0000-0002-9268-810X; Abecasis, Goncalo/0000-0003-1509-1825; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254; Wang, Thomas/0000-0003-4063-6508; Ellinor, Patrick/0000-0002-2067-0533	US National Institutes of Health [N01-AG-12100]; US National Institute on Aging (NIA); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic parliament); US National Heart, Lung, and Blood Institute (NHLBI); US National Eye Institute; US National Institute on Deafness and Other Communication Disorders; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694, R01-HL-054512, R01-HL090620, P50-HL077107, N01-HC85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652]; US National Human Genome Research Institute (NHGRI) [U01-HG004402]; NIH [HHSN268200625226C, UL1-RR025005, N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025, 6R01-NS-17950]; Donald W. Reynolds Cardiovascular Clinical Research Center; Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic; US National Center for Research Resources [M01-RR-00425]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; US National Institute of Neurological Disorders and Stroke; Cedars-Sinai Board of Governors; Boston University School of Medicine and Boston Medical Center (LINGA-II); Robert Dawson Evans Endowment; Doris Duke Charitable Foundation; Deutsche Forschungsgemeinschaft [SCHN 1149/1-1]; Pfizer; Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz; Leducq Foundation [07-03 Ludvig 03]; Ludwig-Maximilians University (LMU) [FuFoLe 557/569]; Helmholtz Zentrum Munchen fur Gesundheit und Umwelt; The Netherlands Organisation for Scientific Research [175.010.2005.011, 911.03.012, 050-060-810]; European Commission; Erasmus Medical Center, Erasmus University Rotterdam; NIA [NO1-AG-1-2109, 263-MA-410953];  [01-GS-0499];  [01-GR-0103];  [01-GR-0803];  [AFNET 01-GI-0204 01-GS-0838]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG007270, ZIAAG006000, ZIAAG000799] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic parliament); US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center; Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic; US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cedars-Sinai Board of Governors; Boston University School of Medicine and Boston Medical Center (LINGA-II); Robert Dawson Evans Endowment; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pfizer(Pfizer); Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz(Federal Ministry of Education & Research (BMBF)); Leducq Foundation(Leducq Foundation); Ludwig-Maximilians University (LMU); Helmholtz Zentrum Munchen fur Gesundheit und Umwelt; The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Erasmus Medical Center, Erasmus University Rotterdam; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge all of the participants in the studies. AGES: US National Institutes of Health (NIH) N01-AG-12100, US National Institute on Aging (NIA) and NIH Intramural Research Programs, Hjartavernd (Icelandic Heart Association), Althingi (Icelandic parliament), US National Heart, Lung, and Blood Institute (NHLBI), US National Eye Institute and US National Institute on Deafness and Other Communication Disorders. ARIC: NHLBI N01-HC-55015, N01-HC-55016, N01-HC-55018 through N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694 and R01-HL-054512; US National Human Genome Research Institute (NHGRI) U01-HG004402; NIH HHSN268200625226C; and the Donald W. Reynolds Cardiovascular Clinical Research Center. Infrastructure was supported by NIH UL1-RR025005. CCAF: NHLBI R01-HL090620 and P50-HL077107, and intramural funding from the Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic. CHS: NHLBI N01-HC85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652 and R01-HL088456; US National Center for Research Resources M01-RR-00425; National Institute of Diabetes and Digestive and Kidney Diseases DK063491; US National Institute of Neurological Disorders and Stroke; and the Cedars-Sinai Board of Governors. FHS: NIH N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025 and 6R01-NS-17950; NHLBI N01-HC-25195; Boston University School of Medicine and Boston Medical Center (LINGA-II); the Robert Dawson Evans Endowment; the Doris Duke Charitable Foundation; the SHARe project; Deutsche Forschungsgemeinschaft fellowship SCHN 1149/1-1; Affymetrix contract for genotyping services (N02-HL-6-4278); and Pfizer. KORA/AFNET: We thank B. Putz, M. Putz and G. Fischer for their contributions to genotyping and imputation. Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz; 01-GS-0499, 01-GR-0103, 01-GR-0803, AFNET 01-GI-0204 01-GS-0838, the Leducq Foundation 07-03 Ludvig 03, Ludwig-Maximilians University (LMU) FuFoLe 557/569, the LMU Excellence Initiative, MC Health as part of LMUinnovativ, the Helmholtz Zentrum Munchen fur Gesundheit und Umwelt and the state of Bavaria. Rotterdam Study: We thank P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the database, K. Estrada for his help with the analyses and M. Struchalin for contributions to genotype imputation. Nederlandse Organisatie voor Wetenschappelijk Onderzoek (The Netherlands Organisation for Scientific Research) 175.010.2005.011, 911.03.012 and 050-060-810, the Research Institute of Diseases in the Elderly, Netherlands Genome Initiative, Stichting Zorgonderzoek Nederland-Medische Wetenschappen (The Netherlands Organisation for Health Research and Development), Netherlands Hartstichting, Netherlands Ministry of Education Culture and Science, Netherlands Ministry of Health Welfare and Sports; the European Commission; Erasmus Medical Center, Erasmus University Rotterdam and the municipality of Rotterdam. SardiNIA: We thank A. Scuteri and M. Orr for longstanding, continual support of the project and for phenotype characterization. NIA NO1-AG-1-2109, 263-MA-410953, NIH and NIA Intramural Research Programs, NHGRI and NHLBI. Role of the sponsors: None of the funding organizations had any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review or approval of the manuscript. More detailed acknowledgments can be found in the Supplementary Note.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Jay PY, 2004, ANAT REC PART A, V280A, P966, DOI 10.1002/ar.a.20102; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; OLSSON SB, 1971, ACTA MED SCAND, V190, P381; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PERZ S, 2004, ANAL BIOMEDICAL SIGN, P47; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; SCHINZEL A, 1987, J MED GENET, V24, P778, DOI 10.1136/jmg.24.12.778; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sinner MF, 2008, EUR HEART J, V29, P907, DOI 10.1093/eurheartj/ehm619; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	51	320	324	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					153	U89		10.1038/ng.517	http://dx.doi.org/10.1038/ng.517			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062060	Green Accepted			2022-12-25	WOS:000274084400013
J	Lam, HYK; Mu, XJ; Stutz, AM; Tanzer, A; Cayting, PD; Snyder, M; Kim, PM; Korbel, JO; Gerstein, MB				Lam, Hugo Y. K.; Mu, Xinmeng Jasmine; Stuetz, Adrian M.; Tanzer, Andrea; Cayting, Philip D.; Snyder, Michael; Kim, Philip M.; Korbel, Jan O.; Gerstein, Mark B.			Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint library	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER VARIATION; HUMAN GENOME; SEGMENTAL DUPLICATIONS; FINE-SCALE; HOT-SPOTS; RECOMBINATION; SEQUENCE; DELETION; ARCHITECTURE; POLYMORPHISM	Structural variants (SVs) are a major source of human genomic variation; however, characterizing them at nucleotide resolution remains challenging. Here we assemble a library of breakpoints at nucleotide resolution from collating and standardizing similar to 2,000 published SVs. For each breakpoint, we infer its ancestral state (through comparison to primate genomes) and its mechanism of formation (e. g., nonallelic homologous recombination, NAHR). We characterize breakpoint sequences with respect to genomic landmarks, chromosomal location, sequence motifs and physical properties, finding that the occurrence of insertions and deletions is more balanced than previously reported and that NAHR-formed breakpoints are associated with relatively rigid, stable DNA helices. Finally, we demonstrate an approach, BreakSeq, for scanning the reads from short-read sequenced genomes against our breakpoint library to accurately identify previously overlooked SVs, which we then validate by PCR. As new data become available, we expect our BreakSeq approach will become more sensitive and facilitate rapid SV genotyping of personal genomes.	[Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Lam, Hugo Y. K.; Mu, Xinmeng Jasmine; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Mu, Xinmeng Jasmine; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Tanzer, Andrea] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Kim, Philip M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Korbel, Jan O.] European Bioinformat Inst, Cambridge, England; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	European Molecular Biology Laboratory (EMBL); Yale University; Yale University; University of Vienna; University of Toronto; University of Toronto; University of Toronto; University of Toronto; European Molecular Biology Laboratory (EMBL); Yale University	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.	jan.korbel@embl.de; mark.gerstein@yale.edu	Korbel, Jan O/G-6470-2012; Tanzer, Andrea/L-3147-2015; Mu, Xinmeng/P-2562-2016; Tanzer, Andrea/AAY-5431-2021	Korbel, Jan O/0000-0002-2798-3794; Tanzer, Andrea/0000-0003-2873-4236; Mu, Xinmeng/0000-0002-8079-0828; Tanzer, Andrea/0000-0003-2873-4236; Stuetz, Adrian/0000-0001-7650-3470; Snyder, Michael/0000-0003-0784-7987	National Institutes of Health; A. L. Williams Professorship funds; European Molecular Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. L. Williams Professorship funds; European Molecular Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge support from the National Institutes of Health, the A. L. Williams Professorship funds and the European Molecular Biology Laboratory. We thank R. Alexander and E. Khurana for proofreading the manuscript, and A. Abyzov, Z. Zhang, T. Rausch and J. Du for helpful discussions. Finally, we thank the 1000 Genomes Project for early data access.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SARAI A, 1989, BIOCHEMISTRY-US, V28, P7842, DOI 10.1021/bi00445a046; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang LY, 2009, GENOME RES, V19, P106, DOI 10.1101/gr.080069.108; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116	49	124	129	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					47	U76		10.1038/nbt.1600	http://dx.doi.org/10.1038/nbt.1600			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20037582	Green Accepted			2022-12-25	WOS:000273430400020
J	Lai, YP; Di Nardo, A; Nakatsuji, T; Leichtle, A; Yang, Y; Cogen, AL; Wu, ZR; Hooper, LV; Schmidt, RR; von Aulock, S; Radek, KA; Huang, CM; Ryan, AF; Gallo, RL				Lai, Yuping; Di Nardo, Anna; Nakatsuji, Teruaki; Leichtle, Anke; Yang, Yan; Cogen, Anna L.; Wu, Zi-Rong; Hooper, Lora V.; Schmidt, Richard R.; von Aulock, Sonja; Radek, Katherine A.; Huang, Chun-Ming; Ryan, Allen F.; Gallo, Richard L.			Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury	NATURE MEDICINE			English	Article							NF-KAPPA-B; STAPHYLOCOCCUS-EPIDERMIDIS; NOSOCOMIAL INFECTIONS; HISTONE ACETYLATION; HUMAN KERATINOCYTES; LIPOTEICHOIC ACID; HOST-DEFENSE; CELLS; EXPRESSION; MODULATION	The normal microflora of the skin includes staphylococcal species that will induce inflammation when present below the dermis but are tolerated on the epidermal surface without initiating inflammation. Here we reveal a previously unknown mechanism by which a product of staphylococci inhibits skin inflammation. This inhibition is mediated by staphylococcal lipoteichoic acid (LTA) and acts selectively on keratinocytes triggered through Toll-like receptor 3(TLR3). We show that TLR3 activation is required for normal inflammation after injury and that keratinocytes require TLR3 to respond to RNA from damaged cells with the release of inflammatory cytokines. Staphylococcal LTA inhibits both inflammatory cytokine release from keratinocytes and inflammation triggered by injury through a TLR2-dependent mechanism. To our knowledge, these findings show for the first time that the skin epithelium requires TLR3 for normal inflammation after wounding and that the microflora can modulate specific cutaneous inflammatory responses.	[Lai, Yuping; Di Nardo, Anna; Nakatsuji, Teruaki; Cogen, Anna L.; Radek, Katherine A.; Huang, Chun-Ming; Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Lai, Yuping; Di Nardo, Anna; Nakatsuji, Teruaki; Leichtle, Anke; Cogen, Anna L.; Radek, Katherine A.; Huang, Chun-Ming; Ryan, Allen F.; Gallo, Richard L.] VA San Diego Healthcare Syst, San Diego, CA USA; [Leichtle, Anke; Ryan, Allen F.] Univ Calif San Diego, Dept Surg Otolaryngol, San Diego, CA 92103 USA; [Yang, Yan; Wu, Zi-Rong] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Schmidt, Richard R.; von Aulock, Sonja] Univ Konstanz, Dept Chem, Constance, Germany; [Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; East China Normal University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Konstanz; University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Leichtle, Anke/AAA-3505-2020; Nakatsuji, Teruaki/O-6794-2014; , Chun-Ming/AAM-1856-2020; von Aulock, Sonja/AGQ-3420-2022; di nardo, anna/AAI-1629-2020; Leichtle, Anke/GPW-7895-2022	Gallo, Richard L/0000-0002-1401-7861; Nakatsuji, Teruaki/0000-0002-6187-2991; , Chun-Ming/0000-0002-3352-5394; di nardo, anna/0000-0002-5575-9968; Lai, Yuping/0000-0001-7445-6738	US National Institutes of Health [R56AI083358, R01AR052728, R01 AI052453, DC00129, DC006279]; US Veterans Administration Merit Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083358, R01AI052453, R01AI083358, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000129, R01DC006279] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration Merit Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Peschel for advice regarding blocking LTA activity by the antibody; E. Raz from the University of California-San Diego for providing a C57BL/6 Tlr3-deficient mouse breeding pair; V. Nizet and E. Tistiskov for helpful discussion; G. Cheng, B. Beutler, R. Modlin and E. Raz for critical reading and helpful advice; and D. Bird for histological sections. This work was supported by US National Institutes of Health grants R56AI083358, R01AR052728 and R01 AI052453 and a US Veterans Administration Merit Award to R. L. G. and US National Institutes of Health grants DC00129 and DC006279 to A. F. R.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baker BS, 2003, BRIT J DERMATOL, V148, P670, DOI 10.1046/j.1365-2133.2003.05287.x; BIBEL DJ, 1983, CAN J MICROBIOL, V29, P700, DOI 10.1139/m83-114; Brown DL, 1997, SURGERY, V121, P372, DOI 10.1016/S0039-6060(97)90306-8; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Fujimoto C, 2004, INT IMMUNOL, V16, P55, DOI 10.1093/intimm/dxh025; Ghosh TK, 2007, INT IMMUNOPHARMACOL, V7, P1111, DOI 10.1016/j.intimp.2007.04.006; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lambert PA, 2000, FEMS IMMUNOL MED MIC, V29, P195, DOI 10.1111/j.1574-695X.2000.tb01523.x; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Netea MG, 2004, TRENDS MICROBIOL, V12, P484, DOI 10.1016/j.tim.2004.09.004; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Szpaderska AM, 2005, SURGERY, V137, P571, DOI 10.1016/j.surg.2005.01.006; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; TIMMERMAN CP, 1993, INFECT IMMUN, V61, P4167, DOI 10.1128/IAI.61.10.4167-4172.1993; Vandenbroucke K, 2004, GASTROENTEROLOGY, V127, P502, DOI 10.1053/j.gastro.2004.05.020; Vanhoutte F, 2008, IMMUNOL LETT, V116, P86, DOI 10.1016/j.imlet.2007.11.014; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	39	483	509	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1377	U4		10.1038/nm.2062	http://dx.doi.org/10.1038/nm.2062			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966777	Green Accepted, Green Submitted			2022-12-25	WOS:000272407800017
J	Bezzina, CR; Pazoki, R; Bardai, A; Marsman, RF; de Jong, JSSG; Blom, MT; Scicluna, BP; Jukema, JW; Bindraban, NR; Lichtner, P; Pfeufer, A; Bishopric, NH; Roden, DM; Meitinger, T; Chugh, SS; Myerburg, RJ; Jouven, X; Kaab, S; Dekker, LRC; Tan, HL; Tanck, MWT; Wilde, AAM				Bezzina, Connie R.; Pazoki, Raha; Bardai, Abdennasser; Marsman, Roos F.; de Jong, Jonas S. S. G.; Blom, Marieke T.; Scicluna, Brendon P.; Jukema, J. Wouter; Bindraban, Navin R.; Lichtner, Peter; Pfeufer, Arne; Bishopric, Nanette H.; Roden, Dan M.; Meitinger, Thomas; Chugh, Sumeet S.; Myerburg, Robert J.; Jouven, Xavier; Kaab, Stefan; Dekker, Lukas R. C.; Tan, Hanno L.; Tanck, Michael W. T.; Wilde, Arthur A. M.			Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction	NATURE GENETICS			English	Article							SUDDEN CARDIAC DEATH; QT INTERVAL DURATION; COMMON VARIANTS; RISK-FACTOR; CARDIOMYOPATHY; ADENOVIRUSES; NETHERLANDS; DISRUPTION; SEQUENCES; GENETICS	Sudden cardiac death from ventricular fibrillation during acute myocardial infarction is a leading cause of total and cardiovascular mortality. To our knowledge, we here report the first genome-wide association study for this trait, conducted in a set of 972 individuals with a first acute myocardial infarction, 515 of whom had ventricular fibrillation and 457 of whom did not, from the Arrhythmia Genetics in The Netherlands (AGNES) study. The most significant association to ventricular fibrillation was found at 21q21 (rs2824292, odds ratio = 1.78, 95% CI 1.47-2.13, P = 3.3 x 10(-10)). The association of rs2824292 with ventricular fibrillation was replicated in an independent case-control set consisting of 146 out-of-hospital cardiac arrest individuals with myocardial infarction complicated by ventricular fibrillation and 391 individuals who survived a myocardial infarction (controls) (odds ratio = 1.49, 95% CI 1.14-1.95, P = 0.004). The closest gene to this SNP is CXADR, which encodes a viral receptor previously implicated in myocarditis and dilated cardiomyopathy and which has recently been identified as a modulator of cardiac conduction. This locus has not previously been implicated in arrhythmia susceptibility.	[Bezzina, Connie R.; Pazoki, Raha; Bardai, Abdennasser; Marsman, Roos F.; Blom, Marieke T.; Scicluna, Brendon P.; Tan, Hanno L.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pazoki, Raha; Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Jonas S. S. G.; Bindraban, Navin R.; Dekker, Lukas R. C.; Tan, Hanno L.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Bindraban, Navin R.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands; [Lichtner, Peter; Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Bishopric, Nanette H.; Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Jouven, Xavier] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kaab, Stefan] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Dekker, Lukas R. C.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Miami; University of Miami; University of Miami; Vanderbilt University; Cedars Sinai Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Catharina Hospital	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl	Meitinger, Thomas/O-1318-2015; Pfeufer, Arne/B-6634-2013; Kaab, Stefan/H-3915-2012; Roden, Dan/ABD-5412-2021; Scicluna, Brendon/T-8112-2018; Jukema, J. Wouter/ABD-6503-2021; , Bardai/AAL-2340-2020	Scicluna, Brendon/0000-0003-2826-0341; Jukema, J. Wouter/0000-0002-3246-8359; Pazoki, Raha/0000-0002-5142-2348; Bezzina, Connie/0000-0002-0633-3514; Meitinger, Thomas/0000-0002-8838-8403; Blom, Marieke Tabo/0000-0002-8088-1105; Tanck, Michael/0000-0001-9828-4459	Netherlands Heart Foundation [2001D019, 2003T302, 2007B202, 2005T024]; Leducq Foundation [05-CVD]; Center for Translational Molecular Medicine (CTMM COHFAR); Interuniversity Cardiology Institute of The Netherlands; Netherlands Organization for Scientific Research (NWO) [918.86.616, 017.003.084]; Medicines Evaluation Board Netherlands (CBG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL065962, R01HL071094] Funding Source: NIH RePORTER	Netherlands Heart Foundation(Netherlands Heart Foundation); Leducq Foundation(Leducq Foundation); Center for Translational Molecular Medicine (CTMM COHFAR); Interuniversity Cardiology Institute of The Netherlands; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medicines Evaluation Board Netherlands (CBG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research grants from The Netherlands Heart Foundation (grants 2001D019, 2003T302 and 2007B202), the Leducq Foundation (grant 05-CVD), the Center for Translational Molecular Medicine (CTMM COHFAR) and the Interuniversity Cardiology Institute of The Netherlands (project 27). C. R. B. is an Established Investigator of The Netherlands Heart Foundation (grant 2005T024). H. L. T. is supported by The Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616) and the Medicines Evaluation Board Netherlands (CBG). A. B. was supported by The Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). A. H. Zwinderman and E. P. A. van Iperen provided the genotype data from the GENDER study. We thank L. Beekman for technical support and N. Bruinsma for assistance in collection of subject data.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Andreoletti L, 2007, J AM COLL CARDIOL, V50, P2207, DOI 10.1016/j.jacc.2007.07.080; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BOWLES NE, 1986, LANCET, V1, P1120; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Eijgelsheim M, 2009, HUM MOL GENET, V18, P4213, DOI 10.1093/hmg/ddp356; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Godbout R, 2003, DEV DYNAM, V227, P409, DOI 10.1002/dvdy.10310; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Myerburg RJ, 2006, HEART RHYTHM, V3, P235, DOI 10.1016/j.hrthm.2005.09.023; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Myerburg RJ., 2007, BRAUNWALDS HEART DIS, P933; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Sampietro ML, 2009, NETH HEART J, V17, P262, DOI 10.1007/BF03086261; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; Wilde AAM, 2005, HEART, V91, P1352, DOI 10.1136/hrt.2004.046334; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	36	124	126	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					688	U64		10.1038/ng.623	http://dx.doi.org/10.1038/ng.623			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622880	Green Accepted			2022-12-25	WOS:000280524000013
J	Ernst, J; Kellis, M				Ernst, Jason; Kellis, Manolis			Discovery and characterization of chromatin states for systematic annotation of the human genome	NATURE BIOTECHNOLOGY			English	Article							IDENTIFICATION; METHYLATIONS; ORGANIZATION; PREDICTION; VERTEBRATE; SIGNATURES; ENHANCERS; ELEMENTS; DISTINCT; BROWSER	A plethora of epigenetic modifications have been described in the human genome and shown to play diverse roles in gene regulation, cellular differentiation and the onset of disease. Although individual modifications have been linked to the activity levels of various genetic functional elements, their combinatorial patterns are still unresolved and their potential for systematic de novo genome annotation remains untapped. Here, we use a multivariate Hidden Markov Model to reveal 'chromatin states' in human T cells, based on recurrent and spatially coherent combinations of chromatin marks. We define 51 distinct chromatin states, including promoter-associated, transcription-associated, active intergenic, large-scale repressed and repeat-associated states. Each chromatin state shows specific enrichments in functional annotations, sequence motifs and specific experimentally observed characteristics, suggesting distinct biological roles. This approach provides a complementary functional annotation of the human genome that reveals the genome-wide locations of diverse classes of epigenetic function.	[Ernst, Jason; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ernst, Jason; Kellis, Manolis] MIT & Harvard, Broad Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	National Science Foundation [0905968]; US National Human Genome Research Institute (NHGRI) [U54-HG004570, RC1-HG005334]; MIT CompBio Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U54HG004570, RC1HG005334] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MIT CompBio Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank P. Kheradpour for regulatory motif instances and M.F. Lin for predicted new exons. We thank M. Garber, A. Siepel, K. Lindblad-Toh, and E. Lander for use of comparative information on 29 mammals. We thank B. Bernstein, N. Shoresh, C. Epstein and T. Mikkelsen for helpful discussions. We thank L. Goff, C. Bristow, R. Sealfon and all members of the MIT CompBio Group for comments, feedback and support. This material is based upon work supported by the National Science Foundation under award no. 0905968 and funding from the US National Human Genome Research Institute (NHGRI) under awards U54-HG004570 and RC1-HG005334.	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; Durbin R., 1998, BIOL SEQUENCE ANAL P; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, CATALOG PUBLISHED GE; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Jaschek R, 2009, LECT NOTES COMPUT SC, V5541, P170, DOI 10.1007/978-3-642-02008-7_12; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Neal RM, 1998, NATO ADV SCI I D-BEH, V89, P355; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A, 1996, REPEATMASKER OPEN 30; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Won KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-547; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	50	704	719	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					817	U94		10.1038/nbt.1662	http://dx.doi.org/10.1038/nbt.1662			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20657582	Green Accepted, Green Submitted			2022-12-25	WOS:000280757500022
J	Funabashi, M; Yang, ZY; Nonaka, K; Hosobuchi, M; Fujita, Y; Shibata, T; Chi, XL; Van Lanen, SG				Funabashi, Masanori; Yang, Zhaoyong; Nonaka, Koichi; Hosobuchi, Masahiko; Fujita, Yoko; Shibata, Tomoyuki; Chi, Xiuling; Van Lanen, Steven G.			An ATP-independent strategy for amide bond formation in antibiotic biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							BACTERIAL TRANSLOCASE-I; GENE-CLUSTER; CLAVULANIC ACID; INHIBITORS; A-500359S; IDENTIFICATION; POLYKETIDE; CATALYZES; PRODUCT; MOIETY	A-503083 B, a capuramycin-type antibiotic, contains an L-aminocaprolactam and an unsaturated hexuronic acid that are linked via an amide bond. A putative class C beta-lactamase (CapW) was identified within the biosynthetic gene cluster that-in contrast to the expected beta-lactamase activity-catalyzed an amide-ester exchange reaction to eliminate the L-aminocaprolactam with concomitant generation of a small but significant amount of the glyceryl ester derivative of A-503083 B, suggesting a potential role for an ester intermediate in the biosynthesis of capuramycins. A carboxyl methyltransferase, CapS, was subsequently demonstrated to function as an S-adenosylmethionine-dependent carboxyl methyltransferase to form the methyl ester derivative of A-503083 B. In the presence of free L-aminocaprolactam, CapW efficiently converts the methyl ester to A-503083 B, thereby generating a new amide bond. This ATP-independent amide bond formation using methyl esterification followed by an ester-amide exchange reaction represents an alternative to known strategies of amide bond formation.	[Yang, Zhaoyong; Chi, Xiuling; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA; [Fujita, Yoko; Shibata, Tomoyuki] Daiichi Sankyo Co Ltd, Exploratory Res Labs 1, Grp 5, Tokyo, Japan; [Funabashi, Masanori; Nonaka, Koichi; Hosobuchi, Masahiko] Daiichi Sankyo Co Ltd, Proc Technol Res Labs, Bioengn Res Grp 1, Fukushima, Japan	University of Kentucky; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Van Lanen, SG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA.	nonaka.koichi.k2@daiichisankyo.co.jp; svanlanen@uky.edu	Funabashi, Masanori/GQZ-8735-2022		Kentucky Science and Technology Corporation	Kentucky Science and Technology Corporation	This work is supported in part by the Kentucky Science and Technology Corporation (S.V.L.). We thank G. Elliott and J. Jacobsen (Univ. Kentucky) for technical assistance in mass and NMR spectroscopy.	Arulanantham H, 2006, J BIOL CHEM, V281, P279, DOI 10.1074/jbc.M507711200; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Gunstone FD, 1999, J SCI FOOD AGR, V79, P1535, DOI 10.1002/(SICI)1097-0010(199909)79:12<1535::AID-JSFA430>3.0.CO;2-7; Hollenhorst MA, 2009, BIOCHEMISTRY-US, V48, P10467, DOI 10.1021/bi9013165; Jensen SE, 2004, ANTIMICROB AGENTS CH, V48, P192, DOI 10.1128/AAC.48.1.192-202.2004; Kadi N, 2007, NAT CHEM BIOL, V3, P652, DOI 10.1038/nchembio.2007.23; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koetsier MJ, 2009, BIOCHEM J, V417, P467, DOI 10.1042/BJ20081257; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; MATTHEWS BW, 1967, NATURE, V214, P652, DOI 10.1038/214652a0; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Nolan EM, 2009, CHEMBIOCHEM, V10, P34, DOI 10.1002/cbic.200800438; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; Palaniappan N, 2006, CHEM BIOL, V13, P753, DOI 10.1016/j.chembiol.2006.05.013; Prates JAM, 2001, STRUCTURE, V9, P1183, DOI 10.1016/S0969-2126(01)00684-0; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Sambrook J, 2001, MOL CLONING LAB MANU; Santi D V, 1974, Methods Enzymol, V29, P620; Saugar I, 2002, EUR J BIOCHEM, V269, P5527, DOI 10.1046/j.1432-1033.2002.03258.x; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; SETO H, 1988, TETRAHEDRON LETT, V29, P2343, DOI 10.1016/S0040-4039(00)86055-4; Sugihara A, 2002, J BIOCHEM, V131, P247, DOI 10.1093/oxfordjournals.jbchem.a003095; SUVOROV M, 2008, PRACTICAL HDB MICROB, P159; TOBIN MB, 1990, J BACTERIOL, V172, P5908, DOI 10.1128/jb.172.10.5908-5914.1990; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Van Lanen SG, 2005, J AM CHEM SOC, V127, P11594, DOI 10.1021/ja052871k	36	45	47	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					581	586		10.1038/NCHEMBIO.393	http://dx.doi.org/10.1038/NCHEMBIO.393			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20562876				2022-12-25	WOS:000280096600008
J	Duncan, MW; Aebersold, R; Caprioli, RM				Duncan, Mark W.; Aebersold, Ruedi; Caprioli, Richard M.			The pros and cons of peptide-centric proteomics	NATURE BIOTECHNOLOGY			English	Article							LARGE-SCALE PROTEOMICS; MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; LIQUID-CHROMATOGRAPHY; SHOTGUN PROTEOMICS; PROTEINS; IDENTIFICATION; GUIDELINES; MIXTURES; DATABASE		[Duncan, Mark W.] Univ Colorado Denver, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Duncan, Mark W.] King Saud Univ, Coll Med, Obes Res Ctr, Riyadh 11461, Saudi Arabia; [Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Caprioli, Richard M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Caprioli, Richard M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; King Saud University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; Vanderbilt University	Duncan, MW (corresponding author), Univ Colorado Denver, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA.	richard.m.caprioli@vanderbilt.edu		Duncan, Mark/0000-0001-9256-8274				Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; Bondarenko PV, 2002, ANAL CHEM, V74, P4741, DOI 10.1021/ac0256991; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Chamrad D, 2005, NAT METHODS, V2, P647, DOI 10.1038/nmeth0905-647; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Duncan MW, 2009, PROTEOMICS, V9, P1124, DOI 10.1002/pmic.200800739; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Hackett M, 2008, PROTEOMICS, V8, P4618, DOI 10.1002/pmic.200800358; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KRISHNA RG, 1993, ADV ENZYMOL RAMB, V67, P265; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; SETTLAGE RE, 2009, PRG 2009 RELATIVE PR; Shen YF, 2008, ANAL CHEM, V80, P1871, DOI 10.1021/ac702328x; WHALEY B, 1991, BIOL MASS SPECTROM, V20, P210, DOI 10.1002/bms.1200200409; Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856	25	101	105	7	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					659	664		10.1038/nbt0710-659	http://dx.doi.org/10.1038/nbt0710-659			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20622832				2022-12-25	WOS:000279723900017
J	Mueller, S; Coleman, JR; Papamichail, D; Ward, CB; Nimnual, A; Futcher, B; Skiena, S; Wimmer, E				Mueller, Steffen; Coleman, J. Robert; Papamichail, Dimitris; Ward, Charles B.; Nimnual, Anjaruwee; Futcher, Bruce; Skiena, Steven; Wimmer, Eckard			Live attenuated influenza virus vaccines by computer-aided rational design	NATURE BIOTECHNOLOGY			English	Article							T-CELL MEMORY; A VIRUS; GENERATION; RESPONSES; CHILDREN; PROTEIN	Despite existing vaccines and enormous efforts in biomedical research, influenza annually claims 250,000-500,000 lives worldwide(1), motivating the search for new, more effective vaccines that can be rapidly designed and easily produced. We applied the previously described synthetic attenuated virus engineering (SAVE) 2 approach to influenza virus strain A/PR/8/34 to rationally design live attenuated influenza virus vaccine candidates through genome-scale changes in codon-pair bias. As attenuation is based on many hundreds of nucleotide changes across the viral genome, reversion of the attenuated variant to a virulent form is unlikely. Immunization of mice by a single intranasal exposure to codon pair-deoptimized virus conferred protection against subsequent challenge with wild-type (WT) influenza virus. The method can be applied rapidly to any emerging influenza virus in its entirety, an advantage that is especially relevant when dealing with seasonal epidemics and pandemic threats, such as H5N1- or 2009-H1N1 influenza.	[Mueller, Steffen; Coleman, J. Robert; Nimnual, Anjaruwee; Futcher, Bruce; Wimmer, Eckard] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Papamichail, Dimitris; Ward, Charles B.; Skiena, Steven] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mueller, S (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	smueller@ms.cc.sunysb.edu	Mueller, Steffen/HGE-0738-2022	Mueller, Steffen/0000-0003-2660-258X	National Institutes of Health [AI075219, AI15122]; Stony Brook University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075219, R01AI015122, R37AI015122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Brook University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are indebted to A. Garcia-Sastre and P. Palese for sharing with us their 8-plasmid system for PR8, antibodies, and information. We thank A. Paul and J. Cello for comments on the manuscript. Supported by National Institutes of Health grants AI075219 and AI15122 (EW) and a TRO-Fusion Award by Stony Brook University (S.M. and S.S.).	Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BELSHE RB, 1984, J INFECT DIS, V150, P834, DOI 10.1093/infdis/150.6.834; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Coffin JM, 2008, NEW ENGL J MED, V359, P2283, DOI 10.1056/NEJMcibr0805820; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; REED LJ, 1938, AM J HYG, V27; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Sant AJ, 2007, EXPERT REV VACCINES, V6, P357, DOI 10.1586/14760584.6.3.357; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; SHIZHEN L, 2004, COMPENDIUM MAT MED; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	25	187	204	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					723	U1729		10.1038/nbt.1636	http://dx.doi.org/10.1038/nbt.1636			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20543832	Green Accepted, Bronze			2022-12-25	WOS:000279723900029
J	Yoshida, T; Mett, I; Bhunia, AK; Bowman, J; Perez, M; Zhang, L; Gandjeva, A; Zhen, LJ; Chukwueke, U; Mao, TZ; Richter, A; Brown, E; Ashush, H; Notkin, N; Gelfand, A; Thimmulappa, RK; Rangasamy, T; Sussan, T; Cosgrove, G; Mouded, M; Shapiro, SD; Petrache, I; Biswal, S; Feinstein, E; Tuder, RM				Yoshida, Toshinori; Mett, Igor; Bhunia, Anil K.; Bowman, Joel; Perez, Mario; Zhang, Li; Gandjeva, Aneta; Zhen, Lijie; Chukwueke, Ugonma; Mao, Tianzhi; Richter, Amy; Brown, Emile; Ashush, Hagit; Notkin, Natalie; Gelfand, Anna; Thimmulappa, Rajesh K.; Rangasamy, Tirumalai; Sussan, Thomas; Cosgrove, Gregory; Mouded, Majd; Shapiro, Steven D.; Petrache, Irina; Biswal, Shyam; Feinstein, Elena; Tuder, Rubin M.			Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema	NATURE MEDICINE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELL APOPTOSIS; MAMMALIAN TARGET; OXIDATIVE STRESS; AIRWAY INFLAMMATION; LUNG INFLAMMATION; GENE-EXPRESSION; TRANSGENIC MICE; DISEASE; HYPOXIA	Rtp801 (also known as Redd1, and encoded by Ddit4), a stress-related protein triggered by adverse environmental conditions, inhibits mammalian target of rapamycin (mTOR) by stabilizing the TSC1-TSC2 inhibitory complex and enhances oxidative stress-dependent cell death. We postulated that Rtp801 acts as a potential amplifying switch in the development of cigarette smoke-induced lung injury, leading to emphysema. Rtp801 mRNA and protein were overexpressed in human emphysematous lungs and in lungs of mice exposed to cigarette smoke. The regulation of Rtp801 expression by cigarette smoke may rely on oxidative stress-dependent activation of the CCAAT response element in its promoter. We also found that Rtp801 was necessary and sufficient for nuclear factor-kappa B (NF-kappa B) activation in cultured cells and, when forcefully expressed in mouse lungs, it promoted NF-kappa B activation, alveolar inflammation, oxidative stress and apoptosis of alveolar septal cells. In contrast, Rtp801 knockout mice were markedly protected against acute cigarette smoke-induced lung injury, partly via increased mTOR signaling, and, when exposed chronically to cigarette smoke, against emphysema. Our data support the notion that Rtp801 may represent a major molecular sensor and mediator of cigarette smoke-induced lung injury.	[Mett, Igor; Ashush, Hagit; Notkin, Natalie; Gelfand, Anna; Feinstein, Elena] Quark Pharmaceut Inc, Fremont, CA 94555 USA; [Yoshida, Toshinori; Bhunia, Anil K.; Zhen, Lijie; Chukwueke, Ugonma; Mao, Tianzhi; Richter, Amy; Brown, Emile; Petrache, Irina; Tuder, Rubin M.] Johns Hopkins Univ, Dept Pathol, Div Cardiopulm Pathol, Baltimore, MD USA; [Bowman, Joel; Perez, Mario; Zhang, Li; Gandjeva, Aneta; Tuder, Rubin M.] Univ Colorado, Program Translat Lung Res,Dept Med, Denver Sch Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Thimmulappa, Rajesh K.; Rangasamy, Tirumalai; Sussan, Thomas; Biswal, Shyam] Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Cosgrove, Gregory] Natl Jewish Hlth, Denver, CO USA; [Mouded, Majd; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA USA; [Petrache, Irina] Indiana Univ, Sch Med, Dept Med, Div Pulm Allergy Crit Care & Occupat Med, Indianapolis, IN USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis	Feinstein, E (corresponding author), Quark Pharmaceut Inc, Fremont, CA 94555 USA.	efeinstein@quarkpharma.com; rubin.tuder@ucdenver.edu	Petrache, Irina/AAZ-9648-2020; Thimmulappa, Rajesh/AAW-5013-2021; Yoshida, Toshinori/B-7255-2015	Thimmulappa, Rajesh/0000-0001-6050-1323; Sussan, Thomas/0000-0002-5240-4299	US National Heart, Lung, and Blood Institute (NHLBI) [RO1 66554, 077328]; Alpha 1 Foundation; Flight Attendant Medical Research Institute; Quark Pharmaceuticals; COPD SCCOR [P01-NHLBI 085609]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL082541, R01HL066554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alpha 1 Foundation; Flight Attendant Medical Research Institute; Quark Pharmaceuticals; COPD SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank T. Stevens (University of South Alabama) for providing the primary rat lung microvascular endothelial cells, J. Whitsett (University of Cincinnati) for allowing us to use the MLE-15 cells, T. Flotte and P. Cruz (Universities of Florida and Massachusetts, respectively) for preparing the AAV5 vectors, Y. Chen (University of Indiana) for the DDIT4 promoter constructs, I. Rahman (University of Rochester) for sharing cigarette smoke-sensitive and cigarette smoke-resistant mouse lung specimens, D. Brenner (University of California, San Diego) for the adenovirus I kappa B superrepressor, L. Ellison (Dana-Farber Cancer Center) for providing the DDIT4-RPAA construct and S. Reynolds (National Jewish Health) for the mouse-specific clara cell antigen 10 antibody. This work was supported by the grants R01 US National Heart, Lung, and Blood Institute (NHLBI) RO1 66554, Alpha 1 Foundation, Flight Attendant Medical Research Institute and Quark Pharmaceuticals (to R. M. T.); R01 NHLBI 077328 (to I. P.), COPD SCCOR P01-NHLBI 085609, Project 1 (to R. M. T. and I. P.) and Project 4 (to S. B.), RO1 NHLBI RO1 081205 to (S. B.) and NHLBI R01 HL082541-01 to (S. D. S.).	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; FLOTTE TR, 1995, GENE THER, V2, P357; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; McGrath-Morrow SA, 2005, AM J RESP CELL MOL, V32, P420, DOI 10.1165/rcmb.2004-0287OC; Morelon E, 2000, NEW ENGL J MED, V343, P225, DOI 10.1056/NEJM200007203430317; Neuhaus P, 2001, LIVER TRANSPLANT, V7, P473, DOI 10.1053/jlts.2001.24645; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Ryter SW, 2009, AUTOPHAGY, V5, P235, DOI 10.4161/auto.5.2.7495; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shi MM, 1999, IMMUNOLOGY, V97, P309; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200	56	170	175	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					767	U65		10.1038/nm.2157	http://dx.doi.org/10.1038/nm.2157			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20473305	Green Accepted			2022-12-25	WOS:000279631900025
J	Melkoumian, Z; Weber, JL; Weber, DM; Fadeev, AG; Zhou, YE; Dolley-Sonneville, P; Yang, JW; Qiu, LQ; Priest, CA; Shogbon, C; Martin, AW; Nelson, J; West, P; Beltzer, JP; Pal, S; Brandenberger, R				Melkoumian, Zara; Weber, Jennifer L.; Weber, David M.; Fadeev, Andrei G.; Zhou, Yue; Dolley-Sonneville, Paula; Yang, Jiwei; Qiu, Liqun; Priest, Catherine A.; Shogbon, Christopher; Martin, Arthur W.; Nelson, Jodelle; West, Peter; Beltzer, James P.; Pal, Santona; Brandenberger, Ralph			Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							UNDIFFERENTIATED GROWTH; HUMAN BLASTOCYSTS; LINES; VITRONECTIN; FIBRONECTIN; HYDROGELS	Human embryonic stem cells (hESCs) have two properties of interest for the development of cell therapies: self-renewal and the potential to differentiate into all major lineages of somatic cells in the human body. Widespread clinical application of hESC-derived cells will require culture methods that are low-cost, robust, scalable and use chemically defined raw materials. Here we describe synthetic peptide-acrylate surfaces (PAS) that support self-renewal of hESCs in chemically defined, xeno-free medium. H1 and H7 hESCs were successfully maintained on PAS for over ten passages. Cell morphology and phenotypic marker expression were similar for cells cultured on PAS or Matrigel. Cells on PAS retained normal karyotype and pluripotency and were able to differentiate to functional cardiomyocytes on PAS. Finally, PAS were scaled up to large culture-vessel formats. Synthetic, xeno-free, scalable surfaces that support the self-renewal and differentiation of hESCs will be useful for both research purposes and development of cell therapies.	[Melkoumian, Zara; Weber, Jennifer L.; Weber, David M.; Fadeev, Andrei G.; Zhou, Yue; Dolley-Sonneville, Paula; Yang, Jiwei; Shogbon, Christopher; Martin, Arthur W.; Nelson, Jodelle; West, Peter; Beltzer, James P.; Pal, Santona] Corning Inc, Corning Life Sci, Corning, NY 14831 USA; [Yang, Jiwei; Qiu, Liqun; Priest, Catherine A.; Brandenberger, Ralph] Geron Corp, Menlo Pk, CA USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College; Geron Corporation	Melkoumian, Z (corresponding author), Corning Inc, Corning Life Sci, Corning, NY 14831 USA.	melkoumiz@corning.com; RBrandenberger@Geron.com	Fadeev, Andrei/AAR-3992-2020		Corning Incorporated; Geron Corporation	Corning Incorporated; Geron Corporation	We would like to thank our sponsors from Corning Incorporated, J. Mooney and M. McFarland, and from Geron Corporation, J. Lebkowski and A. H. Davies. From Corning Incorporated we thank A. Frutos for critical reading and helpful comments on the manuscript, M. Lewis for his chemistry expertise, T. Garvey for his assistance in PAS fabrication, P. Gagnon and P. Szlosek for substrate plate supply and T. Heck for his confocal imaging help. From Geron Corporation we thank K. Delavan-Boorsma and S. Edell for their support of in vivo studies.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; PEKKANENMATTILA M, 2009, ANN MED, V22, P1; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	22	335	364	0	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					606	U95		10.1038/nbt.1629	http://dx.doi.org/10.1038/nbt.1629			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20512120				2022-12-25	WOS:000278820200025
J	Shoubridge, C; Tarpey, PS; Abidi, F; Ramsden, SL; Rujirabanjerd, S; Murphy, JA; Boyle, J; Shaw, M; Gardner, A; Proos, A; Puusepp, H; Raymond, FL; Schwartz, CE; Stevenson, RE; Turner, G; Field, M; Walikonis, RS; Harvey, RJ; Hackett, A; Futreal, PA; Stratton, MR; Gecz, J				Shoubridge, Cheryl; Tarpey, Patrick S.; Abidi, Fatima; Ramsden, Sarah L.; Rujirabanjerd, Sinitdhorn; Murphy, Jessica A.; Boyle, Jackie; Shaw, Marie; Gardner, Alison; Proos, Anne; Puusepp, Helen; Raymond, F. Lucy; Schwartz, Charles E.; Stevenson, Roger E.; Turner, Gill; Field, Michael; Walikonis, Randall S.; Harvey, Robert J.; Hackett, Anna; Futreal, P. Andrew; Stratton, Michael R.; Gecz, Jozef			Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability	NATURE GENETICS			English	Article							LINKED MENTAL-RETARDATION; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; ACTIVATION	The first family identified as having a nonsyndromic intellectual disability was mapped in 1988. Here we show that a mutation of IQSEC2, encoding a guanine nucleotide exchange factor for the ADP-ribosylation factor family of small GTPases, caused this disorder. In addition to MRX1, IQSEC2 mutations were identified in three other families with X-linked intellectual disability. This discovery was made possible by systematic and unbiased X chromosome exome resequencing.	[Shoubridge, Cheryl; Rujirabanjerd, Sinitdhorn; Shaw, Marie; Gardner, Alison; Gecz, Jozef] SA Pathol, Adelaide, SA, Australia; [Shoubridge, Cheryl; Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Tarpey, Patrick S.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Abidi, Fatima; Schwartz, Charles E.; Stevenson, Roger E.] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Ramsden, Sarah L.; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Rujirabanjerd, Sinitdhorn] Prince Songkla Univ, Fac Med, Dept Pathol, Hat Yai, Thailand; [Murphy, Jessica A.; Walikonis, Randall S.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Boyle, Jackie; Turner, Gill; Field, Michael; Hackett, Anna] Genet Learning Disabil Serv New S Wales, Newcastle, NSW, Australia; [Proos, Anne; Puusepp, Helen] Royal N Shore Hosp, Lab & Community Genet, Pacific Lab Med Serv, St Leonards, NSW 2065, Australia; [Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge, England	SA Pathology; University of Adelaide; University of Cambridge; Wellcome Trust Sanger Institute; Greenwood Genetic Center; University of London; University College London; University of London School of Pharmacy; Prince of Songkla University; University of Connecticut; Royal North Shore Hospital; University of Cambridge	Shoubridge, C (corresponding author), SA Pathol, Adelaide, SA, Australia.	cheryl.shoubridge@adelaide.edu.au; jozef.gecz@adelaide.edu.au	Gecz, Jozef/X-3469-2019; Harvey, Robert/D-3994-2016; Shoubridge, Cheryl/A-1571-2016	Gecz, Jozef/0000-0002-7884-6861; Harvey, Robert/0000-0001-5956-6664; Shoubridge, Cheryl/0000-0002-0157-3084	Australian National Health and Medical Research Council; SMILE Foundation; Women's and Children's Hospital Foundation; US National Institutes of Health [HD26202]; South Carolina Department of Disabilities and Special Needs (SCDDSN); Medical Research Council; Action Medical Research; Wellcome Trust [077012/Z/05/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); SMILE Foundation; Women's and Children's Hospital Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs (SCDDSN); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research; Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to express our gratitude to the participating individuals and families and to N. Briggs for assistance with statistical analysis. The work has been supported by the Australian National Health and Medical Research Council to J.G., the SMILE Foundation, the Women's and Children's Hospital Foundation, D. Harwood, US National Institutes of Health (HD26202) to C.E.S., the South Carolina Department of Disabilities and Special Needs (SCDDSN), the Medical Research Council (S.R. and R.J.H.), Action Medical Research and the Wellcome Trust for support under grant reference 077012/Z/05/Z.	Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Morleo M, 2008, MOL MED REP, V1, P33; MULLEY JC, 1992, AM J MED GENET, V43, P383, DOI 10.1002/ajmg.1320430159; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; SUTHERS GK, 1988, AM J MED GENET, V30, P485, DOI 10.1002/ajmg.1320300151; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; TURNER G, 1971, DEV MED CHILD NEUROL, V13, P71	15	106	110	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2010	42	6					486	488		10.1038/ng.588	http://dx.doi.org/10.1038/ng.588			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20473311	Green Accepted			2022-12-25	WOS:000278081500010
J	Yang, L; Besschetnova, TY; Brooks, CR; Shah, JV; Bonventre, JV				Yang, Li; Besschetnova, Tatiana Y.; Brooks, Craig R.; Shah, Jagesh V.; Bonventre, Joseph V.			Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury	NATURE MEDICINE			English	Article							TISSUE-GROWTH-FACTOR; MESENCHYMAL TRANSITION; HISTONE H3; P53; REPAIR; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; MOLECULE-1; MECHANISM	Fibrosis is responsible for chronic progressive kidney failure, which is present in a large number of adults in the developed world. It is increasingly appreciated that acute kidney injury (AKI), resulting in aberrant incomplete repair, is a major contributor to chronic fibrotic kidney disease. The mechanism that triggers the fibrogenic response after injury is not well understood. In ischemic, toxic and obstructive models of AKI, we demonstrate a causal association between epithelial cell cycle G2/M arrest and a fibrotic outcome. G2/M-arrested proximal tubular cells activate c-jun NH2-terminal kinase (JNK) signaling, which acts to upregulate profibrotic cytokine production. Treatment with a JNK inhibitor, or bypassing the G2/M arrest by administration of a p53 inhibitor or the removal of the contralateral kidney, rescues fibrosis in the unilateral ischemic injured kidney. Hence, epithelial cell cycle arrest at G2/M and its subsequent downstream signaling are hitherto unrecognized therapeutic targets for the prevention of fibrosis and interruption of the accelerated progression of kidney disease.	[Yang, Li; Besschetnova, Tatiana Y.; Brooks, Craig R.; Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Brigham & Womens Hosp, Div Renal, Sch Med,Dept Med, Boston, MA 02115 USA; [Yang, Li] Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100871, Peoples R China; [Besschetnova, Tatiana Y.; Shah, Jagesh V.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Peking University; Harvard University; Harvard Medical School; Harvard University	Bonventre, JV (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Renal, Sch Med,Dept Med, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu			US National Institutes of Health (NIH) [DK39773, DK72381, DK074030]; International Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, R37DK039773, P50DK074030, F32DK088418, R01DK072381] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grants DK39773 and DK72381 to J.V.B. and DK074030 to J.V.S. L.Y. was supported by a fellowship from the International Society of Nephrology.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chkhotua AB, 2006, TRANSPL INT, V19, P72, DOI 10.1111/j.1432-2277.2005.00227.x; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Forbes JM, 2000, KIDNEY INT, V57, P2375, DOI 10.1046/j.1523-1755.2000.00097.x; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HICKSON I, 1999, SCIENCE, V285, P1733; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ikawa Y, 2008, J CELL PHYSIOL, V216, P680, DOI 10.1002/jcp.21449; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lameire N, 2005, KIDNEY INT, V68, P30, DOI 10.1111/j.1523-1755.2005.09907.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li KL, 2007, BIOCELL, V31, P213; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Megyesi J, 1999, P NATL ACAD SCI USA, V96, P10830, DOI 10.1073/pnas.96.19.10830; Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Okada H, 2005, J AM SOC NEPHROL, V16, P133, DOI 10.1681/ASN.2004040339; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Price PM, 2004, KIDNEY INT, V66, P509, DOI 10.1111/j.1523-1755.2004.761_8.x; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; SILVA FG, 1993, ARCH PATHOL LAB MED, V117, P1233; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tanaka Hiroyuki, 2005, Nephron Physiology, V101, pP27, DOI 10.1159/000086642; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YU CCW, 1992, HISTOCHEM J, V24, P121, DOI 10.1007/BF01047461; Zahedi K, 2006, AM J PHYSIOL-RENAL, V290, pF1559, DOI 10.1152/ajprenal.00424.2005; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	51	854	890	6	90	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					535	U27		10.1038/nm.2144	http://dx.doi.org/10.1038/nm.2144			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436483	Green Accepted			2022-12-25	WOS:000277394700031
J	Axtell, RC; de Jong, BA; Boniface, K; van der Voort, LF; Bhat, R; De Sarno, P; Naves, R; Han, M; Zhong, F; Castellanos, JG; Mair, R; Christakos, A; Kolkowitz, I; Katz, L; Killestein, J; Polman, CH; Malefyt, RD; Steinman, L; Raman, C				Axtell, Robert C.; de Jong, Brigit A.; Boniface, Katia; van der Voort, Laura F.; Bhat, Roopa; De Sarno, Patrizia; Naves, Rodrigo; Han, May; Zhong, Franklin; Castellanos, Jim G.; Mair, Robert; Christakos, Athena; Kolkowitz, Ilan; Katz, Liat; Killestein, Joep; Polman, Chris H.; Malefyt, Rene de Waal; Steinman, Lawrence; Raman, Chander			T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis	NATURE MEDICINE			English	Article							AUTOIMMUNE INFLAMMATION; NEUROMYELITIS-OPTICA; IFN-ALPHA; TGF-BETA; GAMMA; DIFFERENTIATION; THERAPY; IL-23; INHIBITION; ACTIVATION	Interferon-beta (IFN-beta) is the major treatment for multiple sclerosis. However, this treatment is not always effective. Here we have found congruence in outcome between responses to IFN-beta in experimental autoimmune encephalomyelitis (EAE) and relapsing-remitting multiple sclerosis (RRMS). IFN-beta was effective in reducing EAE symptoms induced by T helper type 1 (T(H)1) cells but exacerbated disease induced by T(H)17 cells. Effective treatment in T(H)1-induced EAE correlated with increased interleukin-10 (IL-10) production by splenocytes. In T(H)17-induced disease, the amount of IL-10 was unaltered by treatment, although, unexpectedly, IFN-beta treatment still reduced IL-17 production without benefit. Both inhibition of IL-17 and induction of IL-10 depended on IFN-gamma. In the absence of IFN-gamma signaling, IFN-beta therapy was ineffective in EAE. In RRMS patients, IFN-beta nonresponders had higher IL-17F concentrations in serum compared to responders. Nonresponders had worse disease with more steroid usage and more relapses than did responders. Hence, IFN-beta is proinflammatory in T(H)17-induced EAE. Moreover, a high IL-17F concentration in the serum of people with RRMS is associated with nonresponsiveness to therapy with IFN-beta.	[Axtell, Robert C.; de Jong, Brigit A.; Bhat, Roopa; Han, May; Zhong, Franklin; Castellanos, Jim G.; Mair, Robert; Christakos, Athena; Kolkowitz, Ilan; Katz, Liat; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [de Jong, Brigit A.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [de Jong, Brigit A.; van der Voort, Laura F.; Killestein, Joep; Polman, Chris H.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Boniface, Katia; Malefyt, Rene de Waal] Schering Plough Biopharma, Palo Alto, CA USA; [Boniface, Katia; Malefyt, Rene de Waal] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; [De Sarno, Patrizia] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, CA USA; [Naves, Rodrigo; Raman, Chander] Univ Alabama, Dept Med, Birmingham, CA USA	Stanford University; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Merck & Company; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu; craman@uab.edu	Boniface, Katia/N-5577-2016; Axtell, Robert/AAJ-5053-2021; Naves, Rodrigo/H-4829-2014	Boniface, Katia/0000-0003-4428-1222; Naves, Rodrigo/0000-0002-1203-3593; de Waal Malefyt, Rene/0000-0002-2663-383X; Killestein, Joep/0000-0002-6347-5957; Steinman, Lawrence/0000-0002-2437-2250; Mair, Robert/0000-0001-5860-7276	US National Institutes of Health [R01NS 55997]; US National Multiple Sclerosis Society [RG3891-A1]; National Institutes of Health [RO1AI1076562-01]; National Multiple Sclerosis Society [FG 1817-A-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI076562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. Mountz (University of Alabama at Birmingham) for the kind gift of Rebif and Y. Rosenberg-Hasson for running the multiplex cytokine assay. This study was funded by US National Institutes of Health grant R01NS 55997 to L. S., US National Multiple Sclerosis Society grant RG3891-A1, National Institutes of Health grant RO1AI1076562-01 to C. R. and National Multiple Sclerosis Society grant FG 1817-A-1 to R. C. A.	Arnason BGW, 1999, ANNU REV MED, V50, P291; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bartosik-Psujek H, 2006, CLIN NEUROL NEUROSUR, V108, P644, DOI 10.1016/j.clineuro.2005.10.011; Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70; Berenson LS, 2006, J IMMUNOL, V177, P5195, DOI 10.4049/jimmunol.177.8.5195; Betti M, 2006, ANN ONCOL, V17, P235; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harries-Rees K, 2005, CHEM WORLD-UK, V2, P6; Hengstman GJD, 2007, MULT SCLER, V13, P679, DOI 10.1177/1352458506070145; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McRae BL, 1998, J IMMUNOL, V160, P4298; Nagai T, 2007, SCAND J IMMUNOL, V65, P107, DOI 10.1111/j.1365-3083.2006.01880.x; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Shimizu Y, 2008, J NEUROL, V255, P305, DOI 10.1007/s00415-007-0730-5; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang K, 2006, NAT PROD COMMUN, V1, P537; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wong LH, 1998, J IMMUNOL, V160, P5475; Zhang ZL, 2009, CYTOKINE, V46, P79, DOI 10.1016/j.cyto.2008.12.019; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	36	423	436	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					406	U21		10.1038/nm.2110	http://dx.doi.org/10.1038/nm.2110			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20348925	Green Accepted			2022-12-25	WOS:000276446800044
J	Li, JN; Rix, U; Fang, B; Bai, Y; Edwards, A; Colinge, J; Bennett, KL; Gao, JC; Song, LX; Eschrich, S; Superti-Furga, G; Koomen, J; Haura, EB				Li, Jiannong; Rix, Uwe; Fang, Bin; Bai, Yun; Edwards, Arthur; Colinge, Jacques; Bennett, Keiryn L.; Gao, Jingchun; Song, Lanxi; Eschrich, Steven; Superti-Furga, Giulio; Koomen, John; Haura, Eric B.			A chemical and phosphoproteomic characterization of dasatinib action in lung cancer	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; SRC-FAMILY KINASES; SMALL-MOLECULE INHIBITOR; TYROSINE KINASE; C-SRC; SENSITIVITY; EXPRESSION; TARGET; PHOSPHORYLATION; MUTATIONS	We describe a strategy for comprehending signaling pathways that are active in lung cancer cells and that are targeted by dasatinib using chemical proteomics to identify direct interacting proteins combined with immunoaffinity purification of tyrosine-phosphorylated peptides corresponding to activated tyrosine kinases. We identified nearly 40 different kinase targets of dasatinib. These include SRC-family kinase (SFK) members (LYN, SRC, FYN, LCK and YES), nonreceptor tyrosine kinases (FRK, BRK and ACK) and receptor tyrosine kinases (Ephrin receptors, DDR1 and EGFR). Using quantitative phosphoproteomics, we identified peptides corresponding to autophosphorylation sites of these tyrosine kinases that are inhibited in a concentration-dependent manner by dasatinib. Using drug-resistant gatekeeper mutants, we show that SFKs (particularly SRC and FYN), as well as EGFR, are relevant targets for dasatinib action. The combined mass spectrometry-based approach described here provides a system-level view of dasatinib action in cancer cells and suggests both functional targets and a rationale for combinatorial therapeutic strategies.	[Li, Jiannong; Bai, Yun; Edwards, Arthur; Gao, Jingchun; Song, Lanxi; Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol Program, Tampa, FL 33612 USA; [Rix, Uwe; Colinge, Jacques; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Fang, Bin; Koomen, John] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote & Mol Oncol Program, Tampa, FL 33612 USA; [Eschrich, Steven] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Bioinformat Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Li, JN (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol Program, Tampa, FL 33612 USA.	gsuperti@cemm.oeaw.ac.at; john.koomen@moffitt.org; eric.haura@moffitt.org	Koomen, John/D-1844-2013; Eschrich, Steven/K-6848-2013; Colinge, Jacques/Z-2613-2019; Superti-Furga, Giulio/F-4755-2015; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/AAE-5681-2019	Eschrich, Steven/0000-0002-9833-2788; Colinge, Jacques/0000-0003-2466-4824; Superti-Furga, Giulio/0000-0002-0570-1768; Colinge, Jacques/0000-0003-2466-4824; Bennett, Keiryn L./0000-0001-9356-7708	US National Functional Genomics Center; Moffitt Cancer Center SPORE in Lung Cancer [P50-CA119997]; Joan's Legacy/LUNGevity Foundation; Austrian Federal Ministry of Science and Research [GZ 200.142/1-VI/I/2006, GZ 200.145/1-VI/1/2006]; Austrian Academy of Sciences; Proteomics Core; Molecular Biology and Sequencing Core; Flow Cytometry Core at the H. Lee Moffitt Cancer Center & Research Institute; NATIONAL CANCER INSTITUTE [R01CA123174] Funding Source: NIH RePORTER	US National Functional Genomics Center; Moffitt Cancer Center SPORE in Lung Cancer; Joan's Legacy/LUNGevity Foundation; Austrian Federal Ministry of Science and Research; Austrian Academy of Sciences; Proteomics Core; Molecular Biology and Sequencing Core; Flow Cytometry Core at the H. Lee Moffitt Cancer Center & Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Lee (Bristol-Myers Squibb Oncology) for providing dasatinib, Genentech and OSI Pharmaceuticals for providing erlotinib, K. Rikova ( Cell Signaling Technology) for providing NSCLC tumor spectral count data, Cell Signaling Technology for allowing reproduction of the kinome map, G. Durnberger for data uploading to PRIDE, J. Du (Broad Institute) and T. Golub ( Broad Institute) for providing lentiviral constructs, T. Yoshida for helpful discussions and P. Johnston for administrative assistance. We thank W. Pao (Vanderbilt University) for the cDNA for L858R EGFR and L858R T790M EGFR and N. Mahajan (Moffitt Cancer Center) for the ACK. We thank J. Cheng ( Moffitt Cancer Center) for the triciribine. The work was partially funded by grants from the US National Functional Genomics Center, the Moffitt Cancer Center SPORE in Lung Cancer (P50-CA119997), Joan's Legacy/LUNGevity Foundation ( E. B. H.), the Austrian Federal Ministry of Science and Research within the GEN-AU program (GZ 200.142/1-VI/I/2006 and GZ 200.145/1-VI/1/2006) and the Austrian Academy of Sciences. This work has been supported in part by the Proteomics Core, the Molecular Biology and Sequencing Core, and the Flow Cytometry Core at the H. Lee Moffitt Cancer Center & Research Institute.	Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; Nur-E-Kamal A, 2005, MOL CANCER RES, V3, P297, DOI 10.1158/1541-7786.MCR-04-0152; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Takanami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-1; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang WN, 2001, J BIOL CHEM, V276, P43987, DOI 10.1074/jbc.M104819200; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504	50	208	218	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					291	299		10.1038/NCHEMBIO.332	http://dx.doi.org/10.1038/NCHEMBIO.332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20190765	Green Accepted			2022-12-25	WOS:000275734000015
J	Codd, V; Mangino, M; van der Harst, P; Braund, PS; Kaiser, M; Beveridge, AJ; Rafelt, S; Moore, J; Nelson, C; Soranzo, N; Zhai, GJ; Valdes, AM; Blackburn, H; Leach, IM; de Boer, RA; Goodall, AH; Ouwehand, W; van Veldhuisen, DJ; van Gilst, WH; Navis, G; Burton, PR; Tobin, MD; Hall, AS; Thompson, JR; Spector, T; Samani, NJ				Codd, Veryan; Mangino, Massimo; van der Harst, Pim; Braund, Peter S.; Kaiser, Michael; Beveridge, Alan J.; Rafelt, Suzanne; Moore, Jasbir; Nelson, Chris; Soranzo, Nicole; Zhai, Guangju; Valdes, Ana M.; Blackburn, Hannah; Leach, Irene Mateo; de Boer, Rudolf A.; Goodall, Alison H.; Ouwehand, Willem; van Veldhuisen, Dirk J.; van Gilst, Wiek H.; Navis, Gerjan; Burton, Paul R.; Tobin, Martin D.; Hall, Alistair S.; Thompson, John R.; Spector, Tim; Samani, Nilesh J.		Wellcome Trust Case Control Consor	Common variants near TERC are associated with mean telomere length	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LEUCINE-RICH REPEAT; GENERAL-POPULATION; HUMANS; LOCUS	We conducted genome-wide association analyses of mean leukocyte telomere length in 2,917 individuals, with follow-up replication in 9,492 individuals. We identified an association with telomere length on 3q26 (rs12696304, combined P = 3.72 x 10(-14)) at a locus that includes TERC, which encodes the telomerase RNA component. Each copy of the minor allele of rs12696304 was associated with an similar to 75-base-pair reduction in mean telomere length, equivalent to similar to 3.6 years of age-related telomere-length attrition.	[Codd, Veryan; van der Harst, Pim; Braund, Peter S.; Kaiser, Michael; Beveridge, Alan J.; Rafelt, Suzanne; Moore, Jasbir; Nelson, Chris; Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Mangino, Massimo; Soranzo, Nicole; Zhai, Guangju; Valdes, Ana M.; Spector, Tim] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [van der Harst, Pim; Leach, Irene Mateo; de Boer, Rudolf A.; van Veldhuisen, Dirk J.; van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Soranzo, Nicole; Blackburn, Hannah] Wellcome Trust Sanger Inst, Hinxton, England; [Ouwehand, Willem] Univ Cambridge, Dept Hematol, Cambridge, England; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Burton, Paul R.; Tobin, Martin D.; Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Burton, Paul R.; Tobin, Martin D.; Thompson, John R.] Univ Leicester, Dept Genet, Leicester, Leics, England; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; King's College London; University of Groningen; Wellcome Trust Sanger Institute; University of Cambridge; University of Groningen; University of Leicester; University of Leicester; University of Leeds	Samani, NJ (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England.	njs@le.ac.uk	van Gilst, Wiek/R-1806-2019; van Veldhuisen, Dirk Jan/E-8967-2014; de Boer, Rudolf/ABE-9879-2020; Hall, Alistair/K-1953-2019; Mangino, Massimo/F-5134-2011; Burton, Paul R/H-7527-2016; van Gilst, Wiek H/C-3828-2008	van Gilst, Wiek/0000-0003-2968-8585; Mangino, Massimo/0000-0002-2167-7470; Valdes, Ana M./0000-0003-1141-4471; Soranzo, Nicole/0000-0003-1095-3852; Codd, Veryan/0000-0002-9430-8254; Goodall, Alison/0000-0002-7883-9645; Hall, Alistair/0000-0003-0306-7887; Tobin, Martin/0000-0002-3596-7874	BHF; Wellcome Trust; Biotechnology and Biological Sciences Research Council [G20234]; Dutch Kidney Foundation [E033]; Netherlands Heart Foundation [2006B140, 2006T003]; EU [FP-6 LSHM CT 2006 037697]; Leicester National Institute of Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease; NIHR Biomedical Research Centre; Netherlands Organisation for Scientific Research (NWO) VENI [916.76.170]; Interuniversity Cardiology Institute of the Netherlands (ICIN); European Network for Genetic and Genomic Epidemiology (ENGAGE) [HEALTH-F4-2007-201413]; Medical Research Council [G0501942] Funding Source: researchfish; MRC [G0501942] Funding Source: UKRI	BHF(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dutch Kidney Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); EU(European Commission); Leicester National Institute of Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Netherlands Organisation for Scientific Research (NWO) VENI(Netherlands Organization for Scientific Research (NWO)); Interuniversity Cardiology Institute of the Netherlands (ICIN); European Network for Genetic and Genomic Epidemiology (ENGAGE); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The BHF-FHS Study and the GRAPHIC Study were supported by the BHF. The WTCCC and recruitment of the UKBS donors were funded by the Wellcome Trust. The TwinsUK study was funded by the Wellcome Trust and Biotechnology and Biological Sciences Research Council project grant G20234. The PREVEND study is supported by the Dutch Kidney Foundation (grant E033), The Netherlands Heart Foundation (grant 2006B140, 2006T003) and the EU project grant Genomic Strategies for Treatment and Prevention of Cardiovascular Death in Uraemia and End-stage Renal Disease (GENECURE) (FP-6 LSHM CT 2006 037697). We thank J. Marchini for generating the imputed genotypes for the WTCCC cohorts and A. Aviv, J. Gardner and M. Kimura for generating the telomere length data in the TwinsUK study. V. C., A. H. G. and N.J.S. are supported by the BHF and the Leicester National Institute of Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease. M. M. and T. D. S. are supported by NIHR Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust in partnership with King's College London. P.vd.H. is supported by the Netherlands Organisation for Scientific Research (NWO) VENI grant 916.76.170 and the Interuniversity Cardiology Institute of the Netherlands (ICIN). Collaboration between the WTCCC Study telomere GWAS and the TwinsUK study was established under the European Framework 7 (FP7/2007-2013) European Network for Genetic and Genomic Epidemiology (ENGAGE) project (HEALTH-F4-2007-201413).	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Hara Y, 2008, FEBS LETT, V582, P2998, DOI 10.1016/j.febslet.2008.07.058; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Rabenau KE, 2004, ONCOGENE, V23, P5056, DOI 10.1038/sj.onc.1207681; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734	15	252	258	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					197	199		10.1038/ng.532	http://dx.doi.org/10.1038/ng.532			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139977	Green Accepted			2022-12-25	WOS:000274912400005
J	Ma, L; Young, J; Prabhala, H; Pan, E; Mestdagh, P; Muth, D; Teruya-Feldstein, J; Reinhardt, F; Onder, TT; Valastyan, S; Westermann, F; Speleman, F; Vandesompele, J; Weinberg, RA				Ma, Li; Young, Jennifer; Prabhala, Harsha; Pan, Elizabeth; Mestdagh, Pieter; Muth, Daniel; Teruya-Feldstein, Julie; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Westermann, Frank; Speleman, Frank; Vandesompele, Jo; Weinberg, Robert A.			miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis	NATURE CELL BIOLOGY			English	Article							MESENCHYMAL TRANSITION; TUMOR INVASION; N-MYC; C-MYC; EXPRESSION; ADHESION; GROWTH; CELLS; GENES; TRANSFORMATION	MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly targets CDH1, the E-cadherin-encoding messenger RNA, leading to increased cell motility and invasiveness. miR-9-mediated E-cadherin downregulation results in the activation of beta-catenin signalling, which contributes to upregulated expression of the gene encoding vascular endothelial growth factor (VEGF); this leads, in turn, to increased tumour angiogenesis. Overexpression of miR-9 in otherwise non-metastatic breast tumour cells enables these cells to form pulmonary micrometastases in mice. Conversely, inhibiting miR-9 by using a 'miRNA sponge' in highly malignant cells inhibits metastasis formation. Expression of miR-9 is activated by MYC and MYCN, both of which directly bind to the mir-9-3 locus. Significantly, in human cancers, miR-9 levels correlate with MYCN amplification, tumour grade and metastatic status. These findings uncover a regulatory and signalling pathway involving a metastasis-promoting miRNA that is predicted to directly target expression of the key metastasis-suppressing protein E-cadherin.	[Ma, Li; Young, Jennifer; Pan, Elizabeth; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ma, Li; Young, Jennifer; Pan, Elizabeth; Reinhardt, Ferenc; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ma, Li; Onder, Tamer T.; Valastyan, Scott; Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02142 USA; [Prabhala, Harsha] Univ Virginia, Med Scientist Training Program, Charlottesville, VA 22908 USA; [Mestdagh, Pieter; Speleman, Frank; Vandesompele, Jo] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Muth, Daniel; Westermann, Frank] German Canc Res Ctr, Dept Tumor Genet, D-69120 Heidelberg, Germany; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Virginia; Ghent University; Ghent University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Onder, Tamer T/H-3330-2013; Vandesompele, Jo/W-3411-2018; Ma, Li/GQR-1313-2022; Onder, Tamer/O-3669-2019; Westermann, Frank/F-7509-2013; speleman, frank/AAR-5184-2020	Onder, Tamer T/0000-0002-2372-9158; Vandesompele, Jo/0000-0001-6274-0184; Ma, Li/0000-0001-9965-989X; Onder, Tamer/0000-0002-2372-9158; speleman, frank/0000-0002-6628-8559; Mestdagh, Pieter/0000-0001-7821-9684; Young-Glazer, Jennifer/0000-0002-3265-9112	Life Sciences Research Foundation; Margaret and Herman Sokol Award; National Institutes of Health (NIH) Pathway to Independence Award [K99/R00]; Howard Hughes Medical Institute; MSKCC Cancer Core Grant; US Department of Defense Breast Cancer; NATIONAL CANCER INSTITUTE [K99CA138572] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Margaret and Herman Sokol Award; National Institutes of Health (NIH) Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MSKCC Cancer Core Grant; US Department of Defense Breast Cancer(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Johannes Schulte, Martin Eilers, Rosa Noguera, Margaret Ebert and Phillip Sharp for providing tumour samples and reagents; the Histology Core Lab at Massachusetts Institute of Technology (MIT) and Memorial Sloan-Kettering Cancer Center (MSKCC) for assistance with sectioning and immunohistochemistry; and members of the Weinberg laboratory for useful discussions. L. M. is a recipient of a Life Sciences Research Foundation Fellowship, a Margaret and Herman Sokol Award, and a National Institutes of Health (NIH) Pathway to Independence Award (K99/R00). J. Y. and E. P. are supported by a Howard Hughes Medical Institute Undergraduate Fellowship. J. T.- F. is supported by the MSKCC Cancer Core Grant. T. T. O. and S. V. are recipients of a US Department of Defense Breast Cancer Research Program Predoctoral Fellowship. R. A. W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Cancer Research Professor. This research is supported by a NIH grant to R. A. W. and the Ludwig Center for Molecular Oncology at MIT.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; ETHIER SP, 1993, CANCER RES, V53, P627; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malynn BA, 2000, GENE DEV, V14, P1390; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MESTDAGH P, ONCOGENE IN PRESS, DOI DOI 10.1038/ONC.2009.429; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; RAK J, 1995, CANCER RES, V55, P4575; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	59	1063	1133	1	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					247	U52		10.1038/ncb2024	http://dx.doi.org/10.1038/ncb2024			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173740	Green Accepted, Green Submitted			2022-12-25	WOS:000275054200010
J	Yadav, VK; Balaji, S; Suresh, PS; Liu, XS; Lu, X; Li, ZS; Guo, XE; Mann, JJ; Balapure, AK; Gershon, MD; Medhamurthy, R; Vidal, M; Karsenty, G; Ducy, P				Yadav, Vijay K.; Balaji, Santhanam; Suresh, Padmanaban S.; Liu, X. Sherry; Lu, Xin; Li, Zhishan; Guo, X. Edward; Mann, J. John; Balapure, Anil K.; Gershon, Michael D.; Medhamurthy, Rudraiah; Vidal, Marc; Karsenty, Gerard; Ducy, Patricia			Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis	NATURE MEDICINE			English	Article							TRYPTOPHAN-HYDROXYLASE INHIBITORS; PARATHYROID-HORMONE; DISORDERS; SYSTEM; MICE; MASS	Osteoporosis is a disease of low bone mass most often caused by an increase in bone resorption that is not sufficiently compensated for by a corresponding increase in bone formation(1). As gut-derived serotonin (GDS) inhibits bone formation(2), we asked whether hampering its biosynthesis could treat osteoporosis through an anabolic mechanism (that is, by increasing bone formation). We synthesized and used LP533401, a small molecule inhibitor of tryptophan hydroxylase-1 (Tph-1), the initial enzyme in GDS biosynthesis. Oral administration of this small molecule once daily for up to six weeks acts prophylactically or therapeutically, in a dose-dependent manner, to treat osteoporosis in ovariectomized rodents because of an isolated increase in bone formation. These results provide a proof of principle that inhibiting GDS biosynthesis could become a new anabolic treatment for osteoporosis.	[Yadav, Vijay K.; Karsenty, Gerard] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10027 USA; [Balaji, Santhanam; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Balaji, Santhanam; Vidal, Marc] Ctr Canc Syst Biol, Boston, MA USA; [Balaji, Santhanam; Vidal, Marc] Dana Farber Canc Inst, Boston, MA 02115 USA; [Suresh, Padmanaban S.; Medhamurthy, Rudraiah] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Liu, X. Sherry; Lu, Xin; Guo, X. Edward] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Li, Zhishan; Gershon, Michael D.; Ducy, Patricia] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Mann, J. John] Columbia Univ, Dept Psychiat, New York, NY USA; [Balapure, Anil K.] Cent Drug Res Inst, Tissue & Cell Culture Unit, Lucknow 226001, Uttar Pradesh, India	Columbia University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Indian Institute of Science (IISC) - Bangalore; Columbia University; Columbia University; Columbia University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Karsenty, G (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10027 USA.	gk2172@columbia.edu; pd2193@columbia.edu	P.S, Suresh/AAX-9666-2020; Liu, Xiaowei Sherry/H-1664-2017; yadav, VIJAY k/Q-2540-2016	Liu, Xiaowei Sherry/0000-0001-7247-2232; yadav, VIJAY k/0000-0003-2345-2846; BALAPURE, ANIL/0000-0003-1213-4586	US National Institutes of Health; International Bone and Mineral Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085328] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Bone and Mineral Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M.-T. Rached, Y.-Y. Huang, N. Suda and G. Ren for help in experiments and D. Landry (Organic Chemistry, Columbia University) for providing LP533401 for the initial stages of these experiments. Special thanks go to S. Kousteni and J. Martin for helpful suggestions. This work was supported by grants from the US National Institutes of Health (V.K.Y., G. K. and P. D.) and a Gideon and Sevgi Rodan fellowship from International Bone and Mineral Society (V.K.Y.).	Andersson N, 2004, ACTA ORTHOP SCAND, V75, P201, DOI 10.1080/00016470412331294465; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; FROST M, J BONE MINE IN PRESS; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; GUNDERSEN HJG, 1993, BONE, V14, P217, DOI 10.1016/8756-3282(93)90144-Y; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Shi ZC, 2008, J MED CHEM, V51, P3684, DOI 10.1021/jm800338j; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Vegni FE, 2004, NEW ENGL J MED, V350, P189; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	25	239	272	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					308	U103		10.1038/nm.2098	http://dx.doi.org/10.1038/nm.2098			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20139991	Green Accepted			2022-12-25	WOS:000275289500036
J	Saxena, R; Hivert, MF; Langenberg, C; Tanaka, T; Pankow, JS; Vollenweider, P; Lyssenko, V; Bouatia-Naji, N; Dupuis, J; Jackson, AU; Kao, WHL; Li, M; Glazer, NL; Manning, AK; Luan, J; Stringham, HM; Prokopenko, I; Johnson, T; Grarup, N; Boesgaard, TW; Lecoeur, C; Shrader, P; O'Connell, J; Ingelsson, E; Couper, DJ; Rice, K; Song, KJ; Andreasen, CH; Dina, C; Kottgen, A; Le Bacquer, O; Pattou, F; Taneera, J; Steinthorsdottir, V; Rybin, D; Ardlie, K; Sampson, M; Qi, L; van Hoek, M; Weedon, MN; Aulchenko, YS; Voight, BF; Grallert, H; Balkau, B; Bergman, RN; Bielinski, SJ; Bonnefond, A; Bonnycastle, LL; Borch-Johnsen, K; Boettcher, Y; Brunner, E; Buchanan, TA; Bumpstead, SJ; Cavalcanti-Proenca, C; Charpentier, G; Chen, YDI; Chines, PS; Collins, FS; Cornelis, M; Crawford, GJ; Delplanque, J; Doney, A; Egan, JM; Erdos, MR; Firmann, M; Forouhi, NG; Fox, CS; Goodarzi, MO; Graessler, J; Hingorani, A; Isomaa, B; Jorgensen, T; Kivimaki, M; Kovacs, P; Krohn, K; Kumari, M; Lauritzen, T; Levy-Marchal, C; Mayor, V; McAteer, JB; Meyre, D; Mitchell, BD; Mohlke, KL; Morken, MA; Narisu, N; Palmer, CNA; Pakyz, R; Pascoe, L; Payne, F; Pearson, D; Rathmann, W; Sandbaek, A; Sayer, AA; Scott, LJ; Sharp, SJ; Sijbrands, E; Singleton, A; Siscovick, DS; Smith, NL; Sparso, T; Swift, AJ; Syddall, H; Thorleifsson, G; Tonjes, A; Tuomi, T; Tuomilehto, J; Valle, TT; Waeber, G; Walley, A; Waterworth, DM; Zeggini, E; Zhao, JH; Illig, T; Wichmann, HE; Wilson, JF; van Duijn, C; Hu, FB; Morris, AD; Frayling, TM; Hattersley, AT; Thorsteinsdottir, U; Stefansson, K; Nilsson, P; Syvanen, AC; Shuldiner, AR; Walker, M; Bornstein, SR; Schwarz, P; Williams, GH; Nathan, DM; Kuusisto, J; Laakso, M; Cooper, C; Marmot, M; Ferrucci, L; Mooser, V; Stumvoll, M; Loos, RJF; Altshuler, D; Psaty, BM; Rotter, JI; Boerwinkle, E; Hansen, T; Pedersen, O; Florez, JC; McCarthy, MI; Boehnke, M; Barroso, I; Sladek, R; Froguel, P; Meigs, JB; Groop, L; Wareham, NJ; Watanabe, RM				Saxena, Richa; Hivert, Marie-France; Langenberg, Claudia; Tanaka, Toshiko; Pankow, James S.; Vollenweider, Peter; Lyssenko, Valeriya; Bouatia-Naji, Nabila; Dupuis, Josee; Jackson, Anne U.; Kao, W. H. Linda; Li, Man; Glazer, Nicole L.; Manning, Alisa K.; Luan, Jian'an; Stringham, Heather M.; Prokopenko, Inga; Johnson, Toby; Grarup, Niels; Boesgaard, Trine W.; Lecoeur, Cecile; Shrader, Peter; O'Connell, Jeffrey; Ingelsson, Erik; Couper, David J.; Rice, Kenneth; Song, Kijoung; Andreasen, Camilla H.; Dina, Christian; Koettgen, Anna; Le Bacquer, Olivier; Pattou, Francois; Taneera, Jalal; Steinthorsdottir, Valgerdur; Rybin, Denis; Ardlie, Kristin; Sampson, Michael; Qi, Lu; van Hoek, Mandy; Weedon, Michael N.; Aulchenko, Yurii S.; Voight, Benjamin F.; Grallert, Harald; Balkau, Beverley; Bergman, Richard N.; Bielinski, Suzette J.; Bonnefond, Amelie; Bonnycastle, Lori L.; Borch-Johnsen, Knut; Boettcher, Yvonne; Brunner, Eric; Buchanan, Thomas A.; Bumpstead, Suzannah J.; Cavalcanti-Proenca, Christine; Charpentier, Guillaume; Chen, Yii-Der Ida; Chines, Peter S.; Collins, Francis S.; Cornelis, Marilyn; Crawford, Gabriel J.; Delplanque, Jerome; Doney, Alex; Egan, Josephine M.; Erdos, Michael R.; Firmann, Mathieu; Forouhi, Nita G.; Fox, Caroline S.; Goodarzi, Mark O.; Graessler, Juergen; Hingorani, Aroon; Isomaa, Bo; Jorgensen, Torben; Kivimaki, Mika; Kovacs, Peter; Krohn, Knut; Kumari, Meena; Lauritzen, Torsten; Levy-Marchal, Claire; Mayor, Vladimir; McAteer, Jarred B.; Meyre, David; Mitchell, Braxton D.; Mohlke, Karen L.; Morken, Mario A.; Narisu, Narisu; Palmer, Colin N. A.; Pakyz, Ruth; Pascoe, Laura; Payne, Felicity; Pearson, Daniel; Rathmann, Wolfgang; Sandbaek, Annelli; Sayer, Avan Aihie; Scott, Laura J.; Sharp, Stephen J.; Sijbrands, Eric; Singleton, Andrew; Siscovick, David S.; Smith, Nicholas L.; Sparso, Thomas; Swift, Amy J.; Syddall, Holly; Thorleifsson, Gudmar; Toenjes, Anke; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Valle, Timo T.; Waeber, Gerard; Walley, Andrew; Waterworth, Dawn M.; Zeggini, Eleftheria; Zhao, Jing Hua; Illig, Thomas; Wichmann, H. Erich; Wilson, James F.; van Duijn, Cornelia; Hu, Frank B.; Morris, Andrew D.; Frayling, Timothy M.; Hattersley, Andrew T.; Thorsteinsdottir, Unnur; Stefansson, Kari; Nilsson, Peter; Syvanen, Ann-Christine; Shuldiner, Alan R.; Walker, Mark; Bornstein, Stefan R.; Schwarz, Peter; Williams, Gordon H.; Nathan, David M.; Kuusisto, Johanna; Laakso, Markku; Cooper, Cyrus; Marmot, Michael; Ferrucci, Luigi; Mooser, Vincent; Stumvoll, Michael; Loos, Ruth J. F.; Altshuler, David; Psaty, Bruce M.; Rotter, Jerome I.; Boerwinkle, Eric; Hansen, Torben; Pedersen, Oluf; Florez, Jose C.; McCarthy, Mark I.; Boehnke, Michael; Barroso, Ines; Sladek, Robert; Froguel, Philippe; Meigs, James B.; Groop, Leif; Wareham, Nicholas J.; Watanabe, Richard M.		GIANT Consortium; MAGIC Investigators	Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge	NATURE GENETICS			English	Article							FASTING PLASMA-GLUCOSE; GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; ASSOCIATION; RISK; RECEPTOR; SENSITIVITY; EXPRESSION; VARIANTS	Glucose levels 2 h after an oral glucose challenge are a clinical measure of glucose tolerance used in the diagnosis of type 2 diabetes. We report a meta-analysis of nine genome-wide association studies (n = 15,234 nondiabetic individuals) and a follow-up of 29 independent loci (n = 6,958-30,620). We identify variants at the GIPR locus associated with 2- h glucose level (rs10423928, beta (s.e.m.) = 0.09 (0.01) mmol/l per A allele, P = 2.0 x 10(-15)). The GIPR A-allele carriers also showed decreased insulin secretion (n = 22,492; insulinogenic index, P = 1.0 x 10(-17); ratio of insulin to glucose area under the curve, P = 1.3 x 10(-16)) and diminished incretin effect (n = 804; P = 4.3 x 10(-4)). We also identified variants at ADCY5 (rs2877716, P = 4.2 x 10(-16)), VPS13C (rs17271305, P = 4.1 x 10(-8)), GCKR (rs1260326, P = 7.1 x 10(-11)) and TCF7L2 (rs7903146, P = 4.2 x 10(-10)) associated with 2-h glucose. Of the three newly implicated loci (GIPR, ADCY5 and VPS13C), only ADCY5 was found to be associated with type 2 diabetes in collaborating studies (n = 35,869 cases, 89,798 controls, OR = 1.12, 95% CI 1.09-1.15, P = 4.8 x 10(-18)).	[Bergman, Richard N.; Buchanan, Thomas A.; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Saxena, Richa; Voight, Benjamin F.; Crawford, Gabriel J.; McAteer, Jarred B.; Altshuler, David; Florez, Jose C.] Harvard & Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Saxena, Richa; Voight, Benjamin F.; McAteer, Jarred B.; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Hivert, Marie-France; Shrader, Peter; Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Hivert, Marie-France; Williams, Gordon H.; Nathan, David M.; Florez, Jose C.; Meigs, James B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Langenberg, Claudia; Luan, Jian'an; Forouhi, Nita G.; Sharp, Stephen J.; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Tanaka, Toshiko] Medstar Res Inst, Baltimore, MD USA; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Vollenweider, Peter; Firmann, Mathieu; Mayor, Vladimir; Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Lyssenko, Valeriya; Taneera, Jalal; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Bouatia-Naji, Nabila; Lecoeur, Cecile; Dina, Christian; Le Bacquer, Olivier; Bonnefond, Amelie; Cavalcanti-Proenca, Christine; Delplanque, Jerome; Meyre, David; Froguel, Philippe] Univ Lille 2, Inst Pasteur, CNRS, Unite Mixte Rech 8090, Lille, France; [Dupuis, Josee; Manning, Alisa K.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Jackson, Anne U.; Stringham, Heather M.; Scott, Laura J.; Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Kao, W. H. Linda; Li, Man; Koettgen, Anna] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kao, W. H. Linda] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kao, W. H. Linda] Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Glazer, Nicole L.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Johnson, Toby] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Grarup, Niels; Boesgaard, Trine W.; Andreasen, Camilla H.; Sparso, Thomas; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [O'Connell, Jeffrey; Mitchell, Braxton D.; Pakyz, Ruth; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Couper, David J.] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Song, Kijoung; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Drug Discovery, Genet, King Of Prussia, PA USA; [Pattou, Francois] Univ Lille Nord France, INSERM, Lille, France; [Pattou, Francois] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Rybin, Denis] Boston Univ, Data Coordinating Ctr, Boston, MA 02215 USA; [Sampson, Michael] Norfolk & Norwich Univ Hosp Natl Hlth Serv Trust, Dept Endocrinol & Diabet, Norwich, Norfolk, England; [Qi, Lu; Cornelis, Marilyn; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Cornelis, Marilyn; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [van Hoek, Mandy; Sijbrands, Eric; van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Weedon, Michael N.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Aulchenko, Yurii S.] Erasmus Univ, Dept Epidemiol & Biostat, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Grallert, Harald; Illig, Thomas; Wichmann, H. Erich] Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany; [Balkau, Beverley] INSERM, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Orsay, France; [Bielinski, Suzette J.] Mayo Clin, Coll Med, Rochester, MN USA; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.; Erdos, Michael R.; Morken, Mario A.; Narisu, Narisu; Pearson, Daniel; Swift, Amy J.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Borch-Johnsen, Knut] Steno Diabet Ctr, Copenhagen, Denmark; [Borch-Johnsen, Knut] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Boettcher, Yvonne; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Brunner, Eric; Hingorani, Aroon; Kivimaki, Mika; Kumari, Meena; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London, England; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Dept Med, Los Angeles, CA 90033 USA; [Bumpstead, Suzannah J.; Payne, Felicity; Zeggini, Eleftheria; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Essonnes, France; [Chen, Yii-Der Ida; Goodarzi, Mark O.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Doney, Alex] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med & Therapeut, Dundee DD1 9SY, Scotland; [Egan, Josephine M.] NIA, Clin Invest Lab, Baltimore, MD 21224 USA; [Fox, Caroline S.; Williams, Gordon H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Fox, Caroline S.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Graessler, Juergen; Bornstein, Stefan R.; Schwarz, Peter] Univ Dresden, Div Prevent & Care Diabet, Dept Med 3, Dresden, Germany; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Malmska Municipal Hlth Care Ctr & Hosp, Pietarsaari, Finland; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Kovacs, Peter; Krohn, Knut] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Lauritzen, Torsten; Sandbaek, Annelli] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Levy-Marchal, Claire] Robert Debre Hosp, INSERM, Paris, France; [Levy-Marchal, Claire] Paris Diderot Univ, Paris, France; [McAteer, Jarred B.; Nathan, David M.; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Palmer, Colin N. A.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Pascoe, Laura; Walker, Mark] Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Rathmann, Wolfgang] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Sayer, Avan Aihie; Syddall, Holly; Cooper, Cyrus] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Siscovick, David S.; Smith, Nicholas L.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Off Res & Dev, Dept Vet Affairs, Epidemiol Res & Informat Ctr, Seattle, WA USA; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Tuomi, Tiinamaija; Tuomilehto, Jaakko] Univ Helsinki, Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Diabet Unit, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Valle, Timo T.] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; [Walley, Andrew; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Frayling, Timothy M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Nilsson, Peter] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21218 USA; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed, DK-1168 Copenhagen, Denmark; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LJ, England; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lund University; Skane University Hospital; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Boston University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Lausanne; Novo Nordisk; Hagedorn Research Institute; University System of Maryland; University of Maryland Baltimore; Karolinska Institutet; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of Exeter; University of Plymouth; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Steno Diabetes Center; Aarhus University; Leipzig University; University of London; University College London; University of Southern California; Wellcome Trust Sanger Institute; Centre Hospitalier Sud Francilien; Cedars Sinai Medical Center; University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Technische Universitat Dresden; Folkhalsan Research Center; University of Copenhagen; Leipzig University; Aarhus University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Dundee; Newcastle University - UK; Deutsches Diabetes-Zentrum (DDZ); University of Southampton; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Leipzig University; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Imperial College London; University of Munich; University of Munich; University of Edinburgh; Harvard University; Brigham & Women's Hospital; University of Exeter; University of Iceland; Lund University; Skane University Hospital; Uppsala University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Southern Denmark; University of Copenhagen; University of Oxford; McGill University; University of Southern California	Watanabe, RM (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.	jmeigs@partners.org; Leif.Groop@med.lu.se; nick.wareham@mrc-epid.cam.ac.uk; rwatanab@usc.edu	Langenberg, Claudia/ABG-9067-2021; Sijbrands, Eric/A-1065-2009; Payne, Felicity/GKF-2573-2022; Voight, Benjamin/F-1775-2011; Grarup, Niels/K-2807-2015; Altshuler, David M/A-4476-2009; Prokopenko, Inga/H-3241-2014; Aulchenko, Yurii/M-8270-2013; Grallert, Harald/B-3424-2013; Bouatia-Naji, Nabila/AGF-1400-2022; Pattou, Francois/O-6151-2017; Saxena, Richa/AAG-7279-2020; Walley, Andrew J/D-2573-2009; Wilson, James F/A-5704-2009; Narisu, Narisu/T-6908-2019; Jørgensen, Torben/Z-1335-2018; Kottgen, Anna/D-2920-2012; Loos, Ruth/GON-5877-2022; BOUATIA-NAJI, NABILA/D-5863-2013; Hivert, Marie-France/GWN-0455-2022; Mitchell, Braxton/CAF-0876-2022; Stefansson, Kari/AAE-7187-2019; Singleton, Andrew B/C-3010-2009; FROGUEL, Philippe/O-6799-2017; Study, GoDARTS/K-9448-2016; Meyre, David/D-7315-2011; Loos, Ruth J F/Q-2862-2016; Sladek, Robert/R-2391-2019; Bonnefond, Amélie/O-2784-2017; Sayer, Avan Aihie/A-4359-2012; Goodarzi, Mark/AAH-7106-2021; Marmot, M G/Y-3920-2019; Pedersen, Oluf/AAG-8015-2020; Dina, Christian R/D-3535-2015; Stumvoll, Michael/ABE-1121-2021; Bielinski, Suzette/A-2238-2009; Rotter, Jerome/AAY-6598-2021; Wichmann, Heinz Erich/AAA-5695-2022; Palmer, Colin NA/C-7053-2008; Colaus, PsyColaus/K-6607-2013; Pedersen, Oluf/Z-1731-2019; Manning, Alisa Knodle/ABC-7711-2021; Brunner, Eric/H-2114-2011; Prokopenko, Inga/AAU-9895-2020; Kivimaki, Mika/B-3607-2012; van Hoek, Mandy/B-9325-2014; Meigs, James/P-3927-2019; Doney, Alexander SF/P-7437-2017; Rice, Kenneth M/A-4150-2013; Schwarz, Peter/AAF-1558-2020; Li, Man/AAX-3400-2020; McCarthy, Mark/M-3763-2015	Langenberg, Claudia/0000-0002-5017-7344; Sijbrands, Eric/0000-0001-8857-7389; Payne, Felicity/0000-0003-4228-581X; Grarup, Niels/0000-0001-5526-1070; Altshuler, David M/0000-0002-7250-4107; Prokopenko, Inga/0000-0003-1624-7457; Aulchenko, Yurii/0000-0002-7899-1575; Bouatia-Naji, Nabila/0000-0001-5424-2134; Pattou, Francois/0000-0001-8388-3766; Walley, Andrew J/0000-0001-7707-7549; Wilson, James F/0000-0001-5751-9178; FROGUEL, Philippe/0000-0003-2972-0784; Meyre, David/0000-0003-4850-7444; Loos, Ruth J F/0000-0002-8532-5087; Sladek, Robert/0000-0002-2730-1204; Bonnefond, Amélie/0000-0001-9976-3005; Goodarzi, Mark/0000-0001-6364-5103; Marmot, M G/0000-0002-2431-6419; Dina, Christian R/0000-0002-7722-7348; Stumvoll, Michael/0000-0001-6225-8240; Bielinski, Suzette/0000-0002-2905-5430; Palmer, Colin NA/0000-0002-6415-6560; Pedersen, Oluf/0000-0002-3321-3972; Brunner, Eric/0000-0002-0595-4474; Kivimaki, Mika/0000-0002-4699-5627; Meigs, James/0000-0002-2439-2657; Doney, Alexander SF/0000-0002-6210-5620; Rice, Kenneth M/0000-0001-5779-4495; Li, Man/0000-0002-3839-0281; Saxena, Richa/0000-0003-2233-1065; Waeber, Gerard/0000-0003-4193-788X; Shuldiner, Alan/0000-0001-9921-4305; McCarthy, Mark/0000-0002-4393-0510; Jorgensen, Torben/0000-0001-9453-2830; Couper, David/0000-0002-4313-9235; Bergman, Richard/0000-0003-1539-4471; Pankow, James/0000-0001-7076-483X; Barroso, Ines/0000-0001-5800-4520; Hansen, Torben/0000-0001-8748-3831; Voight, Benjamin/0000-0002-6205-9994; Cooper, Cyrus/0000-0003-3510-0709; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Dupuis, Josee/0000-0003-2871-3603; Van Duijn, Cornelia/0000-0002-2374-9204; Taneera, Jalal/0000-0002-3341-1063; Aihie Sayer, Avan/0000-0003-1283-6457; Kumari, Meena/0000-0001-9716-1035; Mitchell, Braxton/0000-0003-4920-4744; Rybin, Denis/0000-0002-3657-4829; Glazer, Nicole/0000-0002-6397-609X; Johnson, Toby/0000-0002-5998-3270; Tuomi, Tiinamaija/0000-0002-8306-6202; Kovacs, Peter/0000-0002-0290-5423; Ballantyne, Christie/0000-0002-6432-1730; Forouhi, Nita/0000-0002-5041-248X; Weedon, Michael/0000-0002-6174-6135; Hingorani, Aroon/0000-0001-8365-0081; Zeggini, Eleftheria/0000-0003-4238-659X; Hattersley, Andrew/0000-0001-5620-473X	Medical Research Council [G0600717B, U1475000001, U1475000002] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC055222, N01HC055022, N01HC055021, N01HC085080, N01HC075150, N01HC085085, N01HC055015, N01HC015103, N01HC045133, N01HC035129, N01HC025195, N01HC055018, N01HC085086, N01HC085084, N01HC055016, N01HC055020, N01HC085082, N01HC055019, N01HC085081, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, M01RR000052, M01RR001066] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, R01HL087641, U01HL072515, U01HL080295, R01HL036310, R01HL059367, R01HL086694, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004399, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK065978, P30DK079637, P60DK079637, R01DK062370, K24DK080140, R01DK072193, R01DK091718, R01DK078616, R01DK054261, P30DK072488, R01DK029867, R01DK069922, R01DK058845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015, R01AG013196, ZIAAG001050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Intramural NIH HHS [Z01 HG000024-14] Funding Source: Medline; Medical Research Council [G19/35, MC_UP_A620_1014, G0701863, G0902037, G0100222, MC_U106188470, MC_U106179471, G8802774, G0600331, MC_UP_A620_1015] Funding Source: Medline; NCI NIH HHS [P01 CA087969, P01 CA087969-12] Funding Source: Medline; NCRR NIH HHS [M01 RR016500-08, M01 RR000052, M01 RR001066, M01 RR001066-26, M01 RR016500, M01 RR000052-46] Funding Source: Medline; NHGRI NIH HHS [U01 HG004399, U01 HG004402-02, U01 HG004402, U01 HG004399-02] Funding Source: Medline; NHLBI NIH HHS [R01 HL087652-03, R01 HL036310-21, N01 HC085082, N01 HC055019, R01 HL087641-03, N01 HC085080, U01 HL072515-06, N01 HC085081, R01 HL086694-03, U01 HL072515, U01 HL080295-04, N01 HC055015, N01 HC085084, N01 HC055020, N01 HC085079, N01 HC055022, U01 HL080295, R01 HL087652, R01 HL059367-10, N01 HC085085, N02 HL64278, R01 HL086694, N01 HC025195, N01 HC055018, N01 HC085083, N01 HC015103, N01 HC085086, R01 HL059367, N01 HC075150, N01 HC055222, R01 HL036310, N01 HC055021, R01 HL087641, N01 HC045133, N01 HC035129, N01 HC055016] Funding Source: Medline; NIA NIH HHS [R01 AG013196-16, R01 AG013196] Funding Source: Medline; NIDA NIH HHS [U54 DA021519-04, U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [R01 DK054261-09, P60 DK079637-04, R01 DK062370-05, P30 DK079637, R01 DK072193-04, R01 DK072193, P60 DK079637, R01 DK078616-03, P30 DK072488-06, K24 DK080140, R01 DK058845-11, R01 DK029867, K23 DK065978, R01 DK054261, R01 DK069922, R01 DK091718, R01 DK069922-03, R01 DK058845, K24 DK080140-04, R01 DK078616, K23 DK065978-05, P30 DK072488, R01 DK062370] Funding Source: Medline; Wellcome Trust [077016, 088885] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; MRC [MC_U106188470, MC_UP_A620_1015, G0600331, G0902037, G0701863] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahren B, 2004, EUR J ENDOCRINOL, V150, P97, DOI 10.1530/eje.0.1500097; Almind K, 1998, DIABETOLOGIA, V41, P1194, DOI 10.1007/s001250051051; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gautier JF, 2008, DIABETES METAB, V34, pS65, DOI 10.1016/S1262-3636(08)73397-4; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; Kubota A, 1996, DIABETES, V45, P1701, DOI 10.2337/diabetes.45.12.1701; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Nauck MA, 2005, DIABETOLOGIA, V48, P608, DOI 10.1007/s00125-005-1704-8; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; Nitz I, 2007, MOL NUTR FOOD RES, V51, P1046, DOI 10.1002/mnfr.200700048; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Qiao Q, 2003, DIABETOLOGIA, V46, pM17, DOI 10.1007/s00125-002-0932-4; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012	35	475	491	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					142	U75		10.1038/ng.521	http://dx.doi.org/10.1038/ng.521			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081857	Green Accepted, Green Published			2022-12-25	WOS:000274084400011
J	Zalevsky, J; Chamberlain, AK; Horton, HM; Karki, S; Leung, IWL; Sproule, TJ; Lazar, GA; Roopenian, DC; Desjarlais, JR				Zalevsky, Jonathan; Chamberlain, Aaron K.; Horton, Holly M.; Karki, Sher; Leung, Irene W. L.; Sproule, Thomas J.; Lazar, Greg A.; Roopenian, Derry C.; Desjarlais, John R.			Enhanced antibody half-life improves in vivo activity	NATURE BIOTECHNOLOGY			English	Article							NEONATAL FC-RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; PHARMACOKINETICS; AFFINITY; PRIMATES; IMPACT; LIVES; MODEL; IGG	Improved affinity for the neonatal Fc receptor (FcRn) is known to extend antibody half-life in vivo. However, this has never been linked with enhanced therapeutic efficacy. We tested whether antibodies with half-lives extended up to fivefold in human (h) FcRn transgenic mice and threefold in cynomolgus monkeys retain efficacy at longer dosing intervals. We observed that prolonged exposure due to FcRn-mediated enhancement of half-life improved antitumor activity of Fc-engineered antibodies in an hFcRn/Rag1(-/-) mouse model. This bridges the demand for dosing convenience with the clinical necessity of maintaining efficacy.	[Sproule, Thomas J.; Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zalevsky, Jonathan; Chamberlain, Aaron K.; Horton, Holly M.; Karki, Sher; Leung, Irene W. L.; Lazar, Greg A.; Desjarlais, John R.] Xencor Inc, Monrovia, CA USA	Jackson Laboratory	Desjarlais, JR (corresponding author), Xencor Inc, Monrovia, CA USA.	jrd@xencor.com		Lazar, Greg/0000-0003-2169-8703	NIDDK NIH HHS [R01 DK056597-07, R01 DK056597] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056597] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; FAN Z, 1994, J BIOL CHEM, V269, P27595; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; NARAMURA M, 1993, CANCER IMMUNOL IMMUN, V37, P343, DOI 10.1007/BF01518458; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Presta LG, 1997, CANCER RES, V57, P4593; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; *US FDA, 2004, 125084 US FOOD DRUG; van Bueren JJL, 2006, CANCER RES, V66, P7630, DOI 10.1158/0008-5472.CAN-05-4010; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182	15	377	535	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					157	159		10.1038/nbt.1601	http://dx.doi.org/10.1038/nbt.1601			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20081867	Green Accepted			2022-12-25	WOS:000274317200024
J	Sales, KU; Masedunskas, A; Bey, AL; Rasmussen, AL; Weigert, R; List, K; Szabo, R; Overbeek, PA; Bugge, TH				Sales, Katiuchia Uzzun; Masedunskas, Andrius; Bey, Alexandra L.; Rasmussen, Amber L.; Weigert, Roberto; List, Karin; Szabo, Roman; Overbeek, Paul A.; Bugge, Thomas H.			Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome	NATURE GENETICS			English	Article							SERINE-PROTEASE INHIBITOR; HUMAN STRATUM-CORNEUM; HEPATOCYTE GROWTH-FACTOR; BARRIER FUNCTION; TRYPSIN-LIKE; PROTEOLYTIC CASCADE; RECEPTORS PARS; EXPRESSION; DESQUAMATION; FILAGGRIN	Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation. Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade. Auto-activation of pro-inflammatory pro-kallikrein-related peptidases that are associated with stratum corneum detachment was either low or undetectable, but they were efficiently activated by matriptase. Ablation of matriptase from LEKTI-deficient mice dampened inflammation, eliminated aberrant protease activity, prevented detachment of the stratum corneum, and improved the barrier function of the epidermis. These results uncover a pathogenic matriptase-pro-kallikrein pathway that could operate in several human skin and inflammatory diseases.	[Sales, Katiuchia Uzzun; Bey, Alexandra L.; Rasmussen, Amber L.; List, Karin; Szabo, Roman; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Masedunskas, Andrius; Weigert, Roberto] Natl Inst Dent & Craniofacial Res, Intracellular Membrane Trafficking Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Baylor College of Medicine	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Masedunskas, Andrius/0000-0002-4533-5467; sales, katiuchia/0000-0002-3768-5790; Overbeek, Paul/0000-0001-9784-2084	NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000717, ZIADE000699] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank D. Martin, L. Fisher and L. Wahl for technical assistance, and J. Silvio Gutkind and M. J. Danton for reviewing this manuscript. Support for this study was provided by the NIDCR Intramural Research Program.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, AM J HUM GENET, V66, P914, DOI 10.1086/302824; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen LM, 2006, AM J PHYSIOL-RENAL, V291, pF567, DOI 10.1152/ajprenal.00047.2006; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Dreher F, 1998, ACTA DERM-VENEREOL, V78, P186; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kishi K, 2001, J BIOCHEM-TOKYO, V130, P425, DOI 10.1093/oxfordjournals.jbchem.a003002; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Marttin E, 1996, SKIN PHARMACOL, V9, P69; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; SMITH DL, 1995, J ALLERGY CLIN IMMUN, V95, P116, DOI 10.1016/S0091-6749(95)70159-1; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	49	80	82	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					676	U54		10.1038/ng.629	http://dx.doi.org/10.1038/ng.629			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20657595	Green Accepted			2022-12-25	WOS:000280524000011
J	Uno, S; Zembutsu, H; Hirasawa, A; Takahashi, A; Kubo, M; Akahane, T; Aoki, D; Kamatani, N; Hirata, K; Nakamura, Y				Uno, Satoko; Zembutsu, Hitoshi; Hirasawa, Akira; Takahashi, Atsushi; Kubo, Michiaki; Akahane, Tomoko; Aoki, Daisuke; Kamatani, Naoyuki; Hirata, Koichi; Nakamura, Yusuke			A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese	NATURE GENETICS			English	Article							CHROMOSOME 9P21; MYOCARDIAL-INFARCTION; 4 SNPS; SUSCEPTIBILITY; EXPRESSION; RISK; P16; HYPERMETHYLATION; TRANSFORMATION; POLYMORPHISMS	Although the pathogenesis of endometriosis is not well understood, genetic factors have been considered to have critical roles in its etiology. Through a genome-wide association study and a replication study using a total of 1,907 Japanese individuals with endometriosis (cases) and 5,292 controls, we identified a significant association of endometriosis with rs10965235 (P = 5.57 x 10(-12), odds ratio = 1.44), which is located in CDKN2BAS on chromosome 9p21, encoding the cyclin-dependent kinase inhibitor 2B antisense RNA. By fine mapping, the SNP showing the strongest association was located in intron 16 of CDKN2BAS and was implicated in regulating the expression of p15, p16 and p14. A SNP, rs16826658, in the LD block including WNT4 on chromosome 1p36, which is considered to play an important role in the development of the female genital tract, revealed a possible association with endometriosis (P = 1.66 x 10(-6), odds ratio = 1.20). Our findings suggest that these regions are new susceptibility loci for endometriosis.	[Uno, Satoko; Zembutsu, Hitoshi; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Uno, Satoko; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg 1, Sapporo, Hokkaido, Japan; [Hirasawa, Akira; Akahane, Tomoko; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	University of Tokyo; Sapporo Medical University; Keio University; RIKEN; RIKEN	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Aoki, Daisuke/E-6650-2014; Kubo, Michiaki/N-7947-2015		Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We also thank the technical staff of the Laboratory for Genotyping Development in RIKEN, Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo and Department of Obstetrics and Gynecology, Keio University, School of Medicine. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Babu KA, 2004, REPROD BIOMED ONLINE, V9, P533, DOI 10.1016/S1472-6483(10)61638-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gaetje R, 2007, FERTIL STERIL, V87, P651, DOI 10.1016/j.fertnstert.2006.07.1533; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Goumenou AG, 2000, INT J MOL MED, V6, P667; Guida M, 2009, EUR J GYNAECOL ONCOL, V30, P267; Han YJ, 2009, FERTIL STERIL, V91, P2324, DOI 10.1016/j.fertnstert.2008.03.047; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Ignatov A, 2008, GYNECOL ONCOL, V111, P365, DOI 10.1016/j.ygyno.2008.07.037; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Juo SH, 2006, HUM REPROD, V21, P1498, DOI 10.1093/humrep/del033; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Martini M, 2002, INT J CANCER, V102, P398, DOI 10.1002/ijc.10715; Matalliotakis IM, 2008, ARCH GYNECOL OBSTET, V278, P507, DOI 10.1007/s00404-008-0644-1; Mori H, 1999, J Obstet Gynaecol Res, V25, P153; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nakashima R, 1999, BRIT J CANCER, V80, P458, DOI 10.1038/sj.bjc.6690379; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OKUDA T, 1995, GENOMICS, V29, P623, DOI 10.1006/geno.1995.9957; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sampson JA, 1927, AM J PATHOL, V3, P93; Sato H, 2008, FERTIL STERIL, V90, P2086, DOI 10.1016/j.fertnstert.2007.10.023; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seracchioli R, 2009, HUM REPROD, V24, P2729, DOI 10.1093/humrep/dep259; Shan Kang, 2005, Mol Hum Reprod, V11, P423, DOI 10.1093/molehr/gah177; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Silander K, 2009, GENOME MED, V1, DOI 10.1186/gm51; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Stern RC, 2001, INT J GYNECOL PATHOL, V20, P133, DOI 10.1097/00004347-200104000-00004; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vietri MT, 2009, FERTIL STERIL, V92, P1532, DOI 10.1016/j.fertnstert.2008.07.1786; Vinatier D, 2001, EUR J OBSTET GYN R B, V96, P21, DOI 10.1016/S0301-2115(00)00405-X; Yanokura M, 2006, ANTICANCER RES, V26, P851; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563	48	186	193	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					707	U88		10.1038/ng.612	http://dx.doi.org/10.1038/ng.612			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601957				2022-12-25	WOS:000280524000017
J	Groeger, AL; Cipollina, C; Cole, MP; Woodcock, SR; Bonacci, G; Rudolph, TK; Rudolph, V; Freeman, BA; Schopfer, FJ				Groeger, Alison L.; Cipollina, Chiara; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Rudolph, Tanja K.; Rudolph, Volker; Freeman, Bruce A.; Schopfer, Francisco J.			Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids	NATURE CHEMICAL BIOLOGY			English	Article							NITRATED FATTY-ACIDS; PPAR-GAMMA; PHASE-2 RESPONSE; RESOLVIN D1; INFLAMMATION; ACTIVATION; MECHANISM; PRODUCTS; PATHWAY; J(2)	Electrophilic fatty acids are generated during inflammation by non-enzymatic reactions and can modulate inflammatory responses. We used a new mass spectrometry-based electrophile capture strategy to reveal the formation of electrophilic oxo-derivatives (EFOX) from the omega-3 fatty acids docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). These EFOX were generated by a cyclooxygenase-2 (COX-2)-catalyzed mechanism in activated macrophages. Modulation of COX-2 activity by aspirin increased the rate of EFOX production and their intracellular levels. Owing to their electrophilic nature, EFOX adducted to cysteine and histidine residues of proteins and activated Nrf2-dependent anti-oxidant gene expression. We confirmed the anti-inflammatory nature of DHA- and DPA-derived EFOX by showing that they can act as peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and inhibit pro-inflammatory cytokine and nitric oxide production, all within biological concentration ranges. These data support the idea that EFOX are signaling mediators that transduce the beneficial clinical effects of omega-3 fatty acids, COX-2 and aspirin.	[Groeger, Alison L.; Cipollina, Chiara; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Cipollina, Chiara] Fdn Ri MED, Palermo, Italy; [Rudolph, Tanja K.; Rudolph, Volker] Univ Heart Ctr Hamburg, Cardiovasc Res Ctr, Hamburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Groeger, AL (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; fjs2@pitt.edu	Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Schopfer, Francisco/AAW-6505-2021	Schopfer, Francisco Jose/0000-0001-9526-695X; cipollina, chiara/0000-0002-0712-8440	National Institutes of Health [HL58115, HL64937]; American Diabetes Association; Fondazione Ri.MED, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, K99HL095769, R01HL064937, R37HL058115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Fondazione Ri.MED, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL58115 and HL64937, the American Diabetes Association (F.J.S.), and Fondazione Ri.MED, Italy (C.C.). We thank J. Ruzicka and A. Hilderbrand at Thermo Fisher Scientific for assistance with accurate mass measurements of EFOX using an LTQ OrbitrapVelos instrument.	Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arita M, 2006, J BIOL CHEM, V281, P22847, DOI 10.1074/jbc.M603766200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bronstein JC, 1997, ARCH BIOCHEM BIOPHYS, V348, P219, DOI 10.1006/abbi.1997.0364; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dinkova-Kostova AT, 2007, CANCER LETT, V245, P341, DOI 10.1016/j.canlet.2006.01.024; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Erlemann KR, 2007, BIOCHEM J, V403, P157, DOI 10.1042/BJ20061617; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; GIERSE JK, 1998, CURRENT PROTOCOLS PH; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Koch T, 2002, TETRAHEDRON, V58, P3271, DOI 10.1016/S0040-4020(02)00231-4; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; LUCHE JL, 1978, J CHEM SOC CHEM COMM, P601, DOI 10.1039/c39780000601; Malur A, 2009, J IMMUNOL, V182, P5816, DOI 10.4049/jimmunol.0803504; Mochizuki M, 2005, AM J RESP CRIT CARE, V171, P1260, DOI 10.1164/rccm.200406-755OC; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Murphy RC, 2002, PROSTAG OTH LIPID M, V68-9, P471, DOI 10.1016/S0090-6980(02)00049-7; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; Penning TM, 1997, STEROIDS, V62, P455; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer F.J., 2010, J BIOL CHEM; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SCHWARTZMAN ML, 1989, J BIOL CHEM, V264, P11658; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Thornalley PJ, 2002, ANTI-CANCER DRUG, V13, P331, DOI 10.1097/00001813-200204000-00001; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489	50	216	231	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					433	441		10.1038/nchembio.367	http://dx.doi.org/10.1038/nchembio.367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20436486	Green Accepted			2022-12-25	WOS:000277748100013
J	Landeira, D; Sauer, S; Poot, R; Dvorkina, M; Mazzarella, L; Jorgensen, HF; Pereira, CF; Leleu, M; Piccolo, FM; Spivakov, M; Brookes, E; Pombo, A; Fisher, C; Skarnes, WC; Snoek, T; Bezstarosti, K; Demmers, J; Klose, RJ; Casanova, M; Tavares, L; Brockdorff, N; Merkenschlager, M; Fisher, AG				Landeira, David; Sauer, Stephan; Poot, Raymond; Dvorkina, Maria; Mazzarella, Luca; Jorgensen, Helle F.; Pereira, C. Filipe; Leleu, Marion; Piccolo, Francesco M.; Spivakov, Mikhail; Brookes, Emily; Pombo, Ana; Fisher, Cynthia; Skarnes, William C.; Snoek, Tim; Bezstarosti, Karel; Demmers, Jeroen; Klose, Robert J.; Casanova, Miguel; Tavares, Ligia; Brockdorff, Neil; Merkenschlager, Matthias; Fisher, Amanda G.			Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB GROUP PROTEINS; TRANSCRIPTION INITIATION; MOUSE DEVELOPMENT; GENE-EXPRESSION; PLURIPOTENCY; CHROMATIN; CIRCUITRY; IDENTITY; NETWORK	Polycomb Repressor Complexes (PRCs) are important regulators of embryogenesis. In embryonic stem (ES) cells many genes that regulate subsequent stages in development are enriched at their promoters for PRC1, PRC2 and Ser 5-phosphorylated RNA Polymerase II (RNAP), and contain domains of 'bivalent' chromatin (enriched for H3K4me3; histone H3 di- or trimethylated at Lys 4 and H3K27me3; histone H3 trimethylated at Lys 27). Loss of individual PRC components in ES cells can lead to gene de-repression and to unscheduled differentiation. Here we show that Jarid2 is a novel subunit of PRC2 that is required for the co-recruitment of PRC1 and RNAP to genes that regulate development in ES cells. Jarid2-deficient ES cells showed reduced H3K4me2/me3 and H3K27me3 marking and PRC1/PRC2 recruitment, and did not efficiently establish Ser 5-phosporylated RNAP at target genes. ES cells lacking Jarid2, in contrast to previously characterized PRC1 and PRC2 mutants, did not inappropriately express PRC2 target genes. Instead, they show a severely compromised capacity for successful differentiation towards neural or mesodermal fates and failed to correctly initiate lineage-specific gene expression in vitro. Collectively, these data indicate that transcriptional priming of bivalent genes in pluripotent ES cells is Jarid2-dependent, and suggests that priming is critical for subsequent multi-lineage differentiation.	[Landeira, David; Sauer, Stephan; Dvorkina, Maria; Mazzarella, Luca; Jorgensen, Helle F.; Pereira, C. Filipe; Leleu, Marion; Piccolo, Francesco M.; Spivakov, Mikhail; Fisher, Cynthia; Merkenschlager, Matthias; Fisher, Amanda G.] Hammersmith Hosp, Lymphocyte Dev Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, London W12 0NN, England; [Poot, Raymond; Snoek, Tim] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Brookes, Emily; Pombo, Ana] Hammersmith Hosp, Genome Funct Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, London W12 0NN, England; [Fisher, Cynthia; Skarnes, William C.] Wellcome Trust Sanger Inst, Mouse Dev Genet Grp, Cambridge CB10 1SA, England; [Bezstarosti, Karel; Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Klose, Robert J.] Univ Oxford, Dept Biochem, Epigenet Regulat Chromatin Funct Grp, Oxford OX1 3QU, England; [Casanova, Miguel; Tavares, Ligia; Brockdorff, Neil] Univ Oxford, Dept Biochem, Dev Epigenet Grp, Oxford OX1 3QU, England	Imperial College London; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of Oxford; University of Oxford	Fisher, AG (corresponding author), Hammersmith Hosp, Lymphocyte Dev Grp, MRC Clin Sci Ctr, Imperial Coll Sch Med, Campus,Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	Pereira, Carlos-Filipe/B-8438-2013; mazzarella, luca/AAC-2391-2019; Landeira, David/ADY-5662-2022; Pombo, Ana/A-1045-2010; Demmers, Jeroen AA/F-4046-2016; Landeira, David/F-5001-2018	Pereira, Carlos-Filipe/0000-0002-9724-1382; mazzarella, luca/0000-0002-4043-3279; Pombo, Ana/0000-0002-7493-6288; Demmers, Jeroen AA/0000-0002-8757-9611; Landeira, David/0000-0002-3267-454X; Jorgensen, Helle/0000-0002-7909-2977; Spivakov, Mikhail/0000-0002-0383-3943; Brockdorff, Neil/0000-0003-4838-2653; Casanova, Miguel/0000-0001-8622-6550; Brookes, Emily/0000-0003-2175-4349; Snoek, Tim/0000-0002-5395-9034; Merkenschlager, Matthias/0000-0003-2889-3288; Tavares, Ligia/0000-0001-9487-7978; Fisher, Cynthia/0000-0001-6089-4868	Medical Research Council (MRC); EU; Medical Research Council [MC_U120061476, MC_U120027516] Funding Source: researchfish; MRC [MC_U120061476, MC_U120027516] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to our colleagues Y. Lee, V. Kouskoff and A. Otte for supplying reagents and advice. We thank N. Ryan, A. Terry and the MRC CSC flow cytometry facility for technical assistance. This work was funded by the Medical Research Council (MRC) and the EU Epigenome Network of Excellence.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; FAUST C, 1995, DEVELOPMENT, V121, P273; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fraser ST, 2003, METHOD ENZYMOL, V365, P59; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Stockard J, 2007, JUDGM DECIS MAK, V2, P9; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Ying QL, 2003, METHOD ENZYMOL, V365, P327	40	228	230	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					618	U214		10.1038/ncb2065	http://dx.doi.org/10.1038/ncb2065			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473294	Green Published, Green Accepted			2022-12-25	WOS:000278213400015
J	Sheng, Z; Li, L; Zhu, LHJ; Smith, TW; Demers, A; Ross, AH; Moser, RP; Green, MR				Sheng, Zhi; Li, Li; Zhu, Lihua J.; Smith, Thomas W.; Demers, Andrea; Ross, Alonzo H.; Moser, Richard P.; Green, Michael R.			A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications	NATURE MEDICINE			English	Article							REFRACTORY SOLID TUMORS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR ATF5; FACTOR RECEPTOR INHIBITOR; ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; ATF/CREB FAMILY; DOWN-REGULATION; RAF KINASE; CELL-DEATH	Activating transcription factor-5 (ATF5) is highly expressed in malignant glioma and has a key role in promoting cell survival. Here we perform a genome-wide RNAi screen to identify transcriptional regulators of ATF5. Our results reveal an essential survival pathway in malignant glioma, whereby activation of a RAS-mitogen-activated protein kinase or phosphoinositide-3-kinase signaling cascade leads to induction of the transcription factor cAMP response element-binding protein-3-like-2 (CREB3L2), which directly activates ATF5 expression. ATF5, in turn, promotes survival by stimulating transcription of myeloid cell leukemia sequence-1 (MCL1), an antiapoptotic B cell leukemia-2 family member. Analysis of human malignant glioma samples indicates that ATF5 expression inversely correlates with disease prognosis. The RAF kinase inhibitor sorafenib suppresses ATF5 expression in glioma stem cells and inhibits malignant glioma growth in cell culture and mouse models. Our results demonstrate that ATF5 is essential in malignant glioma genesis and reveal that the ATF5-mediated survival pathway described here provides potential therapeutic targets for treatment of malignant glioma.	[Sheng, Zhi; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Sheng, Zhi; Green, Michael R.] Univ Massachusetts, Sch Med, Program & Mol Med, Worcester, MA USA; [Li, Li; Ross, Alonzo H.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Smith, Thomas W.] Univ Massachusetts, Sch Med, Dept Pathol & Neurol, Worcester, MA USA; [Demers, Andrea; Moser, Richard P.] Univ Massachusetts, Sch Med, Dept Surg,Div Neurosurg, Massachusetts Ctr Translat Res Neurosurg Oncol, Worcester, MA USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Sheng, Zhi/F-8433-2010	Zhu, Lihua/0000-0001-7416-0590	US National Institutes of Health [RO1CA115817]; NATIONAL CANCER INSTITUTE [R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021716] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Gillespie (University of Alabama at Birmingham) for GL261 cells, D. Bigner (Duke University) for D456MG cells and R. Lang (University of Cincinnati) for mCD11C-DTR-EFGP; the University of Massachusetts Medical School (UMMS) RNAi Core Facility for providing shRNAs; the UMMS Department of Pathology for providing human tissue sections and the UMMS Diabetes and Endocrinology Research Center core for performing the immunohistochemistry; K. Rock for suggesting the diphtheria toxin strategy; Y. Sun for critical advice on MRI; C. Gilbert for maintaining GS9-6 cells; S. Griggs for technical support; and S. Evans for editorial assistance. This work is supported by US National Institutes of Health grant RO1CA115817 to M.R.G. M.R.G. is an investigator of the Howard Hughes Medical Institute.	Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Aoki H, 2007, CLIN CANCER RES, V13, P6603, DOI 10.1158/1078-0432.CCR-07-0145; Awada A, 2005, BRIT J CANCER, V92, P1855, DOI 10.1038/sj.bjc.6602584; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; da Fonseca CO, 2006, SURG NEUROL S1, V65; Discafani CM, 1999, BIOCHEM PHARMACOL, V57, P917, DOI 10.1016/S0006-2952(98)00356-6; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARA M, 1993, P NATL ACAD SCI USA, V90, P2281, DOI 10.1073/pnas.90.6.2281; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McCubrey JA, 2009, EXPERT OPIN EMERG DR, V14, P633, DOI 10.1517/14728210903232633; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Richly H, 2006, ANN ONCOL, V17, P866, DOI 10.1093/annonc/mdl017; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Sen A, 2004, TISSUE ENG, V10, P904, DOI 10.1089/1076327041348554; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sparidans RW, 2009, J CHROMATOGR B, V877, P269, DOI 10.1016/j.jchromb.2008.12.026; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841	51	120	124	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					671	U73		10.1038/nm.2158	http://dx.doi.org/10.1038/nm.2158			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495567	Green Submitted, Green Accepted			2022-12-25	WOS:000278394200033
J	Torres, C				Torres, Christian			Up against the wall	NATURE MEDICINE			English	News Item							INFECTIOUS-DISEASES SOCIETY; AMERICA		[Torres, Christian] Nat Med, San Diego, CA USA									Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, P528, DOI 10.1086/652152; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754	5	8	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					628	631		10.1038/nm0610-628	http://dx.doi.org/10.1038/nm0610-628			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526310				2022-12-25	WOS:000278394200021
J	Woodward, R; Yi, W; Li, L; Zhao, GH; Eguchi, H; Sridhar, PR; Guo, HJ; Song, JK; Motari, E; Cai, L; Kelleher, P; Liu, XW; Han, WQ; Zhang, WP; Ding, Y; Li, M; Wang, PG				Woodward, Robert; Yi, Wen; Li, Lei; Zhao, Guohui; Eguchi, Hironobu; Sridhar, Perali Ramu; Guo, Hongjie; Song, Jing Katherine; Motari, Edwin; Cai, Li; Kelleher, Patrick; Liu, Xianwei; Han, Weiqing; Zhang, Wenpeng; Ding, Yan; Li, Mei; Wang, Peng George			In vitro bacterial polysaccharide biosynthesis: defining the functions of Wzy and Wzz	NATURE CHEMICAL BIOLOGY			English	Article							N-LINKED GLYCOSYLATION; LIPID-A-CORE; CHAIN-LENGTH DETERMINANT; GRAM-NEGATIVE BACTERIA; O-REPEATING UNIT; ESCHERICHIA-COLI; PEPTIDOGLYCAN GLYCOSYLTRANSFERASES; OLIGOSACCHARYL TRANSFERASE; CAMPYLOBACTER-JEJUNI; ENZYMATIC-SYNTHESIS	Polysaccharides constitute a major component of bacterial cell surfaces and play critical roles in bacteria-host interactions. The biosynthesis of such molecules, however, has mainly been characterized through in vivo genetic studies, thus precluding discernment of the details of this pathway. Accordingly, we present a chemical approach that enabled reconstitution of the E. coli O-polysaccharide biosynthetic pathway in vitro. Starting with chemically prepared undecaprenyl-diphospho-N-acetyl-D-galactosamine, the E. coli O86 oligosaccharide repeating unit was assembled by means of sequential enzymatic glycosylation. Successful expression of the putative polymerase Wzy using a chaperone coexpression system then allowed demonstration of polymerization in vitro using this substrate. Analysis of more substrates revealed a defined mode of recognition for Wzy toward the lipid moiety. Specific polysaccharide chain length modality was furthermore demonstrated to result from the action of Wzz. Collectively, polysaccharide biosynthesis was chemically reconstituted in vitro, providing a well defined system for further underpinning molecular details of this biosynthetic pathway.	[Woodward, Robert; Motari, Edwin; Cai, Li; Kelleher, Patrick; Wang, Peng George] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Yi, Wen; Li, Lei; Zhao, Guohui; Eguchi, Hironobu; Sridhar, Perali Ramu; Guo, Hongjie; Song, Jing Katherine; Liu, Xianwei; Han, Weiqing; Zhang, Wenpeng; Li, Mei; Wang, Peng George] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Li, Lei; Liu, Xianwei; Ding, Yan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Shandong, Peoples R China; [Li, Lei; Liu, Xianwei; Ding, Yan] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Zhao, Guohui] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Shandong University; Shandong University; Nankai University	Woodward, R (corresponding author), Ohio State Univ, Dept Chem, 120 W 18th Ave, Columbus, OH 43210 USA.	wang.892@osu.edu	Zhao, Guohui/J-6782-2012; WANG, Peng/GSN-5263-2022; Yi, Wen/C-8756-2009; Yi, Wen/M-5905-2014; Cai, Li/A-2214-2012; Zhao, Guohui/K-8624-2012	Cai, Li/0000-0002-6098-1168; guo, hongjie/0000-0001-8446-6788	NIH Predoctoral Trainee Program [T32 GM008512]; China Scholarship Council [2007102057]; US National Cancer Institute [R01 CA118208]; US National Institutes of Health [R01 GM085267]; US National Science Foundation [CHE-0616892]; Bill & Melinda Gates Foundation [51946]; NATIONAL CANCER INSTITUTE [R01CA118208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085267, T32GM008512] Funding Source: NIH RePORTER	NIH Predoctoral Trainee Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Liu (University of North Carolina) for providing the GroES/EL expression vector and helpful discussions of expression conditions. R.W. acknowledges the NIH Predoctoral Trainee Program (T32 GM008512). L.L. acknowledges support from the China Scholarship Council (2007102057). P.G.W. acknowledges the US National Cancer Institute (R01 CA118208), US National Institutes of Health (R01 GM085267), US National Science Foundation (CHE-0616892) and Bill & Melinda Gates Foundation (51946) for financial support.	Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Al-Dabbagh B, 2009, ANAL BIOCHEM, V391, P163, DOI 10.1016/j.ab.2009.05.011; Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Briles D. E., 2006, Gram-positive pathogens, P289; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Finn A, 2004, BRIT MED BULL, V70, P1, DOI 10.1093/bmb/ldh021; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Guo HJ, 2005, APPL ENVIRON MICROB, V71, P7995, DOI 10.1128/AEM.71.12.7995-8001.2005; Guo H, 2008, CURR TOP MED CHEM, V8, P141; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; Jenkinson Howard F., 1994, Trends in Microbiology, V2, P209, DOI 10.1016/0966-842X(94)90114-K; KANEGASAKI S, 1970, P NATL ACAD SCI USA, V67, P951, DOI 10.1073/pnas.67.2.951; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robbins J. B., 1980, MOL BASIS MICROBIAL, P115; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Sahly H, 2008, INFECT IMMUN, V76, P1322, DOI 10.1128/IAI.00910-07; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Valvano MA, 2008, MOL MICROBIOL, V67, P232, DOI 10.1111/j.1365-2958.2007.06052.x; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WESTPHAL O, 1983, PROG ALLERGY, V33, P9; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Ye XY, 2001, J AM CHEM SOC, V123, P3155, DOI 10.1021/ja010028q; Yi W, 2006, BIOCHEM BIOPH RES CO, V344, P631, DOI 10.1016/j.bbrc.2006.03.181; Yi W, 2006, CARBOHYD RES, V341, P100, DOI 10.1016/j.carres.2005.11.001; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Zhang Y, 2007, J AM CHEM SOC, V129, P3080, DOI 10.1021/ja069060g	47	123	135	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					418	423		10.1038/nchembio.351	http://dx.doi.org/10.1038/nchembio.351			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20418877	Green Accepted			2022-12-25	WOS:000277748100011
J	Trapnell, C; Williams, BA; Pertea, G; Mortazavi, A; Kwan, G; van Baren, MJ; Salzberg, SL; Wold, BJ; Pachter, L				Trapnell, Cole; Williams, Brian A.; Pertea, Geo; Mortazavi, Ali; Kwan, Gordon; van Baren, Marijke J.; Salzberg, Steven L.; Wold, Barbara J.; Pachter, Lior			Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION; GENOME; ALIGNMENT; ARRAYS; MYOD	High-throughput mRNA sequencing (RNA-Seq) promises simultaneous transcript discovery and abundance estimation(1-3). However, this would require algorithms that are not restricted by prior gene annotations and that account for alternative transcription and splicing. Here we introduce such algorithms in an open-source software program called Cufflinks. To test Cufflinks, we sequenced and analyzed >430 million paired 75-bp RNA-Seq reads from a mouse myoblast cell line over a differentiation time series. We detected 13,692 known transcripts and 3,724 previously unannotated ones, 62% of which are supported by independent expression data or by homologous genes in other species. Over the time series, 330 genes showed complete switches in the dominant transcription start site (TSS) or splice isoform, and we observed more subtle shifts in 1,304 other genes. These results suggest that Cufflinks can illuminate the substantial regulatory flexibility and complexity in even this well-studied model of muscle development and that it can improve transcriptome-based genome annotation.	[Trapnell, Cole; Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Trapnell, Cole; Salzberg, Steven L.] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Trapnell, Cole; Pertea, Geo; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Williams, Brian A.; Mortazavi, Ali; Kwan, Gordon; Wold, Barbara J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Williams, Brian A.; Mortazavi, Ali; Kwan, Gordon; Wold, Barbara J.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [van Baren, Marijke J.] Washington Univ, Genome Sci Ctr, St Louis, MO USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; California Institute of Technology; California Institute of Technology; Washington University (WUSTL); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pachter, L (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.	lpachter@math.berkeley.edu	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Califano, Andrea/F-7239-2012; Peng, Bo/A-6920-2009	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Peng, Bo/0000-0001-8225-2284; Pachter, Lior/0000-0002-9164-6231	US National Institutes of Health (NIH) [R01-LM006845]; ENCODE [U54-HG004576]; Beckman Foundation; Bren Foundation; Moore Foundation; Miller Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004576, R01HG006102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ENCODE; Beckman Foundation; Bren Foundation; Moore Foundation(Gordon and Betty Moore Foundation); Miller Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the US National Institutes of Health (NIH) grants R01-LM006845 and ENCODE U54-HG004576, as well as the Beckman Foundation, the Bren Foundation, the Moore Foundation (Cell Center Program) and the Miller Research Institute. We thank I. Antosechken and L. Schaeffer of the Caltech Jacobs Genome Center for DNA sequencing, and D. Trout, B. King and H. Amrhein for data pipeline and database design, operation and display. We are grateful to R. K. Bradley, K. Datchev, I. Hallgrimsdottir, J. Landolin, B. Langmead, A. Roberts, M. Schatz and D. Sturgill for helpful discussions.	Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; DILWORTH RP, 1950, ANN MATH, V51, P161, DOI 10.2307/1969503; ENDO T, 1986, MOL CELL BIOL, V6, P1412, DOI 10.1128/MCB.6.5.1412; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fuglede B, 2004, 2004 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, PROCEEDINGS, P31; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; SAMMETH M, FLUX SIMULATOR; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	29	10188	10574	44	1213	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					511	U174		10.1038/nbt.1621	http://dx.doi.org/10.1038/nbt.1621			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20436464	Green Accepted			2022-12-25	WOS:000277452700032
J	Anitei, M; Stange, C; Parshina, I; Baust, T; Schenck, A; Raposo, G; Kirchhausen, T; Hoflack, B				Anitei, Mihaela; Stange, Christoph; Parshina, Irina; Baust, Thorsten; Schenck, Annette; Raposo, Graca; Kirchhausen, Tomas; Hoflack, Bernard			Protein complexes containing CYFIP/Sra/PIR121 coordinate Arf1 and Rac1 signalling during clathrin-AP-1-coated carrier biogenesis at the TGN	NATURE CELL BIOLOGY			English	Article							TRANS-GOLGI NETWORK; CLATHRIN-MEDIATED ENDOCYTOSIS; LINKED MENTAL-RETARDATION; MANNOSE 6-PHOSPHATE RECEPTORS; ACTIN DYNAMICS; ARP2/3 COMPLEX; AMPA RECEPTORS; NEURONAL CONNECTIVITY; VESICLE FORMATION; PLASMA-MEMBRANE	Actin dynamics is a tightly regulated process involved in various cellular events including biogenesis of clathrin-coated, AP-1 (adaptor protein 1)-coated transport carriers connecting the trans-Golgi network (TGN) and the endocytic pathway. However, the mechanisms coordinating coat assembly, membrane and actin remodelling during post-TGN transport remain poorly understood. Here we show that the Arf1 (ADP-ribosylation factor 1) GTPase synchronizes the TGN association of clathrin-AP-1 coats and protein complexes comprising CYFIP (cytoplasmic fragile-X mental retardation interacting protein; Sra, PIR121), a clathrin heavy chain binding protein associated with mental retardation. The Rac1 GTPase and its exchange factor beta-PIX (PAK-interacting exchange factor) activate these complexes, allowing N-WASP-dependent and Arp2/3-dependent actin polymerization towards membranes, thus promoting tubule formation. These phenomena can be recapitulated with synthetic membranes. This protein-network-based mechanism facilitates the sequential coordination of Arf1-dependent membrane priming, through the recruitment of coats and CYFIP-containing complexes, and of Rac1-dependent actin polymerization, and provides complementary but independent levels of regulation during early stages of clathrin-AP1-coated carrier biogenesis.	[Anitei, Mihaela; Stange, Christoph; Parshina, Irina; Baust, Thorsten; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Baust, Thorsten; Kirchhausen, Tomas] Harvard Univ, Sch Med, CBRI, Boston, MA 02115 USA; [Schenck, Annette] Nijmegen Ctr Mol Life Sci, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Raposo, Graca] Inst Curie, Ctr Rech, F-75231 Paris, France; [Raposo, Graca] CNRS, UMR144, F-75700 Paris, France; [Raposo, Graca] IBiSA, Cell & Tissue Imaging Facil, F-75248 Paris, France	Technische Universitat Dresden; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Hoflack, B (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	Schenck, Annette/E-4514-2012; HOFLACK, Bernard/AAZ-6668-2020; Anitei, Mihaela/A-2541-2015	Schenck, Annette/0000-0002-6918-3314; Anitei, Mihaela/0000-0002-3156-7195; Raposo, graca/0000-0001-9590-1298	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM075252, R01 GM075252-04, GM075252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Egorov MV, 2009, MOL BIOL CELL, V20, P2413, DOI 10.1091/mbc.E08-11-1136; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; LeBorgne R, 1997, J CELL BIOL, V137, P335; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0	63	75	77	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					330	U65		10.1038/ncb2034	http://dx.doi.org/10.1038/ncb2034			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228810	Green Accepted			2022-12-25	WOS:000276194600006
J	Kleifeld, O; Doucet, A; Keller, UAD; Prudova, A; Schilling, O; Kainthan, RK; Starr, AE; Foster, LJ; Kizhakkedathu, JN; Overall, CM				Kleifeld, Oded; Doucet, Alain; Keller, Ulrich Auf Dem; Prudova, Anna; Schilling, Oliver; Kainthan, Rajesh K.; Starr, Amanda E.; Foster, Leonard J.; Kizhakkedathu, Jayachandran N.; Overall, Christopher M.			Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products	NATURE BIOTECHNOLOGY			English	Article							BREAST-CANCER; POSITIONAL PROTEOMICS; PROTEOLYTIC EVENTS; GELATINASE-A; PEPTIDES; CELLS; DISCOVERY; CHEMISTRY; RECOVERY; SITES	Effective proteome-wide strategies that distinguish the N-termini of proteins from the N-termini of their protease cleavage products would accelerate identification of the substrates of proteases with broad or unknown specificity. Our approach, named terminal amine isotopic labeling of substrates (TAILS), addresses this challenge by using dendritic polyglycerol aldehyde polymers that remove tryptic and C-terminal peptides. We analyze unbound naturally acetylated, cyclized or labeled N-termini from proteins and their protease cleavage products by tandem mass spectrometry, and use peptide isotope quantification to discriminate between the substrates of the protease of interest and the products of background proteolysis. We identify 731 acetylated and 132 cyclized N-termini, and 288 matrix metalloproteinase (MMP)-2 cleavage sites in mouse fibroblast secretomes. We further demonstrate the potential of our strategy to link proteases with defined biological pathways in complex samples by analyzing mouse inflammatory bronchoalveolar fluid and showing that expression of the poorly defined breast cancer protease MMP-11 in MCF-7 human breast cancer cells cleaves both endoplasmin and the immunomodulator and apoptosis inducer galectin-1.	[Kleifeld, Oded; Doucet, Alain; Keller, Ulrich Auf Dem; Prudova, Anna; Schilling, Oliver; Starr, Amanda E.; Foster, Leonard J.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Kleifeld, Oded; Doucet, Alain; Keller, Ulrich Auf Dem; Prudova, Anna; Schilling, Oliver; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Kainthan, Rajesh K.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Kleifeld, Oded; Doucet, Alain; Keller, Ulrich Auf Dem; Prudova, Anna; Schilling, Oliver; Kainthan, Rajesh K.; Starr, Amanda E.; Kizhakkedathu, Jayachandran N.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	jay@pathology.ubc.ca; chris.overall@ubc.ca	Schilling, O/AAC-8302-2019; Kleifeld, Oded/G-7304-2012; Keller, Ulrich auf dem/X-2710-2019; Keller, Ulrich auf dem/G-6004-2012	Keller, Ulrich auf dem/0000-0002-3431-7415; Keller, Ulrich auf dem/0000-0002-3431-7415; Schilling, Oliver/0000-0001-7678-7653	Ministry of Education, Culture, Sports, Science and Technology-Japan; National Institute of Biomedical Innovation; Takeda Science Foundation; Uehara Memorial Foundation; National Institutes of Health [CA20408]	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Tanaka and M. Yamaguchi for assistance with confocal microscopy. We thank T. Kanabayashi for assistance with histological studies. We thank M. Narita for assistance with patient data collection. This work was supported through grants from the Ministry of Education, Culture, Sports, Science and Technology-Japan, National Institute of Biomedical Innovation, Takeda Science Foundation and Uehara Memorial Foundation to F. I. and National Institutes of Health grant CA20408 to L.D.S.	Ahmad A, 1998, AM J PATHOL, V152, P721; Andarawewa KL, 2003, CANCER RES, V63, P5844; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BROWN JL, 1976, J BIOL CHEM, V251, P1009; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; CHANG TK, 1994, P NATL ACAD SCI USA, V91, P12544, DOI 10.1073/pnas.91.26.12544; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Dormeyer W, 2007, J PROTEOME RES, V6, P4634, DOI 10.1021/pr070375k; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Ji CJ, 2005, J PROTEOME RES, V4, P2099, DOI 10.1021/pr050215d; Kainthan RK, 2006, MACROMOLECULES, V39, P7708, DOI 10.1021/ma0613483; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; KLEIFELD O, NAT PROTOC, DOI DOI 10.1038/NPROT.2010.30; Kuhn K, 2003, J PROTEOME RES, V2, P598, DOI 10.1021/pr034026b; LeDissez C, 1996, MACROMOLECULES, V29, P953, DOI 10.1021/ma950403x; Leitner A, 2006, PROTEOMICS, V6, P5418, DOI 10.1002/pmic.200600255; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; McDonald L, 2006, NAT PROTOC, V1, P1790, DOI 10.1038/nprot.2006.317; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; PEI DQ, 1994, J BIOL CHEM, V269, P25849; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Simon GM, 2009, ACS CHEM BIOL, V4, P401, DOI 10.1021/cb900082q; Staes A, 2008, PROTEOMICS, V8, P1362, DOI 10.1002/pmic.200700950; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Timmer JC, 2007, BIOCHEM J, V407, P41, DOI 10.1042/BJ20070775; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; VEH RW, 1977, BIOCHIM BIOPHYS ACTA, V486, P145, DOI 10.1016/0005-2760(77)90079-0	48	379	391	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					281	U144		10.1038/nbt.1611	http://dx.doi.org/10.1038/nbt.1611			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20208520				2022-12-25	WOS:000275288300028
J	Mishra, RK; Chakraborty, P; Arnaoutov, A; Fontoura, BMA; Dasso, M				Mishra, Ram Kumar; Chakraborty, Papia; Arnaoutov, Alexei; Fontoura, Beatriz M. A.; Dasso, Mary			The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; NUCLEAR-PORE; MAMMALIAN-CELLS; MESSENGER-RNA; SPINDLE; SUBCOMPLEX; TUBULIN; MITOSIS; RAN; ORGANIZATION	The metazoan nuclear pore complex (NPC) disassembles during mitosis, and many of its constituents distribute onto spindles and kinetochores, including the Nup107-160 subcomplex(1,2). We have found that Nup107-160 interacts with the gamma-tubulin ring complex (gamma-TuRC), an essential and conserved microtubule nucleator(3,4), and recruits gamma-TuRC to unattached kinetochores. The unattached kinetochores nucleate microtubules in a manner that is regulated by Ran GTPase(5); such microtubules contribute to the formation of kinetochore fibres (k-fibres)(6), microtubule bundles connecting kinetochores to spindle poles. Our data indicate that Nup107-160 and gamma-TuRC act cooperatively to promote spindle assembly through microtubule nucleation at kinetochores: HeLa cells lacking Nup107-160 or gamma-TuRC were profoundly deficient in kinetochore-associated microtubule nucleation. Moreover, co-precipitated Nup107-160-gamma-TuRC complexes nucleated microtubule formation in assays using purified tubulin. Although Ran did not regulate microtubule nucleation by gamma-TuRC alone, Nup107-160-gamma-TuRC complexes required RanGTP for microtubule nucleation. Collectively, our observations show that Nup107-160 promotes spindle assembly through Ran-GTP-regulated nucleation of microtubules by gamma-TuRC at kinetochores, and reveal a relationship between nucleoporins and the microtubule cytoskeleton.	[Mishra, Ram Kumar; Arnaoutov, Alexei; Dasso, Mary] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Chakraborty, Papia; Fontoura, Beatriz M. A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas	Dasso, M (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	mdasso@helix.nih.gov	Mishra, Ram/AAJ-1538-2020; Mishra, Ram/ABA-6071-2020	Mishra, Ram/0000-0002-9528-0476; Arnaoutov, Alexei/0000-0001-7647-7217; Dasso, Mary/0000-0002-5410-1371	Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds [Z01 HD008816, Z01 HD008740]; National Institutes of Health [R01 GM07159]; Texas HEB [010019-0022-2006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008740, ZIAHD008816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008816, Z01HD008740] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas HEB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	R. K. M., A. A. and M. D. were supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Intramural funds (Z01 HD008816 and Z01 HD008740). B. M. A. F. and P. C. were supported by National Institutes of Health R01 GM07159 and Texas HEB (Higher Education Board) 010019-0022-2006.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Desai A, 1999, METHOD CELL BIOL, V61, P385; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Knop M, 1999, BIOL CELL, V91, P291, DOI 10.1016/S0248-4900(99)80090-2; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.e05-11-1061; Rebollo E, 2004, PLOS BIOL, V2, P54, DOI 10.1371/journal.pbio.0020008; Resendes KK, 2008, MOL CELL BIOL, V28, P1755, DOI 10.1128/MCB.01697-07; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	29	129	132	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					164	U154		10.1038/ncb2016	http://dx.doi.org/10.1038/ncb2016			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081840	Green Accepted			2022-12-25	WOS:000274139400010
J	Sun, YH; Hahn, F; Demydchuk, Y; Chettle, J; Tosin, M; Osada, H; Leadlay, PF				Sun, Yuhui; Hahn, Frank; Demydchuk, Yuliya; Chettle, James; Tosin, Manuela; Osada, Hiroyuki; Leadlay, Peter F.			In vitro reconstruction of tetronate RK-682 biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							GENE-CLUSTER; POLYKETIDE SYNTHASES; SPIROTETRONATE ANTIBIOTICS; THIOESTERASES; CONSTRUCTION; INHIBITOR; INSIGHTS; PATHWAY	The protein phosphatase inhibitor RK-682 is one of a number of potentially valuable tetronate polyketide natural products. Understanding how the tetronate ring is formed has been frustrated by the inaccessibility of the putative substrates. We report the heterologous expression of rk genes in Saccharopolyspora erythraea and reconstitution of the RK-682 pathway using recombinant enzymes, and we show that RkD is the enzyme required for RK-682 formation from acyl carrier protein-bound substrates.	[Sun, Yuhui; Hahn, Frank; Demydchuk, Yuliya; Chettle, James; Tosin, Manuela; Leadlay, Peter F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Hahn, Frank; Tosin, Manuela] Univ Cambridge, Dept Chem, Cambridge CB2 1QW, England; [Osada, Hiroyuki] RIKEN, Dept Biol Chem, Wako, Saitama, Japan	University of Cambridge; University of Cambridge; RIKEN	Sun, YH (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	ys293@mole.bio.cam.ac.uk; pfl10@mole.bio.cam.ac.uk	Osada, Hiroyuki/N-4305-2014; Hahn, Frank/AAB-3147-2020; Osada, Hiroyuki/AAY-6254-2020	Hahn, Frank/0000-0002-0603-3482; Tosin, Manuela/0000-0003-4340-9431; Leadlay, Peter/0000-0002-3247-509X	Biotechnology and Biological Sciences Research Council, Deutsche Forschungsgemeinschaft Research Fellowship [BB/D018943/1]; Marie Curie Intra-European Fellowship; Cambridge University; Biotechnology and Biological Sciences Research Council [BB/D018943/1] Funding Source: researchfish; BBSRC [BB/D018943/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Deutsche Forschungsgemeinschaft Research Fellowship(German Research Foundation (DFG)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Intra-European Fellowship(European Commission); Cambridge University(University of Cambridge); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council through project grant BB/D018943/1 to P. F. L. F. H. was supported by a Deutsche Forschungsgemeinschaft Research Fellowship and a Marie Curie Intra-European Fellowship. M. T. was supported by a fellowship from the Herchel Smith Fund of Cambridge University.	BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; Bister B, 2004, ANGEW CHEM INT EDIT, V43, P2574, DOI 10.1002/anie.200353160; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Chen AY, 2007, CHEM BIOL, V14, P784, DOI 10.1016/j.chembiol.2007.05.015; Demydchuk Y, 2008, CHEMBIOCHEM, V9, P1136, DOI 10.1002/cbic.200700715; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; Fang J, 2008, J BACTERIOL, V190, P6014, DOI 10.1128/JB.00533-08; Fecik RA, 2007, NAT CHEM BIOL, V3, P531, DOI 10.1038/nchembio0907-531; Gaitatzis N, 2001, J BIOCHEM, V129, P119, DOI 10.1093/oxfordjournals.jbchem.a002821; HAMAGUCHI T, 1995, FEBS LETT, V372, P54, DOI 10.1016/0014-5793(95)00953-7; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; Kwon SJ, 2007, ACS CHEM BIOL, V2, P419, DOI 10.1021/cb700033s; ROGGO BE, 1994, J ANTIBIOT, V47, P143, DOI 10.7164/antibiotics.47.143; Rowe CJ, 1998, GENE, V216, P215, DOI 10.1016/S0378-1119(98)00327-8; Sodeoka M, 2001, CHEM PHARM BULL, V49, P206, DOI 10.1248/cpb.49.206; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Sun YH, 2008, CHEMBIOCHEM, V9, P150, DOI 10.1002/cbic.200700492; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854; Zhao P, 2009, ORG BIOMOL CHEM, V7, P1454, DOI 10.1039/b817312e	25	56	57	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					99	101		10.1038/NCHEMBIO.285	http://dx.doi.org/10.1038/NCHEMBIO.285			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081823	Green Accepted			2022-12-25	WOS:000273651700007
J	Burgin, AB; Magnusson, OT; Singh, J; Witte, P; Staker, BL; Bjornsson, JM; Thorsteinsdottir, M; Hrafnsdottir, S; Hagen, T; Kiselyov, AS; Stewart, LJ; Gurney, ME				Burgin, Alex B.; Magnusson, Olafur T.; Singh, Jasbir; Witte, Pam; Staker, Bart L.; Bjornsson, Jon M.; Thorsteinsdottir, Margret; Hrafnsdottir, Sigrun; Hagen, Timothy; Kiselyov, Alex S.; Stewart, Lance J.; Gurney, Mark E.			Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety	NATURE BIOTECHNOLOGY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AMP-SPECIFIC PHOSPHODIESTERASE; PROTEIN-KINASE; ANTIDEPRESSANT DRUGS; ROLIPRAM BINDING; SUNCUS-MURINUS; GENE COMPOSER; INHIBITORS; PHOSPHORYLATION	Phosphodiesterase 4 (PDE4), the primary cAMP-hydrolyzing enzyme in cells, is a promising drug target for a wide range of conditions. Here we present seven co-crystal structures of PDE4 and bound inhibitors that show the regulatory domain closed across the active site, thereby revealing the structural basis of PDE4 regulation. This structural insight, together with supporting mutagenesis and kinetic studies, allowed us to design small-molecule allosteric modulators of PDE4D that do not completely inhibit enzymatic activity (I(max) similar to 80-90%). These allosteric modulators have reduced potential to cause emesis, a dose-limiting side effect of existing active site-directed PDE4 inhibitors, while maintaining biological activity in cellular and in vivo models. Our results may facilitate the design of CNS therapeutics modulating cAMP signaling for the treatment of Alzheimer's disease, Huntington's disease, schizophrenia and depression, where brain distribution is desired for therapeutic benefit.	[Burgin, Alex B.; Witte, Pam; Staker, Bart L.; Stewart, Lance J.] deCODE Biostruct, Bainbridge Isl, WA USA; [Magnusson, Olafur T.; Bjornsson, Jon M.; Thorsteinsdottir, Margret; Hrafnsdottir, Sigrun; Gurney, Mark E.] deCODE Genet, Reykjavik, Iceland; [Singh, Jasbir; Hagen, Timothy; Kiselyov, Alex S.] deCODE Chem, Woodridge, IL USA		Burgin, AB (corresponding author), deCODE Biostruct, Bainbridge Isl, WA USA.	aburgin@embios.com; mgurney@decode.com	Hagen, Timothy J/A-8971-2013	Hagen, Timothy/0000-0003-1929-9121; Staker, Bart/0000-0001-9570-5086	National Institute of General Medical Sciences [U54 GM074961]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The development of Gene Composer software used to design protein constructs was supported in part by the National Institute of General Medical Sciences-National Center for Research Resources, co- sponsored PSI-2 Specialized Center Grant U54 GM074961 for the Accelerated Technologies Center for Gene to 3D Structure. The authors would like to thank M. Smith, M. H. Haraldsson, G. V. Halldorsdottir, B. B. Sigurdsson, G. Bragason, I. Saemundsdottir, B. Gudmundsdottir, T. J. Dagbjartsdottir, K. Astradsdottir, S. Gunnarsdottir, B. Eiriksdottir, N. Zhou, D. Sullins, P. Rauen, A. Motta, W. Zeller, J. Christensen and M. O'Connell for contributions to the research. We also thank Dr. Akira Ito and colleagues at Dainippon Sumitomo and Dr. Klaus Mendla and colleagues at Boerhinger Ingelheim for contributions to the animal studies.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Aoki M, 2001, J PHARMACOL EXP THER, V298, P1142; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Brideau C, 1999, BRIT J PHARMACOL, V126, P979, DOI 10.1038/sj.bjp.0702387; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Chambers RJ, 2006, BIOORG MED CHEM LETT, V16, P718, DOI 10.1016/j.bmcl.2005.10.026; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; DESCHENES D, 2000, Patent No. 9422852; Giembycz M A, 2002, Monaldi Arch Chest Dis, V57, P48; Giembycz MA, 2005, CURR OPIN PHARMACOL, V5, P238, DOI 10.1016/j.coph.2005.04.001; Hersperger R, 2000, J MED CHEM, V43, P675, DOI 10.1021/jm991094u; Hirose R, 2007, EUR J PHARMACOL, V573, P93, DOI 10.1016/j.ejphar.2007.06.045; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jacobitz S, 1996, MOL PHARMACOL, V50, P891; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Lim J, 1999, J BIOL CHEM, V274, P19677, DOI 10.1074/jbc.274.28.19677; Lorimer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-36; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Mihara T, 2007, J PHARMACOL EXP THER, V323, P708, DOI 10.1124/jpet.107.121962; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Reid Peter, 2002, Curr Opin Investig Drugs, V3, P1165; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 1999, NEUROPHARMACOLOGY, V38, P289, DOI 10.1016/S0028-3908(98)00190-7; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Rocque WJ, 1997, BIOCHEMISTRY-US, V36, P14250, DOI 10.1021/bi971112e; Saldou N, 1998, CELL SIGNAL, V10, P427, DOI 10.1016/S0898-6568(97)00169-1; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; SINGH J, 2008, Patent No. 2008084193; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; SOUNESS JE, 1995, BRIT J PHARMACOL, V115, P39; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; UENO S, 1987, LIFE SCI, V41, P513, DOI 10.1016/0024-3205(87)90229-3; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wang HC, 2007, J MOL BIOL, V371, P302, DOI 10.1016/j.jmb.2007.05.060; Wang P, 1997, BIOCHEM BIOPH RES CO, V234, P320, DOI 10.1006/bbrc.1997.6636; WILHELM R, 1993, Patent No. 5264437; Xu RX, 2004, J MOL BIOL, V337, P355, DOI 10.1016/j.jmb.2004.01.040; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhang J, 2008, TOXICOL PATHOL, V36, P827, DOI 10.1177/0192623308322308	57	301	320	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					63	U93		10.1038/nbt.1598	http://dx.doi.org/10.1038/nbt.1598			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20037581				2022-12-25	WOS:000273430400022
J	Barlow, JL; Drynan, LF; Hewett, DR; Holmes, LR; Lorenzo-Abalde, S; Lane, AL; Jolin, HE; Pannell, R; Middleton, AJ; Wong, SH; Warren, AJ; Wainscoat, JS; Boultwood, J; McKenzie, ANJ				Barlow, Jillian L.; Drynan, Lesley F.; Hewett, Duncan R.; Holmes, Luke R.; Lorenzo-Abalde, Silvia; Lane, Alison L.; Jolin, Helen E.; Pannell, Richard; Middleton, Angela J.; Wong, See Heng; Warren, Alan J.; Wainscoat, James S.; Boultwood, Jacqueline; McKenzie, Andrew N. J.			A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome	NATURE MEDICINE			English	Article							COMMONLY DELETED REGION; RIBOSOMAL-PROTEIN S19; TCOF1 GENE-PRODUCT; P53; RNA; ACTIVATION; COLLINSSYNDROME,TREACHER; HAPLOINSUFFICIENCY; IDENTIFICATION; INACTIVATION	The identification of the genes associated with chromosomal translocation breakpoints has fundamentally changed understanding of the molecular basis of hematological malignancies. By contrast, the study of chromosomal deletions has been hampered by the large number of genes deleted and the complexity of their analysis. We report the generation of a mouse model for human 5q-syndrome using large-scale chromosomal engineering. Haploinsufficiency of the Cd74-Nid67 interval (containing Rps14, encoding the ribosomal protein S14) caused macrocytic anemia, prominent erythroid dysplasia and monolobulated megakaryocytes in the bone marrow. These effects were associated with defective bone marrow progenitor development, the appearance of bone marrow cells expressing high amounts of the tumor suppressor p53 and increased bone marrow cell apoptosis. Notably, intercrossing with p53-deficient mice completely rescued the progenitor cell defect, restoring common myeloid progenitor and megakaryocytic-erythroid progenitor, granulocyte-monocyte progenitor and hematopoietic stem cell bone marrow populations. This mouse model suggests that a p53-dependent mechanism underlies the pathophysiology of the 5q-syndrome.	[Barlow, Jillian L.; Drynan, Lesley F.; Hewett, Duncan R.; Holmes, Luke R.; Lorenzo-Abalde, Silvia; Lane, Alison L.; Jolin, Helen E.; Pannell, Richard; Middleton, Angela J.; Wong, See Heng; Warren, Alan J.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Wainscoat, James S.; Boultwood, Jacqueline] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Leukaemia Res Fund Mol Haematol Unit, Oxford OX3 9DU, England; [Warren, Alan J.] Univ Cambridge, Dept Haematol, Cambridge, England	MRC Laboratory Molecular Biology; University of Oxford; University of Cambridge	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	anm@mrc-lmb.cam.ac.uk	Lorenzo, Silvia/K-1110-2014; Drynan, Lesley/V-2984-2019	Holmes, Luke/0000-0002-6389-5425; Boultwood, Jacqueline/0000-0002-4330-2928; Barlow, Jillian Lynne/0000-0002-8680-3589	Leukaemia Research UK; Medical Research Council [MC_U105178805, MC_U105161083] Funding Source: researchfish; MRC [MC_U105161083, MC_U105178805] Funding Source: UKRI	Leukaemia Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Thanks go to members of the McKenzie lab for their comments on the manuscript. We are grateful to the Laboratory of Molecular Biology animal facility staff, especially V. Smith. We are also grateful to K. Grobe (University of Munster) for providing blood from the Ndst1<SUP>+/-</SUP> mice and T. Rabbitts (Leeds Institute of Molecular Medicine) for providing Lmo2Cre mice. A.N.J.M., D.R.H., S.L.-A., A. L. L., J.S.W., J.B. and A.J.W. were funded by Leukaemia Research UK.	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BOULTWOOD J, 1994, GENOMICS, V19, P425, DOI 10.1006/geno.1994.1090; BOULTWOOD J, 1994, BLOOD, V84, P3253; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Boultwood J, 2007, BRIT J HAEMATOL, V139, P578, DOI 10.1111/j.1365-2141.2007.06833.x; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dokal I, 2008, BLOOD REV, V22, P141, DOI 10.1016/j.blre.2007.11.003; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Giagounidis A A N, 2004, Hematology, V9, P271, DOI 10.1080/10245330410001723824; Gonzales B, 2005, HUM MOL GENET, V14, P2035, DOI 10.1093/hmg/ddi208; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; Lehmann S, 2007, LEUKEMIA, V21, P1931, DOI 10.1038/sj.leu.2404852; LePage DF, 2000, P NATL ACAD SCI USA, V97, P10471, DOI 10.1073/pnas.97.19.10471; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Montaville P, 2006, BBA-MOL CELL RES, V1763, P1335, DOI 10.1016/j.bbamcr.2006.09.003; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Pellagatti A, 2008, BRIT J HAEMATOL, V142, P57, DOI 10.1111/j.1365-2141.2008.07178.x; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Vician L, 2001, J NEUROSCI RES, V64, P108, DOI 10.1002/jnr.1058; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Zhu YW, 2000, P NATL ACAD SCI USA, V97, P1137, DOI 10.1073/pnas.97.3.1137	49	250	259	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					59	U93		10.1038/nm.2063	http://dx.doi.org/10.1038/nm.2063			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	19966810	Green Submitted, Green Accepted			2022-12-25	WOS:000273395500037
J	Liebgott, PP; Leroux, F; Burlat, B; Dementin, S; Baffert, C; Lautier, T; Fourmond, V; Ceccaldi, P; Cavazza, C; Meynial-Salles, I; Soucaille, P; Fontecilla-Camps, JC; Guigliarelli, B; Bertrand, P; Rousset, M; Leger, C				Liebgott, Pierre-Pol; Leroux, Fanny; Burlat, Benedicte; Dementin, Sebastien; Baffert, Carole; Lautier, Thomas; Fourmond, Vincent; Ceccaldi, Pierre; Cavazza, Christine; Meynial-Salles, Isabelle; Soucaille, Philippe; Fontecilla-Camps, Juan Carlos; Guigliarelli, Bruno; Bertrand, Patrick; Rousset, Marc; Leger, Christophe			Relating diffusion along the substrate tunnel and oxygen sensitivity in hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							NIFE HYDROGENASE; ACTIVE-SITE; MIGRATION PATHWAYS; LIGAND MIGRATION; GAS-DIFFUSION; DESULFOVIBRIO; BINDING; O-2; PROTEINS; KINETICS	In hydrogenases and many other redox enzymes, the buried active site is connected to the solvent by a molecular channel whose structure may determine the enzyme's selectivity with respect to substrate and inhibitors. The role of these channels has been addressed using crystallography and molecular dynamics, but kinetic data are scarce. Using protein film voltammetry, we determined and then compared the rates of inhibition by CO and O-2 in ten NiFe hydrogenase mutants and two FeFe hydrogenases. We found that the rate of inhibition by CO is a good proxy of the rate of diffusion of O-2 toward the active site. Modifying amino acids whose side chains point inside the tunnel can slow this rate by orders of magnitude. We quantitatively define the relations between diffusion, the Michaelis constant for H-2 and rates of inhibition, and we demonstrate that certain enzymes are slowly inactivated by O-2 because access to the active site is slow.	[Liebgott, Pierre-Pol; Leroux, Fanny; Burlat, Benedicte; Dementin, Sebastien; Baffert, Carole; Fourmond, Vincent; Ceccaldi, Pierre; Guigliarelli, Bruno; Bertrand, Patrick; Rousset, Marc; Leger, Christophe] CNRS, Unite Propre Rech 9036, Unite Bioenerget & Ingenierie Proteines, Inst Federatif Rech 88,Inst Microbiol Mediterrane, Marseille, France; [Leroux, Fanny; Burlat, Benedicte; Baffert, Carole; Ceccaldi, Pierre; Guigliarelli, Bruno; Bertrand, Patrick] Aix Marseille Univ, Marseille, France; [Lautier, Thomas; Meynial-Salles, Isabelle; Soucaille, Philippe] Univ Toulouse, Toulouse, France; [Lautier, Thomas; Meynial-Salles, Isabelle; Soucaille, Philippe] Univ Toulouse 3, Inst Natl Sci Appl, Inst Natl Polytech, Lab Ingenierie Syst Biol & Procedes, F-31062 Toulouse, France; [Lautier, Thomas; Meynial-Salles, Isabelle; Soucaille, Philippe] INRA, UMR 792, F-31931 Toulouse, France; [Lautier, Thomas; Meynial-Salles, Isabelle; Soucaille, Philippe] CNRS, UMR 5504, Toulouse, France; [Fontecilla-Camps, Juan Carlos] Univ Grenoble 1, CNRS, CEA,Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Proteines, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Leger, C (corresponding author), CNRS, Unite Propre Rech 9036, Unite Bioenerget & Ingenierie Proteines, Inst Federatif Rech 88,Inst Microbiol Mediterrane, Marseille, France.	christophe.leger@ifr88.cnrs-mrs.fr	Léger, Christophe/C-7230-2016; Cavazza, Christine/AAL-5795-2020; Ceccaldi, Pierre/AAH-3860-2020; Fourmond, Vincent/K-1706-2014; Baffert, Carole/C-4638-2018; LIEBGOTT, Pierre-Pol/K-1045-2016	Léger, Christophe/0000-0002-8871-6059; Fourmond, Vincent/0000-0001-9837-6214; Baffert, Carole/0000-0003-3993-3089; LIEBGOTT, Pierre-Pol/0000-0002-2559-1738; Dementin, Sebastien/0000-0001-6168-5371; Lautier, Thomas/0000-0002-5465-1963; Soucaille, Philippe/0000-0002-1724-7136; Ceccaldi, Pierre/0000-0001-8156-5035	Centre National de la Recherche Scientifique, Commissariat a l'Energie Atomique, Agence Nationale de la Recherche; University of Provence; City of Marseilles; Pole de Competitivite Capenergies	Centre National de la Recherche Scientifique, Commissariat a l'Energie Atomique, Agence Nationale de la Recherche(French National Research Agency (ANR)Centre National de la Recherche Scientifique (CNRS)); University of Provence; City of Marseilles(Region Provence-Alpes-Cote d'Azur); Pole de Competitivite Capenergies	This work was funded by the Centre National de la Recherche Scientifique, Commissariat a l'Energie Atomique, Agence Nationale de la Recherche, the University of Provence and the City of Marseilles, and supported by the Pole de Competitivite Capenergies. The Groupe de Recherche 2977 ("Bio-hydrogene") paid the publication fees for this article.	Almeida MG, 2007, FEBS LETT, V581, P284, DOI 10.1016/j.febslet.2006.12.023; Baffert C, 2008, ANGEW CHEM INT EDIT, V47, P2052, DOI 10.1002/anie.200704313; Barney BM, 2009, J BIOL INORG CHEM, V14, P1015, DOI 10.1007/s00775-009-0544-2; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; Fourmond V, 2009, ANAL CHEM, V81, P2962, DOI 10.1021/ac8025702; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; GUIGLIARELLI B, 1995, BIOCHEMISTRY-US, V34, P4781, DOI 10.1021/bi00014a036; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; HATCHIKIAN EC, 1992, EUR J BIOCHEM, V209, P357, DOI 10.1111/j.1432-1033.1992.tb17297.x; Karyakin AA, 2007, ANGEW CHEM INT EDIT, V46, P7244, DOI 10.1002/anie.200701096; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; Leger C, 2008, CHEM REV, V108, P2379, DOI 10.1021/cr0680742; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Maynard EL, 1999, J AM CHEM SOC, V121, P9221, DOI 10.1021/ja992120g; Nienhaus K, 2003, J BIOL CHEM, V278, P42532, DOI 10.1074/jbc.M306888200; Riistama S, 2000, BIOCHEMISTRY-US, V39, P6365, DOI 10.1021/bi000123w; ROHLFS RJ, 1988, J BIOL CHEM, V263, P1803; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Rousset M, 1998, PLASMID, V39, P114, DOI 10.1006/plas.1997.1321; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Salomonsson L, 2004, P NATL ACAD SCI USA, V101, P11617, DOI 10.1073/pnas.0402242101; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, NAT CHEM BIOL, V3, P760, DOI 10.1038/nchembio.2007.47; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2002, INT J HYDROGEN ENERG, V27, P1449, DOI 10.1016/S0360-3199(02)00072-1	36	154	154	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					63	70		10.1038/NCHEMBIO.276	http://dx.doi.org/10.1038/NCHEMBIO.276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19966788				2022-12-25	WOS:000272802500013
J	Chatterjee, MS; Purvis, JE; Brass, LF; Diamond, SL				Chatterjee, Manash S.; Purvis, Jeremy E.; Brass, Lawrence F.; Diamond, Scott L.			Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli	NATURE BIOTECHNOLOGY			English	Article							PLATELET ACTIVATION; TYROSINE PHOSPHORYLATION; ADP; TRANSDUCTION; AGGREGATION; RECEPTORS; STABILITY; SECRETION; THROMBIN; KINETICS	Prediction of cellular response to multiple stimuli is central to evaluating patient-specific clinical status and to basic understanding of cell biology. Cross-talk between signaling pathways cannot be predicted by studying them in isolation and the combinatorial complexity of multiple agonists acting together prohibits an exhaustive exploration of the complete experimental space. Here we describe pairwise agonist scanning (PAS), a strategy that trains a neural network model based on measurements of cellular responses to individual and all pairwise combinations of input signals. We apply PAS to predict calcium signaling responses of human platelets in EDTA-treated plasma to six different agonists (ADP, convulxin, U46619, SFLLRN, AYPGKF and PGE(2)) at three concentrations (0.1, 1 and 10 x EC50). The model predicted responses to sequentially added agonists, to ternary combinations of agonists and to 45 different combinations of four to six agonists (R = 0.88). Furthermore, we use PAS to distinguish between the phenotypic responses of platelets from ten donors. Training neural networks with pairs of stimuli across the dose-response regime represents an efficient approach for predicting complex signal integration in a patient-specific disease milieu.	[Chatterjee, Manash S.; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Brass, Lawrence F.] Univ Penn, Inst Med & Engn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Diamond, SL (corresponding author), Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	sld@seas.upenn.edu			US National Institutes of Health [R01-HL-56621, R33-HL-87317, T32-HG000046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087317, R01HL056621] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank H. Li for suggesting the permutation test to evaluate the significance of donor clustering. This work was supported by the US National Institutes of Health R01-HL-56621 (S.L.D.), R33-HL-87317 (S.L.D. and L.F.B.) and T32-HG000046 (J.E.P.).	Bohne A, 2002, PLATELETS, V13, P437, DOI 10.1080/0953710021000057794; BRASS LF, 1985, J BIOL CHEM, V260, P7875; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; CHO MJ, 1978, PROSTAGLANDINS, V15, P943, DOI 10.1016/0090-6980(78)90037-0; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Diaconescu E., 2008, WSEAS T COMPUT RES, V3, P182; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; GRANT JA, 1980, BRIT J HAEMATOL, V44, P109, DOI 10.1111/j.1365-2141.1980.tb01189.x; HALLAM TJ, 1982, THROMB RES, V27, P435, DOI 10.1016/0049-3848(82)90061-5; Hers I, 2000, EUR J BIOCHEM, V267, P2088, DOI 10.1046/j.1432-1327.2000.01214.x; Hsueh RC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000054; Jain L.C., 1999, RECURRENT NEURAL NET, V1st; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kemp ML, 2007, J IMMUNOL, V178, P4984, DOI 10.4049/jimmunol.178.8.4984; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; LAGES B, 1988, BRIT J HAEMATOL, V68, P53, DOI 10.1111/j.1365-2141.1988.tb04179.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; PACKHAM MA, 1973, AM J PHYSIOL, V225, P38, DOI 10.1152/ajplegacy.1973.225.1.38; Panzer S, 2006, ANN HEMATOL, V85, P121, DOI 10.1007/s00277-005-0029-5; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Purvis JE, 2008, BLOOD, V112, P4069, DOI 10.1182/blood-2008-05-157883; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; Yee DL, 2005, BLOOD, V106, P2723, DOI 10.1182/blood-2005-03-1290	33	65	68	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					727	U1737		10.1038/nbt.1642	http://dx.doi.org/10.1038/nbt.1642			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20562863	Green Accepted			2022-12-25	WOS:000279723900030
J	Turnbull, C; Rapley, EA; Seal, S; Pernet, D; Renwick, A; Hughes, D; Ricketts, M; Linger, R; Nsengimana, J; Deloukas, P; Huddart, RA; Bishop, DT; Easton, DF; Stratton, MR; Rahman, N				Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Nsengimana, Jeremie; Deloukas, Panagiotis; Huddart, Robert A.; Bishop, D. Timothy; Easton, Douglas F.; Stratton, Michael R.; Rahman, Nazneen		UK Testicular Canc Collaboration	Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; TELOMERE DYSFUNCTION; SUSCEPTIBILITY LOCI; SEX REVERSAL; 5P15.33; TUMORS; RISK; GENE; INSTABILITY	We conducted a genome-wide association study for testicular germ cell tumor, genotyping 298,782 SNPs in 979 affected individuals and 4,947 controls from the UK and replicating associations in a further 664 cases and 3,456 controls. We identified three new susceptibility loci, two of which include genes that are involved in telomere regulation. We identified two independent signals within the TERT-CLPTM1L locus on chromosome 5, which has previously been associated with multiple other cancers (rs4635969, OR = 1.54, P = 1.14 x 10(-23); rs2736100, OR = 1.33, P = 7.55 x 10(-15)). We also identified a locus on chromosome 12 (rs2900333, OR = 1.27, P = 6.16 x 10(-10)) that contains ATF7IP, a regulator of TERT expression. Finally, we identified a locus on chromosome 9 (rs755383, OR = 1.37, P = 1.12 x 10(-23)), containing the sex determination gene DMRT1, which has been linked to teratoma susceptibility in mice.	[Turnbull, Clare; Rapley, Elizabeth A.; Seal, Sheila; Pernet, David; Renwick, Anthony; Hughes, Deborah; Ricketts, Michelle; Linger, Rachel; Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Surrey, England; [Nsengimana, Jeremie; Bishop, D. Timothy] Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Deloukas, Panagiotis; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Sutton, Surrey, England; [Easton, Douglas F.] Strangeways Res Lab, Genet Epidemiol Unit, Canc Res UK, Cambridge CB1 4RN, England	University of London; Institute of Cancer Research - UK; University of Leeds; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Turnbull, C (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	clare.turnbull@icr.ac.uk	Deloukas, Panos/B-2922-2013; Rahman, Nazneen/B-8890-2012; Nsengimana, Jeremie/AAP-3185-2020; Nsengimana, Jeremie/AGK-5625-2022; Turnbull, Clare/AAA-6596-2019; Rahman, Nazneen/D-2802-2013	Deloukas, Panos/0000-0001-9251-070X; Rahman, Nazneen/0000-0003-4376-0440; huddart, robert/0000-0003-3604-1990; Turnbull, Clare/0000-0002-1734-5772; Bishop, Tim/0000-0002-8752-8785	National Health Service; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; Institute of Cancer Research; Cancer Research UK; Cancer Research UK [10589, 11022, 10118] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish; MRC [G0000934, G0700491] Funding Source: UKRI	National Health Service; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank subjects with TGCT and the clinicians involved in their care for participation in this study. We also thank D. Dudakia, J. Pugh, H. McDonald and J. Marke for recruitment of subjects and database entry for the TGCT collections. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. We acknowledge use of DNA from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. C.T. is a Medical Research Council Clinical Research Fellow. D.F.E. is a Principal Research Fellow of Cancer Research UK. The study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust.	Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; FERLAY J, 2002, IARC CANCERBASE, V5; Fernandez-Garcia I, 2008, J THORAC ONCOL, V3, P1085, DOI 10.1097/JTO.0b013e3181886713; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Horvath A, 2009, CANCER RES, V69, P5301, DOI 10.1158/0008-5472.CAN-09-0884; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Livadas S, 2003, CANCER GENET CYTOGEN, V143, P174, DOI 10.1016/S0165-4608(02)00849-X; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rashid HH, 2004, UROL ONCOL-SEMIN ORI, V22, P285, DOI 10.1016/S1078-1439(03)00177-7; Schrader M, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-32; Schrader M, 2002, ONCOL REP, V9, P1097; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Zhang A, 2002, INT J CANCER, V101, P427, DOI 10.1002/ijc.10627	30	265	273	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2010	42	7					604	U178		10.1038/ng.607	http://dx.doi.org/10.1038/ng.607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20543847	Green Accepted			2022-12-25	WOS:000279242400013
J	Wu, YW; Oesterlin, LK; Tan, KT; Waldmann, H; Alexandrov, K; Goody, RS				Wu, Yao-Wen; Oesterlin, Lena K.; Tan, Kui-Thong; Waldmann, Herbert; Alexandrov, Kirill; Goody, Roger S.			Membrane targeting mechanism of Rab GTPases elucidated by semisynthetic protein probes	NATURE CHEMICAL BIOLOGY			English	Article							GDP-DISSOCIATION INHIBITOR; GUANINE-NUCLEOTIDE EXCHANGE; ESCORT PROTEIN; BOUND RAB; COMPLEX; DISPLACEMENT; ACTIVATION; RABEX-5; GERANYLGERANYLTRANSFERASE; GERANYLGERANYLATION	Post-translationally isoprenylated proteins represent major hubs in most membrane-connected signaling networks. GDP dissociation inhibitors (GDIs) are molecular chaperones that shuttle geranylgeranylated GTPases between membranes and the cytosol. Despite numerous studies, the mechanism of targeted membrane delivery of GTPases remains unknown. Here we have combined chemical synthesis and expressed protein ligation to generate fluorescent lipidated RabGTPase-based sensor molecules. Using these protein probes, we have demonstrated that RabGDI and the related Rab escort protein REP show a three-order-of-magnitude greater affinity for GDP-bound Rab GTPase than for the GTP-bound state. Combined with a relatively high dissociation rate of the Rab-GDI complex, this would enable guanine nucleotide exchange factors (GEFs) to efficiently dissociate the complex and promote membrane attachment of the GTPase. The findings suggest strongly that GEFs are necessary and sufficient for membrane targeting of GTPases and that the previously proposed GDI displacement factors (GDFs) are not thermodynamically required for this process. (C) 2010 Nature America, Inc. All rights reserved.	[Wu, Yao-Wen; Oesterlin, Lena K.; Goody, Roger S.] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44139 Dortmund, Germany; [Tan, Kui-Thong; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Alexandrov, Kirill] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	Max Planck Society; Max Planck Society; University of Queensland; University of Queensland	Wu, YW (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Rheinlanddamm 201, D-44139 Dortmund, Germany.	yaowen.wu@mpi-dortmund.mpg.de; goody@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; Wu, Yaowen/N-9802-2015; Goody, Roger S/J-8845-2014; Alexandrov, Kirill/A-5830-2013	Waldmann, Herbert/0000-0002-9606-7247; Wu, Yaowen/0000-0002-2573-8736; Goody, Roger S/0000-0002-0772-0444; Alexandrov, Kirill/0000-0002-0957-6511	Deutsche Forschungsgemeinschaft [642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Itzen (Max Planck Institute of Molecular Physiology, Dortmund, Germany) for providing DrrA proteins and helpful discussions on DrrA nucleotide exchange. T. Durek (Institute for Molecular Bioscience, The University of Queensland, Australia) is acknowledged for help in protein ligation. This work was supported in part by the Deutsche Forschungsgemeinschaft (grants to K.A., R.S.G. and H.W. in the program SFB 642).	Alexandrov K, 1998, FEBS LETT, V425, P460, DOI 10.1016/S0014-5793(98)00290-7; Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; BERANGER F, 1994, MOL CELL BIOL, V14, P744, DOI 10.1128/MCB.14.1.744; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Durek T, 2004, J AM CHEM SOC, V126, P16368, DOI 10.1021/ja046164n; Dursina BE, 2005, PROTEIN EXPRES PURIF, V39, P71, DOI 10.1016/j.pep.2004.09.015; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; GITLER C, 1995, METHOD ENZYMOL, V251, P366, DOI 10.1016/0076-6879(95)51140-7; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; SANFORD JC, 1993, J BIOL CHEM, V268, P23773; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Seabra MC, 1996, J BIOL CHEM, V271, P14398, DOI 10.1074/jbc.271.24.14398; SHAPIRO AD, 1995, J BIOL CHEM, V270, P11085, DOI 10.1074/jbc.270.19.11085; Sivars U, 2005, METHOD ENZYMOL, V403, P348, DOI 10.1016/S0076-6879(05)03030-2; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2006, CHEMBIOCHEM, V7, P1859, DOI 10.1002/cbic.200600377; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	35	78	80	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					534	540		10.1038/NCHEMBIO.386	http://dx.doi.org/10.1038/NCHEMBIO.386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20512138				2022-12-25	WOS:000278878700014
J	Alves, JC; Sonego, F; Souto, FO; Freitas, A; Verri, WA; Auxiliadora-Martins, M; Basile, A; McKenzie, AN; Xu, DM; Cunha, FQ; Liew, FY				Alves-Filho, Jose C.; Sonego, Fabiane; Souto, Fabricio O.; Freitas, Andressa; Verri, Waldiceu A., Jr.; Auxiliadora-Martins, Maria; Basile-Filho, Anibal; McKenzie, Andrew N.; Xu, Damo; Cunha, Fernando Q.; Liew, Foo Y.			Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection	NATURE MEDICINE			English	Article							RECEPTOR ACCESSORY PROTEIN; IL-33; CYTOKINE; EXPRESSION; ST2; MIGRATION; INHIBITION; ACTIVATION; ARRESTINS; ANTIGEN	Sepsis is a systemic inflammatory condition following bacterial infection with a high mortality rate and limited therapeutic options(1,2). Here we show that interleukin-33 (IL-33) reduces mortality in mice with experimental sepsis from cecal ligation and puncture (CLP). IL-33-treated mice developed increased neutrophil influx into the peritoneal cavity and more efficient bacterial clearance than untreated mice. IL-33 reduced the systemic but not the local proinflammatory response, and it did not induce a T helper type 1 (T(H)1) to T(H)2 shift. The chemokine receptor CXCR2 is crucial for recruitment of neutrophils from the circulation to the site of infection(3). Activation of Toll-like receptors (TLRs) in neutrophils downregulates CXCR2 expression and impairs neutrophil migration(4). We show here that IL-33 prevents the downregulation of CXCR2 and inhibition of chemotaxis induced by the activation of TLR4 in mouse and human neutrophils. Furthermore, we show that IL-33 reverses the TLR4-induced reduction of CXCR2 expression in neutrophils via the inhibition of expression of G protein coupled receptor kinase-2 (GRK2), a serine-threonine protein kinase that induces internalization of chemokine receptors(5,6). Finally, we find that individuals who did not recover from sepsis had significantly more soluble ST2 (sST2, the decoy receptor of IL-33) than those who did recover. Together, our results indicate a previously undescribed mechanism of action of IL-33 and suggest a therapeutic potential of IL-33 in sepsis.	[Alves-Filho, Jose C.; Sonego, Fabiane; Souto, Fabricio O.; Freitas, Andressa; Verri, Waldiceu A., Jr.; Cunha, Fernando Q.] Univ Sao Paulo, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil; [Alves-Filho, Jose C.; Xu, Damo; Liew, Foo Y.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Auxiliadora-Martins, Maria; Basile-Filho, Anibal] Univ Sao Paulo, Div Intens Care, Dept Surg & Anat, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [McKenzie, Andrew N.] MRC, Mol Med Lab, Cambridge, England	Universidade de Sao Paulo; University of Glasgow; Universidade de Sao Paulo	Cunha, FQ (corresponding author), Univ Sao Paulo, Dept Pharmacol, BR-14049 Ribeirao Preto, Brazil.	fdqcunha@fmrp.usp.br; f.y.liew@clinmed.gla.ac.uk	Souto, Fabricio/AAS-7671-2020; Basile-Filho, Anibal/J-8354-2016; de Freitas, Andressa/B-7264-2012; Xu, Damo/A-8212-2011; Souto, Fabricio/I-3071-2013; Cunha, Fernando Q/M-3090-2014; Alves-Filho, Jose Carlos/B-5814-2008; Souto, Fabricio/AAX-8668-2021; Inofar, Inct/J-8605-2013; WA, Verri/I-1330-2013; Auxiliadora-Martins, Maria/L-2412-2014	Basile-Filho, Anibal/0000-0002-6547-0615; de Freitas, Andressa/0000-0001-8453-7742; Souto, Fabricio/0000-0002-2392-8499; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Souto, Fabricio/0000-0002-2392-8499; WA, Verri/0000-0003-2756-9283; Auxiliadora-Martins, Maria/0000-0003-3923-4464; Cunha, Fernando Queiroz/0000-0003-4755-1670	Wellcome Trust; UK Medical Research Council, the UK; EU; State of Sao Paulo Research Foundation; National Research Council, Brazil; MRC [G0801198, MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805, G0801198] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council, the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the UK Medical Research Council, the UK and the EU (to F.Y.L.) and the State of Sao Paulo Research Foundation and National Research Council, Brazil (to F.Q.C.). Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were from S. Akira (University of Osaka).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Cummings CJ, 1999, J IMMUNOL, V162, P2341; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Manley MO, 2005, SHOCK, V23, P521, DOI 10.1097/01.shk.0000161386.23817.7f; Moritz DR, 1998, J IMMUNOL, V161, P4866; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rios-Santos F, 2007, AM J RESP CRIT CARE, V175, P490, DOI 10.1164/rccm.200601-103OC; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	39	358	379	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					708	U113		10.1038/nm.2156	http://dx.doi.org/10.1038/nm.2156			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473304				2022-12-25	WOS:000278394200038
J	Vuilleumier, R; Springhorn, A; Patterson, L; Koidl, S; Hammerschmidt, M; Affolter, M; Pyrowolakis, G				Vuilleumier, Robin; Springhorn, Alexander; Patterson, Lucy; Koidl, Stefanie; Hammerschmidt, Matthias; Affolter, Markus; Pyrowolakis, George			Control of Dpp morphogen signalling by a secreted feedback regulator	NATURE CELL BIOLOGY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CALCIUM-BINDING PROTEIN; WING IMAGINAL DISC; GRADIENT FORMATION; DROSOPHILA DEVELOPMENT; PATTERN-FORMATION; EXPRESSION; ZEBRAFISH; HEDGEHOG; BMP	In many instances during development, morphogens specify cell fates by forming concentration gradients. In the Drosophila melanogaster wing imaginal disc, Decapentaplegic (Dpp), a bone morphogenetic protein (BMP), functions as a long-range morphogen to control patterning and growth(1). Dpp is secreted from a stripe of cells at the anterior-posterior compartment boundary and spreads into both compartments to generate a characteristic BMP activity gradient(2-6). Ever since the identification of the morphogen activity of Dpp in the developing wing, the system has served as a paradigm to understand how long-range gradients are established and how cells respond to such gradients. Here we reveal the tight and direct connection of these two processes with the identification and characterization of pentagone (pent), a transcriptional target of BMP signalling encoding a secreted regulator of the pathway. Absence of pent in the wing disc causes a severe contraction of the BMP activity gradient resulting in patterning and growth defects. We show that Pent interacts with the glypican Dally to control Dpp distribution and provide evidence that proper establishment of the BMP morphogen gradient requires the inbuilt feedback loop embodied by Pent.	[Pyrowolakis, George] Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Patterson, Lucy; Hammerschmidt, Matthias] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Affolter, Markus] Biozentrum Univ Basel, CH-4056 Basel, Switzerland	University of Freiburg; Max Planck Society; University of Basel	Pyrowolakis, G (corresponding author), Univ Freiburg, Inst Biol 1, Ctr Biol Signalling Studies BIOSS, Hauptstr 1, D-79104 Freiburg, Germany.	g.pyrowolakis@biologie.uni-freiburg.de	Patterson, Lucy/G-1803-2011	Patterson, Lucy/0000-0002-2578-381X; Affolter, Markus/0000-0002-5171-0016				Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thomas JT, 2009, J BIOL CHEM, V284, P18994, DOI 10.1074/jbc.M807759200; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012	51	98	98	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					611	U198		10.1038/ncb2064	http://dx.doi.org/10.1038/ncb2064			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453847				2022-12-25	WOS:000278213400014
J	Alimonti, A; Carracedo, A; Clohessy, JG; Trotman, LC; Nardella, C; Egia, A; Salmena, L; Sampieri, K; Haveman, WJ; Brogi, E; Richardson, AL; Zhang, JW; Pandolfi, PP				Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Trotman, Lloyd C.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Brogi, Edi; Richardson, Andrea L.; Zhang, Jiangwen; Pandolfi, Pier Paolo			Subtle variations in Pten dose determine cancer susceptibility	NATURE GENETICS			English	Article							EXPRESSION; MUTATION; REVEALS; GENE; MICE	Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor suppressor gene (TSG)(1). It has been hypothesized that subtle variations in TSG expression can promote cancer development(2,3). However, this hypothesis has not yet been definitively supported in vivo. PTEN is a TSG frequently lost in human cancer and mutated in inherited cancer-predisposition syndromes(4). Here we analyze Pten hypermorphic mice (Pten(hy/+)), expressing 80% normal levels of Pten. Ptenhy/+ mice develop a spectrum of tumors, with breast tumors occurring at the highest penetrance. All breast tumors analyzed here retained two intact copies of Pten and maintained Pten levels above heterozygosity. Notably, subtle downregulation of Pten altered the steady-state biology of the mammary tissues and the expression profiles of genes involved in cancer cell proliferation. We present an alterative working model for cancer development in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner.	[Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Canc Genet Program, Boston, MA 02115 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Sampieri, Katia; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Med Sch, Dept Pathol, Boston, MA 02215 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Trotman, Lloyd C.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Alimonti, Andrea; Carracedo, Arkaitz; Clohessy, John G.; Nardella, Caterina; Egia, Ainara; Salmena, Leonardo; Haveman, William J.; Brogi, Edi; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, New York, NY 10021 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhang, Jiangwen] Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Dept Med, Canc Genet Program, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Alimonti, Andrea/J-4150-2012; Carracedo, Arkaitz/F-7029-2011; Zhang, Jiangwen/A-7654-2013	Carracedo, Arkaitz/0000-0001-5957-1260; Zhang, Jiangwen/0000-0002-2911-8446; Nardella, Caterina/0000-0002-1901-7916; Alimonti, Andrea/0000-0002-9362-2313; Clohessy, John/0000-0001-5186-9775; Salmena, Leonardo/0000-0003-4023-658X	US National Cancer Institute [SPORE 92629, MMHCC CA-84292, RO1 CA-82328]; European Molecular Biology Organization; NATIONAL CANCER INSTITUTE [R01CA137050, P50CA092629, U01CA141457, RC2CA147940, U01CA084292, R01CA082328] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Z. Chen for help with genotyping and characterization of the Pten hypomorphic mutant mice. This study was supported, in part, by US National Cancer Institute grants (SPORE 92629 in Prostate Cancer, MMHCC CA-84292 and RO1 CA-82328). A. C. was supported by a long-term European Molecular Biology Organization fellowship.	Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Friend SH, 2003, GENE CHROMOSOME CANC, V38, P326, DOI 10.1002/gcc.10257; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799	21	412	426	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					454	U136		10.1038/ng.556	http://dx.doi.org/10.1038/ng.556			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20400965	Green Accepted			2022-12-25	WOS:000277179500019
J	Kiemeney, LA; Sulem, P; Besenbacher, S; Vermeulen, SH; Sigurdsson, A; Thorleifsson, G; Gudbjartsson, DF; Stacey, SN; Gudmundsson, J; Zanon, C; Kostic, J; Masson, G; Bjarnason, H; Palsson, ST; Skarphedinsson, OB; Gudjonsson, SA; Witjes, JA; Grotenhuis, AJ; Verhaegh, GW; Bishop, DT; Sak, SC; Choudhury, A; Elliott, F; Barrett, JH; Hurst, CD; de Verdier, PJ; Ryk, C; Rudnai, P; Gurzau, E; Koppova, K; Vineis, P; Polidoro, S; Guarrera, S; Sacerdote, C; Campagna, M; Placidi, D; Arici, C; Zeegers, MP; Kellen, E; Gutierrez, BS; Sanz-Velez, JI; Sanchez-Zalabardo, M; Valdivia, G; Garcia-Prats, MD; Hengstler, JG; Blaszkewicz, M; Dietrich, H; Ophoff, RA; van den Berg, LH; Alexiusdottir, K; Kristjansson, K; Geirsson, G; Nikulasson, S; Petursdottir, V; Kong, A; Thorgeirsson, T; Mungan, NA; Lindblom, A; van Es, MA; Porru, S; Buntinx, F; Golka, K; Mayordomo, JI; Kumar, R; Matullo, G; Steineck, G; Kiltie, AE; Aben, KKH; Jonsson, E; Thorsteinsdottir, U; Knowles, MA; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Sulem, Patrick; Besenbacher, Soren; Vermeulen, Sita H.; Sigurdsson, Asgeir; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Stacey, Simon N.; Gudmundsson, Julius; Zanon, Carlo; Kostic, Jelena; Masson, Gisli; Bjarnason, Hjordis; Palsson, Stefan T.; Skarphedinsson, Oskar B.; Gudjonsson, Sigurjon A.; Witjes, J. Alfred; Grotenhuis, Anne J.; Verhaegh, Gerald W.; Bishop, D. Timothy; Sak, Sei Chung; Choudhury, Ananya; Elliott, Faye; Barrett, Jennifer H.; Hurst, Carolyn D.; de Verdier, Petra J.; Ryk, Charlotta; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Vineis, Paolo; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Campagna, Marcello; Placidi, Donatella; Arici, Cecilia; Zeegers, Maurice P.; Kellen, Eliane; Saez Gutierrez, Berta; Sanz-Velez, Jose I.; Sanchez-Zalabardo, Manuel; Valdivia, Gabriel; Garcia-Prats, Maria D.; Hengstler, Jan G.; Blaszkewicz, Meinolf; Dietrich, Holger; Ophoff, Roel A.; van den Berg, Leonard H.; Alexiusdottir, Kristin; Kristjansson, Kristleifur; Geirsson, Gudmundur; Nikulasson, Sigfus; Petursdottir, Vigdis; Kong, Augustine; Thorgeirsson, Thorgeir; Mungan, N. Aydin; Lindblom, Annika; van Es, Michael A.; Porru, Stefano; Buntinx, Frank; Golka, Klaus; Mayordomo, Jose I.; Kumar, Rajiv; Matullo, Giuseppe; Steineck, Gunnar; Kiltie, Anne E.; Aben, Katja K. H.; Jonsson, Eirikur; Thorsteinsdottir, Unnur; Knowles, Margaret A.; Rafnar, Thorunn; Stefansson, Kari			A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							UROTHELIAL CELL-CARCINOMA; FGFR3 MUTATIONS; DISEASE; RISK; EXPRESSION	Previously, we reported germline DNA variants associated with risk of urinary bladder cancer (UBC) in Dutch and Icelandic subjects. Here we expanded the Icelandic sample set and tested the top 20 markers from the combined analysis in several European case-control sample sets, with a total of 4,739 cases and 45,549 controls. The T allele of rs798766 on 4p16.3 was found to associate with UBC (odds ratio = 1.24, P = 9.9 x 10(-12)). rs798766 is located in an intron of TACC3, 70 kb from FGFR3, which often harbors activating somatic mutations in low-grade, noninvasive UBC. Notably, rs798766[T] shows stronger association with low-grade and low-stage UBC than with more aggressive forms of the disease and is associated with higher risk of recurrence in low-grade stage Ta tumors. The frequency of rs798766[T] is higher in Ta tumors that carry an activating mutation in FGFR3 than in Ta tumors with wildtype FGFR3. Our results show a link between germline variants, somatic mutations of FGFR3 and risk of UBC.	[Kiemeney, Lambertus A.; Vermeulen, Sita H.; Grotenhuis, Anne J.; Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Verhaegh, Gerald W.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Sulem, Patrick; Besenbacher, Soren; Sigurdsson, Asgeir; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Stacey, Simon N.; Gudmundsson, Julius; Kostic, Jelena; Masson, Gisli; Bjarnason, Hjordis; Palsson, Stefan T.; Skarphedinsson, Oskar B.; Gudjonsson, Sigurjon A.; Kristjansson, Kristleifur; Kong, Augustine; Thorgeirsson, Thorgeir; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Bishop, D. Timothy; Elliott, Faye; Barrett, Jennifer H.] St James Univ Hosp, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Sak, Sei Chung; Hurst, Carolyn D.; Knowles, Margaret A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds, W Yorkshire, England; [Choudhury, Ananya] Christie Hosp Natl Hlth Serv Fdn Trust, Manchester, Lancs, England; [de Verdier, Petra J.; Ryk, Charlotta] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Vineis, Paolo; Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Inst Sci Interchange ISI Fdn, Turin, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Unit Canc Epidemiol, Turin, Italy; [Sacerdote, Carlotta] CPO Piemonte, Ctr Canc Epidemiol & Prevent, Turin, Italy; [Campagna, Marcello; Placidi, Donatella; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, Brescia, Italy; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Nutr & Toxicol Res Inst, Cluster Genet & Cell Biol, Dept Complex Genet, Maastricht, Netherlands; [Kellen, Eliane] Leuven Univ Ctr Canc Prevent LUCK, Leuven, Belgium; [Saez Gutierrez, Berta] Univ Zaragoza, Dept Med, Zaragoza, Spain; [Sanz-Velez, Jose I.] San Jorge Hosp, Div Urol, Huesca, Spain; [Sanchez-Zalabardo, Manuel] Hosp Clin, Div Urol, Zaragoza, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, Zaragoza, Spain; [Garcia-Prats, Maria D.] San Jorge Hosp, Div Surg Pathol, Huesca, Spain; [Hengstler, Jan G.; Blaszkewicz, Meinolf; Golka, Klaus] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Dietrich, Holger] Paul Gerhardt Fdn, Dept Urol, Lutherstadt Wittenberg, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [van den Berg, Leonard H.; van Es, Michael A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Alexiusdottir, Kristin] Landspitali Univ Hosp, Dept Med Oncol, Reykjavik, Iceland; [Geirsson, Gudmundur; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Mungan, N. Aydin] Zonguldak Karaelmas Univ, Dept Urol, Zonguldak, Turkey; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Buntinx, Frank] Katholieke Univ Leuven, Dept Gen Practice, Leuven, Belgium; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Zaragoza, Spain; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Steineck, Gunnar] Karolinska Inst, Dept Pathol & Oncol, Sect Clin Canc Epidemiol, Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Inst Clin Sci, Dept Oncol, Div Clin Canc Epidemiol, Gothenburg, Sweden; [Kiltie, Anne E.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	Radboud University Nijmegen; Radboud University Nijmegen; Saint James's University Hospital; Saint James's University Hospital; University of Leeds; Christie NHS Foundation Trust; Christie Hospital; Karolinska Institutet; Imperial College London; University of Turin; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Brescia; University of Birmingham; Maastricht University; University of Zaragoza; Hospital Universidad San Jorge; University of Zaragoza; Hospital Universidad San Jorge; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; Utrecht University; Utrecht University Medical Center; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Bulent Ecevit University; Karolinska Institutet; KU Leuven; Maastricht University; University of Zaragoza; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; University of Gothenburg; University of Oxford; University of Iceland	Kiemeney, LA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Kumar, Rajiv/H-6431-2019; Placidi, Donatella/A-6965-2011; Hengstler, Jan G./O-1415-2013; Guarrera, Simonetta/AAB-8482-2022; Arici, Cecilia/AAO-7689-2020; Aben, Katja KH/G-9686-2016; Campagna, Marcello/L-1011-2016; Stefansson, Kari/AAE-7187-2019; Matullo, Giuseppe/K-6383-2016; Kiemeney, Lambertus A./D-3357-2009; Witjes, Fred/N-9665-2013; Buntinx, Frank/E-4950-2011; van+Es, Michael/AAC-5772-2021; Polidoro, Silvia/GYJ-3517-2022; Mayordomo, Jose/K-3453-2013; Steineck, Gunnar/W-1515-2019; Verhaegh, Gerald/L-4708-2015; Grotenhuis, Anne/Q-1596-2015; Vermeulen, Sita H./L-4716-2015	Kumar, Rajiv/0000-0002-6093-0395; Placidi, Donatella/0000-0003-1606-5397; Arici, Cecilia/0000-0003-1493-590X; Aben, Katja KH/0000-0002-0214-2147; Campagna, Marcello/0000-0002-5277-8477; Matullo, Giuseppe/0000-0003-0674-7757; Kiemeney, Lambertus A./0000-0002-2368-1326; Steineck, Gunnar/0000-0002-0787-3969; Verhaegh, Gerald/0000-0003-0227-2280; Vermeulen, Sita H./0000-0003-4913-8601; Gudbjartsson, Daniel/0000-0002-5222-9857; Sacerdote, Carlotta/0000-0002-8008-5096; Gurzau, Eugen/0000-0002-8688-6118; Choudhury, Ananya/0000-0002-3561-6580; Polidoro, Silvia/0000-0003-2968-0575; Kiltie, Anne/0000-0001-7208-2912; Besenbacher, Soren/0000-0003-1455-1738; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Zanon, Carlo/0000-0003-2539-7238; Hengstler, Jan/0000-0002-1427-5246; Barrett, Jenny/0000-0002-1720-7724; Saez, Berta/0000-0003-0753-1165; Ryk, Charlotta/0000-0002-7881-7614; van Es, Michael/0000-0002-7709-5883; Knowles, Margaret/0000-0002-9363-8657; Bishop, Tim/0000-0002-8752-8785	FP7-MC-IAPP Grant [218071]; European Commission [POLYGENE: LSHC-CT-2005]; Radboud University Nijmegen Medical Centre; US National Institute of Mental Health; Cancer Research UK and Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility); European Union; Priority 5: 'Food Quality and Safety' [513943]; Compagnia di San Paolo; Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy; Cancer Research UK [10589, 12933] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	FP7-MC-IAPP Grant; European Commission(European CommissionEuropean Commission Joint Research Centre); Radboud University Nijmegen Medical Centre; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cancer Research UK and Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility); European Union(European Commission); Priority 5: 'Food Quality and Safety'; Compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals who participated in the study and whose contribution made this work possible. We also thank the nurses at deCODE's recruitment center and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. C.Z. and S.B. are funded by a FP7-MC-IAPP Grant agreement no. 218071 (CancerGene). Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005) and a research investment grant of the Radboud University Nijmegen Medical Centre. Control samples for the Dutch follow-up group were genotyped with generous support from the 'Prinses Beatrix Fonds', VSB Fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, J.R. van Dijk and the Adessium foundation. The controls from the Dutch Schizophrenia GWA study were genotyped with the support of the US National Institute of Mental Health (R.A.O.). The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. The Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union Sixth Framework Program, Priority 5: 'Food Quality and Safety' (Contract No. 513943), and by grants of the Compagnia di San Paolo, of the Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy. The Belgian case-control study on bladder cancer risk	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Bakkar AA, 2010, MOL CARCINOGEN, V49, P25, DOI 10.1002/mc.20573; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mostofi FK, 1973, HISTOLOGICAL TYPING; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; *UICC, 1978, TNM CLASS MAL TUM BL, P113; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; Wallerand H, 2005, CARCINOGENESIS, V26, P177, DOI 10.1093/carcin/bgh275; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421	28	138	142	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					415	U67		10.1038/ng.558	http://dx.doi.org/10.1038/ng.558			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348956	Green Accepted			2022-12-25	WOS:000277179500012
J	Willyard, C				Willyard, Cassandra			Combination antimalarials confound anticounterfeit tests	NATURE MEDICINE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					362	362		10.1038/nm0410-362a	http://dx.doi.org/10.1038/nm0410-362a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376030				2022-12-25	WOS:000276446800020
J	Winnay, JN; Boucher, J; Mori, MA; Ueki, K; Kahn, CR				Winnay, Jonathon N.; Boucher, Jeremie; Mori, Marcelo A.; Ueki, Kohjiro; Kahn, C. Ronald			A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; PHOSPHATIDYLINOSITOL 3-KINASE; ER STRESS; SKELETAL-MUSCLE; MESSENGER-RNA; PURIFICATION METHOD; METABOLIC SYNDROME; P85-ALPHA SUBUNIT; ADIPOSE-TISSUE	Class Ia phosphoinositide 3-kinase (PI3K), an essential mediator of the metabolic actions of insulin, is composed of a catalytic (p110 alpha or p110 beta) and regulatory (p85 alpha, p85 beta or p55 gamma) subunit. Here we show that p85 alpha interacts with X-box-binding protein-1 (XBP-1), a transcriptional mediator of the unfolded protein response (UPR), in an endoplasmic reticulum (ER) stress-dependent manner. Cell lines with knockout or knockdown of p85 alpha show marked alterations in the UPR, including reduced ER stress-dependent accumulation of nuclear XBP-1, decreased induction of UPR target genes and increased rates of apoptosis. This is associated with a decreased activation of inositol-requiring protein-1 alpha (IRE1 alpha) and activating transcription factor-6 alpha (ATF6 alpha). Mice with deletion of p85 alpha in liver (L-Pik3r1(-/-)) show a similar attenuated UPR after tunicamycin administration, leading to an increased inflammatory response. Thus, p85 alpha forms a previously unrecognized link between the PI3K pathway, which is central to insulin action, and the regulation of the cellular response to ER stress, a state that when unresolved leads to insulin resistance.	[Winnay, Jonathon N.; Boucher, Jeremie; Mori, Marcelo A.; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA; [Ueki, Kohjiro] Univ Tokyo, Dept Metab Dis, Grad Sch Med, Tokyo, Japan	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Tokyo	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Boucher, Jeremie/G-6602-2015; Mori, Marcelo A/R-2881-2018	Kahn, Ronald/0000-0002-7583-9228; Mori, Marcelo A/0000-0001-7112-5263	US National Institutes of Health [DK55545, DK07260-30]; Joslin Diabetes and Endocrine Research Center [DK36836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055545, T32DK007260, P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes and Endocrine Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank D. Ron (New York University School of Medicine) for providing the Flag-XBP-1u and Flag-XBP-1s expression plasmids. This work was supported by US National Institutes of Health grant DK55545 and National Institutes of Health training grant DK07260-30, as well as Core laboratory support from the Joslin Diabetes and Endocrine Research Center grant DK36836. We would also like to thank U. Ozcan for useful advice and discussion and S. Green and S. Flaherty for assistance in preparation of this manuscript.	Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen D, 2004, MOL CELL BIOL, V24, P320, DOI 10.1128/MCB.24.1.320-329.2004; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fonseca SG, 2007, ANTIOXID REDOX SIGN, V9, P2335, DOI 10.1089/ars.2007.1790; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Garcia Z, 2006, EMBO J, V25, P4740, DOI 10.1038/sj.emboj.7601324; Gotto AM, 2006, CORONARY ARTERY DIS, V17, P77, DOI 10.1097/00019501-200602000-00013; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; HEYDRICK SJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE604, DOI 10.1152/ajpendo.1995.268.4.E604; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Khalfallah Y, 2001, J ENDOCRINOL, V171, P285, DOI 10.1677/joe.0.1710285; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Vanhaesebroeck B, 1996, CANCER SURV, V27, P249; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yeates LC, 1999, ANTICANCER RES, V19, P4171; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	57	140	150	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					438	U120		10.1038/nm.2121	http://dx.doi.org/10.1038/nm.2121			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20348923	Green Accepted			2022-12-25	WOS:000276446800048
J	Coolen, MW; Stirzaker, C; Song, JZ; Statham, AL; Kassir, Z; Moreno, CS; Young, AN; Varma, V; Speed, TP; Cowley, M; Lacaze, P; Kaplan, W; Robinson, MD; Clark, SJ				Coolen, Marcel W.; Stirzaker, Clare; Song, Jenny Z.; Statham, Aaron L.; Kassir, Zena; Moreno, Carlos S.; Young, Andrew N.; Varma, Vijay; Speed, Terence P.; Cowley, Mark; Lacaze, Paul; Kaplan, Warren; Robinson, Mark D.; Clark, Susan J.			Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity	NATURE CELL BIOLOGY			English	Article							CANDIDATE TUMOR-SUPPRESSOR; POLYCOMB GROUP PROTEIN; HUMAN PROSTATE-CANCER; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; DNA HYPERMETHYLATION; PROMOTER METHYLATION; COLORECTAL-CANCER; ABERRANT METHYLATION; BREAST-CANCER	Silencing of individual genes can occur by genetic and epigenetic processes during carcinogenesis, but the underlying mechanisms remain unclear. By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing (LRES). We identified 47 LRES regions in prostate cancer, typically spanning about 2 Mb and harbouring approximately 12 genes, with a prevalence of tumour suppressor and miRNA genes. Our data reveal that LRES is associated with regional histone deacetylation combined with subdomains of different epigenetic remodelling patterns, which include re-enforcement, gain or exchange of repressive histone, and DNA methylation marks. The transcriptional and epigenetic state of genes in normal prostate epithelial and human embryonic stem cells can play a critical part in defining the mode of cancer-associated epigenetic remodelling. We propose that consolidation or effective reduction of the cancer genome commonly occurs in domains through a combination of LRES and LOH or genomic deletion, resulting in reduced transcriptional plasticity within these regions.	[Coolen, Marcel W.; Stirzaker, Clare; Song, Jenny Z.; Statham, Aaron L.; Kassir, Zena; Robinson, Mark D.; Clark, Susan J.] Garvan Inst Med Res, Canc Program, Epigenet Lab, Sydney, NSW 2010, Australia; [Moreno, Carlos S.; Young, Andrew N.; Varma, Vijay] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Varma, Vijay] Atlanta VA Med Ctr, Atlanta, GA USA; [Speed, Terence P.; Robinson, Mark D.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Cowley, Mark; Lacaze, Paul; Kaplan, Warren] Garvan Inst Med Res, Peter Wills Bioinformat Ctr, Sydney, NSW 2010, Australia; [Clark, Susan J.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Walter & Eliza Hall Institute; Garvan Institute of Medical Research; University of New South Wales Sydney	Clark, SJ (corresponding author), Garvan Inst Med Res, Canc Program, Epigenet Lab, Sydney, NSW 2010, Australia.	s.clark@garvan.org.au	Robinson, Mark D/A-6432-2015; Cowley, Mark/D-4504-2012; Cowley, Mark/K-8731-2019; Moreno, Carlos S/B-3863-2009; Clark, Susan J/B-2272-2008; Clark, Susan J/U-7365-2019; Speed, Terence P/B-8085-2009; Simon, Simon/D-5128-2012; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Cowley, Mark/0000-0002-9519-5714; Moreno, Carlos S/0000-0002-5582-0028; Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030; Speed, Terence P/0000-0002-5403-7998; Robinson, Mark D./0000-0002-3048-5518; Lacaze, Paul/0000-0002-0902-6798; Coolen, Marcel/0000-0002-8188-8480; Stirzaker, Clare/0000-0001-5601-3140	Cancer Institute NSW (CINSW); National Health and Medical Research Council (NHMRC) [427614, 481347]; NBCF; NATIONAL CANCER INSTITUTE [K22CA096560, R01CA106826] Funding Source: NIH RePORTER	Cancer Institute NSW (CINSW); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NBCF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Patterson, P. Molloy and T. Hulf for reviewing the manuscript. We thank the Ramaciotti Centre, University of NSW (Sydney, Australia) for array hybridizations. This work is supported by Cancer Institute NSW (CINSW) program (S. J. C.), CINSW Fellowship (M. W. C.) and CINSW Student (A. L. S.) grants and National Health and Medical Research Council (NH&MRC) project (427614, 481347) and Fellowship grants (S. J. C. and T. S.) and NBCF program grant.	Bachmann N, 2008, CANCER GENET CYTOGEN, V182, P103, DOI 10.1016/j.cancergencyto.2008.01.006; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chene L, 2004, INT J CANCER, V111, P798, DOI 10.1002/ijc.20337; Cher ML, 1996, CANCER RES, V56, P3091; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Dumur CI, 2003, GENOMICS, V81, P260, DOI 10.1016/S0888-7543(03)00020-X; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Henrique R, 2007, CLIN CANCER RES, V13, P6122, DOI 10.1158/1078-0432.CCR-07-1042; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Khalili A, 2007, CANCER INFORM, V3, P43; Kim H, 2005, CANCER RES, V65, P8118, DOI 10.1158/0008-5472.CAN-04-4562; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Latil A, 1995, CLIN CANCER RES, V1, P1385; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Luo J, 2001, CANCER RES, V61, P4683; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Palmisano WA, 2003, CANCER RES, V63, P4620; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Smith JS, 2006, NAT GENET, V38, P504, DOI 10.1038/ng0506-504; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Welsh JB, 2001, CANCER RES, V61, P5974; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	69	129	134	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					235	U37		10.1038/ncb2023	http://dx.doi.org/10.1038/ncb2023			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173741	Green Accepted			2022-12-25	WOS:000275054200009
J	Berndt, A; Miller, S; Williams, O; Le, DD; Houseman, BT; Pacold, JI; Gorrec, F; Hon, WC; Liu, Y; Rommel, C; Gaillard, P; Ruckle, T; Schwarz, MK; Shokat, KM; Shaw, JP; Williams, RL				Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.			The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							I PHOSPHATIDYLINOSITIDE 3-KINASES; PHOSPHOINOSITIDE 3-KINASE; ANTITUMOR-ACTIVITY; RHEUMATOID-ARTHRITIS; CATALYTIC SUBUNIT; P110 DELTA; PI3 KINASE; ACTIVATION; MUTATIONS; FAMILY	Deregulation of the phosphoinositide-3-OH kinase (PI(3) K) pathway has been implicated in numerous pathologies-including cancer, diabetes, thrombosis, rheumatoid arthritis and asthma. Recently, small-molecule and ATP-competitive PI(3) K-inhibitors with a wide range of selectivities have entered clinical development. In order to understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to determine to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3) K p110 delta. Structures of this enzyme in complex with a broad panel of isoform-and pan-selective class I PI(3) K inhibitors reveal that selectivity toward p110 delta can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP. We have used these observations to rationalize and synthesize highly selective inhibitors for p110 delta with greatly improved potencies.	[Berndt, Alex; Miller, Simon; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Liu, Yi; Rommel, Christian] Intellikine Inc, La Jolla, CA USA; [Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shaw, Jeffrey P.] Merck Serono Res Ctr, Geneva, Switzerland	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck KGaA; EMD Serono Inc.	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rlw@mrc-lmb.cam.ac.uk		Gorrec, Fabrice/0000-0002-9998-3611; Williams, Roger/0000-0001-7754-4207; Pacold, Joseph/0000-0002-4697-5896	US National Science Foundation Graduate Research Fellowship; University of California [2008-005]; Merck-Serono, Geneva; MRC [MC_U105184308] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089938] Funding Source: NIH RePORTER; Medical Research Council [MC_U105184308] Funding Source: researchfish	US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of California(University of California System); Merck-Serono, Geneva; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the beamline scientists and members of staff at the European Synchrotron Radiation Facility beamlines ID14-1, ID14-2, ID14-4, ID23-1, ID29 and BM30A (Grenoble, France), the Swiss Light Source beamline X06SA (Villigen, Switzerland) and the Diamond beamline I02 (Oxfordshire, UK). We are grateful to M. Allen for collecting the p110d-ZSTK474 dataset and to O. Perisic for her help with the manuscript and for numerous contributions to this study. Part of this material is based on work supported under a US National Science Foundation Graduate Research Fellowship to O. W. and was supported by the Graduate Research and Education in Adaptive bio-Technology Training Program of the University of California Systemwide Biotechnology Research and Education Program, grant number 2008-005 to O. W. A. B. is supported by Merck-Serono, Geneva.	Ameriks MK, 2009, CURR TOP MED CHEM, V9, P738, DOI 10.2174/156802609789044434; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Ghigo A, 2008, RECENT PATENTS INFLA, V2, P1, DOI 10.2174/187221308783399270; Hayakawa M, 2007, BIOORG MED CHEM LETT, V17, P2438, DOI 10.1016/j.bmcl.2007.02.032; Hickey FB, 2006, J BIOL CHEM, V281, P2441, DOI 10.1074/jbc.M511173200; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Ihle NT, 2004, MOL CANCER THER, V3, P763; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Park SJ, 2008, RESPIROLOGY, V13, P764, DOI 10.1111/j.1440-1843.2008.01369.x; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Sundstrom TJ, 2009, ORG BIOMOL CHEM, V7, P840, DOI 10.1039/b819067b; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; WILLIAMS O, CHEM BIOL IN PRESS; Williams R, 2009, BIOCHEM SOC T, V37, P615, DOI 10.1042/BST0370615; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yu K, 2005, CANCER BIOL THER, V4, P538, DOI 10.4161/cbt.4.5.1660; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	47	218	255	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					117	124		10.1038/NCHEMBIO.293	http://dx.doi.org/10.1038/NCHEMBIO.293			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081827	Green Accepted			2022-12-25	WOS:000273651700011
J	Oliveira, RA; Hamilton, RS; Pauli, A; Davis, I; Nasmyth, K				Oliveira, Raquel A.; Hamilton, Russell S.; Pauli, Andrea; Davis, Ilan; Nasmyth, Kim			Cohesin cleavage and Cdk inhibition trigger formation of daughter nuclei	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SISTER-CHROMATID COHESION; TOPOISOMERASE-II; DROSOPHILA CELLS; ANAPHASE; MITOSIS; PROTEIN; CENTROMERE; COMPLEXES; KINASE	The metaphase-anaphase transition is orchestrated through proteolysis of numerous proteins by a ubiquitin protein ligase called the anaphase-promoting complex or cyclosome (APC/C)(1). A crucial aspect of this process is sister chromatid separation, which is thought to be mediated by separase, a thiol protease activated by the APC/C. Separase cleaves cohesin, a ring-shaped complex that entraps sister DNAs2,3. It is a matter of debate whether cohesin-independent forces also contribute to sister chromatid cohesion(4-6). Using 4D live-cell imaging of Drosophila melanogaster syncytial embryos blocked in metaphase (via APC/C inhibition), we show that artificial cohesin cleavage(7) is sufficient to trigger chromosome disjunction. This is nevertheless insufficient for correct chromosome segregation. Kinetochore-microtubule attachments are rapidly destabilized by the loss of tension caused by cohesin cleavage in the presence of high Cdk1 (cyclin-dependent kinase 1) activity, as occurs when the APC/C cannot destroy mitotic cyclins. Metaphase chromosomes undergo a bona fide anaphase when cohesin cleavage is combined with Cdk1 inhibition. We conclude that only two key events, opening of cohesin rings and downregulation of Cdk1, are sufficient to drive proper segregation of chromosomes in anaphase.	[Oliveira, Raquel A.; Hamilton, Russell S.; Pauli, Andrea; Davis, Ilan; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Hamilton, Russell/T-7240-2019; Oliveira, Raquel A/F-4405-2012; Oliveira, Raquel A/AAE-8231-2022	Hamilton, Russell/0000-0002-0598-3793; Oliveira, Raquel A/0000-0002-8293-8603; Oliveira, Raquel A/0000-0002-8293-8603; Nasmyth, Kim/0000-0001-7030-4403; Davis, Ilan/0000-0002-5385-3053; Pauli, Andrea/0000-0001-9646-2303	Fundacao para a Ciencia e a Tecnologia of Portugal; Welcome Trust; Medical Research Council (MRC); MRC [G0001292] Funding Source: UKRI; Medical Research Council [G0001292, G0501615] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Welcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Heidmann, J. Mummery- Widmer, R. Karess, T. Hunt and M. Rape for fly strains and plasmids, A. Musacchio, T. Hunt and J.- M. Peters for helpful advice, S. Dixon, J. Metson and P. Guna for technical assistance, R. Parton for help with microscopy and microinjection and J. Raff, B. Novak and all the members of the K. N. laboratory for discussions and comments on the manuscript. R. A. O. holds a post-doctoral fellowship from the Fundacao para a Ciencia e a Tecnologia of Portugal. R. S. H. and I. D. were supported by a Senior Research Fellowship from the Welcome Trust to I. D. Work in the laboratory of K. N. is supported by grants from Medical Research Council (MRC) and Wellcome Trust.	BUCHENAU P, 1993, J CELL SCI, V104, P1175; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Coelho PA, 2008, PLOS BIOL, V6, P1758, DOI 10.1371/journal.pbio.0060207; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Guacci V, 2007, GENES CELLS, V12, P693, DOI 10.1111/j.1365-2443.2007.01093.x; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vass S, 2003, CURR BIOL, V13, P208, DOI 10.1016/S0960-9822(03)00047-2; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712	41	121	123	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					185	U211		10.1038/ncb2018	http://dx.doi.org/10.1038/ncb2018			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081838	Green Accepted			2022-12-25	WOS:000274139400013
J	Wallace, C; Smyth, DJ; Maisuria-Armer, M; Walker, NM; Todd, JA; Clayton, DG				Wallace, Chris; Smyth, Deborah J.; Maisuria-Armer, Meeta; Walker, Neil M.; Todd, John A.; Clayton, David G.			The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; IMPUTATION; CLUSTER; TUMORS; LOCUS; TESTS; RISK; DLK1; FA1	Genome-wide association (GWA) studies to map common disease susceptibility loci have been hugely successful, with over 300 reproducibly associated loci reported to date(1). However, these studies have not yet provided convincing evidence for any susceptibility locus subject to parent-of-origin effects. Using imputation to extend existing GWA datasets(2-4), we have obtained robust evidence at rs941576 for paternally inherited risk of type 1 diabetes (T1D; ratio of allelic effects for paternal versus maternal transmissions = 0.75; 95% confidence interval (CI) = 0.71-0.79). This marker is in the imprinted region of chromosome 14q32.2, which contains the functional candidate gene DLK1. Our meta-analysis also provided support at genome-wide significance for a T1D locus at chromosome 19p13.2. The highest association was at marker rs2304256 (odds ratio (OR) = 0.86; 95% CI = 0.82-0.90) in the TYK2 gene, which has previously been associated with systemic lupus erythematosus(5) and multiple sclerosis(6).	[Wallace, Chris; Smyth, Deborah J.; Maisuria-Armer, Meeta; Walker, Neil M.; Todd, John A.; Clayton, David G.] Univ Cambridge, Addenbrookes Hosp,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wallace, C (corresponding author), Univ Cambridge, Addenbrookes Hosp,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn,Dept Med Genet, Cambridge CB2 2QQ, England.	chris.wallace@cimr.cam.ac.uk	; Todd, John/A-3542-2010	Walker, Neil/0000-0001-9796-7688; smyth, deborah/0000-0002-6330-2669; Todd, John/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703	Medical Research Council [G0000934, grant G0000934] Funding Source: Medline; NIDDK NIH HHS [U01 DK062418] Funding Source: Medline; NIMH NIH HHS [MH067257, MH059588, R01 MH059566, MH59566, MH059571, R01 MH060879, MH59587, R01 MH061675, MH061675, MH60870, MH59586, R01 MH060870, MH060879, MH63420, R01 MH067257, R01 MH059588, R01 MH063420, R01 MH059586, MH059565, R01 MH059587, R01 MH059565, R01 MH059571] Funding Source: Medline; PHS HHS [U01] Funding Source: Medline; Wellcome Trust [068545/Z/02, 079895, 061858, 076113/C/04/Z, 089989, 076113] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059571, R01MH060870, R01MH059565, R01MH061675, R01MH067257, R01MH063420, R01MH059566, R01MH059588, R01MH059587, R01MH059586, R01MH060879] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bennett ST, 1997, NAT GENET, V17, P350, DOI 10.1038/ng1197-350; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hindorff LA, CATALOG PUBLISHED GE; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mero IL, 2010, EUR J HUM GENET, V18, P502, DOI 10.1038/ejhg.2009.195; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; Tornehave D, 1996, HISTOCHEM CELL BIOL, V106, P535; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; *WELLC TRUST CAS C, 2007, NATURE, V47, P661	33	222	232	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					68	U85		10.1038/ng.493	http://dx.doi.org/10.1038/ng.493			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19966805	Green Accepted, Bronze			2022-12-25	WOS:000273055100018
J	Herber, DL; Cao, W; Nefedova, Y; Novitskiy, SV; Nagaraj, S; Tyurin, VA; Corzo, A; Cho, HI; Celis, E; Lennox, B; Knight, SC; Padhya, T; McCaffrey, TV; McCaffrey, JC; Antonia, S; Fishman, M; Ferris, RL; Kagan, VE; Gabrilovich, DI				Herber, Donna L.; Cao, Wei; Nefedova, Yulia; Novitskiy, Sergey V.; Nagaraj, Srinivas; Tyurin, Vladimir A.; Corzo, Alex; Cho, Hyun-Il; Celis, Esteban; Lennox, Brianna; Knight, Stella C.; Padhya, Tapan; McCaffrey, Thomas V.; McCaffrey, Judith C.; Antonia, Scott; Fishman, Mayer; Ferris, Robert L.; Kagan, Valerian E.; Gabrilovich, Dmitry I.			Lipid accumulation and dendritic cell dysfunction in cancer	NATURE MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; MACROPHAGE SCAVENGER RECEPTOR; CLASS-A; INHIBITION; ACTIVATION; EXPRESSION; MATURATION	Dendritic cells (DCs), a type of professional antigen-presenting cells, are responsible for initiation and maintenance of immune responses. Here we report that a substantial proportion of DCs in tumor-bearing mice and people with cancer have high amounts of triglycerides as compared with DCs from tumor-free mice and healthy individuals. In our studies, lipid accumulation in DCs was caused by increased uptake of extracellular lipids due to upregulation of scavenger receptor A. DCs with high lipid content were not able to effectively stimulate allogeneic T cells or present tumor-associated antigens. DCs with high and normal lipid levels did not differ in expression of major histocompatibility complex and co-stimulatory molecules. However, lipid-laden DCs had a reduced capacity to process antigens. Pharmacological normalization of lipid abundance in DCs with an inhibitor of acetyl-CoA carboxylase restored the functional activity of DCs and substantially enhanced the effects of cancer vaccines. These findings suggest that immune responses in cancer can be improved by manipulating the lipid levels in DCs.	[Herber, Donna L.; Cao, Wei; Nefedova, Yulia; Novitskiy, Sergey V.; Nagaraj, Srinivas; Corzo, Alex; Cho, Hyun-Il; Celis, Esteban; Lennox, Brianna; Gabrilovich, Dmitry I.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Tyurin, Vladimir A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm Hlth, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA; [Celis, Esteban; Gabrilovich, Dmitry I.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Knight, Stella C.] Univ London Imperial Coll Sci Technol & Med, Dept Immunopathol, London, England; [Padhya, Tapan; McCaffrey, Thomas V.; McCaffrey, Judith C.] Univ S Florida, Dept Otolaryngol, Tampa, FL USA; [Antonia, Scott] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Fishman, Mayer] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA; [Ferris, Robert L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of South Florida; Imperial College London; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gabrilovich, DI (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA.	dmitry.gabrilovich@moffitt.org	Gabrilovich, Dmitry/ABE-7122-2020; Fishman, Mayer/AAG-6640-2021; Bharadwaj, Srinivas Nagaraj/I-4947-2012	Kagan, Valerian E./0000-0002-7245-1885; Nefedova, Yulia/0000-0002-5121-9294; Ferris, Robert/0000-0001-6605-2071; Tyurin, Vladimir/0000-0002-3474-1697	US National Institutes of Health [1R21AI070598]; National Institutes of Health [HL70755, HL094488, OH008282]; MRC [G0500677] Funding Source: UKRI; Medical Research Council [G0500677] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K24CA128953] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094488, R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070598] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant 1R21AI070598 to D.I.G., National Institutes of Health grants HL70755, HL094488 and OH008282 to V.E.K. and, in part, by the flow cytometry core of H. Lee Moffitt Cancer Center. Poly-IC was provided by A. Salazar (Oncovir).	Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Calder P. C., 2004, BIOACTIVE LIPIDS, V17, P1; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Delimaris L, 2007, CLIN BIOCHEM, V40, P1129, DOI 10.1016/j.clinbiochem.2007.06.007; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Knight SC, 2008, IMMUNITY, V28, P135, DOI 10.1016/j.immuni.2008.01.003; Motta M, 2003, PANMINERVA MED, V45, P69; Nagaraj S, 2007, J IMMUNOTHER, V30, P169, DOI 10.1097/01.cji.0000211329.83890.ba; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Packard RRS, 2008, CIRC RES, V103, P965, DOI 10.1161/CIRCRESAHA.108.185793; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Saemann MD, 2002, J LEUKOCYTE BIOL, V71, P238; Sanderson P, 1997, J LEUKOCYTE BIOL, V62, P771, DOI 10.1002/jlb.62.6.771; Shaikh SR, 2006, AM J CLIN NUTR, V84, P1277, DOI 10.1093/ajcn/84.6.1277; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Shurin Michael R., 2008, P101, DOI 10.1007/978-0-387-69118-3_6; Touitou E, 2002, J CONTROL RELEASE, V80, P1, DOI 10.1016/S0168-3659(02)00004-4; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200	30	399	415	5	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					880	U57		10.1038/nm.2172	http://dx.doi.org/10.1038/nm.2172			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20622859	Green Accepted, Green Submitted			2022-12-25	WOS:000280649200027
J	Miserey-Lenkei, S; Chalancon, G; Bardin, S; Formstecher, E; Goud, B; Echard, A				Miserey-Lenkei, S.; Chalancon, G.; Bardin, S.; Formstecher, E.; Goud, B.; Echard, A.			Rab and actomyosin-dependent fission of transport vesicles at the Golgi complex	NATURE CELL BIOLOGY			English	Article							NONMUSCLE MYOSIN-II; TO-TGN TRANSPORT; ACTIN DYNAMICS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; ARP2/3 COMPLEX; CIS-GOLGI; IN-VITRO; F-ACTIN; NETWORK	Trafficking between membrane compartments is a characteristic of eukaryotic cells and relies on transport carriers that bud and fission from a donor membrane, before being transported and fusing with the correct acceptor compartment. Rab GTPases ensure specificity and directionality of trafficking steps by regulating the movement of transport carriers along cytoskeletal tracks, and the recruitment of tethering factors required for the docking and fusion processes. Here we show that Rab6, a Golgi-associated Rab, forms a complex with myosin II, contributes to its localization at the Golgi complex and, unexpectedly, controls the fission of Rab6 vesicles. Inhibition of either Rab6 or myosin II function impairs both the fission of Rab6 transport carriers from Golgi membranes and the trafficking of anterograde and retrograde cargo from the Golgi. These effects are consistent with myosin II being an effector of Rab6 in these processes. Our results provide evidence that the actomyosin system is required in vesicle biogenesis at the Golgi, and uncover a function for Rab GTPases in vesicle fission.	[Miserey-Lenkei, S.; Chalancon, G.; Bardin, S.; Goud, B.; Echard, A.] Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, UMR 144, F-75248 Paris 05, France; [Formstecher, E.] Hybrigen SA, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Goud, B (corresponding author), Inst Curie, CNRS, Mol Mech Intracellular Transport Lab, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.	bruno.goud@curie.fr; arnaud.echard@pasteur.fr	Goud, Bruno/GWC-4807-2022	Echard, Arnaud/0000-0001-7402-1398; FORMSTECHER, Etienne/0000-0002-6410-4365	Institut Curie; CNRS; GenHomme Network [02490-6088]; Agence Nationale pour la Recherche [ANR BLAN05 0107, ANR BLAN06-3-139786, ANR JC07-188506]; Association pour la Recherche sur le Cancer (ARC) [1095]	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); GenHomme Network; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	We thank R. S. Adelstein, P. Benaroch, A. Burgess, P. Chavrier, D. Dambournet, V. Doye, M. Heuze, F. Jollivet, A-M. Lennon, G. Montagnac, F. Perez, J. Saraste, J. Stow and J. Young for providing reagents and plasmids; A. Paoletti and P. Tran for the use of their spinning disk confocal microscope; V. Fraisier, J-B. Sibarita and the staff imagerie for their expertise in microscopy. We thank P. Bassereau, Y. Bellaiche, E. Crowell, A-M. Lennon, K. Schauer, P. Tran and J. Young for critical reading of the manuscript. This work has been supported by the Institut Curie, the CNRS, the GenHomme Network Grant 02490-6088 to Hybrigenics and Institut Curie, the Agence Nationale pour la Recherche (grants ANR BLAN05 0107 and ANR BLAN06-3-139786 to BG and ANR JC07-188506 to AE), the Association pour la Recherche sur le Cancer (ARC grant 1095 to SML).	Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; BROSCHAT KO, 1983, CELL, V35, P561, DOI 10.1016/0092-8674(83)90190-3; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Duran JM, 2003, MOL BIOL CELL, V14, P445, DOI 10.1091/mbc.E02-04-0214; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Ikonen E, 1997, J CELL SCI, V110, P2155; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MAUPIN P, 1994, J CELL SCI, V107, P3077; Miserey-Lenkei S, 2001, MOL ENDOCRINOL, V15, P294, DOI 10.1210/me.15.2.294; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rios RM, 2004, CELL, V118, P323; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Simon JP, 1998, P NATL ACAD SCI USA, V95, P1073, DOI 10.1073/pnas.95.3.1073; Smith RD, 2009, TRAFFIC, V10, P1502, DOI 10.1111/j.1600-0854.2009.00965.x; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	62	194	199	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					645	U49		10.1038/ncb2067	http://dx.doi.org/10.1038/ncb2067			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20562865				2022-12-25	WOS:000279374400008
J	Uygun, BE; Soto-Gutierrez, A; Yagi, H; Izamis, ML; Guzzardi, MA; Shulman, C; Milwid, J; Kobayashi, N; Tilles, A; Berthiaume, F; Hertl, M; Nahmias, Y; Yarmush, ML; Uygun, K				Uygun, Basak E.; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Izamis, Maria-Louisa; Guzzardi, Maria A.; Shulman, Carley; Milwid, Jack; Kobayashi, Naoya; Tilles, Arno; Berthiaume, Francois; Hertl, Martin; Nahmias, Yaakov; Yarmush, Martin L.; Uygun, Korkut			Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix	NATURE MEDICINE			English	Article							HEPATOCYTE TRANSPLANTATION; EXTRACELLULAR-MATRIX; STEM-CELLS; IN-VITRO; FAILURE; OXYGEN; DIFFERENTIATION; ATTACHMENT; PERFUSION; SURVIVAL	Orthotopic liver transplantation is the only available treatment for severe liver failure, but it is currently limited by organ shortage. One technical challenge that has thus far limited the development of a tissue-engineered liver graft is oxygen and nutrient transport. Here we demonstrate a novel approach to generate transplantable liver grafts using decellularized liver matrix. The decellularization process preserves the structural and functional characteristics of the native microvascular network, allowing efficient recellularization of the liver matrix with adult hepatocytes and subsequent perfusion for in vitro culture. The recellularized graft supports liver-specific function including albumin secretion, urea synthesis and cytochrome P450 expression at comparable levels to normal liver in vitro. The recellularized liver grafts can be transplanted into rats, supporting hepatocyte survival and function with minimal ischemic damage. These results provide a proof of principle for the generation of a transplantable liver graft as a potential treatment for liver disease.	[Uygun, Basak E.; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Izamis, Maria-Louisa; Guzzardi, Maria A.; Shulman, Carley; Milwid, Jack; Tilles, Arno; Berthiaume, Francois; Nahmias, Yaakov; Yarmush, Martin L.; Uygun, Korkut] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, Boston, MA 02129 USA; [Guzzardi, Maria A.] Scuola Super Sant Anna, Sector Med, Pisa, Italy; [Kobayashi, Naoya] Okayama Univ, Grad Sch Med & Dent, Dept Surg, Shikata, Okayama, Japan; [Berthiaume, Francois; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Hertl, Martin] Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Scuola Superiore Sant'Anna; Okayama University; Rutgers State University New Brunswick; Harvard University; Massachusetts General Hospital	Uygun, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, Boston, MA 02129 USA.	kuygun@partners.org	Uygun, Korkut/AAH-3950-2020; aksel, hacer/H-1572-2015; Guzzardi, Maria-Angela/K-1389-2016; Berthiaume, Francois/ABD-2139-2020; Nahmias, Yaakov/AAM-3872-2020; Nahmias, Yaakov/H-4725-2013; Uygun, Basak/I-1792-2012; Sano, Michael/E-1715-2011	Uygun, Korkut/0000-0003-2088-7860; Guzzardi, Maria-Angela/0000-0001-9574-5088; Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Uygun, Basak/0000-0002-2600-7900; Yarmush, Martin/0000-0003-4986-8444	US National Institutes of Health [R01DK59766, R01DK084053, K99/R00 DK080942, K99DK083556]; US National Science Foundation [CBET-0853569]; Shriners Hospitals for Children [8503]; American Liver Foundation; Massachusetts General Hospital; Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK088962, R01DK059766, K99DK083556, R00DK083556, R01DK084053, R00DK080942, K99DK080942, K99DK088962] Funding Source: NIH RePORTER; Directorate For Engineering [0853569] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Shriners Hospitals for Children; American Liver Foundation; Massachusetts General Hospital(General Electric); Shriners Hospitals for Children; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the US National Institutes of Health, R01DK59766 and R01DK084053 to M.L.Y., K99/R00 DK080942 to K. U. and K99DK083556 to A. S.-G., and US National Science Foundation CBET-0853569 to K. U. We thank the support of the Shriners Hospitals for Children to B. E. U. (grant no. 8503), the American Liver Foundation to A. S.-G. and Massachusetts General Hospital Junior Faculty Grant to K. U. and the Shriners Hospitals for Children. We would like to thank A. Vitalo, C. Calhoun and B. Crowther for technical support.	Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cho CH, 2008, FASEB J, V22, P898, DOI 10.1096/fj.06-7764com; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; HOFFENBERG R, 1972, BIOCHEM J, V129, pP9; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005; LANGER R, 1993, SCIENCE, V920, P260, DOI DOI 10.1126/SCIENCE.8493529; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Melonie Heron Ph.D, 2009, NATL VITAL STAT REPO, V57; Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Punch JD, 2007, AM J TRANSPLANT, V7, P1327, DOI 10.1111/j.1600-6143.2007.01779.x; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; SAFAR P, 1988, CRIT CARE MED, V16, P919; Schechner JS, 2003, FASEB J, V17, P2250, DOI 10.1096/fj.03-0257com; Schleimer K, 2006, LANGENBECK ARCH SURG, V391, P102, DOI 10.1007/s00423-006-0032-x; Shafritz DA, 2006, HEPATOLOGY, V43, pS89, DOI 10.1002/hep.21047; Smets F, 2008, PEDIATR TRANSPLANT, V12, P6, DOI 10.1111/j.1399-3046.2007.00788.x; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Totsugawa T, 2007, J HEPATOL, V47, P74, DOI 10.1016/j.jhep.2007.02.019; UYGUN K, TRANSPLANT IN PRESS; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4	38	950	1014	12	352	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					814	U120		10.1038/nm.2170	http://dx.doi.org/10.1038/nm.2170			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20543851	Green Accepted			2022-12-25	WOS:000279631900033
J	Zaltsman, Y; Shachnai, L; Yivgi-Ohana, N; Schwarz, M; Maryanovich, M; Houtkooper, RH; Vaz, FM; De Leonardis, F; Fiermonte, G; Palmieri, F; Gillissen, B; Daniel, PT; Jimenez, E; Walsh, S; Koehler, CM; Roy, SS; Walter, L; Hajnoczky, G; Gross, A				Zaltsman, Yehudit; Shachnai, Liat; Yivgi-Ohana, Natalie; Schwarz, Michal; Maryanovich, Maria; Houtkooper, Riekelt H.; Vaz, Frederic Maxime; De Leonardis, Francesco; Fiermonte, Giuseppe; Palmieri, Ferdinando; Gillissen, Bernhard; Daniel, Peter T.; Jimenez, Erin; Walsh, Susan; Koehler, Carla M.; Roy, Soumya Sinha; Walter, Ludivine; Hajnoczky, Gyoergy; Gross, Atan			MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria	NATURE CELL BIOLOGY			English	Article							OUTER-MEMBRANE; CELL-DEATH; CRE RECOMBINASE; BCL-2 FAMILY; INDUCE APOPTOSIS; BARTH-SYNDROME; BAX; PROTEINS; PERMEABILIZATION; OLIGOMERIZATION	The BH3-only BID (BH3-interacting domain death agonist) protein has a critical function in the death-receptor pathway in the liver by triggering mitochondrial outer membrane permeabilization (MOMP). Here we show that MTCH2/MIMP (mitochondrial carrier homologue 2/Met-induced mitochondrial protein), a novel truncated BID (tBID)-interacting protein, is a surface-exposed outer mitochondrial membrane protein that facilitates the recruitment of tBID to mitochondria. Knockout of MTCH2/MIMP in embryonic stem cells and in mouse embryonic fibroblasts hinders the recruitment of tBID to mitochondria, the activation of Bax/Bak, MOMP, and apoptosis. Moreover, conditional knockout of MTCH2/MIMP in the liver decreases the sensitivity of mice to Fas-induced hepatocellular apoptosis and prevents the recruitment of tBID to liver mitochondria both in vivo and in vitro. In contrast, MTCH2/MIMP deletion had no effect on apoptosis induced by other pro-apoptotic Bcl-2 family members and no detectable effect on the outer membrane lipid composition. These loss-of-function models indicate that MTCH2/MIMP has a critical function in liver apoptosis by regulating the recruitment of tBID to mitochondria.	[Zaltsman, Yehudit; Shachnai, Liat; Yivgi-Ohana, Natalie; Schwarz, Michal; Maryanovich, Maria; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Houtkooper, Riekelt H.] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Vaz, Frederic Maxime] Univ Amsterdam, Dept Clin Chem & Pediat, NL-1100 DE Amsterdam, Netherlands; [De Leonardis, Francesco; Fiermonte, Giuseppe; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, I-70125 Bari, Italy; [Gillissen, Bernhard; Daniel, Peter T.] Humboldt Univ, Univ Med Ctr Charite, Dept Hematol Oncol & Tumor Immunol, D-13125 Berlin, Germany; [Jimenez, Erin; Walsh, Susan; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Roy, Soumya Sinha; Walter, Ludivine; Hajnoczky, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Weizmann Institute of Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Universita degli Studi di Bari Aldo Moro; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; Jefferson University	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il	Houtkooper, Riekelt/P-5001-2019; Gross, Atan/ABC-2640-2020; Fiermonte, Giuseppe/D-3680-2018; Fiermonte, Giuseppe/F-3159-2010; Walter, Ludivine/S-4456-2017; Houtkooper, Riekelt H/E-1602-2011	Fiermonte, Giuseppe/0000-0002-6764-9395; Walter, Ludivine/0000-0001-7214-0676; Houtkooper, Riekelt H/0000-0001-9961-0842; De Leonardis, Francesco/0000-0002-6278-1565; Jimenez, Erin/0000-0001-7655-8412; Schwarz, Michal/0000-0003-4358-7502; Sinha Roy, Soumya/0000-0002-4135-0141; Vaz, Frederic/0000-0002-9048-1041; Gillissen, Bernhard/0000-0002-1815-2091	USA-Israel Binational Science Foundation; Ministero dell'Universita e della Ricerca; Apulia Region; University of Bari; Prinses Beatrix Fonds; Barth Syndrome Foundation; National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM059419, R01GM061721] Funding Source: NIH RePORTER	USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Apulia Region; University of Bari; Prinses Beatrix Fonds; Barth Syndrome Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Jung for advice regarding the animal studies; A. Harmelin, R. Haffner, A. Maizenberg, G. Damari and T. Berkutzki for help with the animal and ES cell studies; H. van Lenthe and F. Stet for technical assistance with the phospholipid analysis; T. Langer (University of Cologne) for the TAT-Cre plasmid; T.S. Tanaka (University of Illinois at Urbana-Champaign) for DNA probes for Brachyury; D. Wallach (Weizmann Institute) for anti-Fas antibodies and Richard Marcellus (McGill University) for recombinant adenoviruses. This study was supported in part by the USA-Israel Binational Science Foundation, the Ministero dell'Universita e della Ricerca, the Apulia Region, and the University of Bari. It was also supported by a grant of the Prinses Beatrix Fonds to F.M.V. and grants of the Barth Syndrome Foundation to W.K. and F.M.V.A.G. is the incumbent of the Armour Family Career Development Chair of cancer research. E.A.J. is funded by a National Institutes of Health (NIH) Minority Access to Research Careers U*STAR Scholarship, and S.W. is funded by a NIH National Research Service Award.	Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; GALLITALIADOROS LA, 1995, J IMMUNOL METHODS, V181, P1, DOI 10.1016/0022-1759(95)00017-5; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Gross A, 2005, J BIOENERG BIOMEMBR, V37, P113, DOI 10.1007/s10863-005-6222-3; Hogan B, 1994, MANIPULATING MOUSE E; Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Leibowitz-Amit R, 2006, CANCER RES, V66, P8687, DOI 10.1158/0008-5472.CAN-05-2294; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	40	125	127	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					553	562		10.1038/ncb2057	http://dx.doi.org/10.1038/ncb2057			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20436477	Green Accepted			2022-12-25	WOS:000278213400007
J	Park, H; Kim, JI; Ju, YS; Gokcumen, O; Mills, RE; Kim, S; Lee, S; Suh, D; Hong, D; Kang, HP; Yoo, YJ; Shin, JY; Kim, HJ; Yavartanoo, M; Chang, YW; Ha, JS; Chong, W; Hwang, GR; Darvishi, K; Kim, H; Yang, SJ; Yang, KS; Kim, H; Hurles, ME; Scherer, SW; Carter, NP; Tyler-Smith, C; Lee, C; Seo, JS				Park, Hansoo; Kim, Jong-Il; Ju, Young Seok; Gokcumen, Omer; Mills, Ryan E.; Kim, Sheehyun; Lee, Seungbok; Suh, Dongwhan; Hong, Dongwan; Kang, Hyunseok Peter; Yoo, Yun Joo; Shin, Jong-Yeon; Kim, Hyun-Jin; Yavartanoo, Maryam; Chang, Young Wha; Ha, Jung-Sook; Chong, Wilson; Hwang, Ga-Ram; Darvishi, Katayoon; Kim, HyeRan; Yang, Song Ju; Yang, Kap-Seok; Kim, Hyungtae; Hurles, Matthew E.; Scherer, Stephen W.; Carter, Nigel P.; Tyler-Smith, Chris; Lee, Charles; Seo, Jeong-Sun			Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; PIK3CA GENE; FINE-SCALE; POLYMORPHISM; POPULATIONS; ASSOCIATION	Copy number variants (CNVs) account for the majority of human genomic diversity in terms of base coverage. Here, we have developed and applied a new method to combine high-resolution array comparative genomic hybridization (CGH) data with whole-genome DNA sequencing data to obtain a comprehensive catalog of common CNVs in Asian individuals. The genomes of 30 individuals from three Asian populations (Korean, Chinese and Japanese) were interrogated with an ultra-high-resolution array CGH platform containing 24 million probes. Whole-genome sequencing data from a reference genome (NA10851, with 28.3x coverage) and two Asian genomes (AK1, with 27.8x coverage and AK2, with 32.0x coverage) were used to transform the relative copy number information obtained from array CGH experiments into absolute copy number values. We discovered 5,177 CNVs, of which 3,547 were putative Asian-specific CNVs. These common CNVs in Asian populations will be a useful resource for subsequent genetic studies in these populations, and the new method of calling absolute CNVs will be essential for applying CNV data to personalized medicine.	[Park, Hansoo; Kim, Jong-Il; Ju, Young Seok; Kim, Sheehyun; Lee, Seungbok; Suh, Dongwhan; Hong, Dongwan; Kang, Hyunseok Peter; Yoo, Yun Joo; Shin, Jong-Yeon; Kim, Hyun-Jin; Yavartanoo, Maryam; Chang, Young Wha; Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Park, Hansoo; Gokcumen, Omer; Mills, Ryan E.; Ha, Jung-Sook; Chong, Wilson; Hwang, Ga-Ram; Darvishi, Katayoon; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Park, Hansoo; Gokcumen, Omer; Mills, Ryan E.; Ha, Jung-Sook; Darvishi, Katayoon; Lee, Charles] Harvard Univ, Sch Med, Boston, MA USA; [Park, Hansoo; Kim, Jong-Il; Shin, Jong-Yeon; Seo, Jeong-Sun] Psoma Therapeut Inc, Seoul, South Korea; [Kim, Jong-Il; Ju, Young Seok; Yavartanoo, Maryam; Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kim, Sheehyun; Kim, HyeRan; Yang, Song Ju; Yang, Kap-Seok; Kim, Hyungtae; Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea; [Lee, Seungbok; Suh, Dongwhan; Kim, Hyun-Jin; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Hurles, Matthew E.; Carter, Nigel P.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge, England; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Seoul National University (SNU); Macrogen, Inc.; Seoul National University (SNU); Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Seo, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea.	clee@rics.bwh.harvard.edu; jeongsun@snu.ac.kr	Scherer, Stephen W./B-3785-2013; KIM, JONG-IL/D-1019-2011; Ju, Young Seok/E-1324-2012; Mills, Ryan/F-4225-2010; Seo, Jeong-Sun/J-2763-2012; Gokcumen, Omer/J-6984-2013	Scherer, Stephen W./0000-0002-8326-1999; KIM, JONG-IL/0000-0002-7240-3744; Ju, Young Seok/0000-0002-5514-4189; Mills, Ryan/0000-0003-3425-6998; Hwang, Ga-Ram/0000-0002-1520-4589; Hong, Dongwan/0000-0002-7816-1299; Gokcumen, Omer/0000-0003-4371-679X; Kim, Sheehyun/0000-0002-4347-4420; Seungbok, Lee/0000-0002-3145-8714	Macrogen Inc. [MG2009009]; Psoma Therapeutics Inc.; Korean Ministry of Education, Science and Technology [M10305030000]; Green Cross Therapeutics [0411-20080023]; Department of Pathology at Brigham and Women's Hospital; US National Institutes of Health [HG004221]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER	Macrogen Inc.; Psoma Therapeutics Inc.; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Green Cross Therapeutics; Department of Pathology at Brigham and Women's Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge R. Govindaraju for editing this manuscript. This work has been supported in part by Macrogen Inc. (MG2009009), Psoma Therapeutics Inc., the Korean Ministry of Education, Science and Technology (grant M10305030000), Green Cross Therapeutics (0411-20080023), the Department of Pathology at Brigham and Women's Hospital (to C. L.) and a US National Institutes of Health Grant (HG004221 to C. L.).	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; COLIN Y, 1991, BLOOD, V78, P2747; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Horowitz RE, 2008, NEW ENGL J MED, V359, P2393, DOI 10.1056/NEJMc081797; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Lindner I, 2005, MOL NUTR FOOD RES, V49, P972, DOI 10.1002/mnfr.200500087; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shiffman D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002895; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang YH, 2005, J LAB CLIN MED, V146, P321, DOI 10.1016/j.lab.2005.07.007	23	157	217	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					400	U61		10.1038/ng.555	http://dx.doi.org/10.1038/ng.555			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20364138	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000277179500009
J	Cullinane, AR; Straatman-Iwanowska, A; Zaucker, A; Wakabayashi, Y; Bruce, CK; Luo, GM; Rahman, F; Gurakan, F; Utine, E; Ozkan, TB; Denecke, J; Vukovic, J; Di Rocco, M; Mandel, H; Cangul, H; Matthews, RP; Thomas, SG; Rappoport, JZ; Arias, IM; Wolburg, H; Knisely, AS; Kelly, DA; Muller, F; Maher, ER; Gissen, P				Cullinane, Andrew R.; Straatman-Iwanowska, Anna; Zaucker, Andreas; Wakabayashi, Yoshiyuki; Bruce, Christopher K.; Luo, Guanmei; Rahman, Fatimah; Gurakan, Figen; Utine, Eda; Ozkan, Tanju B.; Denecke, Jonas; Vukovic, Jurica; Di Rocco, Maja; Mandel, Hanna; Cangul, Hakan; Matthews, Randolph P.; Thomas, Steve G.; Rappoport, Joshua Z.; Arias, Irwin M.; Wolburg, Hartwig; Knisely, A. S.; Kelly, Deirdre A.; Mueller, Ferenc; Maher, Eamonn R.; Gissen, Paul			Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization	NATURE GENETICS			English	Article							RECYCLING ENDOSOMES; CARCINOEMBRYONIC ANTIGEN; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; ARC SYNDROME; E-CADHERIN; MYOSIN VB; CELL; COMPLEX; RAB11	Arthrogryposis, renal dysfunction and cholestasis syndrome (ARC) is a multisystem disorder associated with abnormalities in polarized liver and kidney cells. Mutations in VPS33B account for most cases of ARC. We identified mutations in VIPAR (also called C14ORF133) in individuals with ARC without VPS33B defects. We show that VIPAR forms a functional complex with VPS33B that interacts with RAB11A. Knockdown of vipar in zebrafish resulted in biliary excretion and E-cadherin defects similar to those in individuals with ARC. Vipar-and Vps33b-deficient mouse inner medullary collecting duct (mIMDC-3) cells expressed membrane proteins abnormally and had structural and functional tight junction defects. Abnormal Ceacam5 expression was due to mis-sorting toward lysosomal degradation, but reduced E-cadherin levels were associated with transcriptional downregulation. The VPS33B-VIPAR complex thus has diverse functions in the pathways regulating apical-basolateral polarity in the liver and kidney.	[Cullinane, Andrew R.; Straatman-Iwanowska, Anna; Zaucker, Andreas; Bruce, Christopher K.; Luo, Guanmei; Rahman, Fatimah; Cangul, Hakan; Mueller, Ferenc; Maher, Eamonn R.; Gissen, Paul] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Wakabayashi, Yoshiyuki; Arias, Irwin M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, US Natl Inst Hlth, Bethesda, MD USA; [Gurakan, Figen] Hacettepe Univ, Dept Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Utine, Eda] Hacettepe Univ, Dept Pediat, Clin Genet Unit, Ankara, Turkey; [Ozkan, Tanju B.] Uludag Univ, Sch Med, Dept Pediat Gastroenterol Hepatol & Nutr, Bursa, Turkey; [Denecke, Jonas] Univ Hosp Rostock, Dept Pediat, Rostock, Germany; [Vukovic, Jurica] Univ Zagreb, Univ Hosp Rebro, Dept Pediat, Zagreb, Croatia; [Di Rocco, Maja] Gaslini Inst, Pediat Unit 2, Genoa, Italy; [Mandel, Hanna] Technion Israel Inst Technol, Rambam Med Ctr, Metabol Unit, Meyer Childrens Hosp,Fac Med, Haifa, Israel; [Cangul, Hakan] Uludag Univ, Dept Med Genet, Sch Med, Bursa, Turkey; [Matthews, Randolph P.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Gastroenterol Hepatol & Nutr,Dept Pediat, Philadelphia, PA 19104 USA; [Thomas, Steve G.] Univ Birmingham, Birmingham Platelet Grp, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Rappoport, Joshua Z.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Kelly, Deirdre A.] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England; [Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Gissen, Paul] Birmingham Childrens Hosp, Inherited Metab Dis Unit, Birmingham, W Midlands, England	University of Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Hacettepe University; Hacettepe University; Uludag University; University of Rostock; University of Zagreb; University of Genoa; IRCCS Istituto Giannina Gaslini; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Uludag University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Birmingham; University of Birmingham; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Birmingham; Birmingham Women's Hospital; University of Birmingham	Gissen, P (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	p.gissen@bham.ac.uk	Vukovic, Jurica/B-3717-2013; MAHER, EAMONN R/A-9507-2008; Gissen, Paul/A-4352-2010; Muller, Ferenc/C-6426-2009	Vukovic, Jurica/0000-0001-8675-9170; MAHER, EAMONN R/0000-0002-6226-6918; Gissen, Paul/0000-0002-9712-6122; Thomas, Steven/0000-0001-8733-7842	Children Liver Disease Foundation; Framework 6 IP EUTRACC [LSGH CT 2006037445]; European Molecular Biology Organization [ASTF 121:2007]; European Science Foundation [2008]; Biotechnology and Biosciences Research Council [BB/H002308/1]; ARC syndrome association; Children Living with Inherited Metabolic Diseases (CLIMB); Birmingham Children's Hospital Research Foundation (BCHRF); WellChild; Wellcome Trust; Eunice Kennedy Shriver National Institute of Child Health and Human Development, US National Institutes of Health; Biotechnology and Biological Sciences Research Council [BB/H002308/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928, R01DK035652] Funding Source: NIH RePORTER; BBSRC [BB/H002308/1] Funding Source: UKRI	Children Liver Disease Foundation; Framework 6 IP EUTRACC; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Science Foundation(European Science Foundation (ESF)European Commission); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ARC syndrome association; Children Living with Inherited Metabolic Diseases (CLIMB); Birmingham Children's Hospital Research Foundation (BCHRF); WellChild; Wellcome Trust(Wellcome TrustEuropean Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A. R. C. holds the Children Liver Disease Foundation PhD Studentship and P. G. is a GlaxoSmithKline Clinician Scientist. A.Z. and F. M. are supported by Framework 6 IP EUTRACC, LSGH CT 2006037445. H. C. is supported by grants from the European Molecular Biology Organization (ASTF 121:2007) and European Science Foundation (Exchange Grant 2008). J.Z.R. is supported by the Biotechnology and Biosciences Research Council (BB/H002308/1). Thanks to F. Lock for her help with the E-cadherin luciferase assay, G. Reynolds for help with E-cadherin immunostaining and R. Knittel for her help with freeze fracture experiments. The authors also wish to thank all the families and clinicians who contributed to this research and thank the ARC syndrome association; Children Living with Inherited Metabolic Diseases (CLIMB); Birmingham Children's Hospital Research Foundation (BCHRF); WellChild; the Wellcome Trust; and the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, US National Institutes of Health, for their generous financial support.	Aijaz S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-49; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Bandler PE, 2008, MOL PHARMACOL, V74, P9, DOI 10.1124/mol.108.045674; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bull LN, 2006, J PEDIATR-US, V148, P269, DOI 10.1016/j.jpeds.2005.10.005; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cullinane AR, 2009, HUM MUTAT, V30, pE330, DOI 10.1002/humu.20900; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Ducharme NA, 2007, AM J PHYSIOL-CELL PH, V293, pC1059, DOI 10.1152/ajpcell.00078.2007; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Gissen P, 2005, HUM MOL GENET, V14, P1261, DOI 10.1093/hmg/ddi137; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Gissen P, 2006, HUM GENET, V120, P396, DOI 10.1007/s00439-006-0232-z; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; HARLOW E, 1998, USING ANTIBODIES LAB; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; HORSLEN SP, 1994, J MED GENET, V31, P62, DOI 10.1136/jmg.31.1.62; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Matthews RP, 2005, DEVELOPMENT, V132, P5295, DOI 10.1242/dev.02140; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; OHANNESIAN DW, 1995, CANCER RES, V55, P2191; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Prekeris Rytis, 2003, ScientificWorldJournal, V3, P870; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shao L, 2006, ANN NY ACAD SCI, V1072, P194, DOI 10.1196/annals.1326.037; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Uzan-Gafsou S, 2007, MOL BIOL CELL, V18, P3169, DOI 10.1091/mbc.E06-09-0779; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wakabayashi Y, 2006, J BIOL CHEM, V281, P27669, DOI 10.1074/jbc.R600013200; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zhu GD, 2009, MOL BIOL CELL, V20, P1223, DOI 10.1091/mbc.E08-07-0728	79	118	129	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					303	U55		10.1038/ng.538	http://dx.doi.org/10.1038/ng.538			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20190753	Green Accepted			2022-12-25	WOS:000276150500009
J	Ji, HK; Liu, XS				Ji, Hongkai; Liu, X. Shirley			Analyzing 'omics data using hierarchical models	NATURE BIOTECHNOLOGY			English	Article									[Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Ji, HK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.	hji@jhsph.edu; xsliu@jimmy.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004069, R01 HG004069-04] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Gelman A., 2004, BAYESIAN DATA ANAL; Hastie T., 2009, UNSUPERVISED LEARNIN; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	10	39	40	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					337	340		10.1038/nbt.1619	http://dx.doi.org/10.1038/nbt.1619			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20379180	Green Accepted, Bronze			2022-12-25	WOS:000276462400020
J	Mavrakis, KJ; Wolfe, AL; Oricchio, E; Palomero, T; de Keersmaecker, K; McJunkin, K; Zuber, J; James, T; Chang, K; Khan, AA; Leslie, CS; Parker, JS; Paddison, PJ; Tam, W; Ferrando, A; Wendel, HG				Mavrakis, Konstantinos J.; Wolfe, Andrew L.; Oricchio, Elisa; Palomero, Teresa; de Keersmaecker, Kim; McJunkin, Katherine; Zuber, Johannes; James, Taneisha; Chang, Kenneth; Khan, Aly A.; Leslie, Christina S.; Parker, Joel S.; Paddison, Patrick J.; Tam, Wayne; Ferrando, Adolfo; Wendel, Hans-Guido			Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia	NATURE CELL BIOLOGY			English	Article							ACTIVATING MUTATIONS; MICRORNAS; EXPRESSION; SURVIVAL; CLUSTER; GENE; MICE; AKT	MicroRNAs (miRNAs) have emerged as novel cancer genes. In particular, the miR-17-92 cluster, containing six individual miRNAs, is highly expressed in haematopoietic cancers and promotes lymphomagenesis in vivo. Clinical use of these findings hinges on isolating the oncogenic activity within the 17-92 cluster and defining its relevant target genes. Here we show that miR-19 is sufficient to promote leukaemogenesis in Notch1-induced T-cell acute lymphoblastic leukaemia (T-ALL) in vivo. In concord with the pathogenic importance of this interaction in T-ALL, we report a novel translocation that targets the 17-92 cluster and coincides with a second rearrangement that activates Notch1. To identify the miR-19 targets responsible for its oncogenic action, we conducted a large-scale short hairpin RNA screen for genes whose knockdown can phenocopy miR-19. Strikingly, the results of this screen were enriched for miR-19 target genes, and include Bim (Bcl2L11), AMP-activated kinase (Prkaa1) and the phosphatases Pten and PP2A (Ppp2r5e). Hence, an unbiased, functional genomics approach reveals a coordinate clampdown on several regulators of phosphatidylinositol-3-OH kinase-related survival signals by the leukaemogenic miR-19.	[Mavrakis, Konstantinos J.; Wolfe, Andrew L.; Oricchio, Elisa; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA; [Wolfe, Andrew L.; Khan, Aly A.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Palomero, Teresa; de Keersmaecker, Kim; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [McJunkin, Katherine] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27502 USA; [Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Tam, Wayne] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10025 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Columbia University; Columbia University; Cold Spring Harbor Laboratory; Fred Hutchinson Cancer Center; Cornell University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	wendelh@mskcc.org	Ferrando, Adolfo A/Q-7026-2016; De Keersmaecker, Kim/W-9702-2018; Zuber, Johannes/E-7517-2011; Parker, Joel/AAG-1108-2019	De Keersmaecker, Kim/0000-0002-7420-9531; Zuber, Johannes/0000-0001-8810-6835; McJunkin, Katherine/0000-0001-9730-442X; Wolfe, Andrew/0000-0003-0418-716X; Oricchio, Elisa/0000-0002-1690-0447	American Cancer Society; Geoffrey Beene Cancer Center; Leukemia Research Foundation; Louis V. Gerstner Foundation; May and Samuel Rudin Foundation; NY Community Trust; William and Blanche Foundation; Andrew Seligson Memorial Clinical Fellowship; NYStar; WOLF Foundation; Rally across America Foundation; Leukemia and Lymphoma Society [1287-08, 6237-08];  [R01CA120196]; NATIONAL CANCER INSTITUTE [R01CA142798, R01CA120196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Center; Leukemia Research Foundation; Louis V. Gerstner Foundation; May and Samuel Rudin Foundation; NY Community Trust; William and Blanche Foundation; Andrew Seligson Memorial Clinical Fellowship; NYStar; WOLF Foundation; Rally across America Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lin He, S. W. Lowe and G. Hannon for access to shRNA and miRNA screening technologies; W. Pear, J. Huse and E. C. Holland for plasmids; H. Zhu for technical assistance; the Memorial Sloan-Kettering (MSK) animal facility and Research Animal Resource Center (RARC), A. Viale of the MSK Genomics Core, H. Zhao of the cBIO program, and J. Schatz and J. Massague for editorial advice; and V. Murty for cytogenetic and fluorescence in situ hybridization analyses. This work was supported by grants from the American Cancer Society, the Geoffrey Beene Cancer Center, the Leukemia Research Foundation, the Louis V. Gerstner Foundation, the May and Samuel Rudin Foundation, the NY Community Trust and the William and Blanche Foundation (to H.-G. W.), from the Andrew Seligson Memorial Clinical Fellowship (to J.Z.), and NYStar (to P.J.P.). A.F. is supported by R01CA120196, the WOLF Foundation, the Rally across America Foundation and the Leukemia and Lymphoma Society (grants 1287-08 and 6237-08), and A.F. is a Leukemia & Lymphoma Society Scholar.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Calin GA, 2007, METHOD ENZYMOL, V427, P193, DOI 10.1016/S0076-6879(07)27011-9; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Palomero T, 2006, LEUKEMIA, V20, P1963, DOI 10.1038/sj.leu.2404409; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; YANG YH, 2006, R PACKAGE VERSION 1	35	249	269	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					372	U159		10.1038/ncb2037	http://dx.doi.org/10.1038/ncb2037			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20190740	Green Accepted			2022-12-25	WOS:000276194600010
J	Ishitani, T; Hirao, T; Suzuki, M; Isoda, M; Ishitani, S; Harigaya, K; Kitagawa, M; Matsumoto, K; Itoh, M				Ishitani, Tohru; Hirao, Tomoko; Suzuki, Maho; Isoda, Miho; Ishitani, Shizuka; Harigaya, Kenichi; Kitagawa, Motoo; Matsumoto, Kunihiro; Itoh, Motoyuki			Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex	NATURE CELL BIOLOGY			English	Article							DROSOPHILA MASTERMIND; PROTEIN; PHOSPHORYLATION; HOMOLOG; PATHWAY; NLK; DIFFERENTIATION; COACTIVATOR; EXPRESSION; RECEPTORS	The Notch signalling pathway has a crucial function in determining cell fates in multiple tissues within metazoan organisms(1). On binding to ligands, the Notch receptor is cleaved proteolytically and releases its intracellular domain (NotchICD). The NotchICD enters the nucleus and acts cooperatively with other factors to stimulate the transcription of target genes. High levels of Notch-mediated transcriptional activation require the formation of a ternary complex consisting of NotchICD, CSL (CBF-1, suppressor of hairless, LAG-1) and a Mastermind family member(2-5). However, it is still not clear how the formation of the ternary complex is regulated. Here we show that Nemo-like kinase (NLK) negatively regulates Notch-dependent transcriptional activation by decreasing the formation of this ternary complex. Using a biochemical screen, we identified Notch as a new substrate of NLK. NLK-phosphorylated Notch1ICD is impaired in its ability to form a transcriptionally active ternary complex. Furthermore, knockdown of NLK leads to hyperactivation of Notch signalling and consequently decreases neurogenesis in zebrafish. Our results both define a new function for NLK and reveal a previously unidentified mode of regulation in the Notch signalling pathway.	[Ishitani, Tohru; Hirao, Tomoko; Isoda, Miho; Itoh, Motoyuki] Nagoya Univ, Unit Nervous Dev Syst, Nagoya, Aichi 4648602, Japan; [Ishitani, Tohru; Suzuki, Maho; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Signal Transduct,Lab Cell Regulat, Nagoya, Aichi 4648602, Japan; [Itoh, Motoyuki] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Ishitani, Tohru; Ishitani, Shizuka] Kyushu Univ, Med Inst Bioregulat, Dept Postgenome Sci Ctr, Div Cell Regulat Syst, Fukuoka 8128582, Japan; [Harigaya, Kenichi; Kitagawa, Motoo] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba 2608670, Japan	Nagoya University; Nagoya University; Nagoya University; Kyushu University; Chiba University	Ishitani, T (corresponding author), Nagoya Univ, Unit Nervous Dev Syst, Nagoya, Aichi 4648602, Japan.	tish@bioreg.kyushu-u.ac.jp; mito@iar.nagoya-u.ac.jp	, Tohru/AAH-8979-2020; Kitagawa, Motoo/W-8468-2019; Ishitani, Tohru/E-9781-2014	, Tohru/0000-0002-6200-7043; Kitagawa, Motoo/0000-0003-1036-840X; 	Yamada Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT of Japan; Grants-in-Aid for Scientific Research programs in Japan	Yamada Science Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research programs in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Honjo, T. C. Sudhof, U. Lendahl, K. Yasutomo, C. Kintner, D. Hayward, J. D. Griffin, L. Wu, M. Takeichi, S. Chiba, A. Kikuchi, H. Fujisawa and K. Hozumi for providing plasmid vectors, antibody and cultured cells; H. Matsuo for technical assistance; members of the H. Aiba laboratory (especially T. Sunohara) for technical advice; and J. Ninomiya-Tsuji for helpful discussions. This research was supported by the Yamada Science Foundation (T. I.), the Astellas Foundation for Research on Metabolic Disorders (T. I. and M. I.), the Program for Improvement of Research Environment for Young Researchers from SCF commissioned by MEXT of Japan (T. I. and M. I.), and the Grants-in-Aid for Scientific Research programs in Japan (T. I., K. M. and M. I.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Hyodo-Miura J, 2002, GENES CELLS, V7, P487, DOI 10.1046/j.1365-2443.2002.00536.x; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Takke C, 1999, DEVELOPMENT, V126, P1811; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Verheyen EM, 1996, GENETICS, V144, P1127; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	33	87	95	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					278	U84		10.1038/ncb2028	http://dx.doi.org/10.1038/ncb2028			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118921	Green Published			2022-12-25	WOS:000275054200014
J	Link, H; Martin, R				Link, Hans; Martin, Roland			New drugs may improve, complicate treatment for multiple sclerosis	NATURE MEDICINE			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; ORAL FINGOLIMOD		[Link, Hans] Karolinska Inst, Dept Neurology, Stockholm, Sweden; [Martin, Roland] Univ Med Ctr Eppendorf, Inst Neuroimmunology & Clin Multiple Sclerosis Res, Hamburg, Germany	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf	Link, H (corresponding author), Karolinska Inst, Dept Neurology, Stockholm, Sweden.			Martin, Roland/0000-0002-0982-1329				Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494	3	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					272	272		10.1038/nm0310-272	http://dx.doi.org/10.1038/nm0310-272			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20208513	Bronze			2022-12-25	WOS:000275289500043
J	Yi, K; Menand, B; Bell, E; Dolan, L				Yi, Keke; Menand, Benoit; Bell, Elizabeth; Dolan, Liam			A basic helix-loop-helix transcription factor controls cell growth and size in root hairs	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; PHOSPHORUS AVAILABILITY; GENES; ELONGATION; CYTOSCAPE; NETWORKS; AUXIN	Postmitotic cell growth defines cell shape and size during development. However, the mechanisms regulating postmitotic cell growth in plants remain unknown. Here we report the discovery of a basic helix-loop-helix (bHLH) transcription factor called RSL4 (ROOT HAIR DEFECTIVE 6-LIKE 4) that is sufficient to promote postmitotic cell growth in Arabidopsis thaliana root-hair cells. Loss of RSL4 function resulted in the development of very short root hairs. In contrast, constitutive RSL4 expression programmed constitutive growth, resulting in the formation of very long root hairs. Hair-cell growth signals, such as auxin and low phosphate availability, modulate hair cell extension by regulating RSL4 transcript and protein levels. RSL4 is thus a regulator of growth that integrates endogenous developmental and exogenous environmental signals that together control postmitotic growth in root hairs. The control of postmitotic growth by transcription factors may represent a general mechanism for regulating cell size across diverse organisms.	[Yi, Keke; Menand, Benoit; Bell, Elizabeth; Dolan, Liam] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Yi, Keke] Zhejiang Univ, State Key Lab Plant Physiol & Biochem, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Menand, Benoit] Aix Marseille Univ, CEA, Lab Genet & Biophys Plantes, CNRS, Marseille, France; [Dolan, Liam] Univ Oxford, Dept Plant Sci, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Zhejiang University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford	Dolan, L (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England.	liam.dolan@plants.ox.ac.uk	Yi, Keke/P-3964-2017; Yi, Keke/N-8482-2019	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X; Menand, Benoit/0000-0001-9713-5275; Dolan, Liam/0000-0003-1206-7096	Biotechnology and Biological Sciences Research Council; Human Frontiers in Science [RGP0012/2005-C]; EU-Marie Curie Program; Natural Environmental Research Council (NERC) [NE/C510732/1]; University of East Anglia and China Scholarship Council; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: researchfish; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontiers in Science; EU-Marie Curie Program(European Commission); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of East Anglia and China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D. was funded by a grant in aid from the Biotechnology and Biological Sciences Research Council to John Innes Centre and Oxford University. L. D., E. B. and K. Y. were funded by a grant from Human Frontiers in Science (RGP0012/2005-C). B. M. was funded by the EU-Marie Curie Program and a Natural Environmental Research Council (NERC) responsive mode grant NE/C510732/1 to L. D. K. Y. was partially supported by a Joint Scholarship between the University of East Anglia and China Scholarship Council. We gratefully thank the Nottingham Arabidopsis Stock Centre for providing T-DNA insertion and RNAi lines. We are also grateful to Y. Tao for the help with microarray analysis and H. Hu for the statistical analysis.	Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Bohme K, 2004, PLANT J, V40, P686, DOI 10.1111/j.1365-313X.2004.02245.x; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; JOHNSON C. M. et al., 1957, Plant and Soil, V8, P337, DOI 10.1007/BF01666323; Jones AR, 2009, NAT CELL BIOL, V11, P78, DOI 10.1038/ncb1815; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schmidt W, 2001, PLANT PHYSIOL, V125, P2078, DOI 10.1104/pp.125.4.2078; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x	19	205	217	5	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					264	U108		10.1038/ng.529	http://dx.doi.org/10.1038/ng.529			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139979				2022-12-25	WOS:000274912400018
J	Guilluy, C; Bregeon, J; Toumaniantz, G; Rolli-Derkinderen, M; Retailleau, K; Loufrani, L; Henrion, D; Scalbert, E; Bril, A; Torres, RM; Offermanns, S; Pacaud, P; Loirand, G				Guilluy, Christophe; Bregeon, Jeremy; Toumaniantz, Gilles; Rolli-Derkinderen, Malvyne; Retailleau, Kevin; Loufrani, Laurent; Henrion, Daniel; Scalbert, Elizabeth; Bril, Antoine; Torres, Raul M.; Offermanns, Stephan; Pacaud, Pierre; Loirand, Gervaise			The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; HETEROTRIMERIC G-PROTEINS; CARDIAC-HYPERTROPHY; MYOSIN PHOSPHATASE; AT(1) RECEPTOR; IN-VIVO; HYPERTENSION; KINASE; ACTIVATION; ALDOSTERONE	Hypertension is one of the most frequent pathologies in the industrialized world. Although recognized to be dependent on a combination of genetic and environmental factors, its molecular basis remains elusive. Increased activity of the monomeric G protein RhoA in arteries is a common feature of hypertension. However, how RhoA is activated and whether it has a causative role in hypertension remains unclear. Here we provide evidence that Arhgef1 is the RhoA guanine exchange factor specifically responsible for angiotensin II-induced activation of RhoA signaling in arterial smooth muscle cells. We found that angiotensin II activates Arhgef1 through a previously undescribed mechanism in which Jak2 phosphorylates Tyr738 of Arhgef1. Arhgef1 inactivation in smooth muscle induced resistance to angiotensin II-dependent hypertension in mice, but did not affect normal blood pressure regulation. Our results show that control of RhoA signaling through Arhgef1 is central to the development of angiotensin II-dependent hypertension and identify Arhgef1 as a potential target for the treatment of hypertension.	[Guilluy, Christophe; Bregeon, Jeremy; Toumaniantz, Gilles; Rolli-Derkinderen, Malvyne; Pacaud, Pierre; Loirand, Gervaise] INSERM, U915, Nantes, France; [Guilluy, Christophe; Bregeon, Jeremy; Toumaniantz, Gilles; Rolli-Derkinderen, Malvyne; Pacaud, Pierre; Loirand, Gervaise] Univ Nantes, Inst Thorax, Nantes, France; [Retailleau, Kevin; Loufrani, Laurent; Henrion, Daniel] INSERM, U771, F-75654 Paris 13, France; [Retailleau, Kevin; Loufrani, Laurent; Henrion, Daniel] CNRS, UMR6214, Fac Med Angers, F-75700 Paris, France; [Scalbert, Elizabeth; Bril, Antoine] Inst Rech Servier, F-92150 Suresnes, France; [Torres, Raul M.] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Offermanns, Stephan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Loirand, Gervaise] CHU Nantes, Inst Thorax, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Servier; Institut de Recherches Internationales Servier; University of Colorado System; University of Colorado Denver; Max Planck Society; Nantes Universite; CHU de Nantes	Loirand, G (corresponding author), INSERM, U915, Nantes, France.	pierre.pacaud@univ-nantes.fr; gervaise.loirand@univ-nantes.fr	loufrani, laurent/K-1713-2015; Loirand, Gervaise/K-1834-2014; Henrion, Daniel/AAK-1995-2021; Pacaud, Pierre/D-6392-2015; TOUMANIANTZ, GILLES/D-6692-2015; Guilluy, Christophe/Z-1015-2019; Henrion, Daniel/N-7023-2015; Rolli-Derkinderen, Malvyne/K-2406-2015; Henrion, Daniel/J-8141-2015; guilluy, christophe/C-6002-2014; Offermanns, Stefan/L-3313-2017	Loirand, Gervaise/0000-0002-2306-3931; Henrion, Daniel/0000-0003-1094-0285; Guilluy, Christophe/0000-0003-1141-0809; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; guilluy, christophe/0000-0003-1141-0809; Offermanns, Stefan/0000-0001-8676-6805	Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-05-PCOD-015-01, ANR-08-GEN-O040-01]; Fondation pour la Recherche Medicale [20051205767]; Programme National de Recherche Maladies Cardiovasculaires; Societe Francaise d'hypertension arterielle; Centre National de la Recherche Scientifique; Institut de Recherches Servier	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Programme National de Recherche Maladies Cardiovasculaires; Societe Francaise d'hypertension arterielle; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherches Servier	The authors are grateful to K. Burridge (University of North Carolina, Chapel Hill), V. Perrot (University of Rouen) and J. Ihle (St. Jude Children's Research Hospital, Memphis) for providing us with GST-RhoA constructs, Arhgef1 and Jak2 plasmids, respectively. We thank C. Schleder, N. Vaillant and M. Rio for excellent technical assistance and the IBISA platform Cardiex for functional explorations. This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Agence Nationale de la Recherche (ANR-05-PCOD-015-01 and ANR-08-GEN-O040-01), the Fondation pour la Recherche Medicale (Dequation (20051205767)), the Programme National de Recherche Maladies Cardiovasculaires and the Societe Francaise d'hypertension arterielle (PNRC 2007), the Centre National de la Recherche Scientifique (Groupement de Recherche 2823) and the Institut de Recherches Servier.	Banes-Berceli AKL, 2007, AM J PHYSIOL-HEART C, V293, pH1291, DOI 10.1152/ajpheart.00181.2007; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chrissobolis S, 2001, CIRC RES, V88, P774, DOI 10.1161/hh0801.090441; CLINE WH, 1981, J PHARMACOL EXP THER, V216, P104; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; de Gasparo M, 2000, PHARMACOL REV, V52, P415; FALCON JC, 1978, AM J PHYSIOL, V235, pH392, DOI 10.1152/ajpheart.1978.235.4.H392; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; FERRARIO CM, 1979, HYPERTENSION, V1, P235, DOI 10.1161/01.HYP.1.3.235; Frank GD, 2002, MOL ENDOCRINOL, V16, P367, DOI 10.1210/me.16.2.367; FUJII AM, 1985, HYPERTENSION, V7, P253, DOI 10.1161/01.HYP.7.2.253; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kataoka C, 2002, HYPERTENSION, V39, P245, DOI 10.1161/hy0202.103271; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lemarie CA, 2008, J MOL MED, V86, P673, DOI 10.1007/s00109-008-0323-5; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Moriki N, 2004, HYPERTENS RES, V27, P263, DOI 10.1291/hypres.27.263; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Ohtsu H, 2008, ENDOCRINOLOGY, V149, P3569, DOI 10.1210/en.2007-1694; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; ROWE BP, 1979, PFLUG ARCH EUR J PHY, V382, P269, DOI 10.1007/BF00583712; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; RUILOPE LM, 1994, HYPERTENSION, V23, P3, DOI 10.1161/01.HYP.23.1.3; Schiffrin EL, 2006, HYPERTENSION, V47, P312, DOI 10.1161/01.HYP.0000201443.63240.a7; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shaw S, 2003, J BIOL CHEM, V278, P30634, DOI 10.1074/jbc.M305008200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666	50	174	183	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					183	U89		10.1038/nm.2079	http://dx.doi.org/10.1038/nm.2079			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20098430				2022-12-25	WOS:000274297000039
J	Jones, KT				Jones, Keith T.			Cohesin and Cdk1: an anaphase barricade	NATURE CELL BIOLOGY			English	Editorial Material							PROTEIN PHOSPHATASE 2A; CHROMOSOMES; ASSOCIATION; CHECKPOINT; MEIOSIS; MITOSIS; KINASE	Separation of sister chromatids at anaphase in metazoan cells requires only the cleavage of the kleisin subunit of centromeric cohesin, but efficient poleward movement of separated sisters requires the associated loss in Cdk1 activity. Activation of the anaphase-promoting complex/cyclosome ensures these events are coordinated.	Univ Newcastle, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia	University of Newcastle	Jones, KT (corresponding author), Univ Newcastle, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia.	keith.jones@newcastle.edu.au	Jones, Keith/AAA-3479-2021; Jones, Keith/C-9821-2013	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851				Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NASMYTH K, 2009, ANNU REV GENET, V525, P558; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712	16	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					106	U14		10.1038/ncb0210-106	http://dx.doi.org/10.1038/ncb0210-106			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20118997				2022-12-25	WOS:000274139400004
J	Muoio, D; Vidal-Puig, A; Nair, KS; Ravussin, E				Muoio, Debbie; Vidal-Puig, Antonio; Nair, K. Sreekumaran; Ravussin, Eric			Burning fat not so sweet	NATURE MEDICINE			English	Editorial Material									[Muoio, Debbie] Duke Univ, Stedman Ctr, Durham, NC 27706 USA; [Vidal-Puig, Antonio] Univ Cambridge, Cambridge, England; [Nair, K. Sreekumaran] Mayo Clin, Rochester, MN USA; [Ravussin, Eric] Pennington Biomed Res Ctr, Nutr Obes Res Ctr, Baton Rouge, LA USA	Duke University; University of Cambridge; Mayo Clinic; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Muoio, D (corresponding author), Duke Univ, Stedman Ctr, Durham, NC 27706 USA.		Ravussin, Eric/N-1985-2017	Ravussin, Eric/0000-0003-2129-547X				Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008	1	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					169	169		10.1038/nm0210-169	http://dx.doi.org/10.1038/nm0210-169			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20134471	Bronze			2022-12-25	WOS:000274297000035
J	Zhao, YF; Quick, M; Shi, L; Mehler, EL; Weinstein, H; Javitch, JA				Zhao, Yongfang; Quick, Matthias; Shi, Lei; Mehler, Ernest L.; Weinstein, Harel; Javitch, Jonathan A.			Substrate-dependent proton antiport in neurotransmitter:sodium symporters	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; TRANSPORT PROTEINS; BACTERIAL HOMOLOG; SODIUM SYMPORTER; IONIZABLE GROUPS; ACID-TRANSPORT; BINDING-SITE; MECHANISM; NA+	Neurotransmitter-sodium symporters (NSS), targets for psychostimulants and therapeutic drugs, have a critical role in-neurotransmission. Whereas eukaryotic NSS show chloride-dependent transport, bacterial NSS feature Cl--independent-substrate transport. Recently we showed that mutation of an acidic residue near one of the sodium ion-binding sites in LeuT of Aquifex aeolicus or Tyt1 of Fusobacterium nucleatum renders substrate binding and/or transport Cl-dependent. We reasoned that the negative charge-provided either by Cl-or by the transporter itself-is required for substrate translocation. Here we show that Tyt1 reconstituted in proteoliposomes is strictly dependent on the Na+ gradient and is stimulated by an inside-negative membrane potential and by an inversely oriented proton gradient. Notably, Na+/substrate symport elicited H+ efflux, indicative of Na+/substrate symport-coupled H+ antiport. Mutations that render the transport phenotype Cl(-)dependent-essentially-abolish the pH dependence. We propose unifying features of charge balance by all NSS members with similar mechanistic features but different molecular solutions.	[Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Shi, Lei; Mehler, Ernest L.; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	jaj2@columbia.edu	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020; Zhao, Yongfang/B-5437-2010	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967	US National Institutes of Health [DA022413, DA17293, P01 DA012923, DA015170, K99 DA023694]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015170, K99DA023694, R01DA017293, K05DA022413, P01DA012923] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Kanner for helpful discussion, M. A. Gawinovicz of the Columbia University Medical Center Protein Core Facility for the MALDI-TOF analysis of Tyt1 and L. Chung for technical assistance. Computations were performed on the Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported by US National Institutes of Health grants DA022413 and DA17293 (J. A. J.), P01 DA012923 (H. W.), DA015170 (E. L. M.) and K99 DA023694 (L. S.).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; GU H, 1994, J BIOL CHEM, V269, P7124; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hall JA, 2007, J BACTERIOL, V189, P880, DOI 10.1128/JB.01452-06; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; Loo DDF, 2005, J GEN PHYSIOL, V125, P13, DOI 10.1085/jgp.200409150; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Mehler EL, 1999, BIOPHYS J, V77, P3, DOI 10.1016/S0006-3495(99)76868-2; Mitchell P., 1963, BIOCHEM SOC SYMP, V22, P142; Norregaard L, 2001, Curr Opin Drug Discov Devel, V4, P591; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Rudnick Gary, 2002, P25; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	44	41	42	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					109	116		10.1038/NCHEMBIO.284	http://dx.doi.org/10.1038/NCHEMBIO.284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081826	Green Accepted			2022-12-25	WOS:000273651700010
J	Bekker-Jensen, S; Danielsen, JR; Fugger, K; Gromova, I; Nerstedt, A; Bartek, J; Lukas, J; Mailand, N				Bekker-Jensen, Simon; Danielsen, Jannie Rendtlew; Fugger, Kasper; Gromova, Irina; Nerstedt, Annika; Bartek, Jiri; Lukas, Jiri; Mailand, Niels			HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes	NATURE CELL BIOLOGY			English	Article							LARGE PROTEIN; UBC13; ORGANIZATION; DEFICIENT; RECOVERY	Regulatory ubiquitylation is emerging as an important mechanism to protect genome integrity in cells exposed to DNA damage(1-9). However, the spectrum of known ubiquitin regulators of the DNA damage response (DDR) is limited and their functional interplay is poorly understood. Here, we identify HERC2 as a factor that regulates ubiquitin-dependent retention of repair proteins on damaged chromosomes. In response to ionising radiation (IR), HERC2 forms a complex with RNF8, a ubiquitin ligase involved in the DDR3-6. The HERC2-RNF8 interaction requires IR-inducible phosphorylation of HERC2 at Thr 4827, which in turn binds to the forkhead-associated (FHA) domain of RNF8. Mechanistically, we provide evidence that HERC2 facilitates assembly of the ubiquitin-conjugating enzyme Ubc13 with RNF8, thereby promoting DNA damage-induced formation of Lys 63-linked ubiquitin chains. We also show that HERC2 interacts with, and maintains the levels of, RNF168, another ubiquitin ligase operating downstream of RNF8 (refs 7, 8). Consequently, knockdown of HERC2 abrogates ubiquitin-dependent retention of repair factors such as 53BP1, RAP80 and BRCA1. Together with the increased radiosensitivity of HERC2-depleted cells, these results uncover a regulatory layer in the orchestration of protein interactions on damaged chromosomes and they underscore the role of ubiquitinmediated signalling in genome maintenance.	[Bekker-Jensen, Simon; Danielsen, Jannie Rendtlew; Fugger, Kasper; Nerstedt, Annika; Bartek, Jiri; Lukas, Jiri; Mailand, Niels] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Gromova, Irina] Danish Canc Soc, Inst Canc Biol, Dept Prote Canc, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; jil@cancer.dk	Fugger, Kasper/J-1231-2014; Bartek, Jiri/G-5870-2014	Fugger, Kasper/0000-0001-9811-3983; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; Gromova, Irina/0000-0003-4357-5958; Lukas, Claudia/0000-0001-7169-6883	Danish Cancer Society; Danish National Research Foundation; European Commission; Lundbeck Foundation; Danish Research Council; John and Birthe Meyer Foundation; Lundbeck Foundation [R34-2009-3790] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; Lundbeck Foundation(Lundbeckfonden)	We thank Z. Ronai and D. Durocher for reagents, and J Chen for sharing unpublished data. This work was supported by grants from the Danish Cancer Society, Danish National Research Foundation, European Commission (integrated projects GENICA and DNA Repair), Lundbeck Foundation, Danish Research Council and the John and Birthe Meyer Foundation.	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	23	214	222	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					80	U209		10.1038/ncb2008	http://dx.doi.org/10.1038/ncb2008			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20023648				2022-12-25	WOS:000272973800016
J	Campaner, S; Doni, M; Hydbring, P; Verrecchia, A; Bianchi, L; Sardella, D; Schleker, T; Perna, D; Tronnersjo, S; Murga, M; Fernandez-Capetillo, O; Barbacid, M; Larsson, LG; Amati, B				Campaner, Stefano; Doni, Mirko; Hydbring, Per; Verrecchia, Alessandro; Bianchi, Lucia; Sardella, Domenico; Schleker, Thomas; Perna, Daniele; Tronnersjo, Susanna; Murga, Matilde; Fernandez-Capetillo, Oscar; Barbacid, Mariano; Larsson, Lars-Gunnar; Amati, Bruno			Cdk2 suppresses cellular senescence induced by the c-myc oncogene	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; IN-VIVO; P53; PROLIFERATION; P16(INK4A); P27(KIP1); APOPTOSIS; LIMITS; CELLS; CYCLIN-DEPENDENT-KINASE-2	Activated oncogenes induce compensatory tumour-suppressive responses, such as cellular senescence or apoptosis, but the signals determining the main outcome remain to be fully understood(1,2). Here, we uncover a role for Cdk2 (cyclin-dependent kinase 2) in suppressing Myc-induced senescence. Short-term activation of Myc promoted cell-cycle progression(3) in either wild-type or Cdk2 knockout(4,5) mouse embryo fibroblasts (MEFs). In the knockout MEFs, however, the initial hyper-proliferative response was followed by cellular senescence. Loss of Cdk2 also caused sensitization to Myc-induced senescence in pancreatic beta-cells or splenic B-cells in vivo, correlating with delayed lymphoma onset in the latter. Cdk2(-/-) MEFs also senesced upon ectopic Wnt signalling or, without an oncogene, upon oxygen-induced culture shock(6). Myc also causes senescence in cells lacking the DNA repair protein Wrn(7). However, unlike loss of Wrn(8), loss of Cdk2 did not enhance Myc-induced replication stress, implying that these proteins suppress senescence through different routes. In MEFs, Myc-induced senescence was genetically dependent on the ARF-p53-p21(Clp1) and p16(INK4a)-pRb pathways, p21(Clp1) and p16(INK4a) being selectively induced in Cdk2(-/-) cells. Thus, although redundant for cell-cycle progression and development(4,5,9-12), Cdk2 has a unique role in suppressing oncogene- and/or stress-induced senescence(1). Pharmacological inhibition of Cdk2 induced Myc-dependent senescence in various cell types, including a p53-null human cancer cell line. Our data warrant re-assessment of Cdk2 as a therapeutic target in Myc- or Wnt-driven tumours.	[Campaner, Stefano; Doni, Mirko; Verrecchia, Alessandro; Bianchi, Lucia; Sardella, Domenico; Schleker, Thomas; Perna, Daniele; Amati, Bruno] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Hydbring, Per; Tronnersjo, Susanna; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden; [Hydbring, Per; Larsson, Lars-Gunnar] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, SE-75007 Uppsala, Sweden; [Sardella, Domenico] Cogentech, I-20139 Milan, Italy; [Murga, Matilde; Fernandez-Capetillo, Oscar] CNIO, Genom Instabil Grp, Mol Oncol Programme, Madrid 28029, Spain; [Barbacid, Mariano] CNIO, Expt Oncol Grp, Mol Oncol Programme, Madrid 28029, Spain	IRCCS European Institute of Oncology (IEO); Karolinska Institutet; Swedish University of Agricultural Sciences; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Doni, Mirko/AAN-6027-2020; Amati, Bruno/AAM-3418-2020; Verrecchia, Alessandro/AAQ-6454-2020; Murga, Matilde/B-3499-2018; Fernandez-Capetillo, Oscar/H-3508-2015; Larsson, Lars-Gunnar/D-9747-2012; Doni, Mirko/ABA-9174-2021	Verrecchia, Alessandro/0000-0002-8596-6650; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Doni, Mirko/0000-0001-7099-2701; Amati, Bruno/0000-0002-2958-1799; CAMPANER, Stefano/0000-0003-4547-6849	Italian Association for Cancer Research (AIRC); Italian Health Ministry; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; Olle Enqkvists's Foundation; Stockholm Cancer Society	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry(Ministry of Health, Italy); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation; Swedish Research Council; Olle Enqkvists's Foundation; Stockholm Cancer Society	We thank C. Gorrini, E. Guccione, A, Magnifico, G. Natoli, S. Piccolo and P.-G. Pelicci for discussions, comments and support, F. Contegno for laboratory management, A. Gobbi, M. Capillo and B. Giulini for mouse management, I. Muradore, S. Ronzoni and M. Faretta for FACS analysis, S. Volorio and S. Minardi for DNA sequencing, K. Igarashi (Hiroshima University Graduate School of Biomedical Sciences, Japan) for sharing unpublished information, F. Liu (The State University of New Jersey, USA) for antibodies, G. Evan and L. Brown-Swigart (both at the University of California, USA) for pIns-MycER<SUP>TAM</SUP> and RIP-Bcl-x<INF>L</INF> mice, J. Cleveland (The Scripps Research Institute, USA) and J.-C. Marine (VIB-UGent, Belgium) for E mu-myc mice, A. Berns for INK4a<SUP>-/-</SUP> mice (Netherlands Cancer Institute), C. Sherr and M. Roussel (both at St. Jude Children's Research Hospital, USA) for ARF<SUP>-/-</SUP> mice, and J. Zablocki at CV Therapeutics for compounds. This work was supported by grants from the Italian Association for Cancer Research (AIRC), the 'Ricerca Finalizzata' and 'Ricerca Corrente' programs of the Italian Health Ministry to B. A., and from the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, the Swedish Research Council, Olle Enqkvists's Foundation and the Stockholm Cancer Society. to L. G. L.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bahram F, 1999, BLOOD, V93, P3900, DOI 10.1182/blood.V93.11.3900.411a42_3900_3912; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Deb-Basu D, 2006, CELL CYCLE, V5, P1348, DOI 10.4161/cc.5.12.2860; Deb-Basu D, 2006, CELL CYCLE, V5, P1342, DOI 10.4161/cc.5.12.2859; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Macias E, 2007, CANCER RES, V67, P9713, DOI 10.1158/0008-5472.CAN-07-2119; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Schmitt C, 2006, BIOCHIM BIOPHYS ACTA, V1775, P5; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104	53	192	197	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					54	U132		10.1038/ncb2004	http://dx.doi.org/10.1038/ncb2004			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010815				2022-12-25	WOS:000272973800012
J	Bao, GH; Clifton, M; Hoette, TM; Mori, K; Deng, SX; Qiu, AD; Viltard, M; Williams, D; Paragas, N; Leete, T; Kulkarni, R; Li, XP; Lee, B; Kalandadze, A; Ratner, AJ; Pizarro, JC; Schmidt-Ott, KM; Landry, DW; Raymond, KN; Strong, RK; Barasch, J				Bao, Guanhu; Clifton, Matthew; Hoette, Trisha M.; Mori, Kiyoshi; Deng, Shi-Xian; Qiu, Andong; Viltard, Melanie; Williams, David; Paragas, Neal; Leete, Thomas; Kulkarni, Ritwij; Li, Xiangpo; Lee, Belinda; Kalandadze, Avtandil; Ratner, Adam J.; Pizarro, Juan Carlos; Schmidt-Ott, Kai M.; Landry, Donald W.; Raymond, Kenneth N.; Strong, Roland K.; Barasch, Jonathan			Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex	NATURE CHEMICAL BIOLOGY			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ISCHEMIA-REPERFUSION INJURY; RENAL INJURY; QUANTITATIVE-ANALYSIS; TRANSFERRIN-IRON; SIMPLE PHENOLS; HUMAN-URINE; CATECHOL; RECEPTOR; INFECTION	The lipocalins are secreted proteins that bind small organic molecules. Scn-Ngal (also known as neutrophil gelatinase associated lipocalin, siderocalin, lipocalin 2) sequesters bacterial iron chelators, called siderophores, and consequently blocks bacterial growth. However, Scn-Ngal is also prominently expressed in aseptic diseases, implying that it binds additional ligands and serves additional functions. Using chemical screens, crystallography and fluorescence methods, we report that Scn-Ngal binds iron together with a small metabolic product called catechol. The formation of the complex blocked the reactivity of iron and permitted its transport once introduced into circulation in vivo. Scn-Ngal then recycled its iron in endosomes by a pH-sensitive mechanism. As catechols derive from bacterial and mammalian metabolism of dietary compounds, the Scn-Ngal-catechol-Fe(III) complex represents an unforeseen microbial-host interaction, which mimics Scn-Ngal-siderophore interactions but instead traffics iron in aseptic tissues. These results identify an endogenous siderophore, which may link the disparate roles of Scn-Ngal in different diseases.	[Bao, Guanhu; Deng, Shi-Xian; Qiu, Andong; Viltard, Melanie; Williams, David; Paragas, Neal; Leete, Thomas; Kulkarni, Ritwij; Li, Xiangpo; Lee, Belinda; Kalandadze, Avtandil; Ratner, Adam J.; Landry, Donald W.; Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; [Clifton, Matthew; Pizarro, Juan Carlos; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Hoette, Trisha M.; Raymond, Kenneth N.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hoette, Trisha M.; Raymond, Kenneth N.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Schmidt-Ott, Kai M.] Max Delbruck Ctr Mol Med, Berlin, Germany	Columbia University; Fred Hutchinson Cancer Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Kyoto University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Barasch, J (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.	rstrong@fhcrc.org; jmb4@columbia.edu	Bao, Guan-Hu/ABG-8217-2020; Schmidt-Ott, Kai/F-4588-2011; Qiu, Andong/AAY-1179-2021; Bao, Guan-Hu/N-6296-2019; Mori, Kiyoshi/N-1267-2014	Schmidt-Ott, Kai/0000-0002-7700-7142; Bao, Guan-Hu/0000-0003-4336-5678; Mori, Kiyoshi/0000-0002-7285-8351; Paragas, Neal/0000-0001-6084-8220; Ratner, Adam/0000-0003-1761-794X; Leete, Thomas/0000-0001-8655-1476	US National Institutes of Health [AI117448, AI59432, DK-55388, DK-58872]; Emerald Foundation; March of Dimes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059432, R01AI011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073462, P01DK055388, R01DK058872] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; March of Dimes(March of Dimes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Abergel, A. Zawadzka and Q. Al-Awqati for helpful discussion. We are grateful to the Gordon lab (Washington University) for gnotobiotic urines and E. I. Christensen (Aarhus University) and T. E. Willnow (Max Delbruck Center for Molecular Medicine) for megalin knockout urines. We salute the classes of 2010 and 2013 of the College of Physicians and Surgeons of Columbia University for donating urine for this study. This work was supported by US National Institutes of Health grants AI117448 (K.N.R.), AI59432 (R.K.S.) and the Emerald Foundation, the March of Dimes and US National Institutes of Health grants DK-55388 and DK-58872 (J.B.).	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Anderson MT, 2008, J BACTERIOL, V190, P3940, DOI 10.1128/JB.00086-08; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAKKE OM, 1969, J NUTR, V98, P209, DOI 10.1093/jn/98.2.209; BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; BOOTH AN, 1960, NATURE, V187, P691, DOI 10.1038/187691a0; CARMELLA SG, 1982, FOOD CHEM TOXICOL, V20, P587, DOI 10.1016/S0278-6915(82)80068-9; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Freestone PPE, 2007, INT J FOOD MICROBIOL, V119, P159, DOI 10.1016/j.ijfoodmicro.2007.07.039; Frisch M., 2016, GAUSSIAN 16 REVISION; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; IWAHASHI H, 1989, J BIOCHEM-TOKYO, V105, P429, DOI 10.1093/oxfordjournals.jbchem.a122681; JONES RL, 1977, NATURE, V267, P63, DOI 10.1038/267063a0; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; KARPISHIN TB, 1991, J AM CHEM SOC, V113, P2977, DOI 10.1021/ja00008a028; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lang R, 2006, J AGR FOOD CHEM, V54, P5755, DOI 10.1021/jf061118n; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li JY, 2004, AM J PHYSIOL-CELL PH, V287, pC1547, DOI 10.1152/ajpcell.00260.2004; Marrubini G, 2005, CHROMATOGRAPHIA, V62, P25, DOI 10.1365/s10337-005-0570-3; MARTIN AK, 1982, BRIT J NUTR, V48, P497, DOI 10.1079/BJN19820135; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; PALLER MS, 1988, KIDNEY INT, V34, P474, DOI 10.1038/ki.1988.205; PARKE DV, 1953, BIOCHEM J, V55, P337, DOI 10.1042/bj0550337; Qu QS, 2000, AM J IND MED, V37, P522, DOI 10.1002/(SICI)1097-0274(200005)37:5<522::AID-AJIM8>3.0.CO;2-G; RENNICK B, 1970, AM J PHYSIOL, V218, P1307, DOI 10.1152/ajplegacy.1970.218.5.1307; Richardson DR, 2005, CELL, V123, P1175, DOI 10.1016/j.cell.2005.12.008; Rodriguez J, 2001, WATER SCI TECHNOL, V44, P251, DOI 10.2166/wst.2001.0299; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sanchez P, 2005, DALTON T, P811, DOI 10.1039/b416669h; SAWAHATA T, 1983, MOL PHARMACOL, V23, P453; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; SMITH AA, 1961, NATURE, V190, P167, DOI 10.1038/190167a0; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; ZAGER RA, 1992, J CLIN INVEST, V90, P711, DOI 10.1172/JCI115942	48	223	233	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					602	609		10.1038/NCHEMBIO.402	http://dx.doi.org/10.1038/NCHEMBIO.402			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20581821	Green Accepted			2022-12-25	WOS:000280096600011
J	Heineke, J; Auger-Messier, M; Correll, RN; Xu, JA; Benard, MJ; Yuan, WP; Drexler, H; Parise, LV; Molkentin, JD				Heineke, Joerg; Auger-Messier, Mannix; Correll, Robert N.; Xu, Jian; Benard, Matthew J.; Yuan, Weiping; Drexler, Helmut; Parise, Leslie V.; Molkentin, Jeffery D.			CIB1 is a regulator of pathological cardiac hypertrophy	NATURE MEDICINE			English	Article							CALCIUM-BINDING PROTEIN; MUSCLE LIM PROTEIN; CALCINEURIN B; HEART; IDENTIFICATION; ACTIVATION; EXPRESSION; INTERACTS; DISEASE; ADHESION	Hypertrophic heart disease is a leading health problem in Western countries. Here we identified the small EF hand domain-containing protein Ca2+ and integrin-binding protein-1 (CIB1) in a screen for previously unknown regulators of cardiomyocyte hypertrophy. Yeast two-hybrid screening for CIB1-interacting partners identified a related EF hand domain-containing protein, calcineurin B, the regulatory subunit of the prohypertrophic protein phosphatase calcineurin. CIB1 localizes primarily to the sarcolemma in mouse and human myocardium, where it anchors calcineurin to control its activation in coordination with the L-type Ca2+ channel. CIB1 protein amounts and membrane association were enhanced in cardiac pathological hypertrophy, but not in physiological hypertrophy. Consistent with these observations, Cib1-deleted mice showed a marked reduction in myocardial hypertrophy, fibrosis, cardiac dysfunction and calcineurin-nuclear factor of activated T cells (NFAT) activity after pressure overload, whereas the degree of physiologic hypertrophy after swimming exercise was not altered. Transgenic mice with inducible and cardiac-specific overexpression of CIB1 showed enhanced cardiac hypertrophy in response to pressure overload or calcineurin signaling. Moreover, mice lacking Ppp3cb (encoding calcineurin A, beta isozyme) showed no enhancement in cardiac hypertrophy associated with CIB1 overexpression. Thus, CIB1 functions as a previously undescribed regulator of cardiac hypertrophy through its ability to regulate the association of calcineurin with the sarcolemma and its activation.	[Heineke, Joerg; Auger-Messier, Mannix; Correll, Robert N.; Xu, Jian; Benard, Matthew J.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Heineke, Joerg; Drexler, Helmut] Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany; [Yuan, Weiping; Parise, Leslie V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Hannover Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Heineke.Joerg@mh-hannover.de; jeff.molkentin@cchmc.org	Xu, Jian/AAE-1415-2019	Molkentin, Jeffery/0000-0002-3558-6529	US National Institutes of Health; Howard Hughes Medical Institute; Fondation Leducq; Deutsche Forschungsgemeinschaft, Bonn, Germany [HE 3658/1-1]; Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft); National Institutes of Health [5 T32 HL07382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL062927] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondation Leducq(Leducq Foundation); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the US National Institutes of Health (J.D.M. and L.V.P.) and the Howard Hughes Medical Institute (J.D.M.) and by the Fondation Leducq (J.D.M. and H.D.). J.H. was supported in part by a grant from the Deutsche Forschungsgemeinschaft, Bonn, Germany (HE 3658/1-1) and the Cluster of Excellence Rebirth (also Deutsche Forschungsgemeinschaft). M.J.B. was supported by National Institutes of Health training grant 5 T32 HL07382 (principal investigator A. Schwartz).	Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hager M, 2008, J BIOL CHEM, V283, P24760, DOI 10.1074/jbc.M801166200; Haq S, 2001, CIRCULATION, V103, P670; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Heineke J, 2003, CIRCULATION, V107, P1424, DOI 10.1161/01.CIR.0000055319.94801.FC; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Iida T, 2008, BIOCHEM BIOPH RES CO, V375, P655, DOI 10.1016/j.bbrc.2008.08.090; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Jernigan NL, 2008, AM J PHYSIOL-HEART C, V294, pH409, DOI 10.1152/ajpheart.00571.2007; Kabaeva Z, 2008, AM J PHYSIOL-HEART C, V294, pH1667, DOI 10.1152/ajpheart.01144.2007; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li W, 2002, BBA-PROTEINS PROTEOM, V1599, P72, DOI 10.1016/S1570-9639(02)00402-8; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; POLITINO M, 1990, J BIOL CHEM, V265, P7619; POLITINO M, 1987, J BIOL CHEM, V262, P10109; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saito T, 1999, MAMM GENOME, V10, P315, DOI 10.1007/s003359900994; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Vila-Carriles WH, 2007, J BIOL CHEM, V282, P34381, DOI 10.1074/jbc.M705354200; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zhu JS, 2004, EXP CELL RES, V300, P440, DOI 10.1016/j.yexcr.2004.07.020	48	75	85	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					872	U68		10.1038/nm.2181	http://dx.doi.org/10.1038/nm.2181			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20639889	Green Accepted, Green Submitted			2022-12-25	WOS:000280649200026
J	Martinez, P; Thanasoula, M; Carlos, AR; Gomez-Lopez, G; Tejera, AM; Schoeftner, S; Dominguez, O; Pisano, DG; Tarsounas, M; Blasco, MA				Martinez, Paula; Thanasoula, Maria; Carlos, Ana R.; Gomez-Lopez, Gonzalo; Tejera, Agueda M.; Schoeftner, Stefan; Dominguez, Orlando; Pisano, David G.; Tarsounas, Madalena; Blasco, Maria A.			Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; PROTEIN; YEAST; COMPLEX; LENGTH; MICE; TRF2; MUTATIONS; RNA; HETEROCHROMATIN	Rap1 is a component of the shelterin complex at mammalian telomeres, but its in vivo role in telomere biology has remained largely unknown to date. Here we show that Rap1 deficiency is dispensable for telomere capping but leads to increased telomere recombination and fragility. We generated cells and mice deleted for Rap1; mice with Rap1 deletion in stratified epithelia were viable but had shorter telomeres and developed skin hyperpigmentation in adulthood. By performing chromatin immunoprecipitation coupled with ultrahigh-throughput sequencing, we found that Rap1 binds to both telomeres and to extratelomeric sites through the (TTAGGG)(2) consensus motif. Extratelomeric Rap1-binding sites were enriched at subtelomeric regions, in agreement with preferential deregulation of subtelomeric genes in Rap1-deficient cells. More than 70% of extratelomeric Rap1-binding sites were in the vicinity of genes, and 31% of the genes deregulated in Rap1-null cells contained Rap1-binding sites, suggesting a role for Rap1 in transcriptional control. These findings place a telomere protein at the interface between telomere function and transcriptional regulation.	[Martinez, Paula; Tejera, Agueda M.; Schoeftner, Stefan; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Thanasoula, Maria; Carlos, Ana R.; Tarsounas, Madalena] CR UK MRC Gray Inst Radiat Oncol & Biol, Telomere & Genome Stabil Grp, Oxford OX3 7DQ, England; [Gomez-Lopez, Gonzalo; Pisano, David G.] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Program, Bioinformat Core Unit, E-28029 Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Biotechnol Program, Genom Core Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Tejera, Agueda/Z-1938-2019; Blasco, Maria A./M-1694-2014; Tejera, Agueda/L-1946-2015; Gomez-Lopez, Gonzalo/D-9123-2016; Tejera, Agueda M./AAU-2000-2021; Carlos, Ana Rita/K-6014-2019; Carlos, Ana Rita/N-1137-2016; Pisano, David/N-5817-2014; Dominguez, Orlando/M-7515-2018	Blasco, Maria A./0000-0002-4211-233X; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Carlos, Ana Rita/0000-0002-6953-1163; Carlos, Ana Rita/0000-0002-6953-1163; Pisano, David/0000-0002-4895-4124; SCHOEFTNER, Stefan/0000-0002-8918-6627; Tejera, Agueda M/0000-0002-6703-9466	Spanish Ministry of Innovation and Science; European Union; European Research Council (ERC); Spanish Association Against Cancer (AECC); Korber European Science Award; Cancer Research UK	Spanish Ministry of Innovation and Science(Spanish Government); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Association Against Cancer (AECC); Korber European Science Award; Cancer Research UK(Cancer Research UK)	We are indebted to L. Harrington for Tert-deficient MEFs; S. West for Rap1 antibodies; and R. Serrano for animal care. P.M. is funded by a 'Ramon y Cajal' grant from the Spanish Ministry of Innovation and Science. M.A.B.'s laboratory is funded by the Spanish Ministry of Innovation and Science, the European Union (FP7-Genica, Telomarker), the European Research Council (ERC Advance Grants), the Spanish Association Against Cancer (AECC) and a Korber European Science Award to M.A.B. The work in MT's laboratory is funded by Cancer Research UK.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Crowley VEE, 2002, NAT REV DRUG DISCOV, V1, P276, DOI 10.1038/nrd770; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Glez-Pena D, 2009, NUCLEIC ACIDS RES, V37, pW329, DOI 10.1093/nar/gkp263; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LONG JD, 2009, WORLDVIEWS IN PRESS; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mignon-Ravix C, 2002, EUR J HUM GENET, V10, P107, DOI 10.1038/sj.ejhg.5200775; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2009, P NATL ACAD SCI USA, V106, P19387, DOI 10.1073/pnas.0909265106; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tan M, 2003, GENE, V323, P1, DOI 10.1016/j.gene.2003.08.026; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048	68	175	181	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					768	U28		10.1038/ncb2081	http://dx.doi.org/10.1038/ncb2081			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622869	Green Accepted			2022-12-25	WOS:000280561600009
J	Dishinger, JF; Kee, HL; Jenkins, PM; Fan, SL; Hurd, TW; Hammond, JW; Truong, YNT; Margolis, B; Martens, JR; Verhey, KJ				Dishinger, John F.; Kee, Hooi Lynn; Jenkins, Paul M.; Fan, Shuling; Hurd, Toby W.; Hammond, Jennetta W.; Truong, Yen Nhu-Thi; Margolis, Ben; Martens, Jeffrey R.; Verhey, Kristen J.			Ciliary entry of the kinesin-2 motor KIF17 is regulated by importin-beta 2 and RanGTP	NATURE CELL BIOLOGY			English	Article							INTRAFLAGELLAR TRANSPORT MOTORS; OLFACTORY SENSORY CILIA; SMALL MOLECULES; RAN/TC4 GTPASE; PROTEIN; LOCALIZATION; MEMBRANE; CELLS; DISEASE; CILIOPATHIES	The biogenesis, maintenance and function of primary cilia are controlled through intraflagellar transport (IFT) driven by two kinesin-2 family members, the heterotrimeric KIF3A/KIF3B/KAP complex and the homodimeric KIF17 motor(1,2). How these motors and their cargoes gain access to the ciliary compartment is poorly understood. Here, we identify a ciliary localization signal (CLS) in the KIF17 tail domain that is necessary and sufficient for ciliary targeting. Similarities between the CLS and classic nuclear localization signals (NLSs) suggest that similar mechanisms regulate nuclear and ciliary import. We hypothesize that ciliary targeting of KIF17 is regulated by a ciliary-cytoplasmic gradient of the small GTPase Ran, with high levels of GTP-bound Ran (RanGTP) in the cilium. Consistent with this, cytoplasmic expression of GTP-locked Ran(G19V) disrupts the gradient and abolishes ciliary entry of KIF17. Furthermore, KIF17 interacts with the nuclear import protein importin-beta 2 in a manner dependent on the CLS and inhibited by RanGTP. We propose that Ran has a global role in regulating cellular compartmentalization by controlling the shuttling of cytoplasmic proteins into nuclear and ciliary compartments.	[Dishinger, John F.; Kee, Hooi Lynn; Hammond, Jennetta W.; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Jenkins, Paul M.; Truong, Yen Nhu-Thi; Martens, Jeffrey R.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Fan, Shuling; Margolis, Ben] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Margolis, Ben] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hurd, Toby W.] Univ Michigan, Sch Med, Div Paediat Nephrol, Dept Paediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823; Katsanis, Nicholas/0000-0002-2480-0171; Hammond, Jennetta/0000-0002-3949-1594	NIH [R01GM070862, R01GM083254, R01DC009606, R01DK084725, T32GM007767, T32DC00011]; NRSAs [F32GM089034, F31DC009524]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089034, R01GM083254, T32GM007767, R01GM070862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009606, T32DC000011, F31DC009524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSAs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants R01GM070862 and R01GM083254 (to K.J.V.), R01DC009606 (to J.R.M.), R01DK084725 (to B. M.), and T32GM007767 and T32DC00011 (to P.M.J.). Work was also supported by NRSAs F32GM089034 (to J.F.D.) and F31DC009524 (to P.M.J.). H.L.K. is supported as a Barbour Fellow at the University of Michigan. pGEX-Ran plasmids were a kind gift from Brian Burke (University of Florida) and rabbit anti-RanGTP antibody was a kind gift from Ian Macara (University of Virginia).	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; DAVIES S, 1987, J MICROSC-OXFORD, V147, P89, DOI 10.1111/j.1365-2818.1987.tb02821.x; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Luby-Phelps K, 2008, VISION RES, V48, P413, DOI 10.1016/j.visres.2007.08.022; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Morris RL, 2004, DEV BIOL, V274, P56, DOI 10.1016/j.ydbio.2004.06.017; Murrell JR, 1999, J NEUROSCI, V19, P8260; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tahara K, 2008, J CELL BIOL, V180, P493, DOI 10.1083/jcb.200708003; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	44	201	202	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					703	U164		10.1038/ncb2073	http://dx.doi.org/10.1038/ncb2073			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20526328	Green Accepted			2022-12-25	WOS:000279374400014
J	Dilts, D				Dilts, David			US cancer trials may go the way of the Oldsmobile	NATURE MEDICINE			English	Editorial Material								Cancer clinical trials in the US are at a major crossroads. Current government-sponsored research is some of the best in the world, but the field shares a worrying number of similarities with the American auto industry in its heyday. For clinical research to survive, the field must transform itself now to prevent a similar decline.	Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Management Res Healthcare, Portland, OR 97201 USA	Oregon Health & Science University	Dilts, D (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Management Res Healthcare, Portland, OR 97201 USA.							ADAMS W, 2004, BIGNESS COMPLEX, V52; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; DILTS DM, 2010, J CLIN CANC RES, DOI DOI 10.1158/1078-0432.CCR-10-1273; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; *I MED, 2010, NAT CANC CLIN TRIAL; *OP EFF WORK GROUP, 2010, COMPR TIM CANC CLIN	7	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					632	632		10.1038/nm0610-632	http://dx.doi.org/10.1038/nm0610-632			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526311	Bronze			2022-12-25	WOS:000278394200022
J	Nakano, A; Kato, H; Watanabe, T; Min, KD; Yamazaki, S; Asano, Y; Seguchi, O; Higo, S; Shintani, Y; Asanuma, H; Asakura, M; Minamino, T; Kaibuchi, K; Mochizuki, N; Kitakaze, M; Takashima, S				Nakano, Atsushi; Kato, Hisakazu; Watanabe, Takashi; Min, Kyung-Duk; Yamazaki, Satoru; Asano, Yoshihiro; Seguchi, Osamu; Higo, Shuichiro; Shintani, Yasunori; Asanuma, Hiroshi; Asakura, Masanori; Minamino, Tetsuo; Kaibuchi, Kozo; Mochizuki, Naoki; Kitakaze, Masafumi; Takashima, Seiji			AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation	NATURE CELL BIOLOGY			English	Article							PROTEIN; LKB1; POLARITY; ENDS	AMP-activated protein kinase ( AMPK) is an energy-sensing Ser/Thr protein kinase originally shown to be regulated by AMP(1). AMPK is activated by various cellular stresses that inhibit ATP production or stimulate ATP consumption(2). In addition to its role in metabolism, AMPK has recently been reported to reshape cells by regulating cell polarity and division(3-6). However, the downstream targets of AMPK that participate in these functions have not been fully identified. Here, we show that phosphorylation of the microtubule plus end protein CLIP-170 by AMPK is required for microtubule dynamics and the regulation of directional cell migration. Both inhibition of AMPK and expression of a non-phosphorylatable CLIP-170 mutant resulted in prolonged and enhanced accumulation of CLIP-170 at microtubule tips, and slower tubulin polymerization. Furthermore, inhibition of AMPK impaired microtubule stabilization and perturbed directional cell migration. All of these phenotypes were rescued by expression of a phosphomimetic CLIP-170 mutant. Our results demonstrate, therefore, that AMPK controls basic cellular functions by regulating microtubule dynamics through CLIP-170 phosphorylation.	[Kato, Hisakazu; Min, Kyung-Duk; Asano, Yoshihiro; Higo, Shuichiro; Shintani, Yasunori; Minamino, Tetsuo; Takashima, Seiji] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakano, Atsushi; Min, Kyung-Duk; Yamazaki, Satoru; Seguchi, Osamu; Asanuma, Hiroshi; Asakura, Masanori; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Div Cardiovasc Med, Osaka 5658565, Japan; [Mochizuki, Naoki] Natl Cardiovasc Ctr, Dept Struct Anal, Res Inst Suita, Osaka 5658565, Japan; [Nakano, Atsushi; Kato, Hisakazu; Asano, Yoshihiro; Takashima, Seiji] Osaka Univ, Dept Mol Cardiol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Watanabe, Takashi] Nagoya Univ, Grad Sch Med, Inst Adv Res, Aichi 4668550, Japan; [Watanabe, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Aichi 4668550, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; Nagoya University; Nagoya University	Takashima, S (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takasima@medone.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Shintani, Yasunori/0000-0001-9579-0727; Watanabe, Takashi/0000-0002-9015-5246	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical Association	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical Association	We thank M. Amano and S. Fukuhara for helpful discussions, and M. Koyama (Olympus Corporation) for technical advice regarding microscopy. This research was supported by: a Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Japan Heart Foundation; grants from the Japan Cardiovascular Research Foundation; a grant from the Japan Society for the Promotion of Science; a grant from the Mochida Memorial Foundation for Medical Association.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; RICKARD JE, 1990, J CELL BIOL, V110, P1623, DOI 10.1083/jcb.110.5.1623; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Watts JL, 2000, DEVELOPMENT, V127, P1467; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	25	151	154	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					583	U139		10.1038/ncb2060	http://dx.doi.org/10.1038/ncb2060			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20495555				2022-12-25	WOS:000278213400010
J	Rissin, DM; Kan, CW; Campbell, TG; Howes, SC; Fournier, DR; Song, L; Piech, T; Patel, PP; Chang, L; Rivnak, AJ; Ferrell, EP; Randall, JD; Provuncher, GK; Walt, DR; Duffy, DC				Rissin, David M.; Kan, Cheuk W.; Campbell, Todd G.; Howes, Stuart C.; Fournier, David R.; Song, Linan; Piech, Tomasz; Patel, Purvish P.; Chang, Lei; Rivnak, Andrew J.; Ferrell, Evan P.; Randall, Jeffrey D.; Provuncher, Gail K.; Walt, David R.; Duffy, David C.			Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations	NATURE BIOTECHNOLOGY			English	Article							PROSTATE-SPECIFIC ANTIGEN; ULTRASENSITIVE DETECTION; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; ALZHEIMERS-DISEASE; FEMTOLITER ARRAYS; DETECTION LIMITS; IMMUNO-PCR; SENSITIVITY; BIOMARKERS	The ability to detect single protein molecules(1,2) in blood could accelerate the discovery and use of more sensitive diagnostic biomarkers. To detect low-abundance proteins in blood, we captured them on microscopic beads decorated with specific antibodies and then labeled the immunocomplexes (one or zero labeled target protein molecules per bead) with an enzymatic reporter capable of generating a fluorescent product. After isolating the beads in 50-fl reaction chambers designed to hold only a single bead, we used fluorescence imaging to detect single protein molecules. Our single-molecule enzyme-linked immunosorbent assay (digital ELISA) approach detected as few as similar to 10-20 enzyme-labeled complexes in 100 mu l of sample (similar to 10(-19) M) and routinely allowed detection of clinically relevant proteins in serum at concentrations (<10(-15) M) much lower than conventional ELISA(3-5). Digital ELISA detected prostate-specific antigen (PSA) in sera from patients who had undergone radical prostatectomy at concentrations as low as 14 fg/ml (0.4 fM). (C) 2010 Nature America, Inc. All rights reserved.	[Rissin, David M.; Kan, Cheuk W.; Campbell, Todd G.; Howes, Stuart C.; Fournier, David R.; Song, Linan; Piech, Tomasz; Patel, Purvish P.; Chang, Lei; Rivnak, Andrew J.; Ferrell, Evan P.; Randall, Jeffrey D.; Provuncher, Gail K.; Duffy, David C.] Quanterix Corp, Cambridge, MA USA; [Walt, David R.] Tufts Univ, Dept Chem, Medford, MA 02155 USA	Tufts University	Duffy, DC (corresponding author), Quanterix Corp, Cambridge, MA USA.	dduffy@quanterix.com			National Cancer Institute [R43CA133987]; NATIONAL CANCER INSTITUTE [R44CA133987, R43CA133987] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported by Award Number R43CA133987 from the National Cancer Institute.	Adler M, 2008, ANALYST, V133, P702, DOI 10.1039/b718587c; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Bao YP, 2006, ANAL CHEM, V78, P2055, DOI 10.1021/ac051798d; Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN; Bock JL, 2004, ARCH PATHOL LAB MED, V128, P341; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; de Jong D, 2007, CLIN CHEM LAB MED, V45, P1421, DOI 10.1515/CCLM.2007.320; Fan R, 2008, NAT BIOTECHNOL, V26, P1373, DOI 10.1038/nbt.1507; Ferguson RA, 1996, CLIN CHEM, V42, P675; Galasko D, 2005, J ALZHEIMERS DIS, V8, P339; Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Gorris HH, 2007, P NATL ACAD SCI USA, V104, P17680, DOI 10.1073/pnas.0705411104; GOSLING JP, 1990, CLIN CHEM, V36, P1408; JACKSON TM, 1986, J IMMUNOL METHODS, V87, P13, DOI 10.1016/0022-1759(86)90338-8; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Pantano P, 1996, CHEM MATER, V8, P2832, DOI 10.1021/cm9603314; Rissin DM, 2008, J AM CHEM SOC, V130, P5349, DOI 10.1021/ja711414f; Rissin DM, 2006, J AM CHEM SOC, V128, P6286, DOI 10.1021/ja058425e; Rissin DM, 2006, ANAL CHIM ACTA, V564, P34, DOI 10.1016/j.aca.2005.10.012; Rissin DM, 2006, NANO LETT, V6, P520, DOI 10.1021/nl060227d; Srinivas PR, 2001, LANCET ONCOL, V2, P698, DOI 10.1016/S1470-2045(01)00560-5; Tan WH, 1997, ANAL CHEM, V69, P4242, DOI 10.1021/ac970631k; Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x; Thaxton CS, 2009, P NATL ACAD SCI USA, V106, P18437, DOI 10.1073/pnas.0904719106; Todd J, 2007, CLIN CHEM, V53, P1990, DOI 10.1373/clinchem.2007.091181; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Wild D., 2005, IMMUNOASSAY HDB; Zhang HQ, 2007, ANALYST, V132, P724, DOI 10.1039/b704256f	30	1184	1259	47	817	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2010	28	6					595	599		10.1038/nbt.1641	http://dx.doi.org/10.1038/nbt.1641			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	611MS	20495550	Green Accepted			2022-12-25	WOS:000278820200023
J	Chambers, JC; Zhang, WH; Lord, GM; van der Harst, P; Lawlor, DA; Sehmi, JS; Gale, DP; Wass, MN; Ahmadi, KR; Bakker, SJL; Beckmann, J; Bilo, HJG; Bochud, M; Brown, MJ; Caulfield, MJ; Connell, JMC; Cook, HT; Cotlarciuc, I; Smith, GD; de Silva, R; Deng, GH; Devuyst, O; Dikkeschei, LD; Dimkovic, N; Dockrell, M; Dominiczak, A; Ebrahim, S; Eggermann, T; Farrall, M; Ferrucci, L; Floege, J; Forouhi, NG; Gansevoort, RT; Han, XJ; Hedblad, B; van der Heide, JJH; Hepkema, BG; Hernandez-Fuentes, M; Hypponen, E; Johnson, T; de Jong, PE; Kleefstra, N; Lagou, V; Lapsley, M; Li, Y; Loos, RJF; Luan, J; Luttropp, K; Marechal, C; Melander, O; Munroe, PB; Nordfors, L; Parsa, A; Peltonen, L; Penninx, BW; Perucha, E; Pouta, A; Prokopenko, I; Roderick, PJ; Ruokonen, A; Samani, NJ; Sanna, S; Schalling, M; Schlessinger, D; Schlieper, G; Seelen, MAJ; Shuldiner, AR; Sjogren, M; Smit, JH; Snieder, H; Soranzo, N; Spector, TD; Stenvinkel, P; Sternberg, MJE; Swaminathan, R; Tanaka, T; Ubink-Veltmaat, LJ; Uda, M; Vollenweider, P; Wallace, C; Waterworth, D; Zerres, K; Waeber, G; Wareham, NJ; Maxwell, PH; McCarthy, MI; Jarvelin, MR; Mooser, V; Abecasis, GR; Lightstone, L; Scott, J; Navis, G; Elliott, P; Kooner, JS				Chambers, John C.; Zhang, Weihua; Lord, Graham M.; van der Harst, Pim; Lawlor, Debbie A.; Sehmi, Joban S.; Gale, Daniel P.; Wass, Mark N.; Ahmadi, Kourosh R.; Bakker, Stephan J. L.; Beckmann, Jacqui; Bilo, Henk J. G.; Bochud, Murielle; Brown, Morris J.; Caulfield, Mark J.; Connell, John M. C.; Cook, H. Terence; Cotlarciuc, Ioana; Smith, George Davey; de Silva, Ranil; Deng, Guohong; Devuyst, Olivier; Dikkeschei, Lambert D.; Dimkovic, Nada; Dockrell, Mark; Dominiczak, Anna; Ebrahim, Shah; Eggermann, Thomas; Farrall, Martin; Ferrucci, Luigi; Floege, Jurgen; Forouhi, Nita G.; Gansevoort, Ron T.; Han, Xijin; Hedblad, Bo; van der Heide, Jaap J. Homan; Hepkema, Bouke G.; Hernandez-Fuentes, Maria; Hypponen, Elina; Johnson, Toby; de Jong, Paul E.; Kleefstra, Nanne; Lagou, Vasiliki; Lapsley, Marta; Li, Yun; Loos, Ruth J. F.; Luan, Jian'an; Luttropp, Karin; Marechal, Celine; Melander, Olle; Munroe, Patricia B.; Nordfors, Louise; Parsa, Afshin; Peltonen, Leena; Penninx, Brenda W.; Perucha, Esperanza; Pouta, Anneli; Prokopenko, Inga; Roderick, Paul J.; Ruokonen, Aimo; Samani, Nilesh J.; Sanna, Serena; Schalling, Martin; Schlessinger, David; Schlieper, Georg; Seelen, Marc A. J.; Shuldiner, Alan R.; Sjogren, Marketa; Smit, Johannes H.; Snieder, Harold; Soranzo, Nicole; Spector, Timothy D.; Stenvinkel, Peter; Sternberg, Michael J. E.; Swaminathan, Ramasamyiyer; Tanaka, Toshiko; Ubink-Veltmaat, Lielith J.; Uda, Manuela; Vollenweider, Peter; Wallace, Chris; Waterworth, Dawn; Zerres, Klaus; Waeber, Gerard; Wareham, Nicholas J.; Maxwell, Patrick H.; McCarthy, Mark I.; Jarvelin, Marjo-Riitta; Mooser, Vincent; Abecasis, Goncalo R.; Lightstone, Liz; Scott, James; Navis, Gerjan; Elliott, Paul; Kooner, Jaspal S.			Genetic loci influencing kidney function and chronic kidney disease	NATURE GENETICS			English	Article							OCT2	Using genome-wide association, we identify common variants at 2p12-p13, 6q26, 17q23 and 19q13 associated with serum creatinine, a marker of kidney function (P = 10(-10) to 10(-15)). Of these, rs10206899 (near NAT8, 2p12-p13) and rs4805834 (near SLC7A9, 19q13) were also associated with chronic kidney disease (P = 5.0 x 10(-5) and P = 3.6 x 10(-4), respectively). Our findings provide insight into metabolic, solute and drug-transport pathways underlying susceptibility to chronic kidney disease.	[Chambers, John C.; Zhang, Weihua; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Chambers, John C.; Zhang, Weihua; Sehmi, Joban S.; de Silva, Ranil; Kooner, Jaspal S.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Lord, Graham M.; Hernandez-Fuentes, Maria; Perucha, Esperanza] Kings Coll London, Dept Nephrol & Transplantat, London, England; [Lord, Graham M.; Hernandez-Fuentes, Maria; Perucha, Esperanza] Kings Coll London, MRC, London, England; [Lord, Graham M.; Hernandez-Fuentes, Maria; Perucha, Esperanza] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England; [Sehmi, Joban S.; de Silva, Ranil; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Gale, Daniel P.; Maxwell, Patrick H.] UCL, Div Med, London, England; [Wass, Mark N.; Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; [Ahmadi, Kourosh R.; Cotlarciuc, Ioana; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Twin Res & Genet Epidemiol Dept, London WC2R 2LS, England; [Beckmann, Jacqui] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Bochud, Murielle] CHU Vaudois, Univ Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Caulfield, Mark J.; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Connell, John M. C.; Dominiczak, Anna] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Histopathol, London, England; [Deng, Guohong] Univ London Imperial Coll Sci Technol & Med, Dept Gastroenterol & Hepatol, London, England; [Devuyst, Olivier; Marechal, Celine] Catholic Univ Louvain, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Dikkeschei, Lambert D.] Isala Clin, Zwolle, Netherlands; [Dimkovic, Nada] Zvezdara Univ, Med Ctr, Ctr Renal Dis, Belgrade, Serbia; [Dockrell, Mark; Lapsley, Marta] Epsom & St Helier Univ Hosp NHS Trust, SW Thames Inst Renal Res, Carshalton, Surrey, England; [Eggermann, Thomas; Zerres, Klaus] Rheinisch Westfael Tech Hsch Univ Hosp Aachen, Dept Human Genet, Aachen, Germany; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ferrucci, Luigi; Tanaka, Toshiko] NIA, Clin Res Branch, Longitudinal Studies Sect, Baltimore, MD 21224 USA; [Floege, Jurgen; Schlieper, Georg] RWTH Univ Hosp Aachen, Dept Nephrol & Clin Immunol, Aachen, Germany; [Forouhi, Nita G.; Loos, Ruth J. F.; Luan, Jian'an; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge, England; [Gansevoort, Ron T.; Seelen, Marc A. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Han, Xijin; Li, Yun; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hedblad, Bo; Melander, Olle; Sjogren, Marketa] Lund Univ, Dept Clin Sci, Malmo, Sweden; [van der Heide, Jaap J. Homan] Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [Hepkema, Bouke G.] Univ Med Ctr Groningen, Dept Transplantat Immunol, NL-9713 AV Groningen, Netherlands; [Hypponen, Elina] UCL, Inst Child Hlth, Ctr Epidemiol Child Hlth, London, England; [Johnson, Toby] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Johnson, Toby] Swiss Inst Bioinformat, Lausanne, Switzerland; [de Jong, Paul E.; Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Lagou, Vasiliki; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Luttropp, Karin; Nordfors, Louise] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden; [Parsa, Afshin] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Peltonen, Leena] Biomedicum Helsinki 2U, Nord European Mol Biol Lab EMBL Partnership Mol M, Inst Mol Med Finland, Helsinki, Finland; [Peltonen, Leena] Univ Helsinki, Helsinki, Finland; [Peltonen, Leena; Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Helsinki, Finland; [Penninx, Brenda W.; Smit, Johannes H.] Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med EMGO, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Prokopenko, Inga; McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Prokopenko, Inga; McCarthy, Mark I.] Oxford NIHR Biomed Res Ctr, Oxford, England; [Roderick, Paul J.] Univ Southampton, Southampton, Hants, England; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, Inst Clin Med, Oulu, Finland; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Leicester, Leics, England; [Sanna, Serena; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Schalling, Martin] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden; [Schlessinger, David] NIA, Genet Lab, US Natl Inst Hlth Biomed Res Ctr, Baltimore, MD 21224 USA; [Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Stenvinkel, Peter] Karolinska Univ Hosp Huddinge, Div Renal Med K56, Stockholm, Sweden; [Swaminathan, Ramasamyiyer] Guys & St Thomas Hosp Trust, London, England; [Vollenweider, Peter; Waeber, Gerard] Univ Lausanne, Univ Hosp Ctr, Dept Internal Med, Lausanne, Switzerland; [Wallace, Chris] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Waterworth, Dawn; Mooser, Vincent] GlaxoSmithKline, Clin Pharmacol & Discovery Med, Med Genet, King Of Prussia, PA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Lightstone, Liz] Univ London Imperial Coll Sci Technol & Med, Div Med, Renal Sect, London, England; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, HPA Ctr Environm & Hlth,MRC, London, England	Imperial College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of Bristol; University of London; University College London; Imperial College London; University of London; King's College London; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Queen Mary University London; University of Glasgow; Imperial College London; Imperial College London; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Isala Clinics; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); RWTH Aachen University; RWTH Aachen University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Groningen; University of Michigan System; University of Michigan; Lund University; University of Groningen; University of Groningen; University of London; University College London; University of Lausanne; Swiss Institute of Bioinformatics; Langerhans Medical Research Group; University of Groningen; Karolinska Institutet; Karolinska University Hospital; University System of Maryland; University of Maryland Baltimore; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Oulu; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Southampton; University of Oulu; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore; Karolinska Institutet; Karolinska University Hospital; Guy's & St Thomas' NHS Foundation Trust; University of Lausanne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; GlaxoSmithKline; University of Oulu; Imperial College London; Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	john.chambers@ic.ac.uk; j.kooner@imperial.ac.uk	Colaus, PsyColaus/K-6607-2013; Ahmadi, Kourosh R/B-6379-2012; Bochud, Murielle/A-3981-2010; Hypponen, Elina/B-2596-2014; Uda, Manuela/AAC-2645-2019; Prokopenko, Inga/AAU-9895-2020; Maxwell, Patrick H/C-5557-2008; Lightstone, Liz/M-4331-2014; Penninx, Brenda WJH/S-7627-2017; Abecasis, Goncalo R/B-7840-2010; Lord, Graham M/B-3797-2011; Eggermann, Thomas/F-3807-2014; Beckmann, Jacques S/A-9772-2008; Bakker, Stephan J. L./J-4023-2015; Gale, Daniel/D-5594-2013; Abraham, Sabu/E-1144-2019; Loos, Ruth J F/Q-2862-2016; Lagou, Vasiliki/N-8451-2013; Dominiczak, Anna F/P-9390-2017; Davey Smith, George/A-7407-2013; Wass, Mark/H-3398-2019; Spector, Tim D/F-6533-2012; Fuentes, Maria/HGA-8617-2022; Loos, Ruth/GON-5877-2022; Prokopenko, Inga/H-3241-2014; Wass, Mark N/F-5540-2010; sanna, serena/H-3009-2019; Maria, Hernandez-Fuentes/B-5011-2010; zhang, weihua/GXV-1334-2022; Perucha, Esperanza/S-7380-2019; Schalling, Martin/F-1518-2015; McCarthy, Mark/M-3763-2015	Bochud, Murielle/0000-0002-5727-0218; Hypponen, Elina/0000-0003-3670-9399; Uda, Manuela/0000-0002-4890-6456; Maxwell, Patrick H/0000-0002-0338-2679; Lightstone, Liz/0000-0002-4603-4076; Penninx, Brenda WJH/0000-0001-7779-9672; Beckmann, Jacques S/0000-0002-9741-1900; Bakker, Stephan J. L./0000-0003-3356-6791; Gale, Daniel/0000-0002-9170-1579; Abraham, Sabu/0000-0002-0916-5827; Loos, Ruth J F/0000-0002-8532-5087; Dominiczak, Anna F/0000-0003-4913-3608; Davey Smith, George/0000-0002-1407-8314; Wass, Mark/0000-0001-5428-6479; Prokopenko, Inga/0000-0003-1624-7457; sanna, serena/0000-0002-3768-1749; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Perucha, Esperanza/0000-0002-7802-0875; Schalling, Martin/0000-0001-5011-2922; Johnson, Toby/0000-0002-5998-3270; Lawlor, Debbie A/0000-0002-6793-2262; Stenvinkel, Peter/0000-0002-8785-4820; Abecasis, Goncalo/0000-0003-1509-1825; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Elliott, Paul/0000-0002-7511-5684; Melander, Olle/0000-0002-2581-484X; Devuyst, Olivier/0000-0003-3744-4767; Kleefstra, Nanne/0000-0003-1473-8519; Wallace, Chris/0000-0001-9755-1703; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Soranzo, Nicole/0000-0003-1095-3852; Munroe, Patricia/0000-0002-4176-2947; Lagou, Vasiliki/0000-0003-3165-8940; Waeber, Gerard/0000-0003-4193-788X; s, hema/0000-0002-3440-9475; Caulfield, Mark/0000-0001-9295-3594; Lord, Graham/0000-0003-2069-4743; Sternberg, Michael/0000-0002-1884-5445; Forouhi, Nita/0000-0002-5041-248X; Dockrell, Mark/0000-0003-3771-4464; Shuldiner, Alan/0000-0001-9921-4305; McCarthy, Mark/0000-0002-4393-0510	NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG000965, ZIAAG000015] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F020481/1] Funding Source: Medline; Intramural NIH HHS [Z01 AG000675-02] Funding Source: Medline; Medical Research Council [G0601966, G0801056, G0701863, G0400874, MC_U106179471, MC_U106188470, G0400546, G0700931, G9521010, G0600420, G0600705, MC_UP_A100_1003] Funding Source: Medline; Wellcome Trust [091746] Funding Source: Medline; Department of Health [PHCS/C4/4/016] Funding Source: Medline; BBSRC [BB/F020481/1] Funding Source: UKRI; MRC [G0801056, MC_U106188470, G0701863, G0700931, G0600705, G9521010, G0400546, G0601966, MC_UP_A100_1003, G0400874] Funding Source: UKRI; Kidney Research UK [RP24/2/2006] Funding Source: researchfish; Medical Research Council [G0801056B, G0400546B] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016, NF-SI-0507-10315] Funding Source: researchfish	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Filipski KK, 2009, CLIN PHARMACOL THER, V86, P396, DOI 10.1038/clpt.2009.139; Fujita T, 2006, J PHARM SCI-US, V95, P25, DOI 10.1002/jps.20536; Kharasch ED, 2008, CLIN PHARMACOL THER, V84, P158, DOI 10.1038/clpt.2008.97; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lash LH, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.1289/ehp.00108s2177; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Marshall JD, 2007, EUR J HUM GENET, V15, P1193, DOI 10.1038/sj.ejhg.5201933; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415	15	208	213	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					373	375		10.1038/ng.566	http://dx.doi.org/10.1038/ng.566			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20383145	Green Accepted, Green Published			2022-12-25	WOS:000277179500005
J	Murphy, BD				Murphy, Bruce D.			What a difference a gene makes	NATURE MEDICINE			English	Editorial Material							TRANSCRIPTION FACTOR FOXL2; POLYCYSTIC-OVARY-SYNDROME; MUTATIONS; BPES		Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada	Universite de Montreal	Murphy, BD (corresponding author), Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.	bruce.d.murphy@umontreal.ca		Murphy, Bruce/0000-0001-7158-3360				Benayoun BA, 2008, PROTEOMICS, V8, P3118, DOI 10.1002/pmic.200800084; Bentsi-Barnes IK, 2010, FERTIL STERIL, V94, P353, DOI 10.1016/j.fertnstert.2009.09.050; Beysen D, 2009, HUM MUTAT, V30, P158, DOI 10.1002/humu.20807; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Kobel M, 2009, CANCER RES, V69, P9160, DOI 10.1158/0008-5472.CAN-09-2669; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Magoffin DA, 2006, FERTIL STERIL, V86, pS9, DOI 10.1016/j.fertnstert.2006.03.015; Meduri G, 2010, HUM REPROD, V25, P235, DOI 10.1093/humrep/dep355; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021	14	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					527	529		10.1038/nm0510-527	http://dx.doi.org/10.1038/nm0510-527			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448577				2022-12-25	WOS:000277394700029
J	Strutt, TM; McKinstry, KK; Dibble, JP; Winchell, C; Kuang, Y; Curtis, JD; Huston, G; Dutton, RW; Swain, SL				Strutt, Tara M.; McKinstry, K. Kai; Dibble, John P.; Winchell, Caylin; Kuang, Yi; Curtis, Jonathan D.; Huston, Gail; Dutton, Richard W.; Swain, Susan L.			Memory CD4(+) T cells induce innate responses independently of pathogen	NATURE MEDICINE			English	Article							INFLUENZA-A; ANTIVIRAL RESPONSES; PROTECTIVE IMMUNITY; VIRAL-INFECTIONS; IFN-GAMMA; ACTIVATION; CD8(+); INTERLEUKIN-12; GENERATION; CHEMOKINES	Inflammation induced by recognition of pathogen-associated molecular patterns markedly affects subsequent adaptive responses. We asked whether the adaptive immune system can also affect the character and magnitude of innate inflammatory responses. We found that the response of memory, but not naive, CD4(+) T cells enhances production of multiple innate inflammatory cytokines and chemokines (IICs) in the lung and that, during influenza infection, this leads to early control of virus. Memory CD4(+) T cell-induced IICs and viral control require cognate antigen recognition and are optimal when memory cells are either T helper type 1 (T(H)1) or T(H)17 polarized but are independent of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) production and do not require activation of conserved pathogen recognition pathways. This represents a previously undescribed mechanism by which memory CD4(+) T cells induce an early innate response that enhances immune protection against pathogens.	[Strutt, Tara M.; McKinstry, K. Kai; Dibble, John P.; Winchell, Caylin; Kuang, Yi; Curtis, Jonathan D.; Huston, Gail; Dutton, Richard W.; Swain, Susan L.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Strutt, TM (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	tms139@mail.usask.ca			US National Institutes of Health [P01AI04630, P01AI04566]; US Department of Defense [3222]; Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046530, R01AI076534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG025805] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (P01AI04630 to and P01AI04566 to S. L. S.), the US Department of Defense (HR#3222) and the Trudeau Institute. We thank J. Kohlmeier and D. Woodland (Trudeau Institute) for Ccr5<SUP>-/-</SUP> and Ifnar2<SUP>-/-</SUP> mice and M. Mohrs (Trudeau Institute) for C57BL/6-Tg (IFN-gamma-EYFP) mice. Influenza A/Philippines was obtained from S. Epstein (CBER FDA), and engineered virus A/PR8-OVA<INF>II</INF> was obtained from P. Doherty (University of Melbourne). LPS-free whole OVA protein was a generous gift from T. Moran (Mount Sinai School of Medicine).	Amichay D, 1996, J IMMUNOL, V157, P4511; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRADLEY LM, 1993, J IMMUNOL, V150, P3119; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; CHACE JH, 1994, J IMMUNOL, V152, P405; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; DE TP, 1994, SCIENCE, V264, P703; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hama Y, 2009, ACTA VIROL, V53, P233, DOI 10.4149/av_2009_04_233; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kalinski P, 2005, NAT REV IMMUNOL, V5, P251, DOI 10.1038/nri1569; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; Lee SW, 1999, VACCINE, V17, P490, DOI 10.1016/S0264-410X(98)00223-0; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Mayer KD, 2005, J IMMUNOL, V174, P7732, DOI 10.4049/jimmunol.174.12.7732; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Monteiro JM, 1998, J VIROL, V72, P4825, DOI 10.1128/JVI.72.6.4825-4831.1998; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Strutt TM, 2006, INT IMMUNOL, V18, P719, DOI 10.1093/intimm/dxl009; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786	50	132	137	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					558	U91		10.1038/nm.2142	http://dx.doi.org/10.1038/nm.2142			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20436484	Green Accepted			2022-12-25	WOS:000277394700034
J	Xu, ZZ; Zhang, L; Liu, T; Park, JY; Berta, T; Yang, R; Serhan, CN; Ji, RR				Xu, Zhen-Zhong; Zhang, Ling; Liu, Tong; Park, Jong Yeon; Berta, Temugin; Yang, Rong; Serhan, Charles N.; Ji, Ru-Rong			Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions	NATURE MEDICINE			English	Article							PRIMARY SENSORY NEURONS; SPINAL NERVE LIGATION; NECROSIS-FACTOR-ALPHA; CENTRAL SENSITIZATION; NEUROPATHIC PAIN; ANTIINFLAMMATORY PROPERTIES; INTRATHECAL MORPHINE; RECEPTOR; MECHANISMS; RESOLUTION	Inflammatory pain, such as arthritis pain, is a growing health problem(1). Inflammatory pain is generally treated with opioids and cyclooxygenase (COX) inhibitors, but both are limited by side effects. Recently, resolvins, a unique family of lipid mediators, including RvE1 and RvD1 derived from omega-3 polyunsaturated fatty acid, have shown marked potency in treating disease conditions associated with inflammation(2,3). Here we report that peripheral (intraplantar) or spinal (intrathecal) administration of RvE1 or RvD1 in mice potently reduces inflammatory pain behaviors induced by intraplantar injection of formalin, carrageenan or complete Freund's adjuvant (CFA), without affecting basal pain perception. Intrathecal RvE1 injection also inhibits spontaneous pain and heat and mechanical hypersensitivity evoked by intrathecal capsaicin and tumor necrosis factor-alpha (TNF-alpha). RvE1 has anti-inflammatory activity by reducing neutrophil infiltration, paw edema and proinflammatory cytokine expression. RvE1 also abolishes transient receptor potential vanilloid subtype-1 (TRPV1)- and TNF-alpha-induced excitatory postsynaptic current increases and TNF-alpha-evoked N-methyl-d-aspartic acid (NMDA) receptor hyperactivity in spinal dorsal horn neurons via inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. Thus, we show a previously unknown role for resolvins in normalizing the spinal synaptic plasticity that has been implicated in generating pain hypersensitivity. Given the potency of resolvins and the well-known side effects of opioids and COX inhibitors, resolvins may represent new analgesics for treating inflammatory pain.	[Xu, Zhen-Zhong; Zhang, Ling; Liu, Tong; Park, Jong Yeon; Berta, Temugin; Ji, Ru-Rong] Brigham & Womens Hosp, Sensory Plast Lab, Pain Res Ctr, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Xu, Zhen-Zhong; Zhang, Ling; Liu, Tong; Park, Jong Yeon; Berta, Temugin; Yang, Rong; Serhan, Charles N.; Ji, Ru-Rong] Harvard Univ, Sch Med, Boston, MA USA; [Yang, Rong; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ji, RR (corresponding author), Brigham & Womens Hosp, Sensory Plast Lab, Pain Res Ctr, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu; rrji@zeus.bwh.harvard.edu	Liu, Tong/E-3648-2010; Berta, Temugin/A-6908-2016; Yang, Rong/ABA-7587-2021; Park, Jong Yeon/AAF-8743-2021; Liu, Tong/C-7810-2012; Ji, Ru-Rong/L-7070-2017; Berta, Temugin/AAK-6365-2020	Berta, Temugin/0000-0002-4486-8288; Ji, Ru-Rong/0000-0002-9355-3688; Berta, Temugin/0000-0002-4486-8288; Xu, Zhen-Zhong/0000-0001-6578-211X; Yang, Rong/0000-0001-8837-0089; Park, Jong Yeon/0000-0003-0588-1903; Zhang, Ling/0000-0002-8308-6553	US National Institutes of Health [R01-DE17794, R01-NS54362, R37 GM38765, R01-DE019938, R01-DK074448, NS67686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938, R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R37GM038765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686, R01NS054932, F30NS054362] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by US National Institutes of Health grants R01-DE17794 and R01-NS54362 to R.-R.J., R37 GM38765, R01-DE019938 and R01-DK074448 to C.N.S. and NS67686 to both R.-R.J. and C.N.S.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2006, J BIOL CHEM, V281, P22847, DOI 10.1074/jbc.M603766200; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gavva NR, 2008, TRENDS PHARMACOL SCI, V29, P550, DOI 10.1016/j.tips.2008.08.003; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goldberg RJ, 2007, PAIN, V129, P210, DOI 10.1016/j.pain.2007.01.020; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Junger H, 2000, PAIN, V85, P145, DOI 10.1016/S0304-3959(99)00262-6; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Nicol GD, 1997, J NEUROSCI, V17, P975; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schafers M, 2003, J NEUROSCI, V23, P2517; Schnitzer TJ, 2006, CLIN RHEUMATOL, V25, pS22, DOI 10.1007/s10067-006-0203-8; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Woolf CJ, 2009, CELL, V137, P987, DOI 10.1016/j.cell.2009.05.033; Yaksh TL, 1999, TRENDS PHARMACOL SCI, V20, P329, DOI 10.1016/S0165-6147(99)01370-X; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	40	411	435	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					592	U129		10.1038/nm.2123	http://dx.doi.org/10.1038/nm.2123			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20383154	Green Accepted			2022-12-25	WOS:000277394700039
J	Garske, AL; Oliver, SS; Wagner, EK; Musselman, CA; LeRoy, G; Garcia, BA; Kutateladze, TG; Denu, JM				Garske, Adam L.; Oliver, Samuel S.; Wagner, Elise K.; Musselman, Catherine A.; LeRoy, Gary; Garcia, Benjamin A.; Kutateladze, Tatiana G.; Denu, John M.			Combinatorial profiling of chromatin binding modules reveals multisite discrimination	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE H3 TAIL; PHD FINGER; LYSINE-4 TRIMETHYLATION; AUTOIMMUNE REGULATOR; PEPTIDE LIBRARIES; PLANT HOMEODOMAIN; GENE REPRESSION; METHYLATION; RECOGNITION; DOMAIN	Specific interactions between post-translational modifications (PTMs) and chromatin-binding proteins are central to the idea of a 'histone code'. Here, we used a 5,000-member, PTM-randomized, combinatorial peptide library based on the N terminus of histone H3 to interrogate the multisite specificity of six chromatin binding modules, which read the methylation status of Lys4. We found that Thr3 phosphorylation, Arg2 methylation and Thr6 phosphorylation are critical additional PTMs that modulate the ability to recognize and bind histone H3. Notably, phosphorylation of Thr6 yielded the most varied effect on protein binding, suggesting an important regulatory mechanism for readers of the H3 tail. Mass spectrometry and antibody-based evidence indicate that this previously uncharacterized modification exists on native H3, and NMR analysis of ING2 revealed the structural basis for discrimination. These investigations reveal a continuum of binding affinities in which multisite PTM recognition involves both switch- and rheostat-like properties, yielding graded effects that depend on the inherent 'reader' specificity.	[Garske, Adam L.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Oliver, Samuel S.; Wagner, Elise K.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Musselman, Catherine A.; Kutateladze, Tatiana G.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA; [LeRoy, Gary; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Anschutz Medical Campus; Princeton University	Garske, AL (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu		Kutateladze, Tatiana/0000-0001-7375-6990; Musselman, Catherine/0000-0002-8356-7971	US National Institutes of Health [GM059785, T32GM008505]; American Society for Mass Spectrometry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059785, T32GM008505] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Mass Spectrometry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Barrett-Wilt and G. Sabat ( University of Wisconsin Biotechnology Center) for their help with MALDI-TOF mass spectrometry. We are grateful to G. Case ( University of Wisconsin Peptide Synthesis Facility) for helpful conversations and advice on peptide synthesis. We thank G. Musco ( Dulbecco Telethon Institute), Y. Shi ( Harvard Medical School), W. Yang ( National Institute of Health) and R.-M. Xu ( New York University) for expression plasmids used in this study. We thank S. Bednarek ( University of Wisconsin-Madison) for the GST-specific antibody. This work was supported by the US National Institutes of Health ( grant GM059785 to J.M.D. and predoctoral fellowship T32GM008505 to S.S.O.) and an American Society for Mass Spectrometry research award ( B. A. G.).	Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; CLARKE G. M., 2004, BASIC COURSE STAT; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Huang HL, 2009, GENOME RES, V19, P674, DOI 10.1101/gr.083402.108; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wavreille AS, 2007, METHODS, V42, P207, DOI 10.1016/j.ymeth.2007.02.010; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; YOUNGQUIST RS, 1995, J AM CHEM SOC, V117, P3900, DOI 10.1021/ja00119a002	35	90	94	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					283	290		10.1038/NCHEMBIO.319	http://dx.doi.org/10.1038/NCHEMBIO.319			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20190764	Green Accepted			2022-12-25	WOS:000275734000014
J	Baker, SP; Phillips, J; Anderson, S; Qiu, QF; Shabanowitz, J; Smith, MM; Yates, JR; Hunt, DF; Grant, PA				Baker, Stephen P.; Phillips, Jennifer; Anderson, Scott; Qiu, Qifeng; Shabanowitz, Jeffrey; Smith, M. Mitchell; Yates, John R., III; Hunt, Donald F.; Grant, Patrick A.			Histone H3 Thr 45 phosphorylation is a replication-associated post-translational modification in S. cerevisiae	NATURE CELL BIOLOGY			English	Article							DAMAGE CHECKPOINT RECOVERY; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; LYSINE-56 ACETYLATION; DNA-REPLICATION; KINASE; CHROMATIN; CDC7; COMPLEXES; PROTEIN	Post-translational histone modifications are crucial for the regulation of numerous DNA-templated processes, and are thought to mediate both alteration of chromatin dynamics and recruitment of effector proteins to specific regions of the genome(1). In particular, histone Ser/Thr phosphorylation regulates multiple nuclear functions in the budding yeast Saccharomyces cerevisiae, including transcription, DNA damage repair, mitosis, apoptosis and sporulation(2). Although modifications to chromatin during replication remain poorly understood, a number of recent studies have described acetylation of the histone H3 N-terminal alpha-helix (alpha N helix) at Lys 56 as a modification that is important for maintenance of genomic integrity during DNA replication and repair(3,4). Here, we report phosphorylation of H3 Thr 45 (H3-T45), a histone modification also located within the H3 alpha N helix in S. cerevisiae. Thr 45 phosphorylation peaks during DNA replication, and is mediated by the S phase kinase Cdc7-Dbf4 as part of a multiprotein complex identified in this study. Furthermore, loss of phosphorylated H3-T45 causes phenotypes consistent with replicative defects, and prolonged replication stress results in H3-T45 phosphorylation accumulation over time. Notably, the phenotypes described here are independent of Lys 56 acetylation status, and combinatorial mutations to both Thr 45 and Lys 56 of H3 cause synthetic growth defects. Together, these data identify and characterize H3-T45 phosphorylation as a replication-associated histone modification in budding yeast.	[Baker, Stephen P.; Phillips, Jennifer; Grant, Patrick A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Anderson, Scott; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Qiu, Qifeng; Smith, M. Mitchell] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA	University of Virginia; Scripps Research Institute; University of Virginia; University of Virginia; University of Virginia	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pag9n@virginia.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368	NIH [5 T32 CA009109-30, 5 P30 CA044579-18, R56 DK082673-01, GM37537, P41 RR011823, GM60444]; NATIONAL CANCER INSTITUTE [P30CA044579, T32CA009109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK082673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060444, R56GM060444, R01GM037537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Grant and Hunt labs for helpful discussion and technical assistance; R. Sclafani for yeast strains and reagents; G. Kupfer for reagents; J. Smith and J. Reese for yeast strains; and D. Auble for yeast strains, helpful discussion and reading of this manuscript. We also thank J. Bone (Active Motif) for assistance with antibody generation. S. P. B. was supported in part by NIH pre-doctoral cancer training grant no. 5 T32 CA009109-30. This work was supported by grants from the NIH to P. A. G. (5 P30 CA044579-18 and R56 DK082673-01), D. F. H. (GM37537), J. R. Y. (P41 RR011823), and M. M. S. (GM60444).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Brachmann CB, 1998, YEAST, V14, P115; CHAPMAN JW, 1989, EXP CELL RES, V180, P419, DOI 10.1016/0014-4827(89)90068-2; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, METH MOL B, V119, P311; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Owen-Hughes T, 1999, METH MOL B, V119, P319; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sclafani RA, 2000, J CELL SCI, V113, P2111; SLATER ML, 1977, P NATL ACAD SCI USA, V74, P3850, DOI 10.1073/pnas.74.9.3850; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207	35	61	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					294	U103		10.1038/ncb2030	http://dx.doi.org/10.1038/ncb2030			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20139971	Green Accepted			2022-12-25	WOS:000275054200016
J	Chaudhury, A; Hussey, GS; Ray, PS; Jin, G; Fox, PL; Howe, PH				Chaudhury, Arindam; Hussey, George S.; Ray, Partho S.; Jin, Ge; Fox, Paul L.; Howe, Philip H.			TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-MIGRATION; MESSENGER-RNA; KINASE; ACTIVATION; EXPRESSION; PATHWAY; CANCER; GENE; AKT	Transforming growth factor-beta (TGF-beta) induces epithelial-mesenchymal transdifferentiation (EMT) accompanied by cellular differentiation and migration(1-5). Despite extensive transcriptomic profiling, the identification of TGF-beta-inducible, EMT-specific genes has met with limited success. Here we identify a post-transcriptional pathway by which TGF-beta modulates the expression of EMT-specific proteins and of EMT itself. We show that heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) binds a structural, 33-nucleotide TGF-beta-activated translation (BAT) element in the 3' untranslated region of disabled-2 (Dab2) and interleukin-like EMT inducer (ILEI) transcripts, and represses their translation. TGF-beta activation leads to phosphorylation at Ser 43 of hnRNP E1 by protein kinase B beta/Akt2, inducing its release from the BAT element and translational activation of Dab2 and ILEI messenger RNAs. Modulation of hnRNP E1 expression or its post-translational modification alters the TGF-beta-mediated reversal of translational silencing of the target transcripts and EMT. These results suggest the existence of a TGF-beta-inducible post-transcriptional regulon that controls EMT during the development and metastatic progression of tumours.	[Chaudhury, Arindam; Hussey, George S.; Jin, Ge; Howe, Philip H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Ray, Partho S.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Chaudhury, Arindam; Hussey, George S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Ray, Partho S.] Indian Inst Sci Educ & Res, Dept Biol, Kolkata 700106, India	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Case Western Reserve University; Indian Institute of Science Education & Research (IISER) - Kolkata	Howe, PH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	howep@ccf.org	Ray, Partho Sarothi/H-3020-2019	Ray, Partho Sarothi/0000-0002-8795-3060; CHAUDHURY, ARINDAM/0000-0002-5625-5278; Chaudhury, Arindam/0000-0001-5916-4534	National Cancer Institute [CA55536, CA80095]; American Heart Association [075080B]; NATIONAL CANCER INSTITUTE [R01CA080095, R01CA154663, R29CA055536, R01CA055536] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Donna M. Driscoll, Barsanjit Mazumder and members of our laboratory for helpful discussions and critical insights. We value the assistance of Michael T. Kinter and Belinda Willard for liquid chromatography-mass spectrometry; of Judith A. Drazba and John Peterson for imaging; and of Michael Budiman for fast performance liquid chromatography. We thank Rakesh Kumar for the gift of the GST-hnRNP E1 construct, Takashi Kobayashi for the gifts of mouse pCMV14-hnRNP E1-Flag and psiRNA-hH1neo-mouse hnRNP E1, and Harold Moses for giving us the EpRas cell line. This work was supported by grants CA55536 and CA80095 from the National Cancer Institute to P. H. H. A. C. is supported by an American Heart Association (Ohio Valley Affiliate) Pre-doctoral Fellowship 075080B.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Greinwald JH, 1998, AM J MED GENET, V78, P107, DOI 10.1002/(SICI)1096-8628(19980630)78:2<107::AID-AJMG2>3.3.CO;2-9; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; Hampton MB, 1998, BIOCHEM J, V329, P95; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kato S, 2007, BIOCHEM BIOPH RES CO, V354, P1061, DOI 10.1016/j.bbrc.2007.01.094; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; LEGAGNEUX V, 1992, DEVELOPMENT, V116, P1193; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	227	232	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					286	U94		10.1038/ncb2029	http://dx.doi.org/10.1038/ncb2029			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154680	Green Accepted			2022-12-25	WOS:000275054200015
J	He, XL; Qian, WF; Wang, Z; Li, Y; Zhang, JZ				He, Xionglei; Qian, Wenfeng; Wang, Zhi; Li, Ying; Zhang, Jianzhi			Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; GENETIC INTERACTIONS; FUNCTIONAL-ANALYSIS; DELETION STRAINS; YEAST GENOME; EVOLUTION; PLASTICITY; BIOLOGY; SYSTEMS	Epistasis refers to the interaction between genes. Although high-throughput epistasis data from model organisms are being generated and used to construct genetic networks(1-3), the extent to which genetic epistasis reflects biologically meaningful interactions remains unclear(4-6). We have addressed this question through in silico mapping of positive and negative epistatic interactions amongst biochemical reactions within the metabolic networks of Escherichia coli and Saccharomyces cerevisiae using flux balance analysis. We found that negative epistasis occurs mainly between nonessential reactions with overlapping functions, whereas positive epistasis usually involves essential reactions, is highly abundant and, unexpectedly, often occurs between reactions without overlapping functions. We offer mechanistic explanations of these findings and experimentally validate them for 61 S. cerevisiae gene pairs.	[He, Xionglei; Qian, Wenfeng; Wang, Zhi; Li, Ying; Zhang, Jianzhi] Dept Ecol & Evolutionary Biol, Ann Arbor, MI USA; [Li, Ying] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, JZ (corresponding author), Dept Ecol & Evolutionary Biol, Ann Arbor, MI USA.	jianzhi@umich.edu		Qian, Wenfeng/0000-0001-6875-0842	US National Institutes of Health; University of Michigan Center for Computational Medicine and Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067030] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Center for Computational Medicine and Biology(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Bharucha, G. Kalay, A. Kumar, J. Ma and B. Williams for advice and assistance in yeast experiments, B. Palsson and his group for instruction on FBA, B.-Y. Liao for drawing Supplementary Figure 2 and M. Bakewell, S. Cho, W. Grus, B.-Y. Liao, and C. Maclean for valuable comments. This work was supported by research grants from the US National Institutes of Health and University of Michigan Center for Computational Medicine and Biology to J. Z.	Amberg DC, 2005, METHODS YEAST GENETI, P59; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bateson W., 1909, MENDELS PRINCIPLES H; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ekino K, 1999, YEAST, V15, P451, DOI 10.1002/(SICI)1097-0061(199904)15:6<451::AID-YEA383>3.0.CO;2-K; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; KACSER H, 1981, GENETICS, V97, P639; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; MEIRON H, 1995, CURR GENET, V28, P367, DOI 10.1007/BF00326435; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SZATHMARY E, 1993, GENETICS, V133, P127; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	42	102	102	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					272	U120		10.1038/ng.524	http://dx.doi.org/10.1038/ng.524			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101242	Green Accepted			2022-12-25	WOS:000274912400020
J	Semple, SC; Akinc, A; Chen, JX; Sandhu, AP; Mui, BL; Cho, CK; Sah, DWY; Stebbing, D; Crosley, EJ; Yaworski, E; Hafez, IM; Dorkin, JR; Qin, J; Lam, K; Rajeev, KG; Wong, KF; Jeffs, LB; Nechev, L; Eisenhardt, ML; Jayaraman, M; Kazem, M; Maier, MA; Srinivasulu, M; Weinstein, MJ; Chen, QM; Alvarez, R; Barros, SA; De, S; Klimuk, SK; Borland, T; Kosovrasti, V; Cantley, WL; Tam, YK; Manoharan, M; Ciufolini, MA; Tracy, MA; de Fougerolles, A; MacLachlan, I; Cullis, PR; Madden, TD; Hope, MJ				Semple, Sean C.; Akinc, Akin; Chen, Jianxin; Sandhu, Ammen P.; Mui, Barbara L.; Cho, Connie K.; Sah, Dinah W. Y.; Stebbing, Derrick; Crosley, Erin J.; Yaworski, Ed; Hafez, Ismail M.; Dorkin, J. Robert; Qin, June; Lam, Kieu; Rajeev, Kallanthottathil G.; Wong, Kim F.; Jeffs, Lloyd B.; Nechev, Lubomir; Eisenhardt, Merete L.; Jayaraman, Muthusamy; Kazem, Mikameh; Maier, Martin A.; Srinivasulu, Masuna; Weinstein, Michael J.; Chen, Qingmin; Alvarez, Rene; Barros, Scott A.; De, Soma; Klimuk, Sandra K.; Borland, Todd; Kosovrasti, Verbena; Cantley, William L.; Tam, Ying K.; Manoharan, Muthiah; Ciufolini, Marco A.; Tracy, Mark A.; de Fougerolles, Antonin; MacLachlan, Ian; Cullis, Pieter R.; Madden, Thomas D.; Hope, Michael J.			Rational design of cationic lipids for siRNA delivery	NATURE BIOTECHNOLOGY			English	Article							INTRACELLULAR DELIVERY; IN-VIVO; NONHUMAN-PRIMATES; MECHANISM; LIPOSOMES; DNA; ENCAPSULATION; THERAPEUTICS; BEHAVIOR; RELEASE	We adopted a rational approach to design cationic lipids for use in formulations to deliver small interfering RNA (siRNA). Starting with the ionizable cationic lipid 1,2-dilinoleyloxy-3-dimethylaminopropane (DLinDMA), a key lipid component of stable nucleic acid lipid particles (SNALP) as a benchmark, we used the proposed in vivo mechanism of action of ionizable cationic lipids to guide the design of DLinDMA-based lipids with superior delivery capacity. The best-performing lipid recovered after screening (DLin-KC2-DMA) was formulated and characterized in SNALP and demonstrated to have in vivo activity at siRNA doses as low as 0.01 mg/kg in rodents and 0.1 mg/kg in nonhuman primates. To our knowledge, this represents a substantial improvement over previous reports of in vivo endogenous hepatic gene silencing.	[Semple, Sean C.; Chen, Jianxin; Sandhu, Ammen P.; Mui, Barbara L.; Cho, Connie K.; Stebbing, Derrick; Crosley, Erin J.; Yaworski, Ed; Lam, Kieu; Jeffs, Lloyd B.; Eisenhardt, Merete L.; Klimuk, Sandra K.; Tam, Ying K.; MacLachlan, Ian; Madden, Thomas D.; Hope, Michael J.] Tekmira Pharmaceut, Burnaby, BC, Canada; [Akinc, Akin; Sah, Dinah W. Y.; Dorkin, J. Robert; Qin, June; Rajeev, Kallanthottathil G.; Nechev, Lubomir; Jayaraman, Muthusamy; Maier, Martin A.; Weinstein, Michael J.; Chen, Qingmin; Alvarez, Rene; Barros, Scott A.; De, Soma; Borland, Todd; Kosovrasti, Verbena; Cantley, William L.; Manoharan, Muthiah; Tracy, Mark A.; de Fougerolles, Antonin] Alnylam Pharmaceut, Cambridge, MA USA; [Hafez, Ismail M.; Wong, Kim F.; Kazem, Mikameh; Cullis, Pieter R.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Srinivasulu, Masuna; Ciufolini, Marco A.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Semple, SC (corresponding author), Tekmira Pharmaceut, Burnaby, BC, Canada.	ssemple@tekmirapharm.com; aakinc@alnylam.com	Xin, Xiaofei/N-4518-2018; abnous, Khalil/R-8103-2017; Badiee, Ali/D-3672-2013	Xin, Xiaofei/0000-0002-7618-0808; abnous, Khalil/0000-0001-6314-0164; Badiee, Ali/0000-0003-1595-2218				Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; BAILEY AL, 1994, BIOCHEMISTRY-US, V33, P12573, DOI 10.1021/bi00208a007; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928; EPAND RM, 1989, BIOCHEMISTRY-US, V28, P9398, DOI 10.1021/bi00450a022; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Heyes J, 2006, J CONTROL RELEASE, V112, P280, DOI 10.1016/j.jconrel.2006.02.012; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Semple SC, 2001, BBA-BIOMEMBRANES, V1510, P152, DOI 10.1016/S0005-2736(00)00343-6; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	23	1076	1252	40	461	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2010	28	2					172	U18		10.1038/nbt.1602	http://dx.doi.org/10.1038/nbt.1602			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	552TT	20081866				2022-12-25	WOS:000274317200027
J	Greinacher, A; Wesche, J; Hammer, E; Furll, B; Volker, U; Reil, A; Bux, J				Greinacher, Andreas; Wesche, Jan; Hammer, Elke; Fuerll, Birgitt; Voelker, Uwe; Reil, Angelika; Bux, Juergen			Characterization of the human neutrophil alloantigen-3a	NATURE MEDICINE			English	Article							ACUTE LUNG INJURY; TRANSFUSION; ALLOANTIBODIES; PATHOGENESIS; PROTEIN; KDA; 5B	Transfusion-related acute lung injury (TRALI) is a frequent cause of transfusion-associated morbidity and mortality. Severe TRALI is often due to antibodies in blood components directed against the human neutrophil alloantigen-3a (HNA-3a). We show here that the HNA-3a antigen arises from a nucleotide polymorphism in the choline transporter-like protein-2 gene (SLC44A2), with the resulting variation at amino acid position 154 determining the reactivity of the protein with HNA-3a-specific antibodies; the variant with an arginine at this position, rather than a glutamine, constitutes the HNA-3a antigen. The molecular identification of this antigen should facilitate the development of assays for blood donor screening to lower the risk of TRALI.	[Greinacher, Andreas; Wesche, Jan; Fuerll, Birgitt] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Hammer, Elke; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfak Inst Genet & Funkt Genomforsch, Greifswald, Germany; [Reil, Angelika; Bux, Juergen] Ruhr Univ Bochum, Bochum, Germany; [Reil, Angelika; Bux, Juergen] Deutsch Rotes Kreuz Blutspendedienst W, Hagen, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ruhr University Bochum	Greinacher, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany.	greinach@uni-greifswald.de		Hammer, Elke/0000-0002-1507-0402; Volker, Uwe/0000-0002-5689-3448	Deutsche Rote Kreuz-Blutspendedienst West, Hagen, Germany; Land Mecklenburg-Vorpommern, Exzellenzinitiative [UG 07-064]; Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz Humorale Immunreaktionen bei Herz-Kreislauf Erkrankungen (ZIK-HIKE) [03Z2CK1, 03Z2CI1]; Zentrum fur Innovationskompetenz Funktionelle Genomforschung [ZIK FunGene 03ZIK331]	Deutsche Rote Kreuz-Blutspendedienst West, Hagen, Germany; Land Mecklenburg-Vorpommern, Exzellenzinitiative; Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz Humorale Immunreaktionen bei Herz-Kreislauf Erkrankungen (ZIK-HIKE)(Federal Ministry of Education & Research (BMBF)); Zentrum fur Innovationskompetenz Funktionelle Genomforschung	We thank A. Teumer for running the data analysis of the Study on Health in Pomerania for population-wide gene frequency analysis of the HNA-3a-encoding polymorphism. We highly appreciate the expertise and support of J. Hoppen and H. Hippe (Chromatec) for expression of recombinant protein fragments. We thank T. E. Warkentin for valuable discussion and suggestions. This work was supported by an unrestricted grant of the Deutsche Rote Kreuz-Blutspendedienst West, Hagen, Germany; by the Land Mecklenburg-Vorpommern, Exzellenzinitiative UG 07-064; by the Bundesministerium fur Bildung und Forschung, Zentrum fur Innovationskompetenz Humorale Immunreaktionen bei Herz-Kreislauf Erkrankungen (ZIK-HIKE) 03Z2CK1 and 03Z2CI1 and Zentrum fur Innovationskompetenz Funktionelle Genomforschung (ZIK FunGene 03ZIK331).	Bierling P, 2009, VOX SANG, V96, P266, DOI 10.1111/j.1423-0410.2008.01144.x; Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Davoren A, 2003, TRANSFUSION, V43, P641, DOI 10.1046/j.1537-2995.2003.00374.x; de Haas M, 2000, TRANSFUSION, V40, P222, DOI 10.1046/j.1537-2995.2000.40020222.x; Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004; Keller-Stanislawski B, 2010, VOX SANG, V98, P70, DOI 10.1111/j.1423-0410.2009.01232.x; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Middelburg RA, 2008, TRANSFUSION, V48, P2167, DOI 10.1111/j.1537-2995.2008.01810.x; Nair TS, 2004, J NEUROSCI, V24, P1772, DOI 10.1523/JNEUROSCI.5063-03.2004; POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x; Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x; SEEGER W, 1990, BLOOD, V76, P1438; Silliman CC, 2003, BLOOD, V101, P454, DOI 10.1182/blood-2002-03-0958; Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495; Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643; VANLEEUWEN A, 1964, VOX SANG, V9, P431; Yasui K, 2008, TRANSFUSION, V48, P978, DOI 10.1111/j.1537-2995.2007.01632.x	20	106	114	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					45	48		10.1038/nm.2070	http://dx.doi.org/10.1038/nm.2070			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	20037594				2022-12-25	WOS:000273395500035
J	May, M				May, Mike			Engineering a new business	NATURE BIOTECHNOLOGY			English	Article							GENOME; YEAST											Bergin J., 2009, SYNTHETIC BIOL EMERG; Carlson SR, 2007, PLOS GENET, V3, P1965, DOI 10.1371/journal.pgen.0030179; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Evans GA, 2003, US Patent, Patent No. [6,521,427, 6521427]; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hayden EC, 2009, NATURE, V458, P818, DOI 10.1038/458818a; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; LOK C, 2009, NAT NEWS        1104, DOI DOI 10.1038/NEWS.2009.1065; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEICHANG Y, 2007, P NATL ACAD SCI USA, V103, P17331; 2007, EXTREME GENETIC ENG	15	12	14	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1112	1120		10.1038/nbt1209-1112	http://dx.doi.org/10.1038/nbt1209-1112			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010588				2022-12-25	WOS:000272708300024
J	Zhang, HX; Zhai, Y; Hu, ZB; Wu, C; Qian, J; Jia, WH; Ma, FC; Huang, WF; Yu, LX; Yue, W; Wang, ZF; Li, PY; Zhang, Y; Liang, RX; Wei, ZL; Cui, Y; Xie, WM; Cai, M; Yu, XS; Yuan, YF; Xia, X; Zhang, XM; Yang, H; Qiu, W; Yang, JM; Gong, F; Chen, MS; Shen, HB; Lin, DX; Zeng, YX; He, FC; Zhou, GQ				Zhang, Hongxing; Zhai, Yun; Hu, Zhibin; Wu, Chen; Qian, Ji; Jia, Weihua; Ma, Fuchao; Huang, Wenfeng; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Liang, Renxiang; Wei, Zhongliang; Cui, Ying; Xie, Weimin; Cai, Mi; Yu, Xinsen; Yuan, Yunfei; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Yang, Jingmin; Gong, Feng; Chen, Minshan; Shen, Hongbing; Lin, Dongxin; Zeng, Yi-Xin; He, Fuchu; Zhou, Gangqiao			Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; CHROMOSOME 1P; GENE; UBIQUITIN; CANCER; KIF1B; HEPATOCARCINOGENESIS; NEUROBLASTOMA; MUTATION; RISK	To identify susceptibility variants for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we conducted a genome-wide association study by genotyping 440,794 SNPs in 355 chronic HBV carriers with HCC and 360 chronic HBV carriers without HCC, all of Chinese ancestry. We identified one intronic SNP (rs17401966) in KIF1B on chromosome 1p36.22 that was highly associated with HBV-related HCC and confirmed this association in five additional independent samples, consisting of 1,962 individuals with HCC, 1,430 control subjects and 159 family trios. Across the six studies, the association with rs17401966 was highly statistically significant (joint odds ratio = 0.61, P = 1.7 x 10(-18)). In addition to KIF1B, the association region tagged two other plausible causative genes, UBE4B and PGD. Our findings provide evidence that the 1p36.22 locus confers susceptibility to HBV-related HCC, and suggest that KIF1B-, UBE4B- or PGD-related pathways might be involved in the pathogenesis of this malignancy.	[Zhang, Hongxing; Zhai, Yun; Yu, Lixia; Yue, Wei; Wang, Zhifu; Li, Peiyao; Zhang, Yang; Cai, Mi; Xia, Xia; Zhang, Xiumei; Yang, Hao; Qiu, Wei; Gong, Feng; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100037, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Qian, Ji; Yang, Jingmin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Weihua; Yuan, Yunfei; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Jia, Weihua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Fuchao; Huang, Wenfeng; Cui, Ying; Xie, Weimin] Canc Inst Guangxi, Nanning, Guangxi, Peoples R China; [Liang, Renxiang; Wei, Zhongliang] Liver Canc Inst Fusui Cty, Guangxi, Peoples R China; [Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Academy of Military Medical Sciences - China; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Fudan University; Fudan University; Fudan University; Sun Yat Sen University; Sun Yat Sen University; Fudan University	Zhou, GQ (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; zhougq114@gmail.com		Yuan, Yunfei/0000-0003-2467-3683; He, Fuchu/0000-0002-8571-2351; Huang, Wenfeng/0000-0002-3194-4368; Wu, Chen/0000-0003-4954-1011; Lin, Dongxin/0000-0002-8723-8868; Zhou, Gangqiao/0000-0002-4895-5063; Shen, Hongbing/0000-0002-2581-5906	Chinese National High-tech Program [2006AA02A412]; Chinese Key Project for Infectious Diseases [2008ZX10002-016]; Chinese National Science Fund for Creative Research Groups Program [30621063]; Beijing Science and Technology NOVA program [2006A54]	Chinese National High-tech Program; Chinese Key Project for Infectious Diseases; Chinese National Science Fund for Creative Research Groups Program(Science Fund for Creative Research Groups); Beijing Science and Technology NOVA program	We thank the subjects and their families for participating in this study, and the clinicians, nurses and study coordinators for their contributions. This study was supported in part by grants from Chinese National High-tech Program 2006AA02A412 (G.Z.), Chinese Key Project for Infectious Diseases 2008ZX10002-016 (G.Z.), Chinese National Science Fund for Creative Research Groups Program 30621063 (F. H.) and Beijing Science and Technology NOVA program 2006A54 (G.Z.).	Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Benn DE, 2000, CANCER RES, V60, P7048; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatterjee A, 2008, CELL CYCLE, V7, P1231, DOI 10.4161/cc.7.9.5795; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Dawson SP, 2008, BBA-MOL BASIS DIS, V1782, P775, DOI 10.1016/j.bbadis.2008.08.003; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kim YJ, 2005, INTERVIROLOGY, V48, P10, DOI 10.1159/000082089; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Krona C, 2003, ONCOGENE, V22, P2343, DOI 10.1038/sj.onc.1206324; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nicodemus KK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-130; NOVELLO F, 1968, BIOCHEM J, V107, P775, DOI 10.1042/bj1070775; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Yang HW, 2001, ONCOGENE, V20, P5075, DOI 10.1038/sj.onc.1204456; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Yu MW, 1997, AM J EPIDEMIOL, V145, P1039, DOI 10.1093/oxfordjournals.aje.a009060; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030	34	270	290	2	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					755	U39		10.1038/ng.638	http://dx.doi.org/10.1038/ng.638			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676096				2022-12-25	WOS:000281388400009
J	Burns, AR; Wallace, IM; Wildenhain, J; Tyers, M; Giaever, G; Bader, GD; Nislow, C; Cutler, SR; Roy, PJ				Burns, Andrew R.; Wallace, Iain M.; Wildenhain, Jan; Tyers, Mike; Giaever, Guri; Bader, Gary D.; Nislow, Corey; Cutler, Sean R.; Roy, Peter J.			A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans	NATURE CHEMICAL BIOLOGY			English	Article							C-ELEGANS; PRIVILEGED SUBSTRUCTURES; SCREENING LIBRARIES; DISCOVERY; IDENTIFICATION; METABOLITES; SIMILARITY; INHIBITORS; MOLECULES; PRODUCTS	The resistance of Caenorhabditis elegans to pharmacological perturbation limits its use as a screening tool for novel small bioactive molecules. One strategy to improve the hit rate of small-molecule screens is to preselect molecules that have an increased likelihood of reaching their target in the worm. To learn which structures evade the worm's defenses, we performed the first survey of the accumulation and metabolism of over 1,000 commercially available drug-like small molecules in the worm. We discovered that fewer than 10% of these molecules accumulate to concentrations greater than 50% of that present in the worm's environment. Using our dataset, we developed a structure-based accumulation model that identifies compounds with an increased likelihood of bioavailability and bioactivity, and we describe structural features that facilitate small-molecule accumulation in the worm. Preselecting molecules that are more likely to reach a target by first applying our model to the tens of millions of commercially available compounds will undoubtedly increase the success of future small-molecule screens with C. elegans.	[Burns, Andrew R.; Tyers, Mike; Giaever, Guri; Bader, Gary D.; Nislow, Corey; Roy, Peter J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Burns, Andrew R.; Wallace, Iain M.; Giaever, Guri; Bader, Gary D.; Nislow, Corey; Roy, Peter J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Wildenhain, Jan; Tyers, Mike] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wildenhain, Jan; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Bader, Gary D.; Nislow, Corey] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Edinburgh; University of Toronto; University of Toronto; University of California System; University of California Riverside	Burns, AR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	peter.roy@utoronto.ca	Wildenhain, Jan/Q-6596-2019; Tyers, Michael/ABE-3194-2021; Wildenhain, Jan/E-5597-2011; Cutler, Sean R/D-6617-2011; Bader, Gary/C-1176-2009; Wallace, Iain/B-9464-2009; Roy, Peter/G-5357-2014	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Bader, Gary/0000-0003-0185-8861; Wallace, Iain/0000-0002-9491-7025; Roy, Peter/0000-0003-2959-2276; Nislow, Corey/0000-0002-4016-8874	Canadian Institutes of Health Research (CIHR) [68813]; Natural Sciences and Engineering Research Council of Canada; Marie Curie Fellowship; Canadian Research Chairs in Chemical Biology and Molecular Neurobiology;  [MOP-81340]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Marie Curie Fellowship(European Commission); Canadian Research Chairs in Chemical Biology and Molecular Neurobiology; 	We thank C. Cummins for critical comments on the manuscript; V. Wong and G. Selman for technical assistance early on in the project; S. Pan at the University of California, Riverside, for MS and MS-MS analyses; and A. Young of the Advanced Instrumentation for Molecular Structure Mass Spectrometry Laboratory at the University of Toronto for accurate mass MS analyses. This work was supported by Canadian Institutes of Health Research (CIHR) operating grants to P.J.R. (grant number 68813) and G.G. and C.N. (MOP-81340), Natural Sciences and Engineering Research Council of Canada support to G.D.B., a Natural Sciences and Engineering Research Council of Canada Graduate Scholarship doctoral award to A.R.B. and a Marie Curie Fellowship to I.M.W.G.G. and P.J.R. are Canadian Research Chairs in Chemical Biology and Molecular Neurobiology, respectively.	Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; BROEKS A, 1995, EMBO J, V14, P1858, DOI 10.1002/j.1460-2075.1995.tb07178.x; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Choy RKM, 1999, MOL CELL, V4, P143, DOI 10.1016/S1097-2765(00)80362-7; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Dickins M., 2004, HDB BIOANALYSIS DRUG, P208; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; Flower DR, 1998, J CHEM INF COMP SCI, V38, P379, DOI 10.1021/ci970437z; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; GARZONABURBEH A, 1986, J MED CHEM, V29, P687, DOI 10.1021/jm00155a018; Hajduk PJ, 2000, J MED CHEM, V43, P3443, DOI 10.1021/jm000164q; Herre S, 1997, J CHROMATOGR B, V692, P111, DOI 10.1016/S0378-4347(96)00472-0; Herzler M, 2003, J ANAL TOXICOL, V27, P233, DOI 10.1093/jat/27.4.233; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; INTURRISI CE, 1983, LIFE SCI, V33, P773, DOI 10.1016/0024-3205(83)90616-1; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; KERWAR SS, 1983, AM J MED, V75, P62, DOI 10.1016/0002-9343(83)90330-3; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Kokel D, 2006, NAT CHEM BIOL, V2, P338, DOI 10.1038/nchembio791; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MANCHEE G, 2004, HDB BIOANALYSIS DRUG, P222; Mason JS, 1999, J MED CHEM, V42, P3251, DOI 10.1021/jm9806998; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Xia XY, 2004, J MED CHEM, V47, P4463, DOI 10.1021/jm0303195; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	43	127	128	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					549	557		10.1038/NCHEMBIO.380	http://dx.doi.org/10.1038/NCHEMBIO.380			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20512140				2022-12-25	WOS:000278878700016
J	Orlicky, S; Tang, XJ; Neduva, V; Elowe, N; Brown, ED; Sicheri, F; Tyers, M				Orlicky, Stephen; Tang, Xiaojing; Neduva, Victor; Elowe, Nadine; Brown, Eric D.; Sicheri, Frank; Tyers, Mike			An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase	NATURE BIOTECHNOLOGY			English	Article							BETA-PROPELLERS; CELL-DIVISION; PROTEIN; SCF; PHOSPHORYLATION; ORIENTATION; PROTEOLYSIS; REFINEMENT; GROWTH	The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins(1,2). We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCFCdc4. A co-crystal structure reveals that SCF-I2 inserts itself between the beta-strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 angstrom away from the substrate binding site. Long-range transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.	[Orlicky, Stephen; Tang, Xiaojing; Sicheri, Frank; Tyers, Mike] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Neduva, Victor; Tyers, Mike] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Elowe, Nadine; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Sicheri, Frank; Tyers, Mike] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Edinburgh; McMaster University; University of Toronto	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; m.tyers@ed.ac.uk	Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Orlicky, Stephen/0000-0002-8172-2042	Canadian Institutes of Health Research [MOP-57795]; Ontario Research and Development Challenge Fund; National Cancer Institute of Canada; European Research Council; Canada Research Chair in Structural Biology of Signal Transduction; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society Wolfson Research Merit Award; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR024031] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); European Research Council(European Research Council (ERC)European Commission); Canada Research Chair in Structural Biology of Signal Transduction(Canada Research Chairs); Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society Wolfson Research Merit Award(Royal Society of London); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M. Auer, J. Walton and M. Bradley for stimulating discussions. This work was supported by grants to F.S. and M.T. from the Canadian Institutes of Health Research (MOP-57795), to E.D.B. from the Ontario Research and Development Challenge Fund and to M.T. from the National Cancer Institute of Canada and the European Research Council. F.S. is supported by a Canada Research Chair in Structural Biology of Signal Transduction and M.T. is supported by a Research Chair of the Scottish Universities Life Sciences Alliance and a Royal Society Wolfson Research Merit Award.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Blanchard JE, 2004, CHEM BIOL, V11, P1445, DOI 10.1016/j.chembiol.2004.08.011; Brunel JM, 2005, CHEM REV, V105, P857, DOI 10.1021/cr040079g; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Eddy S R, 1995, J Comput Biol, V2, P9, DOI 10.1089/cmb.1995.2.9; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	40	115	122	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					733	U1743		10.1038/nbt.1646	http://dx.doi.org/10.1038/nbt.1646			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20581844	Green Accepted			2022-12-25	WOS:000279723900031
J	Loser, K; Vogl, T; Voskort, M; Lueken, A; Kupas, V; Nacken, W; Klenner, L; Kuhn, A; Foell, D; Sorokin, L; Luger, TA; Roth, J; Beissert, S				Loser, Karin; Vogl, Thomas; Voskort, Maik; Lueken, Aloys; Kupas, Verena; Nacken, Wolfgang; Klenner, Lars; Kuhn, Annegret; Foell, Dirk; Sorokin, Lydia; Luger, Thomas A.; Roth, Johannes; Beissert, Stefan			The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8(+) T cells	NATURE MEDICINE			English	Article							CUTANEOUS LUPUS-ERYTHEMATOSUS; CD40 LIGAND; S100 PROTEINS; SYSTEMIC AUTOIMMUNITY; DENDRITIC CELLS; IN-VITRO; ARTHRITIS; DISEASE; SKIN; EXPRESSION	Mechanisms linking innate immunity and autoimmune responses are poorly understood(1). Myeloid-related protein-8 (Mrp8) and Mrp14 are damage-associated molecular pattern molecules (DAMPs) highly upregulated in various autoimmune disorders. We show in a mouse autoimmune model that local Mrp8 and Mrp14 production is essential for the induction of autoreactive CD8(+) T cells and the development of systemic autoimmunity. This effect is mediated via Toll-like receptor 4 (TLR4) signaling leading to increased interleukin-17 (IL-17) expression. Notably, expression of Mrp8 and Mrp14 was upregulated in cutaneous lupus erythematosus, and stimulation of CD8(+) T cells from individuals with lupus erythematosus with MRP proteins resulted in an upregulation of IL-17, suggesting a key role for MRP8 and MRP14 for the development of autoreactive lymphocytes during human autoimmunity as well. These results demonstrate a link between local expression of DAMP molecules and the development of systemic autoimmunity.	[Loser, Karin; Voskort, Maik; Kupas, Verena; Klenner, Lars; Kuhn, Annegret; Luger, Thomas A.; Beissert, Stefan] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Loser, Karin; Vogl, Thomas; Luger, Thomas A.; Roth, Johannes; Beissert, Stefan] Univ Munster, Interdisciplinary Ctr Clin Res, D-4400 Munster, Germany; [Vogl, Thomas; Lueken, Aloys; Foell, Dirk; Roth, Johannes] Univ Munster, Inst Immunol, D-4400 Munster, Germany; [Nacken, Wolfgang] Univ Munster, Inst Mol Virol, D-4400 Munster, Germany; [Sorokin, Lydia] Univ Munster, Inst Pathobiochem, D-4400 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster	Loser, K (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-4400 Munster, Germany.	loserk@uni-muenster.de		Sorokin, Lydia/0000-0001-7704-7921	Interdisciplinary Center of Clinical Research [Lo2/017/07, Vo2/014/09]; German Cancer Society [107891]; Federal Ministry of Education and Research [AID-Net]; German Research Association [Lo817/21]	Interdisciplinary Center of Clinical Research; German Cancer Society; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Association(German Research Foundation (DFG))	We would like to thank H. Hinte and C. Sole for excellent technical assistance. This work was supported by the Interdisciplinary Center of Clinical Research grant Lo2/017/07 to K.L. and S.B. as well as grant Vo2/014/09 to T.V., by the German Cancer Society grant 107891 to K.L. and S.B., by the Federal Ministry of Education and Research, project AID-Net to J.R. and by the German Research Association grant Lo817/21 to K.L. and S.B.	Bogumil T, 1998, NEUROSCI LETT, V247, P195, DOI 10.1016/S0304-3940(98)00263-8; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Caproni M, 2007, J RHEUMATOL, V34, P2412; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Lee HJ, 2006, AUTOIMMUNITY, V39, P433, DOI 10.1080/08916930600886851; Loser K, 2005, GENE THER, V12, P1294, DOI 10.1038/sj.gt.3302567; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Mehling A, 2001, J EXP MED, V194, P615, DOI 10.1084/jem.194.5.615; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stutte S, 2008, J INVEST DERMATOL, V128, P1470, DOI 10.1038/sj.jid.5701228; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	29	212	222	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					713	U119		10.1038/nm.2150	http://dx.doi.org/10.1038/nm.2150			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473308				2022-12-25	WOS:000278394200039
J	Ishiguro, T; Tanaka, K; Sakuno, T; Watanabe, Y				Ishiguro, Tadashi; Tanaka, Koichi; Sakuno, Takeshi; Watanabe, Yoshinori			Shugoshin-PP2A counteracts casein-kinase-1-dependent cleavage of Rec8 by separase	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; CHROMOSOME SEGREGATION; MONOPOLAR ATTACHMENT; FISSION YEAST; KINASE CDC5; MEIOSIS; PHOSPHORYLATION; COHESIN; CENTROMERES; SUBUNIT	During meiosis, the cohesin complexes that maintain sister chromatid cohesion are lost in a stepwise manner(1,2). At meiosis I the cohesin subunit Rec8 is cleaved only along the chromosome arms; until meiosis II it is protected at centromeres by the action of shugoshin (Sgo1)-protein phosphatase 2A (PP2A)(3-5). Although this regulation hypothetically involves phosphorylation that is antagonized by Sgo1-PP2A, the kinase and substrate that are responsible are as yet unknown(6,7). Using a genetic screen for 'anti-shugoshin', we identify Hhp2, an orthologue of casein kinase 1 delta/epsilon (CK1), as a factor required for Rec8 cleavage in fission yeast. We show that CK1, rather than a Polo-like kinase that is widely believed to do so, acts as the cohesin kinase to promote this cleavage during meiosis. Crucially, forced localization of excess Hhp2 at the pericentromeric region abrogates the ability of Sgo1-PP2A to protect centromeric Rec8. Thus, our studies prove the key notion that the balance between Rec8 phosphorylation and its dephosphorylation by Sgo1-PP2A regulates the step-wise loss of chromosomal cohesion in meiosis.	[Ishiguro, Tadashi; Tanaka, Koichi; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Ishiguro, Tadashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Special Coordination Funds for Promoting Science and Technology; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Silke Hauf for critically reading the manuscript; Iain Hagan and the Yeast Genetic Resource Center (YGRC) for yeast strains; and all the members of our laboratory for their valuable support and discussion. We also thank Kim Nasmyth and Wolfgang Zachariae for communicating unpublished results. This work was supported in part by Special Coordination Funds for Promoting Science and Technology (to T. S.) and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) and a Grant-in-Aid for Scientific research on Priority Areas (to K. T. and T. S.) and for Specially Promoted Research (to Y.W.), MEXT, Japan.	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	35	117	119	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					500	U201		10.1038/ncb2052	http://dx.doi.org/10.1038/ncb2052			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383139				2022-12-25	WOS:000277283700016
J	Yu, Y; Jin, H; Holder, D; Ozer, JS; Villarreal, S; Shughrue, P; Shi, S; Figueroa, DJ; Clouse, H; Su, M; Muniappa, N; Troth, SP; Bailey, W; Seng, J; Aslamkhan, AG; Thudium, D; Sistare, FD; Gerhold, DL				Yu, Yan; Jin, Hong; Holder, Daniel; Ozer, Josef S.; Villarreal, Stephanie; Shughrue, Paul; Shi, Shu; Figueroa, David J.; Clouse, Holly; Su, Ming; Muniappa, Nagaraja; Troth, Sean P.; Bailey, Wendy; Seng, John; Aslamkhan, Amy G.; Thudium, Douglas; Sistare, Frank D.; Gerhold, David L.			Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury	NATURE BIOTECHNOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED NEPHROTOXICITY; RAT; PROTEINURIA; CISPLATIN; EXPRESSION; PEPTIDE; MICROALBUMINURIA; AMINOGLYCOSIDES; TOXICOLOGY	The capacities of urinary trefoil factor 3 (TFF3) and urinary albumin to detect acute renal tubular injury have never been evaluated with sufficient statistical rigor to permit their use in regulated drug development instead of the current preclinical biomarkers serum creatinine (SCr) and blood urea nitrogen (BUN). Working with rats, we found that urinary TFF3 protein levels were markedly reduced, and urinary albumin were markedly increased in response to renal tubular injury. Urinary TFF3 levels did not respond to nonrenal toxicants, and urinary albumin faithfully reflected alterations in renal function. In situ hybridization localized TFF3 expression in tubules of the outer stripe of the outer medulla. Albumin outperformed either SCr or BUN for detecting kidney tubule injury and TFF3 augmented the potential of BUN and SCr to detect kidney damage. Use of urinary TFF3 and albumin will enable more sensitive and robust diagnosis of acute renal tubular injury than traditional biomarkers.	[Yu, Yan; Jin, Hong; Ozer, Josef S.; Shi, Shu; Su, Ming; Bailey, Wendy; Aslamkhan, Amy G.; Thudium, Douglas; Sistare, Frank D.; Gerhold, David L.] Merck Res Labs, Dept Investigat Lab Sci, West Point, PA USA; [Holder, Daniel] Merck Res Labs, Dept Biometr, West Point, PA USA; [Villarreal, Stephanie; Shughrue, Paul] Merck Res Labs, Dept Integrat Syst Neurosci, West Point, PA USA; [Figueroa, David J.] GlaxoSmithKline Inc, Dept Clin Oncol, Collegeville, PA USA; [Clouse, Holly] Merck Res Labs, Dept Exploratory Toxicol, West Point, PA USA; [Muniappa, Nagaraja; Troth, Sean P.] Merck Res Labs, Dept Pathol, West Point, PA USA; [Seng, John] Charles River Labs, Preclin Serv, Redfield, AR USA	Merck & Company; Merck & Company; Merck & Company; GlaxoSmithKline; Merck & Company; Merck & Company	Gerhold, DL (corresponding author), Merck Res Labs, Dept Investigat Lab Sci, West Point, PA USA.	david_gerhold@merck.com	Troth, Sean P./R-6885-2019	Troth, Sean P./0000-0002-4696-5129; Gerhold, David/0000-0001-5739-730X				ANSARI NH, 1992, RES COMMUN CHEM PATH, V75, P221; Baracho NCV, 1998, BRAZ J MED BIOL RES, V31, P1221, DOI 10.1590/S0100-879X1998000900016; BARKER EA, 2007, HEPATO-GASTROENTEROL, V54, P1339; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Boroushaki M, 2003, COMP BIOCHEM PHYS C, V136, P367, DOI 10.1016/j.cca.2003.10.010; BROOKS DP, 1990, J PHARMACOL EXP THER, V254, P375; CHINERY R, 1993, EUR J BIOCHEM, V212, P557, DOI 10.1111/j.1432-1033.1993.tb17693.x; Christensen E, 2007, KIDNEY INT, V72, P1192, DOI 10.1038/sj.ki.5002526; CROXATTO HR, 1976, AGENTS ACTIONS, V6, P420, DOI 10.1007/BF01973219; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Dossinger V, 2002, CELL PHYSIOL BIOCHEM, V12, P197, DOI 10.1159/000066279; FELDMAN S, 1982, J PHARMACOL EXP THER, V220, P514; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; GOLDMAN L, 2000, CECIL TEXBOOK MED; HALMAN J, 1986, TOXICOLOGY, V41, P43, DOI 10.1016/0300-483X(86)90103-4; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kern W, 2000, ANTICANCER RES, V20, P3679; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Ky B, 2002, J HISTOCHEM CYTOCHEM, V50, P1031, DOI 10.1177/002215540205000805; LeSimple P, 2007, AM J RESP CELL MOL, V36, P296, DOI 10.1165/rcmb.2006-0270OC; LOEB FW, 1999, CLIN CHEM LAB ANIMAL; Loncar MB, 2003, GUT, V52, P1297, DOI 10.1136/gut.52.9.1297; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Martinez-Salgado C, 2007, TOXICOL APPL PHARM, V223, P86, DOI 10.1016/j.taap.2007.05.004; Masuda Y, 2006, YAKUGAKU ZASSHI, V126, P885, DOI 10.1248/yakushi.126.885; Mattes WB, 2009, CLIN PHARMACOL THER, V85, P327, DOI 10.1038/clpt.2008.270; MEHENDALE HM, 1989, TOXICOL LETT, V49, P215, DOI 10.1016/0378-4274(89)90034-9; NGUYEN TKT, 2001, REN FAIL, V42, P23; Nogueira PCK, 1998, PEDIATR NEPHROL, V12, P572, DOI 10.1007/s004670050507; Ozer JS, 2010, NAT BIOTECHNOL, V28, P486, DOI 10.1038/nbt.1627; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Debata PR, 2007, BIOGERONTOLOGY, V8, P25, DOI 10.1007/s10522-006-9032-z; SAFIRSTEIN R, 1987, INT J ANDROL, V10, P325, DOI 10.1111/j.1365-2605.1987.tb00200.x; Safirstein R, 1985, AM J PHYSIOL, V249, P490; Sarafidis P A, 2007, Minerva Med, V98, P693; SCHWAB SJ, 1987, ARCH INTERN MED, V147, P943, DOI 10.1001/archinte.147.5.943; Sirica AE, 1996, TOXICOL PATHOL, V24, P90, DOI 10.1177/019262339602400113; Sistare FD, 2010, NAT BIOTECHNOL, V28, P446, DOI 10.1038/nbt.1634; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thulesen J, 1997, REGUL PEPTIDES, V72, P179, DOI 10.1016/S0167-0115(97)01058-6; Tugay S, 2006, PEDIATR NEPHROL, V21, P1389, DOI 10.1007/s00467-006-0131-5; TUNE BM, 1990, TOXICOL LETT, V53, P81, DOI 10.1016/0378-4274(90)90098-7; TUNE BM, 1994, MINER ELECTROL METAB, V20, P221; Venkat KK, 2004, SOUTH MED J, V97, P969, DOI 10.1097/01.SMJ.0000140833.51533.46; Williams RE, 2004, TOXICOLOGY, V201, P231, DOI 10.1016/j.tox.2004.05.001; YAMANO T, 1974, AM J PATHOL, V74, P575; York M, 2007, TOXICOL PATHOL, V35, P606, DOI 10.1080/01926230701389316; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242; ZOJA C, 1989, TOXICOL LETT, V46, P65, DOI 10.1016/0378-4274(89)90117-3	52	141	162	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					470	U124		10.1038/nbt.1624	http://dx.doi.org/10.1038/nbt.1624			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458317				2022-12-25	WOS:000277452700027
J	Guirao, B; Meunier, A; Mortaud, S; Aguilar, A; Corsi, JM; Strehl, L; Hirota, Y; Desoeuvre, A; Boutin, C; Han, YG; Mirzadeh, Z; Cremer, H; Montcouquiol, M; Sawamoto, K; Spassky, N				Guirao, Boris; Meunier, Alice; Mortaud, Stephane; Aguilar, Andrea; Corsi, Jean-Marc; Strehl, Laetitia; Hirota, Yuki; Desoeuvre, Angelique; Boutin, Camille; Han, Young-Goo; Mirzadeh, Zaman; Cremer, Harold; Montcouquiol, Mireille; Sawamoto, Kazunobu; Spassky, Nathalie			Coupling between hydrodynamic forces and planar cell polarity orients mammalian motile cilia	NATURE CELL BIOLOGY			English	Article							NEURAL STEM-CELLS; INTRAFLAGELLAR TRANSPORT; EPENDYMAL CELLS; DYSFUNCTIONAL CILIA; CEREBROSPINAL-FLUID; BASAL BODY; EXPRESSION; MOUSE; POLARIZATION; PROTEINS	In mammals, motile cilia cover many organs, such as fallopian tubes, respiratory tracts and brain ventricles. The development and function of these organs critically depend on efficient directional fluid flow ensured by the alignment of ciliary beating. To identify the mechanisms involved in this process, we analysed motile cilia of mouse brain ventricles, using biophysical and molecular approaches. Our results highlight an original orientation mechanism for ependymal cilia whereby basal bodies first dock apically with random orientations, and then reorient in a common direction through a coupling between hydrodynamic forces and the planar cell polarity (PCP) protein Vangl2, within a limited time-frame. This identifies a direct link between external hydrodynamic cues and intracellular PCP signalling. Our findings extend known PCP mechanisms by integrating hydrodynamic forces as long-range polarity signals, argue for a possible sensory role of ependymal cilia, and will be of interest for the study of fluid flow-mediated morphogenesis.	[Guirao, Boris; Meunier, Alice; Mortaud, Stephane; Aguilar, Andrea; Corsi, Jean-Marc; Strehl, Laetitia; Spassky, Nathalie] CNRS, UMR8197, Inst Natl Sante & Rech Med U1024, IBENS, F-75005 Paris, France; [Guirao, Boris] Inst Curie, UMR 168, Lab Physicochim Curie, F-75248 Paris, France; [Hirota, Yuki; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol, Nagoya, Aichi 4678601, Japan; [Desoeuvre, Angelique; Boutin, Camille; Cremer, Harold] Univ Mediterranee, CNRS, IBDML, Marseille, France; [Han, Young-Goo; Mirzadeh, Zaman] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Montcouquiol, Mireille] INSERM, U862, Neuroctr Magendie, Mol Basis Planar Polar Grp, F-33000 Bordeaux, France; [Montcouquiol, Mireille] Univ Bordeaux, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Nagoya City University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Spassky, N (corresponding author), CNRS, UMR8197, Inst Natl Sante & Rech Med U1024, IBENS, F-75005 Paris, France.	spassky@biologie.ens.fr	Spassky, Nathalie/E-3932-2016; Han, Young-Goo/N-2664-2018; montcouquiol, mireille/L-6199-2017; Hirota, Yuki/A-9736-2015	Han, Young-Goo/0000-0002-4008-294X; montcouquiol, mireille/0000-0001-8739-6519; Hirota, Yuki/0000-0001-9629-0038; Aguilar, Andrea/0000-0002-6115-0040; Meunier, Alice/0000-0001-6131-7747; Guirao, Boris/0000-0002-5583-0226; Mortaud, Stephane/0000-0003-0873-4781; spassky, nathalie/0000-0003-4722-6464; Sawamoto, Kazunobu/0000-0003-1984-5129; Cremer, Harold/0000-0002-8673-5176	Agence Nationale de la Recherche; International Human Frontier Science Program Organization; Fondation NRJ-Institut de France; Mairie de Paris start-up Grant; Fondation pour la Recherche Medicale; AXA Research Funds	Agence Nationale de la Recherche(French National Research Agency (ANR)); International Human Frontier Science Program Organization(Human Frontier Science Program); Fondation NRJ-Institut de France(Fondation de France); Mairie de Paris start-up Grant; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AXA Research Funds(AXA Research Fund)	We thank A. Buguin, B. Lemaire and J.-H. Codarbox for their help with the flow set-up realization. We thank Marie-Paule Muriel for excellent technical assistance and for having shared her T. E. M. background. We thank the Pitie-Salpetrisre and Cochin hospitals imaging centres. We thank B. Yoder (University of Alabama, Birmingham) and L. S. Goldstein (University of California San Diego) for providing us with Ift88<SUP>fl/fl</SUP> and Kif3a<SUP>fl/KO</SUP> mice, respectively. We thank A. Alvarez-Buylla for making Ift88<SUP>fl/fl</SUP> mice available. We thank M. Bornens for the gift of CTR453 antibody, X. Morin for the gift of pCX plasmid and MH. Bre for the gift of TAP antibody. We also thank M. Bornens, B. Durand, J.-F. Joanny and Y. Bellaiche for discussions and reading of this manuscript. This work was supported by grants from the Agence Nationale de la Recherche (to N.S.), The International Human Frontier Science Program Organization (to N.S. and K. S.), the Fondation NRJ-Institut de France (to N.S.), the Mairie de Paris start-up Grant ( to N.S.), by Fondation pour la Recherche Medicale and AXA Research Funds fellowships to A. M. and Neuropole de Recherche Francilien fellowship to J.-M.C.B.G. and A. A. were fellows of the Ministere de l'enseignement superieur et de la recherche.	Afzelius B A, 1979, Int Rev Exp Pathol, V19, P1; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cartwright JHE, 2009, HFSP J, V3, P77, DOI 10.2976/1.3043738; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; El Zein L, 2009, J CELL SCI, V122, P3180, DOI 10.1242/jcs.048348; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Genzen JR, 2009, PURINERG SIGNAL, V5, P299, DOI 10.1007/s11302-009-9143-5; Gosgnach W, 2000, AM J PHYSIOL-CELL PH, V279, pC1880, DOI 10.1152/ajpcell.2000.279.6.C1880; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Iftode F, 2003, BIOL CELL, V95, P39, DOI 10.1016/S0248-4900(03)00005-4; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; MACHEMER H, 1972, J EXP BIOL, V57, P239; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May-Simera HL, 2009, J COMP NEUROL, V514, P174, DOI 10.1002/cne.22001; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Miyan JA, 2003, CAN J PHYSIOL PHARM, V81, P317, DOI 10.1139/Y03-027; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Paltieli Y, 2000, J ASSIST REPROD GEN, V17, P103, DOI 10.1023/A:1009465900824; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; RAUTIAINEN M, 1990, EUR ARCH OTO-RHINO-L, V247, P100; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; TAMM SL, 1975, J CELL BIOL, V64, P98, DOI 10.1083/jcb.64.1.98; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; VANABEEL.JH, 1968, EXPERIENTIA, V24, P191; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	59	271	276	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					341	U86		10.1038/ncb2040	http://dx.doi.org/10.1038/ncb2040			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305650				2022-12-25	WOS:000276194600007
J	Harmon, GS; Dumlao, DS; Ng, DT; Barrett, KE; Dennis, EA; Dong, H; Glass, CK				Harmon, Gregory S.; Dumlao, Darren S.; Ng, Damian T.; Barrett, Kim E.; Dennis, Edward A.; Dong, Hui; Glass, Christopher K.			Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; CYSTIC-FIBROSIS; PROSTAGLANDIN E-2; EPITHELIAL-CELLS; BICARBONATE SECRETION; LIGAND ROSIGLITAZONE; FATTY-ACIDS; GENE; PROTEIN	Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (encoded by Cftr) that impair its role as an apical chloride channel that supports bicarbonate transport(1). Individuals with cystic fibrosis show retained, thickened mucus that plugs airways and obstructs luminal organs(2) as well as numerous other abnormalities that include inflammation of affected organs(1), alterations in lipid metabolism(3) and insulin resistance(4). Here we show that colonic epithelial cells and whole lung tissue from Cftr-deficient mice show a defect in peroxisome proliferator activated receptor-gamma (PPAR-gamma, encoded by Pparg) function that contributes to a pathological program of gene expression. Lipidomic analysis of colonic epithelial cells suggests that this defect results in part from reduced amounts of the endogenous PPAR-gamma ligand 15-keto-prostaglandin E(2) (15-keto-PGE(2)). Treatment of Cftr-deficient mice with the synthetic PPAR-gamma ligand rosiglitazone partially normalizes the altered gene expression pattern associated with Cftr deficiency and reduces disease severity. Rosiglitazone has no effect on chloride secretion in the colon, but it increases expression of the genes encoding carbonic anhydrases 4 and 2 (Car4 and Car2), increases bicarbonate secretion and reduces mucus retention. These studies reveal a reversible defect in PPAR-gamma signaling in Cftr-deficient cells that can be pharmacologically corrected to	[Harmon, Gregory S.; Barrett, Kim E.; Dong, Hui; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dumlao, Darren S.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dumlao, Darren S.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Ng, Damian T.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Harmon, GS (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	gharmon@ucsd.edu; ckg@ucsd.edu	Barrett, Kim Elaine/AAE-7762-2019; Dennis, Edward A./M-5554-2019; Glass, Christopher/AAI-3933-2021; Barrett, Kim/AAE-2794-2022	Barrett, Kim Elaine/0000-0002-6704-998X; Dennis, Edward A./0000-0003-3738-3140; Glass, Christopher/0000-0003-4344-3592; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P01DK074868, R01DK091183, T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007202, P01 DK074868-029001, P01 DK074868-01A1, P01 DK074868, P30 DK063491, P01DK074868, DK007202, DK063491, P30 DK063491-019003, P01 DK074868-030001, R01 DK091183] Funding Source: Medline; NIGMS NIH HHS [GM 069338-03, U54 GM069338-010002, U54 GM069338] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Ashburner M, 2001, GENOME RES, V11, P1425; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Clarke LL, 1996, LAB ANIM SCI, V46, P612; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; HAMOSH A, 1992, HUM MOL GENET, V1, P542, DOI 10.1093/hmg/1.7.542; Hardin DS, 1997, J PEDIATR-US, V130, P948, DOI 10.1016/S0022-3476(97)70282-8; Konstan MW, 2003, J PHARMACOL EXP THER, V306, P1086, DOI 10.1124/jpet.103.052449; Leppilampi M, 2005, P NATL ACAD SCI USA, V102, P15247, DOI 10.1073/pnas.0508007102; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Lucidi V, 2008, FREE RADICAL BIO MED, V45, P913, DOI 10.1016/j.freeradbiomed.2008.06.026; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Nichols DP, 2008, CLIN REV ALLERG IMMU, V35, P135, DOI 10.1007/s12016-008-8081-2; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ollero M, 2004, J CELL PHYSIOL, V200, P235, DOI 10.1002/jcp.20020; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; Quehenberger O, 2008, PROSTAG LEUKOTR ESS, V79, P123, DOI 10.1016/j.plefa.2008.09.021; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Rogler G, 1998, LAB INVEST, V78, P889; Sellers ZM, 2005, AM J PHYSIOL-GASTR L, V288, pG654, DOI 10.1152/ajpgi.00386.2004; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Wigren J, 2003, J ENDOCRINOL, V177, P207, DOI 10.1677/joe.0.1770207; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; ZUELZER WW, 1949, PEDIATRICS, V4, P53	40	77	79	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					313	U110		10.1038/nm.2101	http://dx.doi.org/10.1038/nm.2101			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20154695	Green Accepted			2022-12-25	WOS:000275289500037
J	Shen, J; Gilmore, EC; Marshall, CA; Haddadin, M; Reynolds, JJ; Eyaid, W; Bodell, A; Barry, B; Gleason, D; Allen, K; Ganesh, VS; Chang, BS; Grix, A; Hill, RS; Topcu, M; Caldecott, KW; Barkovich, AJ; Walsh, CA				Shen, Jun; Gilmore, Edward C.; Marshall, Christine A.; Haddadin, Mary; Reynolds, John J.; Eyaid, Wafaa; Bodell, Adria; Barry, Brenda; Gleason, Danielle; Allen, Kathryn; Ganesh, Vijay S.; Chang, Bernard S.; Grix, Arthur; Hill, R. Sean; Topcu, Meral; Caldecott, Keith W.; Barkovich, A. James; Walsh, Christopher A.			Mutations in PNKP cause microcephaly, seizures and defects in DNA repair	NATURE GENETICS			English	Article							STRAND BREAK REPAIR; HUMAN POLYNUCLEOTIDE KINASE; LIGASE IV; HAPLOTYPE RECONSTRUCTION; SPINOCEREBELLAR ATAXIA; MICE; DAMAGE; XRCC1; IMMUNODEFICIENCY; 3'-PHOSPHATASE	Maintenance of DNA integrity is crucial for all cell types, but neurons are particularly sensitive to mutations in DNA repair genes, which lead to both abnormal development and neurodegeneration(1). We describe a previously unknown autosomal recessive disease characterized by microcephaly, early-onset, intractable seizures and developmental delay (denoted MCSZ). Using genome-wide linkage analysis in consanguineous families, we mapped the disease locus to chromosome 19q13.33 and identified multiple mutations in PNKP (polynucleotide kinase 3'-phosphatase) that result in severe neurological disease; in contrast, a splicing mutation is associated with more moderate symptoms. Unexpectedly, although the cells of individuals carrying this mutation are sensitive to radiation and other DNA-damaging agents, no such individual has yet developed cancer or immunodeficiency. Unlike other DNA repair defects that affect humans, PNKP mutations universally cause severe seizures. The neurological abnormalities in individuals with MCSZ may reflect a role for PNKP in several DNA repair pathways.	[Shen, Jun; Marshall, Christine A.; Bodell, Adria; Barry, Brenda; Allen, Kathryn; Ganesh, Vijay S.; Chang, Bernard S.; Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Dept Neurol, Howard Hughes Med Inst, Boston, MA 02215 USA; [Shen, Jun; Marshall, Christine A.; Bodell, Adria; Barry, Brenda; Allen, Kathryn; Ganesh, Vijay S.; Chang, Bernard S.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Gilmore, Edward C.; Gleason, Danielle; Hill, R. Sean; Walsh, Christopher A.] Childrens Hosp Boston, Div Genet, Boston, MA USA; [Gilmore, Edward C.; Gleason, Danielle; Hill, R. Sean; Walsh, Christopher A.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Dept Med, Boston, MA USA; [Gilmore, Edward C.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp,Div Child Neurol, Boston, MA 02115 USA; [Haddadin, Mary] Al Bashir Hosp, Minist Hlth, Dept Pathol, Cytogenet Lab, Amman, Jordan; [Reynolds, John J.; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Eyaid, Wafaa] King Fahad Natl Guard Hosp, Dept Pediat, King Abdul Aziz Med City, Saudi Arabia; [Grix, Arthur] Kaiser Permanente, Point W Med Off, Dept Med Genet, Sacramento, CA USA; [Topcu, Meral] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat,Sect Pediat Neurol, Ankara, Turkey; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, Dept Neurol, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Walsh, Christopher A.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Walsh, Christopher A.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Sussex; King Abdulaziz Medical City; Kaiser Permanente; Hacettepe University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Walsh, CA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Howard Hughes Med Inst, Boston, MA 02215 USA.	Christopher.Walsh@childrens.harvard.edu	Caldecott, Keith/S-4245-2019	Walsh, Christopher/0000-0002-0156-2238; Caldecott, Keith/0000-0003-4255-9016	Victoria and Stuart Quan Fellowship; US National Institute of Neurological Disorders and Stroke [5K08NS059673-02, NSR01-35129]; Fogarty International Center [R21 NS061772]; Manton Center for Orphan Disease Research; Simons Foundation; Dubai Harvard Foundation for Medical Research; K12 Child Health Research Center [1 K12 HD052896-01A1]; Child Neurology Foundation; UK Medical Research Council [G0400959]; US National Institutes of Health [HHSN268200782096C, N01-HG-65403]; Intellectual and Developmental Disabilities Research Centers [P30 HD18655];  [G0600776]; MRC [G0600776, G9900837, G0700089, G0400959] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, K12HD052896] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R21TW008223] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS059673, R01NS035129] Funding Source: NIH RePORTER; Medical Research Council [G0801130B, G9900837, G0400959, G0600776, G0700089] Funding Source: researchfish	Victoria and Stuart Quan Fellowship; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Manton Center for Orphan Disease Research; Simons Foundation; Dubai Harvard Foundation for Medical Research; K12 Child Health Research Center; Child Neurology Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Centers; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	J.S. was supported by the Victoria and Stuart Quan Fellowship. Research was supported by grants from the US National Institute of Neurological Disorders and Stroke to E. C. G. (5K08NS059673-02) and to C. A. W. (NSR01-35129), the Fogarty International Center (R21 NS061772), the Manton Center for Orphan Disease Research, the Simons Foundation and by Dubai Harvard Foundation for Medical Research. E. C. G. was also supported by a K12 Child Health Research Center award to Children's Hospital Boston (1 K12 HD052896-01A1) and a Research in Training Award from the Child Neurology Foundation. J.J.R. and K. W. C. are supported by the UK Medical Research Council (G0600776 & G0400959). C. A. W. is an Investigator of the Howard Hughes Medical Institute. We thank S. Lindsay and S. Lisgo from the Medical Research Council-Wellcome Trust Human Developmental Biology Resource (HDBR), Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne, UK, for performing human in situ hybridizations. We are grateful for genotyping services provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the US National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C and NIH N01-HG-65403. Genotyping at Children's Hospital Boston is supported by the Intellectual and Developmental Disabilities Research Centers (CHB MRDDRC, P30 HD18655).	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HUE YK, 1994, CANCER RES, V54, P2544; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McDonald JH., 2008, HDB BIOL STAT; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun X, 2002, J PEDIATR-US, V140, P724, DOI 10.1067/mpd.2002.123879; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vemuri MC, 2001, CELL DEATH DIFFER, V8, P245, DOI 10.1038/sj.cdd.4400806; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7	28	204	212	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					245	U38		10.1038/ng.526	http://dx.doi.org/10.1038/ng.526			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20118933	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000274912400014
J	Auer-Grumbach, M; Olschewski, A; Papic, L; Kremer, H; McEntagart, ME; Uhrig, S; Fischer, C; Frohlich, E; Balint, Z; Tang, B; Strohmaier, H; Lochmuller, H; Schlotter-Weigel, B; Senderek, J; Krebs, A; Dick, KJ; Petty, R; Longman, C; Anderson, NE; Padberg, GW; Schelhaas, HJ; van Ravenswaaij-Arts, CMA; Pieber, TR; Crosby, AH; Guelly, C				Auer-Grumbach, Michaela; Olschewski, Andrea; Papic, Lea; Kremer, Hannie; McEntagart, Meriel E.; Uhrig, Sabine; Fischer, Carina; Froehlich, Eleonore; Balint, Zoltan; Tang, Bi; Strohmaier, Heimo; Lochmueller, Hanns; Schlotter-Weigel, Beate; Senderek, Jan; Krebs, Angelika; Dick, Katherine J.; Petty, Richard; Longman, Cheryl; Anderson, Neil E.; Padberg, George W.; Schelhaas, Helenius J.; van Ravenswaaij-Arts, Conny M. A.; Pieber, Thomas R.; Crosby, Andrew H.; Guelly, Christian			Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; CATION CHANNEL; REPEAT DOMAIN; TRAFFICKING; LOCALIZATION; SENSITIVITY; DISEASE; BIND; MICE	Spinal muscular atrophies (SMA, also known as hereditary motor neuropathies) and hereditary motor and sensory neuropathies (HMSN) are clinically and genetically heterogeneous disorders of the peripheral nervous system. Here we report that mutations in the TRPV4 gene cause congenital distal SMA, scapuloperoneal SMA, HMSN 2C. We identified three missense substitutions (R269H, R315W and R316C) affecting the intracellular N-terminal ankyrin domain of the TRPV4 ion channel in five families. Expression of mutant TRPV4 constructs in cells from the HeLa line revealed diminished surface localization of mutant proteins. In addition, TRPV4-regulated Ca(2+) influx was substantially reduced even after stimulation with 4. PDD, a TRPV4 channel-specific agonist, and with hypo-osmotic solution. In summary, we describe a new hereditary channelopathy caused by mutations in TRPV4 and present evidence that the resulting substitutions in the N-terminal ankyrin domain affect channel maturation, leading to reduced surface expression of functional TRPV4 channels.	[Auer-Grumbach, Michaela; Papic, Lea; Uhrig, Sabine] Med Univ Graz, Inst Human Genet, Graz, Austria; [Auer-Grumbach, Michaela; Pieber, Thomas R.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Nucl Med, Graz, Austria; [Olschewski, Andrea; Balint, Zoltan] Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria; [Kremer, Hannie] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Padberg, George W.; Schelhaas, Helenius J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Kremer, Hannie] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [McEntagart, Meriel E.; Dick, Katherine J.; Crosby, Andrew H.] St Georges Univ London, London, England; [Fischer, Carina; Froehlich, Eleonore; Strohmaier, Heimo; Krebs, Angelika; Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Tang, Bi] Med Univ Graz, Div Pulm, Univ Clin Internal Med, Graz, Austria; [Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Schlotter-Weigel, Beate] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Schlotter-Weigel, Beate] Univ Munich, Dept Neurol, D-8000 Munich, Germany; [Senderek, Jan] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Petty, Richard] So Gen Hosp, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland; [Longman, Cheryl] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland; [Anderson, Neil E.] Auckland City Hosp, Dept Neurol, Auckland, New Zealand; [van Ravenswaaij-Arts, Conny M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Medical University of Graz; Medical University of Graz; Medical University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; St Georges University London; Medical University of Graz; Medical University of Graz; Newcastle University - UK; University of Munich; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Glasgow; Auckland City Hospital; University of Groningen	Auer-Grumbach, M (corresponding author), Med Univ Graz, Inst Human Genet, Graz, Austria.	michaela.auergrumbach@medunigraz.at	Padberg, G.W.A.M./H-8079-2014; Senderek, Jan/F-8405-2015; Fröhlich, Eleonore/M-8943-2014; Schelhaas, Helenius Jurgen/E-2815-2010; Crosby, Andrew H/E-2218-2015; Kremer, Hannie/F-5126-2010; Bálint, Zoltán/AAJ-3080-2020	Senderek, Jan/0000-0002-8263-1783; Fröhlich, Eleonore/0000-0002-6056-6829; Crosby, Andrew H/0000-0003-3667-9054; Kremer, Hannie/0000-0002-0841-8693; Olschewski, Andrea/0000-0002-8189-3634; Pieber, Thomas/0000-0003-3554-0405; Lochmuller, Hanns/0000-0003-2324-8001; Balint, Zoltan/0000-0001-8598-2784	Austrian Science Fund (FWF) [P19455-B05]; Oesterreichische Nationalbank (NB) [13010]; Interdisciplinary Centre for Clinical Research BIOMAT; MRC [G0600983] Funding Source: UKRI; Medical Research Council [G0600983, G0601943B] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Oesterreichische Nationalbank (NB); Interdisciplinary Centre for Clinical Research BIOMAT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the subjects and their families who participated in this study. This work was supported by the Austrian Science Fund (FWF, P19455-B05), the Oesterreichische Nationalbank (NB, project 13010) and by the Interdisciplinary Centre for Clinical Research BIOMAT within the Faculty of Medicine, RWTH Aachen. J. S. is a Heisenberg fellow of the Deutsche Forschungsgemeinschaft (DFG). We thank M. Absenger, M. Hatz, A. Hof, H. Knausz, M. Schabhuttl, A. Gungl and T. Kueznik for expert technical assistance.	Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; FLEURY P, 1985, J NEUROL NEUROSUR PS, V48, P1037, DOI 10.1136/jnnp.48.10.1037; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; McEntagart ME, 2005, ANN NEUROL, V57, P609, DOI 10.1002/ana.20466; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; van der Vleuten AJW, 1998, EUR J HUM GENET, V6, P376, DOI 10.1038/sj.ejhg.5200229; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	30	183	186	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					160	U96		10.1038/ng.508	http://dx.doi.org/10.1038/ng.508			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20037588	Green Published, Green Accepted			2022-12-25	WOS:000274084400014
J	Crowther-Swanepoel, D; Broderick, P; Di Bernardo, MC; Dobbins, SE; Torres, M; Mansouri, M; Ruiz-Ponte, C; Enjuanes, A; Rosenquist, R; Carracedo, A; Jurlander, J; Campo, E; Juliusson, G; Montserrat, E; Smedby, KE; Dyer, MJS; Matutes, E; Dearden, C; Sunter, NJ; Hall, AG; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Parker, A; Oscier, D; Allan, JM; Catovsky, D; Houlston, RS				Crowther-Swanepoel, Dalemari; Broderick, Peter; Di Bernardo, Maria Chiara; Dobbins, Sara E.; Torres, Maria; Mansouri, Mahmoud; Ruiz-Ponte, Clara; Enjuanes, Anna; Rosenquist, Richard; Carracedo, Angel; Jurlander, Jesper; Campo, Elias; Juliusson, Gunnar; Montserrat, Emilio; Smedby, Karin E.; Dyer, Martin J. S.; Matutes, Estella; Dearden, Claire; Sunter, Nicola J.; Hall, Andrew G.; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Parker, Anton; Oscier, David; Allan, James M.; Catovsky, Daniel; Houlston, Richard S.			Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; COLORECTAL-CANCER; PROSTATE-CANCER; GENE; FAMILIES; SCAN; IG; METAANALYSIS; NUCLEOTIDE	To identify new risk variants for chronic lymphocytic leukemia (CLL), we conducted a genome-wide association study of 299,983 tagging SNPs, with validation in four additional series totaling 2,503 cases and 5,789 controls. We identified four new risk loci for CLL at 2q37.3 (rs757978, FARP2; odds ratio (OR) = 1.39; P = 2.11 x 10(-9)), 8q24.21 (rs2456449; OR = 1.26; P = 7.84 x 10(-10)), 15q21.3 (rs7169431; OR = 1.36; P = 4.74 x 10(-7)) and 16q24.1 (rs305061; OR = 1.22; P = 3.60 x 10(-7)). We also found evidence for risk loci at 15q25.2 (rs783540, CPEB1; OR = 1.18; P = 3.67 x 10(-6)) and 18q21.1 (rs1036935; OR = 1.22; P = 2.28 x 10(-6)). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy.	[Crowther-Swanepoel, Dalemari; Broderick, Peter; Di Bernardo, Maria Chiara; Dobbins, Sara E.; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Torres, Maria; Ruiz-Ponte, Clara; Carracedo, Angel] Univ Santiago de Compostela, Genom Med Grp, Santiago De Compostela, Spain; [Torres, Maria; Ruiz-Ponte, Clara; Carracedo, Angel] CIBERER, Galician Fdn Genom Med, Santiago De Compostela, Spain; [Mansouri, Mahmoud; Rosenquist, Richard] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Enjuanes, Anna; Campo, Elias] Univ Barcelona, Hematopathol Unit, Ctr Biomed Diag Hosp Clin, Barcelona, Spain; [Jurlander, Jesper] Rigshosp, Leukemia Lab, Dept Hematol, DK-2100 Copenhagen, Denmark; [Juliusson, Gunnar] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Montserrat, Emilio] Univ Barcelona, Dept Hematol, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Barcelona, Spain; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Matutes, Estella; Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Div Haematol, Sch Canc Studies, Liverpool L69 3BX, Merseyside, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England; [Pepper, Chris] Cardiff Univ, Dept Haematol, Sch Med, Cardiff, S Glam, Wales; [Fegan, Chris] Cardiff & Vale Natl Hlth Serv Trust, Cardiff, S Glam, Wales; [Parker, Anton; Oscier, David] Royal Bournemouth Hosp, Bournemouth, Dorset, England	University of London; Institute of Cancer Research - UK; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Uppsala University; University of Barcelona; Rigshospitalet; University of Copenhagen; Lund University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Karolinska Institutet; University of Leicester; University of London; Institute of Cancer Research - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Liverpool; University of Hull; University of Hull; University of York - UK; University of Hull; Heart of England NHS Foundation Trust; University of Birmingham; Cardiff University	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Allsup, David/H-2195-2017; Campo, Elias/AAC-5593-2019; Jackson, Graham/GMW-7638-2022; Torres, Maria/R-5162-2019; Carracedo, Angel/D-4257-2012; ENJUANES, Anna/H-3245-2015; Allan, James/B-4448-2009; Ruiz-Ponte, Clara/I-3849-2015; Dyer, Martin/F-2691-2014	Allsup, David/0000-0001-6159-6109; Campo, Elias/0000-0001-9850-9793; Jackson, Graham/0000-0003-0756-969X; Torres, Maria/0000-0002-2658-0133; Carracedo, Angel/0000-0003-1085-8986; ENJUANES, Anna/0000-0002-4679-6687; Ruiz-Ponte, Clara/0000-0002-2200-0162; Dyer, Martin/0000-0002-5033-2236; Allan, James/0000-0002-7580-5087; Broderick, Peter/0000-0002-8348-5829; Rosenquist, Richard/0000-0002-0211-8788; Houlston, Richard/0000-0002-5268-0242; Pepper, Chris/0000-0003-3603-8839	Leukaemia Research Fund [LRF05001, 06002]; CLL Global Research Foundation; Cancer Research UK [C1298/A8362]; Arbib Fund; Institute of Cancer Research. Funding; Wellcome Trust [076113, 085475]; UK, National Health Service; Insituto de Salud Carlos III [SAF 08/3630]; Xunta de Galicia [PGIDIT 08CSA005208PR]; Spanish National Genotyping Center; MRC [G0000934, MC_U132670597] Funding Source: UKRI; Medical Research Council [G0000934, MC_U132670597] Funding Source: researchfish	Leukaemia Research Fund; CLL Global Research Foundation; Cancer Research UK(Cancer Research UK); Arbib Fund; Institute of Cancer Research. Funding; Wellcome Trust(Wellcome TrustEuropean Commission); UK, National Health Service; Insituto de Salud Carlos III(Instituto de Salud Carlos III); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish National Genotyping Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Padyukov (Karolinska Institutet) and the EIRA group for providing control samples from the Swedish population for the Swedish replication study. We also acknowledge the work of S. Richards and R. Wade (CTSU, Oxford) in furbishing survival data from CLL-4. We are grateful to all clinicians for their involvement in patient ascertainment. Finally, we are grateful to all the patients and other individuals for their participation. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 1 and 2. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/. Leukaemia Research Fund provided principal funding for the study (LRF05001 and 06002). Additional funding was provided by CLL Global Research Foundation, Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund) and the Arbib Fund. D.C.-S. was supported by the Institute of Cancer Research. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. In the UK, National Health Service funding for the Royal Marsden Biomedical Research Centre is acknowledged. E. C. and A. E. acknowledge Fundacion Genoma Espana and CICYT funding (SAF 08/3630) and the Red Ternatica de Investigacion Cooperativa en Cancer from the Insituto de Salud Carlos III. A. C. and M. T. acknowledge Xunta de Galicia funding for Spanish control population (PGIDIT 08CSA005208PR) and the support of the Spanish National Genotyping Center (USC Node).	Allan JM, 2001, P NATL ACAD SCI USA, V98, P11592, DOI 10.1073/pnas.191211198; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; CARTWRIGHT RA, 1987, BRIT J CANCER, V56, P79, DOI 10.1038/bjc.1987.158; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2003, BRIT J HAEMATOL, V121, P866, DOI 10.1046/j.1365-2141.2003.04372.x; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Ikeda M, 2009, VIROLOGY, V385, P183, DOI 10.1016/j.virol.2008.11.018; Jaffe ES, 2001, WHO CLASSIFICATION T; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Miyamoto Y, 2003, J BIOL CHEM, V278, P29890, DOI 10.1074/jbc.M301559200; Petitti D, 1994, METAANALYSIS DECISIO; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Sellick GS, 2005, AM J HUM GENET, V77, P420, DOI 10.1086/444472; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Soderberg KC, 2006, EUR J CANCER, V42, P3028, DOI 10.1016/j.ejca.2006.04.021; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Weiss N S, 1979, Natl Cancer Inst Monogr, P139; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zenz T, 2007, BEST PRACT RES CL HA, V20, P439, DOI 10.1016/j.beha.2007.02.006; ZHANG XY, 1990, CANCER RES, V50, P6865	42	169	174	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					132	U59		10.1038/ng.510	http://dx.doi.org/10.1038/ng.510			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062064	Green Accepted			2022-12-25	WOS:000274084400009
J	Deng, HX; Klein, CJ; Yan, JH; Shi, Y; Wu, YH; Fecto, F; Yau, HJ; Yang, Y; Zhai, H; Siddique, N; Hedley-Whyte, ET; DeLong, R; Martina, M; Dyck, PJ; Siddique, T				Deng, Han-Xiang; Klein, Christopher J.; Yan, Jianhua; Shi, Yong; Wu, Yanhong; Fecto, Faisal; Yau, Hau-Jie; Yang, Yi; Zhai, Hong; Siddique, Nailah; Hedley-Whyte, E. Tessa; DeLong, Robert; Martina, Marco; Dyck, Peter J.; Siddique, Teepu			Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4	NATURE GENETICS			English	Article							MARIE-TOOTH-DISEASE; ANKYRIN REPEAT DOMAIN; HEREDITARY MOTOR; CATION CHANNEL; NEUROPATHY; MUTATIONS; VARIANTS; GENE; MICE	Scapuloperoneal spinal muscular atrophy (SPSMA) and hereditary motor and sensory neuropathy type IIC (HMSN IIC, also known as HMSN2C or Charcot-Marie-Tooth disease type 2C (CMT2C)) are phenotypically heterogeneous disorders involving topographically distinct nerves and muscles. We originally described a large New England family of French-Canadian origin with SPSMA and an American family of English and Scottish descent with CMT2C(1,2). We mapped SPSMA and CMT2C risk loci to 12q24.1-q24.31 with an overlapping region between the two diseases(3,4). Further analysis reduced the CMT2C risk locus to a 4-Mb region(5). Here we report that SPSMA and CMT2C are allelic disorders caused by mutations in the gene encoding the transient receptor potential cation channel, subfamily V, member 4 (TRPV4). Functional analysis revealed that increased calcium channel activity is a distinct property of both SPSMA- and CMT2C-causing mutant proteins. Our findings link mutations in TRPV4 to altered calcium homeostasis and peripheral neuropathies, implying a pathogenic mechanism and possible options for therapy for these disorders.	[Deng, Han-Xiang; Yan, Jianhua; Shi, Yong; Fecto, Faisal; Yang, Yi; Zhai, Hong; Siddique, Nailah; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA; [Klein, Christopher J.; Dyck, Peter J.] Mayo Clin Fdn, Dept Neurol, Div Peripheral Nerve Dis, Rochester, MN USA; [Wu, Yanhong] Mayo Clin Fdn, Dept Lab Med & Pathol, Rochester, MN USA; [Fecto, Faisal; Siddique, Teepu] Northwestern Univ, Interdept Neurosci Program, Feinberg Sch Med, Chicago, IL 60611 USA; [Yau, Hau-Jie; Martina, Marco] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [DeLong, Robert] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA	Northwestern University; Feinberg School of Medicine; Mayo Clinic; Mayo Clinic; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Duke University	Deng, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA.	h-deng@northwestern.edu; t-siddique@northwestern.edu	Siddique, Teepu/AAT-8166-2021; Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Siddique, Teepu/0000-0001-7293-9146; Deng, Han-Xiang/0000-0002-0030-8465; Fecto, Faisal/0000-0002-7587-8024; Klein, Christopher/0000-0002-4012-8856; YAU, HAU-JIE/0000-0001-7454-7971; martina, marco/0000-0002-9648-2918	National Institute of Neurological Disorders and Stroke [NS050641]; Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS065007, R01NS050641] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; David C. Asselin MD Memorial Fund; Help America Foundation; Les Turner ALS Foundation/Herbert C. Wenske Foundation; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the support from the National Institute of Neurological Disorders and Stroke (NS050641), the Les Turner ALS Foundation, the Vena E. Schaff ALS Research Fund, the Harold Post Research Professorship, the Herbert and Florence C. Wenske Foundation, the David C. Asselin MD Memorial Fund, the Help America Foundation, the Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship and the Epilepsy Foundation. We thank R.J. Miller and A. Belmadani for help with the calcium imaging studies and J. Caliendo for proofreading this manuscript.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; DELONG R, 1992, ARCH NEUROL-CHICAGO, V49, P905, DOI 10.1001/archneur.1992.00530330027010; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Liu XB, 2008, J BIOL CHEM, V283, P3688; McEntagart ME, 2005, ANN NEUROL, V57, P609, DOI 10.1002/ana.20466; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2	31	179	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					165	U102		10.1038/ng.509	http://dx.doi.org/10.1038/ng.509			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20037587	Green Accepted, Green Published			2022-12-25	WOS:000274084400015
J	Tian, C; Stokowski, RP; Kershenobich, D; Ballinger, DG; Hinds, DA				Tian, Chao; Stokowski, Renee P.; Kershenobich, David; Ballinger, Dennis G.; Hinds, David A.			Variant in PNPLA3 is associated with alcoholic liver disease	NATURE GENETICS			English	Article							ADIPONUTRIN; AMERICANS; CIRRHOSIS; RISK	Two genome-wide association studies (GWAS) have described associations of variants in PNPLA3 with nonalcoholic fatty liver and plasma liver enzyme levels. We investigated the contributions of these variants to liver disease in Mestizo subjects with a history of alcohol dependence. We found that rs738409 in PNPLA3 is strongly associated with alcoholic liver disease and clinically evident alcoholic cirrhosis (unadjusted OR = 2.25, P = 1.7 x 10(-10); ancestry-adjusted OR = 1.79, P = 1.9 x 10(-5)).	[Tian, Chao; Stokowski, Renee P.; Ballinger, Dennis G.; Hinds, David A.] Perlegen Sci, Mountain View, CA USA; [Kershenobich, David] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Ballinger, Dennis G.] Complete Genom, Mountain View, CA USA	Universidad Nacional Autonoma de Mexico	Hinds, DA (corresponding author), Perlegen Sci, Mountain View, CA USA.	david_hinds@perlegen.com						Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Flores YN, 2008, AM J GASTROENTEROL, V103, P2231, DOI 10.1111/j.1572-0241.2008.02022.x; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hoyumpa A, 2005, HEPATOLOGY, V42, p442A; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kollerits B, 2010, J MED GENET, V47, P116, DOI 10.1136/jmg.2009.066597; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Yoon Y.-H., 2008, 83 NAT I ALC AB ALC; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	15	325	329	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					21	23		10.1038/ng.488	http://dx.doi.org/10.1038/ng.488			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19946271	Bronze			2022-12-25	WOS:000273055100010
J	Ingerson-Mahar, M; Briegel, A; Werner, JN; Jensen, GJ; Gitai, Z				Ingerson-Mahar, Michael; Briegel, Ariane; Werner, John N.; Jensen, Grant J.; Gitai, Zemer			The metabolic enzyme CTP synthase forms cytoskeletal filaments	NATURE CELL BIOLOGY			English	Article							CYTIDINE TRIPHOSPHATE SYNTHETASE; CAULOBACTER-CRESCENTUS; CRYSTAL-STRUCTURE; PROTEIN; DIVISION; ACTIN; FTSZ; PROTEOLYSIS; ALIGNMENT; LOCATION	Filament-forming cytoskeletal proteins are essential for the structure and organization of all cells. Bacterial homologues of the major eukaryotic cytoskeletal families have now been discovered, but studies suggest that yet more remain to be identified. We demonstrate that the metabolic enzyme CTP synthase (CtpS) forms filaments in Caulobacter crescent us. CtpS is bifunctional, as the filaments it forms regulate the curvature of C. crescentus cells independently of its catalytic function. The morphogenic role of CtpS requires its functional interaction with the intermediate filament, crescentin (CreS). Interestingly, the Escherichia coli CtpS homologue also forms filaments both in vivo and in vitro, suggesting that CtpS polymerization may be widely conserved. E. coli CtpS can replace the enzymatic and morphogenic functions of C. crescentus CtpS, indicating that C. crescentus has adapted a conserved filament-forming protein for a secondary role. These results implicate CtpS as a novel bifunctional member of the bacterial cytoskeleton and suggest that localization and polymerization may be important properties of metabolic enzymes.	[Ingerson-Mahar, Michael; Werner, John N.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Lewis Thomas Labs, Princeton, NJ 08544 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Labs, Washington Rd, Princeton, NJ 08544 USA.	zgitai@princeton.edu	Briegel, Ariane/AAC-1085-2021; Gitai, Zemer/AAI-6989-2021	Briegel, Ariane/0000-0003-3733-3725; 	National Institute of Allergy and Infectious Diseases [1F32A1073043-01A1]; National Institutes of Health (NIH) [R01 AI067548]; Howard Hughes Medical Institute; U.S. Department of Energy Office of Science [DE-FG02-05ER64136]; NIH [1DP2OD004389-01]; Human Frontiers Science Program; Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548, F32AI073043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004389] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Beckman Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to B. Bassler, C. Murphy, E. Klein and K. Cowles for critical reading of the manuscript. We thank M. Cabeen, C. Jacobs-Wagner, J. Williamson, Alison Michaelis and other members of the Gitai lab for reagents and discussions. J.N.W. is supported by a postdoctoral fellowship from the National Institute of Allergy and Infectious Diseases (grant 1F32A1073043-01A1). A.B. and G.J.J. were supported in part by the National Institutes of Health (NIH) grant R01 AI067548, the Howard Hughes Medical Institute, and a gift to Caltech from the Gordon and Betty Moore Foundation. Z.G. is supported by funding from the U.S. Department of Energy Office of Science (Biological and Environmental Research; grant DE-FG02-05ER64136), NIH grant 1DP2OD004389-01, the Human Frontiers Science Program and the Beckman Foundation.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Briegel A, 2008, MOL MICROBIOL, V69, P30, DOI 10.1111/j.1365-2958.2008.06219.x; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carrey EA, 2002, REPRODUCTION, V123, P757, DOI 10.1530/rep.0.1230757; Charbon G, 2009, GENE DEV, V23, P1131, DOI 10.1101/gad.1795509; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELLGAARD AK, 1989, ANNU M AM SOC MICROB, V209, P208; ELY B, 1991, METHOD ENZYMOL, V204, P372; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; HARTMAN SC, 1963, J BIOL CHEM, V238, P3036; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KLEINSCH.AK, 1969, SCIENCE, V166, P1276, DOI 10.1126/science.166.3910.1276; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3365, DOI 10.1021/bi00794a008; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Li Z, 2009, CURR OPIN MICROBIOL, V12, P333, DOI 10.1016/j.mib.2009.03.007; LONG CW, 1970, J BIOL CHEM, V245, P80; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lunn FA, 2008, BIOCHEM J, V412, P113, DOI 10.1042/BJ20071163; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; PALUH JL, 1985, J BIOL CHEM, V260, P1889; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Simard D, 2003, EUR J BIOCHEM, V270, P2195, DOI 10.1046/j.1432-1033.2003.03588.x; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Srinivasan R, 2007, CURR BIOL, V17, P266, DOI 10.1016/j.cub.2006.11.069; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005; ZIGLER JS, 1991, FASEB J, V5, P223, DOI 10.1096/fasebj.5.2.2004667	40	188	191	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					739	U4		10.1038/ncb2087	http://dx.doi.org/10.1038/ncb2087			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639870	Green Accepted			2022-12-25	WOS:000280561600006
J	Leatherman, JL; DiNardo, S				Leatherman, Judith L.; DiNardo, Stephen			Germline self-renewal requires cyst stem cells and stat regulates niche adhesion in Drosophila testes	NATURE CELL BIOLOGY			English	Article							BAG-OF-MARBLES; JAK/STAT PATHWAY; IN-VIVO; DIVISION; TRANSCRIPTION; MAINTENANCE; CENTROSOME; SPERMATOGENESIS; PROLIFERATION; OVARY	Adults maintain tissue-specific stem cells through niche signals. A model for niche function is the Drosophila melanogaster testis, where a small cluster of cells called the hub produce locally available signals that allow only adjacent cells to self-renew. We show here that the principal signalling pathway implicated in this niche, chemokine activation of STAT(1,2), does not primarily regulate self-renewal of germline stem cells (GSCs), but rather governs GSC adhesion to hub cells. In fact, GSC renewal does not require hub cell contact, as GSCs can be renewed solely by contact with the second resident stem cell population, somatic cyst stem cells (CySCs), and this involves BMP signalling. These data suggest a modified model whereby the hub cells function as architects of the stem cell environment, drawing into proximity cellular components necessary for niche function. Self-renewal functions are shared by the hub cells and the CySCs. This work also reconciles key differences in GSC renewal between Drosophila testis and ovary niches, and highlights how a niche can coordinate the production of distinct lineages by having one stem cell type rely on a second cell type.	[Leatherman, Judith L.; DiNardo, Stephen] Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania	DiNardo, S (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA.	sdinardo@mail.med.upenn.edu	Leatherman, Judith/HDN-5767-2022	DiNardo, Stephen/0000-0003-4131-5511	NIH [R01GM8060804, 060804-10S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the fly community, Bloomington Stock Center, Vienna Drosophila Resource Center, and the Developmental Studies Hybridoma Bank for reagents. We thank Erika Matunis for helpful comments on the manuscript, and Seth Donoughe for technical assistance. This work was supported by NIH R01GM8060804 and 060804-10S1 to S.D.	Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Evans TA, 2009, DEV BIOL, V326, P36, DOI 10.1016/j.ydbio.2008.10.002; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; SINGH SR, J CELL PHYSL, V223, P500; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wang LW, 2008, J CELL BIOL, V180, P721, DOI 10.1083/jcb.200711022; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yu K, 2000, DEVELOPMENT, V127, P2143	27	174	179	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					806	U59		10.1038/ncb2086	http://dx.doi.org/10.1038/ncb2086			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622868	Green Accepted			2022-12-25	WOS:000280561600013
J	Polo, JM; Liu, S; Figueroa, ME; Kulalert, W; Eminli, S; Tan, KY; Apostolou, E; Stadtfeld, M; Li, YS; Shioda, T; Natesan, S; Wagers, AJ; Melnick, A; Evans, T; Hochedlinger, K				Polo, Jose M.; Liu, Susanna; Figueroa, Maria Eugenia; Kulalert, Warakorn; Eminli, Sarah; Tan, Kah Yong; Apostolou, Effie; Stadtfeld, Matthias; Li, Yushan; Shioda, Toshi; Natesan, Sridaran; Wagers, Amy J.; Melnick, Ari; Evans, Todd; Hochedlinger, Konrad			Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; EPIGENETIC MEMORY; DNA METHYLATION; GENERATION; DIFFERENTIATION; INDUCTION; EFFICIENT; CHROMATIN; ABSENCE; SYSTEM	Induced pluripotent stem cells (iPSCs) have been derived from various somatic cell populations through ectopic expression of defined factors. It remains unclear whether iPSCs generated from different cell types are molecularly and functionally similar. Here we show that iPSCs obtained from mouse fibroblasts, hematopoietic and myogenic cells exhibit distinct transcriptional and epigenetic patterns. Moreover, we demonstrate that cellular origin influences the in vitro differentiation potentials of iPSCs into embryoid bodies and different hematopoietic cell types. Notably, continuous passaging of iPSCs largely attenuates these differences. Our results suggest that early-passage iPSCs retain a transient epigenetic memory of their somatic cells of origin, which manifests as differential gene expression and altered differentiation capacity. These observations may influence ongoing attempts to use iPSCs for disease modeling and could also be exploited in potential therapeutic applications to enhance differentiation into desired cell lineages.	[Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Tan, Kah Yong; Apostolou, Effie; Stadtfeld, Matthias; Wagers, Amy J.; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Tan, Kah Yong; Apostolou, Effie; Stadtfeld, Matthias; Wagers, Amy J.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Tan, Kah Yong; Apostolou, Effie; Stadtfeld, Matthias; Wagers, Amy J.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Apostolou, Effie; Stadtfeld, Matthias; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Apostolou, Effie; Stadtfeld, Matthias; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Kulalert, Warakorn; Eminli, Sarah; Tan, Kah Yong; Apostolou, Effie; Stadtfeld, Matthias; Wagers, Amy J.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA; [Liu, Susanna; Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Figueroa, Maria Eugenia; Li, Yushan; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Tan, Kah Yong; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Natesan, Sridaran] Sanofi Aventis Cambridge Genom Ctr, Cambridge, MA USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Cornell University; Cornell University; Harvard University; Joslin Diabetes Center, Inc.; Sanofi-Aventis	Hochedlinger, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020; Figueroa, Maria/AAE-8662-2019; Melnick, Ari/AAA-5763-2020	Polo, Jose M/0000-0002-2531-778X; Stadtfeld, Matthias/0000-0002-5852-9906; Figueroa, Maria Eugenia/0000-0003-4887-4981; Tan, Kah Yong/0000-0002-6825-2752	MGH ECOR fellowship; Jane Coffin Childs fellowship; Schering fellowship; Agency of Science, Technology and Research Singapore; Lymphoma Society, SCOR [7132-08]; National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056182, R37HL056182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	MGH ECOR fellowship; Jane Coffin Childs fellowship; Schering fellowship; Agency of Science, Technology and Research Singapore(Agency for Science Technology & Research (A*STAR)); Lymphoma Society, SCOR; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Maherali and R. Walsh for helpful suggestions and critical reading of the manuscript, B. Wittner for statistical advice, J. LaVecchio, G. Buruzula, K. Folz-Donahue and L. Prickett for expert cell sorting and K. Coser for technical assistance. J.M.P. was supported by an MGH ECOR fellowship, E.A. by a Jane Coffin Childs fellowship, M.S. by a Schering fellowship and K.Y.T. by the Agency of Science, Technology and Research Singapore. Support to A.M. was from the Lymphoma Society, SCOR no. 7132-08; to T.E. from National Institutes of Health (NIH) grant HL056182 and NYSTEM; to A.J.W. in part from the Burroughs Wellcome Fund, Harvard Stem Cell Institute, Peabody Foundation, and NIH 1 DP2 OD004345-01, and the Joslin Diabetes Center DERC (P30DK036836); to K.H. from Howard Hughes Medical Institute, the NIH Director's Innovator Award and the Harvard Stem Cell Institute. The content is solely the responsibility	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Figueroa Maria E., 2009, V538, P395, DOI 10.1007/978-1-59745-418-6_20; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K., 2010, NATURE, V467, P285, DOI [10.1038/nature09342, DOI 10.1038/NATURE09342]; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	859	897	1	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					848	U130		10.1038/nbt.1667	http://dx.doi.org/10.1038/nbt.1667			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20644536	Green Submitted, Green Accepted			2022-12-25	WOS:000280757500025
J	Bachmann, BO				Bachmann, Brian O.			Biosynthesis: Is it time to go retro?	NATURE CHEMICAL BIOLOGY			English	Article							PATHWAYS; ACID		[Bachmann, Brian O.] Vanderbilt Univ, Dept Chem, Nashville, TN 37203 USA; [Bachmann, Brian O.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Bachmann, BO (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37203 USA.	brian.bachmann@vanderbilt.edu		Bachmann, Brian/0000-0001-5815-1176	NIGMS NIH HHS [R01 GM077189] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077189] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carothers JM, 2009, CURR OPIN BIOTECH, V20, P498, DOI 10.1016/j.copbio.2009.08.001; CHENG XM, 1995, LOGIC CHEM SYNTHESIS; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; COREY EJ, 1991, ANGEW CHEM INT EDIT, V30, P455, DOI 10.1002/anie.199104553; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Hubbard BK, 2000, CHEM BIOL, V7, P931, DOI 10.1016/S1074-5521(00)00043-0; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnson AP, 2008, SCIENCE, V322, P404, DOI 10.1126/science.1161527; Larock R.C., 2018, COMPREHENSIVE ORGANI; Li WS, 2005, J AM CHEM SOC, V127, P2874, DOI 10.1021/ja045148n; Marner Wesley D. II, 2009, Biotechnology Journal, V4, P1406, DOI 10.1002/biot.200900167; Metzenberg RL, 2005, GENETICS, V171, P1445; Moutselos K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-324; Prather KLJ, 2008, CURR OPIN BIOTECH, V19, P468, DOI 10.1016/j.copbio.2008.07.009; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Zhang MQ, 2008, J MED CHEM, V51, P5494, DOI 10.1021/jm8006068; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012	18	30	32	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					390	393		10.1038/nchembio.377	http://dx.doi.org/10.1038/nchembio.377			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20479744				2022-12-25	WOS:000277748100002
J	Weller, ML; Amornphimoltham, P; Schmidt, M; Wilson, PA; Gutkind, JS; Chiorini, JA				Weller, Melodie L.; Amornphimoltham, Panomwat; Schmidt, Michael; Wilson, Paul A.; Gutkind, J. Silvio; Chiorini, John A.			Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6	NATURE MEDICINE			English	Article							PROTEIN-TYROSINE KINASE; GENE-EXPRESSION; VECTORS; TRANSDUCTION; EGFR; LUNG	A key step in gene therapy is the efficient transfer of genes in a cell type- and tissue-specific manner. To better understand the mechanism of adeno-associated virus serotype 6 (AAV6) transduction, we used comparative gene analysis (CGA) combined with pathway visualization software to identify a positive correlation between AAV6 transduction and epidermal growth factor receptor (EGFR) expression. Subsequent experiments suggested that EGFR is necessary for vector internalization and probably functions as a co-receptor for AAV6.	[Weller, Melodie L.; Schmidt, Michael; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, US Natl Inst Hlth NIH, Bethesda, MD USA; [Amornphimoltham, Panomwat; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Wilson, Paul A.] NIH, Custom Applicat Branch, Div Enterprise & Custom Applicat, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, US Natl Inst Hlth NIH, Bethesda, MD USA.	jchiorini@dir.nidcr.nih.gov	Amornphimoltham, Walt/AAP-9654-2020; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; 	Intramural NIH HHS [Z01 DE000695-09] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000695, ZIADE000551] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Gilbert JL, 2008, ANTI-CANCER DRUG, V19, P783, DOI 10.1097/CAD.0b013e32830c432d; Halbert CL, 2007, HUM GENE THER, V18, P344, DOI 10.1089/hum.2006.182; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Lebherz C, 2005, HUM GENE THER, V16, P178, DOI 10.1089/hum.2005.16.178; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Mah C, 1998, J VIROL, V72, P9835, DOI 10.1128/JVI.72.12.9835-9843.1998; Schmidt M, 2006, J VIROL, V80, P5082, DOI 10.1128/JVI.80.10.5082-5085.2006; Thariat J, 2007, INT J CLIN ONCOL, V12, P99, DOI 10.1007/s10147-006-0663-5; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	15	84	90	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					662	664		10.1038/nm.2145	http://dx.doi.org/10.1038/nm.2145			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473307	Green Accepted			2022-12-25	WOS:000278394200031
J	Boulter, E; Garcia-Mata, R; Guilluy, C; Dubash, A; Rossi, G; Brennwald, PJ; Burridge, K				Boulter, Etienne; Garcia-Mata, Rafael; Guilluy, Christophe; Dubash, Adi; Rossi, Guendalina; Brennwald, Patrick J.; Burridge, Keith			Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1	NATURE CELL BIOLOGY			English	Article							BINDING PROTEIN; FAMILY GTPASES; CELL; DISSOCIATION; CDC42; GDP; ACTIVATION; ADHESION; CYTOSOL; RAC1	At steady state, most Rho GTPases are bound in the cytosol to Rho guanine nucleotide dissociation inhibitors (RhoGDIs)(1). RhoGDIs have generally been considered to hold Rho proteins passively in an inactive state within the cytoplasm. Here we describe an evolutionarily conserved mechanism by which RhoGDI1 controls the homeostasis of Rho proteins in eukaryotic cells. We found that depletion of RhoGDI1 promotes misfolding and degradation of the cytosolic geranylgeranylated pool of Rho GTPases while activating the remaining membrane-bound fraction. Because RhoGDI1 levels are limiting, and Rho proteins compete for binding to RhoGDI1, overexpression of an exogenous Rho GTPase displaces endogenous Rho proteins bound to RhoGDI1, inducing their degradation and inactivation. These results raise important questions about the conclusions drawn from studies that manipulate Rho protein levels. In many cases the response observed may arise not simply from the overexpression itself but from additional effects on the levels and activity of other Rho GTPases as a result of competition for binding to RhoGDI1; this may require a re-evaluation of previously published studies that rely exclusively on these techniques.	[Boulter, Etienne; Garcia-Mata, Rafael; Guilluy, Christophe; Dubash, Adi; Rossi, Guendalina; Brennwald, Patrick J.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burridge, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.		Guilluy, Christophe/Z-1015-2019; guilluy, christophe/C-6002-2014; Boulter, Etienne/R-1737-2016	Guilluy, Christophe/0000-0003-1141-0809; guilluy, christophe/0000-0003-1141-0809; Boulter, Etienne/0000-0001-6597-9086; Garcia-Mata, Rafael/0000-0002-7116-4411	National Institutes of Health [GM029860, GM054712]; Department of Defense [BC051092]; Susan Komen Foundation; AHA [5-40078, 0825333E]; Fondation pour la Recherche Medicale Fellowship; Allocation INSERM InCa/AVENIR [R08227AS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, R01GM054712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); AHA(American Heart Association); Fondation pour la Recherche Medicale Fellowship(Fondation pour la Recherche Medicale); Allocation INSERM InCa/AVENIR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lisa Sharek for her technical support, and Channing Der, Jim Bear and Chloe Feral for comments. This study was supported by National Institutes of Health Grants GM029860 (to K. B.) and GM054712 (to P. B.), a Department of Defense Breast Cancer Predoctoral Fellowship (BC051092 to A. D.), a Susan Komen Foundation Postdoctoral Fellowship and a AHA Beginning Grant in Aid (5-40078 to R. G. M.) and a Fondation pour la Recherche Medicale Fellowship (to E. B.), an AHA Postdoctoral Fellowship (0825333E to E. B.) and an Allocation INSERM InCa/AVENIR (R08227AS to E. B.).	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; [Anonymous], 1991, Methods Enzymol, V194, P1; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bielek H, 2009, CELL SIGNAL, V21, P1974, DOI 10.1016/j.cellsig.2009.09.008; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dransart E, 2005, J BIOL CHEM, V280, P4674, DOI 10.1074/jbc.M409741200; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; UEDA T, 1990, J BIOL CHEM, V265, P9373; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Vouret-Craviari V, 2004, J CELL SCI, V117, P4559, DOI 10.1242/jcs.01331; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	28	232	237	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					477	U136		10.1038/ncb2049	http://dx.doi.org/10.1038/ncb2049			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20400958	Green Accepted, Green Submitted			2022-12-25	WOS:000277283700013
J	Conrad, DF; Bird, C; Blackburne, B; Lindsay, S; Mamanova, L; Lee, C; Turner, DJ; Hurles, ME				Conrad, Donald F.; Bird, Christine; Blackburne, Ben; Lindsay, Sarah; Mamanova, Lira; Lee, Charles; Turner, Daniel J.; Hurles, Matthew E.			Mutation spectrum revealed by breakpoint sequencing of human germline CNVs	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; COPY NUMBER; COMPLEX REARRANGEMENTS; GENOME; MECHANISMS; DUPLICATIONS; INSTABILITY; SELECTION; REPAIR	Precisely characterizing the breakpoints of copy number variants (CNVs) is crucial for assessing their functional impact. However, fewer than 10% of known germline CNVs have been mapped to the single-nucleotide level. We characterized the sequence breakpoints from a dataset of all CNVs detected in three unrelated individuals in previous array-based CNV discovery experiments. We used targeted hybridization-based DNA capture and 454 sequencing to sequence 324 CNV breakpoints, including 315 deletions. We observed two major breakpoint signatures: 70% of the deletion breakpoints have 1-30 bp of microhomology, whereas 33% of deletion breakpoints contain 1-367 bp of inserted sequence. The co-occurrence of microhomology and inserted sequence is low (10%), suggesting that there are at least two different mutational mechanisms. Approximately 5% of the breakpoints represent more complex rearrangements, including local microinversions, suggesting a replication-based strand switching mechanism. Despite a rich literature on DNA repair processes, reconstruction of the molecular events generating each of these mutations is not yet possible.	[Conrad, Donald F.; Bird, Christine; Blackburne, Ben; Lindsay, Sarah; Mamanova, Lira; Turner, Daniel J.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge, England; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA USA	Wellcome Trust Sanger Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	meh@sanger.ac.uk	Lindsay, Sarah/CAF-4613-2022; Pillay, Nischalan/F-9536-2012	Fosker, Christine/0000-0002-3799-9474; Lindsay, Sarah/0000-0002-0965-3070; Blackburne, Benjamin/0000-0002-8158-3070	Wellcome Trust [077014/Z/05/Z]; NimbleGen	Wellcome Trust(Wellcome TrustEuropean Commission); NimbleGen	This research was funded by Wellcome Trust grant 077014/Z/05/Z. We thank the Wellcome Trust Sanger Institute for informatics and sequencing support, H. Lam for sharing sequenced CNV breakpoint locations and colleagues at NimbleGen for support and discussions.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bois P, 1999, CELL MOL LIFE SCI, V55, P1636, DOI 10.1007/s000180050402; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; CONRAD DF, 2009, NATURE, V464, P704, DOI DOI 10.1038/NATURE08516; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Staden R, 2000, Methods Mol Biol, V132, P115; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	37	184	189	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					385	U43		10.1038/ng.564	http://dx.doi.org/10.1038/ng.564			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20364136	Green Accepted			2022-12-25	WOS:000277179500007
J	Guttman, M; Garber, M; Levin, JZ; Donaghey, J; Robinson, J; Adiconis, X; Fan, L; Koziol, MJ; Gnirke, A; Nusbaum, C; Rinn, JL; Lander, ES; Regev, A				Guttman, Mitchell; Garber, Manuel; Levin, Joshua Z.; Donaghey, Julie; Robinson, James; Adiconis, Xian; Fan, Lin; Koziol, Magdalena J.; Gnirke, Andreas; Nusbaum, Chad; Rinn, John L.; Lander, Eric S.; Regev, Aviv			Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNAS; X-CHROMOSOME; STEM-CELL; GENOME; GENE; MAPS; SEQUENCES; SEQ	Massively parallel cDNA sequencing (RNA-Seq) provides an unbiased way to study a transcriptome, including both coding and noncoding genes. Until now, most RNA-Seq studies have depended crucially on existing annotations and thus focused on expression levels and variation in known transcripts. Here, we present Scripture, a method to reconstruct the transcriptome of a mammalian cell using only RNA-Seq reads and the genome sequence. We applied it to mouse embryonic stem cells, neuronal precursor cells and lung fibroblasts to accurately reconstruct the full-length gene structures for most known expressed genes. We identified substantial variation in protein coding genes, including thousands of novel 5' start sites, 3' ends and internal coding exons. We then determined the gene structures of more than a thousand large intergenic noncoding RNA (lincRNA) and antisense loci. Our results open the way to direct experimental manipulation of thousands of noncoding RNAs and demonstrate the power of ab initio reconstruction to render a comprehensive picture of mammalian transcriptomes.	[Guttman, Mitchell; Garber, Manuel; Levin, Joshua Z.; Donaghey, Julie; Robinson, James; Adiconis, Xian; Fan, Lin; Koziol, Magdalena J.; Gnirke, Andreas; Nusbaum, Chad; Rinn, John L.; Lander, Eric S.; Regev, Aviv] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Guttman, Mitchell; Lander, Eric S.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Koziol, Magdalena J.; Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Guttman, M (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA USA.	mguttman@mit.edu; aregev@broad.mit.edu		Koziol, Magdalena/0000-0002-4123-4343; Levin, Joshua/0000-0002-0170-3598; Rinn, John/0000-0002-7231-7539	Merkin Family Foundation; Vertex; Burroughs Wellcome Fund; US National Institutes of Health PIONEER; US National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005111, U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Merkin Family Foundation; Vertex(Vertex Pharmaceuticals); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health PIONEER; US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Wernig (MIT) for providing NPC; M. Lin and M. Kellis (MIT) for CSF code; the Broad Sequencing Platform for sample sequencing; L. Gaffney for assistance with graphics; and C. Burge, J. Merkin, R. Bradley and members of Lander and Regev laboratories-in particular, M. Yassour, T. Mikkelsen and I. Amit-for discussions. A.R. and J.L.R. were supported by the Merkin Family Foundation for Stem Cell Research at the Broad Institute. M. Guttman was supported by a Vertex scholarship. Work was supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface, a US National Institutes of Health PIONEER award, a US National Human Genome Research Institute (NHGRI) R01 grant and the Howard Hughes Medical Institute (A.R.), and NHGRI and the Broad Institute of MIT and Harvard (E.S.L.).	Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Ewens W, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b137845; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; GLAZ J, 2001, SCAN STAT; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	32	912	990	1	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					503	U166		10.1038/nbt.1633	http://dx.doi.org/10.1038/nbt.1633			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20436462	Green Accepted, Green Submitted			2022-12-25	WOS:000277452700031
J	Borovina, A; Superina, S; Voskas, D; Ciruna, B				Borovina, Antonia; Superina, Simone; Voskas, Daniel; Ciruna, Brian			Vangl2 directs the posterior tilting and asymmetric localization of motile primary cilia	NATURE CELL BIOLOGY			English	Article							PLANAR CELL POLARITY; EMBRYONIC-DEVELOPMENT; CONVERGENT EXTENSION; KUPFFERS VESICLE; NODAL FLOW; ZEBRAFISH; DISEASE; GASTRULATION; MOVEMENTS; MORPHOGENESIS	Cilia are microtubule-based organelles that project into the extracellular space, function in the perception and integration of environmental cues(1), and regulate Hedgehog signal transduction(2). The emergent association of ciliary defects with diverse and pleiotropic human disorders(3,4) has fuelled investigation into the molecular genetic regulation of ciliogenesis. Although recent studies implicate planar cell polarity (PCP) in cilia formation, this conclusion is based on analyses of proteins that are not specific to, or downstream effectors of PCP signal transduction(5-10). Here we characterize zebrafish embryos devoid of all Vangl2 function(11), a core and specific component of the PCP signalling pathway. Using Arl13b-GFP as a live marker of the ciliary axoneme, we demonstrate that Vangl2 is not required for ciliogenesis. Instead, Vangl2 controls the posterior tilting of primary motile cilia lining the neurocoel, Kupffer's vesicle and pronephric duct. Furthermore, we show that Vangl2 is required for asymmetric localization of cilia to the posterior apical membrane of neuroepithelial cells. Our results indicate a and essential role for PCP in the asymmetric localization and orientation of motile primary cilia, establishing directional flow implicated in normal embryonic development and	[Borovina, Antonia; Superina, Simone; Voskas, Daniel; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Borovina, Antonia; Superina, Simone; Ciruna, Brian] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ciruna, B (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ciruna@sickkids.ca						Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Jessen JR, 2004, GENE EXPR PATTERNS, V4, P339, DOI 10.1016/j.modgep.2003.09.012; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Okabe N, 2008, DEV DYNAM, V237, P3602, DOI 10.1002/dvdy.21730; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; RIDA P, 2009, SEMIN CELL DEV BIOL; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	40	241	244	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					407	U242		10.1038/ncb2042	http://dx.doi.org/10.1038/ncb2042			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305649				2022-12-25	WOS:000276194600014
J	Ding, J; Huang, SL; Wu, SQ; Zhao, YJ; Liang, LH; Yan, MX; Ge, C; Yao, J; Chen, TY; Wan, DF; Wang, HY; Gu, JR; Yao, M; Li, JJ; Tu, H; He, XH				Ding, Jie; Huang, Shenglin; Wu, Shunquan; Zhao, Yingjun; Liang, Linhui; Yan, Mingxia; Ge, Chao; Yao, Jian; Chen, Taoyang; Wan, Dafang; Wang, Hongyang; Gu, Jianren; Yao, Ming; Li, Jinjun; Tu, Hong; He, Xianghuo			Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA	NATURE CELL BIOLOGY			English	Article							FOCAL-ADHESION KINASE; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN HEPATOCELLULAR-CARCINOMA; ALLELIC IMBALANCE; CLINICOPATHOLOGICAL SIGNIFICANCE; GENETIC ALTERATIONS; PROGNOSTIC VALUE; HETEROZYGOSITY; CANCER; IDENTIFICATION	Recurrent chromosomal aberrations are often observed in hepatocellular carcinoma (HCC), but little is known about the functional non-coding sequences, particularly microRNAs (miRNAs), at the chromosomal breakpoints in HCC. Here we show that 22 miRNAs are often amplified or deleted in HCC. MicroRNA-151 (miR-151), a frequently amplified miRNA on 8q24.3, is correlated with intrahepatic metastasis of HCC. We further show that miR-151, which is often expressed together with its host gene FAK, encoding focal adhesion kinase, significantly increases HCC cell migration and invasion in vitro and in vivo, mainly through miR-151-5p, but not through miR-151-3p. Moreover, miR-151 exerts this function by directly targeting RhoGDIA, a putative metastasis suppressor in HCC, thus leading to the activation of Rac1, Cdc42 and Rho GTPases. In addition, miR-151 can function synergistically with FAK to enhance HCC cell motility and spreading. Thus, our findings indicate that chromosome gain of miR-151 is a crucial stimulus for tumour invasion and metastasis of HCC.	[Ding, Jie; Huang, Shenglin; Wu, Shunquan; Zhao, Yingjun; Liang, Linhui; Ge, Chao; Yao, Jian; Wan, Dafang; Wang, Hongyang; Gu, Jianren; Li, Jinjun; Tu, Hong; He, Xianghuo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China; [Zhao, Yingjun; Yao, Jian] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Yan, Mingxia; Yao, Ming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Dept Expt Pathol, Shanghai 200032, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong 226200, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China.	xhhe@shsci.org	Huang, Shenglin/N-9472-2018; He, Xianghuo/I-1497-2014; Jian, YAO/AAT-4231-2021	Huang, Shenglin/0000-0003-1279-0794; He, Xianghuo/0000-0001-8872-668X; Jian, YAO/0000-0002-3746-1279; Tu, Hong/0000-0002-8298-5207				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Blackhall FH, 2004, LUNG CANCER, V46, P197, DOI 10.1016/j.lungcan.2004.04.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan KL, 2002, CANCER, V94, P3179, DOI 10.1002/cncr.10612; Chen YJ, 2000, GASTROENTEROLOGY, V119, P431, DOI 10.1053/gast.2000.9373; Chow VTK, 1998, GENOME, V41, P543, DOI 10.1139/gen-41-4-543; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dykema KJ, 2004, GENE CHROMOSOME CANC, V41, P390, DOI 10.1002/gcc.20090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang W, 2000, GENE CHROMOSOME CANC, V28, P269, DOI 10.1002/1098-2264(200007)28:3<269::AID-GCC4>3.3.CO;2-B; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Hammond C, 1999, HEPATOLOGY, V29, P1479, DOI 10.1002/hep.510290513; HE L, 2004, NAT REV GENET, V5, P522; Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Kahng YS, 2003, J GASTROEN HEPATOL, V18, P430, DOI 10.1046/j.1440-1746.2003.02997.x; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Koshikawa K, 2004, HEPATO-GASTROENTEROL, V51, P186; Lau SH, 2005, ACTA PHARMACOL SIN, V26, P659, DOI 10.1111/j.1745-7254.2005.00126.x; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Liew CT, 1999, INT J CANCER, V81, P319, DOI 10.1002/(SICI)1097-0215(19990505)81:3<319::AID-IJC1>3.0.CO;2-K; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maddala R, 2008, DEV BIOL, V315, P217, DOI 10.1016/j.ydbio.2007.12.039; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mihara M, 1999, BRIT J CANCER, V79, P164, DOI 10.1038/sj.bjc.6690027; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishimura T, 2005, GENE CHROMOSOME CANC, V42, P34, DOI 10.1002/gcc.20117; Okabe H, 2000, HEPATOLOGY, V31, P1073, DOI 10.1053/he.2000.6409; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parada LA, 1998, GENE CHROMOSOME CANC, V23, P26; Piao Z, 1999, BRIT J CANCER, V80, P850, DOI 10.1038/sj.bjc.6690431; Piao Z, 1998, CANCER LETT, V122, P201, DOI 10.1016/S0304-3835(97)00403-5; Pineau P, 1999, ONCOGENE, V18, P3127, DOI 10.1038/sj.onc.1202648; Ricketts SL, 2003, MOL CARCINOGEN, V36, P90, DOI 10.1002/mc.10101; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; von Sengbusch A, 2005, AM J PATHOL, V166, P585, DOI 10.1016/S0002-9440(10)62280-8; Wang G, 2001, GENE CHROMOSOME CANC, V31, P221, DOI 10.1002/gcc.1138; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Xu ZH, 2003, BIOCHEM BIOPH RES CO, V311, P1057, DOI 10.1016/j.bbrc.2003.10.109; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yeh SH, 2004, HEPATOLOGY, V40, P847, DOI 10.1002/hep.20409; Yeh SH, 2001, GASTROENTEROLOGY, V121, P699, DOI 10.1053/gast.2001.27211; Yuan BZ, 2003, J MOL DIAGN, V5, P48, DOI 10.1016/S1525-1578(10)60451-5; Zhang LH, 2003, J CANCER RES CLIN, V129, P279, DOI 10.1007/s00432-002-0407-5; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang SH, 2005, WORLD J GASTROENTERO, V11, P3034, DOI 10.3748/wjg.v11.i20.3034; Zhu GN, 2004, WORLD J GASTROENTERO, V10, P1975	64	262	297	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					390	U208		10.1038/ncb2039	http://dx.doi.org/10.1038/ncb2039			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20305651				2022-12-25	WOS:000276194600012
J	Himburg, HA; Muramoto, GG; Daher, P; Meadows, SK; Russell, JL; Doan, P; Chi, JT; Salter, AB; Lento, WE; Reya, T; Chao, NJ; Chute, JP				Himburg, Heather A.; Muramoto, Garrett G.; Daher, Pamela; Meadows, Sarah K.; Russell, J. Lauren; Doan, Phuong; Chi, Jen-Tsan; Salter, Alice B.; Lento, William E.; Reya, Tannishtha; Chao, Nelson J.; Chute, John P.			Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells	NATURE MEDICINE			English	Article							EX-VIVO CULTURE; ENDOTHELIAL-CELLS; SELF-RENEWAL; IN-VIVO; CD34(+)CD38(-) CELLS; PATHWAYS; NICHE; RECONSTITUTION; TRANSDUCTION; ENGRAFTMENT	Hematopoietic stem cell (HSC) self-renewal is regulated by both intrinsic and extrinsic signals. Although some of the pathways that regulate HSC self-renewal have been uncovered, it remains largely unknown whether these pathways can be triggered by deliverable growth factors to induce HSC growth or regeneration. Here we show that pleiotrophin, a neurite outgrowth factor with no known function in hematopoiesis, efficiently promotes HSC expansion in vitro and HSC regeneration in vivo. Treatment of mouse bone marrow HSCs with pleiotrophin caused a marked increase in long-term repopulating HSC numbers in culture, as measured in competitive repopulating assays. Treatment of human cord blood CD34+CDCD38(-)Lin(-) cells with pleiotrophin also substantially increased severe combined immunodeficient (SCID)-repopulating cell counts in culture, compared to input and cytokine-treated cultures. Systemic administration of pleiotrophin to irradiated mice caused a pronounced expansion of bone marrow stem and progenitor cells in vivo, indicating that pleiotrophin is a regenerative growth factor for HSCs. Mechanistically, pleiotrophin activated phosphoinositide 3-kinase (PI3K) signaling in HSCs; antagonism of PI3K or Notch signaling inhibited pleiotrophin-mediated expansion of HSCs in culture. We identify the secreted growth factor pleiotrophin as a new regulator of both HSC expansion and regeneration.	[Himburg, Heather A.; Muramoto, Garrett G.; Daher, Pamela; Meadows, Sarah K.; Russell, J. Lauren; Doan, Phuong; Chi, Jen-Tsan; Salter, Alice B.; Chao, Nelson J.; Chute, John P.] Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA; [Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Lento, William E.; Reya, Tannishtha; Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Chao, Nelson J.] Duke Univ, Dept Immunol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Chute, JP (corresponding author), Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA.	john.chute@duke.edu	Doan, Phuong L./Q-2093-2019; Chi, Jen-Tsan/AAI-4125-2020	Doan, Phuong L./0000-0003-1361-2068; Chi, Jen-Tsan/0000-0003-3433-903X	US National Institutes of Health [AI067798]; Center for Biomolecular and Tissue Engineering; US National Institute of Biomedical Imaging and Bioengineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomolecular and Tissue Engineering; US National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. Whitesides for assistance with cell sorting procedures. This work was supported in part by US National Institutes of Health grant AI067798 to J. P. C., H. A. H. is supported by a post-doctoral training grant from the Center for Biomolecular and Tissue Engineering, US National Institute of Biomedical Imaging and Bioengineering.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Chute JP, 2005, BLOOD, V105, P576, DOI 10.1182/blood-2004-04-1467; Chute JP, 2002, BLOOD, V100, P4433, DOI 10.1182/blood-2002-04-1238; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Dorrell C, 2000, BLOOD, V95, P102; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	40	216	231	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					475	U163		10.1038/nm.2119	http://dx.doi.org/10.1038/nm.2119			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20305662	Green Accepted			2022-12-25	WOS:000276446800054
J	Park, SW; Zhou, YJ; Lee, J; Lu, A; Sun, C; Chung, J; Ueki, K; Ozcan, U				Park, Sang Won; Zhou, Yingjiang; Lee, Justin; Lu, Allen; Sun, Cheng; Chung, Jason; Ueki, Kohjiro; Ozcan, Umut			The regulatory subunits of PI3K, p85 alpha and p85 beta, interact with XBP-1 and increase its nuclear translocation	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE PROTEIN; SIGNALING PATHWAYS; MESSENGER-RNA; ER; DEPHOSPHORYLATION; TRANSCRIPTION; BIOSYNTHESIS; TRANSLATION; ACTIVATION	Despite the fact that X-box binding protein-1 (XBP-1) is one of the main regulators of the unfolded protein response (UPR), the modulators of XBP-1 are poorly understood. Here, we show that the regulatory subunits of phosphotidyl inositol 3-kinase (PI3K), p85 alpha (encoded by Pik3r1) and p85 beta (encoded by Pik3r2) form heterodimers that are disrupted by insulin treatment. This disruption of heterodimerization allows the resulting monomers of p85 to interact with, and increase the nuclear translocation of, the spliced form of XBP-1 (XBP-1s). The interaction between p85 and XBP-1s is lost in ob/ob mice, resulting in a severe defect in XBP-1s translocation to the nucleus and thus in the resolution of endoplasmic reticulum (ER) stress. These defects are ameliorated when p85 alpha and p85 beta are overexpressed in the liver of ob/ob mice. Our results define a previously unknown insulin receptor signaling pathway and provide new mechanistic insight into the development of ER stress during obesity.	[Ueki, Kohjiro] Univ Tokyo, Dept Metab Dis, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Park, Sang Won; Zhou, Yingjiang; Lee, Justin; Lu, Allen; Sun, Cheng; Chung, Jason; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol Childrens Hosp Boston, Boston, MA USA	University of Tokyo; Harvard University; Harvard Medical School	Ueki, K (corresponding author), Univ Tokyo, Dept Metab Dis, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	ueki-tky@umin.net; umut.ozcan@childrens.harvard.edu	Longo, Kenneth A/A-5631-2010		Children's Hospital Boston; Translational Research Award; Timothy Murphy funds;  [R01DK081009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009] Funding Source: NIH RePORTER	Children's Hospital Boston; Translational Research Award; Timothy Murphy funds; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Ozcan laboratory for their contributions to this project. We are grateful to L. Cantley (Harvard Medical School) for kindly providing us with the Pik3r1<SUP>f/f</SUP>; Pik3r2<SUP>-/-</SUP> mice. We would like to thank the Children's Hospital Boston Proteomics Core Facility and H. Steen for the tandem mass spectroscopy analysis. This study was supported by junior faculty start-up funds provided to U.O. by Children's Hospital Boston, Translational Research Award, an RO1 grant (R01DK081009) provided to U.O., and Timothy Murphy funds provided to Division of Endocrinology, Children's Hospital Boston.	Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Dai YX, 2007, J PSYCHIATR NEUROSCI, V32, P323; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Furuya F, 2007, STEROIDS, V72, P171, DOI 10.1016/j.steroids.2006.11.005; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MORI K, 1993, CELL, V74, P743; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sephton CF, 2008, J NEUROSCI RES, V86, P675, DOI 10.1002/jnr.21516; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	33	206	218	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					429	U111		10.1038/nm.2099	http://dx.doi.org/10.1038/nm.2099			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20348926	Green Accepted			2022-12-25	WOS:000276446800047
J	Sareen, D; Svendsen, CN				Sareen, Dhruv; Svendsen, Clive N.			Stem cell biologists sure play a mean pinball	NATURE BIOTECHNOLOGY			English	Editorial Material							DEFINED FACTORS; FIBROBLASTS; NEURONS; SKIN		[Sareen, Dhruv; Svendsen, Clive N.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Sareen, D (corresponding author), Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA.	dhruv.sareen@cshs.org; clive.svendsen@cshs.org			NINDS NIH HHS [P01 NS057778, P01 NS057778-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS057778] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Motohashi T, 2009, STEM CELLS, V27, P888, DOI 10.1634/stemcells.2008-0678; Nicholas CR, 2010, NATURE, V463, P1031, DOI 10.1038/4631031a; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	11	11	12	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					333	335		10.1038/nbt0410-333	http://dx.doi.org/10.1038/nbt0410-333			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20379177	Green Accepted			2022-12-25	WOS:000276462400019
J	Li, HH; Rybicki, AC; Suzuka, SM; von Bonsdorff, L; Breuer, W; Hall, CB; Cabantchik, ZI; Bouhassira, EE; Fabry, ME; Ginzburg, YZ				Li, Huihui; Rybicki, Anne C.; Suzuka, Sandra M.; von Bonsdorff, Leni; Breuer, William; Hall, Charles B.; Cabantchik, Z. Ioav; Bouhassira, Eric E.; Fabry, Mary E.; Ginzburg, Yelena Z.			Transferrin therapy ameliorates disease in beta-thalassemic mice	NATURE MEDICINE			English	Article							LABILE PLASMA IRON; INEFFECTIVE ERYTHROPOIESIS; HEPCIDIN EXPRESSION; REDOX ACTIVITY; ALPHA-GLOBIN; MOUSE MODEL; BINDING; PATHOPHYSIOLOGY; QUANTIFICATION; IDENTIFICATION	Individuals with beta-thalassemia develop progressive systemic iron overload, resulting in high morbidity and mortality. These complications are caused by labile plasma iron, which is taken up by parenchymal cells in a dysregulated manner; in contrast, erythropoiesis depends on transferrin-bound iron uptake via the transferrin receptor. We hypothesized that the ineffective erythropoiesis and anemia observed in beta-thalassemia might be ameliorated by increasing the amount of circulating transferrin. We tested the ability of transferrin injections to modulate iron metabolism and erythropoiesis in Hbb(th1/th1) mice, an experimental model of beta-thalassemia. Injected transferrin reversed or markedly improved the thalassemia phenotype in these mice. Specifically, transferrin injections normalized labile plasma iron concentrations, increased hepcidin expression, normalized red blood cell survival and increased hemoglobin production; this treatment concomitantly decreased reticulocytosis, erythropoietin abundance and splenomegaly. These results indicate that transferrin is a limiting factor contributing to anemia in these mice and suggest that transferrin therapy might be beneficial in human beta-thalassemia.	[Li, Huihui; Ginzburg, Yelena Z.] New York Blood Ctr, Lindsley F Kimball Res Inst, Erythropoiesis Lab, New York, NY 10021 USA; [Rybicki, Anne C.] Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA; [Suzuka, Sandra M.; Bouhassira, Eric E.; Fabry, Mary E.] Albert Einstein Coll Med, Div Hematol, Bronx, NY 10467 USA; [von Bonsdorff, Leni] Sanquin, Helsinki, Finland; [Breuer, William; Cabantchik, Z. Ioav] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91905 Jerusalem, Israel; [Hall, Charles B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	New York Blood Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Hebrew University of Jerusalem; Yeshiva University; Albert Einstein College of Medicine	Ginzburg, YZ (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Erythropoiesis Lab, New York, NY 10021 USA.	yginzburg@nybloodcenter.org	Hall, Charles B./AAX-8216-2020; Bouhassira, Eric/AAZ-4184-2021	Hall, Charles/0000-0001-9982-8120	US National Institutes of Health-National Heart, Lung, and Blood Institute [HL68962, HL07556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068962] Funding Source: NIH RePORTER	US National Institutes of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We extend special thanks to M. Knutson ( University of Florida, Gainesville) for providing mouse antibodies to FPN-1, Jacobi Medical Center for sample analysis, T. Ganz, E. Nemeth and S. Rivella for stimulating discussions and R. Nagel and M. Narla for unparalleled guidance and support. This work was supported in part by contract grant sponsor US National Institutes of Health-National Heart, Lung, and Blood Institute number HL68962 and HL07556.	Adamsky K, 2004, BRIT J HAEMATOL, V124, P123, DOI 10.1046/j.1365-2141.2003.04734.x; Beauchemin H, 2004, J BIOL CHEM, V279, P19471, DOI 10.1074/jbc.M309989200; Centis F, 2000, BLOOD, V96, P3624; Chaudhury C, 2006, J NUTR, V136, P2993, DOI 10.1093/jn/136.12.2993; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; De Franceschi L, 2006, HAEMATOLOGICA, V91, P1336; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; FINCH C, 1994, BLOOD, V84, P1697; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; GARRICK LM, 1989, EXP HEMATOL, V17, P423; Ginzburg YZ, 2009, EXP HEMATOL, V37, P172, DOI 10.1016/j.exphem.2008.10.004; HOSAIN F, 1967, J CLIN INVEST, V46, P1, DOI 10.1172/JCI105501; HUEBERS HA, 1987, PHYSIOL REV, V67, P520, DOI 10.1152/physrev.1987.67.2.520; HUEBERS HA, 1984, P NATL ACAD SCI-BIOL, V81, P4326, DOI 10.1073/pnas.81.14.4326; HUEBERS HA, 1983, P NATL ACAD SCI-BIOL, V80, P300, DOI 10.1073/pnas.80.1.300; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkkinen J, 2006, BRIT J HAEMATOL, V135, P228, DOI 10.1111/j.1365-2141.2006.06273.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; PIPPARD MJ, 1979, LANCET, V2, P819; Pootrakul P, 2004, BLOOD, V104, P1504, DOI 10.1182/blood-2004-02-0630; POOTRAKUL P, 1988, BLOOD, V71, P1124; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Silva AMN, 2009, BBA-PROTEINS PROTEOM, V1794, P1449, DOI 10.1016/j.bbapap.2009.06.003; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; SORENSEN S, 1990, BLOOD, V75, P1333; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; von Bonsdorff L, 2001, BIOLOGICALS, V29, P27, DOI 10.1006/biol.2001.0273; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3	44	148	157	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					177	U80		10.1038/nm.2073	http://dx.doi.org/10.1038/nm.2073			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20098432				2022-12-25	WOS:000274297000038
J	Stein, S; Ott, MG; Schultze-Strasser, S; Jauch, A; Burwinkel, B; Kinner, A; Schmidt, M; Kramer, A; Schwable, J; Glimm, H; Koehl, U; Preiss, C; Ball, C; Martin, H; Gohring, G; Schwarzwaelder, K; Hofmann, WK; Karakaya, K; Tchatchou, S; Yang, RX; Reinecke, P; Kuhlcke, K; Schlegelberger, B; Thrasher, AJ; Hoelzer, D; Seger, R; von Kalle, C; Grez, M				Stein, Stefan; Ott, Marion G.; Schultze-Strasser, Stephan; Jauch, Anna; Burwinkel, Barbara; Kinner, Andrea; Schmidt, Manfred; Kraemer, Alwin; Schwaeble, Joachim; Glimm, Hanno; Koehl, Ulrike; Preiss, Carolin; Ball, Claudia; Martin, Hans; Goehring, Gudrun; Schwarzwaelder, Kerstin; Hofmann, Wolf-Karsten; Karakaya, Kadin; Tchatchou, Sandrine; Yang, Rongxi; Reinecke, Petra; Kuehlcke, Klaus; Schlegelberger, Brigitte; Thrasher, Adrian J.; Hoelzer, Dieter; Seger, Reinhard; von Kalle, Christof; Grez, Manuel			Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease	NATURE MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RETROVIRAL VECTOR INSERTION; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELLS; EXPRESSION; METHYLATION; MLL5; PROLIFERATION; INTEGRATION; REPRESSION	Gene-modified autologous hematopoietic stem cells (HSC) can provide ample clinical benefits to subjects suffering from X-linked chronic granulomatous disease (X-CGD), a rare inherited immunodeficiency characterized by recurrent, often life-threatening bacterial and fungal infections. Here we report on the molecular and cellular events observed in two young adults with X-CGD treated by gene therapy in 2004. After the initial resolution of bacterial and fungal infections, both subjects showed silencing of transgene expression due to methylation of the viral promoter, and myelodysplasia with monosomy 7 as a result of insertional activation of ecotropic viral integration site 1 (EVI1). One subject died from overwhelming sepsis 27 months after gene therapy, whereas a second subject underwent an allogeneic HSC transplantation. Our data show that forced overexpression of EVI1 in human cells disrupts normal centrosome duplication, linking EVI1 activation to the development of genomic instability, monosomy 7 and clonal progression toward myelodysplasia.	[Stein, Stefan; Schultze-Strasser, Stephan; Kinner, Andrea; Preiss, Carolin; Grez, Manuel] Inst Biomed Res, Frankfurt, Germany; [Ott, Marion G.; Schwaeble, Joachim; Martin, Hans; Hoelzer, Dieter] Univ Med Sch, Dept Hematol Oncol, Frankfurt, Germany; [Jauch, Anna] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany; [Burwinkel, Barbara; Tchatchou, Sandrine; Yang, Rongxi] German Canc Res Ctr, Mol Epidemiol Grp, D-6900 Heidelberg, Germany; [Burwinkel, Barbara; Tchatchou, Sandrine; Yang, Rongxi] Univ Womens Clin, Div Mol Biol Breast Canc, Heidelberg, Germany; [Schmidt, Manfred; Glimm, Hanno; Ball, Claudia; Schwarzwaelder, Kerstin; von Kalle, Christof] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Kraemer, Alwin; Karakaya, Kadin] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, D-6900 Heidelberg, Germany; [Kraemer, Alwin; Karakaya, Kadin] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Koehl, Ulrike] Hannover Med Sch, Dept Cell & Mol Pathol, D-3000 Hannover, Germany; [Goehring, Gudrun; Schlegelberger, Brigitte] Charite, Dept Hematol Oncol & Transfus Med, Berlin, Germany; [Hofmann, Wolf-Karsten] Univ Dusseldorf, Inst Pathol, D-4000 Dusseldorf, Germany; [Reinecke, Petra] EUFETS AG, Idar Oberstein, Germany; [Kuehlcke, Klaus] UCL Inst Child Hlth, Ctr Immunodeficiency, London, England; [Kuehlcke, Klaus] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Thrasher, Adrian J.] Univ Childrens Hosp Zurich, Div Hematol Immunol, Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University Children's Hospital Zurich	Grez, M (corresponding author), Inst Biomed Res, Frankfurt, Germany.	grez@em.uni-frankfurt.de		Thrasher, Adrian/0000-0002-6097-6115; Ball, Claudia/0000-0002-1749-3791; Stein, Stefan/0000-0003-1473-9706; Koehl, Ulrike/0000-0002-8159-9160	Bundesministerium fur Bildung und Forschung [01GU0507, TP6b]; Chronic Granulomatous Disorder Research Trust, London [J4G/04B/GT]; Georg-Speyer-Haus [T300131]; EU; Deutsche Forschungsgemeinschaft; Wellcome Trust; Department of Health [HTH/011/025/004]; Deutsche Krebshilfe [108560]; Bundesministerium fur Gesundheit and the Hessisches Ministerium fur Wissenschaft und Kunst; Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Chronic Granulomatous Disorder Research Trust, London; Georg-Speyer-Haus; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Department of Health; Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Gesundheit and the Hessisches Ministerium fur Wissenschaft und Kunst; Great Ormond Street Hospital Childrens Charity	We are indebted to K. Bleuel and S. Wehner for contributions and advice during the study; to H. Holtgreve-Grez and B. Schoell for I-FISH and M-FISH analysis, respectively; to H. Konrad Muller-Hermelink for reference pathology; to B. Staehle for quantitative PCR; to M. C. Dinauer ( Indiana University School of Medicine) for plasmid gp91<SUP>phox</SUP>(P415H) and to H. Kunkel, E. Rudolf, A. Dillmann, R. Kramer, B. Moreno, I. Vogler and L. Chen-Wichmann for assistance during this work. This work was supported by the Bundesministerium fur Bildung und Forschung ( grant 01GU0507, TP6b), the Chronic Granulomatous Disorder Research Trust, London ( grant J4G/04B/GT), the Georg-Speyer-Haus (T300131), the EU ( VIth Framework Program, CONSERT), the Research Priority Program 1230 from the Deutsche Forschungsgemeinschaft and, in part, by a grant of the Tumorzentrum Heidelberg/Mannheim to A.J.A.J.T. is also supported by the Wellcome Trust and the Department of Health ( HTH/011/025/004). A. Kramer is supported by the Deutsche Krebshilfe ( grant 108560). The Georg-Speyer-Haus is supported by the Bundesministerium fur Gesundheit and the Hessisches Ministerium fur Wissenschaft und Kunst.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Burns WR, 2009, BLOOD, V114, P2888, DOI 10.1182/blood-2009-01-199216; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattaneo F, 2008, J CELL BIOCHEM, V105, P344, DOI 10.1002/jcb.21869; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Charrin Christiane, 2002, Hematol J, V3, P21, DOI 10.1038/sj.thj.6200143; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; DREYFUS F, 1995, LEUKEMIA, V9, P203; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Frank O, 2004, BLOOD, V104, P3543, DOI 10.1182/blood-2004-03-0852; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hamaguchi H, 1997, BRIT J HAEMATOL, V98, P399, DOI 10.1046/j.1365-2141.1997.2143029.x; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kearns WG, 2004, GENE CHROMOSOME CANC, V40, P329, DOI 10.1002/gcc.20043; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kramer A, 2002, LEUKEMIA, V16, P767, DOI 10.1038/sj.leu.2402454; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Laricchia-Robbio L, 2008, BLOOD CELL MOL DIS, V40, P141, DOI 10.1016/j.bcmd.2007.07.012; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Lin P, 2006, CANCER GENET CYTOGEN, V166, P82, DOI 10.1016/j.cancergencyto.2005.10.007; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Malech HL, 2007, CURR OPIN HEMATOL, V14, P29, DOI 10.1097/00062752-200701000-00007; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Neben K, 2003, BLOOD, V101, P289, DOI 10.1182/blood-2002-04-1188; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; Nucifora G, 1997, LEUKEMIA, V11, P2022, DOI 10.1038/sj.leu.2400880; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PERKINS AS, 1991, DEVELOPMENT, V111, P479; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROOS D, 1994, IMMUNOL REV, V138, P121, DOI 10.1111/j.1600-065X.1994.tb00850.x; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Senyuk V, 2007, CANCER RES, V67, P5658, DOI 10.1158/0008-5472.CAN-06-3962; Spensberger D, 2008, FEBS LETT, V582, P2761, DOI 10.1016/j.febslet.2008.06.056; Spensberger D, 2008, BIOCHEMISTRY-US, V47, P6418, DOI 10.1021/bi800267f; Stevens-Kroef M, 2004, LEUKEMIA, V18, P1108, DOI 10.1038/sj.leu.2403346; Trubia M, 2006, LEUKEMIA, V20, P48, DOI 10.1038/sj.leu.2404020; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Wang LJ, 1998, HUM GENE THER, V9, P2321, DOI 10.1089/hum.1998.9.16-2321; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905	59	584	600	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					198	U105		10.1038/nm.2088	http://dx.doi.org/10.1038/nm.2088			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20098431	Green Published			2022-12-25	WOS:000274297000041
J	Hutt, DM; Herman, D; Rodrigues, APC; Noel, S; Pilewski, JM; Matteson, J; Hoch, B; Kellner, W; Kelly, JW; Schmidt, A; Thomas, PJ; Matsumura, Y; Skach, WR; Gentzsch, M; Riordan, JR; Sorscher, EJ; Okiyoneda, T; Yates, JR; Lukacs, GL; Frizzell, RA; Manning, G; Gottesfeld, JM; Balch, WE				Hutt, Darren M.; Herman, David; Rodrigues, Ana P. C.; Noel, Sabrina; Pilewski, Joseph M.; Matteson, Jeanne; Hoch, Ben; Kellner, Wendy; Kelly, Jeffery W.; Schmidt, Andre; Thomas, Philip J.; Matsumura, Yoshihiro; Skach, William R.; Gentzsch, Martina; Riordan, John R.; Sorscher, Eric J.; Okiyoneda, Tsukasa; Yates, John R., III; Lukacs, Gergely L.; Frizzell, Raymond A.; Manning, Gerard; Gottesfeld, Joel M.; Balch, William E.			Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis	NATURE CHEMICAL BIOLOGY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SURFACE LIQUID VOLUME; EPITHELIAL-CELLS; DELTA-F508 CFTR; WILD-TYPE; SODIUM 4-PHENYLBUTYRATE; ENDOPLASMIC-RETICULUM; CHLORIDE TRANSPORT; IN-VIVO; INHIBITORS	Chemical modulation of histone deacetylase (HDAC) activity by HDAC inhibitors (HDACi) is an increasingly important approach for modifying the etiology of human disease. Loss-of-function diseases arise as a consequence of protein misfolding and degradation, which lead to system failures. The Delta F508 mutation in cystic fibrosis transmembrane conductance regulator (CFTR) results in the absence of the cell surface chloride channel and a loss of airway hydration, leading to the premature lung failure and reduced lifespan responsible for cystic fibrosis. We now show that the HDACi suberoylanilide hydroxamic acid (SAHA) restores surface channel activity in human primary airway epithelia to levels that are 28% of those of wild-type CFTR. Biological silencing of all known class I and II HDACs reveals that HDAC7 plays a central role in restoration of Delta F508 function. We suggest that the tunable capacity of HDACs can be manipulated by chemical biology to counter the onset of cystic fibrosis and other human misfolding disorders.	[Hutt, Darren M.; Matteson, Jeanne; Kellner, Wendy; Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Herman, David; Hoch, Ben; Gottesfeld, Joel M.; Balch, William E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Noel, Sabrina; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Pilewski, Joseph M.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Schmidt, Andre; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Matsumura, Yoshihiro; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Gentzsch, Martina] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Sorscher, Eric J.; Balch, William E.] Univ Alabama, Dept Cell Biol & Physiol, Birmingham, NC USA; [Okiyoneda, Tsukasa; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Scripps Research Institute; Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; McGill University; Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu	Pilewski, Joseph/AAF-5149-2021; Manning, Gerard/C-8308-2009; Gentzsch, Martina/AAY-1815-2021; Rodrigues, Ana/B-7446-2011; Thomas, Philip J/F-7115-2012; Noel, Sabrina/H-5567-2011	Noel, Sabrina/0000-0003-1803-6434; Sorscher, Eric J./0000-0001-9341-3354; Gottesfeld, Joel/0000-0002-4643-5777; Okiyoneda, Tsukasa/0000-0002-5175-2224; Grant, Ana/0000-0002-5439-9331; Lukacs, Gergely/0000-0003-0900-0675; Manning, Gerard/0000-0002-5087-9151; Matsumura, Yoshihiro/0000-0002-3108-0440	US National Institutes of Health (NIH) [HL79442, GM42336, NS055781, DK68196, DK72506, UR98647, AG03197, DK23567, AG78594, DK075302]; Cystic Fibrosis Consortium; Canadian Institutes of Health Research; Canadian Cystic Fibrosis Foundation; Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442, R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302, P30DK072506, R01DK068196, R37DK049835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301, R01GM042336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Consortium; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J.P. Clancy (University of Alabama, Birmingham) for the CFBE41o-expressing Delta F508 and the corrected CFBE41o- (WT-HBE41o-) expressing wild-type CFTR. This work was supported by US National Institutes of Health (NIH) grants HL79442 and GM42336 and aid from the Cystic Fibrosis Consortium to W.E.B.; NIH grant NS055781 to J.M.G.; NIH grants DK68196 and DK72506 and aid from the Cystic Fibrosis Consortium to R.A.F.; NIH grant UR98647 and aid from the Cystic Fibrosis Consortium to E.J.S.; NIH grant AG03197 to J.W.K.; NIH grant DK23567 to J.R.R.; NIH grant AG78594 to G.M.; and NIH grant DK075302 and aid from the Canadian Institutes of Health Research to G.L.L.D.M.H. has received support by fellowships from the Canadian Cystic Fibrosis Foundation and the Canadian Institutes of Health Research; D.H. was supported by a fellowship from the Friedreich's Ataxia Research Alliance. T.O. was supported by a fellowship from the Canadian Cystic Fibrosis Foundation.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Ekins S, 2007, METH MOL B, V356, P319; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Kasler HG, 2007, MOL CELL BIOL, V27, P5184, DOI 10.1128/MCB.02091-06; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lei DC, 1996, GENE THER, V3, P427; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Mai A, 2007, MOL PHARMACOL, V72, P1111, DOI 10.1124/mol.107.036772; Mai A, 2007, EXPERT OPIN THER TAR, V11, P835, DOI 10.1517/14728222.11.6.835; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P453; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	50	210	215	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					25	33		10.1038/NCHEMBIO.275	http://dx.doi.org/10.1038/NCHEMBIO.275			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	19966789	Green Accepted, Green Submitted			2022-12-25	WOS:000272802500008
J	Taghibiglou, C; Martin, HGS; Lai, TW; Cho, T; Prasad, S; Kojic, L; Lu, J; Liu, YT; Lo, E; Zhang, S; Wu, JZZ; Li, YP; Wen, YH; Imm, JH; Cynader, MS; Wang, YT				Taghibiglou, Changiz; Martin, Henry G. S.; Lai, Ted Weita; Cho, Taesup; Prasad, Shiv; Kojic, Luba; Lu, Jie; Liu, Yitao; Lo, Edmund; Zhang, Shu; Wu, Julia Z. Z.; Li, Yu Ping; Wen, Yan Hua; Imm, Joon-Hyuk; Cynader, Max S.; Wang, Yu Tian			Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries	NATURE MEDICINE			English	Article							ELEMENT-BINDING PROTEINS; PANCREATIC BETA-CELLS; NF-KAPPA-B; BRAIN-INJURY; IN-VITRO; CHOLESTEROL-SYNTHESIS; TRANSCRIPTION FACTORS; GLUCOSE DEPRIVATION; MEMBRANE-PROTEIN; GENE-EXPRESSION	Excitotoxic neuronal damage caused by overactivation of N-methyl-D-aspartate glutamate receptors (NMDARs) is thought to be a principal cause of neuronal loss after stroke and brain trauma. Here we report that activation of sterol regulatory element binding protein-1 (SREBP-1) transcription factor in affected neurons is an essential step in NMDAR-mediated excitotoxic neuronal death in both in vitro and in vivo models of stroke. The NMDAR-mediated activation of SREBP-1 is a result of increased insulin-induced gene-1 (Insig-1) degradation, which can be inhibited with an Insig-1-derived interference peptide (Indip) that we have developed. Using a focal ischemia model of stroke, we show that systemic administration of Indip not only prevents SREBP-1 activation but also substantially reduces neuronal damage and improves behavioral outcome. Our study suggests that agents that reduce SREBP-1 activation such as Indip may represent a new class of neuroprotective therapeutics against stroke.	[Taghibiglou, Changiz; Martin, Henry G. S.; Lai, Ted Weita; Cho, Taesup; Prasad, Shiv; Kojic, Luba; Lu, Jie; Liu, Yitao; Lo, Edmund; Zhang, Shu; Wu, Julia Z. Z.; Li, Yu Ping; Wen, Yan Hua; Imm, Joon-Hyuk; Cynader, Max S.; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Taghibiglou, Changiz; Martin, Henry G. S.; Lai, Ted Weita; Cho, Taesup; Prasad, Shiv; Kojic, Luba; Lu, Jie; Liu, Yitao; Lo, Edmund; Zhang, Shu; Wu, Julia Z. Z.; Li, Yu Ping; Wen, Yan Hua; Imm, Joon-Hyuk; Cynader, Max S.; Wang, Yu Tian] Univ British Columbia, Dept Med, Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Wang, Yu Tian] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Wang, Yu Tian] China Med Univ Hosp, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health Research Institute; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada.	ytwang@interchange.ubc.ca	Taghibiglou, Changiz/H-4590-2019; Lai, Ted Weita/E-9392-2016; Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015	Lai, Ted Weita/0000-0002-6229-4134; Martin, Henry/0000-0002-6504-1044	Heart and Stroke Foundation of British Columbia and the Yukon; Canadian Institutes of Health Research and CHDI (Cure Huntington's Disease Initiative) Foundation; Michael Smith Foundation for Health	Heart and Stroke Foundation of British Columbia and the Yukon; Canadian Institutes of Health Research and CHDI (Cure Huntington's Disease Initiative) Foundation(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health(Michael Smith Foundation for Health Research)	We thank J.Ye (University of Texas Southwestern Medical Center) for myc-Insig-1 plasmid, T. Osborne (University of California-Irvine) for Flag-nt-SREBP-1 and Y.P. Auberson (Novartis Pharma AG) for the generous gift of NVP AAM077. We also thank J. Wang for his technical support. This work was supported by the Heart and Stroke Foundation of British Columbia and the Yukon, the Canadian Institutes of Health Research and CHDI (Cure Huntington's Disease Initiative) Foundation. Y.T.W. is a Howard Hughes Medical Institute International Scholar and Heart and Stroke Foundation of British Columbia and the Yukon Chair in Stroke Research. C. T. was supported by post-doctoral fellowships from the Canadian Institutes of Health Research and Michael Smith Foundation for Health.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adibhatla RM, 2006, AAPS J, V8, pE314; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mielke JG, 2005, J NEUROCHEM, V92, P103, DOI 10.1111/j.1471-4159.2004.02841.x; Mutel V, 1998, J NEUROCHEM, V70, P2147; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Park HJ, 2002, CIRC RES, V91, P32, DOI 10.1161/01.RES.0000026502.79063.66; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Sandberg MB, 2005, MOL CELL ENDOCRINOL, V240, P94, DOI 10.1016/j.mce.2005.05.005; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SIESJO BK, 1992, ADV EXP MED BIOL, V318, P41; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Taghibiglou C, 2009, FEBS LETT, V583, P831, DOI 10.1016/j.febslet.2009.01.045; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Tigaret CM, 2006, MOL PHARMACOL, V69, P1251, DOI 10.1124/mol.105.018580; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Yamashita T, 2004, ENDOCRINOLOGY, V145, P3566, DOI 10.1210/en.2003-1602; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zou J, 2006, CELL MOL NEUROBIOL, V26, P385, DOI 10.1007/s10571-006-9045-9	54	105	114	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1399	U7		10.1038/nm.2064	http://dx.doi.org/10.1038/nm.2064			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966780				2022-12-25	WOS:000272407800020
J	Christ, F; Voet, A; Marchand, A; Nicolet, S; Desimmie, BA; Marchand, D; Bardiot, D; Van der Veken, NJ; Van Remoortel, B; Strelkov, SV; De Maeyer, M; Chaltin, P; Debyser, Z				Christ, Frauke; Voet, Arnout; Marchand, Arnaud; Nicolet, Stefan; Desimmie, Belete A.; Marchand, Damien; Bardiot, Dorothee; Van der Veken, Nam Joo; Van Remoortel, Barbara; Strelkov, Sergei V.; De Maeyer, Marc; Chaltin, Patrick; Debyser, Zeger			Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; INTEGRASE INHIBITOR; CATALYTIC DOMAIN; SCORING FUNCTION; BINDING-SITE; HIGH-LEVEL; LEDGF/P75; IDENTIFICATION; RALTEGRAVIR; REVEALS	Lens epithelium-derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase that promotes viral integration by tethering the preintegration complex to the chromatin. By virtue of its crucial role in the early steps of HIV replication, the interaction between LEDGF/p75 and integrase represents an attractive target for antiviral therapy. We have rationally designed a series of 2-(quinolin-3-yl) acetic acid derivatives (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concentration by blocking the integration step. A 1.84-angstrom resolution crystal structure corroborates the binding of the inhibitor in the LEDGF/p75-binding pocket of integrase. Together with the lack of cross-resistance with two clinical integrase inhibitors, these findings define the 2-(quinolin-3-yl) acetic acid derivatives as the first genuine allosteric HIV-1 integrase inhibitors. Our work demonstrates the feasibility of rational design of small molecules inhibiting the protein-protein interaction between a viral protein and a cellular host factor.	[Christ, Frauke; Desimmie, Belete A.; Van der Veken, Nam Joo; Van Remoortel, Barbara; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Div Mol Med, Louvain, Belgium; [Voet, Arnout; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, Dept Chem, Div Biochem Mol & Struct Biol, Louvain, Belgium; [Nicolet, Stefan; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Lab Biocrystallog, Louvain, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Drug Design & Dev, Kuleuven R&D, Louvain, Belgium; [Marchand, Arnaud; Marchand, Damien; Bardiot, Dorothee; Chaltin, Patrick] Ctr Innovat & Stimulat Med Dev, Louvain, Belgium; [Nicolet, Stefan] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland	KU Leuven; KU Leuven; KU Leuven; KU Leuven; University of Basel	Christ, F (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Div Mol Med, Louvain, Belgium.	zeger.debyser@med.kuleuven.be	Christ, Frauke/H-7513-2018; Strelkov, Sergei V/G-7425-2014; debyser, zeger/H-1310-2013; voet, arnout/O-5248-2014	Strelkov, Sergei V/0000-0001-7189-4652; debyser, zeger/0000-0002-3982-1565; voet, arnout/0000-0002-3329-2703; Desimmie, Belete/0000-0002-1157-4224; Christ, Frauke/0000-0001-9580-3874	Flemish Agentschap voor Innovatie door Wetenschap en Technologie [60813]; FWO [G.0530.08]; EC [THINC (HEALTH-F3-2008-201032)]; Research Fund; K.U. Leuven; Science and Technology in Flanders; Industrieel Onderzoeksfonds mandate; Bijzonder Onderzoeksfonds-PhD scholarship	Flemish Agentschap voor Innovatie door Wetenschap en Technologie; FWO(FWO); EC(European CommissionEuropean Commission Joint Research Centre); Research Fund; K.U. Leuven(KU Leuven); Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Industrieel Onderzoeksfonds mandate; Bijzonder Onderzoeksfonds-PhD scholarship	We acknowledge A. Calleja for performing analytical chemistry on the compounds, M. Michiels for macrophage and integrase assays and L. Desender for performing large-scale protein purifications. We thank A. Jonckheer for information and communication technology support. X-ray diffraction data collection was done at the X06DA beamline of the Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. We thank R. Clayton of Tibotec for providing raltegravir and elvitegravir as well as HXB2D-IN<SUP>N155H</SUP> <SUP>E92Q</SUP> <SUP>Q148H</SUP>. Research was funded by the CellCoVir SBO grant (60813) of the Flemish Agentschap voor Innovatie door Wetenschap en Technologie, the FWO grant G.0530.08, the EC grant THINC (HEALTH-F3-2008-201032), the Research Fund and the Industrieel Onderzoeksfonds Program of the K.U. Leuven. A.V. is supported by a grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders. F.C. is funded by an Industrieel Onderzoeksfonds mandate, and B.A.D. is funded by a Bijzonder Onderzoeksfonds-PhD scholarship for international cooperation with non-EEA countries outside the EEA.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Debyser Zeger, 2002, Antiviral Chemistry & Chemotherapy, V13, P1; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Hazuda DJ, 2006, CURR OPIN HIV AIDS, V1, P212, DOI 10.1097/01.COH.0000221594.57035.55; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Johnson NP, 2007, OPTO-ELECTRON REV, V15, P125, DOI 10.2478/s11772-007-0009-5; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; NUNBERG JH, 1991, J VIROL, V65, P4887, DOI 10.1128/JVI.65.9.4887-4892.1991; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; TSANTRIZOS YS, 2007, Patent No. 2007; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u	50	364	390	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					442	448		10.1038/nchembio.370	http://dx.doi.org/10.1038/nchembio.370			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20473303				2022-12-25	WOS:000277748100014
J	Saito, T; Fukai, A; Mabuchi, A; Ikeda, T; Yano, F; Ohba, S; Nishida, N; Akune, T; Yoshimura, N; Nakagawa, T; Nakamura, K; Tokunaga, K; Chung, U; Kawaguchi, H				Saito, Taku; Fukai, Atsushi; Mabuchi, Akihiko; Ikeda, Toshiyuki; Yano, Fumiko; Ohba, Shinsuke; Nishida, Nao; Akune, Toru; Yoshimura, Noriko; Nakagawa, Takumi; Nakamura, Kozo; Tokunaga, Katsushi; Chung, Ung-il; Kawaguchi, Hiroshi			Transcriptional regulation of endochondral ossification by HIF-2 alpha during skeletal growth and osteoarthritis development	NATURE MEDICINE			English	Article							METALLOPROTEINASE 13-DEFICIENT MICE; EXPERIMENTAL MOUSE MODELS; KNEE-JOINT INSTABILITY; BONE-DEVELOPMENT; CHONDROCYTE HYPERTROPHY; METABOLIC ABNORMALITIES; TRANSACTIVATION DOMAIN; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; COLLAGEN-X	Chondrocyte hypertrophy followed by cartilage matrix degradation and vascular invasion, characterized by expression of type X collagen (COL10A1), matrix metalloproteinase-13 (MMP-13) and vascular endothelial growth factor (VEGF), respectively, are central steps of endochondral ossification during normal skeletal growth and osteoarthritis development. A COL10A1 promoter assay identified hypoxia-inducible factor-2 alpha (HIF-2 alpha, encoded by EPAS1) as the most potent transactivator of COL10A1. HIF-2 alpha enhanced promoter activities of COL10A1, MMP13 and VEGFA through specific binding to the respective hypoxia-responsive elements. HIF-2 alpha, independently of oxygen-dependent hydroxylation, was essential for endochondral ossification of cultured chondrocytes and embryonic skeletal growth in mice. HIF-2 alpha expression was higher in osteoarthritic cartilages versus nondiseased cartilages of mice and humans. Epas1-heterozygous deficient mice showed resistance to osteoarthritis development, and a functional single nucleotide polymorphism (SNP) in the human EPAS1 gene was associated with knee osteoarthritis in a Japanese population. The EPAS1 promoter assay identified RELA, a nuclear factor-kappa B (NF-kappa B) family member, as a potent inducer of HIF-2 alpha expression. Hence, HIF-2 alpha is a central transactivator that targets several crucial genes for endochondral ossification and may represent a therapeutic target for osteoarthritis.	[Saito, Taku; Fukai, Atsushi; Mabuchi, Akihiko; Ikeda, Toshiyuki; Nishida, Nao; Nakagawa, Takumi; Nakamura, Kozo; Tokunaga, Katsushi; Kawaguchi, Hiroshi] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; [Yano, Fumiko; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Akune, Toru; Yoshimura, Noriko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022	Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 20689028]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Yamaguchi and H. Kawahara for technical assistance. This study was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (19109007 and 20689028). The sponsor had no role in study design, data collection, data analysis, data interpretation or writing of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kawaguchi H, 2008, MOL CELLS, V25, P1; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kitamura T, 1998, INT J HEMATOL, V67, P351; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Miyagishi Makoto, 2004, Methods Mol Biol, V252, P483; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Ostergaard K, 1999, ANN RHEUM DIS, V58, P208, DOI 10.1136/ard.58.4.208; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2000, GENE DEV, V14, P1983; Srinivas V, 2009, CELL CYCLE, V8, P391, DOI 10.4161/cc.8.3.7545; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	53	377	397	6	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2010	16	6					678	U83		10.1038/nm.2146	http://dx.doi.org/10.1038/nm.2146			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20495570				2022-12-25	WOS:000278394200034
J	McLean, CY; Bristor, D; Hiller, M; Clarke, SL; Schaar, BT; Lowe, CB; Wenger, AM; Bejerano, G				McLean, Cory Y.; Bristor, Dave; Hiller, Michael; Clarke, Shoa L.; Schaar, Bruce T.; Lowe, Craig B.; Wenger, Aaron M.; Bejerano, Gill			GREAT improves functional interpretation of cis-regulatory regions	NATURE BIOTECHNOLOGY			English	Article							SERUM RESPONSE FACTOR; CHIP-SEQ EXPERIMENTS; HUMAN GENOME; GENE-EXPRESSION; TRANSCRIPTION FACTOR; ELEMENTS; LIMB; PROLIFERATION; DISCOVERY; SOFTWARE	We developed the Genomic Regions Enrichment of Annotations Tool (GREAT) to analyze the functional significance of cis-regulatory regions identified by localized measurements of DNA binding events across an entire genome. Whereas previous methods took into account only binding proximal to genes, GREAT is able to properly incorporate distal binding sites and control for false positives using a binomial test over the input genomic regions. GREAT incorporates annotations from 20 ontologies and is available as a web application. Applying GREAT to data sets from chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-seq) of multiple transcription-associated factors, including SRF, NRSF, GABP, Stat3 and p300 in different developmental contexts, we recover many functions of these factors that are missed by existing gene-based tools, and we generate testable hypotheses. The utility of GREAT is not limited to ChIP-seq, as it could also be applied to open chromatin, localized epigenomic markers and similar functional data sets, as well as comparative genomics sets.	[McLean, Cory Y.; Bristor, Dave; Wenger, Aaron M.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Bristor, Dave; Hiller, Michael; Schaar, Bruce T.; Bejerano, Gill] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Clarke, Shoa L.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lowe, Craig B.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Santa Cruz	Bejerano, G (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	bejerano@stanford.edu	Clarke, Shoa/AAZ-6735-2021	Clarke, Shoa/0000-0002-6592-1172; McLean, Cory/0000-0001-9928-8216	Bio-X graduate; German Research Foundation [Hi 1423/2-1]; Human Frontier Science Program [LT000896/2009-l]; Stanford Graduate; US National Institutes of Health [1R01HD059862]; Edward Mallinckrodt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER	Bio-X graduate; German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Stanford Graduate; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Sirota for an early survey of ontologies, F. Sathira for developing an intermediary core calculation engine, T. Capellini for critical reading of the manuscript, M. Davis and S. Gutierrez for system administration and the communities of ontology developers and curators for providing invaluable data sources. C.Y.M. is supported by a Bio-X graduate fellowship. M.H. is supported by a German Research Foundation Fellowship (Hi 1423/2-1) and the Human Frontier Science Program (fellowship LT000896/2009-l). S.L.C. is a Howard Hughes Medical Institute Gilliam Fellow. A.M.W. is supported by a Stanford Graduate Fellowship. G. B. is a Packard Fellow, Searle Scholar, Microsoft Research Faculty Fellow and an Alfred P. Sloan Fellow. Research was also supported by an Edward Mallinckrodt, Jr. Foundation junior faculty grant and US National Institutes of Health grant 1R01HD059862 to G.B.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bertolotto C, 2000, J BIOL CHEM, V275, P12941, DOI 10.1074/jbc.275.17.12941; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Cerami EG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-497; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dopazo J, 2006, OMICS, V10, P398, DOI 10.1089/omi.2006.10.398; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lee HJ, 2007, ONCOGENE, V26, P173, DOI 10.1038/sj.onc.1209774; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2008, ADV GENET, V61, P175, DOI 10.1016/S0065-2660(07)00006-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	50	2396	2410	4	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					495	U155		10.1038/nbt.1630	http://dx.doi.org/10.1038/nbt.1630			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20436461	Green Accepted			2022-12-25	WOS:000277452700030
J	Mooney, P				Mooney, Paul			China cracks down on counterfeiters	NATURE MEDICINE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					360	360		10.1038/nm0410-360a	http://dx.doi.org/10.1038/nm0410-360a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376025	Bronze			2022-12-25	WOS:000276446800016
J	Mitchell, KJ; Pannerec, A; Cadot, B; Parlakian, A; Besson, V; Gomes, ER; Marazzi, G; Sassoon, DA				Mitchell, Kathryn J.; Pannerec, Alice; Cadot, Bruno; Parlakian, Ara; Besson, Vanessa; Gomes, Edgar R.; Marazzi, Giovanna; Sassoon, David A.			Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; STEM-CELLS; SELF-RENEWAL; MYOGENIC SPECIFICATION; MORPHOMETRIC-ANALYSIS; INTERSTITIAL SPACES; BONE-MARROW; PEG3/PW1; EXPRESSION; DISTINCT	Satellite cells are resident myogenic progenitors in postnatal skeletal muscle involved in muscle postnatal growth and adult regenerative capacity. Here, we identify and describe a population of muscle-resident stem cells, which are located in the interstitium, that express the cell stress mediator PW1 but do not express other markers of muscle stem cells such as Pax7. PW1(+)/Pax7(-) interstitial cells (PICs) are myogenic in vitro and efficiently contribute to skeletal muscle regeneration in vivo as well as generating satellite cells and PICs. Whereas Pax7 mutant satellite cells show robust myogenic potential, Pax7 mutant PICs are unable to participate in myogenesis and accumulate during postnatal growth. Furthermore, we found that PICs are not derived from a satellite cell lineage. Taken together, our findings uncover a new and anatomically identifiable population of muscle progenitors and define a key role for Pax7 in a non-satellite cell population during postnatal muscle growth.	[Mitchell, Kathryn J.; Pannerec, Alice; Cadot, Bruno; Parlakian, Ara; Besson, Vanessa; Gomes, Edgar R.; Marazzi, Giovanna; Sassoon, David A.] Univ Paris 06, INSERM, Myol Grp, F-75634 Paris, France; [Cadot, Bruno; Gomes, Edgar R.] Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sassoon, DA (corresponding author), Univ Paris 06, INSERM, Myol Grp, F-75634 Paris, France.	david.a.sassoon@gmail.com	Gomes, Edgar r/D-9000-2015; SASSOON, David A/G-2502-2013; CADOT, bruno/E-1710-2013; Gomes, Edgar/ABH-7441-2020	Gomes, Edgar r/0000-0002-6941-4872; SASSOON, David A/0000-0001-6074-048X; CADOT, bruno/0000-0002-1888-3898; Gomes, Edgar/0000-0002-6941-4872; Marazzi, giovanna/0000-0002-5388-1038; ARA, PARLAKIAN/0000-0002-0928-2185	NIH [NCI PO1 CA80058-06]; French Ministry of Research; Muscular Dystrophy Association of America; INSERM; Fondation pour la Recherche Medicale (FRM); European Community [Health-F5-2009-223098]; Association Francaise contre les Myopathies (AFM); NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Muscular Dystrophy Association of America(Muscular Dystrophy Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Community(European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully thank F. Relaix for fruitful discussions and critical reading of the manuscript. We thank A. Galy, E. Negroni and L. Arandel for technical advice and C. Blanc (Cytometrie en Flux platform, Institut Federatif de Recherche 113) for FACs assistance. This work was supported by a grant from the NIH (NCI PO1 CA80058-06, subproject 3), a French Ministry of Research 'Chaire d'Excellence' to D. S. and the Muscular Dystrophy Association of America to D. S. and E. R. G. K. M. is a recipient of an INSERM 'contrat de jeunes chercheurs'. B. C. is a recipient of a grant from Fondation pour la Recherche Medicale (FRM). E. R. G. is supported in part by the Inserm Avenir Program. This work benefited from funding from the European Community's Seventh Framework Programme project OPTISTEM (Optimization of stem cell therapy for degenerative epithelial and muscle diseases contract number Health-F5-2009-223098). The Myology Group is the beneficiary of a Strategic Plan Support from the Association Francaise contre les Myopathies (AFM) and is affiliated with the Institute of Myology/Association Institut Myologie.	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Asakura A, 2003, TRENDS CARDIOVAS MED, V13, P123, DOI 10.1016/S1050-1738(03)00024-0; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; CAMPION D R, 1979, Journal of Animal Science, V48, P1109; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen Jennifer C J, 2003, Reprod Biol Endocrinol, V1, P101, DOI 10.1186/1477-7827-1-101; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Endo T, 2007, REGEN MED, V2, P243, DOI 10.2217/17460751.2.3.243; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; HUGHES DS, 1992, DEV DYNAM, V193, P175, DOI 10.1002/aja.1001930209; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mansouri A, 1996, DEVELOPMENT, V122, P831; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; MouraNeto V, 1996, GENE, V168, P261, DOI 10.1016/0378-1119(95)00789-X; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; ONTELL M, 1988, AM J ANAT, V181, P279, DOI 10.1002/aja.1001810306; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SAX CM, 1989, GENE, V78, P235, DOI 10.1016/0378-1119(89)90226-6; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; TAMAKI T, 2008, STEM CELLS DEV; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	61	296	302	2	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					257	U56		10.1038/ncb2025	http://dx.doi.org/10.1038/ncb2025			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20118923	Green Published			2022-12-25	WOS:000275054200011
J	Qiu, T; Wu, XW; Zhang, FJ; Clemens, TL; Wan, M; Cao, X				Qiu, Tao; Wu, Xiangwei; Zhang, Fengjie; Clemens, Thomas L.; Wan, Mei; Cao, Xu			TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling	NATURE CELL BIOLOGY			English	Article							PARATHYROID-HORMONE RECEPTOR; GROWTH-FACTOR-BETA; PROTEIN-COUPLED RECEPTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; (PTH)/PTH-RELATED PEPTIDE; EXPRESSION CLONING; CRYSTAL-STRUCTURE; LINKED RECEPTOR; CELLS; INTERNALIZATION	Parathyroid hormone (PTH) regulates calcium homeostasis and bone metabolism by activating PTH type I receptor (PTH1R). Here we show that transforming growth factor (TGF)-beta type II receptor (T beta RII) forms an endocytic complex with PTH1R in response to PTH and regulates signalling by PTH and TGF-beta. T beta RII directly phosphorylates the PTH1R cytoplasmic domain, which modulates PTH-induced endocytosis of the PTH1R-T beta RII complex. Deletion of T beta RII in osteoblasts increases the cell-surface expression of PTH1R and augments PTH signalling. Conditional knockout of T beta RII in osteoblasts in mice results in a high bone mass with increased trabecular bone and decreased cortical bone, similar to the bone phenotype in mice expressing a constitutively active PTH1R. Disruption of PTH signalling by injection of PTH(7-34) or ablation of PTH1R rescues the bone phenotype of T beta RII knockout mice. These studies reveal a previously unrecognized function for T beta RII and a mechanism for integration of PTH and local growth factor at the membrane receptor level.	[Qiu, Tao; Wu, Xiangwei; Clemens, Thomas L.; Wan, Mei; Cao, Xu] Johns Hopkins Med Inst, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Wu, Xiangwei; Zhang, Fengjie] Shihezi Univ, Sch Med, Shihezi 832000, Xinjiang, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Shihezi University	Cao, X (corresponding author), Johns Hopkins Med Inst, Dept Orthopaed Surg, 720 Rutland Ave,Ross Bldg 232, Baltimore, MD 21205 USA.	xcao11@jhmi.edu			National Institutes of Health [DK080898, DK057501]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057501, Z01DK057501, R01DK080898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge Stephen Michnick and Odyssey Thera, Inc., for YFP-based PCA constructs; Harold Moses for T beta RH<SUP>flox/flox</SUP> mice; Henry Kronenberg for PTH1R<SUP>flox/flox</SUP> mice; Lijuan Pang and Hui Deng for technical assistance; Robert Cole and Tatiana Boronina for mass spectrometry analysis; and Elaine Henz for editorial service. This work was supported by National Institutes of Health grant DK080898 and DK057501 (X. C).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hardie LJ, 1998, CYTOKINE, V10, P555, DOI 10.1006/cyto.1997.0334; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Juppner H, 1994, Curr Opin Nephrol Hypertens, V3, P371; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Laing KJ, 1999, VET IMMUNOL IMMUNOP, V72, P45, DOI 10.1016/S0165-2427(99)00116-6; Langub MC, 2003, ENDOCRINOLOGY, V144, P1135, DOI 10.1210/en.2002-221026; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Potts JT, 1997, OSTEOPOROSIS INT, V7, P169, DOI 10.1007/BF03194366; Qiu T, 2007, EMBO J, V26, P346, DOI 10.1038/sj.emboj.7601499; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reinecke M, 1998, INT REV CYTOL, V183, P1, DOI 10.1016/S0074-7696(08)60142-4; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; SCHIPANI E, 1993, ENDOCRINOLOGY, V132, P2157, DOI 10.1210/en.132.5.2157; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Sebastian EM, 2008, BONE, V43, P1022, DOI 10.1016/j.bone.2008.07.250; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhan Y, 2000, FISH SHELLFISH IMMUN, V10, P309, DOI 10.1006/fsim.1999.0239; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	53	103	110	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					224	U29		10.1038/ncb2022	http://dx.doi.org/10.1038/ncb2022			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20139972	Green Accepted			2022-12-25	WOS:000275054200008
J	Clarke, TB; Davis, KM; Lysenko, ES; Zhou, AY; Yu, YM; Weiser, JN				Clarke, Thomas B.; Davis, Kimberly M.; Lysenko, Elena S.; Zhou, Alice Y.; Yu, Yimin; Weiser, Jeffrey N.			Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTORS; STREPTOCOCCUS-PNEUMONIAE; MURAMYL PEPTIDES; HOST-DEFENSE; ACTIVATION; COMMENSAL; RESPONSES; MICROFLORA; INFECTION; BACTERIA	Humans are colonized by a large and diverse bacterial flora (the microbiota) essential for the development of the gut immune system(1-3). A broader role for the microbiota as a major modulator of systemic immunity has been proposed(4,5); however, evidence and a mechanism for this role have remained elusive. We show that the microbiota are a source of peptidoglycan that systemically primes the innate immune system, enhancing killing by bone marrow-derived neutrophils of two major pathogens: Streptococcus pneumoniae and Staphylococcus aureus. This requires signaling via the pattern recognition receptor nucleotide-binding, oligomerization domain-containing protein-1 (Nod1, which recognizes meso-diaminopimelic acid (mesoDAP)-containing peptidoglycan found predominantly in Gram-negative bacteria), but not Nod2 ( which detects peptidoglycan found in Gram-positive and Gram-negative bacteria) or Toll-like receptor 4 (Tlr4, which recognizes lipopolysaccharide)(6,7). We show translocation of peptidoglycan from the gut to neutrophils in the bone marrow and show that peptidoglycan concentrations in sera correlate with neutrophil function. In vivo administration of Nod1 ligands is sufficient to restore neutrophil function after microbiota depletion. Nod1(-/-) mice are more susceptible than wild-type mice to early pneumococcal sepsis, demonstrating a role for Nod1 in priming innate defenses facilitating a rapid response to infection. These data establish a mechanism for systemic immunomodulation by the microbiota and highlight potential adverse consequences of microbiota disruption by broad-spectrum antibiotics on innate immune defense to infection.	[Clarke, Thomas B.; Davis, Kimberly M.; Lysenko, Elena S.; Zhou, Alice Y.; Weiser, Jeffrey N.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Yu, Yimin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Weiser, Jeffrey N.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Weiser, JN (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	weiser@mail.med.upenn.edu		Weiser, Jeffrey/0000-0001-7168-8090; Davis, Kimberly/0000-0003-1870-3137	US Public Health Service [AI038446, AI044231, AI078538, AI037108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037108, R01AI078538, R01AI044231, R01AI038446, R21AI044231, R37AI037108] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. G. Dowson and D. I. Roper (University of Warwick) for peptidoglycan fragments, D. J. Philpott (University of Toronto) for Nod vector, and D. Kobuley for assistance with germ-free mice. This work was supported by grants AI038446 (J.N.W.), AI044231 (J.N.W.), AI078538 (J.N.W.) and AI037108 (Y.Y.) from the US Public Health Service.	Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ismair MG, 2006, CAN J PHYSIOL PHARM, V84, P1313, DOI 10.1139/Y06-076; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; KRUEGER JM, 1984, J BIOL CHEM, V259, P2659; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Matthias KA, 2008, J IMMUNOL, V180, P6246, DOI 10.4049/jimmunol.180.9.6246; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MINE Y, 1983, J ANTIBIOT, V36, P1059, DOI 10.7164/antibiotics.36.1059; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; Roche AM, 2007, INFECT IMMUN, V75, P2469, DOI 10.1128/IAI.01972-06; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014	31	769	799	10	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					228	U137		10.1038/nm.2087	http://dx.doi.org/10.1038/nm.2087			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20081863	Green Accepted			2022-12-25	WOS:000274297000046
J	Joe, AWB; Yi, L; Natarajan, A; Le Grand, F; So, L; Wang, J; Rudnicki, MA; Rossi, FMV				Joe, Aaron W. B.; Yi, Lin; Natarajan, Anuradha; Le Grand, Fabien; So, Leslie; Wang, Joy; Rudnicki, Michael A.; Rossi, Fabio M. V.			Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE; SATELLITE-CELL; STEM-CELLS; SELF-RENEWAL; DIFFERENTIATION; REGENERATION; MYOFIBROBLASTS; IDENTIFICATION; PROLIFERATION; HETEROGENEITY	Efficient tissue regeneration is dependent on the coordinated responses of multiple cell types. Here, we describe a new subpopulation of fibro/adipogenic progenitors (FAPs) resident in muscle tissue but arising from a distinct developmental lineage. Transplantation of purified FAPs results in the generation of ectopic white fat when delivered subcutaneously or intramuscularly in a model of fatty infiltration, but not in healthy muscle, suggesting that the environment controls their engraftment. These cells are quiescent in intact muscle but proliferate efficiently in response to damage. FAPs do not generate myofibres, but enhance the rate of differentiation of primary myogenic progenitors in co-cultivation experiments. In summary, FAPs expand upon damage to provide a transient source of pro-differentiation signals for proliferating myogenic progenitors.	[Joe, Aaron W. B.; Yi, Lin; Natarajan, Anuradha; So, Leslie; Wang, Joy; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Joe, Aaron W. B.] Univ British Columbia, MD PhD Program, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Rossi, Fabio M. V.] Univ British Columbia, Dept Med Genet, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Le Grand, Fabien; Rudnicki, Michael A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013; Le Grand, Fabien/D-8803-2019	Rossi, Fabio MV/0000-0002-0368-2620; Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249	Foundation for Cell therapy (Jesse's Journey); Canadian Institute for Health Research (CIHR) [MOP-97856, CSB-94219, MUS-94019]; Michael Smith Foundation for Health Research; Heart and Stroke Foundation of Canada; NSERC [PGSD2-362406-2008]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Foundation for Cell therapy (Jesse's Journey); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Qiao, C. Chang, J. M. Joe, the BRC Animal Facility, the BRC Core Staff and A. Johnson and J. Duenas of the UBC FACS Facility for their expert technical assistance. We are also grateful to A. Uezumi for advice on modelling fatty degeneration in murine skeletal muscle. This research was supported by grants from The Foundation for Cell therapy (Jesse's Journey) and The Canadian Institute for Health Research (CIHR MOP-97856; CSB-94219; MUS-94019) to F. M. V. R. who holds a Canada Research Chair in Regenerative medicine and is a fellow of the Michael Smith Foundation for Health Research. A. W. B. J. is supported by a fellowship from CIHR, A. N. from the Heart and Stroke Foundation of Canada and L. S. from NSERC (PGSD2-362406-2008).	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Goss R., 1992, WOUND HEALING BIOCHE, P20; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Harris JB, 2003, J ANAT, V202, P363, DOI 10.1046/j.1469-7580.2003.00171.x; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; LIPTON BH, 1979, MUSCLE REGENERATION, P31; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216	46	964	982	8	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					153	U144		10.1038/ncb2015	http://dx.doi.org/10.1038/ncb2015			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081841	Green Accepted			2022-12-25	WOS:000274139400009
J	Uezumi, A; Fukada, S; Yamamoto, N; Takeda, S; Tsuchida, K				Uezumi, Akiyoshi; Fukada, So-ichiro; Yamamoto, Naoki; Takeda, Shin'ichi; Tsuchida, Kunihiro			Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR; INSULIN-RESISTANCE; STEM-CELLS; RECEPTOR; DIFFERENTIATION; POPULATION; ALPHA; REGENERATION; PURIFICATION; FIBROBLASTS	Ectopic fat deposition in skeletal muscle is closely associated with several disorders, however, the origin of these adipocytes is not clear, nor is the mechanism of their formation. Satellite cells function as adult muscle stem cells but are proposed to possess multipotency. Here, we identify PDGFR alpha(+) mesenchymal progenitors as being distinct from satellite cells and located in the muscle interstitium. We show that, of the muscle-derived cell populations, only PDGFRa+ cells show efficient adipogenic differentiation both in vitro and in vivo. Reciprocal transplantation between regenerating and degenerating muscles, and co-culture experiments revealed that adipogenesis of PDGFR alpha(+) cells is strongly inhibited by the presence of satellite cell-derived myofibres. These results suggest that PDGFR alpha(+) mesenchymal progenitors are the major contributor to ectopic fat cell formation in skeletal muscle, and emphasize that interaction between muscle cells and PDGFRa+ mesenchymal progenitors, not the fate decision of satellite cells, has a considerable impact on muscle homeostasis.	[Uezumi, Akiyoshi; Tsuchida, Kunihiro] Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, Aichi 4701192, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Lab Mol Biol & Histochem, Joint Res Lab, Aichi 4701192, Japan; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan	Fujita Health University; Osaka University; Fujita Health University; National Center for Neurology & Psychiatry - Japan	Uezumi, A (corresponding author), Fujita Hlth Univ, Div Therapies Intractable Dis, Inst Comprehens Med Sci, 1-98 Dengakugakubo, Aichi 4701192, Japan.	uezumi@fujita-hu.ac.jp	Uezumi, Akiyoshi/ABF-7359-2020; Yamamoto, Naoki/L-2603-2019; Fukada, So-ichiro/AAI-9151-2020; Tsuchida, Kunihiro/A-4501-2012	Uezumi, Akiyoshi/0000-0003-4294-0116; Fukada, So-ichiro/0000-0003-4051-5108; Tsuchida, Kunihiro/0000-0002-3983-5756	JSPS KAKENHI [18890216]; MEXT KAKENHI [21790884, H20-018]; Ministry of Health, Labour and Welfare [20B-13]; Grants-in-Aid for Scientific Research [21300149] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Miura, M. Nakatani and T. Sato for technical assistance, F. Rossi for providing DyLight 649-conjugated rat anti-integrin alpha 7, A. Miyajima for providing a rat anti-Dlk1 antibody and N. Hashimoto for providing a rabbit anti-myogenin antibody. This work was supported by JSPS KAKENHI (18890216; to A. U.), MEXT KAKENHI (21790884; to A. U.), a research grant (H20-018) on psychiatric and neurological diseases and mental health and a research grant (20B-13) for nervous and mental disorders from the Ministry of Health, Labour and Welfare.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Banker B.Q., 2004, MYOLOGY, V3rd ed., P691; Bischoff R., 2004, MYOLOGY, V1, P66; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Carpenter S., 2001, PATHOLOGY SKELETAL M, P314; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2008, EXP CELL RES, V314, P193, DOI 10.1016/j.yexcr.2007.09.020; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Greco AV, 2002, DIABETES, V51, P144, DOI 10.2337/diabetes.51.1.144; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; SHINBROT E, 1994, DEV DYNAM, V199, P169, DOI 10.1002/aja.1001990302; Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128	36	773	787	8	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					143	U116		10.1038/ncb2014	http://dx.doi.org/10.1038/ncb2014			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081842				2022-12-25	WOS:000274139400008
J	Merte, J; Jensen, D; Wright, K; Sarsfield, S; Wang, YS; Schekman, R; Ginty, DD				Merte, Janna; Jensen, Devon; Wright, Kevin; Sarsfield, Sarah; Wang, Yanshu; Schekman, Randy; Ginty, David D.			Sec24b selectively sorts Vangl2 to regulate planar cell polarity during neural tube closure	NATURE CELL BIOLOGY			English	Article							CONVERGENT EXTENSION; MEMBRANE-PROTEINS; EMBRYONIC-DEVELOPMENT; COPII VESICLES; MOUSE STRAINS; GENETIC-BASIS; HAIR-CELLS; DEFECTS; MUTATION; COAT	Craniorachischisis is a rare but severe birth defect that results in a completely open neural tube. Mouse mutants in planar cell polarity (PCP) signalling components have deficits in the morphological movements of convergent extension that result in craniorachischisis. Using a forward genetic screen in mice, we identified Sec24b, a cargo-sorting member of the core complex of the endoplasmic reticulum (ER)-to-Golgi transport vesicle COPII, as critical for neural tube closure. Sec24b(Y613) mutant mice exhibit craniorachischisis, deficiencies in convergent extension and other PCP-related phenotypes. Vangl2, a key component of the PCP-signalling pathway critical for convergent extension, is selectively sorted into COPII vesicles by Sec24b. Moreover, Sec24b(Y613) genetically interacts with a loss-of-function Vangl2 allele (Vangl2(LP)), causing a marked increase in the prevalence of spina bifida. Interestingly, the Vangl2 looptail point mutants Vangl2(D255E) and Vangl2(S464N), known to cause defects in convergent extension, fail to sort into COPII vesicles and are trapped in the ER. Thus, during COPII vesicle formation, Sec24b shows cargo specificity for a core PCP component, Vangl2, of which proper ER-to-Golgi transport is essential for the establishment of PCP, convergent extension and closure of the neural tube.	[Merte, Janna; Wright, Kevin; Sarsfield, Sarah; Ginty, David D.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Merte, Janna; Wright, Kevin; Sarsfield, Sarah; Wang, Yanshu; Ginty, David D.] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Jensen, Devon; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jensen, Devon; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wang, Yanshu] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Sarsfield, Sarah/Y-5113-2019	Wright, Kevin/0000-0001-5094-5270	NIH [NS34814]; Johns Hopkins Mind Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R37NS034814, R01NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Mind Brain Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Nathans, T. Makita, A. Kolodkin, and members of the Ginty laboratory for discussions and critical reading of this manuscript; P. Gros for providing the Vangl2 antibody; J. C. Fromme, B. Kleizen and A. Schindler for Anti-Sec13 and AntiSec-22 antiserum; C. Chan for recombinant Sec23A/Sec24A and Sec23A/Sec24C; B. Yang and Y. Wu for excellent technical help. This work was funded by NIH grants NS34814 (D.D.G.) and the Johns Hopkins Mind Brain Institute. D.D.G. and R.S. are investigators of the Howard Hughes Medical Institute.	Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; De Marco P, 2006, NEUROGENETICS, V7, P201, DOI 10.1007/s10048-006-0052-2; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	32	155	158	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					41	U94		10.1038/ncb2002	http://dx.doi.org/10.1038/ncb2002			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	19966784	Green Accepted			2022-12-25	WOS:000272973800010
J	Hase, K; Kimura, S; Takatsu, H; Ohmae, M; Kawano, S; Kitamura, H; Ito, M; Watarai, H; Hazelett, CC; Yeaman, C; Ohno, H				Hase, Koji; Kimura, Shunsuke; Takatsu, Hiroyuki; Ohmae, Masumi; Kawano, Sayaka; Kitamura, Hiroshi; Ito, Masatoshi; Watarai, Hiroshi; Hazelett, C. Clayton; Yeaman, Charles; Ohno, Hiroshi			M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex	NATURE CELL BIOLOGY			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; PRIMARY RESPONSE GENE; NECROSIS-FACTOR-ALPHA; M-CELLS; IMMUNE CELLS; CUTTING EDGE; ANIMAL-CELLS; GTPASE; FILOPODIA; TRANSMISSION	Cell-cell communication is essential for the development and homeostasis of multicellular organisms. Recently, a new type of cell-cell communication was discovered that is based on the formation of thin membranous nanotubes between remote cells(1,2). These long membrane tethers, termed tunneling nanotubes (TNTs), form an intercellular conduit and have been shown to enable the transport of various cellular components and signals. However, the molecular basis for TNT formation remains to be elucidated. Here we report that a mammalian protein, M-Sec, induces de novo formation of numerous membrane protrusions extending from the plasma membrane, some of which tether onto adjacent cells and subsequently form TNT-like structures. Depletion of M-Sec by RNA interference (RNAi) greatly reduced endogenous TNT formation as well as intercellular propagation of a calcium flux in a macrophage cell line. Furthermore, blockage of the interaction of M-Sec with Ral and the exocyst complex, which serves as a downstream effector of Ral, attenuated the formation of membrane nanotubes. Our results reveal that M-Sec functions as a key regulator of membrane nanotube formation through interaction with the Ral-exocyst pathway.	[Hase, Koji; Kimura, Shunsuke; Takatsu, Hiroyuki; Ohmae, Masumi; Kawano, Sayaka; Ohno, Hiroshi] RIKEN, Lab Epithelial Immunobiol, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Kitamura, Hiroshi; Ito, Masatoshi] RIKEN, Lab Immunogenom, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Watarai, Hiroshi] RIKEN, Lab Immune Regulat, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Ito, Masatoshi; Ohno, Hiroshi] Yokohama City Univ, Dept Supramol Biol, Grad Sch Nanobiosci, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN; University of Iowa; Yokohama City University	Ohno, H (corresponding author), RIKEN, Lab Epithelial Immunobiol, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan.	ohno@rcai.riken.jp	Watarai, Hiroshi/G-9894-2012; Kimura, Shunsuke/D-7093-2012; Yeaman, Charles A/A-1624-2009; Ohno, Hiroshi/L-7899-2014	Watarai, Hiroshi/0000-0003-1511-2593; Kimura, Shunsuke/0000-0001-9408-2884; Ohno, Hiroshi/0000-0001-8776-9661; Yeaman, Charles/0000-0001-6149-628X; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institutes of Health [GM067002]; Takeda Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank I. Yamashita and Y. Fujimura for technical assistance, and. P. Burrows and C. Blaumueller for critically reviewing the manuscript. This study was supported in part by Grants-in-Aid for Young Scientists ( B) ( K. H.), Scientific Research ( B) (H.O.), Scientific Research in Priority Areas ( H.O. and K. H.) and Scientific Research on Innovative Areas ( H.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the National Institutes of Health (GM067002; C. Y.) and the Takeda Science Foundation ( K. H.).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SARMA V, 1992, J IMMUNOL, V148, P3302; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WOLF FW, 1994, J BIOL CHEM, V269, P3633; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	33	222	233	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1427	U91		10.1038/ncb1990	http://dx.doi.org/10.1038/ncb1990			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935652				2022-12-25	WOS:000272251300008
J	Haffner, MC; Aryee, MJ; Toubaji, A; Esopi, DM; Albadine, R; Gurel, B; Isaacs, WB; Bova, GS; Liu, WN; Xu, JF; Meeker, AK; Netto, G; De Marzo, AM; Nelson, WG; Yegnasubramanian, S				Haffner, Michael C.; Aryee, Martin J.; Toubaji, Antoun; Esopi, David M.; Albadine, Roula; Gurel, Bora; Isaacs, William B.; Bova, G. Steven; Liu, Wennuan; Xu, Jianfeng; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.; Yegnasubramanian, Srinivasan			Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements	NATURE GENETICS			English	Article							DNA-TOPOISOMERASE-II; CHROMOSOMAL TRANSLOCATIONS; RECEPTOR; FUSION; PROGRESSION; ERG; CHEMOTHERAPY; TMPRSS2-ERG; ABERRATIONS; ACTIVATION	DNA double-strand breaks (DSBs) can lead to the development of genomic rearrangements, which are hallmarks of cancer. Fusions between TMPRSS2, encoding the transmembrane serine protease isoform 2, and ERG, encoding the v-ets erythroblastosis virus E26 oncogene homolog, are among the most common oncogenic rearrangements observed in human cancer. We show that androgen signaling promotes co-recruitment of androgen receptor and topoisomerase II beta (TOP2B) to sites of TMPRSS2-ERG genomic breakpoints, triggering recombinogenic TOP2B-mediated DSBs. Furthermore, androgen stimulation resulted in de novo production of TMPRSS2-ERG fusion transcripts in a process that required TOP2B and components of the DSB repair machinery. Finally, unlike normal prostate epithelium, prostatic intraepithelial neoplasia cells showed strong coexpression of androgen receptor and TOP2B. These findings implicate androgen-induced TOP2B-mediated DSBs in generating TMPRSS2-ERG rearrangements.	[Haffner, Michael C.; Aryee, Martin J.; Esopi, David M.; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.; Yegnasubramanian, Srinivasan] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Aryee, Martin J.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Toubaji, Antoun; Albadine, Roula; Gurel, Bora; Bova, G. Steven; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; [Isaacs, William B.; Meeker, Alan K.; Netto, George; De Marzo, Angelo M.; Nelson, William G.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Liu, Wennuan; Xu, Jianfeng] Wake Forest Univ Hlth Sci, Ctr Canc Genom, Winston Salem, NC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Wake Forest University; Wake Forest University School of Medicine	Yegnasubramanian, S (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	bnelson@jhmi.edu; syegnasu@jhmi.edu	Aryee, Martin/AAC-8113-2020; Gurel, Bora/A-5458-2016	Gurel, Bora/0000-0002-5018-8078; Netto, George/0000-0003-3915-9134; Bova, George/0000-0003-1639-3104	NIH/NCI; Department of Defense PCRP; Prostate Cancer Foundation; Maryland Cigarette Restitution Fund; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA058236, R01CA070196] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense PCRP(United States Department of Defense); Prostate Cancer Foundation; Maryland Cigarette Restitution Fund; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Coffey for helpful comments and C. Heaphy, H. Zhang and L. Dasko-Vincent from the SKCCC Cell Imaging Core Facility for technical support. We also thank the Brady Urological Research Institute Prostate Specimen Repository for providing TMA sections. This work was supported by funding from the NIH/NCI, Department of Defense PCRP, Prostate Cancer Foundation, Maryland Cigarette Restitution Fund and the Patrick C. Walsh Prostate Cancer Research Fund/Dr. and Mrs. Peter S. Bing Scholarship.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Denmeade SR, 1996, PROSTATE, V28, P251; DeWeese TL, 1997, INT J RADIAT ONCOL, V37, P145, DOI 10.1016/S0360-3016(96)00448-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Hallstrom TMKA, 2008, PROSTATE, V68, P902, DOI 10.1002/pros.20746; Hermans KG, 2008, CANCER RES, V68, P3094, DOI 10.1158/0008-5472.CAN-08-0198; IRIZARRY RA, 2009, GENE SET ENRICHMENT; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu WN, 2007, GENE CHROMOSOME CANC, V46, P972, DOI 10.1002/gcc.20482; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marker PC, 2008, DIFFERENTIATION, V76, P736, DOI 10.1111/j.1432-0436.2008.00297.x; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morgan WF, 1998, MUTAT RES-FUND MOL M, V404, P125, DOI 10.1016/S0027-5107(98)00104-3; NELSON WG, 1986, NATURE, V322, P187, DOI 10.1038/322187a0; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Padilla PI, 2008, P NATL ACAD SCI USA, V105, P3357, DOI 10.1073/pnas.0712387105; Pedersen-Bjergaard J, 1998, J CLIN ONCOL, V16, P1897, DOI 10.1200/JCO.1998.16.5.1897; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Smith MA, 1996, JNCI-J NATL CANCER I, V88, P407, DOI 10.1093/jnci/88.7.407; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	52	420	430	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					668	U45		10.1038/ng.613	http://dx.doi.org/10.1038/ng.613			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20601956	Green Accepted			2022-12-25	WOS:000280524000010
J	Esmon, CT				Esmon, Charles T.			BENCH TO BEDSIDE Counteracting coagulation	NATURE MEDICINE			English	Editorial Material							MEDIATORS		[Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Howard Hughes Med Inst, Cardiovasc Biol Res Program,Oklahoma Med Res Fdn, Oklahoma City, OK 73190 USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA	Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Esmon, CT (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Howard Hughes Med Inst, Cardiovasc Biol Res Program,Oklahoma Med Res Fdn, Oklahoma City, OK 73190 USA.	Chuck-Esmon@omrf.ouhsc.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875 , 10.1080/10408360802485875]; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; RATNOFF OD, 1968, NEW ENGL J MED, V279, P760, DOI 10.1056/NEJM196810032791407; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	10	8	9	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					759	760		10.1038/nm0710-759	http://dx.doi.org/10.1038/nm0710-759			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613754				2022-12-25	WOS:000279631900023
J	Valente, EM; Logan, CV; Mougou-Zerelli, S; Lee, JH; Silhavy, JL; Brancati, F; Iannicelli, M; Travaglini, L; Romani, S; Illi, B; Adams, M; Szymanska, K; Mazzotta, A; Lee, JE; Tolentino, JC; Swistun, D; Salpietro, CD; Fede, C; Gabriel, S; Russ, C; Cibulskis, K; Sougnez, C; Hildebrandt, F; Otto, EA; Held, S; Diplas, BH; Davis, EE; Mikula, M; Strom, CM; Ben-Zeev, B; Lev, D; Sagie, TL; Michelson, M; Yaron, Y; Krause, A; Boltshauser, E; Elkhartoufi, N; Roume, J; Shalev, S; Munnich, A; Saunier, S; Inglehearn, C; Saad, A; Alkindy, A; Thomas, S; Vekemans, M; Dallapiccola, B; Katsanis, N; Johnson, CA; Attie-Bitach, T; Gleeson, JG				Valente, Enza Maria; Logan, Clare V.; Mougou-Zerelli, Soumaya; Lee, Jeong Ho; Silhavy, Jennifer L.; Brancati, Francesco; Iannicelli, Miriam; Travaglini, Lorena; Romani, Sveva; Illi, Barbara; Adams, Matthew; Szymanska, Katarzyna; Mazzotta, Annalisa; Lee, Ji Eun; Tolentino, Jerlyn C.; Swistun, Dominika; Salpietro, Carmelo D.; Fede, Carmelo; Gabriel, Stacey; Russ, Carsten; Cibulskis, Kristian; Sougnez, Carrie; Hildebrandt, Friedhelm; Otto, Edgar A.; Held, Susanne; Diplas, Bill H.; Davis, Erica E.; Mikula, Mario; Strom, Charles M.; Ben-Zeev, Bruria; Lev, Dorit; Sagie, Tally Lerman; Michelson, Marina; Yaron, Yuval; Krause, Amanda; Boltshauser, Eugen; Elkhartoufi, Nadia; Roume, Joelle; Shalev, Stavit; Munnich, Arnold; Saunier, Sophie; Inglehearn, Chris; Saad, Ali; Alkindy, Adila; Thomas, Sophie; Vekemans, Michel; Dallapiccola, Bruno; Katsanis, Nicholas; Johnson, Colin A.; Attie-Bitach, Tania; Gleeson, Joseph G.			Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; PLANAR CELL POLARITY; GRUBER-SYNDROME; ACTIN CYTOSKELETON; RENAL SYNDROME; GENE; PROTEINS; CILIARY; DISSECTION; MECHANISMS	Joubert syndrome (JBTS), related disorders (JSRDs) and Meckel syndrome (MKS) are ciliopathies. We now report that MKS2 and CORS2 (JBTS2) loci are allelic and caused by mutations in TMEM216, which encodes an uncharacterized tetraspan transmembrane protein. Individuals with CORS2 frequently had nephronophthisis and polydactyly, and two affected individuals conformed to the oro-facio-digital type VI phenotype, whereas skeletal dysplasia was common in fetuses affected by MKS. A single G218T mutation (R73L in the protein) was identified in all cases of Ashkenazi Jewish descent (n = 10). TMEM216 localized to the base of primary cilia, and loss of TMEM216 in mutant fibroblasts or after knockdown caused defective ciliogenesis and centrosomal docking, with concomitant hyperactivation of RhoA and Dishevelled. TMEM216 formed a complex with Meckelin, which is encoded by a gene also mutated in JSRDs and MKS. Disruption of tmem216 expression in zebrafish caused gastrulation defects similar to those in other ciliary morphants. These data implicate a new family of proteins in the ciliopathies and further support allelism between ciliopathy disorders.	[Lee, Jeong Ho; Silhavy, Jennifer L.; Lee, Ji Eun; Tolentino, Jerlyn C.; Swistun, Dominika; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Inst Genom Med,Neurogenet Lab, San Diego, CA 92103 USA; [Valente, Enza Maria; Brancati, Francesco; Iannicelli, Miriam; Travaglini, Lorena; Romani, Sveva; Illi, Barbara; Mazzotta, Annalisa] Ist Ricovero Cura Carattere Sci Casa Sollievo Sof, Mendel Lab, San Giovanni Rotondo, Italy; [Valente, Enza Maria; Salpietro, Carmelo D.; Fede, Carmelo] Univ Messina, Dept Med & Surg Paediat Sci, Messina, Italy; [Logan, Clare V.; Adams, Matthew; Szymanska, Katarzyna; Inglehearn, Chris; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Mougou-Zerelli, Soumaya; Munnich, Arnold; Thomas, Sophie; Vekemans, Michel; Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Dept Genet,U781, Paris, France; [Mougou-Zerelli, Soumaya; Saad, Ali] Hop Farhat Hached, Serv Cytogenet Genet Mol & Biol Reprod, Sousse, Tunisia; [Brancati, Francesco] Univ G dAnnunzio, Ctr Excellence Aging, Dept Biomed Sci, Chieti, Italy; [Brancati, Francesco] Univ G dAnnunzio, Ctr Excellence Aging, Aging Res Ctr, Chieti, Italy; [Gabriel, Stacey; Russ, Carsten; Cibulskis, Kristian; Sougnez, Carrie] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA USA; [Hildebrandt, Friedhelm; Otto, Edgar A.; Held, Susanne] Univ Michigan, Howard Hughes Med Inst, Dept Pediat, Ann Arbor, MI 48109 USA; [Diplas, Bill H.; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Mikula, Mario; Strom, Charles M.] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA; [Ben-Zeev, Bruria] Safra Pediat Hosp, Sheba Med Ctr, Pediat Neurol Unit, Ramat Gan, Israel; [Lev, Dorit; Sagie, Tally Lerman; Michelson, Marina] Wolfson Med Ctr, Metab Neurogenet Serv, Inst Med Genet, Holon, Israel; [Yaron, Yuval] Tel Aviv Sourasky Med Ctr, Genet Inst, Prenatal Diag Unit, Tel Aviv, Israel; [Krause, Amanda] Univ Witwatersrand, Sch Pathol, Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa; [Boltshauser, Eugen] Univ Childrens Hosp Zurich, Dept Paediat Neurol, Zurich, Switzerland; [Elkhartoufi, Nadia; Munnich, Arnold; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; [Roume, Joelle] CHI Poissy, St Germain En Laye, France; [Shalev, Stavit] HaEmek Med Ctr, Genet Inst, Afula, Israel; [Saunier, Sophie] Univ Paris 05, Hop Necker Enfants Malad, AP HP, INSERM,U983, Paris, France; [Alkindy, Adila] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Dallapiccola, Bruno] Ist Ricovero & Cura Carattere Sci Bambino Gesu Ho, Rome, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Messina; Saint James's University Hospital; University of Leeds; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Sousse; Hopital Farhat Hached; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Duke University; Nichols Institute; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; National Health Laboratory Service; University of Witwatersrand; University Children's Hospital Zurich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Chi of Poissy Saint Germain; Emek Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cardiff University; IRCCS Bambino Gesu	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Inst Genom Med,Neurogenet Lab, San Diego, CA 92103 USA.	e.valente@css-mendel.it; c.johnson@leeds.ac.uk; tania.attie@inserm.fr; jogleeson@ucsd.edu	Valente, Enza Maria/G-2942-2017; Travaglini, Lorena/AAA-6245-2020; Lee, Jeong Ho/G-7361-2012; THOMAS, Sophie/F-4492-2017; Katsanis, Nicholas/E-1837-2012; Cibulskis, Kristian/AAC-7380-2019; Damiano, Carmelo Salpietro/AAL-2945-2020; Brancati, Francesco/AAC-3778-2022; Inglehearn, Chris/GYD-9783-2022; Mazzotta, Annalisa/AAG-8145-2020; Lerman-Sagie, Tally/AAY-7598-2021; ATTIE-BITACH, Tania/K-1453-2017; Saunier, Sophie/G-6044-2015; Illi, Barbara/AAY-8650-2020; thomas, sophie/GVS-1279-2022; Krause, Amanda/AAQ-7038-2020; Dallapiccola, Bruno/K-8692-2016	Valente, Enza Maria/0000-0002-0600-6820; THOMAS, Sophie/0000-0002-8569-3277; Damiano, Carmelo Salpietro/0000-0001-8794-2292; Brancati, Francesco/0000-0003-3624-2354; Lerman-Sagie, Tally/0000-0001-6641-6875; ATTIE-BITACH, Tania/0000-0002-1155-3626; Saunier, Sophie/0000-0002-1069-0047; Krause, Amanda/0000-0002-7157-0807; Otto, Edgar/0000-0002-2387-9973; Cibulskis, Kristian/0000-0003-1343-1582; Johnson, Colin/0000-0002-2979-8234; Travaglini, Lorena/0000-0003-0142-6516; Mikula, Mario/0000-0001-5782-0681; Mazzotta, Annalisa/0000-0002-1937-9765; Katsanis, Nicholas/0000-0002-2480-0171; Diplas, Bill/0000-0001-9248-7351; Dallapiccola, Bruno/0000-0002-5031-1013; Logan, Clare/0000-0003-4323-1602; Davis, Erica/0000-0002-2412-8397	US National Institutes of Health National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke [P30NS047101]; INSERM-DGRSRT [CS/RN/2008]; Italian Ministry of Health [RC2010]; Telethon Foundation Italy [GGP08145]; Pierfranco and Luisa Mariani Foundation; American Heart Association [O9POST2250641]; Medical Research Council [G0700073]; Sir Jules Thorn Charitable Trust [09/JTA]; l'Agence National pour la Recherche [ANR 07-MRAR]; US National Institutes of Health [R01 DK068306, R01 DK072301, R01 HD04260, R01 DK075972]; National Research Service [F32 DK079541, R01 NS052455, R01 NS04843]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R01DK072301, R01DK075972, F32DK079541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, P30NS047101] Funding Source: NIH RePORTER; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [G0700073] Funding Source: UKRI	US National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); INSERM-DGRSRT(Institut National de la Sante et de la Recherche Medicale (Inserm)); Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation Italy(Fondazione Telethon); Pierfranco and Luisa Mariani Foundation; American Heart Association(American Heart Association); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Charitable Trust; l'Agence National pour la Recherche(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Marshfield Clinic Research Foundation, Center for Inherited Disease Research (supported by the US National Institutes of Health National Heart, Lung, and Blood Institute) for genotyping support and A. Felsenfeld and the Medical Sequencing Initiative at the National Human Genome Research Institute. We acknowledge support for sequencing from the Broad Institute and the Broad Sequencing Platform and J. Meerloo at the University of California, San Diego Neurosciences Microscopy Core (Supported by National Institute of Neurological Disorders and Stroke grant P30NS047101). For patient referrals, we thank C. Jalas at Bonei Olam Center for Rare Jewish Genetic Disorders; M.R. Eccles at the University of Otago; H.M. Harville at University of Michigan; G. Tortorella, S. Briuglia, R. Chimenz, R. Gallizzi and M. Briguglio at University of Messina; E. Bertini and the International JSRD Study Group; and the French Society of Foetal Pathology. We thank E. Morrison, P. Novick and S. Ferro-Novick for helpful discussions; C. Janke (Macromolecular Biochemistry Research Center) for GT335 antibody; P. Robinson (University of Leeds) for siRNA duplexes against Hhari; E. Genin for linkage analysis, S. Audolent, C. Babarit, F. Legendre and H.-M. Gaude for technical help and O. Duc for confocal microscopy. S.M.-Z. is supported by INSERM-DGRSRT (CS/RN/2008 no. 87). This work was supported by the Italian Ministry of Health (RC2010, Ricerca Finalizzata 2006), Telethon Foundation Italy (GGP08145 to E.M.V.), Pierfranco and Luisa Mariani Foundation (E.M.V.), American Heart Association grant O9POST2250641 (J.E.L.), BDF Newlife, the Medical Research Council (G0700073) and the Sir Jules Thorn Charitable Trust (09/JTA to C.A.J.), l'Agence National pour la Recherche (ANR 07-MRAR-Fetalciliopathies to T. A.-B.), the US National Institutes of Health (R01 DK068306 to F. H.; R01 DK072301, R01 HD04260 and R01 DK075972 to N.K.; National Research Service Award fellowship F32 DK079541 to E. E. D., R01 NS052455 and R01 NS04843 to J.G.G.), Burroughs Wellcome Fund and Howard Hughes Medical Institute (F. H. and J. G. G.).	Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Caplan MJ, 2007, CURR OPIN NEPHROL HY, V16, P353, DOI 10.1097/MNH.0b013e328177b1fa; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hubner K, 2002, INT REV CYTOL, V214, P103; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Johnson CA, 2001, J BIOL CHEM, V276, P4539, DOI 10.1074/jbc.C000824200; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Trueba SS, 2005, J CLIN ENDOCR METAB, V90, P455, DOI 10.1210/jc.2004-1358; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; VARADI V, 1980, J MED GENET, V17, P119, DOI 10.1136/jmg.17.2.119; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	35	187	191	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					619	U100		10.1038/ng.594	http://dx.doi.org/10.1038/ng.594			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20512146	Green Accepted			2022-12-25	WOS:000279242400016
J	Zhao, Y; Yang, J; Liao, WJ; Liu, XY; Zhang, H; Wang, S; Wang, DL; Feng, JN; Yu, L; Zhu, WG				Zhao, Ying; Yang, Jing; Liao, Wenjuan; Liu, Xiangyu; Zhang, Hui; Wang, Shan; Wang, Donglai; Feng, Jingnan; Yu, Li; Zhu, Wei-Guo			Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTORS; CELL-DEATH; LIFE-SPAN; ACTIVATION; BECLIN-1; TARGET; GENE; TUMORIGENESIS; EXPRESSION; PROTEINS	Autophagy is characterized by the sequestration of bulk cytoplasm, including damaged proteins and organelles, and delivery of the cargo to lysosomes for degradation. Although the autophagic pathway is also linked to tumour suppression activity, the mechanism is not yet clear. Here we report that cytosolic FoxO1, a forkhead O family protein, is a mediator of autophagy. Endogenous FoxO1 was required for autophagy in human cancer cell lines in response to oxidative stress or serum starvation, but this process was independent of the transcriptional activity of FoxO1. In response to stress, FoxO1 was acetylated by dissociation from sirtuin-2 (SIRT2), a NAD(+)-dependent histone deacetylase, and the acetylated FoxO1 bound to Atg7, an E1-following protein, to influence the autophagic process leading to cell death. This FoxO1-modulated cell death is associated with tumour suppressor activity in human colon tumours and a xenograft mouse model. Our finding links the anti-neoplastic activity of FoxO1 and the process of autophagy.	[Zhao, Ying; Yang, Jing; Liao, Wenjuan; Liu, Xiangyu; Zhang, Hui; Wang, Donglai; Feng, Jingnan; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Zhang, Hui; Wang, Shan] Peking Univ, Hlth Sci Ctr, Dept Surg, Affiliated Hosp 2, Beijing 100044, Peoples R China; [Yu, Li] Tsinghua Univ, Dept Biol Sci, Beijing 100084, Peoples R China; Peking Univ, Beijing 00142, Peoples R China; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Sch Oncol, Beijing 00142, Peoples R China	Peking University; Peking University; Tsinghua University; Peking University; Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China.	zhuweiguo@bjmu.edu.cn	liu, xiangyu/D-8213-2014; zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581				Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Al-Mubarak B, 2009, CHANNELS, V3, P233; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Juhasz G, 2007, CELL DEATH DIFFER, V14, P1181, DOI 10.1038/sj.cdd.4402123; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	65	430	461	3	91	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					665	U88		10.1038/ncb2069	http://dx.doi.org/10.1038/ncb2069			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20543840				2022-12-25	WOS:000279374400010
J	Albagha, OME; Visconti, MR; Alonso, N; Langston, AL; Cundy, T; Dargie, R; Dunlop, MG; Fraser, WD; Hooper, MJ; Isaia, G; Nicholson, GC; Montes, JD; Gonzalez-Sarmiento, R; di Stefano, M; Tenesa, A; Walsh, JP; Ralston, SH				Albagha, Omar M. E.; Visconti, Micaela R.; Alonso, Nerea; Langston, Anne L.; Cundy, Tim; Dargie, Rosemary; Dunlop, Malcolm G.; Fraser, William D.; Hooper, Michael J.; Isaia, Gianluca; Nicholson, Geoff C.; del Pino Montes, Javier; Gonzalez-Sarmiento, Rogelio; di Stefano, Marco; Tenesa, Albert; Walsh, John P.; Ralston, Stuart H.			Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone	NATURE GENETICS			English	Article							COLONY-STIMULATING FACTOR; FAMILIAL EXPANSILE OSTEOLYSIS; NF-KAPPA-B; SUSCEPTIBILITY LOCI; MINERAL DENSITY; OPTINEURIN; RANK; OSTEOCLASTOGENESIS; MUTATIONS; DUPLICATION	Paget's disease of bone (PDB) is a common disorder with a strong genetic component characterized by focal increases in bone turnover, which in some cases is caused by mutations in SQSTM1. To identify additional susceptibility genes, we performed a genome-wide association study in 750 individuals with PDB (cases) without SQSTM1 mutations and 1,002 controls and identified three candidate disease loci, which were then replicated in an independent set of 500 cases and 535 controls. The strongest signal was with rs484959 on 1p13 near the CSF1 gene (P = 5.38 x 10(-24)). Significant associations were also observed with rs1561570 on 10p13 within the OPTN gene (P = 6.09 x 10(-13)) and with rs3018362 on 18q21 near the TNFRSF11A gene (P = 5.27 x 10(-13)). These studies provide new insights into the pathogenesis of PDB and identify OPTN, CSF1 and TNFRSF11A as candidate genes for disease susceptibility.	[Albagha, Omar M. E.; Visconti, Micaela R.; Alonso, Nerea; Langston, Anne L.; Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland; [Langston, Anne L.; Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Cundy, Tim] Univ Auckland, Dept Med, Auckland, New Zealand; [Dargie, Rosemary] Glasgow Royal Infirm, Univ Dept Med, Glasgow G4 0SF, Lanark, Scotland; [Dunlop, Malcolm G.; Tenesa, Albert] Univ Edinburgh, Human Genet Unit, MRC, Western Gen Hosp,Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Fraser, William D.] Royal Liverpool Univ Hosp, Dept Clin Chem, Liverpool, Merseyside, England; [Hooper, Michael J.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Hooper, Michael J.] Cent Sydney Area Hlth Serv, Sydney, NSW, Australia; [Isaia, Gianluca; di Stefano, Marco] Univ Turin, Dept Med & Surg, Geriatr Sect, Turin, Italy; [Nicholson, Geoff C.] Univ Melbourne, Geelong Hosp, Dept Clin & Biomed Sci, Melbourne, Vic, Australia; [del Pino Montes, Javier; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Dept Med, Unidad Med Mol, E-37008 Salamanca, Spain; [del Pino Montes, Javier; Gonzalez-Sarmiento, Rogelio] Hosp Univ Salamanca, RETICEF, Salamanca, Spain; [Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia	University of Edinburgh; University of Edinburgh; University of Auckland; University of Glasgow; University of Edinburgh; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Sydney; University of Turin; Geelong Hospital; University of Melbourne; University of Salamanca; University of Salamanca; University of Western Australia	Ralston, SH (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland.	stuart.ralston@ed.ac.uk	IBSAL, Secretaría/H-3719-2011; Nicholson, Geoffrey C/F-1901-2010; Del Pino-Montes, Javier/M-3544-2014; Gonzalez-Sarmiento, Rogelio/V-5526-2019	Nicholson, Geoffrey C/0000-0002-0152-1153; Del Pino-Montes, Javier/0000-0002-3145-6137; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; Tenesa, Albert/0000-0003-4884-4475; Cundy, Timothy/0000-0003-4890-9400; Walsh, John/0000-0002-1766-2612; ISAIA, Gianluca/0000-0002-0249-9170	Arthritis Research Campaign [13724, 17646, 15389]; National Association for Relief of Paget's Disease; Cancer Research UK [C348/A3758, C348/A8896]; Medical Research Council [G0000657-53203]; MRC [MC_U127527198, G0801462] Funding Source: UKRI; Medical Research Council [MC_U127527198, G0801462] Funding Source: researchfish; Versus Arthritis [18304] Funding Source: researchfish	Arthritis Research Campaign(Versus Arthritis); National Association for Relief of Paget's Disease; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	We acknowledge the contribution of the many participants who provided samples for the analysis. We thank L. Murphy and A. Fawkes of the Wellcome Trust Clinical Research Facility for technical support with the Illumina genotyping. We also thank A. Khatib for assistance with data management. The study was supported in part by grants to S. H. R. from the Arthritis Research Campaign (grants 13724, 17646 and 15389) and a grant to O.M.E.A. and S. H. R. from the National Association for Relief of Paget's Disease. The work was also supported by grants from Cancer Research UK (C348/A3758, C348/A8896) and the Medical Research Council (G0000657-53203) to M. G. D. and A. T.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouyer P, 2007, ENDOCRINOLOGY, V148, P831, DOI 10.1210/en.2006-0547; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cooper C, 1999, J BONE MINER RES, V14, P192, DOI 10.1359/jbmr.1999.14.2.192; Hocking L, 2000, BONE, V26, P577, DOI 10.1016/S8756-3282(00)00278-7; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hocking LJ, 2001, AM J HUM GENET, V69, P1055, DOI 10.1086/323798; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Langston AL, 2010, J BONE MINER RES, V25, P20, DOI 10.1359/jbmr.090709; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lucas GJA, 2008, J BONE MINER RES, V23, P58, DOI 10.1359/JBMR.071004; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Nakatsuka K, 2003, J BONE MINER RES, V18, P1381, DOI 10.1359/jbmr.2003.18.8.1381; Neale SD, 2002, QJM-INT J MED, V95, P233, DOI 10.1093/qjmed/95.4.233; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rezaie T, 2005, INVEST OPHTH VIS SCI, V46, P2404, DOI 10.1167/iovs.04-1243; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Siris ES, 1998, J BONE MINER RES, V13, P1061, DOI 10.1359/jbmr.1998.13.7.1061; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tsurukai T, 2000, J BONE MINER METAB, V18, P177, DOI 10.1007/s007740070018; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Whyte MP, 2002, J BONE MINER RES, V17, P26, DOI 10.1359/jbmr.2002.17.1.26; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wuyts W, 2001, BONE, V28, P104, DOI 10.1016/S8756-3282(00)00411-7; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	43	198	204	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					520	U26		10.1038/ng.562	http://dx.doi.org/10.1038/ng.562			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436471	Green Accepted			2022-12-25	WOS:000278081500018
J	Sherborne, AL; Hosking, FJ; Prasad, RB; Kumar, R; Koehler, R; Vijayakrishnan, J; Papaemmanuil, E; Bartram, CR; Stanulla, M; Schrappe, M; Gast, A; Dobbins, SE; Ma, Y; Sheridan, E; Taylor, M; Kinsey, SE; Lightfoot, T; Roman, E; Irving, JAE; Allan, JM; Moorman, AV; Harrison, CJ; Tomlinson, IP; Richards, S; Zimmermann, M; Szalai, C; Semsei, AF; Erdelyi, DJ; Krajinovic, M; Sinnett, D; Healy, J; Neira, AG; Kawamata, N; Ogawa, S; Koeffler, HP; Hemminki, K; Greaves, M; Houlston, RS				Sherborne, Amy L.; Hosking, Fay J.; Prasad, Rashmi B.; Kumar, Rajiv; Koehler, Rolf; Vijayakrishnan, Jayaram; Papaemmanuil, Elli; Bartram, Claus R.; Stanulla, Martin; Schrappe, Martin; Gast, Andreas; Dobbins, Sara E.; Ma, Yussanne; Sheridan, Eamonn; Taylor, Malcolm; Kinsey, Sally E.; Lightfoot, Tracey; Roman, Eve; Irving, Julie A. E.; Allan, James M.; Moorman, Anthony V.; Harrison, Christine J.; Tomlinson, Ian P.; Richards, Sue; Zimmermann, Martin; Szalai, Csaba; Semsei, Agnes F.; Erdelyi, Daniel J.; Krajinovic, Maja; Sinnett, Daniel; Healy, Jasmine; Gonzalez Neira, Anna; Kawamata, Norihiko; Ogawa, Seishi; Koeffler, H. Phillip; Hemminki, Kari; Greaves, Mel; Houlston, Richard S.			Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; VARIANTS; LOCI	Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage.	[Sherborne, Amy L.; Hosking, Fay J.; Vijayakrishnan, Jayaram; Papaemmanuil, Elli; Dobbins, Sara E.; Ma, Yussanne; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Prasad, Rashmi B.; Kumar, Rajiv; Gast, Andreas; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Koehler, Rolf; Bartram, Claus R.] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Stanulla, Martin; Schrappe, Martin] Univ Kiel, Dept Pediat, Acute Lymphoblast Leukemia Berlin Frankfurt Munst, D-2300 Kiel, Germany; [Sheridan, Eamonn] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Sch Canc Sci, Canc Immunogenet Grp, Manchester M13 0JH, Lancs, England; [Kinsey, Sally E.] St James Univ Hosp, Dept Paediat & Adolescent Oncol & Haematol, Leeds, W Yorkshire, England; [Lightfoot, Tracey; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England; [Irving, Julie A. E.; Allan, James M.; Moorman, Anthony V.; Harrison, Christine J.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tomlinson, Ian P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Richards, Sue] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Richards, Sue] Epidemiol Studies Unit, Oxford, England; [Zimmermann, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Szalai, Csaba; Semsei, Agnes F.; Erdelyi, Daniel J.] Semmelweis Univ, SNP Core Facil Lab, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Krajinovic, Maja; Sinnett, Daniel; Healy, Jasmine] Univ Montreal, St Justine Univ Hlth Ctr, Res Ctr, Div Hematol Oncol, Montreal, PQ, Canada; [Gonzalez Neira, Anna] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Kawamata, Norihiko] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol & Oncol, Los Angeles, CA 90048 USA; [Ogawa, Seishi] Univ Tokyo, Sch Med, Tokyo 113, Japan; [Koeffler, H. Phillip] Natl Univ Singapore, Inst Human Genet, Singapore 117548, Singapore; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Kiel; Saint James's University Hospital; University of Manchester; Saint James's University Hospital; University of York - UK; Newcastle University - UK; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of Oxford; Hannover Medical School; Semmelweis University; Universite de Montreal; Centro Nacional de Investigaciones Oncologicas (CNIO); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo; National University of Singapore; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Moorman, Anthony/F-5518-2010; Allan, James/B-4448-2009; Prasad, Rashmi/Y-4276-2019; Prasad, Rashmi B/D-7067-2017; Moorman, Anthony/G-1468-2014; Prasad, Rashmi B/GRJ-5491-2022; Kumar, Rajiv/H-6431-2019; Stanulla, Martin/N-4674-2017; Schrappe, Martin/ABA-6144-2020; Schrappe, Martin/A-8109-2010; Gonzalez-Neira, Anna/C-5791-2015; Stanulla, Martin/D-2528-2010; Prasad, Rashmi B/H-7381-2016; Ogawa, Seishi/AAE-7088-2019; Erdelyi, Daniel J/N-8957-2017; sinnett, daniel/S-4589-2017	Prasad, Rashmi B/0000-0002-4400-6741; Moorman, Anthony/0000-0002-9781-6107; Prasad, Rashmi B/0000-0002-4400-6741; Kumar, Rajiv/0000-0002-6093-0395; Stanulla, Martin/0000-0002-3834-0727; Gonzalez-Neira, Anna/0000-0002-5421-2020; Prasad, Rashmi B/0000-0002-4400-6741; Erdelyi, Daniel J/0000-0001-5544-9209; sinnett, daniel/0000-0003-3625-6676; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Harrison, Christine/0000-0002-0526-6794; Houlston, Richard/0000-0002-5268-0242; Semsei, Agnes F./0000-0002-8709-2459; Sherborne, Amy/0000-0002-9717-4773; Roman, Eve/0000-0001-7603-3704; Hosking, Fay/0000-0002-1101-039X; Allan, James/0000-0002-7580-5087	Kay Kendall Leukemia Fund; Leukemia Research (UK); Cancer Research UK [C1298/A8362]; Children with Leukemia; Tumorzentrum Heidelberg-Mannheim, EU [Food-CT-2005-016320, Health-F3-2007-2007-200767]; Deutsche Krebshilfe; Hungarian Scientific Research Fund [T042500]; Economic Competitiveness Operational Programme, Hungary [GVOP 3.1.1-2004-05-0022/3.0]; NKTH (National Research and Technology) [TECH_ 08-A1/2-2008-0120]; National Sciences and Engineering Research Council Canada; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; Medical Research Council [MC_U137686856] Funding Source: researchfish; MRC [MC_U137686856] Funding Source: UKRI	Kay Kendall Leukemia Fund; Leukemia Research (UK); Cancer Research UK(Cancer Research UK); Children with Leukemia; Tumorzentrum Heidelberg-Mannheim, EU; Deutsche Krebshilfe(Deutsche Krebshilfe); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Economic Competitiveness Operational Programme, Hungary; NKTH (National Research and Technology)(National Office for Research and Technology); National Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Kay Kendall Leukemia Fund and Leukemia Research (UK) provided principal funding for the study. Support from Cancer Research UK (C1298/A8362, supported by the Bobby Moore Fund) is also acknowledged. The study made use of genotyping data from the 1958 Birth Cohort which was generated and generously supplied to us by Panagiotis Deloukas of the Wellcome Trust Sanger Institute. For a full list of the investigators who contributed to the generation of the 1958 data, see URL section. We are grateful to S. Richards and J. Burrett (Clinical Trials Service Unit, Oxford) and L. Chilton (Leukaemia Research Cytogenetics Group, Northern Institute of Cancer Research, Newcastle Univ.), J. Simpson (Univ. York), P. Thomson and A. Hussain (Cancer Immunogenetics, School of Cancer Sciences, Univ. Manchester) for assistance with data harmonization. We thank the Leukaemia Research (LR) Childhood Cancer Leukaemia Group (CCLG) Childhood Leukaemia Cell Bank for access to the Medical Research Council ALL trial samples. We are grateful to the UK Cancer Cytogenetics Group (UKCCG) for data collection and provision of samples. P. Thomson (Cancer Immunogenetics, School of Cancer Sciences, University of Manchester) is funded by Children with Leukemia and we acknowledge their support. Genotyping of German cases and controls was partly covered by funding from Tumorzentrum Heidelberg-Mannheim, EU (Food-CT-2005-016320 and Health-F3-2007-2007-200767) and Deutsche Krebshilfe. The Hungarian sample collection was financially supported by grants from the Hungarian Scientific Research Fund (T042500), the Economic Competitiveness Operational Programme, Hungary (GVOP 3.1.1-2004-05-0022/3.0) and NKTH (National Research and Technology) TECH_ 08-A1/2-2008-0120. M. K. is a scholar of the Fonds de la Recherche en Sante du Quebec. D. S. holds the Francois-Karl Viau Chair in Pediatric Oncogenomics and is also a scholar of the Fonds de la Recherche en Sante du Quebec. J. H. is the recipient of a National Sciences and Engineering Research Council Canada Graduate's scholarship. P. Garcia-Miguel and A. Sastre from Hospital Infantil La Paz, Madrid, and J. Luis Vivanco Martinez from Hospital 12 de Octubre, Madrid, were involved in the sample collection of the Spanish samples, and R. Alonso from Centro Nacional de Investigaciones Oncologicas was involved in the genotyping.	BATEMAN C, 2010, BLOOD, DOI DOI 10.1182/BLOOD-2009-10-25143; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Iacobucci I, 2010, LEUKEMIA, V24, P66, DOI 10.1038/leu.2009.197; Kitagawa Y, 2002, J BIOL CHEM, V277, P46289, DOI 10.1074/jbc.M208353200; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Mullighan CG, 2009, LEUKEMIA, V23, P1209, DOI 10.1038/leu.2009.18; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sulong S, 2009, BLOOD, V113, P100, DOI 10.1182/blood-2008-07-166801; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432	15	194	198	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					492	494		10.1038/ng.585	http://dx.doi.org/10.1038/ng.585			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20453839	Green Accepted			2022-12-25	WOS:000278081500012
J	Bechtel, W; McGoohan, S; Zeisberg, EM; Muller, GA; Kalbacher, H; Salant, DJ; Muller, CA; Kalluri, R; Zeisberg, M				Bechtel, Wibke; McGoohan, Scott; Zeisberg, Elisabeth M.; Mueller, Gerhard A.; Kalbacher, Hubert; Salant, David J.; Mueller, Claudia A.; Kalluri, Raghu; Zeisberg, Michael			Methylation determines fibroblast activation and fibrogenesis in the kidney	NATURE MEDICINE			English	Article							TO-MESENCHYMAL TRANSITION; HUMAN RENAL FIBROBLASTS; DNA METHYLATION; INTERSTITIAL FIBROSIS; TGF-BETA; DISEASE; CANCER; PROTEIN; CELLS; IDENTIFICATION	Fibrogenesis is a pathological wound repair process that fails to cease, even when the initial insult has been removed. Fibroblasts are principal mediators of fibrosis, and fibroblasts from fibrotic tissues fail to return to their quiescent stage, including when cultured in vitro. In a search for underlying molecular mechanisms, we hypothesized that this perpetuation of fibrogenesis is caused by epigenetic modifications. We demonstrate here that hypermethylation of RASAL1, encoding an inhibitor of the Ras oncoprotein, is associated with the perpetuation of fibroblast activation and fibrogenesis in the kidney. RASAL1 hypermethylation is mediated by the methyltransferase Dnmt1 in renal fibrogenesis, and kidney fibrosis is ameliorated in Dnmt1(+/-) heterozygous mice. These studies demonstrate that epigenetic modifications may provide a molecular basis for perpetuated fibroblast activation and fibrogenesis in the kidney.	[Bechtel, Wibke; McGoohan, Scott; Zeisberg, Elisabeth M.; Kalluri, Raghu; Zeisberg, Michael] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Bechtel, Wibke; McGoohan, Scott; Zeisberg, Elisabeth M.; Kalluri, Raghu; Zeisberg, Michael] Harvard Univ, Sch Med, Boston, MA USA; [Mueller, Gerhard A.] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, Gottingen, Germany; [Kalbacher, Hubert; Mueller, Claudia A.] Univ Med Clin, Sect Transplantat Immunol & Immunohematol, Med Res Ctr, Tubingen, Germany; [Salant, David J.] Boston Univ, Med Ctr, Renal Sect, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Gottingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Boston University	Zeisberg, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	mzeisber@bidmc.harvard.edu	Zeisberg, Elisabeth/ABG-4970-2021; Kalluri, Raghu/E-2677-2015	Bechtel-Walz, Wibke/0000-0001-6032-3627; Kalluri, Raghu/0000-0002-2190-547X; Salant, David/0000-0002-3866-3120	National Institutes of Health [R01DK081576, R03DK081687, R01DK30932, R01DK55001, R01CA125550, 1K08 CA129204, K08 DK074558]; American Society of Nephrology; American Heart Association [SDG0735602T]; Deutsche Forschungsgemeinschaft-Stipendium [BE4211/1-1]; Champalimaud Metastasis Research Program; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE [K08CA129204, R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081576, R01DK055001, R01DK030932, K08DK074558, R03DK081687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft-Stipendium; Champalimaud Metastasis Research Program; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partially funded by research grants R01DK081576 (M.Z.), R03DK081687 (M.Z.), R01DK30932 (D.J.S.), R01DK55001 (R. K.), R01CA125550 (R. K.), Mentored Clinical Scientist Development Awards 1K08 CA129204 (E. M.Z.) and K08 DK074558 (M.Z.) from the National Institutes of Health, the American Society of Nephrology Carl W. Gottschalk Scholar Grant (M.Z.), American Heart Association Scientist Development Grant SDG0735602T, Deutsche Forschungsgemeinschaft-Stipendium BE4211/1-1 (W. B.), Champalimaud Metastasis Research Program (R. K.) and research funds from the Beth Israel Deaconess Medical Center for the Division of Matrix Biology. We thank A. Lau and T. Zhong Hu for technical assistance. FSP-1-specific antibodies were a gift from E. Neilson (Vanderbilt University).	Arun D, 2004, CURR OPIN NEUROL, V17, P101, DOI 10.1097/00019052-200404000-00004; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Basile DP, 2005, AM J PHYSIOL-RENAL, V288, pF953, DOI 10.1152/ajprenal.00329.2004; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; BOS JL, 1989, CANCER RES, V49, P4682; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chatterjee PK, 2001, KIDNEY INT, V59, P2073, DOI 10.1046/j.1523-1755.2001.00722.x; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; FEINBERG AP, 1987, SEMIN SURG ONCOL, V3, P149, DOI 10.1002/ssu.2980030304; Forbes JM, 1999, KIDNEY INT, V55, P198, DOI 10.1046/j.1523-1755.1999.00253.x; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gius D, 2005, CANCER, V104, P1789, DOI 10.1002/cncr.21395; Hendry Bruce M., 2003, Nephron, V93, pe129, DOI 10.1159/000070236; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khwaja A, 2005, KIDNEY INT, V68, P474, DOI 10.1111/j.1523-1755.2005.00425.x; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Lafyatis Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P395; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; MULLER GA, 1991, AM J KIDNEY DIS, V17, P680; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; WEBER KT, 1992, BASIC RES CARDIOL, V87, P291; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	47	455	478	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2010	16	5					544	U75		10.1038/nm.2135	http://dx.doi.org/10.1038/nm.2135			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20418885	Green Accepted			2022-12-25	WOS:000277394700032
J	Chan, CH; Lee, SW; Li, CF; Wang, J; Yang, WL; Wu, CY; Wu, J; Nakayama, KI; Kang, HY; Huang, HY; Hung, MC; Pandolfi, PP; Lin, HK				Chan, Chia-Hsin; Lee, Szu-Wei; Li, Chien-Feng; Wang, Jing; Yang, Wei-Lei; Wu, Ching-Yuan; Wu, Juan; Nakayama, Keiichi I.; Kang, Hong-Yo; Huang, Hsuan-Ying; Hung, Mien-Chie; Pandolfi, Pier Paolo; Lin, Hui-Kuan			Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis	NATURE CELL BIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; C-MYC; TUMOR PROGRESSION; LUNG METASTASIS; SKP2; REPRESSION; UBIQUITIN; TRANSFORMATION; PROTEOLYSIS; PROTEINS	The RhoA GTPase is crucial in numerous biological functions and is linked to cancer metastasis. However, the understanding of the molecular mechanism responsible for RhoA transcription is still very limited. Here we show that RhoA transcription is orchestrated by the Myc-Skp2-Miz1-p300 transcriptional complex. Skp2 cooperates with Myc to induce RhoA transcription by recruiting Miz1 and p300 to the RhoA promoter independently of Skp1-Cullin-F-box protein containing complex (SCF)-Skp2 E3 ligase activity. Deficiency of this complex results in impairment in RhoA expression, cell migration, invasion, and breast cancer metastasis, recapitulating the phenotypes observed in RhoA knockdown, and RhoA restoration rescues the defect in cell invasion. Overexpression of the Myc-Skp2-Miz1 complex is found in metastatic human cancers and is correlated with RhoA expression. Our study provides insight into how oncogenic Skp2 and Myc coordinate to induce RhoA transcription and establishes a novel SCF-Skp2 E3-ligase-independent function for oncogenic Skp2 in transcription and cancer metastasis.	[Chan, Chia-Hsin; Lee, Szu-Wei; Wang, Jing; Yang, Wei-Lei; Wu, Ching-Yuan; Wu, Juan; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lee, Szu-Wei; Yang, Wei-Lei; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas Houston, Sch Biomed Sci, Houston, TX 77030 USA; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Wu, Ching-Yuan] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Chinese Med,Med Ctr, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Kang, Hong-Yo] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Grad Inst Clin Med Sci,Med Ctr, Kaohsiung 833, Taiwan; [Wang, Jing; Wu, Juan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Peoples R China; [Wang, Jing; Wu, Juan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Peoples R China; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Huang, Hsuan-Ying] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Pathol,Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02115 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol & Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Chi Mei Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Sun Yat Sen University; Sun Yat Sen University; Kyushu University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Chan, Chia-Hsin/F-2272-2011; Yang, Wei-Lei/E-2598-2012; Hung, Mien-Chie/ABD-5911-2021; Kang, Hong-Yo/W-9031-2019; Chan, Chia-Hsin/AAT-7782-2020	Hung, Mien-Chie/0000-0003-4317-4740; Kang, Hong-Yo/0000-0003-0626-5037; Chan, Chia-Hsin/0000-0001-8506-7500	M. D. Anderson Cancer Center; National Cancer Institute; Department of Defense; Department of Health, Taiwan; NATIONAL CANCER INSTITUTE [R01CA136787] Funding Source: NIH RePORTER	M. D. Anderson Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Department of Health, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Weinberg, W. Sellers, D. Bohmann, W. Tansey, J. M. Sedivy, W. Wei, M. Pagano, M. Eilers, W. S. El-Deiry, L. Yao and D. Sarbassov for reagents. We also thank D. Sarbassov, M. H. Lee and M. G. Lee for comments and suggestions. Special thanks are extended to S. Patterson for editing and critical reading of the manuscript. This work was supported by Research Trust Scholar funds from the M. D. Anderson Cancer Center, the National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) at the M. D. Anderson Cancer Center, a Department of Defense Prostate Cancer New Investigator Award (to H. K. L.) and a grant from the Department of Health, Taiwan (to C. F. L.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bellizzi A, 2008, INT J MOL MED, V22, P25; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faried A, 2005, EJSO, V31, P410, DOI 10.1016/j.ejso.2004.12.014; Faried A, 2007, ANN SURG ONCOL, V14, P3593, DOI 10.1245/s10434-007-9562-x; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kamai T, 2003, BJU INT, V91, P234, DOI 10.1046/j.1464-410X.2003.03063.x; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOSCOW JA, 1994, ONCOGENE, V9, P189; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Rihet S, 2001, J CANCER RES CLIN, V127, P733; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Smit MA, 2008, CANCER CELL, V14, P5, DOI 10.1016/j.ccr.2008.06.012; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907	44	171	175	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					457	U103		10.1038/ncb2047	http://dx.doi.org/10.1038/ncb2047			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20383141	Green Accepted			2022-12-25	WOS:000277283700011
J	Narva, E; Autio, R; Rahkonen, N; Kong, LJ; Harrison, N; Kitsberg, D; Borghese, L; Itskovitz-Eldor, J; Rasool, O; Dvorak, P; Hovatta, O; Otonkoski, T; Tuuri, T; Cui, W; Brustle, O; Baker, D; Maltby, E; Moore, HD; Benvenisty, N; Andrews, PW; Yli-Harja, O; Lahesmaa, R				Narva, Elisa; Autio, Reija; Rahkonen, Nelly; Kong, Lingjia; Harrison, Neil; Kitsberg, Danny; Borghese, Lodovica; Itskovitz-Eldor, Joseph; Rasool, Omid; Dvorak, Petr; Hovatta, Outi; Otonkoski, Timo; Tuuri, Timo; Cui, Wei; Brustle, Oliver; Baker, Duncan; Maltby, Edna; Moore, Harry D.; Benvenisty, Nissim; Andrews, Peter W.; Yli-Harja, Olli; Lahesmaa, Riitta			High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ES CELLS; EXPRESSION; ARRAY; CHROMOSOME-16; POLYMORPHISM; INSTABILITY; CARCINOMA	Prolonged culture of human embryonic stem cells (hESCs) can lead to adaptation and the acquisition of chromosomal abnormalities, underscoring the need for rigorous genetic analysis of these cells. Here we report the highest-resolution study of hESCs to date using an Affymetrix SNP 6.0 array containing 906,600 probes for single nucleotide polymorphisms (SNPs) and 946,000 probes for copy number variations (CNVs). Analysis of 17 different hESC lines maintained in different laboratories identified 843 CNVs of 50 kb-3 Mb in size. We identified, on average, 24% of the loss of heterozygosity (LOH) sites and 66% of the CNVs changed in culture between early and late passages of the same lines. Thirty percent of the genes detected within CNV sites had altered expression compared to samples with normal copy number states, of which >44% were functionally linked to cancer. Furthermore, LOH of the q arm of chromosome 16, which has not been observed previously in hESCs, was detected.	[Narva, Elisa; Autio, Reija; Rahkonen, Nelly; Rasool, Omid; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Narva, Elisa; Autio, Reija; Rahkonen, Nelly; Rasool, Omid; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Autio, Reija; Kong, Lingjia; Yli-Harja, Olli] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Harrison, Neil; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England; [Harrison, Neil; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Kitsberg, Danny] Stem Cell Technol Ltd, Jerusalem, Israel; [Borghese, Lodovica; Brustle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-5300 Bonn, Germany; [Borghese, Lodovica; Brustle, Oliver] Hertie Fdn, Bonn, Germany; [Itskovitz-Eldor, Joseph] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Itskovitz-Eldor, Joseph] Rambam Med Ctr, Dept Obstet & Gynecol, IL-31096 Haifa, Israel; [Dvorak, Petr] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Dvorak, Petr] Acad Sci Czech Republ, Dept Mol Embryol, Inst Expt Med, Brno, Czech Republic; [Hovatta, Outi] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept CLINTEC, Stockholm, Sweden; [Otonkoski, Timo; Tuuri, Timo] Univ Helsinki, Program Mol Neurol, Biomedicum Stem Cell Ctr, Helsinki, Finland; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Cui, Wei] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Fac Med, London, England; [Baker, Duncan; Maltby, Edna] Sheffield Childrens NHS Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England; [Moore, Harry D.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Stem Cell Unit, Inst Life Sci, IL-91904 Jerusalem, Israel; [Yli-Harja, Olli] Inst Syst Biol, Seattle, WA USA	University of Turku; Abo Akademi University; Tampere University; University of Sheffield; University of Sheffield; University of Bonn; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Masaryk University Brno; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Helsinki; Imperial College London; Sheffield Children's NHS Foundation Trust; University of Sheffield; Hebrew University of Jerusalem; Institute for Systems Biology (ISB)	Lahesmaa, R (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	elisa.narva@btk.fi; riitta.lahesmaa@btk.fi	Otonkoski, Timo/F-1189-2011; Harrison, Nicholas/H-3198-2013; Vopenkova, Katerina/C-7133-2012; Dvorak, Petr/G-2509-2013; Autio, Reija/D-2037-2014; Närvä, Elisa Maarit/AAA-4885-2022; Cui, Wei/AAD-1690-2019; Dvorak, Petr/N-8936-2016	Harrison, Nicholas/0000-0001-7498-8144; Dvorak, Petr/0000-0002-3229-140X; Närvä, Elisa Maarit/0000-0003-0517-9436; Dvorak, Petr/0000-0002-3229-140X; Cui, Wei/0000-0003-2019-380X; Kong, Lingjia/0000-0003-1016-030X; Autio, Reija/0000-0002-6519-2715; Andrews, Peter/0000-0001-7215-4410; Yli-Harja, Olli/0000-0001-8581-4414	European Union; Juvenile Diabetes Research Foundation; Academy of Finland; Improving Outcomes Guidance Trust; Ministry of Education, Youth, and Sport of the Czech Republic; Ida Montin Foundation; Academy of Finland [129657, 134117]; Medical Research Council, UK; MRC [G0700785, G0801059] Funding Source: UKRI; Medical Research Council [G0801059, G0700785] Funding Source: researchfish	European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Academy of Finland(Academy of Finland); Improving Outcomes Guidance Trust; Ministry of Education, Youth, and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ida Montin Foundation; Academy of Finland(Academy of Finland); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to everyone who has taken care of sample collection and handling: T. Golan-Lev, A. Urrutikoetxea-Uriguen, S. Haupt, P. Koch, I. Laufenberg, B. Ley, A. Hampl, M. Vodinska, K. Koudelkova, S. Strom, F. Holm, A.-M. Stromberg, C. Olsson, M. Mikkola, S. Vuoristo, P. Junni and M. Hakkarainen. We especially acknowledge M. Linja, T. Heinonen and the Finnish DNA Microarray Centre for their excellent technical assistance. We acknowledge the Turku Graduate School of Biomedical Sciences. This study is supported by funding for the ESTOOLS consortium under the Sixth Research Framework Programme of the European Union, Juvenile Diabetes Research Foundation, The Academy of Finland and the Finnish Cancer Organizations, The Improving Outcomes Guidance Trust, The Ministry of Education, Youth, and Sport of the Czech Republic, Ida Montin Foundation, The Academy of Finland, projects no. 129657 (Finnish Centre of Excellence program 2006-11) and no. 134117 and the Medical Research Council, UK.	Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; BENGLSSON H, 2008, 745 U CAL DEP STAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Caisander G, 2006, CHROMOSOME RES, V14, P131, DOI 10.1007/s10577-006-1019-8; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cleton-Jansen AM, 2004, GENE CHROMOSOME CANC, V41, P109, DOI 10.1002/gcc.20070; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Donahue SL, 2006, P NATL ACAD SCI USA, V103, P11642, DOI 10.1073/pnas.0510741103; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Hanson C, 2005, APMIS, V113, P751, DOI 10.1111/j.1600-0463.2005.apm_305.x; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Hautaniemi S, 2004, J FRANKLIN I, V341, P77, DOI 10.1016/j.jfranklin.2003.12.005; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Rodriguez-Jimenez FJ, 2008, STEM CELLS, V26, P2052, DOI 10.1634/stemcells.2007-1016; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Jong K, 2007, ONCOGENE, V26, P1499, DOI 10.1038/sj.onc.1209919; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; LINDBLOM A, 1993, CANCER RES, V53, P3707; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Zheng HT, 2005, WORLD J GASTROENTERO, V11, P6740, DOI 10.3748/wjg.v11.i43.6740	42	203	212	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2010	28	4					371	U103		10.1038/nbt.1615	http://dx.doi.org/10.1038/nbt.1615			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	580PW	20351689				2022-12-25	WOS:000276462400026
J	Rudolph, V; Andrie, RP; Rudolph, TK; Friedrichs, K; Klinke, A; Hirsch-Hoffmann, B; Schwoerer, AP; Lau, D; Fu, XM; Klingel, K; Sydow, K; Didie, M; Seniuk, A; von Leitner, EC; Szoecs, K; Schrickel, JW; Treede, H; Wenzel, U; Lewalter, T; Nickenig, G; Zimmermann, WH; Meinertz, T; Boger, RH; Reichenspurner, H; Freeman, BA; Eschenhagen, T; Ehmke, H; Hazen, SL; Willems, S; Baldus, S				Rudolph, Volker; Andrie, Rene P.; Rudolph, Tanja K.; Friedrichs, Kai; Klinke, Anna; Hirsch-Hoffmann, Birgit; Schwoerer, Alexander P.; Lau, Denise; Fu, XiaoMing; Klingel, Karin; Sydow, Karsten; Didie, Michael; Seniuk, Anika; von Leitner, Eike-Christin; Szoecs, Katalin; Schrickel, Jan W.; Treede, Hendrik; Wenzel, Ulrich; Lewalter, Thorsten; Nickenig, Georg; Zimmermann, Wolfram-Hubertus; Meinertz, Thomas; Boeger, Rainer H.; Reichenspurner, Hermann; Freeman, Bruce A.; Eschenhagen, Thomas; Ehmke, Heimo; Hazen, Stanley L.; Willems, Stephan; Baldus, Stephan			Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation	NATURE MEDICINE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE MECHANISM; CATALYZED OXIDATION; FIBROSIS; MATRIX; MICE; INFLAMMATION; INVOLVEMENT; MATRILYSIN; SUBSTRATE	Observational clinical and ex vivo studies have established a strong association between atrial fibrillation and inflammation(1). However, whether inflammation is the cause or the consequence of atrial fibrillation and which specific inflammatory mediators may increase the atria's susceptibility to fibrillation remain elusive. Here we provide experimental and clinical evidence for the mechanistic involvement of myeloperoxidase (MPO), a heme enzyme abundantly expressed by neutrophils, in the pathophysiology of atrial fibrillation. MPO-deficient mice pretreated with angiotensin II (AngII) to provoke leukocyte activation showed lower atrial tissue abundance of the MPO product 3-chlorotyrosine, reduced activity of matrix metalloproteinases and blunted atrial fibrosis as compared to wild-type mice. Upon right atrial electrophysiological stimulation, MPO-deficient mice were protected from atrial fibrillation, which was reversed when MPO was restored. Humans with atrial fibrillation had higher plasma concentrations of MPO and a larger MPO burden in right atrial tissue as compared to individuals devoid of atrial fibrillation. In the atria, MPO colocalized with markedly increased formation of 3-chlorotyrosine. Our data demonstrate that MPO is a crucial prerequisite for structural remodeling of the myocardium, leading to an increased vulnerability to atrial fibrillation.	[Rudolph, Volker; Rudolph, Tanja K.; Friedrichs, Kai; Klinke, Anna; Lau, Denise; Sydow, Karsten; von Leitner, Eike-Christin; Szoecs, Katalin; Meinertz, Thomas; Willems, Stephan; Baldus, Stephan] Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Rudolph, Volker; Rudolph, Tanja K.; Friedrichs, Kai; Klinke, Anna; Lau, Denise; Sydow, Karsten; von Leitner, Eike-Christin; Szoecs, Katalin; Meinertz, Thomas; Willems, Stephan; Baldus, Stephan] Univ Heart Ctr, Cardiovasc Res Ctr, Hamburg, Germany; [Andrie, Rene P.; Schrickel, Jan W.; Lewalter, Thorsten; Nickenig, Georg] Univ Bonn, Dept Med Cardiol, D-5300 Bonn, Germany; [Hirsch-Hoffmann, Birgit; Schwoerer, Alexander P.; Seniuk, Anika; Ehmke, Heimo] Univ Hosp Eppendorf, Dept Physiol, Hamburg, Germany; [Fu, XiaoMing; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA; [Klingel, Karin] Univ Tubingen Hosp, Inst Pathol, Dept Mol Pathol, Tubingen, Germany; [Didie, Michael; Zimmermann, Wolfram-Hubertus; Boeger, Rainer H.; Eschenhagen, Thomas] Univ Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Hamburg, Germany; [Didie, Michael; Zimmermann, Wolfram-Hubertus] Univ Gottingen, Dept Pharmacol, Gottingen, Germany; [Treede, Hendrik; Reichenspurner, Hermann] Univ Heart Ctr Hamburg, Dept Cardiovasc Surg, Hamburg, Germany; [Wenzel, Ulrich] Univ Hosp Eppendorf, Div Nephrol, Dept Med, Hamburg, Germany; [Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cleveland Clinic Foundation; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baldus, S (corresponding author), Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany.	baldus@uke.uni-hamburg.de	Freeman, Bruce A/H-9342-2012; Zimmermann, Wolfram-Hubertus H/I-6838-2012; Treede, Hendrik/I-3630-2017; Hazen, Stanley L/ABD-5845-2021	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; 	Deutsche Forschungsgemeinschaft [BA 1870/3-2, BA 1870/7-1, Ru 1472/1-1, SFB-TR19]; US National Institutes of Health [P01 HL076491-055328, P01 HL087018-02001]; Deutsche Herzstiftung; Werner Otto Stiftung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, R37HL058115, P01HL076491] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; Werner Otto Stiftung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank H. Wieboldt for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (BA 1870/3-2 and BA 1870/7-1 to S. B., Ru 1472/1-1 to T. K. R. and SFB-TR19 to K. K.), the US National Institutes of Health (P01 HL076491-055328 and P01 HL087018-02001 to S. H.), the Deutsche Herzstiftung (to V. R. and R. P. A.) and the Werner Otto Stiftung (to S. B.).	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Baldus S, 2001, J CLIN INVEST, V108, P1759; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Burstein B, 2007, CARDIOVASC RES, V76, P442, DOI 10.1016/j.cardiores.2007.07.013; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Chen CL, 2008, J MOL CELL CARDIOL, V45, P742, DOI 10.1016/j.yjmcc.2008.07.007; Conway DSG, 2004, AM HEART J, V148, P462, DOI 10.1016/j.ahj.2004.01.026; DESROCHERS PE, 1992, J BIOL CHEM, V267, P5005; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; Fontes ML, 2005, ANESTH ANALG, V101, P17, DOI 10.1213/01.ANE.0000155260.93406.29; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; KANNEL WB, 1998, AM J CARDIOL, V0082; Lang C, 2008, J MOL MED-JMM, V86, P49, DOI 10.1007/s00109-007-0249-3; Lin CS, 2008, CELL MOL LIFE SCI, V65, P1489, DOI 10.1007/s00018-008-7408-8; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Nattel S, 2006, LANCET, V367, P262, DOI 10.1016/S0140-6736(06)68037-9; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rossi MA, 1998, J HYPERTENS, V16, P1031, DOI 10.1097/00004872-199816070-00018; Sata N, 2004, JPN HEART J, V45, P441, DOI 10.1536/jhj.45.441; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	37	229	237	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					470	U19		10.1038/nm.2124	http://dx.doi.org/10.1038/nm.2124			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20305660	Green Accepted			2022-12-25	WOS:000276446800053
J	Yan, JB; Kandianis, CB; Harjes, CE; Bai, L; Kim, EH; Yang, XH; Skinner, DJ; Fu, ZY; Mitchell, S; Li, Q; Fernandez, MGS; Zaharieva, M; Babu, R; Fu, Y; Palacios, N; Li, JS; DellaPenna, D; Brutnell, T; Buckler, ES; Warburton, ML; Rocheford, T				Yan, Jianbing; Kandianis, Catherine Bermudez; Harjes, Carlos E.; Bai, Ling; Kim, Eun-Ha; Yang, Xiaohong; Skinner, Debra J.; Fu, Zhiyuan; Mitchell, Sharon; Li, Qing; Fernandez, Maria G. Salas; Zaharieva, Maria; Babu, Raman; Fu, Yang; Palacios, Natalia; Li, Jiansheng; DellaPenna, Dean; Brutnell, Thomas; Buckler, Edward S.; Warburton, Marilyn L.; Rocheford, Torbert			Rare genetic variation at Zea mays crtRB1 increases beta-carotene in maize grain	NATURE GENETICS			English	Article							BIOFORTIFICATION; BIOSYNTHESIS; ARABIDOPSIS; HYDROXYLASE; PROVITAMIN; GERMPLASM; LOCUS; CROPS	Breeding to increase beta-carotene levels in cereal grains, termed provitamin A biofortification, is an economical approach to address dietary vitamin A deficiency in the developing world. Experimental evidence from association and linkage populations in maize (Zea mays L.) demonstrate that the gene encoding beta-carotene hydroxylase 1 (crtRB1) underlies a principal quantitative trait locus associated with beta-carotene concentration and conversion in maize kernels. crtRB1 alleles associated with reduced transcript expression correlate with higher beta-carotene concentrations. Genetic variation at crtRB1 also affects hydroxylation efficiency among encoded allozymes, as observed by resultant carotenoid profiles in recombinant expression assays. The most favorable crtRB1 alleles, rare in frequency and unique to temperate germplasm, are being introgressed via inexpensive PCR marker-assisted selection into tropical maize germplasm adapted to developing countries, where it is most needed for human health.	[Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Yan, Jianbing; Zaharieva, Maria; Babu, Raman; Palacios, Natalia; Warburton, Marilyn L.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Yan, Jianbing; Yang, Xiaohong; Fu, Zhiyuan; Li, Qing; Fu, Yang; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Yan, Jianbing; Harjes, Carlos E.; Mitchell, Sharon; Fernandez, Maria G. Salas; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Bai, Ling; Brutnell, Thomas] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Kim, Eun-Ha; DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fernandez, Maria G. Salas] Iowa State Univ, Dept Agron, Ames, IA USA; [Buckler, Edward S.] USDA ARS, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA; [Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS USA; [Harjes, Carlos E.] Monsanto Co, Leesburg, GA USA	University of Illinois System; University of Illinois Urbana-Champaign; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); China Agricultural University; Cornell University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; Boyce Thompson Institute for Plant Research; Michigan State University; Iowa State University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); Monsanto	Rocheford, T (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	marilyn.warburton@ars.usda.gov; torbert@purdue.edu	Buckler, Edward/GPS-4932-2022; Brutnell, Thomas/M-2840-2013; Pillay, Nischalan/F-9536-2012; Buckler, Edward/L-7651-2019; Warburton, Marilyn/J-2250-2017	Brutnell, Thomas/0000-0002-3581-8211; Buckler, Edward/0000-0002-3100-371X; Warburton, Marilyn/0000-0002-9542-9912; Skinner, Debra/0000-0003-4715-670X; palacios rojas, natalia/0000-0002-3072-4611	US Agency for International Development; HarvestPlus; National Science Foundation (NSF) [DBI-0321467, DBI-0820619, DBI-0604923, DBI-0501713, 30821140352]; USDA-ARS; TRIAD Foundation; China Scholarship Fund; JBT Fellowship-UIUC	US Agency for International Development(United States Agency for International Development (USAID)); HarvestPlus; National Science Foundation (NSF)(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); TRIAD Foundation; China Scholarship Fund; JBT Fellowship-UIUC	We thank K. Pixley and J. Chandler for seed and field experiment coordination and W. White, P. Bermudez, S. Islam, C. Paul, W. Liu, S. Xu and Y. Zhou for carotenoid HPLC profiling. Helpful comments on the manuscript from J. Wilkinson and J. Yu are appreciated. This research was supported by the US Agency for International Development (T. R.), HarvestPlus (T. R., D. D. P., J. Y., J. L., M. L. W.), National Science Foundation (NSF) DBI-0321467, DBI-0820619 (E. S. B.), NSF DBI-0604923 (T. R.), USDA-ARS (E. S. B.), NSF DBI-0501713 (T. B.), TRIAD Foundation (T. B.), China NSF-30821140352 (J. L., J. Y.), China Scholarship Fund (Y. F.) and JBT Fellowship-UIUC (C. B. K.).	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Cunningham FX, 2007, EUKARYOT CELL, V6, P533, DOI 10.1128/EC.00265-06; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; KANDIANIS C, THESIS U ILLINOIS UR; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; MATTHEWS PD, 2007, FOOD COLORANTS CHEM, P361; Ooijen J., 2001, JOINMAP VERSION 3 0; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Pritchard JK, 2000, GENETICS, V155, P945; SAS Institute, 2008, SAS STAT US GUID VER; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tanumihardjo SA, 2008, COMPR REV FOOD SCI F, V7, P329; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; UTZ HF, 1993, PLABQTL COMPUTER PRO; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Wang S, 2005, WINDOWS QTL CARTOGRA; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	25	323	349	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					322	U74		10.1038/ng.551	http://dx.doi.org/10.1038/ng.551			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20305664	Green Published			2022-12-25	WOS:000276150500011
J	Mangold, E; Ludwig, KU; Birnbaum, S; Baluardo, C; Ferrian, M; Herms, S; Reutter, H; de Assis, NA; Al Chawa, T; Mattheisen, M; Steffens, M; Barth, S; Kluck, N; Paul, A; Becker, J; Lauster, C; Schmidt, G; Braumann, B; Scheer, M; Reich, RH; Hemprich, A; Potzsch, S; Blaumeiser, B; Moebus, S; Krawczak, M; Schreiber, S; Meitinger, T; Wichmann, HE; Steegers-Theunissen, RP; Kramer, FJ; Cichon, S; Propping, P; Wienker, TF; Knapp, M; Rubini, M; Mossey, PA; Hoffmann, P; Nothen, MM				Mangold, Elisabeth; Ludwig, Kerstin U.; Birnbaum, Stefanie; Baluardo, Carlotta; Ferrian, Melissa; Herms, Stefan; Reutter, Heiko; de Assis, Nilma Almeida; Al Chawa, Taofik; Mattheisen, Manuel; Steffens, Michael; Barth, Sandra; Kluck, Nadine; Paul, Anna; Becker, Jessica; Lauster, Carola; Schmidt, Guel; Braumann, Bert; Scheer, Martin; Reich, Rudolf H.; Hemprich, Alexander; Poetzsch, Simone; Blaumeiser, Bettina; Moebus, Susanne; Krawczak, Michael; Schreiber, Stefan; Meitinger, Thomas; Wichmann, Hans-Erich; Steegers-Theunissen, Regine P.; Kramer, Franz-Josef; Cichon, Sven; Propping, Peter; Wienker, Thomas F.; Knapp, Michael; Rubini, Michele; Mossey, Peter A.; Hoffmann, Per; Noethen, Markus M.			Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate	NATURE GENETICS			English	Article							GENE	We conducted a genome-wide association study for nonsyndromic cleft lip with or without cleft palate (NSCL/P) in 401 affected individuals and 1,323 controls, with replication in an independent sample of 793 NSCL/P triads. We report two new loci associated with NSCL/P at 17q22 (rs227731, combined P = 1.07 x 10(-8), relative risk in homozygotes = 1.84, 95% CI 1.34-2.53) and 10q25.3 (rs7078160, combined P = 1.92 x 10(-8), relative risk in homozygotes = 2.17, 95% CI 1.32-3.56).	[Mangold, Elisabeth; Ludwig, Kerstin U.; Birnbaum, Stefanie; Herms, Stefan; Reutter, Heiko; de Assis, Nilma Almeida; Al Chawa, Taofik; Mattheisen, Manuel; Barth, Sandra; Kluck, Nadine; Becker, Jessica; Cichon, Sven; Propping, Peter; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-5300 Bonn, Germany; [Herms, Stefan; Mattheisen, Manuel; Barth, Sandra; Kluck, Nadine; Becker, Jessica; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Baluardo, Carlotta; Ferrian, Melissa; Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Mattheisen, Manuel; Steffens, Michael; Wienker, Thomas F.; Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Paul, Anna] Asklepios Klin Altona, Dept Otolaryngol, Hamburg, Germany; [Lauster, Carola; Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, Berlin, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, Cologne, Germany; [Scheer, Martin] Univ Cologne, Dept Oral & Maxillofacial Surg, Cologne, Germany; [Reich, Rudolf H.] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-5300 Bonn, Germany; [Hemprich, Alexander] Univ Leipzig, Dept Oral & Maxillofacial Surg, Leipzig, Germany; [Poetzsch, Simone] Univ Magdeburg, D-39106 Magdeburg, Germany; [Blaumeiser, Bettina] Univ Antwerp Hosp, Dept Med Genet, Antwerp, Belgium; [Blaumeiser, Bettina] Univ Antwerp, B-2020 Antwerp, Belgium; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Krawczak, Michael; Schreiber, Stefan] Univ Kiel, PopGen Biobank, Kiel, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Human Genet, D-8000 Munich, Germany; [Wichmann, Hans-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, Hans-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, Hans-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol, NL-6525 ED Nijmegen, Netherlands; [Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee, Scotland	University of Bonn; University of Bonn; University of Ferrara; University of Bonn; Asklepios Klinik Altona; Humboldt University of Berlin; University of Cologne; University of Cologne; University of Bonn; Leipzig University; Otto von Guericke University; University of Antwerp; University of Antwerp; University of Duisburg Essen; University of Kiel; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Gottingen; University of Dundee	Mangold, E (corresponding author), Univ Bonn, Life & Brain Ctr, Inst Human Genet, D-5300 Bonn, Germany.	e.mangold@uni-bonn.de	Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Herms, Stefan/J-1949-2014; Ludwig, Kerstin/H-7828-2019; Wichmann, Heinz Erich/AAA-5695-2022; Hoffmann, Per/A-5149-2010; Nöthen, Markus/B-2027-2009; Meitinger, Thomas/O-1318-2015; Krawczak, Michael/A-8964-2010; Mattheisen, Manuel/B-4949-2012; Rubini, Michele/AFF-8477-2022; Mattheisen, Manuel/S-3725-2019	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Herms, Stefan/0000-0002-2786-8200; Ludwig, Kerstin/0000-0002-8541-2519; Hoffmann, Per/0000-0002-6573-983X; Nöthen, Markus/0000-0002-8770-2464; Krawczak, Michael/0000-0003-2603-1502; Mattheisen, Manuel/0000-0002-8442-493X; Rubini, Michele/0000-0003-1448-9516; Mattheisen, Manuel/0000-0002-8442-493X; Meitinger, Thomas/0000-0002-8838-8403; Mossey, Peter/0000-0002-9914-6901; Steffens, Michael/0000-0002-6445-8593; Ferrian, Melissa/0000-0002-3746-4576; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft [FOR 423, MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Heinz Nixdorf Foundation, Germany; Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany; German Federal Ministry of Education and Research; German Federal Ministry of Education and Research (BMBF); European Commission [QLG1-CT-2000-01019]; University of Ferrara, Italy [FAR-2008]; Conselho Nacional de Pesquisa (CNPq), Brasil; Ministry of Higher Education, Syrian Arab Republic	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Nixdorf Foundation, Germany; Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Ferrara, Italy; Conselho Nacional de Pesquisa (CNPq), Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Higher Education, Syrian Arab Republic	We thank all affected individuals and their families for their participation in this study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e. V.). We acknowledge our collaborating clinical partners, all colleagues who contributed to the European Collaboration on Craniofacial Anomalies (EUROCRAN) project, our laboratory technicians and colleagues responsible for database management (for a complete list of all individuals see Supplementary Note). The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1 and WI 1555/5-1). The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany (Chairman: G. Schmidt). POPGEN biobank is financed by the local Ministry of Science, Economy and Transport of Schleswig-Holstein, Germany. The Kooperative Gesundheitforschung in der Region Augsburg (KORA) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the state of Bavaria. The work of KORA is supported by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The EUROCRAN study was supported by the European Commission FP5 (contract no. QLG1-CT-2000-01019), and the ITALCLEFT study was supported by a FAR-2008 grant from the University of Ferrara, Italy. N. A. d. A. is supported by the Conselho Nacional de Pesquisa (CNPq), Brasil. T. A. C. is supported by a grant from the Ministry of Higher Education, Syrian Arab Republic. Additional acknowledgments are found in the	Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Drieschner N, 2007, GENE, V403, P110, DOI 10.1016/j.gene.2007.06.029; Goodnough LH, 2007, DEV DYNAM, V236, P1918, DOI 10.1002/dvdy.21195; Guo CY, 2009, GENET EPIDEMIOL, V33, P54, DOI 10.1002/gepi.20356; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Magee AC, 1998, CLIN GENET, V54, P65; MULCAHY MT, 1982, CLIN GENET, V21, P33; Petersen B, 1998, AM J MED GENET, V77, P60, DOI 10.1002/(SICI)1096-8628(19980428)77:1<60::AID-AJMG13>3.3.CO;2-Z; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; YUNIS E, 1979, HUM GENET, V48, P241, DOI 10.1007/BF00286910; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	14	299	320	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					24	26		10.1038/ng.506	http://dx.doi.org/10.1038/ng.506			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20023658	Bronze			2022-12-25	WOS:000273055100011
J	Takeichi, M				Takeichi, Masatoshi			Accidental encounters: the chance to solve a mystery	NATURE CELL BIOLOGY			English	Editorial Material									RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Takeichi, M (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378					0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					2	2		10.1038/ncb0110-2	http://dx.doi.org/10.1038/ncb0110-2			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20027196	Bronze			2022-12-25	WOS:000272973800003
J	Cerchietti, LC; Lopes, EC; Yang, SN; Hatzi, K; Bunting, KL; Tsikitas, LA; Mallik, A; Robles, AI; Walling, J; Varticovski, L; Shaknovich, R; Bhalla, KN; Chiosis, G; Melnick, A				Cerchietti, Leandro C.; Lopes, Eloisi C.; Yang, Shao Ning; Hatzi, Katerina; Bunting, Karen L.; Tsikitas, Lucas A.; Mallik, Alka; Robles, Ana I.; Walling, Jennifer; Varticovski, Lyuba; Shaknovich, Rita; Bhalla, Kapil N.; Chiosis, Gabriela; Melnick, Ari			A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas	NATURE MEDICINE			English	Article							KINASE; EXPRESSION; DEGRADATION; APOPTOSIS; CHAPERONE; BINDING; HEAT-SHOCK-PROTEIN-90; PHOSPHORYLATION; DIFFERENTIATION; GELDANAMYCIN	We report that heat shock protein 90 (Hsp90) inhibitors selectively kill diffuse large B cell lymphomas (DLBCLs) that depend on the BCL-6 transcriptional repressor. We found that endogenous Hsp90 interacts with BCL-6 in DLBCL cells and can stabilize BCL-6 mRNA and protein. Hsp90 formed a complex with BCL-6 at its target promoters, and Hsp90 inhibitors derepressed BCL-6 target genes. A stable mutant of BCL-6 rescued DLBCL cells from Hsp90 inhibitor-induced apoptosis. BCL-6 and Hsp90 were almost invariantly coexpressed in the nuclei of primary DLBCL cells, suggesting that their interaction is relevant in this disease. We examined the pharmacokinetics, toxicity and efficacy of PU-H71, a recently developed purine-derived Hsp90 inhibitor. PU-H71 preferentially accumulated in lymphomas compared to normal tissues and selectively suppressed BCL-6-dependent DLBCLs in vivo, inducing reactivation of key BCL-6 target genes and apoptosis. PU-H71 also induced cell death in primary human DLBCL specimens.	[Lopes, Eloisi C.; Chiosis, Gabriela] Sloan Kettering Inst, Dept Mol Pharmacol & Chem, New York, NY USA; [Cerchietti, Leandro C.; Yang, Shao Ning; Hatzi, Katerina; Bunting, Karen L.; Tsikitas, Lucas A.; Mallik, Alka; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10021 USA; [Cerchietti, Leandro C.; Hatzi, Katerina; Bunting, Karen L.; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Robles, Ana I.; Varticovski, Lyuba] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; [Walling, Jennifer] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Shaknovich, Rita] Cornell Univ, Weill Cornell Med Coll, Dept Pathol, New York, NY 10021 USA; [Bhalla, Kapil N.] Georgia Canc Ctr, Coll Med, Augusta, GA USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Chiosis, G (corresponding author), Sloan Kettering Inst, Dept Mol Pharmacol & Chem, New York, NY USA.	chiosisg@mskcc.org; amm2014@med.cornell.edu	Melnick, Ari/AAA-5763-2020	Varticovski, Lyuba/0000-0002-5105-9008; Robles, Ana/0000-0001-5019-4374; Cerchietti, Leandro/0000-0003-0608-1350	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R56 CA104348-06, R56 CA104348, R01-CA10434, R01 CA104348, R01 CA104348-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA104348, R01CA104348] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abramson JS, 2009, BRIT J HAEMATOL, V144, P358, DOI 10.1111/j.1365-2141.2008.07484.x; Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Bonvini P, 2002, CANCER RES, V62, P1559; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chiosis G., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P1, DOI 10.2174/187152006774755483; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Chiosis G, 2003, CURR CANCER DRUG TAR, V3, P371, DOI 10.2174/1568009033481778; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Liu JM, 1999, MOL ENDOCRINOL, V13, P355, DOI 10.1210/me.13.3.355; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Valbuena JR, 2005, MODERN PATHOL, V18, P1343, DOI 10.1038/modpathol.3800459; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wax S, 2003, ARTHRITIS RHEUM, V48, P541, DOI 10.1002/art.10780; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	37	130	142	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1369	U3		10.1038/nm.2059	http://dx.doi.org/10.1038/nm.2059			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966776	Green Accepted			2022-12-25	WOS:000272407800016
J	Lu, TK; Khalil, AS; Collins, JJ				Lu, Timothy K.; Khalil, Ahmad S.; Collins, James J.			Next-generation synthetic gene networks	NATURE BIOTECHNOLOGY			English	Review							INVERSION RECOMBINATION SWITCH; FLUORESCENT AMINO-ACID; ESCHERICHIA-COLI; SPIDER SILK; DIRECTED EVOLUTION; MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; EUKARYOTIC CELLS; GUT MICROBIOME	Synthetic biology is focused on the rational construction of biological systems based on engineering principles. During the field's first decade of development, significant progress has been made in designing biological parts and assembling them into genetic circuits to achieve basic functionalities. These circuits have been used to construct proof-of-principle systems with promising results in industrial and medical applications. However, advances in synthetic biology have been limited by a lack of interoperable parts, techniques for dynamically probing biological systems and frameworks for the reliable construction and operation of complex, higher-order networks. As these challenges are addressed, synthetic biologists will be able to construct useful next-generation synthetic gene networks with real-world applications in medicine, biotechnology, bioremediation and bioenergy.	[Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Lu, Timothy K.] Harvard Mit Hlth Sci & Technol, Cambridge, MA USA; [Lu, Timothy K.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [Lu, Timothy K.; Khalil, Ahmad S.; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	timlu@mit.edu	Lu, Timothy/G-4267-2012	Lu, Timothy/0000-0002-3918-8923	Howard Hughes Medical Institute; National Institutes of Health; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the Howard Hughes Medical Institute and the National Institutes of Health Director's Pioneer Award Program for their financial support. We also thank the reviewers for their insights and suggestions.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.3.CO;2-I; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Carrera J, 2009, MOL BIOSYST, V5, P733, DOI 10.1039/b904400k; Chandran Deepak, 2009, J Biol Eng, V3, P19, DOI 10.1186/1754-1611-3-19; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dueber JE, 2007, NAT BIOTECHNOL, V25, P660, DOI 10.1038/nbt1308; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fritz Georg, 2007, Syst Synth Biol, V1, P89, DOI 10.1007/s11693-007-9006-8; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goldberg SD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.41; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Gulati S, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0083.focus; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Hamad-Schifferli K, 2002, NATURE, V415, P152, DOI 10.1038/415152a; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kaznessis Yiannis N., 2009, Biotechnology Journal, V4, P1392, DOI 10.1002/biot.200900163; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Klein-Marcuschamer D, 2008, P NATL ACAD SCI USA, V105, P2319, DOI 10.1073/pnas.0712177105; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lu T, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036006; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; MOLIN S, 1993, ANNU REV MICROBIOL, V47, P139, DOI 10.1146/annurev.micro.47.1.139; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarpeshkar R, 2002, NEURAL COMPUT, V14, P2003, DOI 10.1162/089976602320263971; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Summerer D, 2006, P NATL ACAD SCI USA, V103, P9785, DOI 10.1073/pnas.0603965103; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; von Maltzahn G, 2007, J AM CHEM SOC, V129, P6064, DOI 10.1021/ja070461l; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang Q, 2009, CHEM BIOL, V16, P323, DOI 10.1016/j.chembiol.2009.03.001; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Wei MQ, 2008, CANCER LETT, V259, P16, DOI 10.1016/j.canlet.2007.10.034; Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Win MN, 2006, NUCLEIC ACIDS RES, V34, P5670, DOI 10.1093/nar/gkl718; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Xu J, 2008, NAT NANOTECHNOL, V3, P666, DOI 10.1038/nnano.2008.274; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	139	257	271	1	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1139	1150		10.1038/nbt.1591	http://dx.doi.org/10.1038/nbt.1591			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010597	Green Accepted			2022-12-25	WOS:000272708300031
J	Hirschfield, GM; Liu, XD; Han, YH; Gorlov, IP; Lu, Y; Xu, C; Lu, Y; Chen, W; Juran, BD; Coltescu, C; Mason, AL; Milkiewicz, P; Myers, RP; Odin, JA; Luketic, VA; Speiciene, D; Vincent, C; Levy, C; Gregersen, PK; Zhang, JY; Heathcote, EJ; Lazaridis, KN; Amos, CI; Siminovitch, KA				Hirschfield, Gideon M.; Liu, Xiangdong; Han, Younghun; Gorlov, Ivan P.; Lu, Yan; Xu, Chun; Lu, Yue; Chen, Wei; Juran, Brian D.; Coltescu, Catalina; Mason, Andrew L.; Milkiewicz, Piotr; Myers, Robert P.; Odin, Joseph A.; Luketic, Velimir A.; Speiciene, Danute; Vincent, Catherine; Levy, Cynthia; Gregersen, Peter K.; Zhang, Jinyi; Heathcote, E. Jenny; Lazaridis, Konstantinos N.; Amos, Christopher I.; Siminovitch, Katherine A.			Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; STRONG RISK-FACTOR; RHEUMATOID-ARTHRITIS; POLYMORPHISM; DISEASE; LUPUS; LOCI	We genotyped individuals with primary biliary cirrhosis and unaffected controls for suggestive risk loci (genome-wide association P < 1 x 10(-4)) identified in a previous genome-wide association study. Combined analysis of the genome-wide association and replication datasets identified IRF5-TNPO3 (combined P = 8.66 x 10(-13)), 17q12-21 (combined P = 3.50 x 10(-13)) and MMEL1 (combined P = 3.15 x 10(-8)) as new primary biliary cirrhosis susceptibility loci. Fine-mapping studies showed that a single variant accounts for the IRF5-TNPO3 association. As these loci are implicated in other autoimmune conditions, these findings confirm genetic overlap among such diseases.	[Hirschfield, Gideon M.; Liu, Xiangdong; Lu, Yan; Xu, Chun; Zhang, Jinyi; Heathcote, E. Jenny; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hirschfield, Gideon M.; Coltescu, Catalina; Heathcote, E. Jenny] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Liu, Xiangdong; Lu, Yan; Xu, Chun; Zhang, Jinyi; Siminovitch, Katherine A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Liu, Xiangdong; Lu, Yan; Xu, Chun; Zhang, Jinyi; Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Han, Younghun; Gorlov, Ivan P.; Lu, Yue; Chen, Wei; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA; [Mason, Andrew L.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Milkiewicz, Piotr] Pomeranian Med Sch, Liver Unit, Szczecin, Poland; [Myers, Robert P.] Univ Calgary, Liver Unit, Calgary, AB, Canada; [Odin, Joseph A.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Luketic, Velimir A.] Virginia Commonwealth Univ, Dept Gastroenterol, Richmond, VA USA; [Speiciene, Danute] Vilnius State Univ, Ctr Gastroenterol & Dietet, Vilnius, Lithuania; [Vincent, Catherine] Univ Montreal, St Luc Hosp, Ctr Hosp, Montreal, PQ, Canada; [Levy, Cynthia] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA; [Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Siminovitch, Katherine A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Siminovitch, Katherine A.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Alberta; Pomeranian Medical University; University of Calgary; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; Vilnius University; Universite de Montreal; State University System of Florida; University of Florida; Northwell Health; University of Toronto; University of Toronto	Siminovitch, KA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	ksimin@mshri.on.ca	Hirschfield, Gideon M/M-2143-2015; Siminovitch, Katherine/K-1475-2013; Mason, Andrew/D-2938-2013	Hirschfield, Gideon M/0000-0002-6736-2255; Mason, Andrew/0000-0002-0470-9522; Milkiewicz, Piotr/0000-0002-1817-0724	Canadian Institutes for Health Research [MOP 74621]; Ontario Research Fund [RE01-061]; Canadian Primary Biliary Cirrhosis Society; Canadian Foundation for Innovation; Ben and Hilda Katz Charitable Foundation; US National Institutes of Health [K23 DK68290, RO3 DK78527, RO1 DK80670]; American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; Canada Research Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK078527, R01DK080670, K23DK068290] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Primary Biliary Cirrhosis Society; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ben and Hilda Katz Charitable Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; A.J. and Sigismunda Palumbo Charitable Trust; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the Canadian Institutes for Health Research (MOP 74621), the Ontario Research Fund (RE01-061), the Canadian Primary Biliary Cirrhosis Society, the Canadian Foundation for Innovation, the Ben and Hilda Katz Charitable Foundation, the US National Institutes of Health (K23 DK68290, RO3 DK78527 and RO1 DK80670), the American Gastroenterological Association and the A.J. and Sigismunda Palumbo Charitable Trust. K. A. S. is a recipient of a Canada Research Chair award. We thank all the study subjects and supporting physicians as well as the technical staff of the University Health Network Analytical Genetics Technology Centre for their assistance in this research.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Miceli-Richard C, 2009, ARTHRITIS RHEUM-US, V60, P1991, DOI 10.1002/art.24662; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Muratori L, 2008, CLIN LIVER DIS, V12, P261, DOI 10.1016/j.cld.2008.02.009; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355	15	168	171	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					655	657		10.1038/ng.631	http://dx.doi.org/10.1038/ng.631			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20639879	Green Accepted, Green Published			2022-12-25	WOS:000280524000006
J	Stewart, ML; Fire, E; Keating, AE; Walensky, LD				Stewart, Michelle L.; Fire, Emiko; Keating, Amy E.; Walensky, Loren D.			The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer	NATURE CHEMICAL BIOLOGY			English	Article							STABILIZED ALPHA-HELICES; BCL-2 PROTEINS; MITOCHONDRIAL APOPTOSIS; TRAIL SENSITIZATION; MIMETIC ABT-737; CELL-DEATH; X-RAY; RESISTANCE; DOMAINS; CANCER	The development of selective inhibitors for discrete anti-apoptotic BCL-2 family proteins implicated in pathologic cell survival remains a formidable but pressing challenge. Such precisely tailored compounds would serve as molecular probes and targeted therapies to study and treat human diseases driven by specific anti-apoptotic blockades. In particular, MCL-1 has emerged as a major resistance factor in human cancer. By screening a library of stabilized alpha-helix of BCL-2 domains (SAHBs), we determined that the MCL-1 BH3 helix is itself a potent and exclusive MCL-1 inhibitor. X-ray crystallography and mutagenesis studies defined key binding and specificity determinants, including the capacity to harness the hydrocarbon staple to optimize affinity while preserving selectivity. MCL-1 SAHB directly targets MCL-1, neutralizes its inhibitory interaction with pro-apoptotic BAK and sensitizes cancer cells to caspase-dependent apoptosis. By leveraging nature's solution to ligand selectivity, we generated an MCL-1-specific agent that defines the structural and functional features of targeted MCL-1 inhibition.	[Stewart, Michelle L.; Walensky, Loren D.] Harvard Univ, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Stewart, Michelle L.; Walensky, Loren D.] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Stewart, Michelle L.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Fire, Emiko; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT)	Walensky, LD (corresponding author), Harvard Univ, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	Loren_Walensky@dfci.harvard.edu		Keating, Amy/0000-0003-4074-8980	US National Institutes of Health [5P01CA92625, 5RO1GM084181]; Burroughs Wellcome Career Award; Ruth L. Kirschstein National Research Service Award [1F31CA144566]; National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA092625, F31CA144566] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084181] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Smith (Dana-Farber Cancer Institute) for editorial and graphics support, R.A. Grant (Massachussets Institute of Technology) for input on the crystallography experiments, X-ray data collection and structural analysis, and C.H. Yun and M.J. Eck (Dana-Farber Cancer Institute) for assistance in generating the hydrocarbon staple parameter file used in the structural refinement. This work was supported by US National Institutes of Health grant 5P01CA92625 and a Burroughs Wellcome Career Award in the Biomedical Sciences to L.D.W., a Ruth L. Kirschstein National Research Service Award 1F31CA144566 to M.L.S. and US National Institutes of Health award 5RO1GM084181 to A.E.K. X-ray diffraction data were acquired at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the US National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Blackwell HE, 2001, J ORG CHEM, V66, P5291, DOI 10.1021/jo015533k; Boersma MD, 2008, PROTEIN SCI, V17, P1232, DOI 10.1110/ps.032896.107; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; LYNCH VM, 1990, ACTA CRYSTALLOGR C, V46, P1351, DOI 10.1107/S0108270190002104; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Warr MR, 2008, CURR MOL MED, V8, P138; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	45	308	339	3	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					595	601		10.1038/NCHEMBIO.391	http://dx.doi.org/10.1038/NCHEMBIO.391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20562877	Green Accepted, Green Submitted			2022-12-25	WOS:000280096600010
J	Teo, HL; Ghosh, S; Luesch, H; Ghosh, A; Wong, ET; Malik, N; Orth, A; de Jesus, P; Perry, AS; Oliver, JD; Tran, NL; Speiser, LJ; Wong, M; Saez, E; Schultz, P; Chanda, SK; Verma, IM; Tergaonkar, V				Teo, Hsiangling; Ghosh, Sourav; Luesch, Hendrik; Ghosh, Arkasubhra; Wong, Ee Tsin; Malik, Najib; Orth, Anthony; de Jesus, Paul; Perry, Anthony S.; Oliver, Jeffrey D.; Tran, Nhan L.; Speiser, Lisa J.; Wong, Marc; Saez, Enrique; Schultz, Peter; Chanda, Sumit K.; Verma, Inder M.; Tergaonkar, Vinay			Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappa B-dependent gene expression	NATURE CELL BIOLOGY			English	Article							PATTERN-RECOGNITION RECEPTORS; IDENTIFICATION; APOPTOSIS; PATHWAYS; INNATE; CELLS; END; PHOSPHORYLATION; PROLIFERATION; PHOSPHATASE	We describe a genome-wide gain-of-function screen for regulators of NF-kappa B, and identify Rap1 (Trf2IP), as an essential modulator of NF-kappa B-mediated pathways. NF-kappa B is induced by ectopic expression of Rap1, whereas its activity is inhibited by Rap1 depletion. In addition to localizing on telomeres, mammalian Rap1 forms a complex with IKKs (I kappa B kinases), and is crucial for the ability of IKKs to be recruited to, and phosphorylate, the p65 subunit of NF-kappa B to make it transcriptionally competent. Rap1-mutant mice display defective NF-kappa B activation and are resistant to endotoxic shock. Furthermore, levels of Rap1 are positively regulated by NF-kappa B, and human breast cancers with NF-kappa B hyperactivity show elevated levels of cytoplasmic Rap1. Similar to inhibiting NF-kappa B, knockdown of Rap1 sensitizes breast cancer cells to apoptosis. These results identify the first cytoplasmic role of Rap1 and provide a mechanism through which it regulates an important signalling cascade in mammals, independent of its ability to regulate telomere function.	[Teo, Hsiangling; Ghosh, Arkasubhra; Wong, Ee Tsin; Malik, Najib; Wong, Marc; Tergaonkar, Vinay] Lab NFkB Signaling, Singapore 138673, Singapore; [Ghosh, Sourav; Speiser, Lisa J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85440 USA; [Luesch, Hendrik] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA; [Orth, Anthony; de Jesus, Paul; Saez, Enrique; Schultz, Peter; Chanda, Sumit K.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Perry, Anthony S.; Oliver, Jeffrey D.] St Josephs Hosp, Dept Pathol, Phoenix, AZ 85004 USA; [Perry, Anthony S.; Oliver, Jeffrey D.] Med Ctr, Phoenix, AZ 85004 USA; [Tran, Nhan L.] Translat Genom Res Inst, CNS Tumour Res Lab, Phoenix, AZ 85004 USA; [Chanda, Sumit K.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of Arizona; State University System of Florida; University of Florida; Novartis; St. Joseph's Hospital and Medical Center; Translational Genomics Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute	Tergaonkar, V (corresponding author), Lab NFkB Signaling, Singapore 138673, Singapore.	vinayt@imcb.a-star.edu.sg		Ghosh, Sourav/0000-0001-5990-8708; Teo, Hsiang Ling/0000-0002-3849-809X; Ghosh, Arkasubhra/0000-0002-6570-5891	Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star); Leducq Foundation; Meriaux Foundation; Ellison Medical Foundation; Ipsen/Biomeasure; Sanofi Aventis; H.N. and Frances C. Berger Foundation	Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star)(Agency for Science Technology & Research (A*STAR)); Leducq Foundation(Leducq Foundation); Meriaux Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); Sanofi Aventis(Sanofi-Aventis); H.N. and Frances C. Berger Foundation	We wish to thank the Agency for Science Technology and Research, Singapore (A<SUP>star</SUP>Star) for funding and support to the V.T. laboratory. I.M.V. is an American Cancer Society Professor of Molecular Biology, and holds the Joan and Irwin Jacobs Chair in Exemplary Life Sciences. This work was supported in part by grants from the Leducq Foundation, Meriaux Foundation, Ellison Medical Foundation, Ipsen/Biomeasure, Sanofi Aventis, and the H.N. and Frances C. Berger Foundation. We thank T. Murphy and N. Tonnu for help with the intial investigations involved in this work. We are grateful to B. Li and T. De Lange for Rap1, deletion constructs and P. Lieberman for the Rap1 shRNA vector. We thank J. Karlseder for helpful discussions.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BATES PW, 2004, SCI STKE, pPE48, DOI DOI 10.1126/STKE.2542004PE48; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Dey A, 2008, CELL DEATH DIFFER, V15, P263, DOI 10.1038/sj.cdd.4402257; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Luesch H, 2006, NAT CHEM BIOL, V2, P158, DOI 10.1038/nchembio769; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Price CM, 2007, MOL CELL, V26, P463, DOI 10.1016/j.molcel.2007.05.005; Rao CV, 2004, J BIOL CHEM, V279, P25503, DOI 10.1074/jbc.M400683200; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; XIA Y, 2009, P NATL ACAD SCI US; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044	63	147	156	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					758	U26		10.1038/ncb2080	http://dx.doi.org/10.1038/ncb2080			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20622870				2022-12-25	WOS:000280561600008
J	Nozawa, RS; Nagao, K; Masuda, HT; Iwasaki, O; Hirota, T; Nozaki, N; Kimura, H; Obuse, C				Nozawa, Ryu-Suke; Nagao, Koji; Masuda, Hiro-Taka; Iwasaki, Osamu; Hirota, Toru; Nozaki, Naohito; Kimura, Hiroshi; Obuse, Chikashi			Human POGZ modulates dissociation of HP1 alpha from mitotic chromosome arms through Aurora B activation	NATURE CELL BIOLOGY			English	Article							HP1 PROTEINS; PERICENTRIC HETEROCHROMATIN; KINETOCHORE PROTEIN; OUTER KINETOCHORE; HUMAN-CELLS; COMPLEX; METHYLATION; DOMAIN; GENE; CENTROMERE	Heterochromatin protein 1 (HP1) has an essential role in heterochromatin formation and mitotic progression through its interaction with various proteins. We have identified a unique HP1 alpha-binding protein, POGZ (pogo transposable element-derived protein with zinc finger domain), using an advanced proteomics approach. Proteins generally interact with HP1 through a PxVxL (where x is any amino-acid residue) motif; however, POGZ was found to bind to HP1 alpha through a zinc-finger-like motif. Binding by POGZ, mediated through its zinc-finger-like motif, competed with PxVxL proteins and destabilized the HP1 alpha-chromatin interaction. Depletion experiments confirmed that the POGZ HP1-binding domain is essential for normal mitotic progression and dissociation of HP1 alpha from mitotic chromosome arms. Furthermore, POGZ is required for the correct activation and dissociation of Aurora B kinase from chromosome arms during M phase. These results reveal POGZ as an essential protein that links HP1 alpha dissociation with Aurora B kinase activation during mitosis.	[Nozawa, Ryu-Suke; Nagao, Koji; Masuda, Hiro-Taka; Iwasaki, Osamu; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Nagao, Koji] Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan; [Hirota, Toru] Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan; [Nozaki, Naohito] Kanagawa Dent Coll, Yokosuka, Kanagawa 2388580, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Hokkaido University; Okinawa Institute of Science & Technology Graduate University; Japanese Foundation for Cancer Research; Kanagawa Dental College; Osaka University	Obuse, C (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan.	obuse@sci.hokudai.ac.jp	Kimura, Hiroshi/B-9524-2015; Nagao, Koji/F-5281-2011; Obuse, Chikashi/F-5273-2011	Kimura, Hiroshi/0000-0003-0854-083X; Nagao, Koji/0000-0003-1418-6988	JSPS (Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan; Inamori; Matrix Science K.K. Foundations; Uehara Memorial; Naito; Mochida Memorial	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Inamori; Matrix Science K.K. Foundations; Uehara Memorial; Naito; Mochida Memorial	We thank D. Goto, J. Nakayama, K. Hamada, Y. Murakami, G. Almouzni and M. Yanagida for comments, Y. Shinkai, M. Tachibana, M. Yanagida, T. Kiyomitsu, K. Yoda, S. Hatakeyama, K. Hanada, T. Kitamura, A. Imura and J-M. Peters for materials, T. Iwanaga and N. Sakai for technical instruction, and E. Ono for administration. R-S.N. was supported by a JSPS (Japan Society for the Promotion of Science) special fellowship. This work was supported by grants-in-aid from MEXT (Ministry of Education, Culture, Sports, Science and Technology) of Japan, and by Inamori, Uehara Memorial, Naito, Mochida Memorial and Matrix Science K.K. Foundations (C.O.).	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; HAYASHITAKANAKA Y, 2009, J CELL BIOL; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KIYOMITSU T, 2010, J CELL BIOL; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LE DB, 1996, EMBO J, V15, P6701; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Pouwels J, 2007, CELL CYCLE, V6, P1579, DOI 10.4161/cc.6.13.4442; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	58	168	181	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2010	12	7					719	U212		10.1038/ncb2075	http://dx.doi.org/10.1038/ncb2075			35	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	618RW	20562864				2022-12-25	WOS:000279374400016
J	Voight, BF; Scott, LJ; Steinthorsdottir, V; Morris, AP; Dina, C; Welch, RP; Zeggini, E; Huth, C; Aulchenko, YS; Thorleifsson, G; McCulloch, LJ; Ferreira, T; Grallert, H; Amin, N; Wu, GM; Willer, CJ; Raychaudhuri, S; McCarroll, SA; Langenberg, C; Hofmann, OM; Dupuis, J; Qi, L; Segre, AV; van Hoek, M; Navarro, P; Ardlie, K; Balkau, B; Benediktsson, R; Bennett, AJ; Blagieva, R; Boerwinkle, E; Bonnycastle, LL; Bostrom, KB; Bravenboer, B; Bumpstead, S; Burtt, NP; Charpentier, G; Chines, PS; Cornelis, M; Couper, DJ; Crawford, G; Doney, ASF; Elliott, KS; Elliott, AL; Erdos, MR; Fox, CS; Franklin, CS; Ganser, M; Gieger, C; Grarup, N; Green, T; Griffin, S; Groves, CJ; Guiducci, C; Hadjadj, S; Hassanali, N; Herder, C; Isomaa, B; Jackson, AU; Johnson, PRV; Jorgensen, T; Kao, WHL; Klopp, N; Kong, A; Kraft, P; Kuusisto, J; Lauritzen, T; Li, M; Lieverse, A; Lindgren, CM; Lyssenko, V; Marre, M; Meitinger, T; Midthjell, K; Morken, MA; Narisu, N; Nilsson, P; Owen, KR; Payne, F; Perry, JRB; Petersen, AK; Platou, C; Proenca, C; Prokopenko, I; Rathmann, W; Rayner, NW; Robertson, NR; Rocheleau, G; Roden, M; Sampson, MJ; Saxena, R; Shields, BM; Shrader, P; Sigurdsson, G; Sparso, T; Strassburger, K; Stringham, HM; Sun, Q; Swift, AJ; Thorand, B; Tichet, J; Tuomi, T; van Dam, RM; van Haeften, TW; van Herpt, T; van Vliet-Ostaptchouk, JV; Walters, GB; Weedon, MN; Wijmenga, C; Witteman, J; Bergman, RN; Cauchi, S; Collins, FS; Gloyn, AL; Gyllensten, U; Hansen, T; Hide, WA; Hitman, GA; Hofman, A; Hunter, DJ; Hveem, K; Laakso, M; Mohlke, KL; Morris, AD; Palmer, CNA; Pramstaller, PP; Rudan, I; Sijbrands, E; Stein, LD; Jaakko, T; Uitterlinden, A; Walker, M; Wareham, NJ; Watanabe, RM; Abecasis, GR; Boehm, BO; Campbell, H; Daly, MJ; Hattersley, AT; Hu, FB; Meigs, JB; Pankow, JS; Pedersen, O; Wichmann, HE; Barroso, I; Florez, JC; Frayling, TM; Groop, L; Sladek, R; Thorsteinsdottir, U; Wilson, JF; Illig, T; Froguel, P; van Duijn, CM; Stefansson, K; Altshuler, D; Boehnke, M; McCarthy, MI				Voight, Benjamin F.; Scott, Laura J.; Steinthorsdottir, Valgerdur; Morris, Andrew P.; Dina, Christian; Welch, Ryan P.; Zeggini, Eleftheria; Huth, Cornelia; Aulchenko, Yurii S.; Thorleifsson, Gudmar; McCulloch, Laura J.; Ferreira, Teresa; Grallert, Harald; Amin, Najaf; Wu, Guanming; Willer, Cristen J.; Raychaudhuri, Soumya; McCarroll, Steve A.; Langenberg, Claudia; Hofmann, Oliver M.; Dupuis, Josee; Qi, Lu; Segre, Ayellet V.; van Hoek, Mandy; Navarro, Pau; Ardlie, Kristin; Balkau, Beverley; Benediktsson, Rafn; Bennett, Amanda J.; Blagieva, Roza; Boerwinkle, Eric; Bonnycastle, Lori L.; Bostrom, Kristina Bengtsson; Bravenboer, Bert; Bumpstead, Suzannah; Burtt, Noisel P.; Charpentier, Guillaume; Chines, Peter S.; Cornelis, Marilyn; Couper, David J.; Crawford, Gabe; Doney, Alex S. F.; Elliott, Katherine S.; Elliott, Amanda L.; Erdos, Michael R.; Fox, Caroline S.; Franklin, Christopher S.; Ganser, Martha; Gieger, Christian; Grarup, Niels; Green, Todd; Griffin, Simon; Groves, Christopher J.; Guiducci, Candace; Hadjadj, Samy; Hassanali, Neelam; Herder, Christian; Isomaa, Bo; Jackson, Anne U.; Johnson, Paul R. V.; Jorgensen, Torben; Kao, Wen H. L.; Klopp, Norman; Kong, Augustine; Kraft, Peter; Kuusisto, Johanna; Lauritzen, Torsten; Li, Man; Lieverse, Aloysius; Lindgren, Cecilia M.; Lyssenko, Valeriya; Marre, Michel; Meitinger, Thomas; Midthjell, Kristian; Morken, Mario A.; Narisu, Narisu; Nilsson, Peter; Owen, Katharine R.; Payne, Felicity; Perry, John R. B.; Petersen, Ann-Kristin; Platou, Carl; Proenca, Christine; Prokopenko, Inga; Rathmann, Wolfgang; Rayner, N. William; Robertson, Neil R.; Rocheleau, Ghislain; Roden, Michael; Sampson, Michael J.; Saxena, Richa; Shields, Beverley M.; Shrader, Peter; Sigurdsson, Gunnar; Sparso, Thomas; Strassburger, Klaus; Stringham, Heather M.; Sun, Qi; Swift, Amy J.; Thorand, Barbara; Tichet, Jean; Tuomi, Tiinamaija; van Dam, Rob M.; van Haeften, Timon W.; van Herpt, Thijs; van Vliet-Ostaptchouk, Jana V.; Walters, G. Bragi; Weedon, Michael N.; Wijmenga, Cisca; Witteman, Jacqueline; Bergman, Richard N.; Cauchi, Stephane; Collins, Francis S.; Gloyn, Anna L.; Gyllensten, Ulf; Hansen, Torben; Hide, Winston A.; Hitman, Graham A.; Hofman, Albert; Hunter, David J.; Hveem, Kristian; Laakso, Markku; Mohlke, Karen L.; Morris, Andrew D.; Palmer, Colin N. A.; Pramstaller, Peter P.; Rudan, Igor; Sijbrands, Eric; Stein, Lincoln D.; Tuomilehto, Jaakko; Uitterlinden, Andre; Walker, Mark; Wareham, Nicholas J.; Watanabe, Richard M.; Abecasis, Goncalo R.; Boehm, Bernhard O.; Campbell, Harry; Daly, Mark J.; Hattersley, Andrew T.; Hu, Frank B.; Meigs, James B.; Pankow, James S.; Pedersen, Oluf; Wichmann, H-Erich; Barroso, Ines; Florez, Jose C.; Frayling, Timothy M.; Groop, Leif; Sladek, Rob; Thorsteinsdottir, Unnur; Wilson, James F.; Illig, Thomas; Froguel, Philippe; van Duijn, Cornelia M.; Stefansson, Kari; Altshuler, David; Boehnke, Michael; McCarthy, Mark I.		MAGIC Investigators; GIANT Consortium	Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; FASTING PLASMA-GLUCOSE; QT INTERVAL DURATION; INSULIN-RESISTANCE; COMMON VARIANTS; COMPLEX DISEASES; GENE-EXPRESSION; HNF1-ALPHA GENE; CROHNS-DISEASE	By combining genome-wide association data from 8,130 individuals with type 2 diabetes (T2D) and 38,987 controls of European descent and following up previously unidentified meta-analysis signals in a further 34,412 cases and 59,925 controls, we identified 12 new T2D association signals with combined P < 5 x 10(-8). These include a second independent signal at the KCNQ1 locus; the first report, to our knowledge, of an X-chromosomal association (near DUSP9); and a further instance of overlap between loci implicated in monogenic and multifactorial forms of diabetes (at HNF1A). The identified loci affect both beta-cell function and insulin action, and, overall, T2D association signals show evidence of enrichment for genes involved in cell cycle regulation. We also show that a high proportion of T2D susceptibility loci harbor independent association signals influencing apparently unrelated complex traits.	[Voight, Benjamin F.; Raychaudhuri, Soumya; McCarroll, Steve A.; Segre, Ayellet V.; Ardlie, Kristin; Burtt, Noisel P.; Crawford, Gabe; Elliott, Amanda L.; Green, Todd; Guiducci, Candace; Saxena, Richa; Daly, Mark J.; Florez, Jose C.; Altshuler, David] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Voight, Benjamin F.; Raychaudhuri, Soumya; McCarroll, Steve A.; Segre, Ayellet V.; Ardlie, Kristin; Burtt, Noisel P.; Crawford, Gabe; Elliott, Amanda L.; Green, Todd; Guiducci, Candace; Saxena, Richa; Daly, Mark J.; Florez, Jose C.] MIT, Cambridge, MA 02139 USA; [Raychaudhuri, Soumya; Segre, Ayellet V.; Green, Todd; Saxena, Richa; Daly, Mark J.; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Voight, Benjamin F.; Shrader, Peter; Meigs, James B.; Florez, Jose C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Scott, Laura J.; Willer, Cristen J.; Ganser, Martha; Jackson, Anne U.; Stringham, Heather M.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Kong, Augustine; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Morris, Andrew P.; Zeggini, Eleftheria; Ferreira, Teresa; Elliott, Katherine S.; Lindgren, Cecilia M.; Prokopenko, Inga; Rayner, N. William; Robertson, Neil R.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dina, Christian; Proenca, Christine; Cauchi, Stephane] CNRS, UMR 8090, Inst Biol, Lille, France; [Dina, Christian; Proenca, Christine; Cauchi, Stephane] Univ Lille 2, Inst Pasteur, Lille, France; [Dina, Christian] CNRS, UMR915, INSERM, ERL3147, Nantes, France; [Welch, Ryan P.] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA; [Zeggini, Eleftheria; Bumpstead, Suzannah; Payne, Felicity; Barroso, Ines] Wellcome Trust Sanger Inst, Hinxton, England; [Huth, Cornelia; Grallert, Harald; Gieger, Christian; Klopp, Norman; Petersen, Ann-Kristin; Thorand, Barbara; Wichmann, H-Erich; Illig, Thomas] Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany; [Huth, Cornelia; Grallert, Harald; Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Aulchenko, Yurii S.; Amin, Najaf; Witteman, Jacqueline; Hofman, Albert; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [McCulloch, Laura J.; Bennett, Amanda J.; Groves, Christopher J.; Hassanali, Neelam; Owen, Katharine R.; Prokopenko, Inga; Rayner, N. William; Robertson, Neil R.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Wu, Guanming; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON, Canada; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; McCarroll, Steve A.; Segre, Ayellet V.; Elliott, Amanda L.; Froguel, Philippe] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02115 USA; [Langenberg, Claudia; Griffin, Simon; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Hofmann, Oliver M.; Hide, Winston A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dupuis, Josee; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Qi, Lu; Kraft, Peter; Sun, Qi; Hunter, David J.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Kraft, Peter; Sun, Qi; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Qi, Lu; Cornelis, Marilyn; van Dam, Rob M.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [van Hoek, Mandy; van Herpt, Thijs; Sijbrands, Eric; Uitterlinden, Andre] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Navarro, Pau] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Balkau, Beverley] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Benediktsson, Rafn; Sigurdsson, Gunnar] Landspitali Univ Hosp, Reykjavik, Iceland; [Benediktsson, Rafn; Sigurdsson, Gunnar] Iceland Heart Assoc, Kopavogur, Iceland; [Blagieva, Roza; Boehm, Bernhard O.] Univ Ulm, Div Endocrinol Diabet & Metab, Ulm, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Bonnycastle, Lori L.; Chines, Peter S.; Erdos, Michael R.; Morken, Mario A.; Narisu, Narisu; Swift, Amy J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Bostrom, Kristina Bengtsson] Skaraborg Primary Care, Ctr Res & Dev, Skovde, Sweden; [Bravenboer, Bert] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Couper, David J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Couper, David J.] Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Diabet Res Ctr, Dundee, Scotland; [Doney, Alex S. F.; Morris, Andrew D.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Pharmacogenom Ctr, Dundee, Scotland; [Elliott, Amanda L.; Saxena, Richa] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Fox, Caroline S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Franklin, Christopher S.; Rudan, Igor; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Grarup, Niels; Sparso, Thomas; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Hadjadj, Samy] Univ Poitiers, INSERM, U927, Ctr Hosp Univ Poitiers,UFR,CIC INSERM 0801, Poitiers, France; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; [Johnson, Paul R. V.] Univ Oxford, Diabet Res & Wellness Fdn Human Islet Isolat Faci, Oxford, England; [Johnson, Paul R. V.] Univ Oxford, Oxford Islet Transplant Programme, Oxford, England; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Kao, Wen H. L.; Li, Man] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Kao, Wen H. L.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Kao, Wen H. L.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lauritzen, Torsten] Univ Aarhus, Dept Gen Med Practice, Aarhus, Denmark; [Lieverse, Aloysius; van Herpt, Thijs] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands; [Lyssenko, Valeriya; Nilsson, Peter; Groop, Leif] Lund Univ, Malmo Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, Malmo, Sweden; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Meitinger, Thomas] Helmholtz Zentrum Muenchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Midthjell, Kristian; Platou, Carl; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Community Med & Gen Practice, Nord Trondelag Hlth Study HUNT Res Ctr, N-7034 Trondheim, Norway; [Perry, John R. B.; Shields, Beverley M.; Weedon, Michael N.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Rathmann, Wolfgang; Strassburger, Klaus] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rocheleau, Ghislain; Sladek, Rob] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Rocheleau, Ghislain; Sladek, Rob] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Rocheleau, Ghislain; Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Sampson, Michael J.] Norfolk & Norwich Univ Hosp Natl Hlth Serv Trust, Dept Endocrinol & Diabet, Norwich, Norfolk, England; [Shrader, Peter; Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Tichet, Jean] Inst Interreg Sante IRSA, La Riche, France; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Helsinki Univ Hosp, Dept Med, Helsinki, Finland; [van Haeften, Timon W.] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, NL-9713 AV Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Bergman, Richard N.; Watanabe, Richard M.] Univ So Calif, Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hansen, Torben] Univ So Denmark, Odense, Denmark; [Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Diabet, London, England; [Hveem, Kristian] Hosp Levanger, Dept Med, Levanger, Norway; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Hosp Sestre Milosrdnice, Inst Clin Med Res, Zagreb, Croatia; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Red RECAVA Grp RD06 0014 0015, Madrid, Spain; [Walker, Mark] Newcastle Univ, Inst Cellular Med, Diabet Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Preventat Med, Los Angeles, CA 90033 USA; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Florez, Jose C.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [McCarthy, Mark I.] Churchill Hosp, Hlth Res Biomed Res Ctr, Oxford Natl Inst, Oxford OX3 7LJ, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Michigan System; University of Michigan; Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Landspitali National University Hospital; Icelandic Heart Association; Ulm University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Catharina Hospital; Centre Hospitalier Sud Francilien; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Dundee; University of Dundee; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Edinburgh; Novo Nordisk; Hagedorn Research Institute; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Folkhalsan Research Center; University of Oxford; University of Oxford; University of Copenhagen; University of Copenhagen; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Aarhus University; Maxima Medical Center; Lund University; Skane University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Norwegian University of Science & Technology (NTNU); University of Exeter; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; McGill University; McGill University; Heinrich Heine University Dusseldorf; Harvard University; Massachusetts General Hospital; University of Helsinki; Helsinki University Central Hospital; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Groningen; University of Southern California; National Institutes of Health (NIH) - USA; Uppsala University; University of Southern Denmark; University of London; Queen Mary University London; University of North Carolina; University of North Carolina Chapel Hill; European Academy of Bozen-Bolzano; University of Split; University of Helsinki; Hospital Universitario La Paz; Newcastle University - UK; University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen; Aarhus University; University of Munich; Harvard University; Massachusetts General Hospital; University of Iceland; Imperial College London; University of Oxford	Altshuler, D (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02138 USA.	jim.wilson@hgu.mrc.ac.uk; illig@helmholtz-muenchen.de; froguel@good.ibl.fr; c.vanduijn@erasmusmc.nl; kstefans@decode.is; altshuler@molbio.mgh.harvard.edu; boehnke@umich.edu; mark.mccarthy@drl.ox.ac.uk	Voight, Benjamin/F-1775-2011; Stefansson, Kari/AAE-7187-2019; Pramstaller, Peter P/C-2357-2008; Benediktsson, Rafn/R-2457-2018; Hide, Winston/R-3815-2019; Meigs, James/P-3927-2019; Pedersen, Oluf/Z-1731-2019; Hveem, Kristian/AFV-4683-2022; FROGUEL, Philippe/O-6799-2017; Altshuler, David M/A-4476-2009; Amin, Najaf N/D-1859-2012; Dina, Christian R/D-3535-2015; Huth, Cornelia/B-5350-2014; Abecasis, Goncalo R/B-7840-2010; Daly, Mark J/B-2453-2017; Payne, Felicity/GKF-2573-2022; Wijmenga, Cisca/D-2173-2009; Saxena, Richa/AAG-7279-2020; Meitinger, Thomas/O-1318-2015; Palmer, Colin NA/C-7053-2008; Walters, G. Bragi/L-4215-2013; Narisu, Narisu/T-6908-2019; Prokopenko, Inga/AAU-9895-2020; Hofmann, Oliver M/F-1800-2013; Pedersen, Oluf/AAG-8015-2020; Wilson, James F/A-5704-2009; Thorand, Barbara/B-5349-2014; Doney, Alexander SF/P-7437-2017; Langenberg, Claudia/ABG-9067-2021; Elliott, Amanda/G-5120-2012; Griffin, Simon J/K-3106-2013; Prokopenko, Inga/H-3241-2014; Roden, Michael/AAD-3843-2019; Jørgensen, Torben/Z-1335-2018; Sladek, Robert/R-2391-2019; Campbell, Harry/E-2959-2010; van Hoek, Mandy/B-9325-2014; Navarro, Pau/AAJ-8091-2021; Grarup, Niels/K-2807-2015; Hide, Winston A/V-2727-2017; van Dam, Rob M/F-9674-2010; Grallert, Harald/B-3424-2013; Sijbrands, Eric/A-1065-2009; Boehm, Bernhard Otto/F-8750-2015; Hide, Winston Hide/C-7217-2009; Segre, Ayellet V/E-9800-2010; Study, GoDARTS/K-9448-2016; Li, Man/AAX-3400-2020; Wijmenga, Cisca/AAE-7719-2019; Aulchenko, Yurii/M-8270-2013; Wichmann, Heinz Erich/AAA-5695-2022; Rudan, Igor/I-1467-2012; McCarthy, Mark/M-3763-2015	Benediktsson, Rafn/0000-0002-2954-9801; Hide, Winston/0000-0002-8621-3271; Meigs, James/0000-0002-2439-2657; Pedersen, Oluf/0000-0002-3321-3972; FROGUEL, Philippe/0000-0003-2972-0784; Altshuler, David M/0000-0002-7250-4107; Dina, Christian R/0000-0002-7722-7348; Huth, Cornelia/0000-0003-2421-433X; Daly, Mark J/0000-0002-0949-8752; Payne, Felicity/0000-0003-4228-581X; Palmer, Colin NA/0000-0002-6415-6560; Walters, G. Bragi/0000-0002-5415-6487; Hofmann, Oliver M/0000-0002-7738-1513; Wilson, James F/0000-0001-5751-9178; Thorand, Barbara/0000-0002-8416-6440; Doney, Alexander SF/0000-0002-6210-5620; Langenberg, Claudia/0000-0002-5017-7344; Griffin, Simon J/0000-0002-2157-4797; Prokopenko, Inga/0000-0003-1624-7457; Sladek, Robert/0000-0002-2730-1204; Campbell, Harry/0000-0002-6169-6262; Navarro, Pau/0000-0001-5576-8584; Grarup, Niels/0000-0001-5526-1070; Hide, Winston A/0000-0002-8621-3271; van Dam, Rob M/0000-0002-7354-8734; Sijbrands, Eric/0000-0001-8857-7389; Hide, Winston Hide/0000-0002-8621-3271; Li, Man/0000-0002-3839-0281; Wijmenga, Cisca/0000-0002-5635-1614; Aulchenko, Yurii/0000-0002-7899-1575; Rudan, Igor/0000-0001-6993-6884; Couper, David/0000-0002-4313-9235; Barroso, Ines/0000-0001-5800-4520; bennett, amanda/0000-0003-2140-8710; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Gloyn, Anna/0000-0003-1205-1844; Morris, Andrew/0000-0002-6805-6014; Pankow, James/0000-0001-7076-483X; McCarthy, Mark/0000-0002-4393-0510; Weedon, Michael/0000-0002-6174-6135; Kong, Augustine/0000-0001-8193-5438; Lindgren, Cecilia/0000-0002-4903-9374; Abecasis, Goncalo/0000-0003-1509-1825; Saxena, Richa/0000-0003-2233-1065; Voight, Benjamin/0000-0002-6205-9994; Hansen, Torben/0000-0001-8748-3831; Bergman, Richard/0000-0003-1539-4471; Pramstaller, Peter P/0000-0002-9831-8302; Meitinger, Thomas/0000-0002-8838-8403; Amin, Najaf/0000-0002-8944-1771; Tuomi, Tiinamaija/0000-0002-8306-6202; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Willer, Cristen/0000-0001-5645-4966; Gieger, Christian/0000-0001-6986-9554; Zeggini, Eleftheria/0000-0003-4238-659X; Marre, Michel/0000-0002-3071-1837; Raychaudhuri, Soumya/0000-0002-1901-8265; Dupuis, Josee/0000-0003-2871-3603; Jorgensen, Torben/0000-0001-9453-2830; Van Duijn, Cornelia/0000-0002-2374-9204; Hattersley, Andrew/0000-0001-5620-473X	National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish; MRC [G0700222, G0601261, MC_U106179474, MC_U127592696, G0600331, G0701863] Funding Source: UKRI; Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [G0601261, MC_U127592696, G0700222(81696), G0700222, MC_U106179474, G0600331, G0701863, MC_U106179471] Funding Source: Medline; NCRR NIH HHS [UL1RR025005, UL1 RR025005] Funding Source: Medline; NHGRI NIH HHS [U01 HG004171, U01HG004399, U01HG004402, U01 HG004399, U01 HG004402, U01HG004171] Funding Source: Medline; NHLBI NIH HHS [N01HC55022, N01HC25195, R01 HL087641, N01-HC-55015, R01 HL059367, N01-HC-55020, R01 HL086694, N01HC55015, N01HC55016, N01HC55019, N01-HC-55019, N02-HL-6-4278, R01HL087641, 1K99HL094535-01A1, N01-HC-55016, N01-HC-55018, N01-HC-55021, N01HC55020, K99 HL094535, R01HL086694, N01HC55021, N01HC55018, R01HL59367, N01-HC-25195, N01-HC-55022] Funding Source: Medline; NIAMS NIH HHS [K08 AR055688-03, K08 AR055688, 1K08AR055688] Funding Source: Medline; NIDA NIH HHS [U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [DK073490, R56 DK062370, K24 DK080140, K24-DK080140, DK062370, DK078616, DK072193, DK58845, K23 DK065978, R01 DK069922, R01 DK072193, R01 DK078616, U01 DK062370, R01 DK062370, K23-DK65978, R01 DK058845, DK069922, U01 DK078616, R01 DK073490] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline; Wellcome Trust [076113, 075491, 081682, 077016, 083270, 090532, 079557, 064890, 072960, 086596, 088885] Funding Source: Medline; Department of Health [DHCS/07/07/008] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055018, N01HC055016, N01HC025195, N01HC055015, N01HC055022, N01HC055020, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, R01HL087641, R41HL055019, R41HL055018, R01HL086694, R42HL055018, R01HL059367, K99HL094535] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, Z01HG000024, U01HG004402, U01HG004171, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069922, U01DK062370, R01DK058845, R56DK062370, R01DK062370, R01DK072193, K23DK065978, K24DK080140, R01DK078616, U01DK078616, R01DK073490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust); Department of Health; Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brants JR, 2004, FEBS LETT, V569, P277, DOI 10.1016/j.febslet.2004.05.075; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; K÷bberling J., 1982, GENETICS DIABETES ME, P201; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Quaranta M, 2009, GENES IMMUN, V10, P654, DOI 10.1038/gene.2009.51; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stolerman ES, 2009, DIABETOLOGIA, V52, P614, DOI 10.1007/s00125-009-1266-2; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weedon MN, 2005, DIABETES, V54, P2487, DOI 10.2337/diabetes.54.8.2487; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winckler W, 2005, DIABETES, V54, P2336, DOI 10.2337/diabetes.54.8.2336; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	69	1342	1383	3	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					579	U155		10.1038/ng.609	http://dx.doi.org/10.1038/ng.609			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20581827	Green Accepted, Green Published			2022-12-25	WOS:000279242400010
J	Kalscheuer, R; Syson, K; Veeraraghavan, U; Weinrick, B; Biermann, KE; Liu, Z; Sacchettini, JC; Besra, G; Bornemann, S; Jacobs, WR				Kalscheuer, Rainer; Syson, Karl; Veeraraghavan, Usha; Weinrick, Brian; Biermann, Karolin E.; Liu, Zhen; Sacchettini, James C.; Besra, Gurdyal; Bornemann, Stephen; Jacobs, William R., Jr.			Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway	NATURE CHEMICAL BIOLOGY			English	Article							STREPTOMYCES-COELICOLOR; TREHALOSE; GLYCOGEN; METABOLISM; EXPRESSION; BIOSYNTHESIS; PERSISTENCE; SURVIVAL; BACTERIA; SYNTHASE	New chemotherapeutics are urgently required to control the tuberculosis pandemic. We describe a new pathway from trehalose to alpha-glucan in Mycobacterium tuberculosis comprising four enzymatic steps mediated by TreS, Pep2, GlgE (which has been identified as a maltosyltransferase that uses maltose 1-phosphate) and GlgB. Using traditional and chemical reverse genetics, we show that GlgE inactivation causes rapid death of M. tuberculosis in vitro and in mice through a self-poisoning accumulation of maltose 1-phosphate. Poisoning elicits pleiotropic phosphosugar-induced stress responses promoted by a self-amplifying feedback loop where trehalose-forming enzymes are upregulated. Moreover, the pathway from trehalose to alpha-glucan exhibited a synthetic lethal interaction with the glucosyltransferase Rv3032, which is involved in biosynthesis of polymethylated alpha-glucans, because key enzymes in each pathway could not be simultaneously inactivated. The unique combination of maltose 1-phosphate toxicity and gene essentiality within a synthetic lethal pathway validates GlgE as a distinct potential drug target that exploits new synergistic mechanisms to induce death in M. tuberculosis.	[Kalscheuer, Rainer; Weinrick, Brian; Biermann, Karolin E.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Syson, Karl; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Veeraraghavan, Usha; Besra, Gurdyal] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Liu, Zhen; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Birmingham; Texas A&M University System; Texas A&M University College Station	Jacobs, WR (corresponding author), Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jacobsw@hhmi.org	Weinrick, Brian/F-6478-2011; Kalscheuer, Rainer/A-2852-2015; Kalscheuer, Rainer/AAF-1381-2020; Bornemann, Stephen/K-2938-2012	Weinrick, Brian/0000-0003-0880-4487; Kalscheuer, Rainer/0000-0002-3378-2067; Bornemann, Stephen/0000-0001-5930-9473; Veeraraghavan, Usha/0000-0002-8691-5716; Besra, Gurdyal/0000-0002-5605-0395; Jacobs, William/0000-0003-3321-3080	US National Institutes of Health [AI26170, AIO-68135]; Albert Einstein College of Medicine Center for AIDS Research [AIO-51519]; UK Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust [081569/2/06/2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI026170, R01AI026170, R37AI026170] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647, BBS/E/J/00000202] Funding Source: researchfish; Medical Research Council [G0901690, G9901077, G0500590] Funding Source: researchfish; BBSRC [BBS/E/J/000C0647] Funding Source: UKRI; MRC [G0500590, G9901077, G0901690] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Center for AIDS Research; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Hatfull for promoting a collaboration between the Bornemann and Jacobs labs. This work was supported by US National Institutes of Health grants AI26170 (to W. R. J.) and AIO-68135 (Structural Biology of TB Drug Targets), the Albert Einstein College of Medicine Center for AIDS Research grant AIO-51519 and the UK Biotechnology and Biological Sciences Research Council through an Institute Strategic Programme Grant to the John Innes Centre. We thank C. Bruton and K. Chater for access to unpublished data and insightful discussions, D. Hopwood for advice on the manuscript and S. Fairhurst and L. Hill for recording NMR and mass spectra at the John Innes Centre. G. B. acknowledges support in the form of a Personal Research Chair from J. Bardrick (Royal Society Wolfson Research Merit Award, as a former Lister Institute Jenner Research Fellow). G. B. also acknowledges support from The Medical Research Council and the Wellcome Trust (081569/2/06/2). We thank P. Illarionov for discussion of NMR results and the staff in technical services of the University of Birmingham (especially N. Spencer, G. Burns and P. Ashton) for help in the NMR, GC and ES- MS experiments. This paper is dedicated to the late Chris Lamb.	Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bosch AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/s10545-006-0382-0; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Jarling M, 2004, J BASIC MICROB, V44, P360, DOI 10.1002/jobm.200410403; Karakousis PC, 2008, J ANTIMICROB CHEMOTH, V61, P323, DOI 10.1093/jac/dkm485; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Pan YT, 2004, EUR J BIOCHEM, V271, P4259, DOI 10.1111/j.1432-1033.2004.04365.x; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Slepak T, 2005, MOL GENET METAB, V86, P360, DOI 10.1016/j.ymgme.2005.08.002; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Streeter JG, 2006, APPL ENVIRON MICROB, V72, P4250, DOI 10.1128/AEM.00256-06; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; USUI T, 1974, CARBOHYD RES, V33, P105, DOI 10.1016/S0008-6215(00)82944-4; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1786, DOI 10.1073/pnas.45.12.1786	37	116	130	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2010	6	5					376	384		10.1038/nchembio.340	http://dx.doi.org/10.1038/nchembio.340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	585KC	20305657	Green Accepted			2022-12-25	WOS:000276823200017
J	Wang, YT; Liu, HZ; McKenzie, G; Witting, PK; Stasch, JP; Hahn, M; Changsirivathanathamrong, D; Wu, BJ; Ball, HJ; Thomas, SR; Kapoor, V; Celermajer, DS; Mellor, AL; Keaney, JF; Hunt, NH; Stocker, R				Wang, Yutang; Liu, Hanzhong; McKenzie, Gavin; Witting, Paul K.; Stasch, Johannes-Peter; Hahn, Michael; Changsirivathanathamrong, Dechaboon; Wu, Ben J.; Ball, Helen J.; Thomas, Shane R.; Kapoor, Vimal; Celermajer, David S.; Mellor, Andrew L.; Keaney, John F., Jr.; Hunt, Nicholas H.; Stocker, Roland			Kynurenine is an endothelium-derived relaxing factor produced during inflammation	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; STIMULATED PHOSPHOPROTEIN VASP; SOLUBLE GUANYLYL CYCLASE; TRYPTOPHAN-METABOLISM; ENDOTOXIC-SHOCK; BLOOD-PRESSURE; L-ARGININE; MALARIA; INHIBITION	Control of blood vessel tone is central to vascular homeostasis. Here we show that metabolism of tryptophan to kynurenine by indoleamine 2,3-dioxygenase (Ido) expressed in endothelial cells contributes to arterial vessel relaxation and the control of blood pressure. Infection of mice with malarial parasites (Plasmodium berghei) or induction of endotoxemia in mice led to endothelial expression of Ido, decreased plasma tryptophan concentration, increased kynurenine concentration and hypotension. Pharmacological inhibition of Ido increased blood pressure in systemically inflamed mice but not in mice deficient in Ido or interferon-gamma, which is required for Ido induction. Both tryptophan and kynurenine dilated preconstricted porcine coronary arteries; the dilating effect of tryptophan required the presence of active Ido and an intact endothelium, whereas the effect of kynurenine was endothelium independent. The arterial relaxation induced by kynurenine was mediated by activation of the adenylate and soluble guanylate cyclase pathways. Kynurenine administration decreased blood pressure in a dose-dependent manner in spontaneously hypertensive rats. Our results identify tryptophan metabolism by Ido as a new pathway contributing to the regulation of vascular tone.	[Wang, Yutang; Changsirivathanathamrong, Dechaboon; Stocker, Roland] Univ Sydney, Fac Med, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia; [Wang, Yutang; Witting, Paul K.; Changsirivathanathamrong, Dechaboon; Stocker, Roland] Univ Sydney, Fac Med, Bosch Inst, Sydney, NSW 2006, Australia; [Wang, Yutang; Liu, Hanzhong; Wu, Ben J.; Thomas, Shane R.; Stocker, Roland] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [McKenzie, Gavin] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Stasch, Johannes-Peter] Bayer HealthCare, Cardiovasc Res, Wuppertal, Germany; [Hahn, Michael] Bayer HealthCare, Med Chem, Wuppertal, Germany; [Kapoor, Vimal] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Celermajer, David S.] Univ Sydney, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Mellor, Andrew L.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Keaney, John F., Jr.] Univ Massachusetts, Sch Med, Worcester, MA USA	University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Western Australia; University of Sydney; University System of Georgia; Augusta University; University of Massachusetts System; University of Massachusetts Worcester	Stocker, R (corresponding author), Univ Sydney, Fac Med, Sch Med Sci Pathol, Ctr Vasc Res, Sydney, NSW 2006, Australia.	roland.stocker@sydney.edu.au	Stocker, Roland/AAV-4489-2021; Witting, Paul/ABD-2053-2020; Wang, Yutang/ABC-0592-2022; Ball, Helen J/A-4242-2010; Witting, Paul/L-9786-2019; Hunt, Nick H/A-3636-2011	Witting, Paul/0000-0003-2237-7004; Ball, Helen J/0000-0003-3733-9748; Celermajer, David/0000-0001-7640-0439; Wu, Ben/0000-0003-2826-4190; Keaney, John/0000-0002-0866-1837; Wang, Yutang/0000-0002-6264-6443	Australian National Heart Foundation [G03S1177]; National Health & Medical Research Council (NHMRC) of Australia [400992, 401106, 512469]; Australian Research Council [DP0987074, DP0343325]; National Heart Foundation [OS 98S0008]; University of Sydney Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041187] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027081] Funding Source: NIH RePORTER	Australian National Heart Foundation(National Heart Foundation of Australia); National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation(National Heart Foundation of Australia); University of Sydney Medical Foundation(University of Sydney); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Andriambeloson, K. Choy, M. Finnemore, A. Mitchell and H. Salahifar for assistance and preliminary experiments, J. Whitworth for the suggestion to test the effect of kynurenine on blood pressure in spontaneously hypertensive rats, G. Head for advice on telemetry and B. H. Chong (University of New South Wales) for providing MEG-01 cells. This work was supported by project grants G03S1177 from the Australian National Heart Foundation to R. S., 400992 and 401106 from the National Health & Medical Research Council (NHMRC) of Australia to R. S., DP0987074 from the Australian Research Council to N.H.H. 512469 from the NHMRC to N.H.H. and National Heart Foundation (OS 98S0008) and Australian Research Council (DP0343325) fellowships to P. K. W. R. S. holds an NHMRC Senior Principal Research Fellowship and University of Sydney Medical Foundation and Professorial Research Fellowships.	ARMSTRONG RS, 1980, BIOCHEM BIOPH RES CO, V95, P682, DOI 10.1016/0006-291X(80)90839-6; Bakker J, 2004, CRIT CARE MED, V32, P1, DOI 10.1097/01.CCM.0000105118.66983.19; Ball HJ, 2002, BRAIN RES PROTOC, V9, P206, DOI 10.1016/S1385-299X(02)00147-2; Becker EM, 2000, J CARDIOVASC PHARM, V35, P390, DOI 10.1097/00005344-200003000-00007; Bruneel F, 1997, INTENS CARE MED, V23, P698, DOI 10.1007/s001340050396; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; CRAWFORD A, 1978, J ENDOCRINOL, V77, P213, DOI 10.1677/joe.0.0770213; GOMEZJIMENEZ J, 1995, CRIT CARE MED, V23, P253, DOI 10.1097/00003246-199502000-00009; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Hansen AM, 2004, INT J PARASITOL, V34, P1309, DOI 10.1016/j.ijpara.2004.07.008; Hansen AM, 2000, REDOX REP, V5, P112, DOI 10.1179/135100000101535384; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kirkeboen KA, 1999, ACTA ANAESTH SCAND, V43, P275; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lau AK, 2003, CIRCULATION, V107, P2031, DOI 10.1161/01.CIR.0000062682.40051.43; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; MEYER J, 1992, J APPL PHYSIOL, V73, P324, DOI 10.1152/jappl.1992.73.1.324; Mitchell AJ, 2005, INFECT IMMUN, V73, P5645, DOI 10.1128/IAI.73.9.5645-5653.2005; Miu J, 2009, INT J PARASITOL, V39, P363, DOI 10.1016/j.ijpara.2008.10.005; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Owe-Young R, 2008, J NEUROCHEM, V105, P1346, DOI 10.1111/j.1471-4159.2008.05241.x; Palmer D, 1998, CIRC RES, V82, P852; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sakash JB, 2002, INFECT IMMUN, V70, P3959, DOI 10.1128/IAI.70.7.3959-3961.2002; Sanni LA, 1998, AM J PATHOL, V152, P611; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schmidt P, 2003, PROTEIN EXPRES PURIF, V31, P42, DOI 10.1016/S1046-5928(03)00142-6; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Tetsutani K, 2007, PARASITOLOGY, V134, P923, DOI 10.1017/S0031182007002326; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; WERNER ER, 1987, BIOL CHEM H-S, V368, P1407, DOI 10.1515/bchm3.1987.368.2.1407; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Wiesel P, 2001, CIRC RES, V88, P1088, DOI 10.1161/hh1001.091521; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129	51	303	320	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					279	U72		10.1038/nm.2092	http://dx.doi.org/10.1038/nm.2092			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20190767	Green Accepted			2022-12-25	WOS:000275289500032
J	Liebman, SW; Meredith, SC				Liebman, Susan W.; Meredith, Stephen C.			PROTEIN FOLDING Sticky N17 speeds huntingtin pile-up	NATURE CHEMICAL BIOLOGY			English	News Item							BETA-SHEET STRUCTURE; AGGREGATION		[Liebman, Susan W.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Meredith, Stephen C.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	sueL@uic.edu; scmeredi@uchicago.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105	7	25	25	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2010	6	1					7	8		10.1038/nchembio.279	http://dx.doi.org/10.1038/nchembio.279			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533DJ	20016493				2022-12-25	WOS:000272802500004
J	Johansen, CT; Wang, JA; Lanktree, MB; Cao, HN; McIntyre, AD; Ban, MR; Martins, RA; Kennedy, BA; Hassell, RG; Visser, ME; Schwartz, SM; Voight, BF; Elosua, R; Salomaa, V; O'Donnell, CJ; Dallinga-Thie, GM; Anand, SS; Yusuf, S; Huff, MW; Kathiresan, S; Hegele, RA				Johansen, Christopher T.; Wang, Jian; Lanktree, Matthew B.; Cao, Henian; McIntyre, Adam D.; Ban, Matthew R.; Martins, Rebecca A.; Kennedy, Brooke A.; Hassell, Reina G.; Visser, Maartje E.; Schwartz, Stephen M.; Voight, Benjamin F.; Elosua, Roberto; Salomaa, Veikko; O'Donnell, Christopher J.; Dallinga-Thie, Geesje M.; Anand, Sonia S.; Yusuf, Salim; Huff, Murray W.; Kathiresan, Sekar; Hegele, Robert A.			Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia	NATURE GENETICS			English	Article							HYPERLIPOPROTEINEMIA PHENOTYPES; LOCI; DISEASE; RISK; TRIGLYCERIDES; CONTRIBUTE; MUTATIONS; ALLELES	Genome-wide association studies (GWAS) have identified multiple loci associated with plasma lipid concentrations(1-5). Common variants at these loci together explain <10% of variation in each lipid trait(4,5). Rare variants with large individual effects may also contribute to the heritability of lipid traits(6,7); however, the extent to which rare variants affect lipid phenotypes remains to be determined. Here we show an accumulation of rare variants, or a mutation skew, in GWAS-identified genes in individuals with hypertriglyceridemia (HTG). Through GWAS, we identified common variants in APOA5, GCKR, LPL and APOB associated with HTG. Resequencing of these genes revealed a significant burden of 154 rare missense or nonsense variants in 438 individuals with HTG, compared to 53 variants in 327 controls (P = 6.2 x 10(-8)), corresponding to a carrier frequency of 28.1% of affected individuals and 15.3% of controls (P = 2.6 x 10(-5)). Considering rare variants in these genes incrementally increased the proportion of genetic variation contributing to HTG.	[Johansen, Christopher T.; Wang, Jian; Lanktree, Matthew B.; Cao, Henian; McIntyre, Adam D.; Ban, Matthew R.; Martins, Rebecca A.; Kennedy, Brooke A.; Hassell, Reina G.; Huff, Murray W.; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, Robarts Res Inst, London, ON, Canada; [Visser, Maartje E.; Dallinga-Thie, Geesje M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Visser, Maartje E.; Dallinga-Thie, Geesje M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Stephen M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Salomaa, Veikko] Natl Inst Hlth & Welf, Chron Dis Epidemiol Unit, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Anand, Sonia S.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Huff, Murray W.; Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); McMaster University; Population Health Research Institute; Western University (University of Western Ontario)	Hegele, RA (corresponding author), Univ Western Ontario, Dept Biochem, Robarts Res Inst, London, ON, Canada.	hegele@robarts.ca	Hegele, Robert/G-3301-2011; Huff, Murray/G-3307-2011; wang, jian/GVS-0711-2022; Hegele, Robert/AAF-6482-2020; Voight, Benjamin/F-1775-2011; Lanktree, Matthew Bruce/I-9790-2019	Hegele, Robert/0000-0003-2861-5325; Lanktree, Matthew Bruce/0000-0002-5750-6286; Yusuf, Salim/0000-0003-4776-5601; Voight, Benjamin/0000-0002-6205-9994; dallinga-thie, geesje/0000-0001-5412-5923	US National Institutes of Health through the National Heart, Lung, and Blood Institute [R01 HL087676]; National Center for Research Resources [U54 RR020278]; Canadian Institutes of Health Research (CIHR) [MOP-13430, MOP-79523, CTP-79853]; Heart and Stroke Foundation of Ontario; Sigrid Juselius Foundation; Finnish Academy [129494]; Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair; Eli Lilly May Cohen Chair in Women's Health Research at McMaster University; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Heart and Stroke Foundation of Ontario [NA-6059, T-6018, PRG-4854]; Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic; Genome Canada through the Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER	US National Institutes of Health through the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy(Academy of Finland); Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair; Eli Lilly May Cohen Chair in Women's Health Research at McMaster University; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic; Genome Canada through the Ontario Genomics Institute(Genome Canada); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the London Regional Genomics Centre (D. Carter, G. Barbe and K. Kang) for their dedication to this project, and the Myocardial Infarction Genetics Consortium (MIGen) study for the use of their genotype data as control data in our study. The MIGen study was funded by the US National Institutes of Health through the National Heart, Lung, and Blood Institute's STAMPEED genomics research program (R01 HL087676) and the National Center for Research Resources (U54 RR020278). This work was made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET). C.T.J. is supported by a Canadian Institutes of Health Research (CIHR) Banting and Best Canada Graduate Scholarship, a Heart and Stroke Foundation of Ontario Program Grant and a CIHR Vascular Research Fellowship. V. S. was supported by the Sigrid Juselius Foundation and by the Finnish Academy (grant 129494). S. S. A. is supported by the Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair and the Eli Lilly May Cohen Chair in Women's Health Research at McMaster University. R. A. H. is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I), the Martha G. Blackburn Chair in Cardiovascular Research and operating grants from the CIHR (MOP-13430, MOP-79523, CTP-79853), the Heart and Stroke Foundation of Ontario (NA-6059, T-6018, PRG-4854), the Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award and Genome Canada through the Ontario Genomics Institute.	Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; GAFFNEY D, 1995, ARTERIOSCL THROM VAS, V15, P1025, DOI 10.1161/01.ATV.15.8.1025; Hegele RA, 2009, HUM MOL GENET, V18, P4189, DOI 10.1093/hmg/ddp361; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mittlbock M, 1999, COMPUT METH PROG BIO, V58, P17, DOI 10.1016/S0169-2607(98)00061-3; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P2450, DOI 10.1161/ATVBAHA.107.150680; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963	27	342	353	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					684	+		10.1038/ng.628	http://dx.doi.org/10.1038/ng.628			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20657596	Green Accepted			2022-12-25	WOS:000280524000012
J	Park, JH; Wacholder, S; Gail, MH; Peters, U; Jacobs, KB; Chanock, SJ; Chatterjee, N				Park, Ju-Hyun; Wacholder, Sholom; Gail, Mitchell H.; Peters, Ulrike; Jacobs, Kevin B.; Chanock, Stephen J.; Chatterjee, Nilanjan			Estimation of effect size distribution from genome-wide association studies and implications for future discoveries	NATURE GENETICS			English	Article							BREAST-CANCER; SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; RISK ALLELES; ODDS RATIOS; VARIANTS; POWER; IDENTIFICATION	We report a set of tools to estimate the number of susceptibility loci and the distribution of their effect sizes for a trait on the basis of discoveries from existing genome-wide association studies (GWASs). We propose statistical power calculations for future GWASs using estimated distributions of effect sizes. Using reported GWAS findings for height, Crohn's disease and breast, prostate and colorectal (BPC) cancers, we determine that each of these traits is likely to harbor additional loci within the spectrum of low-penetrance common variants. These loci, which can be identified from sufficiently powerful GWASs, together could explain at least 15-20% of the known heritability of these traits. However, for BPC cancers, which have modest familial aggregation, our analysis suggests that risk models based on common variants alone will have modest discriminatory power (63.5% area under curve), even with new discoveries.	[Park, Ju-Hyun; Wacholder, Sholom; Gail, Mitchell H.; Chanock, Stephen J.; Chatterjee, Nilanjan] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Jacobs, Kevin B.; Chanock, Stephen J.] NCI, Core Genotyping Facil, NIH, US Dept HHS, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chatterjee, N (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Rockville, MD USA.	chattern@mail.nih.gov		Jacobs, Kevin/0000-0002-4657-6473	National Cancer Institute; US National Institutes of Health; National Institutes of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the intramural program of the National Cancer Institute, US National Institutes of Health. The research of N.C. and J.-H.P. was also partially funded by the Gene-Environment Initiative of the National Institutes of Health.	Ambrosius WT, 2004, AM J HUM GENET, V74, P683, DOI 10.1086/383282; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eberle MA, 2007, PLOS GENET, V3, P1827, DOI 10.1371/journal.pgen.0030170; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gail MH, 2009, J NATL CANCER I, V101, P959, DOI 10.1093/jnci/djp130; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Schork NJ, 2002, AM J HUM GENET, V70, P1480, DOI 10.1086/340788; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Xu JF, 2009, PROSTATE, V69, P1565, DOI 10.1002/pros.21002; Yu K, 2007, AM J HUM GENET, V81, P540, DOI 10.1086/520678; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	36	468	479	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					570	U139		10.1038/ng.610	http://dx.doi.org/10.1038/ng.610			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20562874	Green Accepted			2022-12-25	WOS:000279242400008
J	Nattel, S				Nattel, Stanley			When normal ECG variants turn lethal	NATURE MEDICINE			English	Editorial Material							EARLY REPOLARIZATION; BRUGADA-SYNDROME; LONG	Numerous factors can contribute to sudden cardiac death, from underlying disease after myocardial infarction to genetic variants that can claim young lives. In 'Bedside to Bench', Stanley Nattel examines recent clinical studies suggesting that a particular type of readout on an electrocardiogram (ECG) may increase the risk of the condition. This ECG 'variant' is relatively common and was previously thought to be benign. In 'Bench to Bedside', Gordon Tomaselli and Andreas Barth take a look at studies at the bench examining how oxidative stress may promote sudden cardiac death.	[Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada; [Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Nattel, S (corresponding author), Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada.	Stanley.nattel@icm-mhi.org		Nattel, Stanley/0000-0002-5565-3311				Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Krahn AD, 2009, CIRCULATION, V120, P278, DOI 10.1161/CIRCULATIONAHA.109.853143; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; MYERS GB, 1947, AM HEART J, V34, P785, DOI 10.1016/0002-8703(47)90144-0; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A	13	7	8	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					646	647		10.1038/nm0610-646	http://dx.doi.org/10.1038/nm0610-646			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526318				2022-12-25	WOS:000278394200028
J	Goodsaid, F; Papaluca, M				Goodsaid, Federico; Papaluca, Marisa			Evolution of biomarker qualification at the health authorities	NATURE BIOTECHNOLOGY			English	Article									[Goodsaid, Federico] US FDA, Silver Spring, MD USA; [Papaluca, Marisa] European Med Agcy, London, England	US Food & Drug Administration (FDA)	Goodsaid, F (corresponding author), US FDA, Silver Spring, MD USA.	federico.goodsaid@fda.hhs.gov; Marisa.Papaluca@ema.europa.eu	Papaluca, Marisa/GWZ-2025-2022					Altar CA, 2008, CLIN PHARMACOL THER, V83, P368, DOI 10.1038/sj.clpt.6100451; [Anonymous], 2008, FIN REP PIL JOINT EM; *EUR AG EV MED PRO, MED EM SCI; *EUR AG EV MED PRO, 2003, PUBL STAT EU US FDA; *EUR MED AG, 2009, GUID DOC QUAL NOV ME; *EUR MED AG, 2004, EMEA CHMP PGXWP 2022; *EUR MED AG, 2007, EMEA1273182007 EUR M; European Medicines Agency, 2010, EUR MED AG ROAD MAP; *FDA, E16 GEN BIOM REL DRU; Food and Drug Administration, 2004, CRIT PATH IN; Food and Drug Administration, 2005, GUID IND PHARM DAT S; Food and Drug Administration, TABL VAL GEN BIOM CO; Goodsaid FM, 2008, TOXICOLOGY, V245, P219, DOI 10.1016/j.tox.2007.12.023; Hunter AJ, 2008, DRUG DISCOV TODAY, V13, P371, DOI 10.1016/j.drudis.2008.02.009; Lathia CD, 2009, CLIN PHARMACOL THER, V86, P32, DOI 10.1038/clpt.2009.69; Uyama Yoshiaki, 2005, Nihon Yakurigaku Zasshi, V126, P432; 2004, FED REG, V69, P42060; 2004, FED REG, V69, P48876	18	34	34	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					441	443		10.1038/nbt0510-441	http://dx.doi.org/10.1038/nbt0510-441			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458312				2022-12-25	WOS:000277452700022
J	Lincecum, JM; Vieira, FG; Wang, MZ; Thompson, K; De Zutter, GS; Kidd, J; Moreno, A; Sanchez, R; Carrion, IJ; Levine, BA; Al-Nakhala, BM; Sullivan, SM; Gill, A; Perrin, S				Lincecum, John M.; Vieira, Fernando G.; Wang, Monica Z.; Thompson, Kenneth; De Zutter, Gerald S.; Kidd, Joshua; Moreno, Andrew; Sanchez, Ricardo; Carrion, Isarelis J.; Levine, Beth A.; Al-Nakhala, Bashar M.; Sullivan, Shawn M.; Gill, Alan; Perrin, Steven			From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD40 LIGAND; GENE-EXPRESSION; SPINAL-CORD; ALLOGRAFT-REJECTION; CELLS; ACTIVATION; BLOCKADE; GP39; MICE	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune responses. Furthermore, we observed that this pathway is upregulated in the blood of 56% of human patients with ALS. A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model. This work demonstrates that unbiased transcript profiling can identify cellular pathways responsive to therapeutic intervention in a preclinical model of human disease.	[Lincecum, John M.; Vieira, Fernando G.; Wang, Monica Z.; Thompson, Kenneth; De Zutter, Gerald S.; Kidd, Joshua; Moreno, Andrew; Sanchez, Ricardo; Carrion, Isarelis J.; Levine, Beth A.; Al-Nakhala, Bashar M.; Sullivan, Shawn M.; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA USA		Perrin, S (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	sperrin@als.net	Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418	ALS; Muscular Dystrophy Association/Augie's Quest; US Department of Defense; RGK Foundation	ALS; Muscular Dystrophy Association/Augie's Quest(Muscular Dystrophy Association); US Department of Defense(United States Department of Defense); RGK Foundation	We thank S. Appel, J. McCoy, S. Hesterlee and R. Goldstein for their thoughtful scientific discussions and contributions, R. Puchalski and the staff of the Allen Institute for Brain Science for the contribution of the in situ hybridization data, S. F. Scott, who lost his battle with ALS in 2009, for establishing the rigorous parameters required to test therapeutics in the SOD1<SUP>G93A</SUP> model, J. Heywood and his family for establishing ALS TDI and continuing to support our efforts and A. Nieto and L. Nieto for their dedication and financial support for the development of therapeutics for ALS. This work was supported by the Muscular Dystrophy Association/Augie's Quest, the US Department of Defense, the RGK Foundation and all our patients with ALS and their families.	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; DeCristofaro Marc F., 2008, V460, P185, DOI 10.1007/978-1-60327-048-9_9; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Gallon L, 1997, J IMMUNOL, V159, P4212; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Honey K, 1999, J IMMUNOL, V163, P4805; HUGHES R, 1992, MUSCLE NERVE, V15, P568, DOI 10.1002/mus.880150506; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kalled SL, 2001, LUPUS, V10, P9, DOI 10.1191/096120301668384751; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kinter J, 2008, Int MS J, V15, P51; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Larsen CP, 1996, TRANSPLANTATION, V61, P4, DOI 10.1097/00007890-199601150-00002; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Ma J, 1996, J IMMUNOL, V157, P417; Merrick BA, 2004, CURR OPIN MOL THER, V6, P600; MOHAN C, 1995, J IMMUNOL, V154, P1470; Monk NJ, 2003, NAT MED, V9, P1275, DOI 10.1038/nm931; Nagelkerken L, 2004, J IMMUNOL, V173, P993, DOI 10.4049/jimmunol.173.2.993; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; ROY M, 1993, J IMMUNOL, V151, P2497; Ruderman Eric M., 2009, P27, DOI 10.1007/978-3-7643-8238-4_2; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; TROOST D, 1989, CLIN NEUROPATHOL, V8, P289	44	88	90	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					392	U45		10.1038/ng.557	http://dx.doi.org/10.1038/ng.557			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348957				2022-12-25	WOS:000277179500008
J	Smith, ZD; Nachman, I; Regev, A; Meissner, A				Smith, Zachary D.; Nachman, Iftach; Regev, Aviv; Meissner, Alexander			Dynamic single-cell imaging of direct reprogramming reveals an early specifying event	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; FIBROBLASTS; GENERATION; MYC; SUPPRESSION; LOCUS; CYCLE; MICE	The study of induced pluripotency often relies on experimental approaches that average measurements across a large population of cells, the majority of which do not become pluripotent. Here we used high-resolution, time-lapse imaging to trace the reprogramming process over 2 weeks from single mouse embryonic fibroblasts (MEFs) to pluripotency factor-positive colonies. This enabled us to calculate a normalized cell-of-origin reprogramming efficiency that takes into account only the initial MEFs that respond to form reprogrammed colonies rather than the larger number of final colonies. Furthermore, this retrospective analysis revealed that successfully reprogramming cells undergo a rapid shift in their proliferative rate that coincides with a reduction in cellular area. This event occurs as early as the first cell division and with similar kinetics in all cells that form induced pluripotent stem (iPS) cell colonies. These data contribute to the theoretical modeling of reprogramming and suggest that certain parts of the reprogramming process follow defined rather than stochastic steps.	[Smith, Zachary D.; Nachman, Iftach; Regev, Aviv; Meissner, Alexander] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Nachman, Iftach] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Tel Aviv University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Meissner, A (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA USA.	alexander_meissner@harvard.edu	Nachman, Iftach/AAK-2051-2020; Nachman, Iftach/E-6750-2010	Nachman, Iftach/0000-0002-4667-0398	Burroughs Wellcome Fund; National Institutes of Health Pioneer; Sloan Foundation; Pew Charitable Trust; Massachusetts Life Science Center (MLSC); Pew; MLSC; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health Pioneer; Sloan Foundation(Alfred P. Sloan Foundation); Pew Charitable Trust; Massachusetts Life Science Center (MLSC); Pew; MLSC; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Carpenter and M. Bray from the Broad Imaging Platform for help with the initial CellProfiler image analysis pipeline. We thank E. S. Lander and C. Bock and R.P.Koche for critical reading of the manuscript as well as M. Thomson, M. Staller, A. De Los Angeles and J. Dennett for technical assistance and intellectual input. I.N. was supported by a Merck postdoctoral fellowship and an Alon fellowship. A.R. was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, an National Institutes of Health Pioneer Award and the Sloan Foundation. A.R. is an Early Career Scientist of the Howard Hughes Medical Institute and an Investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. A.M. was supported by the Pew Charitable Trust and a New Investigator grant by the Massachusetts Life Science Center (MLSC). This work was funded by the Pew and MLSC.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	30	155	161	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					521	U188		10.1038/nbt.1632	http://dx.doi.org/10.1038/nbt.1632			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20436460	Green Accepted, Green Submitted			2022-12-25	WOS:000277452700034
J	Urban, E; Jacob, S; Nemethova, M; Resch, GP; Small, JV				Urban, Edit; Jacob, Sonja; Nemethova, Maria; Resch, Guenter P.; Small, J. Victor			Electron tomography reveals unbranched networks of actin filaments in lamellipodia	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; LEADING-EDGE; DENDRITIC ORGANIZATION; CULTURED-CELLS; FILOPODIA; PROTRUSION; NUCLEATION; PROTEIN; POLYMERIZATION; LOCALIZATION	Eukaryotic cells can initiate movement using the forces exerted by polymerizing actin filaments to extend lamellipodial and filopodial protrusions. In the current model, actin filaments in lamellipodia are organized in a branched, dendritic network. We applied electron tomography to vitreously frozen 'live' cells, fixed cells and cytoskeletons, embedded in vitreous ice or in deep-negative stain. In lamellipodia from four cell types, including rapidly migrating fish keratocytes, we found that actin filaments are almost exclusively unbranched. The vast majority of apparent filament junctions proved to be overlapping filaments, rather than branched end-to-side junctions. Analysis of the tomograms revealed that actin filaments terminate at the membrane interface within a zone several hundred nanometres wide at the lamellipodium front, and yielded the first direct measurements of filament densities. Actin filament pairs were also identified as lamellipodium components and bundle precursors. These data provide a new structural basis for understanding actin-driven protrusion during cell migration.	[Urban, Edit; Jacob, Sonja; Nemethova, Maria; Resch, Guenter P.; Small, J. Victor] Inst Mol Biotechnol, A-1030 Vienna, Austria; [Resch, Guenter P.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Small, JV (corresponding author), Inst Mol Biotechnol, Dr Bohr Gasse 3-7, A-1030 Vienna, Austria.	vic.small@imba.oeaw.ac.at			Austrian Science Research Council; Vienna Science Research and Technology Fund (WWTF); City of Vienna/Zentrum fur Innovation und Technologie; Austrian Science Fund (FWF) [P 21292] Funding Source: researchfish	Austrian Science Research Council(Austrian Science Fund (FWF)); Vienna Science Research and Technology Fund (WWTF); City of Vienna/Zentrum fur Innovation und Technologie; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank T. Kulcsar for help with graphics, M. Brandstaetter for support in electron microscopy, T. Stradal and K. Rottner for the p16 ArpC5 construct, and R. Tsien for mCherry. J.V.S. was supported by the Austrian Science Research Council and the Vienna Science Research and Technology Fund (WWTF). G. P. R and J.V.S. acknowledge the support by the City of Vienna/Zentrum fur Innovation und Technologie through the spot of excellence grant "Center of Molecular and Cellular Nanostructure".	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Anderson KI, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P372; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Dickinson RB, 2009, J MATH BIOL, V58, P81, DOI 10.1007/s00285-008-0200-4; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Flinn HM, 1996, J CELL SCI, V109, P1133; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Hoglund A S, 1980, J Muscle Res Cell Motil, V1, P127, DOI 10.1007/BF00711795; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Koestler SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004810; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; LANGANGER G, 1984, J CELL BIOL, V99, P1324, DOI 10.1083/jcb.99.4.1324; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Small J V, 1988, Electron Microsc Rev, V1, P155; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; SMALL JV, 1981, COLD SPRING HARB SYM, V46, P599, DOI 10.1101/SQB.1982.046.01.056; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873; Steven AC, 2003, TRENDS CELL BIOL, V13, P107, DOI 10.1016/S0962-8924(03)00023-0; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vallotton P, 2009, J CELL SCI, V122, P1955, DOI 10.1242/jcs.042036; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317	67	152	158	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2010	12	5					429	U36		10.1038/ncb2044	http://dx.doi.org/10.1038/ncb2044			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	591FB	20418872				2022-12-25	WOS:000277283700008
J	Hagel, JM; Facchini, PJ				Hagel, Jillian M.; Facchini, Peter J.			Dioxygenases catalyze the O-demethylation steps of morphine biosynthesis in opium poppy	NATURE CHEMICAL BIOLOGY			English	Article							PSEUDOMONAS-PUTIDA M10; PAPAVER-SOMNIFERUM; BENZYLISOQUINOLINE ALKALOIDS; 2-OXOGLUTARATE OXYGENASES; ARABIDOPSIS-THALIANA; CODEINE; ENZYMES; REDUCTASE; THEBAINE; PATHWAY	Two previously undetected enzymes involved in morphine biosynthesis and unique among plants to opium poppy have been identified as non-heme dioxygenases, in contrast to the functionally analogous cytochrome P450s found in mammals. We used functional genomics to isolate thebaine 6-O-demethylase (T6ODM) and codeine O-demethylase (CODM), the only known 2-oxoglutarate/Fe(II)-dependent dioxygenases that catalyze O-demethylation. Virus-induced gene silencing of T6ODM and CODM in opium poppy efficiently blocked metabolism at thebaine and codeine, respectively.	[Hagel, Jillian M.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Hagel, JM (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca		Facchini, Peter/0000-0002-7693-290X	Alberta Ingenuity Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Plant Metabolic Processes Biotechnology	Alberta Ingenuity Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Plant Metabolic Processes Biotechnology	We are grateful to D. Kumar ( Yale University) for the pTRV1 and pTRV2 vectors, V. Irish ( Yale University) for the pTRV2-PapPDS construct, the Canadian National Research Council Plant Biotechnology Institute for hosting our sequence data on their FIESTA2 annotation platform, and Sanofi-Aventis for the gift of the opium poppy varieties and the alkaloid standards used in this work. We also thank K. Zulak, R. Bourgault and J. Ziegler for technical assistance with cDNA library construction, microarray preparation and mass spectrometry, respectively. J. M. H. is the recipient of an Alberta Ingenuity Graduate Scholarship. Funding for this work was provided through a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada and a Canada Research Chair in Plant Metabolic Processes Biotechnology, both awarded to P. J. F.	BROCHMANNHANSSEN E, 1984, PLANTA MED, V50, P343, DOI 10.1055/s-2007-969727; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cotterill P., 2005, International Patent Application, Patent No. 2005107436; Craig DH, 1998, BIOCHEMISTRY-US, V37, P7598, DOI 10.1021/bi980345i; DECAROLIS E, 1994, PHYTOCHEMISTRY, V36, P1093, DOI 10.1016/S0031-9422(00)89621-1; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hagel JM, 2008, PLANT PHYSIOL, V147, P1805, DOI 10.1104/pp.108.120493; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; *INT NARC CONTR BO, 2007, EINCB20062 UN; ISHIDA T, 1991, DRUG METAB DISPOS, V19, P895; Lister DL, 1999, FEMS MICROBIOL LETT, V181, P137; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Millgate AG, 2004, NATURE, V431, P413, DOI 10.1038/431413a; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; NIELSEN B, 1983, PLANTA MED, V48, P205, DOI 10.1055/s-2007-969921; NYMAN U, 1978, HEREDITAS, V89, P43; PARKER HI, 1972, J AM CHEM SOC, V94, P1276, DOI 10.1021/ja00759a039; RAPOPORT R, 1994, ANAL BIOCHEM, V218, P309, DOI 10.1006/abio.1994.1183; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Zhu W, 2008, MED SCI MONITOR, V14, pSC15; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	25	140	167	5	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					273	275		10.1038/NCHEMBIO.317	http://dx.doi.org/10.1038/NCHEMBIO.317			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20228795				2022-12-25	WOS:000275734000012
J	Lee, JS; Gladwin, MT				Lee, Janet S.; Gladwin, Mark T.			Bad Blood The risks of red cell storage	NATURE MEDICINE			English	Editorial Material							RESPIRATORY-DISTRESS SYNDROME; CARDIAC-SURGERY; TRANSFUSION; HEMOGLOBIN	Blood transfusion saves many lives but carries the risk of injury, such as severe damage to the lungs. In 'Bedside to Bench', Janet S. Lee and Mark T. Gladwin examine the implications of clinical studies assessing such damage. The risk of injury seems to increase with the number of units transfused and may be greater with blood that has been stored longer. Researchers have yet to understand why, but several mechanisms are under scrutiny. In 'Bench to Bedside', Paul S. Frenette and Narla Mohandas discuss recent studies pinpointing a trigger-a specific antigen on neutrophils for a severe form of transfusion-related acute lung injury (TRALI). The findings could lead to new ways to diagnose TRALI and identify people at risk.	[Lee, Janet S.; Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, JS (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	gladwinmt@upmc.edu		Lee, Janet/0000-0002-6812-6043	NHLBI NIH HHS [R01 HL086884] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086884] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; COLLINS JA, 1978, ANN SURG, V188, P513, DOI 10.1097/00000658-197810000-00008; Dzik W, 2008, TRANSFUSION MED, V18, P260, DOI 10.1111/j.1365-3148.2008.00870.x; FOWLER AA, 1983, ANN INTERN MED, V98, P593, DOI 10.7326/0003-4819-98-5-593; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Silliman CC, 2009, BLOOD REV, V23, P245, DOI 10.1016/j.blre.2009.07.005; Valles J, 2002, BLOOD, V99, P3978, DOI 10.1182/blood.V99.11.3978	12	59	60	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					381	382		10.1038/nm0410-381	http://dx.doi.org/10.1038/nm0410-381			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376046	Bronze, Green Accepted			2022-12-25	WOS:000276446800036
J	Lee, JY; Udugamasooriya, DG; Lim, HS; Kodadek, T				Lee, Jiyong; Udugamasooriya, D. Gomika; Lim, Hyun-Suk; Kodadek, Thomas			Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates	NATURE CHEMICAL BIOLOGY			English	Article							PROTEASOME REGULATORY PARTICLE; ASSISTED LIGHT INACTIVATION; LASER INACTIVATION; MOLECULAR-OXYGEN; 20S PROTEASOME; INHIBITOR; IDENTIFICATION; PHARMACOPHORE; COMPLEXES; ATPASES	Advances in high-throughput screening now enable the rapid discovery of bioactive small molecules, but these primary hits almost always exhibit modest potency. We report a strategy for the transformation of these hits into much more potent inhibitors without compound optimization. Appending a derivative of Ru(II)(tris-bipyridyl)(2+), an efficient photosensitizer of singlet oxygen production, to synthetic protein-binding compounds results in highly potent and specific target protein inactivation upon irradiation with visible light.	[Kodadek, Thomas] Scripps Res Inst, Dept Chem, Jupiter, FL USA; [Kodadek, Thomas] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Lee, Jiyong; Udugamasooriya, D. Gomika; Lim, Hyun-Suk] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA	Scripps Research Institute; Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lee, JY (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	kodadek@scripps.edu	Lee, Jiyong/B-4894-2017; Moon, Heejo/F-5355-2013	Kodadek, Thomas/0000-0003-1930-4795; Lee, Jiyong/0000-0002-4455-3358	US National Heart, Lung, and Blood Institute [NO1 HV28185]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000663] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a contract from the US National Heart, Lung, and Blood Institute (NO1 HV28185) for the University of Texas Southwestern Center for Proteomics Research. We thank M. Rosen (University of Texas Southwestern) and B. Cravatt (The Scripps Research Institute) for a critical reading of the manuscript.	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Colas Pierre, 2008, Curr Drug Discov Technol, V5, P190, DOI 10.2174/157016308785739875; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Diller DJ, 2008, CURR OPIN DRUG DISC, V11, P346; Fuller ZJ, 2003, ANAL CHEM, V75, P2670, DOI 10.1021/ac0261707; Ito Y, 1996, INT J CANCER, V67, P148, DOI 10.1002/(SICI)1097-0215(19960703)67:1<148::AID-IJC24>3.3.CO;2-6; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; Lee JY, 2008, MOL BIOSYST, V4, P59, DOI 10.1039/b712307h; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Lim HS, 2008, CHEM COMMUN, P1064, DOI 10.1039/b717861a; Lim HS, 2007, J AM CHEM SOC, V129, P12936, DOI 10.1021/ja075469+; Lim HS, 2007, J AM CHEM SOC, V129, P7750, DOI 10.1021/ja072027p; Marks KM, 2004, P NATL ACAD SCI USA, V101, P9982, DOI 10.1073/pnas.0401609101; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Udugamasooriya DG, 2008, BIOORG MED CHEM LETT, V18, P5892, DOI 10.1016/j.bmcl.2008.07.023; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; WINTERLE JS, 1976, J AM CHEM SOC, V98, P3719, DOI 10.1021/ja00428a062; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Yogo T, 2004, CHEM BIOL, V11, P1053, DOI 10.1016/j.chembiol.2004.05.012; Yu P, 2005, NAT BIOTECHNOL, V23, P746, DOI 10.1038/nbt1099; ZHANG XY, 1995, J PHYS CHEM-US, V99, P12797, DOI 10.1021/j100034a018	25	72	72	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					258	260		10.1038/NCHEMBIO.333	http://dx.doi.org/10.1038/NCHEMBIO.333			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20228793	Green Accepted			2022-12-25	WOS:000275734000007
J	Akahata, W; Yang, ZY; Andersen, H; Sun, SY; Holdaway, HA; Kong, WP; Lewis, MG; Higgs, S; Rossmann, MG; Rao, S; Nabel, GJ				Akahata, Wataru; Yang, Zhi-Yong; Andersen, Hanne; Sun, Siyang; Holdaway, Heather A.; Kong, Wing-Pui; Lewis, Mark G.; Higgs, Stephen; Rossmann, Michael G.; Rao, Srinivas; Nabel, Gary J.			A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection	NATURE MEDICINE			English	Article							IMMUNOGENICITY; GLYCOPROTEIN; ORGANIZATION; EXPRESSION	Chikungunya virus (CHIKV) has infected millions of people in Africa, Europe and Asia(1,2) since this alphavirus reemerged from Kenya in 2004. The severity of the disease and the spread of this epidemic virus present a serious public health threat in the absence of vaccines or antiviral therapies. Here, we describe a new vaccine that protects against CHIKV infection of nonhuman primates. We show that selective expression of viral structural proteins gives rise to virus-like particles (VLPs) in vitro that resemble replication-competent alpha-viruses. Immunization with these VLPs elicited neutralizing antibodies against envelope proteins from alternative CHIKV strains. Monkeys immunized with VLPs produced high-titer neutralizing antibodies that protected against viremia after high-dose challenge. We transferred these antibodies into immunodeficient mice, where they protected against subsequent lethal CHIKV challenge, indicating a humoral mechanism of protection. Immunization with alphavirus VLP vaccines represents a strategy to contain the spread of CHIKV and related pathogenic viruses in humans.	[Akahata, Wataru; Yang, Zhi-Yong; Kong, Wing-Pui; Rao, Srinivas; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Sun, Siyang; Holdaway, Heather A.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Andersen, Hanne; Lewis, Mark G.] Bioqual Inc, Rockville, MD USA; [Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Purdue University System; Purdue University; Purdue University West Lafayette Campus; BIOQUAL Inc.; University of Texas System; University of Texas Medical Branch Galveston	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov		Elyard, Hanne/0000-0003-1103-9608	Vaccine Research Center, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005097] Funding Source: NIH RePORTER	Vaccine Research Center, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Nagashima for help with electron microscopy and J. D. Yoder for initiating cryoelectron microscopy reconstruction. We also thank A. Tislerics and J. Stein for help with manuscript preparation, B. Hartman for graphic arts and members of the Nabel lab for helpful discussions. We thank R. Seder and D. D. Pinschewer (Department of Pathology and Immunology, University of Geneva) for their kind gift of Ifnar1<SUP>-/-</SUP> mice, A. Ault, J.-P. Todd, A. Zajac, C. Chiedi (Vaccine Research Center) and D. Gordon (Bioqual) for plaque assay and processed animal blood samples, J. Greenhouse for RT-PCR assay, B. W. Finneyfrock, T. Jenkins and A. Dodson for animal sampling and care, K. Foulds, M. Donaldson and M. Roederer for monkey sample procedures and J. Lee for preparing 293F cells for VLP production. This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, US National Institutes of Health.	Akahata W, 2005, J VIROL, V79, P626, DOI 10.1128/JVI.79.1.626-631.2005; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; CHENG RH, 1995, CELL, V80, P621; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; ECKELS KH, 1970, APPL MICROBIOL, V19, P321, DOI 10.1128/AEM.19.2.321-325.1970; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; HARRISON VR, 1971, J IMMUNOL, V107, P643; HARRISON VR, 1967, AM J TROP MED HYG, V16, P786, DOI 10.4269/ajtmh.1967.16.786; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; ROSS R. W., 1956, JOUR HYG, V54, P177; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002	35	329	355	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					334	U134		10.1038/nm.2105	http://dx.doi.org/10.1038/nm.2105			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20111039	Green Accepted, Bronze			2022-12-25	WOS:000275289500041
J	Flatz, L; Hegazy, AN; Bergthaler, A; Verschoor, A; Claus, C; Fernandez, M; Gattinoni, L; Johnson, S; Kreppel, F; Kochanek, S; van den Broek, M; Radbruch, A; Levy, F; Lambert, PH; Siegrist, CA; Restifo, NP; Lohning, M; Ochsenbein, AF; Nabel, GJ; Pinschewer, DD				Flatz, Lukas; Hegazy, Ahmed N.; Bergthaler, Andreas; Verschoor, Admar; Claus, Christina; Fernandez, Marylise; Gattinoni, Luca; Johnson, Susan; Kreppel, Florian; Kochanek, Stefan; van den Broek, Maries; Radbruch, Andreas; Levy, Frederic; Lambert, Paul-Henri; Siegrist, Claire-Anne; Restifo, Nicholas P.; Loehning, Max; Ochsenbein, Adrian F.; Nabel, Gary J.; Pinschewer, Daniel D.			Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8(+) T cell immunity	NATURE MEDICINE			English	Article							DENDRITIC CELLS; LISTERIA-MONOCYTOGENES; CYTOLYTIC ACTIVITY; ANTIBODIES; MICE; RESPONSES; ADENOVIRUS; IMMUNIZATION; PREVALENCE; PROTECTION	Lymphocytic choriomeningitis virus (LCMV) exhibits natural tropism for dendritic cells and represents the prototypic infection that elicits protective CD8(+) T cell (cytotoxic T lymphocyte (CTL)) immunity. Here we have harnessed the immunobiology of this arenavirus for vaccine delivery. By using producer cells constitutively synthesizing the viral glycoprotein (GP), it was possible to replace the gene encoding LCMV GP with vaccine antigens to create replication-defective vaccine vectors. These rLCMV vaccines elicited CTL responses that were equivalent to or greater than those elicited by recombinant adenovirus 5 or recombinant vaccinia virus in their magnitude and cytokine profiles, and they exhibited more effective protection in several models. In contrast to recombinant adenovirus 5, rLCMV failed to elicit vector-specific antibody immunity, which facilitated re-administration of the same vector for booster vaccination. In addition, rLCMV elicited T helper type 1 CD4(+) T cell responses and protective neutralizing antibodies to vaccine antigens. These features, together with low seroprevalence in humans, suggest that rLCMV may show utility as a vaccine platform against infectious diseases and cancer.	[Flatz, Lukas; Bergthaler, Andreas; Fernandez, Marylise; Johnson, Susan; Siegrist, Claire-Anne; Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Flatz, Lukas; Hegazy, Ahmed N.; Bergthaler, Andreas; Verschoor, Admar; van den Broek, Maries; Loehning, Max; Pinschewer, Daniel D.] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Flatz, Lukas; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hegazy, Ahmed N.; Radbruch, Andreas; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Hegazy, Ahmed N.; Radbruch, Andreas; Loehning, Max] Deutsch Rheuma Forschungszentrum, Berlin, Germany; [Bergthaler, Andreas] Inst Syst Biol, Seattle, WA USA; [Verschoor, Admar] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Claus, Christina; Ochsenbein, Adrian F.] Univ Bern, Dept Clin Res, Bern, Switzerland; [Fernandez, Marylise; Johnson, Susan; Lambert, Paul-Henri; Siegrist, Claire-Anne; Pinschewer, Daniel D.] Univ Geneva, World Hlth Org Collaborating Ctr Neonatal Vaccino, Geneva, Switzerland; [Gattinoni, Luca; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kreppel, Florian; Kochanek, Stefan] Univ Ulm, Div Gene Therapy, Ulm, Germany; [van den Broek, Maries] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Levy, Frederic] Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Dept Pediat, Geneva, Switzerland	University of Geneva; University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Institute for Systems Biology (ISB); Technical University of Munich; University of Bern; University of Geneva; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ulm University; University of Zurich; University Zurich Hospital; Ludwig Institute for Cancer Research; University of Geneva	Pinschewer, DD (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	lukas.flatz@gmail.com; daniel.pinschewer@gmx.ch	van den Broek, Maries/L-6532-2019; Löhning, Max/AAL-2967-2021; Bergthaler, Andreas/ABG-5047-2020; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Gattinoni, Luca/A-2281-2008	Löhning, Max/0000-0001-6382-7281; Bergthaler, Andreas/0000-0003-0597-1976; Gattinoni, Luca/0000-0003-2239-3282; Radbruch, Andreas/0000-0001-5753-0000; Hegazy, Ahmed N./0000-0002-2946-8251; Restifo, Nicholas P./0000-0003-4229-4580; Ochsenbein, Adrian/0000-0003-1773-5436; Pinschewer, Daniel/0000-0002-1594-3189	Schweizerische Stiftung fur medizinisch-biologische Stipendien; German Research Foundation [GRAKO1121]; Volkswagen Foundation; Boehringer Ingelheim Fonds; Roche Research Foundation; Swiss National Science Foundation [PP00A-114913, 3100A0-104067/1]; NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005002] Funding Source: NIH RePORTER	Schweizerische Stiftung fur medizinisch-biologische Stipendien; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Hengartner and R. Zinkernagel for critical comments, suggestions, discussions and long-term support; E. Horvath for technical assistance; S. A. Rosenberg and J. R. Wunderlich for samples from patients with melanoma; M. Roederer and K. Foulds for reagents and flow cytometry support; A. Oxenius, R. Sprri and N. Joller for providing access to their flow cytometry facility; A. Pegu, R. Roychoudhuri and C. Cheng for discussions and advice on human DC cultures; D. von Laer (Georg-Speyer-Haus) for plasmid M369 and GP-expressing 293T cells; H. Shen (University of Pennsylvania School of Medicine) for rLM-OVA; M. Groettrup (University of Constance) for VACC-OVA, originally generated by J. Yewdell (National Institute of Allergy and Infectious Diseases); and R. Schirmbeck (University of Ulm) for StT-OVA-G cDNA. L. F. was supported by a fellowship of the Schweizerische Stiftung fur medizinisch-biologische Stipendien. A. N. H. is a fellow of GRAKO1121 of the German Research Foundation. M. L. is a Lichtenberg fellow funded by the Volkswagen Foundation. A. B. was supported by a PhD scholarship of the Boehringer Ingelheim Fonds and by a post-doctoral fellowship of the Roche Research Foundation. D. D. P. holds a stipendiary professorship of the Swiss National Science Foundation (PP00A-114913) and was supported by grant 3100A0-104067/1 of the Swiss National Science Foundation.	Anton LC, 1998, J IMMUNOL, V160, P4859; Bellier B, 2006, VACCINE, V24, P2643, DOI 10.1016/j.vaccine.2005.11.034; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Lamballerie X, 2007, TRANSFUSION, V47, P172, DOI 10.1111/j.1537-2995.2007.01081.x; Elbers ARW, 1999, VET QUART, V21, P50, DOI 10.1080/01652176.1999.9694991; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; HANY M, 1989, EUR J IMMUNOL, V19, P417, DOI 10.1002/eji.1830190302; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jensen ER, 1997, IMMUNOL REV, V158, P147, DOI 10.1111/j.1600-065X.1997.tb01001.x; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Lledo L, 2003, J MED VIROL, V70, P273, DOI 10.1002/jmv.10389; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Matter M, 2007, CANCER RES, V67, P7467, DOI 10.1158/0008-5472.CAN-06-4372; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Pinschewer DD, 2003, P NATL ACAD SCI USA, V100, P7895, DOI 10.1073/pnas.1332709100; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Seiler P, 1998, J EXP MED, V187, P649, DOI 10.1084/jem.187.4.649; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; STEPHENSEN CB, 1992, J MED VIROL, V38, P27, DOI 10.1002/jmv.1890380107; Valmori D, 2000, J IMMUNOL, V164, P1125, DOI 10.4049/jimmunol.164.2.1125; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306	40	104	119	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					339	U142		10.1038/nm.2104	http://dx.doi.org/10.1038/nm.2104			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20139992	Green Accepted, Green Published			2022-12-25	WOS:000275289500042
J	Hawrylowicz, C; Ryanna, K				Hawrylowicz, Catherine; Ryanna, Kimuli			BENCH TO BEDSIDE The early beginnings	NATURE MEDICINE			English	Editorial Material							ASTHMA; DISEASE; PREVENTION; MICE		[Hawrylowicz, Catherine; Ryanna, Kimuli] Kings Coll London, UK Med Res Council, London WC2R 2LS, England; [Hawrylowicz, Catherine; Ryanna, Kimuli] Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hawrylowicz, C (corresponding author), Kings Coll London, UK Med Res Council, London WC2R 2LS, England.	catherine.hawrylowicz@kcl.ac.uk; kimuli.ryanna@kcl.ac.uk	Hawrylowicz, Catherine/Q-8483-2017	Hawrylowicz, Catherine/0000-0002-2337-7463				Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Devereux G, 2007, PEDIATR PULM, V42, P663, DOI 10.1002/ppul.20640; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Holt PG, 2007, CURR OPIN ALLERGY CL, V7, P547, DOI 10.1097/ACI.0b013e3282f14a17; Johannsen H, 2009, CLIN EXP ALLERGY, V39, P1801, DOI 10.1111/j.1365-2222.2009.03368.x; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Ozkan S, 2010, FERTIL STERIL, V94, P1314, DOI 10.1016/j.fertnstert.2009.05.019; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	13	14	14	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					274	275		10.1038/nm0310-274	http://dx.doi.org/10.1038/nm0310-274			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20208515				2022-12-25	WOS:000275289500031
J	Manganaro, L; Lusic, M; Gutierrez, MI; Cereseto, A; Del Sal, G; Giacca, M				Manganaro, Lara; Lusic, Marina; Gutierrez, Maria Ines; Cereseto, Anna; Del Sal, Giannino; Giacca, Mauro			Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4(+) T lymphocytes	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PIN1-DEPENDENT PROLYL ISOMERIZATION; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; VIRAL-DNA; CELLS; INFECTION; PHOSPHORYLATION; REPLICATION; ENTRY	Long-standing evidence indicates that quiescent human peripheral blood T lymphocytes (PBLs) do not support efficient HIV infection. In resting PBLs, reverse transcription of viral RNA takes longer than in activated cells(1), partially because formation of the late products of reverse transcription is decreased by RNA binding by apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G)(2). In a subsequent step, integration of the viral complementary DNA that is eventually formed is markedly impaired(3,4). Here we show that cellular c-Jun N-terminal kinase (JNK), an enzyme that is not expressed in resting CD4(+) T cells, regulates permissiveness to HIV-1 infection, and we unravel a new, sequential post-translational pathway of protein modification that regulates viral DNA integration. We found that, in activated T lymphocytes, viral integrase, which mediates HIV-1 cDNA integration into the host cell genome, is phosphorylated by JNK on a highly conserved serine residue in its core domain. Phosphorylated integrase, in turn, becomes a substrate for the cellular peptidyl prolyl-isomerase enzyme Pin1, which catalyzes a conformational modification of integrase. These concerted activities increase integrase stability and are required for efficient HIV-1 integration and infection. Lack of these modifications restricts viral infection in nonactivated, primary CD4(+) T lymphocytes.	[Manganaro, Lara; Lusic, Marina; Gutierrez, Maria Ines; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Trieste, Italy; [Cereseto, Anna] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy; [Del Sal, Giannino] Lab Nazl Consorzio Interuniv Biotechnol, Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Scuola Normale Superiore di Pisa; University of Trieste	Giacca, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Area Sci Pk, Trieste, Italy.	lusic@icgeb.org; giacca@icgeb.org	Manganaro, Lara/AAL-8632-2020; Lusic, Marina/AAS-9704-2020; Giacca, Mauro/J-9287-2016	Manganaro, Lara/0000-0003-2743-2658; Lusic, Marina/0000-0002-0120-3569; Giacca, Mauro/0000-0003-2927-7225; DEL SAL, GIANNINO/0000-0003-2185-6003; Cereseto, Anna/0000-0003-4453-2597	Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy; Associazione Italiana per la Ricerca sul Cancro	Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We wish to thank A. Engelman (Dana-Farber Cancer Institute) for the pFlag-IN codon-optimized expression vector, L. Collavin (Laboratorio Nazionale CIB and University of Trieste) for the p-Cs2-JNK plasmid and F. Kirchhoff (Institute of Molecular Virology, Universitatsklinikum Ulm) for the HIV-2-Rod Luc clone. We are grateful to S. Kerbavcic for excellent editorial assistance and to M. Sturnega for the technical support in raising the rabbit phospho-integrase-specific antibody. This work was supported by grants from the Italian National Research Programme on AIDS of the Istituto Superiore di Sanita, Italy to M. G. and from the Associazione Italiana per la Ricerca sul Cancro to G. D. S.	Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Tan WJ, 2004, J VIROL, V78, P1301, DOI 10.1128/JVI.78.3.1301-1313.2004; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	39	82	85	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2010	16	3					329	U128		10.1038/nm.2102	http://dx.doi.org/10.1038/nm.2102			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20173753				2022-12-25	WOS:000275289500040
J	Petersen, GM; Amundadottir, L; Fuchs, CS; Kraft, P; Stolzenberg-Solomon, RZ; Jacobs, KB; Arslan, AA; Bueno-de-Mesquita, HB; Gallinger, S; Gross, M; Helzlsouer, K; Holly, EA; Jacobs, EJ; Klein, AP; LaCroix, A; Li, DH; Mandelson, MT; Olson, SH; Risch, HA; Zheng, W; Albanes, D; Bamlet, WR; Berg, CD; Boutron-Ruault, MC; Buring, JE; Bracci, PM; Canzian, F; Clipp, S; Cotterchio, M; de Andrade, M; Duell, EJ; Gaziano, JM; Giovannucci, EL; Goggins, M; Hallmans, G; Hankinson, SE; Hassan, M; Howard, B; Hunter, DJ; Hutchinson, A; Jenab, M; Kaaks, R; Kooperberg, C; Krogh, V; Kurtz, RC; Lynch, SM; McWilliams, RR; Mendelsohn, JB; Michaud, DS; Parikh, H; Patel, AV; Peeters, PHM; Rajkovic, A; Riboli, E; Rodriguez, L; Seminara, D; Shu, XO; Thomas, G; Tjonneland, A; Tobias, GS; Trichopoulos, D; Van Den Eeden, SK; Virtamo, J; Wactawski-Wende, J; Wang, ZM; Wolpin, BM; Yu, H; Yu, K; Zeleniuch-Jacquotte, A; Fraumeni, JF; Hoover, RN; Hartge, P; Chanock, SJ				Petersen, Gloria M.; Amundadottir, Laufey; Fuchs, Charles S.; Kraft, Peter; Stolzenberg-Solomon, Rachael Z.; Jacobs, Kevin B.; Arslan, Alan A.; Bueno-de-Mesquita, H. Bas; Gallinger, Steven; Gross, Myron; Helzlsouer, Kathy; Holly, Elizabeth A.; Jacobs, Eric J.; Klein, Alison P.; LaCroix, Andrea; Li, Donghui; Mandelson, Margaret T.; Olson, Sara H.; Risch, Harvey A.; Zheng, Wei; Albanes, Demetrius; Bamlet, William R.; Berg, Christine D.; Boutron-Ruault, Marie-Christine; Buring, Julie E.; Bracci, Paige M.; Canzian, Federico; Clipp, Sandra; Cotterchio, Michelle; de Andrade, Mariza; Duell, Eric J.; Gaziano, J. Michael; Giovannucci, Edward L.; Goggins, Michael; Hallmans, Goran; Hankinson, Susan E.; Hassan, Manal; Howard, Barbara; Hunter, David J.; Hutchinson, Amy; Jenab, Mazda; Kaaks, Rudolf; Kooperberg, Charles; Krogh, Vittorio; Kurtz, Robert C.; Lynch, Shannon M.; McWilliams, Robert R.; Mendelsohn, Julie B.; Michaud, Dominique S.; Parikh, Hemang; Patel, Alpa V.; Peeters, Petra H. M.; Rajkovic, Aleksandar; Riboli, Elio; Rodriguez, Laudina; Seminara, Daniela; Shu, Xiao-Ou; Thomas, Gilles; Tjonneland, Anne; Tobias, Geoffrey S.; Trichopoulos, Dimitrios; Van Den Eeden, Stephen K.; Virtamo, Jarmo; Wactawski-Wende, Jean; Wang, Zhaoming; Wolpin, Brian M.; Yu, Herbert; Yu, Kai; Zeleniuch-Jacquotte, Anne; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Hartge, Patricia; Chanock, Stephen J.			A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33	NATURE GENETICS			English	Article							BASE-LINE CHARACTERISTICS; RECOMBINATION HOTSPOTS; WOMENS HEALTH; BREAST-CANCER; RISK; GENE; VARIANTS; TELOMERASE; CELLS; LUNG	We conducted a genome-wide association study of pancreatic cancer in 3,851 affected individuals (cases) and 3,934 unaffected controls drawn from 12 prospective cohort studies and 8 case-control studies. Based on a logistic regression model for genotype trend effect that was adjusted for study, age, sex, self-described ancestry and five principal components, we identified eight SNPs that map to three loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Two correlated SNPs, rs9543325 (P = 3.27 x 10(-11), per-allele odds ratio (OR) 1.26, 95% CI 1.18-1.35) and rs9564966 (P = 5.86 x 10(-8), per-allele OR 1.21, 95% CI 1.13-1.30), map to a nongenic region on chromosome 13q22.1. Five SNPs on 1q32.1 map to NR5A2, and the strongest signal was at rs3790844 (P = 2.45 x 10(-10), per-allele OR 0.77, 95% CI 0.71-0.84). A single SNP, rs401681 (P = 3.66 x 10(-7), per-allele OR 1.19, 95% CI 1.11-1.27), maps to the CLPTM1L-TERT locus on 5p15.33, which is associated with multiple cancers. Our study has identified common susceptibility loci for pancreatic cancer that warrant follow-up studies.	[Amundadottir, Laufey; Parikh, Hemang; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Petersen, Gloria M.; Bamlet, William R.; de Andrade, Mariza; McWilliams, Robert R.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Fuchs, Charles S.; Wolpin, Brian M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fuchs, Charles S.; Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Giovannucci, Edward L.; Hankinson, Susan E.; Hunter, David J.; Michaud, Dominique S.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD USA; [Arslan, Alan A.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Inst Canc, New York, NY USA; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gross, Myron] Univ Minnesota, Dept Lab Med & Pathol, Sch Med, Minneapolis, MN 55455 USA; [Helzlsouer, Kathy] Mercy Med Ctr, Prevent & Res Ctr, Baltimore, MD USA; [Holly, Elizabeth A.; Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jacobs, Eric J.; Patel, Alpa V.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Klein, Alison P.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Res Ctr, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [LaCroix, Andrea; Mandelson, Margaret T.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Li, Donghui; Hassan, Manal] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Mandelson, Margaret T.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA; [Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Risch, Harvey A.; Yu, Herbert] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Boutron-Ruault, Marie-Christine] Univ Paris Sud, INSERM, Inst Gustave Roussy, Villejuif, France; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Dept Aging, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Clipp, Sandra] George W Comstock Ctr Publ Hlth Res & Prevent, Johns Hopkins Bloomberg Sch Publ Hlth, Hagerstown, MD USA; [Cotterchio, Michelle] Univ Toronto, Canc Care Ontario & Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Duell, Eric J.] Catalan Inst Oncol, Barcelona, Spain; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Aging, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Cardiovasc Dis, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Phys Hlth Study, Div Prevent Med, Dept Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Howard, Barbara] Georgetown Univ, MedStar Res Inst, Hyattsville, MD USA; [Krogh, Vittorio] Fdn IRCCS, Ist Nazl Tumoridi Milano, Nutr Epidemiol Unit, Milan, Italy; [Kurtz, Robert C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lynch, Shannon M.; Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Michaud, Dominique S.; Peeters, Petra H. M.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London, England; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rajkovic, Aleksandar] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Biol, Pittsburgh, PA USA; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Thomas, Gilles] Ctr Leon Berard, INSERM, F-69373 Lyon, France; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Van Den Eeden, Stephen K.] Kaiser Permanente, Div Res, Oakland, CA USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; New York University; New York University; New York University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Minnesota System; University of Minnesota Twin Cities; Mercy Medical Center - Maryland; University of California System; University of California San Francisco; American Cancer Society; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cancer Care Ontario; University of Toronto; Catalan Institute of Oncology; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Umea University; Georgetown University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Utrecht University; Utrecht University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Danish Cancer Society; Academy of Athens; Kaiser Permanente; Finland National Institute for Health & Welfare; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chanock, SJ (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	zhang, weihua/GXV-1334-2022; Stolzenberg-Solomon, Rachael/Y-9280-2018; Albanes, Demetrius/B-9749-2015; Canzian, Federico/I-2804-2014; Boutron-Ruault, Marie-Christine/H-3936-2014; Wactawski-Wende, Jean/AGH-5457-2022; Wang, Zhaoming/R-5527-2018; Krogh, Vittorio/AAA-9171-2019; Amundadottir, Laufey T/L-7656-2016; Michaud, Dominique S/I-5231-2014; Tobias, Geoffrey S/M-4135-2016; Parikh, Hemang/AAY-7174-2021; Gallinger, Steven/E-4575-2013; Zheng, Wei/O-3351-2013; Krogh, Vittorio/K-2628-2016	Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Wactawski-Wende, Jean/0000-0003-3096-9595; Wang, Zhaoming/0000-0001-7556-3869; Krogh, Vittorio/0000-0003-0122-8624; Amundadottir, Laufey T/0000-0003-1859-8971; Tobias, Geoffrey S/0000-0002-2878-8253; Zheng, Wei/0000-0003-1226-070X; Krogh, Vittorio/0000-0003-0122-8624; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Olson, Sara/0000-0003-0182-2754; Arslan, Alan/0000-0002-7775-8085; Canzian, Federico/0000-0002-4261-4583; Jenab, Mazda/0000-0002-0573-1852; Riboli, Elio/0000-0001-6795-6080; Jacobs, Kevin/0000-0002-4657-6473; Bamlet, William/0000-0003-2903-1284; Duell, Eric J/0000-0001-5256-0163; Tjonneland, Anne/0000-0003-4385-2097	Intramural NIH HHS [ZIA CP010193-03] Funding Source: Medline; NCI NIH HHS [P50 CA062924-150011, P50 CA062924-160011, P50 CA062924-140011, R37 CA070867, R01 CA097193, P50 CA062924-130011, R01 CA082729, K07 CA140790, P50 CA102701, R01 CA124908, P50 CA062924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA062924, R37CA070867, K07CA140790, R01CA124908, P50CA102701, R01CA082729, ZIACP010193, R01CA097193] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Duell EJ, 2008, CANCER EPIDEM BIOMAR, V17, P1470, DOI 10.1158/1055-9965.EPI-07-2797; Eppel A, 2007, INT J CANCER, V121, P2241, DOI 10.1002/ijc.22884; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Ferlay J, 2004, IARC CANC BASE; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gallicchio L, 2008, AM J EPIDEMIOL, V167, P807, DOI 10.1093/aje/kwm378; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee YK, 2008, FRONT BIOSCI, V13, P5950, DOI 10.2741/3128; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li N, 2003, GENETICS, V165, P2213; Li Y, 2007, AM J HUM GENET, V80, P705, DOI 10.1086/513205; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Olson SH, 2007, CANCER DETECT PREV, V31, P345, DOI 10.1016/j.cdp.2007.10.002; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Risch HA, 2003, JNCI-J NATL CANCER I, V95, P948, DOI 10.1093/jnci/95.13.948; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi C, 2009, ARCH PATHOL LAB MED, V133, P365, DOI 10.1043/1543-2165-133.3.365; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolpin BM, 2007, CANCER RES, V67, P7923, DOI 10.1158/0008-5472.CAN-07-0373; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228; Zeleniuch-Jacquotte A, 2005, INT J CANCER, V114, P323, DOI 10.1002/ijc.20694; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	63	450	455	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					224	U29		10.1038/ng.522	http://dx.doi.org/10.1038/ng.522			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101243	Green Accepted			2022-12-25	WOS:000274912400010
J	Geisler, S; Holmstrom, KM; Skujat, D; Fiesel, FC; Rothfuss, OC; Kahle, PJ; Springer, W				Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter			PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-PROTEIN LIGASE; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CELL-DEATH; PINK1; DEGRADATION; MUTATIONS; AUTOPHAGY; DOMAIN; GENE	Parkinson's disease is the most common neurodegenerative movement disorder. Mutations in PINK1 and PARKIN are the most frequent causes of recessive Parkinson's disease. However, their molecular contribution to pathogenesis remains unclear. Here, we reveal important mechanistic steps of a PINK1/Parkin-directed pathway linking mitochondrial damage, ubiquitylation and autophagy in non-neuronal and neuronal cells. PINK1 kinase activity and its mitochondrial localization sequence are prerequisites to induce translocation of the E3 ligase Parkin to depolarized mitochondria. Subsequently, Parkin mediates the formation of two distinct poly-ubiquitin chains, linked through Lys 63 and Lys 27. In addition, the autophagic adaptor p62/SQSTM1 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria. Strikingly, we identified VDAC1 (voltage-dependent anion channel 1) as a target for Parkin-mediated Lys 27 poly-ubiquitylation and mitophagy. Moreover, pathogenic Parkin mutations interfere with distinct steps of mitochondrial translocation, ubiquitylation and/or final clearance through mitophagy. Thus, our data provide functional links between PINK1, Parkin and the selective autophagy of mitochondria, which is implicated in the pathogenesis of Parkinson's disease.	[Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Kahle, Philipp J.; Springer, Wolfdieter] Univ Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Geisler, Sven; Holmstroem, Kira M.; Skujat, Diana; Fiesel, Fabienne C.; Rothfuss, Oliver C.; Kahle, Philipp J.; Springer, Wolfdieter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de; wolfdieter.springer@klinikum.uni-tuebingen.de	Holmstrom, Kira/G-1158-2010	Fiesel, Fabienne/0000-0002-1919-9676; Holmstrom, Kira/0000-0001-6434-7909; Springer, Wolfdieter/0000-0002-1178-3149	Medical Faculty of the University of Tubingen [1667-0-0, 1842-0-0]; German National Genome Research Network [01GS08134]; Hertie Foundation; European Union research program FP6	Medical Faculty of the University of Tubingen; German National Genome Research Network; Hertie Foundation; European Union research program FP6	We are grateful to O. Corti and R. Baer for providing Parkin and ubiquitin mutants, and to R. de Silva for providing the pDsRed2-Mito construct. We thank Thomas Gasser for support. This work was supported by grants from the fortune-program of the Medical Faculty of the University of Tubingen to W. S. (1667-0-0 and 1842-0-0), by the German National Genome Research Network (NGFNplus, 01GS08134) to P. J. K., and by the Hertie Foundation. K. M. H. is a NEUROTRAIN Early Stage Research Training fellow funded through the European Union research program FP6.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	39	1920	1988	16	464	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					119	U70		10.1038/ncb2012	http://dx.doi.org/10.1038/ncb2012			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098416				2022-12-25	WOS:000274139400006
J	Hashimoto, M; Shinohara, K; Wang, JB; Ikeuchi, S; Yoshiba, S; Meno, C; Nonaka, S; Takada, S; Hatta, K; Wynshaw-Boris, A; Hamada, H				Hashimoto, Masakazu; Shinohara, Kyosuke; Wang, Jianbo; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Nonaka, Shigenori; Takada, Shinji; Hatta, Kohei; Wynshaw-Boris, Anthony; Hamada, Hiroshi			Planar polarization of node cells determines the rotational axis of node cilia	NATURE CELL BIOLOGY			English	Article							LEFT-RIGHT ASYMMETRY; MOUSE; FLOW; POLARITY; SEGMENTATION; ORIENTATION; MAINTENANCE; EXPRESSION; GENERATION; FLUID	Rotational movement of the node cilia generates a leftward fluid flow in the mouse embryo(1) because the cilia are posteriorly tilted(2,3). However, it is not known how anterior-posterior information is translated into the posterior tilt of the node cilia. Here, we show that the basal body of node cilia is initially positioned centrally but then gradually shifts toward the posterior side of the node cells. Positioning of the basal body and unidirectional flow were found to be impaired in compound mutant mice lacking Dvl genes. Whereas the basal body was normally positioned in the node cells of Wnt3a(-/-) embryos, inhibition of Rac1, a component of the noncanonical Wnt signalling pathway, impaired the polarized localization of the basal body in wild-type embryos. Dvl2 and Dvl3 proteins were found to be localized to the apical side of the node cells, and their location was polarized to the posterior side of the cells before the posterior positioning of the basal body. These results suggest that posterior positioning of the basal body, which provides the posterior tilt to node cilia, is determined by planar polarization mediated by noncanonical Wnt signalling.	[Hashimoto, Masakazu; Shinohara, Kyosuke; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Hamada, Hiroshi] Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hashimoto, Masakazu; Shinohara, Kyosuke; Ikeuchi, Shingo; Yoshiba, Satoko; Meno, Chikara; Hamada, Hiroshi] Japan Sci & Technol Corp JST, CREST, Suita, Osaka 5650871, Japan; [Wang, Jianbo; Wynshaw-Boris, Anthony] Univ Calif San Diego, Dept Pediat & Med, La Jolla, CA 92093 USA; [Nonaka, Shigenori] Natl Inst Basic Biol, Dev Biol Sect, Okazaki, Aichi 4448585, Japan; [Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Hatta, Kohei] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Osaka University; Japan Science & Technology Agency (JST); University of California System; University of California San Diego; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Hyogo; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hamada, H (corresponding author), Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	wynshawborist@peds.ucsf.edu; hamada@fbs.osaka-u.ac.jp	Yoshiba, Satoko/AAD-1546-2019; Nonaka, Shigenori/I-2132-2013; Hamada, Hiroshi/N-6374-2015; Shinohara, Kyosuke/I-1470-2016; Shinohara, Kyosuke/AAU-2471-2020	Nonaka, Shigenori/0000-0002-8093-0325; Hamada, Hiroshi/0000-0002-7196-5948; Shinohara, Kyosuke/0000-0002-6350-1684; Takada, Shinji/0000-0003-4125-6056; Yoshiba, Satoko/0000-0002-9415-3619	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institutes of Health [HD43173]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043173] Funding Source: NIH RePORTER	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Gleeson (University of California, San Diego) for Centrin2-EGFP transgenic mice, K. Nakao (RIKEN, CDB) for KikGR mice, S. Piccolo (University of Padua) for BAT-gal, Y. Ikawa and S. Ohishi (Osaka University) for technical assistance and J. Axelrod and D. Antic (UCSF) for communicating their results on Prickle2 before publication. This work was supported by a grant from CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. H.) as well as grants from the National Institutes of Health (HD43173) and March of Dimes (to A. W.-B.).	BLUM M, 2008, SEMIN CELL DEV BIOL; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P194, DOI 10.1016/j.semcdb.2006.05.003; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Raffel M., 1998, EXP FLUID MECH; Shinohara K, 2004, MEAS SCI TECHNOL, V15, P1965, DOI 10.1088/0957-0233/15/10/003; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	26	148	154	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					170	U172		10.1038/ncb2020	http://dx.doi.org/10.1038/ncb2020			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20098415				2022-12-25	WOS:000274139400011
J	Cooney, R; Baker, J; Brain, O; Danis, B; Pichulik, T; Allan, P; Ferguson, DJP; Campbell, BJ; Jewell, D; Simmons, A				Cooney, Rachel; Baker, John; Brain, Oliver; Danis, Benedicte; Pichulik, Tica; Allan, Philip; Ferguson, David J. P.; Campbell, Barry J.; Jewell, Derek; Simmons, Alison			NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation	NATURE MEDICINE			English	Article							INVASIVE ESCHERICHIA-COLI; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SUSCEPTIBILITY; INFECTION; ATG16L1; LOCI	Nucleotide-binding oligomerization domain-containing-2 (NOD2) acts as a bacterial sensor in dendritic cells (DCs), but it is not clear how bacterial recognition links with antigen presentation after NOD2 stimulation. NOD2 variants are associated with Crohn's disease, where breakdown in self-recognition of commensal bacteria leads to gastrointestinal inflammation. Here we show NOD2 triggering by muramyldipeptide induces autophagy in DCs. This effect requires receptor-interacting serine-threonine kinase-2 (RIPK-2), autophagy-related protein-5 (ATG5), ATG7 and ATG16L1 but not NLR family, pyrin domain containing-3 (NALP3). We show that NOD2-mediated autophagy is required for both bacterial handling and generation of major histocompatibility complex (MHC) class II antigen-specific CD4(+) T cell responses in DCs. DCs from individuals with Crohn's disease expressing Crohn's disease-associated NOD2 or ATG16L1 risk variants are defective in autophagy induction, bacterial trafficking and antigen presentation. Our findings link two Crohn's disease-associated susceptibility genes in a single functional pathway and reveal defects in this pathway in Crohn's disease DCs that could lead to bacterial persistence via impaired lysosomal destruction and immune mediated clearance.	[Cooney, Rachel; Baker, John; Brain, Oliver; Danis, Benedicte; Pichulik, Tica; Allan, Philip; Simmons, Alison] John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Cooney, Rachel; Brain, Oliver; Allan, Philip; Jewell, Derek; Simmons, Alison] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England; [Ferguson, David J. P.] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Campbell, Barry J.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England	University of Oxford; University of Oxford; University of Oxford; University of Liverpool	Simmons, A (corresponding author), John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	alison.simmons@imm.ox.ac.uk		Simmons, Alison/0000-0003-3454-0710; Ferguson, David/0000-0001-5045-819X; Cooney, Rachel/0000-0003-3710-157X; Allan, Philip/0000-0003-2682-772X	UK Medical Research Council; UK Higher Education Funding Council; Oxford National Institute for Health Research Biomedical Research Centre; National Institute of Health Research Specialist Biomedical Research Centre in Microbial Disease [01CD1]; Action Medical Research; Digestive Disorders Foundation and National Association for Crohn's and Colitis and The Barbour Trust in Memory of Simon Ash; Fondation Philippe Weiner Maurice Anspach; Wellcome Trust	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Higher Education Funding Council; Oxford National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Health Research Specialist Biomedical Research Centre in Microbial Disease; Action Medical Research; Digestive Disorders Foundation and National Association for Crohn's and Colitis and The Barbour Trust in Memory of Simon Ash; Fondation Philippe Weiner Maurice Anspach; Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to acknowledge the previous researchers in our department involved in genotyping of the Oxford Crohn's disease cohort and thank A.-K. Simon and A. McMichael for helpful discussions. Most particularly, we would like to thank all of our donors who generously gave blood samples for this study. We are supported by grants from the UK Medical Research Council (J.B., T. P. and A. S.), the UK Higher Education Funding Council (A. S.), Oxford National Institute for Health Research Biomedical Research Centre (A. S.) and the National Institute of Health Research Specialist Biomedical Research Centre in Microbial Disease (01CD1) (B. J. C.), Action Medical Research (R. C.), Digestive Disorders Foundation and National Association for Crohn's and Colitis and The Barbour Trust in Memory of Simon Ash (O.B.), Fondation Philippe Weiner Maurice Anspach (B. D.) and the Wellcome Trust (P. A.). The GFP-LC3 construct was a kind gift from H. Mellor (University of Oxford) GFP-S. enterica typhimurium was a kind gift from D. Holden (Imperial College, University of London) and SL5338 pTECH1 was a kind gift from K. Turner (Sanger Centre).	Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	25	789	823	3	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2010	16	1					90	U128		10.1038/nm.2069	http://dx.doi.org/10.1038/nm.2069			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	541EA	19966812				2022-12-25	WOS:000273395500041
J	Giles, KE; Ghirlando, R; Felsenfeld, G				Giles, Keith E.; Ghirlando, Rodolfo; Felsenfeld, Gary			Maintenance of a constitutive heterochromatin domain in vertebrates by a Dicer-dependent mechanism	NATURE CELL BIOLOGY			English	Article							BETA-GLOBIN LOCUS; HUMAN-CELLS; RNA INTERFERENCE; GENE; TRANSCRIPTION; INSULATOR	The 16 kilobase (kb) heterochromatin domain between the chicken beta-globin locus and the folate receptor gene is used here to study the roles of RNA-dependent mechanisms and histone modifications in the maintenance of a constitutive heterochromatic structure. Inhibition of histone deacetylase (HDAC) activity is shown to both increase intergenic transcription and render the heterochromatin more accessible to MspI digestion. We show that short interfering RNA (siRNA)-mediated downregulation of the enzyme Dicer has similar effects: histone acetylation is increased, transcript levels rise and the compact chromatin structure becomes more accessible to restriction endonucleases. We also show that the chicken Argonaute 2 homologue binds the 16 kb region in a Dicer-dependent manner and is necessary for a condensed chromatin structure. Heterochromatic domains of this kind, which are widely distributed in vertebrate genomes, thus seem to be maintained in their condensed form by highly conserved mechanisms.	[Giles, Keith E.; Ghirlando, Rodolfo; Felsenfeld, Gary] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov	Ghirlando, Rodolfo/A-8880-2009		NIH, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK036151] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases.	Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Giles KE, 2004, RNA, V10, P299, DOI 10.1261/rna.2150604; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	15	43	43	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					94	U246		10.1038/ncb2010	http://dx.doi.org/10.1038/ncb2010			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010811	Green Accepted			2022-12-25	WOS:000272973800018
J	Idaghdour, Y; Czika, W; Shianna, KV; Lee, SH; Visscher, PM; Martin, HC; Miclaus, K; Jadallah, SJ; Goldstein, DB; Wolfinger, RD; Gibson, G				Idaghdour, Youssef; Czika, Wendy; Shianna, Kevin V.; Lee, Sang H.; Visscher, Peter M.; Martin, Hilary C.; Miclaus, Kelci; Jadallah, Sami J.; Goldstein, David B.; Wolfinger, Russell D.; Gibson, Greg			Geographical genomics of human leukocyte gene expression variation in southern Morocco	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; DETERMINANTS; ASSOCIATION; TRANSCRIPTION; DISCOVERY; PROTEIN; ORIGIN	Studies of the genetics of gene expression can identify expression SNPs (eSNPs) that explain variation in transcript abundance. Here we address the robustness of eSNP associations to environmental geography and population structure in a comparison of 194 Arab and Amazigh individuals from a city and two villages in southern Morocco. Gene expression differed between pairs of locations for up to a third of all transcripts, with notable enrichment of transcripts involved in ribosomal biosynthesis and oxidative phosphorylation. Robust associations were observed in the leukocyte samples: cis eSNPs (P < 10(-08)) were identified for 346 genes, and trans eSNPs (P < 10(-11)) for 10 genes. All of these associations were consistent both across the three sample locations and after controlling for ancestry and relatedness. No evidence of large-effect trans-acting mediators of the pervasive environmental influence was found; instead, genetic and environmental factors acted in a largely additive manner.	[Idaghdour, Youssef; Gibson, Greg] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Czika, Wendy; Miclaus, Kelci; Wolfinger, Russell D.] SAS Inst Inc, Cary, NC USA; [Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Lee, Sang H.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Martin, Hilary C.; Gibson, Greg] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Jadallah, Sami J.] HRH Prince Sultan Int Fdn Conservat & Dev Wildlif, Agadir, Morocco	University of North Carolina; North Carolina State University; SAS Institute Inc; Duke University; QIMR Berghofer Medical Research Institute; University of Queensland	Gibson, G (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	ggibson.uq@gmail.com	Goldstein, David/AAY-8125-2020; Visscher, Peter/ABB-6151-2020; Lee, Sang Hong/A-2569-2011	Visscher, Peter/0000-0002-2143-8760; Lee, Sang Hong/0000-0001-9701-2718	University of Queensland; Fulbright; ARC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061600] Funding Source: NIH RePORTER	University of Queensland(University of Queensland); Fulbright; ARC(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all of the study participants in Agadir, Ighrem and Boutroch, and numerous individuals who facilitated sample collection, in particular the Idaghdour family. D. Ge and A. Motsinger-Reif provided timely computational support, and we also thank S. Biswas and J. Akey for providing HapMap genotypes. Funding for the study was provided by the University of Queensland. Y. I. was supported by a Fulbright Fellowship and G. G. by an ARC Australian Professorial Fellowship.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Bosch E, 1997, HUM BIOL, V69, P295; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Coudray C, 2007, FORENSIC SCI INT, V167, P81, DOI 10.1016/j.forsciint.2006.01.003; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; IDAGHDOUR Y, 2009, THESIS N CAROLINA ST; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Kao CF, 2004, J BIOMED SCI, V11, P72, DOI 10.1159/000075291; Kefi R, 2005, ANTHROPOL-INT J HUM, V43, P1; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Pare G, 2008, PLOS GENET, V4; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	45	109	113	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					62	U79		10.1038/ng.495	http://dx.doi.org/10.1038/ng.495			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19966804	Green Accepted, Bronze			2022-12-25	WOS:000273055100017
J	Thomas, R; Apps, R; Qi, Y; Gao, XJ; Male, V; O'hUigin, C; O'Connor, G; Ge, DL; Fellay, J; Martin, JN; Margolick, J; Goedert, JJ; Buchbinder, S; Kirk, GD; Martin, MP; Telenti, A; Deeks, SG; Walker, BD; Goldstein, D; McVicar, DW; Moffett, A; Carrington, M				Thomas, Rasmi; Apps, Richard; Qi, Ying; Gao, Xiaojiang; Male, Victoria; O'hUigin, Colm; O'Connor, Geraldine; Ge, Dongliang; Fellay, Jacques; Martin, Jeffrey N.; Margolick, Joseph; Goedert, James J.; Buchbinder, Susan; Kirk, Gregory D.; Martin, Maureen P.; Telenti, Amalio; Deeks, Steven G.; Walker, Bruce D.; Goldstein, David; McVicar, Daniel W.; Moffett, Ashley; Carrington, Mary			HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C	NATURE GENETICS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-KILLER-CELLS; SINGLE AMINO-ACID; MONOCLONAL-ANTIBODIES; INHIBITORY RECEPTORS; HIV-1 INFECTION; AIDS; PROGRESSION; POLYMORPHISMS; INDIVIDUALS	A variant 35 kb upstream of the HLA-C gene (-35C/T) was previously shown to associate with HLA-C mRNA expression level and steady-state plasma HIV RNA levels. We genotyped this variant in 1,698 patients of European ancestry with HIV. Individuals with known seroconversion dates were used for disease progression analysis and those with longitudinal viral load data were used for viral load analysis. We further tested cell surface expression of HLA-C in normal donors using an HLA-C-specific antibody. We show that the -35C allele is a proxy for high HLA-C cell surface expression, and that individuals with high-expressing HLA-C alleles progress more slowly to AIDS and control viremia significantly better than individuals with low HLA-C expressing alleles. These data strongly implicate high HLA-C expression levels in more effective control of HIV-1, potentially through better antigen presentation to cytotoxic T lymphocytes or recognition and killing of infected cells by natural killer cells.	[Thomas, Rasmi; Qi, Ying; Gao, Xiaojiang; O'hUigin, Colm; Martin, Maureen P.; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21701 USA; [Apps, Richard; Male, Victoria; Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Ge, Dongliang; Fellay, Jacques; Goldstein, David] Duke Univ, Ctr Populat Genom & Pharmacogenet, Durham, NC USA; [Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Margolick, Joseph] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Goedert, James J.] Natl Canc Inst, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Rockville, MD USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [Deeks, Steven G.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Cambridge; Duke University; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); San Francisco Department of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Lausanne; San Francisco General Hospital Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Carrington, M (corresponding author), NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21701 USA.	carringm@mail.nih.gov	Ge, Dongliang/A-2073-2010; Telenti, Amalio/AAY-1674-2021; Fellay, Jacques/A-6681-2009; McVicar, Daniel/G-1970-2015; Moffett, Ashley/J-9754-2013; Thomas, Rasmi/AAI-4921-2020; Goldstein, David/AAY-8125-2020; VALLET, Yannick/F-9979-2011	Fellay, Jacques/0000-0002-8240-939X; McVicar, Daniel/0000-0002-1112-5111; Male, Victoria/0000-0001-5654-5083; O'Connor, Geraldine/0000-0002-7440-162X	National Cancer Institute, National Institutes of Health [HHSN261200800001E, N02-CP-55504, R01-DA04334, R01-DA12568]; Intramural Research Program of the NIH; National Cancer Institute, Center for Cancer Research; Bill & Melinda Gates Foundation; Swiss National Science Foundation; SCOPE; Clinical and Translational Sciences Award [UL1 RR024131]; Center for AIDS Research [P30 AI27763]; Cambridge Center for Trophoblast Research; NATIONAL CANCER INSTITUTE [ZICBC011237, ZIABC010747, ZIABC010791] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SCOPE; Clinical and Translational Sciences Award; Center for AIDS Research; Cambridge Center for Trophoblast Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contracts HHSN261200800001E, N02-CP-55504, R01-DA04334 and R01-DA12568. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This research was partially funded by a grant from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery. We would also like to acknowledge the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation, and the SCOPE study was funded by the UL1 RR024131 (Clinical and Translational Sciences Award) and P30 AI27763 (Center for AIDS Research) grants. R. A. is funded by the Cambridge Center for Trophoblast Research. We also thank R. Fernando and the Anthony Nolan Research Institute for the Luminex analysis.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; Apps R, 2008, IMMUNOLOGY, V124, P322, DOI 10.1111/j.1365-2567.2007.02789.x; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Jin X, 2002, J VIROL, V76, P12603, DOI 10.1128/JVI.76.24.12603-12610.2002; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lee N, 1998, J IMMUNOL, V160, P4951; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Winter CC, 1997, J IMMUNOL, V158, P4026; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	41	235	241	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1290	U46		10.1038/ng.486	http://dx.doi.org/10.1038/ng.486			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19935663	Green Accepted, Green Submitted			2022-12-25	WOS:000272144900009
J	Liu, GQ; Chen, XM; Bissler, JJ; Sinden, RR; Leffak, M				Liu, Guoqi; Chen, Xiaomi; Bissler, John J.; Sinden, Richard R.; Leffak, Michael			Replication-dependent instability at (CTG)center dot(CAG) repeat hairpins in human cells	NATURE CHEMICAL BIOLOGY			English	Article							DNA SECONDARY STRUCTURE; TRINUCLEOTIDE REPEAT; CTG REPEATS; SOMATIC MOSAICISM; GENOMIC CONTEXT; CGG REPEATS; MOUSE MODEL; EXPANSION; STRAND; TRANSCRIPTION	Instability of (CTG)center dot(CAG) microsatellite trinucleotide repeat (TNR) sequences is responsible for more than a dozen neurological or neuromuscular diseases. TNR instability during DNA synthesis is thought to involve slipped-strand or hairpin structures in template or nascent DNA strands, although direct evidence for hairpin formation in human cells is lacking. We have used targeted recombination to create a series of isogenic HeLa cell lines in which (CTG)center dot(CAG) repeats are replicated from an ectopic copy of the Myc (also known as c-myc) replication origin. In this system, the tendency of chromosomal (CTG)center dot(CAG) tracts to expand or contract was affected by origin location and the leading or lagging strand replication orientation of the repeats, and instability was enhanced by prolonged cell culture, increased TNR length and replication inhibition. Hairpin cleavage by synthetic zinc finger nucleases in these cells has provided the first direct evidence for the formation of hairpin structures during replication in vivo.	[Liu, Guoqi; Chen, Xiaomi; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Bissler, John J.] Cincinnati Childrens Hosp, Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA; [Sinden, Richard R.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	University System of Ohio; Wright State University Dayton; Cincinnati Children's Hospital Medical Center; Florida Institute of Technology	Liu, GQ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Michael.Leffak@wright.edu	Sinden, Richard/AAE-3086-2019	Bissler, John/0000-0001-9685-9183	Wright State University Boonshoft School of Medicine; US National Institutes of Health [GM53819, DK61458]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099874, R01GM053819] Funding Source: NIH RePORTER	Wright State University Boonshoft School of Medicine; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Pearson and D.G. Monckton for their comments on this work. This work was supported by a grant from the Wright State University Boonshoft School of Medicine to G.L. and by grants from the US National Institutes of Health to M.L. (GM53819) and to J.J.B. (DK61458).	Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; Rivera MLC, 2007, J TOXICOL ENV HEAL A, V70, P1713, DOI 10.1080/10937400601171241; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cleary JD, 2005, TRENDS GENET, V21, P272, DOI 10.1016/j.tig.2005.03.008; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gacy AM, 1998, BIOCHEMISTRY-US, V37, P9426, DOI 10.1021/bi980157s; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2004, MUTAT RES-FUND MOL M, V554, P95, DOI 10.1016/j.mrfmmm.2004.03.012; Hashem VI, 2002, MUTAT RES-FUND MOL M, V502, P25, DOI 10.1016/S0027-5107(02)00026-X; Jackson SM, 2005, GENE, V347, P35, DOI 10.1016/j.gene.2004.12.008; Khajavi M, 2001, HUM MOL GENET, V10, P855, DOI 10.1093/hmg/10.8.855; Lia AS, 1998, HUM MOL GENET, V7, P1285, DOI 10.1093/hmg/7.8.1285; Libby RT, 2003, HUM MOL GENET, V12, P41, DOI 10.1093/hmg/ddg006; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Malott M, 1999, MOL CELL BIOL, V19, P5685; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Potaman VN, 2003, J MOL BIOL, V326, P1095, DOI 10.1016/S0022-2836(03)00037-8; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Sinden RR, 2007, FRONT BIOSCI-LANDMRK, V12, P4788, DOI 10.2741/2427; Sinden Richard R., 2006, V19, P3; Spiro C, 2003, MOL CELL BIOL, V23, P6063, DOI 10.1128/MCB.23.17.6063-6074.2003; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; van den Broek WJAA, 2006, FEBS LETT, V580, P5208, DOI 10.1016/j.febslet.2006.08.059; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523	48	114	116	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					652	659		10.1038/NCHEMBIO.416	http://dx.doi.org/10.1038/NCHEMBIO.416			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20676085	Green Accepted			2022-12-25	WOS:000281084900008
J	Holt, N; Wang, JB; Kim, K; Friedman, G; Wang, XC; Taupin, V; Crooks, GM; Kohn, DB; Gregory, PD; Holmes, MC; Cannon, PM				Holt, Nathalia; Wang, Jianbin; Kim, Kenneth; Friedman, Geoffrey; Wang, Xingchao; Taupin, Vanessa; Crooks, Gay M.; Kohn, Donald B.; Gregory, Philip D.; Holmes, Michael C.; Cannon, Paula M.			Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo	NATURE BIOTECHNOLOGY			English	Article							VIRUS TYPE-1 INFECTION; STABLE GENE-TRANSFER; CD4(+) T-CELLS; ADENOSINE-DEAMINASE DEFICIENCY; ACTIVE ANTIRETROVIRAL THERAPY; SLEEPING-BEAUTY TRANSPOSON; HU MOUSE MODEL; CHEMOKINE RECEPTOR; LENTIVIRAL VECTOR; LYMPHOID-TISSUE	CCR5 is the major HIV-1 co-receptor, and individuals homozygous for a 32-bp deletion in CCR5 are resistant to infection by CCR5-tropic HIV-1. Using engineered zinc-finger nucleases (ZFNs), we disrupted CCR5 in human CD34(+) hematopoietic stem/progenitor cells (HSPCs) at a mean frequency of 17% of the total alleles in a population. This procedure produces both mono- and bi-allelically disrupted cells. ZFN-treated HSPCs retained the ability to engraft NOD/SCID/IL2 gamma(null) mice and gave rise to polyclonal multi-lineage progeny in which CCR5 was permanently disrupted. Control mice receiving untreated HSPCs and challenged with CCR5-tropic HIV-1 showed profound CD4(+) T-cell loss. In contrast, mice transplanted with ZFN-modified HSPCs underwent rapid selection for CCR5(-/-) cells, had significantly lower HIV-1 levels and preserved human cells throughout their tissues. The demonstration that a minority of CCR5(-/-) HSPCs can populate an infected animal with HIV-1-resistant, CCR5(-/-) progeny supports the use of ZFN-modified autologous hematopoietic stem cells as a clinical approach to treating HIV-1.	[Holt, Nathalia; Cannon, Paula M.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Wang, Jianbin; Kim, Kenneth; Friedman, Geoffrey; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci Inc, Richmond, CA USA; [Wang, Xingchao; Taupin, Vanessa] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Crooks, Gay M.; Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Southern California; Sangamo Therapeutics, Inc.; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cannon, PM (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	pcannon@usc.edu	Kohn, Donald/N-5085-2016	Kohn, Donald/0000-0003-1840-6087; Gregory, Philip/0000-0001-9249-2468	California HIV/AIDS Research; Saban Research Institute; National Heart, Lung, and Blood Institute [P01 HL73104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104] Funding Source: NIH RePORTER	California HIV/AIDS Research; Saban Research Institute; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank A. Cuddihy, S. Ge, R. Hollis and N. Smiley for expert technical assistance; C. Lutzko, V. Garcia, R. Akkina, B. Torbett and M. McCune for advice regarding humanized mice; and M. McCune for communicating unpublished data. This work was supported by funding from the California HIV/AIDS Research Project (P.M.C.), The Saban Research Institute (V.T.), and the National Heart, Lung, and Blood Institute P01 HL73104 (G.M.C., D.B.K. and P.M.C.).	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Anderson J, 2007, MOL THER, V15, P1182, DOI 10.1038/sj.mt.6300157; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bai JR, 2000, MOL THER, V1, P244, DOI 10.1006/mthe.2000.0038; Basu S, 2009, J IMMUNOL, V183, P7478, DOI 10.4049/jimmunol.0900542; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Bibikova M, 2002, GENETICS, V161, P1169; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Choudhary SK, 2005, J VIROL, V79, P458, DOI 10.1128/JVI.79.1.458-471.2005; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Dau B, 2009, DRUGS, V69, P31, DOI 10.2165/00003495-200969010-00003; Davis BR, 2009, IMMUNOL RES, V44, P127, DOI 10.1007/s12026-008-8091-4; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Hollis RP, 2006, EXP HEMATOL, V34, P1333, DOI 10.1016/j.exphem.2006.05.023; Hutter G, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-10; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Husman AD, 1999, J IMMUNOL, V163, P4597; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kantarci OH, 2005, J NEUROIMMUNOL, V169, P137, DOI 10.1016/j.jneuroim.2005.07.025; Krishnan A, 2001, BLOOD, V98, P3857, DOI 10.1182/blood.V98.13.3857; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LOKEN MR, 1990, CYTOMETRY, V11, P453, DOI 10.1002/cyto.990110402; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MARGOLICK JB, 2007, J ACQ IMMUN DEF SYND, V42, P620; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; Ogert RA, 2008, VIROLOGY, V373, P387, DOI 10.1016/j.virol.2007.12.009; Oh DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002747; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Rossol M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2733; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Soulie C, 2008, AIDS, V22, P2212, DOI 10.1097/QAD.0b013e328313bf9c; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Stoddart CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000766; Sumiyoshi T, 2009, HUM GENE THER, V20, P1607, DOI 10.1089/hum.2009.109; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Swan CH, 2006, J MED PRIMATOL, V35, P236, DOI 10.1111/j.1600-0684.2006.00172.x; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; Talal AH, 2001, J ACQ IMMUN DEF SYND, V26, P208, DOI 10.1097/00126334-200103010-00002; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Veazey RS, 2001, TRENDS IMMUNOL, V22, P626, DOI 10.1016/S1471-4906(01)02039-7; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005	74	526	590	5	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					839	U120		10.1038/nbt.1663	http://dx.doi.org/10.1038/nbt.1663			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20601939	Green Accepted, Green Submitted			2022-12-25	WOS:000280757500024
J	Beaty, TH; Murray, JC; Marazita, ML; Munger, RG; Ruczinski, I; Hetmanski, JB; Liang, KY; Wu, T; Murray, T; Fallin, MD; Redett, RA; Raymond, G; Schwender, H; Jin, SC; Cooper, ME; Dunnwald, M; Mansilla, MA; Leslie, E; Bullard, S; Lidral, AC; Moreno, LM; Menezes, R; Vieira, AR; Petrin, A; Wilcox, AJ; Lie, RT; Jabs, EW; Wu-Chou, YH; Chen, PK; Wang, H; Ye, XQ; Huang, SZ; Yeow, V; Chong, SS; Jee, SH; Shi, B; Christensen, K; Melbye, M; Doheny, KF; Pugh, EW; Ling, H; Castilla, EE; Czeizel, AE; Ma, L; Field, LL; Brody, L; Pangilinan, F; Mills, JL; Molloy, AM; Kirke, PN; Scott, JM; Arcos-Burgos, M; Scott, AF				Beaty, Terri H.; Murray, Jeffrey C.; Marazita, Mary L.; Munger, Ronald G.; Ruczinski, Ingo; Hetmanski, Jacqueline B.; Liang, Kung Yee; Wu, Tao; Murray, Tanda; Fallin, M. Daniele; Redett, Richard A.; Raymond, Gerald; Schwender, Holger; Jin, Sheng-Chih; Cooper, Margaret E.; Dunnwald, Martine; Mansilla, Maria A.; Leslie, Elizabeth; Bullard, Stephen; Lidral, Andrew C.; Moreno, Lina M.; Menezes, Renato; Vieira, Alexandre R.; Petrin, Aline; Wilcox, Allen J.; Lie, Rolv T.; Jabs, Ethylin W.; Wu-Chou, Yah Huei; Chen, Philip K.; Wang, Hong; Ye, Xiaoqian; Huang, Shangzhi; Yeow, Vincent; Chong, Samuel S.; Jee, Sun Ha; Shi, Bing; Christensen, Kaare; Melbye, Mads; Doheny, Kimberly F.; Pugh, Elizabeth W.; Ling, Hua; Castilla, Eduardo E.; Czeizel, Andrew E.; Ma, Lian; Field, L. Leigh; Brody, Lawrence; Pangilinan, Faith; Mills, James L.; Molloy, Anne M.; Kirke, Peadar N.; Scott, James M.; Arcos-Burgos, Mauricio; Scott, Alan F.			A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4	NATURE GENETICS			English	Article							INTERFERON-REGULATORY-FACTOR-6 IRF6; UNIFIED APPROACH; RELATIVES; COHORT; MARKER; TESTS	Case-parent trios were used in a genome-wide association study of cleft lip with and without cleft palate. SNPs near two genes not previously associated with cleft lip with and without cleft palate (MAFB, most significant SNP rs13041247, with odds ratio (OR) per minor allele = 0.704, 95% CI 0.635-0.778, P = 1.44 x 10(-11); and ABCA4, most significant SNP rs560426, with OR = 1.432, 95% CI 1.292-1.587, P = 5.01 x 10(-12)) and two previously identified regions (at chromosome 8q24 and IRF6) attained genome-wide significance. Stratifying trios into European and Asian ancestry groups revealed differences in statistical significance, although estimated effect sizes remained similar. Replication studies from several populations showed confirming evidence, with families of European ancestry giving stronger evidence for markers in 8q24, whereas Asian families showed stronger evidence for association with MAFB and ABCA4. Expression studies support a role for MAFB in palatal development.	[Beaty, Terri H.; Ruczinski, Ingo; Hetmanski, Jacqueline B.; Liang, Kung Yee; Wu, Tao; Murray, Tanda; Fallin, M. Daniele; Schwender, Holger; Jin, Sheng-Chih] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA; [Murray, Jeffrey C.; Dunnwald, Martine; Mansilla, Maria A.; Leslie, Elizabeth; Petrin, Aline] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Menezes, Renato; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA; [Munger, Ronald G.] Utah State Univ, Logan, UT 84322 USA; [Wu, Tao] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Redett, Richard A.; Raymond, Gerald; Jabs, Ethylin W.; Wang, Hong; Scott, Alan F.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bullard, Stephen; Lidral, Andrew C.; Moreno, Lina M.] Univ Iowa, Dept Orthodont, Iowa City, IA USA; [Wilcox, Allen J.] NIEHS, NIH, Durham, NC USA; [Lie, Rolv T.] Univ Bergen, Bergen, Norway; [Jabs, Ethylin W.; Ye, Xiaoqian] Mt Sinai Sch Med, New York, NY USA; [Wu-Chou, Yah Huei; Chen, Philip K.] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Ye, Xiaoqian] Wuhan Univ, Wuhan 430072, Peoples R China; [Huang, Shangzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yeow, Vincent] KK Womens & Childrens Hosp, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Singapore, Singapore 117548, Singapore; [Jee, Sun Ha] Yonsei Univ, Seoul 120749, South Korea; [Shi, Bing] Sichuan Univ, W China Sch Stomatol, Chengdu 610064, Peoples R China; [Christensen, Kaare] Univ So Denmark, Odense, Denmark; [Melbye, Mads] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Doheny, Kimberly F.; Pugh, Elizabeth W.; Ling, Hua] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; [Castilla, Eduardo E.] Fundacao Oswaldo Cruz FIOCRUZ, Dept Genet, Rio De Janeiro, Brazil; [Czeizel, Andrew E.] Fdn Community Control Hereditary Dis, Budapest, Hungary; [Ma, Lian] Beijing Univ, Sch Stomatol, Beijing 100871, Peoples R China; [Field, L. Leigh] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Brody, Lawrence; Pangilinan, Faith] NHGRI, NIH, Bethesda, MD 20892 USA; [Mills, James L.] NICHHD, NIH, Bethesda, MD 20892 USA; [Molloy, Anne M.; Scott, James M.] Trinity Coll Dublin, Dublin, Ireland; [Kirke, Peadar N.] Hlth Res Board, Dublin, Ireland; [Arcos-Burgos, Mauricio] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Johns Hopkins University; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; Utah State University; Peking University; Johns Hopkins University; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Icahn School of Medicine at Mount Sinai; Chang Gung Memorial Hospital; Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; KK Women's & Children's Hospital; National University of Singapore; Yonsei University; Sichuan University; University of Southern Denmark; Statens Serum Institut; Johns Hopkins University; Fundacao Oswaldo Cruz; Peking University; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Trinity College Dublin; Health Research Board - Ireland; University of Miami	Beaty, TH (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA.	tbeaty@jhsph.edu	Vargas Alfonso, Alba Lucia/E-1581-2015; Liang, Kung-Yee/F-8299-2011; Wilcox, Allen J/C-7723-2019; Leslie, Elizabeth/AAP-8941-2021; Petrin, Aline/I-1880-2019; Christensen, Kaare/C-2360-2009; Inagemp, Inct/J-9451-2013; Arcos-Burgos, Mauricio/H-1326-2017; Chong, Samuel S./D-8098-2015	Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Wilcox, Allen J/0000-0002-3376-1311; Leslie, Elizabeth/0000-0002-5735-1712; Petrin, Aline/0000-0003-2239-8120; Christensen, Kaare/0000-0002-5429-5292; Mills, James/0000-0003-4496-332X; melbye, mads/0000-0001-8264-6785; Jabs, Ethylin/0000-0001-8983-5466; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Molloy, Anne/0000-0002-1688-9049; Chong, Samuel S./0000-0002-1872-5937; Jin, Sheng Chih/0000-0002-5777-7262; Jee, Sun Ha/0000-0001-9519-3068	National Institute for Dental and Craniofacial Research [U01-DE-018993]; International Consortium to Identify Genes and Interactions Controlling Oral Clefts [2007 2009]; National Human Genome Research Institute (NHGRI); US National Institutes of Health (NIH) [HHSN268200782096C]; March of Dimes Basil O'Connor award [FY 98-0718]; Research Grant [6-FY01-61]; NIH [R03-AR-055313, P50-DE-16215, K99-DE-018441]; Canadian Institutes of Health Research [MT-11263]; NIH National Institute of Environmental Health Sciences;  [R01-DE-014581];  [R37-DE08559];  [R01-DE09886];  [R01-DE012472];  [R01-DE014677];  [R01-DE016148];  [P50-DE016215];  [R21-DE016930];  [R01-HD390661];  [R01-DE016877];  [JK02-AEO15291]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581, R01DE016148, R37DE008559, R00DE018413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016930, R21DE016877, P50DE016215, K99DE018413, R01DE012472, R01DE009886, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); International Consortium to Identify Genes and Interactions Controlling Oral Clefts; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor award(March of Dimes); Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; ; ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We sincerely thank all of the families at each recruitment site for participating in this study, and we gratefully acknowledge the invaluable assistance of clinical, field and laboratory staff who contributed to making this work possible. We are particularly grateful to K. Durda and J. L'Heureux of the University of Iowa for assistance with samples and phenotype data; L. Henkle for technical assistance; J. Resick, C. Brandon and K. Bardi of the University of Pittsburgh for assistance with recruitment; W. Carricato, K. Deeley and J. Ruff of the University of Pittsburgh for sample handling; P. Patel and M. Rose of Johns Hopkins for assistance with data analysis; F. Cheah of the National University of Singapore for sample processing and management; M. Feldkamp and J. Carey of the Utah Birth Defects Network for assistance with recruitment and case review; and D. Pearce of the Utah State University for sample collection and processing. Funding to support data collection, genotyping and analysis came from several sources, some to individual investigators and some to the consortium itself. The consortium for GWAS genotyping and analysis was supported by the National Institute for Dental and Craniofacial Research through U01-DE-018993; the International Consortium to Identify Genes and Interactions Controlling Oral Clefts, 2007 2009. This project was part of the Gene, Environment Association Studies Consortium (GENEVA) funded by the National Human Genome Research Institute (NHGRI) to enhance communication and collaboration among investigators conducting genome-wide studies for a variety of complex diseases. Our group benefited greatly from the work and efforts of the entire consortium, especially the work by the Coordinating Center (directed by B. Weir and C. Laurie of the University of Washington) in data cleaning and preparation of these case-parent trios for submission to the Database for Genotypes and Phenotypes (dbGaP). We also acknowledge the leadership of T. Manolio of NHGRI and E. Harris of National Institute of Dental and Craniofacial Research. Genotyping services were provided by the Center for Inherited Disease Research (CIDR), funded through a federal contract from the US National Institutes of Health (NIH) to Johns Hopkins University (contract number HHSN268200782096C). Funding for individual investigators and the replication studies include: R01-DE-014581 (T. H. B.); R37-DE08559 (J. C. M. and M. L. M.), R01-DE09886 (M. L. M., L. M. and L. L. F.), R01-DE012472 (M. L. M.), R01-DE014677 (A. C. L. and M. L. M.), R01-DE016148 (M. L. M.), P50-DE016215 (J. C. M. and M. L. M.), R21-DE016930 (M. L. M., E. E. C. and A. E. C.), R01-HD390661 and R01-DE016877 (R. G. M.). JK02-AEO15291 (A. C. L.), March of Dimes Basil O'Connor award #FY 98-0718 and Research Grant #6-FY01-61 (A. C. L.); NIH R03-AR-055313 and NIH P50-DE-16215 (project #3) (M. D.), K99-DE-018441 (R. M.); and the Canadian Institutes of Health Research MT-11263 (L. L. F.). The Smile Train Foundation supported data collection in Chengdu (E.W.J. and B. S.). This research was supported in part by the Intramural Research Program of the NIH National Institute of Environmental Health Sciences (A.J.W.).	Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; CORNELIS MC, 2010, GENET EPIDEMIOL, DOI DOI 10.1002/GEPI.20492; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Laird NM, 2008, ADV GENET, V60, P219, DOI 10.1016/S0065-2660(07)00410-5; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; MITCHELL LE, 2002, CLEFT LIP PALATE, P214; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Vieira AR, 2007, AM J MED GENET A, V143A, P2075, DOI 10.1002/ajmg.a.31884; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	22	420	453	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2010	42	6					525	U76		10.1038/ng.580	http://dx.doi.org/10.1038/ng.580			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436469	Green Accepted, Green Submitted			2022-12-25	WOS:000278081500019
J	Ozer, JS; Dieterle, F; Troth, S; Perentes, E; Cordier, A; Verdes, P; Staedtler, F; Mahl, A; Grenet, O; Roth, DR; Wahl, D; Legay, F; Holder, D; Erdos, Z; Vlasakova, K; Jin, H; Yu, Y; Muniappa, N; Forest, T; Clouse, HK; Reynolds, S; Bailey, WJ; Thudium, DT; Topper, MJ; Skopek, TR; Sina, JF; Glaab, WE; Vonderscher, J; Maurer, G; Chibout, SD; Sistare, FD; Gerhold, DL				Ozer, Josef S.; Dieterle, Frank; Troth, Sean; Perentes, Elias; Cordier, Andre; Verdes, Pablo; Staedtler, Frank; Mahl, Andreas; Grenet, Olivier; Roth, Daniel R.; Wahl, Daniel; Legay, Francois; Holder, Daniel; Erdos, Zoltan; Vlasakova, Katerina; Jin, Hong; Yu, Yan; Muniappa, Nagaraja; Forest, Tom; Clouse, Holly K.; Reynolds, Spencer; Bailey, Wendy J.; Thudium, Douglas T.; Topper, Michael J.; Skopek, Thomas R.; Sina, Joseph F.; Glaab, Warren E.; Vonderscher, Jacky; Maurer, Gerard; Chibout, Salah-Dine; Sistare, Frank D.; Gerhold, David L.			A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function	NATURE BIOTECHNOLOGY			English	Article							CYSTATIN-C; KIDNEY INJURY; MOLECULE-1; CLUSTERIN; PROTEIN	The Predictive Safety Testing Consortium's first regulatory submission to qualify kidney safety biomarkers revealed two deficiencies. To address the need for biomarkers that monitor recovery from agent-induced renal damage, we scored changes in the levels of urinary biomarkers in rats during recovery from renal injury induced by exposure to carbapenem A or gentamicin. All biomarkers responded to histologic tubular toxicities to varied degrees and with different kinetics. After a recovery period, all biomarkers returned to levels approaching those observed in uninjured animals. We next addressed the need for a serum biomarker that reflects general kidney function regardless of the exact site of renal injury. Our assay for serum cystatin C is more sensitive and specific than serum creatinine (SCr) or blood urea nitrogen (BUN) in monitoring generalized renal function after exposure of rats to eight nephrotoxicants and two hepatotoxicants. This sensitive serum biomarker will enable testing of renal function in animal studies that do not involve urine collection.	[Ozer, Josef S.; Erdos, Zoltan; Vlasakova, Katerina; Jin, Hong; Yu, Yan; Forest, Tom; Reynolds, Spencer; Bailey, Wendy J.; Thudium, Douglas T.; Topper, Michael J.; Skopek, Thomas R.; Sina, Joseph F.; Glaab, Warren E.; Sistare, Frank D.; Gerhold, David L.] Merck Res Labs, Dept Investigat Lab Sci, West Point, PA USA; [Dieterle, Frank; Perentes, Elias; Cordier, Andre; Verdes, Pablo; Staedtler, Frank; Mahl, Andreas; Grenet, Olivier; Roth, Daniel R.; Wahl, Daniel; Legay, Francois; Vonderscher, Jacky; Maurer, Gerard; Chibout, Salah-Dine] Novartis Inst BioMed Res, Basel, Switzerland; [Troth, Sean; Muniappa, Nagaraja] Merck Res Labs, Dept Pathol, West Point, PA USA; [Holder, Daniel] Merck Res Labs, Dept Biometr, West Point, PA USA; [Clouse, Holly K.] Merck Res Labs, Dept Exploratory Toxicol, West Point, PA USA	Merck & Company; Novartis; Merck & Company; Merck & Company; Merck & Company	Gerhold, DL (corresponding author), Merck Res Labs, Dept Investigat Lab Sci, West Point, PA USA.	david_gerhold@merck.com	Troth, Sean P./R-6885-2019	Troth, Sean P./0000-0002-4696-5129; Gerhold, David/0000-0001-5739-730X				Bailly V, 2002, J BIOL CHEM, V277, P39739, DOI 10.1074/jbc.M200562200; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; Mattes WB, 2009, CLIN PHARMACOL THER, V85, P327, DOI 10.1038/clpt.2008.270; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Orlandi A, 2005, ARTERIOSCL THROM VAS, V25, P348, DOI 10.1161/01.ATV.0000152609.28569.e1; Razzaque Mohammed S., 2002, Medical Electron Microscopy, V35, P68, DOI 10.1007/s007950200009; Rosen H, 1999, SCIENCE, V283, P703, DOI 10.1126/science.283.5402.703; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Silkensen JR, 1997, J AM SOC NEPHROL, V8, P302; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sistare FD, 2010, NAT BIOTECHNOL, V28, P446, DOI 10.1038/nbt.1634; Takuwa S, 2002, PEDIATR INT, V44, P28, DOI 10.1046/j.1442-200X.2002.01499.x; Vaidya VS, 2006, EXPERT OPIN DRUG MET, V2, P697, DOI 10.1517/17425255.2.5.697; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624; 2007, SUBSTANTIAL EQUIVALE	29	166	192	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2010	28	5					486	U146		10.1038/nbt.1627	http://dx.doi.org/10.1038/nbt.1627			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	593KG	20458319				2022-12-25	WOS:000277452700029
J	Erion, DM; Shulman, GI				Erion, Derek M.; Shulman, Gerald I.			Diacylglycerol-mediated insulin resistance	NATURE MEDICINE			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; INDUCED HEPATIC STEATOSIS; MUSCLE GLYCOGEN-SYNTHESIS; A-ZIP/F-1 FATLESS MICE; FATTY LIVER-DISEASE; SKELETAL-MUSCLE; DIABETES-MELLITUS; GLUCOSE-TRANSPORT; KNOCKOUT MICE	Understanding the molecular mechanisms of insulin resistance remains a major medical challenge of the twenty-first century. Over the last half-century, many hypotheses have been proposed to explain insulin resistance, and, most recently, inflammation associated with alterations in adipocytokines has become the prevailing hypothesis. Here we discuss diacylglycerol-mediated insulin resistance as an alternative and unifying hypothesis to explain the most common forms of insulin resistance associated with obesity and type 2 diabetes mellitus, as well as lipodystrophy and aging.	[Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06520 USA; [Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, New Haven, CT USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Erion, DM (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK040936, U24DK059635] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK040936, P30 DK034989, U24 DK059635] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kim JK, 2003, DIABETES, V52, P1311, DOI 10.2337/diabetes.52.6.1311; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Luzi L, 2003, AM J PHYSIOL-ENDOC M, V284, pE274, DOI 10.1152/ajpendo.00391.2001; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; RANDLE PJ, 1965, ANN NY ACAD SCI, V131, P324, DOI 10.1111/j.1749-6632.1965.tb34800.x; RANDLE PJ, 1963, LANCET, V1, P785; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Weigert C, 2007, J APPL PHYSIOL, V102, P820, DOI 10.1152/japplphysiol.01353.2006; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	57	322	336	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					400	402		10.1038/nm0410-400	http://dx.doi.org/10.1038/nm0410-400			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376053	Green Accepted			2022-12-25	WOS:000276446800042
J	Mullard, A				Mullard, Asher			The anticounterfeiter's technological tool kit	NATURE MEDICINE			English	News Item																			0	23	23	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					361	361		10.1038/nm0410-361a	http://dx.doi.org/10.1038/nm0410-361a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376027	Bronze			2022-12-25	WOS:000276446800018
J	Qin, YJ; Yao, L; King, EE; Buddavarapu, K; Lenci, RE; Chocron, ES; Lechleiter, JD; Sass, M; Aronin, N; Schiavi, F; Boaretto, F; Opocher, G; Toledo, RA; Toledo, SPA; Stiles, C; Aguiar, RCT; Dahia, PLM				Qin, Yuejuan; Yao, Li; King, Elizabeth E.; Buddavarapu, Kalyan; Lenci, Romina E.; Chocron, E. Sandra; Lechleiter, James D.; Sass, Meghan; Aronin, Neil; Schiavi, Francesca; Boaretto, Francesca; Opocher, Giuseppe; Toledo, Rodrigo A.; Toledo, Sergio P. A.; Stiles, Charles; Aguiar, Ricardo C. T.; Dahia, Patricia L. M.			Germline mutations in TMEM127 confer susceptibility to pheochromocytoma	NATURE GENETICS			English	Article							MTOR; SIGNALS; RAPTOR; PHOSPHORYLATION; APOPTOSIS; INTERACTS; AKT/PKB; COMPLEX; BREAST; RICTOR	Pheochromocytomas, which are catecholamine-secreting tumors of neural crest origin, are frequently hereditary(1). However, the molecular basis of the majority of these tumors is unknown(2). We identified the transmembrane-encoding gene TMEM127 on chromosome 2q11 as a new pheochromocytoma susceptibility gene. In a cohort of 103 samples, we detected truncating germline TMEM127 mutations in approximately 30% of familial tumors and about 3% of sporadic-appearing pheochromocytomas without a known genetic cause. The wild-type allele was consistently deleted in tumor DNA, suggesting a classic mechanism of tumor suppressor gene inactivation. Pheochromocytomas with mutations in TMEM127 are transcriptionally related to tumors bearing NF1 mutations and, similarly, show hyperphosphorylation of mammalian target of rapamycin (mTOR) effector proteins. Accordingly, in vitro gain-of-function and loss-of-function analyses indicate that TMEM127 is a negative regulator of mTOR. TMEM127 dynamically associates with the endomembrane system and colocalizes with perinuclear (activated) mTOR, suggesting a subcompartmental-specific effect. Our studies identify TMEM127 as a tumor suppressor gene and validate the power of hereditary tumors to elucidate cancer pathogenesis.	[Qin, Yuejuan; Yao, Li; King, Elizabeth E.; Buddavarapu, Kalyan; Lenci, Romina E.; Aguiar, Ricardo C. T.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chocron, E. Sandra; Lechleiter, James D.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sass, Meghan] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Schiavi, Francesca; Boaretto, Francesca; Opocher, Giuseppe] Veneto Inst Oncol, Padua, Italy; [Toledo, Rodrigo A.; Toledo, Sergio P. A.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Stiles, Charles] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Aguiar, Ricardo C. T.; Dahia, Patricia L. M.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; IRCCS Istituto Oncologico Veneto (IOV); Universidade de Sao Paulo; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Dahia, PLM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	dahia@uthscsa.edu	Toledo, Rodrigo/GQQ-1711-2022; boaretto, francesca/K-9811-2016; Schiavi, Francesca/AAB-9908-2022; Qin, Yuejuan/F-6801-2010; Toledo, Rodrigo/ABH-5248-2020; Toledo, Rodrigo/N-4078-2013; Opocher, Giuseppe/F-3950-2014; Toledo, Sergio P. A./S-9291-2018	boaretto, francesca/0000-0003-2015-929X; Schiavi, Francesca/0000-0001-8529-4455; Toledo, Rodrigo/0000-0003-3070-6795; Toledo, Rodrigo/0000-0003-3070-6795; Opocher, Giuseppe/0000-0002-9845-9623; Lenci, Romina/0000-0002-0025-3134; Toledo, Sergio P. A./0000-0002-2590-3519	Voelcker Foundation Young Investigator Award; Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA); NIH [P30 CA54174]; Voelcker Fund; US National Institutes of Health (NIH)National Cancer Institute [P30 CA54174]; NIH-National Institute on Aging (NIA) [P30 AG013319, P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319] Funding Source: NIH RePORTER	Voelcker Foundation Young Investigator Award; Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund; US National Institutes of Health (NIH)National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Jiang for technical assistance, V. Frohlich and J. Wewer for help with optical imaging, J. Blenis for kindly providing the 293E cell line, W. Kaelin Jr. for his comments and suggestions, and M. Jech, C. Colin, N. V. Nguyen, M. Pujana, M. Vidal, D. Hill, J. Bruder and the Familial Pheochromocytoma Consortium members for their contribution to earlier phases of this project. We also thank the subjects and families that participated in the study for their cooperation. P. L. M. D. is a Kimmel Foundation Scholar and a recipient of a Voelcker Foundation Young Investigator Award and is supported by the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA) (NIH-P30 CA54174). R. C. T. A. is supported by the Voelcker Fund. Immunofluorescence images were generated in the Core Optical Imaging Facility which is supported by UTHSCSA, US National Institutes of Health (NIH)National Cancer Institute P30 CA54174 (CTRC), NIH-National Institute on Aging (NIA) P30 AG013319 (Nathan Shock Center) and NIH-NIA P01AG19316.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Dahia PLM, 2006, CURR OPIN ONCOL, V18, P1, DOI 10.1097/01.cco.0000198017.45982.06; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Dahia PLM, 2005, CANCER RES, V65, P9651, DOI 10.1158/0008-5472.CAN-05-1427; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	29	285	294	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					229	U31		10.1038/ng.533	http://dx.doi.org/10.1038/ng.533			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20154675	Green Accepted			2022-12-25	WOS:000274912400011
J	Stowell, SR; Arthur, CM; Dias-Baruffi, M; Rodrigues, LC; Gourdine, JP; Heimburg-Molinaro, J; Ju, TZ; Molinaro, RJ; Rivera-Marrero, C; Xia, BY; Smith, DF; Cummings, RD				Stowell, Sean R.; Arthur, Connie M.; Dias-Baruffi, Marcelo; Rodrigues, Lilian C.; Gourdine, Jean-Philippe; Heimburg-Molinaro, Jamie; Ju, Tongzhong; Molinaro, Ross J.; Rivera-Marrero, Carlos; Xia, Baoyun; Smith, David F.; Cummings, Richard D.			Innate immune lectins kill bacteria expressing blood group antigen	NATURE MEDICINE			English	Article							HUMAN COLON ECOSYSTEMS; ENTERIC BACTERIA; GENE-CLUSTER; GALECTIN-8; RECOGNITION; DEGRADATION	The expression of ABO(H) blood group antigens causes deletion of cells that generate self-specific antibodies to these antigens but this deletion limits adaptive immunity toward pathogens bearing cognate blood group antigens. To explore potential defense mechanisms against such pathogens, given these limitations in adaptive immunity, we screened for innate proteins that could recognize human blood group antigens. Here we report that two innate immune lectins, galectin-4 (Gal-4) and Gal-8, which are expressed in the intestinal tract, recognize and kill human blood group antigen-expressing Escherichia coli while failing to alter the viability of other E. coli strains or other Gram-negative or Gram-positive organisms both in vitro and in vivo. The killing activity of both Gal-4 and Gal-8 is mediated by their C-terminal domains, occurs rapidly and independently of complement and is accompanied by disruption of membrane integrity. These results demonstrate that innate defense lectins can provide immunity against pathogens that express blood group-like antigens on their surface.	[Stowell, Sean R.; Arthur, Connie M.; Gourdine, Jean-Philippe; Heimburg-Molinaro, Jamie; Ju, Tongzhong; Rivera-Marrero, Carlos; Xia, Baoyun; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dias-Baruffi, Marcelo; Rodrigues, Lilian C.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Molinaro, Ross J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Universidade de Sao Paulo; Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu	Gourdine, Jean-Philippe/P-4323-2018; Gourdine, Jean-Philippe F/E-3739-2012; Baruffi, Marcelo D/I-7199-2015; Terra, Lilian Cataldi Rodrigues/GYV-2597-2022	Gourdine, Jean-Philippe/0000-0001-9969-8610; Gourdine, Jean-Philippe F/0000-0001-9969-8610; Baruffi, Marcelo D/0000-0002-2039-1884; Terra, Lilian Cataldi Rodrigues/0000-0002-2014-2263; Ju, Tongzhong/0000-0002-4429-1976	US National Institutes of Health [HL085607, GM085448]; Consortium for Functional Glycomics; US National Institute of General Medical Sciences/US National of Institutes of Health [GM62116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R01GM085448] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics; US National Institute of General Medical Sciences/US National of Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Cummings and M. Willard for technical assistance. We also thank P. G. Wang (Ohio State University) for providing the original E. coli O86:B7 strain, as well as the a-Gal bacteria mutant versions of this strain lacking expression of either the wzy or waaL genes. We obtained P. aeruginosa strain 8830 from A. Chakrabaty (University of Illinois College of Medicine) and plasmid pSMC21 encoding GFP from G. O'Toole (Dartmouth Medical School). We also thank the staff at the Robert P. Apkarian Integrated Electron Microscopy Core Facility at Emory University for their help with electron microscopy. This work was supported by grants from the US National Institutes of Health to R. D. C. (HL085607) and D. F. S. (GM085448) and by resources from the Consortium for Functional Glycomics (Core D and Core H), funded by the US National Institute of General Medical Sciences/US National of Institutes of Health (GM62116).	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Garratty G, 2000, TRANSFUS MED REV, V14, P291, DOI 10.1053/tmrv.2000.16228; Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954; Guo HJ, 2005, APPL ENVIRON MICROB, V71, P7995, DOI 10.1128/AEM.71.12.7995-8001.2005; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hansson G C, 1988, Adv Exp Med Biol, V228, P465; HOSKINS LC, 1976, J CLIN INVEST, V57, P74, DOI 10.1172/JCI108271; HOSKINS LC, 1976, J CLIN INVEST, V57, P63, DOI 10.1172/JCI108270; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; LARSON G, 1987, FEBS LETT, V214, P41, DOI 10.1016/0014-5793(87)80009-1; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; REEVES P, 1995, TRENDS MICROBIOL, V3, P381, DOI 10.1016/S0966-842X(00)88983-0; RIBI HO, 1988, SCIENCE, V239, P1272, DOI 10.1126/science.3344432; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Wooters MA, 2005, J HISTOCHEM CYTOCHEM, V53, P197, DOI 10.1369/jhc.4A6439.2005; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y	31	208	212	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2010	16	3					295	U90		10.1038/nm.2103	http://dx.doi.org/10.1038/nm.2103			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	565KA	20154696	Green Accepted			2022-12-25	WOS:000275289500034
J	Turner, TL; Bourne, EC; Von Wettberg, EJ; Hu, TT; Nuzhdin, SV				Turner, Thomas L.; Bourne, Elizabeth C.; Von Wettberg, Eric J.; Hu, Tina T.; Nuzhdin, Sergey V.			Population resequencing reveals local adaptation of Arabidopsis lyrata to serpentine soils	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; MICROSATELLITE MARKERS; GENOMIC ANALYSIS; CANDIDATE GENES; DIFFERENTIATION	A powerful way to map functional genomic variation and reveal the genetic basis of local adaptation is to associate allele frequency across the genome with environmental conditions(1-5). Serpentine soils, characterized by high heavy-metal content and low calcium-to-magnesium ratios, are a classic context for studying adaptation of plants to local soil conditions(6,7). To investigate whether Arabidopsis lyrata is locally adapted to serpentine soil, and to map the polymorphisms responsible for such adaptation, we pooled DNA from individuals from serpentine and nonserpentine soils and sequenced each 'gene pool' with the Illumina Genome Analyzer. The polymorphisms that are most strongly associated with soil type are enriched at heavy-metal detoxification and calcium and magnesium transport loci, providing numerous candidate mutations for serpentine adaptation. Sequencing of three candidate loci in the European subspecies of A. lyrata indicates parallel differentiation of the same polymorphism at one locus, confirming ecological adaptation, and different polymorphisms at two other loci, which may indicate convergent evolution.	[Turner, Thomas L.] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria; [Bourne, Elizabeth C.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland; [Turner, Thomas L.; Hu, Tina T.; Nuzhdin, Sergey V.] Univ So Calif, Los Angeles, CA USA; [Von Wettberg, Eric J.] Univ Calif Davis, Davis, CA 95616 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); James Hutton Institute; University of Southern California; University of California System; University of California Davis	Turner, TL (corresponding author), Univ Calif Santa Barbara, Evolut Ecol & Marine Biol Dept, Santa Barbara, CA 93106 USA.	tturner@lifesci.ucsb.edu	von Wettberg, Eric/C-1115-2016	von Wettberg, Eric/0000-0002-2724-0317; Bourne, Elizabeth/0000-0002-6369-9133	US National Science Foundation (NSF) [DEB-0548991, RGM-076643, DEB-0723935]; University of Southern California; Macaulay Development Fund; Gregor Mendel Institute; NIH NRSA	US National Science Foundation (NSF)(National Science Foundation (NSF)); University of Southern California; Macaulay Development Fund; Gregor Mendel Institute; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Nordborg, R. Pakeman and R. Brooker for their advice and support, and to M. Woodhead, J. Russell and C. Booth for assistance with microsatellite analysis. This work was supported by the US National Science Foundation (NSF) grant DEB-0548991 and US National Institutes of Health (NIH) grant RGM-076643 (S. V. N.), NSF DEB-0723935 (to M. Nordborg), the University of Southern California (S. V. N., T. L. T. and T. T. H.), an NSF predoctoral fellowship (T. L. T.), the Macaulay Development Fund (E. C. B.), the Gregor Mendel Institute (T. L. T.) and an NIH NRSA fellowship (E. J. V. W.).	Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2002, MOL ECOL, V11, P591, DOI 10.1046/j.0962-1083.2002.01465.x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Woodhead M, 2007, MOL ECOL NOTES, V7, P631, DOI 10.1111/j.1471-8286.2006.01656.x; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875	18	334	345	1	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					260	U42		10.1038/ng.515	http://dx.doi.org/10.1038/ng.515			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101244				2022-12-25	WOS:000274912400017
J	Youssef, KK; Van Keymeulen, A; Lapouge, G; Beck, B; Michaux, C; Achouri, Y; Sotiropoulou, PA; Blanpain, C				Youssef, Khalil Kass; Van Keymeulen, Alexandra; Lapouge, Gaeelle; Beck, Benjamin; Michaux, Cindy; Achouri, Younes; Sotiropoulou, Panagiota A.; Blanpain, Cedric			Identification of the cell lineage at the origin of basal cell carcinoma	NATURE CELL BIOLOGY			English	Article							HAIR FOLLICLE BULGE; STEM-CELLS; SONIC HEDGEHOG; HUMAN HOMOLOG; MOUSE SKIN; EPIDERMIS; POPULATION; CANCER; KERATINOCYTES; EXPRESSION	For most types of cancers, the cell at the origin of tumour initiation is still unknown. Here, we used mouse genetics to identify cells at the origin of basal cell carcinoma (BCC), which is one of the most frequently occurring types of cancer in humans, and can result from the activation of the Hedgehog signalling pathway. Using mice conditionally expressing constitutively active Smoothened mutant (SmoM2), we activated Hedgehog signalling in different cellular compartments of the skin epidermis and determined in which compartments Hedgehog activation induces BCC formation. Activation of SmoM2 in hair follicle bulge stem cells and their transient amplifying progenies did not induce cancer formation, demonstrating that BCC does not originate from bulge stem cells, as previously thought. Using clonal analysis, we found that BCC arises from long-term resident progenitor cells of the interfollicular epidermis and the upper infundibulum. Our studies uncover the cells at the origin of BCC in mice and demonstrate that expression of differentiation markers in tumour cells is not necessarily predictive of the cancer initiating cells.	[Youssef, Khalil Kass; Van Keymeulen, Alexandra; Lapouge, Gaeelle; Beck, Benjamin; Michaux, Cindy; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Achouri, Younes] Catholic Univ Louvain, B-1200 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021	Youssef, Khalil Kass/0000-0002-4572-3160; Beck, Benjamin/0000-0001-8162-7566; ACHOURI, Younes/0000-0001-7409-1441	FNRS; Human Frontier Science Program Organization; Schlumberger Foundation; CIBLES of the Wallonia Region; EMBO Young Investigator program; European Research Council	FNRS(Fonds de la Recherche Scientifique - FNRS); Human Frontier Science Program Organization(Human Frontier Science Program); Schlumberger Foundation(Schlumberger); CIBLES of the Wallonia Region; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided reagents, and whose gifts are cited in the text. We thank C. Govaerts, H. Nguyen, P. Vanderhaeghen and G. Vassart for their critical comments on the manuscript. C. B. and A. V. K. are Chercheur Qualifie of the FRS/FNRS; K. K. Y is a Research Fellow of the FRIA; and G. L. is Collaborateur Scientifique of the FRS/FNRS. This work was supported by a Mandat D'impulsion Scientifique of the FNRS, a career development award of the Human Frontier Science Program Organization, a research grant of the Schlumberger Foundation, the programme CIBLES of the Wallonia Region, the EMBO Young Investigator program and from a starting grant of the European Research Council.	Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CAMPBELL C, 1993, CANCER RES, V53, P2697; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Crowson AN, 2006, MODERN PATHOL, V19, pS127, DOI 10.1038/modpathol.3800512; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	42	275	286	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					299	U111		10.1038/ncb2031	http://dx.doi.org/10.1038/ncb2031			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20154679				2022-12-25	WOS:000275054200017
J	Morin, RD; Johnson, NA; Severson, TM; Mungall, AJ; An, JH; Goya, R; Paul, JE; Boyle, M; Woolcock, BW; Kuchenbauer, F; Yap, D; Humphries, RK; Griffith, OL; Shah, S; Zhu, H; Kimbara, M; Shashkin, P; Charlot, JF; Tcherpakov, M; Corbett, R; Tam, A; Varhol, R; Smailus, D; Moksa, M; Zhao, YJ; Delaney, A; Qian, H; Birol, I; Schein, J; Moore, R; Holt, R; Horsman, DE; Connors, JM; Jones, S; Aparicio, S; Hirst, M; Gascoyne, RD; Marra, MA				Morin, Ryan D.; Johnson, Nathalie A.; Severson, Tesa M.; Mungall, Andrew J.; An, Jianghong; Goya, Rodrigo; Paul, Jessica E.; Boyle, Merrill; Woolcock, Bruce W.; Kuchenbauer, Florian; Yap, Damian; Humphries, R. Keith; Griffith, Obi L.; Shah, Sohrab; Zhu, Henry; Kimbara, Michelle; Shashkin, Pavel; Charlot, Jean F.; Tcherpakov, Marianna; Corbett, Richard; Tam, Angela; Varhol, Richard; Smailus, Duane; Moksa, Michelle; Zhao, Yongjun; Delaney, Allen; Qian, Hong; Birol, Inanc; Schein, Jacqueline; Moore, Richard; Holt, Robert; Horsman, Doug E.; Connors, Joseph M.; Jones, Steven; Aparicio, Samuel; Hirst, Martin; Gascoyne, Randy D.; Marra, Marco A.			Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin	NATURE GENETICS			English	Article							GROUP PROTEIN EZH2; METHYLATION; BIOLOGY; SUBGROUPS; SURVIVAL; GENES	Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL) derive from germinal center B cells(1). Targeted resequencing studies have revealed mutations in various genes encoding proteins in the NF-kappa B pathway(2,3) that contribute to the activated B-cell (ABC) DLBCL subtype, but thus far few GCB-specific mutations have been identified(4). Here we report recurrent somatic mutations affecting the polycomb-group oncogene(5) EZH2, which encodes a histone methyltransferase responsible for trimethylating Lys27 of histone H3 (H3K27). After the recent discovery of mutations in KDM6A (UTX), which encodes the histone H3K27me3 demethylase UTX, in several cancer types(6), EZH2 is the second histone methyltransferase gene found to be mutated in cancer. These mutations, which result in the replacement of a single tyrosine in the SET domain of the EZH2 protein (Tyr641), occur in 21.7% of GCB DLBCLs and 7.2% of FLs and are absent from ABC DLBCLs. Our data are consistent with the notion that EZH2 proteins with mutant Tyr641 have reduced enzymatic activity in vitro.	[Morin, Ryan D.; Severson, Tesa M.; Mungall, Andrew J.; An, Jianghong; Goya, Rodrigo; Paul, Jessica E.; Griffith, Obi L.; Corbett, Richard; Tam, Angela; Varhol, Richard; Smailus, Duane; Moksa, Michelle; Zhao, Yongjun; Delaney, Allen; Qian, Hong; Birol, Inanc; Schein, Jacqueline; Moore, Richard; Holt, Robert; Jones, Steven; Hirst, Martin; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Zhu, Henry; Kimbara, Michelle; Shashkin, Pavel; Charlot, Jean F.; Tcherpakov, Marianna] BPS Biosci, San Diego, CA USA; [Horsman, Doug E.; Gascoyne, Randy D.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Connors, Joseph M.] Univ British Columbia, Div Med Oncol, Vancouver, BC V5Z 1M9, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Marra, MA (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada.	mmarra@bcgsc.ca	Holt, Robert A/C-3303-2009; Hirst, Martin/B-7684-2016; Connors, Joseph/AAF-5284-2019; Morin, Ryan/AAE-7824-2019; Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011; Mungall, Andrew J./U-7067-2018; Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Griffith, Obi/P-1286-2014	Holt, Robert A/0000-0002-7259-1247; Connors, Joseph/0000-0002-1361-7531; Morin, Ryan/0000-0003-2932-7800; Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Aparicio, Samuel/0000-0002-0487-9599; Griffith, Obi/0000-0002-0843-4271; Humphries, Richard/0000-0003-0540-7005; Yap, Damian/0000-0002-5370-4592	National Cancer Institute Office of Cancer Genomics; National Cancer Institute of Canada (NCIC) Terry Fox Foundation [016003]; The Terry Fox Foundation [019001]; NCIC [019005]; Michael Smith Foundation for Health Research (MSFHR) [ST-DF-01793]; The Leukemia & Lymphoma Society; MSFHR; BC Cancer Foundation; Lion's Club International; National Cancer Institute; National Institutes of Health [NO1-CO-12400]; NATIONAL CANCER INSTITUTE [U24CA143866] Funding Source: NIH RePORTER	National Cancer Institute Office of Cancer Genomics; National Cancer Institute of Canada (NCIC) Terry Fox Foundation; The Terry Fox Foundation; NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); MSFHR(Michael Smith Foundation for Health Research); BC Cancer Foundation; Lion's Club International; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by grants from the National Cancer Institute Office of Cancer Genomics (see below), the National Cancer Institute of Canada (NCIC) Terry Fox Foundation New Frontiers Program Project Grant (grant no. 016003/grant type 230/project title: Biology of Cancer: Follicular Lymphoma as a Model of Cancer Progression) and Genome Canada/Genome BC Grant Competition III (project title: High Resolution Analysis of Follicular Lymphoma Genomes) to J.M.C., M.A.M., R.D.G. and D.E.H. and was supported by The Terry Fox Foundation (grant no. 019001). In addition, N.A.J. is a research fellow of the Terry Fox Foundation through an award from the NCIC (019005) and the Michael Smith Foundation for Health Research (MSFHR) (ST-DF-01793). M. A. M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar. A.J.M. is supported by a Fellowship Award from The Leukemia & Lymphoma Society. R.D.M. is a Vanier Scholar (Canadian Institutes for Health Research) and is also supported by a MSFHR senior graduate fellowship. The laboratory work for this study was undertaken at the Genome Sciences Centre, British Columbia Cancer Research Centre and the Centre for Translational and Applied Genomics, a program of the Provincial Health Services Authority Laboratories. The authors thank the BC Cancer Foundation and the Lion's Club International for their support. The authors gratefully acknowledge D. Gerhard for helpful discussions. Special thanks to C. Suragh and A. Drobnies for expert project management assistance. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. NO1-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Al-Katib AM, 1998, CLIN CANCER RES, V4, P1305; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2002, CURR PROTOC BIOINFOR; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; BECKWITH M, 1990, J NATL CANCER I, V82, P501, DOI 10.1093/jnci/82.6.501; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; DELANEY AD, 2008, CURR PROTOC HUM GENE, V59; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DYER MJS, 1990, BLOOD, V75, P709; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Hans CP, 2003, BLOOD, V101, P2363, DOI 10.1182/blood-2002-07-2298; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Krzywinski M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r224; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TWEEDDALE ME, 1987, BLOOD, V69, P1307; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	42	1234	1293	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					181	U124		10.1038/ng.518	http://dx.doi.org/10.1038/ng.518			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081860	Green Accepted			2022-12-25	WOS:000274084400018
J	Palmer, AC; Angelino, E; Kishony, R				Palmer, Adam C.; Angelino, Elaine; Kishony, Roy			Chemical decay of an antibiotic inverts selection for resistance	NATURE CHEMICAL BIOLOGY			English	Article							TETRACYCLINE-RESISTANCE; DEGRADATION-PRODUCTS; METABOLISM; EXPRESSION; INDUCTION; BACTERIA; TOXICITY; FITNESS; OPERON	Antibiotics are often unstable and can decay into various compounds with potential biological activities. We found that as tetracycline degrades, the competitive advantage conferred to bacteria by resistance not only diminishes but actually reverses to become a prolonged disadvantage due to the activities of more stable degradation products. Tetracycline decay can lead to net selection against resistance, which may help explain the puzzling coexistence of sensitive and resistant strains in natural environments.	[Palmer, Adam C.; Angelino, Elaine; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, England	Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	Palmer, Adam C/J-3589-2012; Palmer, Adam/N-5495-2019	Palmer, Adam C/0000-0001-5028-7028; Palmer, Adam/0000-0001-5028-7028	US National Institutes of Health [R01 GM081617]; George Murray Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Murray Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lenski (Michigan State University) for the gift of plasmids, and we thank R. Chait, D. Kahne and F. Solomon for helpful insights and R. Ward and M. Elowitz for comments on the manuscript. This work was supported in part by US National Institutes of Health grant R01 GM081617 (to R. K.) and a George Murray Scholarship (to A. C. P.).	Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Halling-Sorensen B, 2002, ARCH ENVIRON CON TOX, V42, P263, DOI 10.1007/s00244-001-0017-2; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Jia A, 2009, J CHROMATOGR A, V1216, P4655, DOI 10.1016/j.chroma.2009.03.073; KELLY RG, 1960, J PHARMACOL EXP THER, V130, P144; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; MCCORMICK JR, 1968, J AM CHEM SOC, V90, P2201, DOI 10.1021/ja01010a063; MOYED HS, 1983, J BACTERIOL, V155, P549, DOI 10.1128/JB.155.2.549-556.1983; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Walsh C., 2003, ANTIBIOTICS ACTIONS; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; YUEN PH, 1977, J PHARM SCI, V66, P1648, DOI 10.1002/jps.2600661143	25	52	53	6	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					105	107		10.1038/NCHEMBIO.289	http://dx.doi.org/10.1038/NCHEMBIO.289			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081825	Green Accepted			2022-12-25	WOS:000273651700009
J	Hu, GA; Cabrera, A; Kono, M; Mok, S; Chaal, BK; Haase, S; Engelberg, K; Cheemadan, S; Spielmann, T; Preiser, PR; Gilberger, TW; Bozdech, Z				Hu, Guangan; Cabrera, Ana; Kono, Maya; Mok, Sachel; Chaal, Balbir K.; Haase, Silvia; Engelberg, Klemens; Cheemadan, Sabna; Spielmann, Tobias; Preiser, Peter R.; Gilberger, Tim-W; Bozdech, Zbynek			Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum	NATURE BIOTECHNOLOGY			English	Article							PROTEIN FUNCTION; GENE-FUNCTION; LIFE-CYCLE; NETWORK; DISCOVERY; RECONSTRUCTION; IDENTIFICATION; TRANSFORMATION; PREDICTION; INVASION	Functions have yet to be defined for the majority of genes of Plasmodium falciparum, the agent responsible for the most serious form of human malaria. Here we report changes in P. falciparum gene expression induced by 20 compounds that inhibit growth of the schizont stage of the intraerythrocytic development cycle. In contrast with previous studies, which reported only minimal changes in response to chemically induced perturbations of P. falciparum growth, we find that similar to 59% of its coding genes display over three-fold changes in expression in response to at least one of the chemicals we tested. We use this compendium for guilt-by-association prediction of protein function using an interaction network constructed from gene co-expression, sequence homology, domain-domain and yeast two-hybrid data. The subcellular localizations of 31 of 42 proteins linked with merozoite invasion is consistent with their role in this process, a key target for malaria control. Our network may facilitate identification of novel antimalarial drugs and vaccines.	[Cabrera, Ana; Kono, Maya; Haase, Silvia; Engelberg, Klemens; Spielmann, Tobias; Gilberger, Tim-W] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Hu, Guangan; Mok, Sachel; Chaal, Balbir K.; Cheemadan, Sabna; Preiser, Peter R.; Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Div Genet & Genom, Singapore, Singapore	Bernhard Nocht Institut fur Tropenmedizin; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gilberger, TW (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany.	gilberger@bni.uni-hamburg.de; zbozdech@ntu.edu.sg	Engelberg, Klemens/ABB-9898-2020; Preiser, Peter R/A-2201-2011; Bozdech, Zbynek/A-2205-2011; Cabrera, Ana/AES-5002-2022	Cabrera, Ana/0000-0003-2246-3471; Engelberg, Klemens/0000-0002-1948-5496; , Peter/0000-0003-4331-7000; Hu, Guangan/0000-0003-1828-0509; Spielmann, Tobias/0000-0002-3968-4601; Haase, Silvia/0000-0003-0870-3715; Mok, Sachel/0000-0002-9605-0154; Gilberger, Tim-Wolf/0000-0002-7965-8272; Bozdech, Zbynek/0000-0002-9830-8446	Singapore Ministry of Education [ARC 11/05 M45080011]; Singaporean National Medical Research Council [IRG07Nov030]; Deutsche Forschungsgemeinschaft [GI312, GRK1459]	Singapore Ministry of Education(Ministry of Education, Singapore); Singaporean National Medical Research Council(National Medical Research Council, Singapore); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Academic Research Council of the Singapore Ministry of Education (grant no. ARC 11/05 M45080011), Singaporean National Medical Research Council (grant # IRG07Nov030) and the Deutsche Forschungsgemeinschaft (GI312 and GRK1459). The authors also thank B. D. Wastuwidyaningtyas and S. Tan for excellent technical assistance with the microarray experiments, K. Jurries for graphical assistance and A. Law, R. Stanway, T. Voss and H. Hoppe for critical reading of the manuscript. We are grateful to M. Blackman (National Institute for Medical Research, London) for providing the MSP-1 antibody, to P. Sharma (National Institute of Immunology, New Delhi) for providing the GAP45 antibody and to Jacobus Pharmaceuticals for providing WR99210.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Chattopadhyay R, 2003, J BIOL CHEM, V278, P25977, DOI 10.1074/jbc.M300865200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2009, TRENDS PARASITOL, V25, P37, DOI 10.1016/j.pt.2008.08.012; Groth P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-136; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Haase S, 2008, INFECT IMMUN, V76, P879, DOI 10.1128/IAI.00144-07; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hu G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-350; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-269; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; MacCarthy T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-11; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Molyneux DH, 2006, ADV PARASIT, V61, P1, DOI 10.1016/S0065-308X(05)61001-9; Morrissette NS, 2002, J CELL SCI, V115, P1017; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Rayavara K, 2009, MOL BIOCHEM PARASIT, V167, P135, DOI 10.1016/j.molbiopara.2009.05.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tamez PA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000118; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Winzeler EA, 2006, NAT REV MICROBIOL, V4, P145, DOI 10.1038/nrmicro1327; Wuchty S, 2007, J PROTEOME RES, V6, P1461, DOI 10.1021/pr0605769; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	55	151	151	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					91	U126		10.1038/nbt.1597	http://dx.doi.org/10.1038/nbt.1597			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20037583	Bronze, Green Published			2022-12-25	WOS:000273430400026
J	Wang, HB; Bauzon, F; Ji, P; Xu, XL; Sun, DQ; Locker, J; Sellers, RS; Nakayama, K; Nakayama, KI; Cobrinik, D; Zhu, L				Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Xu, Xiaoliang; Sun, Daqian; Locker, Joseph; Sellers, Rani S.; Nakayama, Keiko; Nakayama, Keiich I.; Cobrinik, David; Zhu, Liang			Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1(+/-) mice	NATURE GENETICS			English	Article							RB MUTANT MICE; TUMOR; RETINOBLASTOMA; P27(KIP1); CANCER; MOUSE; SUPPRESSION; APOPTOSIS; MUTATION; PROTEIN	Heterozygosity of the retinoblastoma gene Rb1 elicits tumorigenesis in susceptible tissues following spontaneous loss of the remaining functional allele. Inactivation of previously studied retinoblastoma protein (pRb) targets partially inhibited tumorigenesis in Rb1(+/-) mice(1-6). Here we report that inactivation of pRb target Skp2 (refs. 7,8) completely prevents spontaneous tumorigenesis in Rb1(+/-) mice. Targeted Rb1 deletion in melanotrophs ablates the entire pituitary intermediate lobe when Skp2 is inactivated. Skp2 inactivation does not inhibit aberrant proliferation of Rb1-deleted melanotrophs but induces their apoptotic death. Eliminating p27 phosphorylation on T187 in p27T187A knock-in mice reproduces the effects of Skp2 knockout, identifying p27 ubiquitination by SCFSkp2 ubiquitin ligase as the underlying mechanism for Skp2's essential tumorigenic role in this setting. RB1-deficient human retinoblastoma cells also undergo apoptosis after Skp2 knockdown; and ectopic expression of p27, especially the p27T187A mutant, induces apoptosis. These results reveal that Skp2 becomes an essential survival gene when susceptible cells incur Rb1 deficiency.	[Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Sun, Daqian; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol & Med, Bronx, NY USA; [Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Sun, Daqian; Locker, Joseph; Sellers, Rani S.; Zhu, Liang] Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10467 USA; [Xu, Xiaoliang; Cobrinik, David] Weill Cornell Med Coll, Dyson Vis Res Inst, New York, NY USA; [Locker, Joseph; Sellers, Rani S.] Albert Einstein Comprehens Canc Ctr, Dept Pathol, Bronx, NY USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Funct Genom, Div Dev Genet, Sendai, Miyagi 980, Japan; [Nakayama, Keiich I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Dyson; Yeshiva University; Tohoku University; Kyushu University	Zhu, L (corresponding author), Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol & Med, Bronx, NY USA.	liang.zhu@einstein.yu.edu			Grants-in-Aid for Scientific Research [19057011] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA131421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131421-01A2, R01 CA131421] Funding Source: Medline	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Ji P, 2007, MOL CANCER THER, V6, P684, DOI 10.1158/1535-7163.MCT-06-0538; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Leung SW, 2004, ONCOGENE, V23, P3296, DOI 10.1038/sj.onc.1207457; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi C, 2006, NAT GENET, V38, P118, DOI 10.1038/ng1703; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	26	89	93	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					83	U105		10.1038/ng.498	http://dx.doi.org/10.1038/ng.498			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19966802	Bronze, Green Accepted			2022-12-25	WOS:000273055100021
J	Zhang, JM; Ji, JY; Yu, M; Overholtzer, M; Smolen, GA; Wang, R; Brugge, JS; Dyson, NJ; Haber, DA				Zhang, Jianmin; Ji, Jun-Yuan; Yu, Min; Overholtzer, Michael; Smolen, Gromoslaw A.; Wang, Rebecca; Brugge, Joan S.; Dyson, Nicholas J.; Haber, Daniel A.			YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; ORGAN SIZE; GROWTH-CONTROL; DROSOPHILA; PROLIFERATION; APOPTOSIS; SALVADOR; FAT; ACTIVATION; ONCOGENE	The Hippo signalling pathway regulates cellular proliferation and survival, thus has profound effects on normal cell fate and tumorigenesis(1-3). The pivotal effector of this pathway is YAP (yes-associated protein), a transcriptional co-activator amplified in mouse and human cancers, where it promotes epithelial to mesenchymal transition (EMT) and malignant transformation(4-10). So far, studies of YAP target genes have focused on cell-autonomous mediators; here we show that YAP-expressing MCF10A breast epithelial cells enhance the proliferation of neighbouring untransfected cells, implicating a non-cell-autonomous mechanism. We identify the gene for the epidermal growth factor receptor ( EGFR) ligand amphiregulin (AREG) as a transcriptional target of YAP, whose induction contributes to YAP-mediated cell proliferation and migration, but not EMT. Knockdown of AREG or addition of an EGFR kinase inhibitor abrogates the proliferative effects of YAP expression. Suppression of the negative YAP regulators LATS1 and 2 ( large tumour suppressor 1 and 2) is sufficient to induce AREG expression, consistent with physiological regulation of AREG by the Hippo pathway. Genetic interaction between the Drosophila YAP orthologue Yorkie and Egfr signalling components supports the link between these two highly conserved signalling pathways. Thus, YAP-dependent secretion of AREG indicates that activation of EGFR signalling is an important non-cell-autonomous effector of the Hippo pathway, which has implications for the regulation of both physiological and malignant cell proliferation.	[Zhang, Jianmin; Ji, Jun-Yuan; Yu, Min; Smolen, Gromoslaw A.; Wang, Rebecca; Dyson, Nicholas J.; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yu, Min; Haber, Daniel A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Overholtzer, Michael; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu	Zhang, Jianmin/AAN-2931-2020	Yu, Min/0000-0002-3969-8720; Ji, Jun-yuan/0000-0002-4483-4336	National Institutes of Health (NIH) [R01 95281]; Doris Duke Foundation Distinguished Clinical Investigator Award; National Foundation for Cancer Research; Howard Hughes Medical Institute; NIH [CA080111, CA089393, CA09361-27, CA09361, F32 CA117737, GM81607, GM053203]; Breast Cancer Research Foundation; Saltonstall Foundation; Tosteson postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009361, P01CA080111, P50CA089393, F32CA117737, F32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053203, R01GM081607] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation Distinguished Clinical Investigator Award(Doris Duke Charitable Foundation (DDCF)); National Foundation for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Saltonstall Foundation; Tosteson postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pan, M. Frolov, G. Halder and Z. Lai for providing Drosophila stocks. We appreciate discussions with J. Wells, F. Yang and T. Zhang and thank B. Fowle for assistance with electron microscopy. This work was supported by the National Institutes of Health (NIH) grant R01 95281, the Doris Duke Foundation Distinguished Clinical Investigator Award, the National Foundation for Cancer Research grant and the Howard Hughes Medical Institute ( to D. A. H.); NIH grants CA080111 and CA089393 and the Breast Cancer Research Foundation ( to J. S. B.); NIH T32 training grants CA09361-27 ( to J. Z.) and CA09361 ( to M. O.); NIH grants F32 CA117737 ( to G. A. S.); NIH grants GM81607 and GM053203 and the Saltonstall Foundation ( to N. J. D.); and the Tosteson postdoctoral Fellowship ( to J. Y. J.).	Berasain C, 2005, J BIOL CHEM, V280, P19012, DOI 10.1074/jbc.M413344200; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SOULE HD, 1990, CANCER RES, V50, P6075; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	31	307	315	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1444	U134		10.1038/ncb1993	http://dx.doi.org/10.1038/ncb1993			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935651	Green Accepted			2022-12-25	WOS:000272251300011
J	Albizu, L; Cottet, M; Kralikova, M; Stoev, S; Seyer, R; Brabet, I; Roux, T; Bazin, H; Bourrier, E; Lamarque, L; Breton, C; Rives, ML; Newman, A; Javitch, J; Trinquet, E; Manning, M; Pin, JP; Mouillac, B; Durroux, T				Albizu, Laura; Cottet, Martin; Kralikova, Michaela; Stoev, Stoytcho; Seyer, Rene; Brabet, Isabelle; Roux, Thomas; Bazin, Herve; Bourrier, Emmanuel; Lamarque, Laurent; Breton, Christophe; Rives, Marie-Laure; Newman, Amy; Javitch, Jonathan; Trinquet, Eric; Manning, Maurice; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry			Time-resolved FRET between GPCR ligands reveals oligomers in native tissues	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED-RECEPTORS; HUMAN OXYTOCIN RECEPTOR; FLUORESCENCE ENERGY-TRANSFER; VASOPRESSIN RECEPTOR; PEPTIDE ANTAGONIST; BINDING-PROPERTIES; HORMONE-RECEPTORS; DIMERIC GPCR; HUMAN V1A; IN-VIVO	G protein-coupled receptor (GPCR) oligomers have been proposed to play critical roles in cell signaling, but confirmation of their existence in a native context remains elusive, as no direct interactions between receptors have been reported. To demonstrate their presence in native tissues, we developed a time-resolved FRET strategy that is based on receptor labeling with selective fluorescent ligands. Specific FRET signals were observed with four different receptors expressed in cell lines, consistent with their dimeric or oligomeric nature in these transfected cells. More notably, the comparison between FRET signals measured with sets of fluorescent agonists and antagonists was consistent with an asymmetric relationship of the two protomers in an activated GPCR dimer. Finally, we applied the strategy to native tissues and succeeded in demonstrating the presence of oxytocin receptor dimers and/or oligomers in mammary gland.	[Albizu, Laura; Cottet, Martin; Seyer, Rene; Brabet, Isabelle; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry] CNRS, Inst Genom Fonct, Montpellier, France; [Albizu, Laura; Cottet, Martin; Seyer, Rene; Brabet, Isabelle; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry] INSERM, Montpellier, France; [Albizu, Laura; Cottet, Martin; Seyer, Rene; Brabet, Isabelle; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry] Univ Montpellier I, Montpellier, France; [Albizu, Laura; Cottet, Martin; Seyer, Rene; Brabet, Isabelle; Pin, Jean-Philippe; Mouillac, Bernard; Durroux, Thierry] Univ Montpellier 2, Montpellier, France; [Kralikova, Michaela; Rives, Marie-Laure; Javitch, Jonathan] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Kralikova, Michaela; Rives, Marie-Laure; Javitch, Jonathan] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Kralikova, Michaela; Rives, Marie-Laure; Javitch, Jonathan] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Stoev, Stoytcho; Manning, Maurice] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Roux, Thomas; Bazin, Herve; Bourrier, Emmanuel; Lamarque, Laurent; Trinquet, Eric] Cisbio Bioassays, Bagnols Sur Ceze, France; [Breton, Christophe] Univ Sci & Technol Lille, Dept Physiol, Lab Neuroendocrinol Dev, Villeneuve Dascq, France; [Newman, Amy] NIDA, Med Chem Sect, Intramural Res Program, NIH, Baltimore, MD USA; [Javitch, Jonathan] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Albizu, Laura; Kralikova, Michaela] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Albizu, Laura; Kralikova, Michaela] Acad Sci Czech Republic, Dept Auditory Neurosci, Prague, Czech Republic	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Columbia University; Columbia University; New York State Psychiatry Institute; University System of Ohio; University of Toledo; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Icahn School of Medicine at Mount Sinai; Czech Academy of Sciences	Pin, JP (corresponding author), CNRS, Inst Genom Fonct, Montpellier, France.	jppin@igf.cnrs.fr; bmouillac@igf.cnrs.fr; tdurroux@igf.cnrs.fr	MOUILLAC, Bernard/M-3896-2014; Kralikova, Michaela/H-2588-2014; Pin, Jean-Philippe/Y-6668-2019	MOUILLAC, Bernard/0000-0002-3906-8673; Pin, Jean-Philippe/0000-0002-1423-345X; Durroux, Thierry/0000-0003-1091-6066; Rives, Marie-Laure/0000-0003-3324-2412; Javitch, Jonathan/0000-0001-7395-2967	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Actions Concertees Incitatives "Molecules Cibles et Therapeutiques" [240, 355, ANR-06-BLAN-0087-03, ANR-09-BLAN-0272]; US National Institutes of Health [GM025280, DA022413, MH54137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, ZIADA000424] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Actions Concertees Incitatives "Molecules Cibles et Therapeutiques"; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Thanks are due to S. Granier, P. Rondard and L. Prezeau for their critical reading of the manuscript. This work was supported by research grants from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Actions Concertees Incitatives "Molecules Cibles et Therapeutiques" (no. 240 and 355), ANR-06-BLAN-0087-03 and ANR-09-BLAN-0272) and the US National Institutes of Health (grants GM025280, DA022413, MH54137). This work was also made possible by the Plateforme de Pharmacologie-Criblage of Montpellier and the Region Languedoc-Roussillon. NAPS and PPHT amines were synthesized by the National Institute of Mental Health Chemical Synthesis and Drug Supply Program and provided by A.N. and J.J.	Albizu L, 2007, J MED CHEM, V50, P4976, DOI 10.1021/jm061404q; Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Breton C, 2001, J BIOL CHEM, V276, P26931, DOI 10.1074/jbc.M102073200; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; Christopoulos A, 1997, BIOCHEM PHARMACOL, V53, P795, DOI 10.1016/S0006-2952(96)00814-3; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Ciruela F, 2001, J BIOL CHEM, V276, P18345, DOI 10.1074/jbc.M006960200; Cotte N, 1998, J BIOL CHEM, V273, P29462, DOI 10.1074/jbc.273.45.29462; Cottet M, 2010, CURR OPIN PHARMACOL, V10, P59, DOI 10.1016/j.coph.2009.10.003; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Devost D, 2003, J MOL ENDOCRINOL, V31, P461, DOI 10.1677/jme.0.0310461; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Durroux T, 1999, J MED CHEM, V42, P1312, DOI 10.1021/jm9804782; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; MATHIS G, 1995, CLIN CHEM, V41, P1391; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mouillac B, 2008, MINI-REV MED CHEM, V8, P996, DOI 10.2174/138955708785740607; Mouillac B, 1998, ADV EXP MED BIOL, V449, P359; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Phalipou S, 1997, J BIOL CHEM, V272, P26536, DOI 10.1074/jbc.272.42.26536; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Serradeil-Le Gal C, 2000, KIDNEY INT, V58, P1613, DOI 10.1046/j.1523-1755.2000.00322.x; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2002, J MED CHEM, V45, P2579, DOI 10.1021/jm010526+; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vivo M, 2006, MOL PHARMACOL, V69, P226, DOI 10.1124/mol.105.012443; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488	50	263	269	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					587	594		10.1038/NCHEMBIO.396	http://dx.doi.org/10.1038/NCHEMBIO.396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20622858	Green Accepted, Green Published			2022-12-25	WOS:000280096600009
J	Fallarino, F; Volpi, C; Fazio, F; Notartomaso, S; Vacca, C; Busceti, C; Bicciato, S; Battaglia, G; Bruno, V; Puccetti, P; Fioretti, MC; Nicoletti, F; Grohmann, U; Di Marco, R				Fallarino, Francesca; Volpi, Claudia; Fazio, Francesco; Notartomaso, Serena; Vacca, Carmine; Busceti, Carla; Bicciato, Silvio; Battaglia, Giuseppe; Bruno, Valeria; Puccetti, Paolo; Fioretti, Maria C.; Nicoletti, Ferdinando; Grohmann, Ursula; Di Marco, Roberto			Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; T-CELL; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; TH17 CELLS; EXPRESSION; INFLAMMATION; ACTIVATION; DIFFERENTIATION	High amounts of glutamate are found in the brains of people with multiple sclerosis, an inflammatory disease marked by progressive demyelination. Glutamate might affect neuroinflammation via effects on immune cells. Knockout mice lacking metabotropic glutamate receptor-4 (mGluR4) were markedly vulnerable to experimental autoimmune encephalomyelitis (EAE, a mouse model of multiple sclerosis) and developed responses dominated by interleukin-17-producing T helper (T(H)17) cells. In dendritic cells (DCs) from those mice, defective mGluR4 signaling-which would normally decrease intracellular cAMP formation-biased T(H) cell commitment to the T(H)17 phenotype. In wild-type mice, mGluR4 was constitutively expressed in all peripheral DCs, and this expression increased after cell activation. Treatment of wild-type mice with a selective mGluR4 enhancer increased EAE resistance via regulatory T (T(reg)) cells. The high amounts of glutamate in neuroinflammation might reflect a counterregulatory mechanism that is protective in nature and might be harnessed therapeutically for restricting immunopathology in multiple sclerosis.	[Fallarino, Francesca; Volpi, Claudia; Vacca, Carmine; Puccetti, Paolo; Fioretti, Maria C.; Grohmann, Ursula] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Fazio, Francesco; Notartomaso, Serena; Busceti, Carla; Battaglia, Giuseppe; Bruno, Valeria; Nicoletti, Ferdinando; Di Marco, Roberto] Ist Neurol Mediterraneo, Pozzilli, Italy; [Notartomaso, Serena; Di Marco, Roberto] Univ Molise, Dept Hlth Sci, Campobasso, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy	University of Perugia; IRCCS Neuromed; University of Molise; Universita di Modena e Reggio Emilia; Sapienza University Rome	Grohmann, U (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	ugrohmann@tin.it	Notartomaso, Serena/A-9118-2013; bruno, Valeria/F-3146-2012; Nicoletti, Ferdinando/K-4410-2016; Bicciato, Silvio/C-9825-2009; Fallarino, Francesca/O-3358-2013; Battaglia, Giuseppe/A-7709-2010; Di Marco, Roberto/G-7765-2012; BICCIATO, Silvio/J-4466-2019; Vacca, Carmine/AAE-7046-2019; notartomaso, serena/S-1810-2019; Grohmann, Ursula/T-6545-2019; Busceti, Carla Letizia/K-6485-2016; Notartomaso, Serena/K-1642-2016; Busceti, Carla Letizia/F-9941-2011; Nicoletti, Ferdinando/T-4898-2019; Fazio, Francesco/B-5662-2013; Nicoletti, Ferdinando/A-2446-2010	bruno, Valeria/0000-0003-4231-0739; Bicciato, Silvio/0000-0002-1944-7078; Fallarino, Francesca/0000-0002-8501-2136; Battaglia, Giuseppe/0000-0001-7571-3417; Di Marco, Roberto/0000-0001-5075-4597; BICCIATO, Silvio/0000-0002-1944-7078; Vacca, Carmine/0000-0002-3799-8164; notartomaso, serena/0000-0003-4374-9233; Busceti, Carla Letizia/0000-0002-1417-1893; Notartomaso, Serena/0000-0003-4374-9233; Fazio, Francesco/0000-0003-2662-1588; VOLPI, CLAUDIA/0000-0002-3967-7954; Nicoletti, Ferdinando/0000-0003-0917-443X; Grohmann, Ursula/0000-0001-7952-1850; NICOLETTI, Ferdinando/0000-0003-3366-7269; Puccetti, Paolo/0000-0001-6674-2128	Fondazione Italiana Sclerosi Multipla [2008/R/2]	Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by Fondazione Italiana Sclerosi Multipla Project No. 2008/R/2 (to G.B., U.G. and R.D.M.). We thank G. Andrielli for digital art and image editing, P. Scarselli for technical support and S. Iacobelli for statistical advice.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Besong G, 2002, J NEUROSCI, V22, P5403; Betti M, 2006, ANN ONCOL, V17, P235; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Chen TC, 1998, LAB INVEST, V78, P165; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2009, J EXP MED, V206, P2511, DOI 10.1084/jem.20090134; Fazio F, 2008, NEUROPHARMACOLOGY, V55, P491, DOI 10.1016/j.neuropharm.2008.06.066; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li K, 2008, BLOOD, V112, P5084, DOI 10.1182/blood-2008-05-156646; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Matrisciano F, 2008, NEUROPHARMACOLOGY, V55, P525, DOI 10.1016/j.neuropharm.2008.05.014; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Ngomba RT, 2008, NEUROPHARMACOLOGY, V54, P344, DOI 10.1016/j.neuropharm.2007.10.004; Orabona C, 2005, EUR J IMMUNOL, V35, P3111, DOI 10.1002/eji.200535289; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Pampliega O, 2008, J NEUROIMMUNOL, V195, P194, DOI 10.1016/j.jneuroim.2008.01.011; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Segal B, 2010, SEMIN IMMUNOPATHOL, V32, P71, DOI 10.1007/s00281-009-0186-z; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Storto M, 2000, J NEUROIMMUNOL, V109, P112, DOI 10.1016/S0165-5728(00)00269-1; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zozulya AL, 2010, J MOL MED, V88, P535, DOI 10.1007/s00109-010-0607-4	51	112	116	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					897	U94		10.1038/nm.2183	http://dx.doi.org/10.1038/nm.2183			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20657581				2022-12-25	WOS:000280649200029
J	Ravikumar, B; Moreau, K; Jahreiss, L; Puri, C; Rubinsztein, DC				Ravikumar, Brinda; Moreau, Kevin; Jahreiss, Luca; Puri, Claudia; Rubinsztein, David C.			Plasma membrane contributes to the formation of pre-autophagosomal structures	NATURE CELL BIOLOGY			English	Article							MUTANT HUNTINGTIN; PROTEIN; CELL; PHOSPHOINOSITIDES; AGGREGATION; ENDOCYTOSIS; BIOGENESIS; LIPIDATION; MATURATION; DISEASE	Autophagy is a catabolic process in which lysosomes degrade cytoplasmic contents transported in double-membraned autophagosomes. Autophagosomes are formed by the elongation and fusion of phagophores, which derive from pre-autophagosomal structures. The membrane origins of autophagosomes are unclear and may involve multiple sources, including the endoplasmic reticulum and mitochondria. Here we show in mammalian cells that the heavy chain of clathrin interacts with Atg16L1 and is involved in the formation of Atg16L1-positive early autophagosome precursors. Atg16L1 associated with clathrin-coated structures, and inhibition of clathrin-mediated internalization decreased the formation of both Atg16L1-positive precursors and mature autophagosomes. We demonstrated that the plasma membrane contributes directly to the formation of early Atg16L1-positive autophagosome precursors. This may be particularly important during periods of increased autophagosome formation, because the plasma membrane may serve as a large membrane reservoir that allows periods of autophagosome synthesis at levels many-fold higher than under basal conditions, without compromising other processes.	[Ravikumar, Brinda; Moreau, Kevin; Jahreiss, Luca; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; [Puri, Claudia] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011		Wellcome Trust; MRC; Cancer Research UK; MRC [G0600194] Funding Source: UKRI; Medical Research Council [G0600194] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to P. Luzio, V. Korolchuk, F. Menzies and S. Sarkar, Cambridge Institute for Medical Research, Cambridge for helpful comments, and for funding from a Wellcome Trust Senior Clinical Research Fellowship (D.C.R.), a MRC Programme grant (D.C.R.), Cancer Research UK (CP.). We thank M. Mizuguchi, Toyama Medical and Pharmaceutical University, Toyama, for hLC3B; R. Tsien, University of California, San Diego, for tdTomato; R. Xavier, Massachusetts General Hospital, Boston, for 3 x Flag Atg16L1; T. Yoshimori, Osaka University, Osaka, for cyan fluorescent protein (CFP)-LC3 and GFP Atg5; B. Beaumelle, Universite Montpellier 2, France, for dominant-negative dynamin II; T. Meyer, Stanford University Medical Center, Stanford, for PLC(PH); and M. Harbour, Cambridge Institute for Medical Research, Cambridge, for help with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	31	627	646	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2010	12	8					747	U15		10.1038/ncb2078	http://dx.doi.org/10.1038/ncb2078			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	634EF	20639872	Green Accepted			2022-12-25	WOS:000280561600007
J	Quan, C; Ren, YQ; Xiang, LH; Sun, LD; Xu, AE; Gao, XH; Chen, HD; Pu, XM; Wu, RN; Liang, CZ; Li, JB; Gao, TW; Zhang, JZ; Wang, XL; Wang, J; Yang, RY; Liang, L; Yu, JB; Zuo, XB; Zhang, SQ; Zhang, SM; Chen, G; Zheng, XD; Li, P; Zhu, J; Li, YW; Wei, XD; Hong, WS; Ye, Y; Zhang, Y; Wu, WS; Cheng, H; Dong, PL; Hu, DY; Li, Y; Li, M; Zhang, X; Tang, HY; Tang, XF; Xu, SX; He, SM; Lv, YM; Shen, M; Jiang, HQ; Wang, Y; Li, K; Kang, XJ; Liu, YQ; Sun, L; Liu, ZF; Xie, SQ; Zhu, CY; Xu, QA; Gao, JP; Hu, WL; Ni, C; Pan, TM; Li, Y; Yao, S; He, CF; Liu, YS; Yu, ZY; Yin, XY; Zhang, FY; Yang, S; Zhou, YW; Zhang, XJ				Quan, Cheng; Ren, Yun-Qing; Xiang, Lei-Hong; Sun, Liang-Dan; Xu, Ai-E; Gao, Xing-Hua; Chen, Hong-Duo; Pu, Xiong-Ming; Wu, Ri-Na; Liang, Chao-Zhao; Li, Jia-Bin; Gao, Tian-Wen; Zhang, Jian-Zhong; Wang, Xiu-Li; Wang, Jun; Yang, Rong-Ya; Liang, Ling; Yu, Jian-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song; Ye, Ying; Zhang, Yong; Wu, Wei-Su; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Shen, Min; Jiang, Hong-Quan; Wang, Ying; Li, Kai; Kang, Xiao-Jing; Liu, Yu-Qin; Sun, Li; Liu, Zhi-Fang; Xie, Shao-Qiong; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun			Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC	NATURE GENETICS			English	Article							GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; ROMANIAN POPULATION; IN-VIVO; GENE; HLA; LINKAGE; FAMILIES; FOP; EPIDEMIOLOGY	We conducted a genome-wide association study of generalized vitiligo in the Chinese Han population by genotyping 1,117 cases and 1,429 controls. The 34 most promising SNPs were carried forward for replication in samples from individuals of the Chinese Han (5,910 cases and 9,916 controls) and Chinese Uygur (713 cases and 824 controls) populations. We identified two independent association signals within the major histocompatibility complex (MHC) region (rs11966200, P-combined = 1.48 x 10(-48), OR = 1.90; rs9468925, P-combined = 2.21 x 10(-33), OR = 0.74). Further analyses suggested that the strong association at rs11966200 might reflect the reported association of the HLA-A*3001, HLA-B*1302, HLA-C*0602 and HLA-DRB1*0701 alleles and that the association at rs9468925 might represent a previously unknown HLA susceptibility allele. We also identified one previously undescribed risk locus at 6q27 (rs2236313, P-combined = 9.72 x 10(-17), OR = 1.20), which contains three genes: RNASET2, FGFR1OP and CCR6. Our study provides new insights into the genetic basis of vitiligo.	[Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Xu, Ai-E; Pu, Xiong-Ming; Liang, Chao-Zhao; Li, Jia-Bin; Wang, Xiu-Li; Yang, Rong-Ya; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Kang, Xiao-Jing; Liu, Yu-Qin; Xie, Shao-Qiong; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol & Venerol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Xiang, Lei-Hong; Ye, Ying; Zhang, Yong; Zhang, Xue-Jun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Xu, Ai-E; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song] Third Peoples Hosp Hangzhou, Hangzhou, Zhejiang, Peoples R China; [Gao, Xing-Hua; Chen, Hong-Duo; Wu, Wei-Su] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Liaoning, Peoples R China; [Pu, Xiong-Ming; Kang, Xiao-Jing; Liu, Yu-Qin] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi, Xinjiang, Peoples R China; [Wu, Ri-Na; Sun, Li; Liu, Zhi-Fang] Inner Mongolia Med Coll, Affiliated Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Gao, Tian-Wen; Li, Kai] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Zhang, Jian-Zhong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Wang, Xiu-Li; Xie, Shao-Qiong] Shanghai Skin Dis & STD Hosp, Shanghai, Peoples R China; [Wang, Jun] Yijishan Hosp, Wannan Med Coll, Dept Dermatol, Wuhu, Anhui, Peoples R China; [Yang, Rong-Ya] Beijing Mil Command PLA, Gen Hosp, Dept Dermatol, Beijing, Peoples R China; [Liang, Ling] Guangxi Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanning, Guangxi, Peoples R China; [Yu, Jian-Bin] Zhengzhou Univ, Affiliated Hosp 1, Dept Dermatol, Zhengzhou, Henan, Peoples R China; [Shen, Min; Jiang, Hong-Quan; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Fudan University; China Medical University; Inner Mongolia Medical University; Air Force Military Medical University; Peking University; Wannan Medical College; Academy of Military Medical Sciences - China; Guangxi Medical University; Zhengzhou University	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China.	Youwen.Zhou@vch.ca; ayzxj@vip.sina.com	Hu, Wenlong/GQY-6243-2022; Zhang, Fengyu/M-1396-2019; Chen, Gang/G-2722-2010	Hu, Wenlong/0000-0001-9706-3769; Zhang, Fengyu/0000-0001-8504-0770; 	Chinese National Natural Science Foundation [30530670]; Chinese Key National Natural Science Foundation for Overseas Youth [30628021]; Anhui Provincial Special Scientific Program	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Key National Natural Science Foundation for Overseas Youth(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program	We thank all study participants. We also thank J.-J. Liu, J.-M. Chen and K. Seng Sim at the Genome Institute of Singapore for performing the imputation, association and LD analyses of HLA alleles. This study was supported in part by the Key Project of the Chinese National Natural Science Foundation (No. 30530670), the Cooperation Project of the Chinese Key National Natural Science Foundation for Overseas Youth (No. 30628021) and the Anhui Provincial Special Scientific Program (2007-7).	Acquati F, 2001, ONCOGENE, V20, P980, DOI 10.1038/sj.onc.1204178; Acquaviva C, 2009, CELL CYCLE, V8, P1217, DOI 10.4161/cc.8.8.8248; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Arcos-Burgos M, 2002, HUM GENET, V110, P334, DOI 10.1007/s00439-002-0687-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birlea SA, 2008, ARCH DERMATOL, V144, P310, DOI 10.1001/archderm.144.3.310; Birlea SA, 2010, J INVEST DERMATOL, V130, P798, DOI 10.1038/jid.2009.347; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Chen JJ, 2005, AM J HUM GENET, V76, P1057, DOI 10.1086/430279; DAS S K, 1985, Genetic Epidemiology, V2, P71; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hann S, 2000, VITILIGO; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Levy C, 2006, BLOOD, V107, P2839, DOI 10.1182/blood-2005-08-3325; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Monti L, 2008, ONCOL RES, V17, P69, DOI 10.3727/096504008784523658; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; PORTER J, 1979, GEN HOSP PSYCHIAT, V1, P73, DOI 10.1016/0163-8343(79)90081-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Tastan HB, 2004, PIGM CELL RES, V17, P181, DOI 10.1111/j.1600-0749.2004.00141.x; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Zamani M, 2001, BRIT J DERMATOL, V145, P90, DOI 10.1046/j.1365-2133.2001.04288.x; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang XJ, 2004, J AM ACAD DERMATOL, V51, P383, DOI 10.1016/j.jaad.2003.12.044; Zhang XJ, 2004, J DERMATOL SCI, V35, P165, DOI 10.1016/j.jdermsci.2004.05.003; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang Z, 2009, ARCH DERMATOL RES, V301, P167, DOI 10.1007/s00403-008-0900-z	47	128	143	4	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					614	U192		10.1038/ng.603	http://dx.doi.org/10.1038/ng.603			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20526339				2022-12-25	WOS:000279242400015
J	Zhu, H; Shah, S; Shyh-Chang, N; Shinoda, G; Einhorn, WS; Viswanathan, SR; Takeuchi, A; Grasemann, C; Rinn, JL; Lopez, MF; Hirschhorn, JN; Palmert, MR; Daley, GQ				Zhu, Hao; Shah, Samar; Shyh-Chang, Ng; Shinoda, Gen; Einhorn, William S.; Viswanathan, Srinivas R.; Takeuchi, Ayumu; Grasemann, Corinna; Rinn, John L.; Lopez, Mary F.; Hirschhorn, Joel N.; Palmert, Mark R.; Daley, George Q.			Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MESSENGER-RNA; PYRUVATE-KINASE; SELF-RENEWAL; EXPRESSION; LIN-28; LOCI; GROWTH; AGE; TRANSACTIVATION	Recently, genome-wide association studies have implicated the human LIN28B locus in regulating height and the timing of menarche(1-5). LIN28B and its homolog LIN28A are functionally redundant RNA-binding proteins that block biogenesis of let-7 microRNAs(6-9). lin-28 and let-7 were discovered in Caenorhabditis elegans as heterochronic regulators of larval and vulval development but have recently been implicated in cancer, stem cell aging and pluripotency(10-13). The let-7 targets Myc, Kras, Igf2bp1 and Hmga2 are known regulators of mammalian body size and metabolism(14-18). To explore the function of the Lin28-Let-7 pathway in vivo, we engineered transgenic mice to express Lin28a and observed in them increased body size, crown-rump length and delayed onset of puberty. Investigation of metabolic and endocrine mechanisms of overgrowth in these transgenic mice revealed increased glucose metabolism and insulin sensitivity. Here we report a mouse that models the human phenotypes associated with genetic variation in the Lin28-Let-7 pathway.	[Zhu, Hao; Shah, Samar; Shyh-Chang, Ng; Shinoda, Gen; Einhorn, William S.; Viswanathan, Srinivas R.; Takeuchi, Ayumu; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Zhu, Hao] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zhu, Hao; Shah, Samar; Shyh-Chang, Ng; Shinoda, Gen; Einhorn, William S.; Viswanathan, Srinivas R.; Takeuchi, Ayumu; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [Einhorn, William S.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Grasemann, Corinna; Palmert, Mark R.] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Grasemann, Corinna; Palmert, Mark R.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Rinn, John L.; Hirschhorn, Joel N.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Rinn, John L.; Hirschhorn, Joel N.] MIT, Cambridge, MA 02139 USA; [Rinn, John L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Lopez, Mary F.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Grasemann, Corinna/AAG-3861-2021; Zhu, Hao/L-5114-2013; Viswanathan, Srinivas/ABA-6316-2021	Zhu, Hao/0000-0002-8417-9698; Viswanathan, Srinivas/0000-0003-1856-3023; Shyh-Chang, Ng/0000-0003-3138-9525; Grasemann, Corinna/0000-0003-1793-4603; Rinn, John/0000-0002-7231-7539	Graduate Training in Cancer Research [5 T32 CA09172-35]; NIH [R01HD048960]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048960] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA157727, T32CA009172] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	Graduate Training in Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Lin28a knockout mice were generously provided by Eric Moss at The University of Medicine and Dentistry of New Jersey and will be described separately (S.R.V., G.S., H.Z., W.S.E., G.C. Heffner et al., unpublished data). We acknowledge J. Powers, H. Rajagopalan and M. Kharas for invaluable discussions and advice regarding this work. We also thank Y.-H. Loh, M. White, L. Wang and J. Majzoub for in-depth discussion and endocrine expertise. This work was supported by a Graduate Training in Cancer Research Grant (5 T32 CA09172-35) to H.Z., a NIH grant (R01HD048960) to M.R.P., a NIH Directors Pioneer Award and a HHMI grant to G.Q.D.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; ELLIOTT M, 1994, CLIN GENET, V46, P168; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nathan BM, 2006, ENDOCRINOLOGY, V147, P5132, DOI 10.1210/en.2006-0745; Nathan BM, 2006, MOL CELL ENDOCRINOL, V254, P103, DOI 10.1016/j.mce.2006.04.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	40	231	246	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					626	U106		10.1038/ng.593	http://dx.doi.org/10.1038/ng.593			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20512147	Green Accepted			2022-12-25	WOS:000279242400017
J	Ong, DST; Mu, TW; Palmer, AE; Kelly, JW				Ong, Derrick Sek Tong; Mu, Ting-Wei; Palmer, Amy E.; Kelly, Jeffery W.			Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK FACTOR-1; CHEMICAL CHAPERONES; RYANODINE RECEPTOR; BETA-GLUCOSIDASE; CALCIUM-RELEASE; CALNEXIN; BINDING; PROTEINS; DEGRADATION; STORAGE	Altering intracellular calcium levels is known to partially restore mutant enzyme homeostasis in several lysosomal storage diseases, but why? We hypothesized that endoplasmic reticulum (ER) calcium increases enhance the folding, trafficking and function of these mutant misfolding- and degradation-prone lysosomal enzymes by increasing chaperone function. Here we report that increasing ER calcium levels by reducing ER calcium efflux through the ryanodine receptor, using antagonists or RNAi, or by promoting ER calcium influx by SERCA2b overexpression enhances mutant glucocerebrosidase (GC) homeo stasis in cells derived from individuals with Gaucher's disease. Post-translational regulation of the calnexin folding pathway by an elevated ER calcium concentration seems to enhance the capacity of this chaperone system to fold mutant misfolding-prone enzymes, increasing the folded mutant GC population that can engage the trafficking receptor at the expense of ER-associated degradation, increasing the lysosomal GC concentration and activity.	[Ong, Derrick Sek Tong; Mu, Ting-Wei; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Ong, Derrick Sek Tong; Mu, Ting-Wei; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Scripps Research Institute; Scripps Research Institute; University of Colorado System; University of Colorado Boulder	Ong, DST (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	jkelly@scripps.edu	Mu, Tingwei/AAU-8596-2020	Mu, Tingwei/0000-0002-6419-9296	NIH [DK75295, GM084027]; Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for their generosity in providing us with plasmids: W.E. Balch (The Scripps Research Institute) for pcDNA3.1+ VSVG, E. Beutler (The Scripps Research Institute) for WT GC cDNA, M. Brenner (Harvard Medical School) for Ap<SUP>r</SUP>-M8-CNX, K. Green (University of California, Irvine) for SERCA2 cDNA and T. Mizushima (Kumamoto University) for pCR(HA) and pcDNA3.1-GRP78. We thank H. Aerts (University of Amsterdam) for the mouse monoclonal anti-GC 8E4, W.E. Balch (The Scripps Research Institute) for mouse monoclonal anti-VSVG, M. Fukuda (Burnham Institute) for the rabbit anti-LAMP2 and C. Fearns for critical feedback on the manuscript. This work was supported by the NIH (DK75295), the Skaggs Institute for Chemical Biology and the Lita Annenberg Hazen Foundation. A.E.P. was supported by the NIH (GM084027).	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; DAVID V, 1993, J BIOL CHEM, V268, P9585; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; KANG JJ, 1994, BRIT J PHARMACOL, V112, P1216, DOI 10.1111/j.1476-5381.1994.tb13213.x; Keller SH, 1998, J BIOL CHEM, V273, P17064, DOI 10.1074/jbc.273.27.17064; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; LE AQ, 1994, J BIOL CHEM, V269, P7514; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; SHOSHANBARMATZ V, 1991, BIOCHEM J, V276, P41, DOI 10.1042/bj2760041; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; VALDIVIA HH, 1990, BIOPHYS J, V58, P471, DOI 10.1016/S0006-3495(90)82392-4; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wang J, 2000, BIOCHEMISTRY-US, V39, P8993, DOI 10.1021/bi000027v; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD A, 1986, DRUGS, V32, P130, DOI 10.2165/00003495-198632020-00003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zimmer KP, 1999, J PATHOL, V188, P407	50	65	66	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2010	6	6					424	432		10.1038/nchembio.368	http://dx.doi.org/10.1038/nchembio.368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	597HS	20453863	Green Accepted			2022-12-25	WOS:000277748100012
J	Sanna, S; Pitzalis, M; Zoledziewska, M; Zara, I; Sidore, C; Murru, R; Whalen, MB; Busonero, F; Maschio, A; Costa, G; Melis, MC; Deidda, F; Poddie, F; Morelli, L; Farina, G; Li, Y; Dei, M; Lai, S; Mulas, A; Cuccuru, G; Porcu, E; Liang, LM; Zavattari, P; Moi, L; Deriu, E; Urru, MF; Bajorek, M; Satta, MA; Cocco, E; Ferrigno, P; Sotgiu, S; Pugliatti, M; Traccis, S; Angius, A; Melis, M; Rosati, G; Abecasis, GR; Uda, M; Marrosu, MG; Schlessinger, D; Cucca, F				Sanna, Serena; Pitzalis, Maristella; Zoledziewska, Magdalena; Zara, Ilenia; Sidore, Carlo; Murru, Raffaele; Whalen, Michael B.; Busonero, Fabio; Maschio, Andrea; Costa, Gianna; Melis, Maria Cristina; Deidda, Francesca; Poddie, Fausto; Morelli, Laura; Farina, Gabriele; Li, Yun; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Cuccuru, Gianmauro; Porcu, Eleonora; Liang, Liming; Zavattari, Patrizia; Moi, Loredana; Deriu, Elisa; Urru, M. Francesca; Bajorek, Michele; Satta, Maria Anna; Cocco, Eleonora; Ferrigno, Paola; Sotgiu, Stefano; Pugliatti, Maura; Traccis, Sebastiano; Angius, Andrea; Melis, Maurizio; Rosati, Giulio; Abecasis, Goncalo R.; Uda, Manuela; Marrosu, Maria Giovanna; Schlessinger, David; Cucca, Francesco			Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis	NATURE GENETICS			English	Article							CELL ANERGY INDUCTION; SUSCEPTIBILITY LOCI; NEGATIVE REGULATION; ACTIVATION	A genome-wide association scan of similar to 6.6 million genotyped or imputed variants in 882 Sardinian individuals with multiple sclerosis (cases) and 872 controls suggested association of CBLB gene variants with disease, which was confirmed in 1,775 cases and 2,005 controls (rs9657904, overall P = 1.60 x 10(-10), OR = 1.40). CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis.	[Sanna, Serena; Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Cuccuru, Gianmauro; Porcu, Eleonora; Uda, Manuela; Cucca, Francesco] CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy; [Pitzalis, Maristella; Zoledziewska, Magdalena; Deidda, Francesca; Poddie, Fausto; Morelli, Laura; Deriu, Elisa; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Zara, Ilenia] Ctr Adv Studies Res & Dev Sardinia CRS4, Lab Bioinformat, Pula, Italy; [Sidore, Carlo; Whalen, Michael B.; Urru, M. Francesca; Angius, Andrea] CRS4, Lab Genom, Pula, Italy; [Murru, Raffaele; Costa, Gianna; Melis, Maria Cristina; Moi, Loredana; Cocco, Eleonora; Marrosu, Maria Giovanna] Univ Cagliari, Dipartimento Sci Neurol & Cardiovasc, Ctr Sclerosi Multipla, Cagliari, Italy; [Farina, Gabriele; Sotgiu, Stefano; Pugliatti, Maura; Rosati, Giulio] Univ Sassari, Ist Clin Neurol, I-07100 Sassari, Italy; [Li, Yun; Liang, Liming; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Zavattari, Patrizia] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; [Bajorek, Michele] Azienda Osped Brotzu, Ctr Trasfusionale, Cagliari, Italy; [Satta, Maria Anna] Azienda Sanit Locale 1, Sassari, Italy; [Ferrigno, Paola; Melis, Maurizio] Azienda Osped Brotzu, Div Neurol, Cagliari, Italy; [Traccis, Sebastiano] Presidio Osped, Div Neurol, Ozieri, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Cagliari; University of Sassari; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cucca, F (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy.	francesco.cucca@inn.cnr.it	Mulas, Antonella/B-4231-2015; Angius, Andrea/P-9549-2015; sanna, serena/H-3009-2019; Angius, Andrea/B-8966-2015; Pugliatti, Maura/K-4071-2016; Cocco, Eleonora/G-5064-2012; sotgiu, stefano/M-1011-2017; Abecasis, Goncalo R/B-7840-2010; Lai, Sandra/AAY-4176-2020; Maschio, Andrea/AAX-8185-2020; Uda, Manuela/AAC-2645-2019; Sidore, Carlo/AAV-7967-2020; Dei, Mariano/AAY-3870-2020; Deidda, Francesca/P-1541-2018	Angius, Andrea/0000-0003-2596-6461; sanna, serena/0000-0002-3768-1749; Pugliatti, Maura/0000-0001-9396-8683; Cocco, Eleonora/0000-0002-3878-8820; Uda, Manuela/0000-0002-4890-6456; Sidore, Carlo/0000-0001-7504-7477; Deidda, Francesca/0000-0003-3447-7440; Zoledziewska, Magdalena/0000-0002-3033-6133; MURRU, RAFFAELE/0000-0001-8830-5084; Marrosu, Maria Giovanna/0000-0003-2334-2081; Mulas, Antonella/0000-0002-6856-1483; cuccuru, gianmauro/0000-0002-5335-545X; CUCCA, Francesco/0000-0002-7414-1995; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; Angius, Andrea/0000-0001-9372-1162; maschio, andrea/0000-0002-4238-9144; Pitzalis, Maristella/0000-0003-4975-6987; Poddie, Fausto PierAngelo/0000-0003-2893-9549; Abecasis, Goncalo/0000-0003-1509-1825; Dei, Mariano/0000-0002-7404-508X; LAI, SANDRA/0000-0003-4198-9989	Fondazione Italiana Sclerosi Multipla (FISM) [Cod. 2008/R/7]; Italian Ministry of Scientific Research (MIUR) [2007KXNKNP]; US National Institutes of Health [NO1-AG-1-2109]; National Institute of Aging (NIA); NIH [HG002651, HG005214, MH084698]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005214, R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM) Cod. 2008/R/7 to F.C., by the Italian Ministry of Scientific Research (MIUR grant 2007KXNKNP) and by US National Institutes of Health contract NO1-AG-1-2109 from National Institute of Aging (NIA) to the SardiNIA ('ProgeNIA') team. The contributions of G.R.A., Y.L. and L.L. were supported in part by NIH grants HG002651, HG005214 and MH084698.	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Loeser S, 2007, SEMIN IMMUNOL, V19, P206, DOI 10.1016/j.smim.2007.02.004; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Qiao GL, 2007, J IMMUNOL, V179, P4473, DOI 10.4049/jimmunol.179.7.4473; Schmitz ML, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.276pe38; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	14	130	133	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					495	497		10.1038/ng.584	http://dx.doi.org/10.1038/ng.584			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20453840	Green Submitted, Green Accepted			2022-12-25	WOS:000278081500013
J	Tomaselli, GF; Barth, AS				Tomaselli, Gordon F.; Barth, Andreas S.			Oxidative stress irritates the heart	NATURE MEDICINE			English	Editorial Material							II INHIBITION PROTECTS; RECEPTOR; MODULATION; COMPLEX		[Tomaselli, Gordon F.; Barth, Andreas S.] Johns Hopkins Univ, Div Cardiol, Baltimore, MD 21218 USA	Johns Hopkins University	Tomaselli, GF (corresponding author), Johns Hopkins Univ, Div Cardiol, Baltimore, MD 21218 USA.	gtomase1@jhmi.edu						[Anonymous], 1989, NEW ENGL J MED, V321, P406; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Munzel T, 2009, J AM COLL CARDIOL, V54, P1491, DOI 10.1016/j.jacc.2009.05.066; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	12	29	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					648	649		10.1038/nm0610-648	http://dx.doi.org/10.1038/nm0610-648			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20526319				2022-12-25	WOS:000278394200029
J	Hirota, Y; Cha, J; Dey, SK				Hirota, Yasushi; Cha, Jeeyeon; Dey, Sudhansu K.			Prematurity and the puzzle of progesterone resistance	NATURE MEDICINE			English	Editorial Material							PRETERM BIRTH; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; HUMAN PARTURITION; DOUBLE-BLIND; RECEPTOR; MYOMETRIUM; PREVENTION; WITHDRAWAL; MODELS; WOMEN		[Hirota, Yasushi; Cha, Jeeyeon; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center	Hirota, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH USA.	sk.dey@cchmc.org	Hirota, Yasushi/AAD-8713-2020	Hirota, Yasushi/0000-0003-0241-9780	NATIONAL INSTITUTE ON AGING [F30AG040858] Funding Source: NIH RePORTER; NIA NIH HHS [F30 AG040858] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; FAIMAN C, 1981, REPROD BIOL GREAT AP, P45; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FRYDMAN R, 1992, OBSTET GYNECOL, V80, P972; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; PINTO RM, 1967, AM J OBSTET GYNECOL, V98, P547, DOI 10.1016/0002-9378(67)90109-3; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808	19	17	17	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					529	531		10.1038/nm0510-529	http://dx.doi.org/10.1038/nm0510-529			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20448578	Green Accepted			2022-12-25	WOS:000277394700030
J	Kottgen, A; Pattaro, C; Boger, CA; Fuchsberger, C; Olden, M; Glazer, NL; Parsa, A; Gao, XY; Yang, Q; Smith, AV; O'Connell, JR; Li, M; Schmidt, H; Tanaka, T; Isaacs, A; Ketkar, S; Hwang, SJ; Johnson, AD; Dehghan, A; Teumer, A; Pare, G; Atkinson, EJ; Zeller, T; Lohman, K; Cornelis, MC; Probst-Hensch, NM; Kronenberg, F; Tonjes, A; Hayward, C; Aspelund, T; Eiriksdottir, G; Launer, LJ; Harris, TB; Rampersaud, E; Mitchell, BD; Arking, DE; Boerwinkle, E; Struchalin, M; Cavalieri, M; Singleton, A; Giallauria, F; Metter, J; de Boer, IH; Haritunians, T; Lumley, T; Siscovick, D; Psaty, BM; Zillikens, MC; Oostra, BA; Feitosa, M; Province, M; de Andrade, M; Turner, ST; Schillert, A; Ziegler, A; Wild, PS; Schnabel, RB; Wilde, S; Munzel, T; Leak, TS; Illig, T; Klopp, N; Meisinger, C; Wichmann, HE; Koenig, W; Zgaga, L; Zemunik, T; Kolcic, I; Minelli, C; Hu, FB; Johansson, A; Igl, W; Zaboli, G; Wild, SH; Wright, AF; Campbell, H; Ellinghaus, D; Schreiber, S; Aulchenko, YS; Felix, JF; Rivadeneira, F; Uitterlinden, AG; Hofman, A; Imboden, M; Nitsch, D; Brandstatter, A; Kollerits, B; Kedenko, L; Magi, R; Stumvoll, M; Kovacs, P; Boban, M; Campbell, S; Endlich, K; Volzke, H; Kroemer, HK; Nauck, M; Volker, U; Polasek, O; Vitart, V; Badola, S; Parker, AN; Ridker, PM; Kardia, SLR; Blankenberg, S; Liu, YM; Curhan, GC; Franke, A; Rochat, T; Paulweber, B; Prokopenko, I; Wang, W; Gudnason, V; Shuldiner, AR; Coresh, J; Schmidt, R; Ferrucci, L; Shlipak, MG; van Duijn, CM; Borecki, I; Kramer, BK; Rudan, I; Gyllensten, U; Wilson, JF; Witteman, JC; Pramstaller, PP; Rettig, R; Hastie, N; Chasman, DI; Kao, WH; Heid, IM; Fox, CS				Koettgen, Anna; Pattaro, Cristian; Boeger, Carsten A.; Fuchsberger, Christian; Olden, Matthias; Glazer, Nicole L.; Parsa, Afshin; Gao, Xiaoyi; Yang, Qiong; Smith, Albert V.; O'Connell, Jeffrey R.; Li, Man; Schmidt, Helena; Tanaka, Toshiko; Isaacs, Aaron; Ketkar, Shamika; Hwang, Shih-Jen; Johnson, Andrew D.; Dehghan, Abbas; Teumer, Alexander; Pare, Guillaume; Atkinson, Elizabeth J.; Zeller, Tanja; Lohman, Kurt; Cornelis, Marilyn C.; Probst-Hensch, Nicole M.; Kronenberg, Florian; Toenjes, Anke; Hayward, Caroline; Aspelund, Thor; Eiriksdottir, Gudny; Launer, Lenore J.; Harris, Tamara B.; Rampersaud, Evadnie; Mitchell, Braxton D.; Arking, Dan E.; Boerwinkle, Eric; Struchalin, Maksim; Cavalieri, Margherita; Singleton, Andrew; Giallauria, Francesco; Metter, Jeffrey; de Boer, Ian H.; Haritunians, Talin; Lumley, Thomas; Siscovick, David; Psaty, Bruce M.; Zillikens, M. Carola; Oostra, Ben A.; Feitosa, Mary; Province, Michael; de Andrade, Mariza; Turner, Stephen T.; Schillert, Arne; Ziegler, Andreas; Wild, Philipp S.; Schnabel, Renate B.; Wilde, Sandra; Munzel, Thomas; Leak, Tennille S.; Illig, Thomas; Klopp, Norman; Meisinger, Christa; Wichmann, H-Erich; Koenig, Wolfgang; Zgaga, Lina; Zemunik, Tatijana; Kolcic, Ivana; Minelli, Cosetta; Hu, Frank B.; Johansson, Asa; Igl, Wilmar; Zaboli, Ghazal; Wild, Sarah H.; Wright, Alan F.; Campbell, Harry; Ellinghaus, David; Schreiber, Stefan; Aulchenko, Yurii S.; Felix, Janine F.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Albert; Imboden, Medea; Nitsch, Dorothea; Brandstaetter, Anita; Kollerits, Barbara; Kedenko, Lyudmyla; Maegi, Reedik; Stumvoll, Michael; Kovacs, Peter; Boban, Mladen; Campbell, Susan; Endlich, Karlhans; Voelzke, Henry; Kroemer, Heyo K.; Nauck, Matthias; Voelker, Uwe; Polasek, Ozren; Vitart, Veronique; Badola, Sunita; Parker, Alexander N.; Ridker, Paul M.; Kardia, Sharon L. R.; Blankenberg, Stefan; Liu, Yongmei; Curhan, Gary C.; Franke, Andre; Rochat, Thierry; Paulweber, Bernhard; Prokopenko, Inga; Wang, Wei; Gudnason, Vilmundur; Shuldiner, Alan R.; Coresh, Josef; Schmidt, Reinhold; Ferrucci, Luigi; Shlipak, Michael G.; van Duijn, Cornelia M.; Borecki, Ingrid; Kraemer, Bernhard K.; Rudan, Igor; Gyllensten, Ulf; Wilson, James F.; Witteman, Jacqueline C.; Pramstaller, Peter P.; Rettig, Rainer; Hastie, Nick; Chasman, Daniel I.; Kao, W. H.; Heid, Iris M.; Fox, Caroline S.			New loci associated with kidney function and chronic kidney disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SERUM CREATININE; PROTEIN; GENE; MUTATIONS; VARIANTS; POPULATION; CANDIDATE; HOMOLOG; MEGALIN	Chronic kidney disease (CKD) is a significant public health problem, and recent genetic studies have identified common CKD susceptibility variants. The CKDGen consortium performed a meta-analysis of genome-wide association data in 67,093 individuals of European ancestry from 20 predominantly population-based studies in order to identify new susceptibility loci for reduced renal function as estimated by serum creat-inine (eGFRcrea), serum cystatin c (eGFRcys) and CKD (eGFRcrea < 60 ml/min/ 1.73 m(2); n = 5,807 individuals with CKD (cases)). Follow-up of the 23 new genome-wide-significant loci (P < 5 x 10(-8)) in 22,982 replication samples identified 13 new loci affecting renal function and CKD (in or near LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA, PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2 and SLC7A9) and 7 loci suspected to affect creatinine production and secretion (CPS1, SLC22A2, TMEM60, WDR37, SLC6A13, WDR72 and BCAS3). These results further our understanding of the biologic mechanisms of kidney function by identifying loci that potentially influence nephrogenesis, podocyte function, angiogenesis, solute transport and metabolic functions of the kidney.	[Hwang, Shih-Jen; Johnson, Andrew D.; Fox, Caroline S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Koettgen, Anna; Li, Man; Coresh, Josef; Kao, W. H.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Pattaro, Cristian; Fuchsberger, Christian; Minelli, Cosetta; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pattaro, Cristian; Fuchsberger, Christian; Minelli, Cosetta; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Boeger, Carsten A.; Olden, Matthias] Univ Med Ctr Regensburg, Dept Internal Med 2, Regensburg, Germany; [Olden, Matthias; Heid, Iris M.] Univ Med Ctr Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Parsa, Afshin; O'Connell, Jeffrey R.; Mitchell, Braxton D.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Gao, Xiaoyi; Ketkar, Shamika; Feitosa, Mary; Province, Michael; Borecki, Ingrid] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Austrian Stroke Prevent Study, Dept Neurogeriatr, Graz, Austria; [Schmidt, Helena] Med Univ Graz, Univ Clin Neurol, Graz, Austria; [Tanaka, Toshiko] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Tanaka, Toshiko] Medstar Res Inst, Baltimore, MD USA; [Isaacs, Aaron; Dehghan, Abbas; Oostra, Ben A.; Aulchenko, Yurii S.; Felix, Janine F.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Witteman, Jacqueline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hwang, Shih-Jen; Johnson, Andrew D.; Fox, Caroline S.] Ctr Populat Studies, Framingham, MA USA; [Dehghan, Abbas; Zillikens, M. Carola; Aulchenko, Yurii S.; Felix, Janine F.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Witteman, Jacqueline C.] NCHA, NGI, Leiden, Netherlands; [Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Atkinson, Elizabeth J.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Zeller, Tanja; Wild, Philipp S.; Schnabel, Renate B.; Wilde, Sandra; Munzel, Thomas; Blankenberg, Stefan] Univ Med Ctr Mainz, Dept Med 2, Mainz, Germany; [Lohman, Kurt] Wake Forest Univ, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Cornelis, Marilyn C.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Probst-Hensch, Nicole M.; Imboden, Medea] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Probst-Hensch, Nicole M.; Imboden, Medea] Univ Basel, Basel, Switzerland; [Kronenberg, Florian; Brandstaetter, Anita; Kollerits, Barbara] Innsbruck Med Univ, Div Genet Epidemiol, Innsbruck, Austria; [Toenjes, Anke; Stumvoll, Michael; Kovacs, Peter] Univ Leipzig, Dept Med, Leipzig, Germany; [Hayward, Caroline; Wright, Alan F.; Campbell, Susan; Voelker, Uwe; Vitart, Veronique; Hastie, Nick] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Rampersaud, Evadnie] Miami Inst Human Genom, Miami, FL USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Struchalin, Maksim] Dept Forens Mol Biol, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Cavalieri, Margherita; Schmidt, Reinhold] Med Univ Graz, Univ Clin Neurol, Austrian Stroke Prevent Study, Dept Neurogeriatr, Graz, Austria; [Singleton, Andrew] NIA, Lab Neurogenet, Bethesda, MD 20892 USA; [Giallauria, Francesco; Metter, Jeffrey; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [de Boer, Ian H.] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [de Boer, Ian H.] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Haritunians, Talin] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Siscovick, David; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Zillikens, M. Carola; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Dept Internal Med, Rotterdam, Netherlands; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN USA; [Schillert, Arne; Ziegler, Andreas] Med Univ Lubeck, Lubeck Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; [Leak, Tennille S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Illig, Thomas; Klopp, Norman; Meisinger, Christa; Wichmann, H-Erich; Heid, Iris M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Koenig, Wolfgang] Univ Ulm Klinikum, Klin Innere Med Kardiol 2, Zentrum Innere Med, Ulm, Germany; [Zgaga, Lina; Wild, Sarah H.; Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zemunik, Tatijana; Boban, Mladen; Wang, Wei] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Kolcic, Ivana; Polasek, Ozren] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Johansson, Asa; Igl, Wilmar; Zaboli, Ghazal; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Nitsch, Dorothea] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Kedenko, Lyudmyla; Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; [Maegi, Reedik; Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maegi, Reedik; Prokopenko, Inga] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Endlich, Karlhans] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, Greifswald, Germany; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Badola, Sunita] Amgen Inc, Cambridge, MA USA; [Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Liu, Yongmei] Wake Forest Univ, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Curhan, Gary C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Rochat, Thierry] Univ Hosp Geneva, Geneva, Switzerland; [Wang, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Coresh, Josef; Kao, W. H.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Shlipak, Michael G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kraemer, Bernhard K.] Heidelberg Univ, Mannheim Univ Hosp, Dept Med 5, D-6800 Mannheim, Germany; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany; [Fox, Caroline S.] Brigham & Womens Hosp, Dept Endocrinol, Boston, MA 02115 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Freiburg; European Academy of Bozen-Bolzano; University of Lubeck; University of Regensburg; University of Regensburg; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Boston University; Icelandic Heart Association; University of Iceland; Medical University of Graz; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; McMaster University; Mayo Clinic; Johannes Gutenberg University of Mainz; Wake Forest University; Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Medical University of Innsbruck; Leipzig University; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Mayo Clinic; University of Lubeck; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Ulm University; University of Edinburgh; University of Split; University of Zagreb; Uppsala University; University of Kiel; University of London; London School of Hygiene & Tropical Medicine; Paracelsus Private Medical University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Amgen; University of Michigan System; University of Michigan; Wake Forest University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Geneva; Capital Medical University; Johns Hopkins University; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Harvard University; Brigham & Women's Hospital	Fox, CS (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	dchasman@rics.bwh.harvard.edu; wkao@jhsph.edu; iris.heid@klinik.uni-regensburg.de; foxca@nhlbi.nih.gov	Feitosa, Mary F/K-8044-2012; Johansson, Åsa/G-5270-2011; Aulchenko, Yurii/M-8270-2013; Stumvoll, Michael/ABE-1121-2021; Kottgen, Anna/D-2920-2012; Fuchsberger, Christian/C-9646-2010; Munzel, Thomas/A-2912-2014; Kronenberg, Florian/B-1736-2008; Gudnason, Vilmundur/AAE-7126-2019; Dehghan, Abbas/ABE-7377-2020; Giallauria, Francesco/B-5681-2013; Franke, Andre/B-2151-2010; Boban, Mladen/E-2777-2017; Johnson, Andrew D/G-6520-2013; Wichmann, Heinz Erich/AAA-5695-2022; Gudnason, Vilmundur/K-6885-2015; Singleton, Andrew B/C-3010-2009; Johansson, Åsa/AAG-6799-2021; Prokopenko, Inga/AAU-9895-2020; Aspelund, Thor/F-4826-2011; Campbell, Harry/E-2959-2010; Rudan, Igor/I-1467-2012; Endlich, Karlhans/G-5485-2013; Smith, Albert Vernon/K-5150-2015; Turner, Stephen/GXM-4654-2022; Schnabel, Renate B/F-6527-2014; Cavalieri, Margherita/G-8053-2012; Aspelund, Thor/C-5983-2008; Ellinghaus, David/ABC-3610-2020; Teumer, Alexander/S-7438-2019; Rivadeneira, Fernando/O-5385-2015; Wild, Philipp S./M-2106-2019; Kolcic, Ivana/E-2713-2017; Schmidt, Reinhold/E-1137-2014; Schnabel, Renate B/ABE-6668-2021; Pramstaller, Peter P/C-2357-2008; Ellinghaus, David/G-4467-2012; liu, li/HGC-0900-2022; Yang, Qiong/G-5438-2014; Pare, Guillaume/T-9631-2018; Polasek, Ozren/B-6002-2011; Hwang, Shih-Jen/HGU-5826-2022; Mägi, Reedik/AAJ-9679-2021; Aspelund, Thor/K-7022-2019; Hayward, Caroline/M-8818-2016; Prokopenko, Inga/H-3241-2014; Fuchsberger, Christian/ABD-7127-2021; Mitchell, Braxton/CAF-0876-2022; Meisinger, Christine/B-5358-2014; Zemunik, Tatijana/D-8584-2017; de Boer, Ian/GYJ-3282-2022; Li, Man/AAX-3400-2020; Zgaga, Lina/Q-9415-2018; Wilson, James F/A-5704-2009; Dehghan, Abbas/B-9896-2008; Ziegler, Andreas/G-4246-2012	Feitosa, Mary F/0000-0002-0933-2410; Johansson, Åsa/0000-0002-2915-4498; Aulchenko, Yurii/0000-0002-7899-1575; Stumvoll, Michael/0000-0001-6225-8240; Munzel, Thomas/0000-0001-5503-4150; Kronenberg, Florian/0000-0003-2229-1120; Gudnason, Vilmundur/0000-0001-5696-0084; Giallauria, Francesco/0000-0003-4119-9397; Franke, Andre/0000-0003-1530-5811; Boban, Mladen/0000-0003-1570-9621; Johnson, Andrew D/0000-0001-6369-5178; Gudnason, Vilmundur/0000-0001-5696-0084; Johansson, Åsa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Rudan, Igor/0000-0001-6993-6884; Smith, Albert Vernon/0000-0003-1942-5845; Aspelund, Thor/0000-0002-7998-5433; Ellinghaus, David/0000-0002-4332-6110; Teumer, Alexander/0000-0002-8309-094X; Rivadeneira, Fernando/0000-0001-9435-9441; Kolcic, Ivana/0000-0001-7918-6052; Schnabel, Renate B/0000-0001-7170-9509; Pare, Guillaume/0000-0002-6795-4760; Polasek, Ozren/0000-0002-5765-1862; Aspelund, Thor/0000-0002-7998-5433; Hayward, Caroline/0000-0002-9405-9550; Prokopenko, Inga/0000-0003-1624-7457; Fuchsberger, Christian/0000-0002-5918-8947; Zemunik, Tatijana/0000-0001-8120-2891; Li, Man/0000-0002-3839-0281; Zgaga, Lina/0000-0003-4089-9703; Wilson, James F/0000-0001-5751-9178; Wild, Philipp/0000-0003-4413-9752; Dehghan, Abbas/0000-0001-6403-016X; Van Duijn, Cornelia/0000-0002-2374-9204; Volker, Uwe/0000-0002-5689-3448; Venkatasubramanian, Siddharth/0000-0002-5860-0768; wang, wei/0000-0002-1430-1360; Ziegler, Andreas/0000-0002-8386-5397; Glazer, Nicole/0000-0002-6397-609X; Shuldiner, Alan/0000-0001-9921-4305; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Mitchell, Braxton/0000-0003-4920-4744; Ballantyne, Christie/0000-0002-6432-1730; Nitsch, Dorothea/0000-0001-5767-248X; Magi, Reedik/0000-0002-2964-6011; Endlich, Karlhans/0000-0001-6052-6061; Felix, Janine/0000-0002-9801-5774; Meisinger, Christa/0000-0002-9026-6544; Kovacs, Peter/0000-0002-0290-5423; Koenig, Wolfgang/0000-0002-2064-9603; Pramstaller, Peter P/0000-0002-9831-8302; Zeller, Tanja/0000-0003-3379-2641	Austrian Science Fund FWF [P 20545] Funding Source: Medline; Medical Research Council [MC_U127561128] Funding Source: Medline; NCRR NIH HHS [K12 RR023250, UL1 RR025005, UL1 RR025005-01, K12 RR023250-01] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402-01, U01 HG004446, U01 HG004399-01, U01 HG004438, U01 HG004422, U01 HG004738-01, U01 HG004726, U01 HG004424-01, U01 HG004422-01, U01 HG004436-01A1, U01 HG004728-01, U01 HG004446-01, U01 HG004735, U01 HG004729-01, U01 HG004729, U01 HG004735-01, U01 HG004424, U01 HG004402, U01 HG004423, U01 HG004738, U01 HG004436, U01 HG004423-01, U01 HG004728, U01 HG004399, U01 HG004726-01, U01 HG004438-01] Funding Source: Medline; NHLBI NIH HHS [N01 HC055021, R01 HL080295-05, R01 HL087652-01, R01 HL087700-01, R01 HL087641-01, U01 HL084756-01, R01 HL059367, R01 HL087660, N01 HC055020, N02 HL64278, U01 HL072515-06, N01 HC015103, N01 HC055018, R01 HL086694, N01 HC025195, U01 HL084756, R01 HL087660-01, R01 HL086694-01A1, U01 HL069757-01, N01 HC055015, R01 HL043851-09, R01 HL080295, U01 HL072515, N01 HC055022, N01 HC075150, N01 HC055016, R01 HL088119-01, N01 HC085086, R01 HL059367-02, N01 HC035129, R01 HL088119, U01 HL069757, R01 HL087700, N01 HC045133, R01 HL087641, R01 HL087652, N01 HC055019, R01 HL117078, N01 HC085079, N01 HC055222] Funding Source: Medline; NIA NIH HHS [N01 AG062106, R01 AG027002, N01 AG062101, R01 AG027002-01, N01 AG012100, R01 AG032098, R01 AG032098-01A1, N01 AG062103, R01 AG018728-01A1, R01 AG018728] Funding Source: Medline; NIDCR NIH HHS [U01 DE018903-01, U01 DE018903, U01 DE018993-01, U01 DE018993] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488-01, P30 DK063491-01, P30 DK079637, P30 DK063491, P30 DK072488, R01 DK066574-01A1, P60 DK079637-01, R01 DK058845-01, R01 DK058845, R01 DK075787, R01 DK066574, P60 DK079637, R01 DK075787-01A1] Funding Source: Medline; NIGMS NIH HHS [U01 GM074518, U01 GM074518-04] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; MRC [MC_U127561128] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC055016, N01HC055222, N01HC055022, N01HC055019, N01HC085079, N01HC055018, N01HC055015, N01HC055020, N01HC055021, N01HC025195, N01HC045133, N01HC085086, N01HC075150, N01HC035129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL043851, U01HL072515, R01HL086694, R01HL087660, R01HL087700, R01HL117078, U01HL069757, R01HL088119, R01HL087641, R01HL064278, R01HL059367, R01HL080295, U01HL084756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004424, U01HG004726, U01HG004436, U01HG004438, U01HG004735, U01HG004729, U01HG004399, U01HG004728, U01HG004446, U01HG004402, U01HG004422, U01HG004423, U01HG004738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066574, P30DK079637, R01DK058845, P30DK063491, R01DK075787, P30DK072488, P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062106, R01AG032098, R01AG018728, N01AG062101, ZIAAG007270, ZIAAG000015, ZIAAG006000, N01AG012100, R01AG027002, ZIAAG000965] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Ayres JA, 2001, GENOMICS, V77, P18, DOI 10.1006/geno.2001.6618; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davis RJ, 2008, GENESIS, V46, P205, DOI 10.1002/dvg.20385; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Evan AP, 2006, KIDNEY INT, V69, P2227, DOI 10.1038/sj.ki.5000268; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fox CS, 2008, DIABETES CARE, V31, P1337, DOI 10.2337/dc07-2348; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hosaka K, 2009, KIDNEY INT, V75, P1308, DOI 10.1038/ki.2009.85; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Joy T, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-49; Juhanson P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-25; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Karihaloo A, 2005, MOL CELL BIOL, V25, P7441, DOI 10.1128/MCB.25.17.7441-7448.2005; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; Marshall JD, 2007, HUM MUTAT, V28, P1114, DOI 10.1002/humu.20577; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ozen H, 2007, WORLD J GASTROENTERO, V13, P2541; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2009, R FDN STAT COMP; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	63	593	612	5	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					376	U34		10.1038/ng.568	http://dx.doi.org/10.1038/ng.568			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20383146	Green Accepted, Green Submitted			2022-12-25	WOS:000277179500006
J	Meindl, A; Hellebrand, H; Wiek, C; Erven, V; Wappenschmidt, B; Niederacher, D; Freund, M; Lichtner, P; Hartmann, L; Schaal, H; Ramser, J; Honisch, E; Kubisch, C; Wichmann, HE; Kast, K; Deissler, H; Engel, C; Muller-Myhsok, B; Neveling, K; Kiechle, M; Mathew, CG; Schindler, D; Schmutzler, RK; Hanenberg, H				Meindl, Alfons; Hellebrand, Heide; Wiek, Constanze; Erven, Verena; Wappenschmidt, Barbara; Niederacher, Dieter; Freund, Marcel; Lichtner, Peter; Hartmann, Linda; Schaal, Heiner; Ramser, Juliane; Honisch, Ellen; Kubisch, Christian; Wichmann, Hans E.; Kast, Karin; Deissler, Helmut; Engel, Christoph; Mueller-Myhsok, Bertram; Neveling, Kornelia; Kiechle, Marion; Mathew, Christopher G.; Schindler, Detlev; Schmutzler, Rita K.; Hanenberg, Helmut			Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene	NATURE GENETICS			English	Article							FANCONI-ANEMIA; MAMMALIAN-CELLS; U1 SNRNA; BRCA2; POPULATION; FAMILY; PALB2; INSTABILITY; PROTEINS; KORA	Germline mutations in a number of genes involved in the recombinational repair of DNA double-strand breaks are associated with predisposition to breast and ovarian cancer. RAD51C is essential for homologous recombination repair, and a biallelic missense mutation can cause a Fanconi anemia-like phenotype. In index cases from 1,100 German families with gynecological malignancies, we identified six monoallelic pathogenic mutations in RAD51C that confer an increased risk for breast and ovarian cancer. These include two frameshift-causing insertions, two splice-site mutations and two nonfunctional missense mutations. The mutations were found exclusively within 480 pedigrees with the occurrence of both breast and ovarian tumors (BC/OC; 1.3%) and not in 620 pedigrees with breast cancer only or in 2,912 healthy German controls. These results provide the first unambiguous evidence of highly penetrant mutations associated with human cancer in a RAD51 paralog and support the 'common disease, rare allele' hypothesis.	[Meindl, Alfons; Hellebrand, Heide; Ramser, Juliane; Kiechle, Marion] Tech Univ Munich, Klinikum Rechts Isar, Div Tumor Genet, Dept Obstet & Gynaecol, D-80804 Munich, Germany; [Wiek, Constanze; Erven, Verena; Freund, Marcel; Hanenberg, Helmut] Univ Dusseldorf, Childrens Hosp, Dept Pediat Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany; [Wappenschmidt, Barbara; Schmutzler, Rita K.] Univ Hosp, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Wappenschmidt, Barbara; Schmutzler, Rita K.] Univ Hosp, Ctr Integrated Oncol, Cologne, Germany; [Niederacher, Dieter; Honisch, Ellen] Univ Dusseldorf, Dept Obstet & Gynecol, Dusseldorf, Germany; [Lichtner, Peter] Helmholtz Zentrum Muenchen, Inst Human Genet, Neuherberg, Germany; [Hartmann, Linda; Schaal, Heiner] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Kubisch, Christian] Univ Cologne, Ctr Mol Med Cologne, Inst Human Genet, Cologne, Germany; [Kubisch, Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Wichmann, Hans E.] Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany; [Kast, Karin] Carl Gustav Carus Univ, Dept Obstet & Gynecol, Dresden, Germany; [Deissler, Helmut] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Neveling, Kornelia; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Mathew, Christopher G.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Hanenberg, Helmut] Indiana Univ Sch Med, Riley Hosp, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA	Technical University of Munich; Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ulm University; Leipzig University; Max Planck Society; University of Wurzburg; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children	Meindl, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Div Tumor Genet, Dept Obstet & Gynaecol, D-80804 Munich, Germany.	alfons.meindl@lrz.tu-muenchen.de; helmut.hanenberg@uni-duesseldorf.de	Mathew, Christopher G/G-3434-2015; Müller-Myhsok, Bertram/A-3289-2013; Wichmann, Heinz Erich/AAA-5695-2022; Kubisch, Christian/F-1893-2011; Schaal, Heiner/A-5115-2008	Mathew, Christopher G/0000-0003-4178-1838; Kubisch, Christian/0000-0003-4220-0978; Engel, Christoph/0000-0002-7247-282X; Wiek, Constanze/0000-0003-2214-8148	German Cancer Aid [107054, 107353]; Juergen-Manchot-Stiftung; Cancer Society Northrhine-Westphalia; Forschungskommission of the Heinrich-Heine-University, Dusseldorf; Bundesministerium fur Bildung und Forschung network for Inherited Bone Marrow Failure Syndromes; Deutsche Forschungsgemeinschaft [SPP1230]	German Cancer Aid(Deutsche Krebshilfe); Juergen-Manchot-Stiftung; Cancer Society Northrhine-Westphalia; Forschungskommission of the Heinrich-Heine-University, Dusseldorf; Bundesministerium fur Bildung und Forschung network for Inherited Bone Marrow Failure Syndromes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank all the families for providing samples for this study. We are deeply indebted to German Cancer Aid for establishing the GC-HBOC and their longstanding patronage. This work was supported by grants from the German Cancer Aid (grant numbers 107054 and 107353), the Juergen-Manchot-Stiftung (L.H., H.S.), the Cancer Society Northrhine-Westphalia (D.N., E. H., H. S.), the Forschungskommission of the Heinrich-Heine-University, Dusseldorf (M. F., D.N., H.S., H. Hanenberg), the Bundesministerium fur Bildung und Forschung network for Inherited Bone Marrow Failure Syndromes (H. S., H. Hanenberg) and the Deutsche Forschungsgemeinschaft SPP1230 (H. Hanenberg). We also thank N. Arnold, C. Bartram, U. Bick, W. Diestler, M. Loeffler, T. Grimm, R. Kreienberg, C. Nestle-Kraemling, B. Schlegelberger and P. Wieacker for their long-standing collaboration within the GC-HBOC. Finally, we acknowledge the excellent technical assistance of B. Kau, G. Krebsbach, J. Koehler, W. Kuss, R. Friedl and S. Engert.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; BETZ B, J CANC RES CLIN ONCO; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; Engert S, 2008, HUM MUTAT, V29, P948, DOI 10.1002/humu.20723; Freund M, 2005, NUCLEIC ACIDS RES, V33, P5112, DOI 10.1093/nar/gki824; Freund M, 2003, NUCLEIC ACIDS RES, V31, P6963, DOI 10.1093/nar/gkg901; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hofmann W, 2002, INT J CANCER, V97, P472, DOI 10.1002/ijc.1626; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Katsura M, 2009, NUCLEIC ACIDS RES, V37, P3959, DOI 10.1093/nar/gkp262; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kuznetsov SG, 2009, CANCER RES, V69, P863, DOI 10.1158/0008-5472.CAN-08-3057; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; RIO P, 2007, FANCONI ANEMIA PARAD, P211; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942	35	512	535	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2010	42	5					410	U65		10.1038/ng.569	http://dx.doi.org/10.1038/ng.569			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20400964				2022-12-25	WOS:000277179500011
J	Maroso, M; Balosso, S; Ravizza, T; Liu, J; Aronica, E; Iyer, AM; Rossetti, C; Molteni, M; Casalgrandi, M; Manfredi, AA; Bianchi, ME; Vezzani, A				Maroso, Mattia; Balosso, Silvia; Ravizza, Teresa; Liu, Jaron; Aronica, Eleonora; Iyer, Anand M.; Rossetti, Carlo; Molteni, Monica; Casalgrandi, Maura; Manfredi, Angelo A.; Bianchi, Marco E.; Vezzani, Annamaria			Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; CHROMATIN PROTEIN HMGB1; HIPPOCAMPAL SCLEROSIS; MOUSE MODEL; RAT HIPPOCAMPUS; CELLS; MICE; INFLAMMATION; ANTAGONISTS; EXPRESSION	Brain inflammation is a major factor in epilepsy, but the impact of specific inflammatory mediators on neuronal excitability is incompletely understood. Using models of acute and chronic seizures in C57BL/6 mice, we discovered a proconvulsant pathway involving high-mobility group box-1 (HMGB1) release from neurons and glia and its interaction with Toll-like receptor 4 (TLR4), a key receptor of innate immunity. Antagonists of HMGB1 and TLR4 retard seizure precipitation and decrease acute and chronic seizure recurrence. TLR4-defective C3H/HeJ mice are resistant to kainate-induced seizures. The proconvulsant effects of HMGB1, like those of interleukin-1 beta (IL-1 beta), are partly mediated by ifenprodil-sensitive N-methyl-D-aspartate (NMDA) receptors. Increased expression of HMGB1 and TLR4 in human epileptogenic tissue, like that observed in the mouse model of chronic seizures, suggests a role for the HMGB1-TLR4 axis in human epilepsy. Thus, HMGB1-TLR4 signaling may contribute to generating and perpetuating seizures in humans and might be targeted to attain anticonvulsant effects in epilepsies that are currently resistant to drugs.	[Maroso, Mattia; Balosso, Silvia; Ravizza, Teresa; Vezzani, Annamaria] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [Liu, Jaron; Bianchi, Marco E.] San Raffaele Univ, Dept Genet & Cell Biol, Milan, Italy; [Liu, Jaron; Manfredi, Angelo A.; Bianchi, Marco E.] San Raffaele Res Inst, Milan, Italy; [Aronica, Eleonora; Iyer, Anand M.] Acad Med Centrum, Dept Neuro Pathol, Amsterdam, Netherlands; [Aronica, Eleonora] Netherlands Fdn Stichting Epilepsie Instellingen, Heemstede, Netherlands; [Rossetti, Carlo] Univ Insubria, Dept Biotechnol & Mol Sci, Varese, Italy; [Rossetti, Carlo; Molteni, Monica] Mario Negri Inst Pharmacol Res, Dept Environm Hlth Sci, I-20157 Milan, Italy; [Casalgrandi, Maura] HMGBiotech Srl, Milan, Italy; [Manfredi, Angelo A.] San Raffaele Univ, Dept Regenerat Med, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; University of Amsterdam; Academic Medical Center Amsterdam; University of Insubria; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University	Vezzani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, I-20157 Milan, Italy.	vezzani@marionegri.it	Ravizza, Teresa/AAB-1440-2020; Manfredi, Angelo A./C-7018-2014; Balosso, Silvia/AAB-1887-2020; Vezzani, Annamaria/AAB-1882-2020; Bianchi, Marco Emilio/K-3417-2018	Ravizza, Teresa/0000-0002-9578-018X; Manfredi, Angelo A./0000-0001-8370-6970; Balosso, Silvia/0000-0001-6712-8023; Vezzani, Annamaria/0000-0003-0573-6175; Bianchi, Marco Emilio/0000-0002-5329-6445; Casalgrandi, Maura/0000-0002-2710-1608; Molteni, Monica/0000-0002-5990-3971; Iyer, Anand/0000-0001-6821-1048; ROSSETTI, CARLO/0000-0002-6806-2975; Aronica, Eleonora/0000-0002-3542-3770	CARIPLO Foundation; Parents Against Childhood Epilepsy; Associazione Italiana Contro l'Epilessia; EU [LSH-CT-2006-037315, 202167]; National Epilepsy Fund [NEF 09-05]; Regione Lombardia	CARIPLO Foundation(Fondazione Cariplo); Parents Against Childhood Epilepsy; Associazione Italiana Contro l'Epilessia; EU(European Commission); National Epilepsy Fund; Regione Lombardia(Regione Lombardia)	This work was supported by a CARIPLO Foundation grant (A. V., M. E. B. and C. R.), by Parents Against Childhood Epilepsy (A. V.), Associazione Italiana Contro l'Epilessia (T. R.), EU FP6 project EPICURE (LSH-CT-2006-037315) (A. V.), EU FP7 project NeuroGlia (No. 202167) and National Epilepsy Fund (NEF 09-05) (E. A.) and a grant from Regione Lombardia to HMGBiotech. J.L. is a recipient of an EU fellowship in the International Graduate Programme in Molecular Medicine training program. We acknowledge F. De Ceglie for technical support in photograph preparation.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Bianchi ME, 2009, SCIENCE, V323, P1683, DOI 10.1126/science.1172794; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; DESARRO GB, 1993, NEUROPHARMACOLOGY, V32, P43, DOI 10.1016/0028-3908(93)90128-P; Ebert U, 1997, EUR J PHARMACOL, V322, P179, DOI 10.1016/S0014-2999(97)00084-8; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Ishida I, 2002, J IMMUNOL, V169, P2069, DOI 10.4049/jimmunol.169.4.2069; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kutuzova GD, 2001, J IMMUNOL, V167, P482, DOI 10.4049/jimmunol.167.1.482; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Macagno A, 2006, J EXP MED, V203, P1481, DOI 10.1084/jem.20060136; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2008, NEUROBIOL DIS, V31, P327, DOI 10.1016/j.nbd.2008.05.007; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Ravizza T, 2006, EPILEPSIA, V47, P1160, DOI 10.1111/j.1528-1167.2006.00590.x; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Sayyah M, 2003, NEUROSCIENCE, V122, P1073, DOI 10.1016/j.neuroscience.2003.08.043; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Singh G, 2008, EPILEPSIA, V49, P1, DOI 10.1111/j.1528-1167.2008.01748.x; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Trisciuoglio L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006234; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Viviani B, 2003, J NEUROSCI, V23, P8692; Yang H, 2002, J ENDOTOXIN RES, V8, P469, DOI 10.1179/096805102125001091; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yourick DL, 1999, EUR J PHARMACOL, V371, P147, DOI 10.1016/S0014-2999(99)00183-1; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhao MR, 2009, J NEUROSCI, V29, P2814, DOI 10.1523/JNEUROSCI.4667-08.2009	55	637	686	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					413	U91		10.1038/nm.2127	http://dx.doi.org/10.1038/nm.2127			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20348922	Green Published			2022-12-25	WOS:000276446800045
J	Oguchi, Y; Mikhailenko, SV; Ohki, T; Olivares, AO; De La Cruz, EM; Ishiwata, S				Oguchi, Yusuke; Mikhailenko, Sergey V.; Ohki, Takashi; Olivares, Adrian O.; De La Cruz, Enrique M.; Ishiwata, Shin'ichi			Robust processivity of myosin V under off-axis loads	NATURE CHEMICAL BIOLOGY			English	Article							ADP BINDING; NECK LENGTH; ACTIN; MOTOR; COORDINATION; MICROTUBULES; MOVEMENT; KINETICS; WALKS	The dimeric motor myosin V transports organelles along actin filament tracks over long distances in cells. Myosin V is a smart 'walker' that is able to swiftly adjust to variable 'road conditions' to continue its processive movement across dense cellular environments. Coordination between the two heads via intramolecular load modulates biochemical kinetics and ensures highly efficient unidirectional motion. However, little is known about how load-induced regulation of the processive stepping occurs in vivo, where myosin V experiences significant off-axis loads applied in various directions. To reveal how myosin V remains processive in cells, we measured the effect of the off-axis loads, applied to individual actomyosin V bonds in a range of angles, on the coordination between the two heads and myosin V processive stepping. We found that myosin V remains highly processive under diagonal loads owing to asymmetrical ADP affinities and that the native 6IQ lever optimizes the subunit coordination, which indicates that myosin V is designed to be an intracellular transporter.	[Oguchi, Yusuke; Mikhailenko, Sergey V.; Ohki, Takashi; Ishiwata, Shin'ichi] Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan; [Olivares, Adrian O.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Ishiwata, Shin'ichi] Waseda Univ, Adv Res Inst Sci & Engn, Tokyo, Japan; [Ishiwata, Shin'ichi] Waseda Biosci Res Inst Singapore WABIOS, Singapore, Singapore	Waseda University; Yale University; Waseda University	Oguchi, Y (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Tokyo 169, Japan.	ishiwata@waseda.jp	Olivares, Adrian/D-7717-2012	Olivares, Adrian/0000-0002-0895-7988	Ministry of Education, Culture, Sports, Science and Technology of Japan; US National Institutes of Health [GM071688, F31AR051614]; Japan Society for the Promotion of Science; American Heart Association Established Investigator Award [0940075N]; US National Science Foundation CAREER Award [MCB-0546353]; Hellman Family Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR051614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071688] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association Established Investigator Award(American Heart Association); US National Science Foundation CAREER Award(National Science Foundation (NSF)); Hellman Family Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kinosita Jr. for critical reading and valuable comments. This work was supported by the Grants-in-Aid for Specially Promoted Research, Scientific Research (A) and the Academic Frontier Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( S. I.). The work was also supported by grant GM071688 from the US National Institutes of Health ( E. M. D. L. C.). Y.O. is supported by the Japan Society for the Promotion of Science. A. O.O. was supported by US National Institutes of Health predoctoral fellowship F31AR051614. E. M. D. L. C. is also supported by an American Heart Association Established Investigator Award (0940075N), a US National Science Foundation CAREER Award (MCB-0546353) and a Hellman Family Fellowship.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	27	19	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					300	305		10.1038/NCHEMBIO.322	http://dx.doi.org/10.1038/NCHEMBIO.322			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20228794	Green Accepted			2022-12-25	WOS:000275734000016
J	Padilla, SL; Carmody, JS; Zeltser, LM				Padilla, Stephanie L.; Carmody, Jill S.; Zeltser, Lori M.			Pomc-expressing progenitors give rise to antagonistic neuronal populations in hypothalamic feeding circuits	NATURE MEDICINE			English	Article							ARCUATE NUCLEUS; LEPTIN; OBESITY; HOMEOSTASIS; ORIGIN; IMPACT; BRAIN; TIME; RAT	Hypothalamic neuron circuits regulating energy balance are highly plastic and develop in response to nutrient and hormonal cues. To identify processes that might be susceptible to gestational influences in mice, we characterized the ontogeny of proopiomelanocortin (POMC) and neuropeptide Y (NPY) cell populations, which exert opposing influences on food intake and body weight. These analyses revealed that Pomc is broadly expressed in immature hypothalamic neurons and that half of embryonic Pomc-expressing precursors subsequently adopt a non-POMC fate in adult mice. Moreover, nearly one quarter of the mature NPY+ cell population shares a common progenitor with POMC+ cells.	[Padilla, Stephanie L.; Carmody, Jill S.; Zeltser, Lori M.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Zeltser, Lori M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Padilla, Stephanie L.; Carmody, Jill S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Zeltser, LM (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	lz146@columbia.edu			Irving Institute Clinical and Translational Science Award; FACS core (National Center for Research Resources) [UL1 RR024156]; US Institute of Human Nutrition Training [2T32DK007647-21]; American Diabetes Association [7-07RA-195]; Columbia Diabetes and Endocrinology Research Center Pilot and Feasibility Award [P30 DK63608-07]; NY Obesity Research Center Pilot and Feasibility Grant [P30 DK26687-26];  [RO1 DK52431-16];  [F31DK079372]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052431, P30DK026687, P30DK063608, T32DK007647, F31DK079372] Funding Source: NIH RePORTER	Irving Institute Clinical and Translational Science Award; FACS core (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Institute of Human Nutrition Training; American Diabetes Association(American Diabetes Association); Columbia Diabetes and Endocrinology Research Center Pilot and Feasibility Award; NY Obesity Research Center Pilot and Feasibility Grant; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Sussel, H. Wichterle and D. Accili for critical reading of our manuscript and helpful comments; R. Leibel for support and major funding for this project (RO1 DK52431-16); J. Overton for help with confocal imaging; L. Yang of the Diabetes and Endocrinology Research Center Pathology Core for cryosectioning and C. Liu of the Irving Institute Clinical and Translational Science Award, FACS core (National Center for Research Resources UL1 RR024156); M. Low for Pomc-GFP mice (University of Michigan Health Center), J. Elmquist for Pomc-Cre mice Univerisity of Texas Southwestern Medical Center) and B. Lowell for Npy-hrGFP mice (Beth Israel Deaconess Medical Center) for generously providing mouse reagents. This work was supported by F31DK079372 (S. L. P.), US Institute of Human Nutrition Training Grant 2T32DK007647-21 (J. S. C.), American Diabetes Association Grant 7-07RA-195 (L.M.Z.), Columbia Diabetes and Endocrinology Research Center Pilot and Feasibility Award P30 DK63608-07 (L.M.Z.) and NY Obesity Research Center Pilot and Feasibility Grant P30 DK26687-26 (L.M.Z.).	ALTMAN J, 1978, J COMP NEUROL, V182, P945, DOI 10.1002/cne.901820511; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broad KD, 2009, DEV NEUROBIOL, V69, P314, DOI 10.1002/dneu.20702; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Van den Top M, 2007, NEUROSCIENCE, V144, P815, DOI 10.1016/j.neuroscience.2006.09.059; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	20	200	202	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2010	16	4					403	405		10.1038/nm.2126	http://dx.doi.org/10.1038/nm.2126			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20348924	Green Accepted			2022-12-25	WOS:000276446800043
J	Bauer, PO; Goswami, A; Wong, HK; Okuno, M; Kurosawa, M; Yamada, M; Miyazaki, H; Matsumoto, G; Kino, Y; Nagai, Y; Nukina, N				Bauer, Peter O.; Goswami, Anand; Wong, Hon Kit; Okuno, Misako; Kurosawa, Masaru; Yamada, Mizuki; Miyazaki, Haruko; Matsumoto, Gen; Kino, Yoshihiro; Nagai, Yoshitaka; Nukina, Nobuyuki			Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein	NATURE BIOTECHNOLOGY			English	Article							DISEASE MOUSE MODEL; NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE; ALPHA-SYNUCLEIN; PROMOTES NEUROGENESIS; PROLONGS SURVIVAL; TRANSGENIC MODEL; SLOWS DISEASE; RICH DOMAINS; MURINE MODEL	Huntington's Disease (HD) is a dominantly inherited pathology caused by the accumulation of mutant huntingtin protein (HTT) containing an expanded polyglutamine (polyQ) tract. As the polyglutamine binding peptide 1 (QBP1) is known to bind an expanded polyQ tract but not the polyQ motif found in normal HTT, we selectively targeted mutant HTT for degradation by expressing a fusion molecule comprising two copies of QBP1 and copies of two different heat shock cognate protein 70 (HSC70)-binding motifs in cellular and mouse models of HD. Chaperone-mediated autophagy contributed to the specific degradation of mutant HTT in cultured cells expressing the construct. Intrastriatal delivery of a virus expressing the fusion molecule ameliorated the disease phenotype in the R6/2 mouse model of HD. Similar adaptor molecules comprising HSC70-binding motifs fused to an appropriate structure-specific binding agent(s) may have therapeutic potential for treating diseases caused by misfolded proteins other than those with expanded polyQ tracts.	[Bauer, Peter O.; Goswami, Anand; Wong, Hon Kit; Okuno, Misako; Kurosawa, Masaru; Yamada, Mizuki; Miyazaki, Haruko; Matsumoto, Gen; Kino, Yoshihiro; Nukina, Nobuyuki] RIKEN Brain Sci Ins, Lab Struct Neuropathol, Wako, Saitama, Japan; [Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Dept Degenerat Neurol Dis, Tokyo, Japan	RIKEN; National Center for Neurology & Psychiatry - Japan	Nukina, N (corresponding author), RIKEN Brain Sci Ins, Lab Struct Neuropathol, Wako, Saitama, Japan.	nukina@brain.riken.jp	Longo, Kenneth A/A-5631-2010; Nukina, Nobuyuki/GPP-6265-2022; Bauer, Peter O./AAD-6502-2022; Wong, Hon-Kit/G-3944-2014	Bauer, Peter O./0000-0003-2811-1354; Matsumoto, Gen/0000-0002-9339-1682; Wong, Hon-Kit/0000-0003-0049-8454	Ministry of Education, Culture, Sports, Science and Technology of Japan [17025044]; Ministry of Health, Welfare and Labor, Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Labor, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas ( Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( 17025044) and by a Grant-in-Aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Welfare and Labor, Japan. This work was supported partly by a grant from the Japan Society for the Promotion of Science (JSPS). P.O.B. was a JSPS postdoctoral fellow. We thank D. W. Chapmon for stylistic revision of the manuscript. Monomeric KikGR (mKikGR) was a kind gift of A. Miyawaki, RIKEN BSI Japan.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Emadi S, 2007, J MOL BIOL, V368, P1132, DOI 10.1016/j.jmb.2007.02.089; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Huang B, 2007, HUM GENE THER, V18, P303, DOI 10.1089/hum.2006.160; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lynch SM, 2008, J MOL BIOL, V377, P136, DOI 10.1016/j.jmb.2007.11.096; MADDEN EA, 1987, ARCH BIOCHEM BIOPHYS, V257, P27, DOI 10.1016/0003-9861(87)90539-X; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Peters MF, 1999, NEUROSCI LETT, V275, P129, DOI 10.1016/S0304-3940(99)00758-2; Popiel HA, 2009, NEUROSCI LETT, V449, P87, DOI 10.1016/j.neulet.2008.06.015; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zemskov EA, 2003, J NEUROCHEM, V87, P395, DOI 10.1046/j.1471-4159.2003.02002.x; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	58	170	177	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2010	28	3					256	U111		10.1038/nbt.1608	http://dx.doi.org/10.1038/nbt.1608			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	565JT	20190739				2022-12-25	WOS:000275288300024
J	Landoure, G; Zdebik, AA; Martinez, TL; Burnett, BG; Stanescu, HC; Inada, H; Shi, YJ; Taye, AA; Kong, LL; Munns, CH; Choo, SS; Phelps, CB; Paudel, R; Houlden, H; Ludlow, CL; Caterina, MJ; Gaudet, R; Kleta, R; Fischbeck, KH; Sumner, CJ				Landoure, Guida; Zdebik, Anselm A.; Martinez, Tara L.; Burnett, Barrington G.; Stanescu, Horia C.; Inada, Hitoshi; Shi, Yijun; Taye, Addis A.; Kong, Lingling; Munns, Clare H.; Choo, Shelly S.; Phelps, Christopher B.; Paudel, Reema; Houlden, Henry; Ludlow, Christy L.; Caterina, Michael J.; Gaudet, Rachelle; Kleta, Robert; Fischbeck, Kenneth H.; Sumner, Charlotte J.			Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C	NATURE GENETICS			English	Article							CATION CHANNEL TRPV4; ANKYRIN REPEAT DOMAIN; SENSORY NEUROPATHY; HEREDITARY MOTOR; ION-CHANNEL; ACTIVATION; MODEL; MICE; EXPRESSION; BIND	Charcot-Marie-Tooth disease type 2C (CMT2C) is an autosomal dominant neuropathy characterized by limb, diaphragm and laryngeal muscle weakness. Two unrelated families with CMT2C showed significant linkage to chromosome 12q24.11. We sequenced all genes in this region and identified two heterozygous missense mutations in the TRPV4 gene, C805T and G806A, resulting in the amino acid substitutions R269C and R269H. TRPV4 is a well-known member of the TRP superfamily of cation channels. In TRPV4-transfected cells, the CMT2C mutations caused marked cellular toxicity and increased constitutive and activated channel currents. Mutations in TRPV4 were previously associated with skeletal dysplasias. Our findings indicate that TRPV4 mutations can also cause a degenerative disorder of the peripheral nerves. The CMT2C-associated mutations lie in a distinct region of the TRPV4 ankyrin repeats, suggesting that this phenotypic variability may be due to differential effects on regulatory protein-protein interactions.	[Martinez, Tara L.; Kong, Lingling; Sumner, Charlotte J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Landoure, Guida; Zdebik, Anselm A.; Stanescu, Horia C.; Kleta, Robert] UCL, Dept Med, London, England; [Landoure, Guida; Zdebik, Anselm A.; Stanescu, Horia C.; Kleta, Robert] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Landoure, Guida; Burnett, Barrington G.; Shi, Yijun; Taye, Addis A.; Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Landoure, Guida] Univ Bamako, Serv Neurol, Ctr Hosp Univ Point G, Bamako, Mali; [Martinez, Tara L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Inada, Hitoshi; Choo, Shelly S.; Phelps, Christopher B.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21218 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Univ, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21218 USA; [Paudel, Reema; Houlden, Henry] UCL, Inst Neurol, London, England; [Ludlow, Christy L.] James Madison Univ, Lab Neural Bases Commun & Swallowing, Harrisonburg, VA 22807 USA	Johns Hopkins University; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bamako; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Johns Hopkins University; Johns Hopkins University; University of London; University College London; James Madison University	Sumner, CJ (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.	csumner1@jhmi.edu	Gaudet, Rachelle/I-4133-2014; Houlden, Henry J/C-1532-2008; Inada, Hitoshi/GQH-1084-2022; Gaudet, Rachelle/Y-3985-2019; Inada, Hitoshi/T-2773-2019	Gaudet, Rachelle/0000-0002-9177-054X; Houlden, Henry J/0000-0002-2866-7777; Inada, Hitoshi/0000-0002-6121-3830; Gaudet, Rachelle/0000-0002-9177-054X; Inada, Hitoshi/0000-0002-6121-3830; Ludlow, Christy/0000-0002-2015-6171	NINDS; Johns Hopkins Department of Neurology; Elaine Potter Charitable Foundation; NIH [R01GM081340]; McKnight Scholar Award; MRC [G0802760] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974, ZIANS003038] Funding Source: NIH RePORTER; Medical Research Council [G0802760] Funding Source: researchfish	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Johns Hopkins Department of Neurology; Elaine Potter Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the subjects and their families for participating in this study. We thank J. Kissel for discussions regarding clinical evaluation of family 1, A. LaPean for aid in subject characterization, M. K. Floeter and T. Lehky for performing neurophysiological studies, R. R. Wang for crystallization and X-ray data collection, J. Hardy for helpful discussion regarding genetic analysis, A. Singleton and D. Hernandez for help with SNP array analysis, the NINDS DNA sequencing facility for help with sequencing, the Maryland Brain and Tissue Bank for providing human spinal cord and tracheal tissues, M. Suzuki for Trpv4 knockout mice, R. Tsien for providing the fluorescent protein mCherry, A. Hoke for providing DRG cells, J. Griffin for aid in nerve pathology evaluation, S. Heller for providing antibody to TRPV4, T. Jentsch for cells and instruments, C. Rojas and J. Alt for help with FLIPR, S. Minogue for assistance in confocal imaging, M. A. Valverde for providing human TRPV4 expression constructs and M. Plomann for providing PACSIN expression constructs and antibodies. This work was supported by intramural funds from the NINDS at NIH, funds from the Johns Hopkins Department of Neurology and the David and Elaine Potter Charitable Foundation, and NIH grant R01GM081340 and a McKnight Scholar Award to R. G.	Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Guler AD, 2002, J NEUROSCI, V22, P6408; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEntagart ME, 2005, ANN NEUROL, V57, P293, DOI 10.1002/ana.20375; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Santoro L, 2002, NEUROMUSCULAR DISORD, V12, P399, DOI 10.1016/S0960-8966(01)00305-4; SKRE H, 1974, CLIN GENET, V6, P98; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200	38	218	226	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					170	U109		10.1038/ng.512	http://dx.doi.org/10.1038/ng.512			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20037586	Green Accepted			2022-12-25	WOS:000274084400016
J	Das-Bradoo, S; Nguyen, HD; Wood, JL; Ricke, RM; Haworth, JC; Bielinsky, AK				Das-Bradoo, Sapna; Nguyen, Hai Dang; Wood, Jamie L.; Ricke, Robin M.; Haworth, Justin C.; Bielinsky, Anja-Katrin			Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-CONJUGATING ENZYMES; CELL-CYCLE ARREST; POSTREPLICATION REPAIR; REPLICATION; PROTEINS; DOMAIN; MCM10; GENE; MUTAGENESIS; MUTATIONS	In all eukaryotes, the ligation of newly synthesized DNA, also known as Okazaki fragments, is catalysed by DNA ligase I (ref. 1). An individual with a DNA ligase I deficiency exhibits growth retardation, sunlight sensitivity and severe immunosuppression(2), probably due to accumulation of DNA damage. Surprisingly, not much is known about the DNA damage response (DDR) in DNA ligase I-deficient cells. As DNA replication and DDR pathways are highly conserved in eukaryotes, we used Saccharomyces cerevisiae as a model system to address this issue. We uncovered a new pathway, which facilitates ubiquitylation at Lys 107 of proliferating cell nuclear antigen (PCNA). Unlike ubiquitylation at Lys 164 of PCNA in response to UV irradiation, which triggers translesion synthesis(3), modification of Lys 107 is not dependent on the ubiquitin conjugating enzyme (E2) Rad6 (ref. 4) nor the ubiquitin ligase (E3) Rad18 (ref. 5), but requires the E2 variant Mms2 (ref. 6) in conjunction with Ubc4 (ref. 7) and the E3 Rad5 (refs 8, 9). Surprisingly, DNA ligase I-deficient S. cerevisiae cdc9-1 cells that carry a PCNA(K107R) mutation are inviable, because they cannot activate a robust DDR. Furthermore, we show that ubiquitylation of PCNA in response to DNA ligase I deficiency is conserved in humans, yet the lysine residue that is modified remains to be determined. We propose that PCNA ubiquitylation provides a 'DNA damage code' that allows cells to categorize different types of defects that arise during DNA replication.	[Das-Bradoo, Sapna; Nguyen, Hai Dang; Wood, Jamie L.; Haworth, Justin C.; Bielinsky, Anja-Katrin] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Ricke, Robin M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Bielinsky, AK (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bieli003@umn.edu		Bielinsky, Anja/0000-0003-1783-619X; Nguyen, Dang/0000-0002-4200-8778	NIH [P41 RR-01081, CA009138, GM074917]; University of Minnesota; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. J. Clarke, J. F. X. Diffley, D. Durocher, S. J. Elledge, M. Hochstrasser, S. Jentsch, D. Koepp and D. M. Livingston for strains and plasmids and J. F. X. Diffley, A. E. Tomkinson and Z. Zhang for antibodies against Rad53, Cdc9 and PCNA. We acknowledge the assistance of the Flow Cytometry Core Facility at the University of Minnesota. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081). J. C. H. was supported by NIH training grant CA009138. This work was supported by a Grant-in-Aid from the University of Minnesota and NIH grant ( GM074917) to A. K. B. who is a Scholar of the Leukemia and Lymphoma Society.	Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; DORNFELD KJ, 1991, MOL CELL BIOL, V11, P2013, DOI 10.1128/MCB.11.4.2013; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ireland MJ, 2000, GENETICS, V155, P1657; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JOHNSTON LH, 1978, NATURE, V274, P891, DOI 10.1038/274891a0; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCHIESTL RH, 1989, MOL CELL BIOL, V9, P1882, DOI 10.1128/MCB.9.5.1882; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; van der Kemp PA, 2009, NUCLEIC ACIDS RES, V37, P2549, DOI 10.1093/nar/gkp105; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEINERT TA, 1993, GENETICS, V134, P63; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	40	53	54	11	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2010	12	1					74	U190		10.1038/ncb2007	http://dx.doi.org/10.1038/ncb2007			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	535MS	20010813	Green Accepted			2022-12-25	WOS:000272973800015
J	Bennett, G; Gilman, N; Stavrianakis, A; Rabinow, P				Bennett, Gaymon; Gilman, Nils; Stavrianakis, Anthony; Rabinow, Paul			From synthetic biology to biohacking: are we prepared?	NATURE BIOTECHNOLOGY			English	Article									[Bennett, Gaymon; Stavrianakis, Anthony; Rabinow, Paul] Univ Calif Berkeley, Dept Anthropol, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA; [Gilman, Nils] Monitor 360, San Francisco, CA USA	University of California System; University of California Berkeley	Bennett, G (corresponding author), Univ Calif Berkeley, Dept Anthropol, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA.	gaymon.bennett@berkeley.edu						BLOOM J, 2009, GUARDIAN        0319; DEGASNE S, 2008, RUE             1103, V89; Garfinkel M.S., 2007, SYNTHETIC GENOMICS O; Hayden EC, 2009, NATURE, V461, P22, DOI 10.1038/461022a; Johnson C., 2008, BOSTON GLOBE 0915; MCKENNA P, 2009, NEW SCI         0107; Nair P, 2009, NAT MED, V15, P230, DOI 10.1038/nm0309-230; OBRIEN D, 2009, IRISH TIMES     0410; Ostfield ML, 2008, BIOSECUR BIOTERROR, V6, P261, DOI 10.1089/bsp.2008.0033; Schmidt Markus, 2008, Syst Synth Biol, V2, P7, DOI 10.1007/s11693-008-9019-y; Taleb N. N., 2010, BLACK SWAN, DOI DOI 10.1176/PS.2009.60.11.1564; WHELAN J, 2009, WALL STREET J   0512; 2008, BIOHACKERS ATTEMPT U	13	38	39	0	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1109	1111		10.1038/nbt1209-1109	http://dx.doi.org/10.1038/nbt1209-1109			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010587				2022-12-25	WOS:000272708300023
J	Henson, JD; Cao, Y; Huschtscha, LI; Chang, AC; Au, AYM; Pickett, HA; Reddel, RR				Henson, Jeremy D.; Cao, Ying; Huschtscha, Lily I.; Chang, Andy C.; Au, Amy Y. M.; Pickett, Hilda A.; Reddel, Roger R.			DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity	NATURE BIOTECHNOLOGY			English	Article							HUMAN CELL-LINE; ALT CELLS; MECHANISM; RECOMBINATION; MAINTENANCE; COMPLEX; ABSENCE; TUMORS	Alternative lengthening of telomeres (ALT)(1) is likely to be an important target for anticancer treatment as similar to 10% of cancers depend on this telomere maintenance mechanism for continued growth(2), and inhibition of ALT can cause cellular senescence(3). However, no ALT inhibitors have been developed for therapeutic use because of the lack of a suitable ALT activity assay and of known ALT-specific target molecules. Here we show that partially single-stranded telomeric (CCCTAA)(n) DNA circles (C-circles) are ALT specific. We provide an assay that is rapidly and linearly responsive to ALT activity and that is suitable for screening for ALT inhibitors. We detect C-circles in blood from ALT(+) osteosarcoma patients, suggesting that the C-circle assay (CC assay) may have clinical utility for diagnosis and management of ALT(+) tumors.	[Henson, Jeremy D.; Cao, Ying; Huschtscha, Lily I.; Chang, Andy C.; Au, Amy Y. M.; Pickett, Hilda A.; Reddel, Roger R.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Reddel, RR (corresponding author), Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia.	rreddel@cmri.usyd.edu.au	Reddel, Roger R/A-6635-2014; Henson, Jeremy/ABD-3494-2021	Reddel, Roger R/0000-0002-6302-6107; Henson, Jeremy/0000-0002-1594-9310				BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Grudic A, 2007, NUCLEIC ACIDS RES, V35, P7267, DOI 10.1093/nar/gkm738; Henson JD, 2005, CLIN CANCER RES, V11, P217; HENSON JD, 2006, THESIS U SYDNEY; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Nabetani A, 2009, MOL CELL BIOL, V29, P703, DOI 10.1128/MCB.00603-08; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831; Varley H, 2002, NAT GENET, V30, P301, DOI 10.1038/ng834; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Yeager TR, 1999, CANCER RES, V59, P4175; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	25	295	303	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1181	U148		10.1038/nbt.1587	http://dx.doi.org/10.1038/nbt.1587			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	19935656				2022-12-25	WOS:000272708300036
J	Wellner, U; Schubert, J; Burk, UC; Schmalhofer, O; Zhu, F; Sonntag, A; Waldvogel, B; Vannier, C; Darling, D; zur Hausen, A; Brunton, VG; Morton, J; Sansom, O; Schuler, J; Stemmler, MP; Herzberger, C; Hopt, U; Keck, T; Brabletz, S; Brabletz, T				Wellner, Ulrich; Schubert, Joerg; Burk, Ulrike C.; Schmalhofer, Otto; Zhu, Feng; Sonntag, Annika; Waldvogel, Bettina; Vannier, Corinne; Darling, Douglas; zur Hausen, Axel; Brunton, Valerie G.; Morton, Jennifer; Sansom, Owen; Schueler, Julia; Stemmler, Marc P.; Herzberger, Christoph; Hopt, Ulrich; Keck, Tobias; Brabletz, Simone; Brabletz, Thomas			The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MALIGNANT-TUMOR PROGRESSION; PANCREATIC-CANCER; MIR-200 FAMILY; E-CADHERIN; COLORECTAL-CANCER; DOWN-REGULATION; BETA-CATENIN; CELLS; EXPRESSION	Invasion and metastasis of carcinomas is promoted by the activation of the embryonic 'epithelial to mesenchymal transition' (EMT) program, which triggers cellular mobility and subsequent dissemination of tumour cells. We recently showed that the EMT-activator ZEB1 (zinc finger E-box binding homeobox 1) is a crucial promoter of metastasis and demonstrated that ZEB1 inhibits expression of the microRNA-200 (miR-200) family, whose members are strong inducers of epithelial differentiation. Here, we report that ZEB1 not only promotes tumour cell dissemination, but is also necessary for the tumour-initiating capacity of pancreatic and colorectal cancer cells. We show that ZEB1 represses expression of stemness-inhibiting miR-203 and that candidate targets of miR-200 family members are also stem cell factors, such as Sox2 and Klf4. Moreover, miR-200c, miR-203 and miR-183 cooperate to suppress expression of stem cell factors in cancer cells and mouse embryonic stem (ES) cells, as demonstrated for the polycomb repressor Bmi1. We propose that ZEB1 links EMT-activation and stemness-maintenance by suppressing stemness-inhibiting microRNAs (miRNAs) and thereby is a promoter of mobile, migrating cancer stem cells. Thus, targeting the ZEB1-miR-200 feedback loop might form the basis of a promising treatment for fatal tumours, such as pancreatic cancer.	[Wellner, Ulrich; Schubert, Joerg; Burk, Ulrike C.; Schmalhofer, Otto; Zhu, Feng; Sonntag, Annika; Waldvogel, Bettina; Vannier, Corinne; Herzberger, Christoph; Hopt, Ulrich; Keck, Tobias; Brabletz, Simone; Brabletz, Thomas] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany; [Schubert, Joerg] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Darling, Douglas] Univ Louisville, Dept Periodont, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [zur Hausen, Axel] Univ Freiburg, Dept Pathol, D-79106 Freiburg, Germany; [Brunton, Valerie G.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Morton, Jennifer; Sansom, Owen] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Schueler, Julia] Oncotest GmbH, Inst Expt Oncol, D-79108 Freiburg, Germany; [Stemmler, Marc P.] Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany; [Brabletz, Thomas] Univ Freiburg, Ctr Comprehens Canc, D-7910 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Louisville; University of Freiburg; University of Edinburgh; Beatson Institute; Oncotest GmbH; Max Planck Society; University of Freiburg	Brabletz, T (corresponding author), Univ Freiburg, Dept Visceral Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.	thomas.brabletz@uniklinik-freiburg.de	Morton, Jennifer/AAJ-5113-2021; Morton, Jennifer P/E-1633-2011; Wellner, Ulrich Friedrich/B-1388-2019; Darling, Douglas S/D-4573-2009	Morton, Jennifer/0000-0001-5766-9141; Morton, Jennifer P/0000-0001-5766-9141; Wellner, Ulrich Friedrich/0000-0002-8632-166X; Sansom, Owen J./0000-0001-9540-3010; Darling, Douglas/0000-0002-9039-1169; Keck, Tobias/0000-0001-7651-6183	EU [037297]; DFG [BR 1399/4-3, BR 1399/5-1]; Deutsche Krebshilfe [106958]; Cancer Research UK [C157/A9148]	EU(European Commission); DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK)	We thank J. Pfannstiel, K. Meyer, M. Berthold, S. Hempel and A. Schmitt for expert technical assistance. This work was supported by grants to T. B. from the EU MCSC contract no. 037297, the DFG ( no. BR 1399/4-3 and BR 1399/5-1) and the Deutsche Krebshilfe ( no. 106958), and to V. G. B. from Cancer Research UK (C157/A9148).	Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Brabletz T, 2004, CANCER RES, V64, P6973, DOI 10.1158/0008-5472.CAN-04-1132; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hlubek F, 2001, CANCER RES, V61, P8089; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Romero C, 2009, J PATHOL, V219, P205, DOI 10.1002/path.2585; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	45	1307	1353	1	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2009	11	12					1487	U236		10.1038/ncb1998	http://dx.doi.org/10.1038/ncb1998			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	525XO	19935649				2022-12-25	WOS:000272251300017
J	Evans, JF; Hutchinson, JH				Evans, Jilly F.; Hutchinson, John H.			Seeing the future of bioactive lipid drug targets	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR RECEPTORS; DISEASES; INFLAMMATION; DISCOVERY; LESSONS; LIGAND; LUNG		[Evans, Jilly F.; Hutchinson, John H.] Amira Pharmaceut, San Diego, CA USA		Evans, JF (corresponding author), Amira Pharmaceut, San Diego, CA USA.	jilly.evans@amirapharm.com						Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Ben-Shlomo I, 2005, MOL ENDOCRINOL, V19, P1097, DOI 10.1210/me.2004-0451; Brown HA, 2009, NAT CHEM BIOL, V5, P602, DOI 10.1038/nchembio0909-602; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Frimurer TM, 2005, BIOORG MED CHEM LETT, V15, P3707, DOI 10.1016/j.bmcl.2005.05.102; Gabrielsson J, 2009, J PHARMACOL EXP THER, V331, P767, DOI 10.1124/jpet.109.157172; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; Hla T, 2005, PROSTAG OTH LIPID M, V77, P197, DOI 10.1016/j.prostaglandins.2005.06.008; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; OKUDAIRA S, 2010, BIOCHIMIE       0422, DOI DOI 10.1016/J.BIOCHI.2010.04.015; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Patrono C, 2009, MOL INTERV, V9, P31, DOI 10.1124/mi.9.1.8; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Stebbins KJ, 2010, J PHARMACOL EXP THER, V332, P764, DOI 10.1124/jpet.109.161919; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Zhang MQ, 2007, CURR OPIN BIOTECH, V18, P478, DOI 10.1016/j.copbio.2007.10.005	26	13	35	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					476	479		10.1038/nchembio.394	http://dx.doi.org/10.1038/nchembio.394			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20559310				2022-12-25	WOS:000278878700003
J	Nishimura, S; Arita, Y; Honda, M; Iwamoto, K; Matsuyama, A; Shirai, A; Kawasaki, H; Kakeya, H; Kobayashi, T; Matsunaga, S; Yoshida, M				Nishimura, Shinichi; Arita, Yuko; Honda, Miyuki; Iwamoto, Kunihiko; Matsuyama, Akihisa; Shirai, Atsuko; Kawasaki, Hisashi; Kakeya, Hideaki; Kobayashi, Toshihide; Matsunaga, Shigeki; Yoshida, Minoru			Marine antifungal theonellamides target 3 beta-hydroxysterol to activate Rho1 signaling	NATURE CHEMICAL BIOLOGY			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; CYTOTOXIC BICYCLIC PEPTIDES; FISSION YEAST; ACTIN CYTOSKELETON; CELL INTEGRITY; BACTERIAL SYMBIONTS; MEMBRANE DOMAINS; NATURAL-PRODUCTS; GLOBAL ANALYSIS; S-POMBE	Linking bioactive compounds to their cellular targets is a central challenge in chemical biology. Here we report the mode of action of theonellamides, bicyclic peptides derived from marine sponges. We generated a chemical-genomic profile of theonellamide F using a collection of fission yeast strains in which each open reading frame (ORF) is expressed under the control of an inducible promoter. Clustering analysis of the Gene Ontology (GO) terms associated with the genes that alter drug sensitivity suggested a mechanistic link between theonellamide and 1,3-beta-D-glucan synthesis. Indeed, theonellamide F induced overproduction of 1,3-beta-D-glucan in a Rho1-dependent manner. Subcellular localization and in vitro binding assays using a fluorescent theonellamide derivative revealed that theonellamides specifically bind to 3 beta-hydroxysterols, including ergosterol, and cause membrane damage. The biological activity of theonellamides was alleviated in mutants defective in ergosterol biosynthesis. Theonellamides thus represent a new class of sterol-binding molecules that induce membrane damage and activate Rho1-mediated 1,3-beta-D-glucan synthesis.	[Nishimura, Shinichi; Kakeya, Hideaki; Yoshida, Minoru] RIKEN Adv Sci Inst, Chem Genom Res Grp, Saitama, Japan; [Nishimura, Shinichi; Kakeya, Hideaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Div Bioinformat & Chem Genom, Kyoto, Japan; [Arita, Yuko; Honda, Miyuki; Matsuyama, Akihisa; Shirai, Atsuko; Yoshida, Minoru] RIKEN Adv Sci Inst, Chem Genet Lab, Saitama, Japan; [Arita, Yuko; Yoshida, Minoru] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Honda, Miyuki; Kawasaki, Hisashi] Tokyo Denki Univ, Dept Green & Sustainable Chem, Tokyo 101, Japan; [Iwamoto, Kunihiko; Kobayashi, Toshihide] RIKEN Adv Sci Inst, Lipid Biol Lab, Saitama, Japan; [Matsuyama, Akihisa; Yoshida, Minoru] Japan Sci & Technol Corp, CREST Res Project, Saitama, Japan; [Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	RIKEN; Kyoto University; RIKEN; Saitama University; Tokyo Denki University; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Nishimura, S (corresponding author), RIKEN Adv Sci Inst, Chem Genom Res Grp, Saitama, Japan.	yoshidam@riken.jp	shirai, atsuko/C-5406-2017; Kobayashi, Toshihide/B-6298-2015; 川崎, 寿/AAY-1352-2021; Yoshida, Minoru/C-8049-2014; Matsuyama, Akihisa/P-7805-2016; Nishimura, Shinichi/AGE-1316-2022; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kakeya, Hideaki/B-3527-2012	shirai, atsuko/0000-0003-1344-4746; Kobayashi, Toshihide/0000-0002-4811-7270; Yoshida, Minoru/0000-0002-4376-5674; Matsuyama, Akihisa/0000-0002-6135-6276; Nishimura, Shinichi/0000-0002-5998-3780; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kakeya, Hideaki/0000-0002-4293-7331; Kawasaki, Hisashi/0000-0001-6662-9301	New Energy and Industrial Technology Development Organization; Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN Advanced Science Institute	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Advanced Science Institute	We thank C. Boone (Univ. Toronto) for sharing unpublished results and discussions, A. Fujie (Astellas Pharma) for kind gifts of FK463 and cispentacin, K. Takegawa (Kyushu Univ.) for erg deletion strains, T. Kuno (Kobe Univ.) for the bgs1 mutant and pck deletion strains and K. Nakano (University of Tsukuba) for rho1-expression plasmids. We also thank J. Ishiguro (Konan Univ.) for the act1/cps8 mutant strain, which was provided through the Yeast Genetic Resource Center (YGRC), N. Kanoh, S. Shimizu and H. Osada (RIKEN Advanced Science Institute) for helping in the preparation of TNM affinity beads, J. Ochi (Kyoto Univ.) for technical assistance and J. Piotrowski (RIKEN Advanced Science Institute) for critical reading of the manuscript. We are grateful to the RIKEN Brain Science Institute's Research Resource Center for mass spectrometry. This work was supported in part by the New Energy and Industrial Technology Development Organization Project on Development of Basic Technology to Control Biological Systems Using Chemical Compounds, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Chemical Genomics Research Project, RIKEN Advanced Science Institute.	Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Arellano M, 1997, J CELL SCI, V110, P2547; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; BEWLEY CA, 1994, J ORG CHEM, V59, P4849, DOI 10.1021/jo00096a028; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Codlin S, 2008, TRAFFIC, V9, P936, DOI 10.1111/j.1600-0854.2008.00735.x; Dawson S, 2007, NAT PROD REP, V24, P109, DOI 10.1039/b516347c; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Garton S, 2003, FEBS LETT, V538, P192, DOI 10.1016/S0014-5793(03)00163-7; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Iwaki N, 2003, BIOCHEM BIOPH RES CO, V312, P414, DOI 10.1016/j.bbrc.2003.10.140; Waki T, 2008, MICROBIOL-SGM, V154, P830, DOI 10.1099/mic.0.2007/011155-0; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Matsunaga S, 2003, CURR ORG CHEM, V7, P945, DOI 10.2174/1385272033486648; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; Piel J, 2006, CURR MED CHEM, V13, P39, DOI 10.2174/092986706775197971; Rovira P, 2000, CURR MED CHEM, V7, P673, DOI 10.2174/0929867003374778; Sayers LG, 2000, GENES CELLS, V5, P17, DOI 10.1046/j.1365-2443.2000.00301.x; Schmidt EW, 1998, J ORG CHEM, V63, P1254, DOI 10.1021/jo9718455; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Takeda T, 2004, NAT CELL BIOL, V6, P1142, DOI 10.1038/ncb1189; TAKEO K, 1993, FEMS MICROBIOL LETT, V108, P265, DOI 10.1111/j.1574-6968.1993.tb06113.x; Tomishima M, 1999, J ANTIBIOT, V52, P674, DOI 10.7164/antibiotics.52.674; Vera MD, 2002, MED RES REV, V22, P102, DOI 10.1002/med.10003; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; Wada S, 2000, MAR BIOTECHNOL, V2, P285, DOI 10.1007/s101260000006	43	94	96	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					519	526		10.1038/NCHEMBIO.387	http://dx.doi.org/10.1038/NCHEMBIO.387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20543850				2022-12-25	WOS:000278878700012
J	Wurtele, H; Tsao, S; Lepine, G; Mullick, A; Tremblay, J; Drogaris, P; Lee, EH; Thibault, P; Verreault, A; Raymond, M				Wurtele, Hugo; Tsao, Sarah; Lepine, Guylaine; Mullick, Alaka; Tremblay, Jessy; Drogaris, Paul; Lee, Eun-Hye; Thibault, Pierre; Verreault, Alain; Raymond, Martine			Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy	NATURE MEDICINE			English	Article							DNA-DAMAGE RESPONSE; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; INVASIVE CANDIDIASIS; H3-K56 ACETYLATION; H3K56 ACETYLATION; CELL-CYCLE; YEAST; RESISTANCE	Candida albicans is a major fungal pathogen that causes serious systemic and mucosal infections in immunocompromised individuals. In yeast, histone H3 Lys56 acetylation (H3K56ac) is an abundant modification regulated by enzymes that have fungal-specific properties, making them appealing targets for antifungal therapy. Here we demonstrate that H3K56ac in C. albicans is regulated by the RTT109 and HST3 genes, which respectively encode the H3K56 acetyltransferase (Rtt109p) and deacetylase (Hst3p). We show that reduced levels of H3K56ac sensitize C. albicans to genotoxic and antifungal agents. Inhibition of Hst3p activity by conditional gene repression or nicotinamide treatment results in a loss of cell viability associated with abnormal filamentous growth, histone degradation and gross aberrations in DNA staining. We show that genetic or pharmacological alterations in H3K56ac levels reduce virulence in a mouse model of C. albicans infection. Our results demonstrate that modulation of H3K56ac is a unique strategy for treatment of C. albicans and, possibly, other fungal infections.	[Wurtele, Hugo; Tsao, Sarah; Lepine, Guylaine; Drogaris, Paul; Lee, Eun-Hye; Thibault, Pierre; Verreault, Alain; Raymond, Martine] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Mullick, Alaka; Tremblay, Jessy] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Mullick, Alaka; Tremblay, Jessy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Raymond, Martine] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; National Research Council Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Verreault, A (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	alain.verreault@umontreal.ca; martine.raymond@umontreal.ca		Tsao, Sarah/0000-0002-9645-4490; Thibault, Pierre/0000-0001-5993-0331	Canadian Institutes of Health Research [CTP-79843, III-94587, CTP-79392]; National Science and Engineering Research Council of Canada [STGP-322143-05]; Canadian Center of Excellence in Commercialization and Research; Canadian Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Center of Excellence in Commercialization and Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	We are grateful to T. Roemer (Merck Research Laboratory) for providing strain CaSS1 and plasmids pHIS3 and pSAT-Tet, G. St-Germain (Laboratoire de sante publique du Quebec) for strains MY067497, MY067743, MY070362, MY070589, MY069520, MY070954, MY070968 and MY070627, C. Restieri and M. Laverdiere (Hospital Maisonneuve-Rosemont) for strain 372.73374.1, C. Bachewich (Concordia University) for strain R153 and T. Edlind (Drexel University College of Medicine) for strain 20464. We are indebted to T. Roemer and M. Whiteway for critical reading of the manuscript. We thank F. Malenfant, J. Leroy, M. Mercier and P. Liscourt for excellent assistance in mouse handling. We are also grateful for the availability of the Candida Genome Database. This work was supported by research grants from the Canadian Institutes of Health Research to M. R. (CTP-79843, III-94587), A. M. (CTP-79843) and A. V. (CTP-79392) and from the National Science and Engineering Research Council of Canada to P. T. (STGP-322143-05). This is National Research Council of Canada publication number 52756. The Institute for Research in Immunology and Cancer is supported by funds from the Canadian Center of Excellence in Commercialization and Research, the Canadian Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Deere D, 1998, YEAST, V14, P147, DOI 10.1002/(SICI)1097-0061(19980130)14:2<147::AID-YEA207>3.3.CO;2-C; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Drogaris P, 2008, ANAL CHEM, V80, P6698, DOI 10.1021/ac800739d; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garske AL, 2006, BIOCHEMISTRY-US, V45, P94, DOI 10.1021/bi052015l; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Horsman MR, 1997, RADIOTHER ONCOL, V45, P167, DOI 10.1016/S0167-8140(97)00127-8; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Kelly J, 2009, MED MYCOL, V47, P697, DOI 10.3109/13693780802552606; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; Niren Neil M, 2006, Cutis, V77, P11; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sims CR, 2005, ARCH MED RES, V36, P660, DOI 10.1016/j.arcmed.2005.05.015; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Trunk K, 2009, EUKARYOT CELL, V8, P756, DOI 10.1128/EC.00332-08; Tsao S, 2009, ANTIMICROB AGENTS CH, V53, P1344, DOI 10.1128/AAC.00926-08; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	53	107	113	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					774	U73		10.1038/nm.2175	http://dx.doi.org/10.1038/nm.2175			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20601951	Green Accepted			2022-12-25	WOS:000279631900026
J	Lee, SH; Hu, LL; Gonzalez-Navajas, J; Seo, GS; Shen, C; Brick, J; Herdman, S; Varki, N; Corr, M; Lee, J; Raz, E				Lee, Sung Hee; Hu, Li-Li; Gonzalez-Navajas, Jose; Seo, Geom Seog; Shen, Carol; Brick, Jonathan; Herdman, Scott; Varki, Nissi; Corr, Maripat; Lee, Jongdae; Raz, Eyal			ERK activation drives intestinal tumorigenesis in Apc(min/+) mice	NATURE MEDICINE			English	Article							C-MYC PROTEOLYSIS; INNATE IMMUNITY; KAPPA-B; INFLAMMATION; CANCER; TRANSCRIPTION; NEOPLASIA; MUTATION; PATHWAY; TARGET	Toll-like receptor (TLR) signaling is essential for intestinal tumorigenesis in Apc(min/+) mice, but the mechanisms by which Apc enhances tumor growth are unknown. Here we show that microflora-MyD88-ERK signaling in intestinal epithelial cells (IECs) promotes tumorigenesis by increasing the stability of the c-Myc oncoprotein. Activation of ERK (extracellular signal-related kinase) phosphorylates c-Myc, preventing its ubiquitination and subsequent proteasomal degradation. Accordingly, Apc(min/+)/Myd88(-/-) mice have lower phospho-ERK (p-ERK) levels and fewer and smaller IEC tumors than Apc(min/+) mice. MyD88 (myeloid differentiation primary response gene 88)-independent activation of ERK by epidermal growth factor (EGF) increased p-ERK and c-Myc and restored the multiple intestinal neoplasia (Min) phenotype in Apc(min)/(+)/Myd88(-/-) mice. Administration of an ERK inhibitor suppressed intestinal tumorigenesis in EGF-treated Apc(min/+)/Myd88(-/-) and Apcmin/+ mice and increased their survival. Our data reveal a new facet of oncogene-environment interaction, in which microflora-induced TLR activation regulates oncogene expression and related IEC tumor growth in a susceptible host.	[Lee, Sung Hee; Hu, Li-Li; Gonzalez-Navajas, Jose; Seo, Geom Seog; Shen, Carol; Brick, Jonathan; Herdman, Scott; Corr, Maripat; Lee, Jongdae; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Nissi] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Raz, E (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	eraz@ucsd.edu	González-Navajas, Jose Manuel/AAB-1575-2019; 高, 雨莉/HGU-8187-2022; LEE, Sunghee/HCH-4510-2022	González-Navajas, Jose Manuel/0000-0002-1591-939X; Lee, Jongdae/0000-0002-6270-4658	US National Institutes of Health [AI068685, CA133702, DK35108, DK080506]; NATIONAL CANCER INSTITUTE [R21CA133702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, P01DK035108] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P. Charos for animal breeding and S. Shenouda for tissue processing. This work was supported by US National Institutes of Health grants AI068685, CA133702, DK35108 and DK080506.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Chang WCL, 2005, ANN NY ACAD SCI, V1059, P41, DOI 10.1196/annals.1339.020; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dakour J, 1999, PLACENTA, V20, P119, DOI 10.1053/plac.1998.0336; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dove WF, 1997, CANCER RES, V57, P812; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Lee YR, 2006, DERMATOL SURG, V32, P1327, DOI 10.1111/j.1524-4725.2006.32302.x; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Michelsen KS, 2007, CURR OPIN HEMATOL, V14, P48, DOI 10.1097/00062752-200701000-00010; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Sanderson IR, 2007, AM J PHYSIOL-GASTR L, V292, pG6, DOI 10.1152/ajpgi.00275.2006; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seo TC, 2008, J MED FOOD, V11, P687, DOI 10.1089/jmf.2007.0053; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wickenden JA, 2008, ONCOGENE, V27, P7150, DOI 10.1038/onc.2008.335; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232	40	159	164	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2010	16	6					665	U65		10.1038/nm.2143	http://dx.doi.org/10.1038/nm.2143			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	606BA	20473309	Green Accepted			2022-12-25	WOS:000278394200032
J	Qiu, L; Pleskow, DK; Chuttani, R; Vitkin, E; Leyden, J; Ozden, N; Itani, S; Guo, LY; Sacks, A; Goldsmith, JD; Modell, MD; Hanlon, EB; Itzkan, I; Perelman, LT				Qiu, Le; Pleskow, Douglas K.; Chuttani, Ram; Vitkin, Edward; Leyden, Jan; Ozden, Nuri; Itani, Sara; Guo, Lianyu; Sacks, Alana; Goldsmith, Jeffrey D.; Modell, Mark D.; Hanlon, Eugene B.; Itzkan, Irving; Perelman, Lev T.			Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus	NATURE MEDICINE			English	Article							LIGHT-SCATTERING SPECTROSCOPY; HIGH-GRADE DYSPLASIA; EARLY ADENOCARCINOMA; EARLY NEOPLASIA; CLASSIFICATION; REFLECTANCE	Esophageal cancer is increasing in frequency in the United States faster than any other cancer. Barrett's esophagus, an otherwise benign complication of esophageal reflux, affects approximately three million Americans and precedes almost all cases of esophageal cancer. If detected as high-grade dysplasia (HGD), most esophageal cancers can be prevented. Standard-of-care screening for dysplasia uses visual endoscopy and a prescribed pattern of biopsy. This procedure, in which a tiny fraction of the affected tissue is selected for pathological examination, has a low probability of detection because dysplasia is highly focal and visually indistinguishable. We developed a system called endoscopic polarized scanning spectroscopy (EPSS), which performs rapid optical scanning and multispectral imaging of the entire esophageal surface and provides diagnoses in near real time. By detecting and mapping suspicious sites, guided biopsy of invisible, precancerous dysplasia becomes practicable. Here we report the development of EPSS and its application in several clinical cases, one of which merits special consideration.	[Qiu, Le; Vitkin, Edward; Itani, Sara; Guo, Lianyu; Modell, Mark D.; Hanlon, Eugene B.; Itzkan, Irving; Perelman, Lev T.] Harvard Univ, Biomed Imaging & Spect Lab, Boston, MA 02115 USA; [Qiu, Le; Vitkin, Edward; Itani, Sara; Guo, Lianyu; Modell, Mark D.; Hanlon, Eugene B.; Itzkan, Irving; Perelman, Lev T.] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Qiu, Le; Vitkin, Edward; Itani, Sara; Guo, Lianyu; Modell, Mark D.; Hanlon, Eugene B.; Itzkan, Irving; Perelman, Lev T.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pleskow, Douglas K.; Chuttani, Ram; Leyden, Jan; Ozden, Nuri; Sacks, Alana] Harvard Univ, Div Gastroenterol, Dept Med, Boston, MA 02115 USA; [Goldsmith, Jeffrey D.] Harvard Univ, Dept Pathol, Boston, MA 02115 USA; [Hanlon, Eugene B.] Dept Vet Affairs, Med Res Serv, Bedford, MA USA; [Hanlon, Eugene B.] Dept Vet Affairs, Ctr Geriatr Res Educ & Clin, Bedford, MA USA	Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Geriatric Research Education & Clinical Center	Perelman, LT (corresponding author), Harvard Univ, Biomed Imaging & Spect Lab, Boston, MA 02115 USA.	ltperel@bidmc.harvard.edu	Pleskow, Douglas K/F-3319-2016	Pleskow, Douglas K/0000-0003-0092-9496	US National Institutes of Health [EB003472, RR017361]; US National Science Foundation [BES0116833]; US Department of Veterans Affairs Office of Research and Development; NATIONAL CENTER FOR RESEARCH RESOURCES [R33RR017361, R21RR017361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003472, R01EB006462] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); US Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by US National Institutes of Health grants EB003472 and RR017361, by US National Science Foundation grant BES0116833 and, in part, by the US Department of Veterans Affairs Office of Research and Development. We thank R. Chinnock and F. Bargoot of Optimum Technologies, Inc., for help with the fiber optic probe development. We thank Olympus for the loan of the endoscope used in the animal experiments.	Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325; Backman V, 2000, NATURE, V406, P35, DOI 10.1038/35017638; Cameron AJ, 1997, AM J GASTROENTEROL, V92, P586; Cameron AJ, 1998, MAYO CLIN PROC, V73, P457; Curvers WL, 2008, GUT, V57, P167, DOI 10.1136/gut.2007.134213; Fang H, 2003, IEEE J SEL TOP QUANT, V9, P267, DOI 10.1109/JSTQE.2003.812515; Georgakoudi I, 2001, GASTROENTEROLOGY, V120, P1620, DOI 10.1053/gast.2001.24842; Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245; Kara MA, 2005, GASTROINTEST ENDOSC, V61, P679, DOI 10.1016/S0016-5107(04)02577-5; Kara MA, 2006, GASTROINTEST ENDOSC, V64, P155, DOI 10.1016/j.gie.2005.11.049; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Macdonald CE, 2000, BMJ-BRIT MED J, V321, P1252, DOI 10.1136/bmj.321.7271.1252; Perelman LT, 1998, PHYS REV LETT, V80, P627, DOI 10.1103/PhysRevLett.80.627; Pohl H, 2008, GUT, V57, P1648, DOI 10.1136/gut.2008.157461; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; Wallace MB, 2000, GASTROENTEROLOGY, V119, P677, DOI 10.1053/gast.2000.16511	16	124	128	5	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					603	U140		10.1038/nm.2138	http://dx.doi.org/10.1038/nm.2138			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20383155	Green Accepted			2022-12-25	WOS:000277394700041
J	Mu, JB; Myers, RA; Jiang, HY; Liu, SF; Ricklefs, S; Waisberg, M; Chotivanich, K; Wilairatana, P; Krudsood, S; White, NJ; Udomsangpetch, R; Cui, LW; Ho, M; Ou, FZ; Li, HB; Song, JP; Li, GQ; Wang, XH; Seila, S; Sokunthea, S; Socheat, D; Sturdevant, DE; Porcella, SF; Fairhurst, RM; Wellems, TE; Awadalla, P; Su, XZ				Mu, Jianbing; Myers, Rachel A.; Jiang, Hongying; Liu, Shengfa; Ricklefs, Stacy; Waisberg, Michael; Chotivanich, Kesinee; Wilairatana, Polrat; Krudsood, Srivicha; White, Nicholas J.; Udomsangpetch, Rachanee; Cui, Liwang; Ho, May; Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao; Wang, Xinhua; Seila, Suon; Sokunthea, Sreng; Socheat, Duong; Sturdevant, Daniel E.; Porcella, Stephen F.; Fairhurst, Rick M.; Wellems, Thomas E.; Awadalla, Philip; Su, Xin-zhuan			Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; QUININE RESISTANCE; MALARIA; CHLOROQUINE; MUTATIONS; MEFLOQUINE; THAILAND; PROTEIN	Antimalarial drugs impose strong selective pressure on Plasmodium falciparum parasites and leave signatures of selection in the parasite genome(1,2); screening for genes under selection may suggest potential drug or immune targets(3). Genome-wide association studies (GWAS) of parasite traits have been hampered by the lack of high-throughput genotyping methods, inadequate knowledge of parasite population history and time-consuming adaptations of parasites to in vitro culture. Here we report the first Plasmodium GWAS, which included 189 culture-adapted P. falciparum parasites genotyped using a custom-built Affymetrix molecular inversion probe 3K malaria panel array with a coverage of similar to 1 SNP per 7 kb. Population structure, variation in recombination rate and loci under recent positive selection were detected. Parasite half-maximum inhibitory concentrations for seven antimalarial drugs were obtained and used in GWAS to identify genes associated with drug responses. This study provides valuable tools and insight into the P. falciparum genome.	[Mu, Jianbing; Jiang, Hongying; Liu, Shengfa; Fairhurst, Rick M.; Wellems, Thomas E.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Myers, Rachel A.; Awadalla, Philip] Univ Montreal, Dept Pediat, Fac Med, St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Myers, Rachel A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Liu, Shengfa] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Ricklefs, Stacy; Sturdevant, Daniel E.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Res Technol Branch,Rocky Mt Labs,NIH, Hamilton, MT USA; [Waisberg, Michael] NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Chotivanich, Kesinee; Wilairatana, Polrat] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Krudsood, Srivicha] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [White, Nicholas J.] Mahidol Univ, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Ho, May] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao] Res Ctr Qinghao, Guangzhou, Guangdong, Peoples R China; [Wang, Xinhua] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China; [Seila, Suon; Sokunthea, Sreng; Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of North Carolina; North Carolina State University; Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; Mahidol University; Mahidol University; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Calgary; Guangzhou University of Chinese Medicine; National Center Parasitology, Entomology & Malaria Control	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmu@niaid.nih.gov; philip.awadalla@umontreal.ca; xsu@niaid.nih.gov	Awadalla, Philip/AAC-4896-2021; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research, NIAID, NIH (USA); Canadian Institute of Health Research [11284, 200183]; US National Academies Keck Genome Initiative; Human Frontiers in Science Program [RGP54/2006]; Wellcome Trust; 973 National Basic Research Program of China [2007CB513103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZICAI001052, ZIAAI001000, ZIAAI000892, ZIAAI000483] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Academies Keck Genome Initiative; Human Frontiers in Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); 973 National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, NIAID, NIH (USA), funds from the Canadian Institute of Health Research #11284 and #200183, the US National Academies Keck Genome Initiative, and the Human Frontiers in Science Program #RGP54/2006 for P. A. K. C. and N.J.W. are supported by the Wellcome Trust. S. L. was supported by the 973 National Basic Research Program of China, #2007CB513103. We also thank J. Sattabongkot for help in parasite shipping, J. Dunn and L. Zhang for assistance in parasite culture and NIAID intramural editor B. R. Marshall for assistance.	BASCO LK, 1993, AM J TROP MED HYG, V49, P301, DOI 10.4269/ajtmh.1993.49.301; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Escalante AA, 1998, GENETICS, V149, P189; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Liu SF, 2008, AM J TROP MED HYG, V79, P178, DOI 10.4269/ajtmh.2008.79.178; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	31	146	152	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					268	U113		10.1038/ng.528	http://dx.doi.org/10.1038/ng.528			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101240	Green Accepted			2022-12-25	WOS:000274912400019
J	Choi, S; Connelly, S; Reixach, N; Wilson, IA; Kelly, JW				Choi, Sungwook; Connelly, Stephen; Reixach, Natalia; Wilson, Ian A.; Kelly, Jeffery W.			Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma	NATURE CHEMICAL BIOLOGY			English	Article							AMYLOID FIBRIL INHIBITORS; TRANSTHYRETIN AMYLOIDOGENESIS INHIBITORS; NATIVE-STATE; KINETIC STABILIZATION; ACIDIC CONDITIONS; DISEASE; BINDING; INSIGHT; BLOOD; AGGREGATION	A small molecule that could bind selectively to and then react chemoselectively with a non-enzyme protein in a complex biological fluid, such as blood, could have numerous practical applications. Herein, we report a family of designed stilbenes that selectively and covalently modify the prominent plasma protein transthyretin in preference to more than 4,000 other human plasma proteins. They react chemoselectively with only one of eight lysine epsilon-amino groups within transthyretin. The crystal structure confirms the expected binding orientation of the stilbene substructure and the anticipated conjugating amide bond. These covalent transthyretin kinetic stabilizers exhibit superior amyloid inhibition potency compared to their noncovalent counterparts, and they prevent cytotoxicity associated with amyloidogenesis. Though there are a few prodrugs that, upon metabolic activation, react with a cysteine residue inactivating a specific non-enzyme, we are unaware of designed small molecules that react with one lysine epsilon-amine within a specific non-enzyme protein in a complex biological fluid.	[Choi, Sungwook; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Choi, Sungwook; Connelly, Stephen; Wilson, Ian A.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Connelly, Stephen; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Reixach, Natalia; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Choi, Sungwook/0000-0002-2656-255X; Reixach, Natalia/0000-0002-7877-0908	US National Institutes of Health [DK46335, CA58896, AI42266]; Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; US Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046335] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge US National Institutes of Health grants DK46335 to J. W. K. and CA58896 and AI42266 to I. A. W. We also thank the Skaggs Institute for Chemical Biology and the Lita Annenberg Hazen Foundation for financial support. Technical support from M. Saure and G. Dendle is greatly appreciated. We are grateful to C. Fearns for carefully reading and editing the manuscript. We thank the General Clinical Research Center of the Scripps Research Institute for providing human blood. The authors also acknowledge R. Stanfield, X. Dai, S. Yoon, R. Xu and D. Ekiert for assisting with X-ray data collection. X-ray diffraction data were collected at GM/CA-CAT 23-IDB beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38.	Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; Baures PW, 1999, BIOORGAN MED CHEM, V7, P1339, DOI 10.1016/S0968-0896(99)00066-8; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Coelho T, 1996, CURR OPIN NEUROL, V9, P355, DOI 10.1097/00019052-199610000-00007; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Estebanez-Perpina E, 2007, MOL ENDOCRINOL, V21, P2919, DOI 10.1210/me.2007-0174; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Guo F, 2006, P NATL ACAD SCI USA, V103, P11009, DOI 10.1073/pnas.0603822103; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2008, J MED CHEM, V51, P6348, DOI 10.1021/jm800435s; Johnson SM, 2008, J MED CHEM, V51, P260, DOI 10.1021/jm0708735; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Marinec PS, 2009, P NATL ACAD SCI USA, V106, P1336, DOI 10.1073/pnas.0805375106; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Petrassi HM, 2000, J AM CHEM SOC, V122, P2178, DOI 10.1021/ja993309v; Purkey HE, 2004, CHEM BIOL, V11, P1719, DOI 10.1016/j.chembiol.2004.10.009; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Razavi H, 2003, ANGEW CHEM INT EDIT, V42, P2758, DOI 10.1002/anie.200351179; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wiseman RL, 2005, J AM CHEM SOC, V127, P5540, DOI 10.1021/ja042929f; WOJTCZAK A, 1992, J BIOL CHEM, V267, P353; Wojtczak A, 2001, ACTA CRYSTALLOGR D, V57, P1061, DOI 10.1107/S0907444901007235; Zhang QH, 2003, BIOCHEMISTRY-US, V42, P8756, DOI 10.1021/bi030077a	50	66	73	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2010	6	2					133	139		10.1038/NCHEMBIO.281	http://dx.doi.org/10.1038/NCHEMBIO.281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544JH	20081815	Green Accepted			2022-12-25	WOS:000273651700013
J	Wild, P; Dikic, I				Wild, Philipp; Dikic, Ivan			Mitochondria get a Parkin' ticket	NATURE CELL BIOLOGY			English	Editorial Material							SELECTIVE AUTOPHAGY; UBIQUITIN; MITOPHAGY; PROTEIN; ATG32	Recent studies have revealed a prominent role of mitochondrial dysfunction in the development of one of the most common neurodegenerative disorders, Parkinson's disease. The ubiquitin ligase Parkin and the protein kinase PINK1, whose mutations are associated with Parkinson's disease, function in a pathway that links ubiquitylation with selective autophagy of damaged mitochondria.	[Wild, Philipp] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Sch Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Wild, P (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Wild, Philipp S./M-2106-2019; Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511				Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	15	44	48	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					104	106		10.1038/ncb0210-104	http://dx.doi.org/10.1038/ncb0210-104			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20118996				2022-12-25	WOS:000274139400003
J	Zhou, YH; Rideout, WM; Zi, T; Bressel, A; Reddypalli, S; Rancourt, R; Woo, JK; Horner, JW; Chin, L; Chiu, MI; Bosenberg, M; Jacks, T; Clark, SC; DePinho, RA; Robinson, MO; Heyer, J				Zhou, Yinghui; Rideout, William M., III; Zi, Tong; Bressel, Angela; Reddypalli, Shailaja; Rancourt, Rebecca; Woo, Jin-Kyeung; Horner, James W.; Chin, Lynda; Chiu, M. Isabel; Bosenberg, Marcus; Jacks, Tyler; Clark, Steven C.; DePinho, Ronald A.; Robinson, Murray O.; Heyer, Joerg			Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITOR; GENE-EXPRESSION; MAMMARY EPITHELIUM; CANCER; RESISTANCE; MUTATION; GEFITINIB; EGFR; ERLOTINIB	To recapitulate the stochastic nature of human cancer development, we have devised a strategy for generating mouse tumor models that involves stepwise genetic manipulation of embryonic stem (ES) cells and chimera generation. Tumors in the chimeric animals develop from engineered cells in the context of normal tissue. Adenocarcinomas arising in an allelic series of lung cancer models containing HER2 (also known as ERBB2), KRAS or EGFR oncogenes exhibit features of advanced malignancies. Treatment of EGFR(L858R) and KRAS(G12V) chimeric models with an EGFR inhibitor resulted in near complete tumor regression and no response to the treatment, respectively, accurately reflecting previous clinical observations. Transcriptome and immunohistochemical analyses reveal that PI3K pathway activation is unique to ERBB family tumors whereas KRAS-driven tumors show activation of the JNK/SAP pathway, suggesting points of therapeutic intervention for this difficult-to-treat tumor category.	[Zhou, Yinghui; Rideout, William M., III; Zi, Tong; Bressel, Angela; Reddypalli, Shailaja; Rancourt, Rebecca; Woo, Jin-Kyeung; Chiu, M. Isabel; Clark, Steven C.; Robinson, Murray O.; Heyer, Joerg] AVEO Pharmaceut, Cambridge, MA USA; [Chin, Lynda] Harvard Univ, Sch Med, Dana Farber Canc Inst,Dept Med Oncol, Belfer Inst Appl Canc Sci,Dept Dermatol, Boston, MA 02115 USA; [Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Horner, James W.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Jacks, Tyler] MIT, Koch Inst, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Heyer, J (corresponding author), AVEO Pharmaceut, Cambridge, MA USA.	jheyer@aveopharma.com		Rancourt, Rebecca/0000-0003-2696-7220; Robinson, Murray/0000-0003-4462-0685; DePinho, Ronald/0000-0002-5625-577X				Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EDWARDS PAW, 1992, ONCOGENE, V7, P2041; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forbes S. A., 2008, CURRENT PROTOCOLS HU, DOI DOI 10.11.1-10.11.26; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lewis BC, 2003, GENE DEV, V17, P3127, DOI 10.1101/gad.1140403; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2003, P NATL ACAD SCI USA, V100, P8764, DOI 10.1073/pnas.1133333100; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Suzuki M, 2006, CANCER-AM CANCER SOC, V106, P2200, DOI 10.1002/cncr.21853; Suzuki T, 2007, CANCER SCI, V98, P1977, DOI 10.1111/j.1349-7006.2007.00613.x; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Weinberg RA, 2007, BIOL CANC; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	42	52	53	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN 10	2010	28	1					71	U102		10.1038/nbt.1595	http://dx.doi.org/10.1038/nbt.1595			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	541PP	20023657				2022-12-25	WOS:000273430400023
J	Cameron, NMD; Caplan, A				Cameron, Nigel M. de S.; Caplan, Arthur			Our synthetic future	NATURE BIOTECHNOLOGY			English	Article									[Cameron, Nigel M. de S.] Ctr for Policy Emerging Technol, Washington, DC USA; [Caplan, Arthur] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania	Cameron, NMD (corresponding author), Ctr for Policy Emerging Technol, Washington, DC USA.	nigel.cameron@c-pet.org; caplan@mail.med.upenn.edu						Rees M., 2003, OUR FINAL HOUR SCI W; Rees M., 2003, OUR FINAL CENTURY WI; Specter Michael, 2009, New Yorker, P56	3	8	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1103	1105		10.1038/nbt1209-1103	http://dx.doi.org/10.1038/nbt1209-1103			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010585				2022-12-25	WOS:000272708300021
J	Kaebnick, GE				Kaebnick, Gregory E.			Should moral objections to synthetic biology affect public policy?	NATURE BIOTECHNOLOGY			English	Article									Hastings Ctr, Garrison, NY USA		Kaebnick, GE (corresponding author), Hastings Ctr, Garrison, NY USA.	kaebnickg@thehastingscenter.org						Boldt J, 2008, NAT BIOTECHNOL, V26, P387, DOI 10.1038/nbt0408-387; Brent R, 2004, NAT BIOTECHNOL, V22, P1211, DOI 10.1038/nbt1004-1211; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; Kaebnick G, 2007, PERSPECT BIOL MED, V50, P572, DOI 10.1353/pbm.2007.0049; Pollan Michael., 2001, BOT DESIRE PLANTS EY; Preston CJ, 2008, ENVIRON VALUE, V17, P23, DOI 10.3197/096327108X271932; Royal Academy of Engineering, 2009, SYNTH BIOL PUBL DIAL; STREIFFER R, 2004, PUBLIC AFFAIRS Q, V18, P223; [No title captured]	9	13	14	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1106	1108		10.1038/nbt1209-1106	http://dx.doi.org/10.1038/nbt1209-1106			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010586				2022-12-25	WOS:000272708300022
J	Oga, T; Matsuoka, T; Yao, CC; Nonomura, K; Kitaoka, S; Sakata, D; Kita, Y; Tanizawa, K; Taguchi, Y; Chin, K; Mishima, M; Shimizu, T; Narumiya, S				Oga, Toru; Matsuoka, Toshiyuki; Yao, Chengcan; Nonomura, Kimiko; Kitaoka, Shiho; Sakata, Daiji; Kita, Yoshihiro; Tanizawa, Kiminobu; Taguchi, Yoshio; Chin, Kazuo; Mishima, Michiaki; Shimizu, Takao; Narumiya, Shuh			Prostaglandin F-2 alpha receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta	NATURE MEDICINE			English	Article							INDUCED LUNG FIBROSIS; MICE LACKING; TGF-BETA; GENE; EXPRESSION; INHIBITOR; ACTIVATION; TGF-BETA-1; COLLAGEN; ELEMENTS	Idiopathic pulmonary fibrosis (IPF) is a progressive disease characterized by fibroblast proliferation and excess deposition of collagen and other extracellular matrix (ECM) proteins, which lead to distorted lung architecture and function(1). Given that anti-inflammatory or immunosuppressive therapy currently used for IPF does not improve disease progression therapies targeted to blocking the mechanisms of fibrogenesis are needed(1). Although transforming growth factor-beta (TGF-beta) functions are crucial in fibrosis(2,3), antagonizing this pathway in bleomycin-induced pulmonary fibrosis, an animal model of IPF, does not prevent fibrosis completely(4-7), indicating an additional pathway also has a key role in fibrogenesis. Given that the loss of cytosolic phospholipase A(2) (cPLA(2)) suppresses bleomycin-induced pulmonary fibrosis(8), we examined the roles of prostaglandins using mice lacking each prostoaglandin receptor(9-15). Here we show that loss of prostaglandin F (PGF) receptor (FP) selectively attenuates pulmonary fibrosis while maintaining similar levels of alveolar inflammation and TGF-beta stimulation as compared to wild-type (WT) mice, and that FP deficiency and inhibition of TGF-beta signaling additively decrease fibrosis. Furthermore, PGF(2 alpha) is abundant in bronchoalveolar lavage fluid (BALF) of subjects with IPF and stimulates proliferation and collagen production of lung fibroblasts via FP, independently of TGF-beta. These findings show that PGF(2 alpha)-FP signaling facilitates pulmonary fibrosis independently of TGF-beta and suggests this signaling pathway as a therapeutic target for IPF.	[Oga, Toru; Matsuoka, Toshiyuki; Yao, Chengcan; Nonomura, Kimiko; Kitaoka, Shiho; Sakata, Daiji; Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Oga, Toru; Chin, Kazuo] Kyoto Univ, Fac Med, Dept Resp Care & Sleep Control Med, Kyoto 606, Japan; [Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Tanizawa, Kiminobu; Mishima, Michiaki] Kyoto Univ, Fac Med, Dept Resp Med, Kyoto 606, Japan; [Taguchi, Yoshio] Tenri Hosp, Dept Resp Med, Nara, Japan	Kyoto University; Kyoto University; University of Tokyo; Kyoto University; Tenri Hospital	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Shimizu, Takao/AAV-7052-2021	Yao, Chengcan/0000-0003-3754-2842; Tanizawa, Kiminobu/0000-0002-5719-0744	Ministry of Education, Culture, Sports, Science and Technology of Japan [18002015]; National Institute of Biomedical Innovation of Japan; Ono Research Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ono Research Foundation	We thank M. Trojanowska (Medical University of South Carolina) and H. Ihn (Kumamoto University) for the - 3500COL1A2/CAT construct, and Ono Pharmaceutical Company for ONO-AE3-208. We also thank Y. Kobashi for BALF analysis, T. Fujiwara for animal care and T. Arai for assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (18002015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant of the Program for Promotion of Fundamental Studies in Health Science from the National Institute of Biomedical Innovation of Japan and a grant from Ono Research Foundation.	Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Bhatt N, 2006, CURR OPIN PHARMACOL, V6, P284, DOI 10.1016/j.coph.2006.03.003; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Handa T, 2005, RESPIRATION, V72, P243, DOI 10.1159/000085364; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jinnin M, 2006, BIOCHEM BIOPH RES CO, V343, P904, DOI 10.1016/j.bbrc.2006.03.037; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kapoun AM, 2006, MOL PHARMACOL, V70, P518, DOI 10.1124/mol.105.021600; Kita Y, 2005, BIOCHEM BIOPH RES CO, V330, P898, DOI 10.1016/j.bbrc.2005.03.055; Ley K, 2008, NAT MED, V14, P20, DOI 10.1038/nm0108-20; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Narumiya S, 2007, P JPN ACAD B-PHYS, V83, P296, DOI [10.2183/pjab.83.296, 10.2183/pjab/83.296]; Peters-Golden M, 2002, AM J RESP CRIT CARE, V165, P229, DOI 10.1164/ajrccm.165.2.2104050; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Wang QJ, 1999, THORAX, V54, P805, DOI 10.1136/thx.54.9.805; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200	36	130	141	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2009	15	12					1426	U12		10.1038/nm.2066	http://dx.doi.org/10.1038/nm.2066			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	527YS	19966781				2022-12-25	WOS:000272407800024
J	Yue, XA; Schwartz, JC; Chu, YJ; Younger, ST; Gagnon, KT; Elbashir, S; Janowski, BA; Corey, DR				Yue, Xuan; Schwartz, Jacob C.; Chu, Yongjun; Younger, Scott T.; Gagnon, Keith T.; Elbashir, Sayda; Janowski, Bethany A.; Corey, David R.			Transcriptional regulation by small RNAs at sequences downstream from 3 ' gene termini	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN-CELLS; MESSENGER-RNA; CANCER-CELLS; REPRESSES TRANSCRIPTION; ANTISENSE TRANSCRIPTS; NATURAL ANTISENSE; INTERFERING RNA; NONCODING RNAS; GROWTH-FACTOR; EXPRESSION	Transcriptome studies reveal many noncoding transcripts overlapping 3' gene termini. The function of these transcripts is unknown. Here we have characterized transcription at the progesterone receptor ( PR) locus and identified noncoding transcripts that overlap the 3' end of the gene. Small RNAs complementary to sequences beyond the 3' terminus of PR mRNA modulated expression of PR, recruited argonaute 2 to a 3' noncoding transcript, altered occupancy of RNA polymerase II, induced chromatin changes at the PR promoter and affected responses to physiological stimuli. We found that the promoter and 3' terminal regions of the PR locus are in close proximity, providing a potential mechanism for RNA-mediated control of transcription over long genomic distances. These results extend the potential for small RNAs to regulate transcription to target sequences beyond the 3' termini of mRNA.	[Yue, Xuan; Schwartz, Jacob C.; Chu, Yongjun; Younger, Scott T.; Gagnon, Keith T.; Janowski, Bethany A.; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yue, Xuan; Schwartz, Jacob C.; Chu, Yongjun; Younger, Scott T.; Gagnon, Keith T.; Janowski, Bethany A.; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Elbashir, Sayda] Alnylam Pharmaceut, Cambridge, MA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Janowski, BA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	bethany.janowski@utsouthwestern.edu; david.corey@utsouthwestern.edu	Younger, Scott/M-3177-2019; Chu, Yongjun/E-9187-2012; Schwartz, Jacob/J-6477-2012	Schwartz, Jacob/0000-0002-5205-564X	US National Institutes of Health (NIGMS) [GM77253, GM85080, NIBIB EB 05556]; Robert A. Welch Foundation [I-1244]; UT Southwestern Medical Center; American Cancer Society [IRG-02-196-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB005556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077253, R01GM085080] Funding Source: NIH RePORTER	US National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert A. Welch Foundation(The Welch Foundation); UT Southwestern Medical Center; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (NIGMS GM77253 to D.R.C., GM85080 to B.A.J. and NIBIB EB 05556 to J.C.S.) and the Robert A. Welch Foundation (I-1244 to D.R.C.). B.A.J. was also supported by the High Impact/High Risk Grants Program, UT Southwestern Medical Center, and an Institutional Research Grant from the American Cancer Society (IRG-02-196-04). We gratefully acknowledge Z. Mourelatos (Univ. Pennsylvania) for providing anti-argonaute antibody. We thank A. Bhat for technical assistance and J. Watts for comments on the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; CHO HS, 1994, ENDOCRINOLOGY, V134, P658, DOI 10.1210/en.134.2.658; Colley SM, 2009, CRIT REV BIOCHEM MOL, V44, P25, DOI [10.1080/10409230802661719 , 10.1080/10409230802661719]; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Goodrich JA, 2009, CRIT REV BIOCHEM MOL, V44, P3, DOI [10.1080/10409230802593995, 10.1080/10409230802593995 ]; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hershberger PA, 2005, CANCER RES, V65, P1598, DOI 10.1158/0008-5472.CAN-04-2694; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kurokawa R, 2009, RNA BIOL, V6, P233, DOI 10.4161/rna.6.3.8329; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P935, DOI 10.1210/endo-122-3-935; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Scsucova S, 2005, NUCLEIC ACIDS RES, V33, P2269, DOI 10.1093/nar/gki503; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; SOUTHGATE C, 1990, NATURE, V345, P640, DOI 10.1038/345640a0; Stoica A, 2000, J ENDOCRINOL, V165, P371, DOI 10.1677/joe.0.1650371; Sun M, 2005, NUCLEIC ACIDS RES, V33, P5533, DOI 10.1093/nar/gki852; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Zaragoza DB, 2006, BIOL REPROD, V75, P697, DOI 10.1095/biolreprod.106.053439	49	82	85	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2010	6	8					621	629		10.1038/NCHEMBIO.400	http://dx.doi.org/10.1038/NCHEMBIO.400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	628EG	20581822	Green Accepted			2022-12-25	WOS:000280096600014
J	Hu, JX; Wang, Y; Zhang, XH; Lloyd, JR; Li, JH; Karpiak, J; Costanzi, S; Wess, J				Hu, Jianxin; Wang, Yan; Zhang, Xiaohong; Lloyd, John R.; Li, Jian Hua; Karpiak, Joel; Costanzi, Stefano; Wess, Juergen			Structural basis of G protein-coupled receptor-G protein interactions	NATURE CHEMICAL BIOLOGY			English	Article							HETEROTRIMERIC G-PROTEINS; LIGHT-ACTIVATED RHODOPSIN; DISULFIDE CROSS-LINKING; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTORS; SULFHYDRYL REACTIVITY; COMPLEX-FORMATION; ALPHA-SUBUNIT; CONTACT SITES; LIVING CELLS	The interaction of G protein-coupled receptors (GPCRs) with heterotrimeric G proteins represents one of the most fundamental biological processes. However, the molecular architecture of the GPCR-G protein complex remains poorly defined. In the present study, we applied a comprehensive GPCR-G protein a subunit (G alpha) chemical cross-linking strategy to map a receptor-G alpha interface, both before and after agonist-induced receptor activation. Using the M(3) muscarinic acetylcholine receptor (M3R)-G alpha(q) system as a model system, we examined the ability of similar to 250 combinations of cysteine-substituted M3R and G alpha(q) proteins to undergo cross-link formation. We identified many specific M3R-G alpha(q) contact sites, in both the inactive and active receptor conformations, allowing us to draw conclusions regarding the basic architecture of the M3R-G alpha(q) interface and the nature of the conformational changes following receptor activation. As heterotrimeric G proteins as well as most GPCRs share a high degree of structural homology, our findings should be of broad general relevance.	[Hu, Jianxin; Wang, Yan; Zhang, Xiaohong; Li, Jian Hua; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD USA; [Lloyd, John R.] NIDDK, Mass Spectrometry Grp, Bioorgan Chem Lab, NIH, Bethesda, MD USA; [Karpiak, Joel; Costanzi, Stefano] NIDDK, Lab Biol Modelling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hu, JX (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD USA.	jianxinh@niddk.nih.gov; jwess@helix.nih.gov	Costanzi, Stefano/G-8990-2013; Li, Jianhua/B-7671-2011	Li, Jianhua/0000-0002-5744-3182; Costanzi, Stefano/0000-0003-3183-7332	US National Institute of Diabetes and Digestive and Kidney Diseases (US National Institutes of Health); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129, ZIADK013025] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the US National Institute of Diabetes and Digestive and Kidney Diseases (US National Institutes of Health) and used the high-performance computational capabilities of the Biowulf Linux cluster at the US National Institutes of Health, Bethesda, Maryland, USA (http://biowulf.nih.gov).	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; CHABRE O, 1994, J BIOL CHEM, V269, P5730; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clark MA, 2007, FEBS LETT, V581, P764, DOI 10.1016/j.febslet.2007.01.045; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; EDGERTON MD, 1994, FEBS LETT, V354, P195, DOI 10.1016/0014-5793(94)01101-X; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; MORO O, 1993, J BIOL CHEM, V268, P22273; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	47	62	63	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2010	6	7					541	548		10.1038/NCHEMBIO.385	http://dx.doi.org/10.1038/NCHEMBIO.385			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	612ED	20512139	Green Accepted			2022-12-25	WOS:000278878700015
J	Karginov, AV; Ding, F; Kota, P; Dokholyan, NV; Hahn, KM				Karginov, Andrei V.; Ding, Feng; Kota, Pradeep; Dokholyan, Nikolay V.; Hahn, Klaus M.			Engineered allosteric activation of kinases in living cells	NATURE BIOTECHNOLOGY			English	Article							FOCAL ADHESION KINASE; LIGAND-BINDING; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; CANCER; MIGRATION; SRC; PHOSPHORYLATION; STABILIZATION; DYNAMICS	Studies of cellular and tissue dynamics benefit greatly from tools that can control protein activity with specificity and precise timing in living systems. Here we describe an approach to confer allosteric regulation specifically on the catalytic activity of protein kinases. A highly conserved portion of the kinase catalytic domain is modified with a small protein insert that inactivates catalytic activity but does not affect other protein functions (Fig. 1a). Catalytic activity is restored by addition of rapamycin or non-immunosuppresive rapamycin analogs. Molecular modeling and mutagenesis indicate that the protein insert reduces activity by increasing the flexibility of the catalytic domain. Drug binding restores activity by increasing rigidity. We demonstrate the approach by specifically activating focal adhesion kinase (FAK) within minutes in living cells and show that FAK is involved in the regulation of membrane dynamics. Successful regulation of Src and p38 by insertion of the rapamycin-responsive element at the same conserved site used in FAK suggests that our strategy will be applicable to other kinases.	[Karginov, Andrei V.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Ding, Feng; Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	dokh@med.unc.edu; khahn@med.unc.edu	Ding, Feng/G-6029-2011; Dokholyan, Nikolay/B-2238-2009	Ding, Feng/0000-0003-1850-6336; Hahn, Klaus/0000-0002-1970-7562; Dokholyan, Nikolay/0000-0002-8225-4025	UNC Cancer Research Fund; National Institutes of Health [GM64346, GM057464, GM080742, GM080742-03S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742, U54GM064346, R01GM057464, R55GM057464] Funding Source: NIH RePORTER	UNC Cancer Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Edwards, D. Dominguez and V. Rao for help with construction and testing of RapR-Src and RapR-p38 alpha constructs, B. Clarke for her design of figures and are grateful to the UNC Cancer Research Fund and the National Institutes of Health for funding (GM64346 and GM057464 to K.M.H.; GM080742 and GM080742-03S1 to N.V.D.). We acknowledge the following gifts: anti-paxillin antibodies and the construct expressing the GST-tagged N-terminal fragment of paxillin from M. Schaller, Department of Biochemistry, West Virginia University; iRap from T. Wandless, Molecular Pharmacology Department, Stanford University; the construct for myc-tagged mouse FAK from S. K. Hanks, Vanderbilt University Medical Center; the flag-tagged mouse p38 alpha, human FKBP12 and FRB domain of human FRAP1 DNA constructs from G. Johnson, Department of Pharmacology, University of North Carolina at Chapel Hill; AP21967 compound was provided by ARIAD Pharmaceuticals.	Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Chatzizacharias NA, 2008, HISTOL HISTOPATHOL, V23, P629, DOI 10.14670/HH-23.629; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Golubovskaya VM, 2009, HISTOL HISTOPATHOL, V24, P503, DOI 10.14670/HH-24.503; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; MARQUISOMER D, 1991, BIOCHEM BIOPH RES CO, V179, P741, DOI 10.1016/0006-291X(91)91879-H; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Teotico DG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000111; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Vogel R, 2008, HUM GENE THER, V19, P167, DOI 10.1089/hum.2007.125; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	34	149	151	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2010	28	7					743	U1756		10.1038/nbt.1639	http://dx.doi.org/10.1038/nbt.1639			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	623FL	20581846	Green Submitted, Green Accepted			2022-12-25	WOS:000279723900033
J	Weinberg, R; Fisher, DE; Rich, J				Weinberg, Robert; Fisher, David E.; Rich, Jeremy			Dynamic and transient cancer stem cells nurture melanoma	NATURE MEDICINE			English	Editorial Material									[Weinberg, Robert] Whitehead Inst Biomed Res, Cambridge, MA USA; [Weinberg, Robert] Massachusetts Inst Tech, Cambridge, MA USA; [Fisher, David E.] Harvard Med Sch, Massachusetts Gen Hosp, Melanoma Program, Boston, MA USA; [Rich, Jeremy] Lerner Res Inst, Dept Stem Cell Biol & Regenerative Med, Cleveland, OH USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Cleveland Clinic Foundation	Weinberg, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA USA.		Rich, Jeremy/AAM-1445-2021; Fisher, David/AAH-2878-2019		Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NCI NIH HHS [R01 CA116659, R01 CA129958] Funding Source: Medline; NIAMS NIH HHS [R01 AR043369] Funding Source: Medline; NINDS NIH HHS [K02 NS047409] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	3	8	8	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2010	16	7					758	758		10.1038/nm0710-758	http://dx.doi.org/10.1038/nm0710-758			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20613753	Green Accepted			2022-12-25	WOS:000279631900037
J	Campbell, KL; Roberts, JEE; Watson, LN; Stetefeld, J; Sloan, AM; Signore, AV; Howatt, JW; Tame, JRH; Rohland, N; Shen, TJ; Austin, JJ; Hofreiter, M; Ho, C; Weber, RE; Cooper, A				Campbell, Kevin L.; Roberts, Jason E. E.; Watson, Laura N.; Stetefeld, Joerg; Sloan, Angela M.; Signore, Anthony V.; Howatt, Jesse W.; Tame, Jeremy R. H.; Rohland, Nadin; Shen, Tong-Jian; Austin, Jeremy J.; Hofreiter, Michael; Ho, Chien; Weber, Roy E.; Cooper, Alan			Substitutions in woolly mammoth hemoglobin confer biochemical properties adaptive for cold tolerance	NATURE GENETICS			English	Article							RIBONUCLEASE SUPERFAMILY; EVOLUTION; LIFE; PROBOSCIDEA; TETRAMERS; DEOXY; GENE; OXY	We have genetically retrieved, resurrected and performed detailed structure-function analyses on authentic woolly mammoth hemoglobin to reveal for the first time both the evolutionary origins and the structural underpinnings of a key adaptive physiochemical trait in an extinct species. Hemoglobin binds and carries O(2); however, its ability to offload O(2) to respiring cells is hampered at low temperatures, as heme deoxygenation is inherently endothermic (that is, hemoglobin-O(2) affinity increases as temperature decreases). We identify amino acid substitutions with large phenotypic effect on the chimeric beta/delta-globin subunit of mammoth hemoglobin that provide a unique solution to this problem and thereby minimize energetically costly heat loss. This biochemical specialization may have been involved in the exploitation of high-latitude environments by this African-derived elephantid lineage during the Pleistocene period. This powerful new approach to directly analyze the genetic and structural basis of physiological adaptations in an extinct species adds an important new dimension to the study of natural selection.	[Campbell, Kevin L.; Roberts, Jason E. E.; Sloan, Angela M.; Signore, Anthony V.; Howatt, Jesse W.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Watson, Laura N.; Austin, Jeremy J.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 232, Japan; [Rohland, Nadin; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Jr Res Grp Mol Ecol, Leipzig, Germany; [Shen, Tong-Jian; Ho, Chien] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Weber, Roy E.] Univ Aarhus, Inst Biol Sci, Aarhus, Denmark	University of Manitoba; University of Adelaide; University of Manitoba; Yokohama City University; Max Planck Society; Carnegie Mellon University; Aarhus University	Campbell, KL (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	campbelk@cc.umanitoba.ca; alan.cooper@adelaide.edu.au	Ho, Chien/O-6112-2016; Cooper, Alan/E-8171-2012; Austin, Jeremy J/F-8729-2010; Stetefeld, Joerg/H-7630-2017; Hofreiter, Michael/A-3996-2017	Ho, Chien/0000-0002-4094-9232; Cooper, Alan/0000-0002-7738-7851; Austin, Jeremy J/0000-0003-4244-2942; Stetefeld, Joerg/0000-0003-1478-3248; Campbell, Kevin/0000-0001-7005-7086; Signore, Anthony/0000-0002-0664-0864; Hofreiter, Michael/0000-0003-0441-4705	National Sciences and Engineering Research Council (NSERC) of Canada; Winnipeg Foundation; Japan Society for the Promotion of Science; Max Planck Society; US National Institutes of Health [R01GM-084614]; Danish Natural Science Research Council; Carlsberg Foundation; Australian Research Council; NSERC; University of Manitoba; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084614] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Winnipeg Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); Australian Research Council(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kuznetsova for the mammoth samples, W. Korver for providing Asian and African elephant blood and A. Bang, T. C. Tam, N. Ho, J. Hare, J. da Silva and M. Pagel for technical assistance. Financial support was provided by the National Sciences and Engineering Research Council (NSERC) of Canada (K. L. C. and J. S.), Winnipeg Foundation (K. L. C.), University of Manitoba Research Grant Program (K. L. C.), Japan Society for the Promotion of Science (J. R. H. T.), Max Planck Society (M. H. and N. R.), US National Institutes of Health grant R01GM-084614; C. H.), Danish Natural Science Research Council and the Carlsberg Foundation (R. E. W.) and the Australian Research Council (A. C. and L. N. W.). J. E. E. R., J. W. H. and A. V. S. were supported by NSERC Undergraduate Research Awards, and A. M. S. was supported by a University of Manitoba Graduate Fellowship.	ABRAHAM DJ, 1992, J MOL BIOL, V227, P480, DOI 10.1016/0022-2836(92)90902-V; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; BAUDIN V, 1993, PROTEIN SCI, V2, P1320, DOI 10.1002/pro.5560020815; BEINTEMA JJ, 1988, PROG BIOPHYS MOL BIO, V51, P165, DOI 10.1016/0079-6107(88)90001-6; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; BRAUNITZER G, 1984, H-S Z PHYSIOL CHEM, V365, P743, DOI 10.1515/bchm2.1984.365.2.743; BRAUNITZER G, 1982, H-S Z PHYSIOL CHEM, V363, P683, DOI 10.1515/bchm2.1982.363.2.683; CLEMENTI ME, 1994, EUR J BIOCHEM, V223, P309, DOI 10.1111/j.1432-1033.1994.tb18996.x; De Rosa MC, 2004, BIOCHEM J, V380, P889, DOI 10.1042/BJ20031421; Fronticelli C, 1995, J BIOL CHEM, V270, P30588, DOI 10.1074/jbc.270.51.30588; IRVING L, 1955, J APPL PHYSIOL, V7, P355, DOI 10.1152/jappl.1955.7.4.355; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; JONES RT, 1980, HEMOGLOBIN, V4, P243, DOI 10.3109/03630268008996208; Lister A., 2007, MAMMOTHS GIANTS ICE; Lister AM, 2005, QUATERN INT, V126, P49, DOI 10.1016/j.quaint.2004.04.014; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; NAKATSUJI T, 2004, BIOCHIM BIOPHYS ACTA, V789, P224; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Opazo JC, 2009, MOL BIOL EVOL, V26, P1469, DOI 10.1093/molbev/msp064; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; Repin V E, 2004, Dokl Biol Sci, V398, P382, DOI 10.1023/B:DOBS.0000046662.43270.66; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; SHIH DTB, 1985, J BIOL CHEM, V260, P5919; TURNER GJ, 1992, PROTEINS, V14, P333, DOI 10.1002/prot.340140303; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611	30	68	70	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2010	42	6					536	U91		10.1038/ng.574	http://dx.doi.org/10.1038/ng.574			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436470				2022-12-25	WOS:000278081500021
J	Yonemura, S; Wada, Y; Watanabe, T; Nagafuchi, A; Shibata, M				Yonemura, Shigenobu; Wada, Yuko; Watanabe, Toshiyuki; Nagafuchi, Akira; Shibata, Mai			alpha-Catenin as a tension transducer that induces adherens junction development	NATURE CELL BIOLOGY			English	Article							CELL-CELL CONTACTS; E-CADHERIN; EPITHELIAL-CELLS; F-ACTIN; ADHESION; VINCULIN; COMPLEX; MORPHOGENESIS; DYNAMICS; DOMAINS	Adherens junctions (AJs), which are organized by adhesion proteins and the underlying actin cytoskeleton, probably sense pulling forces from adjacent cells and modulate opposing forces to maintain tissue integrity, but the regulatory mechanism remains unknown at the molecular level. Although the possibility that alpha-catenin acts as a direct linker between the membrane and the actin cytoskeleton for AJ formation and function has been minimized, here we show that alpha-catenin recruits vinculin, another main actin-binding protein of AJs, through force-dependent changes in alpha-catenin conformation. We identified regions in the alpha-catenin molecule that are required for its force-dependent binding of vinculin by introducing mutant alpha-catenin into cells and using in vitro binding assays. Fluorescence recovery after photobleaching analysis for alpha-catenin mobility and the existence of an antibody recognizing alpha-catenin in a force-dependent manner further supported the notion that alpha-catenin is a tension transducer that translates mechanical stimuli into a chemical response, resulting in AJ development.	[Yonemura, Shigenobu; Wada, Yuko; Watanabe, Toshiyuki; Shibata, Mai] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan; [Watanabe, Toshiyuki] Kobe Univ, Dept Life Sci, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Nagafuchi, Akira] Kumamoto Univ, Dept Cellular Interact, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan	RIKEN; Kobe University; Kumamoto University	Yonemura, S (corresponding author), RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan.	yonemura@cdb.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18657065, 17048034]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank F. van Roy, E. Reichman and the Health Science Research Resources Bank for cells; M. Takeichi for cells, antibodies and plasmids; Sa. Tsukita for antibodies; R. Y. Tsien (Howard Hughes Medical Institute, University of California San Diego) for a plasmid; M. Furuse for discussions; and T. Hakoshima and H. Hiraga for critical reading of the manuscript. We also thank Y. Hayashizaki (RIKEN GSC) for a mouse vinculin complementary DNA from FANTOM2 clones. This work was supported by grants-in-aid for Exploratory Research (18657065) and Scientific Research in Priority Areas (17048034) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; AMERONGEN HM, 1989, J CELL BIOL, V109, P2129, DOI 10.1083/jcb.109.5.2129; BAKER PC, 1967, DEV BIOL, V15, P432, DOI 10.1016/0012-1606(67)90036-X; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 2006, NATURE, V440, P38, DOI 10.1038/440038b; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEVI G, 1991, DEVELOPMENT, V111, P159; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; MORTENSEN RM, 1991, P NATL ACAD SCI USA, V88, P7036, DOI 10.1073/pnas.88.16.7036; NAGAFUCHI A, 1994, DEV GROWTH DIFFER, V36, P59; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Xu WM, 1998, DEVELOPMENT, V125, P327; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; YONEMURA S, 1995, J CELL SCI, V108, P127	51	639	648	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					533	U35		10.1038/ncb2055	http://dx.doi.org/10.1038/ncb2055			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20453849				2022-12-25	WOS:000278213400005
J	McKinney, EF; Lyons, PA; Carr, EJ; Hollis, JL; Jayne, DRW; Willcocks, LC; Koukoulaki, M; Brazma, A; Jovanovic, V; Kemeny, DM; Pollard, AJ; MacAry, PA; Chaudhry, AN; Smith, KGC				McKinney, Eoin F.; Lyons, Paul A.; Carr, Edward J.; Hollis, Jane L.; Jayne, David R. W.; Willcocks, Lisa C.; Koukoulaki, Maria; Brazma, Alvis; Jovanovic, Vojislav; Kemeny, D. Michael; Pollard, Andrew J.; MacAry, Paul A.; Chaudhry, Afzal N.; Smith, Kenneth G. C.			A CD8(+) T cell transcription signature predicts prognosis in autoimmune disease	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; GENE-EXPRESSION; WEGENERS-GRANULOMATOSIS; MICROARRAY ANALYSIS; CLASS DISCOVERY; BREAST-CANCER; MEMORY; EFFECTOR; VASCULITIS	Autoimmune diseases are common and debilitating, but their severe manifestations could be reduced if biomarkers were available to allow individual tailoring of potentially toxic immunosuppressive therapy. Gene expression-based biomarkers facilitating such tailoring of chemotherapy in cancer, but not autoimmunity, have been identified and translated into clinical practice(1,2). We show that transcriptional profiling of purified CD8(+) T cells, which avoids the confounding influences of unseparated cells(3,4), identifies two distinct subject subgroups predicting long-term prognosis in two autoimmune diseases, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a chronic, severe disease characterized by inflammation of medium-sized and small blood vessels(5), and systemic lupus erythematosus (SLE), characterized by autoantibodies, immune complex deposition and diverse clinical manifestations ranging from glomerulonephritis to neurological dysfunction(6). We show that the subset of genes defining the poor prognostic group is enriched for genes involved in the interleukin-7 receptor (IL-7R) pathway and T cell receptor (TCR) signaling and those expressed by memory T cells. Furthermore, the poor prognostic group is associated with an expanded CD8(+) T cell memory population. These subgroups, which are also found in the normal population and can be identified by measuring expression of only three genes, raise the prospect of individualized therapy and suggest new potential therapeutic targets in autoimmunity.	[McKinney, Eoin F.; Lyons, Paul A.; Carr, Edward J.; Willcocks, Lisa C.; Koukoulaki, Maria; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [McKinney, Eoin F.; Lyons, Paul A.; Carr, Edward J.; Hollis, Jane L.; Jayne, David R. W.; Willcocks, Lisa C.; Koukoulaki, Maria; Chaudhry, Afzal N.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Brazma, Alvis] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Jovanovic, Vojislav; Kemeny, D. Michael; MacAry, Paul A.] Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore; [Jovanovic, Vojislav; Kemeny, D. Michael; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Ctr Life Sci, Singapore 117548, Singapore; [Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Ctr Clin Vaccinol & Trop Med, Oxford, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; European Molecular Biology Laboratory (EMBL); National University of Singapore; National University of Singapore; University of Oxford	Smith, KGC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.	pal34@cam.ac.uk; kgcs2@cam.ac.uk		MacAry, Paul/0000-0002-1139-8996; Brazma, Alvis/0000-0001-5988-7409; Carr, Edward/0000-0001-9343-4593; McKinney, Eoin/0000-0003-3516-3072; Smith, Kenneth/0000-0003-3829-4326; Jayne, David/0000-0002-1712-0637	UK National Institute of Health Research; Cambridge Biomedical Research Centre; Wellcome Trust [083650/Z/07/Z, 079895]; UK Medical Research Council; Evelyn Trust, Kidney Research UK; National Medical Research Council of Singapore [IRG07nov089]; Wellcome Fellowship; Medical Research Council; Medical Research Council [G0400929] Funding Source: researchfish; MRC [G0400929] Funding Source: UKRI	UK National Institute of Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evelyn Trust, Kidney Research UK; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Wellcome Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Fearon and J. Todd for critical review of the manuscript, T. Rayner, M. Kapushesky and M. Clatworthy for helpful discussions, K. Townsend for help with subject recruitment, H. Woffendin and T. Freeman for help with optimizing the custom array platform and A. Hatton and H. Ratlamwala for technical support, along with all subjects and clinicians involved in enrollment and clinical follow up. We are grateful to E. Clutterbuck, R. Lazarus and the volunteers at the Oxford Vaccine Group for their help with recruitment of healthy controls. This work was supported by the UK National Institute of Health Research, the Cambridge Biomedical Research Centre, the Wellcome Trust (Programme Grant number 083650/Z/07/Z), the UK Medical Research Council, the Evelyn Trust, Kidney Research UK and the National Medical Research Council of Singapore (grant reference IRG07nov089). E. F. M. holds a Wellcome Fellowship, and L. C. W. a Medical Research Council, Clinical Training Fellowship. K. G. C. S. is a Lister Prize Fellow and Khoo Oon Teik Professor of Nephrology at the National University of Singapore. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895).	Abdulahad WH, 2007, ANN NY ACAD SCI, V1107, P22, DOI 10.1196/annals.1381.003; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Bryant PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004427; Buentke E, 2006, BLOOD, V108, P1949, DOI 10.1182/blood-2006-04-016857; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Illei Gabor G, 2004, Curr Rheumatol Rep, V6, P382, DOI 10.1007/s11926-004-0013-4; Ippolito A, 2008, CLIN EXP RHEUMATOL, V26, pS72; Jennette JC, 2006, J AM SOC NEPHROL, V17, P1235, DOI 10.1681/ASN.2005101048; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Lamprecht P, 2005, CLIN EXP IMMUNOL, V141, P201, DOI 10.1111/j.1365-2249.2005.02808.x; Lane SE, 2005, QJM-INT J MED, V98, P97, DOI 10.1093/qjmed/hci015; Langford CA, 2004, CLIN EXP RHEUMATOL, V22, pS3; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Lyons PA, 2010, ANN RHEUM DIS, V69, P1208, DOI 10.1136/ard.2009.108043; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Torrente A, 2005, BIOINFORMATICS, V21, P3993, DOI 10.1093/bioinformatics/bti644; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895	37	254	263	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2010	16	5					586	U122		10.1038/nm.2130	http://dx.doi.org/10.1038/nm.2130			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	592QP	20400961	Green Submitted, Green Accepted			2022-12-25	WOS:000277394700038
J	Gastaldello, S; Hildebrand, S; Faridani, O; Callegari, S; Palmkvist, M; Di Guglielmo, C; Masucci, MG				Gastaldello, Stefano; Hildebrand, Sebastian; Faridani, Omid; Callegari, Simone; Palmkvist, Mia; Di Guglielmo, Claudia; Masucci, Maria G.			A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-SPECIFIC PROTEASE; CYSTEINE PROTEASE; STRUCTURAL BASIS; S-PHASE; PHOSPHORYLATION; DEGRADATION; COMPLEX; ENZYME; NEDD8; ACTIVATION	The large tegument proteins of herpesviruses encode conserved cysteine proteases of unknown function. Here we show that BPLF1, the Epstein-Barr-virus-encoded member of this protease family, is a deneddylase that regulates virus production by modulating the activity of cullin-RING ligases (CRLs). BPLF1 hydrolyses NEDD8 conjugates in vitro, acts as a deneddylase in vivo, binds to cullins and stabilizes CRL substrates. Expression of BPLF1 alone or in the context of the productive virus cycle induces accumulation of the licensing factor CDT1 and deregulates S-phase DNA synthesis. Inhibition of BPLF1 during the productive virus cycle prevents cellular DNA re-replication and inhibits virus replication. Viral DNA synthesis is restored by overexpression of CDT1. Homologues encoded by other herpesviruses share the deneddylase activity. Thus, these enzymes are likely to have a key function in the virus life cycle by inducing a replication-permissive S-phase-like cellular environment.	[Gastaldello, Stefano; Hildebrand, Sebastian; Faridani, Omid; Callegari, Simone; Palmkvist, Mia; Di Guglielmo, Claudia; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Gastaldello, Stefano/AAD-3788-2020; Gastaldello, Stefano/AAM-6768-2020; Masucci, Maria/AAC-6666-2019	Gastaldello, Stefano/0000-0001-7369-8452; Masucci, Maria/0000-0002-5541-2809; Di Guglielmo, Claudia/0000-0002-2846-3731; Faridani, Omid/0000-0001-9330-887X				Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Boettcher S, 2008, J VIROL, V82, P6009, DOI 10.1128/JVI.00280-08; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; CHRISP P, 1991, DRUGS, V41, P104, DOI 10.2165/00003495-199141010-00009; Ciechanover A, 2000, J CELL BIOCHEM, P40; Cook JG, 2009, FRONT BIOSCI-LANDMRK, V14, P5013, DOI 10.2741/3584; DAIBATA M, 1990, J IMMUNOL, V144, P4788; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gredmark-Russ S, 2009, J VIROL, V83, P10644, DOI 10.1128/JVI.01017-09; Guerreiro-Cacais AO, 2007, J VIROL, V81, P1390, DOI 10.1128/JVI.01999-06; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jarosinski K, 2007, P NATL ACAD SCI USA, V104, P20025, DOI 10.1073/pnas.0706295104; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Ohta T, 2001, CANCER RES, V61, P1347; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Sompallae R, 2008, J VIROL, V82, P10477, DOI 10.1128/JVI.01113-08; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wilsker D, 2009, CELL CYCLE, V8, P1161, DOI 10.4161/cc.8.8.8148; YAO GQ, 1993, ANTIMICROB AGENTS CH, V37, P1420, DOI 10.1128/AAC.37.7.1420; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	50	78	86	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					351	U110		10.1038/ncb2035	http://dx.doi.org/10.1038/ncb2035			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20190741				2022-12-25	WOS:000276194600008
J	Schwarz, F; Huang, W; Li, CS; Schulz, BL; Lizak, C; Palumbo, A; Numao, S; Neri, D; Aebi, M; Wang, LX				Schwarz, Flavio; Huang, Wei; Li, Cishan; Schulz, Benjamin L.; Lizak, Christian; Palumbo, Alessandro; Numao, Shin; Neri, Dario; Aebi, Markus; Wang, Lai-Xi			A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation	NATURE CHEMICAL BIOLOGY			English	Article							O-ANTIGEN LIPOPOLYSACCHARIDE; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; BACTERIAL OLIGOSACCHARYLTRANSFERASE; CHEMOENZYMATIC SYNTHESIS; PROTEIN GLYCOSYLATION; LINKED GLYCOSYLATION; GLYCANS	We describe a new method for producing homogeneous eukaryotic N-glycoproteins. The method involves the engineering and functional transfer of the Campylobacter jejuni glycosylation machinery in Escherichia coli to express glycosylated proteins with the key GlcNAc-Asn linkage. The bacterial glycans were then trimmed and remodeled in vitro by enzymatic transglycosylation to fulfill a eukaryotic N-glycosylation. It provides a potentially general platform for producing eukaryotic N-glycoproteins.	[Schwarz, Flavio; Schulz, Benjamin L.; Lizak, Christian; Numao, Shin; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland; [Huang, Wei; Li, Cishan; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Huang, Wei; Li, Cishan; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Palumbo, Alessandro; Neri, Dario] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schwarz, F (corresponding author), ETH, Inst Microbiol, Dept Biol, CH-8092 Zurich, Switzerland.	aebi@micro.biol.ethz.ch; lwang@som.umaryland.edu	Huang, Wei/A-2167-2011; Wang, Lai-Xi/E-8755-2019; Wang, Lai-Xi/E-8790-2019; Schulz, Benjamin L/B-3911-2009; Neri, Dario/P-4368-2016; Huang, Wei/P-9631-2017; wang, xl/Y-8251-2019	Wang, Lai-Xi/0000-0003-4293-5819; Schulz, Benjamin L/0000-0002-4823-7758; Neri, Dario/0000-0001-5234-7370; Huang, Wei/0000-0001-6432-1848; Numao, Shin/0000-0002-6204-7117; Schwarz, Flavio/0000-0002-1060-1585	Swiss National Science Foundation [3100AQ-105541]; EidgenOssische Technische Hochschule Zurich; US National Institutes of Health [GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EidgenOssische Technische Hochschule Zurich; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Aebi and Wang labs for fruitful discussions. This work was supported in part by the Swiss National Science Foundation (grant 3100AQ-105541 to M.A.), the EidgenOssische Technische Hochschule Zurich and the US National Institutes of Health (grant GM080374 to L.-X. W.). We thank K. Takegawa (Kyushu University) for providing the pGEX-2T/Endo-A plasmid and K. Yamamoto (Kyoto University) for providing the pET23b-Endo-M plasmid, which were used to express the endo enzymes. F. S. and C. Lizak are members of the Zurich PhD Program in Molecular Life Sciences.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bennett CS, 2007, CHEM SOC REV, V36, P1227, DOI 10.1039/b617709c; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gamblin DP, 2009, CHEM REV, V109, P131, DOI 10.1021/cr078291i; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	25	142	156	4	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2010	6	4					264	266		10.1038/NCHEMBIO.314	http://dx.doi.org/10.1038/NCHEMBIO.314			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	571EJ	20190762	Green Accepted			2022-12-25	WOS:000275734000009
J	Torres, C				Torres, Christian			Counterfeiting goes cinematic in public campaigns	NATURE MEDICINE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					363	363		10.1038/nm0410-363a	http://dx.doi.org/10.1038/nm0410-363a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376032				2022-12-25	WOS:000276446800023
J	Komatsu, M; Kurokawa, H; Waguri, S; Taguchi, K; Kobayashi, A; Ichimura, Y; Sou, YS; Ueno, I; Sakamoto, A; Tong, KI; Kim, M; Nishito, Y; Iemura, S; Natsume, T; Ueno, T; Kominami, E; Motohashi, H; Tanaka, K; Yamamoto, M				Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi; Taguchi, Keiko; Kobayashi, Akira; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Tong, Kit I.; Kim, Mihee; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Ueno, Takashi; Kominami, Eiki; Motohashi, Hozumi; Tanaka, Keiji; Yamamoto, Masayuki			The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1	NATURE CELL BIOLOGY			English	Article							CUL3-BASED E3 LIGASE; BETA-CELL MASS; OXIDATIVE STRESS; STRUCTURAL BASIS; DLG MOTIFS; PROTEIN; DEGRADATION; INDUCTION; MICE; MECHANISM	Impaired selective turnover of p62 by autophagy causes severe liver injury accompanied by the formation of p62-positive inclusions and upregulation of detoxifying enzymes. These phenotypes correspond closely to the pathological conditions seen in human liver diseases, including alcoholic hepatitis and hepatocellular carcinoma. However, the molecular mechanisms and pathophysiological processes in these events are still unknown. Here we report the identification of a novel regulatory mechanism by p62 of the transcription factor Nrf2, whose target genes include antioxidant proteins and detoxification enzymes. p62 interacts with the Nrf2-binding site on Keap1, a component of Cullin-3-type ubiquitin ligase for Nrf2. Thus, an overproduction of p62 or a deficiency in autophagy competes with the interaction between Nrf2 and Keap1, resulting in stabilization of Nrf2 and transcriptional activation of Nrf2 target genes. Our findings indicate that the pathological process associated with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defence enzyme genes.	[Komatsu, Masaaki; Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Izumi; Sakamoto, Ayako; Nishito, Yasumasa; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kurokawa, Hirofumi; Taguchi, Keiko; Tong, Kit I.; Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kurokawa, Hirofumi; Taguchi, Keiko; Tong, Kit I.; Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO JST, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Kobayashi, Akira; Kim, Mihee] Doshisha Univ, Dept Med Life Syst, Kyoto 6100394, Japan; [Ichimura, Yoshinobu; Sou, Yu-Shin; Ueno, Takashi; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr JBIRC, Kohtoh Ku, Tokyo 1350064, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Fukushima Medical University; Doshisha University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST)	Komatsu, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	komatsu-ms@igakuken.or.jp; tanaka-kj@igakuken.or.jp; masiyamamoto@m.tains.tohoku.ac.jp	Kurokawa, Hirofumi/A-7231-2010; Yamamoto, Masayuki/A-4873-2010; Komatsu, Masaaki/B-8321-2011; Natsume, Tohru/M-7627-2018; Kobayashi, Akira/AAN-8003-2020; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Komatsu, Masaaki/0000-0001-7672-7722; Natsume, Tohru/0000-0002-1510-2582; Kobayashi, Akira/0000-0001-9727-1218; Sou, Yu-shin/0000-0002-7219-9106; Taguchi, Keiko/0000-0002-5798-0076	Japan Science and Technology Agency; Ministry of Education, Science and Culture of Japan; Targeted Proteins Research Program	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Kouno and K. Endo (Tokyo Metropolitan Institute of Medical Science) for technical assistance, and the beamline staff at NW12 of PF-AR (Tsukuba, Japan) for technical help in data collection. We also thank A. Yamada, K. Kanno and A. Yabashi (Fukushima Medical University School of Medicine) for their help in histological studies; J. Yanagisawa (Tsukuba University) and Y. Saeki (Tokyo Metropolitan Institute of Medical Science) for mass spectrometric analyses; Y. Kawatani (Tohoku University) for technical assistance in microarray analyses; and R. Kopito and B. E. Riley (Stanford University) and T. Mizushima and T. Kumanomidou (Nagoya University) for helpful discussion. p62-knockout mice were provided by T. Ishii (Tsukuba University). The Biomedical Research Core of Tohoku University Graduate School of Medicine provided DRI-CHEM 7000V (Fuji Film Corp.). This work was supported by grants from the Japan Science and Technology Agency (M. K.), the Ministry of Education, Science and Culture of Japan (M. K., K. T. and M. Y.) and the Targeted Proteins Research Program (H. K., K. T. and M. Y.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Matsumoto N, 2008, BIOCHEM BIOPH RES CO, V368, P643, DOI 10.1016/j.bbrc.2008.01.112; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	54	1519	1579	8	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2010	12	3					213	U17		10.1038/ncb2021	http://dx.doi.org/10.1038/ncb2021			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	562MD	20173742				2022-12-25	WOS:000275054200007
J	Lei, XF; Bai, ZQ; Ye, FC; Xie, JP; Kim, CG; Huang, YF; Gao, SJ				Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Kim, Chan-Gil; Huang, Yufei; Gao, Shou-Jiang			Regulation of NF-kappa B inhibitor I kappa B alpha and viral replication by a KSHV microRNA	NATURE CELL BIOLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; KAPOSIS-SARCOMA; TRANSCRIPTIONAL PROGRAM; GENE-EXPRESSION; LATENT; IDENTIFICATION; INFECTION; PATHWAY; TARGETS	Kaposi's sarcoma-associated herpesvirus (KSHV) is causally linked to several acquired immune deficiency syndrome-related malignancies, including Kaposi's sarcoma, primary effusion lymphoma (PEL) and a subset of multicentric Castleman's disease(1). Control of viral lytic replication is essential for KSHV latency, evasion of the host immune system and induction of tumours(1). Here, we show that deletion of a 14 microRNA (miRNA) cluster from the KSHV genome significantly enhances viral lytic replication as a result of reduced NF-kappa B activity. The miRNA cluster regulates the NF-kappa B pathway by reducing expression of I kappa B alpha protein, an inhibitor of NF-kappa B complexes. Computational and miRNA seed mutagenesis analyses were used to identify KSHV miR-K1, which directly regulates the I kappa B alpha protein level by targeting the 3'UTR of its transcript. Expression of miR-K1 is sufficient to rescue NF-kappa B activity and inhibit viral lytic replication, whereas inhibition of miR-K1 in KSHV-infected PEL cells has the opposite effect. Thus, KSHV encodes an miRNA to control viral replication by activating the NF-kappa B pathway. These results demonstrate an important role for KSHV miRNAs in regulating viral latency and lytic replication by manipulating the host survival pathway.	[Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Kim, Chan-Gil; Huang, Yufei; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, Tumor Virol Program, San Antonio, TX 78229 USA; [Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat Microbiol & Immunol Med & Mol Med, San Antonio, TX 78229 USA; [Lei, Xiufen; Bai, Zhiqiang; Ye, Fengchun; Xie, Jianping; Gao, Shou-Jiang] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Bai, Zhiqiang; Gao, Shou-Jiang] Chinese Acad Sci, Wuhan Inst Virol, Tumor Virol Grp, Wuhan 430071, Hubei, Peoples R China; [Bai, Zhiqiang; Gao, Shou-Jiang] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Kim, Chan-Gil] Konkuk Univ, Dept Biotechnol, Chungju 380701, South Korea; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Konkuk University; University of Texas System; University of Texas at San Antonio (UTSA)	Gao, SJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, Tumor Virol Program, San Antonio, TX 78229 USA.	gaos@uthscsa.edu	Gao, Shou-Jiang/B-8641-2012; xu, li/AAO-4684-2021; Huang, Yufei/AAU-2891-2021; xu, li/GNH-3667-2022	Gao, Shou-Jiang/0000-0001-6194-1742	American Cancer Society [RSG-04-195]; National Institutes of Health [CA096512, CA124332, CA132637, DE017333]; National Science Foundation [CCF-0546345]; Konkuk University; NATIONAL CANCER INSTITUTE [R01CA096512, R01CA124332, R01CA132637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017333] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Konkuk University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank K. Izumi and A. Griffiths for their valuable suggestions. This work was supported by grants from the American Cancer Society (#RSG-04-195) and the National Institutes of Health (CA096512, CA124332, CA132637 and DE017333) to S.-J. G, and the National Science Foundation (CCF-0546345) to Y. F. H. C.-G. K. was supported by Konkuk University in 2008.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Hara AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000389; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; UMBACH JL, 2008, NATURE; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Yoo SM, 2005, VIROLOGY, V343, P47, DOI 10.1016/j.virol.2005.08.018; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	39	205	217	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2010	12	2					193	U232		10.1038/ncb2019	http://dx.doi.org/10.1038/ncb2019			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	550PD	20081837	Green Accepted			2022-12-25	WOS:000274139400014
J	Li, Y; Zou, LH; Li, QY; Haibe-Kains, B; Tian, RY; Li, Y; Desmedt, C; Sotiriou, C; Szallasi, Z; Iglehart, JD; Richardson, AL; Wang, ZC				Li, Yang; Zou, Lihua; Li, Qiyuan; Haibe-Kains, Benjamin; Tian, Ruiyang; Li, Yan; Desmedt, Christine; Sotiriou, Christos; Szallasi, Zoltan; Iglehart, J. Dirk; Richardson, Andrea L.; Wang, Zhigang Charles			Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer	NATURE MEDICINE			English	Article							GENE-EXPRESSION; MULTIDRUG-RESISTANCE; HISTOLOGIC GRADE; SIGNATURE; ABERRATIONS; METASTASIS; PREDICTION; PROFILES; SURVIVAL; TUMORS	Adjuvant chemotherapy for breast cancer after surgery has effectively lowered metastatic recurrence rates(1). However, a considerable proportion of women suffer recurrent cancer at distant metastatic sites despite adjuvant treatment. Identification of the genes crucial for tumor response to specific chemotherapy drugs is a challenge but is necessary to improve outcomes(2). By using integrated genomics, we identified a small number of overexpressed and amplified genes from chromosome 8q22 that were associated with early disease recurrence despite anthracycline-based adjuvant chemotherapy. We confirmed the association in an analysis of multiple independent cohorts. SiRNA-mediated knockdown of either of two of these genes, the antiapoptotic gene YWHAZ and a lysosomal gene LAPTM4B, sensitized tumor cells to anthracyclines, and overexpression of either of the genes induced anthracycline resistance. Overexpression of LAPTM4B resulted in sequestration of the anthracycline doxorubicin, delaying its appearance in the nucleus. Overexpression of these two genes was associated with poor tumor response to anthracycline treatment in a neoadjuvant chemotherapy trial in women with primary breast cancer. Our results suggest that 8q22 amplification and overexpression of LAPTM4B and YWHAZ contribute to de novo chemoresistance to anthracyclines and are permissive for metastatic recurrence. Overexpression of these two genes may predict anthracycline resistance and influence selection of chemotherapy.	[Li, Yang; Zou, Lihua; Tian, Ruiyang; Li, Yan; Iglehart, J. Dirk; Richardson, Andrea L.; Wang, Zhigang Charles] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Li, Yang; Iglehart, J. Dirk; Wang, Zhigang Charles] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Zou, Lihua] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Li, Qiyuan; Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Haibe-Kains, Benjamin; Desmedt, Christine; Sotiriou, Christos] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium; [Haibe-Kains, Benjamin] Univ Libre Bruxelles, Machine Learning Grp, Brussels, Belgium; [Szallasi, Zoltan] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Denmark; Institut Jules Bordet; Universite Libre de Bruxelles; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Richardson, AL (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	arichardson@partners.org; zhigang_wang@dfci.harvard.edu	Desmedt, Christine/P-7438-2017; Zou, Lihua/E-6748-2010; Haibe-Kains, Benjamin/D-3702-2011	Desmedt, Christine/0000-0002-5223-5579; Haibe-Kains, Benjamin/0000-0002-7684-0079; Szallasi, Zoltan/0000-0001-5395-7509	NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NCI NIH HHS [BC053041, P50 CA089393, P50 CA089393-01, CA89393, P50 CA089393-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gyorffy B, 2005, ONCOGENE, V24, P7542, DOI 10.1038/sj.onc.1208908; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Ingvarsson S, 1999, SEMIN CANCER BIOL, V9, P277, DOI 10.1006/scbi.1999.0124; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; SILVER DP, J CLIN ONCO IN PRESS; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; ZWEIG MH, 1993, CLIN CHEM, V39, P561	36	257	268	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2010	16	2					214	U121		10.1038/nm.2090	http://dx.doi.org/10.1038/nm.2090			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	552MZ	20098429	Green Accepted			2022-12-25	WOS:000274297000043
J	Martinez-Estrada, OM; Lettice, LA; Essafi, A; Guadix, JA; Slight, J; Velecela, V; Hall, E; Reichmann, J; Devenney, PS; Hohenstein, P; Hosen, N; Hill, RE; Munoz-Chapuli, R; Hastie, ND				Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Antonio Guadix, Juan; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hosen, Naoki; Hill, Robert E.; Munoz-Chapuli, Ramon; Hastie, Nicholas D.			Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin	NATURE GENETICS			English	Article							WILMS-TUMOR GENE; STEM-CELLS; EXPRESSION; MOUSE; ACTIVATION; EPICARDIUM; RECEPTOR; BIOLOGY; PROTEIN; TOOL	The epicardial epithelial-mesenchymal transition (EMT) is hypothesized to generate cardiovascular progenitor cells that differentiate into various cell types, including coronary smooth muscle and endothelial cells, perivascular and cardiac interstitial fibroblasts and cardiomyocytes. Here we show that an epicardial-specific knockout of the gene encoding Wilms' tumor-1 (Wt1) leads to a reduction in mesenchymal progenitor cells and their derivatives. We show that Wt1 is essential for repression of the epithelial phenotype in epicardial cells and during embryonic stem cell differentiation through direct transcriptional regulation of the genes encoding Snail (Snai1) and E-cadherin (Cdh1), two of the major mediators of EMT. Some mesodermal lineages do not form in Wt1-null embryoid bodies, but this effect is rescued by the expression of Snai1, underscoring the importance of EMT in generating these differentiated cells. These new insights into the molecular mechanisms regulating cardiovascular progenitor cells and EMT will shed light on the pathogenesis of heart diseases and may help the development of cell-based therapies.	[Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Martinez-Estrada, Ofelia M.; Lettice, Laura A.; Essafi, Abdelkader; Slight, Joan; Velecela, Victor; Hall, Emma; Reichmann, Judith; Devenney, Paul S.; Hohenstein, Peter; Hill, Robert E.; Hastie, Nicholas D.] Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Antonio Guadix, Juan; Munoz-Chapuli, Ramon] Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain; [Hosen, Naoki] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan	University of Edinburgh; Universidad de Malaga; Osaka University	Hastie, ND (corresponding author), MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.	n.hastie@hgu.mrc.ac.uk	Munoz-Chapuli, Ramon/K-7306-2014; Martinez-Estrada, Ofelia M/V-4733-2017; Hohenstein, Peter/Y-2428-2018	Munoz-Chapuli, Ramon/0000-0001-6392-6802; Martinez-Estrada, Ofelia M/0000-0002-1814-1974; Reichmann, Judith/0000-0003-3288-2856; Hohenstein, Peter/0000-0001-8548-4734; Hall, Emma/0000-0002-6944-6719	MRC [MC_U127584494, MC_U127527180] Funding Source: UKRI; Medical Research Council [MC_U127584494, MC_U127527180, U.1275.03.013.00001.01] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Miyoshi Y, 2002, CLIN CANCER RES, V8, P1167; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129	23	265	276	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					89	U112		10.1038/ng.494	http://dx.doi.org/10.1038/ng.494			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20023660	Green Accepted, Bronze			2022-12-25	WOS:000273055100022
J	Beronja, S; Livshits, G; Williams, S; Fuchs, E				Beronja, Slobodan; Livshits, Geulah; Williams, Scott; Fuchs, Elaine			Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos	NATURE MEDICINE			English	Article							ALPHA-CATENIN; IN-VIVO; SKIN CARCINOGENESIS; STEM-CELLS; E-CADHERIN; MICE; RESPONSES; RAS; HOMEOSTASIS; EXPRESSION	Using ultrasound-guided in utero infections of fluorescently traceable lentiviruses carrying RNAi or Cre recombinase into mouse embryos, we have demonstrated noninvasive, highly efficient selective transduction of surface epithelium, in which progenitors stably incorporate and propagate the desired genetic alterations. We achieved epidermal-specific infection using small generic promoters of existing lentiviral short hairpin RNA libraries, thus enabling rapid assessment of gene function as well as complex genetic interactions in skin morphogenesis and disease in vivo. We adapted this technology to devise a new quantitative method for ascertaining whether a gene confers a growth advantage or disadvantage in skin tumorigenesis. Using alpha 1-catenin as a model, we uncover new insights into its role as a widely expressed tumor suppressor and reveal physiological interactions between Ctnna1 and the Hras1-Mapk3 and Trp53 gene pathways in regulating skin cell proliferation and apoptosis. Our study illustrates the strategy and its broad applicability for investigations of tissue morphogenesis, lineage specification and cancers.	[Beronja, Slobodan; Livshits, Geulah; Williams, Scott; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334; Beronja, Slobodan/0000-0002-6769-9261	International Human Frontier Science Program Organization; US National Institutes of Health [R01-AR27883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Takeichi (RIKEN CDB) for antibodies and reagents; N. Stokes and Rockefeller Comparative Bioscience Center staff for expert care of mice; M. Schober and M. Perez-Moreno for helpful discussions; A. North and Rockefeller Bioimaging Resource Center staff for assistance with image acquisition and analysis; and S. Mazel and Rockefeller Flow Cytometry Resource Center staff for assistance with FACS. S. B. is supported by the International Human Frontier Science Program Organization. S. W. is an American Cancer Society Postdoctoral Fellow. This work was supported by a grant from the US National Institutes of Health (R01-AR27883). E. F. is an investigator with the Howard Hughes Medical Institute.	Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Che XM, 1999, ONCOLOGY-BASEL, V57, P131, DOI 10.1159/000012020; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Follenzi A, 2007, CURR GENE THER, V7, P306, DOI 10.2174/156652307782151515; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; HOLZINGER A, 1995, PEDIATR RES, V38, P844, DOI 10.1203/00006450-199512000-00004; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lu B, 1997, J INVEST DERMATOL, V108, P803, DOI 10.1111/1523-1747.ep12292254; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Nozawa N, 2006, PATHOL RES PRACT, V202, P639, DOI 10.1016/j.prp.2006.03.007; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072	33	135	139	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2010	16	7					821	U128		10.1038/nm.2167	http://dx.doi.org/10.1038/nm.2167			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	622BA	20526348	Green Accepted			2022-12-25	WOS:000279631900034
J	Comas, I; Chakravartti, J; Small, PM; Galagan, J; Niemann, S; Kremer, K; Ernst, JD; Gagneux, S				Comas, Inaki; Chakravartti, Jaidip; Small, Peter M.; Galagan, James; Niemann, Stefan; Kremer, Kristin; Ernst, Joel D.; Gagneux, Sebastien			Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved	NATURE GENETICS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENOME VARIATION; VACCINE; PATHOGENS; SEQUENCE; INSIGHTS; STRAINS; GENES; HIV-1; BCG	Mycobacterium tuberculosis is an obligate human pathogen capable of persisting in individual hosts for decades. We sequenced the genomes of 21 strains representative of the global diversity and six major lineages of the M. tuberculosis complex (MTBC) at 40- to 90-fold coverage using Illumina next-generation DNA sequencing. We constructed a genome-wide phylogeny based on these genome sequences. Comparative analyses of the sequences showed, as expected, that essential genes in MTBC were more evolutionarily conserved than nonessential genes. Notably, however, most of the 491 experimentally confirmed human T cell epitopes showed little sequence variation and had a lower ratio of nonsynonymous to synonymous changes than seen in essential and nonessential genes. We confirmed these findings in an additional data set consisting of 16 antigens in 99 MTBC strains. These findings are consistent with strong purifying selection acting on these epitopes, implying that MTBC might benefit from recognition by human T cells.	[Chakravartti, Jaidip; Ernst, Joel D.] NYU, Sch Med, New York, NY 10016 USA; [Comas, Inaki; Gagneux, Sebastien] Natl Inst Med Res, MRC, London NW7 1AA, England; [Small, Peter M.] Inst Syst Biol, Seattle, WA USA; [Small, Peter M.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Galagan, James] MIT, Broad Inst, Cambridge, MA 02139 USA; [Galagan, James] Harvard Univ, Cambridge, MA 02138 USA; [Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Kremer, Kristin] Natl Inst Publ Hlth & Environm, Mycobacteria Reference Lab CIb LIS, NL-3720 BA Bilthoven, Netherlands; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland	New York University; MRC National Institute for Medical Research; Institute for Systems Biology (ISB); Bill & Melinda Gates Foundation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Forschungszentrum Borstel; Netherlands National Institute for Public Health & the Environment; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Ernst, JD (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	joel.ernst@med.nyu.edu; sebastien.gagneux@unibas.ch	Niemann, Stefan/C-9327-2011; Comas, Iñaki/AAA-1155-2019; Gagneux, Sebastien/ABE-7909-2020; Comas, Iñaki/F-1185-2011	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Gagneux, Sebastien/0000-0001-7783-9048; Ernst, Joel/0000-0001-9951-6207; Galagan, James/0000-0003-0542-3291; Niemann, Stefan/0000-0002-6604-0684	National Institute of Allergy and Infectious Disease; US National Institutes of Health (NIH); US Department of Health and Human Services [HHSN266200400001C]; NIH [AI046097, AI051242, HHSN266200700022C, AI034238]; Medical Research Council UK; Royal Society; Swiss National Science Foundation; MRC [MC_U117588500] Funding Source: UKRI; Medical Research Council [MC_U117588500] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051242, R01AI046097, R01AI034238, R01AI090928] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Gonzalez-Candelas, S. Borrell and D. Young for comments on the manuscript. This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Disease, US National Institutes of Health (NIH), US Department of Health and Human Services, under contract no. HHSN266200400001C. J.C. is a Howard Hughes Medical Institute Research Training Fellow. J.D.E. was supported by NIH grants AI046097 and AI051242 and S.G. by the Medical Research Council UK, the Royal Society, the Swiss National Science Foundation and NIH grants HHSN266200700022C and AI034238. .	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Ernst JD, 2008, TUBERCULOSIS, V88, P366, DOI 10.1016/j.tube.2007.11.002; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Frank SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-229; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Plotkin JB, 2004, NATURE, V428, P942, DOI 10.1038/nature02458; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rodrigo T, 1997, INT J TUBERC LUNG D, V1, P352; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; World Health Organization. World Health Organization, 2009, WHOHTMTB2008393; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	53	491	502	0	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					498	U41		10.1038/ng.590	http://dx.doi.org/10.1038/ng.590			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20495566	Bronze, Green Accepted, Green Submitted			2022-12-25	WOS:000278081500014
J	Huang, E; Qu, DAB; Zhang, Y; Venderova, K; Haque, ME; Rousseaux, MWC; Slack, RS; Woulfe, JM; Park, DS				Huang, En; Qu, Dianbo; Zhang, Yi; Venderova, Katerina; Haque, M. Emdadul; Rousseaux, Maxime W. C.; Slack, Ruth S.; Woulfe, John M.; Park, David S.			The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASE-5; BASE EXCISION-REPAIR; MYOCYTE ENHANCER FACTOR-2; DNA-DAMAGE; PARKINSONS-DISEASE; CELL-DEATH; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CDK5 ACTIVITY; MOUSE MODEL	Accumulating evidence suggests that deregulated cyclin-dependent kinase 5 (Cdk5) plays a critical part in neuronal death. However, the pathogenic targets of Cdk5 are not fully defined. Here we demonstrate that the Cdk5 activator p35 interacts directly with apurinic/apyrimidinic endonuclease 1 (Ape1), a protein crucial for base excision repair (BER) following DNA damage. Cdk5 complexes phosphorylate Ape1 at Thr 232 and thereby reduces its apurinic/apyrimidinic (AP) endonuclease activity. Ape1 phosphorylation is dependent on Cdk5 in in vitro and in vivo. The reduced endonuclease activity of phosphorylated Ape1 results in accumulation of DNA damage and contributes to neuronal death. Overexpression of Ape1(WT) and Ape1(T232A), but not the phosphorylation mimic Ape1(T232E), protects neurons against MPP(+)/MPTP. Loss of Ape1 sensitizes neurons to death. Importantly, increased phosphorylated Ape1 was also observed in post-mortem brain tissue from patients with Parkinson's and Alzheimer's diseases, suggesting a potential link between Ape1 phosphorylation and the pathogenesis of neurodegenerative diseases.	[Huang, En; Qu, Dianbo; Zhang, Yi; Venderova, Katerina; Haque, M. Emdadul; Rousseaux, Maxime W. C.; Slack, Ruth S.; Park, David S.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada; [Woulfe, John M.] Univ Ottawa, Dept Pathol & Lab Med, Canc Res Grp, OHRI,Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada; [Woulfe, John M.] Univ Ottawa, Dept Biochem, Canc Res Grp, OHRI,Ottawa Hosp, Ottawa, ON K1Y 4E9, Canada; [Park, David S.] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	, Dianbo/AAU-8480-2021; Qu, Dianbo/C-5121-2011	, Dianbo/0000-0002-0435-9585; Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784; Rousseaux, Maxime/0000-0002-2737-6193	Parkinson Society Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Parkinson's Disease Foundation; Parkinson Research Consortium; Brain Repair Program-Neuroscience Canada; National Research Foundation, Ministry of Education, Science & Technology, South Korea [R31-2008-000-20009-0]	Parkinson Society Canada; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson's Disease Foundation; Parkinson Research Consortium; Brain Repair Program-Neuroscience Canada; National Research Foundation, Ministry of Education, Science & Technology, South Korea	This work was partially supported by Parkinson Society Canada (E.H., D. Q.); by the Heart and Stroke Foundation of Ontario (M.W.C.R); and by funds from the Canadian Institutes of Health Research, Parkinson Society Canada, Parkinson's Disease Foundation, Parkinson Research Consortium, Heart and Stroke Foundation of Ontario, Brain Repair Program-Neuroscience Canada, and World Class University Program, National Research Foundation, Ministry of Education, Science & Technology, South Korea, Grant (R31-2008-000-20009-0) (D.S.P.). D.S.P. is a Heart and Stroke Foundation of Ontario career investigator.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; CHEN TS, 1995, J NEURAL TRANSM-GEN, V100, P153, DOI 10.1007/BF01271538; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Deganuto M, 2007, J CELL PHYSIOL, V212, P223, DOI 10.1002/jcp.21023; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; Hallows JL, 2003, J NEUROSCI, V23, P10633; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Keramaris E, 2008, J BIOL CHEM, V283, P405, DOI 10.1074/jbc.M701552200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1992, J BIOL CHEM, V267, P13383; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Maly DJ, 2004, J AM CHEM SOC, V126, P9160, DOI 10.1021/ja048659i; Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Nakamura J, 1998, CANCER RES, V58, P222; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Robertson KA, 2001, CANCER RES, V61, P2220; Rudolph J, 2007, NAT REV CANCER, V7, P202, DOI 10.1038/nrc2087; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xiang H, 1996, J NEUROSCI, V16, P6753; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	54	88	91	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					563	U100		10.1038/ncb2058	http://dx.doi.org/10.1038/ncb2058			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473298				2022-12-25	WOS:000278213400008
J	Kleppe, M; Lahortiga, I; El Chaar, T; De Keersmaecker, K; Mentens, N; Graux, C; Van Roosbroeck, K; Ferrando, AA; Langerak, AW; Meijerink, JPP; Sigaux, F; Haferlach, T; Wlodarska, I; Vandenberghe, P; Soulier, J; Cools, J				Kleppe, Maria; Lahortiga, Idoya; El Chaar, Tiama; De Keersmaecker, Kim; Mentens, Nicole; Graux, Carlos; Van Roosbroeck, Katrien; Ferrando, Adolfo A.; Langerak, Anton W.; Meijerink, Jules P. P.; Sigaux, Francois; Haferlach, Torsten; Wlodarska, Iwona; Vandenberghe, Peter; Soulier, Jean; Cools, Jan			Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							MOLECULAR PATHOGENESIS; ACTIVATION; IDENTIFICATION; TRANSLOCATION; REGULATOR; FUSION; ABL1	PTPN2 (protein tyrosine phosphatase non-receptor type 2, also known as TC-PTP) is a cytosolic tyrosine phosphatase that functions as a negative regulator of a variety of tyrosine kinases and other signaling proteins(1-3). In agreement with its role in the regulation of the immune system, PTPN2 was identified as a susceptibility locus for autoimmune diseases(4,5). In this work, we describe the identification of focal deletions of PTPN2 in human T-cell acute lymphoblastic leukemia (T-ALL). Deletion of PTPN2 was specifically found in T-ALLs with aberrant expression of the TLX1 transcription factor oncogene(6), including four cases also expressing the NUP214-ABL1 tyrosine kinase(7). Knockdown of PTPN2 increased the proliferation and cytokine sensitivity of T-ALL cells. In addition, PTPN2 was identified as a negative regulator of NUP214-ABL1 kinase activity. Our study provides genetic and functional evidence for a tumor suppressor role of PTPN2 and suggests that expression of PTPN2 may modulate response to treatment.	[El Chaar, Tiama; Sigaux, Francois; Soulier, Jean] INSERM, U944, Paris, France; [El Chaar, Tiama; Sigaux, Francois; Soulier, Jean] Hop St Louis, Hematol Lab, Inst Univ Hematol, Paris, France; [Kleppe, Maria; Lahortiga, Idoya; De Keersmaecker, Kim; Mentens, Nicole; Van Roosbroeck, Katrien; Cools, Jan] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Kleppe, Maria; Lahortiga, Idoya; De Keersmaecker, Kim; Mentens, Nicole; Van Roosbroeck, Katrien; Wlodarska, Iwona; Vandenberghe, Peter; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY USA; [Graux, Carlos] Clin Univ Mt Godinne, Yvoir, Belgium; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Langerak, Anton W.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Meijerink, Jules P. P.] Erasmus Med Ctr Sophia, Dept Pediat, Rotterdam, Netherlands; [Haferlach, Torsten] Munich Leukemia Lab, Munich, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Flanders Institute for Biotechnology (VIB); KU Leuven; Columbia University; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Columbia University; Columbia University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; MLL Munich Leukemia Laboratory	Soulier, J (corresponding author), INSERM, U944, Paris, France.	jean.soulier@sls.aphp.fr; jan.cools@cme.vib-kuleuven.be	De Keersmaecker, Kim/W-9702-2018; Kleppe, Maria/C-6341-2014; Meijerink, Jules/D-4393-2017	De Keersmaecker, Kim/0000-0002-7420-9531; Kleppe, Maria/0000-0002-4372-6704; Vandenberghe, Peter/0000-0003-4719-1935; Cools, Jan/0000-0001-6626-5843; Meijerink, Jules/0000-0002-6860-798X	K.U. Leuven; FWO-Vlaanderen [G.0287.07]; Foundation against Cancer [SCIE2006-34]; European Research Council; European Hematology Association; Federal Office for Scientific, Technical and Cultural Affairs, Belgium; French program Carte d'Identite des Tumeurs; Canceropole d'Ile de France; New York Community Trust; National Institutes of Health [CA120196, CA129382]; NATIONAL CANCER INSTITUTE [R01CA129382, R01CA120196] Funding Source: NIH RePORTER	K.U. Leuven(KU Leuven); FWO-Vlaanderen(FWO); Foundation against Cancer; European Research Council(European Research Council (ERC)European Commission); European Hematology Association; Federal Office for Scientific, Technical and Cultural Affairs, Belgium; French program Carte d'Identite des Tumeurs; Canceropole d'Ile de France(Region Ile-de-France); New York Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Aerts for assistance with data analysis. This work was supported by grants from the K.U. Leuven (concerted action grant to J.C., I. W. and P. V.), the FWO-Vlaanderen (G.0287.07, J.C.), the Foundation against Cancer (SCIE2006-34, J.C.), a European Research Council starting grant (J.C.), a Jose-Carreras Fellowship grant from the European Hematology Association (J.C.), the Interuniversity Attraction Poles granted by the Federal Office for Scientific, Technical and Cultural Affairs, Belgium (J.C. and P. V.), a grant from the French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer) and from Canceropole d'Ile de France (F. S. and J.S.); a Blood Disease Research Project research grant from The New York Community Trust (A. A. F.) and the National Institutes of Health (grants CA120196 and CA129382 to A. A. F.). A. A. F. is a Leukemia and Lymphoma Society Scholar. K. D. K. is a postdoctoral researcher, and P. V. is a senior clinical investigator of FWO-Vlaanderen.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; BENE MC, 1995, LEUKEMIA, V9, P1783; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; De Keersmaecker K, 2005, BLOOD, V105, P4849, DOI 10.1182/blood-2004-12-4897; De Keersmaecker K, 2008, MOL CELL, V31, P134, DOI 10.1016/j.molcel.2008.05.005; De Keersmaecker K, 2008, HAEMATOLOGICA, V93, P533, DOI 10.3324/haematol.11894; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; JAFFE ES, 2001, WHO CLASSIFICATION T, P84; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429	31	127	131	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					530	U84		10.1038/ng.587	http://dx.doi.org/10.1038/ng.587			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20473312	Green Accepted			2022-12-25	WOS:000278081500020
J	Sotiropoulou, PA; Candi, A; Mascre, G; De Clercq, S; Youssef, KK; Lapouge, G; Dahl, E; Semeraro, C; Denecker, G; Marine, JC; Blanpain, C				Sotiropoulou, Panagiota A.; Candi, Aurelie; Mascre, Guilhem; De Clercq, Sarah; Youssef, Khalil Kass; Lapouge, Gaelle; Dahl, Ellen; Semeraro, Claudio; Denecker, Geertrui; Marine, Jean-Christophe; Blanpain, Cedric			Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death	NATURE CELL BIOLOGY			English	Article							RADIATION-INDUCED APOPTOSIS; STRAND BREAK REPAIR; SCID MUTATION; P53; EXPRESSION; MICE; HYPERSENSITIVITY; IDENTIFICATION; KERATINOCYTES; MAINTENANCE	Adult stem cells (SCs) are at high risk of accumulating deleterious mutations because they reside and self-renew in adult tissues for extended periods. Little is known about how adult SCs sense and respond to DNA damage within their natural niche. Here, using mouse epidermis as a model, we define the functional consequences and the molecular mechanisms by which adult SCs respond to DNA damage. We show that multipotent hair-follicle-bulge SCs have two important mechanisms for increasing their resistance to DNA-damage-induced cell death: higher expression of the anti-apoptotic gene Bcl-2 and transient stabilization of p53 after DNA damage in bulge SCs. The attenuated p53 activation is the consequence of a faster DNA repair activity, mediated by a higher non-homologous end joining (NHEJ) activity, induced by the key protein DNA-PK. Because NHEJ is an error-prone mechanism, this novel characteristic of adult SCs may have important implications in cancer development and ageing.	[Sotiropoulou, Panagiota A.; Candi, Aurelie; Mascre, Guilhem; Youssef, Khalil Kass; Lapouge, Gaelle; Dahl, Ellen; Semeraro, Claudio; Blanpain, Cedric] Univ Libre Bruxelles, Interdisciplinary Res Inst IRIBHM, B-1070 Brussels, Belgium; [De Clercq, Sarah; Denecker, Geertrui; Marine, Jean-Christophe] Univ Gent VIB, Lab Mol Canc Biol, Brussels, Belgium	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University	Blanpain, C (corresponding author), Univ Libre Bruxelles, Interdisciplinary Res Inst IRIBHM, 808,Route Lennik,BatC,C6-130, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Youssef, Khalil Kass/AAB-6528-2021; Marine, Jean-Christophe/K-3292-2016; Denecker, Geertrui/E-8134-2010; Marine, Jean Christophe/J-2237-2015	Youssef, Khalil Kass/0000-0002-4572-3160; Marine, Jean-Christophe/0000-0003-2433-9837; Denecker, Geertrui/0000-0002-2515-2911	FNRS; Human Frontier Science Program Organization (HFSPO); Schlumberger Foundation; Wallonia Region; Fondation Contre le Cancer; Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program	FNRS(Fonds de la Recherche Scientifique - FNRS); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Schlumberger Foundation(Schlumberger); Wallonia Region; Fondation Contre le Cancer; Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We thank the members of the Blanpain and Vanderhaeghen laboratories for comments during the realization of this study. We thank V. de Maertelaer for help with the statistical analyses. C.B. is a chercheur qualifie of the Fonds de la Recherche Scientifique (F.R.S.)/Fonds National de la Recherche Scientifique (FNRS). A.C. is a research fellow of the F.R.S./Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). This work was supported by a 'mandat d'impulsion scientifique' of the FNRS, a career development award of the Human Frontier Science Program Organization (HFSPO), a research grant of the Schlumberger Foundation, the programme CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer and the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Botchkarev VA, 2000, CANCER RES, V60, P5002; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dorr W, 2005, FRONT RADIAT THER ON, V39, P96, DOI 10.1159/000090854; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; FitzGerald TJ, 2008, DERMATOL CLIN, V26, P161, DOI 10.1016/j.det.2007.08.005; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kemp CJ, 1999, CARCINOGENESIS, V20, P2051, DOI 10.1093/carcin/20.11.2051; Kim DJ, 2009, MOL CARCINOGEN, V48, P873, DOI 10.1002/mc.20527; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MERRITT AJ, 1995, J CELL SCI, V108, P2261; MERRITT AJ, 1994, CANCER RES, V54, P614; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; PLOEMACHER RE, 1992, INT J RADIAT BIOL, V61, P489, DOI 10.1080/09553009214551251; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Song SY, 1999, AM J PATHOL, V155, P1121, DOI 10.1016/S0002-9440(10)65215-7; STENN KS, 1994, J INVEST DERMATOL, V103, P107, DOI 10.1111/1523-1747.ep12391844; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weil MM, 1996, RADIAT RES, V146, P646, DOI 10.2307/3579380; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	57	188	195	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2010	12	6					572	U121		10.1038/ncb2059	http://dx.doi.org/10.1038/ncb2059			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	603MT	20473297				2022-12-25	WOS:000278213400009
J	Turnbull, C; Ahmed, S; Morrison, J; Pernet, D; Renwick, A; Maranian, M; Seal, S; Ghoussaini, M; Hines, S; Healey, CS; Hughes, D; Warren-Perry, M; Tapper, W; Eccles, D; Evans, DG; Hooning, M; Schutte, M; van den Ouweland, A; Houlston, R; Ross, G; Langford, C; Pharoah, PDP; Stratton, MR; Dunning, AM; Rahman, N; Easton, DF				Turnbull, Clare; Ahmed, Shahana; Morrison, Jonathan; Pernet, David; Renwick, Anthony; Maranian, Mel; Seal, Sheila; Ghoussaini, Maya; Hines, Sarah; Healey, Catherine S.; Hughes, Deborah; Warren-Perry, Margaret; Tapper, William; Eccles, Diana; Evans, D. Gareth; Hooning, Maartje; Schutte, Mieke; van den Ouweland, Ans; Houlston, Richard; Ross, Gillian; Langford, Cordelia; Pharoah, Paul D. P.; Stratton, Michael R.; Dunning, Alison M.; Rahman, Nazneen; Easton, Douglas F.		Breast Canc Susceptibility	Genome-wide association study identifies five new breast cancer susceptibility loci	NATURE GENETICS			English	Article							COMMON VARIANTS; CONFER SUSCEPTIBILITY; RISK; ALLELES; GLIOMA; 9P21	Breast cancer is the most common cancer in women in developed countries. To identify common breast cancer susceptibility alleles, we conducted a genome-wide association study in which 582,886 SNPs were genotyped in 3,659 cases with a family history of the disease and 4,897 controls. Promising associations were evaluated in a second stage, comprising 12,576 cases and 12,223 controls. We identified five new susceptibility loci, on chromosomes 9, 10 and 11 (P = 4.6 x 10(-7) to P = 3.2 x 10(-15)). We also identified SNPs in the 6q25.1 (rs3757318, P = 2.9 x 10(-6)), 8q24 (rs1562430, P = 5.8 x 10(-7)) and LSP1 (rs909116, P = 7.3 x 10(-7)) regions that showed more significant association with risk than those reported previously. Previously identified breast cancer susceptibility loci were also found to show larger effect sizes in this study of familial breast cancer cases than in previous population-based studies, consistent with polygenic susceptibility to the disease.	[Ahmed, Shahana; Maranian, Mel; Ghoussaini, Maya; Healey, Catherine S.; Pharoah, Paul D. P.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cambridge, England; [Turnbull, Clare; Pernet, David; Renwick, Anthony; Seal, Sheila; Hines, Sarah; Hughes, Deborah; Warren-Perry, Margaret; Houlston, Richard; Stratton, Michael R.; Rahman, Nazneen; Breast Canc Susceptibility] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Morrison, Jonathan; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Tapper, William; Eccles, Diana] Univ Southampton, Southampton Gen Hosp, Acad Unit Genet Med, Southampton, Hants, England; [Evans, D. Gareth] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Hooning, Maartje; Schutte, Mieke] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Ross, Gillian] Royal Marsden Natl Hlth Serv Fdn Trust, Breast Canc Unit, London, England; [Langford, Cordelia; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton, England	University of Cambridge; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Southampton; University of Manchester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Marsden NHS Foundation Trust; Wellcome Trust Sanger Institute	Easton, DF (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Oncol, Cambridge, England.	douglas@srl.cam.ac.uk	Pharoah, Paul/V-6658-2019; Turnbull, Clare/AAA-6596-2019; Evans, D Gareth/AAB-4308-2022; Rahman, Nazneen/B-8890-2012; Eccles, Diana/K-6327-2019; Rahman, Nazneen/D-2802-2013	Pharoah, Paul/0000-0001-8494-732X; Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Rahman, Nazneen/0000-0003-4376-0440; Tapper, William/0000-0002-5896-1889; Turnbull, Clare/0000-0002-1734-5772; Dunning, Alison Margaret/0000-0001-6651-7166; Houlston, Richard/0000-0002-5268-0242	Wellcome Trust [068545/Z/02, 085475]; Cancer Research UK; Medical Research Council [G0000934]; US Military Acquisition (ACQ) Activity; Era of Hope Award [W81XWH-05-1-0204]; Institute of Cancer Research (UK); MRC [G0700491, G0000934] Funding Source: UKRI; Cancer Research UK [11022, 11021, 10118] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish; The Francis Crick Institute [10119, 10124] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US Military Acquisition (ACQ) Activity; Era of Hope Award; Institute of Cancer Research (UK)(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Wellcome Trust and by Cancer Research UK. D.F.E. is a Principal Research Fellow of Cancer Research UK. C.T. is funded by a Medical Research Council Clinical Research Fellowship. The samples were collected and screened for BRCA mutations through funding from Cancer Research UK; US Military Acquisition (ACQ) Activity, Era of Hope Award (W81XWH-05-1-0204) and the Institute of Cancer Research (UK). This study makes use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) 2. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Funding for this project was provided by the Wellcome Trust under award 085475. We thank the SEARCH team and Eastern Cancer Registry and Information Centre (ECRIC) for recruitment of the SEARCH cases. We acknowledge the clinicians from the Rotterdam Family Cancer Clinic who were involved in collecting the RBCS samples: C. Seynaeve, J. Klijn, J. Collee and R. Oldenburg.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kamb A, 1994, Nat Genet, V8, P23; KAMB A, 1994, SCIENCE, V264, P440; KARLSEDER J, 1994, GENE CHROMOSOME CANC, V9, P42, DOI 10.1002/gcc.2870090108; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	30	546	565	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					504	U47		10.1038/ng.586	http://dx.doi.org/10.1038/ng.586			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20453838	Green Accepted			2022-12-25	WOS:000278081500015
J	Amaro, AC; Samora, CP; Holtackers, R; Wang, E; Kingston, IJ; Alonso, M; Lampson, M; McAinsh, AD; Meraldi, P				Amaro, Ana C.; Samora, Catarina P.; Holtackers, Rene; Wang, Enxiu; Kingston, Isabel J.; Alonso, Maria; Lampson, Michael; McAinsh, Andrew D.; Meraldi, Patrick			Molecular control of kinetochore-microtubule dynamics and chromosome oscillations	NATURE CELL BIOLOGY			English	Article							CENP-A; AURORA-B; OUTER KINETOCHORE; CENTROMERIC DNA; HUMAN-CELLS; COMPLEX; SPINDLE; PROTEINS; ANAPHASE; MCAK	Chromosome segregation in metazoans requires the alignment of sister kinetochores on the metaphase plate. During chromosome alignment, bioriented kinetochores move chromosomes by regulating the plus-end dynamics of the attached microtubules. The bundles of kinetochore-bound microtubules alternate between growth and shrinkage, leading to regular oscillations along the spindle axis. However, the molecular mechanisms that coordinate microtubule plus-end dynamics remain unknown. Here we show that centromere protein (CENP)-H, a subunit of the CENP-A nucleosome-associated and CENP-A distal complexes (CENP-A NAC/CAD), is essential for this coordination, because kinetochores lacking CENP-H establish bioriented attachments but fail to generate regular oscillations, as a result of an uncontrolled rate of microtubule plus-end turnover. These alterations lead to rapid erratic movements that disrupt metaphase plate organization. We also show that the abundance of the CENP-A NAC/CAD subunits CENP-H and CENP-I dynamically change on individual sister kinetochores in vivo, because they preferentially bind the sister kinetochore attached to growing microtubules, and that one other subunit, CENP-Q, binds microtubules in vitro. We therefore propose that CENP-A NAC/CAD is a direct regulator of kinetochore-microtubule dynamics, which physically links centromeric DNA to microtubule plus ends.	[Amaro, Ana C.; Holtackers, Rene; Meraldi, Patrick] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Samora, Catarina P.; McAinsh, Andrew D.] Marie Curie Res Inst, Chromosome Segregat Lab, Oxted RH8 0TL, Surrey, England; [Wang, Enxiu; Lampson, Michael] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kingston, Isabel J.] Canc Res UK, Lincolns Inn Fields Labs, London Res Inst, London, England; [Alonso, Maria] Marie Curie Res Inst, Mol Motors Grp, Oxted RH8 0TL, Surrey, England; [Samora, Catarina P.; Alonso, Maria; McAinsh, Andrew D.] Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Pennsylvania; Cancer Research UK; University of Warwick	Meraldi, P (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	a.d.mcainsh@warwick.ac.uk; patrick.meraldi@bc.biol.ethz.ch	Meraldi, Patrick/D-6190-2013; McAinsh, Andrew/C-6438-2012	Meraldi, Patrick/0000-0001-9742-8756; McAinsh, Andrew/0000-0001-6808-0711	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083988, R01 GM083988-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; HUGHES AF, 1948, J EXP BIOL, V25, P45; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; LEWIS WH, 1939, SCIENCE, V89, P400; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu J, 2008, P NATL ACAD SCI USA, V105, P13752, DOI 10.1073/pnas.0807007105; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; McClelland SE, 2009, METHODS MOL BIOL, V545, P81, DOI 10.1007/978-1-60327-993-2_5; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Pereira AL, 2006, MOL BIOL CELL, V17, P4526, DOI 10.1091/mbc.E06-07-0579; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; SALMON ED, 1980, J CELL BIOL, V86, P355, DOI 10.1083/jcb.86.2.355; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schuyler SC, 2002, METHOD ENZYMOL, V351, P150; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	61	110	110	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2010	12	4					319	U42		10.1038/ncb2033	http://dx.doi.org/10.1038/ncb2033			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577BI	20228811	Green Accepted			2022-12-25	WOS:000276194600005
J	Shepherd, M				Shepherd, Marv			Beef up international cooperation on counterfeits	NATURE MEDICINE			English	Editorial Material								Counterfeit drugs are a menacing and deadly problem worldwide. The proliferation of fake drugs is astounding, with over 100 countries reporting incidents of fake drugs, according to a 2008 report from the Pharmaceutical Security Institute. And incidents of drug counterfeiting show no evidence of declining: some industry insiders suggest that the number of counterfeit medicines on the market has increased as much as 25% each year over the past several years.	[Shepherd, Marv] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Shepherd, Marv] A Vienna, Vienna, Austria	University of Texas System; University of Texas Austin	Shepherd, M (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.								0	13	13	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2010	16	4					366	366		10.1038/nm0410-366	http://dx.doi.org/10.1038/nm0410-366			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	580KJ	20376036				2022-12-25	WOS:000276446800028
J	Cho, MH; Boutaoui, N; Klanderman, BJ; Sylvia, JS; Ziniti, JP; Hersh, CP; DeMeo, DL; Hunninghake, GM; Litonjua, AA; Sparrow, D; Lange, C; Won, S; Murphy, JR; Beaty, TH; Regan, EA; Make, BJ; Hokanson, JE; Crapo, JD; Kong, XY; Anderson, WH; Tal-Singer, R; Lomas, DA; Bakke, P; Gulsvik, A; Pillai, SG; Silverman, EK				Cho, Michael H.; Boutaoui, Nadia; Klanderman, Barbara J.; Sylvia, Jody S.; Ziniti, John P.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Sparrow, David; Lange, Christoph; Won, Sungho; Murphy, James R.; Beaty, Terri H.; Regan, Elizabeth A.; Make, Barry J.; Hokanson, John E.; Crapo, James D.; Kong, Xiangyang; Anderson, Wayne H.; Tal-Singer, Ruth; Lomas, David A.; Bakke, Per; Gulsvik, Amund; Pillai, Sreekumar G.; Silverman, Edwin K.			Variants in FAM13A are associated with chronic obstructive pulmonary disease	NATURE GENETICS			English	Article							GENE-EXPRESSION	We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD) in three population cohorts, including 2,940 cases and 1,380 controls who were current or former smokers with normal lung function. We identified a new susceptibility locus at 4q22.1 in FAM13A and replicated this association in one case-control group (n = 1,006) and two family-based cohorts (n = 3,808) (rs7671167, combined P = 1.2 x 10(-11), combined odds ratio in case-control studies 0.76, 95% confidence interval 0.69-0.83).	[Cho, Michael H.; Boutaoui, Nadia; Klanderman, Barbara J.; Sylvia, Jody S.; Ziniti, John P.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Cho, Michael H.; Hersh, Craig P.; DeMeo, Dawn L.; Hunninghake, Gary M.; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Sparrow, David] Vet Adm Boston Healthcare Syst, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lange, Christoph; Won, Sungho] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Murphy, James R.; Regan, Elizabeth A.; Make, Barry J.; Crapo, James D.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Beaty, Terri H.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Hokanson, John E.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Kong, Xiangyang; Tal-Singer, Ruth] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA; [Anderson, Wayne H.; Pillai, Sreekumar G.] GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA; [Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Bakke, Per; Gulsvik, Amund] Haukeland Hosp, N-5021 Bergen, Norway; [Bakke, Per; Gulsvik, Amund] Univ Bergen, Inst Med, Bergen, Norway	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; National Jewish Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; GlaxoSmithKline; GlaxoSmithKline; University of Cambridge; University of Bergen	Cho, MH (corresponding author), Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	remhc@channing.harvard.edu	Tal-Singer, Ruth/AAQ-2925-2021	Tal-Singer, Ruth/0000-0002-5275-8062; Kong, xiangyang/0000-0001-8184-2493; Litonjua, Augusto/0000-0003-0422-5875; Regan, Elizabeth/0000-0003-0624-9184	US National Institutes of Health (NIH) [R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856, K12HL089990, U01 HL089897]; National Heart, Lung, and Blood Institute; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality; US Department of Veterans Affairs; GlaxoSmithKline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL089990, U01HL089856, K08HL092222, R01HL075478, U01HL089897, P01HL083069, R01HL084323] Funding Source: NIH RePORTER; Medical Research Council [G0500306] Funding Source: researchfish; MRC [G0500306] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Veterans Affairs(US Department of Veterans Affairs); GlaxoSmithKline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by US National Institutes of Health (NIH) grants R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856 (E. K. S.), K12HL089990 (M. H. C) and U01 HL089897 (J.D.C.). The National Emphysema Treatment Trial was supported by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/ERIC of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The Norway cohort, the ECLIPSE study (Clinicaltrials.gov identifier NCT00292552; GSK Code SCO104960) and the ICGN study are funded by GlaxoSmithKline.	BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cohen M, 2004, GENOMICS, V84, P374, DOI 10.1016/j.ygeno.2004.03.005; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wade KC, 2006, AM J RESP CELL MOL, V34, P727, DOI 10.1165/rcmb.2004-0389OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC	15	283	292	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					200	202		10.1038/ng.535	http://dx.doi.org/10.1038/ng.535			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20173748	Green Accepted			2022-12-25	WOS:000274912400006
J	Girirajan, S; Rosenfeld, JA; Cooper, GM; Antonacci, F; Siswara, P; Itsara, A; Vives, L; Walsh, T; McCarthy, SE; Baker, C; Mefford, HC; Kidd, JM; Browning, SR; Browning, BL; Dickel, DE; Levy, DL; Ballif, BC; Platky, K; Farber, DM; Gowans, GC; Wetherbee, JJ; Asamoah, A; Weaver, DD; Mark, PR; Dickerson, J; Garg, BP; Ellingwood, SA; Smith, R; Banks, VC; Smith, W; McDonald, MT; Hoo, JJ; French, BN; Hudson, C; Johnson, JP; Ozmore, JR; Moeschler, JB; Surti, U; Escobar, LF; El-Khechen, D; Gorski, JL; Kussmann, J; Salbert, B; Lacassie, Y; Biser, A; McDonald-McGinn, DM; Zackai, EH; Deardorff, MA; Shaikh, TH; Haan, E; Friend, KL; Fichera, M; Romano, C; Gecz, J; DeLisi, LE; Sebat, J; King, MC; Shaffer, LG; Eichler, EE				Girirajan, Santhosh; Rosenfeld, Jill A.; Cooper, Gregory M.; Antonacci, Francesca; Siswara, Priscillia; Itsara, Andy; Vives, Laura; Walsh, Tom; McCarthy, Shane E.; Baker, Carl; Mefford, Heather C.; Kidd, Jeffrey M.; Browning, Sharon R.; Browning, Brian L.; Dickel, Diane E.; Levy, Deborah L.; Ballif, Blake C.; Platky, Kathryn; Farber, Darren M.; Gowans, Gordon C.; Wetherbee, Jessica J.; Asamoah, Alexander; Weaver, David D.; Mark, Paul R.; Dickerson, Jennifer; Garg, Bhuwan P.; Ellingwood, Sara A.; Smith, Rosemarie; Banks, Valerie C.; Smith, Wendy; McDonald, Marie T.; Hoo, Joe J.; French, Beatrice N.; Hudson, Cindy; Johnson, John P.; Ozmore, Jillian R.; Moeschler, John B.; Surti, Urvashi; Escobar, Luis F.; El-Khechen, Dima; Gorski, Jerome L.; Kussmann, Jennifer; Salbert, Bonnie; Lacassie, Yves; Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.; Haan, Eric; Friend, Kathryn L.; Fichera, Marco; Romano, Corrado; Gecz, Jozef; DeLisi, Lynn E.; Sebat, Jonathan; King, Mary-Claire; Shaffer, Lisa G.; Eichler, Evan E.			A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATIONS; COMORBID SCHIZOPHRENIA; CHROMOSOMAL IMBALANCE; LEARNING-DISABILITY; MENTAL-RETARDATION; DELETION SYNDROME; INCREASE RISK; COSTA-RICA; ARRAY CGH	We report the identification of a recurrent, 520-kb 16p12.1 microdeletion associated with childhood developmental delay. The microdeletion was detected in 20 of 11,873 cases compared with 2 of 8,540 controls (P = 0.0009, OR = 7.2) and replicated in a second series of 22 of 9,254 cases compared with 6 of 6,299 controls (P = 0.028, OR = 2.5). Most deletions were inherited, with carrier parents likely to manifest neuropsychiatric phenotypes compared to non-carrier parents (P = 0.037, OR = 6). Probands were more likely to carry an additional large copy-number variant when compared to matched controls (10 of 42 cases, P = 5.7 x 10(-5), OR = 6.6). The clinical features of individuals with two mutations were distinct from and/or more severe than those of individuals carrying only the co-occurring mutation. Our data support a two-hit model in which the 16p12.1 microdeletion both predisposes to neuropsychiatric phenotypes as a single event and exacerbates neurodevelopmental phenotypes in association with other large deletions or duplications. Analysis of other microdeletions with variable expressivity indicates that this two-hit model might be more generally applicable to neuropsychiatric disease.	[Girirajan, Santhosh; Cooper, Gregory M.; Antonacci, Francesca; Siswara, Priscillia; Itsara, Andy; Vives, Laura; Baker, Carl; Mefford, Heather C.; Kidd, Jeffrey M.; Dickel, Diane E.; King, Mary-Claire; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA USA; [Walsh, Tom; King, Mary-Claire] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [McCarthy, Shane E.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Browning, Sharon R.; Browning, Brian L.] Univ Auckland, Dept Stat, Fac Sci, Auckland 1, New Zealand; [Levy, Deborah L.] McLean Hosp, Psychol Res Lab, Belmont, MA 02178 USA; [Levy, Deborah L.; DeLisi, Lynn E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Platky, Kathryn; Gowans, Gordon C.; Wetherbee, Jessica J.; Asamoah, Alexander] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Farber, Darren M.] Univ Louisville, Sch Med, Dept Neurol, Div Child Neurol, Louisville, KY 40292 USA; [Weaver, David D.; Mark, Paul R.] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Dickerson, Jennifer; Garg, Bhuwan P.] Indiana Univ, Sch Med, Dept Neurol, Div Pediat Neurol, Indianapolis, IN 46202 USA; [Ellingwood, Sara A.; Smith, Rosemarie; Banks, Valerie C.; Smith, Wendy] Maine Med Ctr, Div Genet, Portland, ME 04102 USA; [McDonald, Marie T.] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA; [Hoo, Joe J.; French, Beatrice N.] Univ Toledo, Coll Med, Dept Pediat, Toledo, OH 43606 USA; [Hoo, Joe J.; French, Beatrice N.] NW Ohio Reg Genet Ctr, Toledo, OH USA; [Hudson, Cindy; Johnson, John P.] Shodair Childrens Hosp, Helena, MT USA; [Ozmore, Jillian R.; Moeschler, John B.] Dartmouth Hitchcock Med Ctr, Div Clin Genet, Lebanon, NH 03766 USA; [Surti, Urvashi] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA; [Escobar, Luis F.; El-Khechen, Dima] St Vincent Childrens Hosp, Med Genet & Neurodev Ctr, Indianapolis, IN USA; [Gorski, Jerome L.; Kussmann, Jennifer] Univ Missouri, Div Med Genet, Columbia, MO USA; [Salbert, Bonnie] Geisinger Med Ctr, Danville, PA 17822 USA; [Lacassie, Yves] Louisiana State Univ, Hlth Sci Ctr, Div Genet, Dept Pediat, New Orleans, LA USA; [Lacassie, Yves] Childrens Hosp, New Orleans, LA USA; [Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.] Univ Penn, Dept Pediat & Genet, Philadelphia, PA 19104 USA; [Biser, Alisha; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Deardorff, Matthew A.; Shaikh, Tamim H.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Haan, Eric] S Australian Pathol Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia; [Haan, Eric; Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Fichera, Marco; Romano, Corrado] Oasi Inst Res & Care Mental Retardat & Brain Ag, Troina, Italy; [DeLisi, Lynn E.] VA Boston Healthcare Syst, Brockton, MA USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cold Spring Harbor Laboratory; University of Auckland; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Louisville; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Maine Medical Center; Duke University; University System of Ohio; University of Toledo; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Columbia; Geisinger Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Adelaide; IRCCS Oasi Maria SS; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Mark, Paul/AAK-2153-2020; McDonald-McGinn, Donna/L-8643-2019; Cooper, Gregory/D-6914-2011; Romano, Corrado/B-9695-2008; Fichera, Marco/K-9220-2016; Browning, Brian L/A-1178-2010; Antonacci, Francesca/F-5457-2013; Gecz, Jozef/X-3469-2019; Browning, Sharon/B-1530-2008	Cooper, Gregory/0000-0001-5509-9923; Romano, Corrado/0000-0003-1049-0683; Fichera, Marco/0000-0002-8225-6880; Browning, Brian L/0000-0001-6454-6633; Antonacci, Francesca/0000-0002-5833-6186; Gecz, Jozef/0000-0002-7884-6861; Browning, Sharon/0000-0001-7251-9715; Dickel, Diane/0000-0001-5497-6824; Walsh, Tom/0000-0002-8875-0310; Sebat, Jonathan/0000-0002-9087-526X; Kidd, Jeffrey/0000-0002-9631-1465; King, Mary-Claire/0000-0001-9426-1743; McDonald-McGinn, Donna/0000-0003-4077-250X; Mark, Paul R./0000-0002-1020-888X	National Institute on Aging, National Heart, Lung, and Blood Institute, National Institutes of Health; Department of Health and Human Services; NIH [HD065285]; Simons Foundation [SFARI 137578]; NARSAD Award; Merck, Jane Coffin Childs Memorial Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institute on Aging, National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH National Institute on Aging (NIA)); Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NARSAD Award(NARSAD); Merck, Jane Coffin Childs Memorial Fund(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the subjects and their families for participating in this study. We thank M. Whyte for providing cardiological evaluation (for case SG07). We thank A. Singleton, L. Ferrucci and R. Krauss for sharing the control CNV data generated with support from the Intramural Research Program of the National Institute on Aging, National Heart, Lung, and Blood Institute (PARC project), and the National Institutes of Health, Department of Health and Human Services. For the schizophrenia study, genotyping of samples was also provided through the genetic association information network (GAIN). Samples and associated phenotype data for the genome-wide association of schizophrenia study were provided by the Molecular Genetics of Schizophrenia Collaboration (principal investigator: P. V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, Illinois, USA). We also thank J. Smith for SNP genotyping; T. Louie for bioinformatics support; C. Campbell, L. Perez-Jurado, G. Kirov, M. K. Rudd and C. Lese-Martin for useful discussions; and T. Brown, P. Sudmant and J. Kitzman for critical review of the manuscript. This work was supported by NIH grant HD065285 (E. E. E.), a grant from the Simons Foundation (SFARI 137578 to E. E. E.) and a NARSAD Award (M.-C. K.). G. M. C. is supported by a Merck, Jane Coffin Childs Memorial Fund post-doctoral fellowship. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; DeLisi LE, 2001, PSYCHIATR GENET, V11, P145, DOI 10.1097/00041444-200109000-00006; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eichler EE, 2001, J HERED, V92, P462, DOI 10.1093/jhered/92.6.462; Feenstra I, 2006, EUR J MED GENET, V49, P279, DOI 10.1016/j.ejmg.2005.10.131; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LINDGREN V, 1992, AM J HUM GENET, V50, P988; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Mao X, 2003, GENE CHROMOSOME CANC, V37, P176, DOI 10.1002/gcc.10184; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Moorhead TWJ, 2004, NEUROIMAGE, V22, P188, DOI 10.1016/j.neuroimage.2003.12.012; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; TURNER TH, 1989, PSYCHOL MED, V19, P301, DOI 10.1017/S0033291700012344; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	46	444	454	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					203	U24		10.1038/ng.534	http://dx.doi.org/10.1038/ng.534			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20154674	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000274912400007
J	Carlson, R				Carlson, Robert			The changing economics of DNA synthesis	NATURE BIOTECHNOLOGY			English	Article							CHEMICAL-SYNTHESIS; GENE; CLONING; PLASMID		Biodesic, Seattle, WA USA		Carlson, R (corresponding author), Biodesic, Seattle, WA USA.	rob@biodesic.com		Carlson, Robert/0000-0001-8696-8386				BOROKOV A, 2008, SYNBUILD ACCURATE HI; CARLSON R, BIOL TECHNO IN PRESS; Carlson R, 2009, NAT BIOTECHNOL, V27, P984, DOI 10.1038/nbt1109-984a; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Carlson Robert, 2007, Syst Synth Biol, V1, P109, DOI 10.1007/s11693-007-9010-z; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Garfinkel M.S., 2007, SYNTHETIC GENOMICS O; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; KEASLING JD, 2008, I SYST BIOL 7 ANN IN; KHORANA HG, 1979, SCIENCE, V203, P614, DOI 10.1126/science.366749; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; MANDECKI W, 1990, GENE, V94, P103, DOI 10.1016/0378-1119(90)90474-6; Newcomb J, 2007, GENOME SYNTHESIS DES; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151	17	106	116	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1091	1094		10.1038/nbt1209-1091	http://dx.doi.org/10.1038/nbt1209-1091			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010582				2022-12-25	WOS:000272708300018
J	Noble, WS				Noble, William S.			How does multiple testing correction work?	NATURE BIOTECHNOLOGY			English	Article							SEQUENCES; GENOME	When prioritizing hits from a high-throughput experiment, it is important to correct for random events that falsely appear significant. How is this done and what methods should be used?	Univ Washington, Dept Comp Sci & Engn, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Noble, WS (corresponding author), Univ Washington, Dept Comp Sci & Engn, Dept Genome Sci, Seattle, WA 98195 USA.	william-noble@u.washington.edu			National Institutes of Health [P41 RR0011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health award P41 RR0011823.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dudoit S, 2008, SPRINGER SER STAT, P1; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Staden R, 1994, Methods Mol Biol, V25, P93; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346	9	414	419	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2009	27	12					1135	1137		10.1038/nbt1209-1135	http://dx.doi.org/10.1038/nbt1209-1135			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	531YC	20010596	Green Accepted, Bronze			2022-12-25	WOS:000272708300030
